compound_id,name,comment,sequence,type,brite,glycan_ids
C00001,H2O;|Water,,,,"Therapeutic category of drugs in Japan [BR:br08301(D00001)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|713  Solvents|7131  Purified water|D00001  Water (JP18/USP); Purified water (JP18); Purified water in containers (JP18); Water, purified (USP); Sterile purified water in containers (JP18); Water for injection (JP18); Water for injection in containers (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00001)]|Third-class OTC drugs|Inorganic and organic chemicals|Water|D00001  Water (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00001)]|Chemicals|D00001  Water|D00001  Purified water|D00001  Purified water in containers|D00001  Sterile purified Water in containers|D00001  Water for injection|D00001  Sterile water for injection in containers",
C00002,ATP;|Adenosine 5'-triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00002  ATP|Vitamins and cofactors|Cofactors|Coenzymes|C00002  ATP|Glycosides [BR:br08021]|N-glycosides|C00002  ATP|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08646)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB10 Adenosine|D08646  Triphosadenine (DCF)|Risk category of Japanese OTC drugs [BR:br08312(D08646)]|Second-class OTC drugs|Inorganic and organic chemicals|Adenosinetriphosphoric acid|D08646  Triphosadenine (DCF)|Target-based classification of drugs [BR:br08310(D08646)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA|D08646  Triphosadenine (DCF),
C00003,NAD+;|NAD;|Nicotinamide adenine dinucleotide;|DPN;|Diphosphopyridine nucleotide;|Nadide;|beta-NAD+,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00003  NAD|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00002)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA01 Nicotinamide|D00002  Nadide (JAN/USAN/INN),
C00004,NADH;|DPNH;|Reduced nicotinamide adenine dinucleotide,,,,,
C00005,NADPH;|TPNH;|Reduced nicotinamide adenine dinucleotide phosphate,,,,,
C00006,NADP+;|NADP;|Nicotinamide adenine dinucleotide phosphate;|beta-Nicotinamide adenine dinucleotide phosphate;|TPN;|Triphosphopyridine nucleotide;|beta-NADP+,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00006  NADP,
C00007,Oxygen;|O2,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00003)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AN Medical gases|V03AN01 Oxygen|D00003  Oxygen (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00003)]|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00003  Oxygen (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00003)]|Chemicals|D00003  Oxygen,
C00008,ADP;|Adenosine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00008  ADP|Glycosides [BR:br08021]|N-glycosides|C00008  ADP,G11113
C00009,Orthophosphate;|Phosphate;|Phosphoric acid;|Orthophosphoric acid,,,,,
C00010,CoA;|Coenzyme A;|CoA-SH,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00010  CoA,
C00011,CO2;|Carbon dioxide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00004)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AN Medical gases|V03AN02 Carbon dioxide|D00004  Carbon dioxide (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00004)]|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00004  Carbon dioxide (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00004)]|Chemicals|D00004  Carbon dioxide,
C00012,Peptide,Generic compound in reaction hierarchy,,,,
C00013,Diphosphate;|Diphosphoric acid;|Pyrophosphate;|Pyrophosphoric acid;|PPi,,,,,
C00014,Ammonia;|NH3,,,,"Risk category of Japanese OTC drugs [BR:br08312(D02916)]|Third-class OTC drugs|Inorganic and organic chemicals|Ammonia solution, strong|D02916  Ammonia solution, strong (NF)",
C00015,UDP;|Uridine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00015  UDP,G10619
C00016,FAD;|Flavin adenine dinucleotide,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00016  FAD|Risk category of Japanese OTC drugs [BR:br08312(D00005)]|Third-class OTC drugs|Inorganic and organic chemicals|Flavin adenine dinucleotide|D00005  Flavin adenine dinucleotide (JAN),
C00017,Protein,Generic compound in reaction hierarchy,,,,
C00018,Pyridoxal phosphate;|Pyridoxal 5'-phosphate;|Pyridoxal 5-phosphate;|PLP,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00018  PLP|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA06 Pyridoxal phosphate|C00018  Pyridoxal phosphate,G00132
C00019,S-Adenosyl-L-methionine;|S-Adenosylmethionine;|AdoMet;|SAM,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00019  SAM,
C00020,AMP;|Adenosine 5'-monophosphate;|Adenylic acid;|Adenylate;|5'-AMP;|5'-Adenylic acid;|5'-Adenosine monophosphate;|Adenosine 5'-phosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00020  AMP|Glycosides [BR:br08021]|N-glycosides|C00020  AMP|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02769)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB10 Adenosine|D02769  Adenosine phosphate (USAN/INN)|Target-based classification of drugs [BR:br08310(D02769)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA|D02769  Adenosine phosphate (USAN/INN),
C00021,S-Adenosyl-L-homocysteine;|S-Adenosylhomocysteine,,,,,
C00022,Pyruvate;|Pyruvic acid;|2-Oxopropanoate;|2-Oxopropanoic acid;|Pyroracemic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00022  Pyruvate; 2-Oxopropanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00022  2-Oxopropanoic acid,
C00023,Iron,Iron and iron compounds|Usually existing as +2 or +3 cations|Iron(2+) [CPD:C14818]|Iron(3+) [CPD:C14819]|Iron-sulfur [CPD:C00824]|Heme [CPD:C00032],,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Crude drugs|Iron powder|C00023  Iron,
C00024,Acetyl-CoA;|Acetyl coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00024  Acetyl-CoA,
C00025,L-Glutamate;|L-Glutamic acid;|L-Glutaminic acid;|Glutamate,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00025  Glutamic acid (Glu)|Hormones and transmitters|Neurotransmitters|Amino acids|C00025  Glutamate|Risk category of Japanese OTC drugs [BR:br08312(D00007)]|Third-class OTC drugs|Inorganic and organic chemicals|Glutamic acid|D00007  Glutamic acid (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00007)]|Chemicals|D00007  L-Glutamic acid,
C00026,2-Oxoglutarate;|Oxoglutaric acid;|2-Ketoglutaric acid;|alpha-Ketoglutaric acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00026  2-Oxoglutarate,
C00027,Hydrogen peroxide;|H2O2;|Oxydol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00008)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB02 Hydrogen peroxide|D00008  Hydrogen peroxide (USP) &lt;JP&gt;|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AX Other antiseptics and disinfectants|D08AX01 Hydrogen peroxide|D00008  Hydrogen peroxide (USP) &lt;JP&gt;|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX25 Hydrogen peroxide|D00008  Hydrogen peroxide (USP) &lt;JP&gt;|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA06 Hydrogen peroxide|D00008  Hydrogen peroxide (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00008)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2614  Peroxides|D00008  Hydrogen peroxide (USP); Oxydol (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00008)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00008  Hydrogen peroxide (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00008)]|Third-class OTC drugs|Inorganic and organic chemicals|Oxydol|D00008  Hydrogen peroxide (USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C00027  Hydrogen peroxide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00008)]|Chemicals|D00008  Oxydol,
C00028,Acceptor;|Hydrogen-acceptor;|A;|Oxidized donor,Generic compound in reaction hierarchy,,,,
C00029,UDP-glucose;|UDPglucose;|UDP-D-glucose;|Uridine diphosphate glucose;|UDP-alpha-D-glucose,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00029  UDP-glucose,G10608
C00030,Reduced acceptor;|AH2;|Hydrogen-donor;|Donor,,,,,
C00031,D-Glucose;|Grape sugar;|Dextrose;|Glucose;|D-Glucopyranose,alpha-D-Glucose [CPD:C00267]|beta-D-Glucose [CPD:C00221],,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00031  D-Glucose|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00009)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CX Other irrigating solutions|B05CX01 Glucose|D00009  Glucose (JP18) &lt;JP&gt;|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CA Tests for diabetes|V04CA02 Glucose|D00009  Glucose (JP18) &lt;JP&gt;|V06 GENERAL NUTRIENTS|V06D OTHER NUTRIENTS|V06DC Carbohydrates|V06DC01 Glucose|D00009  Glucose (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00009)]|3  Agents affecting metabolism|32  Nutrients, tonics|323  Saccharide preparations|3231  Glucoses|D00009  Glucose (JP18); Purified glucose (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00009)]|Third-class OTC drugs|Inorganic and organic chemicals|Glucose|D00009  Glucose (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9641  Dextrose and preparations|C00031  D-Glucose|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00009)]|Chemicals|D00009  Glucose|D00009  Purified glucose|D00009  Glucose injection",
C00032,Heme;|Haem;|Protoheme;|Heme B;|Protoheme IX,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00032  Heme B,
C00033,Acetate;|Acetic acid;|Ethanoic acid,,,,"Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C00033  Acetate; Ethanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00033  Acetic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00010)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AD Organic acids|G01AD02 Acetic acid|D00010  Acetic acid, glacial (USP) &lt;JP/US&gt;|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA10 Acetic acid|D00010  Acetic acid, glacial (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00010)]|Antibacterials|Antibacterials, Other|Acetic Acid|D00010  Acetic acid, glacial (USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Acetic Acid|D00010  Acetic acid, glacial (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00010)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)|266  Emollients|2661  Organic acids|D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D00010  Acetic acid, glacial (USP); Acetic acid (JP18/NF); Glacial acetic acid (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00010)]|Third-class OTC drugs|Inorganic and organic chemicals|Acetic acid|D00010  Acetic acid, glacial (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00010)]|Chemicals|D00010  Acetic acid|D00010  Glacial acetic acid",
C00034,Manganese,Manganese and manganese compounds|Usually existing as +2 cations|Mn2+ [CPD:C19610],,,,
C00035,GDP;|Guanosine 5'-diphosphate;|Guanosine diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00035  GDP,G10620
C00036,Oxaloacetate;|Oxalacetic acid;|Oxaloacetic acid;|2-Oxobutanedioic acid;|2-Oxosuccinic acid;|keto-Oxaloacetate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00036  Oxaloacetate; 2-Oxosuccinate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00036  2-Oxobutanedioic acid,
C00037,Glycine;|Aminoacetic acid;|Gly,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00037  Glycine (Gly)|Hormones and transmitters|Neurotransmitters|Amino acids|C00037  Glycine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00011)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CX Other irrigating solutions|B05CX03 Glycine|D00011  Glycine (JP18/USP) &lt;US&gt;|Risk category of Japanese OTC drugs [BR:br08312(D00011)]|Third-class OTC drugs|Inorganic and organic chemicals|Glycine|D00011  Glycine (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00011)]|Chemicals|D00011  Glycine,
C00038,Zinc cation;|Zn2+;|Zn(II);|Zinc ion,,,,,
C00039,DNA;|DNAn;|DNAn+1;|(Deoxyribonucleotide)n;|(Deoxyribonucleotide)m;|(Deoxyribonucleotide)n+m;|Deoxyribonucleic acid,Generic compound in reaction hierarchy,,,,
C00040,Acyl-CoA;|Acyl coenzyme A,Generic compound in reaction hierarchy,,,,
C00041,L-Alanine;|L-2-Aminopropionic acid;|L-alpha-Alanine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00041  Alanine (Ala)|Risk category of Japanese OTC drugs [BR:br08312(D00012)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Alanine|D00012  Alanine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00012)]|Chemicals|D00012  L-Alanine,
C00042,Succinate;|Succinic acid;|Butanedionic acid;|Ethylenesuccinic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C00042  Succinate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00042  Butanedionic acid,
C00043,UDP-N-acetyl-alpha-D-glucosamine;|UDP-N-acetyl-D-glucosamine;|UDP-N-acetylglucosamine,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0101 Monoacylaminosugars|C00043  UDP-N-acetyl-alpha-D-glucosamine,G10610
C00044,GTP;|Guanosine 5'-triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00044  GTP,
C00045,Amino acid;|Amino acids,Generic compound in reaction hierarchy,,,,
C00046,RNA;|RNAn;|RNAn+1;|RNA(linear);|(Ribonucleotide)n;|(Ribonucleotide)m;|(Ribonucleotide)n+m;|Ribonucleic acid,Generic compound in reaction hierarchy,,,,
C00047,"L-Lysine;|Lysine acid;|2,6-Diaminohexanoic acid",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00047  Lysine (Lys)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02304)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XB Amino acids|B05XB03 Lysine|D02304  Lysine (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D02304)]|Third-class OTC drugs|Inorganic and organic chemicals|Lysine|D02304  Lysine (USAN/INN),
C00048,Glyoxylate;|Glyoxalate;|Glyoxylic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00048  Glyoxylate; Oxoacetate,
C00049,L-Aspartate;|L-Aspartic acid;|2-Aminosuccinic acid;|L-Asp,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00049  Aspartic acid (Asp)|Hormones and transmitters|Neurotransmitters|Amino acids|C00049  Aspartate|Risk category of Japanese OTC drugs [BR:br08312(D00013)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Aspartic acid|D00013  Aspartic acid (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00013)]|Chemicals|D00013  L-Aspartic acid,
C00051,Glutathione;|5-L-Glutamyl-L-cysteinylglycine;|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine;|gamma-L-Glutamyl-L-cysteinyl-glycine;|GSH;|Reduced glutathione,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00051  Glutathione|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00014)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB32 Glutathione|D00014  Glutathione (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00014)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3922  Glutathiones|D00014  Glutathione (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9676  Other amino acid and preparations|C00051  Glutathione|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00014)]|Chemicals|D00014  Glutathione,
C00052,UDP-alpha-D-galactose;|UDP-D-galactose;|UDP-galactose;|UDP-D-galactopyranose;|UDP-alpha-D-galactopyranose,,,,,G10609
C00053,3'-Phosphoadenylyl sulfate;|3'-Phosphoadenosine 5'-phosphosulfate;|3'-Phospho-5'-adenylyl sulfate;|PAPS,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00053  PAPS,
C00054,"Adenosine 3',5'-bisphosphate;|PAP;|3'-Phosphoadenylate;|Phosphoadenosine phosphate",,,,,
C00055,CMP;|Cytidine-5'-monophosphate;|Cytidylic acid,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00055  CMP|Glycosides [BR:br08021]|N-glycosides|C00055  CMP,G10621
C00058,Formate;|Methanoic acid;|Formic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C00058  Formate; Methanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00058  Formic acid,
C00059,Sulfate;|Sulfuric acid,,,,,
C00060,Carboxylate;|R-COOH;|Monocarboxylate;|Carboxylic acid,Generic compound in reaction hierarchy,,,,
C00061,FMN;|Riboflavin-5-phosphate;|Flavin mononucleotide,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00061  FMN|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Riboflavin sodium phosphate|C00061  FMN,
C00062,L-Arginine;|(S)-2-Amino-5-guanidinovaleric acid;|L-Arg,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00062  Arginine (Arg)|Risk category of Japanese OTC drugs [BR:br08312(D02982)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Arginine|D02982  Arginine (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02982)]|Chemicals|D02982  L-Arginine,
C00063,CTP;|Cytidine 5'-triphosphate;|Cytidine triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00063  CTP|Vitamins and cofactors|Cofactors|Coenzymes|C00063  CTP|Glycosides [BR:br08021]|N-glycosides|C00063  CTP,
C00064,L-Glutamine;|L-2-Aminoglutaramic acid,,,,"Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00064  Glutamine (Gln)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00015)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AA Amino acids and derivatives|A16AA03 Glutamine|D00015  Glutamine (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00015)]|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Glutamine|D00015  Glutamine (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00015)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2322  Glutamines|D00015  Glutamine (USP); L-Glutamine (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00015)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Glutamine|D00015  Glutamine (USP)|Drug groups [BR:br08330(D00015)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|D00015  Glutamine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00015)]|Chemicals|D00015  L-Glutamine|New drug approvals in the USA [br08319.html(D00015)]|New molecular entities and new therapeutic biological products|D00015|New drug approvals in the USA, Europe and Japan [br08328.html(D00015)]|Approval dates by FDA, EMA and PMDA|D00015",
C00065,L-Serine;|L-2-Amino-3-hydroxypropionic acid;|L-3-Hydroxy-alanine;|Serine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00065  Serine (Ser)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00016)]|Chemicals|D00016  L-Serine,
C00066,tRNA;|tRNA(n);|tRNA(n+1);|transfer RNA,Generic compound in reaction hierarchy,,,,
C00067,Formaldehyde;|Methanal;|Oxomethane;|Oxomethylene;|Methylene oxide;|Formalin,,,,Therapeutic category of drugs in Japan [BR:br08301(D00017)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2619  Others|D00017  Formaldehyde (USP); Formalin (JP18)|27  Dental preparations|273  Analgesics and sedatives|2730  Analgesics and sedatives|D00017  Formaldehyde (USP); Formalin (JP18)|7  Agents not mainly for therapeutic purpose|73  Public health agents|732  Germicides and disinfectants|7321  Alcohols and aldehydes|D00017  Formaldehyde (USP); Formalin (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00017)]|Agents for sanitation|81 Disinfectants|D00017  Formaldehyde (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00017)]|Drugs requiring guidance|Powerful drugs|Formalin|D00017  Formaldehyde (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00017)]|Chemicals|D00017  Formalin,
C00068,Thiamin diphosphate;|Thiamine diphosphate;|Thiamin pyrophosphate;|TPP;|ThPP,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00068  TPP,
C00069,Alcohol,Generic compound in reaction hierarchy,,,,
C00070,Copper,Copper and copper compounds|Usually existing as +1 or +2 cations|Copper(1+) [CPD:C22423]|Copper(2+) [CPD:C22424],,,,
C00071,Aldehyde;|RCHO,Generic compound in reaction hierarchy,,,,
C00072,Ascorbate;|Ascorbic acid;|L-Ascorbate;|L-Ascorbic acid;|Vitamin C,,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00072  Ascorbic acid (Vitamin C)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00018)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS|A11GA Ascorbic acid (vitamin C), plain|A11GA01 Ascorbic acid (vit C)|D00018  Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AD Organic acids|G01AD03 Ascorbic acid|D00018  Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA15 Ascorbic acid|D00018  Ascorbic acid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00018)]|Electrolytes/Minerals/Metals/Vitamins|Vitamins|Ascorbic Acid|D00018  Ascorbic acid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00018)]|3  Agents affecting metabolism|31  Vitamins|314  Vitamin C preparations|3140  Vitamin C preparations|D00018  Ascorbic acid (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00018)]|Nourishing tonics and health supplements|38 Vitamin C based drugs|D00018  Ascorbic acid (JP18/USP/INN)|41 Vitamin EC based drugs|D00018  Ascorbic acid (JP18/USP/INN)|43 Vitamin containing supplements|D00018  Ascorbic acid (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00018)]|Third-class OTC drugs|Inorganic and organic chemicals|Ascorbic acid|D00018  Ascorbic acid (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9624  Vitamin C and preparations|C00072  Ascorbate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00018)]|Chemicals|D00018  Ascorbic acid|D00018  Ascorbic acid powder|D00018  Ascorbic acid injection",
C00073,L-Methionine;|Methionine;|L-2-Amino-4methylthiobutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00073  Methionine (Met)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00019)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB26 Methionine|D00019  Methionine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00019)]|Third-class OTC drugs|Inorganic and organic chemicals|Methionine|D00019  Methionine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00019)]|Chemicals|D00019  L-Methionine,
C00074,Phosphoenolpyruvate;|Phosphoenolpyruvic acid;|PEP,,,,,
C00075,UTP;|Uridine 5'-triphosphate;|Uridine triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00075  UTP,
C00076,Calcium cation;|Ca2+;|Calcium(2+);|Calcium ion,,,,Classification of Japanese OTC drugs [BR:br08313]|Nourishing tonics and health supplements|44 Calcium based drugs|C00076  Calcium,
C00077,"L-Ornithine;|(S)-2,5-Diaminovaleric acid;|(S)-2,5-Diaminopentanoic acid;|(S)-2,5-Diaminopentanoate",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00077  L-Ornithine,
C00078,L-Tryptophan;|Tryptophan;|(S)-alpha-Amino-beta-(3-indolyl)-propionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00078  Tryptophan (Trp)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00020)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX02 Tryptophan|D00020  Tryptophan (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00020)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Tryptophan|D00020  Tryptophan (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00020)]|Chemicals|D00020  L-Tryptophan,
C00079,L-Phenylalanine;|(S)-alpha-Amino-beta-phenylpropionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00079  Phenylalanine (Phe)|Risk category of Japanese OTC drugs [BR:br08312(D00021)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Phenylalanine|D00021  Phenylalanine (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00021)]|Chemicals|D00021  L-Phenylalanine,
C00080,H+;|Hydron,,,,,
C00081,ITP;|Inosine 5'-triphosphate;|Inosine triphosphate;|Inosine tripolyphosphate,,,,Glycosides [BR:br08021]|N-glycosides|C00081  ITP,
C00082,L-Tyrosine;|(S)-3-(p-Hydroxyphenyl)alanine;|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid;|Tyrosine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00082  Tyrosine (Tyr)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00022)]|Chemicals|D00022  L-Tyrosine,
C00083,Malonyl-CoA;|Malonyl coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00083  Malonyl-CoA,
C00084,Acetaldehyde;|Ethanal,,,,,
C00085,D-Fructose 6-phosphate;|D-Fructose 6-phosphoric acid;|Neuberg ester,,,,,
C00086,Urea;|Carbamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00023)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05B I.V. SOLUTIONS|B05BC Solutions producing osmotic diuresis|B05BC02 Carbamide|D00023  Urea (JP18/USP) &lt;JP&gt;|D DERMATOLOGICALS|D02 EMOLLIENTS AND PROTECTIVES|D02A EMOLLIENTS AND PROTECTIVES|D02AE Carbamide products|D02AE01 Carbamide|D00023  Urea (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00023)]|2  Agents affecting individual organs|26  Epidermides|266  Emollients|2669  Others|D00023  Urea (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00023)]|Agents for integumentary system|59 Skin emollient (incl. pus extrusion)|D00023  Urea (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00023)]|Third-class OTC drugs|Inorganic and organic chemicals|Urea|D00023  Urea (JP18/USP)|Drug groups [BR:br08330(D00023)]|Dermatological agent|DG03243  Atopic dermatitis agent|D00023  Urea|Drug classes [BR:br08332(D00023)]|Dermatological agent|DG03243  Atopic dermatitis agent|D00023  Urea|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00023)]|Chemicals|D00023  Urea,
C00087,Sulfur;|S;|Elemental sulfur,usually forming a cyclooctasulfur(S8) molecule (CAS: 10544-50-0),,,"Pesticides [BR:br08007]|Pesticides|Fungicides|Inorganic fungicides|C00087  Sulfur|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00024)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AB Preparations containing sulfur|D10AB02 Sulfur|D00024  Sulfur, precipitated (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00024)]|2  Agents affecting individual organs|26  Epidermides|265  Antiparasitic dermatosis agents|2659  Others|D00024  Sulfur, precipitated (USP); Sulfur, sublimed (USP); Sulfur (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00024)]|Agents for integumentary system|56 Purulent skin remedies|D00024  Sulfur, precipitated (USP)|58 Ringworm drugs|D00024  Sulfur, precipitated (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00024)]|Third-class OTC drugs|Inorganic and organic chemicals|Sulfur|D00024  Sulfur, precipitated (USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C00087  Sulfur|954  Anti-dermoinfectives|9544  Sulfur compounds and preparations|C00087  Sulfur|956  Bath and disinfectants preparations|9561  Sulfur preparations, sulfide preparations|C00087  Sulfur|96  Agents affecting metabolism|965  Hemostatics|9659  Other hemostatics|C00087  Sulfur|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00024)]|Chemicals|D00024  Sulfur",
C00088,Nitrite,,,,,
C00089,Sucrose;|Cane sugar;|Saccharose;|1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside,,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C00089  Sucrose; Cane sugar|Therapeutic category of drugs in Japan [BR:br08301(D00025)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D00025  Sucrose (JP18/NF); White soft sugar (JP18); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF)|Risk category of Japanese OTC drugs [BR:br08312(D00025)]|Third-class OTC drugs|Inorganic and organic chemicals|White soft sugar|D00025  Sucrose (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00025)]|Chemicals|D00025  White soft sugar|D00025  Sucrose",G00370
C00090,"Catechol;|1,2-Benzenediol;|o-Benzenediol;|1,2-Dihydroxybenzene;|Brenzcatechin;|Pyrocatechol",,,,,
C00091,Succinyl-CoA;|Succinyl coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00091  Succinyl-CoA,
C00092,D-Glucose 6-phosphate;|Glucose 6-phosphate;|Robison ester,,,,,
C00093,sn-Glycerol 3-phosphate;|Glycerophosphoric acid;|D-Glycerol 1-phosphate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium glycerophosphate|C00093  sn-Glycerol 3-phosphate,
C00094,Sulfite;|Sulfurous acid,Bisulfite (conjugate base) [CPD:C11481],,,,
C00095,D-Fructose;|Levulose;|Fruit sugar;|D-arabino-Hexulose,D-Fructose (pyranose) [CPD:C05003]|D-Fructose (open-chain) [CPD:C10906]|L-Fructose [CPD:C01719],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00095  D-Fructose; Fruit sugar|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9642  Fructose and preparations|C00095  D-Fructose,
C00096,GDP-mannose;|GDP-D-mannose;|GDP-alpha-D-mannose,,,,,G10614
C00097,L-Cysteine;|L-2-Amino-3-mercaptopropionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00097  Cysteine (Cys)|Therapeutic category of drugs in Japan [BR:br08301(D00026)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00026  L-Cysteine (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00026)]|Nourishing tonics and health supplements|45 Protein and amino acid based drugs|D00026  L-Cysteine (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00026)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Cysteine|D00026  L-Cysteine (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00026)]|Chemicals|D00026  L-Cysteine,
C00098,Oligopeptide,,,,,
C00099,beta-Alanine;|3-Aminopropionic acid;|3-Aminopropanoate,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00099  beta-Alanine|Amines|Biogenic amines|C00099  beta-Alanine,
C00100,Propanoyl-CoA;|Propionyl-CoA;|Propionyl coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00100  Propanoyl-CoA,
C00101,"Tetrahydrofolate;|5,6,7,8-Tetrahydrofolate;|Tetrahydrofolic acid;|THF;|(6S)-Tetrahydrofolate;|(6S)-Tetrahydrofolic acid;|(6S)-THFA",,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00101  THF,
C00102,"2,6-Dichloroindophenol;|2,6-Dichlorophenolindophenol;|DCIP",,,,,
C00103,D-Glucose 1-phosphate;|alpha-D-Glucose 1-phosphate;|Cori ester;|D-Glucose alpha-1-phosphate,,,,,
C00104,IDP;|Inosine 5'-diphosphate;|Inosine diphosphate,,,,Glycosides [BR:br08021]|N-glycosides|C00104  IDP,
C00105,UMP;|Uridylic acid;|Uridine monophosphate;|Uridine 5'-monophosphate;|5'Uridylic acid;|Uridylate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00105  UMP,
C00106,Uracil,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Bases|Pyrimidines|C00106  Uracil (Ura),
C00107,Dipeptide,,,,,
C00108,Anthranilate;|Anthranilic acid;|o-Aminobenzoic acid;|Vitamin L1;|2-Aminobenzoate,,,,,
C00109,2-Oxobutanoate;|2-Ketobutyric acid;|2-Oxobutyric acid;|2-Oxobutyrate;|2-Oxobutanoic acid;|alpha-Ketobutyric acid;|alpha-Ketobutyrate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00109  2-Oxobutanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00109  2-Oxobutanoic acid,
C00110,Dolichyl phosphate;|Dolichol phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C00110  Dolichyl phosphate,G10622
C00111,Glycerone phosphate;|Dihydroxyacetone phosphate;|3-Hydroxy-2-oxopropyl phosphate,,,,,
C00112,CDP;|Cytidine 5'-diphosphate;|Cytidine diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00112  CDP,
C00113,"PQQ;|Pyrrolo-quinoline quinone;|Pyrroloquinoline-quinone;|Pyrroloquinoline quinone;|4,5-Dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylate;|Methoxatin",,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00113  PQQ,
C00114,Choline;|Bilineurine,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C00114  Choline|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Choline|C00114  Choline,
C00116,"Glycerol;|Glycerin;|1,2,3-Trihydroxypropane;|1,2,3-Propanetriol",,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar alcohols|C00116  Glycerol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00028)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AG Enemas|A06AG04 Glycerol|D00028  Glycerin (JP18/USP) &lt;JP&gt;|A06AX Other drugs for constipation|A06AX01 Glycerol|D00028  Glycerin (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00028)]|2  Agents affecting individual organs|23  Digestive organ agents|235  Purgatives, clysters|2357  Glycerins|D00028  Glycerin (JP18/USP); Concentrated glycerin (JP18); Glycerin, concentrated (JAN); Glycerol (INN)|Classification of Japanese OTC drugs [BR:br08313(D00028)]|Agents for digestive organs|18 Enema|D00028  Glycerin (JP18/USP)|Agents for integumentary system|55 Chilblain and chap remedies|D00028  Glycerin (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00028)]|Second-class OTC drugs|Inorganic and organic chemicals|Glycerin|D00028  Glycerin (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Glycerin|D00028  Glycerin (JP18/USP)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|937  Clysters|9371  Glycerine and preparations|C00116  Glycerine|Drug groups [BR:br08330(D00028)]|Gastrointestinal agent|DG01770  Laxative|D00028  Glycerin|Drug classes [BR:br08332(D00028)]|Gastrointestinal agent|DG01770  Laxative|D00028  Glycerin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00028)]|Chemicals|D00028  Glycerin|D00028  Concentrated glycerin",
C00117,D-Ribose 5-phosphate;|Ribose 5-phosphate,,,,,
C00118,D-Glyceraldehyde 3-phosphate;|(2R)-2-Hydroxy-3-(phosphonooxy)-propanal;|Glyceraldehyde 3-phosphate,,,,,
C00119,5-Phospho-alpha-D-ribose 1-diphosphate;|5-Phosphoribosyl diphosphate;|5-Phosphoribosyl 1-pyrophosphate;|PRPP,,,,,
C00120,Biotin;|D-Biotin;|Vitamin H;|Coenzyme R,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00120  Biotin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00029)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA05 Biotin|D00029  Biotin (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00029)]|3  Agents affecting metabolism|31  Vitamins|319  Miscellaneous vitamins|3190  Miscellaneous vitamins|D00029  Biotin (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00029)]|Third-class OTC drugs|Inorganic and organic chemicals|Biotin|D00029  Biotin (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00029)]|Chemicals|D00029  Biotin,
C00121,D-Ribose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00121  D-Ribose,
C00122,Fumarate;|Fumaric acid;|trans-Butenedioic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02308)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AX Other antipsoriatics for topical use|D05AX01 Fumaric acid|D02308  Fumaric acid (NF),
C00123,L-Leucine;|2-Amino-4-methylvaleric acid;|(2S)-alpha-2-Amino-4-methylvaleric acid;|(2S)-alpha-Leucine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00123  Leucine (Leu)|Risk category of Japanese OTC drugs [BR:br08312(D00030)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Leucine|D00030  Leucine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00030)]|Chemicals|D00030  L-Leucine,
C00124,D-Galactose;|D-Galactopyranose,Galactose [CPD:C01582]|L-Galactose [CPD:C01825]|alpha-D-Galactose [CPD:C00984]|beta-D-Galactose [CPD:C00962],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00124  D-Galactose,
C00125,Ferricytochrome c;|Cytochrome c3+,Heme type: Heme C [CPD:C15817],,,,
C00126,Ferrocytochrome c;|Cytochrome c2+;|Reduced cytochrome c,Heme type: Heme C [CPD:C15817],,,,
C00127,Glutathione disulfide;|GSSG;|Oxiglutatione;|Oxidized glutathione,,,,Therapeutic category of drugs in Japan [BR:br08301(D00031)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00031  Oxiglutatione (JAN/INN),
C00128,CMP-N-acetylneuraminate;|CMP-N-acetyl-beta-neuraminate,,,,,G10616
C00129,Isopentenyl diphosphate;|Delta3-Isopentenyl diphosphate;|Delta3-Methyl-3-butenyl diphosphate;|3-Methylbut-3-en-1-yl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0101 C5 isoprenoids (hemiterpenes)|C00129  Isopentenyl diphosphate,
C00130,IMP;|Inosinic acid;|Inosine monophosphate;|Inosine 5'-monophosphate;|Inosine 5'-phosphate;|5'-Inosinate;|5'-Inosinic acid;|5'-Inosine monophosphate;|5'-IMP,,,,Glycosides [BR:br08021]|N-glycosides|C00130  IMP,
C00131,dATP;|2'-Deoxyadenosine 5'-triphosphate;|Deoxyadenosine 5'-triphosphate;|Deoxyadenosine triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00131  dATP,
C00132,Methanol;|Methyl alcohol;|CH3OH,,,,,
C00133,D-Alanine;|D-2-Aminopropionic acid;|D-Ala,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00133  D-Alanine,
C00134,"Putrescine;|1,4-Butanediamine;|1,4-Diaminobutane;|Tetramethylenediamine;|Butane-1,4-diamine",,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C00134  Putrescine,
C00135,L-Histidine;|(S)-alpha-Amino-1H-imidazole-4-propionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00135  Histidine (His)|Risk category of Japanese OTC drugs [BR:br08312(D00032)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Histidine|D00032  Histidine (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00032)]|Chemicals|D00032  L-Histidine|D00032  L-Histidine hydrochloride hydrate,
C00136,Butanoyl-CoA;|Butyryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00136  Butanoyl-CoA,
C00137,myo-Inositol;|D-myo-Inositol;|1D-myo-Inositol;|L-myo-Inositol;|1L-myo-Inositol;|meso-Inositol;|Inositol;|Dambose;|Cyclohexitol;|Meat sugar;|Bios I,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar alcohols|C00137  myo-Inositol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08079)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA07 Inositol|D08079  Inositol (NF)|Risk category of Japanese OTC drugs [BR:br08312(D08079)]|Third-class OTC drugs|Inorganic and organic chemicals|Inositol|D08079  Inositol (NF),
C00140,N-Acetyl-D-glucosamine;|N-Acetylchitosamine;|2-Acetamido-2-deoxy-D-glucose;|GlcNAc,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C00140  N-Acetyl-D-glucosamine,
C00141,3-Methyl-2-oxobutanoic acid;|3-Methyl-2-oxobutyric acid;|3-Methyl-2-oxobutanoate;|2-Oxo-3-methylbutanoate;|2-Oxoisovalerate;|2-Oxoisopentanoate;|alpha-Ketovaline;|2-Ketovaline;|2-Keto-3-methylbutyric acid;|alpha-Ketoisovalerate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00141  2-Oxoisovalerate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C00141  3-Methyl-2-oxobutanoic acid,
C00143,"5,10-Methylenetetrahydrofolate;|(6R)-5,10-Methylenetetrahydrofolate;|5,10-Methylene-THF",,,,,
C00144,GMP;|Guanosine 5'-phosphate;|Guanosine monophosphate;|Guanosine 5'-monophosphate;|Guanylic acid,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Ribonucleotides|C00144  GMP,
C00145,Thiol;|Mercaptan,Generic compound in reaction hierarchy,,,,
C00146,Phenol;|Benzenol;|Hydroxybenzene;|Phenic acid;|Phenylic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00033)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05B ANTIVARICOSE THERAPY|C05BB Sclerosing agents for local injection|C05BB05 Phenol|D00033  Phenol (JP18/USP) &lt;JP&gt;|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AE Phenol and derivatives|D08AE03 Phenol|D00033  Phenol (JP18/USP) &lt;JP&gt;|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BX Other local anesthetics|N01BX03 Phenol|D00033  Phenol (JP18/USP) &lt;JP&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA19 Phenol|D00033  Phenol (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00033)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|255  Hemorrhoidal preparations|2559  Others|D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18)|26  Epidermides|261  Antimicrobial agents|2619  Others|D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18)|27  Dental preparations|273  Analgesics and sedatives|2730  Analgesics and sedatives|D00033  Phenol (JP18/USP); Liquefied phenol (JP18); Phenol for disinfection (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00033)]|Agents for otolaryngologic use|71 Ear drops|D00033  Phenol (JP18/USP)|Agents for dental and stomatological use|75 Toothache and pyorrhea remedies|D00033  Phenol (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00033)]|Second-class OTC drugs|Inorganic and organic chemicals|Phenol|D00033  Phenol (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C00146  Phenol|Drug groups [BR:br08330(D00033)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG00301  Phenol|D00033  Phenol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00033)]|Chemicals|D00033  Phenol|D00033  Liquefied phenol|D00033  Phenol for disinfection",
C00147,Adenine;|6-Aminopurine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Bases|Purines|C00147  Adenine (Ade)|Therapeutic category of drugs in Japan [BR:br08301(D00034)]|4  Agents affecting cellular function|41  Cellular function activating agents|419  Miscellaneous|4191  Adenines|D00034  Adenine (JAN/USP),
C00148,L-Proline;|2-Pyrrolidinecarboxylic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00148  Proline (Pro)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00035)]|Chemicals|D00035  L-Proline,
C00149,(S)-Malate;|L-Malate;|L-Apple acid;|L-Malic acid;|L-2-Hydroxybutanedioic acid;|Malate;|Malic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Hydroxycarboxylic acids|C00149  Malate; (S)-2-Hydroxybutanediate,
C00150,Molybdenum,Molybdenum and molybdenum compounds|Usually existing as molybdate [CPD:C06232],,,,
C00151,L-Amino acid;|L-2-Amino acid,Generic compound in reaction hierarchy,,,,
C00152,L-Asparagine;|2-Aminosuccinamic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00152  Asparagine (Asn),
C00153,Nicotinamide;|Nicotinic acid amide;|Niacinamide;|Vitamin PP,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00153  Nicotinamide (Vitamin B3)|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C00153  Nicotinamide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00036)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA01 Nicotinamide|D00036  Niacinamide (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00036)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3132  Nicotinic acids|D00036  Niacinamide (USP); Nicotinamide (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00036)]|Agents for otolaryngologic use|72 Other agents for otolaryngologic use|D00036  Niacinamide (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00036)]|Third-class OTC drugs|Inorganic and organic chemicals|Nicotinamide|D00036  Niacinamide (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00036)]|Chemicals|D00036  Nicotinamide,
C00154,Palmitoyl-CoA;|Hexadecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00154  Hexadecanoyl-CoA,
C00155,L-Homocysteine;|L-2-Amino-4-mercaptobutyric acid;|Homocysteine,Homocysteine (generic) [CPD:C05330],,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00155  L-Homocysteine,
C00156,4-Hydroxybenzoate;|Hydroxybenzoic acid;|4-Hydroxybenzoic acid;|Hydroxybenzenecarboxylic acid,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C00156,
C00157,"Phosphatidylcholine;|Lecithin;|Phosphatidyl-N-trimethylethanolamine;|1,2-Diacyl-sn-glycero-3-phosphocholine;|Choline phosphatide;|3-sn-Phosphatidylcholine",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C00157  Phosphatidylcholine; Lecithin|Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C00157  1,2-Diacyl-sn-glycero-3-phosphocholine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C00157  Phosphatidylcholine",
C00158,"Citrate;|Citric acid;|2-Hydroxy-1,2,3-propanetricarboxylic acid;|2-Hydroxytricarballylic acid",,,,"Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Tricarboxylic acids|C00158  Citrate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00037)]|A ALIMENTARY TRACT AND METABOLISM|A09 DIGESTIVES, INCL. ENZYMES|A09A DIGESTIVES, INCL. ENZYMES|A09AB Acid preparations|A09AB04 Citric acid|D00037  Citric acid, anhydrous (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00037)]|Third-class OTC drugs|Inorganic and organic chemicals|Anhydrous citric acid|D00037  Citric acid, anhydrous (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00037)]|Chemicals|D00037  Anhydrous citric acid",
C00159,D-Mannose;|Mannose;|Seminose;|Carubinose;|D-Mannopyranose,alpha-D-Mannose [CPD:C00936]|beta-D-Mannose [CPD:C02209],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00159  D-Mannose,
C00160,Glycolate;|Glycolic acid;|Hydroxyacetic acid,,,,,
C00161,2-Oxo acid;|2-Oxocarboxylate;|2-Oxocarboxylic acid;|2-Oxo carboxylate,Generic compound in reaction hierarchy,,,,
C00162,Fatty acid,Generic compound in reaction hierarchy,,,,
C00163,Propanoate;|Propionate;|Propanoic acid;|Propionic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C00163  Propionate; Propanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00163  Propanoic acid,
C00164,Acetoacetate;|3-Oxobutanoic acid;|beta-Ketobutyric acid;|Acetoacetic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|3-Oxocarboxylic acids|C00164  Acetoacetate; 3-Oxobutanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00164  3-Oxobutanoic acid,
C00165,Diacylglycerol;|Diglyceride,"Generic compound in reaction hierarchy|Including 1,2-Diacyl-sn-glycerol [CPD:C00641] and 2,3-Diacyl-sn-glycerol",,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C00165  Diacylglycerol,
C00166,Phenylpyruvate;|Phenylpyruvic acid;|alpha-Ketohydrocinnamic acid;|keto-Phenylpyruvate;|3-Phenyl-2-oxopropanoate;|2-Oxo-3-phenylpropanoate,,,,,
C00167,UDP-glucuronate;|UDPglucuronate;|UDP-D-glucuronate;|UDP-alpha-D-glucuronate,,,,,G10612
C00168,Hydroxypyruvate;|Hydroxypyruvic acid;|3-Hydroxypyruvate;|3-Hydroxypyruvic acid,,,,,
C00169,Carbamoyl phosphate,,,,,
C00170,5'-Methylthioadenosine;|Methylthioadenosine;|S-Methyl-5'-thioadenosine;|5-Methylthioadenosine;|5'-Deoxy-5'-(methylthio)adenosine;|Thiomethyladenosine;|MTA;|5'-Deoxy-5'-(methylsulfanyl)adenosine,,,,,
C00171,5'-Phosphomononucleotide;|5'-Nucleotide,,,,,
C00172,3'-Phosphooligonucleotide,,,,,
C00173,Acyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R= acyl-carrier protein,,,,
C00174,Acid,"Generic compound in reaction hierarchy|""An acid"" also means a carboxylic acid (see [CPD:C00060])",,,,
C00175,Cobalt ion;|Cobalt(2+);|Co2+;|Co(II),,,,,
C00176,Flavin,Generic compound in reaction hierarchy,,,,
C00177,Cyanide ion;|Prussiate;|CN-;|Cyano;|Cyanide,Hydrogen cyanide (conjugate acid) [CPD:C01326],,,,
C00178,Thymine;|5-Methyluracil,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Bases|Pyrimidines|C00178  Thymine (Thy),
C00179,Agmatine;|(4-Aminobutyl) guanidine,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amines|C00179  Agmatine,
C00180,Benzoate;|Benzoic acid;|Benzenecarboxylic acid;|Phenylformic acid;|Dracylic acid,,,,Therapeutic category of drugs in Japan [BR:br08301(D00038)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D00038  Benzoic acid (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00038)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Benzoic acid|D00038  Benzoic acid (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Benzoic acid|D00038  Benzoic acid (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Benzoic acid|D00038  Benzoic acid (JP18/USP)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C00180  Benzoate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00038)]|Chemicals|D00038  Benzoic acid,
C00181,D-Xylose;|Wood sugar,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00181  D-Xylose,
C00182,Glycogen,,,,,
C00183,L-Valine;|2-Amino-3-methylbutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00183  Valine (Val)|Risk category of Japanese OTC drugs [BR:br08312(D00039)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Valine|D00039  Valine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00039)]|Chemicals|D00039  L-Valine,
C00184,"Glycerone;|Dihydroxyacetone;|1,3-Dihydroxyacetone;|1,3-Dihydroxy-2-propanone;|1,3-Dihydroxypropan-2-one",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00184  Dihydroxyacetone,
C00185,Cellobiose;|1-beta-D-Glucopyranosyl-4-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C00185  Cellobiose,G00289
C00186,(S)-Lactate;|L-Lactate;|L-Lactic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Hydroxycarboxylic acids|C00186  L-Lactate; (S)-2-Hydroxypropanoate,
C00187,Cholesterol;|Cholest-5-en-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Cholestane derivatives|C00187  Cholesterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C00187  Cholesterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C00187  Cholesterol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00040)]|Chemicals|D00040  Cholesterol,
C00188,L-Threonine;|2-Amino-3-hydroxybutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00188  Threonine (Thr)|Risk category of Japanese OTC drugs [BR:br08312(D00041)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Threonine|D00041  Threonine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00041)]|Chemicals|D00041  L-Threonine,
C00189,Ethanolamine;|Aminoethanol;|2-Hydroxyethylamine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C00189  Ethanolamine,
C00190,UDP-D-xylose;|UDP-xylose;|UDP-alpha-D-xylose,,,,,G10613
C00191,D-Glucuronate;|Glucuronic acid;|Glucuronate,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C00191  D-Glucuronic acid|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Sodium glucuronate hydrate|C00191  D-Glucuronate,
C00192,Hydroxylamine;|NH2OH,,,,,
C00193,Aromatic aldehyde,Generic compound in reaction hierarchy,,,,
C00194,"Cobamide coenzyme;|Adenosylcobalamin;|Adenosylcob(III)alamin;|Deoxyadenosylcobalamin;|Cobamamide;|Vitamin B12 coenzyme;|5,6-Dimethylbenzimidazolyl-5-deoxyadenosyl-cobamide;|(5'-Deoxy-5'-adenosyl)cobamide coenzyme;|(5,6-Dimethylbenzimidazolyl)cobamide coenzyme;|alpha-(5,6-Dimethylbenzimidazolyl)cobamide coenzyme;|5'-Deoxy-5'-adenosylcobalamin;|5'-Deoxy-5'-adenosyl vitamin B12;|5'-Deoxy-5'-adenosyl-5,6-dimethylbenzimidazolylcobamide;|5,6-Dimethylbenzimidazolyl-Co-5'-deoxy-5'-adenosylcobamide;|Calomide;|Cobalamin coenzyme;|Coenzyme B12;|DMBC coenzyme;|Dibencozide;|Funacomide",Coordination compound|Representative chemical structure of Cobamide [CPD:C00210].,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00194  Cobamamide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00042)]|B BLOOD AND BLOOD FORMING ORGANS|B03 ANTIANEMIC PREPARATIONS|B03B VITAMIN B12 AND FOLIC ACID|B03BA Vitamin B12 (cyanocobalamin and analogues)|B03BA04 Cobamamide|D00042  Cobamamide (JAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00042)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3136  Vitamin B12 preparations|D00042  Cobamamide (JAN/INN),
C00195,N-Acylsphingosine;|Ceramide;|N-Acylsphing-4-enine;|(4E)-Sphing-4-enine ceramide,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0201 N-acylsphingosines (ceramides)|C00195  N-Acylsphingosine,
C00196,"2,3-Dihydroxybenzoate;|2,3-Dihydroxybenzoic acid",,,,,
C00197,3-Phospho-D-glycerate;|D-Glycerate 3-phosphate;|3-Phospho-(R)-glycerate;|3-Phosphoglycerate,,,,,
C00198,"D-Glucono-1,5-lactone;|Gluconic lactone;|Gluconic acid lactone;|1,5-Gluconolactone;|delta-Gluconolactone;|D-Gluconolactone;|Gluconolactone",,,,,
C00199,D-Ribulose 5-phosphate,,,,,
C00200,Phenazine methosulfate;|N-Methylphenazonium methosulfate;|5-Methylphenazinium methyl sulphate,,,,,
C00201,Nucleoside triphosphate;|NTP;|Nucleoside 5'-triphosphate,Generic compound in reaction hierarchy,,,,
C00202,Isoflurophate;|Diisopropyl fluorophosphate;|DFP,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00043)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB07 Fluostigmine|D00043  Isoflurophate|Drug groups [BR:br08330(D00043)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|D00043  Isoflurophate|DG01594  Butyrylcholinesterase inhibitor|D00043  Isoflurophate|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00043  Isoflurophate|Target-based classification of drugs [BR:br08310(D00043)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D00043  Isoflurophate|BCHE|D00043  Isoflurophate,
C00203,UDP-N-acetyl-D-galactosamine;|UDP-N-acetyl-alpha-D-galactosamine,,,,,G10611
C00204,2-Dehydro-3-deoxy-D-gluconate;|2-Keto-3-deoxy-D-gluconate;|2-Dehydro-3-deoxy-D-gluconic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C00204  2-Dehydro-3-deoxy-D-gluconic acid,
C00205,hn;|Light;|Photon;|hnu,,,,,
C00206,dADP;|2'-Deoxyadenosine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00206  dADP,
C00207,Acetone;|Dimethyl ketone;|2-Propanone;|Propan-2-one,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C00207  Propan-2-one|Drug groups [BR:br08330(D02311)]|Metabolizing enzyme substrate|DG02855  CYP2E1 substrate|D02311  Acetone|Drug metabolizing enzymes and transporters [br08309.html(D02311)]|Drug metabolizing enzymes|D02311,
C00208,Maltose;|Malt sugar;|alpha-D-Glucopyranosyl-(1->4)-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C00208  Maltose; Malt sugar,G00275
C00209,Oxalate;|Oxalic acid;|Ethanedioic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C00209  Oxalate,
C00210,Cobamide,"Generic compound in reaction hierarchy|Cobamide coenzyme [CPD:C00194] (R1 = adenosyl group, R2 = dimethylbenzimidazolyl group)|Methylcobalamin [CPD:C06453] (R1 = CH3, R2 = dimethylbenzimidazolyl group)|Co-Methyl-5-hydroxybenzimidazolylcobamide [CPD:C04665] (R1 = CH3, R2 = 5-hydroxybenzimidazolyl group)",,,,
C00211,Collagen,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02B VITAMIN K AND OTHER HEMOSTATICS|B02BC Local hemostatics|B02BC07 Collagen|C00211  Collagen|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX11 Collagen|C00211  Collagen,
C00212,Adenosine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Ribonucleosides|C00212  Adenosine (A)|Glycosides [BR:br08021]|N-glycosides|C00212  Adenosine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00045)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB10 Adenosine|D00045  Adenosine (JAN/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00045)]|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00045  Adenosine (JAN/USP)|Target-based classification of drugs [BR:br08310(D00045)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA|D00045  Adenosine (JAN/USP) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00045)]|Drugs with new active ingredients|D00045,
C00213,Sarcosine;|N-Methylglycine,,,,,
C00214,Thymidine;|Deoxythymidine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Deoxyribonucleosides|C00214  Deoxythymidine (dT)|Target-based classification of drugs [BR:br08310(D12466)]|Enzymes|Transferases (EC2)|Phosphotransferase|TK2|D12466  Doxribtimine (USAN/INN),
C00215,Nucleotide,Generic compound in reaction hierarchy,,,,
C00216,D-Arabinose;|D-Arabinopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00216  D-Arabinose,
C00217,D-Glutamate;|D-Glutamic acid;|D-Glutaminic acid;|D-2-Aminoglutaric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00217  D-Glutamic acid,
C00218,Methylamine;|Methanamine,,,,,
C00219,"Arachidonate;|Arachidonic acid;|(5Z,8Z,11Z,14Z)-Icosatetraenoic acid;|cis-5,8,11,14-Eicosatetraenoic acid;|5Z,8Z,11Z,14Z-Eicosatetraenoic acid;|(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C00219  Arachidonic acid (20:4;5,8,11,14)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C00219  (5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoic acid",
C00220,Methylene blue;|Methylthioninium chloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB17 Methylthioninium chloride|C00220  Methylene blue|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CG Tests for gastric secretion|V04CG05 Methylthioninium chloride|C00220  Methylene blue|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C00220  Methylene blue|Drug groups [BR:br08330]|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG01156  Methylthioninium chloride|C00220  Methylene blue|DG02892  CYP2B6 inhibitor|DG01156  Methylthioninium chloride|C00220  Methylene blue|DG01643  CYP2C9 inhibitor|DG01156  Methylthioninium chloride|C00220  Methylene blue|DG01933  CYP2C19 inhibitor|DG01156  Methylthioninium chloride|C00220  Methylene blue,G01156
C00221,beta-D-Glucose;|beta-D-Glucopyranose,D-Glucose [CPD:C00031],,,,
C00222,3-Oxopropanoate;|Malonate semialdehyde,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|3-Oxocarboxylic acids|C00222  3-Oxopropanoate,
C00223,p-Coumaroyl-CoA;|4-Coumaroyl-CoA;|4-Hydroxycinnamoyl-CoA;|trans-4-Coumaroyl-CoA;|(E)-4-Coumaroyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00223  4-Coumaroyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C00223  p-Coumaroyl-CoA,
C00224,Adenylyl sulfate;|Adenosine 5'-phosphosulfate;|APS;|5'-Adenylyl sulfate,,,,,
C00225,"Methyl viologen;|Paraquat dichloride;|1,1'-Dimethyl-4,4'-bipyridinium dichloride",,,,,
C00226,Primary alcohol;|1-Alcohol,Generic compound in reaction hierarchy,,,,
C00227,Acetyl phosphate,,,,,
C00229,Acyl-carrier protein;|ACP;|[Acyl-carrier protein];|Holo-[acyl-carrier protein],Generic compound in reaction hierarchy|R = 4'-phosphopantetheine or 2'-(5-phosphoribosyl)-3'-dephospho-CoA group attached to protein serine|Including peptidyl-carrier proteins and ACP domains of enzymes,,,,
C00230,"3,4-Dihydroxybenzoate;|3,4-Dihydroxybenzoic acid;|Protocatechuate;|Protocatechuic acid",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C00230,
C00231,D-Xylulose 5-phosphate,,,,,
C00232,Succinate semialdehyde;|Succinic semialdehyde;|4-Oxobutanoate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|4-Oxocarboxylic acid|C00232  Succinate semialdehyde; 4-Oxobutanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C00232  Succinate semialdehyde,
C00233,4-Methyl-2-oxopentanoate;|2-Oxoisocaproate;|alpha-Ketoisocaproate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00233  2-Oxoisocaproate,
C00234,10-Formyltetrahydrofolate;|10-Formyl-THF,,,,,
C00235,Dimethylallyl diphosphate;|2-Isopentenyl diphosphate;|Delta2-Isopentenyl diphosphate;|Dimethylallyl pyrophosphate;|DMAPP;|Monoprenyl diphosphate;|Prenyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0101 C5 isoprenoids (hemiterpenes)|C00235  Dimethylallyl diphosphate,
C00236,"3-Phospho-D-glyceroyl phosphate;|1,3-Bisphospho-D-glycerate;|(R)-2-Hydroxy-3-(phosphonooxy)-1-monoanhydride with phosphoric propanoic acid;|D-Glycerate 1,3-diphosphate",,,,,
C00237,CO;|Carbon monoxide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09706)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CX Other diagnostic agents|V04CX08 Carbon monoxide|D09706  Carbon monoxide (USAN),
C00238,Potassium cation;|K+;|Potassium(1+);|Potassium ion,,,,,
C00239,dCMP;|Deoxycytidylic acid;|Deoxycytidine monophosphate;|Deoxycytidylate;|2'-Deoxycytidine 5'-monophosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00239  dCMP|Glycosides [BR:br08021]|N-glycosides|C00239  dCMP,
C00240,rRNA;|Ribosomal RNA,Generic compound in reaction hierarchy,,,,
C00241,Amide,Generic compound in reaction hierarchy,,,,
C00242,Guanine;|2-Amino-6-hydroxypurine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Bases|Purines|C00242  Guanine (Gua),
C00243,Lactose;|1-beta-D-Galactopyranosyl-4-D-glucopyranose;|beta-D-Gal-(1->4)-D-Glc;|Milk sugar,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C00243  Lactose; Milk sugar|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00046)]|Chemicals|D00046  Anhydrous lactose,G10504
C00244,Nitrate;|Nitric acid,,,,,
C00245,Taurine;|2-Aminoethanesulfonic acid;|Aminoethylsulfonic acid,,,,Therapeutic category of drugs in Japan [BR:br08301(D00047)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D00047  Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2119  Others|D00047  Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)|3  Agents affecting metabolism|39  Other agents affecting metabolism|391  Liver disease agents|3919  Others|D00047  Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)|Classification of Japanese OTC drugs [BR:br08313(D00047)]|Agents for ophthalmologic use|62 General eye drops|D00047  Taurine (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00047)]|Third-class OTC drugs|Inorganic and organic chemicals|Aminoethylsulfonic acid; Taurine|D00047  Taurine (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9674  Taurine and preparations|C00245  Aminoethylsulfonic acid|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00047)]|Chemicals|D00047  Taurine,
C00246,Butanoic acid;|Butanoate;|Butyrate;|Butyric acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C00246  Butyrate; Butanoate|Lipids|Fatty acids|Saturated fatty acids|C00246  Butyric acid (4:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00246  Butanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C00246  Butyric acid,
C00247,L-Sorbose;|L-xylo-Hexulose,Sorbose [CPD:C01452]|D-Sorbose [CPD:C00764],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00247  L-Sorbose,
C00248,Lipoamide;|Thioctic acid amide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C00248  Lipoamide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00048)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AX Various alimentary tract and metabolism products|A16AX01 Thioctic acid|D00048  Thioctic acid amide (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00048)]|Third-class OTC drugs|Inorganic and organic chemicals|Thioctic acid amide|D00048  Thioctic acid amide (JAN),
C00249,Hexadecanoic acid;|Hexadecanoate;|Hexadecylic acid;|Palmitic acid;|Palmitate;|Cetylic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C00249  Palmitic acid (16:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00249  Hexadecanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C00249  Palmitic acid,
C00250,Pyridoxal,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00250  Pyridoxal (Vitamin B6)|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Pyridoxine hydrochloride|C00250  Pyridoxal,
C00251,"Chorismate;|Chorismic acid;|(3R,4R)-3-[(1-Carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylate",,,,,
C00252,Isomaltose;|Brachiose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C00252  Isomaltose,G01318
C00253,Nicotinate;|Nicotinic acid;|Niacin;|3-Pyridinecarboxylic acid,,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00253  Nicotinic acid (Vitamin B3)|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C00253  Nicotinate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00049)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AC Nicotinic acid and derivatives|C04AC01 Nicotinic acid|D00049  Niacin (USP) &lt;US&gt;|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AD Nicotinic acid and derivatives|C10AD02 Nicotinic acid|D00049  Niacin (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00049)]|Cardiovascular Agents|Dyslipidemics, Other|Niacin|D00049  Niacin (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00049)]|Third-class OTC drugs|Inorganic and organic chemicals|Nicotinic acid|D00049  Niacin (USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9623  Vitamin B and preparations (except vitamin B1 preparations)|C00253  Nicotinate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00049)]|Chemicals|D00049  Nicotinic acid|D00049  Nicotinic acid injection",
C00254,Prephenate;|Prephenic acid,,,,,
C00255,"Riboflavin;|Lactoflavin;|7,8-Dimethyl-10-ribitylisoalloxazine;|Vitamin B2",,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00255  Riboflavin (Vitamin B2)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00050)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA04 Riboflavin (vit B2)|D00050  Riboflavin (JP18/USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA26 Riboflavin|D00050  Riboflavin (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00050)]|Nourishing tonics and health supplements|36 Vitamin B2 based drugs|D00050  Riboflavin (JP18/USP/INN)|40 Vitamin B2B6 based drugs|D00050  Riboflavin (JP18/USP/INN)|43 Vitamin containing supplements|D00050  Riboflavin (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00050)]|Third-class OTC drugs|Inorganic and organic chemicals|Riboflavin|D00050  Riboflavin (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00050)]|Chemicals|D00050  Riboflavin|D00050  Riboflavin powder,
C00256,(R)-Lactate;|D-Lactate;|D-Lactic acid;|D-2-Hydroxypropanoic acid;|D-2-Hydroxypropionic acid,,,,,
C00257,D-Gluconic acid;|D-Gluconate;|D-gluco-Hexonic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C00257  D-Gluconic acid|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium gluconate|C00257  D-Gluconic acid,
C00258,D-Glycerate;|Glycerate;|(R)-Glycerate;|Glyceric acid,,,,,
C00259,L-Arabinose;|L-Arabinopyranose,L-Arabinofuranose [CPD:C06115]|L-Arabinose (open-chain) [CPD:C11476]|alpha-L-Arabinopyranose [CPD:C02604]|beta-L-Arabinopyranose [CPD:C02479],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00259  L-Arabinose,
C00261,Benzaldehyde;|Benzoic aldehyde,,,,,
C00262,Hypoxanthine;|Purine-6-ol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C00262  Hypoxanthine,
C00263,L-Homoserine;|2-Amino-4-hydroxybutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00263  L-Homoserine,
C00264,3-Oxoacyl-CoA,Generic compound in reaction hierarchy,,,,
C00265,"Dithiothreitol;|1,4-Dithiothreitol;|threo-1,4-Dimercapto-2,3-butanediol;|DL-threo-1,4-Dimercapto-2,3-butanediol",Relative configuration (including both enantiomers),,,,
C00266,Glycolaldehyde;|Hydroxyacetaldehyde,,,,,
C00267,alpha-D-Glucose,D-Glucose [CPD:C00031],,,,
C00268,"Dihydrobiopterin;|6,7-Dihydrobiopterin;|Quinoid-dihydrobiopterin;|6-[(1R,2S)-1,2-Dihydroxypropyl]-6,7-dihydropterin",,,,,
C00269,"CDP-diacylglycerol;|CDP-1,2-diacylglycerol;|1,2-Diacyl-sn-glycero-3-cytidine-5'-diphosphate",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP13 CDP-Glycerols|GP1301 CDP-diacylglycerols|C00269  CDP-1,2-diacylglycerol",
C00270,"N-Acetylneuraminate;|N-Acetylneuraminic acid;|5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid;|Neu5Ac",Aceneuramate (open-chain) [CPD:C22382]|N-Acetyl-alpha-neuraminate [CPD:C19909]|N-Acetyl-beta-neuraminate [CPD:C19910],,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C00270  N-Acetylneuraminic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D11016)]|M MUSCULO-SKELETAL SYSTEM|M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09AX Other drugs for disorders of the musculo-skeletal system|M09AX05 Aceneuramic acid|D11016  Aceneuramic acid (JAN/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D11016)]|1  Agents affecting nervous system and sensory organs|19  Other agents affecting nervous system and sensory organs|190  Other agents affecting nervous system and sensory organs|1900  Other agents affecting nervous system and sensory organs|D11016  Aceneuramic acid (JAN/USAN)|Drug groups [BR:br08330(D11016)]|Unclassified|DG03304  NPL substrate|DG02580  Aceneuramic acid|D11016  Aceneuramic acid|New drug approvals in Japan [br08318.html(D11016)]|Drugs with new active ingredients|D11016|New drug approvals in the USA, Europe and Japan [br08328.html(D11016)]|Approval dates by FDA, EMA and PMDA|D11016|Drug metabolizing enzymes and transporters [br08309.html(D11016)]|Drug metabolizing enzymes|D11016",
C00272,"Tetrahydrobiopterin;|5,6,7,8-Tetrahydrobiopterin;|2-Amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydoro-4(1H)-pteridinone;|L-erythro-Tetrahydrobiopterin",,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00272  Tetrahydrobiopterin,
C00273,5-Dehydro-D-fructose,,,,,
C00275,D-Mannose 6-phosphate,,,,,
C00279,D-Erythrose 4-phosphate,,,,,
C00280,"Androstenedione;|Androst-4-ene-3,17-dione;|4-Androstene-3,17-dione",,,,"Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C00280  Androstenedione|Hormones and transmitters|Steroid hormones|Androgens|C00280  Androstenedione|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C00280  Androst-4-ene-3,17-dione|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Androstane|C00280  Androstenedione",
C00282,Hydrogen;|H2,,,,,
C00283,Hydrogen sulfide;|Hydrogen-sulfide;|H2S;|Sulfide,"The name ""Sulfide"" also means Thioether [CPD:C00297].",,,,
C00284,EDTA;|Ethylenediaminetetraacetic acid;|Edetic acid;|Ethylenediaminetetraacetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00052)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB03 Edetates|D00052  Edetic acid (NF/INN)|Drug groups [BR:br08330(D00052)]|Vitamin and mineral|DG01692  Chelator|DG01152  Edetate|D00052  Edetic acid,
C00286,dGTP;|2'-Deoxyguanosine 5'-triphosphate;|Deoxyguanosine 5'-triphosphate;|Deoxyguanosine triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00286  dGTP,
C00288,HCO3-;|Hydrogencarbonate;|Bicarbonate;|Hydrogen carbonate;|Acid carbonate,Dihydrogen carbonate (conjugate acid) [CPD:C01353],,,,
C00291,Nickel,Nickel and nickel compounds|Usually existing as +2 cations|Ni2+ [CPD:C19609],,,,
C00292,Aniline;|Phenylamine;|Benzenamine;|Arylamine,,,,,
C00294,Inosine,,,,"Glycosides [BR:br08021]|N-glycosides|C00294  Inosine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00054)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BB Antivirals|D06BB05 Inosine|D00054  Inosine (JAN/INN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AX Other antiinfectives and antiseptics|G01AX02 Inosine|D00054  Inosine (JAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA10 Inosine|D00054  Inosine (JAN/INN)",
C00295,Orotate;|Orotic acid;|Uracil-6-carboxylic acid,,,,Risk category of Japanese OTC drugs [BR:br08312(D00055)]|Third-class OTC drugs|Inorganic and organic chemicals|Orotic acid|D00055  Orotic acid (JAN),
C00296,Quinate;|Quinic acid;|Kinic acid;|Chinic acid;|L-Quinic acid;|L-Quinate;|(-)-Quinic acid,,,,,
C00297,Sulfide;|Thioether,"Generic compound in reaction hierarchy|The name ""Sulfide"" also means Hydrogen sulfide [CPD:C00283] or its conjugate base, Sulfide anion.",,,,
C00299,Uridine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Ribonucleosides|C00299  Uridine (U),
C00300,Creatine;|alpha-Methylguanidino acetic acid;|Methylglycocyamine,,,,,
C00301,ADP-ribose;|ADP-D-ribose;|Adenosine diphosphate ribose,,,,,
C00302,Glutamate;|Glutaminic acid;|2-Aminoglutaric acid,D-Glutamate [CPD:C00217]|L-Glutamate [CPD:C00025],,,Risk category of Japanese OTC drugs [BR:br08312(D04341)]|Third-class OTC drugs|Inorganic and organic chemicals|Glutamic acid|D04341  Glutamic acid (USAN),
C00303,Glutamine;|2-Aminoglutaramic acid,,,,,
C00304,Kanamycin,"Comprised of three components, Kanamycin A [CPD:C01822], the major component (usually designated as Kanamycin), Kanamycin B [CPD:C00825] and Kanamycin C [CPD:C01823].",,,"Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|2-Deoxystreptamines|C00304  Kanamycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA08 Kanamycin|C00304  Kanamycin|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB04 Kanamycin|C00304  Kanamycin|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA24 Kanamycin|C00304  Kanamycin|Drug groups [BR:br08330]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00085  Kanamycin|C00304  Kanamycin|DG01966  Antitubercular|DG00085  Kanamycin|C00304  Kanamycin",G00085
C00305,Magnesium cation;|Mg2+;|Magnesium(2+);|Magnesium ion,,,,,
C00306,Bradykinin,,Arg Pro Pro Gly Phe Ser Pro Phe Arg,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Bradykinin|C00306  Bradykinin|Bioactive peptides [BR:br08005]|Cardiovascular peptides|Bradykinin|C00306  Bradykinin,
C00307,CDP-choline;|Cytidine 5'-diphosphocholine;|Citicoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00057)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BX Other psychostimulants and nootropics|N06BX06 Citicoline|D00057  Citicoline (JP18/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00057)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D00057  Citicoline (JP18/INN)|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D00057  Citicoline (JP18/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00057)]|Chemicals|D00057  Citicoline",
C00308,Canavanine;|L-Canavanine;|2-Amino-4-(guanidinooxy)butyric acid,,,,,
C00309,D-Ribulose;|D-erythro-2-Pentulose;|D-Arabinoketose;|D-Arabinulose;|D-Riboketose,alpha-D-Ribulose [CPD:C08354],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00309  D-Ribulose,
C00310,D-Xylulose;|D-threo-Pentulose;|D-Lyxulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00310  D-Xylulose,
C00311,"Isocitrate;|Isocitric acid;|1-Hydroxytricarballylic acid;|1-Hydroxypropane-1,2,3-tricarboxylic acid",,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Tricarboxylic acids|C00311  Isocitrate,
C00312,L-Xylulose;|L-threo-Pentulose;|L-Lyxulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00312  L-Xylulose,
C00313,Oxalyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00313  Oxalyl-CoA,
C00314,Pyridoxine;|Pyridoxol,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00314  Pyridoxine (Vitamin B6)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08454)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA02 Pyridoxine (vit B6)|D08454  Pyridoxine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08454)]|Third-class OTC drugs|Inorganic and organic chemicals|Pyridoxine hydrochloride|D08454  Pyridoxine (INN),
C00315,"Spermidine;|N-(3-Aminopropyl)-1,4-butane-diamine",,,,,
C00318,"L-Carnitine;|L-gamma-Trimethyl-beta-hydroxybutyrobetaine;|Vitamin BT;|3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium hydroxide, inner salt;|Levocarnitine;|(R)-Carnitine",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02176)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AA Amino acids and derivatives|A16AA01 Levocarnitine|D02176  Levocarnitine (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02176)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D02176  Levocarnitine (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D02176)]|Third-class OTC drugs|Inorganic and organic chemicals|Carnitine|D02176  Levocarnitine (JAN/USP/INN)|New drug approvals in Japan [br08318.html(D02176)]|Drugs with new active ingredients|D02176,
C00319,Sphingosine;|Sphingenine;|Sphingoid;|Sphing-4-enine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0101 Sphing-4-enines (Sphingosines)|C00319  Sphing-4-enine,
C00320,Thiosulfate;|Hyposulfite,,,,,
C00322,2-Oxoadipate;|2-Oxoadipic acid;|2-Oxohexanedioic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00322  2-Oxoadipate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00322  2-Oxohexanedioic acid,
C00323,"Caffeoyl-CoA;|(2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoyl-CoA",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00323  Caffeoyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C00323  Caffeoyl-CoA,
C00324,Ferricyanide;|Hexacyanoferrate(III),,,,,
C00325,GDP-L-fucose;|GDP-beta-L-fucose,,,,,G10615
C00327,L-Citrulline;|2-Amino-5-ureidovaleric acid;|Citrulline,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00327  L-Citrulline,
C00328,L-Kynurenine;|3-Anthraniloyl-L-alanine,,,,,
C00329,D-Glucosamine;|Chitosamine;|2-Amino-2-deoxy-D-glucose,,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C00329  D-Glucosamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04334)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AX Other antiinflammatory and antirheumatic agents, non-steroids|M01AX05 Glucosamine|D04334  Glucosamine (USAN/INN)",
C00330,Deoxyguanosine;|2'-Deoxyguanosine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Deoxyribonucleosides|C00330  Deoxyguanosine (dG),
C00331,Indolepyruvate;|Indolepyruvic acid;|(Indol-3-yl)pyruvate;|Indole-3-pyruvate;|3-(Indol-3-yl)pyruvate,,,,,
C00332,Acetoacetyl-CoA;|Acetoacetyl coenzyme A;|3-Acetoacetyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00332  Acetoacetyl-CoA,
C00333,D-Galacturonate;|D-Galacturonic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C00333  D-Galacturonic acid,
C00334,4-Aminobutanoate;|4-Aminobutanoic acid;|4-Aminobutyrate;|4-Aminobutyric acid;|gamma-Aminobutyric acid;|GABA,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00334  gamma-Aminobutyric acid|Amines|Biogenic amines|C00334  gamma-Aminobutyric acid (GABA)|Hormones and transmitters|Neurotransmitters|Amino acids|C00334  GABA|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C00334  4-Aminobutanoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00058)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AG Fatty acid derivatives|N03AG03 Aminobutyric acid|D00058  gamma-Aminobutyric acid (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00058)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00058  gamma-Aminobutyric acid (JAN)|Drug groups [BR:br08330(D00058)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D00058  gamma-Aminobutyric acid|DG01565  GABA-B receptor agonist|D00058  gamma-Aminobutyric acid|DG03199  Antiepileptic agent|DG02037  GABA mimetic antiepileptic|D00058  gamma-Aminobutyric acid|Drug classes [BR:br08332(D00058)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00058  gamma-Aminobutyric acid|Target-based classification of drugs [BR:br08310(D00058)]|G Protein-coupled receptors|Metabotropic glutamate receptor family|GABA (metabotropic)|GABBR|D00058  gamma-Aminobutyric acid (JAN) &lt;JP&gt;|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00058  gamma-Aminobutyric acid (JAN) &lt;JP&gt;,
C00337,"(S)-Dihydroorotate;|(S)-4,5-Dihydroorotate;|L-Dihydroorotate;|L-Dihydroorotic acid;|Dihydro-L-orotic acid",,,,,
C00339,Long-chain alcohol,Generic compound in reaction hierarchy,,,,
C00341,Geranyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C00341  Geranyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C00341  Geranyl diphosphate,
C00342,Thioredoxin;|Reduced thioredoxin,Generic compound in reaction hierarchy|Thioredoxin motif (CXXC),,,,
C00343,Thioredoxin disulfide;|Oxidized thioredoxin;|Thioredoxin sulfide,Generic compound in reaction hierarchy,,,,
C00344,Phosphatidylglycerol;|3-(3-sn-Phosphatidyl)glycerol;|3(3-Phosphatidyl-)glycerol;|PtdGro,Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C00344  Phosphatidylglycerol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C00344  Phosphatidylglycerol",
C00345,6-Phospho-D-gluconate,,,,,
C00346,Ethanolamine phosphate;|O-Phosphorylethanolamine;|Phosphoethanolamine;|O-Phosphoethanolamine,,,,,
C00347,Long-chain carboxylate;|Long-chain carboxylic acid,Generic compound in reaction hierarchy,,,,
C00348,all-trans-Undecaprenyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C00348  all-trans-Undecaprenyl phosphate,
C00349,2-Methyl-3-oxopropanoate;|3-Oxo-2-methylpropanoate;|Methylmalonate semialdehyde,"(S)-Methylmalonate semialdehyde [CPD:C06002]|(R)-Methylmalonate semialdehyde [CPD:C21030]|(non-enzymatic racemization, see [RN:R11028])",,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00349  2-Methyl-3-oxopropanoate,
C00350,Phosphatidylethanolamine;|(3-Phosphatidyl)ethanolamine;|(3-Phosphatidyl)-ethanolamine;|Cephalin;|O-(1-beta-Acyl-2-acyl-sn-glycero-3-phospho)ethanolamine;|1-Acyl-2-acyl-sn-glycero-3-phosphoethanolamine;|L-1-Phosphatidylethanolamine,Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C00350  Phosphatidylethanolamine|Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0201 Diacylglycerophosphoethanolamines|C00350  1-Acyl-2-acyl-sn-glycero-3-phosphoethanolamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C00350  Phosphatidylethanolamine",
C00351,5'-Phosphooligonucleotide,,,,,
C00352,D-Glucosamine 6-phosphate;|D-Glucosamine phosphate,,,,,
C00353,"Geranylgeranyl diphosphate;|Geranylgeranyl pyrophosphate;|all-trans-Geranylgeranyl diphosphate;|all-trans-Geranylgeranyl pyrophosphate;|(2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C00353  Geranylgeranyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Linear diterpenes|C00353  Geranylgeranyl diphosphate,
C00354,"D-Fructose 1,6-bisphosphate",,,,,
C00355,"3,4-Dihydroxy-L-phenylalanine;|L-Dopa;|3-Hydroxy-L-tyrosine;|L-beta-(3,4-Dihydroxyphenyl)alanine;|Levodopa;|Dihydroxy-L-phenylalanine",,,,"Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00355  3,4-Dihydroxy-L-phenylalanine|Hormones and transmitters|Neurotransmitters|Amino acids|C00355  Dopa|Prodrugs [br08324.html]|C00355|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00059)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BA Dopa and dopa derivatives|N04BA01 Levodopa|D00059  Levodopa (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00059)]|Antiparkinson Agents|Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors|Levodopa|D00059  Levodopa (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00059)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|116  Antiparkinsonian agents|1164  Levodopas|D00059  Levodopa (JP18/USP/INN)|Drug groups [BR:br08330(D00059)]|Neuropsychiatric agent|DG01472  Dopamine agonist|D00059  Levodopa|DG01967  Antiparkinson agent|D00059  Levodopa|Drug classes [BR:br08332(D00059)]|Neuropsychiatric agent|DG01967  Antiparkinson agent|D00059  Levodopa|Target-based classification of drugs [BR:br08310(D00059)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD|D00059  Levodopa (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00059)]|Chemicals|D00059  Levodopa|New drug approvals in Europe [br08329.html(D00059)]|European public assessment reports (EPAR) authorised medicine|D00059|Prodrugs [br08324.html(D00059)]|D00059",
C00356,(S)-3-Hydroxy-3-methylglutaryl-CoA;|Hydroxymethylglutaryl-CoA;|Hydroxymethylglutaroyl coenzyme A;|HMG-CoA;|3-Hydroxy-3-methylglutaryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00356  (S)-3-Hydroxy-3-methylglutaryl-CoA,
C00357,N-Acetyl-D-glucosamine 6-phosphate,,,,,
C00360,dAMP;|2'-Deoxyadenosine 5'-phosphate;|2'-Deoxyadenosine 5'-monophosphate;|Deoxyadenylic acid;|Deoxyadenosine monophosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00360  dAMP,
C00361,dGDP;|2'-Deoxyguanosine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00361  dGDP,
C00362,dGMP;|2'-Deoxyguanosine 5'-monophosphate;|2'-Deoxyguanosine 5'-phosphate;|Deoxyguanylic acid;|Deoxyguanosine monophosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00362  dGMP,
C00363,dTDP;|Deoxythymidine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00363  dTDP,
C00364,dTMP;|Thymidine 5'-phosphate;|Deoxythymidine 5'-phosphate;|Thymidylic acid;|5'-Thymidylic acid;|Thymidine monophosphate;|Deoxythymidylic acid;|Thymidylate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00364  dTMP,
C00365,dUMP;|Deoxyuridylic acid;|Deoxyuridine monophosphate;|Deoxyuridine 5'-phosphate;|2'-Deoxyuridine 5'-phosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00365  dUMP,
C00366,Urate;|Uric acid,,,,,
C00369,Starch;|Glycogen,,,,Risk category of Japanese OTC drugs [BR:br08312(D06507)]|Third-class OTC drugs|Inorganic and organic chemicals|Starch|D06507  Starch,G10545
C00370,Sterol,Generic compound in reaction hierarchy,,,,
C00371,Zeatin;|N6-(4-Hydroxyisopentenyl)adenine;|(E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol;|trans-Zeatin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00371,
C00372,"Dextran;|1,6-alpha-D-Glucan;|(1,6-alpha-D-Glucosyl)n;|(1,6-alpha-D-Glucosyl)n+1;|(1,6-alpha-D-Glucosyl)m;|(1,6-alpha-D-Glucosyl)m+1;|Dextran 40;|Dextran 70;|Dextran 75",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00060)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05A BLOOD AND RELATED PRODUCTS|B05AA Blood substitutes and plasma protein fractions|B05AA05 Dextran|D00060  Dextran 1 (USP),G10502
C00374,Heparin;|Enoxaparin;|Bemiparin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07510)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AB Heparin group|B01AB01 Heparin|D07510  Adomiparin (USAN)|B01AB12 Bemiparin|D07510  Adomiparin (USAN)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05B ANTIVARICOSE THERAPY|C05BA Heparins or heparinoids for topical use|C05BA03 Heparin|D07510  Adomiparin (USAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA14 Heparin|D07510  Adomiparin (USAN)|Drug groups [BR:br08330(D07510)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01709  Heparin anticoagulant|DG00150  Heparin|D07510  Adomiparin|Target-based classification of drugs [BR:br08310(D07510)]|Not elsewhere classified|Organismal systems|Complement and coagulation|SERPINC1 (AT3)|D07510  Adomiparin (USAN),
C00375,RCH2NH2,Generic compound in reaction hierarchy,,,,
C00376,Retinal;|Vitamin A aldehyde;|Retinene;|all-trans-Retinal;|all-trans-Vitamin A aldehyde;|all-trans-Retinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C00376  Retinal,
C00378,Thiamine;|Thiamin;|Vitamin B1;|Aneurin;|Antiberiberi factor,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00378  Thiamine (Vitamin B1),
C00379,Xylitol,,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar alcohols|C00379  Xylitol|Therapeutic category of drugs in Japan [BR:br08301(D00061)]|3  Agents affecting metabolism|32  Nutrients, tonics|323  Saccharide preparations|3234  Xylitols|D00061  Xylitol (JP18/NF)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9643  Xylitol and preparations|C00379  Xylitol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00061)]|Chemicals|D00061  Xylitol|D00061  Xylitol injection",
C00380,Cytosine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Bases|Pyrimidines|C00380  Cytosine (Cyt),
C00381,"Dolichol;|ditrans,polycis-Dolichol",Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0307 Dolichols|C00381  Dolichol,
C00383,Malonate;|Malonic acid;|Propanedioic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C00383  Malonate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00383  Propanedioic acid,
C00384,Neomycin,Generic compound|Neomycin A [CPD:C01441]|Neomycin B [CPD:C01737]|Neomycin C [CPD:C15652],,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08260)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB08 Neomycin|D08260  Neomycin (INN)|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA01 Neomycin|D08260  Neomycin (INN)|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA09 Neomycin|D08260  Neomycin (INN)|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX04 Neomycin|D08260  Neomycin (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB05 Neomycin|D08260  Neomycin (INN)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AB Antibiotics|R02AB01 Neomycin|D08260  Neomycin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA03 Neomycin|D08260  Neomycin (INN)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA07 Neomycin|D08260  Neomycin (INN)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA01 Neomycin|D08260  Neomycin (INN)|Drug groups [BR:br08330(D08260)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00003  Neomycin|D08260  Neomycin|Antimicrobials [BR:br08307(D08260)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08260  Neomycin (INN)",
C00385,Xanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C00385  Xanthine,
C00386,Carnosine;|Nalpha-(beta-alanyl)-L-histidine,Dipeptide consists of Histidine and beta-Alanine.,,,Compounds with biological roles [BR:br08001]|Peptides|Peptides|Dipeptides|C00386  Carnosine,
C00387,Guanosine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Ribonucleosides|C00387  Guanosine (G),
C00388,Histamine;|1H-Imidazole-4-ethanamine;|2-(4-Imidazolyl)ethylamine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C00388  Histamine|Hormones and transmitters|Other hormones|Histamine|C00388  Histamine|Neurotransmitters|Biogenic amines|C00388  Histamine|Target-based classification of drugs [BR:br08310(D08040)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08040  Histamine (DCF)|HRH2|D08040  Histamine (DCF)|HRH3|D08040  Histamine (DCF)|HRH4|D08040  Histamine (DCF),
C00389,"Quercetin;|3,3',4,5,7-Pentahydroxyflavone;|3,5,7,3',4'-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C00389  Quercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C00389  Quercetin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00389|Dietary phytochemicals [br08012.html]|Flavonoids|C00389,
C00390,Ubiquinol;|QH2;|CoQH2;|Ubiquinol-n,Generic compound in reaction hierarchy|n=5-9,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C00390  Ubiquinol,
C00392,Mannitol;|D-Mannitol,,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar alcohols|C00392  Mannitol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00062)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD16 Mannitol|D00062  Mannitol (USP) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05B I.V. SOLUTIONS|B05BC Solutions producing osmotic diuresis|B05BC01 Mannitol|D00062  Mannitol (USP) &lt;JP/US&gt;|B05C IRRIGATING SOLUTIONS|B05CX Other irrigating solutions|B05CX04 Mannitol|D00062  Mannitol (USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS|R05CB Mucolytics|R05CB16 Mannitol|D00062  Mannitol (USP) &lt;JP/US&gt;|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CX Other diagnostic agents|V04CX04 Mannitol|D00062  Mannitol (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00062)]|Respiratory Tract/Pulmonary Agents|Cystic Fibrosis Agents|Cystic Fibrosis Agents, Other|Mannitol|D00062  Mannitol (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00062)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00062  Mannitol (USP); D-Mannitol (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00062)]|Chemicals|D00062  D-Mannitol|D00062  D-Mannitol injection|New drug approvals in Europe [br08329.html(D00062)]|European public assessment reports (EPAR) authorised medicine|D00062",
C00394,GDP-glucose;|GDP-D-glucose;|GDP-alpha-D-glucose,,,,,G11108
C00395,Penicillin;|Penam,Generic compound in reaction hierarchy,0 Aad  1 Cys  2 Val,NRP,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00395,
C00396,Pyrimidine;|Pyrimidine base,Generic compound in reaction hierarchy,,,,
C00397,Tobramycin;|Nebramycin factor 6;|3'-Deoxykanamycin B,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00063)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB01 Tobramycin|D00063  Tobramycin (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA12 Tobramycin|D00063  Tobramycin (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00063)]|Antibacterials|Aminoglycosides|Tobramycin|D00063  Tobramycin (JP18/USP)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Tobramycin|D00063  Tobramycin (JP18/USP)|Respiratory Tract/Pulmonary Agents|Cystic Fibrosis Agents|Inhaled Anti-infectives|Tobramycin|D00063  Tobramycin (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00063)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1317  Ophthalmic antibiotics|D00063  Tobramycin (JP18/USP)|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6123  Amino sugars|D00063  Tobramycin (JP18/USP)|Drug groups [BR:br08330(D00063)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00608  Tobramycin|D00063  Tobramycin|Drug classes [BR:br08332(D00063)]|Antibacterial|DG01447  Aminoglycoside antibiotic|D00063  Tobramycin|Antimicrobials [BR:br08307(D00063)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D00063  Tobramycin (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00063)]|Chemicals|D00063  Tobramycin|D00063 Tobramycin injection|New drug approvals in Europe [br08329.html(D00063)]|European public assessment reports (EPAR) authorised medicine|D00063|Pharmacogenomic biomarkers [br08341.html(D00063)]|Polymorphisms and mutations affecting drug response|D00063",
C00398,Tryptamine;|3-(2-Aminoethyl)indole,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C00398  Tryptamine,
C00399,Ubiquinone;|Coenzyme Q;|CoQ;|Q,Generic compound in reaction hierarchy|n=5-9|Ubiquinone-6 [CPD:C17568]|Ubiquinone-8 [CPD:C17569]|Ubiquinone-9 [CPD:C01967]|Ubiquinone-10 [CPD:C11378] [DR:D01065],,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C00399  Ubiquinone,
C00400,(-)-Menthol;|L-Menthol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00400  (-)-Menthol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00400  (-)-Menthol|Therapeutic category of drugs in Japan [BR:br08301(D00064)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D00064  l-Menthol (JP18)|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00064  l-Menthol (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00064)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00064  l-Menthol (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00064)]|Third-class OTC drugs|Inorganic and organic chemicals|Menthol|D00064  l-Menthol (JP18)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C00400  L-Menthol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00400|Target-based classification of drugs [BR:br08310(D00064)]|Ion channels|Voltage-gated ion channels|Transient receptor potential channels|TRPA1|D00064  l-Menthol (JP18) &lt;JP&gt;|TRPM8|D00064  l-Menthol (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00064)]|Chemicals|D00064  l-Menthol",
C00401,Chondroitin;|Chondroitin-D-glucuronate,,,,Compounds with biological roles [BR:br08001(G11334)]|Carbohydrates|Polysaccharides|Heteropolysaccharides|G11334  Chondroitin,G11334
C00402,D-Aspartate;|D-Aspartic acid,L-Aspartate [CPD:C00049],,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00402  D-Aspartic acid,
C00403,Polypeptide,Generic compound in reaction hierarchy,,,,
C00404,Polyphosphate;|(Phosphate)n;|(Phosphate)n+1;|(Phosphate)n-1;|(Polyphosphate)n;|(Polyphosphate)n-1,Generic compound in reaction hierarchy,,,,
C00405,D-Amino acid,Generic compound in reaction hierarchy,,,,
C00406,Feruloyl-CoA;|trans-Feruloyl-CoA;|4-Hydroxy-3-methoxycinnamoyl-CoA;|(E)-3-(4-Hydroxy-3-methoxyphenyl)propenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00406  Feruloyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C00406  Feruloyl-CoA,
C00407,L-Isoleucine;|2-Amino-3-methylvaleric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Common amino acids|C00407  Isoleucine (Ile)|Risk category of Japanese OTC drugs [BR:br08312(D00065)]|Third-class OTC drugs|Inorganic and organic chemicals|L-Isoleucine|D00065  Isoleucine (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00065)]|Chemicals|D00065  L-Isoleucine,
C00408,L-Pipecolate;|Pipecolinic acid;|Pipecolic acid;|2-Piperidinecarboxylic acid;|(S)-Piperidine-2-carboxylic acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C00408  L-Pipecolate,
C00409,Methanethiol;|Methylmercaptan,,,,,
C00410,"Progesterone;|4-Pregnene-3,20-dione",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C00410  Progesterone|Hormones and transmitters|Steroid hormones|Progestagens|C00410  Progesterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C00410  Progesterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00066)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DA Pregnen (4) derivatives|G03DA04 Progesterone|D00066  Progesterone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00066)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Progesterone|D00066  Progesterone (JP18/USP/INN)|Infertility Agents|Progesterone|D00066  Progesterone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00066)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2477  Progesterones|D00066  Progesterone (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9415  Luteinizing hormone and preparations|C00410  Progesterone|Drug groups [BR:br08330(D00066)]|Hormonal agent|DG02004  Progesterone|D00066  Progesterone|DG01666  Progesterone receptor agonist|D00066  Progesterone|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D00066  Progesterone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00066  Progesterone|Drug classes [BR:br08332(D00066)]|Endocrine and hormonal agent|DG02004  Progesterone|D00066  Progesterone|Target-based classification of drugs [BR:br08310(D00066)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00066  Progesterone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00066)]|Chemicals|D00066  Progesterone|D00066  Progesterone injection|Drug metabolizing enzymes and transporters [br08309.html(D00066)]|Drug metabolizing enzymes|D00066",
C00411,Sinapoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00411  Sinapoyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C00411  Sinapoyl-CoA,
C00412,Stearoyl-CoA;|Stearyl-CoA;|Stearyl coenzyme A;|Octadecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00412  Octadecanoyl-CoA,
C00413,Streptomycin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|Streptidines|C00413  Streptomycin|Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C00413  Streptomycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00413|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08531)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA04 Streptomycin|D08531  Streptomycin (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GA Streptomycins|J01GA01 Streptomycin|D08531  Streptomycin (INN)|Drug groups [BR:br08330(D08531)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00082  Streptomycin|D08531  Streptomycin|DG01966  Antitubercular|DG00082  Streptomycin|D08531  Streptomycin|Antimicrobials [BR:br08307(D08531)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08531  Streptomycin (INN)",
C00414,Cyclohexanone,,,,,
C00415,"Dihydrofolate;|Dihydrofolic acid;|7,8-Dihydrofolate;|7,8-Dihydrofolic acid;|7,8-Dihydropteroylglutamate",,,,,
C00416,"Phosphatidate;|Phosphatidic acid;|1,2-Diacyl-sn-glycerol 3-phosphate;|3-sn-Phosphatidate",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C00416  Phosphatidic acid|Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1001 Diacylglycerophosphates|C00416  1,2-Diacyl-sn-glycerol 3-phosphate",
C00417,cis-Aconitate;|cis-Aconitic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Tricarboxylic acids|C00417  cis-Aconitate,
C00418,"(R)-Mevalonate;|Mevalonic acid;|3,5-Dihydroxy-3-methylvaleric acid;|(3R)-3,5-Dihydroxy-3-methylpentanoic acid;|(R)-Mevalonic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C00418  (R)-Mevalonic acid,
C00419,Polynucleotide,Generic compound in reaction hierarchy,,,,
C00420,Polysaccharide;|Glycan;|Polyglycose,Generic compound in reaction hierarchy,,,,
C00422,Triacylglycerol;|Triglyceride,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Fats|Acylglycerols|C00422  Triacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0301 Triacylglycerols|C00422  Triacyl-sn-glycerol,
C00423,trans-Cinnamate;|trans-Cinnamic acid;|(E)-Cinnamate;|(2E)-3-Phenylprop-2-enoate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C00423  trans-Cinnamate,
C00424,(S)-Lactaldehyde;|L-Lactaldehyde;|L-2-Hydroxypropionaldehyde,,,,,
C00426,Dermatan sulfate,Generic compound in reaction hierarchy|R = SO3- or H,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AX Other antithrombotic agents|B01AX04 Dermatan sulfate|C00426  Dermatan sulfate,
C00427,"Prostaglandin H2;|(5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate;|(5Z,13E,15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate;|PGH2;|(5Z,9alpha,11alpha,13E,15S)-9,11-Epidioxy-15-hydroxy-prosta-5,13-dienoate",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C00427  Prostaglandin H2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C00427  Prostaglandin H2,
C00429,"5,6-Dihydrouracil;|Dihydro-2,4(1H,3H)-pyrimidinedione;|Dihydrouracile;|Dihydrouracil;|5,6-Dihydro-2,4-dihydroxypyrimidine;|Hydrouracil;|2,4-Dioxotetrahydropyrimidine",,,,,
C00430,5-Aminolevulinate;|5-Amino-4-oxopentanoate;|5-Amino-4-oxovaleric acid;|5-Amino-4-oxopentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C00430  5-Amino-4-oxopentanoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07567)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XD Sensitizers used in photodynamic/radiation therapy|L01XD04 Aminolevulinic acid|D07567  Aminolevulinic acid,
C00431,5-Aminopentanoate;|5-Aminopentanoic acid;|5-Aminovaleric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C00431  5-Aminopentanoic acid,
C00433,"2,5-Dioxopentanoate;|2-Oxoglutarate semialdehyde",,,,,
C00434,Double-stranded DNA,,,,,
C00436,N-Carbamoylputrescine,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amines|C00436  N-Carbamoylputrescine,
C00437,N-Acetylornithine;|N2-Acetyl-L-ornithine,,,,,
C00438,N-Carbamoyl-L-aspartate,,,,,
C00439,N-Formimino-L-glutamate;|N-Formimidoyl-L-glutamate,,,,,
C00440,5-Methyltetrahydrofolate,,,,,
C00441,L-Aspartate 4-semialdehyde;|Aspartate beta-semialdehyde;|L-Aspartic 4-semialdehyde,,,,,
C00444,5'-Phosphooligoribonucleotide,,,,,
C00445,"5,10-Methenyltetrahydrofolate",,,,,
C00446,alpha-D-Galactose 1-phosphate;|alpha-D-Galactopyranose 1-phosphate,,,,,
C00447,"Sedoheptulose 1,7-bisphosphate;|D-Sedoheptulose 1,7-bisphosphate;|D-altro-Heptulose 1,7-biphosphate",,,,,
C00448,"trans,trans-Farnesyl diphosphate;|Farnesyl diphosphate;|Farnesyl pyrophosphate;|2-trans,6-trans-Farnesyl diphosphate;|(2E,6E)-Farnesyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C00448  trans,trans-Farnesyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C00448  Farnesyl diphosphate",
C00449,"N6-(L-1,3-Dicarboxypropyl)-L-lysine;|Saccharopine;|L-Saccharopine;|N-[(S)-5-Amino-5-carboxypentyl]-L-glutamic acid",,,,,
C00450,"(S)-2,3,4,5-Tetrahydropyridine-2-carboxylate;|Delta1-Piperideine-6-L-carboxylate",,,,,
C00451,"(1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate;|D-threo-Isocitric acid",,,,,
C00454,NDP;|Nucleoside diphosphate;|Nucleoside 5'-diphosphate,Generic compound in reaction hierarchy|see the classified Nucleotide,,,,
C00455,Nicotinamide D-ribonucleotide;|NMN;|Nicotinamide mononucleotide;|Nicotinamide ribonucleotide;|Nicotinamide nucleotide;|beta-Nicotinamide D-ribonucleotide;|beta-Nicotinamide ribonucleotide;|beta-Nicotinamide mononucleotide,,,,,
C00458,dCTP;|Deoxycytidine 5'-triphosphate;|Deoxycytidine triphosphate;|2'-Deoxycytidine 5'-triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00458  dCTP,
C00459,dTTP;|Deoxythymidine triphosphate;|Deoxythymidine 5'-triphosphate;|TTP,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00459  dTTP,
C00460,dUTP;|2'-Deoxyuridine 5'-triphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00460  dUTP,
C00461,"Chitin;|beta-1,4-Poly-N-acetyl-D-glucosamine;|[1,4-(N-Acetyl-beta-D-glucosaminyl)]n;|[1,4-(N-Acetyl-beta-D-glucosaminyl)]n+1",,,,Compounds with biological roles [BR:br08001(G10483)]|Carbohydrates|Polysaccharides|Homopolysaccharides|G10483  Chitin,G10483
C00463,"Indole;|2,3-Benzopyrrole",,,,,
C00466,Acetoin;|2-Acetoin;|3-Hydroxybutan-2-one;|3-Hydroxy-2-butanone;|Dimethylketol,(R)-Acetoin [CPD:C00810]|(S)-Acetoin [CPD:C01769],,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C00466  3-Hydroxybutan-2-one,
C00468,"Estrone;|3-Hydroxy-1,3,5(10)-estratrien-17-one",,,,"Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C00468  Estrone|Hormones and transmitters|Steroid hormones|Estrogens|C00468  Estrone (E1)|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C00468  Estrone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Estrane|C00468  Estrone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00067)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA07 Estrone|D00067  Estrone (JAN/USP/INN)|G03CC Estrogens, combinations with other drugs|G03CC04 Estrone|D00067  Estrone (JAN/USP/INN)|Drug groups [BR:br08330(D00067)]|Hormonal agent|DG01986  Estrogen|DG00464  Estrone|D00067  Estrone|DG01584  Estrogen receptor agonist|DG00464  Estrone|D00067  Estrone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00464  Estrone|D00067  Estrone|Target-based classification of drugs [BR:br08310(D00067)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00067  Estrone (JAN/USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00067)]|Drug metabolizing enzymes|D00067",
C00469,Ethanol;|Ethyl alcohol;|Methylcarbinol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00068)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AX Other antiseptics and disinfectants|D08AX08 Ethanol|D00068  Alcohol (USP) &lt;JP/US&gt;|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB16 Ethanol|D00068  Alcohol (USP) &lt;JP/US&gt;|V03AZ Nerve depressants|V03AZ01 Ethanol|D00068  Alcohol (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00068)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2615  Alcohols|D00068  Alcohol (USP); Anhydrous ethanol (JP18)|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00068  Alcohol (USP); Anhydrous ethanol (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00068)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00068  Alcohol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00068)]|Second-class OTC drugs|Inorganic and organic chemicals|Ethanol|D00068  Alcohol (USP)|Third-class OTC drugs|Inorganic and organic chemicals|Ethanol|D00068  Alcohol (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00068)]|Chemicals|D00068  Anhydrous ethanol,
C00470,"Pectate;|Pectic acid;|alpha-D-Polygalacturonic acid;|Poly(1,4-alpha-D-galacturonate);|Poly(1,4-alpha-D-galacturonate)(n);|(1,4-alpha-D-Galacturonide)n;|[(1->4)-alpha-D-Galacturonosyl]n;|De-esterified pectin;|(1,4-alpha-D-Galacturonosyl)n",,,,,G10506
C00472,"p-Benzoquinone;|Quinone;|Chinone;|2,5-Cyclohexadiene-1,4-dione;|1,4-Benzoquinone",,,,,
C00473,Retinol;|all-trans-Retinol;|Vitamin A;|Vitamin A1,,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C00473  Retinol (Vitamin A)|Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C00473  Retinol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06543)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CA Vitamin A, plain|A11CA01 Retinol (vit A)|D06543  Vitamin A (USP) &lt;JP&gt;|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD02 Retinol|D06543  Vitamin A (USP) &lt;JP&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX02 Retinol|D06543  Vitamin A (USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA02 Retinol|D06543  Vitamin A (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D06543)]|3  Agents affecting metabolism|31  Vitamins|311  Vitamins A and D preparations|3111  Synthetic vitamin A preparations|D06543  Vitamin A (USP)|Classification of Japanese OTC drugs [BR:br08313(D06543)]|Nourishing tonics and health supplements|32 Vitamin A based drugs|D06543  Vitamin A (USP)|39 Vitamin AD based drugs|D06543  Vitamin A (USP)|43 Vitamin containing supplements|D06543  Vitamin A (USP)|Risk category of Japanese OTC drugs [BR:br08312(D06543)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Retinol|D06543  Vitamin A (USP)|Second-class OTC drugs|Inorganic and organic chemicals|Vitamin A|D06543  Vitamin A (USP)|Third-class OTC drugs|Inorganic and organic chemicals|Vitamin A|D06543  Vitamin A (USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9621  Vitamin A, D and preparations|C00473  Vitamin A|Drug groups [BR:br08330(D06543)]|Vitamin and mineral|DG01604  Retinol derivative|DG00123  Retinol (vit A)|D06543  Vitamin A|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00123  Retinol (vit A)|D06543  Vitamin A|Target-based classification of drugs [BR:br08310(D06543)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D06543  Vitamin A (USP) &lt;JP&gt;|Drug metabolizing enzymes and transporters [br08309.html(D06543)]|Drug metabolizing enzymes|D06543",
C00474,Ribitol;|Adonitol,,,,,
C00475,Cytidine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Ribonucleosides|C00475  Cytidine (C),
C00476,D-Lyxose,alpha-D-Lyxose [CPD:C02204],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00476  D-Lyxose,
C00477,"Ecdysone;|(2beta,3beta,5beta,22R)-2,3,14,22,25-Pentahydroxycholest-7-en-6-one",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Cholestane derivatives|C00477  Ecdysone|Hormones and transmitters|Steroid hormones|Others|C00477  Ecdysone|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C00477  Ecdysone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C00477  Ecdysone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00477,
C00478,Lichenin;|Lichenan,,,,,
C00479,Propanal;|Propionaldehyde,,,,,
C00480,Pullulan,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D05363)]|Chemicals|D05363  Pullulan capsules|D05363  Pullulan,
C00481,"Pyrazole;|1,2-Diazole",,,,,
C00482,"Sinapate;|Sinapic acid;|3,5-Dimethoxy-4-hydroxycinnamic acid",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C00482  Sinapate,
C00483,Tyramine;|2-(p-Hydroxyphenyl)ethylamine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C00483  Tyramine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C00483  Tyramine,
C00484,Arylamide,,,,,
C00486,Bilirubin,,,,,
C00487,Carnitine;|gamma-Trimethyl-hydroxybutyrobetaine;|3-Hydroxy-4-trimethylammoniobutanoate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Carnitine|C00487  Carnitine,
C00488,Formamide;|Methanamide,,,,,
C00489,"Glutarate;|Glutaric acid;|Pentanedioic acid;|1,3-Propanedicarboxylic acid",,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C00489  Glutarate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00489  Pentanedioic acid,
C00490,Itaconate;|Itaconic acid;|Methylenesuccinic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00490  Itaconic acid,
C00491,L-Cystine;|L-Dicysteine;|L-alpha-Diamino-beta-dithiolactic acid,,,,Risk category of Japanese OTC drugs [BR:br08312(D03636)]|Third-class OTC drugs|Inorganic and organic chemicals|Cystine|D03636  Cystine (USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D03636)]|Chemicals|D03636  L-Cystine,
C00492,Raffinose;|Melitose;|Melitriose;|Gossypose;|6G-alpha-D-galactosylsucrose,,,,,G00249
C00493,"Shikimate;|Shikimic acid;|3,4,5-Trihydroxy-1-cyclohexenecarboxylic acid",,,,,
C00494,Sisomicin;|Antibiotic 6640;|Dehydrogentamicin Cla;|Rickamicin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02544)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB08 Sisomicin|D02544  Sisomicin (USAN/INN)|Drug groups [BR:br08330(D02544)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00610  Sisomicin|D02544  Sisomicin|Antimicrobials [BR:br08307(D02544)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D02544  Sisomicin (USAN/INN),
C00495,Sulochrin,,,,,
C00497,(R)-Malate;|D-Malate;|D-Malic acid,,,,,
C00498,ADP-glucose;|ADP-alpha-D-glucose;|Adenosine diphosphoglucose,,,,,G11109
C00499,Allantoate;|Allantoic acid,,,,,
C00500,Biliverdin;|Biliverdin IX alpha,,,,,
C00501,CDP-glucose;|CDP-D-Glucose,,,,,
C00502,D-Xylonate,,,,,
C00503,Erythritol;|Erythrol;|Phycitol;|Phycite;|Erythrite,,,,,
C00504,Folate;|Pteroylglutamic acid;|Folic acid,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00504  Folic acid (Vitamin B9)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00070)]|B BLOOD AND BLOOD FORMING ORGANS|B03 ANTIANEMIC PREPARATIONS|B03B VITAMIN B12 AND FOLIC ACID|B03BB Folic acid and derivatives|B03BB01 Folic acid|D00070  Folic acid (JP18/USP/INN) &lt;JP/US&gt;|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CX Other diagnostic agents|V04CX02 Folic acid|D00070  Folic acid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00070)]|Electrolytes/Minerals/Metals/Vitamins|Vitamins|Folic Acid|D00070  Folic acid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00070)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3135  Folic acids|D00070  Folic acid (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00070)]|Agents for circulatory system and blood|24 Anemia drugs|D00070  Folic acid (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00070)]|Third-class OTC drugs|Inorganic and organic chemicals|Folic acid|D00070  Folic acid (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00070)]|Chemicals|D00070  Folic acid|D00070  Folic acid tablets|D00070  Folic acid injection,
C00505,Gentamicin,"Gentamicin is a generic name for the 2-deoxystreptamine-derived aminoglycosides produced by M.echinospora and related species, and also an antibiotic complex, consisting of three closely related components, Gentamicin C1 [CPD:C07656], Gentamicin C2 [CPD:C02033], Gentamicin C1a [CPD:C00908] and Gentamicin A [CPD:C01917].",,,,
C00506,L-Cysteate;|L-Cysteic acid;|3-Sulfoalanine;|2-Amino-3-sulfopropionic acid,,,,,
C00507,L-Rhamnose;|6-Deoxy-L-mannose;|L-Mannomethylose;|L-Rhamnopyranose,alpha-L-Rhamnose [CPD:C02476]|beta-L-Rhamnose [CPD:C02338],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C00507  L-Rhamnose,
C00508,L-Ribulose;|L-erythro-Pentulose;|L-Arabinoketose;|L-Arabinulose;|L-Riboketose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00508  L-Ribulose,
C00509,"Naringenin;|4',5,7-Trihydroxyflavanone;|(2S)-Naringenin;|(-)-(2S)-Naringenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C00509  Naringenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C00509  Naringenin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00509|Dietary phytochemicals [br08012.html]|Flavonoids|C00509,
C00510,Oleoyl-CoA;|(9Z)-Octadecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00510  (9Z)-Octadecenoyl-CoA,
C00511,Acrylic acid;|Propenoate;|Acrylate;|2-Propenoic acid;|Vinylformic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C00511  2-Propenoic acid,
C00512,Benzoyl-CoA;|S-Benzoyl-coenzyme A,,,,,
C00513,CDP-glycerol,,,,,
C00514,D-Mannonate,,,,,
C00515,D-Ornithine,,,,,
C00517,Hexadecanal;|Palmitaldehyde,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C00517  Hexadecanal,
C00518,"Hyaluronate;|Hyaluronic acid;|Hyaluronan;|[beta-N-Acetyl-D-glucosaminyl(1,4)beta-D-glucuronosyl(1,3)]n",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08043)]|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX05 Hyaluronic acid|D08043  Hyaluronic acid (BAN)|M MUSCULO-SKELETAL SYSTEM|M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09AX Other drugs for disorders of the musculo-skeletal system|M09AX01 Hyaluronic acid|D08043  Hyaluronic acid (BAN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX09 Hyaluronic acid|D08043  Hyaluronic acid (BAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01K SURGICAL AIDS|S01KA Viscoelastic substances|S01KA01 Hyaluronic acid|D08043  Hyaluronic acid (BAN)|USP drug classification [BR:br08302(D08043)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Hyaluronate|D08043  Hyaluronic acid (BAN)|Risk category of Japanese OTC drugs [BR:br08312(D08043)]|Third-class OTC drugs|Inorganic and organic chemicals|Hyaluronic acid|D08043  Hyaluronic acid (BAN),G10505
C00519,Hypotaurine;|2-Aminoethanesulfinic acid,,,,,
C00521,(S)-Limonene;|(-)-Limonene;|(4S)-1-Methyl-4-(prop-1-en-2-yl)cyclohexene;|(-)-(S)-Limonene;|(-)-(4S)-Limonene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00521  (-)-Limonene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00521  (-)-Limonene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00521,
C00522,(R)-Pantoate;|Pantoate;|Pantoic acid,,,,,
C00523,Androsterone;|3alpha-Hydroxy-5alpha-androstan-17-one,,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C00523  Androsterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C00523  3alpha-Hydroxy-5alpha-androstan-17-one,
C00524,Cytochrome c;|Holocytochrome c,Heme type: Heme C [CPD:C15817]|Reduced form [CPD:C00126]|Oxidized form [CPD:C00125],,,,
C00525,D-Tryptophan,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00525  D-Tryptophan,
C00526,Deoxyuridine;|2-Deoxyuridine;|2'-Deoxyuridine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Deoxyribonucleosides|C00526  Deoxyuridine (dU),
C00527,Glutaryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00527  Glutaryl-CoA,
C00528,Glycopeptide,,,,,
C00530,"Hydroquinone;|p-Benzenediol;|1,4-Benzenediol;|1,4-Dihydroxybenzene;|Benzene-1,4-diol;|Quinol;|4-Hydroxyphenol",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00073)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX11 Hydroquinone|D00073  Hydroquinone (USP)|Drug groups [BR:br08330(D00073)]|Cardiovascular agent|DG01617  Catecholamine synthesis inhibitors|D00073  Hydroquinone|Target-based classification of drugs [BR:br08310(D00073)]|Enzymes|Oxidoreductases (EC1)|Other monooxygenases|TYR|D00073  Hydroquinone (USP)|Dietary phytochemicals [br08012.html]|Other phytochemicals|C00530,
C00531,Itaconyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00531  Itaconyl-CoA,
C00532,L-Arabitol;|L-Arabinol;|L-Arabinitol;|L-Lyxitol,D-Arabitol [CPD:C01904],,,,
C00533,Nitric oxide;|NO;|Nitrogen monoxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00074)]|R RESPIRATORY SYSTEM|R07 OTHER RESPIRATORY SYSTEM PRODUCTS|R07A OTHER RESPIRATORY SYSTEM PRODUCTS|R07AX Other respiratory system products|R07AX01 Nitric oxide|D00074  Nitric oxide (JAN/USAN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00074)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00074  Nitric oxide (JAN/USAN)|New drug approvals in the USA [br08319.html(D00074)]|New molecular entities and new therapeutic biological products|D00074|New drug approvals in Europe [br08329.html(D00074)]|European public assessment reports (EPAR) authorised medicine|D00074|New drug approvals in Japan [br08318.html(D00074)]|Drugs with new active ingredients|D00074|New drug approvals in the USA, Europe and Japan [br08328.html(D00074)]|Approval dates by FDA, EMA and PMDA|D00074",
C00534,Pyridoxamine;|PM,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00534  Pyridoxamine (Vitamin B6)|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Pyridoxine hydrochloride|C00534  Pyridoxamine,
C00535,Testosterone;|17beta-Hydroxy-4-androsten-3-one,,,,"Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C00535  Testosterone|Hormones and transmitters|Steroid hormones|Androgens|C00535  Testosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C00535  17beta-Hydroxy-4-androsten-3-one|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Androstane|C00535  Testosterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00075)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D00075  Testosterone (JAN/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00075)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Androgens|Testosterone|D00075  Testosterone (JAN/USP)|Classification of Japanese OTC drugs [BR:br08313(D00075)]|Agents for  urogenital organs and anus|31 Other drugs for  urogenital organs and anus|D00075  Testosterone (JAN/USP)|Agents for integumentary system|61 Other agents for integumentary system|D00075  Testosterone (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00075)]|First-class OTC drugs|Inorganic and organic chemicals|Testosterone|D00075  Testosterone (JAN/USP)|Drug groups [BR:br08330(D00075)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D00075  Testosterone|DG02006  Testosterone|DG00460  Testosterone|D00075  Testosterone|Target-based classification of drugs [BR:br08310(D00075)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00075  Testosterone (JAN/USP) &lt;US&gt;",
C00536,Triphosphate;|Triphosphoric acid;|Tripolyphosphate;|Inorganic triphosphate,,,,,
C00538,2-Oxoaldehyde,Generic compound in reaction hierarchy,,,,
C00539,Aromatic acid;|Aromatic carboxylic acid,Generic compound in reaction hierarchy,,,,
C00540,Cinnamoyl-CoA;|S-(Cinnamoyl) coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00540  Cinnamoyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C00540  Cinnamoyl-CoA,
C00541,Cob(II)alamin;|Vitamin B12r,,,,,
C00542,Cystathionine,,,,,
C00543,Dimethylamine;|(CH3)2NH,,,,,
C00544,"Homogentisate;|Homogentisic acid;|2,5-Dihydroxyphenylacetic acid;|2,5-Dihydroxyphenylacetate",,,,,
C00545,L-Arabinonate,,,,,
C00546,Methylglyoxal;|Pyruvaldehyde;|Pyruvic aldehyde;|2-Ketopropionaldehyde;|2-Oxopropanal,,,,,
C00547,"L-Noradrenaline;|Noradrenaline;|Norepinephrine;|Arterenol;|4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol",,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Other hormones|Adrenalines|C00547  Noradrenaline|Neurotransmitters|Biogenic amines|C00547  Norepinephrine; Noradrenaline|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00076)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA03 Norepinephrine|D00076  Noradrenaline (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00076)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2451  Epinephrines|D00076  Noradrenaline (JP18); Norepinephrine (INN)|Drug groups [BR:br08330(D00076)]|Cardiovascular agent|DG01703  Cardiotonic|DG01699  Catecholamine cardiotonic|DG00212  Norepinephrine|D00076  Noradrenaline|DG01456  Adrenergic receptor agonist|DG00212  Norepinephrine|D00076  Noradrenaline|DG01951  Catecholamine adrenergic receptor agonist|DG00212  Norepinephrine|D00076  Noradrenaline|Metabolizing enzyme substrate|DG01592  COMT substrate|DG00212  Norepinephrine|D00076  Noradrenaline|DG02917  MAO substrate|DG00212  Norepinephrine|D00076  Noradrenaline|Target-based classification of drugs [BR:br08310(D00076)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00076  Noradrenaline (JP18) &lt;JP&gt;|ADRA2|D00076  Noradrenaline (JP18) &lt;JP&gt;|ADRB|D00076  Noradrenaline (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00076)]|Chemicals|D00076  Noradrenaline|D00076  Noradrenaline injection|Drug metabolizing enzymes and transporters [br08309.html(D00076)]|Drug metabolizing enzymes|D00076,
C00548,"Phenyl acetate;|Acetylphenol;|Acetic acid,phenyl ester",Phenyl acetate (generic) [CPD:C15583],,,,
C00549,RNA (poly(U)),,,,,
C00550,Sphingomyelin,Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Phosphosphingolipids|C00550  Sphingomyelin|Lipids [BR:br08002]|SP  Sphingolipids|SP03 Phosphosphingolipids|SP0301 Ceramide phosphocholines (sphingomyelins)|C00550  Sphingomyelin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C00550  Sphingomyelin",
C00552,meso-Tartaric acid;|meso-Tartrate,,,,,
C00553,(+)-Neomenthol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00553  (+)-Neomenthol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00553  (+)-Neomenthol,
C00555,4-Aminobutyraldehyde;|4-Aminobutanal,,,,,
C00556,Benzyl alcohol;|alpha-Hydroxytoluene;|Benzenemethanol;|Phenylmethanol;|Phenylcarbinol;|Hydroxymethylbenzene,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00077)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AX Other ectoparasiticides, incl. scabicides|P03AX06 Benzyl alcohol|D00077  Benzyl alcohol (JP18/NF/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00077)]|Third-class OTC drugs|Inorganic and organic chemicals|Benzyl alcohol|D00077  Benzyl alcohol (JP18/NF/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00077)]|Chemicals|D00077  Benzyl alcohol|New drug approvals in the USA [br08319.html(D00077)]|New molecular entities and new therapeutic biological products|D00077|New drug approvals in the USA, Europe and Japan [br08328.html(D00077)]|Approval dates by FDA, EMA and PMDA|D00077",
C00557,Cyclopentanone,,,,,
C00558,D-Tagaturonate;|D-Tagaturonic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C00558  D-Tagaturonic acid,
C00559,Deoxyadenosine;|2'-Deoxyadenosine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Deoxyribonucleosides|C00559  Deoxyadenosine (dA),
C00561,Mandelonitrile;|Benzaldehyde cyanohydrin;|(R)-Mandelonitrile,,,,,
C00563,Phosphoramidon,,,,,
C00565,"Trimethylamine;|(CH3)3N;|N,N-Dimethylmethanamine",,,,,
C00566,(3S)-Citryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00566  (3S)-Citryl-CoA,
C00568,4-Aminobenzoate;|ABEE;|4-Aminobenzoic acid;|p-Aminobenzoate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02456)]|D DERMATOLOGICALS|D02 EMOLLIENTS AND PROTECTIVES|D02B PROTECTIVES AGAINST UV-RADIATION|D02BA Protectives against UV-radiation for topical use|D02BA01 Aminobenzoic acid|D02456  Aminobenzoic acid (USP)|Drug groups [BR:br08330(D02456)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00379  Aminobenzoic acid|D02456  Aminobenzoic acid|Target-based classification of drugs [BR:br08310(D02456)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D02456  Aminobenzoic acid (USP)|SCN2A|D02456  Aminobenzoic acid (USP)|SCN3A|D02456  Aminobenzoic acid (USP)|SCN4A|D02456  Aminobenzoic acid (USP)|SCN5A|D02456  Aminobenzoic acid (USP)|SCN8A|D02456  Aminobenzoic acid (USP)|SCN9A|D02456  Aminobenzoic acid (USP)|SCN10A|D02456  Aminobenzoic acid (USP)|SCN11A|D02456  Aminobenzoic acid (USP),
C00570,CDP-ethanolamine;|Cytidine diphosphate ethanolamine,,,,,
C00571,Cyclohexylamine;|Cyclohexanamine,,,,,
C00573,Keratan sulfate;|Kerato sulfate;|Keratan 6'-sulfate;|Keratan;|Kerato 6'-sulfate,,,,,
C00574,beta-D-Fucoside,,,,,
C00575,"3',5'-Cyclic AMP;|Cyclic adenylic acid;|Cyclic AMP;|Adenosine 3',5'-phosphate;|Adenosine 3',5'-cyclic phosphate;|cAMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C00575  3',5'-Cyclic AMP",
C00576,Betaine aldehyde,,,,,
C00577,D-Glyceraldehyde,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C00577  D-Glyceraldehyde,
C00579,Dihydrolipoamide;|Dihydrothioctamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C00579  Dihydrolipoamide,
C00580,Dimethyl sulfide;|Methyl sulfide;|Methyl thioether,,,,,
C00581,Guanidinoacetate;|Guanidinoacetic acid;|Glycocyamine;|N-Amidinoglycine;|Guanidoacetic acid,,,,,
C00582,Phenylacetyl-CoA;|Phenylacetyl coenzyme A,,,,,
C00583,"Propane-1,2-diol;|1,2-Propanediol;|Propylene glycol",,,,Therapeutic category of drugs in Japan [BR:br08301(D00078)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|713  Solvents|7139  Others|D00078  Propylene glycol (JP18/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9646  Propylene glycol and preparations|C00583  Propylene glycol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00078)]|Chemicals|D00078  Propylene glycol,
C00584,"Prostaglandin E2;|(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate;|Dinoprostone;|PGE2",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C00584  Prostaglandin E2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C00584  Prostaglandin E2|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00079)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AD Prostaglandins|G02AD02 Dinoprostone|D00079  Dinoprostone (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00079)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D00079  Dinoprostone (JAN/USP/INN)|Drug groups [BR:br08330(D00079)]|Hormonal agent|DG01961  Prostaglandin derivative|DG01959  Prostaglandin E2 derivative|DG00448  Dinoprostone|D00079  Dinoprostone|Target-based classification of drugs [BR:br08310(D00079)]|G Protein-coupled receptors|Rhodopsin family|Prostaglandin|PTGER2|D00079  Dinoprostone (JAN/USP/INN) &lt;JP/US&gt;,
C00585,Protein tyrosine;|[Protein]-L-tyrosine,Generic compound in reaction hierarchy,,,,
C00586,2-Deoxy-D-glucose;|2-Deoxy-D-arabino-hexose;|D-arabino-2-Deoxyhexose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C00586  2-Deoxy-D-glucose,
C00587,3-Hydroxybenzoate;|3-Hydroxybenzoic acid;|m-Hydroxybenzoic acid,,,,,
C00588,Choline phosphate;|Phosphorylcholine;|Phosphocholine;|O-Phosphocholine,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Phosphorylcholine|C00588  Choline phosphate,
C00590,Coniferyl alcohol;|Coniferol;|4-(3-Hydroxy-1-propenyl)-2-methoxyphenol;|trans-Coniferyl alcohol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C00590  Coniferyl alcohol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00590,
C00591,N-Acylneuraminate,Generic compound in reaction hierarchy|R = CH3 [CPD:C00270]|R = CH2OH [CPD:C03410],,,,
C00593,Sulfoacetaldehyde;|2-Sulfoacetaldehyde;|2-Oxoethanesulfonate,,,,,
C00596,"2-Hydroxy-2,4-pentadienoate;|cis-2-Hydroxypenta-2,4-dienoate;|Oxopent-4-enoate;|2-Oxopent-4-enoate;|2-Hydroxypenta-2,4-dienoate",,,,,
C00597,Glycerate 3-phosphate;|3-Phosphoglycerate,"The name ""3-Phosphoglycerate"" usually means 3-Phospho-D-glycerate [CPD:C00197].",,,,
C00599,Cholest-4-en-3-one;|Cholestenone;|4-Cholesten-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C00599  Cholest-4-en-3-one,
C00601,Phenylacetaldehyde;|alpha-Tolualdehyde,,,,,
C00602,beta-D-Galactoside,,,,,
C00603,(S)-Ureidoglycolate;|(-)-Ureidoglycolate,,,,,
C00604,"1,10-Phenanthroline;|o-Phenanthroline",,,,,
C00605,"2,3-Dehydroacyl-CoA;|Dehydroacyl-CoA",Generic compound in reaction hierarchy,,,,
C00606,3-Sulfino-L-alanine;|L-Cysteinesulfinic acid;|3-Sulphino-L-alanine;|3-Sulfinoalanine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00606  3-Sulfino-L-alanine,
C00607,Chondroitin sulfate,Generic compound|R = SO3- or H|Chondroitin sulfate A [CPD:C00634]|Chondroitin sulfate B [CPD:C20908]|Chondroitin sulfate C [CPD:C00635]|Chondroitin sulfate D [CPD:C22505]|Chondroitin sulfate E [CPD:C20907],,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AX Other antiinflammatory and antirheumatic agents, non-steroids|M01AX25 Chondroitin sulfate|C00607  Chondroitin sulfate",G00762
C00608,Deoxyribonucleotide,,,,,
C00609,Long-chain aldehyde,Generic compound in reaction hierarchy,,,,
C00611,"N-Acetyllactosamine;|beta-D-Galactosyl-1,4-N-acetyl-D-glucosamine;|beta-D-Galactosyl-1,4-N-acetyl-beta-D-glucosamine",,,,,G00246
C00612,N1-Acetylspermidine,,,,,
C00613,Protein-L-arginine;|Peptide L-arginine,Generic compound in reaction hierarchy,,,,
C00614,Protein glutamate;|Protein L-glutamate,Generic compound in reaction hierarchy,,,,
C00615,Protein histidine;|Protein L-histidine;|[Protein]-L-histidine,Generic compound in reaction hierarchy,,,,
C00616,Quercetin 3-sulfate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C00616  Quercetin 3-sulfate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C00616  Quercetin 3-sulfate,
C00617,UDP-D-galacturonate;|UDPgalacturonate;|UDP-alpha-D-galacturonate,,,,,G11110
C00618,3-Dehydro-L-gulonate,,,,,
C00619,3-Oxo-Delta4-steroid,Generic compound in reaction hierarchy,,,,
C00620,alpha-D-Ribose 1-phosphate;|Ribose 1-phosphate;|D-Ribose 1-phosphate,,,,,
C00621,Dolichyl diphosphate;|Dolichol diphosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C00621  Dolichyl diphosphate,
C00623,sn-Glycerol 1-phosphate;|sn-Gro-1-P;|L-Glycerol 1-phosphate,,,,,
C00624,N-Acetyl-L-glutamate;|N-Acetyl-L-glutamic acid,,,,,
C00625,N-Acyl-D-mannosamine,Generic compound in reaction hierarchy,,,,
C00627,Pyridoxine phosphate;|Pyridoxine 5'-phosphate;|Pyridoxine 5-phosphate;|Pyridoxol 5'-phosphate,,,,,
C00628,"2,5-Dihydroxybenzoate;|2,5-Dihydroxybenzoic acid;|Gentisic acid;|Hydroquinonecarboxylic acid;|Gentisate",,,,,
C00630,2-Methylpropanoyl-CoA;|2-Methylpropionyl-CoA;|Isobutyryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00630  2-Methylpropanoyl-CoA,
C00631,2-Phospho-D-glycerate;|D-Glycerate 2-phosphate;|2-Phospho-(R)-glycerate,,,,,
C00632,3-Hydroxyanthranilate;|3-Hydroxyanthranilic acid,,,,,
C00633,4-Hydroxybenzaldehyde;|p-Hydroxybenzaldehyde,,,,,
C00634,Chondroitin 4-sulfate;|Chondroitin sulfate A;|Chondroitin 4'-sulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00080)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AX Other antiinflammatory and antirheumatic agents, non-steroids|M01AX25 Chondroitin sulfate|D00080  Chondroitin sulfate A (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00080)]|Third-class OTC drugs|Inorganic and organic chemicals|Chondroitin sulfate A|D00080  Chondroitin sulfate A (JAN)",
C00635,Chondroitin 6-sulfate;|Chondroitin sulfate C;|Chondroitin 6'-sulfate,,,,,
C00636,D-Mannose 1-phosphate;|alpha-D-Mannose 1-phosphate,,,,,
C00637,Indole-3-acetaldehyde;|2-(Indol-3-yl)acetaldehyde;|Indoleacetaldehyde,,,,,
C00638,Long-chain fatty acid;|Higher fatty acid,Generic compound in reaction hierarchy,,,,
C00639,"Prostaglandin F2alpha;|(5Z,13E)-(15S)-9alpha,11alpha,15-Trihydroxyprosta-5,13-dienoate;|(+)-Prostaglandin F2a;|7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid;|9a,11a-PGF2;|Amoglandin;|Cyclosin;|Dinoprost;|Enzaprost;|Enzaprost F;|Panacelan;|PGF2a;|9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-oic acid;|Prostaglandin F2a;|Prostin F 2 alpha;|Protamodin;|U 14583;|(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoate",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C00639  Prostaglandin F2alpha|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C00639  Prostaglandin F2alpha|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00081)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AD Prostaglandins|G02AD01 Dinoprost|D00081  Dinoprost (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00081)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D00081  Dinoprost (JP18/USAN/INN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9419  Other hormone preparations|C00639  Dinoprost|Drug groups [BR:br08330(D00081)]|Hormonal agent|DG01961  Prostaglandin derivative|DG01960  Prostaglandin F derivative|DG00447  Dinoprost|D00081  Dinoprost|Target-based classification of drugs [BR:br08310(D00081)]|G Protein-coupled receptors|Rhodopsin family|Prostaglandin|PTGFR|D00081  Dinoprost (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00081)]|Chemicals|D00081  Dinoprost,
C00640,(3S)-3-Hydroxyacyl-CoA;|(S)-3-Hydroxyacyl-CoA,Generic compound in reaction hierarchy,,,,
C00641,"1,2-Diacyl-sn-glycerol;|1,2-Diacylglycerol;|L-1,2-Diacylglycerol",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Fats|Acylglycerols|C00641  1,2-Diacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C00641  1,2-Diacyl-sn-glycerol",
C00642,4-Hydroxyphenylacetate;|4-Hydroxyphenylacetic acid,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C00642,
C00643,5-Hydroxy-L-tryptophan;|Oxitriptan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07339)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX01 Oxitriptan|D07339  Oxitriptan (INN),
C00644,D-Mannitol 1-phosphate,,,,,
C00645,N-Acetyl-D-mannosamine;|2-Acetamido-2-deoxy-D-mannose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C00645  N-Acetyl-D-mannosamine,
C00647,Pyridoxamine phosphate;|Pyridoxamine 5'-phosphate;|Pyridoxamine 5-phosphate,,,,,
C00650,4-Hydroxymandelonitrile,,,,,
C00651,4-Methylene-L-glutamate,,,,,
C00652,"D-Arabinono-1,4-lactone",,,,,
C00653,"Poly(ribitol phosphate);|Poly-1,5-ribitol phosphate;|(Ribitol phosphate)n;|(Ribitol phosphate)n+1",,,,,G10558
C00655,Xanthosine 5'-phosphate;|Xanthylic acid;|XMP;|(9-D-Ribosylxanthine)-5'-phosphate,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C00655  Xanthosine 5'-phosphate,
C00658,"trans-2,3-Dehydroacyl-CoA;|trans-2-Enoyl-CoA;|trans-2,3-Didehydroacyl-CoA;|trans-Didehydroacyl-CoA;|(2E)-2-Enoyl-CoA",Generic compound in reaction hierarchy,,,,
C00659,2-Aceto-2-hydroxybutanoate,,,,,
C00661,Glyceraldehyde 3-phosphate,"The name ""Glyceraldehyde 3-phosphate"" usually means D-Glyceraldehyde 3-phosphate [CPD:C00118].",,,,
C00663,beta-D-Glucose 1-phosphate,,,,,
C00664,5-Formiminotetrahydrofolate;|5-Formimidoyltetrahydrofolate,,,,,
C00665,"beta-D-Fructose 2,6-bisphosphate;|D-Fructose 2,6-bisphosphate",,,,,
C00666,"LL-2,6-Diaminoheptanedioate;|LL-2,6-Diaminopimelate;|LL-2,6-Diaminopimelic acid;|(2S,6S)-2,6-Diaminoheptanedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00666  (2S,6S)-2,6-Diaminoheptanedioic acid",
C00668,alpha-D-Glucose 6-phosphate,,,,,
C00669,gamma-L-Glutamyl-L-cysteine;|L-gamma-Glutamylcysteine;|5-L-Glutamyl-L-cysteine;|gamma-Glutamylcysteine,,,,,
C00670,sn-Glycero-3-phosphocholine;|Glycerophosphocholine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07349)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AX Other parasympathomimetics|N07AX02 Choline alfoscerate|D07349  Choline alfoscerate (INN)|Drug groups [BR:br08330(D07349)]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|D07349  Choline alfoscerate|DG01719  Parasympathomimetic agent|D07349  Choline alfoscerate|Target-based classification of drugs [BR:br08310(D07349)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D07349  Choline alfoscerate (INN),
C00671,(S)-3-Methyl-2-oxopentanoic acid;|(S)-3-Methyl-2-oxopentanoate;|(3S)-3-Methyl-2-oxopentanoic acid;|(3S)-3-Methyl-2-oxopentanoate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00671  (S)-3-Methyl-2-oxopentanoic acid|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C00671  (3S)-3-Methyl-2-oxopentanoic acid,
C00672,2-Deoxy-D-ribose 1-phosphate;|2-Deoxy-alpha-D-ribose 1-phosphate,,,,,
C00673,2-Deoxy-D-ribose 5-phosphate,,,,,
C00674,"5alpha-Androstane-3,17-dione;|Androstanedione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C00674  5alpha-Androstane-3,17-dione",
C00675,Deoxynucleoside 3'-phosphate;|2'-Deoxyribonucleoside 3'-phosphate,Generic compound in reaction hierarchy,,,,
C00676,Deoxynucleoside 5'-phosphate;|2'-Deoxynucleoside 5'-phosphate;|2'-Deoxyribonucleoside 5'-phosphate;|2'-Deoxynucleoside 5'-monophosphate;|2'-Deoxyribonucleoside 5'-monophosphate,Generic compound in reaction hierarchy,,,,
C00677,Deoxynucleoside triphosphate;|2'-Deoxyribonucleoside 5'-triphosphate;|2'-Deoxyribonucleoside triphosphate,Generic compound in reaction hierarchy,,,,
C00679,"5-Dehydro-4-deoxy-D-glucarate;|(2R,3S)-2,3-Dihydroxy-5-oxohexanedioate",,,,,
C00680,"meso-2,6-Diaminoheptanedioate;|meso-2,6-Diaminopimelate;|meso-2,6-Diaminopimelic acid;|meso-Diaminoheptanedioate",,,,,
C00681,1-Acyl-sn-glycerol 3-phosphate;|2-Lysophosphatidate;|Lysophosphatidate;|Lysophosphatidic acid,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1005 Monoacylglycerophosphates|C00681  1-Acyl-sn-glycerol 3-phosphate,
C00682,2-Hydroxymuconate semialdehyde;|2-Hydroxymuconic semialdehyde;|2-Hydroxymuconate-6-semialdehyde,,,,,
C00683,(S)-Methylmalonyl-CoA;|(S)-Methylmalonyl-coenzyme A;|(2S)-Methylmalonyl-CoA;|D-Methylmalonyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00683  (S)-Methylmalonyl-CoA,
C00684,2-Dehydro-3-deoxy-L-arabinonate;|2-Dehydro-3-deoxy-L-pentonate;|2-Dehydro-3-deoxy-L-arabinonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C00684  2-Dehydro-3-deoxy-L-arabinonic acid,
C00685,3-Oxoacyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C00686,N-Acyl-D-mannosamine 6-phosphate,Generic compound in reaction hierarchy,,,,
C00688,dTDP-4-dehydro-beta-L-rhamnose;|dTDP-4-dehydro-6-deoxy-beta-L-mannose;|dTDP-4-oxo-6-deoxy-L-mannose;|dTDP-4-oxo-L-rhamnose,,,,,
C00689,"alpha,alpha'-Trehalose 6-phosphate;|Trehalose 6-phosphate",,,,,G09795
C00691,"2,4,6/3,5-Pentahydroxycyclohexanone;|scyllo-Inosose;|2-Inosose",,,,,
C00692,UDP-N-acetylmuramoyl-L-alanyl-D-glutamate;|UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate,,,,,
C00693,"trans-2,3-Dehydroacyl-[acyl-carrier protein];|trans-2-Enoyl-[acyl-carrier protein];|(2E)-Unsaturated fatty acyl-[acyl-carrier protein]",Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C00694,"beta-D-Galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R;|beta-D-Galactosyl-1,4-N-acetyl-D-glucosaminyl-R;|beta-D-Galactosyl-(1->4)-N-acetyl-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C00695,"Cholic acid;|Cholate;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanate;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C00695  Cholic acid|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C00695  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10699)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05A BILE THERAPY|A05AA Bile acids and derivatives|A05AA03 Cholic acid|D10699  Cholic acid (JAN/USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D10699)]|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Cholic Acid|D10699  Cholic acid (JAN/USAN)|Therapeutic category of drugs in Japan [BR:br08301(D10699)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D10699  Cholic acid (JAN/USAN)|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Cholic acid|C00695  Cholic acid|Drug groups [BR:br08330(D10699)]|Gastrointestinal agent|DG01956  Bile acid preparation|D10699  Cholic acid|Target-based classification of drugs [BR:br08310(D10699)]|Nuclear receptors|Thyroid hormone like receptors|Liver X receptor like receptor|NR1H4 (FXR)|D10699  Cholic acid (JAN/USAN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D10699)]|New molecular entities and new therapeutic biological products|D10699|New drug approvals in Europe [br08329.html(D10699)]|European public assessment reports (EPAR) authorised medicine|D10699|New drug approvals in Japan [br08318.html(D10699)]|Drugs with new active ingredients|D10699|New drug approvals in the USA, Europe and Japan [br08328.html(D10699)]|Approval dates by FDA, EMA and PMDA|D10699",
C00696,"Prostaglandin D2;|(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate;|(5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate;|PGD2",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C00696  Prostaglandin D2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C00696  Prostaglandin D2,
C00697,Nitrogen;|N2,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00083)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AN Medical gases|V03AN04 Nitrogen|D00083  Nitrogen (JP18/NF) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00083)]|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00083  Nitrogen (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00083)]|Chemicals|D00083  Nitrogen,
C00698,Cl-;|Chloride;|Chloride ion,,,,,
C00700,XTP;|Xanthosine 5'-triphosphate,,,,,
C00701,Base;|Nucleobase;|Base1;|Base2,Generic compound in reaction hierarchy|Pyrimidine base [CPD:C00396]|Purine base [CPD:C15587],,,,
C00703,Mercury(2+);|Hg2+;|Mercuric ion,,,,,
C00704,Superoxide;|O2.-;|Superoxide anion;|O2-,,,,,
C00705,dCDP;|2'-Deoxycytidine diphosphate;|2'-Deoxycytidine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C00705  dCDP,
C00706,Amine;|Primary amine;|Substituted amine,Generic compound in reaction hierarchy,,,,
C00707,Xylan,,,,,
C00708,Iodide;|I-;|Iodide ion,,,,,
C00711,Malate;|Malic acid;|2-Hydroxybutanedioic acid,"The name ""malate"" usually means (S)-Malate [CPD:C00149].",,,Risk category of Japanese OTC drugs [BR:br08312(D04843)]|Third-class OTC drugs|Inorganic and organic chemicals|Malic acid|D04843  Malic acid (NF),
C00712,(9Z)-Octadecenoic acid;|(Z)-Octadec-9-enoic acid;|Oleate;|Oleic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C00712  Oleic acid (18:1;9)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C00712  (Z)-Octadec-9-enoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C00712  Oleic acid,
C00713,Panose,,,,,
C00714,"Pectin;|Poly(1,4-alpha-D-galacturonide)",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02316)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07B INTESTINAL ADSORBENTS|A07BC Other intestinal adsorbents|A07BC01 Pectin|D02316  Pectin (USP)|Risk category of Japanese OTC drugs [BR:br08312(D02316)]|Third-class OTC drugs|Crude drugs|Pectin|D02316  Pectin (USP)",G10591
C00715,Pterin;|2-Amino-4-oxopteridine;|2-Amino-4-hydroxypteridine,,,,,
C00716,Serine;|2-Amino-3-hydroxypropionic acid;|3-Hydroxyalanine,D-Serine [CPD:C00740]|L-Serine [CPD:C00065],,,,
C00717,Alditol;|Glycitol;|Sugar alcohol,Generic compound in reaction hierarchy,,,,
C00718,"Amylose;|Amylose chain;|(1,4-alpha-D-Glucosyl)n;|(1,4-alpha-D-Glucosyl)n+1;|(1,4-alpha-D-Glucosyl)n-1;|4-{(1,4)-alpha-D-Glucosyl}(n-1)-D-glucose;|1,4-alpha-D-Glucan",,,,Compounds with biological roles [BR:br08001(G10495)]|Carbohydrates|Polysaccharides|Homopolysaccharides|G10495  Amylose,G10495
C00719,"Betaine;|Trimethylaminoacetate;|Glycine betaine;|N,N,N-Trimethylglycine;|Trimethylammonioacetate",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07523)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AA Amino acids and derivatives|A16AA06 Betaine|D07523  Betaine (JAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D07523)]|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Betaine|D07523  Betaine (JAN)|Therapeutic category of drugs in Japan [BR:br08301(D07523)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D07523  Betaine (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D07523)]|Third-class OTC drugs|Inorganic and organic chemicals|Betaine|D07523  Betaine (JAN)|New drug approvals in Europe [br08329.html(D07523)]|European public assessment reports (EPAR) authorised medicine|D07523|New drug approvals in Japan [br08318.html(D07523)]|Drugs with new active ingredients|D07523|New drug approvals in the USA, Europe and Japan [br08328.html(D07523)]|Approval dates by FDA, EMA and PMDA|D07523",
C00720,RBr,Generic compound in reaction hierarchy,,,,
C00721,Dextrin,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00084)]|Chemicals|D00084  Dextrin,G10545
C00722,Epoxide;|Oxirane;|Alkene oxide;|Olefin oxide,Generic compound in reaction hierarchy,,,,
C00725,Lipoate;|Lipoic acid;|Thioctic acid;|dl-alpha-Lipoic acid;|DL-Thioctic acid,racemic mixture,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00725  Lipoate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00086)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AX Various alimentary tract and metabolism products|A16AX01 Thioctic acid|D00086  Thioctic acid (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00086)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00086  Thioctic acid (JAN)|Classification of Japanese OTC drugs [BR:br08313(D00086)]|Nourishing tonics and health supplements|43 Vitamin containing supplements|D00086  Thioctic acid (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00086)]|Third-class OTC drugs|Inorganic and organic chemicals|Thioctic acid|D00086  Thioctic acid (JAN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9679  Other agents for liver disease and antidotes|C00725  Thioctic acid,
C00726,Nitrile;|R-CN,Generic compound in reaction hierarchy,,,,
C00727,"Orcinol;|5-Methyl-1,3-benzenediol;|5-Methylresorcinol;|3,5-Toluenediol;|3,5-Dihydroxytoluene",,,,,
C00729,Tropine;|3alpha-Tropanol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C00729  Tropine,
C00732,Ubenimex,,,,Therapeutic category of drugs in Japan [BR:br08301(D00087)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4299  Others|D00087  Ubenimex (JP18/INN)|Target-based classification of drugs [BR:br08310(D00087)]|Enzymes|Hydrolases (EC3)|Aminopeptidases|ANPEP (CD13)|D00087  Ubenimex (JP18/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00087)]|Chemicals|D00087  Ubenimex|D00087  Ubenimex capsules,
C00734,"Chitosan;|beta-1,4-Poly-D-glucosamine",,,,Compounds with biological roles [BR:br08001(G10536)]|Carbohydrates|Polysaccharides|Homopolysaccharides|G10536  Chitosan,G10536
C00735,"Cortisol;|Hydrocortisone;|11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione;|Kendall's compound F;|Reichstein's substance M",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C00735  Cortisol|Hormones and transmitters|Steroid hormones|Glucocorticoids|C00735  Cortisol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C00735  Cortisol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00088)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00088)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, Low Potency|Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN)|Inflammatory Bowel Disease Agents|Glucocorticoids|Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00088)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2452  Cortisones|D00088  Hydrocortisone (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00088)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00088  Hydrocortisone (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00088)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Hydrocortisone|D00088  Hydrocortisone (JP18/USP/INN)|Drug groups [BR:br08330(D00088)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D00088  Hydrocortisone|Dermatological agent|DG03243  Atopic dermatitis agent|D00088  Hydrocortisone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D00088  Hydrocortisone|Drug classes [BR:br08332(D00088)]|Anti-inflammatory|DG01955  Corticosteroid|D00088  Hydrocortisone|Dermatological agent|DG03243  Atopic dermatitis agent|D00088  Hydrocortisone|Target-based classification of drugs [BR:br08310(D00088)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00088  Hydrocortisone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00088)]|Chemicals|D00088  Hydrocortisone|New drug approvals in Europe [br08329.html(D00088)]|European public assessment reports (EPAR) authorised medicine|D00088|Drug metabolizing enzymes and transporters [br08309.html(D00088)]|Drug metabolizing enzymes|D00088|Topical steroids potency [br08317.html(D00088)]|Classification in the USA|D00088|Rx-to-OTC switch list in the USA [br08315.html(D00088)]|D00088",
C00736,Cysteine;|2-Amino-3-mercaptopropionic acid,,,,,
C00737,D-Aldose;|D-Aldose1;|D-Aldose2,Generic compound in reaction hierarchy,,,,
C00738,D-Hexose;|Hexose,Generic compound in reaction hierarchy,,,,
C00739,"D-Lysine;|D-2,6-Diaminohexanoic acid",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00739  D-Lysine,
C00740,D-Serine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00740  D-Serine,
C00741,"Diacetyl;|Biacetyl;|Dimethylglyoxal;|2,3-Butanedione",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C00741  2,3-Butanedione",
C00742,Fluoride;|F-;|Fluoride ion,,,,,
C00744,Macrocin;|Tylosin C,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C00744  Macrocin,
C00745,Nicotine;|(S)-3-(1-Methylpyrrolidin-2-yl)pyridine;|(S)-Nicotine;|3-[(S)-1-Methylpyrrolidin-2-yl]pyridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C00745  Nicotine|Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C00745  Nicotine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C00745  Nicotine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03365)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BA Drugs used in nicotine dependence|N07BA01 Nicotine|D03365  Nicotine (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D03365)]|Anti-Addiction/Substance Abuse Treatment Agents|Smoking Cessation Agents|Nicotine|D03365  Nicotine (USP)|Therapeutic category of drugs in Japan [BR:br08301(D03365)]|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D03365  Nicotine (USP)|Classification of Japanese OTC drugs [BR:br08313(D03365)]|Stop smoking aid|77 Stop smoking aid|D03365  Nicotine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D03365)]|First-class OTC drugs|Inorganic and organic chemicals|Nicotine|D03365  Nicotine (USP)|Designated second-class OTC drugs|Inorganic and organic chemicals|Nicotine|D03365  Nicotine (USP)|Second-class OTC drugs|Inorganic and organic chemicals|Nicotine|D03365  Nicotine (USP)|Drug groups [BR:br08330(D03365)]|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00994  Nicotine|D03365  Nicotine|Metabolizing enzyme inducer|DG01637  CYP1A2 inducer|DG00994  Nicotine|D03365  Nicotine|Target-based classification of drugs [BR:br08310(D03365)]|Ion channels|Ligand-gated ion channels|Acetylcholine (nicotinic)|CHRN|D03365  Nicotine (USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D03365)]|Drug metabolizing enzymes|D03365|Rx-to-OTC switch list in the USA [br08315.html(D03365)]|D03365|Rx-to-OTC switch list in Japan [br08314.html(D03365)]|D03365,
C00746,Oxytocin;|Ocytocin;|OT;|OXT,,Cys Tyr Ile Gln Asn Cys Pro Leu Gly (Disulfide bridge: 1-6),Peptide,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Oxytocin|C00746  Oxytocin|Bioactive peptides [BR:br08005]|Pituitary hormones|Posterior pituitary hormone|C00746  Oxytocin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00089)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01B POSTERIOR PITUITARY LOBE HORMONES|H01BB Oxytocin and analogues|H01BB02 Oxytocin|D00089  Oxytocin (JP18/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00089)]|2  Agents affecting individual organs|24  Hormones|241  Pituitary hormone preparations|2414  Posterior pituitary hormones|D00089  Oxytocin (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|942  Oxytocics|9422  Posterior pituitary hormone and preparations|C00746  Oxytocin|Target-based classification of drugs [BR:br08310(D00089)]|G Protein-coupled receptors|Rhodopsin family|Oxytocin|OXTR|D00089  Oxytocin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00089)]|Chemicals|D00089  Oxytocin|D00089  Oxytocin injection",
C00747,Pyridine;|Azabenzene,,,,,
C00748,Siroheme,,,,,
C00750,"Spermine;|N,N'-Bis(3-aminopropyl)-1,4-butanediamine",,,,,
C00751,Squalene;|Spinacene;|Supraene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C00751  Squalene|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Liner triterpenes|C00751  Squalene,
C00753,Tungsten,Tungsten and tungsten compounds|Usually existing as tungstate [CPD:C20679],,,,
C00755,4-Hydroxy-3-methoxy-benzaldehyde;|Vanillin;|Vanillaldehyde;|4-Hydroxy-3-methoxybenzaldehyde,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00755,
C00756,1-Octanol;|Octan-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C00756  1-Octanol,
C00757,Berberine;|Umbellatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C00757  Berberine|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Berberine|C00757  Berberine|Third-class OTC drugs|Inorganic and organic chemicals|Coptis rhizome|C00757  Berberine,G01773
C00758,Bergaptol;|5-Hydroxypsoralen;|5-Hydroxyfuranocoumarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C00758  Bergaptol,
C00760,"Cellulose;|(1,4-beta-D-Glucosyl)n;|(1,4-beta-D-Glucosyl)n+1;|(1,4-beta-D-Glucosyl)n-1;|1,4-beta-D-Glucan;|Microcrystalline cellulose",,,,Risk category of Japanese OTC drugs [BR:br08312(D00093)]|Third-class OTC drugs|Inorganic and organic chemicals|Cellulose|D00093  Microcrystalline cellulose (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00093)]|Chemicals|D00093  Microcrystalline cellulose|D00093  Powdered cellulose,G10481
C00761,Coniferin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C00761  Coniferin,
C00762,"Cortisone;|17alpha,21-Dihydroxy-4-pregnene-3,11,20-trione;|Kendall's compound E;|Reichstein's substance Fa",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C00762  Cortisone|Hormones and transmitters|Steroid hormones|Glucocorticoids|C00762  Cortisone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C00762  Cortisone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07749)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB10 Cortisone|D07749  Cortisone (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA03 Cortisone|D07749  Cortisone (INN)|Drug groups [BR:br08330(D07749)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00509  Cortisone|D07749  Cortisone|Target-based classification of drugs [BR:br08310(D07749)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07749  Cortisone (INN)",
C00763,D-Proline,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00763  D-Proline,
C00764,D-Sorbose;|D-xylo-Hexulose,Sorbose [CPD:C01452]|L-Sorbose [CPD:C00247],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00764  D-Sorbose,
C00765,Digitonin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C00765  Digitonin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C00765  Digitonin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C00765  Digitonin,
C00766,"Flavanone;|2,3-Dihydroflavone",Generic compound in reaction hierarchy,,,,
C00768,Histidine;|alpha-Amino-1H-imidazole-4-propionic acid,D-Histidine [CPD:C06419]|L-Histidine [CPD:C00135],,,,
C00770,L-Idonate,,,,,
C00771,Laminarin;|Laminaran,,,,,
C00772,Mevaldate;|Mevaldic acid,,,,,
C00773,Pepstatin,,,,,
C00774,"Phloretin;|3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C00774  Phloretin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C00774  Phloretin,
C00777,"Retinoate;|Retinoic acid;|Vitamin A acid;|all-trans-Retinoate;|Acide retinoique (French) (DSL);|Tretinoine (French) (EINECS);|3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ECL);|(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid;|beta-Retinoic acid;|AGN 100335;|all-(E)-Retinoic acid;|all-trans-beta-Retinoic acid;|all-trans-Retinoic acid;|all-trans-Tretinoin;|all-trans-Vitamin A acid;|Ro 1-5488;|trans-Retinoic acid;|Tretin M;|all-trans-Vitamin A1 acid",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C00777  Retinoate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00094)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD01 Tretinoin|D00094  Tretinoin (JAN/USP/INN) &lt;JP/US&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XF Retinoids for cancer treatment|L01XF01 Tretinoin|D00094  Tretinoin (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00094)]|Antineoplastics|Retinoids|Tretinoin|D00094  Tretinoin (JAN/USP/INN)|Dermatological Agents|Acne and Rosacea Agents|Retinoids|Tretinoin|D00094  Tretinoin (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00094)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00094  Tretinoin (JAN/USP/INN)|Drug groups [BR:br08330(D00094)]|Vitamin and mineral|DG01604  Retinol derivative|DG00433  Tretinoin|D00094  Tretinoin|Target-based classification of drugs [BR:br08310(D00094)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D00094  Tretinoin (JAN/USP/INN) &lt;JP/US&gt;|PML-RARA|D00094  Tretinoin (JAN/USP/INN) &lt;JP/US&gt;,
C00778,Rhodopsin;|Visual purple,Generic compound in reaction hierarchy|R = scotopsin,,,,
C00779,"Scytalone;|3,4-Dihydro-3,6,8-trihydoroxy-1(2H)-napthalenone",,,,,
C00780,Serotonin;|3-(2-Aminoethyl)-1H-indol-5-ol;|5-Hydroxytryptamine;|Enteramine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C00780  Serotonin|Hormones and transmitters|Neurotransmitters|Biogenic amines|C00780  Serotonin|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C00780  Serotonin,
C00783,Tropinone;|3-Tropanone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C00783  Tropinone,
C00785,Urocanate;|Urocanic acid,,,,,
C00786,(-)-Vestitone;|Vestitone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C00786  (-)-Vestitone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C00786  (-)-Vestitone,
C00788,"L-Adrenaline;|(R)-(-)-Adrenaline;|(R)-(-)-Epinephrine;|(R)-(-)-Epirenamine;|(R)-(-)-Adnephrine;|4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Other hormones|Adrenalines|C00788  Adrenaline|Neurotransmitters|Biogenic amines|C00788  Epinephrine; Adrenaline|Prodrugs [br08324.html]|C00788|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00095)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AD Other agents for local oral treatment|A01AD01 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02B VITAMIN K AND OTHER HEMOSTATICS|B02BC Local hemostatics|B02BC09 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA24 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA14 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AA Alpha- and beta-adrenoreceptor agonists|R03AA01 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EA Sympathomimetics in glaucoma therapy|S01EA01 Epinephrine|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00095)]|Respiratory Tract/Pulmonary Agents|Bronchodilators, Sympathomimetic|Epinephrine|D00095  Epinephrine (USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00095)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2451  Epinephrines|D00095  Epinephrine (USP/INN); Adrenaline (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00095)]|Second-class OTC drugs|Inorganic and organic chemicals|Adrenaline (Epinephrine)|D00095  Epinephrine (USP/INN)|Drug groups [BR:br08330(D00095)]|Cardiovascular agent|DG01703  Cardiotonic|DG01699  Catecholamine cardiotonic|DG00013  Epinephrine|D00095  Epinephrine|DG01456  Adrenergic receptor agonist|DG00013  Epinephrine|D00095  Epinephrine|DG01951  Catecholamine adrenergic receptor agonist|DG00013  Epinephrine|D00095  Epinephrine|Metabolizing enzyme substrate|DG01592  COMT substrate|DG00013  Epinephrine|D00095  Epinephrine|DG02917  MAO substrate|DG00013  Epinephrine|D00095  Epinephrine|Target-based classification of drugs [BR:br08310(D00095)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|ADRA2|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|ADRB|D00095  Epinephrine (USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00095)]|Chemicals|D00095  Adrenaline|D00095  Adrenaline solution|D00095  Adrenaline injection|Drug metabolizing enzymes and transporters [br08309.html(D00095)]|Drug metabolizing enzymes|D00095|Prodrugs [br08324.html(D00095)]|D00095",
C00789,CDP-ribitol;|CDP-L-ribitol;|CDP 5-ester with D-ribitol,,,,,
C00791,Creatinine;|1-Methylglycocyamidine,,,,,
C00792,D-Arginine;|D-2-Amino-5-guanidinovaleric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00792  D-Arginine,
C00793,D-Cysteine;|D-Amino-3-mercaptopropionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00793  D-Cysteine,
C00794,D-Sorbitol;|D-Glucitol;|L-Gulitol;|Sorbitol,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar alcohols|C00794  Sorbitol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00096)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD18 Sorbitol|D00096  Sorbitol solution (USP) &lt;JP/US&gt;|A06AG Enemas|A06AG07 Sorbitol|D00096  Sorbitol solution (USP) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CX Other irrigating solutions|B05CX02 Sorbitol|D00096  Sorbitol solution (USP) &lt;JP/US&gt;|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CC Tests for bile duct patency|V04CC01 Sorbitol|D00096  Sorbitol solution (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00096)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|251  Urinary organ agents|2519  Others|D00096  Sorbitol solution (USP); D-Sorbitol (JP18); Sorbitol (NF)|7  Agents not mainly for therapeutic purpose|79  Other agents not mainly for therapeutic purpose|799  Miscellaneous|7990  Miscellaneous|D00096  Sorbitol solution (USP); D-Sorbitol (JP18); Sorbitol (NF)|Risk category of Japanese OTC drugs [BR:br08312(D00096)]|Third-class OTC drugs|Inorganic and organic chemicals|D-Sorbitol|D00096  Sorbitol solution (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00096)]|Chemicals|D00096  D-Sorbitol|D00096  D-Sorbitol solution,
C00795,D-Tagatose;|lyxo-Hexulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C00795  D-Tagatose,
C00796,Dicumarol;|Dicoumarol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C00796  Dicumarol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03798)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AA Vitamin K antagonists|B01AA01 Dicoumarol|D03798  Dicumarol (USAN)|Drug groups [BR:br08330(D03798)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01708  Coumarin anticoagulant|DG01759  Dicumarol type coumarin derivative|D03798  Dicumarol|Target-based classification of drugs [BR:br08310(D03798)]|Enzymes|Oxidoreductases (EC1)|Vitamin-K-epoxide reductase|VKORC1|D03798  Dicumarol (USAN),
C00797,Ethylamine,,,,,
C00798,Formyl-CoA,,,,,
C00799,Isoflavone,Generic compound in reaction hierarchy,,,,
C00800,L-Gulonate;|L-Gulonic acid;|Gulonate;|Gulonic acid,,,,,
C00801,Nucleoside,Generic compound in reaction hierarchy,,,,
C00802,Oxalureate;|Oxaluric acid;|Monooxalylurea;|Oxalurate;|N-Carbamoyl-2-oxoglycine,,,,,
C00803,Pentanoate;|Valerate;|Pentanoic acid;|Valeric acid;|Valerianic acid;|n-Pentanoate;|n-Valeric acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C00803  Valerate; Pentanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C00803  Pentanoic acid,
C00804,Propynoate;|Propiolic acid;|Acetylenecarboxylic acid;|Acetylenemonocarboxylate,,,,,
C00805,Salicylate;|o-Hydroxybenzoic acid;|Salicylic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00097)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE12 Salicylic acid|D00097  Salicylic acid (JP18/USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC08 Salicylic acid|D00097  Salicylic acid (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00097)]|2  Agents affecting individual organs|26  Epidermides|265  Antiparasitic dermatosis agents|2652  Salicylic acids for external use|D00097  Salicylic acid (JP18/USP)|266  Emollients|2661  Organic acids|D00097  Salicylic acid (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00097)]|Agents for integumentary system|56 Purulent skin remedies|D00097  Salicylic acid (JP18/USP)|58 Ringworm drugs|D00097  Salicylic acid (JP18/USP)|59 Skin emollient (incl. pus extrusion)|D00097  Salicylic acid (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00097)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Salicylic acid|D00097  Salicylic acid (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Salicylic acid|D00097  Salicylic acid (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C00805  Salicylate|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C00805  Salicylate|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C00805  Salicylate|Drug groups [BR:br08330(D00097)]|Transporter inhibitor|DG02883  SLC22A7 inhibitor|D00097  Salicylic acid|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00097)]|Chemicals|D00097  Salicylic acid|D00097  Salicylic acid spirit|D00097  Salicylic acid adhesive plaster|Drug metabolizing enzymes and transporters [br08309.html(D00097)]|Drug transporters|D00097",
C00806,Tryptophan;|alpha-Amino-beta-(3-indolyl)-propionic acid,,,,,
C00808,"(+)-Camphor;|d-Camphor;|(1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C00808  (+)-Camphor|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00808  (+)-Camphor|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00808|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06392)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB02 Camphora|D06392  d-Camphor (JP18)|Classification of Japanese OTC drugs [BR:br08313(D06392)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D06392  d-Camphor (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D06392)]|Third-class OTC drugs|Crude drugs|Camphor|D06392  d-Camphor (JP18)|Crude drugs [BR:br08305(D06392)]|Other flowering plants|Lauraceae (laurel family)|D06392  d-Camphor|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D06392)]|Chemicals|D06392  d-Camphor",
C00809,"(-)-Camphor;|(-)-Bornan-2-one;|(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C00809  (-)-Camphor|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00809  (-)-Camphor,
C00810,(R)-Acetoin;|(R)-2-Acetoin;|(R)-3-Hydroxy-2-butanone;|(R)-Dimethylketol;|(R)-3-Hydroxybutan-2-one;|(3R)-3-Hydroxybutan-2-one,Acetoin [CPD:C00466]|(S)-Acetoin [CPD:C01769],,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C00810  (3R)-3-Hydroxybutan-2-one,
C00811,4-Coumarate;|p-Coumaric acid;|trans-4-Hydroxycinnamate;|trans-p-Hydroxycinnamate;|4-Hydroxycinnamic acid;|4-Hydroxycinnamate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C00811  4-Coumarate,
C00812,Alkyl thiol,Generic compound in reaction hierarchy,,,,
C00813,Barbiturate;|Barbituric acid;|Malonylurea,,,,,
C00814,Biochanin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C00814  Biochanin A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C00814  Biochanin A|Dietary phytochemicals [br08012.html]|Flavonoids|C00814,
C00815,Citramalate;|Citramalic acid;|alpha-Hydroxypyrotartaric acid;|2-Methylmalic acid,,,,,
C00817,D-Altronate,,,,,
C00818,D-Glucarate;|D-Glucaric acid;|L-Gularic acid;|D-Saccharic acid;|D-Glucosaccharic acid;|Glucaric acid;|Glucarate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00818  D-Glucaric acid,
C00819,D-Glutamine;|D-2-Aminoglutaramic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00819  D-Glutamine,
C00820,D-Threonine;|D-2-Amino-3-hydroxybutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00820  D-Threonine,
C00821,DNA adenine;|Adenine in DNA,Generic compound in reaction hierarchy,,,,
C00822,Dopaquinone,,,,,
C00823,1-Hexadecanol;|Hexadecanol;|Cetyl alcohol;|Palmityl alcohol;|16-Hexadecanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C00823  1-Hexadecanol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00099)]|Chemicals|D00099  Cetanol,
C00825,Kanamycin B;|Bekanamycin;|Nebramycin factor 5,Component of Kanamycin [CPD:C00304],,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07497)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB13 Bekanamycin|D07497  Bekanamycin (INN)|Drug groups [BR:br08330(D07497)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00615  Bekanamycin|D07497  Bekanamycin|Antimicrobials [BR:br08307(D07497)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D07497  Bekanamycin (INN)|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00825,
C00826,L-Arogenate;|L-Arogenic acid;|Pretyrosine,,,,,
C00827,Lactoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00827  Lactoyl-CoA,
C00828,Menaquinone;|Vitamin K2,Menatetrenone (n=3) [DR:D00100],,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C00828  Menaquinone (Vitamin K2)|Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C00828  Menaquinone|PR0203 Vitamin K|C00828  Menaquinone (Vitamin K2),
C00829,Naphthalene,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Fumigants|C00829  Naphthalene,
C00830,Oxomalonate;|Oxomalonic acid;|Ketomalonic acid;|Mesoxalic acid,,,,,
C00831,Pantetheine;|(R)-Pantetheine,,,,,
C00832,Paromomycin;|Paromomycin I;|Aminosidin;|Catenulin;|Hydroxymycin;|Monomycin A;|Zygomycin A1;|Neomycin E,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07467)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA06 Paromomycin|D07467  Paromomycin (INN)|Drug groups [BR:br08330(D07467)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00084  Paromomycin|D07467  Paromomycin|Antimicrobials [BR:br08307(D07467)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D07467  Paromomycin (INN)|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00832",
C00835,Sepiapterin,,,,,
C00836,"Sphinganine;|Dihydrosphingosine;|2-Amino-1,3-dihydroxyoctadecane",,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0102 Sphinganines|C00836  Sphinganine,
C00837,Streptidine,,,,,
C00839,Tropomyosin;|Tropomyosin serine;|Unphosphorylated tropomyosin,,,,,
C00841,Xanthotoxol;|8-Hydroxypsoralen;|8-Hydroxyfuranocoumarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C00841  Xanthotoxol,
C00842,dTDP-glucose;|dTDP-D-glucose;|dTDP-alpha-D-glucose,,,,,
C00843,(-)-Menthone;|l-Menthone;|p-Menthan-3-one,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00843  (-)-Menthone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00843  (-)-Menthone,
C00844,Prunasin;|(R)-Prunasin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C00844  Prunasin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cyanogenic glycosides|C00844  Prunasin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C00844  Prunasin,
C00845,2-Furoyl-CoA,,,,,
C00846,3-Oxoadipate;|3-Oxoadipic acid;|3-Keto-adipate;|3-Oxohexanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00846  3-Oxohexanedioic acid,
C00847,4-Pyridoxate;|4-Pyridoxic acid,,,,,
C00848,"6-Oxocineole;|(1R,4S)-1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octan-6-one;|2-Oxo-1,8-cineole",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00848  6-Oxocineole,
C00849,Ethyl acetate,,,,,
C00850,Aryl sulfate;|Phenol sulfate,Generic compound in reaction hierarchy,,,,
C00852,Chlorogenate;|Chlorogenic acid;|Caffeoyl quinic acid;|trans-5-O-Caffeoyl-D-quinate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C00852  Chlorogenate,
C00853,Cob(I)alamin;|Cbl;|Vitamin B12s,,,,,
C00854,Cyclohexanol;|Hexalin;|Hexahydrophenol;|Cyclohexan-1-ol,,,,,
C00855,D-Methionine;|D-2-Amino-4-(methylthio)butyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C00855  D-Methionine,
C00856,DNA cytosine;|Cytosine (in DNA),,,,,
C00857,Deamino-NAD+;|Deamido-NAD+;|Deamido-NAD;|Nicotinic acid adenine dinucleotide,,,,,
C00858,Formononetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C00858  Formononetin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C00858  Formononetin|Dietary phytochemicals [br08012.html]|Flavonoids|C00858,
C00859,Gibberellin A1;|Gibberellin 1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C00859  Gibberellin A1|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C00859  Gibberellin A1|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00859,
C00860,L-Histidinol,,,,,
C00861,L-Rhamnulose;|6-Deoxy-L-fructose,,,,,
C00862,Methanofuran;|Carbon dioxide reduction factor,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C00862  Methanofuran,
C00863,Monoterpenol,Generic compound in reaction hierarchy|R = monoterpenyl group,,,,
C00864,Pantothenate;|Pantothenic acid;|(R)-Pantothenate,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C00864  Pantothenic acid (Vitamin B5)|Risk category of Japanese OTC drugs [BR:br08312(D07413)]|Third-class OTC drugs|Inorganic and organic chemicals|Pantothenic acid|D07413  Pantothenic acid (BAN),
C00865,Phospholipid,Generic compound in reaction hierarchy,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Phospholipid|C00865  Phospholipid,
C00868,tRNA uridine;|Uracil in tRNA,,,,,
C00869,2-Oxooctadecanoic acid;|2-Oxostearate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00869  2-Oxooctadecanoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C00869  2-Oxooctadecanoic acid,
C00870,4-Nitrophenol;|p-Nitrophenol;|PNP;|Niphen;|4-Hydroxynitrobenzene,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Nitrophenol|C00870  4-Nitrophenol,
C00871,Alkylated DNA,,,,,
C00872,Aminomalonate;|Aminomalonic acid;|2-Aminomalonic acid,,,,,
C00873,Angiotensin I,Human angiotensin I is illustrated.,Asp Arg Val Tyr Ile His Pro Phe His Leu,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Angiotensin|C00873  Angiotensin I|Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C00873  Angiotensin I,
C00875,Cephalosporin,Generic compound in reaction hierarchy,0 Aad  1 Cys  2 Val,NRP,,
C00876,Coenzyme F420;|Oxidized coenzyme F420;|Coenzyme gamma-F420-2,,,,,
C00877,Crotonoyl-CoA;|Crotonyl-CoA;|2-Butenoyl-CoA;|trans-But-2-enoyl-CoA;|But-2-enoyl-CoA;|(E)-But-2-enoyl-CoA;|(2E)-But-2-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00877  (2E)-Butenoyl-CoA,
C00878,D-Arabinonate;|D-Arabinonic acid,,,,,
C00879,D-Galactarate;|D-Mucic acid;|D-Galactaric acid;|Galactaric acid;|Galactarate;|Mucic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C00879  Galactaric acid,
C00880,D-Galactonate;|D-Galactonic acid,,,,,
C00881,Deoxycytidine;|2'-Deoxycytidine,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleosides|Deoxyribonucleosides|C00881  Deoxycytidine (dC)|Target-based classification of drugs [BR:br08310(D12465)]|Enzymes|Transferases (EC2)|Phosphotransferase|TK2|D12465  Doxecitine (USAN/INN),
C00882,Dephospho-CoA;|Dephosphocoenzyme A;|3'-Dephospho-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00882  Dephospho-CoA,
C00883,Galactomannan;|Galactomannoglycan,,,,,
C00884,Homocarnosine;|L-Homocarnosine;|gamma-Aminobutyryl histidine;|N-(4-Amino-1-oxobutyryl)histidine,,,,,
C00885,Isochorismate;|Isochorismic acid,,,,,
C00886,L-Alanyl-tRNA;|L-Alanyl-tRNA(Ala),Generic compound in reaction hierarchy,,,,
C00887,Nitrous oxide;|Dinitrogen monoxide;|Dinitrogen oxide;|N2O,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00102)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX13 Nitrous oxide|D00102  Nitrous oxide (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00102)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1116  Nitrous oxides|D00102  Nitrous oxide (JP18/USP)|Drug groups [BR:br08330(D00102)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|D00102  Nitrous oxide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00102)]|Chemicals|D00102  Nitrous oxide",
C00888,Pentanoyl-CoA;|Valeryl-coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00888  Pentanoyl-CoA,
C00889,Peptidoglycan;|Peptideglycan;|Murein;|Mucopeptide,,,,,
C00891,Pregnan-21-al,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C00891  Pregnan-21-al",
C00892,Pregnan-21-ol;|5-beta-Pregnan-21-ol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C00892  Pregnan-21-ol",
C00893,Primary monoamine,,,,,
C00894,Propenoyl-CoA;|Acryloyl-CoA;|Acrylyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C00894  Propenoyl-CoA,
C00895,RNA (poly(A));|Poly(A);|Polyadenylic acid,,,,,
C00896,Tos-Lys-CH2Cl,,,,,
C00897,alpha-Maltose;|alpha-Malt sugar,,,,,
C00898,"(R,R)-Tartaric acid;|(R,R)-Tartrate;|L-Tartaric acid;|Tartaric acid;|Tartrate;|2,3-Dihydroxybutanedioic acid;|(2R,3R)-Tartaric acid;|(+)-Tartaric acid",,,,"Therapeutic category of drugs in Japan [BR:br08301(D00103)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D00103  Tartaric acid (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00103)]|Chemicals|D00103  Tartaric acid",
C00899,11-cis-Retinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C00899  11-cis-Retinol,
C00900,2-Acetolactate;|2-Hydroxy-2-methyl-3-oxobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C00900  2-Hydroxy-2-methyl-3-oxobutanoic acid,
C00902,2-Oxohexanoic acid;|2-Oxohexanoate;|alpha-Ketocaproic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C00902  2-Oxohexanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C00902  2-Oxohexanoic acid,
C00903,Cinnamaldehyde,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C00903  Cinnamaldehyde,
C00904,Citramalyl-CoA,(3S)-Citramalyl-CoA [CPD:C01011]|(3R)-Citramalyl-CoA [CPD:C20746],,,,
C00905,D-Fructuronate;|D-Fructuronic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C00905  D-Fructuronic acid,
C00906,"5,6-Dihydrothymine;|Dihydrothymine;|5,6-Dihydro-5-methyluracil",,,,,
C00908,Gentamicin C1a,Component of Gentamicin C  [CPD:C01918],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C00908,
C00909,"Leukotriene A4;|LTA4;|(7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoic acid;|(7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoate;|(7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyicosa-7,9,11,14-tetraenoate;|(5S,6S,7E,9E,11Z,14Z)-5,6-Epoxyicosa-7,9,11,14-tetraenoate",,,,"Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C00909  Leukotriene A4|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C00909  (7E,9E,11Z,14Z)-(5S,6S)-5,6-Epoxyeicosa-7,9,11,14-tetraenoic acid|FA03 Eicosanoids|FA0302 Leukotrienes|C00909  Leukotriene A4",
C00911,Ribonucleoside,Generic compound in reaction hierarchy,,,,
C00913,3-Methyladenine,,,,,
C00915,Benzyl viologen,,,,,
C00916,Cephalosporin C,,,,Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Cephems|C00916  Cephalosporin C,
C00918,Chloramphenicol,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Others|Aromatic compounds|C00918  Chloramphenicol|Prodrugs [br08324.html]|C00918|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00104)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX02 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF03 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA05 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01B AMPHENICOLS|J01BA Amphenicols|J01BA01 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA01 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA01 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA08 Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D00104)]|Antibacterials|Antibacterials, Other|Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00104)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1317  Ophthalmic antibiotics|D00104  Chloramphenicol (JP18/USP/INN)|132  Otic and nasal agents|1325  Otolaryngologic antibiotics|D00104  Chloramphenicol (JP18/USP/INN)|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2521  Antibiotics|D00104  Chloramphenicol (JP18/USP/INN)|26  Epidermides|263  Suppurative dermatosis agents|2634  Antibiotics for external use|D00104  Chloramphenicol (JP18/USP/INN)|6  Agents against pathologic organisms and parasites|61  Antibiotics|615  Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia|6151  Chloramphenicols|D00104  Chloramphenicol (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00104)]|Agents for integumentary system|56 Purulent skin remedies|D00104  Chloramphenicol (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00104)]|Second-class OTC drugs|Inorganic and organic chemicals|Chloramphenicol|D00104  Chloramphenicol (JP18/USP/INN)|Drug groups [BR:br08330(D00104)]|Antibacterial|DG01576  Amphenicol type antibacterial|DG00399  Chloramphenicol|D00104  Chloramphenicol|Metabolizing enzyme inhibitor|DG01933  CYP2C19 inhibitor|D00104  Chloramphenicol|Antimicrobials [BR:br08307(D00104)]|Antibacterials|Protein biosynthesis inhibitor|Amphenicol|D00104  Chloramphenicol (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00104)]|Chemicals|D00104  Chloramphenicol|Drug metabolizing enzymes and transporters [br08309.html(D00104)]|Drug metabolizing enzymes|D00104|Prodrugs [br08324.html(D00104)]|D00104",
C00919,Choline sulfate,,,,,
C00920,CoA-glutathione;|Coenzyme A-glutathione mixed disulfide,,,,,
C00921,"Dihydropteroate;|7,8-Dihydropteroate",,,,,
C00922,"2,3-Dimethylmaleate;|Dimethylmaleic acid",,,,,
C00923,Ferricytochrome,,,,,
C00924,Ferrocytochrome,,,,,
C00925,Heparan sulfate;|Heparitin sulfate;|Heparin sulfate;|Heparin monosulfate,Generic compound in reaction hierarchy|R1 = SO3- or H|R2 = COCH3 or SO3-,,,Drug groups [BR:br08330(D08536)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01709  Heparin anticoagulant|D08536  Suleparoid,
C00927,Isonocardicin A;|1-Azetidineacetic acid,,,,,
C00928,Mercaptoethanol;|2-Mercaptoethanol;|Thioglycol,,,,,
C00929,Oligonucleotide,,,,,
C00930,Oligosaccharide,,,,,
C00931,Porphobilinogen,Porphyrin [CPD:C05113] precursor,,,,
C00933,Sinapine;|Sinapoylcholine,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C00933  Sinapine,
C00935,UDP-L-arabinose;|UDP-L-arabinopyranose;|UDP-beta-L-arabinopyranose,,,,,G11111
C00936,alpha-D-Mannose;|alpha-D-Mannopyranose,D-Mannose [CPD:C00159]|beta-D-Mannose [CPD:C02209],,,,
C00937,(R)-Lactaldehyde;|D-Lactaldehyde;|D-2-Hydroxypropionaldehyde,,,,,
C00938,"1,3-beta-D-Xylan",,,,,
C00939,2-Aminoadenosine,,,,,
C00940,2-Oxoglutaramate;|2-Oxoglutaramic acid;|alpha-Ketoglutaramate;|2-Ketoglutaramate,,,,,
C00941,"3',5'-Cyclic CMP;|Cytidine 3',5'-cyclic monophosphate",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C00941  3',5'-Cyclic CMP",
C00942,"3',5'-Cyclic GMP;|Guanosine 3',5'-cyclic monophosphate;|Guanosine 3',5'-cyclic phosphate;|Cyclic GMP;|cGMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C00942  3',5'-Cyclic GMP",
C00943,"3',5'-Cyclic IMP;|Inosine 3',5'-cyclic monophosphate",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C00943  3',5'-Cyclic IMP",
C00944,3-Dehydroquinate;|3-Dehydroquinic acid;|5-Dehydroquinate;|5-Dehydroquinic acid,"formerly called ""5-Dehydroquinate"" on old nomenclature system of numbering",,,,
C00946,Adenosine 2'-phosphate;|2'-Adenylic acid;|Adenosine-2'-monophosphate;|AMP 2'-phosphate,,,,,
C00950,"Dithioerythritol;|erythro-1,4-Dimercapto-2,3-butanediol;|DTE",,,,,
C00951,Estradiol-17beta;|Estradiol;|beta-Estradiol,,,,"Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C00951  Estradiol-17beta|Hormones and transmitters|Steroid hormones|Estrogens|C00951  Estradiol-17beta (E2)|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C00951  Estradiol-17beta|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00105)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA03 Estradiol|D00105  Estradiol (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00105)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Estrogens|Estradiol|D00105  Estradiol (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00105)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2473  Estradiols|D00105  Estradiol (JAN/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00105)]|Drugs for women|51 Other drugs for women|D00105  Estradiol (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00105)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Estradiol|D00105  Estradiol (JAN/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Estradiol|D00105  Estradiol (JAN/USP/INN)|Drug groups [BR:br08330(D00105)]|Hormonal agent|DG01986  Estrogen|DG00462  Estradiol|D00105  Estradiol|DG01584  Estrogen receptor agonist|DG00462  Estradiol|D00105  Estradiol|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00105  Estradiol|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00462  Estradiol|D00105  Estradiol|Drug classes [BR:br08332(D00105)]|Endocrine and hormonal agent|DG01986  Estrogen|D00105  Estradiol|DG01584  Estrogen receptor agonist|D00105  Estradiol|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00105  Estradiol|Target-based classification of drugs [BR:br08310(D00105)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00105  Estradiol (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00105)]|Drug metabolizing enzymes|D00105",
C00954,Indole-3-acetate;|Indole-3-acetic acid;|(Indol-3-yl)acetate;|Indoleacetate;|Indoleacetic acid;|(1H-indol-3-yl)acetate;|IAA,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C00954  Indole-3-acetate|Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C00954  Indole-3-acetate,
C00955,Indole-3-ethanol;|Tryptophol,,,,,
C00956,L-2-Aminoadipate;|L-alpha-Aminoadipate;|L-alpha-Aminoadipic acid;|L-2-Aminoadipic acid;|L-2-Aminohexanedioate,,,,,
C00957,Mercaptopyruvate;|2-Oxo-3-sulfanylpropanoate;|3-Mercaptopyruvic acid;|3-Mercaptopyruvate,,,,,
C00958,Plasmenylcholine;|Choline plasmalogen;|1-Alkenyl-2-acylglycerophosphocholine;|2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C00958  Plasmenylcholine|Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0103 1-(1Z-alkenyl),2-acylglycerophosphocholines|C00958  2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphocholine",
C00959,Prostaglandin B1;|PGB1,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C00959  Prostaglandin B1|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C00959  Prostaglandin B1,
C00960,RNA 5'-phosphate,,,,,
C00961,Sterigmatocystin,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C00961  Sterigmatocystin|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C00961  Sterigmatocystin,
C00962,beta-D-Galactose,D-Galactose [CPD:C00124],,,,
C00963,beta-D-Glucoside,,,,,
C00964,(-)-trans-Carveol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C00964  (-)-trans-Carveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C00964  (-)-trans-Carveol,
C00965,"1,3-beta-D-Glucan;|1,3-beta-Glucan;|(1,3-beta-D-Glucosyl)n;|(1,3-beta-D-Glucosyl)n+1;|(1,3-beta-D-Glucosyl)n-1",,,,,G10477
C00966,2-Dehydropantoate,,,,,
C00968,"3',5'-Cyclic dAMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C00968  3',5'-Cyclic dAMP",
C00969,3-Hydroxypropanal,,,,,
C00971,4-Pyridoxolactone;|4-Pyridoxic acid lactone,,,,,
C00972,Aromatic oxo acid,Generic compound in reaction hierarchy|R = aromatic group,,,,
C00973,Cyclomaltodextrin;|Cyclodextrin,n=6-8|alpha-Cyclodextrin (n=6)|beta-Cyclodextrin (n=7) [CPD:C13183]|gamma-Cyclodextrin (n=8),,,,G10546
C00974,Dihydrokaempferol;|Aromadendrin;|(+)-Dihydrokaempferol;|(+)-Aromadendrin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C00974  Dihydrokaempferol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C00974  Dihydrokaempferol,
C00975,Dihydroxyfumarate;|Dihydroxyfumaric acid,,,,,
C00976,GDP-D-mannuronate;|GDP-D-mannuronic acid,,,,,
C00977,L-Tryptophanamide,,,,,
C00978,N-Acetylserotonin;|N-Acetyl-5-hydroxytryptamine,,,,,
C00979,O-Acetyl-L-serine;|O3-Acetyl-L-serine,,,,,
C00980,Polyvinyl alcohol;|PVA,,,,Classification of Japanese OTC drugs [BR:br08313(D02320)]|Agents for ophthalmologic use|66 Contact lens solutions|D02320  Polyvinyl alcohol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D02320)]|Third-class OTC drugs|Inorganic and organic chemicals|Polyvinyl alcohol|D02320  Polyvinyl alcohol (USP),
C00982,"Renilla luciferin;|Coelenterazine h;|2,8-Dibenzyl-6-(4-hydroxyphenyl)imidazo[1,2-a]pyrazin-3(7H)-one",,,,,
C00984,alpha-D-Galactose,D-Galactose [CPD:C00124],,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04291)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CE Tests for liver functional capacity|V04CE01 Galactose|D04291  Galactose (NF)|Risk category of Japanese OTC drugs [BR:br08312(D04291)]|Third-class OTC drugs|Inorganic and organic chemicals|Galactose|D04291  Galactose (NF),
C00985,p-Mercuribenzoate;|p-Mercuribanzoic acid,Generic compound|p-Chloromercuribenzoate (R = Cl) [CPD:C03444]|p-Hydroxymercuribenzoate (R = OH),,,,
C00986,"1,3-Diaminopropane;|Trimethylenediamine;|1,3-Propanediamine;|Propane-1,3-diamine",,,,,
C00988,2-Phosphoglycolate;|Phosphoglycolic acid,,,,,
C00989,4-Hydroxybutanoic acid;|4-Hydroxybutanoate;|4-Hydroxybutyric acid,4-Hydroxyacid (generic) [CPD:C01991],,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Hydroxycarboxylic acids|C00989  4-Hydroxybutanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C00989  4-Hydroxybutanoic acid|Drug groups [BR:br08330]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG00798  Hydroxybutyric acid|C00989  4-Hydroxybutanoic acid|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C00989,G00798
C00990,5-Aminopentanamide,,,,,
C00992,Aquacob(III)alamin;|Aquacobalamin,,,,,
C00993,D-Alanyl-D-alanine;|D-Ala-D-Ala,,,,Compounds with biological roles [BR:br08001]|Peptides|Peptides|Dipeptides|C00993  D-Alanyl-D-alanine,
C00994,D-Prephenyllactate,,,,,
C01001,Formylmethanofuran,,,,,
C01002,Hexose 1-phosphate,,,,,
C01003,Myosin light chain,Generic compound in reaction hierarchy,,,,
C01004,N-Methylnicotinate;|Trigonelline;|Trigenelline;|1-Methylpyridinio-3-carboxylate;|Betaine nicotinate;|Caffearin;|Gynesine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C01004  N-Methylnicotinate|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01004,
C01005,O-Phospho-L-serine;|L-O-Phosphoserine;|3-Phosphoserine;|Dexfosfoserine;|3-Phospho-L-serine,O-Phospho-D-serine [CPD:C02532],,,,
C01007,Reduced riboflavin,,,,,
C01008,Trimethylsulfonium,,,,,
C01009,UDP-2-deoxyglucose,,,,,
C01010,Urea-1-carboxylate;|Allophanate;|Allophanic acid,,,,,
C01011,(3S)-Citramalyl-CoA;|L-Citramalyl-CoA;|(S)-Citramalyl-CoA;|(3S)-3-Carboxy-3-hydroxybutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01011  (3S)-Citramalyl-CoA,
C01012,"(R)-Pantolactone;|(R)-Pantoyl lactone;|(3R)-Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanone",,,,,
C01013,3-Hydroxypropanoate;|3-Hydroxypropanoic acid;|3-Hydroxypropionate;|3-Hydroxypropionic acid;|Hydracrylic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Hydroxycarboxylic acids|C01013  3-Hydroxypropanoate,
C01014,3-Isopropylcatechol,,,,,
C01015,cis-4-Hydroxy-L-proline;|L-Allohydroxyproline,trans-4-Hydroxy-L-proline [CPD:C01157],,,,
C01016,5'-Phosphomonoester,,,,,
C01017,5-Hydroxytryptophan;|5-HTP,,,,,
C01018,6-Deoxy-D-galactose;|D-Fucose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C01018  D-Fucose,
C01019,L-Fucose;|L-Fucopyranose;|6-Deoxy-L-galactose,D-Fucose [CPD:C01018],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C01019  L-Fucose,
C01020,6-Hydroxynicotinate;|6-Hydroxynicotinic acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C01020  6-Hydroxynicotinate,
C01021,Aromatic amino acid;|Aromatic L-amino acid,Generic compound in reaction hierarchy|R = aromatic group,,,,
C01023,Dihydrostreptomycin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07840)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA15 Dihydrostreptomycin|D07840  Dihydrostreptomycin (INN)|Drug groups [BR:br08330(D07840)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG01122  Dihydrostreptomycin|D07840  Dihydrostreptomycin|Antimicrobials [BR:br08307(D07840)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D07840  Dihydrostreptomycin (INN),
C01024,Hydroxymethylbilane,,,,,
C01025,Lipid hydroperoxide,Generic compound in reaction hierarchy|R = an aliphatic chain with chain-length greater than C10,,,,
C01026,"N,N-Dimethylglycine;|Dimethylglycine",,,,,
C01028,N6-Hydroxy-L-lysine,,,,,
C01029,N8-Acetylspermidine,,,,,
C01031,S-Formylglutathione,,,,,
C01032,alpha-L-Arabinoside,,,,,
C01033,2-Methylbutanoyl-CoA;|2-Methylbutyryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01033  2-Methylbutanoyl-CoA,
C01034,3-Oxo-Delta5-steroid,Generic compound in reaction hierarchy,,,,
C01035,4-Guanidinobutanoate;|4-Guanidinobutyric acid,,,,,
C01036,"4-Maleylacetoacetate;|4-Maleylacetoacetic acid;|(2Z)-4,6-Dioxooct-2-enedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C01036  (2Z)-4,6-Dioxooct-2-enedioic acid",
C01037,"7,8-Diaminononanoate;|7,8-Diaminopelargonic acid;|DAPA;|7,8-Diaminononanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C01037  7,8-Diaminononanoate",
C01040,"L-Gulono-1,4-lactone;|L-Gulono-gamma-lactone;|gamma-Gulonolactone;|L-Gulonic acid gamma-lactone;|L-Gulonolactone",,,,,
C01041,Monodehydroascorbate;|Monodehydroascorbate radical;|Ascorbate radical;|Semidehydroascorbic acid,,,,,
C01042,N-Acetyl-L-aspartate;|N-Acetyl-L-aspartic acid,,,,,
C01043,N-Carbamoylsarcosine,,,,,
C01044,N-Formyl-L-aspartate,,,,,
C01045,N-Formyl-L-glutamate,,,,,
C01046,N-Methyl-L-glutamate;|N-Methyl-L-glutamic acid,,,,,
C01047,N5-Ethyl-L-glutamine;|L-Theanine,,,,,
C01048,Polyprenyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C01048  Polyprenyl phosphate,
C01050,UDP-N-acetylmuramate;|UDP-N-acetyl-alpha-D-muramate;|UDP-N-acetylmuramic acid;|UDP-MurNAc,,,,,
C01051,Uroporphyrinogen III,,,,,
C01053,(R)-4-Dehydropantoate;|(R)-4-Dehydropantoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01053  (R)-4-Dehydropantoic acid,
C01054,"(S)-2,3-Epoxysqualene;|Squalene 2,3-epoxide;|Squalene 2,3-oxide;|(S)-Squalene-2,3-epoxide;|2,3-Oxidosqualene;|(3S)-2,3-Epoxy-2,3-dihydrosqualene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C01054  (S)-2,3-Epoxysqualene|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Liner triterpenes|C01054  (S)-2,3-Epoxysqualene",
C01056,(S)-6-Hydroxynicotine,,,,,
C01059,"2,5-Dihydroxypyridine",,,,,
C01060,"3,5-Diiodo-L-tyrosine;|3,5-Diiodotyrosine;|L-Diiodotyrosine",,,,"Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01060  3,5-Diiodo-L-tyrosine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BX Other antithyroid preparations|H03BX01 Diiodotyrosine|C01060  3,5-Diiodo-L-tyrosine",
C01061,"4-Fumarylacetoacetate;|4-Fumarylacetoacetic acid;|Fumarylacetoacetate;|(2E)-4,6-Dioxooct-2-enedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C01061  (2E)-4,6-Dioxooct-2-enedioic acid",
C01062,5-Dehydro-D-gluconate;|5-Dehydrogluconate,,,,,
C01063,Pimeloyl-CoA;|6-Carboxyhexanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01063  Pimeloyl-CoA,
C01064,CMP-N-acylneuraminate,Generic compound in reaction hierarchy|R = CH3 [CPD:C00128]|R = CH2OH [CPD:C03691],,,,
C01066,"Cyclohexane-1,3-dione;|1,3-Cyclohexanedione;|Dihydroresorcinol",,,,,
C01067,D-Galactose 6-sulfate,,,,,
C01068,D-Ribitol 5-phosphate;|Ribitol 5-phosphate;|L-Ribitol 1-phosphate,,,,,
C01069,Desulfoglucotropeolin,,,,Glycosides [BR:br08021]|S-glycosides|C01069  Desulfoglucotropeolin,
C01073,N-Acetyl-beta-alanine,,,,,
C01074,N-Acetylgalactosamine;|N-Acetylchondrosamine;|2-Acetamido-2-deoxygalactose;|GalNAc,,,,,
C01075,N-Sulfo-D-glucosamine,,,,,
C01076,N-Terminal amino acid,,,,,
C01077,O-Acetyl-L-homoserine;|O-Acetylhomoserine,,,,,
C01078,Procollagen L-proline;|[Procollagen]-L-proline,,,,,
C01079,Protoporphyrinogen IX,,,,,
C01080,Reduced coenzyme F420,,,,,
C01081,Thiamin monophosphate;|Thiamine monophosphate;|Thiamin phosphate;|Thiamine phosphate;|TMP,,,,,
C01083,"alpha,alpha-Trehalose;|alpha,alpha'-Trehalose;|Trehalose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01083  Trehalose,G00293
C01086,(3R)-3-Hydroxyacyl-CoA;|(R)-3-Hydroxyacyl-CoA,Generic compound in reaction hierarchy,,,,
C01087,(R)-2-Hydroxyglutarate;|(R)-Hydroxyglutarate,,,,,
C01088,"(R)-3,3-Dimethylmalate",,,,,
C01089,(R)-3-Hydroxybutanoate;|(R)-3-Hydroxybutanoic acid;|(R)-3-Hydroxybutyric acid;|D-beta-Hydroxybutyric acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Hydroxycarboxylic acids|C01089  (R)-3-Hydroxybutanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01089  (R)-3-Hydroxybutanoic acid,
C01090,16alpha-Hydroxysteroid,Generic compound in reaction hierarchy,,,,
C01091,Deacetylvindoline;|17-O-Deacetylvindoline;|Desacetylvindoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C01091  Deacetylvindoline,
C01092,8-Amino-7-oxononanoate;|8-Amino-7-oxononanoic acid;|7-Keto-8-aminopelargonic acid;|KAPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C01092  8-Amino-7-oxononanoic acid,
C01093,"Cellobiono-1,5-lactone;|Cellobiose-1,5-lactone;|Cellobionolactone",,,,,G10590
C01094,D-Fructose 1-phosphate,,,,,
C01095,D-Ribose 5-diphosphate,,,,,
C01096,Sorbitol 6-phosphate;|D-Sorbitol 6-phosphate;|D-Glucitol 6-phosphate,,,,,
C01097,D-Tagatose 6-phosphate,,,,,
C01099,L-Fuculose 1-phosphate,,,,,
C01100,L-Histidinol phosphate,,,,,
C01101,L-Ribulose 5-phosphate,,,,,
C01102,O-Phospho-L-homoserine,,,,,
C01103,Orotidine 5'-phosphate;|Orotidylic acid,,,,,
C01104,Trimethylamine N-oxide;|(CH3)3NO,,,,,
C01107,(R)-5-Phosphomevalonate;|(R)-5-Phosphomevalonic acid;|(R)-Mevalonic acid 5-phosphate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01107  (R)-5-Phosphomevalonic acid,
C01108,"1,2,3-Trihydroxybenzene;|Pyrogallol;|Pyrogallic acid;|1,2,3-Benzenetriol",,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Gallotannins|C01108  Pyrogallol,
C01109,4-Methylene-L-glutamine,,,,,
C01110,5-Amino-2-oxopentanoic acid;|5-Amino-2-oxopentanoate;|2-Oxo-5-amino-pentanoate;|2-Oxo-5-aminopentanoate;|alpha-Keto-delta-aminopentanoate;|2-Oxo-5-aminovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C01110  5-Amino-2-oxopentanoic acid,
C01111,"7,8-Dihydroxykynurenate",,,,,
C01112,D-Arabinose 5-phosphate,,,,,
C01113,D-Galactose 6-phosphate;|6-Phospho-D-galactose,,,,,
C01114,"L-Arabinono-1,4-lactone;|L-Arabonolactone",,,,,
C01115,"L-Galactono-1,4-lactone",,,,,
C01117,Nucleoside 5'-phosphate,Generic compound in reaction hierarchy,,,,
C01118,O-Succinyl-L-homoserine;|O4-Succinyl-L-homoserine;|O-Succinylhomoserine,,,,,
C01119,Oxidized dithiothreitol,,,,,
C01120,Sphinganine 1-phosphate;|Dihydrosphingosine 1-phosphate,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0105 Sphingoid base 1-phosphates|C01120  Sphinganine 1-phosphate,
C01121,Streptidine 6-phosphate,,,,,
C01122,"cis-2,3-Dehydroacyl-CoA",Generic compound in reaction hierarchy,,,,
C01123,(-)-trans-Isopiperitenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C01123  (-)-trans-Isopiperitenol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01123  (-)-trans-Isopiperitenol,
C01124,18-Hydroxycorticosterone,,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Mineralocorticoids|C01124  18-Hydroxycorticosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C01124  18-Hydroxycorticosterone",
C01125,"Dihydro-4,4-dimethyl-2,3-furandione;|2-Dehydropantoyl lactone;|2-Dehydropantolactone",,,,,
C01126,"(2E,6E)-Farnesol;|2-trans,6-trans-Farnesol;|trans-Farnesol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C01126  2-trans,6-trans-Farnesol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C01126  trans-Farnesol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01126",
C01127,4-Hydroxy-2-oxoglutarate;|4-Hydroxy-2-oxoglutaric acid,,,,,
C01131,L-Rhamnulose 1-phosphate,,,,,
C01132,N-Acetyl-D-galactosamine;|N-Acetyl-D-chondrosamine;|2-Acetamido-2-deoxy-D-galactose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C01132  N-Acetyl-D-galactosamine,
C01133,N-Acetyl-D-glucosaminate,,,,,
C01134,Pantetheine 4'-phosphate;|4'-Phosphopantetheine;|Phosphopantetheine;|D-Pantetheine 4'-phosphate,,,,,
C01136,S-Acetyldihydrolipoamide;|6-S-Acetyldihydrolipoamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C01136  S-Acetyldihydrolipoamide,
C01137,S-Adenosylmethioninamine;|(5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium;|(5-Deoxy-5-adenosyl)(3-aminopropyl)methylsulfonium cation;|S-Adenosyl-(5')-3-methylthiopropylamine;|S-Adenosyl 3-(methylthio)propylamine;|S-Adenosyl 3-(methylsulfanyl)propylamine;|Decarboxy-AdoMet,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C01137  S-Adenosylmethioninamine,
C01138,Streptomycin 6-phosphate,,,,,
C01139,[Acetyl-CoA carboxylase],Generic compound in reaction hierarchy,,,,
C01140,alpha-D-Glucosyl-protein,Generic compound in reaction hierarchy|R = protein,,,,
C01141,beta-Adrenergic receptor;|[beta-Adrenergic receptor],Generic compound in reaction hierarchy,,,,
C01142,"(3S)-3,6-Diaminohexanoate;|L-beta-Lysine",,,,,
C01143,(R)-5-Diphosphomevalonate;|(R)-5-Diphosphomevalonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01143  (R)-5-Diphosphomevalonic acid,
C01144,(S)-3-Hydroxybutanoyl-CoA;|(S)-3-Hydroxybutyryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01144  (S)-3-Hydroxybutanoyl-CoA,
C01146,2-Hydroxy-3-oxopropanoate;|Tartronate semialdehyde,,,,,
C01147,2-Hydroxycyclohexan-1-one;|2-Hydroxycyclohexanone;|Adipoin,,,,,
C01149,4-Trimethylammoniobutanal,,,,,
C01151,"D-Ribose 1,5-bisphosphate;|Ribose 1,5-bisphosphate;|alpha-D-Ribose 1,5-bisphosphate",,,,,
C01152,N(pi)-Methyl-L-histidine;|N-pros-Methyl-L-histidine;|3-Methylhistidine;|1-Methylhistidine,,,,,
C01153,Orthophosphoric monoester;|Phosphate monoester,Generic compound in reaction hierarchy,,,,
C01155,"Quercetin 3,3'-bissulfate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01155  Quercetin 3,3'-bissulfate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C01155  Quercetin 3,3'-bissulfate",
C01156,"Quercetin 3,4'-bissulfate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01156  Quercetin 3,4'-bissulfate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C01156  Quercetin 3,4'-bissulfate",
C01157,Hydroxyproline;|L-Hydroxyproline;|trans-4-Hydroxy-L-proline,cis-4-Hydroxy-L-proline [CPD:C01015],,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01157  Hydroxyproline,
C01158,1-O-Galloyl-beta-D-glucose;|1-Galloyl-beta-glucose;|beta-Glucogallin;|1-Galloyl-beta-D-glucose,,,,,
C01159,"2,3-Bisphospho-D-glycerate;|2,3-Diphospho-D-glycerate;|D-Greenwald ester;|DPG",,,,,
C01161,"3,4-Dihydroxyphenylacetate;|3,4-Dihydroxyphenylacetic acid;|Homoprotocatechuate",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C01161,
C01162,3-(Pyrazol-1-yl)-L-alanine;|beta-Pyrazol-1-ylalanine,,,,,
C01163,"3-Carboxy-cis,cis-muconate;|beta-Carboxy-cis,cis-muconate;|cis,cis-Butadiene-1,2,4-tricarboxylate",,,,,
C01164,"7-Dehydrocholesterol;|Provitamin D3;|Cholesta-5,7-dien-3beta-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Cholestane derivatives|C01164  7-Dehydrocholesterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C01164  7-Dehydrocholesterol|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C01164  Provitamin D3,
C01165,L-Glutamate 5-semialdehyde;|L-Glutamate gamma-semialdehyde,,,,,
C01166,Oxidized polyvinyl alcohol,Polyvinyl alcohol [CPD:C00980],,,,
C01167,Protein tyrosine phosphate;|[Protein]-L-tyrosine phosphate,Generic compound in reaction hierarchy,,,,
C01168,Pseudouridine 5'-phosphate,,,,,
C01169,S-Succinyldihydrolipoamide,,,,,
C01170,UDP-N-acetyl-D-mannosamine;|UDP-N-acetyl-alpha-D-mannosamine,,,,,G11112
C01171,alpha-D-Hexose 1-phosphate,Generic compound in reaction hierarchy,,,,
C01172,beta-D-Glucose 6-phosphate,,,,,
C01173,"1,3,8-Naphthalenertriol;|1,3,8-Trihydroxynaphthalene",,,,,
C01175,1-O-Sinapoyl-beta-D-glucose;|1-O-Sinapoyl beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C01175  1-O-Sinapoyl-beta-D-glucose,
C01176,"17alpha-Hydroxyprogesterone;|17alpha-Hydroxy-4-pregnene-3,20-dione;|Pregn-4-ene-3,20-dione-17-ol;|17alpha-Hydroxy-progesterone",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Progestagens|C01176  17alpha-Hydroxyprogesterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C01176  17alpha-Hydroxyprogesterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08052)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DA Pregnen (4) derivatives|G03DA03 Hydroxyprogesterone|D08052  Hydroxyprogesterone (INN)|Drug groups [BR:br08330(D08052)]|Hormonal agent|DG02004  Progesterone|DG00467  Hydroxyprogesterone|D08052  Hydroxyprogesterone|DG01666  Progesterone receptor agonist|DG00467  Hydroxyprogesterone|D08052  Hydroxyprogesterone|Target-based classification of drugs [BR:br08310(D08052)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D08052  Hydroxyprogesterone (INN)",
C01177,Inositol 1-phosphate;|myo-Inositol 1-phosphate;|1D-myo-Inositol 1-phosphate;|D-myo-Inositol 1-phosphate;|1D-myo-Inositol 1-monophosphate,,,,,
C01179,3-(4-Hydroxyphenyl)pyruvate;|4-Hydroxyphenylpyruvate;|p-Hydroxyphenylpyruvic acid,,,,,
C01180,4-Methylthio-2-oxobutanoic acid;|4-Methylthio-2-oxobutanoate;|4-(Methylsulfanyl)-2-oxobutanoate;|2-Keto-4-methylthiobutyric acid;|2-Oxo-4-methylthiobutanoate;|2-Oxo-4-methylthiobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C01180  2-Oxo-4-methylthiobutanoic acid,
C01181,4-Trimethylammoniobutanoate;|Butyro-betaine;|gamma-Butyrobetaine,,,,,
C01182,"D-Ribulose 1,5-bisphosphate",,,,,
C01183,"N,N-Dimethylaniline N-oxide",,,,,
C01185,Nicotinate D-ribonucleotide;|beta-Nicotinate D-ribonucleotide;|Nicotinate ribonucleotide;|Nicotinic acid ribonucleotide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C01185  Nicotinate D-ribonucleotide,
C01186,"(3S,5S)-3,5-Diaminohexanoate;|L-erythro-3,5-Diaminohexanoate;|(3S,5S)-3,5-Diaminocaproate;|L-erythro-3,5-Diaminocaproate",,,,,
C01187,3-Deoxy-D-manno-octulosonate;|Ketodeoxyoctonate;|KDO;|2-Dehydro-3-deoxy-D-octonate;|3-Deoxy-D-manno-2-octulosonate;|3-Deoxyoctulosonic acid,Ketodeoxyoctonate (pyranose) [CPD:C21063],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C01187  3-Deoxy-D-manno-octulosonic acid,
C01188,3-Hydroxy-2-methylpropanoate;|3-Hydroxyisobutyrate;|3-Hydroxyisobutyric acid,,,,,
C01189,Lathosterol;|5alpha-Cholest-7-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C01189  Lathosterol,
C01190,Glucosylceramide;|Glucocerebroside;|beta-D-Glucosyl-(1<->1)-ceramide;|D-Glucosyl-N-acylsphingosine;|beta-D-Glucosyl-N-acylsphingosine,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C01190  Glucosylceramide|Lipids [BR:br08002(G10238)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0501 Simple Glc series|G10238  Glc-beta1->1'Cer (GlcCer),G10238
C01191,Dolichyl D-xylosyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C01191  Dolichyl D-xylosyl phosphate,
C01192,Palmitoylglycerone phosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP00 Other Glycerophospholipids|C01192  Palmitoylglycerone phosphate,
C01194,"1-Phosphatidyl-D-myo-inositol;|1-Phosphatidyl-1D-myo-inositol;|1-Phosphatidyl-myo-inositol;|Phosphatidyl-1D-myo-inositol;|(3-Phosphatidyl)-1-D-inositol;|1,2-Diacyl-sn-glycero-3-phosphoinositol;|Phosphatidylinositol",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C01194  Phosphatidylinositol|Lipids [BR:br08002]|GP  Glycerophospholipids|GP06 Glycerophosphoinositols|GP0601 Diacylglycerophosphoinositols|C01194  1,2-Diacyl-sn-glycero-3-phosphoinositol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C01194  1-Phosphatidyl-D-myo-inositol",
C01196,3'-Hydroxyoligoribonucleotide,,,,,
C01197,"Caffeate;|Caffeic acid;|3,4-Dihydroxy-trans-cinnamate;|trans-Caffeate;|(2E)-3-(3,4-Dihydroxyphenyl)prop-2-enoate",Caffeate (generic) [CPD:C01481],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C01197  Caffeate,
C01198,3-(2-Hydroxyphenyl)propanoate;|2-Hydroxyphenylpropanoate;|3-(2-Hydroxyphenyl)propionic acid;|Melilotate;|3-(2-Hydroxyphenyl)propionate,,,,,
C01199,5'-Hydroxyoligoribonucleotide,,,,,
C01200,N-Acylneuraminate 9-phosphate,,,,,
C01201,N(omega)-(ADP-D-ribosyl)-L-arginine;|Nomega-(ADP-D-ribosyl)-L-arginine,,,,,
C01203,Oleoyl-[acyl-carrier protein];|Octadecenoyl-[acyl-carrier protein];|Octadecenoyl-[acp];|(9Z)-Octadecenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C01203  (9Z)-Octadecenoyl-[acp],
C01204,"Phytic acid;|Phytate;|myo-Inositol hexakisphosphate;|1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate;|D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate;|myo-Inositol 1,2,3,4,5,6-hexakisphosphate;|Inositol 1,2,3,4,5,6-hexakisphosphate;|1D-myo-Inositol hexakisphosphate",,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Phytin|C01204  Phytic acid,
C01205,(R)-3-Amino-2-methylpropanoate;|(R)-3-Aminoisobutyrate;|D-3-Aminoisobutanoate;|(R)-beta-Aminoisobutyrate;|(R)-3-Aminoisobutyric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C01205  (R)-3-Aminoisobutyric acid,
C01207,"3-(3,4-Dihydroxyphenyl)lactate;|3,4-Dihydroxyphenyllactic acid",,,,,
C01209,Malonyl-[acyl-carrier protein];|Malonyl-[acp],Generic compound in reaction hierarchy|R = acyl-carrier protein,,,,
C01210,N-Methylethanolamine phosphate,,,,,
C01211,"Procollagen 5-hydroxy-L-lysine;|Procollagen L-erythro-5-hydroxylysine;|[Procollagen]-(2S,5R)-5-hydroxy-L-lysine",Generic compound in reaction hierarchy,,,,
C01212,UDP-N-acetylmuramoyl-L-alanine;|UDP-N-acetyl-alpha-D-muramoyl-L-alanine,,,,,
C01213,(R)-Methylmalonyl-CoA;|L-Methylmalonyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01213  (R)-Methylmalonyl-CoA,
C01214,1-Amino-1-deoxy-scyllo-inositol;|scyllo-Inosamine,,,,,
C01215,2-(Acetamidomethylene)succinate;|2-(Acetamidomethylidene)succinate,,,,,
C01216,2-Dehydro-3-deoxy-D-galactonate;|2-Dehydro-3-deoxy-D-galactonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01216  2-Dehydro-3-deoxy-D-galactonic acid,
C01217,"5,6,7,8-Tetrahydromethanopterin;|H4MPT;|THMPT;|Tetrahydromethanopterin",,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C01217  5,6,7,8-Tetrahydromethanopterin",
C01218,6-Phospho-2-dehydro-D-gluconate;|2-Dehydro-D-gluconate 6-phosphate,,,,,
C01219,CDP-4-dehydro-6-deoxy-D-glucose,,,,,
C01220,"1D-myo-Inositol 1,4-bisphosphate;|D-myo-Inositol 1,4-bisphosphate;|myo-Inositol 1,4-bisphosphate;|Inositol 1,4-bisphosphate",,,,,
C01221,Dihydrostreptomycin 6-phosphate,,,,,
C01222,GDP-4-dehydro-6-deoxy-D-mannose;|GDP-4-dehydro-6-deoxy-D-talose;|GDP-4-oxo-6-deoxy-D-mannose;|GDP-4-dehydro-D-rhamnose;|GDP-4-keto-6-deoxy-D-mannose;|GDP-4-dehydro-alpha-D-rhamnose;|GDP-4-dehydro-6-deoxy-alpha-D-mannose,,,,,
C01223,Methyl 2-diazoacetamidohexonate,,,,,
C01225,sn-Glycero-3-phospho-1-inositol;|1-(sn-Glycero-3-phospho)-1D-myo-inositol,,,,,
C01226,"(9S,13S,15Z)-12-Oxophyto-10,15-dienoate;|12-OPDA;|(15Z)-12-Oxophyto-10,15-dienoate;|(15Z)-12-Oxophyto-10,15-dienoic acid;|9(S),13(S)-12-Oxo-PDA;|12-Oxo-10,15(Z)-phytodienoic acid;|(9S,13S)-12-Oxophytodienoate;|(9S,13S)-OPDA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0201 12-oxophytodienoic acid metabolites|C01226  (15Z)-12-Oxophyto-10,15-dienoic acid",
C01227,Dehydroepiandrosterone;|3beta-Hydroxyandrost-5-en-17-one;|Dehydroisoandrosterone;|DHA;|DHEA,,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C01227  Dehydroepiandrosterone|Hormones and transmitters|Steroid hormones|Androgens|C01227  Dehydroepiandrosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C01227  3beta-Hydroxyandrost-5-en-17-one|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08409)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AA Androstan derivatives|A14AA07 Prasterone|D08409  Prasterone (USAN/INN) &lt;US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03XX Other sex hormones and modulators of the genital system|G03XX01 Prasterone|D08409  Prasterone (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D08409)]|Sexual Disorder Agents|Sexual Disorder Agents (Female)|Prasterone|D08409  Prasterone (USAN/INN)|Drug groups [BR:br08330(D08409)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG00141  Prasterone|D08409  Prasterone|Target-based classification of drugs [BR:br08310(D08409)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D08409  Prasterone (USAN/INN) &lt;US&gt;|3-Ketosteroid receptor|NR3C4 (AR)|D08409  Prasterone (USAN/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D08409)]|European public assessment reports (EPAR) authorised medicine|D08409,
C01228,"Guanosine 3',5'-bis(diphosphate);|Guanosine 3'-diphosphate 5'-diphosphate;|Guanosine 5'-diphosphate,3'-diphosphate",,,,,
C01229,Phospholipid olefinic fatty acid,Generic compound in reaction hierarchy,,,,
C01230,all-trans-Hexaprenyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C01230  all-trans-Hexaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C01230  all-trans-Hexaprenyl diphosphate,
C01231,"alpha-D-Glucose 1,6-bisphosphate;|alpha-D-Glucose 1,6-biphosphate;|D-Glucose 1,6-bisphosphate",,,,,
C01233,sn-Glycero-3-phosphoethanolamine;|Glycerophosphoethanolamine,,,,,
C01234,1-Aminocyclopropane-1-carboxylate;|1-Aminocyclopropane-1-carboxylic acid,,,,,
C01235,alpha-D-Galactosyl-(1->3)-1D-myo-inositol;|O-alpha-D-Galactosyl-(1->3)-1D-myo-inositol;|3-O-alpha-D-Galactosyl-1D-myo-inositol;|1-alpha-D-Galactosyl-myo-inositol;|Galactinol,,,,,G10488
C01236,"D-Glucono-1,5-lactone 6-phosphate;|6-Phospho-D-glucono-1,5-lactone",,,,,
C01239,N-Acetyl-beta-D-glucosaminylamine,,,,,
C01240,"2',3'-Cyclic nucleotide;|Nucleoside 2',3'-cyclic phosphate",Generic compound in reaction hierarchy,,,,
C01241,Phosphatidyl-N-methylethanolamine,,,,,
C01242,[Protein]-S8-aminomethyldihydrolipoyllysine;|[H-protein]-S-aminomethyldihydrolipoyllysine;|S-Aminomethyldihydrolipoylprotein;|[Glycine-cleavage complex H protein]-S-aminomethyl-N6-dihydrolipoyl-L-lysine;|[GCSH]-S-aminomethyl-N6-dihydrolipoyl-L-lysine;|[GcvH]-S-aminomethyl-N6-dihydrolipoyl-L-lysine,Generic compound in reaction hierarchy|The lipoyl-bearing H protein,,,,
C01243,"1D-myo-Inositol 1,3,4-trisphosphate;|D-myo-Inositol 1,3,4-trisphosphate;|Inositol 1,3,4-trisphosphate",,,,,
C01244,"3,5-Diiodo-4-hydroxyphenylpyruvate;|3-(3,5-Diiodo-4-hydroxyphenyl)pyruvate",,,,,
C01245,"D-myo-Inositol 1,4,5-trisphosphate;|1D-myo-Inositol 1,4,5-trisphosphate;|Inositol 1,4,5-trisphosphate;|Ins(1,4,5)P3",,,,,
C01246,Dolichyl beta-D-glucosyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C01246  Dolichyl beta-D-glucosyl phosphate,G10618
C01247,[Acetyl-CoA carboxylase] phosphate,Generic compound in reaction hierarchy,,,,
C01249,"7,8-Dihydro-7,8-dihydroxykynurenate",,,,,
C01250,N-Acetyl-L-glutamate 5-semialdehyde;|2-Acetamido-5-oxopentanoate,,,,,
C01251,"(R)-2-Hydroxybutane-1,2,4-tricarboxylate;|Homocitrate;|Homocitric acid;|3-Hydroxy-3-carboxyadipic acid;|(R)-2-Hydroxy-1,2,4-butanetricarboxylic acid",,,,,
C01252,"4-(2-Aminophenyl)-2,4-dioxobutanoate",,,,,
C01253,ADP-D-ribosyl-[dinitrogen reductase];|[Dinitrogen reductase]-Nomega-alpha-(ADP-D-ribosyl)-L-arginine,Generic compound in reaction hierarchy|Dinitrogen reductase (ec 1.18.6.1) is inactivated by ADP-ribosylation.|See active form [CPD:C03315],,,,
C01255,N-(6-Aminohexanoyl)-6-aminohexanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C01255  N-(6-Aminohexanoyl)-6-aminohexanoate,
C01256,[Pyruvate dehydrogenase (acetyl-transferring)],Generic compound in reaction hierarchy|Pyruvate dehydrogenase (ec 1.2.4.1) is inactivated by phosphorylation.|See [CPD:C01293],,,,
C01259,"(3S)-3-Hydroxy-N6,N6,N6-trimethyl-L-lysine",,,,,
C01260,"P1,P4-Bis(5'-adenosyl)tetraphosphate;|AppppA",,,,,
C01261,"P1,P4-Bis(5'-guanosyl) tetraphosphate;|GppppG;|Bis(5'-guanosyl) tetraphosphate",,,,,
C01262,beta-Alanyl-N(pi)-methyl-L-histidine;|Anserine,,,,Compounds with biological roles [BR:br08001]|Peptides|Peptides|Dipeptides|C01262  Anserine,
C01263,"3,6,9-Trihydroxypterocarpan;|(6aS,11aS)-3,6a,9-Trihydroxypterocarpan;|(-)-Glycinol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C01263  (6aS,11aS)-3,6a,9-Trihydroxypterocarpan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C01263  3,6,9-Trihydroxypterocarpan",
C01264,2-Acetyl-1-alkyl-sn-glycero-3-phosphate;|1-Alkyl-2-acetyl-sn-glycero-3-phosphate;|1-Alkyl-2-acetyl-sn-glycerol 3-phosphate,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1002 1-alkyl,2-acylglycerophosphates|C01264  1-Alkyl-2-acetyl-sn-glycerol 3-phosphate",
C01265,"3,7-Di-O-methylquercetin;|3',4',5-Trihydroxy-3,7-dimethoxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01265  3,7-Di-O-methylquercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C01265  3,7-Di-O-methylquercetin",
C01266,3'-Deoxydihydrostreptomycin 6-phosphate,,,,,
C01267,3-(Imidazol-4-yl)-2-oxopropyl phosphate;|Imidazole-acetol phosphate,,,,,
C01268,"5-Amino-6-(5'-phosphoribosylamino)uracil;|5-Amino-6-(ribosylamino)-2,4-(1H,3H)-pyrimidinedione 5'-phosphate;|5-Amino-6-(5-phosphoribosylamino)uracil",,,,Glycosides [BR:br08021]|N-glycosides|C01268  5-Amino-6-(5'-phosphoribosylamino)uracil,
C01269,5-O-(1-Carboxyvinyl)-3-phosphoshikimate;|O5-(1-Carboxyvinyl)-3-phosphoshikimate,,,,,
C01270,3-Hydroxy-2-methylpyridine-5-carboxylate,,,,,
C01271,(3R)-3-Hydroxyacyl-[acyl-carrier protein];|(R)-3-Hydroxyacyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C01272,"1D-myo-Inositol 1,3,4,5-tetrakisphosphate;|D-myo-Inositol 1,3,4,5-tetrakisphosphate;|Inositol 1,3,4,5-tetrakisphosphate",,,,,
C01273,"2-Hydroxy-6-oxo-6-phenylhexa-2,4-dienoate;|2,6-Dioxo-6-phenylhexa-3-enoate",,,,,
C01274,"5-Formyl-5,6,7,8-tetrahydromethanopterin;|5-Formyl-H4MPT",,,,,
C01275,(3E)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate;|trans-2'-Carboxybenzalpyruvate,,,,,
C01277,"1-Phosphatidyl-1D-myo-inositol 4-phosphate;|Phosphatidylinositol 4-phosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP07 Glycerophosphoinositol monophosphates|GP0701 Diacylglycerophosphoinositol monophosphates|C01277  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4'-phosphate)",
C01278,"2-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;|5-Carboxy-2,5-dihydro-2-oxofuran-5-acetate;|4-Carboxymuconolactone;|gamma-Carboxymuconolactone",,,,,
C01279,4-Amino-5-hydroxymethyl-2-methylpyrimidine;|Toxopyrimidine;|4-Amino-2-methyl-5-pyrimidinemethanol;|HMP,,,,,
C01280,"Dihydrostreptomycin 3'alpha,6-bisphosphate",,,,,
C01281,[L-Glutamate:ammonia ligase (ADP-forming)];|[L-Glutamate:ammonia ligase (ADP-forming)]-L-tyrosine;|[Glutamine synthetase]-L-tyrosine,L-Glutamate:ammonia ligase(ec 6.3.1.2) is inactivated by adenylation.|See [CPD:C01299],,,,
C01282,1-Acyl-2-oleoyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C01282  1-Acyl-2-oleoyl-sn-glycero-3-phosphocholine,
C01283,1-Amino-1-deoxy-scyllo-inositol 4-phosphate;|scyllo-Inosamine 4-phosphate,,,,,
C01284,"1D-myo-Inositol 1,3,4,5,6-pentakisphosphate;|D-myo-Inositol 1,3,4,5,6-pentakisphosphate;|Inositol 1,3,4,5,6-pentakisphosphate",,,,,
C01285,"2,6-Dichlorophenol-4-(2,3-dihydro-1,4-naphthoquinone imine);|4-(3,5-Dichloro-4-hydroxyphenylimino)tetralin-1-one",,,,,
C01286,2-Dehydro-3-deoxy-6-phospho-D-galactonate;|2-Dehydro-3-deoxy-D-galactonate 6-phosphate,,,,,
C01288,N-Acetyl-D-glucosaminylphosphatidylinositol;|6-(N-Acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C01288  N-Acetyl-D-glucosaminylphosphatidylinositol,
C01289,"N-Acetyl-D-glucosaminyldiphosphoundecaprenol;|N-Acetyl-D-glucosaminyldiphospho-ditrans,octacis-undecaprenol;|N-Acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol;|Lipid I",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C01289  N-Acetyl-D-glucosaminyldiphosphoundecaprenol,G13164
C01290,"Lactosylceramide;|beta-D-Galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide;|beta-D-Galactosyl-1,4-beta-D-glucosylceramide;|Gal-beta1->4Glc-beta1->1'Cer;|LacCer;|Lactosyl-N-acylsphingosine;|D-Galactosyl-1,4-beta-D-glucosylceramide",Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C01290  Lactosylceramide|Lipids [BR:br08002(G00092)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0501 Simple Glc series|G00092  Gal-beta1->4Glc-beta1->1'Cer (LacCer),G00092
C01291,3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA;|Isohexenyl-glutaconyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01291  3-(4-Methylpent-3-en-1-yl)pent-2-enedioyl-CoA,
C01292,"3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C01292  3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanic acid",
C01293,[Pyruvate dehydrogenase (acetyl-transferring)] phosphate,Generic compound in reaction hierarchy|Pyruvate dehydrogenase (ec 1.2.4.1) is inactivated by phosphorylation.|See [CPD:C01256],,,,
C01294,1-Guanidino-1-deoxy-scyllo-inositol 4-phosphate;|N-Amidino-scyllo-inosamine 4-phosphate,,,,,
C01295,"2D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone;|5D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone;|D-5-O-Methyl-2,3,5/4,6-pentahydroxycyclohexanone",,,,,
C01297,6-Hydroxypseudooxynicotine;|1-(6-Hydroxypyridin-3-yl)-4-(methylamino)butan-1-one,,,,,
C01298,"1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol;|Amidinostreptamine",,,,,
C01299,Adenylyl-[L-glutamate:ammonia ligase (ADP-forming)];|[L-Glutamate:ammonia ligase (ADP-forming)] inactive form;|[L-Glutamate:ammonia ligase (ADP-forming)]-O4-(5'-adenylyl)-L-tyrosine;|[Glutamine synthetase]-O4-(5'-adenylyl)-L-tyrosine,Generic compound in reaction hierarchy|L-Glutamate:ammonia ligase (ec 6.3.1.2) is inactivated by adenylation.|See [CPD:C01281],,,,
C01300,"6-(Hydroxymethyl)-7,8-dihydropterin;|6-Hydroxymethyl-7,8-dihydropterin;|2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine",,,,,
C01301,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C01301  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al",
C01302,1-(2-Carboxyphenylamino)-1-deoxy-D-ribulose 5-phosphate,,,,,
C01304,"2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one;|2,5-Diamino-6-(1-D-ribosylamino)pyrimidin-4(3H)-one 5'-phosphate",,,,"Glycosides [BR:br08021]|N-glycosides|C01304  2,5-Diamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one",
C01306,N-Acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-D-galactosaminyl-R;|N-Acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R;|Core 3,Generic compound in reaction hierarchy|R = Ser/Thr residue of glycoprotein,,,,G00028
C01308,[3-Methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)] phosphate;|[3-Methyl-2-oxobutanoate dehydrogenase (lipoamide)] phosphate,Generic compound in reaction hierarchy|3-Methyl-2-oxobutanoate dehydrogenase (ec 1.2.4.4) is inactivated by phosphorylation.|See [CPD:C04726],,,,
C01310,"4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine",,,,,G00375
C01311,"beta-D-Galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosaminyl-R;|1,4-beta-D-Galactosyl-(alpha-1,3-L-fucosyl)-N-acetyl-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C01312,"Prostaglandin I2;|(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate;|Prostacyclin;|PGI2;|Epoprostenol",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C01312  Prostaglandin I2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C01312  Prostaglandin I2|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00106)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AC Platelet aggregation inhibitors excl. heparin|B01AC09 Epoprostenol|D00106  Epoprostenol (USAN/INN)|Drug groups [BR:br08330(D00106)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|DG00157  Epoprostenol|D00106  Epoprostenol|Hormonal agent|DG01961  Prostaglandin derivative|DG01810  Prostacycline derivative|DG00157  Epoprostenol|D00106  Epoprostenol|Target-based classification of drugs [BR:br08310(D00106)]|G Protein-coupled receptors|Rhodopsin family|Prostacyclin|PTGIR|D00106  Epoprostenol (USAN/INN),
C01313,"(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxoprolyl]glycine",,,,,
C01314,"(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxoprolyl]-(S)-alanine",,,,,
C01315,"(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]glycine benzyl ester",,,,,
C01316,"(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester",,,,,
C01319,Hg;|Mercury;|Elemental mercury,,,,,
C01321,RI,,,,,
C01324,Bromide;|Br-,,,,,
C01326,Hydrogen cyanide;|HCN;|Cyanide,,,,,
C01327,Hydrochloric acid;|HCl;|Hydrogen chloride;|Hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02057)]|A ALIMENTARY TRACT AND METABOLISM|A09 DIGESTIVES, INCL. ENZYMES|A09A DIGESTIVES, INCL. ENZYMES|A09AB Acid preparations|A09AB03 Hydrochloric acid|D02057  Hydrochloric acid (JP18/USP) &lt;JP&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA13 Hydrochloric acid|D02057  Hydrochloric acid (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02057)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D02057  Hydrochloric acid (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02057)]|Chemicals|D02057  Hydrochloric acid",
C01328,HO-;|OH-;|Hydroxide ion,,,,,
C01329,Nucleoside phosphate;|Nucleoside monophosphate;|NMP,Generic compound in reaction hierarchy|R = base,,,,
C01330,Sodium cation;|Na+;|Sodium(1+);|Sodium ion,,,,,
C01334,RCl,Generic compound in reaction hierarchy,,,,
C01335,ROH,Generic compound in reaction hierarchy|R = alkyl group [CPD:C00069]|R = aromatic group [CPD:C15584],,,,
C01336,Aryl thiol;|RSH,Generic compound in reaction hierarchy|R = aromatic group,,,,
C01337,XDP;|Xanthosine 5'-pyrophosphate;|Xanthosine 5'-diphosphate,,,,,
C01341,E-64;|Proteinase inhibitor E 64,,,,,
C01342,NH4+;|Ammonia ion;|Ammonium(1+),,,,,
C01343,Alkylmercury;|RHg+;|Alkylmercury ion,Generic compound in reaction hierarchy|R = CH3 [CPD:C18672],,,,
C01344,dIDP;|2'-Deoxyinosine-5'-diphosphate;|2'-Deoxyinosine 5'-diphosphate,,,,,
C01345,dITP;|2'-Deoxyinosine-5'-triphosphate;|2'-Deoxyinosine 5'-triphosphate,,,,,
C01346,dUDP;|2'-Deoxyuridine 5'-diphosphate,,,,Compounds with biological roles [BR:br08001]|Nucleic acids|Nucleotides|Deoxyribonucleotides|C01346  dUDP,
C01347,dXDP,,,,,
C01348,dXTP,,,,,
C01349,Docebenone;|AA861,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C01349  Docebenone|Target-based classification of drugs [BR:br08310(D03882)]|Enzymes|Oxidoreductases (EC1)|Dioxygenases|ALOX5|D03882  Docebenone (USAN/INN),
C01352,FADH2,,,,,
C01353,Carbonic acid;|Dihydrogen carbonate;|H2CO3,Bicarbonate (conjugate base) [CPD:C00288],,,,
C01358,NH4OH;|Ammonium hydroxide,,,,"Therapeutic category of drugs in Japan [BR:br08301(D04594)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2643  Ammonium agents|D04594  Ammonia water (JP18)|Classification of Japanese OTC drugs [BR:br08313(D04594)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D04594  Ammonia water (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D04594)]|Chemicals|D04594  Ammonia water",
C01359,PQQH2;|Reduced pyrroloquinoline-quinone,,,,,
C01367,3'-AMP;|3'-Adenylic acid;|3'-Adenosine monophosphate;|Adenosine-3'-monophosphate;|Adenosine 3'-phosphate;|AMP 3'-phosphate,,,,,
C01368,3'-UMP;|Uridine 3'-monophosphate;|Uridine 3'-phosphate,,,,,
C01370,Aldose,Generic compound in reaction hierarchy,,,,
C01371,Alkane;|RH,Generic compound in reaction hierarchy,,,,
C01372,Alkene,Generic compound in reaction hierarchy,,,,
C01375,Tacrolimus;|FK506;|FK 506,4 Pyd is modified by vinyl. (allylmalonyl-CoA extension unit),0 Ska  1 Mtk  2 Mtk  3 Man  4 Pyd  5 Mte  6 Mte  7 Mak  8 Mae|9 Mtn  10 Man  11 Pip,PKNRP,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01375  Tacrolimus (FK506)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08556)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AH Agents for dermatitis, excluding corticosteroids|D11AH01 Tacrolimus|D08556  Tacrolimus (INN)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AD Calcineurin inhibitors|L04AD02 Tacrolimus|D08556  Tacrolimus (INN)|Drug groups [BR:br08330(D08556)]|Immunological agent|DG03129  Calcineurin inhibitor|DG00439  Tacrolimus|D08556  Tacrolimus|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG00439  Tacrolimus|D08556  Tacrolimus|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00439  Tacrolimus|D08556  Tacrolimus|Target-based classification of drugs [BR:br08310(D08556)]|Enzymes|Hydrolases (EC3)|Phosphatases|PPP3C/PPP3R/CHP|D08556  Tacrolimus (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08556)]|Drug metabolizing enzymes|D08556",
C01378,"Fustin;|2,3-Dihydrofisetin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C01378  Fustin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C01378  Fustin,
C01380,"Ethylene glycol;|1,2-Ethanediol;|Ethane-1,2-diol",,,,,
C01382,Iodine;|I2;|Diiodine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00108)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AG Iodine products|D08AG03 Iodine|D00108  Iodine (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00108)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2612  Iodates|D00108  Iodine (JP18/USP)|269  Miscellaneous|2699  Others|D00108  Iodine (JP18/USP)|27  Dental preparations|279  Miscellaneous|2790  Miscellaneous|D00108  Iodine (JP18/USP)|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D00108  Iodine (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00108)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00108  Iodine (JP18/USP)|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D00108  Iodine (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00108)]|Third-class OTC drugs|Inorganic and organic chemicals|Iodine|D00108  Iodine (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9511  Iodine compounds and preparations|C01382  Iodine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00108)]|Chemicals|D00108  Iodine,
C01384,Maleic acid;|Maleate;|cis-Butenedioic acid,,,,,
C01386,NH2Mec;|7-Amino-4-methylcoumarin,,,,,
C01387,Octane;|n-Octane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C01387  n-Octane,
C01389,Phytol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C01389  Phytol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Linear diterpenes|C01389  Phytol,
C01390,Prenol;|Prenyl alcohol;|3-Methyl-2-buten-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C01390  3-Methyl-2-buten-1-ol,
C01392,alpha-Tubulin;|C-terminal-tyrosinated alpha-Tubulin,Generic compound in reaction hierarchy,,,,
C01394,Xylose,,,,,
C01397,Arachidonyltrifluoromethane;|AACOCF3,,,,,
C01398,Acyloin,"Generic compound in reaction hierarchy|Acetoin (R = CH3) [CPD:C00466]|(R)-Acetoin (R = CH3, (R)-form) [CPD:C00810]|(S)-Acetoin (R = CH3, (S)-form) [CPD:C01769]",,,,
C01399,Agarose,,,,,
C01401,Alanine;|2-Aminopropionic acid;|2-Aminopropanoic acid,D-Alanine [CPD:C00133]|L-Alanine [CPD:C00041],,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|L-Alanine|C01401  Alanine,
C01402,Anilide,Generic compound in reaction hierarchy,,,,
C01403,Anisole;|Methoxybenzene;|Methyl phenyl ether;|Phenol methyl ether,,,,,
C01404,Arg-OEt,,,,,
C01405,Aspirin;|Acetylsalicylic acid;|2-Acetoxybenzenecarboxylic acid;|Acetylsalicylate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00109)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AD Other agents for local oral treatment|A01AD05 Acetylsalicylic acid|D00109  Aspirin (JP18/USP) &lt;JP&gt;|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AC Platelet aggregation inhibitors excl. heparin|B01AC06 Acetylsalicylic acid|D00109  Aspirin (JP18/USP) &lt;JP&gt;|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BA Salicylic acid and derivatives|N02BA01 Acetylsalicylic acid|D00109  Aspirin (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00109)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1143  Salicylates|D00109  Aspirin (JP18/USP); Aspalon (JAN)|3  Agents affecting metabolism|33  Blood and body fluid agents|339  Miscellaneous|3399  Others|D00109  Aspirin (JP18/USP); Aspalon (JAN)|Classification of Japanese OTC drugs [BR:br08313(D00109)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00109  Aspirin (JP18/USP)|03 Antipyretic analgesic agents|D00109  Aspirin (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00109)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Aspirin|D00109  Aspirin (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Aspirin|D00109  Aspirin (JP18/USP)|Drug groups [BR:br08330(D00109)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|DG00015  Acetylsalicylic acid|D00109  Aspirin|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|DG00015  Acetylsalicylic acid|D00109  Aspirin|Drug classes [BR:br08332(D00109)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00109  Aspirin|Target-based classification of drugs [BR:br08310(D00109)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00109  Aspirin (JP18/USP) &lt;JP&gt;|PTGS2 (COX2)|D00109  Aspirin (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00109)]|Chemicals|D00109  Aspirin|D00109  Aspirin tablets|Rx-to-OTC switch list in the USA [br08315.html(D00109)]|D00109",
C01407,Benzene,,,,,
C01408,"Benzoin;|2-Hydroxy-1,2-diphenylethanone;|Benzoin tincture",,,,,
C01410,Boc-Asn;|N-alpha-Boc-L-asparagine,,,,,
C01411,Borneol,(+)-Borneol [CPD:C01765]|(-)-Borneol [CPD:C01766],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C01411  Borneol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01411  Borneol,
C01412,Butanal;|Butyraldehyde,,,,,
C01413,Cadmium,Cadmium and cadmium compounds|Usually existing as +2 cations|Cadmium chloride [CPD:C15233],,,,
C01414,Casbene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010429 Casbane diterpenoids|C01414  Casbene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Cembrenes|C01414  Casbene,
C01416,Cocaine;|l-Cocain;|beta-Cocain,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C01416  Cocaine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01416|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00110)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BC Esters of benzoic acid|N01BC01 Cocaine|D00110  Cocaine (USP)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AD Anesthetics, local|R02AD03 Cocaine|D00110  Cocaine (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA01 Cocaine|D00110  Cocaine (USP)|S02 OTOLOGICALS|S02D OTHER OTOLOGICALS|S02DA Analgesics and anesthetics|S02DA02 Cocaine|D00110  Cocaine (USP)|Drug groups [BR:br08330(D00110)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00808  Cocaine|D00110  Cocaine|Target-based classification of drugs [BR:br08310(D00110)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00110  Cocaine (USP)|SCN2A|D00110  Cocaine (USP)|SCN3A|D00110  Cocaine (USP)|SCN4A|D00110  Cocaine (USP)|SCN5A|D00110  Cocaine (USP)|SCN8A|D00110  Cocaine (USP)|SCN9A|D00110  Cocaine (USP)|SCN10A|D00110  Cocaine (USP)|SCN11A|D00110  Cocaine (USP)|Potassium channels|KCNH2|D00110  Cocaine (USP)|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D00110  Cocaine (USP)|SLC6A3 (DAT1)|D00110  Cocaine (USP)|SLC6A4 (HTT)|D00110  Cocaine (USP)|Narcotics and psychotropics in Japan [br08308.html(D00110)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D00110",
C01417,Cyanate;|Cyanic acid,,,,,
C01418,Cycasin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Others|C01418  Cycasin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cyanogenic glycosides|C01418  Cycasin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C01418  Cycasin,
C01419,Cys-Gly;|L-Cysteinylglycine,,,,,
C01420,Cystine;|Dicysteine;|alpha-Diamino-beta-dithiolactic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01420  Cystine,
C01421,Daphnin,,,,,
C01424,"Gallate;|Gallic acid;|3,4,5-Trihydroxybenzoic acid;|3,4,5-Trihydroxybenzoate;|Pyrogallol-5-carboxylic acid",,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Galloyl derivatives|C01424  Gallate|Dietary phytochemicals [br08012.html]|Flavonoids|C01424,
C01425,Glutamyl-glutamic acid;|L-alpha-Glutamyl-L-glutamic acid;|Glu-Glu,,,,,
C01432,Lactate;|Lactic acid;|2-Hydroxypropanoic acid;|2-Hydroxypropionic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00111)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AD Organic acids|G01AD01 Lactic acid|D00111  Lactic acid (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00111)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D00111  Lactic acid (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00111)]|Third-class OTC drugs|Inorganic and organic chemicals|Lactic acid|D00111  Lactic acid (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00111)]|Chemicals|D00111  Lactic acid",
C01433,Loganin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C01433  Loganin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C01433  Loganin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C01433  Loganin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01433|Dietary phytochemicals [br08012.html]|Other phytochemicals|C01433",
C01438,Methane;|CH4,,,,,
C01441,Neamine;|Neomycin A,Component of Neomycin [CPD:C00384],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01441,
C01443,Ouabain;|G-Strophanthin,,,,Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C01443  Ouabain|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C01443  Ouabain|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C01443  Ouabain|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C01443  Ouabain|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C01443  Ouabain,
C01444,Oxamate;|Oxamic acid;|Oxalic monoamide,,,,,
C01445,Poly(G),,,,,
C01448,Questin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C01448  Questin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C01448  Questin,
C01449,Queuine;|Base Q,,,,,
C01450,Ketone;|R-CO-R',Generic compound in reaction hierarchy,,,,
C01451,Salicin;|Salicoside,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C01451  Salicin,
C01452,Sorbose;|xylo-Hexulose,Relative configuration|D-Sorbose [CPD:C00764]|L-Sorbose [CPD:C00247],,,,
C01453,Tacrine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08555)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06D ANTI-DEMENTIA DRUGS|N06DA Anticholinesterases|N06DA01 Tacrine|D08555  Tacrine (INN)|Drug groups [BR:br08330(D08555)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00982  Tacrine|D08555  Tacrine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00982  Tacrine|D08555  Tacrine|Target-based classification of drugs [BR:br08310(D08555)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D08555  Tacrine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08555)]|Drug metabolizing enzymes|D08555,
C01454,Toluate;|p-Toluate;|p-Toluic acid;|4-Methylbenzoic acid;|Toluenecarboxylic acid;|Crithminic acid,,,,,
C01455,Toluene;|Methylbenzene;|Toluol,,,,,
C01456,Tropate;|Tropic acid;|alpha-(Hydroxymethyl)phenylacetic acid,,,,,
C01457,Tylosin,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Macrolides|C01457  Tylosin|Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01457  Tylosin|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9762  Antibiotic preparations for peroral and feed additive use|C01457  Tylosin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01457|Drug groups [BR:br08330(D02490)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG01436  Tylosin|D02490  Tylosin|Antimicrobials [BR:br08307(D02490)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D02490  Tylosin (USP/INN),
C01458,Tyr-OEt,,,,,
C01460,Vitexin;|Apigenin 8-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01460  Vitexin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01460  Vitexin|Glycosides [BR:br08021]|C-glycosides|C01460  Vitexin|Dietary phytochemicals [br08012.html]|Flavonoids|C01460,
C01464,Xanthan;|Xanthene,,,,,
C01467,3-Cresol;|m-Cresol;|3-Hydroxytoluene;|3-Methylphenol,,,,,
C01468,4-Cresol;|p-Cresol;|4-Hydroxytoluene;|4-Methylphenol,,,,,
C01469,ADP-sugar,Generic compound in reaction hierarchy,,,,
C01470,"Acacetin;|5,7-Dihydroxy-4'-methoxyflavone;|4'-Methoxy-5,7-dihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01470  Acacetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01470  Acacetin,
C01471,Acrolein;|Acrylaldehyde;|Acrylic aldehyde;|Propenal,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C01471  Acrolein,
C01474,"Alizarin;|Dihydroxyanthraquinone;|1,2-Dihydroxyanthraquinone;|Dihydroxy-9,10-anthracenedione",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C01474  Alizarin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C01474  Alizarin,
C01477,"Apigenin;|4',5,7-Trihydroxyflavone;|5,7,4'-Trihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01477  Apigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01477  Apigenin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01477|Dietary phytochemicals [br08012.html]|Flavonoids|C01477,
C01478,Arsenic acid;|Orthoarsenic acid,,,,,
C01479,Atropine;|dl-Hyoscyamine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C01479  Atropine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Tropan alkaloids|C01479  Atropine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00113)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03B BELLADONNA AND DERIVATIVES, PLAIN|A03BA Belladonna alkaloids, tertiary amines|A03BA01 Atropine|D00113  Atropine (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FA Anticholinergics|S01FA01 Atropine|D00113  Atropine (USP)|Drug groups [BR:br08330(D00113)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00052  Atropine|D00113  Atropine|Target-based classification of drugs [BR:br08310(D00113)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00113  Atropine (USP) &lt;US&gt;",
C01481,"Caffeate;|Caffeic acid;|3,4-Dihydroxycinnamic acid",Generic compound in reaction hierarchy|Usually trans-form [CPD:C01197]|Exists in cis and trans forms (the trans-form is shown here),,,,
C01484,"Chalcone;|Benzylideneacetophenone;|1,3-Diphenyl-2-propen-1-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C01484  Chalcone,
C01485,Chloric acid;|Chlorate,,,,,
C01486,Chlorous acid;|Chlorite,,,,,
C01487,D-Allose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C01487  D-Allose,
C01488,D-Apiose,D-Apiose (furanose) [CPD:C21040]|beta-D-Apiose [CPD:C08346],,,,
C01489,D-Iditol,L-Iditol [CPD:C01507],,,,
C01490,Dermatan;|Dermatan L-iduronate,,,,,
C01494,Ferulate;|Ferulic acid;|4-Hydroxy-3-methoxycinnamic acid;|3-Methoxy-4-hydroxy-trans-cinnamate;|4-Hydroxy-3-methoxycinnamate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C01494  Ferulate,
C01495,Flavonol,Generic compound in reaction hierarchy,,,,
C01499,Geranial;|trans-Citral,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C01499  Geranial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C01499  Geranial,
C01500,Geraniol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C01500  Geraniol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C01500  Geraniol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01500,
C01502,o-Methoxyphenol;|Guaiacol;|Catechol mono methyl ether;|2-Methoxyphenol,,,,Therapeutic category of drugs in Japan [BR:br08301(D00117)]|2  Agents affecting individual organs|27  Dental preparations|273  Analgesics and sedatives|2730  Analgesics and sedatives|D00117  Guaiacol (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00117)]|Second-class OTC drugs|Inorganic and organic chemicals|Guaiacol|D00117  Guaiacol (JAN),
C01504,"Indanone;|Hydrindone;|1-Indanone;|1H-Inden-1-one, 2,3-dihydro-",,,,,
C01505,Kallidin;|Lysylbradykinin;|Lysyl-bradykinin,,Lys Arg Pro Pro Gly Phe Ser Pro Phe Arg,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Bradykinin|C01505  Kallidin,
C01506,L-Glycol,Generic compound in reaction hierarchy,,,,
C01507,L-Iditol,D-Iditol [CPD:C01489],,,,
C01508,L-Lyxose,D-Lyxose [CPD:C00476],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C01508  L-Lyxose,
C01510,L-Xylose;|L-Xylofuranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C01510  L-Xylose,
C01512,Loganate;|Loganic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C01512  Loganate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C01512  Loganate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C01512  Loganate",
C01513,Lupinate;|Lupinic acid;|3-[N6-(4-Hydroxyisopentenyl)adeninyl]-L-alanine;|(S)-2-Amino-3-{[(E)-4-hydroxy-3-methylbut-2-enylamino]purin-9-yl}propanoic acid,,,,,
C01514,"Luteolin;|3',4',5,7-Tetrahydroxyflavone;|5,7,3',4'-Tetrahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01514  Luteolin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01514  Luteolin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01514|Dietary phytochemicals [br08012.html]|Flavonoids|C01514,
C01516,Morphine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C01516  Morphine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01516|Prodrugs [br08324.html]|C01516|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08233)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AA Natural opium alkaloids|N02AA01 Morphine|D08233  Morphine (BAN)|Drug groups [BR:br08330(D08233)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00810  Morphine|D08233  Morphine|Analgesic|DG01984  Opioid analgesics|DG00810  Morphine|D08233  Morphine|Metabolizing enzyme substrate|DG02924  UGT substrate|DG00810  Morphine|D08233  Morphine|Target-based classification of drugs [BR:br08310(D08233)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08233  Morphine (BAN)|Drug metabolizing enzymes and transporters [br08309.html(D08233)]|Drug metabolizing enzymes|D08233|Prodrugs [br08324.html(D08233)]|D08233|Narcotics and psychotropics in Japan [br08308.html(D08233)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08233|Opium and Cannabis|D08233,
C01517,Naproxen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00118)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02C OTHER GYNECOLOGICALS|G02CC Antiinflammatory products for vaginal administration|G02CC02 Naproxen|D00118  Naproxen (JP18/USP/INN) &lt;JP/US&gt;|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE02 Naproxen|D00118  Naproxen (JP18/USP/INN) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA12 Naproxen|D00118  Naproxen (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00118)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Naproxen|D00118  Naproxen (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00118)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00118  Naproxen (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00118)]|Drugs requiring guidance|New approved switch OTC drugs|Naproxen|D00118  Naproxen (JP18/USP/INN)|Drug groups [BR:br08330(D00118)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|DG00455  Naproxen|D00118  Naproxen|Drug classes [BR:br08332(D00118)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00118  Naproxen|Target-based classification of drugs [BR:br08310(D00118)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00118  Naproxen (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00118  Naproxen (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00118)]|Chemicals|D00118  Naproxen|Rx-to-OTC switch list in Japan [br08314.html(D00118)]|D00118",
C01518,Nigerose;|Sakebiose;|3-O-alpha-D-Glucopyranosyl-D-glucose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01518  Nigerose,
C01523,Pregnane;|5beta-Pregnane,,,,,
C01525,R'C(R)SH,Generic compound in reaction hierarchy,,,,
C01526,Ricinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C01526  Ricinine,
C01527,Scopolin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C01527  Scopolin|Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C01527  Scopolin,
C01528,Hydrogen selenide;|Selenide,,,,,
C01529,Selenium,Selenium and selenium compounds,,,,
C01530,Octadecanoic acid;|Stearate;|Stearic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C01530  Stearic acid (18:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C01530  Octadecanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C01530  Stearic acid|Risk category of Japanese OTC drugs [BR:br08312(D00119)]|Third-class OTC drugs|Inorganic and organic chemicals|Stearic acid|D00119  Stearic acid (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00119)]|Chemicals|D00119  Stearic acid,
C01531,Sulindac,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00120)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB02 Sulindac|D00120  Sulindac (JP18/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00120)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Sulindac|D00120  Sulindac (JP18/USP/INN)|Drug groups [BR:br08330(D00120)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|D00120  Sulindac|Drug classes [BR:br08332(D00120)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00120  Sulindac|Target-based classification of drugs [BR:br08310(D00120)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00120  Sulindac (JP18/USP/INN) &lt;US&gt;|PTGS2 (COX2)|D00120  Sulindac (JP18/USP/INN) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00120)]|Chemicals|D00120  Sulindac",
C01533,Syringin;|Eleutheroside B,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C01533  Syringin,
C01536,Tyrosine;|3-(p-Hydroxyphenyl)alanine;|2-Amino-3-(p-hydroxyphenyl)propionic acid,D-Tyrosine [CPD:C06420]|L-Tyrosine [CPD:C00082],,,,
C01537,Urethane;|Ethyl carbamate,,,,,
C01540,Viomycin,"4 Ala is modified by beta-Ureidodehydro. (i.e. beta-Ureidodehydroalanine, Uda)",0 beta-Lys  1 Dpr  2 Ser  3 Ser  4 Ala  5 Cpd  (Cyclization: 1-5),NRP,,
C01541,Warfarin,,,,"Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C01541  Warfarin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08682)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AA Vitamin K antagonists|B01AA03 Warfarin|D08682  Warfarin (INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|994  Rodentickides|9943  Cumarin, derivatives and preparations|C01541  Warfarin|Drug groups [BR:br08330(D08682)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01708  Coumarin anticoagulant|DG01760  Warfarin and analog|DG00149  Warfarin|D08682  Warfarin|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00149  Warfarin|D08682  Warfarin|Target-based classification of drugs [BR:br08310(D08682)]|Enzymes|Oxidoreductases (EC1)|NAD(P)H dehydrogenase|NQO1|D08682  Warfarin (INN)|Vitamin-K-epoxide reductase|VKORC1|D08682  Warfarin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08682)]|Drug metabolizing enzymes|D08682",
C01542,o-Cresol;|2-Hydroxytoluene;|o-Methylphenol,,,,,
C01545,Octanal;|1-Octanal;|1-Caprylaldehyde;|1-Octylaldehyde;|1-Octaldehyde,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C01545  Octanal,
C01546,2-Furoate;|2-Furoic acid;|2-Furancarboxylic acid;|Pyromucic acid,,,,,
C01548,Acetylene;|Ethyne,,,,,
C01550,Agaritine,,,,,
C01551,Allantoin;|5-Ureidohydantoin;|Glyoxyldiureide,Generic compound in reaction hierarchy|(R)-Allantoin [CPD:C02348]|(S)-Allantoin [CPD:C02350],,,"Classification of Japanese OTC drugs [BR:br08313(D00121)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00121  Allantoin (JAN/USP)|Agents for integumentary system|55 Chilblain and chap remedies|D00121  Allantoin (JAN/USP)|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00121  Allantoin (JAN/USP)|Agents for ophthalmologic use|62 General eye drops|D00121  Allantoin (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00121)]|Third-class OTC drugs|Inorganic and organic chemicals|Allantoin|D00121  Allantoin (JAN/USP)",
C01552,Amastatin,,,,,
C01553,Amsacrine;|mAMSA;|4'-(9-Acridinylamino)-3'-methoxymethanesulfonanilide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02321)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX01 Amsacrine|D02321  Amsacrine (USAN/INN)|Drug groups [BR:br08330(D02321)]|Antineoplastic|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|D02321  Amsacrine|Target-based classification of drugs [BR:br08310(D02321)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D02321  Amsacrine (USAN/INN),
C01554,5alpha-Androstane,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C01554  5alpha-Androstane,
C01555,Apramycin,,,,Drug groups [BR:br08330(D02322)]|Antibacterial|DG01447  Aminoglycoside antibiotic|D02322  Apramycin|Antimicrobials [BR:br08307(D02322)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D02322  Apramycin (USAN/INN)|Antimicrobials abbreviations [BR:br08327(D02322)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D02322  Apramycin (USAN/INN),
C01557,Bergapten;|5-Methoxypsoralen;|O-Methylbergaptol;|5-Methoxyfuranocoumarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C01557  Bergapten|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07521)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05B ANTIPSORIATICS FOR SYSTEMIC USE|D05BA Psoralens for systemic use|D05BA03 Bergapten|D07521  Bergaptene (DCF),
C01558,Bile salt;|Bile acid,,,,,
C01561,"Calcidiol;|25-Hydroxyvitamin D3;|Calcifediol;|Calcifediol anhydrous;|(3S,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-3,25-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C01561  Calcidiol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CC Vitamin D and analogues|A11CC06 Calcifediol|C01561  Calcidiol|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H05 CALCIUM HOMEOSTASIS|H05B ANTI-PARATHYROID AGENTS|H05BX Other anti-parathyroid agents|H05BX05 Calcifediol|C01561  Calcidiol",G00124
C01562,Calycosin;|3'-Hydroxyformononetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C01562  Calycosin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C01562  Calycosin,
C01563,Carbamate;|Carbamic acid;|Aminoformic acid,,,,,
C01564,Cetraxate,,,,Risk category of Japanese OTC drugs [BR:br08312(D07663)]|Third-class OTC drugs|Inorganic and organic chemicals|Cetraxate|D07663  Cetraxate (INN)|Drug groups [BR:br08330(D07663)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|DG01870  Cetraxate|D07663  Cetraxate,
C01566,Cyanamide;|Carbodiimide,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C01566  Cyanamide|Therapeutic category of drugs in Japan [BR:br08301(D00123)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|393  Habitual intoxication agents|3932  Cyanamides|D00123  Cyanamide (JP18)|Target-based classification of drugs [BR:br08310(D00123)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|ALDH|D00123  Cyanamide (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00123)]|Chemicals|D00123  Cyanamide,
C01567,Cytomycin,,,,,
C01569,D-Apiitol;|3-(Hydroxymethyl)erythritol,,,,,
C01570,D-Leucine;|D-2-Amino-4-methylvaleric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01570  D-Leucine,
C01571,Decanoic acid;|Decanoate;|Decylic acid;|n-Capric acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C01571  Capric acid (10:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C01571  Decanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C01571  Capric acid,
C01572,Digallate;|Digallic acid,,,,,
C01573,Peptide diphthine;|Diphthine;|EF-2 diphthine;|Elongation factor 2 diphthine;|Diphthine-[translation elongation factor 2],Generic compound in reaction hierarchy|Precursor of Diphthamide [CPD:C02872]|Modified histidine residue of elongation factor 2(EF-2),,,,
C01575,"Ephedrine;|(-)-(1R,2S)-Ephedrine;|(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane;|(-)-Ephedrine;|L-Ephedrine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Phenylalanine derived alkaloids|C01575  Ephedrine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01575|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00124)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA26 Ephedrine|D00124  Ephedrine (USP)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA03 Ephedrine|D00124  Ephedrine (USP)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB05 Ephedrine|D00124  Ephedrine (USP)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03C ADRENERGICS FOR SYSTEMIC USE|R03CA Alpha- and beta-adrenoreceptor agonists|R03CA02 Ephedrine|D00124  Ephedrine (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FB Sympathomimetics excl. antiglaucoma preparations|S01FB02 Ephedrine|D00124  Ephedrine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00124)]|Second-class OTC drugs|Inorganic and organic chemicals|Ephedrine|D00124  Ephedrine (USP)|Drug groups [BR:br08330(D00124)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00227  Ephedrine|D00124  Ephedrine|DG01456  Adrenergic receptor agonist|DG00227  Ephedrine|D00124  Ephedrine|Unclassified|DG03282  Ephedrine-containing preparation|DG00227  Ephedrine|D00124  Ephedrine|Target-based classification of drugs [BR:br08310(D00124)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00124  Ephedrine (USP)|ADRA2|D00124  Ephedrine (USP)|ADRB|D00124  Ephedrine (USP)",
C01576,Etoposide;|VP-16,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00125)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CB Podophyllotoxin derivatives|L01CB01 Etoposide|D00125  Etoposide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00125)]|Antineoplastics|Molecular Target Inhibitors|Etoposide|D00125  Etoposide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00125)]|4  Agents affecting cellular function|42  Antineoplastics|424  Plant extract preparations|4240  Plant extract preparations|D00125  Etoposide (JP18/USP/INN)|Drug groups [BR:br08330(D00125)]|Antineoplastic|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|DG00693  Etoposide|D00125  Etoposide|Target-based classification of drugs [BR:br08310(D00125)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D00125  Etoposide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00125)]|Chemicals|D00125  Etoposide,
C01581,GDPhexose,Generic compound in reaction hierarchy,,,,
C01582,Galactose,D-Galactose [CPD:C00124]|L-Galactose [CPD:C01825],,,,
C01585,Hexanoic acid;|Hexanoate;|Hexylic acid;|n-Caproic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C01585  Capronate; Hexanoate|Lipids|Fatty acids|Saturated fatty acids|C01585  Caproic acid (6:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C01585  Hexanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C01585  Caproic acid,
C01586,Hippurate;|Hippuric acid;|N-Benzoylglycine;|Benzoylaminoacetic acid,,,,,
C01588,Ibuprofen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00126)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB16 Ibuprofen|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02C OTHER GYNECOLOGICALS|G02CC Antiinflammatory products for vaginal administration|G02CC01 Ibuprofen|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE01 Ibuprofen|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA13 Ibuprofen|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AX Other throat preparations|R02AX02 Ibuprofen|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00126)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Ibuprofen|D00126  Ibuprofen (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00126)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00126  Ibuprofen (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00126)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00126  Ibuprofen (JP18/USP/INN)|03 Antipyretic analgesic agents|D00126  Ibuprofen (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00126)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Ibuprofen|D00126  Ibuprofen (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Ibuprofen|D00126  Ibuprofen (JP18/USP/INN)|Drug groups [BR:br08330(D00126)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|DG00245  Ibuprofen|D00126  Ibuprofen|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00245  Ibuprofen|D00126  Ibuprofen|Drug classes [BR:br08332(D00126)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00126  Ibuprofen|Target-based classification of drugs [BR:br08310(D00126)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00126  Ibuprofen (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00126)]|Chemicals|D00126  Ibuprofen|New drug approvals in Europe [br08329.html(D00126)]|European public assessment reports (EPAR) authorised medicine|D00126|Drug metabolizing enzymes and transporters [br08309.html(D00126)]|Drug metabolizing enzymes|D00126|Prodrugs [br08324.html(D00126)]|D00126|Rx-to-OTC switch list in the USA [br08315.html(D00126)]|D00126|Rx-to-OTC switch list in Japan [br08314.html(D00126)]|D00126|Prodrugs [br08324.html]|C01588",
C01589,"Imidazole;|Glyoxaline;|1,3-Diazole",,,,,
C01590,Kievitone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C01590  Kievitone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C01590  Kievitone,
C01591,Leupeptin,,,,,
C01592,"Licodione;|1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)propane-1,3-dione",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C01592  Licodione,
C01593,Limonoate,,,,,
C01594,Linamarin;|Phaseolunatin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from valine or isoleucine|C01594  Linamarin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C01594  Linamarin,
C01595,"Linoleate;|Linoleic acid;|(9Z,12Z)-Octadecadienoic acid;|9-cis,12-cis-Octadecadienoate;|9-cis,12-cis-Octadecadienoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C01595  Linoleic acid (18:2;9,12)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C01595  (9Z,12Z)-Octadeca-9,12-dienoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C01595  Linoleic acid|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Linoleate|C01595  Linoleate",
C01596,Maleamate;|Maleamic acid,,,,,
C01598,Melatonin;|N-Acetyl-5-methoxytryptamine,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Other hormones|Melatonin|C01598  Melatonin|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C01598  Melatonin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08170)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CH Melatonin receptor agonists|N05CH01 Melatonin|D08170  Melatonin (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D08170)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D08170  Melatonin (JAN)|Drug groups [BR:br08330(D08170)]|Neuropsychiatric agent|DG01589  Melatonin receptor agonist|D08170  Melatonin|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|D08170  Melatonin|Target-based classification of drugs [BR:br08310(D08170)]|G Protein-coupled receptors|Rhodopsin family|Melatonin|MTNR1|D08170  Melatonin (JAN) &lt;JP&gt;|New drug approvals in Europe [br08329.html(D08170)]|European public assessment reports (EPAR) authorised medicine|D08170|New drug approvals in Japan [br08318.html(D08170)]|Drugs with new active ingredients|D08170|Drug metabolizing enzymes and transporters [br08309.html(D08170)]|Drug metabolizing enzymes|D08170,
C01600,NDP-hexose,Generic compound in reaction hierarchy,,,,
C01601,Nonanoic acid;|Nonanoate;|Pelargonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C01601  Nonanoic acid,
C01602,"Ornithine;|2,5-Diaminovaleric acid;|2,5-Diaminopentanoic acid;|2,5-Diaminopentanoate",,,,,
C01604,Phlorizin;|Phlorhizin;|Phloridzin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C01604  Phlorizin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C01604  Phlorizin|Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C01604  Phlorizin,
C01606,"Phthalate;|o-Phthalic acid;|1,2-Benzenedicarboxylic acid",,,,,
C01607,"Phytanate;|Phytanic acid;|3,7,11,15-Tetramethylhexadecanoic acid",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C01607  Phytanate,
C01608,Piroxicam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00127)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AC Oxicams|M01AC01 Piroxicam|D00127  Piroxicam (JP18/USP/INN) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA07 Piroxicam|D00127  Piroxicam (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC06 Piroxicam|D00127  Piroxicam (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00127)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Piroxicam|D00127  Piroxicam (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00127)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00127  Piroxicam (JP18/USP/INN)|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00127  Piroxicam (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00127)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00127  Piroxicam (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00127)]|Second-class OTC drugs|Inorganic and organic chemicals|Piroxicam|D00127  Piroxicam (JP18/USP/INN)|Drug groups [BR:br08330(D00127)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01910  Anti-inflammatory drug, oxicams|DG00752  Piroxicam|D00127  Piroxicam|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00752  Piroxicam|D00127  Piroxicam|Drug classes [BR:br08332(D00127)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00127  Piroxicam|Target-based classification of drugs [BR:br08310(D00127)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00127  Piroxicam (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00127  Piroxicam (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00127)]|Chemicals|D00127  Piroxicam|Drug metabolizing enzymes and transporters [br08309.html(D00127)]|Drug metabolizing enzymes|D00127|Pharmacogenomic biomarkers [br08341.html(D00127)]|Polymorphisms and mutations affecting drug response|D00127|Prodrugs [br08324.html(D00127)]|D00127|Rx-to-OTC switch list in Japan [br08314.html(D00127)]|D00127|Prodrugs [br08324.html]|C01608",
C01610,Puromycin,,,,Antimicrobials [BR:br08307(D05653)]|Antibacterials|Protein biosynthesis inhibitor|Other protein biosynthesis inhibitor|D05653  Puromycin (USAN)|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01610,
C01612,Secondary alcohol;|R-CHOH-R',Generic compound in reaction hierarchy,,,,
C01613,Stachyose,,,,,G00278
C01614,Sulfamate;|Sulfamic acid;|Amidosulfuric acid;|Sulfamidic acid;|Aminosulfonic acid,Generic compound in reaction hierarchy,,,,
C01615,Sulfinate;|Sulfinic acid,,,,,
C01616,Tauropine;|N2-(D-1-Carboxyethyl)taurine,,,,,
C01617,Taxifolin;|Dihydroquercetin;|(+)-Dihydroquercetin;|(+)-Taxifolin;|trans-Dihydroquercetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C01617  Taxifolin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C01617  Taxifolin|Dietary phytochemicals [br08012.html]|Flavonoids|C01617,
C01618,Testolate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C01618  Testolate,
C01619,Thiorphan,,,,,
C01620,"Threonate;|L-Threonate;|(2R,3S)-2,3,4-Trihydroxybutanoic acid",,,,,
C01621,Tolrestat,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02323)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10X OTHER DRUGS USED IN DIABETES|A10XA Aldose reductase inhibitors|A10XA01 Tolrestat|D02323  Tolrestat (USAN/INN)|Drug groups [BR:br08330(D02323)]|Antidiabetic agent|DG01882  Aldose reductase inhibitor|D02323  Tolrestat|Target-based classification of drugs [BR:br08310(D02323)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|AKR1B1|D02323  Tolrestat (USAN/INN),
C01623,UDP-apiose;|UDP-D-apiose;|UDP-alpha-D-apiose,,,,,
C01624,"Vermelone;|3,4-Dihydro-3,8-dihydroxy-1(2H)-naphthalenone",,,,,
C01625,Vicianose;|O-alpha-L-Arabinopyranosyl-(1-6)-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01625  Vicianose,G00688
C01626,Vindoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C01626  Vindoline|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C01626  Vindoline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01626,
C01628,Vitamin K,Generic compound in reaction hierarchy|Vitamin K1 (R = phytyl group) [CPD:C02059]|Vitamin K2 (R = all-trans-polyprenyl group) [CPD:C00828]|Vitamin K3 (R = H) [CPD:C05377],,,,
C01630,Xylobiose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01630  Xylobiose,
C01632,N-Carbobenzoxyglycylproline;|Z-Gly-Pro;|Z-Gly-Pro-OH,,,,,
C01633,1-Decanol;|n-Decanol;|Decyl alcohol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C01633  1-Decanol|Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C01633  1-Decanol,
C01654,"1,6-Mannan",,,,,
C01655,2-AminoAMP,,,,,
C01656,3-Oxo acid;|3-Keto acid,Generic compound in reaction hierarchy,,,,
C01657,Ac-Tyr-OEt;|N-Acetyl-L-tyrosine ethyl ester;|Ethyl N-alpha-acetyl-tyrosinate,,,,,
C01658,Acid amide,,,,,
C01659,Acrylamide;|2-Propenamide,,,,,
C01661,Doxorubicin;|Adriamycin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Other polyketides|C01661  Adriamycin|Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C01661  Adriamycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01661|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03899)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DB Anthracyclines and related substances|L01DB01 Doxorubicin|D03899  Doxorubicin (USAN/INN)|Drug groups [BR:br08330(D03899)]|Antineoplastic|DG01682  Anthracycline antineoplastic|DG00696  Doxorubicin|D03899  Doxorubicin|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|DG00696  Doxorubicin|D03899  Doxorubicin|Target-based classification of drugs [BR:br08310(D03899)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D03899  Doxorubicin (USAN/INN),
C01663,Alkylamide,,,,,
C01664,Alkylamine,Generic compound in reaction hierarchy,,,,
C01670,Bz-Arg-OEt,,,,,
C01672,"Cadaverine;|1,5-Pentanediamine;|1,5-Diaminopentane;|Pentamethylenediamine",,,,,
C01673,"Calcitriol;|1alpha,25-Dihydroxyvitamin D3;|(1S,3R,5Z,7E)-9,10-Seco-5,7,10(19)-cholestatriene-1,3,25-triol",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Others|C01673  Calcitriol (Vitamin D)|Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C01673  Calcitriol|Prodrugs [br08324.html]|C01673|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00129)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CC Vitamin D and analogues|A11CC04 Calcitriol|D00129  Calcitriol (JAN/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AX Other antipsoriatics for topical use|D05AX03 Calcitriol|D00129  Calcitriol (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00129)]|Dermatological Agents|Dermatological Agents, Other|Psoriasis Agents|Calcitriol|D00129  Calcitriol (JAN/USP/INN)|Metabolic Bone Disease Agents|Vitamin D-related Agents|Calcitriol|D00129  Calcitriol (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00129)]|3  Agents affecting metabolism|31  Vitamins|311  Vitamins A and D preparations|3112  Synthetic vitamin D preparations|D00129  Calcitriol (JAN/USP/INN)|Drug groups [BR:br08330(D00129)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|DG01606  Activated vitamin D3|D00129  Calcitriol|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00129  Calcitriol|Drug classes [BR:br08332(D00129)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00129  Calcitriol|Target-based classification of drugs [BR:br08310(D00129)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00129  Calcitriol (JAN/USP/INN) &lt;JP/US&gt;|Prodrugs [br08324.html(D00129)]|D00129",
C01674,"Chitobiose;|Diacetylchitobiose;|N,N'-Diacetylchitobiose",,,,,G10336
C01675,Cilastatin,,,,Target-based classification of drugs [BR:br08310(D07698)]|Enzymes|Hydrolases (EC3)|Dipeptidases|DPEP1|D07698  Cilastatin (INN),
C01677,Coformycin,,,,,
C01678,Cysteamine;|2-Aminoethanethiol;|beta-Aminoethanethiol;|beta-Mercaptoethylamine;|Mercaptamine;|Thioethanolamine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C01678  Cysteamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03634)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AA Amino acids and derivatives|A16AA04 Mercaptamine|D03634  Cysteamine (USAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA21 Mercaptamine|D03634  Cysteamine (USAN)|New drug approvals in Europe [br08329.html(D03634)]|European public assessment reports (EPAR) authorised medicine|D03634,
C01680,D-Fuconate,,,,,
C01682,"Nopaline;|D-Nopaline;|N2-(D-1,3-Dicarboxypropyl)-L-arginine;|N-[(1S)-4-Carbamimidamido-1-carboxybutyl]-D-glutamic acid",,,,,
C01683,Ornaline;|Nopalinic acid,,,,,
C01684,D-Rhamnose;|6-Deoxy-D-mannose;|D-Mannomethylose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C01684  D-Rhamnose,
C01685,D-Ribonate;|D-Ribonic acid,,,,,
C01687,Tylosin B;|Desmycosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01687  Desmycosin,
C01688,Destomysin;|Destomycin A,,,,,
C01690,Diclofenac,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07816)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX18 Diclofenac|D07816  Diclofenac (USAN/INN)|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB05 Diclofenac|D07816  Diclofenac (USAN/INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA15 Diclofenac|D07816  Diclofenac (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC03 Diclofenac|D07816  Diclofenac (USAN/INN)|USP drug classification [BR:br08302(D07816)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Diclofenac|D07816  Diclofenac (USAN/INN)|Dermatological Agents|Dermatological Agents, Other|Warts and Actinic Keratosis Agents|Diclofenac|D07816  Diclofenac (USAN/INN)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Nonsteroidal Anti-Inflammatory Drugs, Ophthalmic|Diclofenac|D07816  Diclofenac (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D07816)]|Second-class OTC drugs|Inorganic and organic chemicals|Diclofenac|D07816  Diclofenac (USAN/INN)|Drug groups [BR:br08330(D07816)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|DG01898  Anti-inflammatory drug, phenylacetic acid derivatives|DG00441  Diclofenac|D07816  Diclofenac|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00441  Diclofenac|D07816  Diclofenac|Transporter inhibitor|DG02866  SLC22A8 inhibitor|DG00441  Diclofenac|D07816  Diclofenac|Target-based classification of drugs [BR:br08310(D07816)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D07816  Diclofenac (USAN/INN)|PTGS2 (COX2)|D07816  Diclofenac (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D07816)]|Drug metabolizing enzymes|D07816|Drug transporters|D07816",
C01691,Diflunisal,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00130)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BA Salicylic acid and derivatives|N02BA11 Diflunisal|D00130  Diflunisal (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00130)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Diflunisal|D00130  Diflunisal (JAN/USP/INN)|Drug groups [BR:br08330(D00130)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|D00130  Diflunisal|Drug classes [BR:br08332(D00130)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00130  Diflunisal|Target-based classification of drugs [BR:br08310(D00130)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D00130  Diflunisal (JAN/USP/INN) &lt;US&gt;",
C01692,Disulfiram;|Tetraethylthiuram disulfide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00131)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BB Drugs used in alcohol dependence|N07BB01 Disulfiram|D00131  Disulfiram (JP18/USP/INN) &lt;JP/US&gt;|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AA Sulfur containing products|P03AA04 Disulfiram|D00131  Disulfiram (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00131)]|Anti-Addiction/Substance Abuse Treatment Agents|Alcohol Deterrents/Anti-craving|Disulfiram|D00131  Disulfiram (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00131)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|393  Habitual intoxication agents|3939  Others|D00131  Disulfiram (JP18/USP/INN)|Drug groups [BR:br08330(D00131)]|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|D00131  Disulfiram|DG02884  CYP2E1 inhibitor|D00131  Disulfiram|Target-based classification of drugs [BR:br08310(D00131)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|ALDH|D00131  Disulfiram (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00131)]|Chemicals|D00131  Disulfiram|Drug metabolizing enzymes and transporters [br08309.html(D00131)]|Drug metabolizing enzymes|D00131",
C01693,"L-Dopachrome;|2-L-Carboxy-2,3-dihydroindole-5,6-quinone",,,,,
C01694,"Ergosterol;|Provitamin D2;|(3beta,22E)-Ergosta-5,7,22-trien-3-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Ergostane derivatives|C01694  Ergosterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C01694  Ergosterol|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C01694  Ergosterol,
C01697,Galactitol;|Dulcitol;|Dulcose,,,,,
C01698,Galactogen,,,,,
C01699,Gibberellin A3;|Gibberellic acid;|Gibberellin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C01699  Gibberellin A3|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C01699  Gibberellin A3|Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C01699  Gibberellin A3|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01699,
C01700,Globomycin,,,,,
C01701,(-)-Glyceollin I;|Glyceollin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C01701  (-)-Glyceollin I|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C01701  (-)-Glyceollin I,
C01702,Glycogenin,Generic compound in reaction hierarchy,,,,
C01705,Glyphosate;|Roundup (TN),Herbicide target: EPSP synthase [KO:K00800],,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C01705  Glyphosate,
C01707,Hemiacetal,,,,,
C01709,"Hesperetin;|3',5,7-Trihydroxy-4'-methoxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C01709  Hesperetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C01709  Hesperetin|Dietary phytochemicals [br08012.html]|Flavonoids|C01709,
C01710,Indan-1-ol,,,,,
C01711,Inulobiose;|1-O-beta-D-Fructo-furanosyl-D-fructose,,,,,G10528
C01712,"(9E)-Octadecenoic acid;|9-Octadecenoic acid, (E)-;|(E)-Oleic acid;|D9-trans-Octadecenoic acid;|9-trans-Octadecenoic acid;|trans-D9-Octadecenoic acid;|trans-9-Octadecenoic acid;|trans-Elaidic acid;|trans-Oleic acid;|Elaidic acid;|Acide elaidique;|Elaidinsaure",,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C01712  Elaidic acid (18:1;9)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C01712  (E)-Octadec-9-enoic acid,
C01714,Isovitexin;|Saponaretin;|Apigenin-6-C-glucoside;|6-C-Glucosylapigenin;|Apigenin 6-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01714  Apigenin-6-C-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01714  Isovitexin|Glycosides [BR:br08021]|C-glycosides|C01714  Isovitexin|Dietary phytochemicals [br08012.html]|Flavonoids|C01714,
C01716,Ketoprofen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00132)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE03 Ketoprofen|D00132  Ketoprofen (JP18/USP/INN) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA10 Ketoprofen|D00132  Ketoprofen (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00132)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Ketoprofen|D00132  Ketoprofen (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00132)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00132  Ketoprofen (JP18/USP/INN)|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00132  Ketoprofen (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00132)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00132  Ketoprofen (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00132)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Ketoprofen|D00132  Ketoprofen (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Ketoprofen|D00132  Ketoprofen (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C01716  Ketoprofen|Drug groups [BR:br08330(D00132)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|DG00753  Ketoprofen|D00132  Ketoprofen|Transporter inhibitor|DG02883  SLC22A7 inhibitor|DG00753  Ketoprofen|D00132  Ketoprofen|Drug classes [BR:br08332(D00132)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00132  Ketoprofen|Target-based classification of drugs [BR:br08310(D00132)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00132  Ketoprofen (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00132  Ketoprofen (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00132)]|Chemicals|D00132  Ketoprofen|Drug metabolizing enzymes and transporters [br08309.html(D00132)]|Drug transporters|D00132|Rx-to-OTC switch list in the USA [br08315.html(D00132)]|D00132|Rx-to-OTC switch list in Japan [br08314.html(D00132)]|D00132",
C01717,4-Hydroxy-2-quinolinecarboxylic acid;|Kynurenic acid;|Kynurenate,,,,,
C01718,Kynurenine;|3-Anthraniloylalanine,,,,,
C01719,L-Fructose;|L-arabino-Hexulose,Fructose [CPD:C05003] (pyranose)|D-Fructose [CPD:C00095] (Fructofuranose)|D-Fructose [CPD:C10906],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C01719  L-Fructose,
C01720,L-Fuconate,,,,,
C01721,L-Fuculose;|6-Deoxy-L-tagatose,,,,,
C01722,L-Glucitol;|L-Sorbitol;|D-Gulitol,,,,,
C01724,"Lanosterol;|4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C01724  Lanosterol,
C01725,Levanbiose,,,,,
C01726,D-Lombricine,,,,,
C01727,"Lumichrome;|7,8-Dimethylalloxazine",,,,,
C01728,"Mannobiose;|alpha-1,6-Mannobiose;|alpha-D-Manp-(1->6)-D-Manp",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01728  Mannobiose,
C01729,(+)-Medicarpin;|3-Hydroxy-9-methoxypterocarpan,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C01729  (+)-Medicarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C01729  (+)-Medicarpin,
C01731,Mercury mercaptide,,,,,
C01732,Mesaconate;|2-Methylfumarate;|Mesaconic acid;|Methylfumaric acid;|(E)-2-Methyl-2-butenedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C01732  Mesaconic acid,
C01733,Methionine;|2-Amino-4-(methylthio)butyric acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04983)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB26 Methionine|D04983  Racemethionine (USAN)|Risk category of Japanese OTC drugs [BR:br08312(D04983)]|Third-class OTC drugs|Inorganic and organic chemicals|Methionine|D04983  Racemethionine (USAN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9671  Methionine and preparations|C01733  Methionine,
C01735,Morphinone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C01735  Morphinone,
C01736,Nebularine;|Purine riboside;|N-D-Ribosylpurine,,,,,
C01737,Neomycin B;|Fradiomycin B;|Framycetin,Component of Neomycin [CPD:C00384],,,Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|2-Deoxystreptamines|C01737  Neomycin B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01737|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05140)]|D DERMATOLOGICALS|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA01 Framycetin|D05140  Framycetin (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX08 Framycetin|D05140  Framycetin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA07 Framycetin|D05140  Framycetin (INN)|Risk category of Japanese OTC drugs [BR:br08312(D05140)]|Second-class OTC drugs|Inorganic and organic chemicals|Fradiomycin|D05140  Framycetin (INN)|Drug groups [BR:br08330(D05140)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG01446  Framycetin|D05140  Framycetin|Antimicrobials [BR:br08307(D05140)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D05140  Framycetin (INN),
C01739,Nocardicin E,,,,,
C01740,Octylamine;|N-Octylamine;|Monoctylamine,,,,,
C01742,Palatinose;|Isomaltulose;|6-O-alpha-D-Glucopyranosyl-D-fructofuranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C01742  Palatinose,G01241
C01743,Paromamine;|Neomycin D,,,,,
C01744,Phloretate;|Phloretic acid;|3-(4-Hydroxyphenyl)propanoate;|3-(4-Hydroxyphenyl)propionic acid,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C01744,
C01745,"Pinosylvin;|3,5-Stilbenediol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C01745  Pinosylvin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C01745  Pinosylvin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01745",
C01746,Piperidine;|Azacyclohexane;|Hexahydropyridine,,,,,
C01747,Psychosine;|Galactosylsphingosine;|O-Galactosylsphingosine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C01747  Psychosine|SP07 Basic glycosphingolipids|C01747  Psychosine,
C01748,Pyocyanine;|Pyocyanin;|5-Methylphenazin-5-ium-1-olate;|5-Methylphenazin-1(5H)-one,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01748,
C01750,Quercitrin;|Quercetin 3-L-rhamnoside;|Quercetin 3-O-alpha-L-rhamnopyranoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01750  Quercitrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C01750  Quercitrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C01750  Quercitrin|Dietary phytochemicals [br08012.html]|Flavonoids|C01750,
C01751,"Resorcinol;|Resorcin;|1,3-Benzenediol;|1,3-Dihydroxybenzene;|m-Hydroquinone",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00133)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AX Other anti-acne preparations for topical use|D10AX02 Resorcinol|D00133  Resorcinol (USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX06 Resorcinol|D00133  Resorcinol (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00133)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2619  Others|D00133  Resorcinol (USP); Resorcin (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00133)]|Second-class OTC drugs|Inorganic and organic chemicals|Resorcin|D00133  Resorcinol (USP),
C01752,Scopoletin;|7-Hydroxy-6-methoxy-2H-chromen-2-one,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C01752  Scopoletin,
C01753,beta-Sitosterol;|Sitosterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C01753  Sitosterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C01753  beta-Sitosterol,
C01754,Spiramycin,Generic compound|Spiramycin I (R = H)|Spiramycin II (R = COCH3) [CPD:C12891]|Spiramycin III (R = COCH2CH3) [CPD:C18844],,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01754  Spiramycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05908)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA02 Spiramycin|D05908  Spiramycin (JAN/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D05908)]|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|641  Antiprotozoans|6419  Others|D05908  Spiramycin (JAN/USAN/INN)|Drug groups [BR:br08330(D05908)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG00602  Spiramycin|D05908  Spiramycin|Drug classes [BR:br08332(D05908)]|Antibacterial|DG01551  Macrolide antibiotic|D05908  Spiramycin|Antimicrobials [BR:br08307(D05908)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D05908  Spiramycin (JAN/USAN/INN) &lt;JP&gt;|New drug approvals in Japan [br08318.html(D05908)]|Drugs with new active ingredients|D05908",
C01755,Thiocyanate;|Thiocyanic acid,,,,,
C01756,Thiopurine,Generic compound in reaction hierarchy,,,,
C01757,"Triacetate;|3,5-Dioxo-hexanoic acid;|3,5-Dioxohexanoate",,,,,
C01759,Ribostamycin;|Vistamycin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08478)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB10 Ribostamycin|D08478  Ribostamycin (INN)|Drug groups [BR:br08330(D08478)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00612  Ribostamycin|D08478  Ribostamycin|Antimicrobials [BR:br08307(D08478)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08478  Ribostamycin (INN),
C01760,"(6S,9R)-Vomifoliol;|(6S,9R)-6-Hydroxy-3-oxo-alpha-ionol",,,,,
C01761,Vomilenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C01761  Vomilenine,
C01762,Xanthosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C01762  Xanthosine,
C01764,tRNA containing uridine at position 54;|tRNA UpsiC,"Generic compound in reaction hierarchy|uridine (U) at position 54, pseudouridine (psi) at position 55 and cytidine (C) at position 56",,,,
C01765,"(+)-Borneol;|d-Borneol;|Borneocamphor;|endo-2-Bornanol;|Sumatra camphor;|(1R,2S,4R)-(+)-Borneol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C01765  (+)-Borneol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01765  (+)-Borneol|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Borneol|C01765  (+)-Borneol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01765,
C01766,"(-)-Borneol;|l-Borneol;|(1S,2R,4S)-(-)-Borneol;|Linderol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C01766  (-)-Borneol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01766  (-)-Borneol,
C01767,(-)-Carvone;|(4R)-Carvone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C01767  (-)-Carvone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01767  (-)-Carvone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01767,
C01768,(Alginate)n;|(Alginate)n+1;|Alginate;|Alginic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02324)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX13 Alginic acid|D02324  Alginic acid (NF)|Drug groups [BR:br08330(D02324)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|DG00028  Alginic acid|D02324  Alginic acid,G00316 G07287 G07471 G08476 G10593
C01769,(S)-Acetoin;|(S)-2-Acetoin;|(3S)-3-Hydroxybutan-2-one,Acetoin [CPD:C00466]|(R)-Acetoin [CPD:C00810],,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C01769  (3S)-3-Hydroxybutan-2-one,
C01770,"gamma-Butyrolactone;|1,4-Lactone",Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0704 Lactones|C01770  gamma-Butyrolactone,
C01771,2-Butenoate;|2-Butenoic acid;|Crotonic acid;|3-Methylacrylic acid;|(E)-But-2-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C01771  (E)-But-2-enoic acid,
C01772,trans-2-Hydroxycinnamate;|trans-2-Hydroxycinnamic acid;|2-Hydroxycinnamate;|2-Coumaric acid;|o-Coumaric acid;|2-Coumarate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C01772  trans-2-Hydroxycinnamate,
C01775,Actinomycin,Generic compound in reaction hierarchy|Actinomycin D [CPD:C06770],,NRP,,
C01776,Aculeacin A,,,,,
C01777,Acylcholine;|Choline ester,Generic compound in reaction hierarchy,,,,
C01779,Albendazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00134)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CA Benzimidazole derivatives|P02CA03 Albendazole|D00134  Albendazole (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00134)]|Antiparasitics|Anthelmintics|Albendazole|D00134  Albendazole (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00134)]|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|642  Anthelmintics|6429  Others|D00134  Albendazole (JAN/USP/INN)|Antimicrobials [BR:br08307(D00134)]|Antiparasitics|Antinematodal agents|Benzimidazole derivatives|D00134  Albendazole (JAN/USP/INN) &lt;JP/US&gt;",
C01780,"Aldosterone;|11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C01780  Aldosterone|Hormones and transmitters|Steroid hormones|Mineralocorticoids|C01780  Aldosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C01780  Aldosterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10528)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AA Mineralocorticoids|H02AA01 Aldosterone|D10528  Aldosterone (INN)|Drug groups [BR:br08330(D10528)]|Anti-inflammatory|DG01955  Corticosteroid|D10528  Aldosterone|Target-based classification of drugs [BR:br08310(D10528)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D10528  Aldosterone (INN)",
C01782,Benzene oxide;|Arene oxide,,,,,
C01783,Arylmercury,Generic compound in reaction hierarchy|p-Mercuribenzoate [CPD:C00985]|p-Chloromercuribenzoate [CPD:C03444]|Phenylmercury acetate [CPD:C11151],,,,
C01784,Benzamidine;|Benzenecarboxamidine,,,,,
C01785,Benzenediol,"Generic compound in reaction hierarchy|Including Catechol [CPD:C00090], Hydroquinone [CPD:C00530] and their related compounds [CPD:C15571 C15603]",,,,
C01788,CDP-abequose;|CDP-alpha-D-abequose,,,,,
C01789,Campesterol,,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Campestane derivatives|C01789  Campesterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C01789  Campesterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C01789  Campesterol,
C01790,Capreomycin,Generic compound,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07607)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB30 Capreomycin|D07607  Capreomycin (INN)|Drug groups [BR:br08330(D07607)]|Antibacterial|DG01966  Antitubercular|DG00641  Capreomycin|D07607  Capreomycin|Antimicrobials [BR:br08307(D07607)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D07607  Capreomycin (INN),
C01792,Chlordecone;|Kepone,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C01792  Chlordecone,
C01793,Chlorophyll,,,,,
C01794,"Choloyl-CoA;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanoyl-CoA;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-one-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C01794  Choloyl-CoA",
C01795,Columbamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C01795  Columbamine,
C01796,D-Erythrose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C01796  D-Erythrose,
C01798,D-Glucoside,Generic compound in reaction hierarchy,,,,
C01799,D-Norvaline;|D-2-Aminovaleric acid;|D-2-Aminopentanoic acid,L-Norvaline [CPD:C01826],,,,
C01800,Deazaflavin;|5-Deazaflavin,Generic compound|coenzyme F420 [CPD:C00876],,,,
C01801,Deoxyribose;|2-Deoxy-D-erythro-pentose;|Thyminose;|2-Deoxy-D-ribose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C01801  Deoxyribose,
C01802,"Desmosterol;|24-Dehydrocholesterol;|Cholesta-5,24-dien-3beta-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Cholestane derivatives|C01802  Desmosterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C01802  Desmosterol,
C01804,Discadenine;|3-(3-Amino-3-carboxypropyl)-N6-(Delta2-isopentenyl)-adenine,,,,,
C01806,GTP-gamma-S,,,,,
C01810,Glucomannan;|Glucomannoglycan,,,,Compounds with biological roles [BR:br08001(G11598)]|Carbohydrates|Polysaccharides|Heteropolysaccharides|G11598  Glucomannan,G11598
C01814,Haloperidol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00136)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AD Butyrophenone derivatives|N05AD01 Haloperidol|D00136  Haloperidol (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00136)]|Antipsychotics|1st Generation/Typical|Haloperidol|D00136  Haloperidol (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00136)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00136  Haloperidol (JP18/USP/INN)|Drug groups [BR:br08330(D00136)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00885  Haloperidol|D00136  Haloperidol|DG03200  Antipsychotic agent|DG01940  Butyrophenone derivative|DG00885  Haloperidol|D00136  Haloperidol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00885  Haloperidol|D00136  Haloperidol|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00885  Haloperidol|D00136  Haloperidol|Target-based classification of drugs [BR:br08310(D00136)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00136  Haloperidol (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00136)]|Chemicals|D00136  Haloperidol|D00136  Haloperidol tablets|D00136  Haloperidol fine granules|D00136  Haloperidol injection|Drug metabolizing enzymes and transporters [br08309.html(D00136)]|Drug metabolizing enzymes|D00136|Prodrugs [br08324.html(D00136)]|D00136|Prodrugs [br08324.html]|C01814,
C01816,Heptadecane;|n-Heptadecane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C01816  n-Heptadecane,
C01817,L-Homocystine;|Homocystine,Homocystine (generic) [CPD:C20788],,,,
C01818,Hyponitrite;|Hyponitrous acid,,,,,
C01819,Indoleamine;|Indolamine,,,,,
C01821,Isoorientin;|Homoorientin;|Luteolin-6-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C01821  Isoorientin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C01821  Isoorientin|Glycosides [BR:br08021]|C-glycosides|C01821  Isoorientin|Dietary phytochemicals [br08012.html]|Flavonoids|C01821,
C01822,Kanamycin A,Component of Kanamycin [CPD:C00304],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01822,
C01823,Kanamycin C,Component of Kanamycin [CPD:C00304],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01823,
C01825,L-Galactose,Galactose [CPD:C01582]|D-Galactose [CPD:C00124],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C01825  L-Galactose,
C01826,L-Norvaline;|L-2-Aminovaleric acid;|L-2-Aminopentanoic acid;|(S)-2-Aminopentanoic acid,D-Norvaline [CPD:C01799],,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C01826  (S)-2-Aminopentanoic acid,
C01829,"Thyroxine;|Levothyroxin;|L-Thyroxine;|O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine;|3,5,3'5'-Tetraiodo-L-thyronine;|T4",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01829  L-Thyroxine|Hormones and transmitters|Other hormones|Thyroid hormones|C01829  Thyroxine|Neurotransmitters|Amino acids|C01829  Thyroxine|Drug groups [BR:br08330(D08125)]|Hormonal agent|DG01953  Thyroid preparation|DG01608  Thyroid hormone replenisher|DG00510  Levothyroxine|D08125  Levothyroxine|Target-based classification of drugs [BR:br08310(D08125)]|Nuclear receptors|Thyroid hormone like receptors|Thyroid hormone receptor (THR)|NR1A (THR)|D08125  Levothyroxine (BAN),
C01832,Lauroyl-CoA;|Lauroyl coenzyme A;|Dodecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01832  Dodecanoyl-CoA,
C01833,Leu-Gly-Pro,,,,,
C01835,Maltotriose;|Amylotriose,,,,,
C01837,Nitroethane,,,,,
C01838,Octadecanal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C01838  Octadecanal,
C01839,"Orsellinate;|o-Orsellinic acid;|2,4-Dihydroxy-6-methylbenzoic acid;|2,4-Dihydroxy-6-methylbenzoate;|4,6-Dihydroxy-o-toluic acid",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1301 Monocyclic aromatic polyketides|C01839  Orsellinic acid,
C01841,Pentalenene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C01841  Pentalenene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C01841  Pentalenene,
C01842,Pentanamide;|Valeramide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C01842  Pentanamide,
C01843,Polyproline,,,,,
C01844,Pravastatin,,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C01844  Pravastatin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08410)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AA HMG CoA reductase inhibitors|C10AA03 Pravastatin|D08410  Pravastatin (INN)|Drug groups [BR:br08330(D08410)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01660  HMG-CoA reductase inhibitor|DG00353  Pravastatin|D08410  Pravastatin|Transporter substrate|DG02861  ABCC2 substrate|DG00353  Pravastatin|D08410  Pravastatin|DG02856  SLCO1B1 substrate|DG00353  Pravastatin|D08410  Pravastatin|DG02933  SLCO2B1 substrate|DG00353  Pravastatin|D08410  Pravastatin|Target-based classification of drugs [BR:br08310(D08410)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HMGCR|D08410  Pravastatin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08410)]|Drug transporters|D08410",
C01845,Propan-2-ol;|2-Propanol;|Isopropanol;|Isopropyl alcohol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00137)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AX Other antiseptics and disinfectants|D08AX05 Isopropanol|D00137  Isopropyl alcohol (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00137)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2615  Alcohols|D00137  Isopropyl alcohol (USP); Isopropanol (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00137)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00137  Isopropyl alcohol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00137)]|Third-class OTC drugs|Inorganic and organic chemicals|Isopropanol|D00137  Isopropyl alcohol (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00137)]|Chemicals|D00137  Isopropanol,
C01847,Reduced FMN;|FMNH2,,,,,
C01848,Rifamycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C01848  Rifamycin B,
C01849,Rifamycin O,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C01849  Rifamycin O,
C01850,Rosmarinate;|Rosmarinic acid,,,,,
C01851,Scopolamine;|(-)-Hyoscine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C01851  Scopolamine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Tropan alkaloids|C01851  Scopolamine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01851|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00138)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AD Other antiemetics|A04AD01 Scopolamine|D00138  Scopolamine (INN) &lt;US&gt;|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM05 Scopolamine|D00138  Scopolamine (INN) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FA Anticholinergics|S01FA02 Scopolamine|D00138  Scopolamine (INN) &lt;US&gt;|USP drug classification [BR:br08302(D00138)]|Antiemetics|Antiemetics, Other|Scopolamine|D00138  Scopolamine (INN)|Gastrointestinal Agents|Antispasmodics, Gastrointestinal|Scopolamine|D00138  Scopolamine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D00138)]|Second-class OTC drugs|Inorganic and organic chemicals|Scopolamine|D00138  Scopolamine (INN)|Drug groups [BR:br08330(D00138)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00065  Scopolamine|D00138  Scopolamine|Gastrointestinal agent|DG01762  Antiemetic|DG00065  Scopolamine|D00138  Scopolamine|Target-based classification of drugs [BR:br08310(D00138)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00138  Scopolamine (INN) &lt;US&gt;",
C01852,Secologanin;|(-)-Secologanin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C01852  Secologanin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Secoiridoids|C01852  Secologanin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C01852  Secologanin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01852",
C01853,"Stipitatate;|Stipitatic acid;|3,6-Dihydroxy-5-oxo-1,3,6-cycloheptatriene-1-carboxylic acid",,,,,
C01854,Streptamine,,,,,
C01855,Taxiphyllin;|(R)-4-Hydroxymandelonitrile beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from thyrosine|C01855  Taxiphyllin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C01855  Taxiphyllin,
C01857,Thioacetate;|Thioacetic acid,,,,,
C01860,Trichodiene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010318 Trichothecane sesquiterpenoids|C01860  Trichodiene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C01860  Trichodiene,
C01861,Trithionate;|(O3S.S.SO3)2-,,,,,
C01863,Xanthoaphin;|Xanthoaphin fb,,,,,
C01864,Xanthotoxin;|Methoxsalen;|O-Methylxanthotoxol;|8-Methoxypsoralen;|8-Methoxyfuranocoumarin,,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C01864  Xanthotoxin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00139)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AD Psoralens for topical use|D05AD02 Methoxsalen|D00139  Methoxsalen (JP18/USP) &lt;JP/US&gt;|D05B ANTIPSORIATICS FOR SYSTEMIC USE|D05BA Psoralens for systemic use|D05BA02 Methoxsalen|D00139  Methoxsalen (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00139)]|Dermatological Agents|Dermatological Agents, Other|Psoriasis Agents|Methoxsalen|D00139  Methoxsalen (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00139)]|2  Agents affecting individual organs|26  Epidermides|269  Miscellaneous|2699  Others|D00139  Methoxsalen (JP18/USP)|Drug groups [BR:br08330(D00139)]|Metabolizing enzyme inhibitor|DG01525  CYP2A6 inhibitor|D00139  Methoxsalen|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00139)]|Chemicals|D00139  Methoxsalen|Drug metabolizing enzymes and transporters [br08309.html(D00139)]|Drug metabolizing enzymes|D00139",
C01865,Zopolrestat,,,,Drug groups [BR:br08330(D02328)]|Antidiabetic agent|DG01882  Aldose reductase inhibitor|D02328  Zopolrestat|Target-based classification of drugs [BR:br08310(D02328)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|AKR1B1|D02328  Zopolrestat (USAN/INN),
C01868,(+)-Sabinone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C01868  (+)-Sabinone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01868  (+)-Sabinone,
C01869,(-)-Sympatol;|(-)-Synephrine;|(R)-Synephrine,Synephrine [CPD:C04548],,,,
C01870,Vicianin;|(R)-Vicianin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C01870  (R)-Vicianin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C01870  Vicianin,
C01871,"1,4-Dithiane",,,,,
C01874,2-Iodophenol,,,,,
C01875,2-Undecanone;|Undecan-2-one;|Methyl nonyl ketone;|2-Hendecanone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C01875  Undecan-2-one,
C01876,3-Oxosteroid,Generic compound in reaction hierarchy,,,,
C01877,4-Oxoproline;|4-Oxo-L-proline,,,,,
C01879,5-Oxoproline;|Pidolic acid;|Pyroglutamic acid;|5-Pyrrolidone-2-carboxylic acid;|Pyroglutamate;|5-Oxo-L-proline;|L-Pyroglutamic acid;|L-5-Pyrrolidone-2-carboxylic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01879  Pidolic acid,
C01880,epsilon-Caprolactone;|6-Hexanolide;|1-Oxa-2-oxocycloheptane;|2-Oxepanone;|Hexano-6-lactone,,,,,
C01881,7-Oxosteroid,Generic compound in reaction hierarchy,,,,
C01882,ADP-D-ribose,,,,,
C01883,Acetic ester;|Acetyl ester,Generic compound in reaction hierarchy,,,,
C01884,Acyldolichol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0307 Dolichols|C01884  Acyldolichol,
C01885,1-Acylglycerol;|Glyceride;|Monoglyceride;|Monoacylglycerol;|1-Monoacylglycerol,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Fats|Acylglycerols|C01885  1-Monoacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0101 Monoacylglycerols|C01885  1-acyl-sn-glycerol,
C01887,Alkylnitrile,,,,,
C01888,Aminoacetone;|1-Amino-2-propanone,,,,,
C01889,Arabinoxylan,,,,,
C01890,Arylalkylamine;|Aralkylamine,Generic compound in reaction hierarchy|R = arylalkyl group,,,,
C01892,"Asparagusate;|Asparagusic acid;|1,2-Dithiolane-4-carboxylate",,,,,
C01893,Biotin amide,,,,,
C01894,Biotinyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01894  Biotinyl-CoA,
C01895,Bleomycin B2,Component of Bleomycin B [CPD:C15775],0 Ser  1 Asn  2 Asn  3 His  4 Ala  5 Man  6 Thr  7 beta-Ala|8 Cys  9 Cys,PKNRP,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C01895  Bleomycin B2|Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C01895  Bleomycin B2,
C01897,Camptothecin,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C01897  Camptothecin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01897,
C01898,Cellodextrin;|Cellooligosaccharide,Generic compound in reaction hierarchy|Cellotriose (n=3) [CPD:C06219]|Cellotetraose (n=4) [CPD:C02013]|Cellopentaose (n=5) [CPD:C06218]|Cellohexaose (n=6) [CPD:C06217]|Celloheptaose (n=7) [CPD:C06216],,,,
C01902,"Cycloartenol;|9beta,19-Cyclo-24-lanosten-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C01902  Cycloartenol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cycloartane|C01902  Cycloartenol,
C01904,D-Arabitol;|D-Arabinitol;|D-Arabinol;|D-Lyxitol,,,,,
C01905,D-Asparagine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C01905  D-Asparagine,
C01906,D-Hamamelose;|Hamamelose,beta-D-Hamamelose [CPD:C08351],,,,
C01907,Daunorubicin;|Daunomycin;|(+)-Daunomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C01907  Daunorubicin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01907|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07776)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DB Anthracyclines and related substances|L01DB02 Daunorubicin|D07776  Daunorubicin (INN)|Drug groups [BR:br08330(D07776)]|Antineoplastic|DG01682  Anthracycline antineoplastic|DG00697  Daunorubicin|D07776  Daunorubicin|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|DG00697  Daunorubicin|D07776  Daunorubicin|Target-based classification of drugs [BR:br08310(D07776)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D07776  Daunorubicin (INN),
C01909,Dethiobiotin;|Desthiobiotin,,,,,
C01910,Dinucleotide,Generic compound in reaction hierarchy,,,,
C01912,Erythromycin;|Erythromycin A;|Abomacetin,,0 Pyk  1 Mtk  2 Mtn  3 Mte  4 Mtk  5 Mtk  6 Mtn,PK,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Macrolides|C01912  Erythromycin|Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01912  Erythromycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01912|Prodrugs [br08324.html]|C01912|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00140)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF02 Erythromycin|D00140  Erythromycin (JP18/USP/INN) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA01 Erythromycin|D00140  Erythromycin (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA17 Erythromycin|D00140  Erythromycin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00140)]|Antibacterials|Macrolides|Erythromycin|D00140  Erythromycin (JP18/USP/INN)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Erythromycin|D00140  Erythromycin (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Erythromycin|D00140  Erythromycin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00140)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|614  Acting mainly on gram-positive bacteria and mycoplasma|6141  Erythromycins|D00140  Erythromycin (JP18/USP/INN)|Drug groups [BR:br08330(D00140)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00436  Erythromycin|D00140  Erythromycin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00436  Erythromycin|D00140  Erythromycin|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00436  Erythromycin|D00140  Erythromycin|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00436  Erythromycin|D00140  Erythromycin|Drug classes [BR:br08332(D00140)]|Antibacterial|DG01551  Macrolide antibiotic|D00140  Erythromycin|Antimicrobials [BR:br08307(D00140)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D00140  Erythromycin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00140)]|Chemicals|D00140  Erythromycin|D00140  Erythromycin enteric-coated tablets|Drug metabolizing enzymes and transporters [br08309.html(D00140)]|Drug metabolizing enzymes|D00140|Drug transporters|D00140|Prodrugs [br08324.html(D00140)]|D00140",
C01913,Ferrocyanide;|Hexacyanoferrate(II),,,,,
C01915,Galactolipid,,,,,
C01917,Gentamicin A,,,,,
C01918,Gentamicin C,"Generic compound in reaction hierarchy|Gentamicin C1 (R1 = CH3, R2 = CH3) [CPD:C07656]|Gentamicin C1a (R1 = H, R2 = H) [CPD:C00908]|Gentamicin C2 (R1 = CH3, R2 = H) [CPD:C02033]",,,Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|2-Deoxystreptamines|C01918  Gentamicin C,
C01920,Geranoyl-CoA;|cis-Geranyl-CoA,,,,,
C01921,"Glycocholate;|Glycocholic acid;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C01921  Glycocholate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C01921  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine|ST05 Steroid conjugates|ST0503 Glycine conjugates|C01921  Glycocholate",
C01924,Homoarginine;|L-Homoarginine,,,,,
C01925,Hygromycin B;|Antibiotic A-396-II,,,,,
C01926,Indomethacin;|Indometacin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00141)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB03 Indometacin|D00141  Indomethacin (USP) &lt;JP/US&gt;|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB01 Indometacin|D00141  Indomethacin (USP) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA23 Indometacin|D00141  Indomethacin (USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC01 Indometacin|D00141  Indomethacin (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00141)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Indomethacin|D00141  Indomethacin (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00141)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1145  Indomethacins|D00141  Indomethacin (USP); Indometacin (JP18/INN)|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00141  Indomethacin (USP); Indometacin (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00141)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00141  Indomethacin (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00141)]|Second-class OTC drugs|Inorganic and organic chemicals|Indometacin|D00141  Indomethacin (USP)|Drug groups [BR:br08330(D00141)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|DG01899  Anti-inflammatory drug, indoleacetic acid derivatives|DG00241  Indometacin|D00141  Indomethacin|Drug classes [BR:br08332(D00141)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00141  Indomethacin|Target-based classification of drugs [BR:br08310(D00141)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00141  Indomethacin (USP) &lt;JP/US&gt;|PTGS2 (COX2)|D00141  Indomethacin (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00141)]|Chemicals|D00141  Indometacin|D00141  Indometacin capsules|D00141  Indometacin suppositories|Prodrugs [br08324.html(D00141)]|D00141|Rx-to-OTC switch list in Japan [br08314.html(D00141)]|D00141|Prodrugs [br08324.html]|C01926",
C01927,Isoflavanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C01927  Isoflavanone,
C01928,Ketoaldehyde,,,,,
C01929,L-Histidinal,,,,,
C01930,L-Lysinamide,,,,,
C01931,L-Lysyl-tRNA;|L-Lysyl-tRNA(Lys),Generic compound in reaction hierarchy,,,,
C01933,L-Norleucine;|L-Aminohexanoic acid;|L-Aminohexanoate;|L-2-Aminohexanoic acid;|L-2-Aminohexanoate;|(S)-2-Aminohexanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C01933  (S)-2-Aminohexanoic acid,
C01934,L-Rhamnonate;|6-Deoxy-L-mannonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C01934  6-Deoxy-L-mannonic acid,
C01935,Maltodextrin;|Maltodextrin(n);|Maltodextrin(n-2);|n+2 Maltodextrin;|Linear maltodextrin;|Maltooligosaccharide,,,,,G10495
C01936,Maltohexaose,Maltodextrin [CPD:C01935],,,,G00755
C01937,Methotrexate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00142)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BA Folic acid analogues|L01BA01 Methotrexate|D00142  Methotrexate (JP18/USP/INN) &lt;JP/US&gt;|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AX Other immunosuppressants|L04AX03 Methotrexate|D00142  Methotrexate (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00142)]|Antineoplastics|Antimetabolites|Methotrexate|D00142  Methotrexate (JP18/USP/INN)|Immunological Agents|Immunosuppressants|Antimetabolites, Antiproliferative|Methotrexate|D00142  Methotrexate (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00142)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00142  Methotrexate (JP18/USP/INN)|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4222  Methotrexates|D00142  Methotrexate (JP18/USP/INN)|Drug groups [BR:br08330(D00142)]|Antineoplastic|DG02018  Antimetabolite|DG01978  Folic acid analog|DG01930  Dihydrofolate reductase inhibitor|DG00681  Methotrexate|D00142  Methotrexate|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG00681  Methotrexate|D00142  Methotrexate|Drug classes [BR:br08332(D00142)]|Antineoplastic|DG02018  Antimetabolite|D00142  Methotrexate|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00142  Methotrexate|Target-based classification of drugs [BR:br08310(D00142)]|Enzymes|Oxidoreductases (EC1)|Dihydrofolate reductase|DHFR|D00142  Methotrexate (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00142)]|Chemicals|D00142  Methotrexate|D00142  Methotrexate tablets|D00142  Methotrexate capsules|D00142  Methotrexate for injection|New drug approvals in Europe [br08329.html(D00142)]|European public assessment reports (EPAR) authorised medicine|D00142",
C01938,"Naphthazarin;|5,8-Dihydroxy-1,4-naphthoquinone",,,,,
C01941,Nocardicin A,,0 D-Hpg  1 Ser  2 D-Hpg,NRP,Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Monobactams|C01941  Nocardicin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01941,
C01942,Nonanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01942  Nonanoyl-CoA,
C01943,"Obtusifoliol;|4alpha,14alpha-Dimethyl-5alpha-ergosta-8,24(28)-dien-3beta-ol;|4alpha,14alpha-Dimethyl-24-methylene-5alpha-cholesta-8-en-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C01943  Obtusifoliol,
C01944,Octanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C01944  Octanoyl-CoA,
C01945,Okadaic acid,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Okadaic acid and derivatives|C01945  Okadaic acid,
C01946,Oleandomycin;|Amimycin;|Landomycin;|Matromycin;|Romicil,,0 Mak  1 Mtk  2 Mtn  3 Mte  4 Mtk  5 Mtk  6 Mtn,PK,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Macrolides|C01946  Oleandomycin|Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C01946  Oleandomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA05 Oleandomycin|C01946  Oleandomycin|Drug groups [BR:br08330]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00603  Oleandomycin|C01946  Oleandomycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C01946",G00603
C01948,Pentadecanal;|1-Pentadecanal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C01948  Pentadecanal,
C01949,Pentan-2-one;|2-Pentanone;|Methyl propyl ketone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C01949  Pentan-2-one,
C01950,Picolinamide,,,,,
C01951,Piperitenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C01951  Piperitenone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C01951  Piperitenone,
C01952,Polyarginine,,,,,
C01953,Pregnenolone;|5-Pregnen-3beta-ol-20-one;|3beta-Hydroxypregn-5-en-20-one,,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C01953  Pregnenolone|Hormones and transmitters|Steroid hormones|Progestagens|C01953  Pregnenolone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C01953  Pregnenolone",
C01956,Pyrazinamide;|Pyrazinoic acid amide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00144)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AK Other drugs for treatment of tuberculosis|J04AK01 Pyrazinamide|D00144  Pyrazinamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00144)]|Antimycobacterials|Antituberculars|Pyrazinamide|D00144  Pyrazinamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00144)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|622  Tuberculosis preparations|6223  Pyrazinamides|D00144  Pyrazinamide (JP18/USP/INN)|Drug groups [BR:br08330(D00144)]|Antibacterial|DG01966  Antitubercular|DG02009  Pyrazinamide derivative|D00144  Pyrazinamide|Antimicrobials [BR:br08307(D00144)]|Antibacterials|Bactericidal action|Pyrazinamide|D00144  Pyrazinamide (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00144)]|Antibacterials|Bactericidal action|Pyrazinamide|D00144  Pyrazinamide (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00144)]|Chemicals|D00144  Pyrazinamide|Prodrugs [br08324.html(D00144)]|D00144|Prodrugs [br08324.html]|C01956,
C01957,Secologanate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C01957  Secologanate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Secoiridoids|C01957  Secologanate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C01957  Secologanate",
C01958,Steryl ester;|Sterol ester,Generic compound in reaction hierarchy,,,,
C01959,Taurocyamine,,,,,
C01960,Tetrapeptide,,,,,
C01961,Thalassemine;|L-Thalassemine,,,,,
C01962,Thiocysteine;|S-Mercapto-L-cysteine;|L-Thiocysteine,,,,,
C01963,Tolylacetate;|p-Cresyl acetate;|p-Tolyacetate,,,,,
C01964,Tos-Ph-CH2Cl,,,,,
C01965,Trimethoprim,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00145)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EA Trimethoprim and derivatives|J01EA01 Trimethoprim|D00145  Trimethoprim (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00145)]|Antibacterials|Antibacterials, Other|Trimethoprim|D00145  Trimethoprim (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9739  Other synthetic antimicrobials|C01965  Trimethoprim|Drug groups [BR:br08330(D00145)]|Antibacterial|DG01581  Trimethoprim antibacterial|DG00595  Trimethoprim|D00145  Trimethoprim|Metabolizing enzyme inhibitor|DG01641  CYP2C8 inhibitor|DG00595  Trimethoprim|D00145  Trimethoprim|Antimicrobials [BR:br08307(D00145)]|Antibacterials|Folic acid biosynthesis inhibitor|Trimethoprim|D00145  Trimethoprim (JAN/USP/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00145)]|Drug metabolizing enzymes|D00145",
C01967,Ubiquinone-9;|Ubiquinone-45;|Coenzyme Q(9),,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C01967  Ubiquinone-9,
C01968,Undecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0301 Bactoprenols|C01968  Undecaprenol,
C01969,Xanthommatin,,,,,
C01970,beta-Lactose;|beta-D-Lactose,,,,,
C01971,beta-Maltose,,,,,
C01972,m7G(5')pppAm-mRNA;|mRNA containing a 2'-O-methyladenosine cap;|5-(N7-Methyl 5-triphosphoguanosine)-2'-O-methyladenosine-[mRNA],Generic compound in reaction hierarchy,,,,
C01977,tRNA guanine;|Guanine in tRNA,Generic compound in reaction hierarchy,,,,
C01978,tRNA queuine;|Queuine in tRNA,Generic compound in reaction hierarchy,,,,
C01983,(R)-Mandelate;|(R)-2-Hydroxy-2-phenylacetic acid;|(R)-2-Hydroxy-2-phenylacetate;|(R)-Mandelic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA06 Mandelic acid|C01983  (R)-Mandelate|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX06 Mandelic acid|C01983  (R)-Mandelate,G00185
C01984,(S)-Mandelate;|(S)-2-Hydroxy-2-phenylacetic acid;|(S)-2-Hydroxy-2-phenylacetate;|(S)-Mandelic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA06 Mandelic acid|C01984  (S)-Mandelate|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX06 Mandelic acid|C01984  (S)-Mandelate,G00185
C01986,16-Oxosteroid,Generic compound in reaction hierarchy,,,,
C01987,2-Aminophenol;|2-Hydroxyaniline;|2-Aminobenzenol;|o-Aminophenol,,,,,
C01988,2-Nitrophenol;|o-Nitrophenol,,,,,
C01989,3-Ethylmalate,,,,,
C01990,3-Oxalomalate;|3-Oxalomalic acid,,,,,
C01991,4-Hydroxyacid;|4-Hydroxyalkanoic acid;|4-Hydroxycarboxylic acid,Generic compound in reaction hierarchy|4-Hydroxybutanoate (non-generic) [CPD:C00989],,,,
C01993,5'-Oxoinosine;|5'-Dehydroinosine,,,,,
C01995,Acetone oxime;|Acetoxime,,,,,
C01996,Acetylcholine;|O-Acetylcholine,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Neurotransmitters|Acetylcholine|C01996  Acetylcholine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB09 Acetylcholine|C01996  Acetylcholine|Drug groups [BR:br08330]|Cardiovascular agent|DG01532  Nicotinic cholinergic receptor agonist|DG01133  Acetylcholine|C01996  Acetylcholine|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG01133  Acetylcholine|C01996  Acetylcholine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01133  Acetylcholine|C01996  Acetylcholine|Metabolizing enzyme substrate|DG02974  ACHE substrate|DG01133  Acetylcholine|C01996  Acetylcholine,G01133
C01997,Histone N6-acetyl-L-lysine;|Acetylhistone,Generic compound in reaction hierarchy,,,,
C01998,Acrylonitrile;|Propenenitrile;|Vinyl cyanide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Fumigants|C01998  Acrylonitrile,
C02000,Alkyl sulfate,Generic compound in reaction hierarchy,,,,
C02001,Allyl alcohol;|2-Propen-1-ol,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C02001  Allyl alcohol,
C02003,Anthocyanidin,Generic compound in reaction hierarchy,,,,
C02004,Aristolochene;|(+)-Aristolochene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010327 Aristolane sesquiterpenoids|C02004  Aristolochene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C02004  Aristolochene,
C02006,Aspulvinone E;|(5Z)-4-Hydroxy-3-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylene]-2(5H)-furanone,,,,,
C02007,Aspulvinone G,,,,,
C02008,Aspulvinone H,,,,,
C02009,Benzimidazole,,,,,
C02010,Blasticidin S,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C02010  Blasticidin S,
C02012,Catecholamine,,,,,
C02013,Cellotetraose,,,,,G00459
C02015,CoA-disulfide,,,,,
C02018,Cyanopyrazine;|2-Cyanopyrazine,,,,,
C02020,Cyclopentanol;|Cyclopentyl alcohol,,,,,
C02022,D-Erythrulose;|D-glycero-Tetrulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C02022  D-Erythrulose,
C02023,D-Galactoside,,,,,
C02024,D-Mannuronate;|D-Mannuronic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C02024  D-Mannuronic acid,
C02026,Deoxycytosine;|2'-Deoxycytosine,,,,,
C02027,Deoxylimonate;|Deoxylimonic acid,,,,,
C02028,Dicarboxylate;|Dicarboxylic acid,Generic compound in reaction hierarchy,,,,
C02029,Dihydrozeatin;|2-Methyl-4-(1H-purin-6-ylamino)butan-1-ol;|N6-(4-Hydroxyisopentanyl)adenine,,,,,
C02030,Farnesoyl-CoA,,,,,
C02031,G(5')pppPur-mRNA;|5'-(5'-Triphosphoguanosine)-[mRNA];|Guanosine 5'-triphospho-mRNA,Generic compound in reaction hierarchy|R1 = adenine or guanine base,,,,
C02033,Gentamicin C2,Component of Gentamicin C  [CPD:C01918],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02033,
C02034,Gibberellin A19;|Gibberellin 19,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C02034  Gibberellin A19|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C02034  Gibberellin A19,
C02035,Gibberellin A20;|Gibberellin 20,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C02035  Gibberellin A20|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C02035  Gibberellin A20,
C02037,Glycylglycine;|N-Glycylglycine,,,,,
C02038,N-Terminal-glycyl-[protein];|Glycylpeptide,Generic compound in reaction hierarchy,,,,
C02040,Hydroxyindole;|4-Hydroxyindole,,,,,
C02041,Eicosanoyl-CoA;|Icosanoyl-CoA;|Arachidoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02041  Icosanoyl-CoA,
C02043,Indolelactate,,,,,
C02045,L-Erythrulose;|L-glycero-Tetrulose,D-Erythrulose [CPD:C02022],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C02045  L-Erythrulose,
C02046,L-Hyoscyamine;|L-Tropine tropate;|Daturine;|Duboisine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C02046  L-Hyoscyamine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Tropan alkaloids|C02046  L-Hyoscyamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00147)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03B BELLADONNA AND DERIVATIVES, PLAIN|A03BA Belladonna alkaloids, tertiary amines|A03BA03 Hyoscyamine|D00147  Hyoscyamine (USP)|Drug groups [BR:br08330(D00147)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00053  Hyoscyamine|D00147  Hyoscyamine|Target-based classification of drugs [BR:br08310(D00147)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00147  Hyoscyamine (USP)",
C02047,L-Leucyl-tRNA;|L-Leucyl-tRNA(Leu),,,,,
C02048,Laminaribiose;|Laminariaceae;|3-beta-D-Glucosyl-D-glucose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C02048  Laminaribiose,G00357
C02050,"Linoleoyl-CoA;|(9Z,12Z)-Octadecadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02050  (9Z,12Z)-Octadecadienoyl-CoA",
C02051,Lipoylprotein;|[H-protein]-lipoyllysine;|[GCSH]-N6-lipoyl-L-lysine;|[GcvH]-N6-lipoyl-L-lysine;|[Glycine cleavage system H]-N6-lipoyl-L-lysine;|[Glycine-cleavage complex H protein]-N6-lipoyl-L-lysine,Generic compound in reaction hierarchy|The lipoyl-bearing H protein,,,,
C02052,Maltotetraose,,,,,
C02055,N-Acylglycine,Generic compound in reaction hierarchy,,,,
C02056,Peptidyl-tRNA,Generic compound in reaction hierarchy,,,,
C02057,Phenylalanine;|alpha-Amino-beta-phenylpropionic acid,D-Phenylalanine [CPD:C02265]|L-Phenylalanine [CPD:C00079],,,,
C02058,Phosphoramide,Generic compound in reaction hierarchy|R = H [CPD:C02306],,,,
C02059,"Phylloquinone;|Vitamin K1;|Phytonadione;|2-Methyl-3-phytyl-1,4-naphthoquinone",,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C02059  Phylloquinone (Vitamin K1)|Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C02059  Phylloquinone (Vitamin K1)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00148)]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02B VITAMIN K AND OTHER HEMOSTATICS|B02BA Vitamin K|B02BA01 Phytomenadione|D00148  Phytonadione (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00148)]|3  Agents affecting metabolism|31  Vitamins|316  Vitamin K preparations|3160  Vitamin K preparations|D00148  Phytonadione (JP18/USP); Phytomenadione (INN)|Risk category of Japanese OTC drugs [BR:br08312(D00148)]|Second-class OTC drugs|Inorganic and organic chemicals|Phytonadione|D00148  Phytonadione (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Phylloquinone|C02059  Phylloquinone|Drug groups [BR:br08330(D00148)]|Blood modifier agent|DG02016  Hemostatics|DG02014  Blood coagulation accelerant|DG01603  Vitamin K|D00148  Phytonadione|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00148)]|Chemicals|D00148  Phytonadione,
C02060,Phytanoyl-CoA,,,,,
C02061,Plastoquinone,Generic compound in reaction hierarchy|Plastoquinone-1 (n=1) [CPD:C16694]|Plastoquinone-9 (n=9) [CPD:C10385],,,,
C02064,Prostanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C02064  Prostanoic acid,
C02065,Protein alanine,,,,,
C02066,Pseudotropine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C02066  Pseudotropine,
C02067,Pseudouridine,,,,,
C02072,RNA (poly(C)),,,,,
C02073,RNA(circular),Generic compound in reaction hierarchy,,,,
C02074,Raucaffricine;|Vomilenine beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C02074  Raucaffricine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02074,
C02075,Retinyl ester;|all-trans-Retinyl ester,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C02075  Retinyl ester,
C02076,Sedoheptulose;|D-altro-Heptulose;|D-Sedoheptulose;|Volemulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C02076  Sedoheptulose,
C02077,Semicarbazide;|Carbamoylhydrazine;|Aminourea;|Hydrazinecarboxamide,,,,,
C02078,Spectinomycin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|Actinamines|C02078  Spectinomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08526)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX04 Spectinomycin|D08526  Spectinomycin (INN)|Drug groups [BR:br08330(D08526)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00634  Spectinomycin|D08526  Spectinomycin|Antimicrobials [BR:br08307(D08526)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08526  Spectinomycin (INN),
C02079,Staurosporine;|STS,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02079,
C02080,Stipitatonate,,,,,
C02081,Streptonigrin,,,,,
C02083,"Styrene oxide;|Styrene-7,8-oxide",,,,,
C02084,Tetrathionate;|Tetrathionic acid,,,,,
C02085,Thioglucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|S-glycosides|C02085  Thioglucoside,
C02086,Thioglycolate;|Mercaptoacetic acid;|Mercaptoethanoic acid;|Thioglycolic acid,,,,,
C02087,Tos-Arg-CH2Cl,,,,,
C02088,Tos-Phe-CH2Cl;|TPCK;|N-Tosyl-L-phenylalanyl chloromethyl ketone,,,,,
C02089,O-Acyltropine,Generic compound in reaction hierarchy,,,,
C02090,"Trypanothione;|N1,N8-Bis(gamma-L-glutamyl-L-cysteinyl-glycyl)spermidine;|N1,N8-Bis(glutathionyl)spermidine;|Reduced trypanothione",,,,,
C02091,(S)-Ureidoglycine;|(S)-(Carbamoylamino)glycine,,,,,
C02094,beta-Carotene;|all-trans-beta-Carotene,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C02094  beta-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C02094  beta-Carotene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02094|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03101)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CA Vitamin A, plain|A11CA02 Betacarotene|D03101  beta Carotene (USP)|D DERMATOLOGICALS|D02 EMOLLIENTS AND PROTECTIVES|D02B PROTECTIVES AGAINST UV-RADIATION|D02BB Protectives against UV-radiation for systemic use|D02BB01 Betacarotene|D03101  beta Carotene (USP)",
C02095,beta-D-Fucose,,,,,
C02096,beta-D-Xylose,,,,,
C02097,dTDP-galactose;|dTDP-D-galactose,,,,,
C02099,(2S)-Flavanone;|(2S)-Flavan-4-one,Generic compound in reaction hierarchy,,,,
C02100,(5')ppPur-mRNA;|5'-Diphospho-[mRNA],Generic compound in reaction hierarchy|R1 = adenine or guanine base,,,,
C02101,Glucomannan longer by one mannose unit,,,,,
C02104,"(S)-Mevalonate;|(S)-Mevalonic acid;|(S)-3,5-Dihydroxy-3-methylvaleric acid",,,,,
C02105,(S)-Reticuline;|(+)-Reticuline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C02105  (S)-Reticuline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02105,
C02106,"(S)-Scoulerine;|(13aS)-5,8,13,13a-Tetrahydro-3,10-dimethoxy-6H-dibenzo[a,g]quinolizine-2,9-diol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C02106  (S)-Scoulerine,
C02107,"(S,S)-Tartaric acid;|(S,S)-Tartrate;|D-Tartrate;|D-Tartaric acid;|(2S,3S)-Tartaric acid;|(-)-Tartaric acid",,,,,
C02108,"1,2-Campholide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02108  1,2-Campholide",
C02110,11-cis-Retinal;|11-cis-Vitamin A aldehyde;|11-cis-Retinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C02110  11-cis-Retinal,
C02111,"2,4-Dioxo acid",,,,,
C02112,2-Acylglycerol;|2-Glyceride;|2-Monoacylglycerol,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Fats|Acylglycerols|C02112  2-Monoacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0101 Monoacylglycerols|C02112  2-acyl-sn-glycerol,
C02115,2-Methylserine,,,,,
C02116,2-Nitropropane,,,,,
C02117,2-Oxophytanate;|2-Oxophytanic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C02117  2-Oxophytanate,
C02118,"3,5-Dioxo acid",,,,,
C02119,3-Acylpyruvate,Generic compound in reaction hierarchy,,,,
C02122,3-Oxohexanoic acid;|3-Oxohexanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C02122  3-Oxohexanoic acid,
C02123,3-Propylmalate;|3-Propylmalic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02123  3-Propylmalic acid,
C02124,4-Chlorophenol;|p-Chlorophenol;|Parachlorophenol,2-Chlorophenol [CPD:C14219]|3-Chlorophenol [CPD:C14270],,,,
C02125,4-Nitroanilide,,,,,
C02126,4-Nitroaniline;|p-Nitroaniline;|4-Nitrobenzeneamine,,,,,
C02128,5'-Phospho-DNA;|DNA 5'-phosphate,Generic compound in reaction hierarchy,,,,
C02129,5-Oxohexanoic acid;|5-Oxohexanoate;|4-Acetylbutyric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C02129  5-Oxohexanoic acid,
C02130,Acetyl-maltose;|6-O-Acetyl-alpha-D-glucopyranosyl-(1->4)-D-glucose,,,,,G10592
C02131,Acetylagmatine,,,,,
C02132,"Acetylpyruvate;|Acetylpyruvic acid;|2,4-Dioxopentanoate",,,,,
C02133,Acyl phosphate;|Fatty acyl phosphate,Generic compound in reaction hierarchy,,,,
C02134,Allocryptopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C02134  Allocryptopine,
C02135,Angiotensin II;|Angiotensin;|Angiotonin;|Hypertensin,Human angiotensin II is illustrated. Angiotensin differs among species only in the amino acid residue in position 5 being either Val or Ile.,Asp Arg Val Tyr Ile His Pro Phe,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Angiotensin|C02135  Angiotensin II|Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C02135  Angiotensin II,
C02137,alpha-Oxo-benzeneacetic acid;|Benzoylformate;|Benzoylformic acid;|Phenylglyoxylic acid;|Phenylglyoxylate;|2-Oxo-2-phenylacetate,,,,,
C02138,Boc-Asn-OPhNO2,,,,,
C02139,Chlorophyllide;|Chlorophyllide a,,,,,
C02140,"Corticosterone;|11beta,21-Dihydroxy-4-pregnene-3,20-dione;|Kendall's compound B;|Reichstein's substance H",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C02140  Corticosterone|Hormones and transmitters|Steroid hormones|Mineralocorticoids|C02140  Corticosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C02140  Corticosterone",
C02141,Cycloeucalenol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C02141  Cycloeucalenol,
C02142,D-Ribosyl-base;|D-Ribosyl-base1;|D-Ribosyl-base2,Generic compound in reaction hierarchy,,,,
C02143,"D-threo-Aldose;|(2S,3R)-Aldose","Generic compound in reaction hierarchy|Including L-Fucose [CPD:C01019], D-Arabinose [CPD:C00216] and L-Xylose",,,,
C02144,Dehydropeptide,,,,,
C02146,Dialkyl ketone,Generic compound in reaction hierarchy,,,,
C02147,Dihydrolipoate;|Dihydrolipoic acid;|Dihydrothioctic acid,,,,,
C02150,Formylpyruvate,,,,,
C02151,"(19E)-Geissoschizine;|(+)-Geissoschizine;|Methyl (16Z,19E)-16-formylcoryn-19-en-17-oate",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C02151  Geissoschizine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02151,
C02153,Glucotropaeolin;|Glucotropeolin;|Benzyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from phenylalanine|C02153  Benzyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C02153  Glucotropaeolin,
C02154,"Glyceraldehyde;|2,3-Dihydroxypropionaldehyde;|2,3-Dihydroxypropanal;|Glycerose;|Aldotriose",,,,,
C02155,Glycyl-leucine;|Glycyl-L-leucine,,,,,
C02159,Hydroxysteroid,Generic compound|16alpha-Hydroxysteroid [CPD:C01090]|16beta-Hydroxysteroid [CPD:C03050],,,,
C02160,Isomaltotriose,,,,,
C02161,2-Aminophenoxazin-3-one;|3-Aminophenoxazone;|Isophenoxazine,,,,,
C02162,"Isopimpinellin;|5,8-Dimethoxypsoralen",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C02162  Isopimpinellin,
C02163,L-Arginyl-tRNA(Arg);|L-Arginyl-tRNA,Generic compound in reaction hierarchy,,,,
C02165,"Leukotriene B4;|(6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyeicosa-6,8,10,14-tetraenoate;|(6Z,8E,10E,14Z)-(5S,12R)-5,12-Dihydroxyicosa-6,8,10,14-tetraenoate;|LTB4",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C02165  Leukotriene B4|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C02165  Leukotriene B4,
C02166,Leukotriene C4;|LTC4,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C02166  Leukotriene C4|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C02166  Leukotriene C4,
C02167,"Maleylpyruvate;|Maleylpyruvic acid;|3-Maleylpyruvate;|(2Z)-4,6-Dioxohept-2-enedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02167  (2Z)-4,6-Dioxohept-2-enedioic acid",
C02168,Mefenamic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00151)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AG Fenamates|M01AG01 Mefenamic acid|D00151  Mefenamic acid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00151)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Mefenamic Acid|D00151  Mefenamic acid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00151)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1141  Anilines|D00151  Mefenamic acid (JP18/USP/INN)|Drug groups [BR:br08330(D00151)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01911  Anti-inflammatory drug, fenamic acid derivatives|D00151  Mefenamic acid|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00151  Mefenamic acid|Drug classes [BR:br08332(D00151)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00151  Mefenamic acid|Target-based classification of drugs [BR:br08310(D00151)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00151  Mefenamic acid (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00151  Mefenamic acid (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00151)]|Chemicals|D00151  Mefenamic acid|Drug metabolizing enzymes and transporters [br08309.html(D00151)]|Drug metabolizing enzymes|D00151",
C02170,Methylmalonate;|Methylmalonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02170  Methylmalonic acid,
C02171,Mononucleotide,Generic compound in reaction hierarchy,,,,
C02172,N-Acetylisatin;|1-Acetylisatin,,,,,
C02173,N-Acylmuramate,,,,,
C02174,Oligophosphate,Generic compound in reaction hierarchy,,,,
C02179,[Peptide]-amide;|Peptidyl amide,Generic compound in reaction hierarchy,,,,
C02180,Phenylsulfate;|Phenol sulfate,,,,,
C02181,Phenoxyacetate;|Phenoxyacetic acid,,,,,
C02183,"Phloroglucinol;|1,3,5-Benzenetriol;|1,3,5-Trihydroxybenzene;|Benzene-1,3,5-triol",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00152)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AX Other drugs for functional gastrointestinal disorders|A03AX12 Phloroglucinol|D00152  Phloroglucinol (JAN)|Drug groups [BR:br08330(D00152)]|Neuropsychiatric agent|DG01497  Catechol O-methyltransferase inhibitor|DG00050  Phloroglucinol|D00152  Phloroglucinol|Target-based classification of drugs [BR:br08310(D00152)]|Enzymes|Transferases (EC2)|Methyltransferases|COMT|D00152  Phloroglucinol (JAN),
C02185,Plastoquinol-1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C02185  Plastoquinol-1,
C02186,Prolyl-peptide,,,,,
C02188,Protein lysine;|Peptidyl-L-lysine;|[Protein]-L-lysine,Generic compound in reaction hierarchy,,,,
C02189,[Protein]-L-serine;|Protein serine;|Protein L-serine,Generic compound in reaction hierarchy,,,,
C02191,Protoporphyrin;|Protoporphyrin IX;|Porphyrinogen IX,,,,,
C02193,Pyruvate oxime,,,,,
C02195,Steryl sulfate,,,,,
C02196,Tertiary amine,,,,,
C02197,"Testolactone;|13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid delta-lactone",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C02197  Testolactone|Drug groups [BR:br08330(D00153)]|Antineoplastic|DG01596  Aromatase inhibitor|D00153  Testolactone|Target-based classification of drugs [BR:br08310(D00153)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP19A1 (ARO)|D00153  Testolactone (USP/INN),
C02198,"Thromboxane A2;|(5Z,13E)-(15S)-9alpha,11alpha-Epoxy-15-hydroxythromboxa-5,13-dienoate;|(5Z,9alpha,11alpha,13E,15S)-9,11-Epoxy-15-hydroxythromboxa-5,13-dien-1-oic acid;|TXA2",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Thromboxanes|C02198  Thromboxane A2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0303 Thromboxanes|C02198  Thromboxane A2,
C02199,UDP-L-rhamnose;|UDP-rhamnose;|UDP-beta-L-rhamnose,,,,,
C02200,UDP-glucosamine;|UDP-alpha-D-glucosamine,,,,,
C02201,"Veratraldehyde;|Veratric aldehyde;|3,4-Dimethoxybenzaldehyde",,,,,
C02202,Z-Phe-Phe-CHN2,,,,,
C02203,Z-Tyr-Leu-NHOH;|Benzyloxycarbonyl-Tyr-Leu-NHOH;|Cbz-Tyr-Leu-NHOH,,,,,
C02204,alpha-D-Lyxose,D-Lyxose [CPD:C00476],,,,
C02205,alpha-D-Xylose;|alpha-D-Xylopyranose,,,,,
C02206,alpha-Santonin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C02206  alpha-Santonin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C02206  alpha-Santonin|Classification of Japanese OTC drugs [BR:br08313(D00154)]|Agents for digestive organs|19 Antiparasitics|D00154  Santonin (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00154)]|Second-class OTC drugs|Inorganic and organic chemicals|Santonin|D00154  Santonin (JP18)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C02206  alpha-Santonin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00154)]|Chemicals|D00154  Santonin,
C02207,beta-Alanopine;|N-(D-1-Carboxyethyl)-beta-alanine,,,,,
C02209,beta-D-Mannose;|beta-D-Mannopyranose,D-Mannose [CPD:C00159]|alpha-D-Mannose [CPD:C00936],,,,
C02211,tRNA precursor,,,,,
C02213,(+)-cis-Sabinol;|Sabinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02213  (+)-cis-Sabinol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02213  (+)-trans-Sabinol,
C02214,(E)-Glutaconate;|trans-Glutaconate;|trans-Glutaconic acid;|Glutaconic acid;|(E)-Glutaconic acid;|(2E)-Pent-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02214  (2E)-Pent-2-enedioic acid,
C02216,1-Methyladenine,,,,,
C02217,10-Oxodecanoate;|10-Oxodecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C02217  10-Oxodecanoic acid,
C02218,Dehydroalanine;|2-Aminoacrylate;|2-Aminoprop-2-enoate,,,,,
C02220,"2-Aminomuconate;|2-Aminomuconic acid;|o-Aminomuconate;|(2E,4Z)-2-Aminohexa-2,4-dienedioate;|(2E,4Z)-2-Aminohexa-2,4-dienedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02220  (2E,4Z)-2-Aminohexa-2,4-dienedioic acid",
C02221,2-Cyanopyridine,,,,,
C02222,2-Maleylacetate;|4-Oxohex-2-enedioate;|Maleylacetate,,,,,
C02223,2-Methylbutanal;|2-Methylbutyraldehyde,,,,,
C02224,2-Methylcholine,,,,,
C02225,"2-Methylcitrate;|(2S,3S)-2-Methylcitrate;|2-Hydroxybutane-1,2,3-tricarboxylate;|(2S,3S)-2-Hydroxybutane-1,2,3-tricarboxylate;|(2S,3S)-2-Methylcitric acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02225  (2S,3S)-2-Methylcitric acid",
C02226,2-Methylmaleate;|Citraconate;|Citraconic acid;|Methylmaleic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02226  Citraconic acid,
C02227,2-Naphthylamine;|2-Naphthalenamine;|2-Aminonaphthalene;|beta-Naphthylamine,,,,,
C02230,"3-Methylguanine;|2-Amino-3,7-dihydro-3-methyl-6H-purin-6-one",,,,,
C02231,3-Nitroacrylate,,,,,
C02232,3-Oxoadipyl-CoA;|beta-Ketoadipyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02232  3-Oxoadipyl-CoA,
C02233,3-Oxopentanoic acid;|3-Oxopentanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C02233  3-Oxopentanoic acid,
C02234,4-Cyanopyridine,,,,,
C02235,4-Nitrocatechol,,,,,
C02236,4-Sulfobenzoate;|4-Sulfobenzoic acid,,,,,
C02237,5-Oxo-D-proline;|D-Pyroglutamic acid;|D-5-Pyrrolidone-2-carboxylic acid,,,,,
C02240,5-Valerolactone;|delta-Valerolactone;|gamma-Valerolactone,,,,,
C02241,7-Methyladenine,,,,,
C02242,7-Methylguanine,,,,,
C02243,8-Oxocoformycin,,,,,
C02245,Alkyl sulfenate,Generic compound in reaction hierarchy,,,,
C02247,Anthraniloyl-CoA;|2-Aminobenzoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02247  Anthraniloyl-CoA,
C02248,Apocytochrome c,Generic compound in reaction hierarchy,,,,
C02249,"Arachidonyl-CoA;|Arachidonoyl-CoA;|(5Z,8Z,11Z,14Z)-Icosatetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02249  (5Z,8Z,11Z,14Z)-Icosatetraenonyl-CoA",
C02252,Arylhydroxamate,,,,,
C02253,Benzoylagmatine,,,,,
C02255,CDP-acylglycerol;|1-Acyl-sn-glycero-3-cytidine-5'-diphosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP13 CDP-Glycerols|GP1305 CDP-Monoacylglycerols|C02255  CDP-acylglycerol,
C02256,Castanospermine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C02256  Castanospermine,
C02261,D-2-Aminobutyrate;|D-2-Aminobutyric acid;|D-2-Aminobutanoic acid;|(R)-2-Aminobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C02261  (R)-2-Aminobutanoic acid,
C02262,D-Galactosamine;|D-Chondrosamine;|2-Amino-2-deoxy-D-galactose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C02262  D-Galactosamine,
C02264,D-Glucose oxime,,,,,
C02265,D-Phenylalanine;|D-alpha-Amino-beta-phenylpropionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C02265  D-Phenylalanine,
C02266,"D-Xylonolactone;|D-Xylono-1,5-lactone",,,,,
C02267,Deoxycoformycin;|Pentostatin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00155)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX08 Pentostatin|D00155  Pentostatin (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00155)]|Antineoplastics|Antimetabolites|Pentostatin|D00155  Pentostatin (JAN/USAN/INN)|Drug groups [BR:br08330(D00155)]|Antineoplastic|DG01500  Adenosine deaminase inhibitor|D00155  Pentostatin|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|D00155  Pentostatin|Drug classes [BR:br08332(D00155)]|Antineoplastic|DG02018  Antimetabolite|D00155  Pentostatin|Target-based classification of drugs [BR:br08310(D00155)]|Enzymes|Hydrolases (EC3)|Adenosine deaminase|ADA|D00155  Pentostatin (JAN/USAN/INN) &lt;US&gt;",
C02269,Deoxynucleoside;|2'-Deoxynucleoside;|2-Deoxy-D-ribosyl-base;|2-Deoxy-D-ribosyl-base1;|2-Deoxy-D-ribosyl-base2;|2'-Deoxyribonucleoside,Generic compound in reaction hierarchy,,,,
C02270,Depurinated DNA;|Apurinic site in DNA,,,,,
C02271,Dichloromethane;|Methylene chloride;|Methylene dichloride,,,,,
C02272,Diethyl sulfide;|Ethyl sulfide;|Ethyl thioether;|Diethyl thioether,,,,,
C02273,Digalacturonate;|Digalacturonic acid;|alpha-D-Galacturonosyl-(1->4)-D-galacturonate,,,,,G02614
C02274,"Dihydrocoumarin;|3,4-Dihydrocoumarin",,,,,
C02277,1-Dodecanol;|Dodecylalcohol;|Dodecyl alcohol;|Lauryl alcohol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C02277  1-Dodecanol,
C02278,Dodecylaldehyde;|Dodecyl aldehyde;|Dodecanal;|1-Dodecanal;|Lauraldehyde,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C02278  Dodecanal,
C02280,GDP-L-galactose;|GDP-beta-L-galactose,,,,,
C02282,Glutaminyl-tRNA;|L-Glutaminyl-tRNA(Gln);|Glutaminyl-tRNA(Gln);|Gln-tRNA(Gln),,,,,
C02283,Glycyrrhetinate;|Enoxolone;|Glycyrrhetinic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C02283  Glycyrrhetinate|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C02283  Glycyrrhetinate|Dietary phytochemicals [br08012.html]|Other phytochemicals|C02283|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00156)]|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX10 Enoxolone|D00156  Glycyrrhetinic acid (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00156)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00156  Glycyrrhetinic acid (JAN); Enoxolone (INN)|Classification of Japanese OTC drugs [BR:br08313(D00156)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00156  Glycyrrhetinic acid (JAN)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00156  Glycyrrhetinic acid (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00156)]|Third-class OTC drugs|Inorganic and organic chemicals|Glycyrrhetinic acid|D00156  Glycyrrhetinic acid (JAN)|Target-based classification of drugs [BR:br08310(D00156)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HSD11B1|D00156  Glycyrrhetinic acid (JAN) &lt;JP&gt;",
C02284,"Glycyrrhizinate;|Glycyrrhizin;|Glycyrrhizic acid;|(3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucuronosyl-beta-D-glucosiduronic acid",Previously considered that the glycoside bound to C-3 of the aglycon had the alpha-configuration (CAS: 1405-86-3),,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C02284  Glycyrrhizinate|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C02284  Glycyrrhizinate|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C02284  Glycyrrhizinate|Dietary phytochemicals [br08012.html]|Other phytochemicals|C02284|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00157)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA08 Glycyrrhizic acid|D00157  Glycyrrhizin (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00157)]|Third-class OTC drugs|Inorganic and organic chemicals|Glycyrrhizin|D00157  Glycyrrhizin (JAN)",
C02287,Hydroxymalonate;|Tartronic acid;|Hydroxymalonic acid;|2-Hydroxymalonate;|2-Hydroxymalonic acid;|2-Tartronic acid,,,,,
C02289,Isopiperitenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C02289  Isopiperitenone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02289  Isopiperitenone,
C02290,L-Carnitinamide,,,,,
C02291,L-Cystathionine,,,,,
C02293,Latia luciferin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C02293  Latia luciferin,
C02294,Methylguanidine,,,,,
C02295,Methylitaconate;|2-Methylene-3-methylsuccinate,,,,,
C02297,N-Acetyldiamine,Generic compound in reaction hierarchy,,,,
C02298,N-Acetylindoxyl;|Acetylindoxyl,,,,,
C02299,N-Methylaniline;|N-Methylbenzenamine,,,,,
C02301,O-Acylcarnitine,Generic compound in reaction hierarchy,,,,
C02303,[Peptide]-glycine;|Peptidylglycine,,,,,
C02304,Phenylhydrazine;|Hydrazinobenzene;|Phenyldiazane,,,,,
C02305,Phosphocreatine;|N-Phosphocreatine;|Creatine phosphate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB06 Fosfocreatine|C02305  Phosphocreatine,
C02306,Phosphoramidate;|Phosphoramidic acid;|Amidophosphoric acid;|Phosphoramide,,,,,
C02311,Primary diamine,,,,,
C02314,"Prostaglandin F2beta;|Prostaglandin F2b;|Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-,(5Z,9beta,11alpha,13E,15S)-;|5-Heptenoic acid, 7-[3,5-dihydroxy-2(3-hydroxy-1-octenyl)cyclopentyl]-, stereoisomer;|9beta,11alpha-PGF2a;|9beta,11alpha-PGF2alpha;|PGF2b;|PGF2beta",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C02314  Prostaglandin F2beta|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C02314  Prostaglandin F2beta,
C02315,Protein dithiol,Generic compound in reaction hierarchy,,,,
C02318,R'C(R)S-S(R)CR',Generic compound in reaction hierarchy,,,,
C02319,R-CHOH-CO-CH2OH,,,,,
C02320,R-S-Glutathione,Generic compound in reaction hierarchy,,,,
C02321,"cis-1,4-Polyisoprene;|Rubber particle;|Rubber;|Rubber (all-cis)",Generic compound in reaction hierarchy,,,Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C02321  Rubber particle,
C02323,Salicyl alcohol;|Saligenin;|2-Hydroxybenzyl alcohol;|2-(Hydroxymethyl)phenol,,,,,
C02324,Secondary amine,,,,,
C02325,Sinapyl alcohol;|Sinapoyl alcohol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C02325  Sinapyl alcohol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02325,
C02327,Thiogalactoside,,,,,
C02328,Tolmetin sodium,,,,,
C02330,UDP-L-iduronate,,,,,
C02331,Vinylacetyl-CoA;|3-Butenoyl-CoA;|But-3-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02331  3-Butenoyl-CoA,
C02332,Vitamin A ester,,,,,
C02333,"Xanthopterin-B2;|1-(7,8-Dihydro-2,4-dihydroxypteridin-6-yl)-2-hydroxypropan-1-one",,,,,
C02334,Z-Arg-Arg-NHMec;|Benzyloxycarbonylarginyl-arginine 4-methylcoumarin-7-ylamide,,,,,
C02335,beta-Alanyl-CoA,,,,,
C02336,beta-D-Fructose;|beta-Fruit sugar;|beta-D-arabino-Hexulose;|beta-Levulose;|Fructose,,,,,
C02337,beta-D-Xyloside,,,,,
C02338,beta-L-Rhamnose;|beta-6-Deoxy-L-mannose;|beta-L-Mannomethylose;|beta-L-Rhamnopyranose,,,,,
C02339,m7G(5')pppR-mRNA;|m7G(5')pppPur-mRNA;|mRNA containing an N7-methylguanine cap;|5'-(N7-Methyl 5'-triphosphoguanosine)-[mRNA];|5'-(N7-Methylguanosine 5'-triphospho)-[mRNA];|5'-(N7-Methyl 5'-triphosphoguanosine)-(purine-ribonucleotide)-[mRNA],Generic compound in reaction hierarchy|R1 = adenine or guanine base,,,,
C02341,trans-Aconitate;|trans-Aconitic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Tricarboxylic acids|C02341  trans-Aconitate,
C02343,(+)-Norephedrine;|d-Norephedrine;|Norephedrine,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C02343,
C02344,(-)-endo-Fenchol;|(-)-alpha-Fenchyl alcohol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02344  (-)-endo-Fenchol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02344  Fenchyl alcohol,
C02345,(2S)-Flavan-4-ol,Generic compound in reaction hierarchy,,,,
C02347,Phosphomannan;|Phosphomannan backbone,,,,,G12741
C02348,(R)(-)-Allantoin;|(R)-Allantoin,,,,,
C02350,(S)-Allantoin;|(S)(+)-Allantoin,,,,,
C02351,"o-Benzoquinone;|1,2-Benzoquinone",,,,,
C02352,"1,4-beta-D-Xylan;|(1,4-beta-D-Xylan)n;|(1,4-beta-D-Xylan)n+1",,,,,G10512
C02353,"2',3'-Cyclic AMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|2',3'-Cyclic nucleotides|C02353  2',3'-Cyclic AMP",
C02354,"2',3'-Cyclic CMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|2',3'-Cyclic nucleotides|C02354  2',3'-Cyclic CMP",
C02355,"2',3'-Cyclic UMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|2',3'-Cyclic nucleotides|C02355  2',3'-Cyclic UMP",
C02356,(S)-2-Aminobutanoate;|(S)-2-Aminobutanoic acid;|(S)-2-Aminobutyric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C02356  (S)-2-Aminobutanoic acid,
C02357,2-Chlorobenzoate;|2-Chlorobenzoic acid;|o-Chlorobenzoic acid,,,,,
C02359,2-Fluorobenzoate;|2-Fluorobenzoic acid,,,,,
C02360,2-Hydroxyadipate;|2-Hydroxyadipic acid;|2-Hydroxyhexanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02360  2-Hydroxyhexanedioic acid,
C02362,2-Oxosuccinamate;|2-Oxosuccinamic acid;|gamma-Aminooxaloacetate;|Oxaloacetamide,,,,,
C02363,3-Ethoxybenzoate;|3-Ethoxybenzoic acid,,,,,
C02364,3-Fluorobenzoate;|3-Fluorobenzoic acid,,,,,
C02366,"3-Methyloxindole;|1,3-Dihydro-3-methyl-2H-indol-2-one",,,,,
C02367,3-Oxododecanoic acid;|3-Oxododecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C02367  3-Oxododecanoic acid,
C02370,4-Chlorobenzoate;|4-Chlorobenzoic acid,,,,,
C02371,4-Fluorobenzoate;|4-Fluorobenzoic acid,,,,,
C02372,4-Hydroxyaniline;|4-Aminophenol;|p-Aminophenol;|4-Aminobenzenol,,,,,
C02373,4-Methylpentanal;|Isocaproaldehyde;|Isohexanal,,,,,
C02374,5'-Dephospho-DNA,Generic compound in reaction hierarchy,,,,
C02375,4-Chlorocatechol,,,,,
C02376,5-Methylcytosine,,,,,
C02377,5-Oxoprolyl-tRNA,,,,,
C02378,6-Aminohexanoate;|6-Aminohexanoic acid;|Epsilcapramine;|6-Aminocaproic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C02378  6-Aminohexanoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00160)]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02A ANTIFIBRINOLYTICS|B02AA Amino acids|B02AA01 Aminocaproic acid|D00160  Aminocaproic acid (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00160)]|Blood Products and Modifiers|Hemostasis Agents|Aminocaproic Acid|D00160  Aminocaproic acid (USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00160)]|Agents for ophthalmologic use|62 General eye drops|D00160  Aminocaproic acid (USP/INN)|67 Eyewash|D00160  Aminocaproic acid (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00160)]|Third-class OTC drugs|Inorganic and organic chemicals|Epsilon-Aminocaproic acid|D00160  Aminocaproic acid (USP/INN)|Drug groups [BR:br08330(D00160)]|Blood modifier agent|DG02016  Hemostatics|DG02012  Antifibrinolytic|DG01540  Plasmin inhibitor|D00160  Aminocaproic acid|Target-based classification of drugs [BR:br08310(D00160)]|Enzymes|Hydrolases (EC3)|Serine peptidases|PLG|D00160  Aminocaproic acid (USP/INN) &lt;US&gt;,
C02379,6-Hydroxymellein,,,,,
C02380,6-Mercaptopurine;|Mercaptopurine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04931)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BB Purine analogues|L01BB02 Mercaptopurine|D04931  Mercaptopurine (INN)|Drug groups [BR:br08330(D04931)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG00683  Mercaptopurine|D04931  Mercaptopurine|Target-based classification of drugs [BR:br08310(D04931)]|Enzymes|Transferases (EC2)|Pentosyltransferases|HPRT1|D04931  Mercaptopurine (INN)",
C02381,6-Methoxymellein,,,,,
C02385,Amino acid(Arg-);|Arginine;|2-Amino-5-guanidinovaleric acid,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|L-Arginine|C02385  Amino acid(Arg-),
C02389,p-Benzosemiquinone;|4-Hydroxyphenoxy radical,,,,,
C02390,Methylazoxymethanol;|CH3-N(O)=N-CH2OH,,,,,
C02391,Ester;|Carboxylic ester,Generic compound in reaction hierarchy,,,,
C02394,Cinnamyl alcohol;|3-Phenyl-2-propen-1-ol;|Styrylcarbinol,,,,,
C02395,Cyclohex-2-enone;|2-Cyclohexen-1-one,,,,,
C02399,D-Xylosylprotein;|O-beta-D-Xylosylprotein;|Protein O-D-xyloside,Generic compound in reaction hierarchy,,,,G00154
C02400,Demethylmacrocin;|2'''-O-Demethyllactenocin,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C02400  Demethylmacrocin,
C02401,Dialkylarylamine,,,,,
C02403,Fatty acid anion;|Alkanate;|Alkane acid,Generic compound in reaction hierarchy,,,,
C02405,Formyl phosphate,,,,,
C02410,Glucosylated DNA,,,,,
C02411,Glutaconyl-1-CoA;|4-Carboxybut-2-enoyl-CoA;|Glutaconyl-CoA;|(E)-Glutaconyl-CoA;|(2E)-4-Carboxybut-2-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02411  (2E)-4-Carboxybut-2-enoyl-CoA,
C02412,Glycyl-tRNA(Gly),Generic compound in reaction hierarchy,,,,
C02415,Histone-L-lysine,Generic compound in reaction hierarchy,,,,
C02419,Hypotaurocyamine,,,,,
C02420,Isobutyronitrile;|2-Methylpropanenitrile,,,,,
C02421,Isonicotineamide;|Isonicotinamide,,,,,
C02424,L-Arginine ester,,,,,
C02426,"L-Glyceraldehyde;|L-2,3-Dihydroxypropionaldehyde;|L-2,3-Dihydroxypropanal;|L-Glycerose;|L-Aldotriose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C02426  L-Glyceraldehyde,
C02427,L-Homocitrulline,,,,,
C02429,L-Leucyl-protein,Generic compound in reaction hierarchy,,,,
C02430,L-Methionyl-tRNA;|L-Methionyl-tRNA(Met),,,,,
C02431,L-Rhamnofuranose,,,,,
C02434,Long-chain ester,Generic compound in reaction hierarchy,,,,
C02436,Methylated amine,Generic compound in reaction hierarchy,,,,
C02440,N-Desulfoheparin;|Heparamine,,,,,
C02441,N-Ethylmaleimide,,,,,
C02442,N-Methyltyramine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C02442  N-Methyltyramine,
C02444,N6-Acyl-L-lysine,Generic compound in reaction hierarchy,,,,
C02445,"Nonane-4,6-dione",,,,,
C02446,O-Alkylglycerone,Generic compound in reaction hierarchy,,,,
C02447,O-Methylated RNA,,,,,
C02451,Pent-2-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02451  (2E)-Pentenoyl-CoA,
C02452,"(-)-Perillyl alcohol;|Perillyl alcohol;|(S)-Perillyl alcohol;|[(4S)-4-(Prop-1-en-2-yl)cyclohex-1-en-1-yl]methanol;|p-Mentha-1,8-dien-7-ol;|(-)-Perillylalcohol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C02452  Perillyl alcohol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02452  Perillyl alcohol,
C02453,Phenolic steroid,Generic compound in reaction hierarchy,,,,
C02454,"Phenylenediamine;|m-Phenylenediamine;|Diaminobenzene;|m-Diaminobenzene;|Benzenediamine;|1,3-Benzenediamine;|meta-Phenylenediamine",o-Phenylenediamine [CPD:C14402]|p-Phenylenediamine [CPD:C19499],,,,
C02455,1-Phenylethylamine;|alpha-Phenylethylamine;|alpha-Methylbenzylamine,,,,,
C02457,"Propane-1,3-diol;|1,3-Propanediol;|Trimethylene glycol",,,,,
C02461,Protein Cys-Cys,,,,,
C02462,Sabinene hydrate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02462  Sabinene hydrate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02462  Sabinene hydrate,
C02463,Precorrin 2;|Dihydrosirohydrochlorin,,,,,
C02465,"Triiodothyronine;|3,3',5-Triiodo-L-thyronine;|L-3,5,3'-Triiodothyronine;|3,5,3'-Triiodothyronine;|Liothyronine;|3,5,3'-Triiodo-L-thyronine;|T3",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C02465  Triiodothyronine|Hormones and transmitters|Other hormones|Thyroid hormones|C02465  Triiodothyronine|Drug groups [BR:br08330(D08128)]|Hormonal agent|DG01953  Thyroid preparation|DG01608  Thyroid hormone replenisher|DG01372  Liothyronine|D08128  Liothyronine|Target-based classification of drugs [BR:br08310(D08128)]|Nuclear receptors|Thyroid hormone like receptors|Thyroid hormone receptor (THR)|NR1A (THR)|D08128  Liothyronine (INN),
C02466,Trimetaphosphoric acid;|Trimetaphosphate;|cyclo-Triphosphoric acid,,,,,
C02467,UDP-galactosamine;|UDP-alpha-D-galactosamine,,,,,
C02469,Uroporphyrin III,,,,,
C02470,Xanthurenic acid;|Xanthurenate,,,,,
C02471,[Glu(-Cys)]n-Gly;|Poly(gamma-glutamylcysteine)glycine;|(gamma-Glutamylcysteine)n-glycine,,,,,
C02472,alpha-D-Fucoside,,,,,
C02473,alpha-D-Lyxoside,,,,,
C02474,Arabinan;|alpha-L-Arabinan;|alpha-L-Araban,Substructure of pectic polysaccharide,,,,G10584
C02475,alpha-L-Fucoside,Generic compound in reaction hierarchy,,,,
C02476,alpha-L-Rhamnose;|alpha-6-Deoxy-L-mannose;|alpha-L-Mannomethylose;|alpha-L-Rhamnopyranose,,,,,
C02477,alpha-Tocopherol;|Vitamin E,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C02477  alpha-Tocopherol (Vitamin E)|Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C02477  alpha-Tocopherol|Classification of Japanese OTC drugs [BR:br08313]|Nourishing tonics and health supplements|34 Vitamin E based drugs|C02477  alpha-Tocopherol|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Tocopherol|C02477  alpha-Tocopherol,
C02478,beta-D-Mannoside,Generic compound in reaction hierarchy,,,,
C02479,beta-L-Arabinopyranose;|beta-L-Arabinose,,,,,
C02480,"cis,cis-Muconate;|cis,cis-Hexadienedioate;|cis,cis-2,4-Hexadienedioic acid;|(2Z,4Z)-Hexa-2,4-dienedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02480  (2Z,4Z)-Hexa-2,4-dienedioic acid",
C02483,gamma-Tocopherol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C02483  gamma-Tocopherol,
C02484,(+)-trans-Pulegol,,,,,
C02485,(-)-Isopiperitenone;|(-)-(4R)-Isopiperitenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C02485  (-)-Isopiperitenone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02485  (-)-Isopiperitenone,
C02486,(3R)-beta-Leucine;|(3R)-3-Amino-4-methylpentanoic acid;|(3R)-3-Amino-4-methylvaleric acid,,,,,
C02487,(Ac)2-L-Lys-D-Ala;|(Ac)2-L-lysyl-D-alanine,,,,,
C02488,(R)-2-Ethylmalate;|(R)-2-Ethylmalic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02488  (R)-2-Ethylmalic acid,
C02489,(R)-2-Hydroxyacid;|(R)-2-Hydroxycarboxylate;|(R)-2-Hydroxycarboxylic acid,Generic compound in reaction hierarchy,,,,
C02490,"1,2-beta-D-Glucan;|[(1->2)-beta-D-Glucosyl]n",,,,,
C02492,"1,4-beta-D-Mannan",,,,,G10532
C02493,"1,6-beta-D-Glucan",,,,,
C02494,1-Methyladenosine,,,,,
C02495,"2'-Hydroxydaidzein;|3-(2,4-Dihydroxyphenyl)-7-hydroxychromen-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C02495  2'-Hydroxydaidzein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C02495  2'-Hydroxydaidzein,
C02496,"2,4-Dinitrophenol",,,,,
C02497,"2-Butyne-1,4-diol;|1,4-Butynediol",,,,,
C02498,2-Ethylhexan-1-ol;|2-Ethyl-1-hexanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C02498  2-Ethylhexan-1-ol,
C02499,2-Hydroxybiphenyl;|Orthophenyl phenol;|2-Biphenylol;|2-Phenylphenol,,,,Pesticides [BR:br08007]|Pesticides|Others|Insect repellents|C02499  2-Hydroxybiphenyl,
C02501,2-Hydroxymuconate,,,,,
C02502,2-Hydroxypyridine;|2-Pyridone;|2-Pyridinol,,,,,
C02504,alpha-Isopropylmalate;|(2S)-2-Isopropylmalate;|(2S)-2-Hydroxy-2-isopropylsuccinic acid;|2-Isopropylmalic acid;|3-Carboxy-3-hydroxy-4-methylpentanoate;|3-Carboxy-3-hydroxyisocaproate;|(2S)-2-Isopropylmalic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02504  (2S)-2-Isopropylmalic acid,
C02505,2-Phenylacetamide;|alpha-Phenylacetamide,,,,,
C02507,"3',5'-Cyclic dGMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|3',5'-Cyclic nuclcleotides|C02507  3',5'-Cyclic dGMP",
C02508,3'-Ribonucleotide;|3'-Phosphomononucleotides;|3'-Nucleoside monophosphate,Generic compound in reaction hierarchy,,,,
C02509,3-(ADP)-glycerate,,,,,
C02512,3-Cyano-L-alanine;|L-3-Cyanoalanine;|L-beta-Cyanoalanine,,,,,
C02513,"3-Dehydroecdysone;|(2beta,5beta,22R)-2,14,22,25-Tetrahydroxycholest-7-ene-3,6-dione",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C02513  3-Dehydroecdysone,
C02514,3-Fumarylpyruvate,,,,,
C02515,3-Iodo-L-tyrosine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C02515  3-Iodo-L-tyrosine,
C02517,3-Oxohexobarbital,,,,,
C02518,4-Aminosalicylate;|4-Aminosalicylic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00162)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AA Aminosalicylic acid and derivatives|J04AA01 4-Aminosalicylic acid|D00162  Aminosalicylic acid (USP)|USP drug classification [BR:br08302(D00162)]|Antimycobacterials|Antituberculars|Aminosalicylic Acid|D00162  Aminosalicylic acid (USP)|Drug groups [BR:br08330(D00162)]|Antibacterial|DG01966  Antitubercular|DG00638  Aminosalicylic acid|D00162  Aminosalicylic acid|Antimicrobials [BR:br08307(D00162)]|Antibacterials|Folic acid biosynthesis inhibitor|Aminosalicylic acid|D00162  Aminosalicylic acid (USP)|New drug approvals in Europe [br08329.html(D00162)]|European public assessment reports (EPAR) authorised medicine|D00162,
C02519,4-Methoxybenzoate;|4-Methoxybenzoic acid;|4-Anisic acid,,,,,
C02520,5'-Ribonucleotide,Generic compound in reaction hierarchy,,,,
C02521,5S-rRNA precursor,,,,,
C02522,6-Deoxy-D-glucose;|D-Quinovose;|6-Deoxy-D-glucopyranose;|D-Chinovose;|D-Glucomethylose;|Isorhamnose;|D-Epifucose;|Isorhodeose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C02522  D-Quinovose,
C02525,Aliphatic alcohol,,,,,
C02526,"Biphenyl-2,3-diol;|2,3-Dihydroxybiphenyl;|3-Phenylcatechol",,,,,
C02527,Butanoylphosphate;|Butanoyl phosphate,,,,,
C02528,"Chenodeoxycholate;|Chenodeoxycholic acid;|3alpha,7alpha-Dihydroxy-5beta-cholanic acid;|Chenodiol",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C02528  Chenodeoxycholate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C02528  3alpha,7alpha-Dihydroxy-5beta-cholanic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00163)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05A BILE THERAPY|A05AA Bile acids and derivatives|A05AA01 Chenodeoxycholic acid|D00163  Chenodiol (USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00163)]|Gastrointestinal Agents|Gastrointestinal Agents, Other|Chenodeoxycholate|D00163  Chenodiol (USAN)|Therapeutic category of drugs in Japan [BR:br08301(D00163)]|2  Agents affecting individual organs|23  Digestive organ agents|236  Cholagogues|2362  Bile acids|D00163  Chenodiol (USAN); Chenodeoxycholic acid (JP18/INN)|Drug groups [BR:br08330(D00163)]|Gastrointestinal agent|DG01956  Bile acid preparation|D00163  Chenodiol|Target-based classification of drugs [BR:br08310(D00163)]|Nuclear receptors|Thyroid hormone like receptors|Liver X receptor like receptor|NR1H4 (FXR)|D00163  Chenodiol (USAN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00163)]|Chemicals|D00163  Chenodeoxycholic acid|New drug approvals in Europe [br08329.html(D00163)]|European public assessment reports (EPAR) authorised medicine|D00163",
C02530,Cholesterol ester,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0102 Steryl esters|C02530  Cholesterol ester,
C02532,O-Phospho-D-serine;|D-O-Phosphoserine,O-phospho-L-serine [CPD:C01005],,,,
C02533,Dehydrovomifoliol;|(6S)-6-Hydroxy-3-oxo-alpha-ionone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C02533  Dehydrovomifoliol,
C02534,Dialkyl phosphate,Generic compound in reaction hierarchy,,,,
C02535,Dimethyl selenide,,,,,
C02536,Dolichyl palmitate,,,,,
C02537,Estradiol-17alpha;|17alpha-Estradiol,,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C02537  Estradiol-17alpha|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C02537  Estradiol-17alpha|Target-based classification of drugs [BR:br08310(D07121)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D07121  Alfatradiol (INN)|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|SRD5A1|D07121  Alfatradiol (INN)|SRD5A2|D07121  Alfatradiol (INN),
C02538,Estrone 3-sulfate,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Estrogens|C02538  Estrone 3-sulfate|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C02538  Estrone 3-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C02538  Estrone 3-sulfate,
C02539,Fenoprofen calcium,,,,,
C02543,Glycerone sulfate;|Dihydroxyacetone sulfate,,,,,
C02546,Glycyl amino acid,,,,,
C02548,2-(2-Aminoethyl)indole,,,,,
C02549,Kievitone hydrate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C02549  Kievitone hydrate|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C02549  Kievitone hydrate,
C02553,L-Seryl-tRNA(Ser),Generic compound in reaction hierarchy,,,,
C02554,L-Valyl-tRNA(Val),Generic compound in reaction hierarchy,,,,
C02555,Luciferyl sulfate,,,,,
C02557,Methylmalonyl-CoA;|Methylmalonyl coenzyme A;|2-Methylmalonyl-CoA,,,,,
C02560,N-Acetylimidazole;|1-Acetyl-1H-imidazole,,,,,
C02562,N-Acyl-L-arginine,,,,,
C02564,N-Feruloylglycine;|N-[3-(4-Hydroxy-3-methoxyphenyl)-1-oxo-2-propen-1-yl]glycine,,,,,
C02565,"N-Methylhydantoin;|N-Methylimidazolidine-2,4-dione",,,,,
C02567,N1-Acetylspermine,,,,,
C02569,Neryl diphosphate;|Neryl pyrophosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C02569  Neryl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C02569  Neryl diphosphate,
C02571,O-Acetylcarnitine;|O-Acetyl-L-carnitine,,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C02571  O-Acetylcarnitine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BX Other psychostimulants and nootropics|N06BX12 Acetylcarnitine|C02571  O-Acetylcarnitine",
C02572,5-O-Feruloylquinic acid;|O-Feruloylquinate;|3-O-Feruloylquinic acid,3-O-Feruloylquinic acid is based on old nomenclature system of numbering.,,,,
C02574,O-Phosphoviomycin,,,,,
C02575,Pentachlorophenol;|PCP,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C02575  Pentachlorophenol|Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C02575  Pentachlorophenol,
C02576,Perillyl aldehyde;|Perillaldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C02576  Perillyl aldehyde|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02576  Perillyl aldehyde,
C02577,Phenoxyacetyl-CoA,,,,,
C02578,Phenylgalactoside,,,,,
C02579,Polygalacturonide,,,,,
C02581,Propanoylagmatine;|Propionylagmatine,,,,,
C02582,Protein disulfide,Generic compound in reaction hierarchy,,,,
C02583,Protein glutamine;|Protein L-glutamine,Generic compound in reaction hierarchy,,,,
C02587,"Pyrimidodiazepine;|2-Amino-6-acetyl-3,7,8,9-tetrahydro-3H-pyrimido[4,5-b][1,4]diazepin-4-one",,,,,
C02588,Retinyl palmitate;|Vitamin A palmitate;|all-trans-Retinyl palmitate;|Retinol palmitate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C02588  Retinyl palmitate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00164)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CA Vitamin A, plain|A11CA01 Retinol (vit A)|D00164  Retinol palmitate (JP18) &lt;JP/US&gt;|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD02 Retinol|D00164  Retinol palmitate (JP18) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX02 Retinol|D00164  Retinol palmitate (JP18) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA02 Retinol|D00164  Retinol palmitate (JP18) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00164)]|3  Agents affecting metabolism|31  Vitamins|311  Vitamins A and D preparations|3111  Synthetic vitamin A preparations|D00164  Retinol palmitate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00164)]|Nourishing tonics and health supplements|32 Vitamin A based drugs|D00164  Retinol palmitate (JP18)|43 Vitamin containing supplements|D00164  Retinol palmitate (JP18)|Agents for ophthalmologic use|62 General eye drops|D00164  Retinol palmitate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00164)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Retinol palmitate|D00164  Retinol palmitate (JP18)|Second-class OTC drugs|Inorganic and organic chemicals|Retinol palmitate|D00164  Retinol palmitate (JP18)|Third-class OTC drugs|Inorganic and organic chemicals|Retinol palmitate|D00164  Retinol palmitate (JP18)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|958  Agents for protective skin|9582  Vitamin preparations (for external use)|C02588  Retinyl palmitate|Drug groups [BR:br08330(D00164)]|Vitamin and mineral|DG01604  Retinol derivative|DG00123  Retinol (vit A)|D00164  Retinol palmitate|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00123  Retinol (vit A)|D00164  Retinol palmitate|Target-based classification of drugs [BR:br08310(D00164)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D00164  Retinol palmitate (JP18) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00164)]|Chemicals|D00164  Retinol palmitate|Drug metabolizing enzymes and transporters [br08309.html(D00164)]|Drug metabolizing enzymes|D00164",
C02589,S-Acylglutathione,Generic compound in reaction hierarchy,,,,
C02590,Steroid O-sulfate;|Phenolic steroid O-sulfate,Generic compound in reaction hierarchy,,,,
C02591,Sucrose 6'-phosphate;|Sucrose 6F-phosphate,,,,,G10508
C02592,Taurolithocholate;|Taurolithocholic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C02592  Taurolithocholate|ST05 Steroid conjugates|ST0504 Taurine conjugates|C02592  Taurolithocholate",
C02593,Tetradecanoyl-CoA;|Myristoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02593  Tetradecanoyl-CoA,
C02595,Thien-2-ylacetate;|2-Thiopheneacetic acid;|2-Thienylacetic acid,,,,,
C02596,Tolylacetonitrile;|o-Tolylacetonitrile;|o-Methylbenzyl cyanide;|2-Methylbezeneacetonitrile,,,,,
C02601,[Pyruvate kinase],Generic compound in reaction hierarchy,,,,
C02603,alpha-D-Mannoside,,,,,
C02604,alpha-L-Arabinopyranose;|alpha-L-Arabinose,,,,,
C02605,beta-L-Rhamnoside,,,,,
C02607,kappa-Carrageenan,,,,,
C02611,"(E,E)-Piperoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02611  (E,E)-Piperoyl-CoA",
C02612,(R)-2-Methylmalate;|(R)-2-Methylmalic acid;|(R)-Citramalate;|(R)-Citramalic acid;|(R)-alpha-Hydroxypyrotartaric acid;|D-Citramalate;|D-Citramalic acid;|D-alpha-Hydroxypyrotartaric acid;|(2R)-2-Hydroxy-2-methylbutanedioate,,,,,
C02614,(S)-2-Methylmalate;|(S)-2-Methylmalic acid;|(S)-Citramalate;|(S)-Citramalic acid;|(S)-alpha-Hydroxypyrotartaric acid;|L-Citramalate;|L-Citramalic acid;|L-alpha-Hydroxypyrotartaric acid;|(2S)-2-Hydroxy-2-methylbutanedioate;|(S)-2-Hydroxy-2-methylsuccinic acid,,,,,
C02615,(S)-Mandelonitrile;|(S)-Benzaldehyde cyanohydrin,,,,,
C02616,"1,3-alpha-D-Glucan;|[alpha-D-Glucosyl-(1,3)]n;|[alpha-D-Glucosyl-(1,3)]n+1;|[(1->3)-alpha-D-Glucosyl]n",Generic compound in reaction hierarchy,,,,G10492
C02617,"1,4-Naphthoquinone;|1,4-Naphthalenedione",,,,,
C02621,13-Hydroxylupanine;|13-Hydroxylupinine;|(+)-13alpha-Hydroxylupanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C02621  13-Hydroxylupanine,
C02623,"2,2-Dialkylglycine",Generic compound in reaction hierarchy,,,,
C02625,"2,4-Dichlorophenol",,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C02625  2,4-Dichlorophenol",
C02627,2-Deoxystreptamine,,,,,
C02628,"2-Deoxystreptidine;|N,N'-Bis(aminoiminomethyl)-2-deoxy-streptamine",,,,,
C02630,2-Hydroxyglutarate;|alpha-Hydroxyglutarate;|2-Hydroxyglutaric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02630  2-Hydroxyglutaric acid,
C02631,2-Isopropylmaleate;|beta-Isopropylmaleate,,,,,
C02632,2-Methylpropanoate;|2-Methylpropanoic acid;|Isobutyric acid;|Isobutanoate;|Dimethylacetic acid;|Isobutyrate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C02632  2-Methylpropanoate,
C02633,"20-Hydroxyecdysone;|Crustecdysone;|Ecdysterone;|(2beta,3beta,5beta,22R)-2,3,14,20,22,25-Hexahydroxycholest-7-en-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C02633  20-Hydroxyecdysone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C02633  20-Hydroxyecdysone,
C02634,3-Chloro-D-alanine,,,,,
C02635,3-Chloro-L-alanine,,,,,
C02636,"3-Dehydrocarnitine;|3-Carboxy-N,N,N-trimethyl-2-oxo-1-propanaminium",,,,,
C02637,3-Dehydroshikimate,"formerly called ""5-Dehydroshikimate"" on old nomenclature system of numbering",,,,
C02638,3-Fluoro-D-alanine;|(S)-3-Fluoroalanine,,,,,
C02639,3-Methoxytropolone,,,,,
C02640,3-Methylbutanamine;|Isoamylamine;|Isopentylamine,,,,,
C02642,3-Ureidopropionate;|3-Ureidopropanoate;|beta-Ureidopropionic acid;|N-Carbamoyl-beta-alanine,,,,,
C02645,"4,5-Leukotriene A4",,,,,
C02646,4-Coumaryl alcohol;|4-Hydroxycinnamyl alcohol;|p-Coumaryl alcohol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C02646  4-Coumaryl alcohol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02646,
C02647,4-Guanidinobutanal,,,,,
C02648,4-Hydroxy-2-butynal;|4-Hydroxybut-2-ynal,,,,,
C02652,5-Dehydroshikimate,"3-Dehydroshikimate [CPD:C02637] was formerly called ""5-Dehydroshikimate"" on old nomenclature system of numbering.",,,,
C02654,5-Substituted dCMP,,,,,
C02655,6-Acetyl-D-glucose,,,,,
C02656,Pimelate;|Pimelic acid;|Heptanedioic acid;|6-Carboxyhexanoate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C02656  Pimelate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02656  Heptanedioic acid,
C02657,6-Methylsalicylate;|6-Methylsalicylic acid;|2-Hydroxy-6-methylbenzoic acid;|6-Methyl-2-hydroxybenzenecarboxylate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1301 Monocyclic aromatic polyketides|C02657  6-Methylsalicylic acid,
C02658,Aldoxime;|Aliphatic aldoxime,Generic compound in reaction hierarchy,,,,
C02659,Acetone cyanohydrin;|alpha-Hydroxyisobutyronitrile;|2-Hydroxy-2-methylpropanenitrile;|2-Methyllactonitrile;|Acetone cyanhydrin;|2-Hydroxyisobutyronitrile,,,,,
C02660,Benzyl thiocyanate,,,,,
C02661,Bromochloromethane;|Methylene chlorobromide,,,,,
C02666,Coniferyl aldehyde;|Coniferaldehyde;|4-Hydroxy-3-methoxycinnamaldehyde;|Ferulaldehyde,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C02666  Coniferyl aldehyde,
C02669,"D-Galactono-1,5-lactone",,,,,
C02670,"D-Glucuronolactone;|Glucurone;|D-Glucurono-3,6-lactone;|D-Glucurone",,,,Risk category of Japanese OTC drugs [BR:br08312(D01800)]|Third-class OTC drugs|Inorganic and organic chemicals|Glucuronolactone|D01800  Glucuronolactone (JAN),
C02671,D-Glutamyl-peptide;|gamma-D-Glutamyl-peptide,Generic compound in reaction hierarchy,,,,
C02672,D-Hexose phosphate,Generic compound in reaction hierarchy,,,,
C02673,"Desacetoxyvindoline;|16-Methoxy-2,3-dihydro-3-hydroxy-N-methyltabersonine;|Deacetoxyvindoline",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C02673  Desacetoxyvindoline,
C02674,Deoxyribonolactone;|2-Deoxyribonolactone,,,,,
C02675,"Dihydrobiochanin A;|2,3-Dihydrobiochanin A",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C02675  Dihydrobiochanin A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C02675  Dihydrobiochanin A,
C02677,Dimethyl telluride,,,,,
C02678,Dodecanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C02678  Dodecanedioic acid,
C02679,Dodecanoic acid;|Dodecanoate;|Dodecylcarboxylate;|Lauric acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C02679  Lauric acid (12:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C02679  Dodecanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C02679  Lauric acid,
C02681,Ecdysone palmitate;|Ecdysone 3-palmitate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0102 Steryl esters|C02681  Ecdysone palmitate,
C02682,Ferricytochrome c3,,,,,
C02684,Ferrocytochrome c3;|Reduced cytochrome c3,,,,,
C02686,Galactosylceramide;|Galactocerebroside;|Cerebroside;|D-Galactosyl-N-acylsphingosine;|D-Galactosylceramide;|beta-D-Galactosyl-N-acylsphingosine,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C02686  Galactosylceramide|Lipids [BR:br08002(G11121)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0501 Simple Glc series|G11121  Gal-beta1->1'Cer (GalCer),G11121
C02687,alpha-D-Glucosylglycogenin,Generic compound in reaction hierarchy,,,,
C02691,Heteropyrithiamine;|1-[(4-Amino-2-methylpyrimidin-5-yl)methyl]pyridinium,,,,,
C02692,"Hexose-1,5-lactone",Generic compound in reaction hierarchy,,,,
C02693,(Indol-3-yl)acetamide;|Indole-3-acetamide,,,,,
C02695,Isomaltosaccharide,,,,,
C02699,L-Citrulline ester,,,,,
C02700,L-Formylkynurenine;|N-Formyl-L-kynurenine;|N-Formylkynurenine,,,,,
C02702,L-Prolyl-tRNA(Pro),,,,,
C02703,L-Serine O-sulfate,,,,,
C02704,Monomethyl sulfate;|Methyl sulfate,,,,,
C02705,Mucus glycoprotein,Generic compound in reaction hierarchy,,,,
C02706,Myelin proteolipid,Generic compound in reaction hierarchy,,,,
C02707,Myosin heavy chain,Generic compound in reaction hierarchy,,,,
C02709,N-(Acetyloxy)benzenamine,,,,,
C02710,N-Acetyl-L-leucine,,,,,
C02711,N-Acetylhexosamine,,,,,
C02712,N-Acetylmethionine;|N-Acetyl-L-methionine,,,,,
C02713,N-Acetylmuramate;|N-Acetylmuramic acid;|N-Acetyl-D-muramoate,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C02713  N-Acetylmuramic acid,
C02714,N-Acetylputrescine,,,,,
C02715,N-Acyl-L-aspartate,Generic compound in reaction hierarchy,,,,
C02716,N-Acyl-L-glutamine,Generic compound in reaction hierarchy,,,,
C02717,N-Feruloyltyramine;|trans-N-Feruloyltyramine,,,,,
C02718,N-Formiminoglycine;|Formiminoglycine;|N-Formimidoylglycine,,,,,
C02720,Hydroxylaminobenzene;|(Hydroxyamino)benzene;|N-Phenylhydroxylamine,,,,,
C02721,N-Methyl-L-alanine,,,,,
C02722,N-Methylhexanamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C02722  N-Methylhexanamide,
C02723,N-Methylputrescine,,,,,
C02724,N-Methylpyridinium,,,,,
C02725,N3'-Acetylneomycin,,,,,
C02726,Phosphoagmatine;|Agmatine phosphate,,,,,
C02727,N6-Acetyl-L-lysine,,,,,
C02728,N6-Methyl-L-lysine,,,,,
C02730,2-Succinylbenzoate;|o-Succinylbenzoate;|Succinylbenzoate,,,,,
C02732,Peptide tryptophan,Generic compound in reaction hierarchy,,,,
C02734,Phenolic phosphate;|Phenylphosphate;|Phenyl phosphate,,,,,
C02735,Phenylethanolamine;|2-Amino-1-phenylethanol,,,,,
C02736,Phosphatidyl ester,,,,,
C02737,"Phosphatidylserine;|Phosphatidyl-L-serine;|1,2-Diacyl-sn-glycerol 3-phospho-L-serine;|3-O-sn-Phosphatidyl-L-serine;|O3-Phosphatidyl-L-serine;|L-1-Phosphatidylserine",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C02737  Phosphatidylserine|Lipids [BR:br08002]|GP  Glycerophospholipids|GP03 Glycerophosphoserines|GP0301 Diacylglycerophosphoserines|C02737  1,2-Diacyl-sn-glycerol 3-phospho-L-serine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C02737  Phosphatidylserine",
C02739,1-(5-Phospho-D-ribosyl)-ATP;|Phosphoribosyl-ATP;|N1-(5-Phospho-D-ribosyl)-ATP;|1-(5-Phosphoribosyl)-ATP;|1-(5-Phospho-beta-D-ribosyl)-ATP,,,,,
C02740,"Photinus luciferin;|(S)-4,5-Dihydro-2-(6-hydroxy-1,3-benzothiazol-2-yl)thiazole-4-carboxylic acid;|(S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid;|Firefly luciferin;|D-Firefly luciferin",,,,,
C02741,Phosphoribosyl-AMP;|N1-(5-Phospho-D-ribosyl)-AMP;|1-(5-Phosphoribosyl)-AMP;|1-(5-Phospho-beta-D-ribosyl)-AMP,,,,,
C02743,[Protein]-L-cysteine;|Protein L-cysteine,Generic compound in reaction hierarchy,,,,
C02744,Psychosine sulfate,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP08 Amphoteric glycosphingolipids|C02744  Psychosine sulfate,
C02749,S-Alkyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C02750,Sinapoyltartronate,,,,,
C02752,Triacetate lactone;|4-Hydroxy-6-methyl-2-pyrone,,,,,
C02753,"D-Xylono-1,4-lactone",,,,,
C02755,[Glu(-Cys)]n+1-Gly,,,,,
C02757,alpha-L-Rhamnoside,,,,,
C02759,alpha-Pinene-oxide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02759  alpha-Pinene-oxide|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02759  alpha-Pinene-oxide,
C02761,beta-L-Arabinoside,Generic compound in reaction hierarchy,,,,
C02762,beta-Limit dextrin,,,,,
C02763,2-Hydroxy-3-phenylpropenoate;|enol-Phenylpyruvate;|enol-Phenylpyruvic acid;|enol-alpha-Ketohydrocinnamic acid,,,,,
C02764,tRNA pseudouridine,Generic compound in reaction hierarchy,,,,
C02765,"(+)-(1S,2S)-Pseudoephedrine;|(+)-Pseudoephedrine;|Pseudoephedrine;|(1S,2S)-2-(Methylamino)-1-phenylpropan-1-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Phenylalanine derived alkaloids|C02765  (+)-Pseudoephedrine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C02765|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08449)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01B NASAL DECONGESTANTS FOR SYSTEMIC USE|R01BA Sympathomimetics|R01BA02 Pseudoephedrine|D08449  Pseudoephedrine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08449)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Pseudoephedrine|D08449  Pseudoephedrine (INN)|Second-class OTC drugs|Inorganic and organic chemicals|Pseudoephedrine|D08449  Pseudoephedrine (INN)|Drug groups [BR:br08330(D08449)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01042  Pseudoephedrine|D08449  Pseudoephedrine|Target-based classification of drugs [BR:br08310(D08449)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08449  Pseudoephedrine (INN)|ADRA2|D08449  Pseudoephedrine (INN)|ADRB|D08449  Pseudoephedrine (INN),
C02766,(R)-Ureidoglycolate;|(+)-Ureidoglycolate;|(+)-Ureidoglycolic acid,,,,,
C02768,(Glycerophosphate)n;|(Glycerophosphate)n+1;|Poly(glycerol phosphate),Generic compound in reaction hierarchy,,,,
C02771,"1,2-Dihydrosantonin;|1,2-Dihydro-alpha-santonin",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C02771  1,2-Dihydrosantonin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C02771  1,2-Dihydrosantonin",
C02773,1-Alkyl-sn-glycerol;|1-O-Alkyl-sn-glycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0102 Monoalkylglycerols|C02773  1-O-Alkyl-sn-glycerol,
C02774,10-Hydroxydecanoic acid;|10-Hydroxydecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02774  10-Hydroxydecanoic acid,
C02775,"2,3-Dihydroxyindole;|Dihydroxyindole",,,,,
C02777,"2,5-Dioxopiperazine;|Diketopiperazine;|2,5-Diazacyclohexane-1,4-dione;|2,5-Piperazinedione;|Glycine anhydride",,,,,
C02778,2-Acetamidofluorene;|N-2-Fluorenylacetamide,,,,,
C02779,2-Dehydro-D-glucose,,,,,
C02780,"2,5-Didehydro-D-gluconate;|2,5-Diketogluconic acid;|2,5-Didehydro-D-gluconic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02780  2,5-Didehydro-D-gluconic acid",
C02781,2-Deoxy-D-galactose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C02781  2-Deoxy-D-galactose,
C02782,2-Deoxy-D-gluconate,,,,,
C02783,2-Deoxy-L-arabinose,,,,,
C02784,2-Fluorobenzoyl-CoA,,,,,
C02785,"3-Hydroxy-vitamin K;|3-Hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone;|3-Hydroxy-2-methyl-3-phytyl-2,3-dihydro-1,4-naphthoquinone",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C02785  3-Hydroxy-vitamin K,
C02787,2-Methylpropanamine;|2-Methyl-1-propanamine;|2-Methylpropan-1-amine;|Isobutylamine,,,,,
C02789,3'-Extranucleotides,,,,,
C02790,3'-Hydroxyflavonoid,Generic compound in reaction hierarchy,,,,
C02791,"3,4-Dichloroaniline",,,,,
C02792,3-Fluorobenzoyl-CoA,,,,,
C02793,"2-Hydroxy-vitamin K;|2-Hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C02793  2-Hydroxy-vitamin K,
C02794,3-Hydroxykynurenine;|3-Hydroxy-DL-kynurenine,3-Hydroxy-L-kynurenine [CPD:C03227],,,,
C02796,3-Methyleneoxindole,,,,,
C02797,3-Oxo-5beta-steroid,Generic compound in reaction hierarchy,,,,
C02798,3-Phosphonopyruvate,,,,,
C02800,"4,5-Dioxopentanoate;|4-Oxoglutarate semialdehyde",,,,,
C02801,4-Aminobutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02801  4-Aminobutanoyl-CoA,
C02802,4-Fluorobenzoyl-CoA,,,,,
C02803,4-Nitroacetophenone;|p-Nitroacetophenone,,,,,
C02804,5-Hydroxypentanoate;|5-Hydroxypentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C02804  5-Hydroxypentanoic acid,
C02805,5-Oxoprolyl-peptide;|Pyroglutamyl-peptide;|Pyrrolidone-carboxylyl-peptide;|Pyrrolidone-carboxyl-peptide,Generic compound in reaction hierarchy,,,,
C02806,"8-Hydroxykaempferol;|Herbacetin;|3,4',5,7,8-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C02806  8-Hydroxykaempferol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C02806  8-Hydroxykaempferol,
C02807,"Acenaphthenequinone;|Acenaphthoquinone;|1,2-Diketoacenaphthene",,,,,
C02808,Acetylblasticidin S,,,,,
C02809,Albendazole S-oxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07106)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CA Benzimidazole derivatives|P02CA03 Albendazole|D07106  Albendazole oxide (INN)|Antimicrobials [BR:br08307(D07106)]|Antiparasitics|Antinematodal agents|Benzimidazole derivatives|D07106  Albendazole oxide (INN)",
C02810,Alditol 6-phosphate;|Hexitol 1-phosphate,Generic compound in reaction hierarchy|D-Mannitol 1-phosphate [CPD:C00644]|Sorbitol 6-phosphate [CPD:C01096]|D-Galactitol 6-phosphate [CPD:C06311],,,,
C02811,Anhydrotetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C02811  Anhydrotetracycline,
C02812,Ascorbate 2-sulfate,,,,,
C02814,"Benzene-1,2,4-triol;|Hydroxyhydroquinone;|1,2,4-Benzenetriol;|1,2,4-Trihydroxybenzene;|Hydroxyquinol",,,,,
C02816,Calmodulin L-lysine,Generic compound in reaction hierarchy,,,,
C02817,Chlordecone alcohol,,,,,
C02821,Cortisol 21-acetate;|Hydrocortisone acetate;|Cortell,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C02821  Cortisol 21-acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00165)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00165)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, Low Potency|Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP)|Inflammatory Bowel Disease Agents|Glucocorticoids|Hydrocortisone|D00165  Hydrocortisone acetate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00165)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00165  Hydrocortisone acetate (JP18/USP)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00165  Hydrocortisone acetate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00165)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Hydrocortisone acetate|D00165  Hydrocortisone acetate (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Hydrocortisone acetate|D00165  Hydrocortisone acetate (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C02821  Hydrocortisone acetate|Drug groups [BR:br08330(D00165)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D00165  Hydrocortisone acetate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D00165  Hydrocortisone acetate|Drug classes [BR:br08332(D00165)]|Anti-inflammatory|DG01955  Corticosteroid|D00165  Hydrocortisone acetate|Target-based classification of drugs [BR:br08310(D00165)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00165  Hydrocortisone acetate (JP18/USP) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00165)]|Chemicals|D00165  Hydrocortisone acetate|Drug metabolizing enzymes and transporters [br08309.html(D00165)]|Drug metabolizing enzymes|D00165|Rx-to-OTC switch list in the USA [br08315.html(D00165)]|D00165",
C02822,Cortisol 21-sulfate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C02822  Cortisol 21-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C02822  Cortisol 21-sulfate",
C02823,Cyanocobalamin;|Cyanocob(III)alamin;|Dicopac;|Vitamin B12 complex,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00166)]|B BLOOD AND BLOOD FORMING ORGANS|B03 ANTIANEMIC PREPARATIONS|B03B VITAMIN B12 AND FOLIC ACID|B03BA Vitamin B12 (cyanocobalamin and analogues)|B03BA01 Cyanocobalamin|D00166  Cyanocobalamin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00166)]|Electrolytes/Minerals/Metals/Vitamins|Vitamins|Cyanocobalamin|D00166  Cyanocobalamin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00166)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00166  Cyanocobalamin (JP18/USP/INN)|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3136  Vitamin B12 preparations|D00166  Cyanocobalamin (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00166)]|Agents for circulatory system and blood|24 Anemia drugs|D00166  Cyanocobalamin (JP18/USP/INN)|Nourishing tonics and health supplements|42 Vitamin B1B6B12 based drugs|D00166  Cyanocobalamin (JP18/USP/INN)|43 Vitamin containing supplements|D00166  Cyanocobalamin (JP18/USP/INN)|Agents for ophthalmologic use|62 General eye drops|D00166  Cyanocobalamin (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00166)]|Third-class OTC drugs|Inorganic and organic chemicals|Cyanocobalamin|D00166  Cyanocobalamin (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9623  Vitamin B and preparations (except vitamin B1 preparations)|C02823  Cyanocob(III)alamin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00166)]|Chemicals|D00166  Cyanocobalamin|D00166  Cyanocobalamin injection,
C02824,Cyclohexylsulfamate;|Cyclohexylsulfamic acid;|Cylamic acid;|Cyclohexylamide sulfate,,,,,
C02825,Cypridina luciferin,,,,,
C02827,D-Glucose 6-sulfate,,,,,
C02828,D-Phe-Pro-Arg-CH2Cl,,,,,
C02834,Heparin-glucosamine,,,,,
C02835,Imidazole-4-acetate;|Imidazoleacetic acid;|4-Imidazoleacetate,,,,,
C02837,"L-Lysine 1,6-lactam;|L-2-Aminohexano-6-lactam;|L-alpha-Aminocaprolactam;|(S)-2-Aminohexano-6-lactam",,,,,
C02838,L-Octanoylcarnitine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C02838  L-Octanoylcarnitine,
C02839,L-Tyrosyl-tRNA(Tyr),Generic compound in reaction hierarchy,,,,
C02843,Long-chain acyl-CoA;|Long-chain-fatty acyl-CoA,Generic compound in reaction hierarchy,,,,
C02845,Methyl ethyl ketone;|Ethyl methyl ketone;|2-Butanone;|Butan-2-one;|MEK,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C02845  Butan-2-one,
C02846,"N,N-Dimethylaniline;|Dimethylaminobenzene;|N,N-Dimethylbenzenamine",,,,,
C02847,N-Acetyl amino acid,,,,,
C02850,N-Acyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C02851,N-Acyl-L-citrulline,,,,,
C02852,N-Ethylglycocyamine,,,,,
C02853,N-Formyl amino acid,,,,,
C02854,N-Furfurylformamide,,,,,
C02855,N-Phospho-D-lombricine,,,,,
C02856,N3'-Acetylapramycin,,,,,
C02857,N3'-Acetylkanamycin,,,,,
C02858,N5-Acyl-L-ornithine,Generic compound in reaction hierarchy,,,,
C02860,N6-Alkylaminopurine,Generic compound in reaction hierarchy,,,,
C02862,O-Butanoylcarnitine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C02862  O-Butanoylcarnitine,
C02863,3-O-(alpha-D-Mannosyl)-L-serinyl-[protein];|O-D-Mannosylprotein,Generic compound in reaction hierarchy|3-O-(alpha-D-Mannosyl)-L-threonyl-[protein] [CPD:C20722],,,,
C02864,O-Demethylpuromycin,,,,,
C02866,O-Sinapoylglucarate,,,,,
C02867,Oligoribonucleotide,,,,,
C02868,Lecanoric acid;|Orsellinate depside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1308 Depsides and depsidones|C02868  Lecanoric acid,
C02871,Peptide L-aspartate,Generic compound in reaction hierarchy,,,,
C02872,Peptide diphthamide;|Diphthamide;|EF-2 diphthamide;|Elongation factor 2 diphthamide,Generic compound in reaction hierarchy|Modified histidine residue of elongation factor 2(EF-2),,,,
C02876,Propanoyl phosphate;|Propionyl phosphate,,,,,
C02879,Protoaphin aglucone;|Protoaphin aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C02879  Protoaphin aglucone,
C02880,Protochlorophyllide;|Protochlorophyllide a,,,,,
C02882,L-Cysteine-S-conjugate;|S-Aryl-L-cysteine,Generic compound in reaction hierarchy|R = aromatic group,,,,
C02884,Ribose triphosphate;|D-Ribose 5-triphosphate,,,,,
C02885,S-Alkyl thiosulfate,Generic compound in reaction hierarchy,,,,
C02886,S-Hexyl-glutathione;|S-Hexyl-L-glutathione,,,,,
C02887,Sinapoyl malate;|Sinapoyl-(S)-malate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C02887  Sinapoyl malate,
C02888,Sorbose 1-phosphate;|L-Sorbose 1P;|L-xylo-Hexulose 1-phosphate;|L-Sorbose 1-phosphate,,,,,
C02890,Tetrahydropalmatine;|(S)-Tetrahydropalmatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C02890  Tetrahydropalmatine,
C02892,Thiamine acetic acid;|Thiamin acetic acid,,,,,
C02893,Unsaturated alcohol,,,,,
C02894,Watasenia luciferin,,,,,
C02895,Xylitol 5-phosphate;|D-Xylitol 5-phosphate,,,,,
C02896,"alpha,omega-Diamine",Generic compound in reaction hierarchy,,,,
C02897,alpha-D-Arabinoside,,,,,
C02899,beta-Cyclopiazonate;|beta-Cyclopiazonic acid,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C02899  beta-Cyclopiazonate,
C02900,beta-D-Galactosyl-R,Generic compound in reaction hierarchy,,,,
C02903,omega-Aminoaldehyde,Generic compound in reaction hierarchy,,,,
C02904,"p-Menthane-3,8-diol;|(-)-3,8-p-Menthanediol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C02904  p-Menthane-3,8-diol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C02904  p-Menthane-3,8-diol",
C02905,Queuosine in tRNA(Asp),Generic compound in reaction hierarchy,,,,
C02906,Dihydromyricetin;|Ampelopsin;|(+)-Dihydromyricetin;|(+)-Ampelopsin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C02906  Dihydromyricetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C02906  Dihydromyricetin,
C02909,(2-Naphthyl)methanol;|2-Naphthalenemethanol;|2-Hydroxymethylnaphthalene,,,,,
C02912,"(R)-Propane-1,2-diol;|(R)-1,2-Propanediol;|(R)-Propylene glycol",,,,,
C02914,(S)-2-O-Sulfolactate,,,,,
C02915,(S)-cis-N-Methylcanadine,,,,,
C02916,(S)-Norlaudanosoline;|(S)-Tetrahydropapaveroline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C02916  (S)-Norlaudanosoline,
C02917,"(S)-Propane-1,2-diol;|(S)-1,2-Propanediol;|(S)-Propylene glycol",,,,,
C02918,1-Methylnicotinamide;|N(1)-Methylnicotinamide,,,,,
C02919,4-O-beta-D-Glucosyl-sinapate,,,,,
C02920,2'-Hydroxyformononetin;|2'-Hydroformononetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C02920  2'-Hydroxyformononetin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C02920  2'-Hydroxyformononetin,
C02921,2'-Hydroxyisoflavone,Generic compound in reaction hierarchy,,,,
C02922,2'-O-Methyllicodione,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C02922  2'-O-Methyllicodione,
C02923,"2,3-Dihydroxytoluene;|3-Methylcatechol",,,,,
C02924,"Dimercaprol;|2,3-Mercaptopropanol;|2,3-Dimercapto-1-propanol;|British anti-lewisite",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00167)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB09 Dimercaprol|D00167  Dimercaprol (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00167)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3923  Mercaptoacetates|D00167  Dimercaprol (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00167)]|Chemicals|D00167  Dimercaprol|D00167  Dimercaprol injection,
C02926,Homoserine lactone;|2-Aminobutan-4-olide,,,,,
C02927,2-Caffeoylisocitrate;|(E)-Caffeoylisocitrate,,,,,
C02928,2-Dehydro-D-xylonate,,,,,
C02929,2-Hydroxy carboxylate,Generic compound in reaction hierarchy,,,,
C02930,2-Methyleneglutarate;|alpha-Methylene glutarate;|2-Methylideneglutaric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C02930  2-Methylideneglutaric acid,
C02932,"3,4-Dihydroxypyridine",,,,,
C02933,"3,5-Dichlorocatechol",,,,,
C02934,3-Dehydrosphinganine;|3-Dehydro-D-sphinganine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0102 Sphinganines|C02934  3-Dehydrosphinganine,
C02937,Indole-3-acetaldehyde oxime;|Indole-3-acetaldoxime;|3-Indoleacetaldoxime;|(E)-Indol-3-ylacetaldoxime;|(Indol-3-yl)acetaldehyde oxime,,,,,
C02938,3-Indoleacetonitrile;|Indol-3-ylacetonitrile;|Indole-3-acetonitrile;|(Indol-3-yl)acetonitrile,,,,,
C02939,3-Methylbutanoyl-CoA;|Isovaleryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02939  3-Methylbutanoyl-CoA,
C02940,3-Oxo-5alpha-steroid,,,,,
C02941,3-Oxo-Delta1-steroid,Generic compound in reaction hierarchy,,,,
C02942,3-Oxo-hydroxysteroid,,,,,
C02943,3-Oxoglycyrrhetinate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C02943  3-Oxoglycyrrhetinate,
C02944,3-cis-Dodecenoyl-CoA;|3-cis-Dodecenoyl coenzyme A;|(3Z)-Dodecenoyl-CoA;|(3Z)-Dodec-3-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C02944  (3Z)-Dodecenoyl-CoA,
C02945,3beta-Hydroxysteroid,Generic compound in reaction hierarchy|3alpha-Hydroxysteroid [CPD:C03072],,,,
C02946,4-Acetamidobutanoate;|N4-Acetylaminobutanoate,,,,,
C02947,4-Coumaroylshikimate;|trans-5-O-(4-Coumaroyl)shikimate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C02947  4-Coumaroylshikimate,
C02948,4-Hydroxyhexan-3-one;|4-Hydroxy-3-hexanone;|Propioin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C02948  4-Hydroxyhexan-3-one,
C02949,4-Hydroxybenzoyl-CoA,,,,,
C02951,5-Hydroxyxanthotoxin,,,,,
C02952,"5-Oxo-1,2-campholide;|(+)-5-Oxo-1,2-campholide;|(1R,5R)-1,8,8-Trimethyl-2-oxabicyclo[3.2.1]octane-3,6-dione",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C02952  5-Oxo-1,2-campholide",
C02953,"7,8-Dihydrobiopterin;|L-erythro-7,8-Dihydrobiopterin",,,,,
C02954,6-Aminopenicillanate;|6-Aminopenicillanic acid,,,,,
C02956,7beta-Hydroxysteroid,Generic compound in reaction hierarchy,,,,
C02957,8-Oxodeoxycoformycin,,,,,
C02960,Ceramide 1-phosphate;|Ceramide phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0205 Ceramide 1-phosphates|C02960  Ceramide 1-phosphate,
C02961,Cytarabine;|Cytosine arabinoside;|Cytosine-1-beta-D-arabinofuranoside;|Ara-C,,,,"Glycosides [BR:br08021]|N-glycosides|C02961  Cytarabine|Prodrugs [br08324.html]|C02961|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00168)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC01 Cytarabine|D00168  Cytarabine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00168)]|Antineoplastics|Antimetabolites|Cytarabine|D00168  Cytarabine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00168)]|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4224  Cytosines|D00168  Cytarabine (JP18/USP/INN)|Drug groups [BR:br08330(D00168)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01439  Arabinofuranosyl type antineoplastic|DG00686  Cytarabine|D00168  Cytarabine|Drug classes [BR:br08332(D00168)]|Antineoplastic|DG02018  Antimetabolite|D00168  Cytarabine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00168)]|Chemicals|D00168  Cytarabine|New drug approvals in Europe [br08329.html(D00168)]|European public assessment reports (EPAR) authorised medicine|D00168|Prodrugs [br08324.html(D00168)]|D00168",
C02962,D-Allose 6-phosphate,,,,,
C02964,4-O-beta-D-Glucopyranosyl-D-mannose,,,,,G01630
C02965,D-Hexose 6-phosphate,Generic compound in reaction hierarchy,,,,
C02967,5-Methylcytosine in DNA;|DNA 5-methylcytosine;|DNA containing 5-methylcytosine,Generic compound in reaction hierarchy,,,,
C02970,"Decaprenol phosphate;|mono-trans, poly-cis-Decaprenyl phosphate;|trans,octacis-Decaprenyl phosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C02970  Decaprenol phosphate,
C02972,Dihydrolipoylprotein;|[H-protein]-dihydrolipoyllysine;|[GCSH]-N6-[(R)-dihydrolipoyl]-L-lysine;|[GcvH]-N6-[(R)-dihydrolipoyl]-L-lysine;|[Glycine cleavage system H]-N6-[(R)-dihydrolipoyl]-L-lysine,Generic compound in reaction hierarchy|The lipoyl-bearing H protein,,,,
C02975,Ethyl 3-oxohexanoate;|Ethyl butyrylacetate,,,,,
C02977,GDP-6-deoxy-D-talose;|GDP-6-deoxy-alpha-D-talose,,,,,
C02979,Glycerol 2-phosphate;|beta-Glycerophosphoric acid,,,,,
C02980,Hydroxyanthraquinone;|1-Hydroxyanthraquinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C02980  Hydroxyanthraquinone,
C02982,L-2-Hydroxyphytanate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C02982  L-2-Hydroxyphytanate,
C02983,Abrine;|L-Abrine;|N-Methyl-L-tryptophane,,,,,
C02984,L-Aspartyl-tRNA(Asp),Generic compound in reaction hierarchy,,,,
C02985,L-Fucose 1-phosphate;|6-Deoxy-L-galactose 1-phosphate;|beta-L-Fucose 1-phosphate,,,,,
C02986,L-Glutaminyl-peptide;|L-Glutaminyl-protein;|N-Terminal L-glutaminyl-[protein],Generic compound in reaction hierarchy,,,,
C02987,L-Glutamyl-tRNA(Glu),,,,,
C02988,L-Histidyl-tRNA(His),Generic compound in reaction hierarchy,,,,
C02989,L-Methionine S-oxide,,,,,
C02990,L-Palmitoylcarnitine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C02990  L-Palmitoylcarnitine,
C02991,"L-Rhamnono-1,4-lactone;|L-Rhamno-1,4-lactone",,,,,
C02992,L-Threonyl-tRNA(Thr),,,,,
C02993,Kyotorphin;|L-Tyrosyl-L-arginine,,,,,
C02994,"L-Xylono-1,4-lactone",,,,,
C02995,Maltose 6'-phosphate,,,,,G10519
C02996,Meclofenamate sodium;|Meclofenamic acid sodium salt,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08162)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AG Fenamates|M01AG04 Meclofenamic acid|D08162  Meclofenamate sodium|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA18 Meclofenamic acid|D08162  Meclofenamate sodium|Drug groups [BR:br08330(D08162)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01911  Anti-inflammatory drug, fenamic acid derivatives|DG00758  Meclofenamic acid|D08162  Meclofenamate sodium|Target-based classification of drugs [BR:br08310(D08162)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D08162  Meclofenamate sodium|PTGS2 (COX2)|D08162  Meclofenamate sodium",
C02997,N-Acetyl-L-histidine,,,,,
C02998,N-Acetylarylalkylamine;|N-Acetylaralkylamine,Generic compound in reaction hierarchy|R = arylalkyl group,,,,
C02999,N-Acetylmuramoyl-Ala;|N-Acetyl-D-muramoyl-L-alanine,,,,,
C03000,N-Acyl-D-glucosamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0101 Monoacylaminosugars|C03000  N-Acyl-D-glucosamine,
C03001,N-Benzoyl-D-arginine,,,,,
C03002,N-Caffeoylputrescine,,,,,
C03003,N-Glucosylnicotinate,,,,,
C03004,N-Hydroxy-L-tyrosine,,,,,
C03005,N-Methylanthranilate;|N-Methylanthranilic acid;|2-(Methylamino)benzoic acid,,,,,
C03007,1-(1-Oxopropyl)-1H-imidazole;|N-Propanoylimidazole;|N-Propionylimidazole,,,,,
C03010,N3'-Acetyltobramycin,,,,,
C03011,Nalpha-Acetylpeptide,Generic compound in reaction hierarchy,,,,
C03012,"Naphthalene-1,2-diol;|1,2-Naphthalenediol;|beta-Naphthohydroquinone;|1,2-Dihydroxynaphthalene",,,,,
C03015,O-Carbamoyl-L-serine,,,,,
C03016,O-Phosphotropomyosin;|Tropomyosin phosphoserine;|Phosphorylated tropomyosin,Generic compound in reaction hierarchy,,,,
C03017,O-Propanoylcarnitine;|O-Propionylcarnitine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C03017  O-Propanoylcarnitine,
C03018,Oligoglycosylglucose,,,,,G10545
C03019,Phorbol 13-butanoate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C03019  Phorbol 13-butanoate,
C03021,Protein asparagine;|Protein L-asparagine,Generic compound in reaction hierarchy,,,,
C03022,Protein L-citrulline,Generic compound in reaction hierarchy,,,,
C03023,Peptide-L-methionine,Generic compound in reaction hierarchy,,,,
C03027,Testosterone acetate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C03027  Testosterone acetate,
C03028,Thiamin triphosphate;|Thiamine triphosphate,,,,,
C03030,Uracil 5-carboxylate;|Uracil 5-carboxylic acid;|5-Carboxyuracil,,,,,
C03031,Uridine 2'-phosphate,,,,,
C03032,Cyclopiazonic acid;|alpha-Cyclopiazonate;|alpha-Cyclopiazonic acid;|CPA,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C03032  Cyclopiazonic acid|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C03032  Cyclopiazonic acid,
C03033,beta-D-Glucuronoside;|O-beta-D-Glucuronoside;|Glucuronide;|beta-D-Glucuronide,Generic compound in reaction hierarchy,,,,
C03034,dTDP-D-galacturonate,,,,,
C03035,"gamma-Linolenoyl-CoA;|(6Z,9Z,12Z)-Octadecatrienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03035  (6Z,9Z,12Z)-Octadecatrienoyl-CoA",
C03036,(+)-Bisdechlorogeodin,,,,,
C03037,"(+)-Bornane-2,5-dione;|(1R)-Bornane-2,5-dione;|2,5-Diketocamphane;|(1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptane-2,5-dione",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C03037  (+)-Bornane-2,5-dione",
C03039,(+)-trans-Piperitenol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C03039  (+)-trans-Piperitenol,
C03040,(-)-Bisdechlorogeodin,,,,,
C03042,(R)-2-Hydroxystearate;|(R)-2-Hydroxystearic acid;|(R)-2-Hydroxyoctadecanoate;|(R)-2-Hydroxyoctadecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03042  (R)-2-Hydroxyoctadecanoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C03042  (R)-2-Hydroxyoctadecanoic acid,
C03043,(R)-6-Hydroxynicotine,,,,,
C03044,"(R,R)-Butane-2,3-diol;|(R,R)-2,3-Butanediol;|(R,R)-2,3-Butylene glycol",,,,,
C03045,(S)-2-Hydroxystearate;|(S)-2-Hydroxystearic acid;|(S)-2-Hydroxyoctadecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03045  (S)-2-Hydroxyoctadecanoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C03045  (S)-2-Hydroxyoctadecanoic acid,
C03046,"(S,S)-Butane-2,3-diol;|(S,S)-2,3-Butanediol;|(S,S)-2,3-Butylene glycol;|(2S,3S)-Butane-2,3-diol",,,,,
C03047,"Arcaine;|1,4-Diguanidinobutane",,,,,
C03049,13-Hydroxydocosanoic acid;|13-Hydroxydocosanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03049  13-Hydroxydocosanoic acid,
C03050,16beta-Hydroxysteroid,Generic compound in reaction hierarchy,,,,
C03051,17beta-Hydroxysteroid,Generic compound in reaction hierarchy,,,,
C03052,"2,3-Dihydrogossypetin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C03052  2,3-Dihydrogossypetin",
C03056,"2,6-Dihydroxypyridine",,,,,
C03057,2-Carboxybenzaldehyde;|Phthalaldehydic acid;|o-Formylbenzoic acid;|2-Formylbenzoic acid;|2-Formylbenzoate,,,,,
C03058,2-Hydroxyglutaryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03058  2-Hydroxyglutaryl-CoA,
C03059,2-Hydroxymethylserine,,,,,
C03062,2-O-Caffeoylglucarate,,,,,
C03063,"2-Oxohept-3-enedioate;|2-Oxohept-3-ene-1,7-dioate",,,,,
C03064,3-Dehydro-L-threonate;|3-Dehydro-D-erythronate,,,,,
C03065,3-Guanidinopropanoate;|Guanidinopropionic acid,,,,Target-based classification of drugs [BR:br08310(D12779)]|Transporters|Solute carrier family|SLC6|SLC6A8|D12779  Ompenaclid (USAN/INN),
C03066,3-Hydroxy-L-glutamate;|3-Hydroxy-L-glutamic acid,,,,,
C03067,3-Hydroxybenzaldehyde,,,,,
C03068,3-Hydroxyhexobarbital,,,,,
C03069,3-Methylcrotonyl-CoA;|3-Methylbut-2-enoyl-CoA;|3-Methylcrotonoyl-CoA;|Dimethylacryloyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03069  3-Methylbut-2-enoyl-CoA,
C03070,3-Oxo-5beta-cholanate;|3-Oxo-5beta-cholan-24-oate,,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C03070  3-Oxo-5beta-cholanate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C03070  3-Oxo-5beta-cholanic acid",
C03071,3-aci-Nitropropanoate;|3-aci-Nitropropionic acid,,,,,
C03072,3alpha-Hydroxysteroid,Generic compound in reaction hierarchy|3beta-Hydroxysteroid [CPD:C02945],,,,
C03074,4'-Methoxyisoflavone;|4'-O-Methylisoflavone,Generic compound in reaction hierarchy,,,,
C03076,4-Bromophenylacetate;|4-Bromophenylacetic acid,,,,,
C03077,4-Chlorophenylacetate;|4-Chlorophenylacetic acid,,,,,
C03078,4-Guanidinobutanamide,,,,,
C03079,4-Hydroxy-L-glutamate;|4-Hydroxy-L-glutamic acid,Generic compound in reaction hierarchy,,,,
C03080,4-Hydroxyhydratropate,,,,,
C03081,4-Methylumbelliferone;|Hymecromone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00170)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05A BILE THERAPY|A05AX Other drugs for bile therapy|A05AX02 Hymecromone|D00170  Hymecromone (JP18/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00170)]|Chemicals|D00170  Hymecromone,
C03082,4-Phospho-L-aspartate;|L-4-Aspartyl phosphate,,,,,
C03083,4-Substituted anilide,,,,,
C03084,4-Substituted aniline,,,,,
C03085,5'-Acylphosphoinosine,,,,,
C03086,5'-Acylphosphouridine,,,,,
C03087,5-Acetamidopentanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C03087  5-Acetamidopentanoate,
C03088,5-Hydroxymethyluracil,,,,,
C03089,5-Methylthio-D-ribose;|S-Methyl-5-thio-D-ribose;|5-(Methylsulfanyl)-D-ribose,,,,,
C03090,5-Phosphoribosylamine;|5-Phospho-beta-D-ribosylamine;|5-Phospho-D-ribosylamine;|5-Phosphoribosyl-1-amine,,,,,
C03091,5beta-Cholestan-3-one;|Coprostan-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C03091  5beta-Cholestan-3-one,
C03092,"6-endo-Hydroxycineole;|2-endo-Hydroxy-1,8-cineole;|(1R,4S,6R)-1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octan-6-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C03092  6-endo-Hydroxycineole,
C03093,"7,8-Dihydroxycoumarin;|Daphnetin",,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C03093  7,8-Dihydroxycoumarin",
C03095,N-Aminoacyl-L-histidine,,,,,
C03097,Aryl beta-D-glucoside,Generic compound in reaction hierarchy,,,,
C03098,Benzyl isothiocyanate,,,,,
C03103,Cyclobutadipyrimidine;|Cyclobutadipyrimidine (in DNA),"Generic compound in reaction hierarchy|Thymine dimer [CPD:C17509], cytosine dimer or thymine-cytosine heterodimer",,,,
C03104,Cytidine 2'-phosphate;|2'-Cytidylic acid;|Cytidine 2'-monophosphate,,,,,
C03105,Cytochrome c L-lysine,Generic compound in reaction hierarchy,,,,
C03107,"D-Glucono-1,4-lactone",,,,,
C03108,D-Glucosylsphingosine,,,,,
C03109,D-Threose 4-phosphate,,,,,
C03110,DNA N4-methylcytosine,Generic compound in reaction hierarchy,,,,
C03112,Deacetylcephalosporin C,,,,,
C03113,Diisopropyl phosphate,,,,,
C03114,"Dimethylbenzimidazole;|5,6-Dimethylbenzimidazole",,,,,
C03115,Farnesyl triphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C03115  Farnesyl triphosphate,
C03117,GDP-6-deoxy-D-mannose;|GDP-D-rhamnose;|GDP-6-deoxy-alpha-D-mannose;|GDP-alpha-D-rhamnose,,,,,
C03120,Glycerophosphodiester,Generic compound in reaction hierarchy,,,,
C03124,beta-L-Aspartylhydroxamate,,,,,
C03125,L-Cysteinyl-tRNA(Cys),Generic compound in reaction hierarchy,,,,
C03126,L-Iduronate 2-sulfate,,,,,
C03127,L-Isoleucyl-tRNA(Ile),,,,,
C03129,Long-chain acid anion,,,,,
C03130,Lower primary alcohol,,,,,
C03134,"N,N-Dimethylformamide;|N,N-Dimethylmethanamide;|DMF",,,,,
C03135,N-Acetyl-D-amino acid,Generic compound in reaction hierarchy,,,,
C03136,N-Acetyl-D-hexosamine,Generic compound in reaction hierarchy,,,,
C03137,N-Acetyl-D-tryptophan,,,,,
C03139,N-Amidino-L-aspartate;|N-Amidino-L-aspartic acid;|Guanidinosuccinic acid,,,,,
C03140,N-Amidino-L-glutamate,,,,,
C03141,N-Benzoylanthranilate;|2-Benzoylaminobenzoic acid,,,,,
C03142,N-D-Glucosylarylamine,,,,,
C03145,N-Formylmethionine;|N-Formyl-L-methionine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C03145  N-Formylmethionine,
C03146,N-Glycolyl-D-glucosamine,,,,,
C03147,N-Malonylanthranilate,,,,,
C03148,N-Methyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C03149,N-Phosphotaurocyamine;|Taurocyamine phosphate;|N(omega)-Phosphotaurocyamine,,,,,
C03150,Nicotinamide-beta-riboside;|N-Ribosylnicotinamide;|1-(beta-D-Ribofuranosyl)nicotinamide,,,,,
C03151,N2-Acylated Arg-CH2Cl,,,,,
C03152,N2-Acylated Lys-CH2Cl,,,,,
C03153,N5-Methyl-L-glutamine,,,,,
C03154,N6'-Acetylkanamycin-B,,,,,
C03156,O-Feruloylgalactarate;|O-Feruloylgalactaric acid;|2'-(E)-O-Feruloylgalactaric acid,,,,,
C03160,2-Succinylbenzoyl-CoA;|o-Succinylbenzoyl-CoA;|Succinylbenzoyl-CoA;|4-(2-Carboxyphenyl)-4-oxobutanoyl-CoA,previously considered that the location of CoA was on the aromatic carboxyl group,,,,
C03164,"Phenanthrene-3,4-diol;|3,4-Dihydroxyphenanthrene",,,,,
C03166,Phosphoguanidinoacetate;|Guanidinoacetate phosphate,,,,,
C03167,Phosphonoacetaldehyde;|2-Phosphonoacetaldehyde;|2-Oxoethylphosphonate,,,,,
C03168,Poly(D-galactosamine),,,,,
C03169,Pyrimidine nucleoside;|N-D-Ribosylpyrimidine,Generic compound in reaction hierarchy,,,,
C03170,Trypanothione disulfide;|Oxidized trypanothione,,,,,
C03172,S-Methyl-L-methionine,,,,,
C03173,S-Methylthioglycolate;|(Methylsulfanyl)acetic acid;|(Methylthio)acetic acid;|(Methylsulfanyl)acetate,,,,,
C03174,S-Succinylglutathione,,,,,
C03175,Shikimate 3-phosphate;|Shikimate 5-phosphate,,,,,
C03176,Steroid hydroperoxide,,,,,
C03177,Streptamine phosphate,,,,,
C03178,Tetrahydroxypteridine,,,,,
C03183,Z-Gly-Pro-Leu-Gly-Pro;|Carbobenzoxyglycyl-prolyl-leucyl-glycyl-proline;|N-[(Phenylmethoxy)carbonyl]glycyl-L-prolyl-L-leucylglycyl-L-proline,,,,,
C03184,Zinc protoporphyrin-9;|Zinc protoporphyrin,,,,,
C03187,dTDP-6-deoxy-beta-L-talose;|dTDP-beta-L-pneumose,,,,,
C03188,omega-Carboxyacyl-CoA,Generic compound in reaction hierarchy,,,,
C03189,DL-Glycerol 1-phosphate;|Glycerol 1-phosphate;|Glycerol-3-phosphate;|rac-Glycerol 1-phosphate;|DL-Glyceryl 1-phosphate;|DL-Glycerol 3-phosphate,,,,,
C03190,(+)-Bornyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C03190  (+)-Bornyl-diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C03190  (+)-Bornyl-diphosphate,
C03193,(5-L-Glutamyl)-peptide,Generic compound in reaction hierarchy,,,,
C03194,(R)-1-Aminopropan-2-ol;|(R)-1-Amino-2-propanol,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C03194  Aminopropanol,
C03195,(R)-10-Hydroxystearate;|(R)-10-Hydroxystearic acid;|(R)-10-Hydroxyoctadecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C03195  (R)-10-Hydroxyoctadecanoic acid,
C03196,(S)-2-Hydroxyglutarate,,,,,
C03197,(S)-3-Hydroxybutanoate;|(S)-3-Hydroxybutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03197  (S)-3-Hydroxybutanoic acid,
C03198,(S)-4-Hydroxymandelate;|(S)-2-Hydroxy-2-(4-hydroxyphenyl)acetate;|L-4-Hydroxymandelate;|L-p-Hydroxymandelate,4-Hydroxymandelate [CPD:C11527],,,,
C03199,"1,2-Didecanoylglycerol;|1,2-Didecanoyl-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C03199  1,2-Didecanoyl-sn-glycerol",
C03200,"1,3-beta-D-Oligoglucan",,,,,
C03201,1-Alkyl-2-acylglycerol;|2-Acyl-1-alkyl-sn-glycerol,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0202 1-alkyl,2-acylglycerols|C03201  1-Alkyl-2-acyl-sn-glycerol",
C03203,1-Hydroxy-2-naphthoate;|1-Hydroxy-2-naphthoic acid;|1-Naphthol-2-carboxylic acid,,,,,
C03204,10-Formyldihydrofolate,,,,,
C03205,"11-Deoxycorticosterone;|Deoxycorticosterone;|Cortexone;|21-Hydroxy-4-pregnene-3,20-dione;|Desoxycortone;|DOC",,,,"Compounds with biological roles [BR:br08001]|Steroids|21-Carbon atoms|Pregnane derivatives|C03205  11-Deoxycorticosterone|Hormones and transmitters|Steroid hormones|Mineralocorticoids|C03205  11-Deoxycorticosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03205  11-Deoxycorticosterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07792)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AA Mineralocorticoids|H02AA03 Desoxycortone|D07792  Desoxycortone (INN)|Target-based classification of drugs [BR:br08310(D07792)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D07792  Desoxycortone (INN)",
C03206,"5a,11a-Dehydrotetracycline;|12-Dehydrotetracycline",,,,"Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C03206  5a,11a-Dehydrotetracycline",
C03207,"16-Dehydroprogesterone;|16,17-Didehydroprogesterone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03207  16-Dehydroprogesterone",
C03209,"2,2'-Dihydroxybiphenyl",,,,,
C03210,"Alanopine;|2,2'-Iminodipropanoate;|meso-N-(1-Carboxyethyl)-alanine",,,,,
C03212,"2,4-Dihydroxypteridine;|Lumazine;|Pteridine-2,4-dione;|2,4(3H,8H)-Pteridinedione",,,,,
C03214,2-Amino-3-oxobutanoate;|2-Amino-acetoacetate,,,,,
C03215,2-Carboxy-D-arabinitol,,,,,
C03217,2-Hydroxy-3-oxoadipate;|2-Hydroxy-3-oxoadipic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03217  2-Hydroxy-3-oxoadipic acid,
C03218,2-Methylaminoadenosine,,,,,
C03219,(E)-2-Methylpropanal oxime;|(E)-Isobutyraldehyde oxime;|(E)-Isobutanal oxime,,,,,
C03220,"(2Z,6E)-Farnesol;|2-cis,6-trans-Farnesol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C03220  2-cis,6-trans-Farnesol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C03220  2-cis,6-trans-Farnesol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C03220",
C03221,2-trans-Dodecenoyl-CoA;|(2E)-Dodec-2-enoyl-CoA;|(2E)-Dodecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03221  (2E)-Dodecenoyl-CoA,
C03223,"3,4-Dihydroxyphthalate;|3,4-Dihydroxyphthalic acid",,,,,
C03224,"3,5-Dibromo-L-tyrosine",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08659)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BX Other antithyroid preparations|H03BX02 Dibromotyrosine|D08659  3,5-Dibromo-L-tyrosine|Drug groups [BR:br08330(D08659)]|Hormonal agent|DG01934  Antithyroid agent|D08659  3,5-Dibromo-L-tyrosine",
C03225,"3,5-Dinitro-L-tyrosine",,,,,
C03226,3-Demethylubiquinone-9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C03226  3-Demethylubiquinone-9,
C03227,3-Hydroxy-L-kynurenine,,,,,
C03228,3-Hydroxycyclohexanone,,,,,
C03230,(Indol-3-yl)glycolaldehyde;|3-Indoleglycolaldehyde,,,,,
C03231,3-Methylglutaconyl-CoA;|trans-3-Methylglutaconyl-CoA;|(E)-3-Methylglutaconyl-1-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03231  (E)-3-Methylglutaconyl-1-CoA,
C03232,3-Phosphonooxypyruvate;|3-Phosphonooxypyruvic acid;|3-Phosphohydroxypyruvate;|3-Phosphohydroxypyruvic acid;|3-Phosphooxypyruvate,,,,,
C03233,"4,5-Dihydroxyphthalate;|4,5-Dihydroxyphthalic acid",,,,,
C03235,4-Hydroxypheoxyacetate,,,,,
C03236,5'-Phosphodinucleotide,,,,,
C03237,5-Hydroxypentanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03237  5-Hydroxypentanoyl-CoA,
C03238,5alpha-Cholestan-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C03238  5alpha-Cholestan-3-one,
C03239,6-Amino-2-oxohexanoate;|2-Oxo-6-aminocaproate,,,,,
C03240,6-Deoxyerythronolide B,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C03240  6-Deoxyerythronolide B,
C03241,6-Hydroxyhexan-6-olide;|6-Hydroxy-6-hexanolactone,,,,,
C03242,"Dihomo-gamma-linolenate;|Dihomo-gamma-linolenic acid;|(8Z,11Z,14Z)-Icosatrienoic acid;|(Z,Z,Z)-8,11,14-Eicosatrienoic acid;|(Z,Z,Z)-8,11,14-Icosatrienoic acid;|(Z,Z,Z)-8,11,14-Eicosatrienoate;|(Z,Z,Z)-8,11,14-Icosatrienoate;|8,11,14-Eicosatrienoate;|8,11,14-Icosatrienoate;|8Z,11Z,14Z-Eicosatrienoic acid;|(8Z,11Z,14Z)-Icosa-8,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C03242  (8Z,11Z,14Z)-Icosa-8,11,14-trienoic acid",
C03243,"9,10-Phenanthroquinone;|9,10-Phenanthrenedione;|Phenanthraquinone;|Phenanthrenequinone",,,,,
C03246,ADPribose 2'-phosphate,,,,,
C03248,Acetylenedicarboxylate;|Acetylenedicarboxylic acid;|2-Butynedioic acid,,,,,
C03251,Aldohexose 6-phosphate,,,,,
C03254,Aryl dialkyl phosphate,Generic compound in reaction hierarchy,,,,
C03256,Cetraxate benzyl ester,,,,,
C03263,Coproporphyrinogen III,,,,,
C03264,(R)-2-Hydroxyisocaproate;|D-2-Hydroxyisocaproate;|(R)-2-Hydroxy-4-methylpentanoate;|(2R)-2-Hydroxy-4-methylpentanoic acid;|D-Leucate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03264  (2R)-2-Hydroxy-4-methylpentanoic acid,
C03267,beta-D-Fructose 2-phosphate;|beta-D-Fructofuranose 2-phosphate,,,,,
C03268,D-Mannosylglycoprotein;|Glycoprotein D-mannose,Generic compound in reaction hierarchy,,,,
C03269,D-galacto-Hexodialdose,,,,,
C03272,"Globoside;|Globoside I;|N-Acetyl-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide;|N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00094)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0502 Galalpha1-4Galbeta1-4Glc- (Globo series)|G00094  GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer (Gb4Cer)|Blood groups and carbohydrate antigens [br08110.html(G00094)]|GLOB blood group|G00094,G00094
C03273,5-Oxopentanoate;|Glutarate semialdehyde;|5-Oxopentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C03273  5-Oxopentanoic acid,
C03274,Glycerophosphoglycerol,,,,,
C03277,Imidazol-5-yl-pyruvate;|3-(Imidazol-5-yl)pyruvate;|Imidazole pyruvate;|Imidazole pyruvic acid,,,,,
C03280,Inosine-5'-carboxylate,,,,,
C03281,Kanamycin A 3'-phosphate;|Kanamycin 3'-phosphate,,,,,
C03283,"L-2,4-Diaminobutanoate;|alpha,gamma-Diaminobutyrate;|L-2,4-Diaminobutyrate",,,,,
C03284,L-3-Aminoisobutanoate;|(S)-3-Aminoisobutyrate;|L-3-Aminoisobutyrate;|(S)-3-Aminoisobutanoate;|(S)-3-Amino-2-methylpropanoate;|(S)-beta-Aminoisobutyrate;|(S)-3-Aminoisobutyric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C03284  (S)-3-Aminoisobutyric acid,
C03287,L-Glutamyl 5-phosphate;|L-Glutamate 5-phosphate,,,,,
C03289,"L-xylo-Hexulonolactone;|L-xylo-Hex-2-ulono-1,4-lactone",,,,,
C03290,L-threo-3-Phenylserine,,,,,
C03291,L-Xylulose 5-phosphate,,,,,
C03292,Mercaptoacetyl-Phe-Leu,,,,,
C03294,N-Formylmethionyl-tRNA,Generic compound in reaction hierarchy,,,,
C03296,N2-Succinyl-L-arginine;|(2S)-2-(3-Carboxypropanoylamino)-5-(diaminomethylideneamino)pentanoic acid,,,,,
C03297,N3-Acetylgentamicin C;|3-N-Acetylgentamicin C;|N3'-Acetylgentamicin C,Generic compound in reaction hierarchy,,,,
C03298,Nalpha-Methylhistidine;|N-Methyl-L-histidine,,,,,
C03299,O-Decanoyl-L-carnitine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0707 Fatty acyl carnitines|C03299  O-Decanoyl-L-carnitine,
C03300,O-beta-D-Xylosylzeatin;|O-beta-D-Xyloxylzeatin,,,,,
C03303,[Peptide]-(2S)-2-hydroxyglycine;|Peptidylamidoglycolate;|Peptidyl(2-hydroxyglycine),Generic compound in reaction hierarchy,,,,
C03305,Prolyl-2-naphthylamide,,,,,
C03306,Protein L-isoaspartate,Generic compound in reaction hierarchy,,,,
C03309,Strictosidine aglycone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C03309  Strictosidine aglycone,
C03311,Thien-2-ylacetonitrile,,,,,
C03312,Urate D-ribonucleotide,,,,,
C03313,Phylloquinol;|Vitamin K1 hydroquinone;|Phytonadiol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C03313  Phylloquinol,
C03314,Xanthine-8-carboxylate,,,,,
C03315,[Dinitrogen reductase];|[Dinitrogen reductase]-L-arginine,Generic compound in reaction hierarchy|Dinitrogen reductase (ec 1.18.6.1) is inactivated by ADP-ribosylation.|See inactive form [CPD:C01253],,,,
C03317,alpha-Amino acid ester,Generic compound in reaction hierarchy,,,,
C03318,[alpha-Tubulin]-L-lysine,Generic compound in reaction hierarchy,,,,
C03319,dTDP-L-rhamnose;|dTDP-6-deoxy-L-mannose;|dTDP-6-deoxy-beta-L-mannose;|dTDP-beta-L-rhamnose,,,,,
C03323,"(2,1-beta-D-Fructosyl)n;|(2,1-beta-D-Fructosyl)n+1;|Inulin;|(1,2-beta-D-Fructosyl)n;|(1,2-beta-D-Fructosyl)m;|(1,2-beta-D-Fructosyl)n+1;|(1,2-beta-D-Fructosyl)m-1",,,,"Therapeutic category of drugs in Japan [BR:br08301(D00171)]|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|722  Various function testing reagents|7225  Diagnostic reagents for renal function|D00171  Inulin (JAN/USP)|New drug approvals in Japan [br08318.html(D00171)]|Drugs with new active ingredients|D00171|New drug approvals in the USA, Europe and Japan [br08328.html(D00171)]|Approval dates by FDA, EMA and PMDA|D00171",G10497
C03325,(6S)-Hydroxyhyoscyamine;|(6S)-6-Hydroxyhyoscyamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C03325  (6S)-Hydroxyhyoscyamine,
C03326,(Ac)2-L-Lys-D-Ala-D-Ala;|(Ac)2-L-lysyl-D-alanyl-D-alanine,,,,,
C03328,(R)-2-(n-Propyl)-malate,,,,,
C03329,"(S)-Canadine;|(S)-Tetrahydroberberine;|(13aS)-5,8,13,13a-Tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine;|(-)-Canadine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C03329  (S)-Canadine,
C03338,"2,3,5-Trihydroxytoluene",,,,,
C03339,"2,3-Bisphosphoglycerate;|2,3-Diphosphoglycerate;|Greenwald ester",,,,,
C03340,"L-2,3-Dihydrodipicolinate;|Dihydrodipicolinic acid;|Dihydrodipicolinate;|2,3-Dihydrodipicolinate;|(S)-2,3-Dihydropyridine-2,6-dicarboxylate",,,,,
C03341,2-Amino-4-oxopentanoic acid;|2-Amino-4-oxopentanoate;|(2R)-2-Amino-4-oxopentanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C03341  2-Amino-4-oxopentanoic acid,
C03342,2-Dehydro-D-galactonate,D-Galactonate [CPD:C00880],,,,
C03343,Mono-(2-ethylhexyl)phthalate;|2-Ethylhexyl phthalate,,,,,
C03344,2-Methylacetoacetyl-CoA;|2-Methyl-3-acetoacetyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03344  2-Methylacetoacetyl-CoA,
C03345,2-Methylbut-2-enoyl-CoA;|trans-2-Methylbut-2-enoyl-CoA;|(E)-2-Methylbut-2-enoyl-CoA;|Tiglyl-CoA;|(E)-2-Methylcrotonoyl-CoA;|Methylcrotonoyl-CoA;|Methylcrotonyl-CoA;|Tigloyl-CoA;|2-Methylcrotanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03345  (E)-2-Methylbut-2-enoyl-CoA,
C03347,"3,5-Dichloro-L-tyrosine",,,,,
C03348,"3,6-Dideoxy-L-galactose;|Colitose;|3,6-Dideoxy-L-xylo-hexose",,,,,
C03349,3-Aminopropanesulfonate;|3-Amino-1-propanesulfonic acid,,,,,
C03351,3-Hydroxybenzyl alcohol;|3-Hydroxybenzenemethanol,,,,,
C03352,3-Methoxybenzyl alcohol;|3-Anise alcohol;|3-Anisyl alcohol,,,,,
C03354,3-Methylthiopropanamine;|3-Methylthiopropylamine;|3-(Methylsulfanyl)propanamine,,,,,
C03356,3-Phospho-D-erythronate,,,,,
C03357,4-Acetamidobutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03357  4-Acetamidobutanoyl-CoA,
C03359,4-Chloro-2-methylphenol,,,,,
C03360,4-Nitrophenyl phosphate,,,,,
C03361,5'-Acylphosphoadenosine,,,,,
C03363,5-L-Glutamyl amino acid;|L-gamma-Glutamyl amino acid,Generic compound in reaction hierarchy,,,,
C03365,5-O-Methyl-myo-inositol;|1D-5-O-Methyl-myo-inositol;|Sequoyitol,,,,,
C03366,5-Phosphooxy-L-lysine;|(5R)-5-Phosphooxy-L-lysine;|5-Phosphonooxy-L-lysine;|O-Phosphohydroxy-L-lysine;|(5R)-5-Phosphonooxy-L-lysine,,,,,
C03367,6-alpha-Maltosylglucose,,,,,
C03368,7''-O-Phosphohygromycin,,,,,
C03371,[Protein]-S-(long-chain-acyl)-L-cysteine,Generic compound in reaction hierarchy,,,,
C03372,Acylglycerone phosphate;|Dihydroxyacetone phosphate acyl ester;|1-Acyl-glycerone 3-phosphate,,,,,
C03373,Aminoimidazole ribotide;|AIR;|1-(5'-Phosphoribosyl)-5-aminoimidazole;|5'-Phosphoribosyl-5-aminoimidazole;|1-(5-Phospho-D-ribosyl)-5-aminoimidazole;|5-Amino-1-(5-phospho-D-ribosyl)imidazole;|5-Amino-1-(5-phospho-beta-D-ribosyl)imidazole,,,,,
C03374,Bilirubin-glucuronoside;|Bilirubin monoglucuronide,,,,,
C03375,"Norspermidine;|Bis(3-aminopropyl)amine;|3,3'-Iminobispropylamine",,,,,
C03383,"D-Galactono-1,4-lactone;|gamma-D-Galactonolactone",,,,,
C03384,D-Galactose 1-phosphate,,,,,
C03387,"D-Glucurono-6,2-lactone",,,,,
C03391,DNA 6-methylaminopurine;|N6-Methyladenine in DNA,Generic compound in reaction hierarchy,,,,
C03392,Dimethylsulfonioacetate,,,,,
C03393,4-Phospho-D-erythronate;|4-Phosphoerythronate,,,,,
C03394,Erythrulose 1-phosphate;|L-Erythrulose 1-phosphate,,,,,
C03395,Fatty acid methyl ester,Generic compound in reaction hierarchy,,,,
C03400,Glycoside of aldohexose,,,,,
C03401,"L-2,3-Diaminopropanoate;|L-2,3-Diaminopropionate;|L-2,3-Diaminopropionic acid;|L-2,3-Diaminopropanoic acid;|3-Amino-L-alanine;|(S)-2,3-Diaminopropanoate;|(2S)-2,3-Diaminopropanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C03401  (2S)-2,3-Diaminopropanoic acid",
C03402,L-Asparaginyl-tRNA(Asn);|Asn-tRNA(Asn);|Asparaginyl-tRNA(Asn),,,,,
C03404,L-Tyrosine methyl ester,,,,,
C03405,Lactosylceramide sulfate;|SM3,,,,Lipids [BR:br08002(G10258)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|G10258  S-3Gal-beta1->4Glc-beta1->1'Cer (SM3)|Lipids [BR:br08002]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|C03405  Lactosylceramide sulfate,G10258
C03406,N-(L-Arginino)succinate;|2-(Nomega-L-Arginino)succinate;|L-Argininosuccinate;|L-Argininosuccinic acid;|L-Arginosuccinic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C03406  L-Argininosuccinate,
C03408,N-acetyl-D-galactosaminate,,,,,
C03409,N-Formimino-L-aspartate;|N-Formimidoyl-L-aspartate,,,,,
C03410,N-Glycoloyl-neuraminate;|N-Glycolylneuraminate;|Neu5Gc,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C03410  N-Glycoloyl-neuraminate,
C03411,N-Glycosyl-L-asparagine,,,,,
C03413,"N1,N12-Diacetylspermine",,,,,
C03414,N2-Malonyl-D-tryptophan,,,,,
C03415,N2-Succinyl-L-ornithine;|(2S)-5-Amino-2-(3-carboxypropanoylamino)pentanoic acid,,,,,
C03416,"N6,N6-Dimethyladenosine",,,,,
C03417,N(omega)-Nitro-L-arginine;|N(G)-Nitro-L-arginine,,,,,
C03418,Nucleoside 2'-phosphate,Generic compound in reaction hierarchy,,,,
C03419,Nucleoside 3'-phosphate,Generic compound in reaction hierarchy,,,,
C03422,O-Palmitoylglycoprotein,Generic compound in reaction hierarchy,,,,
C03423,O-beta-D-Glucosylzeatin;|O-beta-D-Glucosyl-trans-zeatin;|trans-Zeatin-O-glucoside,,,,,
C03425,Oleic acid methyl ester;|Methyl oleate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C03425  Methyl oleate,
C03427,Prephytoene diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C03427  Prephytoene diphosphate,
C03428,Presqualene diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C03428  Presqualene diphosphate,
C03429,Protein 5-hydroxylysine,,,,,
C03431,S-Inosyl-L-homocysteine,,,,,
C03433,Streptamine 4-phosphate,,,,,
C03434,"Tetrachlorohydroquinone;|2,3,5,6-Tetrachlorohydroquinone",,,,,
C03437,beta-D-Fructofuranoside,,,,,
C03438,beta-Lactam antibiotics,,,,,
C03440,cis-4-Hydroxy-D-proline,,,,,
C03442,dTDP-L-dihydrostreptose,,,,,
C03444,p-Chloromercuribenzoate;|p-Chloromercuribenzoic acid;|PCMB,,,,,
C03446,tRNA containing ribothymidine at position 54;|tRNA TpsiC,"ribothymidine (T) at position 54, pseudouridine (psi) at position 55 and cytidine (C) at position 56|Generic compound in reaction hierarchy",,,,
C03448,"(+)-exo-5-Hydroxycamphor;|5-exo-Hydroxycamphor;|(1R,4R,5R)-5-Hydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C03448  (+)-exo-5-Hydroxycamphor,
C03450,(3-Arylcarbonyl)-alanine,,,,,
C03451,(R)-S-Lactoylglutathione;|S-D-Lactoylglutathione,,,,,
C03453,gamma-Oxalocrotonate;|(Z)-5-Oxohex-2-enedioate;|4-Oxalocrotonate;|(2Z)-5-Oxohex-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C03453  (2Z)-5-Oxohex-2-enedioic acid,
C03454,1-Alkenyl-2-acylglycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0204 1Z-alkenylacylglycerols|C03454  1-Alkenyl-2-acyl-sn-glycerol,
C03455,11-cis-Retinyl palmitate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C03455  11-cis-Retinyl palmitate,
C03456,2''-Nucleotidylkanamycin,,,,,
C03457,2''-Nucleotidylsisomicin,,,,,
C03458,"2,3,6-Trihydroxypyridine",,,,,
C03459,2-Hydroxy-3-oxosuccinate;|Oxaloglycolate,,,,,
C03460,2-Methylprop-2-enoyl-CoA;|Methacrylyl-CoA;|Methylacrylyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03460  2-Methylprop-2-enoyl-CoA,
C03461,"2-trans,6-trans-Farnesal;|trans,trans-Farnesal;|Farnesal;|(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienal;|(2E,6E)-Farnesal",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C03461  2-trans,6-trans-Farnesal|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C03461  2-trans,6-trans-Farnesal",
C03462,3''-Adenylylstreptomycin,,,,,
C03463,3'-Phosphopolynucleotide,Generic compound in reaction hierarchy,,,,
C03465,3-Methyl-2-oxopentanoate;|2-Oxo-3-methylvalerate,,,,,
C03466,3-Methylbut-3-enoyl-CoA;|3-Methyl-vinylacetyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03466  3-Methylbut-3-enoyl-CoA,
C03467,beta-Ketoisocaproate;|beta-Ketoisocaproic acid;|3-Oxo-4-methylpentanoate;|4-Methyl-3-oxopentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C03467  3-Oxo-4-methylpentanoic acid,
C03470,3-alpha(S)-Strictosidine;|Strictosidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C03470  3-alpha(S)-Strictosidine,
C03473,1-(p-Hydroxyphenyl)ethylamine,,,,,
C03474,4-Nitroquinoline N-oxide;|4-Nitroquinoline 1-oxide;|Nitrochin,,,,,
C03475,5'-Phosphopolynucleotide,Generic compound in reaction hierarchy,,,,
C03476,"5,12-Dihydroxanthommatin",,,,,
C03479,"Folinic acid;|Leucovorin;|5-Formyltetrahydrofolate;|L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid",,,,,
C03483,Adenosine tetraphosphate;|Adenosine 5'-tetraphosphate,,,,,
C03485,Aromatic primary alcohol;|Aromatic alcohol,Generic compound in reaction hierarchy,,,,
C03486,CDP-N-methylethanolamine,,,,,
C03492,D-4'-Phosphopantothenate;|(R)-4'-Phosphopantothenate,,,,,
C03493,D-4-Hydroxyphenylglycine;|(alphaR)-alpha-Amino-4-hydroxybenzeneacetic acid,,,,,
C03494,D-Erythritol 4-phosphate;|L-Erythritol 1-phosphate,,,,,
C03495,Deoxy-5-methylcytidylate;|5-Methyldeoxycytidine 5'-phosphate,,,,,
C03497,Ester of phosphinic acid,,,,,
C03498,Ester of phosphonic acid,,,,,
C03499,Ethyl (R)-3-hydroxybutanoate,,,,,
C03500,Ethyl 3-oxobutanoate;|Ethyl acetoacetate,,,,,
C03502,Flavonol 3-O-D-galactoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C03502  Flavonol 3-O-D-galactoside,
C03503,Glucosyloxyanthraquinone,,,,Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C03503  Glucosyloxyanthraquinone,
C03505,Hydroxyacetone phosphate;|Acetol phosphate,,,,,
C03506,"Indoleglycerol phosphate;|1-C-(Indol-3-yl)glycerol 3-phosphate;|(3-Indolyl)-glycerol phosphate;|C1-(3-Indolyl)-glycerol 3-phosphate;|(1S,2R)-1-C-(Indol-3-yl)glycerol 3-phosphate;|Indole-3-glycerol phosphate",,,,,
C03508,L-2-Amino-3-oxobutanoic acid;|L-2-Amino-3-oxobutanoate;|L-2-Amino-acetoacetate;|(S)-2-Amino-3-oxobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C03508  L-2-Amino-3-oxobutanoic acid,
C03509,L-Arabinitol 5-phosphate,,,,,
C03510,L-Methionine sulfoximine;|(2S)-2-Amino-4-(S-methylsufonimidoyl)-butanoic acid,,,,,
C03511,L-Phenylalanyl-tRNA(Phe),Generic compound in reaction hierarchy,,,,
C03512,L-Tryptophanyl-tRNA(Trp),Generic compound in reaction hierarchy,,,,
C03514,Limonin;|Evodin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C03514  Limonin,
C03515,Luteolin 7-O-glucuronide;|Luteolin 7-O-beta-D-glucuronide,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C03515  Luteolin 7-O-glucuronide|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C03515  Luteolin 7-O-glucuronide|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C03515  Luteolin 7-O-glucuronide|Dietary phytochemicals [br08012.html]|Flavonoids|C03515,
C03516,Magnesium protoporphyrin;|Magnesium protoporphyrin IX;|Mg-protoporphyrin IX,,,,,
C03517,Monoterpenyl diphosphate,Generic compound in reaction hierarchy|R = monoterpenyl group,,,,
C03518,N-Acetyl-beta-D-glucosaminide;|N-Acetyl-beta-D-glucosaminyl-R,Generic compound in reaction hierarchy,,,,
C03519,N-Acetyl-L-phenylalanine,,,,,
C03521,Glycolyl-D-mannosamine;|N-Glycolyl-D-mannosamine,,,,,
C03522,N-Methyl-4-aminobenzoate,,,,,
C03523,N-Substituted amino acid,Generic compound in reaction hierarchy,,,,
C03524,N2'-Acetylgentamicin C1a,,,,,
C03525,O-Acetylneuraminic acid;|O-Acetylated sialic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C03525  O-Acetylneuraminic acid,
C03526,O-Sinapoylglucarolactone,,,,,
C03527,Oxidized Latia luciferin,,,,,
C03529,Peptide formylkynurenine,Generic compound in reaction hierarchy,,,,
C03531,[Protein]-(S)-2-amino-6-oxohexanoate,Generic compound in reaction hierarchy,,,,
C03535,Polysulfate of cellulose,,,,,
C03536,Pyrimidine 5'-nucleotide,Generic compound in reaction hierarchy,,,,
C03537,S-Acetylthioethanolamine,,,,,
C03539,S-Ribosyl-L-homocysteine;|S-D-Ribosyl-L-homocysteine;|Ribose-5-S-homocysteine;|S-Ribosylhomocysteine;|S-(5-Deoxy-D-ribos-5-yl)-L-homocysteine,,,,,
C03541,THF-polyglutamate;|Tetrahydropteroyl-[gamma-Glu]n;|Tetrahydrofolyl-[Glu](n-1);|(6S)-H4PteGlu(n);|Tetrahydropteroyl-[gamma-Glu]n+1;|Tetrahydrofolyl-[Glu](n),(6S)-H4PteGlu2 (n=2) [CPD:C09332]|(6S)-H4PteGlu3 (n=3) [CPD:C04144],,,,
C03546,myo-Inositol 4-phosphate;|D-myo-Inositol 4-phosphate;|1D-myo-Inositol 4-phosphate;|1D-myo-Inositol 4-monophosphate;|Inositol 4-phosphate,,,,,
C03547,omega-Hydroxy fatty acid,,,,,
C03548,"trans-2,3-Epoxysuccinate",Relative configuration (including both enantiomers),,,,
C03557,2-Aminoethylphosphonate;|(2-Aminoethyl)phosphonate;|Ciliatine,,,,,
C03561,(R)-3-Hydroxybutanoyl-CoA;|(3R)-3-Hydroxybutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03561  (R)-3-Hydroxybutanoyl-CoA,
C03564,1-Pyrroline-2-carboxylate;|1-Pyrroline-2-carboxylic acid;|Delta1-Pyrroline 2-carboxylate;|1-Pyrroline 2-carboxylate,,,,,
C03566,2''-Nucleotidyltobramycin,,,,,
C03567,"2'-Hydroxydihydrodaidzein;|2'-Hydroxy-2,3-dihydrodaidzein",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C03567  2'-Hydroxydihydrodaidzein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C03567  2'-Hydroxydihydrodaidzein,
C03568,2'-Phosphoadenylylsulfate,,,,,
C03569,"2,2',3-Trihydroxybiphenyl",,,,,
C03570,D-Mannosamine;|2-Amino-2-deoxy-D-mannose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C03570  D-Mannosamine,
C03571,2-Amino-2-methylbutanoate,,,,,
C03572,"2-Chloro-cis,cis-muconate",,,,,
C03573,2-Deoxy-alpha-D-glucoside,Generic compound in reaction hierarchy,,,,
C03574,2-Formylaminobenzaldehyde,,,,,
C03575,2-Iodophenol methyl ether,,,,,
C03576,Coenzyme M;|2-Mercaptoethanesulfonate;|Reduced coenzyme M;|HS-CoM;|CoM,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C03576  Coenzyme M,
C03577,20-Hydroxyleukotriene E4;|20-OH-LTE4;|20-OH-Leukotriene E4,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C03577  20-Hydroxy-leukotriene E4,
C03579,Gibberellin A8;|2beta-Hydroxygibberellin 1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C03579  Gibberellin A8|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C03579  Gibberellin A8,
C03580,3''-Adenylylspectinomycin,,,,,
C03582,"Resveratrol;|3,4',5-Trihydroxystilbene;|trans-Resveratrol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C03582  3,4',5-Trihydroxystilbene|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C03582  Resveratrol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C03582|Dietary phytochemicals [br08012.html]|Other phytochemicals|C03582",
C03584,3-(Uracil-1-yl)-L-alanine;|Willardiine,,,,,
C03585,"3-Chloro-cis,cis-muconate;|(2E,4Z)-3-Chlorohexa-2,4-dienedioate;|3-Chloro-cis,cis-muconic acid;|(2E,4Z)-3-Chlorohexa-2,4-dienedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C03585  3-Chloro-cis,cis-muconic acid",
C03586,"2-Oxo-2,3-dihydrofuran-5-acetate;|3-Oxoadipate enol-lactone;|4,5-Dihydro-5-oxofuran-2-acetate;|5-Oxo-4,5-dihydrofuran-2-acetate",,,,,
C03587,3beta-Hydroxysteroid ester,Generic compound in reaction hierarchy,,,,
C03588,"4,5alpha-Dihydrocortisone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03588  4,5alpha-Dihydrocortisone",
C03589,4-Hydroxy-2-oxopentanoate;|4-Hydroxy-2-oxovalerate,,,,,
C03590,4-Hydroxyphenylglyoxylate;|4-Hydroxybenzoylformate;|4-Hydroxyphenylglyoxylic acid;|2-(4-Hydroxyphenyl)-2-oxoacetate,,,,,
C03591,5-Chloro-3-methylcatechol,,,,,
C03592,5-Methyl-2'-deoxycytidine,,,,,
C03594,"7alpha-Hydroxycholesterol;|Cholest-5-ene-3beta,7alpha-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C03594  7alpha-Hydroxycholesterol,
C03595,"8,11,14-Eicosatrienoyl-CoA;|8,11,14-Icosatrienoyl-CoA;|(8Z,11Z,14Z)-Icosatrienoyl-CoA;|(8Z,11Z,14Z)-Icosa-8,11,14-trienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03595  (8Z,11Z,14Z)-Icosatrienoyl-CoA",
C03598,"CDP-3,6-dideoxy-D-glucose;|CDP-paratose;|CDP-alpha-D-paratose;|CDP-3,6-dideoxy-alpha-D-ribo-hexose",,,,,
C03599,"CDP-3,6-dideoxy-D-mannose;|CDP-tyvelose;|CDP-alpha-D-tyvelose;|CDP-3,6-dideoxy-alpha-D-arabino-hexose",,,,,
C03600,Carboxymethyloxysuccinate;|(Carboxymethoxy) succinic acid,,,,,
C03601,Chloramphenicol 3-acetate,,,,,
C03604,D-Erythrulose 4-phosphate,,,,,
C03606,D-Hamamelose 2(1)-phosphate,,,,,
C03611,Galactose oligosaccharide,,,,,
C03614,Inosine 5'-tetraphosphate,,,,,
C03617,L-Methionylaminoacyl-tRNA,Generic compound in reaction hierarchy,,,,
C03618,"L-threo-3-Methylaspartate;|(2S,3S)-3-Methylaspartate",,,,,
C03619,Methyl beta-D-galactoside;|Methyl beta-D-galactopyranoside,,,,,
C03620,Monocarboxylic acid amide,Generic compound in reaction hierarchy,,,,
C03621,N-Acetoxy-4-aminobiphenyl,,,,,
C03622,N-Hydroxy-4-aminobiphenyl,,,,,
C03623,N-Methyl-2-oxoglutaramate;|N-Methyl-2-oxoglutaramic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C03623  N-Methyl-2-oxoglutaramic acid,
C03624,N-Phosphohypotaurocyamine;|N(omega)-Phosphohypotaurocyamine,,,,,
C03625,N5-Acyl-L-ornithine ester,Generic compound in reaction hierarchy,,,,
C03626,"NG,NG-Dimethyl-L-arginine;|N,N-Dimethylarginine;|Nomega,Nomega-Dimethyl-L-arginine;|ADMA",,,,,
C03629,O-Phosphorylhydroxylamine;|O-Phosphonohydroxylamine,,,,,
C03630,Oleoylglycerone phosphate,,,,,
C03631,Oleoylphosphatidylcholine,,,,,
C03632,Oligosaccharide phosphate,Generic compound in reaction hierarchy,,,,
C03633,Peptidylproline (omega=0),Generic compound in reaction hierarchy,,,,
C03634,"Phorbol 12,13-dibutanoate;|Phorbol-12,13-dibutyrate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C03634  Phorbol 12,13-dibutanoate",
C03636,Protein N5-alkylglutamine,,,,,
C03637,Protein serine D-xyloside,,,,,
C03638,RNA 3'-terminal-phosphate,Generic compound in reaction hierarchy,,,,
C03640,Sphingosyl-phosphocholine;|Sphingosine-1-phosphocholine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0106 Lysosphingomyelins and lysoglycosphingolipids|C03640  Sphingosyl-phosphocholine,
C03641,Sterol 3-beta-D-glucoside,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C03641  Sterol 3-beta-D-glucoside,
C03642,Taurolithocholate sulfate;|3alpha-Sulfatolithocholyltaurine;|Taurolithocholic acid 3-sulfate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C03642  Taurolithocholate sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C03642  Taurolithocholate sulfate|ST0504 Taurine conjugates|C03642  Taurolithocholate sulfate",
C03645,alpha-L-Arabinofuranoside,,,,,
C03646,Bis-gamma-glutamylcystine;|Oxidized gamma-glutamylcysteine;|Bis-gamma-L-glutamyl-L-cystine;|Oxidized gamma-L-glutamyl-L-cysteine,,,,,
C03647,"cis,trans-Hexadienedioate",,,,,
C03648,"cis-3,4-Leucopelargonidin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C03648  cis-3,4-Leucopelargonidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3,4-diols|C03648  cis-3,4-Leucopelargonidin",
C03649,gamma-L-Glutamyl-acceptor,Generic compound in reaction hierarchy,,,,
C03651,trans-4-Hydroxy-D-proline,,,,,
C03652,"(2R,3S)-2,3-Dimethylmalate",,,,,
C03654,"(3S,4R)-Ketose 1-phosphate",,,,,
C03656,(S)-5-Amino-3-oxohexanoic acid;|(S)-5-Amino-3-oxohexanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C03656  (5S)-5-Amino-3-oxohexanoic acid,
C03657,"1,4-Dihydroxy-2-naphthoate;|1,4-Dihydroxy-2-naphthoic acid",,,,,
C03658,1-Hydroxyalkyl-sn-glycerol;|1-O-(1-Hydroxyalkyl)-sn-glycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0102 Monoalkylglycerols|C03658  1-O-(1-Hydroxyalkyl)-sn-glycerol,
C03659,D-Bornesitol;|(-)-Bornesitol;|1-O-Methyl-myo-inositol;|1D-1-O-Methyl-myo-inositol,"formerly called ""3-O-Methyl-myo-inositol"" on old nomenclature system of numbering",,,,
C03660,L-Bornesitol;|(+)-Bornesitol;|3-O-Methyl-myo-inositol;|1D-3-O-Methyl-myo-inositol,"formerly called ""1-O-Methyl-myo-inositol"" on old nomenclature system of numbering",,,,
C03661,1F-beta-D-Fructosylsucrose;|beta-D-Fructofuranosyl-(2->1)-beta-D-fructofuranosyl alpha-D-glucopyranoside;|1-Kestose,,,,,G02515
C03662,2'-Hydroxypseudobaptigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C03662  2'-Hydroxypseudobaptigenin,
C03663,"2',4'-Dihydroxyacetophenone;|2,4-Dihydroxyacetophenone;|Resacetophenone",,,,,
C03664,"2,4-Dichlorophenoxyacetate;|2,4-Dichlorophenoxyacetic acid;|2,4-D",,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Phenoxy herbicides|C03664  2,4-Dichlorophenoxyacetate|Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C03664  2,4-Dichlorophenoxyacetate",
C03665,2-Amino-2-methylpropanoate;|2-Aminoisobutyric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C03665  2-Aminoisobutyric acid,
C03666,"2-Carboxy-cis,cis-muconate;|2-Carboxy-cis,cis-muconic acid;|(3Z)-Buta-1,3-diene-1,1,4-tricarboxylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C03666  (3Z)-Buta-1,3-diene-1,1,4-tricarboxylic acid",
C03667,2-Hydroxycarbonyl compound,Generic compound in reaction hierarchy,,,,
C03668,2-Hydroxydicarboxylic acid,,,,,
C03671,"2-Pyrone-4,6-dicarboxylate",,,,,
C03672,3-(4-Hydroxyphenyl)lactate;|4-Hydroxyphenyllactate;|p-Hydroxyphenyllactate;|2-Hydroxy-3-(4-hydroxyphenyl)propanoate,,,,,
C03673,3-(ADP)-2-phosphoglycerate,,,,,
C03674,3-Carbamoyloxymethylcephem,Generic compound in reaction hierarchy,,,,
C03676,"3-Hydroxy-cis,cis-muconate;|(2E,4Z)-3-Hydroxyhexa-2,4-dienedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C03676  (2E,4Z)-3-Hydroxyhexa-2,4-dienedioic acid",
C03677,"4,21-Dehydrogeissoschizine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C03677  4,21-Dehydrogeissoschizine",
C03678,4-Amino-3-hydroxybutanoate;|4-Amino-3-hydroxybutanoic acid;|gamma-Amino-beta-hydroxybutyric acid;|GABOB,,,,,
C03679,4-Chlorophenylacetonitrile;|4-Chlorobenzyl cyanide,,,,,
C03680,"4-Imidazolone-5-propanoate;|4-Imidazolone-5-propionic acid;|4,5-Dihydro-4-oxo-5-imidazolepropanoate",,,,,
C03681,"5alpha-Pregnane-3,20-dione;|5alpha-Dihydroprogesterone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03681  5alpha-Pregnane-3,20-dione",
C03682,6-Acetamido-3-oxohexanoate,,,,,
C03683,6-Demethylsterigmatocystin,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C03683  6-Demethylsterigmatocystin,
C03684,"6-Pyruvoyltetrahydropterin;|6-(1,2-Dioxopropyl)-5,6,7,8-tetrahydropterin;|6-Pyruvoyl-5,6,7,8-tetrahydropterin",,,,,
C03685,7-Methyl-3-oxooctanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03685  7-Methyl-3-oxooctanoyl-CoA,
C03686,O-Methylsterigmatocystin;|8-O-Methylsterigmatocystin,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C03686  7-O-Methylsterigmatocystin,
C03687,"Alkane-alpha,omega-diamine",Generic compound in reaction hierarchy,,,,
C03690,Bis(2-ethylhexyl)phthalate;|Di(2-ethylhexyl)phthalate;|Dioctyl phthalate;|DEHP,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C03690  Diethylhexyl phthalate,
C03691,CMP-N-glycoloylneuraminate;|CMP-N-glycolylneuraminate;|CMP-Neu5Gc,,,,,
C03692,"1,2-Diacyl-3-beta-D-galactosyl-sn-glycerol;|D-Galactosyldiacylglycerol;|3-beta-D-Galactosyl-1,2-diacylglycerol;|Monogalactosyldiglyceride;|Monogalactosyl-diacylglycerol;|MGDG;|Galbeta1->3acyl2Gro;|3-(beta-D-Galactosyl)-1,2-diacyl-sn-glycerol;|1,2-Diacyl-3-O-(beta-D-galactopyranosyl)-sn-glycerol",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glyceroglycolipids|C03692  Monogalactosyldiacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C03692  1,2-Diacyl-3-O-(beta-D-galactopyranosyl)-sn-glycerol",
C03693,"D-Mannose 1,6-bisphosphate",,,,,
C03701,Glycosyl-N-acylsphingosine,Generic compound in reaction hierarchy,,,,
C03702,Histone N6-methyl-L-lysine,Generic compound in reaction hierarchy,,,,
C03703,L-5-Carboxymethylhydantoin,,,,,
C03706,Lysosomal-enzyme D-mannose,Generic compound in reaction hierarchy,,,,
C03707,Monoterpenol acetate ester,Generic compound in reaction hierarchy|R = monoterpenyl group,,,,
C03709,N-Adenylyl-L-phenylalanine,,,,,
C03710,N-Benzyloxycarbonylglycine;|N-CBZ-glycine,,,,,
C03711,N-Methylphenylethanolamine;|alpha-[(Methylamino)methyl]-benzyl alcohol,,,,,
C03712,"N2,N5-Dibenzoyl-L-ornithine;|L-Ornithuric acid",,,,,
C03715,O-Alkylglycerone phosphate;|Alkyl-glycerone 3-phosphate;|Dihydroxyacetone phosphate alkyl ether,Generic compound in reaction hierarchy,,,,
C03716,Oxaloacetate 4-methyl ester,,,,,
C03717,Oxidized Renilla luciferin;|Coelenteramide h;|N-[3-Benzyl-5-(4-hydroxyphenyl)pyrazin-2-yl]-2-phenylacetamide,,,,,
C03719,Phenylacetothiohydroximate;|(Z)-2-Phenyl-1-thioacetohydroximate,,,,,
C03721,Protein tyrosine-O-sulfate,Generic compound in reaction hierarchy,,,,
C03722,"Quinolinate;|Pyridine-2,3-dicarboxylate;|Quinolinic acid;|2,3-Pyridinedicarboxylic acid",,,,,
C03723,Ribonucleoside diphosphate;|Ribonucleoside 5'-diphosphate,Generic compound in reaction hierarchy,,,,
C03724,S-(5-Hydroxy-2-furoyl)-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C03724  S-(5-Hydroxy-2-furoyl)-CoA,
C03725,S-Acetylphosphopantetheine,,,,,
C03726,S-Alkyl-L-cysteine S-oxide,Generic compound in reaction hierarchy,,,,
C03727,S-Carboxymethyl-L-cysteine;|L-Carbocisteine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00175)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS|R05CB Mucolytics|R05CB03 Carbocisteine|D00175  L-Carbocisteine (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00175)]|2  Agents affecting individual organs|22  Respiratory organ agents|223  Expectorants|2233  Cysteines|D00175  L-Carbocisteine (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00175)]|Agents for respiratory organs|26 Antitussives and expectorants|D00175  L-Carbocisteine (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00175)]|Second-class OTC drugs|Inorganic and organic chemicals|Carbocysteine|D00175  L-Carbocisteine (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00175)]|Chemicals|D00175  L-Carbocisteine|D00175  L-Carbocisteine tablets",
C03730,Single-stranded nucleotide,,,,,
C03731,Streptomycin 3''-phosphate,,,,,
C03733,"UDP-alpha-D-galactofuranose;|UDP-alpha-D-galacto-1,4-furanose;|UDP-D-galacto-1,4-furanose",,,,,G13125
C03734,alpha-D-Glutamyl phosphate,,,,,
C03735,alpha-D-Hexose 6-phosphate,,,,,
C03736,alpha-D-Ribose 5-phosphate,,,,,
C03737,alpha-D-Xylose 1-phosphate,,,,,
C03738,gamma-L-Glutamyl-D-alanine;|L-gamma-Glutamyl-D-alanine,,,,,
C03739,"trans-1,2-Cyclohexanediol;|trans-Cyclohexane-1,2-diol",,,,,
C03740,(5-L-Glutamyl)-L-amino acid;|L-gamma-Glutamyl-L-amino acid;|alpha-(gamma-L-Glutamyl)-L-amino acid,Generic compound in reaction hierarchy,,,,
C03741,(S)-4-Amino-5-oxopentanoate;|L-Glutamate 1-semialdehyde,,,,,
C03742,(S)-4-Hydroxymandelonitrile,,,,,
C03743,"1,2,3,5-Tetrahydroxybenzene",,,,,
C03747,"11alpha-Hydroxyprogesterone;|11alpha-Hydroxypregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03747  11alpha-Hydroxyprogesterone",
C03748,16alpha-Hydroxyprogesterone;|16-alpha-Hydroxyprogesterone,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C03748  16alpha-Hydroxyprogesterone",
C03750,"2,6-Dioxo-6-phenylhexanoate",,,,,
C03752,2-Amino-2-deoxy-D-gluconate;|D-Glucosaminate;|D-Glucosaminic acid;|Glucosaminate,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C03752  D-Glucosaminic acid,
C03753,"2-Chloro-1,4-naphthoquinone",,,,,
C03754,2-Methylpropanoyl phosphate;|2-Methylpropionyl phosphate,,,,,
C03755,3'-Deoxydihydrostreptomycin,,,,,
C03757,"3,4-Dihydroxymandelonitrile",,,,,
C03758,"Dopamine;|4-(2-Aminoethyl)-1,2-benzenediol;|4-(2-Aminoethyl)benzene-1,2-diol;|3,4-Dihydroxyphenethylamine;|2-(3,4-Dihydroxyphenyl)ethylamine",,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C03758  Dopamine|Hormones and transmitters|Other hormones|Dopamine|C03758  Dopamine|Neurotransmitters|Biogenic amines|C03758  Dopamine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C03758  Dopamine|Prodrugs [br08324.html]|C03758|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07870)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA04 Dopamine|D07870  Dopamine (INN)|Drug groups [BR:br08330(D07870)]|Cardiovascular agent|DG01703  Cardiotonic|DG01699  Catecholamine cardiotonic|DG00213  Dopamine|D07870  Dopamine|Neuropsychiatric agent|DG01472  Dopamine agonist|DG00213  Dopamine|D07870  Dopamine|Metabolizing enzyme substrate|DG01592  COMT substrate|DG00213  Dopamine|D07870  Dopamine|DG02917  MAO substrate|DG03179  MAOB substrate|DG00213  Dopamine|D07870  Dopamine|Transporter substrate|DG02854  SLC22A2 substrate|DG00213  Dopamine|D07870  Dopamine|Target-based classification of drugs [BR:br08310(D07870)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD|D07870  Dopamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07870)]|Drug metabolizing enzymes|D07870|Drug transporters|D07870|Prodrugs [br08324.html(D07870)]|D07870,
C03761,3-Hydroxy-3-methylglutarate;|3-Hydorxy-3-methylglutaric acid;|beta-Hydroxy-beta-methylglutaric acid;|Dicrotalic acid;|3-Hydroxy-3-methylpentanedioic acid;|Meglutol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04897)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AX Other lipid modifying agents|C10AX05 Meglutol|D04897  Meglutol (USAN/INN)",
C03762,3-Imidazole-2-oxopropanoate,,,,,
C03764,"para-(Dimethylamino)azobenzene;|N,N-Dimethyl-4-(phenylazo)benzenamine;|Dimethyl yellow;|Methyl yellow;|4-(Dimethylamino)phenylazobenzene",,,,,
C03765,4-Hydroxyphenylacetaldehyde;|2-(4-Hydroxyphenyl)acetaldehyde,,,,,
C03766,4-Hydroxyphenylacetonitrile;|4-Hydroxybenzyl cyanide,,,,,
C03767,4-Oxocyclohexanecarboxylate;|4-Oxocyclohexane-1-carboxylate,,,,,
C03768,4-Substituted phenylacetate,,,,,
C03771,5-Guanidino-2-oxopentanoate;|5-Guanidino-2-oxo-pentanoate;|2-Oxo-5-guanidinopentanoate;|2-Oxo-5-guanidino-pentanoate;|2-Oxoarginine,,,,,
C03772,"5beta-Androstane-3,17-dione",,,,"Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C03772  5beta-Androstane-3,17-dione|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C03772  5beta-Androstane-3,17-dione",
C03773,6-Acetyl-beta-D-galactoside,Generic compound in reaction hierarchy,,,,
C03776,N-Acetyl-D-mannosaminolactone,,,,,
C03779,Bis(4-nitrophenyl)phosphate;|Bis-4-nitrophenyl phosphate,,,,,
C03782,D-(1-Aminoethyl)phosphonate;|D-(1-Aminoethyl)phosphonic acid,,,,,
C03783,D-Galactosamine 1-phosphate,,,,,
C03785,"D-Tagatose 1,6-bisphosphate",,,,,
C03788,Microsomal-membrane protein,Generic compound in reaction hierarchy,,,,
C03789,"N,6-O-Disulfo-D-glucosamine;|N2,6-Disulfo-D-glucosamine",,,,,
C03790,N-(Carboxymethyl)-D-alanine;|Strombine,,,,,
C03792,N-Acyl-D-mannosaminolactone,Generic compound in reaction hierarchy,,,,
C03793,"N6,N6,N6-Trimethyl-L-lysine",,,,,
C03794,"N6-(1,2-Dicarboxyethyl)-AMP;|N6-(1,2-Dicarboxyethyl)AMP;|Adenylosuccinate;|Adenylosuccinic acid",,,,,
C03795,N6-Methyl-2'-deoxyadenosine,,,,,
C03796,Oleandomycin 2'-O-phosphate,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C03796  Oleandomycin 2'-O-phosphate,
C03797,"Oxidized Photinus luciferin;|Firefly oxyluciferin;|4,5-Dihydro-2-(6-hydroxy-1,3-benzothiazol-2-yl)thiazol-4-one",,,,,
C03798,Peptidylproline (omega=180),Generic compound in reaction hierarchy,,,,
C03799,Polyprenylphosphate-glucose,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C03799  Polyprenylphosphate-glucose,
C03800,Protein S-methyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C03801,Pteroylpoly-gamma-glutamate,,,,,
C03802,Ribonucleoside triphosphate;|Ribonucleoside 5'-triphosphate,Generic compound in reaction hierarchy,,,,
C03803,Ribosomal-protein L-alanine;|Ribosomal-protein N-terminal-L-alanine,Generic compound in reaction hierarchy,,,,
C03804,S-Methyl-1-thio-D-glycerate,,,,,
C03805,Stearoylglycerone phosphate,,,,,
C03808,[Pyruvate kinase] phosphate,Generic compound in reaction hierarchy,,,,
C03811,alpha-D-Glucose 3-phosphate,,,,,
C03817,(S)-3-(Imidazol-5-yl)lactate,,,,,
C03819,1-Acylglycerophosphoinositol;|1-Acyl-sn-glycero-3-phosphoinositol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP06 Glycerophosphoinositols|GP0605 Monoacylglycerophosphoinositols|C03819  1-Acyl-sn-glycero-3-phosphoinositol,
C03820,1-Alkyl-2-acetyl-sn-glycerol;|2-Acetyl-1-alkyl-sn-glycerol;|1-O-Alkyl-2-acetyl-sn-glycerol,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0202 1-alkyl,2-acylglycerols|C03820  1-Alkyl-2-acetyl-sn-glycerol",
C03822,"2,6-Dichlorophenolindophenol sodium salt;|2,6-Dichloroindophenol sodium salt",,,,,
C03823,2-(2-Hydroxyacyl)sphingosine,Generic compound in reaction hierarchy,,,,
C03824,2-Aminomuconate semialdehyde;|2-Aminomuconate 6-semialdehyde,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C03824  2-Aminomuconate semialdehyde,
C03826,"2-Dehydro-3-deoxy-D-xylonate;|2-Dehydro-3-deoxy-D-arabinonate;|2-Dehydro-3-deoxy-D-pentonate;|(4S)-4,5-Dihydroxy-2-oxopentanoate;|2-Dehydro-3-deoxy-D-arabinonic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C03826  2-Dehydro-3-deoxy-D-arabinonic acid,
C03827,"2-Dehydro-3-deoxy-L-fuconate;|(4S,5S)-4,5-Dihydroxy-2-oxohexanoate",,,,,
C03828,2-Deoxystreptamine phospahte,,,,,
C03829,"2S,5S-Methionine sulfoximine;|(R-(R*,S*))-S-(3-Amino-3-carboxypropyl)-S-methylsulphoximide",,,,,
C03830,"3,4-Dehydro-6-hydroxymellein",,,,,
C03832,"3,5,3'-Triiodothyropyruvate;|3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-2-oxopropanoate",,,,,
C03834,3-Hydroxymonocarboxylic acid,,,,,
C03836,3beta-Hydroxy-Delta5-steroid,Generic compound in reaction hierarchy,,,,
C03837,4-Methylumbelliferyl acetate,,,,,
C03838,5'-Phosphoribosylglycinamide;|GAR;|N1-(5-Phospho-D-ribosyl)glycinamide;|Glycinamide ribonucleotide;|N1-(5-Phospho-beta-D-ribosyl)glycinamide,,,,Glycosides [BR:br08021]|N-glycosides|C03838  5'-Phosphoribosylglycinamide,
C03840,"Juglone;|5-Hydroxy-1,4-naphthoquinone",,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C03840  Juglone,
C03843,"5-exo-Hydroxy-1,2-campholide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C03843  5-exo-Hydroxy-1,2-campholide",
C03844,D-Pinitol;|1D-3-O-Methyl-chiro-inositol;|5D-5-O-Methyl-chiro-inositol,,,,,
C03845,5alpha-Cholest-8-en-3beta-ol;|Zymostenol;|Cholestenol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C03845  5alpha-Cholest-8-en-3beta-ol,
C03846,6-Acetamido-3-aminohexanoate,,,,,
C03847,6-Phospho-beta-D-galactoside,Generic compound in reaction hierarchy,,,,
C03848,6F-alpha-D-Galactosylsucrose;|Planteose,,,,,G09080
C03849,Acyl-sn-glycerol 3-phosphate,Generic compound in reaction hierarchy,,,,
C03850,"Adenosine 2',5'-bisphosphate",,,,,
C03851,Adenosine 5'-phosphoramidate,,,,,
C03852,"Androstan-3alpha,17beta-diol;|5alpha-Androstan-3alpha,17beta-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C03852  Androstan-3alpha,17beta-diol",
C03853,Bis(glycerophospho)-glycerol,,,,,
C03855,Cholesteryl-beta-D-glucoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C03855  Cholesteryl-beta-D-glucoside,
C03858,D-Glucosyldihydrosphingosine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C03858  D-Glucosyldihydrosphingosine,
C03860,Deaminohydroxyblasticidin S,,,,,
C03861,"Dibenzo[1,4]dioxin-2,3-dione;|Diphenylenedioxide-2,3-quinone",,,,,
C03862,Dolichyl phosphate D-mannose;|Dolichyl D-mannosyl phosphate;|Dolichyl beta-D-mannosyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C03862  Dolichyl phosphate D-mannose,G10617
C03864,Ethyl (R)-3-hydroxyhexanoate,,,,,
C03865,Ethyl (S)-3-hydroxyhexanoate,,,,,
C03866,Glucuronoxylan D-glucuronate;|Glucuronoxylan,,,,,
C03868,Indole-3-acetyl-myo-inositol;|Indol-3-ylacetyl-myo-inositol;|Indole-3-ylacetyl-myo-inositol,,,,,
C03870,Isoorientin 2''-O-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C03870  Isoorientin 2''-O-rhamnoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C03870  Isoorientin 2''-O-rhamnoside|Glycosides [BR:br08021]|C-glycosides|C03870  Isoorientin 2''-O-rhamnoside,
C03871,L-2-Amino-6-oxoheptanedioate;|L-2-Amino-6-oxopimelate,,,,,
C03872,L-Serine-phosphoethanolamine;|Serine phosphoethanolamine,,,,,
C03873,Linoleoylphosphatidylcholine;|2-Acyl-1-linoleoyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C03873  2-Acyl-1-linoleoyl-sn-glycero-3-phosphocholine,
C03874,Myosin heavy-chain phosphate,Generic compound in reaction hierarchy,,,,
C03875,Myosin light chain phosphate;|Myosin light-chain phosphate,Generic compound in reaction hierarchy,,,,
C03878,N-Acetyl-beta-D-glucosamine,,,,,
C03879,N-Acetyl-beta-D-hexosaminide,Generic compound in reaction hierarchy|N-Acetyl-beta-D-glucosaminide [CPD:C03518]|N-Acetyl-beta-D-galactosaminide [CPD:C04135],,,,
C03880,N-Substituted aminoacyl-tRNA,Generic compound in reaction hierarchy,,,,
C03881,N-Terminal-N-tetradecanoylglycyl-[protein];|N-Tetradecanoylglycylpeptide,Generic compound in reaction hierarchy,,,,
C03882,"Piperine;|N-[(E,E)-Piperoyl]-piperidine;|1-Piperoyl-piperidine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C03882  Piperine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C03882,
C03884,N(omega)-Methyl-L-arginine;|N(G)-Monomethyl-L-arginine,,,,,
C03885,3-Nonaprenyl-4-hydroxybenzoate;|Nonaprenyl-4-hydroxybenzoate,,,,,
C03886,Nucleoside 5'-phosphoacylate,,,,,
C03887,Oxidized Cypridina luciferin,,,,,
C03888,Oxidized Watasenia luciferin,,,,,
C03889,Palmitoylphosphatidylcholine;|1-Palmitoyl-2-acyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C03889  1-Palmitoyl-2-acyl-sn-glycero-3-phosphocholine,
C03890,"Peptide(N-Glu, Asp, Cystine)",,,,,
C03892,"Phosphatidylglycerophosphate;|1-(3-sn-Phosphatidyl)-sn-glycerol 3-phosphate;|3-(3-Phosphatidyl)-D-glycerol 1-phosphate;|1,2-Diacyl-sn-glycero-3-phospho-sn-glycerol 3'-phosphate",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP05 Glycerophosphoglycerophosphates|GP0501 Diacylglycerophosphoglycerophosphates|C03892  1,2-Diacyl-sn-glycero-3-phospho-sn-glycerol 3'-phosphate",
C03893,"Poly(alpha-L-1,4-guluronate)",,,,,
C03894,"Propane-1,2-diol 1-phosphate",,,,,
C03895,Peptide-L-methionine (S)-S-oxide,Generic compound in reaction hierarchy,,,,
C03897,"Quercetin 3,3',7-trissulfate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C03897  Quercetin 3,3',7-trissulfate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C03897  Quercetin 3,3',7-trissulfate",
C03898,"Quercetin 3,4',7-trissulfate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C03898  Quercetin 3,4',7-trissulfate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C03898  Quercetin 3,4',7-trissulfate",
C03899,S-(2-Hydroxyacyl)glutathione,Generic compound in reaction hierarchy,,,,
C03900,S-(4-Bromophenyl)-L-cysteine,,,,,
C03901,Thiomorpholine 3-carboxylate,,,,,
C03904,alpha-N-Peptidyl-L-glutamate,Generic compound in reaction hierarchy,,,,
C03905,alpha-N-Peptidyl-L-glutamine,Generic compound in reaction hierarchy,,,,
C03906,beta-L-Arabinose 1-phosphate,,,,,
C03910,"(24R,24(1)R)-Fucosterol epoxide;|(24R,28R)-Fucosterol epoxide;|(3beta,24R,28R)-24,28-Epoxystigmast-5-en-3-ol;|(24R,24'R)-Fucosterol epoxide",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C03910  (24R,24'R)-Fucosterol epoxide",
C03912,(S)-1-Pyrroline-5-carboxylate;|L-1-Pyrroline-5-carboxylate;|1-Pyrroline-5-carboxylate,,,,,
C03916,1-Oleoylglycerophosphocholine;|1-Oleoyl-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0105 Monoacylglycerophosphocholines|C03916  1-Oleoyl-sn-glycero-3-phosphocholine,
C03917,Dihydrotestosterone;|17beta-Hydroxyandrostan-3-one;|Androstanolone;|17beta-Hydroxy-5alpha-androstan-3-one,,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C03917  Dihydrotestosterone|Hormones and transmitters|Steroid hormones|Androgens|C03917  Dihydrotestosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C03917  17beta-Hydroxy-5alpha-androstan-3-one|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07456)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AA Androstan derivatives|A14AA01 Androstanolone|D07456  Androstanolone (INN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BB 5-androstanon (3) derivatives|G03BB02 Androstanolone|D07456  Androstanolone (INN)|Drug groups [BR:br08330(D07456)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|D07456  Androstanolone|Target-based classification of drugs [BR:br08310(D07456)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D07456  Androstanolone (INN),
C03918,"2,4-Dichloro-cis,cis-muconate;|2,4-Dichloro-cis,cis-muconic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C03918  2,4-Dichloro-cis,cis-muconic acid",
C03920,2-(Methylthio)ethanesulfonate;|Methylcoenzyme M;|Methyl-CoM;|2-(Methylsulfanyl)ethane-1-sulfonate,,,,,
C03921,2-Dehydro-3-deoxy-D-glucarate,,,,,
C03922,2-Deoxystreptamine antibiotic,"Generic compound in reaction hierarchy|including gentamicin, kanamycin, tobramycin, neomycin and apramycin",,,,
C03924,3'-Phosphooligoribonucleotide,,,,,
C03925,"3,5-Dibromo-4-hydroxybenzoate",,,,,
C03926,3-Dehydro-2-deoxy-D-gluconate,,,,,
C03927,3-Hydroxy-4H-pyrid-4-one;|3-Hydroxypyridin-4(1H)-one;|3-Hydroxy-4(1H)-pyridinone,,,,,
C03928,3-Phosphoglycerol-glutathione,,,,,
C03929,3-tert-Butyl-5-methylcatechol,,,,,
C03930,3alpha-Hydroxyglycyrrhetinate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C03930  3alpha-Hydroxyglycyrrhetinate,
C03933,5-D-Glutamyl-D-glutamyl-peptide;|gamma-D-Glutamyl-D-glutamyl-peptide,Generic compound in reaction hierarchy,,,,
C03935,6beta-Hydroxy-17beta-estradiol;|6beta-Hydroxyestradiol-17beta,,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C03935  6beta-Hydroxyestradiol-17beta|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C03935  6beta-Hydroxyestradiol-17beta,
C03939,Acetyl-[acyl-carrier protein];|Acetyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C03939  Acetyl-[acp],
C03941,Calmodulin N6-methyl-L-lysine,Generic compound in reaction hierarchy,,,,
C03943,"(2R,4S)-2,4-Diaminopentanoate;|D-threo-2,4-Diaminopentanoate;|2,4-Diaminopentanoate",,,,,
C03944,Dihydro-O-methylsterigmatocystin;|DHOMST;|Dihydromethylsterigmatocystin;|8-O-Methyldihydrosterigmatocystin,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C03944  Dihydromethylsterigmatocystin,
C03946,Flavonol 3-O-beta-D-glucoside;|Flavonol 3-O-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C03946  Flavonol 3-O-beta-D-glucoside,
C03947,"Glycerol 1,2-cyclic phosphate;|1,3,2-Dioxaphospholane-4-methanol",,,,,
C03948,N-Glycolyl-D-mannosaminolactone;|Glycolyl-D-mannosaminolactone,,,,,
C03951,"Luteolin 7-O-beta-D-glucoside;|Luteolin 7-O-glucoside;|7-O-beta-D-Glucosyl-5,7,3',4'-tetrahydroxyflavone;|Cynaroside;|Luteoloside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C03951  Luteolin 7-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C03951  Luteolin 7-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C03951  Luteolin 7-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C03951,
C03953,N-Acetylglucosamine 4-sulfate;|N-Acetyl-D-glucosamine 4-sulfate,,,,,
C03954,N-Hydroxy-2-acetamidofluorene,,,,,
C03955,N6-Acetyl-N6-hydroxy-L-lysine;|N6-Acetyl-N6-hydroxylysine,,,,,
C03956,Oligoglycosylglucosylceramide,Generic compound in reaction hierarchy,,,,G10544
C03957,Peptide 3-hydroxy-L-aspartate,Generic compound in reaction hierarchy,,,,
C03958,Thyrotropin-releasing hormone;|TRH;|Protirelin;|Thyroliberin,,Glp His Pro-NH2,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Thyrotropin-releasing hormone|C03958  Thyrotropin-releasing hormone|Bioactive peptides [BR:br08005]|Hypothalamic hormones|Thyrotropin-releasing hormone|C03958  Thyrotropin-releasing hormone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00176)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CJ Tests for thyreoidea function|V04CJ02 Protirelin|D00176  Protirelin (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00176)]|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|722  Various function testing reagents|7223  Diagnostic reagents for endocrine function|D00176  Protirelin (JP18/USAN/INN)|Target-based classification of drugs [BR:br08310(D00176)]|G Protein-coupled receptors|Rhodopsin family|Thyrotropin-releasing hormone|TRHR|D00176  Protirelin (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00176)]|Chemicals|D00176  Protirelin,
C03961,erythro-3-Hydroxy-Ls-aspartate;|erythro-3-Hydroxy-Ls-aspartic acid;|erythro-3-Hydroxy-L-aspartate;|erythro-3-Hydroxy-L-aspartic acid,,,,,
C03962,(-)-Menthyl O-beta-D-glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C03962  (-)-Menthyl O-beta-D-glucoside,
C03963,Sarsasapogenin;|(25S)-5beta-Spirostan-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C03963  Sarsasapogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C03963  (25S)-5beta-Spirostan-3beta-ol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C03963  Sarsasapogenin,
C03964,(R)-3-(4-Hydroxyphenyl)lactate,,,,,
C03968,1-Alkyl-sn-glycero-3-phosphate;|1-Alkyl-sn-glycerol 3-phosphate;|1-O-Alkyl-sn-glycerol 3-phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1006 Monoalkylglycerophosphates|C03968  1-Alkyl-sn-glycerol 3-phosphate,
C03969,1-Aminocyclopentanecarboxylate;|1-Aminocyclopentanecarboxylic acid;|Cycloleucine,,,,,
C03972,"2,3,4,5-Tetrahydrodipicolinate;|Delta1-Piperidine-2,6-dicarboxylate;|L-2,3,4,5-Tetrahydrodipicolinate;|(S)-2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate",,,,,
C03974,2-Acyl-sn-glycerol 3-phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1005 Monoacylglycerophosphates|C03974  2-Acyl-sn-glycerol 3-phosphate,
C03975,"Isoxanthopterin;|2-Amino-4,7-dihydroxypteridine",,,,,
C03979,2-Dehydro-3-deoxy-L-rhamnonate,,,,,
C03980,2-Deoxystreptamine 4-phosphate,,,,,
C03981,2-Hydroxyethylenedicarboxylate;|enol-Oxaloacetate;|enol-Oxaloacetic acid;|2-Hydroxybut-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C03981  2-Hydroxybut-2-enedioic acid,
C03982,2-Methylpropanal O-methyloxime;|Isobutyraldoxime O-methyl ether,,,,,
C03983,3'-Hydroxyloligoribonucleotide,,,,,
C03985,"Linalool;|3,7-Dimethylocta-1,6-dien-3-ol;|(RS)-Linalool",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C03985  Linalool|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C03985  Linalool,
C03986,3-Hydroxy-4-methylanthranilate,,,,,
C03987,3-Iodo-4-hydroxyphenylpyruvate,,,,,
C03989,Isolychnose;|3F-alpha-D-Galactosylraffinose,,,,,
C03990,Lithocholic acid;|Lithocholate;|3alpha-Hydroxy-5beta-cholanate;|3alpha-Hydroxy-5beta-cholanic acid,,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C03990  Lithocholic acid|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C03990  3alpha-Hydroxy-5beta-cholanic acid",
C03993,4-(beta-D-Glucosyloxy)benzoate;|4-Hydroxybenzoate-O-glucoside,,,,,
C03994,4-Hydroxymethylphenylhydrazine,,,,,
C03995,4-Nitrophenyl-3-ketovalidamine;|p-Nitrophenyl-3-ketovalidamine;|N-(4-Nitrophenyl)-3-ketovalidamine,,,,,
C03996,5'-O-beta-D-Glucosylpyridoxine,,,,,
C03997,5-Hydroxymethyldeoxycytidylate;|5-Hydroxymethyldeoxycytidylic acid;|2'-Deoxy-5-hydroxymethylcytidine 5'-phosphate,,,,,
C03998,7-Methylguanosine 5'-phosphate;|N7-Methyl-GMP,,,,,
C03999,Alanyl-poly(glycerolphosphate);|(D-Ala1->2Gro-1-P)n,,,,,
C04000,Benzyl 2-methyl-3-oxobutanoate,,,,,
C04002,"(Z)-But-1-ene-1,2,4-tricarboxylate;|Homo-cis-aconitate;|cis-Homoaconitate;|(Z)-1,2,4-But-1-enetricarboxylic acid;|(1Z)-But-1-ene-1,2,4-tricarboxylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C04002  (1Z)-But-1-ene-1,2,4-tricarboxylic acid",
C04006,1D-myo-Inositol 3-phosphate;|D-myo-Inositol 3-phosphate;|myo-Inositol 3-phosphate;|Inositol 3-phosphate;|1D-myo-Inositol 3-monophosphate;|D-myo-Inositol 3-monophosphate;|myo-Inositol 3-monophosphate;|Inositol 3-monophosphate;|1L-myo-Inositol 1-phosphate;|L-myo-Inositol 1-phosphate,,,,,
C04007,Flavanone 7-O-beta-D-glucoside;|Flavanone 7-O-glucoside,Generic compound in reaction hierarchy,,,,
C04010,Glycoprotein phospho-D-mannose,Generic compound in reaction hierarchy,,,,
C04013,Multi-methyl-branched acyl-CoA,,,,,
C04015,N-Acetyl-4-O-acetylneuraminate,,,,,
C04016,N-Acetyl-7-O-acetylneuraminate,,,,,
C04017,N-Acetyl-9-O-acetylneuraminate;|N-Acetyl-9-O-acetylneuraminic acid,,,,,
C04019,N-Acetyl-alpha-D-glucosaminide,,,,,
C04020,D-Lysopine;|N2-(D-1-Carboxyethyl)-L-lysine;|Lysopine,,,,,
C04021,"Phosphatidylinositol phosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-inositol-4'-phosphate)",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP07 Glycerophosphoinositol monophosphates|GP0701 Diacylglycerophosphoinositol monophosphates|C04021  1,2-Diacyl-sn-glycero-3-phospho-(1'-inositol-4'-phosphate)",
C04022,"S,S-Dimethyl-beta-propiothetin;|S-Dimethylsulfonium propionic acid;|Dimethylpropiothetin;|DMPT;|DMSP",,,,,
C04024,Vitexin 2''-O-beta-D-glucoside;|Flavosativaside;|2''-O-Glucosylvitexin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04024  Vitexin 2''-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C04024  Vitexin 2''-O-beta-D-glucoside|Glycosides [BR:br08021]|C-glycosides|C04024  Vitexin 2''-O-beta-D-glucoside,
C04025,"alpha,omega-Dicarboxylic acid",,,,,
C04026,alpha-N-Substituted L-arginine,,,,,
C04030,"(2,3-Dihydroxybenzoyl)adenylate",,,,,
C04031,(3S)-3-Hydroxyacyl-hydrolipoate,,,,,
C04033,"1,3,6,8-Naphthalenetetrol;|1,3,6,8-Tetrahydroxynaphthalene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C04033  1,3,6,8-Naphthalenetetrol",
C04034,"(1->6)-beta-D-Galactosylgalactogen;|1,6-beta-D-Galactosylgalactogen",,,,,
C04036,1-Palmitoylglycerol 3-phosphate;|1-Hexadecanoyl-sn-glycero-3-phosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1005 Monoacylglycerophosphates|C04036  1-Hexadecanoyl-sn-glycero-3-phosphate,
C04037,1-Phospho-alpha-D-galacturonate;|D-Galacturonate 1-phosphate,,,,,
C04039,"2,3-Dihydroxy-3-methylbutanoate;|2,3-Dihydroxy-isovalerate;|2,3-Dihydroxy-isovaleric acid",,,,,
C04042,20alpha-Hydroxy-4-pregnen-3-one;|20alpha-Hydroxypregn-4-en-3-one;|20alpha-Hydroxyprogesterone;|(S)-20-Hydroxypregn-4-en-3-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C04042  20alpha-Hydroxy-4-pregnen-3-one",
C04043,"3,4-Dihydroxyphenylacetaldehyde;|DOPAL;|Protocatechuatealdehyde",,,,,
C04044,"3-(2,3-Dihydroxyphenyl)propanoate;|2,3-Dihydroxyphenylpropanoate",,,,,
C04045,"3-(3,4-Dihydroxyphenyl)pyruvate;|3,4-Dihydroxyphenylpyruvate",,,,,
C04046,"3-D-Glucosyl-1,2-diacylglycerol;|1,2-Diacyl-3-beta-D-glucosyl-sn-glycerol;|Monoglucosyldiglyceride;|Monoglucosyldiacylglycerol;|Glcbeta1->3acyl2Gro;|1,2-Diacyl-3-O-(beta-D-glucopyranosyl)-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C04046  1,2-Diacyl-3-O-(beta-D-glucopyranosyl)-sn-glycerol",G13181
C04047,3-Hydroxy-2-methylpropanoyl-CoA;|3-Hydroxy-2-methylpropionyl-CoA;|3-Hydroxyisobutyryl-CoA;|3-Hydroxyisobutyryl coenzyme A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C04047  3-Hydroxy-2-methylpropanoyl-CoA,
C04049,4-Hydroxy-4-methyl-2-oxoadipate,,,,,
C04050,4-Hydroxyaminoquinoline N-oxide,,,,,
C04051,5-Amino-4-imidazolecarboxyamide,,,,,
C04052,"5-Carboxy-2-oxohept-3-enedioate;|5-Oxopent-3-ene-1,2,5-tricarboxylate",,,,,
C04053,"5-Dehydro-4-deoxy-D-glucuronate;|4-Deoxy-L-threo-5-hexosulose uronate;|(4S,5R)-4,5-Dihydroxy-2,6-dioxohexanoate",,,,,
C04054,5-Hydroxybenzimidazolylcob(I)amide,,,,,
C04056,"Rumenic acid;|9-cis,11-trans-Octadecadienoate;|(9Z,11E)-Octadecadienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C04056  (9Z,11E)-Octadeca-9,11-dienoic acid",
C04058,"Bis(5'-adenosyl) pentaphosphate;|P1,P5-Bis(5'-adenosyl)pentaphosphate",,,,,
C04061,Cytochrome c N6-methyl-L-lysine,Generic compound in reaction hierarchy,,,,
C04062,"D-myo-Inositol 1,3-bisphosphate;|1D-myo-Inositol 1,3-bisphosphate;|myo-Inositol 1,3-bisphosphate;|Inositol 1,3-bisphosphate",,,,,
C04063,"D-myo-Inositol 3,4-bisphosphate;|1D-myo-Inositol 3,4-bisphosphate;|Inositol 3,4-bisphosphate",,,,,
C04064,"D-myo-Inositol 4,5-bisphosphate",,,,,
C04067,"Diethyl 2-methyl-3-oxosuccinate;|Diethyl oxalpropionate;|Butanedioic acid, 2-methyl-3-oxo-, 1,4-diethyl ester",,,,,
C04068,Flavonol 3-O-D-xylosylglucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04068  Flavonol 3-O-D-xylosylglucoside,
C04069,Flavonol 3-O-D-xylosylglycoside;|Flavonol 3-O-[D-xylosyl-(1->2)-beta-D-glycoside];|Flavonol 3-[beta-D-xylosyl-(1->2)-beta-D-glycoside],Generic compound in reaction hierarchy|Xylosylglucoside or xylosylgalactoside,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04069  Flavonol 3-O-D-xylosylglycoside,
C04070,Gibberellin 2-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C04070  Gibberellin 2-O-beta-D-glucoside,
C04071,Guanidinoethyl methyl phosphate,,,,,
C04072,Heparin-glucosamine 3-O-sulfate,,,,,
C04073,Heparosan-N-sulfate L-iduronate;|Poly[(1->4)-alpha-L-iduronosyl-(1->4)-N-sulfo-alpha-D-glucosaminyl],The disaccharide repeating unit is shown here.|R = linear polysaccharide,,,,
C04074,Isoflavone 7-O-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C04074  Isoflavone 7-O-beta-D-glucoside,
C04075,2-Amino-4-chloro-4-pentenoic acid;|(S)-2-Amino-4-chloro-4-pentenoic acid;|L-2-Amino-4-chloropent-4-enoate;|4-Chloro-allyl-L-glycine,,,,,
C04076,L-2-Aminoadipate 6-semialdehyde;|2-Aminoadipate 6-semialdehyde;|L-Allysine;|Allysine;|(S)-2-Amino-6-oxohexanoate,,,,,
C04078,Methylmethionine sulfonium salt;|Methylmethionine sulfonium chloride;|Vitamin U,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00177)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX04 Methiosulfonium chloride|D00177  Methylmethionine sulfonium chloride (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00177)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2321  Methylmethionines|D00177  Methylmethionine sulfonium chloride (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D00177)]|Third-class OTC drugs|Inorganic and organic chemicals|Methylmethionine sulfonium chloride|D00177  Methylmethionine sulfonium chloride (JAN)|Drug groups [BR:br08330(D00177)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|D00177  Methylmethionine sulfonium chloride,
C04079,N-((R)-Pantothenoyl)-L-cysteine;|D-Pantothenoyl-L-cysteine;|N-Pantothenoylcysteine,,,,,
C04080,N-(Long-chain-acyl)ethanolamine,Generic compound in reaction hierarchy,,,,
C04081,N-Hydroxy-4-acetylaminobiphenyl,,,,,
C04083,"N6-(Delta2-Isopentenyl)-adenine;|N6-(3-Methylbut-2-enyl)adenine;|6-(gamma,gamma-Dimethylallylamino)purine;|N6-Dimethylallyladenine;|N6-Prenyladenine",,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Cytokinins|C04083  N6-(delta2-Isopentenyl)-adenine,
C04084,"Pregna-4,9(11)-diene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C04084  Pregna-4,9(11)-diene-3,20-dione",
C04087,Protein N(tau)-methyl-L-histidine;|Protein N-tele-methyl-L-histidine,Generic compound in reaction hierarchy,,,,
C04088,Octadecanoyl-[acyl-carrier protein];|Stearoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04088  Octadecanoyl-[acp],
C04089,UDP-4-dehydro-6-deoxy-D-glucose;|UDP-4-keto-6-deoxy-D-glucose;|UDP-4-oxo-6-deoxy-D-glucose;|UDP-4-dehydro-6-deoxy-alpha-D-glucose,,,,,
C04091,"cis-1,2-Dihydrobenzene-1,2-diol;|cis-Benzeneglycol;|cis-Cyclohexa-3,5-diene-1,2-diol",,,,,
C04092,"Delta1-Piperideine-2-carboxylate;|1,2-Didehydropiperidine-2-carboxylate;|1-Piperideine-2-carboxylate",,,,,
C04093,poly-cis-Polyprenyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C04093  poly-cis-Polyprenyl diphosphate,
C04099,"1,4-alpha-D-Glucooligosaccharide;|1,4-alpha-D-Glucooligosaccharide in lipopolysaccharide precursor",,,,,
C04100,1-Linoleoylglycerophosphocholine;|1-Linoleoyl-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0105 Monoacylglycerophosphocholines|C04100  1-Linoleoyl-sn-glycero-3-phosphocholine,
C04101,"1-O,6-O-Digalloyl-beta-D-glucose",,,,,
C04102,1-Palmitoylglycerophosphocholine;|1-Palmitoyl-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0105 Monoacylglycerophosphocholines|C04102  1-Palmitoyl-sn-glycero-3-phosphocholine,
C04103,13-beta-D-Glucosyloxydocosanoate;|13-(beta-D-Glucosyloxy)docosanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA13 Fatty acyl glycosides|FA1301 Fatty acyl glycosides of mono- and disaccharides|C04103  13-(beta-D-Glucosyloxy)docosanoic acid,
C04104,"2,3-Dihydroxy-3-methylpentanoate;|2,3-Dihydroxy-3-methylvalerate",,,,,
C04105,"2,5-Dihydro-5-oxofuran-2-acetate;|2-Oxo-2,5-dihydrofuran-5-acetate;|Muconolactone;|5-Oxo-2,5-dihydrofuran-2-acetate;|4-Carboxymethyl-4-hydroxyisocrotonolactone",,,,,
C04106,2-(Hydroxymethyl)-4-oxobutanoate;|alpha-Hydroxymethyl succinate semialdehyde;|2-Hydroxymethyl succinate semialdehyde,,,,,
C04108,20-Hydroxy-3-oxopregn-4-en-21-al,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C04108  20-Hydroxy-3-oxopregn-4-en-21-al",
C04109,"Gossypetin;|3,3',4',5,7,8-Hexahydroxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04109  3,3',4',5,7,8-Hexahydroxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04109  Gossypetin",
C04110,"3,5-Dihydroxy-1,4-naphthoquinone",,,,,
C04111,3-(Phosphoacetylamido)-L-alanine,,,,,
C04112,"3-Methyl-cis,cis-hexadienedioate;|3-Methyl-cis,cis-muconate",,,,,
C04114,(E)-4-(Trimethylammonio)but-2-enoate;|Crotono-betaine;|Crotonobetaine,,,,,
C04115,"4-Carboxy-4-hydroxy-2-oxoadipate;|4-Hydroxy-4-carboxymethyl-2-oxoglutarate;|2-Hydroxy-4-oxobutane-1,2,4-tricarboxylate;|4-Carboxy-4-hydroxy-2-oxoadipic acid;|2-Hydroxy-4-oxobutane-1,2,4-tricarboxylic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C04115  4-Carboxy-4-hydroxy-2-oxoadipic acid,
C04116,4-Substituted phenylacetonitrile,,,,,
C04117,5'-Phospho-RNA 3'-mononucleotide,,,,,
C04118,"Isocorypalmine;|5,8,13,13a-Tetrahydrocolumbamine;|(S)-Tetrahydrocolumbamine;|(13aS)-5,8,13,13a-Tetrahydro-3,9,10-trimethoxy-6H-dibenzo[a,g]quinolizin-2-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C04118  (S)-Tetrahydrocolumbamine,
C04121,CMP-3-deoxy-D-manno-octulosonate;|CMP-KDO;|CMP-beta-KDO,,,,,
C04122,D-1-Aminopropan-2-ol O-phosphate;|(R)-1-Aminopropan-2-yl phosphate,,,,,
C04125,[Isocitrate dehydrogenase (NADP+)],,,,,
C04126,L-1-Aminopropan-2-ol O-phosphate;|(S)-1-Aminopropan-2-yl phosphate,,,,,
C04128,Low-density lipoprotein L-serine,Generic compound in reaction hierarchy,,,,
C04130,Methyl 2-diazoacetamidohexanoate,,,,,
C04131,Monoamide of dicarboxylate;|Monoamide of dicarboxylic acid,Generic compound in reaction hierarchy,,,,
C04132,N-Acetyl-D-glucosamine 6-sulfate,,,,,
C04133,N-Acetyl-L-glutamate 5-phosphate;|N-Acetyl-L-glutamyl 5-phosphate,,,,,
C04134,N-Acetyl-alpha-D-galactosaminide,,,,,
C04135,N-Acetyl-beta-D-galactosaminyl-R;|N-Acetyl-beta-D-galactosaminide,Generic compound in reaction hierarchy,,,,
C04136,N-Acyl-D-glucosamine 6-phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0101 Monoacylaminosugars|C04136  N-Acyl-D-glucosamine 6-phosphate,
C04137,"Octopine;|D-Octopine;|N2-(D-1-Carboxyethyl)-L-arginine;|N2-(1-Carboxyethyl)-L-arginine;|Arginine, N2-(1-carboxyethyl)-, L-;|D-(+)-Octopine;|L-Arginine, N2-(1-carboxyethyl)-, (R)-;|L-Arginine, N2-[(1R)-1-carboxyethyl]-",,,,,
C04138,N(alpha)-gamma-L-Glutamylhistamine;|Nalpha-gamma-L-glutamylhistamine,,,,,
C04141,Phospho-beta-adrenergic receptor;|[beta-Adrenergic receptor] phosphate,Generic compound in reaction hierarchy,,,,
C04142,Protein glutamate methyl ester;|Protein L-glutamate methyl ester;|Protein L-glutamate O5-methyl ester,Generic compound in reaction hierarchy,,,,
C04143,Protein N(omega)-methyl-L-arginine,Generic compound in reaction hierarchy,,,,
C04144,Tetrahydropteroyltri-L-glutamate;|(6S)-H4PteGlu3,,,,,
C04145,all-trans-Nonaprenyl diphosphate;|Solanesyl pyrophosphate;|Solanesyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04145  all-trans-Nonaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C04145  all-trans-Nonaprenyl diphosphate,
C04146,all-trans-Octaprenyl diphosphate;|Farnesylfarnesylgeraniol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C04146  all-trans-Octaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C04146  all-trans-Octaprenyl diphosphate,
C04147,"alpha-D-Glucosyl-(1,3)-D-mannose",,,,,
C04148,Phenylacetylglutamine;|alpha-N-Phenylacetyl-L-glutamine;|N2-(2-Phenylacetyl)-L-glutamine,,,,,
C04149,[alpha-Tubulin]-N6-acetyl-L-lysine,Generic compound in reaction hierarchy,,,,
C04150,beta-D-Mannosylphosphodecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C04150  beta-D-Mannosylphosphodecaprenol,
C04152,rRNA containing N1-methylguanine,Generic compound in reaction hierarchy,,,,
C04153,rRNA containing N2-methylguanine,Generic compound in reaction hierarchy,,,,
C04154,rRNA containing N6-methyladenine;|rRNA(N6-methyladenine);|N6-Methyladenine in rRNA,Generic compound in reaction hierarchy,,,,
C04155,tRNA containing 5-methylcytosine,Generic compound in reaction hierarchy,,,,
C04156,tRNA containing N1-methyladenine,,,,,
C04157,tRNA containing N1-methylguanine;|N1-Methylguanine in tRNA,Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in tRNA|N1-Methylguanine in tRNA(Phe) [CPD:C20688],,,,
C04158,tRNA containing N2-methylguanine,Generic compound in reaction hierarchy,,,,
C04159,tRNA containing N6-methyladenine,Generic compound in reaction hierarchy,,,,
C04160,tRNA containing N7-methylguanine,Generic compound in reaction hierarchy,,,,
C04164,trans-Cinnamoyl beta-D-glucoside;|1-O-trans-Cinnamoyl-beta-D-glucopyranose,,,,,
C04165,(+)-Neomenthyl O-beta-D-glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C04165  (+)-Neomenthyl O-beta-D-glucoside,
C04166,(+/-)-6-Hydroxy-3-oxo-alpha-ionol;|Vomifoliol,,,,,
C04167,"(+/-)-trans-Acenaphthene-1,2-diol",,,,,
C04170,13-(2-Methylcrotonoyl)oxylupanine;|13-(2-Methylcrotonoyl)oxylupinine;|(+)-13alpha-Tigloyloxylupanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C04170  13-(2-Methylcrotonoyl)oxylupanine,
C04171,"(2S,3S)-2,3-Dihydro-2,3-dihydroxybenzoate;|(2S,3S)-2,3-Dihydroxy-2,3-dihydroxybenzoate",,,,,
C04175,"2-Deoxy-D-ribose 1,5-bisphosphate",,,,,
C04178,"Bromoxynil;|3,5-Dibromo-4-hydroxybenzonitrile",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrile herbicides|C04178  Bromoxynil,
C04180,cis-Dec-3-enoyl-[acp];|cis-Dec-3-enoyl-[acyl-carrier protein];|cis-3-Decenoyl-[acyl-carrier protein];|(3Z)-Dec-3-enoyl-[acp];|(3Z)-Decenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04180  (3Z)-Decenoyl-[acp],
C04181,3-Hydroxy-3-methyl-2-oxobutanoic acid;|3-Hydroxy-3-methyl-2-oxobutanoate;|2-Oxo-3-hydroxyisovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C04181  3-Hydroxy-3-methyl-2-oxobutanoic acid,
C04185,"5,6-Dihydroxyindole-2-carboxylate;|DHICA",,,,,
C04186,5-Carboxymethyl-2-hydroxymuconate,,,,,
C04187,5-Methyldeoxycytidine diphosphate,,,,,
C04188,S-Methyl-5-thio-D-ribose 1-phosphate;|S-Methyl-5-thio-alpha-D-ribose 1-phosphate;|S-Methyl-5-thio-5-deoxy-D-ribose 1-phosphate,,,,,
C04191,Dihydrostreptomycin 3''-phosphate,,,,,
C04193,Flavonol 3-O-D-xylosylgalactoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04193  Flavonol 3-O-D-xylosylgalactoside,
C04194,Flavonol 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside];|Flavonol 3-O-rutinoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04194  Flavonol 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside],
C04196,Heparosan-N-sulfate D-glucuronate;|Poly[(1->4)-beta-D-glucuronosyl-(1->4)-N-sulfo-alpha-D-glucosaminyl],The disaccharide repeating unit is shown here.|R = linear polysaccharide,,,,
C04197,Indole-3-acetyl-beta-1-D-glucoside;|1-O-(Indol-3-yl)acetyl-beta-D-glucose,,,,,
C04199,Isovitexin 2''-O-beta-D-glucoside;|Isovitexin 2''-O-glucoside;|Meloside A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04199  Isovitexin 2''-O-beta-D-glucoside|Glycosides [BR:br08021]|C-glycosides|C04199  Isovitexin 2''-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C04199,
C04201,L-Tyrosine methyl ester 4-sulfate,,,,,
C04202,Long-chain-fatty-acyl ethyl ester,Generic compound in reaction hierarchy,,,,
C04203,"N,N-Dimethyl-1,4-phenylenediamine;|N,N-Dimethyl-p-phenylenediamine;|p-Amino-N,N-dimethylaniline",,,,,
C04204,"N-(2,3-Dihydroxybenzoyl)-L-serine;|2,3-Dihydroxy-N-benzoyl-L-serine;|2,3-Dihydroxybenzoylserine",,,,,
C04205,"N-(3,4-Dichlorophenyl)-malonamate",,,,,
C04207,N-Benzoyl-4-hydroxyanthranilate,,,,,
C04208,N-Benzoyl-4-methoxyanthranilate,,,,,
C04209,"3-(Carboxycarbonylamino)-L-alanine;|N3-Oxalyl-L-2,3-diaminopropanoate;|L-alpha-Amino-beta-oxalylaminopropionic acid;|beta-ODAP",,,,,
C04210,N5-(L-1-Carboxyethyl)-L-ornithine,,,,,
C04211,N(6)-[(Indol-3-yl)acetyl]-L-lysine;|N6-[(Indol-3-yl)acetyl]-L-lysine,,,,,
C04212,"3',5'-Cyclic nucleotide;|Nucleoside 3',5'-cyclic phosphate",Generic compound in reaction hierarchy,,,,
C04213,Dolichyl diphosphooligosaccharide;|Oligosaccharide-diphosphodolichol;|Oligosaccharide-PP-Dol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C04213  Dolichyl diphosphooligosaccharide,
C04215,Phospholipid methylene fatty acid,Generic compound in reaction hierarchy|intermediate to form Tuberculostearic acid [CPD:C16794],,,,
C04216,all-trans-Heptaprenyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04216  all-trans-Heptaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C04216  all-trans-Heptaprenyl diphosphate,
C04217,"all-trans-Pentaprenyl diphosphate;|Geranylfarnesyl diphosphate;|(2E,6E,10E,14E)-Geranylfarnesyl diphosphate;|all-trans-Geranylfarnesyl diphosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0105 C25 isoprenoids (sesterterpenes)|PR010501 Acyclic sesterterpenoids|C04217  all-trans-Pentaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C04217  all-trans-Pentaprenyl diphosphate,
C04218,"alpha,alpha'-Trehalose 6-mycolate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0116 Mycolic acids|C04218  alpha,alpha'-Trehalose 6-mycolate|SL  Saccharolipids|SL03 Acyltrehaloses|C04218  alpha,alpha'-Trehalose 6-mycolate",
C04219,alpha-D-Aldosyl beta-D-fructoside;|alpha-D-Aldosyl1 beta-D-fructoside;|alpha-D-Aldosyl2 beta-D-fructoside,Generic compound in reaction hierarchy,,,,
C04221,"trans-1,2-Dihydrobenzene-1,2-diol",,,,,
C04223,(+/-)-6-Hydroxy-3-oxo-alpha-ionone,,,,,
C04225,"(Z)-But-2-ene-1,2,3-tricarboxylate;|cis-2-Methylaconitate",,,,,
C04226,"6-Oxo-1,4,5,6-tetrahydronicotinate;|1,4,5,6-Tetrahydro-6-oxonicotinate;|1,4,5,6-Tetrahydro-6-oxonicotinic acid",,,,,
C04227,Octopamine;|1-(4-Hydroxyphenyl)-2-aminoethanol;|p-Hydroxyphenylethanolamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA18 Octopamine|C04227  Octopamine|Drug groups [BR:br08330]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00225  Octopamine|C04227  Octopamine|DG01699  Catecholamine cardiotonic|DG00225  Octopamine|C04227  Octopamine,G00225
C04229,1-(Indol-3-yl)propanol 3-phosphate;|Indolepropanol phosphate,,,,,
C04230,1-Acyl-sn-glycero-3-phosphocholine;|1-Acyl-sn-glycerol-3-phosphocholine;|alpha-Acylglycerophosphocholine;|2-Lysolecithin;|2-Lysophosphatidylcholine;|1-Acylglycerophosphocholine,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C04230  2-Lysolecithin|Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0105 Monoacylglycerophosphocholines|C04230  1-Acyl-sn-glycero-3-phosphocholine,
C04232,2'-Deoxyribonucleoside diphosphate;|2'-Deoxyribonucleoside 5'-diphosphate,Generic compound in reaction hierarchy,,,,
C04233,2-Acyl-sn-glycero-3-phosphocholine;|2-Acylglycero-3-phosphocholine;|1-Lysophosphatidylcholine;|1-Lysolecithin;|3-Lysolecithin,Generic compound in reaction hierarchy|3-Lysolecithin (name based on D- numbering system and not sn- numbering),,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0105 Monoacylglycerophosphocholines|C04233  2-Acyl-sn-glycero-3-phosphocholine,
C04234,2-Carboxy-D-arabinitol 1-phosphate;|2-Carboxyarabinitol 1-phosphate,,,,,
C04235,3-Acetylenic fatty acyl thioesters,,,,,
C04236,(2S)-2-Isopropyl-3-oxosuccinate;|3-Carboxy-4-methyl-2-oxopentanoate;|2-Oxo-4-methyl-3-carboxypentanoate,,,,,
C04237,3-Hydroxy-3-methyl-2-oxopentanoic acid;|3-Hydroxy-3-methyl-2-oxopentanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C04237  3-Hydroxy-3-methyl-2-oxopentanoic acid,
C04239,5'-Dephospho-RNA 3'-mononucleotide,,,,,
C04242,5-Fluorodeoxyuridine monophosphate,,,,,
C04244,"6-Lactoyl-5,6,7,8-tetrahydropterin",,,,,
C04246,But-2-enoyl-[acyl-carrier protein];|(2E)-But-2-enoyl-[acp];|(2E)-Butenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04246  (2E)-Butenoyl-[acp],
C04247,"D-Galactosyl-(1->4)-beta-D-glucosyl-R;|D-Galactosyl-1,4-beta-D-glucosyl-R;|beta-D-Galactosyl-(1->4)-beta-D-glucosyl-R",Generic compound in reaction hierarchy,,,,
C04248,6-(alpha-D-Glucosaminyl)-1-phosphatidyl-1D-myo-inositol;|D-Glucosaminylphosphatidylinositol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C04248  6-(alpha-D-Glucosaminyl)-1-phosphatidyl-1D-myo-inositol,
C04250,DNA containing 6-O-methylguanine,Generic compound in reaction hierarchy,,,,
C04251,Deoxylimononic acid D-ring-lactone,,,,,
C04255,N-Acetyl-D-galactosamine 6-sulfate,,,,,
C04256,N-Acetyl-D-glucosamine 1-phosphate,,,,,
C04257,N-Acetyl-D-mannosamine 6-phosphate;|N-Acetylmannosamine 6-phosphate,,,,,
C04258,N-Formyl-L-methionylaminoacyl-tRNA,Generic compound in reaction hierarchy,,,,
C04259,"N,N-Dimethylhistidine;|Nalpha,Nalpha-Dimethyl-L-histidine",,,,,
C04260,O-D-Alanyl-poly(ribitol phosphate),,,,,
C04261,Protein N(pi)-phospho-L-histidine;|Protein N-pros-phospho-L-histidine;|Protein N-pros-phosphohistidine;|Protein Npi-phospho-L-histidine,Generic compound in reaction hierarchy,,,,
C04262,Protein N(tau)-phospho-L-histidine;|Protein N-tele-phospho-L-histidine;|Protein N-tele-phosphohistidine,Generic compound in reaction hierarchy,,,,
C04264,3-[(4-Bromophenyl)sulfanyl]-2-oxopropanoate;|S-(4-Bromophenyl)-mercaptopyruvate,,,,,
C04265,"alpha,alpha'-Trehalose 6-palmitate",,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C04265  alpha,alpha'-Trehalose 6-palmitate",
C04268,"dTDP-4-amino-4,6-dideoxy-D-glucose;|dTDP-4-amino-4,6-dideoxy-alpha-D-glucose;|dTDP-viosamine;|dTDP-4-amino-4,6-dideoxy-alpha-D-glucopyranose",,,,,
C04271,"3,9-Dihydroxypterocarpan;|(6aR,11aR)-3,9-Dihydroxypterocarpan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C04271  3,9-Dihydroxypterocarpan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C04271  3,9-Dihydroxypterocarpan",
C04272,"(R)-2,3-Dihydroxy-3-methylbutanoate;|(R)-2,3-Dihydroxy-isovalerate;|(R)-2,3-Dihydroxy-isovaleric acid;|(2R)-2,3-Dihydroxy-3-methylbutanoate;|(2R)-2,3-Dihydroxy-3-methylbutanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C04272  (2R)-2,3-Dihydroxy-3-methylbutanoic acid",
C04273,(S)-Mandelonitrile beta-D-glucoside,,,,,
C04274,"1,2-Epoxy-3-(p-Nitrophenoxy)propane;|EPNP",,,,,
C04275,"1,2-Bis-O-sinapoyl-beta-D-glucose;|1,2-Bis-O-sinapoyl-beta-D-glucoside",,,,,
C04276,"1,6-alpha-D-Mannosyloligosaccharide",,,,,G10509
C04277,"1,8-Diazacyclotetradecane-2,9-dione",,,,,
C04280,1-Guanidino-1-deoxy-scyllo-inositol;|Amidino-scyllo-inosamine,,,,,
C04281,"L-1-Pyrroline-3-hydroxy-5-carboxylate;|3-Hydroxy-L-1-pyrroline-5-carboxylate;|(3R,5S)-1-Pyrroline-3-hydroxy-5-carboxylate;|(3R,5S)-3-Hydroxy-1-pyrroline-5-carboxylate",,,,,
C04282,1-Pyrroline-4-hydroxy-2-carboxylate,,,,,
C04284,2-Heptyl-4-hydroxyquinoline-N-oxide;|HQNO,,,,,
C04285,"3,5-Dibromo-4-hydroxyphenylpyruvate",,,,,
C04286,"3,5-Dinitro-4-hydroxyphenylpyruvate",,,,,
C04287,"3D-3,5/4-Trihydroxycyclohexane-1,2-dione;|D-2,3-Diketo-4-deoxy-epi-inositol;|(3R,4S,5R)-3,4,5-Trihydroxy-1,2-cyclohexanedione;|3,5/4-Trihydroxycyclohexa-1,2-dione",,,,,
C04290,4-(3-Methylbut-2-enyl)-L-tryptophan;|4-Dimethylallyl-L-tryptophan;|4-Prenyl-L-tryptophan;|4-(3-Methylbut-2-en-1-yl)-L-tryptophan,,,,,
C04291,4-(Dimethylamino)phenylazoxybenzene,,,,,
C04292,5'-Phosphonucleoside 3'-diphosphate,Generic compound in reaction hierarchy,,,,
C04293,"Chrysoeriol;|5,7,4'-Trihydroxy-3'-methoxyflavone;|3'-O-Methylluteolin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04293  Chrysoeriol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C04293  Chrysoeriol,
C04294,5-(2-Hydroxyethyl)-4-methylthiazole;|4-Methyl-5-(2'-hydroxyethyl)-thiazole;|4-Methyl-5-(2-hydroxyethyl)thiazole;|HET,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Thiazole alkaloids|C04294  5-(2-Hydroxyethyl)-4-methylthiazole,
C04295,"Androstenediol;|Androst-5-ene-3beta,17beta-diol;|3beta,17beta-Dihydroxyandrost-5-ene;|3beta,17beta-Dihydroxy-5-androstene",,,,"Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C04295  Androstenediol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04295  3beta,17beta-Dihydroxyandrost-5-ene",
C04297,"CDP-4-dehydro-3,6-dideoxy-D-glucose;|CDP-3,6-dideoxy-D-erythro-hexos-4-ulose;|CDP-4-dehydro-3,6-dideoxy-alpha-D-glucose",,,,,
C04298,Holo-[citrate (pro-3S)-lyase],Generic compound in reaction hierarchy,,,,
C04299,"D-myo-Inositol 1,2-cyclic phosphate;|1D-myo-Inositol 1,2-cyclic phosphate",,,,,
C04300,Estradiol-17alpha 3-D-glucuronoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C04300  Estradiol-17alpha 3-D-glucuronoside|ST05 Steroid conjugates|ST0501 Glucuronides|C04300  Estradiol-17alpha 3-D-glucuronoside,
C04301,N(alpha)-t-Butoxycarbonyl-L-leucine,,,,,
C04302,N-(5-Phospho-D-ribosyl)anthranilate;|N-(5-Phospho-beta-D-ribosyl)anthranilate;|N-(5-Phosphoribosyl)anthranilic acid,,,,Glycosides [BR:br08021]|N-glycosides|C04302  N-(5-Phospho-D-ribosyl)anthranilate,
C04303,N-Benzoyl-D-arginine-4-nitroanilide;|Bz-Arg-p-nitroanilide,,,,,
C04305,N-Long-chain-fatty-acyl-L-glutamate,Generic compound in reaction hierarchy,,,,
C04307,"P1,P2-Bis(5'-adenosyl) triphosphate",,,,,
C04308,Phosphatidyl-N-dimethylethanolamine,Generic compound in reaction hierarchy,,,,
C04309,Phosphoenol-4-deoxy-3-tetrulosonate,,,,,
C04311,Protein L-isoaspartate methyl ester;|Protein L-isoaspartate alpha-methyl ester,Generic compound in reaction hierarchy,,,,
C04312,"RNA terminal-2',3'-cyclic-phosphate",Generic compound in reaction hierarchy,,,,
C04313,beta-Substituted alpha-L-amino acid,,,,,
C04314,"cis-1,2-Dihydronaphthalene-1,2-diol;|(1R,2S)-1,2-Dihydronaphthalene-1,2-diol",,,,,
C04315,2-Acyl-3-O-(beta-D-galactosyl)-sn-glycerol;|Monogalactosyl-monoacylglycerol;|Gal-beta1->3acyl1Gro;|Galbeta1->3acyl1Gro;|Mono-beta-D-galactosylacylglycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL04 Glycosylmonoradylglycerols|GL0401 Glycosylmonoacylglycerols|C04315  sn-3-D-Galactosyl-sn-2-acylglycerol,
C04316,(1-Hydroxycyclohexan-1-yl)acetyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C04316  (1-Hydroxycyclohexan-1-yl)acetyl-CoA,
C04317,1-Organyl-2-lyso-sn-glycero-3-phosphocholine;|1-Radyl-2-lyso-sn-glycero-3-phosphocholine;|1-Alkyl-2-lyso-sn-glycero-3-phosphocholine;|1-Alkyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0106 Monoalkylglycerophosphocholines|C04317  1-Alkyl-2-lyso-sn-glycero-3-phosphocholine,
C04318,11-O-Demethyl-17-O-deacetylvindoline,,,,,
C04322,"Delta1-Pyrroline-5-carboxylate;|3,4-Dihydro-2H-pyrrole-2-carboxylate",,,,,
C04323,"3,5-Dichloro-4-hydroxyphenylpyruvate",,,,,
C04324,"(1E,3E)-4-Hydroxybuta-1,3-diene-1,2,4-tricarboxylate;|2-Hydroxy-4-carboxyhexa-2,4-dienedioate;|4-Carboxy-2-hydroxy-cis,cis-muconate;|4-Carboxy-2-hydroxyhexa-2,4-cis,cis-dienedioate;|(1E,3E)-4-Hydroxybuta-1,3-diene-1,2,4-tricarboxylic acid",4-oxalomesaconate (keto tautomer) [CPD:C04434],,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C04324  (1E,3E)-4-Hydroxybuta-1,3-diene-1,2,4-tricarboxylic acid",
C04327,4-Methyl-5-(2-phosphooxyethyl)thiazole;|4-Methyl-5-(2-phosphonooxyethyl)thiazole;|5-(2-Hydroxyethyl)-4-methylthiazole phosphate;|HET-P,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Thiazole alkaloids|C04327  4-Methyl-5-(2-phosphoethyl)-thiazole,
C04328,5'-Phosphomonoester oligonucleotides,,,,,
C04330,"5,10-Methenyltetrahydromethanopterin;|5,10-Methenyl-5,6,7,8-tetrahydromethanopterin;|N5,N10-Methenyltetrahydromethanopterin",,,,,
C04332,"6,7-Dimethyl-8-(D-ribityl)lumazine",,,,,
C04333,"Bis-D-fructose 2',1:2,1'-dianhydride;|Difructose anhydride I",,,,,
C04334,Acetyl-[citrate (pro-3S)-lyase],Generic compound in reaction hierarchy,,,,
C04335,N(alpha)-Benzyloxycarbonyl-L-leucine,,,,,
C04336,N-Glycolyl-D-mannosamine 6-phosphate,,,,,
C04337,N(omega)-Nitro-L-arginine methyl ester;|N(G)-Nitro-L-arginine methyl ester,,,,,
C04339,Peptide N-(ADP-D-ribosyl)diphthamide;|EF-2 N-(ADP-D-ribosyl)diphthamide;|Elongation factor 2 N-(ADP-D-ribosyl)diphthamide,Generic compound in reaction hierarchy|Elongation factor 2 inactivated by diphtheria toxin,,,,
C04340,Phospholipid cyclopropane fatty acid,Generic compound in reaction hierarchy,,,,
C04341,Ribosomal-protein N-acetyl-L-alanine,Generic compound in reaction hierarchy,,,,
C04342,Soluble variant-surface-glycoprotein,Generic compound in reaction hierarchy,,,,
C04346,"dTDP-4-amino-4,6-dideoxy-D-galactose;|dTDP-4-amino-4,6-dideoxy-alpha-D-galactose",,,,,
C04347,"(+)-2,3-Dienoyl fatty acyl thioesters",,,,,
C04348,L-Malyl-CoA;|(S)-Malyl-CoA;|Malyl-CoA;|(3S)-3-Carboxy-3-hydroxypropanoyl-CoA;|(3S)-3-Carboxy-3-hydroxypropionyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C04348  (S)-Malyl-CoA,
C04349,"(4S)-4,6-Dihydroxy-2,5-dioxohexanoate;|3-Deoxy-D-glycero-2,5-hexodiulosonate;|2,5-Diketo-3-deoxy-D-gluconate;|3-Deoxy-D-glycero-hexo-2,5-diulosonic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C04349  3-Deoxy-D-glycero-hexo-2,5-diulosonic acid",
C04350,(E)-4-Hydroxyphenylacetaldehyde oxime;|(E)-[4-Hydroxyphenylacetaldehyde oxime],,,,,
C04351,(R)-2-Methylimino-1-phenylpropan-1-ol,,,,,
C04352,(R)-4'-Phosphopantothenoyl-L-cysteine;|N-[(R)-4'-Phosphopantothenoyl]-L-cysteine,,,,,
C04353,(Z)-4-Hydroxyphenylacetaldehyde oxime;|(Z)-[4-Hydroxyphenylacetaldehyde oxime],,,,,
C04354,"1,2-beta-D-Glucuronosyl-D-glucuronate;|(1->2)-beta-D-Glucuronosyl-D-glucuronate",,,,,G00301
C04359,1-Deoxy-D-altro-heptulose 7-phosphate,,,,,
C04360,"1-O,2-O,6-O-Trigalloyl-beta-D-glucose;|1,2,6-Trigalloylglucose",,,,,
C04361,1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol;|2-Acetyl-1-O-alkyl-3-acyl-sn-glycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0302 Alkyldiacylglycerols|C04361  1-O-Alkyl-2-acetyl-3-acyl-sn-glycerol,
C04365,3'-Hydroxy-terminated oligonucleotide,,,,,
C04366,"3-(2-Carboxyethenyl)-cis,cis-muconate",,,,,
C04367,"3-(3,5-Diiodo-4-hydroxyphenyl)lactate",,,,,
C04368,3-Amino-3-(4-hydroxyphenyl)propanoate;|beta-Tyrosine,,,,,
C04371,3-Sulfanyl-2-(sulfanylmethyl)propanoate;|3-Mercapto-2-mercaptomethylpropanoate,,,,,
C04372,3-O-L-Alanyl-1-O-phosphatidylglycerol,Generic compound in reaction hierarchy,,,,
C04373,Etiocholanolone;|3alpha-Hydroxy-5beta-androstan-17-one;|Etiocholan-3alpha-ol-17-one;|3alpha-Hydroxyetiocholan-17-one,,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C04373  Etiocholanolone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04373  3alpha-Hydroxy-5beta-androstan-17-one,
C04375,4-N-(N-Acetyl-D-glucosaminyl)-protein;|Peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine,Generic compound in reaction hierarchy,,,,
C04376,5'-Phosphoribosyl-N-formylglycinamide;|N-Formyl-GAR;|N-Formylglycinamide ribonucleotide;|N2-Formyl-N1-(5-phospho-D-ribosyl)glycinamide;|N2-Formyl-N1-(5-phospho-beta-D-ribosyl)glycinamide,,,,,
C04377,"5,10-Methylenetetrahydromethanopterin;|N5,N10-Methylenetetrahydromethanopterin",,,,,
C04378,7-alpha-D-Ribosyladenine 5'-phosphate,,,,,
C04379,"9,11alpha-Epoxypregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C04379  9,11alpha-Epoxypregn-4-ene-3,20-dione",
C04381,"DNA 4,6-diamino-5-formamidopyrimidine",Generic compound in reaction hierarchy,,,,
C04382,Dihydrostreptomycin 3'alpha-phosphate,,,,,
C04384,Heparan sulfate alpha-D-glucosaminide,,,,,
C04385,Flavonol 3-O-(6-O-malonyl-beta-D-glucoside),Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04385  Flavonol 3-O-(6-O-malonyl-beta-D-glucoside),
C04386,Myelin proteolipid O-palmitoylprotein;|O-Palmitoyl-[myelin proteolipid],Generic compound in reaction hierarchy,,,,
C04387,N-Acetyl-alpha-D-galactosaminyl-polypeptide;|N-Acetyl-alpha-D-galactosaminyl-R;|N-Acetyl-D-galactosaminyl-polypeptide;|N-Acetyl-D-galactosaminyl-R;|Tn antigen,Generic compound in reaction hierarchy|R = Ser/Thr residue of glycoprotein,,,,G00023
C04390,"N6-Acetyl-LL-2,6-diaminoheptanedioate;|N2-Acetyl-LL-2,6-diaminoheptanedioate;|N6-Acetyl-LL-2,6-diaminopimelate;|N2-Acetyl-LL-2,6-diaminopimelate;|N6-Acetyl-L-2,6-diaminoheptanedioate;|N6-Acetyl-L-2,6-diaminopimelate;|N-Acetyl-LL-2,6-diaminoheptanedioate",,,,,
C04391,O-Phospho-microsomal-membrane protein,Generic compound in reaction hierarchy,,,,
C04392,"P1,P4-Bis(5'-xanthosyl) tetraphosphate;|XppppX",,,,,
C04394,Peptidoglycan(N-acetyl-D-glucosamine);|Peptideglycan(N-acetyl-D-glucosamine),"Generic compound in reaction hierarchy|R = tetrapeptide, pentapeptide or cross-linked peptide",,,,
C04397,Procollagen trans-3-hydroxy-L-proline;|[Procollagen]-trans-3-hydroxy-L-proline,Generic compound in reaction hierarchy,,,,
C04398,Procollagen trans-4-hydroxy-L-proline,Generic compound in reaction hierarchy,,,,
C04399,S-Methyl-3-phospho-1-thio-D-glycerate,,,,,
C04403,beta-D-Glucosyl-1-phosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C04403  beta-D-Glucosyl-1-phosphoundecaprenol,
C04404,trans-4-Hydroxycyclohexanecarboxylate;|trans-4-Hydroxycyclohexane-1-carboxylate,,,,,
C04405,"(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA;|(S)-3-Hydroxy-2-methylbutyryl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C04405  (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA",
C04409,2-Amino-3-carboxymuconate semialdehyde;|2-Amino-3-(3-oxoprop-1-enyl)-but-2-enedioate;|2-Amino-3-(3-oxoprop-1-en-1-yl)but-2-enedioate,,,,,
C04411,"(2R,3S)-3-Isopropylmalate;|3-Isopropylmalate;|3-Carboxy-2-hydroxy-4-methylpentanoate;|2-D-threo-Hydroxy-3-carboxy-isocaproate",,,,,
C04415,4-O-beta-D-Glucosyl-4-hydroxycinnamate,,,,,
C04416,"5alpha-Ergosta-7,22-diene-3beta,5-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C04416  5alpha-Ergosta-7,22-diene-3beta,5-diol|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C04416  5alpha-Ergosta-7,22-diene-3beta,5-diol",
C04417,"6-alpha-D-(1,4-alpha-D-Glucano)-glucan",,,,,
C04418,"N-Acetyl-L-phenylalanyl-L-diiodotyrosine;|N-Acetylphenylalanyl-3,5-diiodotyrosine",,,,,
C04419,Carboxybiotin-carboxyl-carrier protein;|[Biotin carboxyl-carrier protein]-carboxybiotin-N6-L-lysine;|[Biotin carboxyl-carrier protein]-N6-carboxybiotinyl-L-lysine,Generic compound in reaction hierarchy,,,,
C04420,"alpha-D-Fructofuranose-beta-D-fructofuranose 2',1:2,3'-dianhydride;|Di-D-fructofuranose 1,2':2,3'-dianhydride;|Difructose anhydride III",,,,,
C04421,"N-Succinyl-LL-2,6-diaminoheptanedioate;|N-Succinyl-LL-2,6-diaminopimelate;|N-Succinyl-L-2,6-diaminoheptanedioate;|N-Succinyl-L-2,6-diaminopimelate",,,,,
C04422,N6-Alkylaminopurine-7-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|N-glycosides|C04422  N6-Alkylaminopurine-7-beta-D-glucoside,
C04423,Nicotinamide hypoxanthine dinucleotide,,,,,
C04424,S-(2-Methylpropanoyl)-dihydrolipoamide;|S-(2-Methylpropionyl)-dihydrolipoamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C04424  S-(2-Methylpropanoyl)-dihydrolipoamide,
C04425,S-Adenosyl-4-methylthio-2-oxobutanoate;|S-Adenosyl-4-(methylsulfanyl)-2-oxobutanoate,,,,,
C04426,UDP-N-acetyl-D-galactosamine 4-sulfate,,,,,
C04428,alpha-D-Galactosyl-N-acetyllactosamine,,,,,
C04429,beta-D-Glucosylpoly(ribitol phosphate),,,,,G10559
C04431,cis-4-Carboxymethylenebut-2-en-4-olide;|4-Carboxymethylenebut-2-en-4-olide,,,,,
C04432,tRNA containing 6-isopentenyladenosine;|N6-(3-Methylbut-2-en-1-yl)-adenosine in tRNA;|N6-(3-Methylbut-2-en-1-yl)-adenine in tRNA;|N6-Dimethylallyladenine in tRNA,Generic compound in reaction hierarchy,,,,
C04433,"(6E)-8-Hydroxylinalool;|(E)-3,7-Dimethylocta-1,6-diene-3,8-diol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C04433  (E)-3,7-Dimethylocta-1,6-diene-3,8-diol|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C04433  (6E)-8-Hydroxylinalool",
C04434,"(1E)-4-Oxobut-1-ene-1,2,4-tricarboxylate;|4-Oxalomesaconate;|4-Oxalmesaconic acid","4-Carboxy-2-hydroxy-cis,cis-muconate (enol tautomer) [CPD:C04324]",,,,
C04435,"(Z)-2-Methyl-5-isopropylhexa-2,5-dienal;|cis-2-Methyl-5-isopropylhexa-2,5-dienal",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010202 Irregular acyclic monoterpenoids|C04435  cis-2-Methyl-5-isopropylhexa-2,5-dienal",
C04437,1-(5-Phosphoribosyl)imidazole-4-acetate,,,,Glycosides [BR:br08021]|N-glycosides|C04437  1-(5-Phosphoribosyl)imidazole-4-acetate,
C04438,1-Acyl-sn-glycero-3-phosphoethanolamine;|L-2-Lysophosphatidylethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0205 Monoacylglycerophosphoethanolamines|C04438  1-Acyl-sn-glycero-3-phosphoethanolamine,
C04441,Peptide 2-(3-carboxy-3-aminopropyl)-L-histidine;|2-(3-Carboxy-3-aminopropyl)-L-histidine;|EF-2 2-(3-carboxy-3-aminopropyl)-L-histidine;|2-[(3S)-3-Amino-3-carboxypropyl]-L-histidine-[translation elongation factor 2],Generic compound in reaction hierarchy|Precursor of Diphthamide [CPD:C02872]|Modified histidine residue of elongation factor 2(EF-2),,,,
C04442,2-Dehydro-3-deoxy-6-phospho-D-gluconate;|6-Phospho-2-dehydro-3-deoxy-D-gluconate;|2-Keto-3-deoxy-6-phosphogluconate;|2-Dehydro-3-deoxy-D-gluconate 6-phosphate,,,,,
C04443,"3-O-Methylquercetin;|3',4',5,7-Tetrahydroxy-3-methoxyflavone;|3-Methoxy-5,7,3',4'-tetrahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04443  3-O-Methylquercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04443  3-O-Methylquercetin,
C04444,"3,7,4'-Tri-O-methylquercetin;|3',5-Dihydroxy-3,4',7-trimethoxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04444  3,7,4'-Tri-O-methylquercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04444  3,7,4'-Tri-O-methylquercetin",
C04445,"3,4-Dehydrothiomorpholine-3-carboxylate",,,,,
C04446,"3-(3,4-Dihydroxypyridin-1-yl)-L-alanine",,,,,
C04447,3-Carboxy-4-methoxy-N-methyl-2-pyridone,,,,,
C04448,3-Hydroxymethyl ceph-3-em-4-carboxylate,Generic compound in reaction hierarchy,,,,
C04452,4-Nitrophenol-alpha-D-galactopyranoside,,,,,
C04453,4alpha-Methyl-5alpha-cholest-7-en-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C04453  4alpha-Methyl-5alpha-cholest-7-en-3-one,
C04454,"5-Amino-6-(5'-phospho-D-ribitylamino)uracil;|5-Amino-2,6-dioxy-4-(5'-phospho-D-ribitylamino)pyrimidine;|5-Amino-6-(5-phospho-D-ribitylamino)uracil",,,,,
C04457,D-Alanyl-alanyl-poly(glycerolphosphate),Generic compound in reaction hierarchy,,,,
C04458,"Dihydrostreptomycin 6,3''-bis-phosphate",,,,,
C04459,Glucuronoxylan 4-O-methyl-D-glucuronate;|4-O-Methylglucuronoxylan,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001(G11623)]|Carbohydrates|Polysaccharides|Heteropolysaccharides|G11623  4-O-Methylglucuronoxylan,G11623
C04461,"N-Acetyl-D-glucosamine 1,6-bisphosphate;|N-Acetyl-alpha-D-glucosamine 1,6-bisphosphate",,,,,
C04462,N-Succinyl-2-L-amino-6-oxoheptanedioate;|N-Succinyl-L-2-amino-6-oxoheptanedioate;|N-Succinyl-L-2-amino-6-oxopimelate;|N-Succinyl-2-amino-6-oxo-L-pimelic acid;|N-Succinyl-epsilon-keto-L-aminopimelic acid;|(S)-2-(Succinylamino)-6-oxoheptanedioate,,,,,
C04465,"alpha,alpha'-Trehalose 6,6'-bismycolate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0116 Mycolic acids|C04465  alpha,alpha'-Trehalose 6,6'-bismycolate|SL  Saccharolipids|SL03 Acyltrehaloses|C04465  alpha,alpha'-Trehalose 6,6'-bismycolate",
C04466,"alpha-2,8-Linked polymer of sialic acid;|Poly(sialoside)",Generic compound in reaction hierarchy|R = CH3 [CPD:C04799] or CH2OH|Hydroxy groups may be also acylated.,,,,
C04468,"(+)-cis-3,4-Dihydrophenanthrene-3,4-diol;|cis-3,4-Dihydroxy-3,4-dihydrophenanthrene",,,,,
C04469,(+/-)-2-(4'-Isobutylphenyl)propionitrile,,,,,
C04471,"(4S,5S)-4,5-Dihydroxy-2,6-dioxohexanoate;|4-Deoxy-L-erythro-hex-5-ulosuronic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C04471  4-Deoxy-L-erythro-hex-5-ulosuronic acid,
C04475,1-Alkyl-2-acylglycerophosphoethanolamine;|1-Radyl-2-acyl-sn-glycero-3-phosphoethanolamine;|1-Organyl-2-acyl-sn-glycero-3-phosphoethanolamine;|O-1-Alkyl-2-acyl-sn-glycero-3-phosphoethanolamine;|2-Acyl-1-alkyl-sn-glycero-3-phosphoethanolamine;|Plasmanylethanolamine,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0202 1-alkyl,2-acylglycerophosphoethanolamines|C04475  2-Acyl-1-alkyl-sn-glycero-3-phosphoethanolamine",
C04476,1-Alkyl-sn-glycero-3-phosphoethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0206 Monoalkylglycerophosphoethanolamines|C04476  1-Alkyl-sn-glycero-3-phosphoethanolamine,
C04477,"1D-myo-Inositol 1,3,4,6-tetrakisphosphate;|D-myo-Inositol 1,3,4,6-tetrakisphosphate;|Inositol 1,3,4,6-tetrakisphosphate",,,,,
C04478,3-Deoxy-D-manno-octulosonate 8-phosphate;|2-Dehydro-3-deoxy-D-octonate 8-phosphate,,,,,
C04479,"2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate;|(2Z,4E)-2-Hydroxy-6-oxonona-2,4-diene-1,9-dioate",,,,,
C04480,3-Carboxy-2-hydroxymuconate semialdehyde,,,,,
C04482,3-O-L-Lysyl-1-O-phosphatidylglycerol,Generic compound in reaction hierarchy,,,,
C04483,"Deoxycholic acid;|Deoxycholate;|3alpha,12alpha-Dihydroxy-5beta-cholanate;|3alpha,12alpha-Dihydroxy-5beta-cholanic acid",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C04483  Deoxycholic acid|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C04483  3alpha,12alpha-Dihydroxy-5beta-cholanic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10781)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX24 Deoxycholic acid|D10781  Deoxycholic acid (NF/INN) &lt;US&gt;|USP drug classification [BR:br08302(D10781)]|Dermatological Agents|Dermatological Agents, Other|Dermatological Agents, Miscellaneous|Deoxycholic Acid|D10781  Deoxycholic acid (NF/INN)|New drug approvals in the USA [br08319.html(D10781)]|New molecular entities and new therapeutic biological products|D10781|New drug approvals in the USA, Europe and Japan [br08328.html(D10781)]|Approval dates by FDA, EMA and PMDA|D10781",
C04484,"4-Carboxy-2-hydroxymuconate semialdehyde;|4-Carboxy-2-hydroxy-cis,cis-muconate 6-semialdehyde",,,,,
C04485,"5-(4-Acetoxybut-1-ynyl)-2,2'-bithiophene",,,,,
C04486,"5-(4-Hydroxybut-1-ynyl)-2,2'-bithiophene;|3-Butyn-1-ol, 4-(5-(2-thienyl)-2-thienyl)-",,,,,
C04487,5-(D-Galactosyloxy)-L-lysine-procollagen;|Procollagen 5-(D-galactosyl)-L-lysine;|Procollagen 5-(D-galactosyloxy)-L-lysine;|Procollagen beta-D-galactosyl-L-hydroxylysine,Generic compound in reaction hierarchy,,,,
C04488,"5-Methyl-5,6,7,8-tetrahydromethanopterin;|5-Methyltetrahydromethanopterin;|5-Methyl-H4MPT;|5-Methyl-THMPT",,,,,
C04489,5-Methyltetrahydropteroyltri-L-glutamate,,,,,
C04491,Cyanidin 3-rutinoside chloride;|Cyanidin-3-rhamnoglucoside chloride;|Keracyanin chloride,Cyanidin 3-O-rutinoside [CPD:C08620],,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C04491  Cyanidin 3-rutinoside chloride|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C04491  Cyanidin-3-rhamnoglucoside chloride|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C04491  Cyanidin-3-rhamnoglucoside chloride,
C04494,"Guanosine 3'-diphosphate 5'-triphosphate;|Guanosine 5'-triphosphate,3'-diphosphate",,,,,
C04498,p-Coumaroylagmatine;|N-(4-Guanidinobutyl)-4-hydroxycinnamide;|N-(4-Guanidinobutyl)-4-hydroxycinnamamide,,,,,
C04500,N-Acetyl-D-glucosaminyldiphosphodolichol;|N-Acetyl-D-glucosaminyl-diphosphodolichol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C04500  N-Acetyl-D-glucosaminyldiphosphodolichol,G00001
C04501,N-Acetyl-alpha-D-glucosamine 1-phosphate,,,,,
C04502,N-Acetyl-beta-D-glucosaminyl-glycopeptide,Generic compound in reaction hierarchy,,,,
C04503,N'-Phosphoguanidinoethyl methyl phosphate,,,,,
C04504,N3-Acetyl-2-deoxystreptamine antibiotic;|N3'-Acetyl-2-deoxystreptamine antibiotic,Generic compound in reaction hierarchy,,,,
C04505,Polysialic acid acetylated at O-7,Generic compound in reaction hierarchy,,,,
C04506,Protein C-terminal S-farnesyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C04507,alpha-D-Galactosyl-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04507  alpha-D-Galactosyl-diphosphoundecaprenol,
C04508,alpha-D-Glucosylpoly(glycerol phosphate),,,,,
C04509,"di-trans,poly-cis-Decaprenyl diphosphate;|ditrans,heptacis-Decaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04509  di-trans,poly-cis-Decaprenyl diphosphate",
C04510,3-[(3S)-3-Amino-3-carboxypropyl]-uridine in tRNA;|tRNA 3-(3-amino-3-carboxypropyl)-uridine;|acp3U in tRNA,Generic compound in reaction hierarchy,,,,
C04511,tRNA(Asp)-O-5''-beta-D-mannosylqueuosine,Generic compound in reaction hierarchy,,,,
C04512,"(2E,4E)-2,4-Dienoyl-CoA;|trans,trans-2,3,4,5-Tetradehydroacyl-CoA",Generic compound in reaction hierarchy,,,,
C04514,"(1S,2S)-1,2-Dihydronaphthalene-1,2-diol;|trans-1,2-Dihydronaphthalene-1,2-diol",,,,,
C04515,(3S)-3-Hydroxyacyl-N-acylthioethanolamine,,,,,
C04516,"1,2,3,6-Tetrakis-O-galloyl-beta-D-glucose;|1,2,3,6-Tetra-O-galloyl-beta-D-glucose",,,,,
C04517,1-(1-Alkenyl)-sn-glycero-3-phosphocholine;|1-Alkenyl-sn-glycero-3-phosphocholine;|1-Alkenylglycerophosphocholine;|1-O-Alk-1-enyl-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0107 1Z-alkenylglycerophosphocholines|C04517  1-(1-Alkenyl)-sn-glycero-3-phosphocholine,
C04518,"17alpha,20alpha-Dihydroxypregn-4-en-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C04518  17alpha,20alpha-Dihydroxypregn-4-en-3-one",
C04520,"1D-myo-Inositol 3,4,5,6-tetrakisphosphate;|D-myo-Inositol 3,4,5,6-tetrakisphosphate;|Inositol 3,4,5,6-tetrakisphosphate",,,,,
C04521,"2,7-Anhydro-alpha-N-acetylneuraminic acid",,,,,
C04522,"2-Chloro-2,5-dihydro-5-oxofuran-2-acetate;|5-Chloro-2,5-dihydro-2-oxofuran-5-acetate;|2-Chloro-5-oxo-2,5-dihydrofuran-2-acetate;|(2R)-2-Chloro-2,5-dihydro-5-oxofuran-2-acetate;|(+)-4-Chloromuconolactone",,,,,
C04524,"2-Protocatechoylphloroglucinolcarboxylate;|2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate",,,,,
C04525,Fecosterol;|24-Methylene-5alpha-cholest-8-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C04525  24-Methylene-5alpha-cholest-8-en-3beta-ol|ST0103 Ergosterols and C24-methyl derivatives|C04525  Fecosterol,
C04526,3'-Deoxydihydrostreptomycin 3''-phosphate,,,,,
C04527,"Corniculatusin;|3,3',4',5,7-Pentahydroxy-8-methoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04527  Corniculatusin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04527  Corniculatusin,
C04529,"(3S,4S)-3-Hydroxytetradecane-1,3,4-tricarboxylate;|(3S,4S)-3-Hydroxytetradecane-1,3,4-tricarboxylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C04529  (3S,4S)-3-Hydroxytetradecane-1,3,4-tricarboxylic acid",
C04530,"4,4-Dimethyl-5alpha-cholest-7-en-3beta-ol;|4,4-Dimethylcholest-7-ene-3-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C04530  4,4-Dimethyl-5alpha-cholest-7-en-3beta-ol",
C04534,"6-Phospho-beta-D-glucosyl-(1,4)-D-glucose;|Cellobiose 6'-phosphate;|Cellobiose 6-phosphate",,,,,G10518
C04535,"7-Methyl-2-hydroxy-6-oxoocta-2,4-dienoate",,,,,
C04536,Magnesium protoporphyrin monomethyl ester;|Magnesium-protoporphyrin IX 13-monomethyl ester;|Mg-protoporphyrin IX 13-monomethyl ester;|Magnesium protoporphyrin IX 13-methyl ester,,,,,
C04537,"N,N'-Diacetylchitobiosyldiphosphodolichol;|Chitobiosyldiphosphodolichol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C04537  N,N'-Diacetylchitobiosyldiphosphodolichol",G00002
C04540,N4-(Acetyl-beta-D-glucosaminyl)asparagine;|N4-(beta-N-Acetyl-D-glucosaminyl)-L-asparagine;|1-beta-Aspartyl-N-acetyl-D-glucosaminylamine,,,,,
C04541,N5-Dinitrophenyl-L-ornithine methyl ester,,,,,
C04542,Protein beta-D-galactosyl-L-hydroxylysine,Generic compound in reaction hierarchy,,,,
C04543,"Buthionine sulfoximine;|S-Butyl-DL-homocysteine-[S,R]-sulfoximine",,,,,
C04544,gamma-L-Glutamyl-L-cysteinyl-beta-alanine,,,,,
C04545,tRNA containing 2'-O-methylguanosine,Generic compound in reaction hierarchy,,,,
C04546,(R)-3-((R)-3-Hydroxybutanoyloxy)butanoate,,,,,
C04547,"1,2-Bis(4-hydroxy-3-methoxyphenyl)ethylene",,,,,
C04548,Synephrine;|(+/-)-Synephrine;|1-(4-Hydroxyphenyl)-2-(methylamino)ethanol,(-)-Synephrine [CPD:C01869],,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07148)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA08 Oxedrine|D07148  Oxedrine (BAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA06 Oxedrine|D07148  Oxedrine (BAN)|Drug groups [BR:br08330(D07148)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00217  Oxedrine|D07148  Oxedrine|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG00217  Oxedrine|D07148  Oxedrine,
C04549,"1-Phosphatidyl-1D-myo-inositol 3-phosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP07 Glycerophosphoinositol monophosphates|GP0701 Diacylglycerophosphoinositol monophosphates|C04549  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate)",
C04552,"Chrysosplenol D;|3',4',5-Trihydroxy-3,6,7-trimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04552  Chrysosplenol D|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04552  Chrysosplenol D,
C04553,"3-Carboxy-2,5-dihydro-5-oxofuran-2-acetate;|4-Carboxy-2,5-dihydro-2-oxofuran-5-acetate",,,,,
C04554,"3alpha,7alpha-Dihydroxy-5beta-cholestanate;|3alpha,7alpha-Dihydroxy-5beta-cholestanoate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C04554  3alpha,7alpha-Dihydroxy-5beta-cholestanoic acid",
C04555,Dehydroepiandrosterone sulfate;|3beta-Hydroxyandrost-5-en-17-one 3-sulfate;|DHEA sulfate,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Androgens|C04555  Dehydroepiandrosterone sulfate|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C04555  3beta-Hydroxyandrost-5-en-17-one 3-sulfate,
C04556,4-Amino-2-methyl-5-(phosphooxymethyl)pyrimidine;|(4-Amino-2-methylpyrimidin-5-yl)methyl phosphate;|4-Amino-5-hydroxymethyl-2-methylpyrimidine phosphate;|HMP-P,,,,,
C04558,"3-Methylmuconolactone;|4-Carboxymethyl-3-methylbut-2-en-1,4-olide",,,,,
C04559,"4-Methylmuconolactone;|4-Carboxymethyl-4-methylbut-2-en-1,4-olide",,,,,
C04561,"Benzyl (2R,3S)-2-methyl-3-hydroxybutanoate",,,,,
C04562,"Benzyl (2S,3S)-2-methyl-3-hydroxybutanoate",,,,,
C04563,"D-myo-Inositol 1,2,4,5,6-pentakisphosphate;|1D-myo-Inositol 1,2,4,5,6-pentakisphosphate;|myo-Inositol 1,2,4,5,6-pentakisphosphate;|Inositol 1,2,4,5,6-pentakisphosphate",,,,,
C04564,[Isocitrate dehydrogenase (NADP+)] phosphate,Generic compound in reaction hierarchy,,,,
C04565,Low-density lipoprotein O-phospho-L-serine,Generic compound in reaction hierarchy,,,,
C04572,S-(N-Hydroxy-N-methylcarbamoyl)glutathione,,,,,
C04573,UDP-N-acetyl-2-amino-2-deoxy-D-glucuronate;|UDP-N-acetyl-D-glucosaminuronate;|UDP-N-acetyl-2-amino-2-deoxy-alpha-D-glucuronate;|UDP-N-acetyl-alpha-D-glucosaminouronate,,,,,
C04574,"di-trans,poly-cis-Undecaprenyl diphosphate;|Undecaprenyl diphosphate;|Bactoprenyl diphosphate;|ditrans,octacis-Undecaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04574  di-trans,poly-cis-Undecaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C04574  di-trans,poly-cis-Undecaprenyl diphosphate",
C04575,"(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate;|2,3-Diketo-L-gulonate;|2,3-Diketo-L-gulonic acid;|(4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C04575  (4R,5S)-4,5,6-Trihydroxy-2,3-dioxohexanoate",
C04576,"Pentagalloylglucose;|1,2,3,4,6-Pentakis-O-galloyl-beta-D-glucose;|Pentagalloyl-beta-D-glucose",,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C04576  Pentagalloylglucose|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C04576,
C04577,"15-OxoETE;|(5Z,8Z,11Z,13E)-15-Oxoicosa-5,8,11,13-tetraenoic acid;|15-Oxo-5,8,11-cis-13-trans-eicosatetraenoate;|15-Oxo-5,8,11-cis-13-trans-icosatetraenoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C04577  15-OxoETE,
C04578,"16-Methoxy-2,3-dihydro-3-hydroxytabersonine;|(3R)-3-Hydroxy-16-methoxy-2,3-dihydrotabersonine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C04578  16-Methoxy-2,3-dihydro-3-hydroxytabersonine",
C04579,"Inositol 1,2,3,5,6-pentakisphosphate;|myo-Inositol 1,2,3,5,6-pentakisphosphate;|1D-myo-Inositol 1,2,3,5,6-pentakisphosphate;|1L-myo-Inositol 1,2,3,4,5-pentakisphosphate",,,,,
C04580,"2-Deoxy-2,3-dehydro-N-acetylneuraminic acid",,,,,
C04581,"Tomentin;|3',4',5,6-Tetrahydroxy-3,7-dimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04581  Tomentin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C04581  Tomentin,
C04582,S-Methyl-5-thio-D-ribulose 1-phosphate;|5-(Methylsulfanyl)-D-ribulose 1-phosphate,,,,,
C04583,"6-Hydroxyl-1,6-dihydropurine ribonucleoside;|(6R)-1,6-Dihydroinosine",,,,"Glycosides [BR:br08021]|N-glycosides|C04583  6-Hydroxyl-1,6-dihydropurine ribonucleoside",
C04584,"6-Imino-5-oxocyclohexa-1,3-dienecarboxylate",,,,,
C04586,"Diethyl (2R,3R)-2-methyl-3-hydroxysuccinate",,,,,
C04587,"Diethyl (2S,3R)-2-methyl-3-hydroxysuccinate",,,,,
C04589,"UDP-N-acetyl-D-galactosamine 4,6-bissulfate",,,,,
C04590,3-(O-Geranylgeranyl)-sn-glycerol 1-phosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1006 Monoalkylglycerophosphates|C04590  sn-3-O-(Geranylgeranyl)glycerol 1-phosphate,
C04592,"Toluene-cis-dihydrodiol;|(1S,2R)-3-Methylcyclohexa-3,5-diene-1,2-diol",,,,,
C04593,"(2S,3R)-3-Hydroxybutane-1,2,3-tricarboxylate;|Methylisocitrate;|Methylisocitric acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C04593  Methylisocitric acid,
C04594,"(9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid;|(9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoate;|13(S)-EOD",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C04594  (9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C04594  (9Z)-(13S)-12,13-Epoxyoctadeca-9,11-dienoic acid",
C04596,"1,1-Dichloro-2,2-bis(4-chlorophenyl)ethylene;|1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethylene;|DDE",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C04596  DDE,
C04597,"1,2-Bis(3,4-dimethoxyphenyl)propane-1,3-diol;|1,2-Bis(3,4-dimethoxyphenyl)-1,3-propanediol",,,,,
C04598,2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine;|Platelet-activating factor;|PAF,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0102 1-alkyl,2-acylglycerophosphocholines|C04598  2-Acetyl-1-alkyl-sn-glycero-3-phosphocholine",
C04599,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine;|MPTP",,,,,
C04604,"3-Hydroxy-2-methylpyridine-4,5-dicarboxylate",,,,,
C04606,"5-(3,4-Diacetoxybut-1-ynyl)-2,2'-bithiophene",,,,,
C04608,"Apigenin 7-O-beta-D-glucoside;|7-O-beta-D-Glucosyl-5,7,4'-trihydroxyflavone;|Apigenin 7-O-glucoside;|Apigetrin;|7-(beta-D-Glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;|Cosmetin;|Cosmosiin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04608  Apigenin 7-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C04608  Apigenin 7-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04608  Apigenin 7-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C04608,
C04611,Indol-3-ylacetyl-myo-inositol L-arabinoside,,,,,
C04613,"UDP-2-acetamido-4-dehydro-2,6-dideoxyglucose;|UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hexos-4-ulose;|UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose;|UDP-2-acetamido-2,6-dideoxy-alpha-D-xylohex-4-ulose;|UDP-4-keto-6-deoxy-GlcNAc","UDP-2-acetamido-2,6-dideoxy-alpha-D-xylo-hex-4-ulose is named incorrectly.",,,,
C04614,"alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2;|3-(alpha-D-Mannosyl)-beta-D-mannosyl-R",,,,,
C04615,alpha-D-Mannosylchitobiosyldiphosphodolichol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C04615  alpha-D-Mannosylchitobiosyldiphosphodolichol,G10594
C04617,"(1S,2S)-1-Hydroxypropane-1,2,3-tricarboxylate;|D-erythro-Isocitric acid",,,,,
C04618,(3R)-3-Hydroxybutanoyl-[acyl-carrier protein];|(R)-3-Hydroxybutanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04618  (3R)-3-Hydroxybutanoyl-[acp],
C04619,(3R)-3-Hydroxydecanoyl-[acyl-carrier protein];|(R)-3-Hydroxydecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04619  (3R)-3-Hydroxydecanoyl-[acp],
C04620,(3R)-3-Hydroxyoctanoyl-[acyl-carrier protein];|(R)-3-Hydroxyoctanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04620  (3R)-3-Hydroxyoctanoyl-[acp],
C04621,(E)-2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide,,,,,
C04622,(Z)-2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide,,,,,
C04623,"DDT;|1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane;|1,1,1-Trichloro-2,2-bis-(4'-chlorophenyl)ethane;|Clofenotane;|Dichlorodiphenyltrichloroethane",,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C04623  DDT|Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C04623  DDT|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07367)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AB Chlorine containing products|P03AB01 Clofenotane|D07367  Clofenotane (INN)",
C04625,"2,4-Dichloro-2,5-dihydro-5-oxofuran-2-acetate;|3,5-Dichloro-2,5-dihydro-2-oxofuran-5-acetate",,,,,
C04627,D-Galactosyl-N-acetyl-alpha-D-galactosaminide,,,,,
C04628,Coenzyme B;|N-(7-Mercaptoheptanoyl)threonine 3-O-phosphate;|N-(7-Mercaptoheptanoyl)threonine O3-phosphate;|HTP;|CoB,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C04628  Coenzyme B,
C04630,"UDP-2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-glucose;|UDP-4-amino-4,6-dideoxy-N-acetyl-alpha-D-glucosamine;|UDP-N-acetylbacillosamine",,,,,
C04631,UDP-N-acetyl-3-(1-carboxyvinyl)-D-glucosamine;|UDP-N-acetyl-3-O-(1-carboxyvinyl)-D-glucosamine;|UDP-N-acetylglucosamine-3-O-pyruvateether;|UDP-N-acetylglucosamine enolpyruvate;|UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine,,,,,
C04632,[Hydroxymethylglutaryl-CoA reductase (NADPH)],Generic compound in reaction hierarchy,,,,
C04633,(3R)-3-Hydroxypalmitoyl-[acyl-carrier protein];|(R)-3-Hydroxypalmitoyl-[acyl-carrier protein];|(3R)-3-Hydroxyhexadecanoyl-[acyl-carrier protein];|(R)-3-Hydroxyhexadecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04633  (3R)-3-Hydroxyhexadecanoyl-[acp],
C04634,"1,6-Dihydroxycyclohexa-2,4-diene-1-carboxylate;|1,2-Dihydroxycyclohexa-3,5-diene-1-carboxylate",,,,,
C04635,1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine;|1-Alkenylglycerophosphoethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0207 1Z-alkenylglycerophosphoethanolamines|C04635  1-(1-Alkenyl)-sn-glycero-3-phosphoethanolamine,
C04636,1-Acyl-2-linoleoyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C04636  1-Acyl-2-linoleoyl-sn-glycero-3-phosphocholine,
C04637,"1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate;|1-Phosphatidyl-1D-myo-inositol 4,5-bisphosphate;|Phosphatidyl-myo-inositol 4,5-bisphosphate;|Phosphatidylinositol-4,5-bisphosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP08 Glycerophosphoinositol bisphosphates|GP0801 Diacylglycerophosphoinositol bisphosphates|C04637  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate)",
C04638,"2,3-Bis-(O-geranylgeranyl)-sn-glycerol 1-phosphate;|2,3-Bis-O-(geranylgeranyl)glycerol 1-phosphate;|2,3-Digeranylgeranyl sn-glycerol 1-phosphate",,,,,
C04639,"2,4-Dioxotetrahydropyrimidine D-ribonucleotide",,,,,
C04640,2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine;|1-(5'-Phosphoribosyl)-N-formylglycinamidine;|5'-Phosphoribosyl-N-formylglycinamidine;|5'-Phosphoribosylformylglycinamidine;|2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine,,,,Glycosides [BR:br08021]|N-glycosides|C04640  2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine,
C04641,2-(alpha-D-Galactosyl)-sn-glycerol 3-phosphate,,,,,
C04642,2-Hydroxy-5-carboxymethylmuconate semialdehyde;|5-Carboxymethyl-2-hydroxymuconate semialdehyde;|5-Carboxymethyl-2-hydroxymuconic semialdehyde,,,,,
C04643,"7-Oxodeoxycholate;|7-Ketocholate;|3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholanoate;|3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholan-24-oate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C04643  3alpha,12alpha-Dihydroxy-7-oxo-5beta-cholanic acid",
C04644,"3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",,,,,
C04645,6-(D-Glucose-1-phospho)-D-mannosylglycoprotein;|Glycoprotein 6-(D-glucose-1-phospho)-D-mannose,Generic compound in reaction hierarchy,,,,
C04646,6-Thioinosine-5'-monophosphate;|9-(5-Phospho-1-ribofuranosyl)-6-mercaptopurine,,,,,
C04648,"alpha-L-Fucosyl-1,2-beta-D-galactoside;|Glycoprotein alpha-L-fucosyl-(1,2)-D-galactose;|Glycolipid alpha-L-fucosyl-1,2-beta-D-galactose;|alpha-L-Fucosyl-(1->2)-D-galactosyl-R",Generic compound in reaction hierarchy,,,,
C04649,Heparan sulfate N-acetyl-alpha-D-glucosaminide,,,,,
C04650,L-Phosphinothricin;|Phosphinothricin;|L-Glufosinate;|L-2-Amino-4-(hydroxymethylphosphinyl)butanoate,,,,,
C04652,"UDP-2,3-bis(3-hydroxytetradecanoyl)glucosamine;|UDP-2,3-bis(beta-hydroxymyristoyl)-D-glucosamine;|UDP-2,3-bis(3-hydroxytetradecanoyl)-D-glucosamine;|UDP-2,3-bis[O-(3R)-3-hydroxymyristoyl]-alpha-D-glucosamine",,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0102 Diacylaminosugars|C04652  UDP-2,3-bis(3-hydroxytetradecanoyl)-D-glucosamine",
C04654,"(13E)-11alpha-Hydroxy-9,15-dioxoprost-13-enoate;|15-Keto-prostaglandin E1",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04654  15-Keto-prostaglandin E1,
C04655,"(2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylate;|(2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C04655  (2S,3S)-2-Hydroxytridecane-1,2,3-tricarboxylic acid",
C04656,"1,3-beta-D-Galactosyl-N-acetyl-D-glucosaminyl-R;|beta-D-Galactosyl-(1->3)-N-acetyl-D-glucosaminyl-R;|beta-D-Galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C04660,"3'-Deoxydihydrostreptomycin 6,3''-bis-phosphate",,,,,
C04661,"3alpha,7alpha,12beta-Trihydroxy-5beta-cholanate;|3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C04661  3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid",
C04662,4-Deoxy-alpha-L-erythro-hex-4-enopyranuronoside,,,,,
C04663,Acadesine;|AICA riboside;|5-Amino-1-beta-D-ribofuranosylimidazole-4-carboxamide;|5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02742)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB13 Acadesine|D02742  Acadesine (USAN/INN),
C04665,Co-methyl-5-hydroxybenzimidazolylcobamide,prosthetic group of some Methylcorrinoid protein [CPD:C06020],,,,
C04666,D-erythro-1-(Imidazol-4-yl)glycerol 3-phosphate;|D-erythro-Imidazole-glycerol 3-phosphate;|D-erythro-Imidazole-glycerol phosphate,,,,,
C04667,N-Acetyl-D-glucosaminyl-poly(ribitol phosphate),,,,,G10560
C04670,"(1S,4S)-4-Hydroxy-3-oxocyclohexane-1-carboxylate",,,,,
C04671,"(5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate;|15-Keto-13,14-dihydroprostaglandin E2",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04671  15-Keto-13,14-dihydroprostaglandin E2",
C04672,"(9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid;|(9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate;|(9Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoate;|12,13(S)-EOT;|12,13(S)-EOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C04672  (9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C04672  (9Z,15Z)-(13S)-12,13-Epoxyoctadeca-9,11,15-trienoic acid",
C04673,1D-1-Guanidino-1-deoxy-3-dehydro-scyllo-inositol;|Amidino-3-keto-scyllo-inosamine,,,,,
C04674,"3-D-Glucuronosyl-N2,6-disulfo-beta-D-glucosamine",,,,,G10530
C04675,3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA;|3-Hydroxy-3-isohexeneylglutaryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C04675  3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA,
C04676,"Testololactone;|3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04676  3-Oxo-13,17-secoandrost-4-ene-17,13alpha-lactone",
C04677,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide;|5'-Phosphoribosyl-5-amino-4-imidazolecarboxamide;|5'-Phospho-ribosyl-5-amino-4-imidazole carboxamide;|AICAR;|5-Aminoimidazole-4-carboxamide ribotide;|5-Phosphoribosyl-4-carbamoyl-5-aminoimidazole;|5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide;|5-Amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide,,,,,
C04678,Archaeal dolichyl N-acetyl-alpha-D-glucosaminyl phosphate;|Dolichyl N-acetyl-alpha-D-glucosaminyl phosphate,n = 7-8,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C04678  Archaeal dolichyl N-acetyl-alpha-D-glucosaminyl phosphate,
C04679,Protein N6-[(R)-4-amino-2-hydroxybutyl]-L-lysine;|[eIF5A-precursor]-hypusine,Generic compound in reaction hierarchy,,,,
C04680,Retinyl-ester-(cellular-retinol-binding-protein),Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C04680  Retinyl-ester-(cellular-retinol-binding-protein),
C04681,[Acetyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)];|Biotin-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[acetyl-CoA carboxylase];|Biotin-[acetyl-CoA carboxylase],Generic compound in reaction hierarchy,,,,
C04682,[Methylmalonyl-CoA:pyruvate carboxytransferase];|Holo-[methylmalonyl-CoA:pyruvate carboxytransferase];|Biotin-[methylmalonyl-CoA:pyruvate carboxytransferase];|Holo-[methylmalonyl-CoA-carboxyltransferase];|Biotin-[methylmalonyl-CoA-carboxyltransferase],Generic compound in reaction hierarchy,,,,
C04683,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-R",Generic compound in reaction hierarchy,,,,
C04684,m-Carboxyphenyl phenylacetamidomethylphosphonate,,,,,
C04685,"(13E)-(15S)-15-Hydroxy-9-oxoprosta-10,13-dienoate;|Prostaglandin A1;|PGA1",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C04685  Prostaglandin A1|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04685  Prostaglandin A1,
C04686,"(13E)-(15S)-15-Hydroxy-9-oxoprosta-11,13-dienoate;|Prostaglandin C1",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C04686  Prostaglandin C1|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04686  Prostaglandin C1,
C04687,"(1S,3R,4S)-3,4-Dihydroxycyclohexane-1-carboxylate",,,,,
C04688,(3R)-3-Hydroxytetradecanoyl-[acyl-carrier protein];|(R)-3-Hydroxytetradecanoyl-[acyl-carrier protein];|beta-Hydroxymyristyl-[acyl-carrier protein];|HMA,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C04688  (3R)-3-Hydroxytetradecanoyl-[acp],
C04690,2-(Hydroxymethyl)-3-(acetamidomethylene)succinate;|2-(Acetamidomethylene)-3-(hydroxymethyl)succinate,,,,,
C04691,2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;|3-Deoxy-D-arabino-hept-2-ulosonate 7-phosphate;|3-Deoxy-arabino-heptulonate 7-phosphate;|3-Deoxy-D-arabino-heptulosonic acid 7-phosphate;|DAHP;|2-Dahp,,,,,
C04692,Peptide 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine;|2-[3-Carboxy-3-(methylammonio)propyl]-L-histidine;|EF-2 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine;|Elongation factor 2 2-[3-carboxy-3-(methylammonio)propyl]-L-histidine;|2-[(3S)-3-Carboxy-3-(methylamino)propyl]-L-histidine-[translation elongation factor 2],Generic compound in reaction hierarchy|Precursor of Diphthamide [CPD:C02872]|Modified histidine residue of elongation factor 2(EF-2),,,,
C04695,5-O-(Indol-3-ylacetyl-myo-inositol) D-galactoside,,,,,
C04696,7-Methylguanosine 5'-triphospho-5'-oligonucleotide;|m7GpppX,Generic compound in reaction hierarchy|m7GpppN (n=1),,,,
C04698,Methyl-2-alpha-L-fucopyranosyl-beta-D-galactoside,,,,,G10523
C04700,UDP-N-acetylmuramoyl-L-alanyl-alpha-D-glutamyl-L-lysine,,,,,
C04702,UDPMurNAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala);|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,,
C04703,"alpha-D-Galactosyl-(1,1')-sn-glycerol 3-phosphate;|1-O-alpha-D-Galactosyl-sn-glycerol 3-phosphate",,,,,
C04706,"cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide;|cis-2-Chlorodienelactone;|cis-4-Carboxymethylene-2-chlorobut-2-en-4-olide",,,,,
C04707,"(5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate;|15-Keto-prostaglandin E2",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04707  15-Keto-prostaglandin E2,
C04708,1-(beta-D-Galactosyl)-2-(2-hydroxyacyl)sphingosine,,,,,
C04709,"3'-Deoxydihydrostreptomycin 3'alpha,6-bisphosphate",,,,,
C04711,"5-(3-Hydroxy-4-acetoxybut-1-ynyl)-2,2'-bithiophene",,,,,
C04712,(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate,,,,,
C04713,N6-(delta2-Isopentenyl)-adenosine 5'-monophosphate;|N6-(Dimethylallyl)adenosine 5'-phosphate;|Isopentenyl-AMP;|N6-Prenyladenosine 5'-phosphate,,,,,
C04714,"alpha-D-Galactosyl-beta-D-galactosyldiacylglycerol;|1,3-Diacyl-2-O-(alpha-D-galactosyl(1->4)-O-beta-D-galactosyl)-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C04714  1,3-Diacyl-2-O-(alpha-D-galactosyl(1->4)-O-beta-D-galactosyl)-sn-glycerol",
C04715,"Nuatigenin;|(20S,22S,25S)-22,25-Epoxyfurost-5-ene-3beta,26-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Furostan derivatives|C04715  Nuatigenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0109 Furospirostanols and derivatives|C04715  Nuatigenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C04715  Nuatigenin,
C04717,"(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid;|(9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoate;|13(S)-HPODE;|13S-Hydroperoxy-9Z,11E-octadecadienoic acid;|(9Z,11E,13S)-13-Hydroperoxy-9,11-octadecadienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C04717  (9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C04717  (9Z,11E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid",
C04718,"1,6,6-Trimethyl-2,7-dioxabicyclo[3.2.2]nonan-3-one",,,,,
C04719,"1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA13 Fatty acyl glycosides|FA1301 Fatty acyl glycosides of mono- and disaccharides|C04719  1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C04719  1-Hydroxy-2-(beta-D-glucosyloxy)-9,10-anthraquinone",
C04720,"DIMBOA;|2,4-Dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one;|2,4-Dihydroxy-7-methoxy-1,4-benzoxazin-3-one",,,,,
C04722,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oate;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C04722  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoic acid",
C04724,alpha-D-Mannosyl-(1->4)-alpha-L-rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol;|alpha-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und;|D-Mannosyl-L-rhamnosyl-D-galactose-1-diphospholipid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04724  alpha-D-Mannosyl-(1->4)-alpha-L-rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol,
C04725,"Oligosaccharide containing 6-methyl-D-glucose units;|1,4-alpha-D-Glucooligosaccharide containing 6-O-methyl-D-glucose units",Generic compound in reaction hierarchy,,,,
C04726,[3-Methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)];|[3-Methyl-2-oxobutanoate dehydrogenase (lipoamide)],Generic compound in reaction hierarchy|3-Methyl-2-oxobutanoate dehydrogenase (ec 1.2.4.4) is inactivated by phosphorylation.|See [CPD:C01308],,,,
C04727,[Propionyl-CoA:carbon-dioxide ligase (ADP-forming)];|[Propanoyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)];|Biotin-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[propionyl-CoA-carboxylase (ATP-hydrolysing)];|Biotin-[propionyl-CoA-carboxylase (ATP-hydrolysing)],Generic compound in reaction hierarchy,,,,
C04728,tRNA containing 5-[(methylamino)methyl]-2-thiouridylate;|tRNA containing mnm5s2U,Generic compound in reaction hierarchy|wobble position in the anticodon (position 34) in tRNA,,,,
C04729,"trans-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide;|trans-2-Chlorodienelactone",,,,,
C04730,"GM3;|(N-Acetylneuraminyl)-D-galactosyl-D-glucosylceramide;|alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide;|N-Acetylneuraminyl-2,3-alpha-D-galactosyl-1,4-beta-D-glucosylceramide;|Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C04730  GM3|Lipids [BR:br08002(G00108)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00108  Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer (GM3)|Cancer-associated carbohydrates [br08441.html(G00108)]|Glycosphingolipid|G00108,G00108
C04731,"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide",,,,,
C04732,"5-Amino-6-(1-D-ribitylamino)uracil;|5-Amino-6-(D-ribitylamino)uracil;|6-(1-D-Ribitylamino)-5-amino-2,4-dihydroxypyrimidine;|6-(1-D-Ribitylamino)-5-aminouracil;|4-(1-D-Ribitylamino)-5-amino-2,6-dihydroxypyrimidine",,,,,
C04733,4-(4-Deoxy-beta-D-gluc-4-enuronosyl)-D-galacturonate,,,,,G10586
C04734,1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide;|5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide;|5-Formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide;|5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide;|FAICAR,,,,,
C04735,Apo-[acetyl-CoA:carbon-dioxide ligase (ADP-forming)];|Apo-[acetyl-CoA carboxylase],Generic compound in reaction hierarchy,,,,
C04736,Apo-[methylmalonyl-CoA:pyruvate carboxytransferase];|Apo-[methylmalonyl-CoA-carboxyltransferase],Generic compound in reaction hierarchy,,,,
C04737,"alpha-D-Galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide;|Globotriosylceramide;|Trihexosylceramide;|Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer;|Gal-alpha1->4LacCer;|D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00093)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0502 Galalpha1-4Galbeta1-4Glc- (Globo series)|G00093  Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer (Gb3Cer)|Blood groups and carbohydrate antigens [br08110.html(G00093)]|P1PK blood group|G00093|Cancer-associated carbohydrates [br08441.html(G00093)]|Glycosphingolipid|G00093,G00093
C04738,UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine;|UDP-3-O-(beta-hydroxymyristoyl)-N-acetylglucosamine;|UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0102 Diacylaminosugars|C04738  UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine,
C04739,UDP-N-acetyl-6-(alpha-D-galactose-1-phospho)-alpha-D-glucosamine;|UDP-N-acetyl-6-(D-galactose-1-phospho)-D-glucosamine,,,,,
C04740,"alpha-N-Acetylneuraminyl-2,6-beta-galactosyl-1,4-beta-D-glucosylceramide;|Neu5Ac-alpha2->6Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G01185)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G01185  Neu5Ac-alpha2->6Gal-beta1->4Glc-beta1->1'Cer,G01185
C04741,"Alprostadil;|Prostaglandin E1;|(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate;|PGE1",,,,"Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C04741  Prostaglandin E1|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04741  Prostaglandin E1|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00180)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EA Prostaglandins|C01EA01 Alprostadil|D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BE Drugs used in erectile dysfunction|G04BE01 Alprostadil|D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00180)]|Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)|Alprostadil|D00180  Alprostadil (JP18/USP/INN)|Sexual Disorder Agents|Sexual Disorder Agents (Male)|Alprostadil|D00180  Alprostadil (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00180)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00180  Alprostadil (JP18/USP/INN)|Drug groups [BR:br08330(D00180)]|Hormonal agent|DG01961  Prostaglandin derivative|DG01611  Prostaglandin E1 derivative|DG00239  Alprostadil|D00180  Alprostadil|Target-based classification of drugs [BR:br08310(D00180)]|G Protein-coupled receptors|Rhodopsin family|Prostaglandin|PTGER1|D00180  Alprostadil (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00180)]|Chemicals|D00180  Alprostadil|D00180  Alprostadil injection",
C04742,"(15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate;|(15S)-15-Hydroxy-5,8,11-cis-13-trans-icosatetraenoate;|(5Z,8Z,11Z,13E)-(15S)-15-Hydroxyicosa-5,8,11,13-tetraenoic acid;|15(S)-HETE",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C04742  15(S)-HETE,
C04744,"2,6-Diamino-4-hydroxy-5-(N-methyl)formamidopyrimidine",,,,,
C04746,3beta-Hydroxy-5alpha-cholest-7-ene-4alpha-carboxylate,,,,,
C04748,Protein C-terminal S-farnesyl-L-cysteine methyl ester,Generic compound in reaction hierarchy,,,,
C04750,"beta-D-Galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-R;|beta-D-Galactosyl-1,3-N-acetyl-D-galactosaminyl-R;|Glycoprotein D-galactosyl-1,3-N-acetyl-D-galactosamine;|beta-D-Galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,G00024
C04751,1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate;|1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxylate;|1-(5'-Phosphoribosyl)-5-amino-4-carboxyimidazole;|5'-Phosphoribosyl-5-amino-4-imidazolecarboxylate;|1-(5'-Phosphoribosyl)-4-carboxy-5-aminoimidazole;|5'-Phosphoribosyl-4-carboxy-5-aminoimidazole;|5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate,,,,,
C04752,4-Amino-5-hydroxymethyl-2-methylpyrimidine diphosphate;|4-Amino-2-methyl-5-(diphosphooxymethyl)pyrimidine;|HMP-PP,,,,,
C04755,Glycoprotein N-acetyl-D-glucosaminyl-phospho-D-mannose,Generic compound in reaction hierarchy,,,,
C04756,O-1-Alk-1-enyl-2-acyl-sn-glycero-3-phosphoethanolamine;|Phosphatidalethanolamine;|Plasmenylethanolamine;|Ethanolamineplasmalogen;|2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine;|1-Alkenyl-2-acylglycerophosphoethanolamine,Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C04756  Plasmenylethanolamine|Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0203 1-(1Z-alkenyl),2-acylglycerophosphoethanolamines|C04756  2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphoethanolamine",
C04758,"(5Z,13E)-9alpha-Hydroxy-11,15-dioxoprosta-5,13-dienoate;|15-Dehydro-prostaglandin D2;|15-Keto-prostaglandin D2",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04758  15-Keto-prostaglandin D2,
C04759,"1,2-D-Glucosyl-5-D-(galactosyloxy)-L-lysine-procollagen;|Procollagen alpha-D-glucosyl-1,2-beta-D-galactosyl-L-hydroxylysine",Generic compound in reaction hierarchy,,,,
C04760,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoyl-CoA",,,,,
C04763,Apo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)];|Apo-[propionyl-CoA-carboxylase (ATP-hydrolysing)],Generic compound in reaction hierarchy,,,,
C04767,O-(1->4)-alpha-L-Dihydrostreptosyl-streptidine 6-phosphate;|alpha-L-Dihydrostreptosyl-(1->4)-streptidine 6-phosphate,,,,,
C04768,[Hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate,Generic compound in reaction hierarchy,,,,
C04771,L-Mimosine;|Leucenol;|(S)-2-Amino-3-(3-hydroxy-4-oxo-4H-pyridin-1-yl)propanoate,,,,,
C04772,"1,6-alpha-D-Mannosyl-1,6-alpha-D-mannosyloligosaccharide",,,,,G10509
C04773,3-Hydroxy-4-hydroxymethyl-2-methylpyridine-5-carboxylate;|5-Pyridoxate;|5-Pyridoxic acid,,,,,
C04775,"D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-R;|D-Galactosyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosyl-R;|beta-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-R",Generic compound in reaction hierarchy,,,,
C04776,Peptide beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-L-serine;|T antigen,Generic compound in reaction hierarchy,,,,G00024
C04778,"N1-(5-Phospho-alpha-D-ribosyl)-5,6-dimethylbenzimidazole;|alpha-Ribazole 5'-phosphate",,,,,
C04779,rRNA containing a single residue of 2'-O-methyladenosine,,,,,
C04780,"(9S,13S,15Z)-12-Oxo-10,11-dihydrophyto-15-enoate;|8-[(1S,2S)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate;|OPC-8:0;|8-[(1S,2S)-3-Oxo-2-[(Z)-pent-2-enyl]cyclopentyl]octanoic acid;|(9S,13S)-10,11-Dihydro-12-oxo-15-phytoenoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0201 12-oxophytodienoic acid metabolites|C04780  8-[(1S,2S)-3-Oxo-2-[(Z)-pent-2-enyl]cyclopentyl]octanoic acid",
C04783,"cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,2-dicarboxylate;|Phthalate-4,5-cis-dihydrodiol",,,,,
C04785,"13(S)-HPOT;|(9Z,11E,15Z)-(13S)-Hydroperoxyoctadeca-9,11,15-trienoate;|(9Z,11E,15Z)-(13S)-13-Hydroperoxyoctadeca-9,11,15-trienoic acid;|13(S)-HpOTrE;|13-HPOT",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C04785  (9Z,11E,15Z)-(13S)-13-Hydroperoxyoctadeca-9,11,15-trienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C04785  (9Z,11E,15Z)-(13S)-13-Hydroperoxyoctadeca-9,11,15-trienoic acid",
C04787,Cyanidin 3-rutinoside 5-glucoside chloride,Cyanidin 3-rutinoside 5-glucoside [CPD:C12646],,,,
C04789,Lysosomal-enzyme N-acetyl-D-glucosaminyl-phospho-D-mannose,Generic compound in reaction hierarchy,,,,
C04791,"beta-D-Galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein",,,,,
C04792,1-Acyl-2-[(S)-12-hydroxyoleoyl]-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C04792  1-Acyl-2-[(S)-12-hydroxyoleoyl]-sn-glycero-3-phosphocholine,
C04793,"3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04793  3,4-Dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione",
C04794,3-(4-Deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine;|3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose,,,,,G02170
C04796,"4-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde",,,,,
C04797,"5-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde;|(2E,4Z,7S)-7-Amino-5-formyl-2-hydroxyocta-2,4-dienedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C04797  (2E,4Z,7S)-7-Amino-5-formyl-2-hydroxyocta-2,4-dienedioic acid",
C04798,"5-Amino-4-chloro-2-(2,3-dihydroxyphenyl)-3(2H)-pyridazinone;|Chloridazon catechol;|5-Amino-4-chloro-2-(2',3'-dihydroxyphenyl)-3(2H)-pyridazinone",,,,,
C04799,Colominic acid(non-reducing N- or O-acylneuraminyl residue);|Colominate,,,,,
C04800,"D-Glucuronyl-N-acetyl-1,3-beta-D-galactosaminylproteoglycan;|[Protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine",Generic compound in reaction hierarchy,,,,
C04801,[3-Methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)];|Biotin-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)];|Holo-[methylcrotonoyl-CoA-carboxylase];|Biotin-[methylcrotonoyl-CoA-carboxylase],Generic compound in reaction hierarchy,,,,
C04802,m7G(5')pppRm-mRNA;|5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-[mRNA];|5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-(ribonucleotide)-[mRNA],Generic compound in reaction hierarchy|R1 = adenine base [CPD:C01972] or guanine base,,,,
C04804,"UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimeloyl-D-alanine;|UDP-N-acetylmuramoyl-L-Ala-D-gamma-Glu-6-carboxy-L-Lys-D-Ala;|UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanine",,,,,
C04805,"5(S)-HETE;|5-Hydroxyeicosatetraenoate;|5-HETE;|(6E,8Z,11Z,14Z)-(5S)-5-Hydroxyicosa-6,8,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C04805  5(S)-HETE,
C04806,17alpha-(N-Acetyl-D-glucosaminyl)-estradiol 3-D-glucuronoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C04806  17alpha-(N-Acetyl-D-glucosaminyl)-estradiol 3-D-glucuronoside|ST05 Steroid conjugates|ST0501 Glucuronides|C04806  17alpha-(N-Acetyl-D-glucosaminyl)-estradiol 3-D-glucuronoside,
C04807,"6-Hydroxymethyl-7,8-dihydropterin diphosphate;|(7,8-Dihydropterin-6-yl)methyl diphosphate;|2-Amino-7,8-dihydro-4-hydroxy-6-(diphosphooxymethyl)pteridine;|2-Amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate;|7,8-Dihydropterin pyrophosphate",,,,,
C04808,alpha-D-Abequosyl-(1->3)-alpha-D-mannosyl-(1->4)-alpha-L-rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol;|alpha-D-Abe-(1->3)-alpha-D-Man-(1->4)-alpha-L-Rha-(1->3)-alpha-D-Gal-PP-Und;|D-Abequosyl-D-mannosyl-rhamnosyl-D-galactose-1-diphospholipid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04808  alpha-D-Abequosyl-(1->3)-alpha-D-mannosyl-(1->4)-alpha-L-rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol,
C04810,Oligosaccharide with 4-deoxy-alpha-D-gluc-4-enuronosyl group;|Oligosaccharide with 4-deoxy-alpha-D-galact-4-enuronosyl group,,,,,
C04811,1-(5-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole,,,,,
C04812,"1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol 4-phosphate",,,,,
C04814,4alpha-Hydroxymethyl-4beta-methyl-5alpha-cholest-7-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C04814  4beta-Hydroxymethyl-4alpha-methyl-5alpha-cholest-7-en-3beta-ol,
C04815,"5-D-(5/6)-5-C-(Hydroxymethyl)-2,6-dihydroxycyclohex-2-en-1-one;|5D-(5/6)-5-C-(Hydroxymethyl)-2,6-dihydroxy-2-cyclohexen-1-one",,,,,
C04817,"Protein alpha-D-glucosyl-1,2-beta-D-galactosyl-L-hydroxylysine",Generic compound in reaction hierarchy,,,,
C04818,"beta-D-Galactosyl-1,4-N-acetyl-beta-D-glucosaminylglycopeptide",,,,,
C04819,"beta-D-Galactosyl-beta-1,4-N-acetyl-D-glucosaminylglycopeptide",,,,,
C04822,"8(R)-HPETE;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoate;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C04822  8(R)-HPETE,
C04823,1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole;|1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole;|5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole;|(S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate;|SAICAR,,,,,
C04824,"Lipid X;|2,3-Diacylglucosamine 1-phosphate;|2,3-Bis[(3R)-3-hydroxymyristoyl]-alpha-D-glucosaminyl 1-phosphate;|2,3-Bis(3-hydroxytetradecanoyl)-alpha-D-glucosaminyl 1-phosphate",,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0102 Diacylaminosugars|C04824  Lipid X,
C04825,3-beta-D-Galactosyl-4-beta-D-galactosyl-O-beta-D-xylosylprotein;|[Protein]-3-O-(beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-xylosyl)-L-serine,Generic compound in reaction hierarchy,,,,G00156
C04827,Apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)];|Apo-[methylcrotonoyl-CoA-carboxylase],Generic compound in reaction hierarchy,,,,
C04830,"beta-D-Glucosyl-1,4-N-acetyl-D-glucosaminyldiphosphoundecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04830  beta-D-Glucosyl-1,4-N-acetyl-D-glucosaminyldiphosphoundecaprenol",G10501
C04831,"DIMBOA-glucoside;|2,4-Dihydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-D-glucoside;|2,4-Dihydroxy-7-methoxy-1,4-benzoxazin-3-one glucoside;|(2R)-4-Hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C04831,
C04832,Coenzyme M 7-mercaptoheptanoylthreonine-phosphate heterodisulfide;|Coenzyme M-HTP heterodisulfide;|CoM-S-S-CoB;|N-{7-[(2-Sulfoethyl)dithio]heptanoyl}-3-O-phospho-L-threonine,,,,,
C04833,"m7G(5')pppm6Am-mRNA;|mRNA containing an N6,2'-O-dimethyladenosine cap;|5-(N7-Methyl 5-triphosphoguanosine)-N6,2'-O-dimethyladenosine-[mRNA]",Generic compound in reaction hierarchy,,,,
C04834,"Juvenile hormone II acid;|(2E,6E)-(10R,11S)-10,11-Epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid;|(2E,6E)-(10R,11S)-10,11-Epoxy-3,7,11-trimethyltrideca-2,6-dienoate;|(2E,6E)-10,11-Epoxy-3,7,11-trimethyltridecadienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C04834  (2E,6E)-(10R,11S)-10,11-Epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid",
C04835,"(5Z,13E)-6,9alpha-Epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate;|15-Keto-prostaglandin I2",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C04835  15-Keto-prostaglandin I2,
C04839,"3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfate",,,,,
C04840,3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C04840  3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylate,
C04843,"(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate;|(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoic acid;|Trioxilin A3",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0309 Hepoxilins|C04843  Trioxilin A3,
C04844,"3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate;|(1E,2Z)-3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate;|DSHA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C04844  3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate",
C04845,"N-Acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide;|Lactotriaosylceramide;|Lactotriosylceramide;|N-Acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-D-glucosylceramide;|Ceramidetrisaccharide;|Ceramidetrihexoside;|N-Acetyl-D-glucosaminyl-1,3-beta-D-galactocyl-1,4-beta-glucosyl-1,1'-beta-ceramide;|GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|GlcNAc-beta1->3LacCer;|N-Acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00036)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00036  GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Lac3Cer)|Cancer-associated carbohydrates [br08441.html(G00036)]|Glycosphingolipid|G00036,G00036
C04847,"alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosamine",,,,,G00304
C04848,"Variant-surface-glycoprotein 1,2-dimyristyl-sn-phosphatidylinositol;|Variant-surface-glycoprotein 1,2-ditetradecanoyl-sn-phosphatidylinositol",Generic compound in reaction hierarchy,,,,
C04849,"(5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid;|(5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoate;|Hepoxilin A3",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C04849  (5Z,9E,14Z)-(8xi,11R,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid|FA03 Eicosanoids|FA0309 Hepoxilins|C04849  Hepoxilin A3",
C04850,"1,3-beta-D-Galactosyl-(alpha-1,4-L-fucosyl)-N-acetyl-D-glucosaminyl-R;|beta-D-Galactosyl-(1->3)-[alpha-L-fucosyl-(1->4)]-N-acetyl-beta-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C04851,MurAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala)-diphospho-undecaprenol;|Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04851  MurAc(oyl-L-Ala-D-gamma-Glu-L-Lys-D-Ala-D-Ala)-diphospho-undecaprenol,G10552
C04853,"20-OH-Leukotriene B4;|20-OH-LTB4;|20-Hydroxy-leukotriene B4;|(6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyeicosa-6,8,10,14-tetraenoate;|(6Z,8E,10E,14Z)-(5S,12R)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C04853  20-Hydroxy-leukotriene B4,
C04855,"alpha-D-Galactosyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R;|alpha-D-Galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R",Generic compound in reaction hierarchy,,,,
C04856,"(6S)-6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide;|(S)-NADH-hydrate;|(S)-NADHX;|(6S)-6-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide;|6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide",,,,,
C04858,"Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside];|7-O-(beta-D-Apiofuranosyl-1,2-beta-D-glucosyl)-5,7,4'-trihydroxyflavone;|Apiin;|7-[(2-O-D-Apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxy-phenyl)-4H-1-benzopyran-4-one;|Apigenin-7-apioglucoside;|Apioside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside]|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside]|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04858  Apigenin 7-O-[beta-D-apiosyl-(1->2)-beta-D-glucoside]|Dietary phytochemicals [br08012.html]|Flavonoids|C04858,
C04859,"Nuatigenin 3beta-D-glucopyranoside;|(20S,22S,25S)-22,25-Epoxyfurost-5-ene-3beta,26-diol 3-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0109 Furospirostanols and derivatives|C04859  Nuatigenin 3beta-D-glucopyranoside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C04859  (20S,22S,25S)-22,25-Epoxyfurost-5-ene-3beta,26-diol 3-O-beta-D-glucoside",
C04861,"1,3-alpha-D-Mannosyl-1,2-alpha-D-mannosyl-1,2-alpha-D-mannosyl-D-mannose",,,,,G00172
C04862,1-Hexadecylthio-1-deoxy-2-hexadecylphosphono-sn-glycero-3-phosphocholine,,,,,
C04864,"4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate",,,,,G00353
C04865,"4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate;|beta-D-4-Deoxy-Delta4-GlcAp-(1->3)-D-GalNAc6S",,,,,G00367
C04866,"alpha-D-Galactosyl-(1,3)-[alpha-L-fucosyl-(1,2)]-D-galactoside;|Glycoprotein alpha-D-galactosyl-(1,3)-[alpha-L-fucosyl-(1,2)]-D-galactose;|alpha-D-Galactosyl-(1->3)-[alpha-L-fucosyl(1->2)]-D-galactosyl-R",Generic compound in reaction hierarchy,,,,
C04867,"Juvenile hormone II;|Methyl (2E,6E)-(10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C04867  Methyl (2E,6E)-(10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoate",
C04871,Haloxyfop;|(RS)-2-[4-(3-Chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy]propionic acid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C04871  Haloxyfop,
C04872,"1,2-Diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C04872  1,2-Diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol",
C04873,"1-Hexadecylthio-2-hexadecanoylamino-1,2-dideoxy-sn-glycero-3-phosphocholine",,,,,
C04874,"7,8-Dihydroneopterin;|Dihydroneopterin;|2-Amino-4-hydroxy-6-(D-erythro-1,2,3-trihydroxypropyl)-7,8-dihydropteridine",,,,,
C04875,"(+/-)-5-[(tert-Butylamino)-2'-hydroxypropoxy]-1,2,3,4-tetrahydro-1-naphthol;|(+/-)-Dihydrobunolol",,,,,
C04876,N-Acetyl-D-glucosaminyl-N-acetylmuramoyl-L-Ala-D-glutamyl-6-carboxy-L-lysine,,,,,
C04877,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate;|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate;|UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate;|UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diaminopimelate;|UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-meso-2,6-diamino-heptanedioate",,,,,
C04880,"N-Acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,3-(R1)-beta-D-mannosyl-R2;|3-(2-[N-Acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannosyl-R",Generic compound in reaction hierarchy,,,,
C04881,"N-Acetyl-beta-D-mannosaminyl-1,4-N-acetyl-D-glucosaminyldiphosphoundecaprenol;|N-Acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C04881  N-Acetyl-beta-D-mannosaminyl-1,4-N-acetyl-D-glucosaminyldiphosphoundecaprenol",G00177
C04882,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine;|UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-6-carboxy-L-lysyl-D-alanyl-D-alanine",,,,,
C04883,"(+/-)-5-[(tert-Butylamino)-2'-hydroxypropoxy]-3,4-dihydro-1(2H)-naphthalenone;|(+/-)-Bunolol",,,,,
C04884,"N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide;|GM2;|Tay-Sachs ganglioside;|N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine;|GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C04884  GM2|Lipids [BR:br08002(G00109)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00109  GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GM2)|Cancer-associated carbohydrates [br08441.html(G00109)]|Glycosphingolipid|G00109,G00109
C04885,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R;|N-Acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,
C04886,"alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine",,,,,G00255
C04887,"alpha-N-Acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-R",Generic compound in reaction hierarchy,,,,
C04890,"N-Acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R;|N-Acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C04891,"N-Acetyl-beta-D-glucosaminyl-1,6-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-R;|N-Acetyl-beta-D-glucosaminyl-(1->6)-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl-R",Generic compound in reaction hierarchy,,,,
C04894,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-N6-(L-alanyl)-L-lysyl-D-alanyl-D-alanine;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-N6-(L-alanyl)-L-lysyl-D-alanyl-D-alanine,,,,,
C04895,"7,8-Dihydroneopterin 3'-triphosphate;|2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate;|6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin;|6-[(1S,2R)-1,2-Dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin",,,,,
C04896,5-(5-Phospho-D-ribosylaminoformimino)-1-(5-phosphoribosyl)-imidazole-4-carboxamide;|N-(5'-Phospho-D-ribosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide;|N-(5'-Phosphoribosylformimino)-5-amino-1-(5''-phosphoribosyl)-4-imidazolecarboxamide;|Phosphoribosyl-formimino-AICAR-phosphate;|1-(5-Phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide;|1-(5-Phospho-beta-D-ribosyl)-5-[(5-phospho-beta-D-ribosylamino)methylideneamino]imidazole-4-carboxamide,,,,,
C04898,Oligosaccharide with terminal 4-deoxy-6-methyl-alpha-D-galact-4-enuronosyl group,Generic compound in reaction hierarchy,,,,
C04899,"(6S)-6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide phosphate;|(S)-NADPH-hydrate;|(S)-NADPHX;|(6S)-6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide 2'-phosphate",,,,,
C04900,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C04900  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C04900  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C04900  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide,
C04901,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,G00026
C04902,"beta-D-Galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R;|beta-D-Galactosyl-(1->3)-[N-acetyl-beta-D-glucosaminyl-(1->6)]-N-acetyl-alpha-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,G00025
C04903,"3-beta-D-Glucuronosyl-3-beta-D-galactosyl-4-beta-D-galactosyl-O-beta-D-xylosylprotein;|beta-D-Glucuronyl-1,3-D-galactosylproteoglycan;|[Protein]-3-O-(beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine",Generic compound in reaction hierarchy,,,,G00157
C04904,N-Acetyl-D-glucosaminyl-N-acetylmuramoyl-L-Ala-D-glutamyl-6-carboxy-L-lysyl-D-alanine,,,,,
C04905,1-(4-Amino-2-methylpyrimid-5-ylmethyl)-3-(beta-hydroxyethyl)-2-methylpyridinium bromide;|Pyrithiamine bromide;|Pyrithiamine,,,,,
C04906,"N-Acetyl-beta-D-glucosaminyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-R;|2,6-Bis(N-acetyl-beta-D-glucosaminyl)-alpha-D-mannosyl-R",Generic compound in reaction hierarchy,,,,
C04907,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein",Generic compound in reaction hierarchy,,,,
C04908,1-(4-Hydroxy-2-methylpyrimid-5-ylmethyl)-3-(beta-hydroxyethyl)-2-methylpyridinium bromide;|Oxypyrithiamine bromide;|Oxypyrithiamine,,,,,
C04909,"alpha-D-Glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0502 Glycosylalkylacylglycerols|C04909  alpha-D-Glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerol",
C04910,"1,3-beta-D-Galactosyl-N-acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-D-glucosylceramide;|Ceramidetetrasaccharide;|Ceramidetetrahexoside;|Paragloboside;|Lc4Cer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00037)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00037  Gal-beta1->3GlcNAc-beta-1->3Gal-beta1->4Glc-beta1->1'Cer (Lc4Cer),G00037
C04911,"D-Galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide;|GM1;|GM1a;|D-Galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine;|Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C04911  GM1|Lipids [BR:br08002(G00110)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00110  Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GM1a),G00110
C04913,"N-Acetyl-beta-D-galactosaminyl-1,4-beta-D-glucuronyl-N-acetyl-1,3-beta-D-galactosaminylproteoglycan;|[Protein]-3-O-(beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-GalNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine",Generic compound in reaction hierarchy,,,,
C04914,"alpha-D-Mannosyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,3)-beta-D-mannosyl-R",,,,,
C04916,N-(5'-Phospho-D-1'-ribulosylformimino)-5-amino-1-(5''-phospho-D-ribosyl)-4-imidazolecarboxamide;|5-[(5-Phospho-1-deoxyribulos-1-ylamino)methylideneamino]-1-(5-phosphoribosyl)imidazole-4-carboxamide;|Phosphoribulosyl-formimino-AICAR-phosphate;|5-[(5-Phospho-1-deoxy-D-ribulos-1-ylamino)methylideneamino]-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide,,,,,
C04917,N-Acetyl-beta-D-glucosaminyl-(1->6)-[N-acetyl-beta-D-glucosaminyl-(1->3)]-N-acetyl-alpha-D-galactosaminyl-R;|N-Acetyl-beta-D-glucosaminyl-(1->6)-[N-acetyl-beta-D-glucosaminyl-(1->3)]-N-acetyl-D-galactosaminyl-R;|Core 4,Generic compound in reaction hierarchy|R = Ser/Thr residue of glycoprotein,,,,G00029
C04919,"2,3,2'3'-Tetrakis(3-hydroxytetradecanoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate;|2,3,2'3'-Tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate;|Lipid A disaccharide bisphosphate;|Lipid IV(A);|Lipid IVA;|2-Deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phospho-alpha-D-glucopyranose",,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0104 Tetraacylaminosugars|C04919  Lipid IV(A),
C04920,"6-Sulfo-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0502 Glycosylalkylacylglycerols|C04920  6-Sulfo-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,6-alpha-D-glucosyl-1,3-1-O-alkyl-2-O-acylglycerol",
C04922,"beta-D-Galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide;|beta-D-Galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide;|D-Galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00050)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00050  Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (nLcCer)|Cancer-associated carbohydrates [br08441.html(G00050)]|Glycosphingolipid|G00050,G00050
C04923,"1,3-alpha-D-Mannosyl-(1,2-N-acetyl-alpha-D-glucosaminyl)-1,2-alpha-D-mannosyl-1,2-alpha-D-mannosyl-D-mannose",,,,,G07376
C04924,"N-Acetyl-D-galactosaminyl-1,4-beta-N-acetylneuraminyl-2,3-alpha-D-galactosyl-1,4-beta-D-glucosylceramide;|GalNAc-beta1->4Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00176)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00176  GalNAc-beta1->4Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer,G00176
C04925,"N-Acetyl-D-galactosaminyl-N-acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide;|Forssman hapten;|GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer;|GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->4LacCer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00095)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0502 Galalpha1-4Galbeta1-4Glc- (Globo series)|G00095  GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer|Blood groups and carbohydrate antigens [br08110.html(G00095)]|Forssman blood group|G00095|Cancer-associated carbohydrates [br08441.html(G00095)]|Glycosphingolipid|G00095,G00095
C04926,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactose-1,3-(alpha-N-acetylneuraminyl-2,6)-N-acetyl-D-galactosaminyl-R;|N-Acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,
C04927,N-Acetylneuraminyl-D-galactosyl-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide;|GD1a;|NeuAc-alpha2->3Gal-beta1->3GalNAc-beta1->4(NeuAc-alpha2->3)LacCer;|NeuAc-alpha2->3Gal-beta1->3GalNAc-beta1->4(NeuAc-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00111)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00111  Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GD1a)|Cancer-associated carbohydrates [br08441.html(G00111)]|Glycosphingolipid|G00111,G00111
C04930,"N-Acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R",Generic compound in reaction hierarchy,,,,
C04931,"Argatroban;|(2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperadinecarboxylic acid",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AE Direct thrombin inhibitors|B01AE03 Argatroban|C04931  Argatroban|Drug groups [BR:br08330]|Blood modifier agent|DG01950  Antithrombotic agent|DG01511  Thrombin inhibitor|DG00163  Argatroban|C04931  Argatroban|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00163  Argatroban|C04931  Argatroban,G00163
C04932,"Lipid A disaccharide;|Tetraacyldisaccharide 1-phosphate;|[2-N,3-O-Bis(3-hydroxytetradecanoyl)-beta-D-glucosaminyl]-(1->6)-[2-N,3-O-bis(3-hydroxytetradecanoyl)-alpha-D-glucosaminyl phosphate];|2,3-Bis[(3R)-3-hydroxytetradecanoyl]-beta-D-glucosaminyl-(1->6)-2,3-bis[(3R)-3-hydroxytetradecanoyl]-alpha-D-glucosaminyl 1-phosphate",,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0104 Tetraacylaminosugars|C04932  Lipid A disaccharide,
C04934,"N-Acetyl-beta-D-glucosaminyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,2)-(N-acetyl-beta-D-glucosaminyl-1,4)-alpha-D-mannosyl-R;|2,4,6-Tris(N-acetyl-beta-D-glucosaminyl)-alpha-D-mannosyl-R",Generic compound in reaction hierarchy,,,,
C04936,"alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-D-glucosylceramide;|Neu5Ac-alpha2->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00062)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00062  Neu5Ac-alpha2->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer|Cancer-associated carbohydrates [br08441.html(G00062)]|Glycosphingolipid|G00062,G00062
C04937,"N-Acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,2-alpha-D-mannosyl-1,3)-beta-D-mannosyl-R",,,,,
C04938,"N-Acetyl-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00066)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00066  GlcNAc-beta1->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (nLc5Cer),G00066
C04939,"N-Acetyl-D-glucosaminyl-1,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00174)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00174  GlcNAc-beta1->6Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G00174
C04940,"(N-Acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-1,3-(beta-N-acetyl-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-beta-D-mannosyl-R",,,,,
C04942,beta-D-Mannosyl-R,Generic compound in reaction hierarchy|R = glycoprotein,,,,
C04943,"N-Acetyl-beta-D-glucosaminyl-1,4-(N-acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-1,3-beta-D-mannosyl-R;|3-(2,4-Bis[N-acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannosyl-R",Generic compound in reaction hierarchy,,,,
C04944,6-(2-[N-Acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannosyl-R,Generic compound in reaction hierarchy,,,,
C05001,Fructose 1-phosphate(pyranose),,,,,
C05003,D-Fructose;|D-arabino-Hex-2-ulopyranose,D-Fructose (furanose) [CPD:C00095]|D-Fructose (open-chain) [CPD:C10906],,,,
C05009,Heme-thiolate(P-450),,,,,
C05010,Histidylleucine;|N-L-Histidyl-L-leucin;|His-Leu,,,,,
C05011,Hydroxytamoxifen;|4-Hydroxytamoxifen,,,,,
C05016,L-Glutamate methylester,,,,,
C05021,N-Acetyl-beta-D-galactosamine,,,,,
C05026,N3-Metyladenine,,,,,
C05028,Norethindrone;|19-Norethisterone;|19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05028  Norethindrone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00182)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC01 Norethisterone|D00182  Norethindrone (USP) &lt;JP/US&gt;|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC02 Norethisterone|D00182  Norethindrone (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00182)]|Contraceptives|Oral Progestins|Norethindrone|D00182  Norethindrone (USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Norethindrone|D00182  Norethindrone (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00182)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2479  Others|D00182  Norethindrone (USP); Norethisterone (JP18)|Drug groups [BR:br08330(D00182)]|Hormonal agent|DG02004  Progesterone|DG00456  Norethisterone|D00182  Norethindrone|DG01666  Progesterone receptor agonist|DG00456  Norethisterone|D00182  Norethindrone|Drug classes [BR:br08332(D00182)]|Endocrine and hormonal agent|DG02004  Progesterone|D00182  Norethindrone|Target-based classification of drugs [BR:br08310(D00182)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00182  Norethindrone (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00182)]|Chemicals|D00182  Norethisterone",
C05031,O6-Methyl-2'-deoxyguanosine,,,,,
C05042,Glufosinate;|Phosphinothricin;|2-Amino-4-(hydroxymethylphosphinyl)butanoic acid,L-Phosphinothricin [CPD:C04650],,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C05042  Glufosinate,
C05052,Ribulose,D-Ribulose [CPD:C00309]|L-Ribulose [CPD:C00508],,,,
C05057,cis-3-Enoyl-CoA,,,,,
C05058,m-Aminophenol;|3-Aminophenol;|3-Hydroxyaniline,,,,,
C05060,o-Benzosemiquinone;|2-Hydroxyphenoxy radical,,,,,
C05067,(3E)-3-Enoyl-CoA;|trans-3-Enoyl-CoA,Generic compound in reaction hierarchy,,,,
C05071,Chlorsulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C05071  Chlorsulfuron,
C05073,Coumermycin A1;|Coumermycin,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C05073  Coumermycin A1|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05073|Antimicrobials [BR:br08307(D02333)]|Antibacterials|Nucleic acid synthesis inhibitor|Other quinolone|D02333  Coumermycin (USAN),
C05076,Imazaquin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Imidazolinone herbicides|C05076  Imazaquin,
C05079,Nalidixic acid,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Quinolones|4-Quinolones|C05079  Nalidixic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00183)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MB Other quinolones|J01MB02 Nalidixic acid|D00183  Nalidixic acid (JP18/USP/INN)|Drug groups [BR:br08330(D00183)]|Antibacterial|DG01550  Quinolone|DG00630  Nalidixic acid|D00183  Nalidixic acid|Antimicrobials [BR:br08307(D00183)]|Antibacterials|Nucleic acid synthesis inhibitor|Other quinolone|D00183  Nalidixic acid (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00183)]|Chemicals|D00183  Nalidixic acid|Pharmacogenomic biomarkers [br08341.html(D00183)]|Polymorphisms and mutations affecting drug response|D00183,
C05080,Novobiocin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Aromatic compounds|C05080  Novobiocin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05080,
C05086,Cyclosporin A;|Ciclosporin;|Cyclosporine,"1, 2, 7 and 9 Leu are modified by N-methyl. (i.e. N-Mehtyl-L-leucine)|3 Val is modified by N-methyl. (i.e. N-Methyl-L-valine)|4 Thr is modified by (4R)-4-[(E)-butenyl]-4,N-dimethyl. (i.e. (4R)-4-[(E)-Butenyl]-4,N-dimethyl-L-threonine)",0 D-Ala  1 Leu  2 Leu  3 Val  4 Thr  5 Abu  6 Sar  7 Leu  8 Val|9 Leu  10 Ala  (Cyclization: 0-10),NRP,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00184)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AD Calcineurin inhibitors|L04AD01 Ciclosporin|D00184  Cyclosporine (USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA18 Ciclosporin|D00184  Cyclosporine (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00184)]|Immunological Agents|Immunosuppressants|Calcineurin Inhibitors|Cyclosporine|D00184  Cyclosporine (USP)|Ophthalmic Agents|Ophthalmic Agents, Other|Cyclosporine|D00184  Cyclosporine (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00184)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00184  Cyclosporine (USP); Ciclosporin (JP18)|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00184  Cyclosporine (USP); Ciclosporin (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|968  Antiallergic agents (including nonspecific antigen preparations)|9689  Other antiallergic agents|C05086  Cyclosporin A|Drug groups [BR:br08330(D00184)]|Immunological agent|DG03129  Calcineurin inhibitor|D00184  Cyclosporine|Dermatological agent|DG03243  Atopic dermatitis agent|D00184  Cyclosporine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00184  Cyclosporine|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00184  Cyclosporine|Transporter inhibitor|DG01622  ABCB1 inhibitor|D00184  Cyclosporine|Drug classes [BR:br08332(D00184)]|Immunological agent|DG03129  Calcineurin inhibitor|D00184  Cyclosporine|Dermatological agent|DG03243  Atopic dermatitis agent|D00184  Cyclosporine|Target-based classification of drugs [BR:br08310(D00184)]|Enzymes|Hydrolases (EC3)|Phosphatases|PPP3C/PPP3R/CHP|D00184  Cyclosporine (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00184)]|Chemicals|D00184  Ciclosporin|New drug approvals in Europe [br08329.html(D00184)]|European public assessment reports (EPAR) authorised medicine|D00184|Drug metabolizing enzymes and transporters [br08309.html(D00184)]|Drug metabolizing enzymes|D00184|Drug transporters|D00184",
C05100,3-Ureidoisobutyrate,,,,,
C05102,alpha-Hydroxy fatty acid;|2-Hydroxy fatty acid,Generic compound in reaction hierarchy,,,,
C05103,4alpha-Methylzymosterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05103  4alpha-Methylzymosterol,
C05104,"Delta7,24-Cholestadien-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05104  Delta7,24-Cholestadien-3beta-ol",
C05107,"7-Dehydrodesmosterol;|Cholesta-5,7,24-triene-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05107  7-Dehydrodesmosterol,
C05108,"14-Demethyllanosterol;|4,4-Dimethyl-5alpha-cholesta-8,24-dien-3beta-ol;|4,4-Dimethyl-8,24-cholestadienol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05108  14-Demethyllanosterol,
C05109,"24,25-Dihydrolanosterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05109  24,25-Dihydrolanosterol",
C05110,4alpha-Methylcholesta-8-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05110  4alpha-Methylcholesta-8-en-3beta-ol,
C05111,Methostenol;|4alpha-Methyl-5alpha-cholesta-7-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05111  Methostenol,
C05113,Porphyrin,,,,,
C05116,3-Hydroxybutanoyl-CoA;|3-Hydroxybutyryl-CoA,,,,,
C05117,3-Aminobutanoyl-CoA;|3-Aminobutyryl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05117  3-Aminobutanoyl-CoA,
C05118,S-(2-Methylbutanoyl)-dihydrolipoamide,,,,,
C05119,S-(3-Methylbutanoyl)-dihydrolipoamide,,,,,
C05122,Taurocholate;|Taurocholic acid;|Cholyltaurine,,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C05122  Taurocholate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C05122  Taurocholic acid|ST05 Steroid conjugates|ST0504 Taurine conjugates|C05122  Taurocholate",
C05123,2-Hydroxyethanesulfonate;|2-Hydroxyethanesulfonic acid;|2-Hydroxyethane-1-sulfonic acid;|Isethionic acid;|Isethionate,,,,,
C05125,2-(alpha-Hydroxyethyl)thiamine diphosphate;|2-Hydroxyethyl-ThPP,,,,,
C05126,"Dimethyl citraconate;|Citraconic acid dimethyl ester;|2-Butenedioic acid, 2-methyl-, dimethyl ester, (Z)-;|Citraconate de dimethyle;|Citraconic acid, dimethyl ester;|Dimethyl methylmaleate;|Methylmaleic acid, dimethyl ester",,,,,
C05127,N-Methylhistamine;|1-Methylhistamine;|1-Methyl-4-(2-aminoethyl)imidazole;|Ntau-Methylhistamine,,,,,
C05130,Imidazole-4-acetaldehyde;|Imidazole acetaldehyde,,,,,
C05131,(1-Ribosylimidazole)-4-acetate,,,,,
C05133,4-Imidazolone-5-acetate;|Imidazolone acetate;|(5-Hydroxyimidazole)-4-acetate;|5-Hydroxy-4-imidazoleacetate,,,,,
C05135,4-(beta-Acetylaminoethyl)imidazole;|N-Acetylhistamine,,,,,
C05136,"GDP-3,6-dideoxy-D-galactose",,,,,
C05138,"17alpha-Hydroxypregnenolone;|3-beta,17alpha-Dihydroxypregn-5-en-20-one",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Progestagens|C05138  17alpha-Hydroxypregnenolone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05138  17alpha-Hydroxypregnenolone",
C05139,"16alpha-Hydroxydehydroepiandrosterone;|5-Androstene-3beta,16alpha-diol-17-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05139  16alpha-Hydroxydehydroepiandrosterone,
C05140,"16alpha-Hydroxyandrost-4-ene-3,17-dione;|4-Androsten-16alpha-ol-3,17-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05140  16alpha-Hydroxyandrost-4-ene-3,17-dione",
C05141,"Estriol;|1,3,5(10)-Estratriene-3,16-alpha,17beta-triol",,,,"Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C05141  Estriol|Hormones and transmitters|Steroid hormones|Estrogens|C05141  Estriol (E3)|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05141  Estriol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00185)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA04 Estriol|D00185  Estriol (JP18/USP) &lt;JP&gt;|G03CC Estrogens, combinations with other drugs|G03CC06 Estriol|D00185  Estriol (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00185)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2475  Estriols|D00185  Estriol (JP18/USP)|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00185  Estriol (JP18/USP)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9414  Follicle stimulating hormone and preparations|C05141  Estriol|Drug groups [BR:br08330(D00185)]|Hormonal agent|DG01986  Estrogen|DG00463  Estriol|D00185  Estriol|DG01584  Estrogen receptor agonist|DG00463  Estriol|D00185  Estriol|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00185  Estriol|Drug classes [BR:br08332(D00185)]|Endocrine and hormonal agent|DG01986  Estrogen|D00185  Estriol|DG01584  Estrogen receptor agonist|D00185  Estriol|Musculo-skeletal system agent|DG03232  Osteoporosis agent|D00185  Estriol|Target-based classification of drugs [BR:br08310(D00185)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00185  Estriol (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00185)]|Chemicals|D00185  Estriol|D00185  Estriol tablets|D00185  Estriol injection (aqueous suspension)",
C05143,Dhurrin;|(S)-4-Hydroxymandelonitrile beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from thyrosine|C05143  Dhurrin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C05143  Dhurrin,
C05144,(beta-D-Mannuronate)n;|Poly(beta-D-mannuronate);|Polymannuronate;|Mannuronan,,,,,
C05145,3-Aminoisobutyric acid;|3-Aminoisobutanoate;|3-Amino-2-methylpropanoate,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C05145  3-Aminoisobutyric acid|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C05145  3-Aminoisobutyric acid,
C05146,Hydantoin;|Glycolylurea,,,,,
C05147,trans-3-Hydroxy-L-proline;|trans-L-3-Hydroxyproline,,,,,
C05148,Debromoaplysiatoxin,,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Aplysiatoxins|C05148  Debromoaplysiatoxin,
C05149,Bryostatin 1,,0 Mtk  1 Mak  2 Mad  3 Mak  4 Isd  5 Mak  6 Mad  7 Mak  8 Mak|9 Isk  10 Mak  11 Mak  12 Man,PK,,
C05150,"Teleocidin B-1;|(4S,7S,10S,13R)-13-Ethenyl-1,3,4,5,7,8,10,11,12,13-decahydro-4-(hydroxymethyl)-8,10,13-trimethyl-7,10-diisopropyl-6H-benzo[g][1,4]diazonino[7,6,5-cd]indol-6-one",,,,,
C05151,12-O-Tetradecanoylphorbol 13-acetate;|TPA;|Phorbol 12-myristate 13-acetate;|12-Tetradecanoylphorbol 13-acetate;|PMA,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C05151  12-O-Tetradecanoylphorbol 13-acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C05151  12-O-Tetradecanoylphorbol 13-acetate,
C05155,5-Amino-4-chloro-2-(5-hydroxymuconoyl)-3(2H)-pyridazinone;|5-Amino-4-chloro-2-(2-hydroxymuconoyl)-3(2H)-pyridazinone,5-Amino-4-chloro-2-(2-hydroxymuconoyl)-3(2H)-pyridazinone is named incorrectly.,,,,
C05156,Aminoacyl-tRNA,Generic compound in reaction hierarchy,,,,
C05157,Peptidyl-aminoacyl-tRNA,Generic compound in reaction hierarchy,,,,
C05158,trans-beta-D-Glucosyl-2-hydroxycinnamate;|beta-D-Glucosyl-2-coumarate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C05158  trans-beta-D-Glucosyl-2-hydroxycinnamate,
C05159,"6-(2,6-Bis[N-acetyl-beta-D-glucosaminyl]-alpha-D-mannosyl)-beta-D-mannosyl-R",Generic compound in reaction hierarchy,,,,
C05161,"(2R,5S)-2,5-Diaminohexanoate",,,,,
C05163,O-Methyl-scyllo-inositol;|1-O-Methyl-scyllo-inositol,,,,,
C05165,2-Amino-5-oxocyclohex-1-enecarbonyl-CoA;|2-Amino-5-oxocyclohex-1-enecarboxyl-CoA,2-Amino-5-oxocyclohex-1-enecarboxyl-CoA is named incorrectly.,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05165  2-Amino-5-oxocyclohex-1-enecarbonyl-CoA,
C05167,alpha-Amino acid,Generic compound in reaction hierarchy,,,,
C05172,Selenophosphoric acid;|Selenophosphate,,,,,
C05174,"(S)-Cheilanthifoline;|(6aS)-6,6a,11,14-Tetrahydro-8-methoxy-12H-benzo[a]-1,3-benzodioxolo[4,5-g]quinolizim-9-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05174  (S)-Cheilanthifoline,
C05175,"Stylopine;|(S)-Stylopine;|l-Tetrahydrocoptisine;|6,7,12b,13e-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05175  Stylopine,
C05176,"(S)-N-Methylcoclaurine;|(S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05176  (S)-N-Methylcoclaurine,
C05177,"Berbamunine;|(1S)-1,2,3,4-Tetrahydro-1-[[4-[2-hydroxy-5-[[(1R)-1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-6-methoxy-2-methyl-7-isoquinolinol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05177  Berbamunine,
C05178,"(R)-Reticuline;|(1R)-1,2,3,4-Tetrahydro-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05178  (R)-Reticuline,
C05179,"Salutaridine;|Sinoacutine;|5,6,8,14-Tetradehydro-4-hydroxy-3,6-dimethoxy-17-methyl-morphinan-7-one",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05179  Salutaridine,
C05189,Protopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05189  Protopine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C05189  Protopine,
C05190,6-Hydroxyprotopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05190  6-Hydroxyprotopine,
C05191,"Dihydrosanguinarine;|13,14-Dihydro-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05191  Dihydrosanguinarine,
C05193,12-Hydroxydihydrochelirubine;|12-Hydroxychelirubine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05193  12-Hydroxydihydrochelirubine,
C05194,"Dihydrochelirubine;|13,14-Dihydro-5-methoxy-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05194  Dihydrochelirubine,
C05195,3-Hydroxybenzoyl-CoA,,,,,
C05197,Protein glycine;|[Enzyme]-glycine,Generic compound in reaction hierarchy|Unactivated form of glycyl radical enzymes,,,,
C05198,5'-Deoxyadenosine,,,,,
C05200,"3-Hexaprenyl-4,5-dihydroxybenzoate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C05200  3-Hexaprenyl-4,5-dihydroxybenzoate",
C05201,"(R,S)-Tetrahydrobenzylisoquinoline;|(RS)-1-Benzyl-1,2,3,4-tetrahydroisoquinoline",,,,,
C05202,3'-Hydroxy-N-methyl-(S)-coclaurine;|(S)-3'-Hydroxy-N-methylcoclaurine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05202  3'-Hydroxy-N-methyl-(S)-coclaurine,
C05203,6-O-Methylnorlaudanosoline,,,,,
C05204,"(S)-Tetrahydroprotoberberine;|(S)-7,8,13,14-Tetrahydroprotoberberine;|(-)-Berbine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05204  (S)-Tetrahydroprotoberberine,
C05205,[Cytochrome c] methionine;|[Cytochrome c] L-methionine,Generic compound in reaction hierarchy,,,,
C05206,Histone L-arginine;|Histone-arginine,Generic compound in reaction hierarchy,,,,
C05207,[Myeline basic protein] L-arginine;|[Myelin basic protein]-arginine,Generic compound in reaction hierarchy,,,,
C05208,1-Alkyl-2-arachidonyl-sn-glycero-3-phosphocholine;|1-Organyl-2-arachidonyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0102 1-alkyl,2-acylglycerophosphocholines|C05208  1-Alkyl-2-arachidonyl-sn-glycero-3-phosphocholine",
C05209,1-Alkyl-2-lyso-sn-glycero-3-phosphoethanolamine;|1-Organyl-2-lyso-sn-glycero-3-phosphoethanolamine;|1-Radyl-2-lyso-sn-glycero-3-phosphoethanolamine,Generic compound in reaction hierarchy|R = alkyl or acyl group,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0206 Monoalkylglycerophosphoethanolamines|C05209  1-Alkyl-2-lyso-sn-glycero-3-phosphoethanolamine,
C05210,1-Alkyl-2-arachidonyl-sn-glycero-3-phosphoethanolamine;|1-Organyl-2-arachidonyl-sn-glycero-3-phosphoethanolamine,,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0202 1-alkyl,2-acylglycerophosphoethanolamines|C05210  1-Alkyl-2-arachidonyl-sn-glycero-3-phosphoethanolamine",
C05212,1-Radyl-2-acyl-sn-glycero-3-phosphocholine;|1-Organyl-2-acyl-sn-glycero-3-phosphocholine;|2-Acyl-1-alkyl-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0102 1-alkyl,2-acylglycerophosphocholines|C05212  2-Acyl-1-alkyl-sn-glycero-3-phosphocholine",
C05217,1-Organyl-2-lyso-sn-glycero-3-phospholipid,Generic compound in reaction hierarchy,,,,
C05218,1-Radyl-2-acetyl-sn-glycero-3-phospholipid;|1-Alkyl-2-acetyl-sn-glycero-3-phospholipid;|1-Organyl-2-acetyl-sn-glycero-3-phospholipid,Generic compound in reaction hierarchy,,,,
C05220,"Salutaridinol;|5,6,8,14-Tetradehydro-3,6-dimethoxy-17-methyl-morphinan-4,7-diol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05220  Salutaridinol,
C05223,Dodecanoyl-[acyl-carrier protein];|Dodecanoyl-[acp];|Lauroyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05223  Dodecanoyl-[acp],
C05226,N-Carbamoyl-D-amino acid,Generic compound in reaction hierarchy,,,,
C05229,Phaseollidin hydrate,,,,,
C05230,Phaseollidin;|(-)-Phaseollidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C05230  Phaseollidin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C05230  Phaseollidin,
C05231,L-3-Aminobutyryl-CoA;|L-3-Aminobutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05231  L-3-Aminobutanoyl-CoA,
C05232,(2S)-2-Methylacyl-CoA,Generic compound in reaction hierarchy,,,,
C05234,Detyrosinated alpha-tubulin,,,,,
C05235,Hydroxyacetone;|Acetol;|1-Hydroxy-2-propanone;|2-Ketopropyl alcohol;|Acetone alcohol;|Pyruvinalcohol;|Pyruvic alcohol;|Methylketol,,,,,
C05239,5-Aminoimidazole;|Aminoimidazole;|4-Aminoimidazole,,,,,
C05243,"(R)-N-Methylcoclaurine;|(R)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-2-methyl-7-isoquinolinol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05243  (R)-N-Methylcoclaurine,
C05247,10-Hydroxydihydrosanguinarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05247  10-Hydroxydihydrosanguinarine,
C05250,[Protein-PII];|Nitrogen regulatory protein P-II,Generic compound in reaction hierarchy,,,,
C05252,"2-Amino-4-oxo-4-alpha-hydroxy-6-(erythro-1',2',3'-Tri-hydroxypropyl)-5,6,7,8-tetrahydroxypterin",,,,,
C05253,"2-Amino-4-oxo-6-(1',2',3'-trihydroxypropyl)-diquinoid-7,8-dihydroxypterin",,,,,
C05258,(S)-3-Hydroxyhexadecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05258  (S)-3-Hydroxyhexadecanoyl-CoA,
C05259,3-Oxopalmitoyl-CoA;|3-Ketopalmitoyl-CoA;|3-Oxohexadecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05259  3-Oxohexadecanoyl-CoA,
C05260,(S)-3-Hydroxytetradecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05260  (S)-3-Hydroxytetradecanoyl-CoA,
C05261,3-Oxotetradecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05261  3-Oxotetradecanoyl-CoA,
C05262,(S)-3-Hydroxydodecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05262  (S)-3-Hydroxydodecanoyl-CoA,
C05263,3-Oxododecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05263  3-Oxododecanoyl-CoA,
C05264,(S)-Hydroxydecanoyl-CoA;|(S)-3-Hydroxydecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05264  (S)-3-Hydroxydecanoyl-CoA,
C05265,3-Oxodecanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05265  3-Oxodecanoyl-CoA,
C05266,(S)-3-Hydroxyoctanoyl-CoA;|(S)-3-Hydroxycapryloyl-CoA;|(S)-Hydroxyoctanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05266  (S)-3-Hydroxyoctanoyl-CoA,
C05267,3-Oxooctanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05267  3-Oxooctanoyl-CoA,
C05268,(S)-Hydroxyhexanoyl-CoA;|(S)-3-Hydroxyhexanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05268  (S)-3-Hydroxyhexanoyl-CoA,
C05269,3-Oxohexanoyl-CoA;|3-Ketohexanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05269  3-Oxohexanoyl-CoA,
C05270,Hexanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05270  Hexanoyl-CoA,
C05271,trans-Hex-2-enoyl-CoA;|(2E)-Hexenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05271  (2E)-Hexenoyl-CoA,
C05272,trans-Hexadec-2-enoyl-CoA;|trans-2-Hexadecenoyl-CoA;|(2E)-Hexadecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05272  (2E)-Hexadecenoyl-CoA,
C05273,trans-Tetradec-2-enoyl-CoA;|(2E)-Tetradecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05273  (2E)-Tetradecenoyl-CoA,
C05274,Decanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05274  Decanoyl-CoA,
C05275,trans-Dec-2-enoyl-CoA;|(2E)-Decenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05275  (2E)-Decenoyl-CoA,
C05276,trans-Oct-2-enoyl-CoA;|(2E)-Octenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05276  (2E)-Octenoyl-CoA,
C05278,(R)-3-Hydroxyoctanoyl-CoA;|(R)-3-Hydroxycapryloyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05278  (R)-3-Hydroxyoctanoyl-CoA,
C05279,"trans,cis-Lauro-2,6-dienoyl-CoA;|(2E,6Z)-Dodecadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05279  (2E,6Z)-Dodecadienoyl-CoA",
C05280,"cis,cis-3,6-Dodecadienoyl-CoA;|(3Z,6Z)-Dodecadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05280  (3Z,6Z)-Dodecadienoyl-CoA",
C05281,5-Methylbarbiturate;|5-Methylbarbituric acid,,,,,
C05282,(5-L-Glutamyl)-L-glutamate,,,,,
C05283,(5-L-Glutamyl)-L-glutamine,,,,,
C05284,"11beta-Hydroxyandrost-4-ene-3,17-dione;|Androst-4-ene-3,17-dione-11beta-ol;|4-Androsten-11beta-ol-3,17-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05284  11beta-Hydroxyandrost-4-ene-3,17-dione",
C05285,"Adrenosterone;|Androst-4-ene-3,11,17-trione",,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C05285  Adrenosterone,
C05290,"19-Hydroxyandrost-4-ene-3,17-dione;|19-Hydroxyandrostenedione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05290  19-Hydroxyandrost-4-ene-3,17-dione",
C05291,7alpha-Hydroxytestosterone,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Androgens|C05291  7alpha-Hydroxytestosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05291  7alpha-Hydroxytestosterone,
C05293,5beta-Dihydrotestosterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05293  5beta-Dihydrotestosterone,
C05294,"19-Hydroxytestosterone;|17beta,19-Dihydroxyandrost-4-en-3-one",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Androgens|C05294  19-Hydroxytestosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05294  17beta,19-Dihydroxyandrost-4-en-3-one",
C05295,19-Oxotestosterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05295  19-Oxotestosterone,
C05296,"7alpha-Hydroxyandrost-4-ene-3,17-dione;|7alpha-Hydroxyandrostenedione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05296  7alpha-Hydroxyandrost-4-ene-3,17-dione",
C05297,"19-Oxoandrost-4-ene-3,17-dione;|19-Oxoandrostenedione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C05297  19-Oxoandrost-4-ene-3,17-dione",
C05298,2-Hydroxyestrone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05298  2-Hydroxyestrone,
C05299,2-Methoxyestrone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05299  2-Methoxyestrone,
C05300,16alpha-Hydroxyestrone,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Estrogens|C05300  16alpha-Hydroxyestrone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05300  16alpha-Hydroxyestrone,
C05301,2-Hydroxyestradiol;|2-Hydroxyestradiol-17beta;|2-OH-Estradiol,,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C05301  2-Hydroxyestradiol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05301  2-Hydroxyestradiol-17beta,
C05302,2-Methoxy-17beta-estradiol;|2-Methoxyestradiol-17beta,,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C05302  2-Methoxyestradiol-17beta|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05302  2-Methoxyestradiol-17beta,
C05306,Chlorophyll a,,,,,
C05307,Chlorophyll b,,,,,
C05308,Linalyl diphosphate;|LPP,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C05308  Linalyl diphosphate,
C05312,Protein glycin-2-yl radical;|[Enzyme]-glycin-2-yl radical,Generic compound in reaction hierarchy|Active form of glycyl radical enzymes,,,,
C05313,3-Hexaprenyl-4-hydroxy-5-methoxybenzoate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C05313  3-Hexaprenyl-4-hydroxy-5-methoxybenzoate,
C05314,"N-Methyl-(R,S)-tetrahydrobenzylisoquinoline;|N-Methyl-(RS)-1-benzyl-1,2,3,4-tetrahydroisoquinoline",,,,,
C05315,"Palmatine;|5,6-Dihydro-2,3,9,10-tetramethoxydibenzo[a,g]quinolizinium",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05315  Palmatine,
C05316,"Dihydromacarpine;|13,14-Dihydro-5,7-dimethoxy-13-methyl-[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05316  Dihydromacarpine,
C05317,Nororientaline,,,,,
C05318,"(S)-cis-N-Methyl-7,8,13,14-tetrahydroprotoberberine",Generic compound in reaction hierarchy,,,,
C05319,[Cytochrome c] S-methylmethionine;|[Cytochrome c] S-methyl-L-methionine,Generic compound in reaction hierarchy,,,,
C05320,Histone N(omega)-methyl-L-arginine;|Histone-N(omega)-methylarginine,Generic compound in reaction hierarchy,,,,
C05321,[Myeline basic protein] N(omega)-methyl-L-arginine;|[Myelin basic protein]-N(omega)-methylarginine,Generic compound in reaction hierarchy,,,,
C05322,7-O-Acetylsalutaridinol;|Salutaridinol acetate;|Salutaridinol 7-O-acetate,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C05322  7-O-Acetylsalutaridinol,
C05324,Nicotianamine,,,,,
C05325,Purine mononucleotide,Generic compound in reaction hierarchy,,,,
C05326,Uridylyl-[protein-PII];|Uridylylated nitrogen regulatory protein P-II;|P-II-UMP,Generic compound in reaction hierarchy,,,,
C05328,D-2-Aminohexano-6-lactam;|(R)-2-Aminohexano-6-lactam,,,,,
C05329,(2R)-2-Methylacyl-CoA,Generic compound in reaction hierarchy,,,,
C05330,Homocysteine;|2-Amino-4-mercaptobutyric acid,"Generic compound in reaction hierarchy|The name ""Homocysteine"" usually means L-Homocysteine [CPD:C00155].",,,,
C05332,Phenethylamine;|2-Phenylethylamine;|beta-Phenylethylamine;|Phenylethylamine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amines|Biogenic amines|C05332  Phenethylamine,
C05334,"Isosakuranetin;|4'-Methoxy-5,7-dihydroxyflavonone;|4'-Methylnaringenin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C05334  4'-Methoxy-5,7-dihydroxyflavonone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C05334  Isosakuranetin",
C05335,L-Selenomethionine,,,,,
C05336,Selenomethionyl-tRNA(Met);|L-Selenomethionyl-tRNA(Met),,,,,
C05337,"Chenodeoxycholoyl-CoA;|3alpha,7alpha-Dihydroxy-5beta-cholanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C05337  Chenodeoxycholoyl-CoA",
C05338,4-Hydroxyphenylacetyl-CoA,,,,,
C05339,Phosphinate;|Phosphinic acid;|Hypophosphorous acid;|Hyopophosphite,,,,,
C05340,beta-Alanyl-L-arginine,,,,,
C05341,beta-Alanyl-L-lysine,,,,,
C05342,Psicofuranine;|Angustmycin C,,,,,
C05343,(R)-4-Hydroxymandelate,4-Hydroxymandelate [CPD:C11527],,,,
C05344,GDP-4-dehydro-6-deoxy-L-mannose;|GDP-4-oxo-6-deoxy-L-mannose;|GDP-4-oxo-L-rhamnose,,,,,
C05345,beta-D-Fructose 6-phosphate;|beta-D-Fructofuranose 6-phosphate,,,,,
C05346,Allosamidine,,,,,
C05349,Ciprofloxacin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00186)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA02 Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE03 Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA15 Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA07 Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00186)]|Antibacterials|Quinolones|Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN)|Otic Agents|Otic Anti-Infectives|Ciprofloxacin|D00186  Ciprofloxacin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00186)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D00186  Ciprofloxacin (JP18/USP/INN)|Drug groups [BR:br08330(D00186)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00617  Ciprofloxacin|D00186  Ciprofloxacin|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00617  Ciprofloxacin|D00186  Ciprofloxacin|Drug classes [BR:br08332(D00186)]|Antibacterial|DG01549  Fluoroquinolone|D00186  Ciprofloxacin|Antimicrobials [BR:br08307(D00186)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00186  Ciprofloxacin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00186)]|Chemicals|D00186  Ciprofloxacin|Drug metabolizing enzymes and transporters [br08309.html(D00186)]|Drug metabolizing enzymes|D00186",
C05350,2-Hydroxy-3-(4-hydroxyphenyl)propenoate;|4-Hydroxy-enol-phenylpyruvate,,,,,
C05353,TES;|N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid,,,,,
C05354,Cyclopropylcarbinyl cation,,,,,
C05356,"5(S)-HPETE;|5(S)-Hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid;|(6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoate;|(6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyeicosa-6,8,11,14-tetraenoic acid;|(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate",,,,"Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C05356  5-HPETE|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C05356  (6E,8Z,11Z,14Z)-(5S)-5-Hydroperoxyicosa-6,8,11,14-tetraenoic acid|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C05356  5(S)-HPETE",
C05359,e-;|Electron,,,,,
C05360,Diimine,,,,,
C05361,Hydrazine,,,,,
C05364,4-Carboxy-2-oxo-3-hexenedioate,,,,,
C05366,(+)-Pinoresinol,(-)-Pinoresinol [CPD:C20455],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C05366  (+)-Pinoresinol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C05366,
C05370,Calyculin A,,,,,
C05371,Microcystin LR;|Microcystin-LR,"6 Ala is modified by N-methyldehydro. (i.e. N-Methyldehydroalanine, Mdha)|9 D-Asp is modified by erythro-beta-methyl. (i.e. D-erythro-beta-Methylaspartic acid, D-MeAsp)",0 Phenylacetate  1 Mtd  2 Mtd  3 Mae  4 Mtn  5 D-Glu  6 Ala|7 D-Ala  8 Leu  9 D-Asp  10 Arg  (Cyclization: 5-10),PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C05371  Microcystin LR|Natural toxins [BR:br08009]|Cyanotoxins|Peptides|Microcystins|C05371  Microcystin LR,
C05372,Tautomycin,,,,,
C05375,"2-Hydroxy-2-hydropyrone-4,6-dicarboxylate",,,,,
C05376,Biochanin A-beta-D-glucoside;|Biochanin A 7-O-beta-D-glucoside;|Sissotrin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C05376  Biochanin A-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C05376  Biochanin A-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C05376  Biochanin A-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C05376,
C05377,"Menadione;|Vitamin K3;|2-Methyl-1,4-naphthoquinone",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C05377  Menadione (Vitamin K3)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02335)]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02B VITAMIN K AND OTHER HEMOSTATICS|B02BA Vitamin K|B02BA02 Menadione|D02335  Menadione (USP)|Drug groups [BR:br08330(D02335)]|Blood modifier agent|DG02016  Hemostatics|DG02014  Blood coagulation accelerant|DG01603  Vitamin K|DG00166  Menadione|D02335  Menadione,
C05378,"beta-D-Fructose 1,6-bisphosphate",,,,,
C05379,Oxalosuccinate;|Oxalosuccinic acid,,,,,
C05380,Nicotinurate;|Nicotinuric acid;|Nicotinylglycine,,,,,
C05381,3-Carboxy-1-hydroxypropyl-ThPP;|Succinate semialdehyde-thiamin diphosphate,,,,,
C05382,Sedoheptulose 7-phosphate;|D-Sedoheptulose 7-phosphate;|D-altro-Heptulose 7-phosphate;|altro-Heptulose 7-phosphate,,,,,
C05385,D-Glucuronate 1-phosphate;|1-Phospho-alpha-D-glucuronate,,,,,
C05386,GDP-6-deoxy-L-mannose;|GDP-L-rhamnose,,,,,
C05392,Oligouronide with 4-deoxy-alpha-L-erythro-hex-4-enopyranuronosyl group,Delta-Dimer (n=1),,,,
C05394,3-Keto-beta-D-galactose,,,,,
C05396,Lactose 6'-phosphate,,,,,G10517
C05399,Melibiitol;|6-O-alpha-D-Galactosyl-D-glucitol,,,,,
C05400,Epimelibiose;|6-O-(alpha-D-Galactopyranosyl)-D-mannopyranose,,,,,G10529
C05401,3-beta-D-Galactosyl-sn-glycerol;|Galactosylglycerol,,,,,
C05402,Melibiose;|6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose;|D-Gal-alpha1->6D-Glucose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C05402  Melibiose,G01275
C05403,3-Ketolactose,,,,,G10531
C05404,D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose;|D-Gal-alpha1->6D-Gal-alpha1->6D-Glucose;|Manninotriose,,,,,G00501
C05405,"L-Arabinono-1,5-lactone",,,,,
C05406,"5-Hydroxy-2,4-dioxopentanoate",,,,,
C05410,"Gulono-1,4-lactone;|Gulonolactone",,,,,
C05411,L-Xylonate;|L-Xylonic acid,,,,,
C05412,L-Lyxonate;|L-Lyxonic acid,,,,,
C05413,all-trans-Phytoene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05413  Phytoene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05413  Phytoene,
C05414,all-trans-Phytofluene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05414  Phytofluene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05414  all-trans-Phytofluene,
C05416,5-Cholestene;|Cholest-5-ene,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05416  5-Cholestene,
C05417,"5,6beta-Epoxy-5beta-cholestane",,,,,
C05418,"Cholesterol-5beta,6beta-epoxide;|5beta,6beta-Epoxycholestan-3beta-ol;|5,6beta-Epoxy-5beta-cholestan-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05418  Cholesterol-5beta,6beta-epoxide",
C05421,15-cis-Phytoene;|Phytoene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05421  cis-Phytoene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05421  15-cis-Phytoene,
C05422,Dehydroascorbate;|Dehydroascorbic acid;|L-Dehydroascorbate;|L-Dehydroascorbic acid,,,,,
C05423,"5,6alpha-Epoxy-5alpha-cholestane",,,,,
C05424,"5alpha-Cholestan-5alpha,6beta-diol",,,,,
C05425,"3beta,5alpha,6beta-Cholestanetriol;|Cholestane-3beta-5alpha,6beta-triol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05425  3beta,5alpha,6beta-Cholestanetriol",
C05427,Phytyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C05427  Phytyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Linear diterpenes|C05427  Phytyl diphosphate,
C05430,all-trans-zeta-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05430  zeta-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05430  all-trans-zeta-Carotene,
C05431,all-trans-Neurosporene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05431  Neurosporene,
C05432,Lycopene;|all-trans-Lycopene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05432  Lycopene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05432  Lycopene,
C05433,alpha-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05433  alpha-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05433  alpha-Carotene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05433,
C05434,beta-Zeacarotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05434  beta-Zeacarotene,
C05435,gamma-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C05435  gamma-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C05435  gamma-Carotene,
C05437,"Zymosterol;|Delta8,24-Cholestadien-3beta-ol;|5alpha-Cholesta-8,24-dien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05437  Zymosterol,
C05439,"5alpha-Cholesta-7,24-dien-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05439  5alpha-Cholesta-7,24-dien-3beta-ol",
C05440,"Ergosta-5,7,22,24(28)-tetraen-3beta-ol;|Ergosta-5,7,22,24(24(1))-tetraen-3beta-ol;|5,7,22,24(28)-Ergostatetraenol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C05440  Ergosta-5,7,22,24(28)-tetraen-3beta-ol",
C05441,Vitamin D2;|Ergocalciferol,,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C05441  Ergocalciferol (Vitamin D2)|Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C05441  Vitamin D2|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00187)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CC Vitamin D and analogues|A11CC01 Ergocalciferol|D00187  Ergocalciferol (JP18/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00187)]|Electrolytes/Minerals/Metals/Vitamins|Vitamins|Ergocalciferol|D00187  Ergocalciferol (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00187)]|Nourishing tonics and health supplements|39 Vitamin AD based drugs|D00187  Ergocalciferol (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00187)]|Second-class OTC drugs|Inorganic and organic chemicals|Ergocalciferol or Cholecalciferol|D00187  Ergocalciferol (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Ergocalciferol|D00187  Ergocalciferol (JP18/USP)|Drug groups [BR:br08330(D00187)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D00187  Ergocalciferol|Target-based classification of drugs [BR:br08310(D00187)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00187  Ergocalciferol (JP18/USP) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00187)]|Chemicals|D00187  Ergocalciferol",
C05442,Stigmasterol,,,,Compounds with biological roles [BR:br08001]|Steroids|29-Carbon atoms|Stigmastane derivatives|C05442  Stigmasterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C05442  Stigmasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C05442  Stigmasterol,
C05443,Vitamin D3;|Cholecalciferol;|Calciol,,,,"Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Fat-soluble vitamins|C05443  Cholecalciferol (Vitamin D3)|Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C05443  Vitamin D3|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00188)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CC Vitamin D and analogues|A11CC05 Colecalciferol|D00188  Cholecalciferol (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00188)]|Nourishing tonics and health supplements|33 Vitamin D based drugs|D00188  Cholecalciferol (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00188)]|Second-class OTC drugs|Inorganic and organic chemicals|Ergocalciferol or Cholecalciferol|D00188  Cholecalciferol (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Ergocalciferol|D00188  Cholecalciferol (JP18/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9621  Vitamin A, D and preparations|C05443  Vitamin D3|Drug groups [BR:br08330(D00188)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D00188  Cholecalciferol|Target-based classification of drugs [BR:br08310(D00188)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00188  Cholecalciferol (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00188)]|Chemicals|D00188  Cholecalciferol",
C05444,"3alpha,7alpha,26-Trihydroxy-5beta-cholestane;|5beta-Cholestane-3alpha,7alpha,26-triol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05444  3alpha,7alpha,26-Trihydroxy-5beta-cholestane",
C05445,"3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05445  3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al",
C05446,"3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane;|5beta-Cholestane-3alpha,7alpha,12alpha,26-tetraol;|5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05446  3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane",
C05447,"(24E)-3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA;|(24E)-3alpha,7alpha-Dihydroxy-5beta-cholest-24-en-26-oyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05447  (24E)-3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA",
C05448,"(24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA;|(24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestan-26-oyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05448  (24R,25R)-3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA",
C05449,"3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05449  3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05449  3alpha,7alpha-Dihydroxy-5beta-24-oxocholestanoyl-CoA",
C05450,"3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA;|3alpha,7alpha,12alpha,24zeta-Tetrahydroxy-5beta-cholestanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05450  3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA",
C05451,7alpha-Hydroxy-5beta-cholestan-3-one;|5beta-Cholestan-7alpha-ol-3-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05451  7alpha-Hydroxy-5beta-cholestan-3-one",
C05452,"3alpha,7alpha-Dihydroxy-5beta-cholestane;|5beta-Cholestane-3alpha,7alpha-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05452  3alpha,7alpha-Dihydroxy-5beta-cholestane",
C05453,"7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one;|5beta-Cholesten-7alpha,12alpha-diol-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05453  7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one",
C05454,"3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane;|5beta-Cholestane-3alpha,7alpha,12alpha-triol;|3alpha,7alpha,12alpha-Trihydroxycoprostane",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05454  3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane",
C05455,7alpha-Hydroxycholest-4-en-3-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05455  7alpha-Hydroxycholest-4-en-3-one|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05455  7alpha-Hydroxycholest-4-en-3-one",
C05458,"7alpha,12alpha-Dihydroxy-5alpha-cholestan-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05458  7alpha,12alpha-Dihydroxy-5alpha-cholestan-3-one",
C05460,"(24E)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA;|3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05460  (24E)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA",
C05463,Taurodeoxycholate;|Taurodeoxycholic acid,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0504 Taurine conjugates|C05463  Taurodeoxycholate,
C05464,"Glycodeoxycholate;|Glycodeoxycholic acid;|3alpha,12alpha-Dihydroxy-5beta-cholan-24-oylglycine",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C05464  Glycodeoxycholic acid|ST05 Steroid conjugates|ST0503 Glycine conjugates|C05464  Glycodeoxycholate",
C05465,Taurochenodeoxycholate;|Taurochenodeoxycholic acid;|Chenodeoxycholoyltaurine,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C05465  Taurochenodeoxycholic acid|ST05 Steroid conjugates|ST0504 Taurine conjugates|C05465  Taurochenodeoxycholate",
C05466,Glycochenodeoxycholate;|Glycochenodeoxycholic acid;|Chenodeoxyglycocholate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C05466  Glycochenodeoxycholic acid|ST05 Steroid conjugates|ST0503 Glycine conjugates|C05466  Glycochenodeoxycholate",
C05467,"3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA;|3alpha,7alpha,12alpha-Trihydroxy-24-oxo-5beta-cholestanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05467  3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA",
C05468,5beta-Cyprinolsulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0502 Sulfates|C05468  5beta-Cyprinolsulfate,
C05469,"17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione;|5beta-Pregnane-17alpha,21-diol-3,11,20-trione;|4,5beta-Dihydrocortisone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05469  4,5beta-Dihydrocortisone",
C05470,Tetrahydrocortisone;|Urocortisone,,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Glucocorticoids|C05470  Tetrahydrocortisone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05470  Urocortisone",
C05471,"Dihydrocortisol;|11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione;|5beta-Pregnane-11beta,17alpha,21-triol-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05471  Dihydrocortisol",
C05472,"Urocortisol;|Tetrahydrocortisol;|5beta-Pregnane-3alpha,11beta,17alpha,21-tetrol-20-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05472  Urocortisol",
C05473,"11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05473  11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al",
C05474,"3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05474  3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al",
C05475,"11beta,21-Dihydroxy-5beta-pregnane-3,20-dione;|5beta-Pregnane-11beta,21-diol-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05475  11beta,21-Dihydroxy-5beta-pregnane-3,20-dione",
C05476,Tetrahydrocorticosterone,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05476  Tetrahydrocorticosterone",
C05477,"21-Hydroxy-5beta-pregnane-3,11,20-trione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05477  21-Hydroxy-5beta-pregnane-3,11,20-trione",
C05478,"3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione;|5beta-Pregnane-3alpha,21-diol-11,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05478  3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione",
C05479,"5beta-Pregnane-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05479  5beta-Pregnane-3,20-dione",
C05480,Pregnanolone;|3alpha-Hydroxy-5beta-pregnan-20-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05480  Pregnanolone",
C05481,"Cortolone;|3alpha,17alpha,20alpha,21-Tetrahydroxy-5beta-pregnan-11-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05481  Cortolone",
C05482,"Cortol;|5beta-Pregnane-3alpha,11beta,17,20alpha,21-pentol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05482  Cortol",
C05483,"3alpha,20alpha,21-Trihydroxy-5beta-pregnan-11-one",,,,,
C05484,"Pregnanediol;|5beta-Pregnane-3alpha,20alpha-diol;|Pregnandiol;|Diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05484  Pregnanediol",
C05485,"21-Hydroxypregnenolone;|3beta,21-Dihydroxypregn-5-en-20-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05485  21-Hydroxypregnenolone",
C05487,"17alpha,21-Dihydroxypregnenolone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05487  17alpha,21-Dihydroxypregnenolone",
C05488,11-Deoxycortisol;|Cortodoxone,,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Glucocorticoids|C05488  11-Deoxycortisol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05488  11-Deoxycortisol",
C05489,"11beta,17alpha,21-Trihydroxypregnenolone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05489  11beta,17alpha,21-Trihydroxypregnenolone",
C05490,"11-Dehydrocorticosterone;|21-Hydroxypregn-4-ene-3,11,20-trione",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Mineralocorticoids|C05490  11-Dehydrocorticosterone|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05490  11-Dehydrocorticosterone",
C05497,"21-Deoxycortisol;|4-Pregnene-11beta,17alpha-diol-3,20-dione;|11beta,17alpha-Dihydroxyprogesterone",,,,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Glucocorticoids|C05497  21-Deoxycortisol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05497  21-Deoxycortisol",
C05498,"11beta-Hydroxyprogesterone;|11beta-Hydroxypregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C05498  11beta-Hydroxyprogesterone",
C05499,"17alpha,20alpha-Dihydroxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05499  17alpha,20alpha-Dihydroxycholesterol|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C05499  17alpha,20alpha-Dihydroxycholesterol",
C05500,20alpha-Hydroxycholesterol;|20-Hydroxycholesterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05500  20alpha-Hydroxycholesterol,
C05501,"20alpha,22beta-Dihydroxycholesterol;|(22R)-20alpha,22-Dihydroxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05501  20alpha,22beta-Dihydroxycholesterol",
C05502,22(R)-Hydroxycholesterol;|(22R)-22-Hydroxycholesterol;|22beta-Hydroxycholesterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C05502  22beta-Hydroxycholesterol,
C05503,Estradiol-17beta 3-glucuronide;|17beta-Estradiol 3-(beta-D-glucuronide),,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05503  17beta-Estradiol 3-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C05503  17beta-Estradiol 3-(beta-D-glucuronide),
C05504,"16-Glucuronide-estriol;|16alpha,17beta-Estriol 16-(beta-D-glucuronide)",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C05504  16alpha,17beta-Estriol 16-(beta-D-glucuronide)",
C05512,Deoxyinosine;|2'-Deoxyinosine,,,,,
C05513,Urate-3-ribonucleoside;|Uric acid ribonucleoside;|Urate D-ribonucleoside,,,,Glycosides [BR:br08021]|N-glycosides|C05513  Urate-3-ribonucleoside,
C05515,5-Ureido-4-imidazole carboxylate;|4-Ureido-5-imidazolecarboxylic acid,,,,,
C05516,5-Amino-4-imidazole carboxylate;|4-Amino-5-imidazolecarboxylic acid,,,,,
C05519,L-Allothreonine;|L-allo-Threonine,,,,,
C05520,2-Amino-3-oxoadipate;|2-Amino-3-oxohexanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C05520  2-Amino-3-oxohexanedioic acid,
C05526,S-Glutathionyl-L-cysteine,,,,,
C05527,3-Sulfinylpyruvate;|3-Sulfinopyruvate,,,,,
C05528,3-Sulfopyruvate;|3-Sulfopyruvic acid,,,,,
C05529,Thiosulfuric acid,,,,,
C05533,Oxaloglutarate,,,,,
C05535,alpha-Aminoadipoyl-S-acyl enzyme;|Aminoadip.-S,Generic compound in reaction hierarchy,,,,
C05537,N-Succinyl-2-amino-6-oxopimelate,,,,,
C05539,N-Acetyl-L-2-amino-6-oxopimelate;|L-2-Acetamido-6-oxoheptanedioate;|L-2-Acetamido-6-oxopimelate,,,,,
C05544,Protein N6-methyl-L-lysine,Generic compound in reaction hierarchy,,,,
C05545,"Protein N6,N6-dimethyl-L-lysine",,,,,
C05546,"Protein N6,N6,N6-trimethyl-L-lysine",Generic compound in reaction hierarchy,,,,
C05548,6-Acetamido-2-oxohexanoate;|2-Oxo-6-acetamidocaproate,,,,,
C05551,Penicillin G;|Benzylpenicillin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Penams|C05551  Penicillin G|Prodrugs [br08324.html]|C05551|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02336)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CE Beta-lactamase sensitive penicillins|J01CE01 Benzylpenicillin|D02336  Benzylpenicillin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA14 Benzylpenicillin|D02336  Benzylpenicillin (INN)|Drug groups [BR:br08330(D02336)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00534  Benzylpenicillin|D02336  Benzylpenicillin|DG01778  beta-Lactamase sensitive penicillin|DG00534  Benzylpenicillin|D02336  Benzylpenicillin|Transporter substrate|DG02860  SLC22A8 substrate|D02336  Benzylpenicillin|Antimicrobials [BR:br08307(D02336)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase sensitive penicillin|D02336  Benzylpenicillin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D02336)]|Drug transporters|D02336|Prodrugs [br08324.html(D02336)]|D02336",
C05552,Biocytin;|N6-D-Biotinyl-L-lysine;|epsilon-N-Biotinyl-L-lysine,,,,,
C05554,Aerobactin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05554,
C05556,delta-(L-2-Aminoadipyl)-L-cysteinyl-D-valine;|N-[L-5-Amino-5-carboxypentanoyl]-L-cysteinyl-D-valine;|L-delta-(alpha-Aminoadipoyl)-L-cysteinyl-D-valine;|ACV,,,,,
C05557,Isopenicillin N,,,,,
C05560,L-2-Aminoadipate adenylate;|5-Adenylyl-2-aminoadipate;|alpha-Aminoadipoyl-C6-AMP,,,,,
C05562,1H-Imidazole-4-methanol;|Imidazole-4-methanol,,,,,
C05565,Hydantoin-5-propionate;|Hydantoin-propionate,,,,,
C05568,Imidazole lactate;|Imidazole lactic acid;|2-Hydroxy-3-(1H-imidazol-5-yl)-propanoic acid,,,,,
C05570,Ergothioneine,,,,,
C05571,Thiourocanic acid,,,,,
C05572,4-Oxoglutaramate;|4-Ketoglutaramate,,,,,
C05574,3-Aminopentanedioate;|Isoglutamate;|Isoglutamic acid;|3-Aminopentanedioic acid,,,,,
C05575,"Hercynine;|Nalpha,Nalpha,Nalpha-Trimethyl-L-histidine",,,,,
C05576,"3,4-Dihydroxyphenylethyleneglycol",,,,,
C05577,"3,4-Dihydroxymandelaldehyde;|3,4-Dihydroxyphenylglycolaldehyde;|DOPEGAL",,,,,
C05578,"5,6-Dihydroxyindole;|DHI",,,,,
C05579,"Indole-5,6-quinone",,,,,
C05580,"3,4-Dihydroxymandelate;|3,4-Dihydroxymandelic acid;|Dihydroxymandelic acid",,,,,
C05581,3-Methoxy-4-hydroxyphenylacetaldehyde;|(4-Hydroxy-3-methoxyphenyl)acetaldehyde;|Homovanillin,,,,,
C05582,Homovanillate;|Homovanillic acid;|3-Methoxy-4-hydroxyphenylacetate,,,,,
C05583,3-Methoxy-4-hydroxyphenylglycolaldehyde,,,,,
C05584,3-Methoxy-4-hydroxymandelate;|Vanillylmandelic acid,,,,,
C05585,"Gentisate aldehyde;|2,5-Dihydroxybenzaldehyde",,,,,
C05587,3-Methoxytyramine,,,,,
C05588,L-Metanephrine,,,,,
C05589,L-Normetanephrine,,,,,
C05590,Hydroiodic acid;|Hydrogen iodide,,,,,
C05592,3-Carboxymethylmuconate,,,,,
C05593,3-Hydroxyphenylacetate;|3-Hydroxyphenylacetic acid,,,,,
C05594,3-Methoxy-4-hydroxyphenylethyleneglycol,,,,,
C05595,4-Hydroxyphenylacetylglutamic acid;|p-Hydroxyphenylacetylglutamic acid;|4-Hydroxyphenylacetylglutamate;|p-Hydroxyphenylacetylglutamate,,,,,
C05596,p-Hydroxyphenylacetylglycine;|4-Hydroxyphenylacetylglycine,,,,,
C05598,Phenylacetylglycine,,,,,
C05600,"2-Hydroxyhepta-2,4-dienedioate;|2-Hydroxyhepta-2,4-diene-1,7-dioate",,,,,
C05601,4-Hydroxy-2-oxo-heptanedioate;|4-Hydroxy-2-ketopimelate;|4-Hydroxy-2-oxoheptanedioic acid;|4-Hydroxy-2-oxoheptanedioate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C05601  4-Hydroxy-2-oxo-heptandioic acid|FA0117 Dicarboxylic acids|C05601  4-Hydroxy-2-oxoheptanedioic acid,
C05604,"2-Carboxy-2,3-dihydro-5,6-dihydroxyindole;|Leucodopachrome;|cyclo-Dopa",,,,,
C05607,Phenyllactate;|(R)-Phenyllactate;|(R)-3-(phenyl)lactate,,,,,
C05608,4-Hydroxycinnamyl aldehyde;|p-Coumaraldehyde,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C05608  4-Hydroxycinnamyl aldehyde,
C05610,Sinapoyl aldehyde;|Sinapaldehyde,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C05610  Sinapoyl aldehyde,
C05613,Benzylformate,,,,,
C05616,"3-O-Methylgallate;|3-O-Methylgallic acid;|5-Hydroxyvanillic acid;|3,4-Dihydroxy-5-methoxybenzoate",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C05616,
C05618,3-Chlorocatechol,,,,,
C05619,5-Hydroxyferulic acid;|5-Hydroxyferulate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C05619  5-Hydroxyferulate,
C05620,N-Acetyl-D-phenylalanine,,,,,
C05622,Malonylapiin;|Apigenin 7-O-[beta-D-apiosyl-(1->2)-(6-malonyl-beta-D-glucoside)],,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05622  Malonylapiin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C05622  Malonylapiin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C05622  Malonylapiin,
C05623,"Isoquercitrin;|Quercetin 3-O-glucoside;|2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one;|Isotrifoliin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05623  Quercetin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C05623  Quercetin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C05623  Quercetin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C05623,
C05625,"Rutin;|3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one;|Quercetin 3-rutinoside;|Rutoside;|Phytomelin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05625  Rutin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C05625  Rutin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C05625  Rutin|Dietary phytochemicals [br08012.html]|Flavonoids|C05625|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08499)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05C CAPILLARY STABILIZING AGENTS|C05CA Bioflavonoids|C05CA01 Rutoside|D08499  Rutoside (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08499)]|Third-class OTC drugs|Inorganic and organic chemicals|Rutin|D08499  Rutoside (INN),
C05627,4-Hydroxystyrene;|4-Vinylphenol,,,,,
C05629,Phenylpropanoate;|3-Phenylpropanoate;|3-Phenyl-propionic acid;|3-Phenylpropanoic acid;|3-Phenylpropionic acid,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C05629,
C05631,Eriodictyol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C05631  Eriodictyol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C05631  Eriodictyol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05631|Dietary phytochemicals [br08012.html]|Flavonoids|C05631,
C05634,5-Hydroxyindoleacetaldehyde,,,,,
C05635,5-Hydroxyindoleacetate,,,,,
C05636,3-Hydroxykynurenamine,,,,,
C05637,"4,8-Dihydroxyquinoline;|Quinoline-4,8-diol",,,,,
C05638,5-Hydroxykynurenamine,,,,,
C05639,"4,6-Dihydroxyquinoline;|Quinoline-4,6-diol",,,,,
C05640,Cinnavalininate;|Cinnabarinic acid,,,,,
C05641,"5-(3'-Carboxy-3'-oxopropenyl)-4,6-dihydroxypicolinate;|5-(3-Carboxy-3-oxopropenyl)-4,6-dihydroxypyridine-2-carboxylate",,,,,
C05642,Formyl-N-acetyl-5-methoxykynurenamine,,,,,
C05643,6-Hydroxymelatonin,,,,,
C05644,3-Methylindolepyruvate,,,,,
C05645,"4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate",,,,,
C05646,5-Hydroxyindolepyruvate,,,,,
C05647,Formyl-5-hydroxykynurenamine,,,,,
C05648,5-Hydroxy-N-formylkynurenine;|5-Hydroxy-N-formyl-L-kynurenine,,,,,
C05649,"Dihydropteridine;|6,7-Dihydropteridine",Generic compound in reaction hierarchy,,,,
C05650,"Tetrahydropteridine;|5,6,7,8-Tetrahydropteridine",Generic compound in reaction hierarchy,,,,
C05651,5-Hydroxykynurenine;|5-Hydroxy-L-kynurenine,,,,,
C05652,"4-(2-Amino-5-hydroxyphenyl)-2,4-dioxobutanoate",,,,,
C05653,Formylanthranilate;|N-Formylanthranilate;|2-(Formylamino)-benzoic acid,,,,,
C05654,"5-(2'-Formylethyl)-4,6-dihydroxypicolinate;|5-(beta-Formylethyl)-4,6-dihydroxypicolinate",,,,,
C05655,"5-(2'-Carboxyethyl)-4,6-dihydroxypicolinate;|5-(beta-Carboxyethyl)-4,6-dihydroxypicolinate",,,,,
C05656,"5-(3'-Carboxy-3'-oxopropyl)-4,6-dihydroxypicolinate;|5-(gamma-Carboxy-gamma-oxopropyl)-4,6-dihydroxypicolinate",,,,,
C05657,6-Hydroxyindolelactate,,,,,
C05658,Indoxyl;|1H-Indol-3-ol,,,,,
C05659,5-Methoxytryptamine;|5-MeOT,,,,,
C05660,5-Methoxyindoleacetate;|5-Methoxyindoleacetic acid,,,,,
C05662,"Homoisocitrate;|3-Carboxy-2-hydroxyadipate;|(-)-1-Hydroxy-1,2,4-butanetricarboxylate;|(1R,2S)-1-Hydroxybutane-1,2,4-tricarboxylate;|(-)-threo-Homoisocitrate",,,,,
C05663,"6-Hydroxykynurenate;|6-Hydroxykynurenic acid;|4,6-Dihydroxyquinaldic acid",6-Hydroxykynurenic acid (tautomer) [CPD:C08480],,,,
C05665,3-Aminopropanal;|beta-Aminopropion aldehyde,,,,,
C05668,3-Hydroxypropionyl-CoA;|3-Hydroxypropionyl coenzyme A;|3-Hydroxypropanoyl-CoA;|3-Hydroxypropanoyl coenzymeA;|beta-Hydroxypropionyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05668  3-Hydroxypropanoyl-CoA,
C05669,beta-Nitropropanoate;|beta-Nitropropanoic acid;|beta-Nitropropionic acid;|3-Nitropropanoate;|3-Nitropropionic acid,,,,,
C05670,3-Aminopropiononitrile;|beta-Aminopropionitrile,,,,,
C05672,2-Amino-3-phosphonopropanoate;|Phosphonoalanine,,,,,
C05673,CMP-2-aminoethylphosphonate;|CMPciliatine,,,,,
C05674,CMP-N-trimethyl-2-aminoethylphosphonate;|CMP-2-trimethylaminoethylphosphonate,,,,,
C05675,Diacylglyceryl-2-aminoethylphosphonate;|Diacylglycerophosphonoethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP17 Glycerophosphonoethanolamines|GP1701 Diacylglycerophosphonoethanolamines|C05675  Diacylglycerophosphonoethanolamine,
C05676,Diacylglyceryl-N-trimethyl-2-aminoethylphosphonate;|Diacylglyceryl-2-trimethylaminoethylphosphonate;|Diacylglycerophosphonocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP16 Glycerophosphonocholines|GP1601 Diacylglycerophosphonocholines|C05676  Diacylglycerophosphonocholine,
C05678,(2-Amino-1-hydroxyethyl)phosphonate;|1-Hydroxy-2-aminoethylphosphonate,,,,,
C05679,N-Monomethyl-2-aminoethylphosphonate;|2-Methylaminoethylphosphonate,,,,,
C05680,N-Dimethyl-2-aminoethylphosphonate;|2-Dimethylaminoethylphosphonate,,,,,
C05681,Ceramide 2-aminoethylphosphonate;|Ceramide ciliatine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP04 Phosphonosphingolipids|C05681  Ceramide 2-aminoethylphosphonate,
C05682,Phosphonoacetate;|Phosphonoacetic acid;|Fosfonet,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AD Phosphonic acid derivatives|J05AD02 Fosfonet|C05682  Phosphonoacetate,G00652
C05683,Ciliatocholate;|Ciliatocholic acid;|2-Aminoethylphosphocholate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C05683  2-Aminoethylphosphocholic acid",
C05684,Selenite,,,,,
C05686,Adenylylselenate;|Adenosine-5'-phosphoselenate,,,,,
C05688,L-Selenocysteine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C05688  Selenocysteine (Sec),
C05689,Se-Methyl-L-selenocysteine,,,,,
C05690,Se-Methylselenomethionine;|Se-Methyl-L-selenomethionine,,,,,
C05691,Se-Adenosylselenomethionine,,,,,
C05692,Se-Adenosyl-L-selenohomocysteine;|Se-Adenosylselenohomocysteine,,,,,
C05695,gamma-Glutamyl-Se-methylselenocysteine;|5-L-Glutamyl-Se-methylselenocysteine,,,,,
C05696,3'-Phosphoadenylylselenate;|3'-Phosphoadenosine-5'-phosphoselenate,,,,,
C05697,Selenate;|Selenic acid,,,,,
C05698,Selenohomocysteine,,,,,
C05699,L-Selenocystathionine,,,,,
C05702,O-Phosphorylhomoserine,,,,,
C05703,Methaneselenol;|Methylselenol,,,,,
C05704,Selenocystine,,,,,
C05705,Selenocysteine seleninic acid;|Selenocysteine seleninate;|3-Seleninoalanine,,,,,
C05706,Se-Propenylselenocysteine Se-oxide,,,,,
C05707,Selenohomocystine,,,,,
C05708,Selenomethionine Se-oxide,,,,,
C05710,N-Hydroxy-amino acid;|N-Hydroxy-L-amino acid,Generic compound in reaction hierarchy,,,,
C05711,gamma-Glutamyl-beta-cyanoalanine,,,,,
C05712,Cyanohydrin,Generic compound in reaction hierarchy,,,,
C05713,Cyanoglycoside;|Cyanoglucoside,Generic compound in reaction hierarchy,,,,
C05714,alpha-Aminopropiononitrile,,,,,
C05715,gamma-Amino-gamma-cyanobutanoate;|4-Amino-4-cyanobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C05715  4-Amino-4-cyanobutanoic acid|FA0111 Cyano fatty acids|C05715  4-Amino-4-cyanobutanoic acid,
C05717,alpha-Amino-gamma-cyanobutanoate;|2-Amino-4-cyanobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C05717  2-Amino-4-cyanobutanoic acid|FA0111 Cyano fatty acids|C05717  2-Amino-4-cyanobutanoic acid,
C05718,2-Oxoacid oxime,Generic compound in reaction hierarchy,,,,
C05720,"Reduced 2,6-dichlorophenolindophenol;|2,6-Dichloro-4-[(4-hydroxyphenyl)amino]-phenol",,,,,
C05721,Leucomethylene blue;|Reduced methylene blue,Methylene blue [CPD:C00220],,,Target-based classification of drugs [BR:br08310(D11427)]|Not elsewhere classified|Cellular process|Cytoskeleton|MAPT (TAU)|D11427  Hydromethylthionine (USAN/INN),
C05723,Poly-gamma-D-glutamate,Generic compound in reaction hierarchy,,,,
C05726,S-Substituted L-cysteine;|R-S-Cysteine;|L-Cysteine S-conjugate,Generic compound in reaction hierarchy|R = alkyl group [CPD:C02749]|R = aromatic group [CPD:C02882],,,,
C05727,S-Substituted N-acetyl-L-cysteine;|Mercapturic acid;|N-Acetyl-L-cysteine S-conjugate,Generic compound in reaction hierarchy,,,,
C05729,R-S-Cysteinylglycine;|[L-Cysteinylglycine]-S-conjugate,Generic compound in reaction hierarchy,,,,
C05730,Glutathionylspermidine;|N1-(gamma-L-Glutamyl-L-cysteinyl-glycyl)-spermidine,,,,,
C05731,3-Ketosucrose;|3'-Dehydrosucrose;|3-Dehydro-alpha-D-glucosyl-beta-D-fructofuranoside,,,,,G10585
C05744,Acetoacetyl-[acp];|Acetoacetyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05744  Acetoacetyl-[acp],
C05745,Butyryl-[acp];|Butyryl-[acyl-carrier protein];|Butanoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05745  Butanoyl-[acp],
C05746,3-Oxohexanoyl-[acp];|3-Oxohexanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05746  3-Oxohexanoyl-[acp],
C05747,(3R)-3-Hydroxyhexanoyl-[acyl-carrier protein];|(R)-3-Hydroxyhexanoyl-[acp];|(R)-3-Hydroxyhexanoyl-[acyl-carrier protein];|D-3-Hydroxyhexanoyl-[acp];|D-3-Hydroxyhexanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05747  (3R)-3-Hydroxyhexanoyl-[acp],
C05748,trans-Hex-2-enoyl-[acp];|trans-Hex-2-enoyl-[acyl-carrier protein];|(2E)-Hexenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05748  (2E)-Hexenoyl-[acp],
C05749,Hexanoyl-[acp];|Hexanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05749  Hexanoyl-[acp],
C05750,3-Oxooctanoyl-[acp];|3-Oxooctanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05750  3-Oxooctanoyl-[acp],
C05751,trans-Oct-2-enoyl-[acp];|trans-Oct-2-enoyl-[acyl-carrier protein];|Oct-2-enoyl-[acyl-carrier protein];|2-Octenoyl-[acyl-carrier protein];|(2E)-Octenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05751  (2E)-Octenoyl-[acp],
C05752,Octanoyl-[acp];|Octanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05752  Octanoyl-[acp],
C05753,3-Oxodecanoyl-[acp];|3-Oxodecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05753  3-Oxodecanoyl-[acp],
C05754,trans-Dec-2-enoyl-[acp];|trans-Dec-2-enoyl-[acyl-carrier protein];|trans-2-Decenoyl-[acyl-carrier protein];|(2E)-Decenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05754  (2E)-Decenoyl-[acp],
C05755,Decanoyl-[acp];|Decanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05755  Decanoyl-[acp],
C05756,3-Oxododecanoyl-[acp];|3-Oxododecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05756  3-Oxododecanoyl-[acp],
C05757,(3R)-3-Hydroxydodecanoyl-[acyl-carrier protein];|(R)-3-Hydroxydodecanoyl-[acp];|(R)-3-Hydroxydodecanoyl-[acyl-carrier protein];|D-3-Hydroxydodecanoyl-[acp];|D-3-Hydroxydodecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05757  (3R)-3-Hydroxydodecanoyl-[acp],
C05758,trans-Dodec-2-enoyl-[acp];|trans-Dodec-2-enoyl-[acyl-carrier protein];|(2E)-Dodecenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05758  (2E)-Dodecenoyl-[acp],
C05759,3-Oxotetradecanoyl-[acp];|3-Oxotetradecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05759  3-Oxotetradecanoyl-[acp],
C05760,trans-Tetradec-2-enoyl-[acp];|trans-Tetradec-2-enoyl-[acyl-carrier protein];|(2E)-Tetradecenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05760  (2E)-Tetradecenoyl-[acp],
C05761,Tetradecanoyl-[acp];|Tetradecanoyl-[acyl-carrier protein];|Myristoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05761  Tetradecanoyl-[acp],
C05762,3-Oxohexadecanoyl-[acp];|3-Oxohexadecanoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05762  3-Oxohexadecanoyl-[acp],
C05763,trans-Hexadec-2-enoyl-[acp];|trans-Hexadec-2-enoyl-[acyl-carrier protein];|(2E)-Hexadecenoyl-[acp],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05763  (2E)-Hexadecenoyl-[acp],
C05764,Hexadecanoyl-[acp];|Hexadecanoyl-[acyl-carrier protein];|Palmitoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C05764  Hexadecanoyl-[acp],
C05765,L-Glutamyl 1-phosphate;|alpha-L-Glutamyl phosphate,,,,,
C05766,Uroporphyrinogen I,,,,,
C05767,Uroporphyrin I,,,,,
C05768,Coproporphyrinogen I,,,,,
C05769,Coproporphyrin I,,,,,
C05770,Coproporphyrin III,,,,,
C05771,1-Aminopropan-2-ol;|1-Amino-2-propanol,,,,,
C05772,Precorrin 3A,,,,,
C05773,Cobyrinate;|Cobyrinic acid;|Cob(II)yrinate;|Cob(II)yrinic acid,,,,,
C05774,Cobinamide;|Cob(I)inamide,,,,,
C05775,"alpha-Ribazole;|N1-(alpha-D-Ribosyl)-5,6-dimethylbenzimidazole",,,,,
C05776,Vitamin B12;|Cobalamin (III);|Cob(III)alamin,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Vitamins|Water-soluble vitamins|C05776  Cobalamin(III) (Vitamin B12)|Risk category of Japanese OTC drugs [BR:br08312(D00191)]|Third-class OTC drugs|Inorganic and organic chemicals|Cyanocobalamin|D00191  Vitamin B12,
C05777,Coenzyme F430;|Factor F430,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C05777  Coenzyme F430,
C05778,Sirohydrochlorin,,,,,
C05786,(3Z)-Phycocyanobilin,,,,,
C05787,Bilirubin beta-diglucuronide;|Bilirubin-bisglucuronoside,,,,,
C05789,L-Urobilinogen;|L-Stercobilinogen;|Stercobilinogen,,,,,
C05790,I-Urobilinogen;|Mesobilirubinogen;|Urobilinogen,,,,,
C05791,D-Urobilinogen,,,,,
C05793,L-Urobilin;|L-Stercobilin;|Stercobilin,,,,,
C05794,Urobilin;|I-Urobilin,,,,,
C05795,D-Urobilin,,,,,
C05796,Galactan,,,,,G10534
C05797,Pheophytin a,,,,,
C05798,Bacteriopheophytin;|Bacteriopheophytin a,,,,,
C05800,2-Hexaprenylphenol,,,,,
C05801,2-Hexaprenyl-6-hydroxyphenol;|3-Hexaprenylcatechol,3-Polyprenylcatechol [CPD:C17551],,,,
C05802,2-Hexaprenyl-6-methoxyphenol,2-Polyprenyl-6-methoxyphenol [CPD:C17552],,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C05802  2-Hexaprenyl-6-methoxyphenol,
C05803,"2-Hexaprenyl-6-methoxy-1,4-benzoquinone",,,,,
C05804,"2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",,,,,
C05805,"2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",,,,,
C05807,2-Polyprenylphenol;|2-(all-trans-Polyprenyl)phenol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C05807  2-Polyprenylphenol,
C05808,5-Hydroxy-2-polyprenylphenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C05808  5-Hydroxy-2-polyprenylphenol,
C05809,3-Octaprenyl-4-hydroxybenzoate;|4-Hydroxy-3-octaprenylbenzoate,,,,,
C05810,2-Octaprenylphenol,,,,,
C05811,2-Octaprenyl-6-hydroxyphenol;|3-Octaprenylcatechol,,,,,
C05812,2-Octaprenyl-6-methoxyphenol,,,,,
C05813,"2-Octaprenyl-6-methoxy-1,4-benzoquinone",,,,,
C05814,"2-Octaprenyl-3-methyl-6-methoxy-1,4-benzoquinone",,,,,
C05815,"2-Octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",,,,,
C05817,"(1R,6R)-6-Hydroxy-2-succinylcyclohexa-2,4-diene-1-carboxylate;|(1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate;|SHCHC",,,,,
C05818,2-Demethylmenaquinone;|Demethylmenaquinone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C05818  2-Demethylmenaquinone,
C05819,Menaquinol;|Reduced menaquinone;|Vitamin K2 hydroquinone;|Reduced vitamin K2,,,,,
C05820,(L-Seryl)adenylate;|L-Seryl-adenylate,,,,,
C05821,"Enterochelin;|Enterobactin;|Tri-(2,3-dihydroxy-N-benzoyl-L-serine)-ester;|Tri-(N-(2,3-dihydroxybenzoyl)-L-serine)-ester",,0 DHBA  1 Ser  (Trimer),NRP,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05821,
C05822,3'-CMP;|Cytidine 3'-phosphate,,,,,
C05823,3-Mercaptolactate;|L-3-Mercaptolactate;|(R)-3-Mercaptolactate,,,,,
C05824,S-Sulfo-L-cysteine,,,,,
C05825,2-Amino-5-oxohexanoate,,,,,
C05827,Methylimidazole acetaldehyde;|1-Methylimidazole-4-acetaldehyde;|Methylimidazoleacetaldehyde,,,,,
C05828,Methylimidazoleacetic acid;|Tele-methylimidazoleacetic acid;|1-Methyl-4-imidazoleacetic acid;|1-Methylimidazole-4-acetate;|Methylimidazoleacetate,,,,,
C05829,N-Carbamyl-L-glutamate;|Carglumic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07130)]|A ALIMENTARY TRACT AND METABOLISM|A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS|A16AA Amino acids and derivatives|A16AA05 Carglumic acid|D07130  Carglumic acid (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D07130)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Carglumic  Acid|D07130  Carglumic acid (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D07130)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D07130  Carglumic acid (JAN/USAN/INN)|Target-based classification of drugs [BR:br08310(D07130)]|Enzymes|Ligases (EC6)|Carbamoyl-phosphate synthase|CPS1|D07130  Carglumic acid (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D07130)]|New molecular entities and new therapeutic biological products|D07130|New drug approvals in Europe [br08329.html(D07130)]|European public assessment reports (EPAR) authorised medicine|D07130|New drug approvals in Japan [br08318.html(D07130)]|Drugs with new active ingredients|D07130|New drug approvals in the USA, Europe and Japan [br08328.html(D07130)]|Approval dates by FDA, EMA and PMDA|D07130|Pharmacogenomic biomarkers [br08341.html(D07130)]|Germline mutations in genetic disorder treatments|D07130",
C05830,8-Methoxykynurenate;|Xanthurenic acid 8-methyl ether,,,,,
C05831,3-Methoxyanthranilate;|3-Methoxyanthranilic acid,,,,,
C05832,5-Hydroxyindoleacetylglycine,,,,,
C05834,3-Methyldioxyindole;|3-Hydroxy-3-methyloxindole,,,,,
C05835,2-Formaminobenzoylacetate,,,,,
C05837,Glucobrassicin;|Indolylmethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from tryptophan|C05837  Glucobrassicin|Glycosides [BR:br08021]|S-glycosides|C05837  Glucobrassicin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05837,
C05838,cis-2-Hydroxycinnamate;|2-Coumarinate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C05838  cis-2-Hydroxycinnamate,
C05839,cis-beta-D-Glucosyl-2-hydroxycinnamate;|beta-D-Glucosyl-2-coumarinate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C05839  cis-beta-D-Glucosyl-2-hydroxycinnamate,
C05840,Iminoaspartate;|Iminoaspartic acid;|Iminosuccinate;|2-Iminosuccinate;|2-Iminobutanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C05840  2-Iminobutanedioic acid,
C05841,Nicotinate D-ribonucleoside;|beta-D-Ribosylnicotinate,,,,Glycosides [BR:br08021]|N-glycosides|C05841  Nicotinate D-ribonucleoside,
C05842,N1-Methyl-2-pyridone-5-carboxamide;|N'-Methyl-2-pyridone-5-carboxamide;|1-Methyl-5-carboxylamide-2-pyridone,,,,,
C05843,N1-Methyl-4-pyridone-5-carboxamide;|N'-Methyl-4-pyridone-5-carboxamide;|1-Methyl-4-pyridone-3-carboximide,,,,,
C05844,5-L-Glutamyl-taurine;|5-Glutamyl-taurine;|Glutaurine,,,,,
C05847,all-trans-Polyprenyl diphosphate;|Polyisopentenylpyrophosphate;|Polyisopentenyldiphosphate;|trans-Polyisopentenyldiphosphate;|Polyprenyl diphosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C05847  all-trans-Polyprenyl diphosphate,
C05848,4-Hydroxy-3-polyprenylbenzoate;|4-Hydroxy-3-all-trans-polyprenylbenzoate;|3-Polyprenyl-4-hydroxybenzoate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C05848  4-Hydroxy-3-polyprenylbenzoate,
C05849,"Vitamin K1 epoxide;|(2,3-Epoxyphytyl)menaquinone;|2,3-Epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone;|2,3-Epoxyphylloquinone;|1a,7a-Dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-naphth[2,3-b]oxirene-2,7-dione;|Phylloquinone oxide;|Phylloquinone epoxide;|Phylloquinone-2,3-epoxide;|Vitamin K1 2,3-epoxide;|Vitamin K1 oxide",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C05849  Vitamin K epoxide,
C05850,Reduced Vitamin K;|Vitamin K hydroquinone,Generic compound in reaction hierarchy,,,,
C05851,"Coumarin;|Coumarine;|Cumarin;|2H-1-Benzopyran-2-one;|1,2-Benzopyrone;|2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone;|5,6-Benzo-2-pyrone;|Benzo-alpha-pyrone;|cis-o-Coumarinic acid lactone;|Coumarinic anhydride;|o-Hydroxycinnamic acid lactone;|Rattex;|Tonka bean camphor",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C05851  Coumarin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05851,
C05852,2-Hydroxyphenylacetate;|2-Hydroxyphenylacetic acid,,,,,
C05853,Phenylethyl alcohol;|Phenethyl alcohol;|2-Phenylethanol,,,,,
C05855,4-Hydroxycinnamyl alcohol 4-D-glucoside;|p-Coumaryl alcohol 4-O-glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Paracoumaryl alcohol derivatives|C05855  4-Hydroxycinnamyl alcohol 4-D-glucoside,
C05856,Thiamine aldehyde;|Thiamin aldehyde,,,,,
C05859,"ditrans,polycis-Polyprenyl diphosphate;|Dehydrodolichol diphosphate;|Dehydrodolichyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C05859  ditrans,polycis-Polyprenyl diphosphate",
C05860,"beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol;|beta-1,4-D-Mannosylchitobiosyldiphosphodolichol;|Man-beta1->4GlcNAc-beta1->4GlcNAc-PP-Dol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C05860  beta-D-Mannosyldiacetylchitobiosyldiphosphodolichol,G00003
C05861,"alpha-D-Mannosyl-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol;|alpha-1,3-D-Mannosyl-beta-1,4-D-mannosylchitobiosyldiphosphodolichol;|Man-alpha1->3Man-beta1->4GlcNAc-beta1->4GlcNAc-PP-Dol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C05861  alpha-D-Mannosyl-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,G00004
C05864,(alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C05864  (alpha-D-Mannosyl)4-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,G00006
C05868,(alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0309 Dolichol diphosphates|C05868  (alpha-D-Mannosyl)8-beta-D-mannosyl-diacetylchitobiosyldiphosphodolichol,G00007
C05892,UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysine;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysine;|UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-L-lysine,,,,,
C05893,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine;|GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol;|GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol;|beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C05893  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-alanine,G10553
C05894,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine;|beta-D-GlcNAc-(1->4)-MurNAc-L-Ala-gamma-D-O-P-Glu-L-Lys-D-Ala-D-Ala-diphospho-ditrans,octacis-undecaprenol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C05894  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-D-alanyl-D-alanine,
C05895,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)5-D-alanyl-D-alanine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C05895  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)5-D-alanyl-D-alanine,
C05897,"Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C05897  Undecaprenyl-diphospho-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",G10556
C05898,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C05898  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-meso-2,6-diaminopimeloyl-D-alanyl-D-alanine",G10555
C05901,"Piceatannol;|3,3',4'5-Tetrahydroxystilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C05901  3,3',4'5-Tetrahydroxystilbene|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C05901  Piceatannol",
C05902,3-Methoxyapigenin;|3-O-Methylkaempferol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05902  3-Methoxyapigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C05902  3-Methoxyapigenin,
C05903,"Kaempferol;|3,4',5,7-Tetrahydroxyflavone;|3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;|5,7,4'-Trihydroxyflavonol;|C.I. 75640;|Indigo yellow;|Kaempherol;|Kempferol;|Nimbecetin;|Pelargidenolon;|Populnetin;|Rhamnolutein;|Rhamnolutin;|Robigenin;|Swartziol;|Trifolitin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05903  Kaempferol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C05903  Kaempferol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05903|Dietary phytochemicals [br08012.html]|Flavonoids|C05903,
C05904,"Pelargonidin;|3,5,7-Trihydroxy-2-(4-hydroxyphenyl)benzopyrylium chloride;|3,4',5,7-Tetrahydroxyflavylium chloride;|Pelargonidin chloride;|Pelargonidol chloride",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C05904  Pelargonidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C05904  Pelargonidin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05904|Dietary phytochemicals [br08012.html]|Flavonoids|C05904,
C05905,"Cyanidin;|3,3',4',5,7-Pentahydroxyflavylium chloride;|Chlorure de 3,3',4',5,7-pentahydroxyflavylium;|3,3',4',5,7-Pentahydroxyflavyliumchlorid;|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyrylium chloride;|3,3',4',5,7-Pentahydroxy-2-phenylbenzopyrylium chloride;|Cyanidin chloride;|Cyanidine;|Cyanidol;|Cyanidol chloride;|IdB 1027",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C05905  Cyanidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C05905  Cyanidin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05905|Dietary phytochemicals [br08012.html]|Flavonoids|C05905,
C05906,"Leucocyanidin;|2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,4,5,7-tetrol;|3,3',4,4',5,7-Flavanhexol;|3,4-Cyanidiol;|Leucoanthocyanidol;|Leucocianidol;|Leucocyanidol;|Leukocyanidine;|Procyanidol;|Resivit;|2,3-trans-3,4-cis-Leucocyanidin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C05906  Leucocyanidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3,4-diols|C05906  Leucocyanidin",
C05907,Luteoforol;|3-Deoxyleucocyanidin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C05907  Luteoforol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 4-ols|C05907  Luteoforol",
C05908,"Delphinidin;|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyrylium chloride;|Chlorure de 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyrylium;|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)benzopyryliumchlorid;|3,3',4',5,5',7-Hexahydroxy-2-phenylbenzopyrylium chloride;|3,3',4',5,5',7-Hexahydroxyflavylium chloride;|Delfinidol chloride;|Delphinidin chloride;|Delphinidine;|Delphinidol;|Ephdine;|IdB 1056",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C05908  Delphinidin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05908|Dietary phytochemicals [br08012.html]|Flavonoids|C05908,
C05909,Leucodelphinidin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C05909  Leucodelphinidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3,4-diols|C05909  Leucodelphinidin",
C05911,Pentahydroxyflavanone;|Dihydrotricetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C05911  Pentahydroxyflavanone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C05911,
C05912,(3Z)-Phycoerythrobilin,,,,,
C05913,(3Z)-Phytochromobilin,,,,,
C05914,Bathorhodopsin,Generic compound in reaction hierarchy,,,,
C05915,Lumirhodopsin,Generic compound in reaction hierarchy,,,,
C05916,Metarhodopsin,Generic compound in reaction hierarchy,,,,
C05917,Iodopsin,Generic compound in reaction hierarchy,,,,
C05918,"all-trans-Dehydroretinal;|Dehydroretinaldehyde;|Dehydroretinaldehyd;|(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-2,4,6,8-nonatetraenal;|alpha-Retinene;|3,4-Didehydroretinal;|3-Dehydroretinal;|all-trans-3-Dehydroretinal;|3-Dehydroretinaldehyde;|all-trans-3,4-Dehydroretinal;|Dehydroretinal;|Retinene 2;|trans-3-Dehydroretinal;|Vitamin A2 aldehyde",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C05918  all-trans-Dehydroretinal,
C05919,11-cis-Dehydroretinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C05919  11-cis-Dehydroretinal,
C05920,Porphyropsin,Generic compound in reaction hierarchy,,,,
C05921,Biotinyl-5'-AMP,,,,,
C05922,Formamidopyrimidine nucleoside triphosphate,,,,,
C05923,"2,5-Diaminopyrimidine nucleoside triphosphate",,,,"Glycosides [BR:br08021]|N-glycosides|C05923  2,5-Diaminopyrimidine nucleoside triphosphate",
C05924,Molybdopterin;|Pyranopterin;|H2Dtpp-mP,,,,,
C05925,"Dihydroneopterin phosphate;|2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine phosphate;|7,8-Dihydroneopterin 3'-phosphate",,,,,
C05926,"Neopterin;|[S-(R*,S*)]-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one;|[S-(R*,S*)]-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridine-4-one;|[S-(R*,S*)]-2-Amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-on;|6-(D-erythro-1,2,3-Trihydroxypropyl)pterin;|6-D-erythro-Neopterin;|D-erythro-Neopterin;|D-Neopterin",,,,,
C05927,"7,8-Dihydromethanopterin",,,,,
C05928,(6R)-10-Formyltetrahydropteroyldiglutamate;|10-Formyl-THF-L-glutamate;|(6R)-10-HCO-H4PteGlu2,,,,,
C05929,10-Formyltetrahydrofolylpolyglutamate;|10-Formyl-THF-polyglutamate,,,,,
C05931,N-Succinyl-L-glutamate;|(2S)-2-(3-Carboxypropanoylamino)pentanedioic acid,,,,,
C05932,N-Succinyl-L-glutamate 5-semialdehyde;|(2S)-2-(3-Carboxypropanoylamino)-5-oxopentanoic acid,,,,,
C05933,N(omega)-Hydroxyarginine;|N(omega)-Hydroxy-L-arginine,,,,,
C05936,N4-Acetylaminobutanal;|4-Acetamidobutanal,,,,,
C05938,L-4-Hydroxyglutamate semialdehyde,,,,,
C05939,Linatine;|N-(gamma-L-Glutamyl)amino-D-proline,,,,,
C05941,2-Oxo-4-hydroxy-5-aminovalerate,,,,,
C05942,Pyrrole-2-carboxylate,,,,,
C05944,"Pantothenol;|(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide;|Dexpanthenol;|2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide;|(+)-Panthenol;|Bepanthen;|Bepanthene;|Bepantol;|D-(+)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;|Cozyme;|D(+)-Panthenol;|D(+)-Pantothenyl alcohol;|D-P-A Injection;|D-Panthenol;|d-Pantothenol;|d-Pantothenyl alcohol;|Ilopan;|Motilyn;|Panadon;|Panthenol;|Panthoderm;|Pantol;|Pantothenyl alcohol;|N-Pantoyl-propanolamine;|Provitamin B;|Synapan;|Thenalton;|Zentinic",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C05944  Pantothenol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00193)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA30 Dexpanthenol|D00193  Dexpanthenol (USP/INN) &lt;JP&gt;|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX03 Dexpanthenol|D00193  Dexpanthenol (USP/INN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA12 Dexpanthenol|D00193  Dexpanthenol (USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00193)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3133  Pantothenic acids|D00193  Dexpanthenol (USP/INN); Panthenol (JAN)|Classification of Japanese OTC drugs [BR:br08313(D00193)]|Agents for ophthalmologic use|62 General eye drops|D00193  Dexpanthenol (USP/INN)|Agents for dental and stomatological use|74 Stomatitis remedies|D00193  Dexpanthenol (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00193)]|Third-class OTC drugs|Inorganic and organic chemicals|Panthenol|D00193  Dexpanthenol (USP/INN)|Target-based classification of drugs [BR:br08310(D00193)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM3|D00193  Dexpanthenol (USP/INN) &lt;JP&gt;,
C05945,L-Arginine phosphate;|N5-[Imino(phosphonoamino)methyl]L-ornithine;|omega-N-Phosphoarginine;|Arginine phosphate;|L-Arginine-NG-phosphoric acid;|Phosphoarginine A;|N-Phospho-L-arginine;|N(omega)-Phospho-L-arginine;|Phosphoarginine,,,,,
C05946,(4R)-4-Hydroxy-2-oxoglutarate;|(R)-2-Hydroxy-4-oxopentanedioate;|D-4-Hydroxy-2-oxoglutarate,,,,,
C05947,L-erythro-4-Hydroxyglutamate;|erythro-4-Hydroxy-L-glutamate,,,,,
C05949,"12-Keto-leukotriene B4;|12-Keto-LTB4;|5-Hydroxy-12-oxo-Delta5,8,11,14-eicosapolyenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C05949  12-Keto-leukotriene B4,
C05950,"20-COOH-Leukotriene B4;|20-COOH-LTB4;|20-Carboxy-leukotriene B4;|5,12-Dihydroxy-Delta5,8,11,14-eicosapolyendioic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C05950  20-Carboxy-leukotriene B4,
C05951,Leukotriene D4;|LTD4,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C05951  Leukotriene D4|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C05951  Leukotriene D4,
C05952,"Leukotriene E4;|LTE4;|(7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyeicosa-7,9,11,14-tetraenoate;|(7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoate",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C05952  Leukotriene E4|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C05952  Leukotriene E4,
C05953,Prostaglandin A2;|PGA2;|Medullin,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C05953  Prostaglandin A2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05953  Prostaglandin A2,
C05954,Prostaglandin B2;|PGB2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C05954  Prostaglandin B2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05954  Prostaglandin B2,
C05955,Prostaglandin C2;|PGC2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C05955  Prostaglandin C2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05955  Prostaglandin C2,
C05956,Prostaglandin G2;|PGG2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C05956  Prostaglandin G2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05956  Prostaglandin G2,
C05957,Prostaglandin J2;|PGJ2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C05957  Prostaglandin J2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05957  Prostaglandin J2,
C05958,Delta-12-Prostaglandin J2;|Delta-12-PGJ2,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05958  delta-12-Prostaglandin J2,
C05959,11-epi-Prostaglandin F2alpha;|11-epi-Prostaglandin F2a;|11-epi-PGF2alpha;|11-epi-PGF2a,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05959  11-epi-Prostaglandin F2alpha,
C05960,15-Keto-prostaglandin F2alpha;|15-Keto-prostaglandin F2a;|15-Keto-PGF2alpha;|15-Keto-PGF2a,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05960  15-Keto-prostaglandin F2alpha,
C05961,6-Keto-prostaglandin F1alpha;|6-Keto-prostaglandin F1a;|6-Keto-PGF1alpha;|6-Keto-PGF1a,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05961  6-Keto-prostaglandin F1alpha,
C05962,6-Keto-prostaglandin E1;|6-Keto-PGE1,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C05962  6-Keto-prostaglandin E1,
C05963,Thromboxane B2;|TXB2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Thromboxanes|C05963  Thromboxane B2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0303 Thromboxanes|C05963  Thromboxane B2,
C05964,11-Dehydro-thromboxane B2,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Thromboxanes|C05964  11-Dehydro-thromboxane B2|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0303 Thromboxanes|C05964  11-Dehydro-thromboxane B2,
C05965,"12(S)-HPETE;|(5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid;|(5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate;|12-Hydroperoxyeicosatetraenoate;|12-Hydroperoxyicosatetraenoate;|12-Hydroperoxyeicosatetraenoic acid;|12-Hydroperoxyicosatetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C05965  (5Z,8Z,10E,14Z)-(12S)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C05965  12(S)-HPETE",
C05966,"15(S)-HPETE;|(5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid;|15-Hydroperoxyeicosatetraenoate;|15-Hydroperoxyicosatetraenoate;|15-Hydroperoxyeicosatetraenoic acid;|15-Hydroperoxyicosatetraenoic acid;|(5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C05966  (5Z,8Z,11Z,13E)-(15S)-15-Hydroperoxyicosa-5,8,11,13-tetraenoic acid|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C05966  15(S)-HPETE",
C05973,2-Acyl-sn-glycero-3-phosphoethanolamine;|L-1-Lysophosphatidylethanolamine;|O-(2-Acyl-sn-glycero-3-phospho)-ethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0205 Monoacylglycerophosphoethanolamines|C05973  2-Acyl-sn-glycero-3-phosphoethanolamine,
C05974,2-Acyl-sn-glycero-3-phosphoserine;|2-Acyl-1-lyso-phosphatidylserine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP03 Glycerophosphoserines|GP0305 Monoacylglycerophosphoserines|C05974  2-Acyl-sn-glycero-3-phosphoserine,
C05976,Aminoacyl-phosphatidylglycerol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP04 Glycerophosphoglycerols|GP0409 Diacylglycerophosphomonoradylglycerols|C05976  Aminoacyl-phosphatidylglycerol,
C05977,2-Acyl-1-alkyl-sn-glycero-3-phosphate;|1-Alkyl-2-acyl-sn-glycerol 3-phosphate,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1002 1-alkyl,2-acylglycerophosphates|C05977  1-Alkyl-2-acyl-sn-glycerol 3-phosphate",
C05979,Propane-1-ol;|Propanol;|1-Propanol;|Propan-1-ol;|Propyl alcohol;|1-Hydroxypropane;|Ethylcarbinol;|n-Propanol;|n-Propyl alcohol;|Optal;|Osmosol extra;|UN 1274,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C05979  1-Propanol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AX Other antiseptics and disinfectants|D08AX03 Propanol|C05979  Propane-1-ol,
C05980,"Cardiolipin;|Diphosphatidylglycerol;|1',3'-Bis(1,2-diacyl-sn-glycero-3-phospho)-sn-glycerol",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Phospholipids|Glycerophospholipids|C05980  Diphosphatidylglycerol; Cardiolipin|Lipids [BR:br08002]|GP  Glycerophospholipids|GP12 Glycerophosphoglycerophosphoglycerols|GP1201 Diacylglycerophosphoglycerophosphodiradylglycerols|C05980  1',3'-Bis(1,2-diacyl-sn-glycero-3-phospho)-sn-glycerol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA10 Phospholipids|C05980  Cardiolipin",
C05981,"Phosphatidylinositol-3,4,5-trisphosphate;|1-Phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-bisphosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP09 Glycerophosphoinositol trisphosphates|GP0901 Diacylglycerophosphoinositol trisphosphates|C05981  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-bisphosphate)",
C05983,Propionyladenylate;|Propionyl-adenosine monophosphate,,,,,
C05984,2-Hydroxybutanoic acid;|2-Hydroxybutyrate;|2-Hydroxybutyric acid;|(S)-2-Hydroxybutanoate;|(2S)-2-Hydroxybutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C05984  2-Hydroxybutanoic acid,
C05985,2-Propynal;|2-Propyn-1-al;|Propiolaldehyde,,,,,
C05986,2-Propyn-1-ol;|Prop-2-yn-1-ol;|Prop-2-yne-1-ol;|Prop-2-in-1-ol;|1-Hydroxy-2-propyne;|1-Propyn-3-ol;|1-Propyn-3-yl alcohol;|2-Propynol;|2-Propynyl alcohol;|3-Hydroxy-1-propyne;|3-Propynol;|Ethynylcarbinol;|NA 1986;|Propargyl alcohol;|Propynyl alcohol,,,,,
C05989,3-Oxopropionyl-CoA;|3-Oxopropanoyl-CoA;|Malonyl semialdehyde-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05989  3-Oxopropanoyl-CoA,
C05990,Isoscoparine;|Isoscoparin;|C-Glucosyl-6 chrysoeriol;|Chrysoeriol 6-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C05990  Isoscoparine|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C05990  Isoscoparine|Glycosides [BR:br08021]|C-glycosides|C05990  Isoscoparine,
C05993,Acetyl adenylate;|5'-Acetylphosphoadenosine,,,,,
C05994,"2-Propylmalate;|2-Propylmalic acid;|Malic acid, 2-propyl-",,,,,
C05995,7-Hydroxy-6-methyl-8-ribityllumazine;|7-Oxolumazine;|6-Methyl-7-oxo-8-ribityllumazine,including tautomers,,,,
C05998,3-Hydroxyisovaleryl-CoA;|3-Hydroxyisovaleryl coenzyme A;|3-Hydroxy-3-methylbutanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C05998  3-Hydroxy-3-methylbutanoyl-CoA,
C05999,Lactaldehyde;|2-Hydroxypropionaldehyde;|2-Hydroxypropanal,,,,,
C06000,(S)-3-Hydroxyisobutyryl-CoA;|(S)-3-Hydroxyisobutanoyl-CoA;|(S)-3-Hydroxy-2-methylpropanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06000  (S)-3-Hydroxy-2-methylpropanoyl-CoA,
C06001,(S)-3-Hydroxyisobutyrate,,,,,
C06002,(S)-Methylmalonate semialdehyde,"Methylmalonate semialdehyde [CPD:C00349] (non-enzymatic racemization, see [RN:R11028])",,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C06002  (S)-Methylmalonate semialdehyde,
C06006,(S)-2-Aceto-2-hydroxybutanoate;|(S)-2-Hydroxy-2-ethyl-3-oxobutanoate;|(2S)-2-Ethyl-2-hydroxy-3-oxobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C06006  (2S)-2-ethyl-2-hydroxy-3-oxobutanoic acid,
C06007,"(R)-2,3-Dihydroxy-3-methylpentanoate;|(R)-2,3-Dihydroxy-3-methylvalerate;|(2R,3R)-2,3-Dihydroxy-3-methylpentanoate;|(2R,3R)-2,3-Dihydroxy-3-methylpentanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C06007  (2R,3R)-2,3-Dihydroxy-3-methylpentanoic acid",
C06008,(3R)-3-Methyl-2-oxopentanoic acid;|(R)-2-Oxo-3-methylpentanoic acid;|(R)-2-Oxo-3-methylpentanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C06008  (3R)-3-Methyl-2-oxopentanoic acid,
C06010,(S)-2-Acetolactate;|(S)-2-Hydroxy-2-methyl-3-oxobutanoate;|(2S)-2-Hydroxy-2-methyl-3-oxobutanoate;|(2S)-2-Hydroxy-2-methyl-3-oxobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C06010  (2S)-2-Hydroxy-2-methyl-3-oxobutanoic acid,
C06011,Benzenamine sulfate,,,,,
C06017,dTDP-D-glucuronate,,,,,
C06018,"dTDP-4-acetamido-4,6-dideoxy-D-glucose;|dTDP-4-acetamido-4,6-dideoxy-alpha-D-glucose;|dTDP-N-acetylviosamine",,,,,
C06019,D-arabino-Hex-3-ulose 6-phosphate;|D-arabino-3-Hexulose 6-phosphate;|D-arabino-6-Phospho-hex-3-ulose,,,,,
C06020,Methyl-Co(III) corrinoid protein;|Methylcorrinoid;|Methylcorrinoid protein;|Corrinoid protein Co2+-CH3,Generic compound in reaction hierarchy,,,,
C06021,Co(I) corrinoid protein;|Corrinoid;|Corrinoid protein;|Corrinoid protein Co+,Generic compound in reaction hierarchy,,,,
C06022,UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine;|UDP-3-O-(beta-hydroxymyristoyl)-D-glucosamine;|UDP-3-O-[(3R)-3-hydroxymyristoyl]-D-glucosamine;|UDP-3-O-[(3R)-3-hydroxymyristoyl]-alpha-D-glucosamine,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0101 Monoacylaminosugars|C06022  UDP-3-O-(3-hydroxytetradecanoyl)-D-glucosamine,
C06023,D-Glucosaminide;|Chitosan oligosaccharide,,,,Compounds with biological roles [BR:br08001(G10536)]|Carbohydrates|Polysaccharides|Homopolysaccharides|G10536  Chitosan,G10536
C06024,"3-Deoxy-D-manno-octulosonyl-lipid IV(A);|KDO-lipid IV(A);|3-Deoxy-D-manno-octulosonyl-2',3',2',3'-tetrakis(beta-hydroxymyristoyl)-D-glucosaminyl-1,6-beta-D-glucosamine 1,4'-bisphosphate;|alpha-Kdo-(2->6)-[lipid IVA]",,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C06024  KDO-lipid IV(A),G11161
C06025,KDO2-lipid IVA;|Di[3-deoxy-D-manno-octulosonyl]-lipid IV(A);|KDO2-lipid IV(A);|alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[lipid IVA],,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C06025  KDO2-lipid IV(A),G11160
C06026,KDO2-lipid A;|Di[3-deoxy-D-manno-octulosonyl]-lipid A;|alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid A;|Dodecanoyl-(tetradecanoyl)-KDO2-lipid IV(A),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C06026  KDO2-lipid A,
C06027,"L-erythro-3-Methylmalyl-CoA;|beta-Methylmalyl-CoA;|(2R,3S)-2-Methylmalyl-CoA;|L-erythro-beta-Methylmalyl-CoA;|(2R,3S)-2-Methyl-3-carboxy-3-hydroxypropanoyl-CoA",,,,,
C06028,2-Methylfumaryl-CoA;|Mesaconyl-CoA;|Mesaconyl-C1-CoA;|(E)-3-Carboxy-2-methylprop-2-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06028  2-Methylfumaryl-CoA,
C06029,L-threo-3-Methylmalate,,,,,
C06030,Methyloxaloacetate,,,,,
C06031,D-threo-3-Methylmalate,,,,,
C06032,"D-erythro-3-Methylmalate;|(2R,3S)-3-Methylmalate",,,,,
C06033,Parapyruvate;|4-Hydroxy-4-methyl-2-oxoglutarate,,,,,
C06034,4-Hydroxy-4-methylglutamate,,,,,
C06035,4-Methylene-2-oxoglutarate;|2-Methylidene-4-oxopentanedioic acid;|4-Carboxy-2-oxo-4-pentenoate;|4-Methylene-2-oxoglutaric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C06035  4-Methylene-2-oxoglutaric acid,
C06036,"Trigalactosyl-diacylglycerol;|TGDG;|Gal-alpha1->6Gal-alpha1->6Galii-beta1->3acyl2Gro;|Galalpha1->6Galalpha1->6Galiibeta1->3acyl2Gro;|1,2-Diacyl-3-O-(alpha-D-galactosyl(1->6)-O-alpha-D-galactosyl(1->6)-O-beta-D-galactosyl)-sn-glycerol;|3-[alpha-D-Galactosyl-(1->6)-alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-1,2-diacyl-sn-glycerol;|1,2-Diacyl-3-O-[alpha-D-galactopyranosyl(1->6)-O-alpha-D-galactopyranosyl(1->6)-O-beta-D-galactopyranosyl]-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06036  1,2-Diacyl-3-O-[alpha-D-galactopyranosyl(1->6)-O-alpha-D-galactopyranosyl(1->6)-O-beta-D-galactopyranosyl]-sn-glycerol",
C06037,"Digalactosyl-diacylglycerol;|DGDG;|Gal-alpha1->6Gal-beta1->3acyl2Gro;|Galalpha1->6Galbeta1->3acyl2Gro;|1,2-Diacyl-3-O-[alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol;|3-[alpha-D-Galactosyl-(1->6)-beta-D-galactosyl]-1,2-diacyl-sn-glycerol;|2,3-Di-O-acyl-1-O-(6-O-alpha-D-galactosyl-beta-D-galactosyl)-D-glycerol",Generic compound in reaction hierarchy,,,"Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glyceroglycolipids|C06037  Digalactosyldiacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06037  1,2-Diacyl-3-O-(alpha-D-galactosyl(1->6)-O-beta-D-galactosyl)-sn-glycerol",
C06038,"Acyl1-monogalactosyl-diacylglycerol;|Acylmono-beta-D-galactosyldiacylglycerol;|acyl1->6Gal-beta1->3acyl2Gro;|acyl1->6Galbeta1->3acyl2Gro;|1,2-Diacyl-3-O-(acyl(1->6)-O-beta-D-galactosyl)-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06038  1,2-Diacyl-3-O-(acyl(1->6)-O-beta-D-galactosyl)-sn-glycerol",
C06040,"Diglucosyldiacylglycerol;|beta-Gentiobiosyldiacylglycerol;|Glc-beta1->6Glc-beta1->3acyl2Gro;|Glcbeta1->6Glcbeta1->3acyl2Gro;|1,2-Diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06040  1,2-Diacyl-3-O-(beta-D-glucopyranosyl(1->6)-O-beta-D-glucopyranosyl)-sn-glycerol",G13182
C06041,Glycerophosphoglycoglycerolipid;|(sn-Gro-1-P)->6Glc-beta1->6Glc-beta1->3acyl2Gro;|(sn-Gro-1-P)->6Glcbeta1->6Glcbeta1->3acyl2Gro,Generic compound in reaction hierarchy,,,,G13183
C06042,Lipoteichoic acid;|(sn-Gro-1-P)25->6Glc-alpha1->2Glc-alpha1->3acyl2Gro,Generic compound in reaction hierarchy|The hydroxy groups of Gro-1-P subunits may be D-alanylated or glycosylated.,,,,
C06044,4-Hydroxyphenylethanol;|Tyrosol,,,,,
C06046,Salidroside;|p-Hydroxyphenethyl alcohol 1-O-beta-D-glucoside;|Tyrosol glucoside,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C06046  Salidroside,
C06047,Stizolobate;|Stizolobic acid,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C06047  Stizolobate,
C06048,Stizolobinate;|Stizolobinic acid,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C06048  Stizolobinate,
C06049,N-Formylderivatives,,,,,
C06050,2-Methyl-3-hydroxy-5-formylpyridine-4-carboxylate;|5-Formyl-3-hydroxy-2-methylpyridine-4-carboxylate,,,,,
C06051,Isopyridoxal,,,,,
C06052,5-Pyridoxolactone,,,,,
C06054,2-Oxo-3-hydroxy-4-phosphobutanoate;|alpha-Keto-3-hydroxy-4-phosphobutyrate;|(3R)-3-Hydroxy-2-oxo-4-phosphonooxybutanoate;|(3R)-3-Hydroxy-2-oxo-4-phosphooxybutanoate,,,,,
C06055,O-Phospho-4-hydroxy-L-threonine;|4-(Phosphonooxy)-threonine;|4-(Phosphonooxy)-L-threonine;|4-Phosphooxy-L-threonine,,,,,
C06056,4-Hydroxy-L-threonine;|Hydroxythreonine,,,,,
C06057,"3-Aminopropane-1,2-diol;|(R)-3-Amino-1,2-propanediol",,,,,
C06058,Nitroalkane,,,,,
C06062,Ceramide phosphoethanolamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP03 Phosphosphingolipids|SP0302 Ceramide phosphoethanolamines|C06062  Ceramide phosphoethanolamine,
C06066,"4,5-Dihydro-5,5-dimethyl-4-(3-oxobutyl)furan-2(3H)-one",,,,,
C06067,Dimethylallyltryptophan;|4-Dimethylallyltryptophan,,,,,
C06068,Elymoclavine;|Dihydrolysergol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06068  Elymoclavine,
C06069,Iridodial;|cis-trans-Iridodial,(+)-Iridodial (tautomer) [CPD:C09785]|cis-trans-Iridodial lactol (tautomer) [CPD:C09804],,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C06069  Iridodial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C06069  Iridodial",
C06070,"Iridotrial;|(1S,2R,3S)-2-Formyl-alpha-(hydroxymethylene)-3-methylcyclopentaneacetaldehyde",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C06070  Iridotrial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C06070  Iridotrial",
C06071,Deoxyloganin;|7-Deoxyloganin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C06071  Deoxyloganin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C06071  Deoxyloganin",
C06074,Myrcene;|beta-Myrcene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C06074  Myrcene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C06074  Myrcene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06074,
C06075,Terpinolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C06075  Terpinolene,
C06076,Camphene;|Comphene,(+)-Camphene [CPD:C06304]|(-)-Camphene [CPD:C06305],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06076  Camphene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06076  Camphene,
C06078,Limonene;|Dipentene;|dl-Limonene;|Cajeputene;|Kautschin,(+)-Limonene [CPD:C06099]|(-)-Limonene [CPD:C00521],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C06078  Limonene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06078  Limonene,
C06079,PR-toxin;|PR Toxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C06079  PR-toxin,
C06080,Nivalenol,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C06080  Nivalenol,
C06081,"Polyprenol;|ditrans,polycis-Polyprenol",Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C06081  Polyprenol,
C06082,Abscisate;|Abscisic acid;|(+)-Abscisic acid;|ABA,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C06082  Abscisate|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C06082  Abscisate|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06082,
C06083,Tetrahymanol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010622 Gammacerane triterpenoids|C06083  Tetrahymanol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Hopanes|C06083  Tetrahymanol,
C06086,"Pimaradiene;|Pimara-8(14),15-diene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C06086  Pimaradiene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C06086  Pimaradiene,
C06087,"Abietate;|Abietic acid;|Abieta-7,13-dien-18-oate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C06087  Abietic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C06087  Abietate|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06087,
C06088,Aphidicolin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010416 Aphidicolane diterpenoids|C06088  Aphidicolin|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Aphidicolane|C06088  Aphidicolin,
C06089,ent-Copalyl diphosphate;|(-)-Copalyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C06089  ent-Copalyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C06089  ent-Copalyl diphosphate,
C06090,ent-Kaurene;|ent-Kaur-16-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C06090  ent-Kaurene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C06090  ent-Kaurene,
C06091,Aconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C06091  Aconitine|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C06091  Aconitine,
C06092,Veatchine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C06092  Veatchine,
C06093,Gibberellin A12 aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C06093  Gibberellin A12 aldehyde|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C06093  Gibberellin A12 aldehyde,
C06094,Gibberellin A53,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C06094  Gibberellin A53|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C06094  Gibberellin A53,
C06095,Gibberellin A44 diacid;|Gibberellin A44 open lactone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C06095  Gibberellin A44 diacid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C06095  Gibberellin A44 diacid,
C06096,Gibberellin A29,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C06096  Gibberellin A29|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C06096  Gibberellin A29,
C06098,"Zeaxanthin;|(3R,3'R)-beta,beta-Carotene-3,3'-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C06098  Zeaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C06098  Zeaxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06098,
C06099,(R)-Limonene;|(+)-Limonene;|d-Limonene;|(4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohexene;|(+)-(R)-Limonene;|(+)-(4R)-Limonene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C06099  (+)-Limonene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06099  (+)-Limonene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06099,
C06102,Adipate semialdehyde;|Hexan-1-one-6-carboxylate;|6-Oxohexanoate;|6-Oxohexanoic acid,,,,,
C06103,6-Hydroxyhexanoic acid;|6-Hydroxyhexanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C06103  6-Hydroxyhexanoic acid,
C06104,"Adipate;|Adipic acid;|Hexanedioate;|Hexan-1,6-dicarboxylate;|Hexanedioic acid",,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C06104  Adipate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C06104  Hexanedioic acid,
C06105,"Cyclohexane-1,2-dione",,,,,
C06108,Fluoroacetate;|Fluoroacetic acid;|Cymonic acid;|Gifblaar poison;|HFA;|UN 2642,,,,,
C06111,Nerolidyl diphosphate;|NPP,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C06111  Nerolidyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C06111  Nerolidyl diphosphate,
C06112,L-Glutamyl-tRNA(Gln);|Glu-tRNA(Gln);|Glutamyl-tRNA(Gln),,,,,
C06113,L-Aspartyl-tRNA(Asn);|Asp-tRNA(Asn);|Aspartyl-tRNA(Asn),,,,,
C06114,gamma-Glutamyl-beta-aminopropiononitrile;|gamma-Glutamyl-3-aminopropiononitrile,,,,,
C06115,L-Arabinofuranose,L-Arabinopyranose [CPD:C00259]|L-Arabinose (open-chain) [CPD:C11476]|beta-L-Arabinofuranose [CPD:C20569],,,,
C06118,4-(4-Deoxy-alpha-D-gluc-4-enuronosyl)-D-galacturonate;|4-(4-Deoxy-alpha-D-galact-4-enuronosyl)-D-galacturonate;|Unsaturated digalacturonate,,,,,G10113
C06121,3-Ketosphingosine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0101 Sphing-4-enines (Sphingosines)|C06121  3-Ketosphingosine,
C06123,Hexadecenal;|2-trans-Hexadecenal;|(2E)-Hexadecenal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C06123  (2E)-Hexadecenal,
C06124,Sphingosine 1-phosphate;|Sphing-4-enine 1-phosphate;|S1P,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0105 Sphingoid base 1-phosphates|C06124  Sphingosine 1-phosphate,
C06125,Sulfatide;|Galactosylceramide sulfate;|Cerebroside 3-sulfate,Generic compound in reaction hierarchy,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glycosphingolipids|C06125  Sulfatide|Lipids [BR:br08002(G11122)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|G11122  S-3Gal-beta1->1'Cer|Lipids [BR:br08002]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|C06125  Sulfatide,G11122
C06126,Digalactosylceramide;|Galabiosylceramide;|Gal-alpha1->4Gal-beta1->1'Cer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00497)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0509 Gal- (Gala series)|G00497  Gal-alpha1->4Gal-beta1->1'Cer,G00497
C06127,Digalactosylceramide sulfate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G10524)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|G10524  S-3Gal-alpha1->4Gal-beta1->1'Cer|Lipids [BR:br08002]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|C06127  Digalactosylceramidesulfate,G10524
C06128,GM4;|N-Acetylneuraminyl-galactosylceramide;|Neu5Ac-alpha2->3Gal-beta1->1'Cer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00317)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00317  Neu5Ac-alpha2->3Gal-beta1->1'Cer (GM4),G00317
C06130,Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00039)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00039  Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCer (Type 1B)|Blood groups and carbohydrate antigens [br08110.html(G00039)]|ABO blood group|G00039,G00039
C06131,Fuc-alpha1->2Gal-beta1->3GlcNAc-beta1->3Gal-beta1->4Glc-beta1-1'Cer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00044)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00044  Fuc-alpha1->2Gal-beta1->3GlcNAc-beta1->3LacCer (Type 1H)|Blood groups and carbohydrate antigens [br08110.html(G00044)]|ABO blood group|G00044,G00044
C06132,Type A glycolipid;|GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCer;|GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00042)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00042  GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GlcNAc-beta1->3LacCer (Type 1A)|Blood groups and carbohydrate antigens [br08110.html(G00042)]|ABO blood group|G00042,G00042
C06133,"GD3;|alpha-N-Acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-glucosyl-1,1'-ceramide;|NeuAc-alpha2->8NeuAc-alpha2->3Gal-beta1->4Glc-beta1->1'Cer;|NeuAc-alpha2->8NeuAc2->3LacCer",Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00113)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00113  Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer (GD3)|Cancer-associated carbohydrates [br08441.html(G00113)]|Glycosphingolipid|G00113,G00113
C06134,GD2;|GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)Gal-beta1->4Glc-beta1->1'Cer;|GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00114)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00114  GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GD2)|Cancer-associated carbohydrates [br08441.html(G00114)]|Glycosphingolipid|G00114,G00114
C06135,GA2;|GalNAc-beta1->4Gal-beta1->4Glc-beta1->1'Cer;|GalNAc-beta1->4LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00123)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0503 GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series)|G00123  GalNAc-beta1->4LacCer (GA2),G00123
C06136,GA1;|Gal-beta1->3GalNAc-beta1->4Gal-beta1->4Glc-beta1->1'Cer;|Gal-beta1->3GalNAc-beta1->4LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00124)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0503 GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series)|G00124  Gal-beta1->3GalNAc-beta1->4LacCer (GA1)|Cancer-associated carbohydrates [br08441.html(G00124)]|Glycosphingolipid|G00124,G00124
C06138,GT1a;|Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer;|Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00112)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00112  Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GT1a),G00112
C06139,GQ1;|Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer;|Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00117)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00117  Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GQ1b),G00117
C06140,GT1b;|Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer;|Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00116)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00116  Neu5Ac-alpha2->3Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GT1b),G00116
C06141,GD1b;|Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer;|Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)LacCer,Generic compound in reaction hierarchy,,,Lipids [BR:br08002(G00115)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00115  Gal-beta1->3GalNAc-beta1->4(Neu5Ac-alpha2->8Neu5Ac-alpha2->3)Gal-beta1->4Glc-beta1->1'Cer (GD1b),G00115
C06142,1-Butanol;|n-Butanol;|Butan-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C06142  1-Butanol,
C06143,Poly-beta-hydroxybutyrate,,,,,
C06144,3-Butynoate;|But-3-ynoate,,,,,
C06145,3-Butyn-1-al,,,,,
C06146,3-Butyn-1-ol,,,,,
C06148,"2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine",,,,,
C06149,"6-(3'-Triphosphoryl-1'-methylglyceryl)-7-methyl-7,8-dihydrobiopterin",,,,,
C06151,1L-chiro-Inositol;|(-)-Inositol,,,,,
C06152,muco-Inositol,,,,,
C06153,scyllo-Inositol;|Scyllitol,,,,,
C06155,myo-Inositol 5-phosphate;|1D-myo-Inositol 5-phosphate,,,,,
C06156,alpha-D-Glucosamine 1-phosphate;|D-Glucosamine 1-phosphate,,,,,
C06157,[Dihydrolipoyllysine-residue succinyltransferase] S-glutaryldihydrolipoyllysine;|S-Glutaryldihydrolipoamide-E,Generic compound in reaction hierarchy,,,,
C06158,"D-Fucono-1,4-lactone",,,,,
C06159,2-Dehydro-3-deoxy-D-fuconate,,,,,
C06160,"(S)-Norcoclaurine;|6,7-Dihydroxy-(1S)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06160  (S)-Norcoclaurine,
C06161,"(S)-Coclaurine;|Coclaurine;|(S)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-7-isoquinolinol;|1-(p-Hydroxybenzyl)-6-methoxy-7-hydroxy-1,2,3,4-tetrahydroisoquinoline",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06161  (S)-Coclaurine,
C06162,Sanguinarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06162  Sanguinarine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C06162  Sanguinarine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06162,
C06163,(S)-cis-N-Methylstylopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06163  (S)-cis-N-methylstylopine,
C06165,Macarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06165  Macarpine,
C06167,"1,2-Dehydroreticuline;|1,2-Dehydroreticulinium;|3,4-Dihydro-7-hydroxy-1-[(3-hydroxy-4-methoxyphenyl)methyl]-6-methoxy-2-(methyl-14C)-isoquinolinium",,,,,
C06171,"Codeinone;|(5alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06171  Codeinone,
C06172,Neopinone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06172  Neopinone,
C06173,Thebaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06173  Thebaine|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C06173,
C06174,"Codeine;|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06174  Codeine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|R05DA Opium alkaloids and derivatives|R05DA04 Codeine|C06174  Codeine|Risk category of Japanese OTC drugs [BR:br08312]|Designated second-class OTC drugs|Inorganic and organic chemicals|Codeine|C06174  Codeine|Second-class OTC drugs|Inorganic and organic chemicals|Codeine|C06174  Codeine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01076  Codeine|C06174  Codeine|Analgesic|DG01984  Opioid analgesics|DG01076  Codeine|C06174  Codeine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG01076  Codeine|C06174  Codeine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01076  Codeine|C06174  Codeine|DG02924  UGT substrate|DG03189  UGT2B4 substrate|DG01076  Codeine|C06174  Codeine|DG03190  UGT2B7 substrate|DG01076  Codeine|C06174  Codeine|Prodrugs [br08324.html]|C06174|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C06174",G01076
C06175,Oripavine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06175  Oripavine|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C06175,
C06176,Senecionine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C06176  Senecionine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Pyrrolizidine alkaloids|C06176  Senecionine,
C06177,Retronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C06177  Retronecine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Pyrrolizidine alkaloids|C06177  Retronecine,
C06178,1-Methylpyrrolinium;|1-Methyl-Delta(1)-pyrrolinium,,,,,
C06179,Hygrine;|(+)-Hygrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C06179  Hygrine,
C06180,Anabasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C06180  Anabasine,
C06181,Piperideine;|1-Piperideine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C06181  Piperideine,
C06182,Pelletierine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C06182  Pelletierine,
C06183,L-(+)-Anaferine;|Anapheline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C06183  L-(+)-Anaferine,
C06184,N-Methylpelletierine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C06184  N-Methylpelletierine,
C06185,Slaframine;|(-)-Slaframine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C06185  Slaframine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06185,
C06186,Arbutin;|Ursin;|Uvasol;|Hydroquinone-O-beta-D-glucopyranoside,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C06186  Arbutin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C06186,
C06187,Arbutin 6-phosphate;|Arbutin-6P,,,,,
C06188,Salicin 6-phosphate;|Salicin-6P,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C06188  Salicin 6-phosphate,
C06189,"Cyclic 2,3-bisphospho-D-glycerate;|Cyclic 2,3-diphospho-D-glycerate;|Cyclic glycerate-2,3P2;|cDPG;|Cyclic 2,3-bisphosphoglycerate",,,,,
C06192,ADP-mannose;|APD-D-mannose,,,,,
C06193,Guanosine 3'-phosphate;|3'-GMP;|3'-Guanylic acid;|Guo-3'-P;|Gp,,,,,
C06194,"2',3'-Cyclic GMP",,,,"Compounds with biological roles [BR:br08001]|Nucleic acids|Cyclic nucleotides|2',3'-Cyclic nucleotides|C06194  2',3'-Cyclic GMP",
C06195,Imidazolone;|4-Imidazolone;|Imidazol-4-one,,,,,
C06196,2'-Deoxyinosine 5'-phosphate;|dIMP,,,,,
C06197,"P1,P3-Bis(5'-adenosyl) triphosphate;|ApppA;|Adenosine 5'-triphosphate 5'-adenosine",,,,,
C06198,"P1,P4-Bis(5'-uridyl) tetraphosphate;|UppppU",,,,,
C06199,Hordenine;|4-[2-(Dimethylamino)ethyl]phenol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C06199  Hordenine,
C06201,"2,4-Dihydroxyhept-2-enedioate;|2,4-Dihydroxyhept-2-1,7-dioate;|2,4-Dihydroxyhept-2-enedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C06201  2,4-Dihydroxyhept-2-enedioc acid",
C06202,Salicylaldehyde;|o-Hydroxybenzaldehyde;|2-Hydroxybenzaldehyde,,,,,
C06203,trans-o-Hydroxybenzylidenepyruvate;|(3E)-4-(2-Hydroxyphenyl)-2-oxobut-3-enoate,,,,,
C06204,2-Hydroxychromene-2-carboxylate;|2-Hydroxy-2H-chromene-2-carboxylate,,,,,
C06205,"1,2-Dihydronaphthalene-1,2-diol",,,,,
C06206,Benzoyl phosphate,,,,,
C06207,"2,6-Dihydroxyphenylacetate",,,,,
C06210,"2-Hydroxy-6-keto-2,4-heptadienoate;|2-Hydroxy-6-oxo-hept-2,4-dienoate",,,,,
C06212,N-Methylserotonin,,,,,
C06213,N-Methyltryptamine;|N-Methylindoleethylamine;|1-Methyl-2-(3-indolyl)ethylamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06213  N-Methyltryptamine,
C06215,"Levan;|(2,6-beta-D-Fructosyl)n;|Levan n;|2,6-beta-D-Fructan;|(2,6-beta-D-Fructosyl)n+1",,,,,G10499
C06216,Celloheptaose,,,,,G01455
C06217,Cellohexaose,,,,,G01967
C06218,Cellopentaose,,,,,G00546
C06219,Cellotriose,,,,,G00318
C06222,Sedoheptulose 1-phosphate;|altro-Heptulose 1-phosphate,,,,,
C06224,"3,4-Dihydroxystyrene",,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C06224  3,4-Dihydroxystyrene",
C06227,Fe(III)hydroxamate;|Fe(III)hydroxamic acid,,,,,
C06228,Ferrichrome,,,,,
C06229,Fe(III)dicitrate;|Iron(III)dicitrate,,,,,
C06230,Fe-enterobactin;|Fe-enterochlin,Enterochelin [CPD:C05821],,,,
C06231,"Ectoine;|L-Ectoine;|(4S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylate",,,,,
C06232,Molybdate,,,,,
C06234,4-Methyl-L-glutamate,,,,,
C06238,L-Arabinose 1-phosphate,,,,,
C06239,alpha-L-Arabinose 1-phosphate,,,,,
C06240,UDP-N-acetyl-D-mannosaminouronate;|UDP-N-acetyl-2-amino-2-deoxy-D-mannuronate;|UDP-N-acetyl-D-mannosaminuronic acid;|UDP-N-acetyl-alpha-D-mannosaminuronate,,,,,
C06241,N-Acetylneuraminate 9-phosphate,,,,,
C06244,Acetamide,,,,,
C06246,Gla protein;|Peptidyl-4-carboxyglutamate,Generic compound in reaction hierarchy|Gla = gamma-carboxyglutamate,,,,
C06247,Gla protein precursor;|Peptidyl-glutamate,Generic compound in reaction hierarchy,,,,
C06248,D-Ribose 1-diphosphate,,,,,
C06249,Apo-[carboxylase];|[Biotin carboxyl-carrier protein]-L-lysine,Generic compound in reaction hierarchy,,,,
C06250,Holo-[carboxylase];|Biotin-carboxyl-carrier protein;|[Biotin carboxyl-carrier protein]-biotin-N6-L-lysine;|[Biotin carboxyl-carrier protein]-N6-biotinyl-L-lysine,Generic compound in reaction hierarchy,,,,
C06251,Lauroyl-KDO2-lipid IV(A);|Dodecanoyl-KDO2-lipid IV(A),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C06251  Lauroyl-KDO2-lipid IV(A),
C06254,Lysophospholipid,Generic compound in reaction hierarchy,,,,
C06255,2-Oxopentanoic acid;|2-Oxovalerate;|2-Oxopentanoate;|alpha-Ketovaleric acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C06255  2-Oxovalerate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C06255  2-Oxopentanoic acid,
C06257,1-Deoxy-D-xylulose,,,,,
C06264,Aluminium;|Al,,,,,
C06268,Chromium;|Cr,"Chromium and chromium compounds|Oxidation states: +3, +4, +5, +6",,,,
C06269,Arsenic;|As,"Arsenic and arsenic compounds|Oxidation states: +3, +5",,,,
C06272,Gal-beta1->3GalNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|Ceramidetetrasaccharide (beta1->3);|Ceramidetetrahexoside (beta 1->3);|Paragloboside (beta 1->3),,,,Lipids [BR:br08002(G01469)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G01469  Gal-beta1->3GalNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G01469
C06273,Gal-beta1->4GalNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|Ceramidetetrasaccharide (beta 1->4);|Ceramidetetrahexoside (beta 1->4);|Paragloboside (beta 1->4),,,,,G01184
C06297,NeuGc-alpha2->8NeuGc2->3Gal-beta1->4Glc-beta1->1'Cer;|NeuGc-alpha2->8NeuGc2->3LacCer,,,,Lipids [BR:br08002(G00453)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00453  Neu5Gc-alpha2->8Neu5Gc2->3Gal-beta1->4Glc-beta1->1'Cer,G00453
C06299,NeuAc-alpha2->8NeuAc-alpha2->8NeuAc2->3LacCer;|NeuAc-alpha2->8NeuAc-alpha2->8NeuAc2->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00118)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00118  Neu5Ac-alpha2->8Neu5Ac-alpha2->8NeuA5c-alpha2->3Gal-beta1->4Glc-beta1->1'Cer (GT3),G00118
C06300,NeuGc-alpha2->8NeuGc-alpha2->8NeuGc2->3LacCer;|NeuGc-alpha2->8NeuGc-alpha2->8NeuGc2->3Gal-beta1->4Glc-beta1->1'Cer,,,,,
C06302,GalNAc-beta1->4(NeuGc-alpha2->8NeuGc2->3)LacCer;|GalNAc-beta1->4(NeuGc-alpha2->8NeuGc2->3)Gal-beta1->4Glc-beta1->1'Cer,,,,,
C06304,(+)-Camphene;|(+)-Comphene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06304  (+)-Camphene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06304  (+)-Camphene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06304,
C06305,(-)-Camphene;|(-)-Comphene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06305  (-)-Camphene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06305  (-)-Camphene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06305,
C06306,"(+)-alpha-Pinene;|(1R,5R)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06306  (+)-alpha-Pinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06306  (+)-alpha-Pinene,
C06307,"(-)-beta-Pinene;|(1S,5S)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptane",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06307  (-)-beta-Pinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06307  (-)-beta-Pinene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06307,
C06308,"(-)-alpha-Pinene;|(1S,5S)-2,6,6-Trimethylbicyclo[3.1.1]hept-2-ene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C06308  (-)-alpha-Pinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06308  (-)-alpha-Pinene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06308,
C06309,Diplopterol;|22-Hopanol;|Hopan-22-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C06309  Hopan-22-ol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06309,
C06310,Diploptene;|22(29)-Hopene;|Hop-22(29)-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C06310  Hop-22(29)-ene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06310,
C06311,Galactitol 1-phosphate;|L-Galactitol 1-phosphate;|D-Galactitol 6-phosphate,,,,,
C06312,L-Tagatose 6-phosphate,,,,,
C06313,"Biopterin;|2-Amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone",,,,,
C06314,"Lipoxin A4;|LXA4;|5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid;|(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0304 Lipoxins|C06314  Lipoxin A4,
C06315,"Lipoxin B4;|LXB4;|5S,14R,15S-Trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid;|(6E,8Z,10E,12E)-(5S,14R,15S)-Trihydroxyicosa-6,8,10,12-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0304 Lipoxins|C06315  Lipoxin B4,
C06316,"Dehydro-D-arabinono-1,4-lactone;|(5R)-3,4-Dihydroxy-5-(hydroxymethyl)furan-2(5H)-one",,,,,
C06317,Vanillyl alcohol;|4-Hydroxy-3-methoxy-benzenemethanol;|4-Hydroxy-3-methoxybenzyl alcohol;|4-Hydroxy-3-methoxybenzenemethanol,,,,,
C06318,"(3S,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1,4-dicarboxylate;|(1R,6S)-Dihydroxycyclohexa-2,4-diene-1,4-dicarboxylate;|Terephthalate-1,2-cis-dihydrodiol;|cis-4,5-Dihydroxycyclohexa-1(6),2-diene-1,4-dicarboxylate",,,,,
C06319,Precorrin 6Y;|Precorrin 6B,,,,,
C06320,Precorrin 6X;|Precorrin 6A,,,,,
C06321,"(1R,6S)-1,6-Dihydroxycyclohexa-2,4-diene-1-carboxylate;|cis-1,2-Dihydroxycyclohexa-3,5-diene-1-carboxylate;|cis-1,6-Dihydroxy-2,4-cyclohexadiene-1-carboxylic acid",,,,,
C06322,"Cyclohexa-1,5-diene-1-carbonyl-CoA;|Cyclohexa-1,5-diene-1-carboxyl-CoA;|Cyclohexa-1,5-dienecarbonyl-CoA;|Cyclohex-1,5-diene-1-carbonyl-CoA;|S-1,5-Cyclohexadiene-1-carboxylate coenzymeA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06322  Cyclohexa-1,5-diene-1-carbonyl-CoA",
C06323,Isoquinoline;|2-Benzazine;|Benzo[c]pyridine,,,,,
C06324,Isocarbostyril;|1(2H)-Isoquinolinone;|Isoquinolin-1(2H)-one,,,,,
C06325,2-Quinolinecarboxylic acid;|Quinaldinic acid;|Quinaldic acid;|2-Quinolinecarboxylate;|Quinaldate,,,,,
C06326,(2S)-2-{[1-(R)-Carboxyethyl]amino}pentanoate,,,,,
C06327,Chelirubine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06327  Chelirubine,
C06328,"6-Chlorobenzene-1,2,4-triol;|6-Chlorohydroxyquinol",,,,,
C06329,2-Chloromaleylacetate,,,,,
C06330,"Quinoline-3,4-diol;|3,4-Dihydroxyquinoline",,,,,
C06331,"2-Methylquinoline-3,4-diol",,,,,
C06332,N-Acetylanthranilate;|2-(Acetylamino)-benzoic acid;|N-Acetylanthranilic acid,,,,,
C06333,2-Aminobenzenesulfonate;|2-Aminobenzenesulfonic acid;|o-Aminobenzenesulfonic acid;|Orthanilic acid,,,,,
C06334,Metanilic acid;|3-Aminobenzenesulfonate;|3-Aminobenzenesulfonic acid;|m-Aminobenzenesulfonic acid,,,,,
C06335,4-Aminobenzenesulfonate;|4-Aminobenzenesulfonic acid;|p-Aminobenzenesulfonic acid;|Sulfanilic acid,,,,,
C06336,"3-Sulfocatechol;|2,3-Dihydroxybenzenesulfonate",,,,,
C06337,"Terephthalate;|Terephthalic acid;|1,4-Benzenedicarboxylic acid",,,,,
C06338,Quinolin-2-ol;|2-Quinolone;|2-Hydroxyquinoline;|2-Quinolinol,2(1H)-Quinolinone (amide tautomer) [CPD:C06415],,,,
C06339,"2,5,6-Trihydroxy-5,6-dihydroquinoline",,,,,
C06341,"7alpha,27-Dihydroxycholesterol;|Cholest-5-ene-3beta,7alpha,26-triol;|Cholest-5-ene-3beta,7alpha,27-triol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C06341  7-alpha,27-Dihydroxycholesterol|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C06341  7alpha,27-Dihydroxycholesterol",
C06342,"Quinolin-2,8-diol",,,,,
C06343,4-Hydroxyquinoline;|Quinolin-4-ol,,,,,
C06344,"3-Methyl-quinolin-2,8-diol",,,,,
C06345,3-Methyl-quinolin-2-ol,,,,,
C06346,"(R,S)-Norcoclaurine;|Norcoclaurine;|6,7-Dihydroxy-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline;|Higenamine",,,,,
C06347,"(R)-Norcoclaurine;|6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline;|(+)-Demethylcoclaurine",,,,,
C06348,"(R,S)-Coclaurine;|dl-Coclaurine;|6-Methoxy-7-hydroxy-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline;|Machiline",,,,,
C06349,"(R)-Coclaurine;|6-Methoxy-7-hydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline;|(R)-1,2,3,4-Tetrahydro-1-[(4-hydroxyphenyl)methyl]-6-methoxy-7-isoquinolinol",,,,,
C06350,"Tetrahydropapaveroline;|(R,S)-Norlaudanosoline;|Norlaudanosoline",,,,,
C06351,(R)-Norlaudanosoline;|(R)-Tetrahydropapaveroline,,,,,
C06352,4-O-Methyl-myo-inositol;|1D-4-O-Methyl-myo-inositol,"formerly called ""6-O-Methyl-myo-inositol"" on old nomenclature system of numbering",,,,
C06353,6-O-Methyl-myo-inositol;|1D-6-O-Methyl-myo-inositol,,,,,
C06354,Benzophenone;|Diphenyl ketone,,,,,
C06355,"2,3',4,6-Tetrahydroxybenzophenone",,,,,
C06356,"2,4,6-Trihydroxybenzophenone;|Phenyl(2,4,6-trihydroxyphenyl)-methanone",,,,,
C06357,Alkyl cinnamate,Generic compound in reaction hierarchy,,,,
C06358,Methyl cinnamate;|3-Phenyl-2-propenoic acid methyl,,,,,
C06359,Ethyl cinnamate;|3-Phenylpropenoic acid ethyl,,,,,
C06360,Propyl cinnamate;|3-Phenylpropenoic acid propyl ester,,,,,
C06361,"Anthocyanidin-3,5-diglucoside;|Anthocyanidin 3,5-di-O-beta-D-glucoside",Generic compound in reaction hierarchy,,,"Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C06361  Anthocyanidin-3,5-diglucoside",
C06363,Anthocyanidin 3-glucoside-5-hydroxycinnamoylglucoside;|Anthocyanidin 3-O-beta-D-glucoside 5-O-beta-D-(6-O-4-hydroxycinnamoylglucoside),Generic compound in reaction hierarchy,,,,
C06364,"1,2-Diacyl-3-alpha-D-glucosyl-sn-glycerol;|1,2-Diacyl-3-O-(alpha-D-glucopyranosyl)-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06364  1,2-Diacyl-3-O-(alpha-D-glucopyranosyl)-sn-glycerol",G13187
C06365,"alpha-Kojibiosyldiacylglycerol;|Glc-alpha1->2Glc-alpha1->3acyl2Gro;|Glcalpha1->2Glcalpha1->3acyl2Gro;|1,2-Diacyl-3-O-[alpha-D-glucopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C06365  1,2-Diacyl-3-O-(alpha-D-glucopyranosyl(1->2)-O-alpha-D-glucopyranosyl)-sn-glycerol",
C06366,sym-Homospermidine;|Homospermidine,,,,,
C06367,1-Carboxyvinyl carboxyphosphonate;|Carboxyphosphonoenolpyruvate,,,,,
C06368,3-(Hydrohydroxyphosphoryl)pyruvate;|(Hydroxyphosphinyl)pyruvate;|3-Phosphinopyruvate,,,,,
C06369,2-Deoxy-D-glucose 6-phosphate,,,,,
C06370,alpha-D-Glucuronoside,Generic compound in reaction hierarchy,,,,
C06371,Lacto-N-tetraose;|beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Tetrasaccharides|C06371  Lacto-N-tetraose,G00395
C06372,Lacto-N-biose;|beta-D-Gal-(1->3)-D-GlcNAc;|beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-glucosamine,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C06372  Lacto-N-biose,G00284
C06374,Phthalylamide;|Phthalyl (N substituted) amide,Generic compound in reaction hierarchy,,,,
C06376,N-Acetyl-D-galactosamine 6-phosphate,,,,,
C06377,D-Galactosamine 6-phosphate,,,,,
C06378,N-Acyl-D-amino acid,Generic compound in reaction hierarchy,,,,
C06379,N-Acyl-D-glutamate,Generic compound in reaction hierarchy,,,,
C06380,N-Acyl-D-aspartate,Generic compound in reaction hierarchy,,,,
C06381,Methylenediurea,,,,,
C06382,N-(Carboxyaminomethyl)urea,,,,,
C06383,N-(Aminomethyl)urea,,,,,
C06384,N-(Hydroxymethyl)urea,,,,,
C06385,Dimethylenetriurea,,,,,
C06386,Trimethylenetetraurea,,,,,
C06387,4-Chlorobenzoyl-CoA,,,,,
C06388,2-Aryl-2-methylmalonate,Generic compound in reaction hierarchy,,,,
C06389,2-Arylpropionate,Generic compound in reaction hierarchy,,,,
C06390,"16alpha-Hydroxypregnenolone;|3beta,16alpha-Dihydroxypregn-5-en-20-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C06390  16alpha-Hydroxypregnenolone",
C06391,"Algestone;|16alpha,17-Dihydroxypregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C06391  Algestone",
C06392,"16,17-Didehydropregnenolone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C06392  16,17-Didehydropregnenolone",
C06393,"2,3-Diaminopropanoate;|2,3-Diaminopropionate;|2,3-Diaminopropionic acid;|2,3-Diaminopropanoic acid",,,,,
C06394,delta-Cadinene;|(+)-delta-Cadinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C06394  (+)-delta-Cadinene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C06394  delta-Cadinene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06394,
C06395,omega-Agatoxin IVC;|[Protein]-L-serine,Generic compound in reaction hierarchy,,,,
C06396,omega-Agatoxin IVB;|[Protein]-D-serine,,,,,
C06397,ADP-D-glycero-beta-D-manno-heptose,ADP-L-glycero-beta-D-manno-heptose [CPD:C06398],,,,
C06398,ADP-L-glycero-beta-D-manno-heptose,ADP-D-glycero-beta-D-manno-heptose [CPD:C06397],,,,
C06399,Hydrogenobyrinate;|Hydrogenobyrinic acid,,,,,
C06400,"1-alpha-D-[(1->4)-alpha-D-Glucosyl](n-1)-alpha-D-glucopyranoside;|4-alpha-D-(1,4-alpha-D-Glucanosyl)n trehalose;|Maltooligosyltrehalose",,,,,G10589
C06403,"[Ribulose-1,5-bisphosphate carboxylase]-L-lysine;|[Ribulose-bisphosphate carboxylase large chain]-L-lysine;|[RbcL]-L-lysine",Generic compound in reaction hierarchy,,,,
C06404,"[Ribulose-1,5-bisphosphate carboxylase]-N6,N6,N6-trimethyl-L-lysine;|[Ribulose-bisphosphate carboxylase large chain]-N6,N6,N6-trimethyl-L-lysine;|[RbcL]-trimethyl-L-lysine",Generic compound in reaction hierarchy,,,,
C06406,Precorrin 3B,,,,,
C06407,Precorrin 4,,,,,
C06408,Precorrin 8X;|Precorrin 8;|Precorrin-8X,,,,,
C06409,[Methionine synthase]-cob(II)alamin,Generic compound in reaction hierarchy|Inactivated form of methionine synthase (ec 2.1.1.13),,,,
C06410,[Methionine synthase]-methylcob(III)alamin,Generic compound in reaction hierarchy,,,,
C06413,Quinoline;|Benzo[b]pyridine,,,,,
C06414,4-Quinolinecarboxylic acid;|Quinoline-4-carboxylate;|Quinoline-4-carboxylic acid;|Cinchonic acid,,,,,
C06415,2(1H)-Quinolinone;|Quinolin-2(1H)-one,Quinolin-2-ol (iminol tautomer) [CPD:C06338],,,,
C06416,Precorrin 5,,,,,
C06417,D-Valine;|(R)-2-Amino-3-methylbutyric acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C06417  D-Valine,
C06418,"D-Isoleucine;|(2R,3R)-2-Amino-3-methylvaleric acid",,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C06418  D-Isoleucine,
C06419,D-Histidine;|(R)-alpha-Amino-1H-imidazole-4-propionic acid,L-Histidine [CPD:C00135],,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C06419  D-Histidine,
C06420,D-Tyrosine;|(R)-3-(p-Hydroxyphenyl)alanine;|(R)-2-Amino-3-(p-hydroxyphenyl)propionic acid,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C06420  D-Tyrosine,
C06421,alpha-Cellobiose;|1-beta-D-Glucopyranosyl-4-alpha-D-glucopyranose,,,,,G00289
C06422,beta-Cellobiose;|1-beta-D-Glucopyranosyl-4-beta-D-glucopyranose,,,,,G00289
C06423,Octanoic acid;|Caprylic acid;|Octylic acid;|Octanoate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C06423  Caprylate; Octanoate|Lipids|Fatty acids|Saturated fatty acids|C06423  Caprylic acid (8:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C06423  Octanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C06423  Octanoic acid,
C06424,Tetradecanoic acid;|Tetradecanoate;|Myristic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C06424  Myristic acid (14:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C06424  Tetradecanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C06424  Myristic acid,
C06425,Icosanoic acid;|Eicosanoic acid;|Arachidic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C06425  Arachidic acid (20:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C06425  Icosanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C06425  Arachidic acid,
C06426,"(6Z,9Z,12Z)-Octadecatrienoic acid;|6,9,12-Octadecatrienoic acid;|gamma-Linolenic acid;|Gamolenic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C06426  gamma-Linolenic acid (18:3;6,9,12)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C06426  (6Z,9Z,12Z)-Octadeca-6,9,12-trienoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C06426  gamma-Linolenic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07213)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX02 Gamolenic acid|D07213  Gamolenic acid (INN)",
C06427,"(9Z,12Z,15Z)-Octadecatrienoic acid;|alpha-Linolenic acid;|9,12,15-Octadecatrienoic acid;|Linolenate;|alpha-Linolenate",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C06427  alpha-Linolenic acid (18:3;9,12,15)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C06427  (9Z,12Z,15Z)-Octadeca-9,12,15-trienoic acid",
C06428,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid;|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid;|Eicosapentaenoic acid;|5,8,11,14,17-Icosapentaenoic acid;|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate;|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoate;|5Z,8Z,11Z,14Z,17Z-Eicosapentaenoic acid;|(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C06428  Eicosapentaenoic acid (20:5;5,8,11,14.17)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C06428  (5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Liner triterpenes|C06428  (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid",
C06429,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid;|4,7,10,13,16,19-Docosahexaenoic acid;|Docosahexaenoic acid;|Docosahexaenoate;|4Z,7Z,10Z,13Z,16Z,19Z-Docosahexaenoic acid;|(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C06429  Docosahexaenoic acid (22:6;4,7,10,13,16,19)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C06429  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid|FA04 Docosanoids|FA0400 Other Docosanoids|C06429  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid",
C06430,D-Galacturonolactone;|D-gamma-Galacturonolactone,,,,,
C06432,UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanine;|UDP-N-acetylmuramoyl-L-alanyl-D-gamma-glutamyl-L-lysyl-D-alanine,,,,,
C06433,5'-Benzoylphosphoadenosine,,,,,
C06435,5'-Butyrylphosphoinosine;|Inosine 5'-phosphobutyrate,,,,,
C06436,5'-Butyrylphosphouridine,,,,,
C06437,"1,3-Diacylglycerol",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fats|Acylglycerols|C06437  1,3-Diacylglycerol|Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C06437  1,3-Diacyl-sn-glycerol",
C06438,Prostaglandin D1,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C06438  Prostaglandin D1|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C06438  Prostaglandin D1,
C06439,Prostaglandin E3,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C06439  Prostaglandin E3|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C06439  Prostaglandin E3,
C06440,"2-Dehydro-D-glucono-1,5-lactone",,,,,
C06441,L-Xylulose 1-phosphate,,,,,
C06442,"N(gamma)-Acetyldiaminobutyrate;|N4-Acetyl-L-2,4-diaminobutyrate;|N4-Acetyl-L-2,4-diaminobutanoate;|(2S)-4-Acetamido-2-aminobutanoate",,,,,
C06443,Hydroxamate;|Hydroxamic acid,,,,,
C06446,"2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine",,,,,
C06447,"2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine amide",,,,,
C06450,Myxochelin C,,,,,
C06451,2-Hydroxyethylphosphonate;|(2-Hydroxyethyl)-phosphonic acid,,,,,
C06452,(S)-2-Hydroxypropylphosphonate,,,,,
C06453,Methylcobalamin;|Methylcob(III)alamin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03246)]|B BLOOD AND BLOOD FORMING ORGANS|B03 ANTIANEMIC PREPARATIONS|B03B VITAMIN B12 AND FOLIC ACID|B03BA Vitamin B12 (cyanocobalamin and analogues)|B03BA05 Mecobalamin|D03246  Mecobalamin (JP18/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D03246)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3136  Vitamin B12 preparations|D03246  Mecobalamin (JP18/USAN)|Classification of Japanese OTC drugs [BR:br08313(D03246)]|Nourishing tonics and health supplements|42 Vitamin B1B6B12 based drugs|D03246  Mecobalamin (JP18/USAN)|Risk category of Japanese OTC drugs [BR:br08312(D03246)]|Third-class OTC drugs|Inorganic and organic chemicals|Mecobalamin|D03246  Mecobalamin (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D03246)]|Chemicals|D03246  Mecobalamin|D03246  Mecobalamin tablets|Rx-to-OTC switch list in Japan [br08314.html(D03246)]|D03246,
C06454,"Fosfomycin;|Phosphonomycin;|(1R,2S)-Epoxypropylphosphonate",,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Others|Aliphatic compounds|C06454  Fosfomycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06454|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04253)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX01 Fosfomycin|D04253  Fosfomycin (USAN/INN)|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA17 Fosfomycin|D04253  Fosfomycin (USAN/INN)|Antimicrobials [BR:br08307(D04253)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Other peptidoglycan biosynthesis inhibitor|D04253  Fosfomycin (USAN/INN)",
C06455,Hydroxymethylphosphonate;|P-(Hydroxymethyl)-phosphonic acid,,,,,
C06456,Phosphonoformate;|Foscarmet;|Foscarnet,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AD Phosphonic acid derivatives|J05AD01 Foscarnet|C06456  Phosphonoformate|Drug groups [BR:br08330]|Antiviral|DG01937  Anti-cytomegalovirus agent|DG00651  Foscarnet|C06456  Phosphonoformate,G00651
C06457,Bialaphos;|Bilanafos;|2-Amino-4-(methylphosphino)butyrylalanylalanine;|gamma-(Hydroxymethylphosphinyl)-L-alpha-aminobutyryl-L-alanyl-L-alanine;|Phosphinothricin tripeptide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C06457  Bialaphos,
C06459,N-Trimethyl-2-aminoethylphosphonate;|2-Trimethylaminoethylphosphonate,,,,,
C06461,Hydroxyaldehyde,,,,,
C06462,Leukotriene F4;|LTF4,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Leukotrienes|C06462  Leukotriene F4|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C06462  Leukotriene F4,
C06463,D-Threose;|D-threo-Tetrose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06463  D-Threose,
C06464,D-Altrose;|D-altro-Hexose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06464  D-Altrose,
C06465,D-Gulose;|D-gulo-Hexose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06465  D-Gulose,
C06466,D-Idose;|D-ido-Hexose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06466  D-Idose,
C06467,D-Talose;|D-talo-Hexose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06467  D-Talose,
C06468,D-Psicose;|D-ribo-Hex-2-ulose;|D-ribo-2-Hexulose;|D-ribo-2-Ketohexulose;|D-erythro-Hexulose;|D-Pseudofructose;|D-Allulose;|D-Altrulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C06468  D-Psicose,
C06469,"Neuraminic acid;|5-Amino-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C06469  Neuraminic acid,
C06470,Muramic acid;|3-O-alpha-Carboxyethyl-D-glucosamine;|2-Amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C06470  Muramic acid,
C06471,"Abequose;|3,6-Dideoxy-D-galactose;|3,6-Dideoxy-D-xylo-hexose;|3-Deoxy-D-fucose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Deoxy sugars|C06471  Abequose,
C06472,L-Iduronic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C06472  L-Iduronic acid,
C06473,2-Keto-D-gluconic acid;|2-Dehydro-D-gluconate;|2-Dehydro-D-gluconic acid;|alpha-D-arabino-2-Hexulosonic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C06473  2-Keto-D-gluconic acid,
C06474,"3,6-Anhydrogalactose;|3,6-Anhydro-D-galactose",,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06474  3,6-Anhydrogalactose",
C06475,"Prostaglandin F1alpha;|(13E,15S)-9alpha,11alpha-9,11,15-Trihydroxyprost-13-en-1-oic acid",,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C06475  Prostaglandin F1alpha|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C06475  Prostaglandin F1alpha,
C06476,Prostaglandin F3alpha,,,,Compounds with biological roles [BR:br08001]|Lipids|Eicosanoids|Prostaglandins|C06476  Prostaglandin F3alpha|Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C06476  Prostaglandin F3alpha,
C06477,L-Guluronic acid,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Sugar acids|C06477  L-Guluronic acid,
C06478,"3,6-Anhydroglucose;|3,6-Anhydro-D-glucose",,,,"Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C06478  3,6-Anhydroglucose",
C06481,L-Seryl-tRNA(Sec),Generic compound in reaction hierarchy|Sec = selenocysteine [CPD:C05688],,,,
C06482,L-Selenocysteinyl-tRNA(Sec),Generic compound in reaction hierarchy,,,,
C06483,"N-Acetyl-alpha-D-galactosaminyl-(1,3)-[alpha-L-fucosyl-(1,2)]-D-galactoside;|Glycoprotein-N-Acetyl-alpha-D-galactosaminyl-(1,3)-[alpha-L-fucosyl-(1,2)]-D-galactose",Generic compound in reaction hierarchy,,,,
C06484,"4,5-cis-Dihydroxy-1,2-dithiacyclohexane;|Oxidized dithioerythritol",,,,,
C06485,"1,5-Anhydro-D-fructose",,,,,
C06488,"XV638;|[4R-(4alpha,5alpha,6beta,7beta)]-3,3'-[[Tetrahydro-5,6-dihydroxy-2-oxo-4,7-bis(phenylmethyl)-1H-1,3-diazepine-1,3(2H)-diyl]bis(methylene)]bis[N-2-thiazolylbenzamide]",,,,,
C06489,"Compound VII;|5-(5-(6-Chloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-methylisoxazole",,,,,
C06490,"WIN VI;|WIN 52035;|5-(5-(4-(4,5-Dihydro-2-oxazoly)phenoxy)pentyl)-3-methylisoxazole",,,,,
C06491,"Compound WIN VIII;|5-(5-(2,6-Dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyloxymethyleneoxymethyl)isoxazole",,,,,
C06492,Compound II(R/S);|5-(7-(6-Chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole,,,,,
C06493,"WIN54954;|5-(5-(2,6-Dichloro-4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methylisoxazole",,,,,
C06494,Compound V(S);|5-(5-(4-(5-Hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methylisoxazole,,,,,
C06495,"Compound III(S);|5-(7-(4-(4-Ethyl-4,5-dihydrooxazol-2-yl)phenoxy)heptyl)-3-methylisoxazole",,,,,
C06496,"Compound IV;|5-(7-(4-(4,5-Dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole;|Disoxaril",,,,"Antimicrobials [BR:br08307(D03874)]|Antivirals|Entry, fusion or uncoating inhibitor|Enterovirus VP1|D03874  Disoxaril (USAN/INN)",
C06497,"WIN I(S);|WIN 52084 (S);|5-(7-(4-(4-Methyl-4,5-dihydrooxazol-2-yl)phenoxy)heptyl)-3-methylisoxazole",,,,,
C06499,"WIN56291;|5-(3-(2,6-Dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methylisoxazole",,,,,
C06500,5'-Guanylylmethylenebisphosphonate;|5'-Guanosyl-methylene-triphosphate,,,,,
C06501,Phosphotyrosine;|Phosphonotyrosine,,,,,
C06502,"4,6-Diamino-5-formamidopyrimidine;|4,6-Diamino-5-N-formamidopyrimidine",,,,,
C06503,"Hydrogenobyrinate a,c diamide;|Hydrogenobyrinate diamide;|Hydrogenobyrinic acid a,c-diamide",,,,,
C06504,"Cob(II)yrinate a,c diamide;|Cob(II)yrinate diamide;|Cob(II)yrinic acid a,c-diamide;|Cobyrinate a,c-diamide;|Cobyrinic acid a,c-diamide",,,,,
C06505,"Cob(I)yrinate a,c diamide;|Cob(I)yrinate diamide;|Cob(I)yrinic acid a,c-diamide",,,,,
C06506,"Adenosyl cobyrinate a,c diamide;|Adenosyl cobyrinate diamide;|Adenosylcob(III)yrinic acid a,c-diamide;|Adenosylcobyrinic acid a,c-diamide",,,,,
C06507,Adenosyl cobyrinate hexaamide;|Adenosylcobyric acid,,,,,
C06508,Adenosyl cobinamide;|Adenosylcobinamide,,,,,
C06509,Adenosyl cobinamide phosphate;|Adenosylcobinamide phosphate,,,,,
C06510,Adenosine-GDP-cobinamide;|Adenosylcobinamide-GDP,,,,,
C06511,"Guattegaumerine;|N,N'-Dimethyllindoldhamine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06511  Guattegaumerine,
C06512,2'-Norberbamunine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06512  2'-Norberbamunine,
C06513,Obamegine;|(+)-Obamegine;|Stepholine,,,,,
C06514,Aromoline,,,,,
C06515,Magnoline,,,,,
C06516,(R)-Norreticuline;|N-Norreticuline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06516  (R)-Norreticuline,
C06517,(S)-6-O-Methylnorlaudanosoline;|(S)-3'-Hydroxycoclaurine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06517  (S)-6-O-Methylnorlaudanosoline,
C06518,(S)-Nororientaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06518  (S)-Nororientaline,
C06520,(S)-Norreticuline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06520  (S)-Norreticuline,
C06521,Cuscohygrine;|Cuskhygrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C06521  Cuscohygrine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06521,
C06522,Strychnine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06522  Strychnine|Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C06522  Strychnine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C06522  Strychnine|Risk category of Japanese OTC drugs [BR:br08312]|First-class OTC drugs|Inorganic and organic chemicals|Strychnine|C06522  Strychnine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06522,
C06523,Coniine;|(+)-Coniine;|Cicutin,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C06523  Coniine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Piperidine alkaloids|C06523  Coniine,
C06524,Nornicotine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C06524  Nornicotine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06524,
C06525,Gentianine,,,,,
C06526,Quinine;|(-)-Quinine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08460)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BC Methanolquinolines|P01BC01 Quinine|D08460  Quinine (BAN)|Drug groups [BR:br08330(D08460)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01019  Quinine|D08460  Quinine|Transporter substrate|DG01665  ABCB1 substrate|DG01019  Quinine|D08460  Quinine|Antimicrobials [BR:br08307(D08460)]|Antiparasitics|Antmalarials|Methanolquinoline|D08460  Quinine (BAN)|Drug metabolizing enzymes and transporters [br08309.html(D08460)]|Drug metabolizing enzymes|D08460|Drug transporters|D08460",
C06527,Quinidine;|(+)-Quinidine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C06527  Quinidine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08458)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA01 Quinidine|D08458  Quinidine (BAN)|Drug groups [BR:br08330(D08458)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG00192  Quinidine|D08458  Quinidine|Target-based classification of drugs [BR:br08310(D08458)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08458  Quinidine (BAN)|SCN2A|D08458  Quinidine (BAN)|SCN3A|D08458  Quinidine (BAN)|SCN4A|D08458  Quinidine (BAN)|SCN5A|D08458  Quinidine (BAN)|SCN8A|D08458  Quinidine (BAN)|SCN9A|D08458  Quinidine (BAN)|SCN10A|D08458  Quinidine (BAN)|SCN11A|D08458  Quinidine (BAN)",
C06528,Cinchonine;|(9S)-Cinchonan-9-ol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C06528  Cinchonine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06528,
C06530,Cupreine,,,,,
C06531,alpha-Erythroidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06531  alpha-Erythroidine,
C06532,beta-Erythroidine,,,,,
C06533,Papaverine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C06533  Papaverine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07425)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AD Papaverine and derivatives|A03AD01 Papaverine|D07425  Papaverine (BAN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BE Drugs used in erectile dysfunction|G04BE02 Papaverine|D07425  Papaverine (BAN)|Risk category of Japanese OTC drugs [BR:br08312(D07425)]|Second-class OTC drugs|Inorganic and organic chemicals|Papaverine|D07425  Papaverine (BAN)|Target-based classification of drugs [BR:br08310(D07425)]|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE|D07425  Papaverine (BAN),
C06534,Heroin;|Diamorphine;|Diacetylmorphine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07286)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BC Drugs used in opioid dependence|N07BC06 Diamorphine|D07286  Diamorphine (BAN)|Drug groups [BR:br08330(D07286)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01003  Diamorphine|D07286  Diamorphine|Analgesic|DG01984  Opioid analgesics|DG01003  Diamorphine|D07286  Diamorphine|Target-based classification of drugs [BR:br08310(D07286)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07286  Diamorphine (BAN)|Prodrugs [br08324.html(D07286)]|D07286|Narcotics and psychotropics in Japan [br08308.html(D07286)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D07286|Prodrugs [br08324.html]|C06534,
C06535,Physostigmine;|Eserine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Pyrroloindole alkaloids|C06535  Physostigmine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00196)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB05 Physostigmine|D00196  Physostigmine (USP)|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB19 Physostigmine|D00196  Physostigmine (USP)|Drug groups [BR:br08330(D00196)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG01132  Physostigmine|D00196  Physostigmine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01132  Physostigmine|D00196  Physostigmine|Target-based classification of drugs [BR:br08310(D00196)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D00196  Physostigmine (USP),
C06536,Harmaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06536  Harmaline,
C06537,Harmalol,,,,,
C06538,Harmine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06538  Harmine,
C06539,Reserpine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06539  Reserpine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00197)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AA Rauwolfia alkaloids|C02AA02 Reserpine|D00197  Reserpine (JP18/USP/INN)|Drug groups [BR:br08330(D00197)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG01737  Rauwolfia alkaloid|D00197  Reserpine|DG01617  Catecholamine synthesis inhibitors|D00197  Reserpine|Transporter inhibitor|DG02867  ABCC2 inhibitor|D00197  Reserpine|Target-based classification of drugs [BR:br08310(D00197)]|Transporters|Solute carrier family|SLC18|SLC18A1 (VMAT1)|D00197  Reserpine (JP18/USP/INN)|SLC18A2 (VMAT2)|D00197  Reserpine (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00197)]|Chemicals|D00197  Reserpine|D00197  Reserpine tablets|D00197  0.1% Reserpine powder|D00197  Reserpine injection|Drug metabolizing enzymes and transporters [br08309.html(D00197)]|Drug transporters|D00197",
C06540,Rescinnamine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06540  Rescinnamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00198)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AA Rauwolfia alkaloids|C02AA01 Rescinnamine|D00198  Rescinnamine (JAN/INN)|Drug groups [BR:br08330(D00198)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG01737  Rauwolfia alkaloid|D00198  Rescinnamine",
C06541,Deserpidine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06541  Deserpidine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08194)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AA Rauwolfia alkaloids|C02AA05 Deserpidine|D08194  Deserpidine (INN)|Drug groups [BR:br08330(D08194)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG01737  Rauwolfia alkaloid|D08194  Deserpidine",
C06542,Ajmaline,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C06542  Ajmaline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06542|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00199)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA05 Ajmaline|D00199  Ajmaline (JP18)|Drug groups [BR:br08330(D00199)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|D00199  Ajmaline|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D00199  Ajmaline|Target-based classification of drugs [BR:br08310(D00199)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00199  Ajmaline (JP18)|SCN2A|D00199  Ajmaline (JP18)|SCN3A|D00199  Ajmaline (JP18)|SCN4A|D00199  Ajmaline (JP18)|SCN5A|D00199  Ajmaline (JP18)|SCN8A|D00199  Ajmaline (JP18)|SCN9A|D00199  Ajmaline (JP18)|SCN10A|D00199  Ajmaline (JP18)|SCN11A|D00199  Ajmaline (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00199)]|Chemicals|D00199  Ajmaline|D00199  Ajmaline tablets|Drug metabolizing enzymes and transporters [br08309.html(D00199)]|Drug metabolizing enzymes|D00199",
C06543,Solanidine,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C06543  Solanidine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C06543  Solanidine,
C06544,Veratridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C06544  Veratridine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C06544  Veratridine,
C06545,Conessine;|Wrightine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C06545  Conessine,
C06546,Mescaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C06546  Mescaline|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C06546,
C06547,Ethylene;|Ethene,,,,,
C06548,Ethylene oxide,,,,Therapeutic category of drugs in Japan [BR:br08301(D03474)]|7  Agents not mainly for therapeutic purpose|73  Public health agents|732  Germicides and disinfectants|7329  Others|D03474  Ethylene oxide|Classification of Japanese OTC drugs [BR:br08313(D03474)]|Agents for sanitation|81 Disinfectants|D03474  Ethylene oxide|Risk category of Japanese OTC drugs [BR:br08312(D03474)]|Second-class OTC drugs|Not used for human|Disinfectants|D03474  Ethylene oxide|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C06548  Ethylene oxide,
C06550,Arsonoacetate,,,,,
C06551,Atrazine,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Triazine herbicides|C06551  Atrazine|Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C06551  Atrazine,
C06552,"Hydroxyatrazine;|4-(Ethylamino)-2-hydroxy-6-(isopropylamino)-1,3,5-triazine",,,,,
C06553,N-Isopropylammelide,,,,,
C06554,Cyanuric acid,,,,,
C06555,Biuret,,,,,
C06556,Deisopropylatrazine,,,,,
C06557,Deisopropylhydroxyatrazine,,,,,
C06558,"N-Ethylammelide;|2,4-Dihydroxy-6-(N'-ethyl)amino-1,3,5-triazine",,,,,
C06559,Deethylatrazine,,,,,
C06560,Deisopropyldeethylatrazine,,,,,
C06561,"Naringenin chalcone;|2',4,4',6'-Tetrahydroxychalcone;|Isosalipurpol;|Chalconaringenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C06561  Naringenin chalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C06561  Naringenin chalcone,
C06562,"(+)-Catechin;|D-Catechin;|Cyanidanol;|(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;|(2R,3S)-Catechin;|(2R,3S)-(+)-Catechin;|Cianidanol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C06562  (+)-Catechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C06562  (+)-Catechin",
C06563,"Genistein;|5,7,4'-Trihydroxyisoflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C06563  Genistein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C06563  Genistein|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06563|Dietary phytochemicals [br08012.html]|Flavonoids|C06563,
C06564,Penicillin N;|Adicillin,,,,,
C06565,Deacetoxycephalosporin C;|DAOC,,,,,
C06566,Cephamycin C,,0 Aad  1 Cys  2 Val,NRP,Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Cephems|C06566  Cephamycin C|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06566,
C06567,Penicilloic acid,Generic compound in reaction hierarchy,,,,
C06568,O-Carbamoyl-deacetylcephalosporin C,,,,,
C06569,7a-Hydroxy-O-carbamoyl-deacetylcephalosporin C,,,,,
C06570,Tetracycline,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Tetracyclines|C06570  Tetracycline|Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06570  Tetracycline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06570|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00201)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB13 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AA Tetracycline and derivatives|D06AA04 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA07 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA09 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA08 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA02 Tetracycline|D00201  Tetracycline (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00201)]|Second-class OTC drugs|Inorganic and organic chemicals|Tetracycline|D00201  Tetracycline (JAN/USP/INN)|Drug groups [BR:br08330(D00201)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00005  Tetracycline|D00201  Tetracycline|Antimicrobials [BR:br08307(D00201)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D00201  Tetracycline (JAN/USP/INN),
C06571,Chlortetracycline;|7-Chlorotetracycline;|Aureomycin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Tetracyclines|C06571  Chlortetracycline|Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06571  Chlortetracycline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06571|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07689)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB21 Chlortetracycline|D07689  Chlortetracycline (INN)|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AA Tetracycline and derivatives|D06AA02 Chlortetracycline|D07689  Chlortetracycline (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA03 Chlortetracycline|D07689  Chlortetracycline (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA02 Chlortetracycline|D07689  Chlortetracycline (INN)|Drug groups [BR:br08330(D07689)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00007  Chlortetracycline|D07689  Chlortetracycline|Antimicrobials [BR:br08307(D07689)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D07689  Chlortetracycline (INN),
C06572,Nystatin,,0 Mak  1 Mtk  2 Mtd  3 Mad  4 Mae  5 Mad  6 Mad  7 Mad  8 Mad|9 Mak  10 Mak  11 Mtk  12 Man  13 Mak  14 Mae  15 Mak  16 Mak|17 Mak  18 Man,PK,"Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C06572  Nystatin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00202)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA02 Nystatin|D00202  Nystatin (JP18/USP/INN) &lt;US&gt;|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA01 Nystatin|D00202  Nystatin (JP18/USP/INN) &lt;US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA01 Nystatin|D00202  Nystatin (JP18/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00202)]|Antifungals|Nystatin|D00202  Nystatin (JP18/USP/INN)|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Nystatin|D00202  Nystatin (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00202)]|Second-class OTC drugs|Inorganic and organic chemicals|Nystatin|D00202  Nystatin (JP18/USP/INN)|Antimicrobials [BR:br08307(D00202)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00202  Nystatin (JP18/USP/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D00202)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00202  Nystatin (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00202)]|Chemicals|D00202  Nystatin",
C06573,Amphotericin B,,0 Mak  1 Mtk  2 Mtd  3 Mad  4 Mad  5 Mad  6 Mad  7 Mad  8 Mad|9 Mak  10 Mak  11 Mtk  12 Man  13 Mak  14 Mak  15 Mae  16 Mak|17 Mak  18 Man,PK,"Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C06573  Amphotericin B|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00203)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB04 Amphotericin B|D00203  Amphotericin B (JP18/USP/INN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA07 Amphotericin B|D00203  Amphotericin B (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA03 Amphotericin B|D00203  Amphotericin B (JP18/USP/INN) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AA Antibiotics|J02AA01 Amphotericin B|D00203  Amphotericin B (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00203)]|Antifungals|Amphotericin B|D00203  Amphotericin B (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00203)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|617  Acting mainly on mold|6173  Amphotericin B|D00203  Amphotericin B (JP18/USP/INN)|Antimicrobials [BR:br08307(D00203)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00203  Amphotericin B (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00203)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00203  Amphotericin B (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00203)]|Chemicals|D00203  Amphotericin B|D00203  Amphotericin B tablets|D00203  Amphotericin B syrup|D00203  Amphotericin B for injection",
C06574,Ampicillin;|Anhydrous ampicillin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Penams|C06574  Ampicillin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00204)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA01 Ampicillin|D00204  Ampicillin (USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA19 Ampicillin|D00204  Ampicillin (USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9761  Antibiotic preparations injection use|C06574  Ampicillin|Prodrugs [br08324.html]|C06574|Drug groups [BR:br08330(D00204)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00517  Ampicillin|D00204  Ampicillin|DG01780  Extended spectrum penicillin|DG00517  Ampicillin|D00204  Ampicillin|Antimicrobials [BR:br08307(D00204)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D00204  Ampicillin (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00204)]|Chemicals|D00204  Anhydrous ampicillin|Prodrugs [br08324.html(D00204)]|D00204",
C06575,p-Cymene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C06575  p-Cymene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06575  p-Cymene,
C06576,p-Cumic alcohol;|4-Isopropylbenzyl alcohol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06576  p-Cumic alcohol,
C06577,4-Isopropylbenzaldehyde;|p-Cumic aldehyde;|Cuminaldehyde,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C06577  p-Cumic aldehyde,
C06578,p-Cumate,,,,,
C06579,"cis-2,3-Dihydroxy-2,3-dihydro-p-cumate;|cis-5,6-Dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate;|(2R,3S)-2,3-Dihydroxy-2,3-dihydro-p-cumate",,,,,
C06580,"2,3-Dihydroxy-p-cumate",,,,,
C06581,"2-Hydroxy-3-carboxy-6-oxo-7-methylocta-2,4-dienoate",,,,,
C06582,"2-Hydroxy-6-oxo-7-methylocta-2,4-dienoate",,,,,
C06584,4-Chlorobiphenyl;|1-Chloro-4-phenyl benzene;|4-Monochloro-biphenyl,,,,,
C06585,"cis-2,3-Dihydro-2,3-dihydroxy-4'-chlorobiphenyl",,,,,
C06586,"2,3-Dihydroxy-4'-chlorobiphenyl",,,,,
C06587,"2-Hydroxy-6-oxo-6-(4'-chlorophenyl)-hexa-2,4-dienoate",,,,,
C06588,"Biphenyl;|Phenylbenzene;|1,1'-Biphenyl;|1,1'-Diphenyl",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C06588  Biphenyl,
C06589,"cis-2,3-Dihydro-2,3-dihydroxybiphenyl;|cis-3-Phenylcyclohexa-3,5-diene-1,2-diol;|(1S,2R)-3-Phenylcyclohexa-3,5-diene-1,2-diol",,,,,
C06592,NDP-N-methyl-L-glucosamine,Generic compound in reaction hierarchy,,,,
C06593,epsilon-Caprolactam,,,,,
C06594,"1,2,4-Trichlorobenzene;|Trichlorobenzene A",,,,,
C06596,gamma-Pentachlorocyclohexene,,,,,
C06597,"1,3,4,6-Tetrachloro-1,4-cyclohexadiene",,,,,
C06598,"2,4,5-Trichloro-2,5-cyclohexadiene-1-ol;|1-Hydroxyl-2,4,5-trichloro-2,5-cyclohexadiene",,,,,
C06599,"2,5-Dichloro-2,5-cyclohexadiene-1,4-diol;|1,4-Dihydroxyl-2,5-dichloro-2,5-cyclohexadiene",,,,,
C06600,"2,5-Dichlorohydroquinone;|2,5-Dichloro-1,4-benzenediol",,,,,
C06601,"Chlorohydroquinone;|1,4-Dihydroxyl-2-chlorobenzene;|Chloroquinol",,,,,
C06602,"2,5-Dichlorophenol;|2,5-DCP",,,,,
C06603,"cis,cis-4-Hydroxymuconic semialdehyde;|4-Hydroxymuconic semialdehyde",,,,,
C06604,"Parathion;|O,O-Diethyl O-p-nitrophenyl phosphorothioate;|Thiophos;|DNTP",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C06604  Parathion|Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C06604  Parathion,
C06605,Aminoparathion,,,,,
C06606,"Paraoxon;|O,O-Diethyl-O-p-nitrophenylphosphoric acid",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10529)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB10 Paraoxon|D10529  Paraoxon|Drug groups [BR:br08330(D10529)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D10529  Paraoxon|Target-based classification of drugs [BR:br08310(D10529)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D10529  Paraoxon,
C06607,Diethylthiophosphoric acid;|DETP,,,,,
C06608,"Diethylphosphoric acid;|O,O-Diethylphosphoric acid",,,,,
C06609,"trans-1,3-Dichloropropene;|trans-3-Chloroallyl chloride",,,,,
C06610,"cis-1,3-Dichloropropene",,,,,
C06611,trans-3-Chloro-2-propene-1-ol;|trans-3-Chloroallyl alcohol,,,,,
C06612,cis-3-Chloro-2-propene-1-ol;|cis-3-Chloroallyl alcohol,,,,,
C06613,trans-3-Chloroallyl aldehyde;|trans-3-Chloro-2-propenal,,,,,
C06614,trans-3-Chloroacrylic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C06614  trans-3-Chloroacrylic acid,
C06615,cis-3-Chloroacrylic acid,,,,,
C06616,Erythromycin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06616  Erythromycin C,
C06620,"dTDP-3,4-dioxo-2,6-dideoxy-D-glucose;|dTDP-3,4-didehydro-2,6-dideoxy-alpha-D-glucose",,,,,
C06622,"dTDP-4-oxo-2,6-dideoxy-L-allose",,,,,
C06624,Oxytetracycline;|Oxytetracycline anhydrous,,,,"Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06624  Oxytetracycline|Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C06624  Oxytetracycline|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB25 Oxytetracycline|C06624  Oxytetracycline|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AA Tetracycline and derivatives|D06AA03 Oxytetracycline|C06624  Oxytetracycline|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA07 Oxytetracycline|C06624  Oxytetracycline|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA06 Oxytetracycline|C06624  Oxytetracycline|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA04 Oxytetracycline|C06624  Oxytetracycline|Drug groups [BR:br08330]|Antibacterial|DG01197  Tetracycline antibiotic|DG00397  Oxytetracycline|C06624  Oxytetracycline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06624",G00397
C06625,Malonamoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06625  Malonamoyl-CoA,
C06626,4-Ketoanhydrochlortetracycline;|4-Ketoanhydro-7-chlorotetracycline;|4-Oxoanhydrochlortetracycline;|4-Dedimethylamine-4-oxo-anhydro-7-Cl-tetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06626  4-Dedimethylamine-4-oxo-anhydro-7-Cl-tetracycline,
C06627,"4-Keto-anhydrotetracycline;|4-Ketoanhydrotetracycline;|4-Keto-ATC;|4-Dedimethylamino-4-oxo-anhydrotetracycline;|4-De(dimethylamino)-4-oxoanhydrotetracycline;|(4aR,12aS)-3,10,11,12a-Tetrahydroxy-6-methyl-1,4,12-trioxo-4a,5-dihydrotetracene-2-carboxamide",,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06627  4-Dedimethylamino-4-oxo-anhydrotetracycline,
C06628,"4-Hydroxy-6-methylpretetramide;|1,3,4,10,11,12-Hexahydroxy-6-methyltetracene-2-carboxamide",,,,,
C06629,"6-Methylpretetramide;|1,3,10,11,12-Pentahydroxy-6-methyltetracene-2-carboxamide",,,,,
C06630,"3-O-alpha-Mycarosylerythronolide B;|3-alpha-L-Mycarosylerythronolide B;|4-(4,5-Dihydroxy-4,6-dimethyl-tetrahydro-pyran-2-yloxy)-14-ethyl-6,7,12-trihydroxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06630  3-O-alpha-Mycarosylerythronolide B,
C06633,Erythromycin D,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06633  Erythromycin D,
C06634,Erythromycin E,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06634  Erythromycin E,
C06635,Erythronolide B,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06635  Erythronolide B,
C06636,"TDE;|DDD;|1,1-Dichloro-2,2-bis(4'-chlorophenyl)ethane;|Dichlorodiphenyldichloroethane",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C06636  DDD,
C06637,"1-Chloro-2,2-bis(4'-chlorophenyl)ethylene;|DDMU",,,,,
C06638,"1-Chloro-2,2-bis(4'-chlorophenyl)ethane;|DDMS",,,,,
C06639,"2,2-Bis(4'-chlorophenyl)ethanol;|DDOH",,,,,
C06640,Bis(4'-chlorophenyl)acetate;|DDA,,,,,
C06641,Bis(4'-chlorophenyl)methane;|DDM,,,,,
C06642,unsym-Bis(4'-chlorophenyl)ethylene;|DDNU,,,,,
C06643,"4,4'-Dichlorobenzophenone;|DBP",,,,,
C06644,"1,1-Dichloro-2-(dihydroxy-4'-chlorophenyl)-2-(4'-chlorophenyl)ethylene;|3-[2,2-Dichloro-1-(4-chlorophenyl)vinyl]-6-chlorobenzene-1,2-diol;|2,3-Dihydroxy-DDE",,,,,
C06645,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8-trichloroocta-2E,4E,7E-trienoate",,,,,
C06646,"2-(4'-Chlorophenyl)-3,3-dichloropropenoate",,,,,
C06647,4-Chloroacetophenone;|p-Chloroacetophenone,,,,,
C06648,4-Chlorobenzaldehyde,,,,,
C06649,"cis-2,3-Dihydrodiol 1,1,1-trichloro-2,2-bis(4'-chlorophenyl)ethane;|cis-2,3-Dihydrodiol DDT",,,,,
C06650,"2,3-Dihydroxy-1,1,1-trichloro-2,2-bis(4'-chlorophenyl)ethane;|2,3-Dihydroxy-DDT",,,,,
C06651,"6-Oxo-2-hydroxy-7-(4'-chlorophenyl)-3,8,8,8-tetrachloroocta-2E,4E-dienoate",,,,,
C06653,Erythromycin B;|Berythromycin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06653  Erythromycin B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06653|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03098)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF02 Erythromycin|D03098  Berythromycin (USAN/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA01 Erythromycin|D03098  Berythromycin (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA17 Erythromycin|D03098  Berythromycin (USAN/INN)|Drug groups [BR:br08330(D03098)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00436  Erythromycin|D03098  Berythromycin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00436  Erythromycin|D03098  Berythromycin|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00436  Erythromycin|D03098  Berythromycin|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00436  Erythromycin|D03098  Berythromycin|Antimicrobials [BR:br08307(D03098)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D03098  Berythromycin (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D03098)]|Drug metabolizing enzymes|D03098|Drug transporters|D03098",
C06654,4-Amino-anhydrotetracycline;|4-Amino-ATC;|4-Dedimethyl-6-dehydro-anhydrotetracycline;|4-Amino-4-de(dimethylamino)anhydrotetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06654  4-Dedimethyl-6-dehydro-anhydrotetracycline,
C06655,L-N2-(2-Carboxyethyl)arginine;|N2-(2-Carboxyethyl)-L-arginine,,,,,
C06656,Deoxyguanidinoproclavaminic acid;|Deoxyguanidinoproclavaminate;|Deoxyamidinoproclavaminate,,,,,
C06657,Guanidinoproclavaminic acid;|Guanidinoproclavaminate;|Amidinoproclavaminate,,,,,
C06658,Proclavaminic acid;|Proclavaminate,,,,,
C06659,Dihydroclavaminic acid;|Dihydroclavaminate,,,,,
C06660,Clavaminic acid;|Clavaminate,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06660,
C06661,Clavulanate-9-aldehyde,,,,,
C06662,Clavulanic acid;|Clavulanate,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Clavams|C06662  Clavulanic acid|Drug groups [BR:br08330(D07711)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01487  Clavam|DG01261  Clavulanic acid|D07711  Clavulanic acid|DG01479  beta-Lactamase inhibitor|DG01261  Clavulanic acid|D07711  Clavulanic acid|Antimicrobials [BR:br08307(D07711)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Beta-lactamase inhibitor|D07711  Clavulanic acid (INN)",
C06663,Olivanic acid,,,,,
C06664,Thienamycin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Carbapenems|C06664  Thienamycin,
C06665,Imipenem;|Imipenem anhydrous,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Carbapenems|C06665  Imipenem|Drug groups [BR:br08330(D04515)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01458  Carbapenem|DG01212  Imipenem|D04515  Imipenem|Antimicrobials [BR:br08307(D04515)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Carbapenem|D04515  Imipenem (INN)",
C06667,Clavamycin A,,,,,
C06668,Valclavam,,,,,
C06669,(5R)-Carbapen-2-em-3-carboxylate;|1-Carbapen-2-em-3-carboxylic acid;|(5R)-Carbapenem-3-carboxylic acid;|(5R)-Carbapenem-3-carboxylate;|(5R)-7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06669,
C06670,"2,4-Dichlorobenzoate;|2,4-Dichlorobenzoic acid",,,,,
C06671,"2,4-Dichlorobenzoyl-CoA",,,,,
C06672,Vanillate;|Vanillic acid;|4-Hydroxy-3-methoxybenzoate;|4-Hydroxy-3-methoxybenzoic acid,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C06672,
C06673,4-Carboxy-4'-sulfoazobenzene,,,,,
C06674,4-Sulfocatechol,,,,,
C06675,3-Sulfomuconate,,,,,
C06676,4-Sulfolactone;|4-Carboxymethyl-4-sulfobut-2-en-4-olide;|4-Sulfomuconolactone,,,,,
C06677,Toluene-4-sulfonate;|Tosylate,,,,,
C06678,4-Sulfobenzyl alcohol;|4-(Hydroxymethyl)benzenesulfonate,,,,,
C06679,4-Sulfobenzaldehyde;|4-Formylbenzenesulfonate,,,,,
C06680,4-Hydroxyphthalate,,,,,
C06681,Mitomycin;|Mitomycin C,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Others|Quinones|C06681  Mitomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00208)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DC Other cytotoxic antibiotics|L01DC03 Mitomycin|D00208  Mitomycin (USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00208)]|Antineoplastics|Antineoplastics, Other|Mitomycin|D00208  Mitomycin (USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00208)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1317  Ophthalmic antibiotics|D00208  Mitomycin (USP/INN); Mitomycin C (JP18)|4  Agents affecting cellular function|42  Antineoplastics|423  Antibiotics|4231  Mytomycin C|D00208  Mitomycin (USP/INN); Mitomycin C (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00208)]|Chemicals|D00208  Mitomycin C|D00208  Mitomycin C for injection",
C06682,DL-Cycloserine,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Amino acid derivatives|C06682  Cycloserine,
C06683,Ceftriaxone,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Cephems|C06683  Ceftriaxone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07659)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD04 Ceftriaxone|D07659  Ceftriaxone (INN)|Drug groups [BR:br08330(D07659)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00573  Ceftriaxone|D07659  Ceftriaxone|DG01776  Third-generation cephalosporin|DG00573  Ceftriaxone|D07659  Ceftriaxone|DG01804  Oxyimino beta-lactam|DG00573  Ceftriaxone|D07659  Ceftriaxone|Antimicrobials [BR:br08307(D07659)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07659  Ceftriaxone (INN)",
C06684,Valinomycin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C06684  Valinomycin,
C06685,Cycloheximide,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Cycloalkane derivatives|C06685  Cycloheximide|Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Antibiotic fungicides|C06685  Cycloheximide,
C06686,Griseofulvin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Other polyketides|C06686  Griseofulvin|Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C06686  Griseofulvin|Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Antibiotic fungicides|C06686  Griseofulvin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00209)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA08 Griseofulvin|D00209  Griseofulvin (JAN/USP/INN) &lt;US&gt;|D01B ANTIFUNGALS FOR SYSTEMIC USE|D01BA Antifungals for systemic use|D01BA01 Griseofulvin|D00209  Griseofulvin (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00209)]|Antifungals|Griseofulvin|D00209  Griseofulvin (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00209)]|Second-class OTC drugs|Inorganic and organic chemicals|Griseofulvin|D00209  Griseofulvin (JAN/USP/INN)|Antimicrobials [BR:br08307(D00209)]|Antifungals|Mitosis inhibitor|Griseofulvin|D00209  Griseofulvin (JAN/USP/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D00209)]|Antifungals|Mitosis inhibitor|Griseofulvin|D00209  Griseofulvin (JAN/USP/INN)",
C06687,Norfloxacin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Quinolones|Fluoroquinolones|C06687  Norfloxacin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00210)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA06 Norfloxacin|D00210  Norfloxacin (JP18/USP/INN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE02 Norfloxacin|D00210  Norfloxacin (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00210)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00210  Norfloxacin (JP18/USP/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D00210  Norfloxacin (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9734  Quinolone, derivatives and preparations|C06687  Norfloxacin|Drug groups [BR:br08330(D00210)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00620  Norfloxacin|D00210  Norfloxacin|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00620  Norfloxacin|D00210  Norfloxacin|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00620  Norfloxacin|D00210  Norfloxacin|DG02852  CYP3A/CYP3A4 inhibitor|DG00620  Norfloxacin|D00210  Norfloxacin|Drug classes [BR:br08332(D00210)]|Antibacterial|DG01549  Fluoroquinolone|D00210  Norfloxacin|Antimicrobials [BR:br08307(D00210)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00210  Norfloxacin (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00210)]|Chemicals|D00210  Norfloxacin|Drug metabolizing enzymes and transporters [br08309.html(D00210)]|Drug metabolizing enzymes|D00210",
C06688,Rifampicin;|Rifampin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Ansamycins|C06688  Rifampicin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00211)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB02 Rifampicin|D00211  Rifampin (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00211)]|Antimycobacterials|Antituberculars|Rifampin|D00211  Rifampin (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00211)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|616  Acting mainly on acid-fast bacteria|6164  Rifampicins|D00211  Rifampin (USP); Rifampicin (JP18/INN)|Drug groups [BR:br08330(D00211)]|Antibacterial|DG01966  Antitubercular|DG01598  Rifamycin antibiotic|DG00639  Rifampicin|D00211  Rifampin|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00639  Rifampicin|D00211  Rifampin|DG03195  UGT inducer|DG00639  Rifampicin|D00211  Rifampin|Transporter inhibitor|DG02865  SLCO1B1 inhibitor|DG00639  Rifampicin|D00211  Rifampin|DG02907  SLCO1B3 inhibitor|DG00639  Rifampicin|D00211  Rifampin|Transporter inducer|DG01893  ABCB1 inducer|DG00639  Rifampicin|D00211  Rifampin|Antimicrobials [BR:br08307(D00211)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D00211  Rifampin (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00211)]|Chemicals|D00211  Rifampicin|D00211  Rifampicin capsules|Drug metabolizing enzymes and transporters [br08309.html(D00211)]|Drug metabolizing enzymes|D00211|Drug transporters|D00211,
C06689,Vancomycin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C06689  Vancomycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06689|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00212)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA09 Vancomycin|D00212  Vancomycin (USP) &lt;US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XA Glycopeptide antibacterials|J01XA01 Vancomycin|D00212  Vancomycin (USP) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA28 Vancomycin|D00212  Vancomycin (USP) &lt;US&gt;|Drug groups [BR:br08330(D00212)]|Antibacterial|DG01580  Glycopeptide antibiotic|DG00086  Vancomycin|D00212  Vancomycin|Antimicrobials [BR:br08307(D00212)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Glycopeptide|D00212  Vancomycin (USP) &lt;US&gt;",
C06690,Candicidin D;|FR-008-III,,0 Abe  1 Mak  2 Mte  3 Mtk  4 Mtd  5 Mad  6 Mad  7 Mad  8 Mad|9 Mad  10 Mad  11 Mak  12 Mak  13 Mtk  14 Man  15 Mak  16 Mak|17 Mae  18 Man  19 Mae  20 Man  21 Man,PK,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Macrolides|C06690  Candicidin D|Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C06690  Candicidin D,
C06691,Actinorhodin;|Actinorhodine,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Other polyketides|C06691  Actinorhodine|Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C06691  Actinorhodin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06691,
C06692,Polyoxin B,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Peptide nucleosides|C06692  Polyoxin B,
C06693,Monensin;|Monensin A,,0 Man  1 Mte  2 Mtd  3 Mae  4 Mtd  5 Ete  6 Mad  7 Mte  8 Man|9 Mak  10 Mtk  11 Mtk  12 Mtn,PK,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Other polyketides|C06693  Monensin|Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C06693  Monensin A,
C06694,Fusidic acid,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Steroids|C06694  Fusidic acid|Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010604 Prostostane and fusidane triterpenoids|C06694  Fusidic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04281)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX01 Fusidic acid|D04281  Fusidic acid (USAN/INN)|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA02 Fusidic acid|D04281  Fusidic acid (USAN/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XC Steroid antibacterials|J01XC01 Fusidic acid|D04281  Fusidic acid (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA13 Fusidic acid|D04281  Fusidic acid (USAN/INN)|Antimicrobials [BR:br08307(D04281)]|Antibacterials|Protein biosynthesis inhibitor|Other protein biosynthesis inhibitor|D04281  Fusidic acid (USAN/INN),
C06695,2-Oxazolidinone,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Cyclic lactones|C06695  2-Oxazolidinone,
C06696,Lead;|Pb,Lead and lead compounds|Usually existing as +2 cations,,,,
C06697,Arsenite;|Trisoxylatoarsine,,,,,
C06701,Phosphonic acid;|Phosphonate;|Phosphorous acid;|Phosphite,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C06701  Phosphonate,
C06710,Silver;|Argentum;|Ag,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AL Silver compounds|D08AL30 Silver|C06710  Silver,
C06711,Fluoren-9-ol;|9-Fluorenol;|9-Hydroxyfluorene;|Diphenylene carbinol,,,,,
C06712,Fluoren-9-one;|9-Fluorenone,,,,,
C06714,3-Hydroxypimeloyl-CoA;|3-Hydroxypimelyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06714  3-Hydroxypimeloyl-CoA,
C06715,3-Oxopimeloyl-CoA;|3-Ketopimelyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06715  3-Oxopimeloyl-CoA,
C06717,Mycothiol,,,,,G11174
C06718,S-Formylmycothiol,,,,,
C06719,Dihydrophloroglucinol,,,,,
C06720,"1,6-Dihydroxy-5-methylcyclohexa-2,4-dienecarboxylate;|1,2-Dihydroxy-3-methylcyclohexa-3,5-dienecarboxylate",,,,,
C06721,"cis-1,2-Dihydroxy-1,2-dihydrodibenzothiophene",,,,,
C06722,"1,2-Dihydroxydibenzothiophene",,,,,
C06723,"6-Carboxyhex-2-enoyl-CoA;|2,3-Didehydro-pimeloyl-CoA",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06723  6-Carboxyhex-2-enoyl-CoA,
C06725,"5,6-Dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline",,,,,
C06726,"5,6-Dihydroxy-3-methyl-2-oxo-1,2,5,6-tetrahydroquinoline",,,,,
C06727,"cis-1,2-Dihydro-3-ethylcatechol;|cis-2,3-Dihydroxy-2,3-dihydroethylbenzene;|cis-3-Ethyl-cyclohexa-3,5-diene-1,2-diol",,,,,
C06728,"3-Ethylcatechol;|2,3-Dihydroxyethylbenzene;|3-Ethyl-benzene-1,2-diol",,,,,
C06729,"cis-1,2-Dihydroxy-4-methylcyclohexa-3,5-diene-1-carboxylate;|4-Methylcyclohexa-3,5-diene-1,2-cis-diol-1-carboxylic acid",,,,,
C06730,"4-Methylcatechol;|3,4-Dihydroxytoluene;|1,2-Dihydroxy-4-methylbenzene;|4-Methyl-1,2-benzenediol",,,,,
C06731,"1,2-Dihydroxy-6-methylcyclohexa-3,5-dienecarboxylate",,,,,
C06732,"alpha,beta-Didehydrotryptophan",,,,,
C06733,8'-apo-beta-Carotenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C06733  8'-apo-beta-Carotenol,
C06734,14'-apo-beta-Carotenal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C06734  14'-apo-beta-Carotenal,
C06735,Aminoacetaldehyde;|2-Aminoacetaldehyde,,,,,
C06736,(E)-11-Tetradecenoyl-CoA;|(11E)-Tetradecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06736  (11E)-Tetradecenoyl-CoA,
C06737,(Z)-11-Tetradecenoyl-CoA;|(11Z)-Tetradecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06737  (11Z)-Tetradecenoyl-CoA,
C06738,cis-p-Coumarate,,,,,
C06739,4'-O-beta-D-Glucosyl-cis-p-coumarate,,,,,
C06740,Glucosyl-limonin;|Limonin 17-O-beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C06740  Glucosyl-limonin,
C06742,2'-Hydroxybiphenyl-2-sulfinate;|2-(2-Hydroxyphenyl)benzenesulfinate,,,,,
C06743,Poly(ADPribose),,,,,
C06746,N-(2-Phenylethyl)-acetamide;|N-Acetylphenylethylamine;|N-Acetyl-2-phenylethylamine,,,,,
C06747,Phenylmethanesulfonyl fluoride;|Benzenemethanesulfonyl fluoride;|PMSF,,,,,
C06748,Isopropylamine;|2-Aminopropane;|Monoisopropylamine;|2-Propanamine,,,,,
C06749,6-Hydroxycyclohex-1-ene-1-carbonyl-CoA;|6-Hydroxycyclohex-1-enecarbonyl-CoA;|6-Hydroxycyclohex-1-ene-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C06749  6-Hydroxycyclohex-1-ene-1-carbonyl-CoA,
C06751,Prenyl-L-cysteine;|S-Prenyl-L-cysteine,"Generic compound in reaction hierarchy|S-(2E,6E)-Farnesyl-L-cysteine (n=3) [CPD:C19691]",,,,
C06752,"1,2-Dichloroethane;|Ethylene dichloride;|Glycol dichloride;|Dutch liquid",,,,,
C06753,2-Chloroethanol;|Ethylene chlorohydrin;|Glycol chlorohydrin,,,,,
C06754,Chloroacetaldehyde;|2-Chloroethanal,,,,,
C06755,Chloroacetic acid;|Chloroethanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C06755  Chloroacetic acid|Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C06755  Chloroacetic acid,
C06756,"p-Xylene;|1,4-Dimethylbenzene;|p-Methyltoluene",,,,,
C06757,4-Methylbenzyl alcohol;|alpha-Hydroxy-p-xylene;|4-Tolylcarbinol,,,,,
C06758,p-Tolualdehyde;|p-Methylbenzaldehyde;|4-Methylbenzaldehyde;|4-Toluylaldehyde;|p-Formyltoluene,,,,,
C06760,"2-Hydroxy-5-methyl-cis,cis-muconic semialdehyde;|(2E,4Z)-2-Hydroxy-5-methyl-6-oxohexa-2,4-dienoate",,,,,
C06761,(4E)-2-Oxohexenoic acid;|2-Oxohex-trans-4-enoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C06761  (4E)-2-Oxohexenoic acid,
C06762,4-Hydroxy-2-oxohexanoic acid;|4-Hydroxy-2-oxohexanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C06762  4-Hydroxy-2-oxohexanoic acid,
C06763,Nojirimycin;|5-Amino-5-deoxy-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Pure sugars|C06763  Nojirimycin,
C06764,Tetranactin,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Other polyketides|C06764  Tetranactin,
C06765,Flavomycin;|Bambermycin;|Moenomycin A,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Others|Glycolipids|C06765  Flavomycin,
C06767,Hemine;|Hemin,,,,,
C06769,Vibriobactin,,0 DHBA  1 Thr,NRP,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06769,
C06770,Actinomycin D;|Dactinomycin,This sequence is NRPS assembly line of the actinomycin half-molecule.|5 Val is modified by N-methyl. (i.e. N-Methyl-L-valine),"0 4MHA  1 Thr  2 D-Val  3 Pro  4 Sar  5 Val|(Cyclization: 1-5, Dimer)",NRP,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C06770  Actinomycin D|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00214)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DA Actinomycines|L01DA01 Dactinomycin|D00214  Dactinomycin (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00214)]|Antineoplastics|Antineoplastics, Other|Dactinomycin|D00214  Dactinomycin (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00214)]|4  Agents affecting cellular function|42  Antineoplastics|423  Antibiotics|4233  Actinomycin D|D00214  Dactinomycin (USP); Actinomycin D (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00214)]|Chemicals|D00214  Actinomycin D",
C06771,Triethanolamine;|Trolamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00215)]|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX12 Trolamine|D00215  Trolamine (NF),
C06772,Diethanolamine,,,,,
C06773,11-O-Demethylpradinone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06773  11-O-Demethylpradinone II,
C06774,11-O-Demethyl-7-methoxypradinone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06774  11-O-Demethyl-7-methoxypradinone II,
C06775,11-O-Demethylpradinone I,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06775  11-O-Demethylpradinone I,
C06776,11-O-Demethylpradimicinone I,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06776  11-O-Demethylpradimicinone I,
C06777,Pradimicinone I,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06777  Pradimicinone I,
C06778,11-O-Demethylpradimicinone II;|Benamicin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06778  11-O-Demethylpradimicinone II,
C06779,11-O-Demethyl-7-methoxypradimicinone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06779  11-O-Demethyl-7-methoxypradimicinone II,
C06780,Pradimicinone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06780  Pradimicinone II,
C06781,7-Methoxypradimicinone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06781  7-Methoxypradimicinone II,
C06782,7-Hydroxylpradimicin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06782  7-Hydroxylpradimicin A,
C06783,Pradimicin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06783  Pradimicin B,
C06784,Pradimicin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06784  Pradimicin A,
C06785,Dexylosylpradimicin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06785  Dexylosylpradimicin C,
C06786,Pradimicin C;|Benanomicin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06786  Pradimicin C,
C06787,Dexylosylbenanomicin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06787  Dexylosylbenanomicin A,
C06788,Benanomicin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06788  Benanomicin A,
C06789,Tetrachloroethene;|Perchloroethylene;|PCE,,,,,
C06790,Trichloroethene;|Trichloroethylene;|TCE,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB05 Trichloroethylene|C06790  Trichloroethene",
C06791,"trans-1,2-Dichloroethene;|trans-Acetylene dichloride",,,,,
C06792,"cis-1,2-Dichloroethene;|cis-Acetylene dichloride",,,,,
C06793,Vinyl chloride;|Chloroethylene,,,,,
C06799,Granaticin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C06799  Granaticin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06799,
C06800,Aflatoxin B1,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C06800  Aflatoxin B1|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Aflatoxins|C06800  Aflatoxin B1|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06800,
C06801,Tetracenomycin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06801  Tetracenomycin C|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06801,
C06802,Acarbose,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00216)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BF Alpha glucosidase inhibitors|A10BF01 Acarbose|D00216  Acarbose (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00216)]|Blood Glucose Regulators|Antidiabetic Agents|Glucose Control Agents, Other|Acarbose|D00216  Acarbose (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00216)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3969  Others|D00216  Acarbose (JAN/USAN/INN)|Drug groups [BR:br08330(D00216)]|Antidiabetic agent|DG02044  Hypoglycemic agent|DG01663  alpha-Glucosidase inhibitor|D00216  Acarbose|Drug classes [BR:br08332(D00216)]|Antidiabetic agent|DG01663  alpha-Glucosidase inhibitor|D00216  Acarbose|DG02044  Hypoglycemic agent|D00216  Acarbose|Target-based classification of drugs [BR:br08310(D00216)]|Enzymes|Hydrolases (EC3)|Glycosidases|AMY|D00216  Acarbose (JAN/USAN/INN) &lt;JP/US&gt;|GAA|D00216  Acarbose (JAN/USAN/INN) &lt;JP/US&gt;|GANC|D00216  Acarbose (JAN/USAN/INN) &lt;JP/US&gt;|MGAM|D00216  Acarbose (JAN/USAN/INN) &lt;JP/US&gt;|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06802",
C06803,Acebutolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02338)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB04 Acebutolol|D02338  Acebutolol (USAN/INN)|Drug groups [BR:br08330(D02338)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00314  Acebutolol|D02338  Acebutolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00314  Acebutolol|D02338  Acebutolol|Target-based classification of drugs [BR:br08310(D02338)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D02338  Acebutolol (USAN/INN)",
C06804,Acetaminophen;|Paracetamol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00217)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BE Anilides|N02BE01 Paracetamol|D00217  Acetaminophen (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00217)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1141  Anilines|D00217  Acetaminophen (JP18/USP); Paracetamol (INN)|Classification of Japanese OTC drugs [BR:br08313(D00217)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00217  Acetaminophen (JP18/USP)|03 Antipyretic analgesic agents|D00217  Acetaminophen (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00217)]|Second-class OTC drugs|Inorganic and organic chemicals|Acetaminophen|D00217  Acetaminophen (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C06804  Acetaminophen|Prodrugs [br08324.html]|C06804|Drug groups [BR:br08330(D00217)]|Anti-inflammatory|DG01981  Anilide derivative, anti-inflammatory|D00217  Acetaminophen|Target-based classification of drugs [BR:br08310(D00217)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00217  Acetaminophen (JP18/USP) &lt;JP/US&gt;|PTGS2 (COX2)|D00217  Acetaminophen (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00217)]|Chemicals|D00217  Acetaminophen|Prodrugs [br08324.html(D00217)]|D00217|Rx-to-OTC switch list in the USA [br08315.html(D00217)]|D00217",
C06805,Acetazolamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00218)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EC Carbonic anhydrase inhibitors|S01EC01 Acetazolamide|D00218  Acetazolamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00218)]|Cardiovascular Agents|Cardiovascular Agents, Other|Acetazolamide|D00218  Acetazolamide (JP18/USP/INN)|Ophthalmic Agents|Intraocular Pressure Lowering Agents|Carbonic Anhydrase Inhibitors, Ophthalmic|Acetazolamide|D00218  Acetazolamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00218)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2134  Carbonic anhydrase inhibitors|D00218  Acetazolamide (JP18/USP/INN)|Drug groups [BR:br08330(D00218)]|Cardiovascular agent|DG01534  Carbonic anhydrase inhibitor|DG01134  Acetazolamide|D00218  Acetazolamide|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01134  Acetazolamide|D00218  Acetazolamide|Drug classes [BR:br08332(D00218)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00218  Acetazolamide|Target-based classification of drugs [BR:br08310(D00218)]|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA|D00218  Acetazolamide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00218)]|Chemicals|D00218  Acetazolamide",
C06806,Acetohexamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00219)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BB Sulfonylureas|A10BB31 Acetohexamide|D00219  Acetohexamide (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00219)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3961  Sulfonylureas|D00219  Acetohexamide (JP18/USP/INN)|Drug groups [BR:br08330(D00219)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01734  Sulfonylurea|D00219  Acetohexamide|DG02044  Hypoglycemic agent|DG01734  Sulfonylurea|D00219  Acetohexamide|Drug classes [BR:br08332(D00219)]|Antidiabetic agent|DG01734  Sulfonylurea|D00219  Acetohexamide|DG02044  Hypoglycemic agent|D00219  Acetohexamide|Target-based classification of drugs [BR:br08310(D00219)]|Transporters|ABC transporters|ABCC subfamily|ABCC8 (SUR1)|D00219  Acetohexamide (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00219)]|Chemicals|D00219  Acetohexamide",
C06807,Acetophenazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB07 Acetophenazine|C06807  Acetophenazine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00878  Acetophenazine|C06807  Acetophenazine,G00878
C06808,Acetohydroxamic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00220)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX03 Acetohydroxamic acid|D00220  Acetohydroxamic acid (USP/INN) &lt;US&gt;,
C06809,Acetylcysteine;|N-Acetyl-L-cysteine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00221)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS|R05CB Mucolytics|R05CB01 Acetylcysteine|D00221  Acetylcysteine (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA08 Acetylcysteine|D00221  Acetylcysteine (JP18/USP/INN) &lt;JP/US&gt;|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB23 Acetylcysteine|D00221  Acetylcysteine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00221)]|Respiratory Tract/Pulmonary Agents|Respiratory Tract Agents, Other|Acetylcysteine|D00221  Acetylcysteine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00221)]|2  Agents affecting individual organs|22  Respiratory organ agents|223  Expectorants|2233  Cysteines|D00221  Acetylcysteine (JP18/USP/INN)|26  Epidermides|269  Miscellaneous|2699  Others|D00221  Acetylcysteine (JP18/USP/INN)|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3929  Others|D00221  Acetylcysteine (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00221)]|Chemicals|D00221  Acetylcysteine",
C06810,Aciclovir;|Acyclovir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00222)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BB Antivirals|D06BB03 Aciclovir|D00222  Acyclovir (USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB01 Aciclovir|D00222  Acyclovir (USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AD Antivirals|S01AD03 Aciclovir|D00222  Acyclovir (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00222)]|Antivirals|Antiherpetic Agents|Acyclovir|D00222  Acyclovir (USP)|Dermatological Agents|Topical Anti-infectives|Antivirals, dermatological|Acyclovir|D00222  Acyclovir (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00222)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00222  Acyclovir (USP); Aciclovir (JP18/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00222  Acyclovir (USP); Aciclovir (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00222)]|Agents for integumentary system|91 Antivirals|D00222  Acyclovir (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00222)]|First-class OTC drugs|Inorganic and organic chemicals|Aciclovir|D00222  Acyclovir (USP)|Drug groups [BR:br08330(D00222)]|Antiviral|DG02840  Anti-herpesvirus agent|DG00406  Aciclovir|D00222  Acyclovir|Transporter substrate|DG02858  SLC22A1 substrate|DG00406  Aciclovir|D00222  Acyclovir|DG02859  SLC22A6 substrate|DG00406  Aciclovir|D00222  Acyclovir|DG02860  SLC22A8 substrate|DG00406  Aciclovir|D00222  Acyclovir|Drug classes [BR:br08332(D00222)]|Antiviral|DG02840  Anti-herpesvirus agent|D00222  Acyclovir|Antimicrobials [BR:br08307(D00222)]|Antivirals|Genome replication inhibitor|Herpesvirus DNA polymerase inhibitor|D00222  Acyclovir (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00222)]|Chemicals|D00222  Aciclovir|D00222  Aciclovir tablets|D00222  Aciclovir granules|D00222  Aciclovir syrup|D00222  Aciclovir for syrup|D00222  Aciclovir injection|D00222  Aciclovir for injection|D00222  Aciclovir ophthalmic oinment|D00222  Aciclovir ointment|Drug metabolizing enzymes and transporters [br08309.html(D00222)]|Drug transporters|D00222|Prodrugs [br08324.html(D00222)]|D00222|Rx-to-OTC switch list in Japan [br08314.html(D00222)]|D00222|Prodrugs [br08324.html]|C06810",
C06812,Lincomycin,,,,"Glycosides [BR:br08021]|S-glycosides|C06812  Lincomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00223)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FF Lincosamides|J01FF02 Lincomycin|D00223  Lincomycin (USAN/INN)|Drug groups [BR:br08330(D00223)]|Antibacterial|DG01578  Lincosamide antibiotic|DG00607  Lincomycin|D00223  Lincomycin|Antimicrobials [BR:br08307(D00223)]|Antibacterials|Protein biosynthesis inhibitor|Lincosamide|D00223  Lincomycin (USAN/INN)",
C06813,Nitrobenzene;|Nitrobenzol,,,,,
C06814,D-Xylose-5-phosphate,,,,,
C06817,Alprazolam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00225)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BA Benzodiazepine derivatives|N05BA12 Alprazolam|D00225  Alprazolam (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00225)]|Anxiolytics|Benzodiazepines|Alprazolam|D00225  Alprazolam (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00225)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00225  Alprazolam (JP18/USP/INN)|Drug groups [BR:br08330(D00225)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D00225  Alprazolam|DG01914  Anxiolytics, benzodiazepine derivatives|D00225  Alprazolam|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00225  Alprazolam|Target-based classification of drugs [BR:br08310(D00225)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00225  Alprazolam (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00225)]|Chemicals|D00225  Alprazolam|Drug metabolizing enzymes and transporters [br08309.html(D00225)]|Drug metabolizing enzymes|D00225|Narcotics and psychotropics in Japan [br08308.html(D00225)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00225",
C06818,Amantadine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07441)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BB Adamantane derivatives|N04BB01 Amantadine|D07441  Amantadine (INN)|Drug groups [BR:br08330(D07441)]|Antiviral|DG03029  Anti-influenza virus agent|DG02841  Viral uncoating inhibitor|DG00860  Amantadine|D07441  Amantadine|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|DG00860  Amantadine|D07441  Amantadine|DG01967  Antiparkinson agent|DG00860  Amantadine|D07441  Amantadine|Transporter substrate|DG02854  SLC22A2 substrate|DG00860  Amantadine|D07441  Amantadine|Target-based classification of drugs [BR:br08310(D07441)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D07441  Amantadine (INN)|Antimicrobials [BR:br08307(D07441)]|Antivirals|Entry, fusion or uncoating inhibitor|Influenza virus uncoating inhibitor|D07441  Amantadine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07441)]|Drug transporters|D07441",
C06819,Amifostine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AF Detoxifying agents for antineoplastic treatment|V03AF05 Amifostine|C06819  Amifostine,G01163
C06820,Amikacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02543)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX12 Amikacin|D02543  Amikacin (USP/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB06 Amikacin|D02543  Amikacin (USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA21 Amikacin|D02543  Amikacin (USP/INN)|Drug groups [BR:br08330(D02543)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00403  Amikacin|D02543  Amikacin|Antimicrobials [BR:br08307(D02543)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D02543  Amikacin (USP/INN),
C06821,Amiloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07447)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS|C03DB Other potassium-sparing agents|C03DB01 Amiloride|D07447  Amiloride (INN)|Drug groups [BR:br08330(D07447)]|Cardiovascular agent|DG01885  Potassium-sparing diuretic|DG00275  Amiloride|D07447  Amiloride|Target-based classification of drugs [BR:br08310(D07447)]|Ion channels|Ligand-gated ion channels|Epithelial sodium channel (SCNN)|SCNN1|D07447  Amiloride (INN),
C06823,Amiodarone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02910)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BD Antiarrhythmics, class III|C01BD01 Amiodarone|D02910  Amiodarone (USAN/INN)|Drug groups [BR:br08330(D02910)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01451  beta1-Adrenergic receptor agonist|DG00204  Amiodarone|D02910  Amiodarone|DG01653  Antiarrhythmics|DG01648  Class III antiarrhythmic agent|DG00204  Amiodarone|D02910  Amiodarone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00204  Amiodarone|D02910  Amiodarone|Target-based classification of drugs [BR:br08310(D02910)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D02910  Amiodarone (USAN/INN)|ADRB1|D02910  Amiodarone (USAN/INN)|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D02910  Amiodarone (USAN/INN)|SCN2A|D02910  Amiodarone (USAN/INN)|SCN3A|D02910  Amiodarone (USAN/INN)|SCN4A|D02910  Amiodarone (USAN/INN)|SCN5A|D02910  Amiodarone (USAN/INN)|SCN8A|D02910  Amiodarone (USAN/INN)|SCN9A|D02910  Amiodarone (USAN/INN)|SCN10A|D02910  Amiodarone (USAN/INN)|SCN11A|D02910  Amiodarone (USAN/INN)|Potassium channels|KCND3|D02910  Amiodarone (USAN/INN)|KCNH2|D02910  Amiodarone (USAN/INN)|KCNQ1|D02910  Amiodarone (USAN/INN)|Inward rectifier channels (Kir)|KCNJ3|D02910  Amiodarone (USAN/INN)|KCNJ5|D02910  Amiodarone (USAN/INN)|KCNJ8|D02910  Amiodarone (USAN/INN)|KCNJ11|D02910  Amiodarone (USAN/INN)|KCNJ12|D02910  Amiodarone (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02910)]|Drug metabolizing enzymes|D02910",
C06824,Amitriptyline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07448)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA09 Amitriptyline|D07448  Amitriptyline (INN)|Drug groups [BR:br08330(D07448)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00934  Amitriptyline|D07448  Amitriptyline|DG01728  Tricyclic antidepressant|DG00934  Amitriptyline|D07448  Amitriptyline|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00934  Amitriptyline|D07448  Amitriptyline|DG01639  CYP2C19 substrate|DG00934  Amitriptyline|D07448  Amitriptyline|DG01644  CYP2D6 substrate|DG00934  Amitriptyline|D07448  Amitriptyline|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00934  Amitriptyline|D07448  Amitriptyline|Target-based classification of drugs [BR:br08310(D07448)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07448  Amitriptyline (INN)|SLC6A4 (HTT)|D07448  Amitriptyline (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07448)]|Drug metabolizing enzymes|D07448,
C06825,Amlodipine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07450)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA01 Amlodipine|D07450  Amlodipine (USP/INN)|Drug groups [BR:br08330(D07450)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00322  Amlodipine|D07450  Amlodipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|DG00322  Amlodipine|D07450  Amlodipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00322  Amlodipine|D07450  Amlodipine|Target-based classification of drugs [BR:br08310(D07450)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D07450  Amlodipine (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D07450)]|Drug metabolizing enzymes|D07450,
C06827,Amoxicillin;|Amoxicillin anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07452)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA04 Amoxicillin|D07452  Amoxicillin (INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9761  Antibiotic preparations injection use|C06827  Amoxicillin|9762  Antibiotic preparations for peroral and feed additive use|C06827  Amoxicillin|Prodrugs [br08324.html]|C06827|Drug groups [BR:br08330(D07452)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00520  Amoxicillin|D07452  Amoxicillin|DG01780  Extended spectrum penicillin|DG00520  Amoxicillin|D07452  Amoxicillin|Antimicrobials [BR:br08307(D07452)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D07452  Amoxicillin (INN)|Prodrugs [br08324.html(D07452)]|D07452",
C06830,Anisotropine methylbromide;|Methyloctatropine bromide,,,,Risk category of Japanese OTC drugs [BR:br08312(D00232)]|Second-class OTC drugs|Inorganic and organic chemicals|Anisotropine methylbromide|D00232  Anisotropine methylbromide (USAN)|Methyloctatropine|D00232  Anisotropine methylbromide (USAN)|Drug groups [BR:br08330(D00232)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|D00232  Anisotropine methylbromide|Target-based classification of drugs [BR:br08310(D00232)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00232  Anisotropine methylbromide (USAN),
C06831,Dithranol;|Anthralin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00233)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AC Antracen derivatives|D05AC01 Dithranol|D00233  Anthralin (USP),
C06832,Astemizole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00234)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX11 Astemizole|D00234  Astemizole (JAN/USP/INN)|Drug groups [BR:br08330(D00234)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|D00234  Astemizole|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00234  Astemizole|Target-based classification of drugs [BR:br08310(D00234)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00234  Astemizole (JAN/USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00234)]|Drug metabolizing enzymes|D00234,
C06834,Atorvastatin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07474)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AA HMG CoA reductase inhibitors|C10AA05 Atorvastatin|D07474  Atorvastatin (INN) &lt;US&gt;|USP drug classification [BR:br08302(D07474)]|Cardiovascular Agents|Dyslipidemics, HMG CoA Reductase Inhibitors|Atorvastatin|D07474  Atorvastatin (INN)|Drug groups [BR:br08330(D07474)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01660  HMG-CoA reductase inhibitor|DG00355  Atorvastatin|D07474  Atorvastatin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00355  Atorvastatin|D07474  Atorvastatin|Transporter substrate|DG01665  ABCB1 substrate|DG00355  Atorvastatin|D07474  Atorvastatin|DG01913  ABCG2 substrate|DG00355  Atorvastatin|D07474  Atorvastatin|DG02856  SLCO1B1 substrate|DG00355  Atorvastatin|D07474  Atorvastatin|DG02932  SLCO1B3 substrate|DG00355  Atorvastatin|D07474  Atorvastatin|Drug classes [BR:br08332(D07474)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D07474  Atorvastatin|Target-based classification of drugs [BR:br08310(D07474)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HMGCR|D07474  Atorvastatin (INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D07474)]|Drug metabolizing enzymes|D07474|Drug transporters|D07474",
C06835,Atovaquone;|Acuvel;|Wellvone;|Mepron,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00236)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX06 Atovaquone|D00236  Atovaquone (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00236)]|Antiparasitics|Antiprotozoals|Atovaquone|D00236  Atovaquone (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00236)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|629  Miscellaneous|6290  Miscellaneous|D00236  Atovaquone (JAN/USP/INN)|Antimicrobials [BR:br08307(D00236)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Others|D00236  Atovaquone (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00236)]|Drugs with new active ingredients|D00236",
C06836,Auranofin,,,,"Glycosides [BR:br08021]|S-glycosides|C06836  Auranofin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00237)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01C SPECIFIC ANTIRHEUMATIC AGENTS|M01CB Gold preparations|M01CB03 Auranofin|D00237  Auranofin (JP18/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00237)]|Immunological Agents|Immunological Agents, Other|Immunological Agents, Miscellaneous|Auranofin|D00237  Auranofin (JP18/USAN/INN)|Drug groups [BR:br08330(D00237)]|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG01912  Gold preparations|D00237  Auranofin|Drug classes [BR:br08332(D00237)]|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00237  Auranofin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00237)]|Chemicals|D00237  Auranofin|D00237  Auranofin tablets",
C06837,Azathioprine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00238)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AX Other immunosuppressants|L04AX01 Azathioprine|D00238  Azathioprine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00238)]|Antineoplastics|Antimetabolites|Azathioprine|D00238  Azathioprine (JP18/USP/INN)|Immunological Agents|Immunosuppressants|Antimetabolites, Purine|Azathioprine|D00238  Azathioprine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00238)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00238  Azathioprine (JP18/USP/INN)|Drug groups [BR:br08330(D00238)]|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG00743  Azathioprine|D00238  Azathioprine|Drug classes [BR:br08332(D00238)]|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00238  Azathioprine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00238)]|Chemicals|D00238  Azathioprine|D00238  Azathioprine tablets|New drug approvals in Europe [br08329.html(D00238)]|European public assessment reports (EPAR) authorised medicine|D00238|Pharmacogenomic biomarkers [br08341.html(D00238)]|Polymorphisms and mutations affecting drug response|D00238",
C06838,Azithromycin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06838  Azithromycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07486)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA10 Azithromycin|D07486  Azithromycin (INN) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA26 Azithromycin|D07486  Azithromycin (INN) &lt;US&gt;|USP drug classification [BR:br08302(D07486)]|Antibacterials|Macrolides|Azithromycin|D07486  Azithromycin (INN)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Azithromycin|D07486  Azithromycin (INN)|Drug groups [BR:br08330(D07486)]|Antibacterial|DG01551  Macrolide antibiotic|DG01875  15-Membered ring macrolide antibiotic|DG00606  Azithromycin|D07486  Azithromycin|Transporter substrate|DG01665  ABCB1 substrate|DG00606  Azithromycin|D07486  Azithromycin|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00606  Azithromycin|D07486  Azithromycin|Drug classes [BR:br08332(D07486)]|Antibacterial|DG01551  Macrolide antibiotic|D07486  Azithromycin|Antimicrobials [BR:br08307(D07486)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D07486  Azithromycin (INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D07486)]|Drug transporters|D07486",
C06839,Azlocillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02339)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA09 Azlocillin|D02339  Azlocillin (USAN/INN)|Drug groups [BR:br08330(D02339)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00524  Azlocillin|D02339  Azlocillin|DG01780  Extended spectrum penicillin|DG00524  Azlocillin|D02339  Azlocillin|Antimicrobials [BR:br08307(D02339)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02339  Azlocillin (USAN/INN)",
C06840,Aztreonam;|Monobactam,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Monobactams|C06840  Aztreonam|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00240)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DF Monobactams|J01DF01 Aztreonam|D00240  Aztreonam (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00240)]|Antibacterials|Antibacterials, Other|Aztreonam|D00240  Aztreonam (JP18/USP/INN)|Respiratory Tract/Pulmonary Agents|Cystic Fibrosis Agents|Inhaled Anti-infectives|Aztreonam|D00240  Aztreonam (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00240)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6122  Monobactams|D00240  Aztreonam (JP18/USP/INN)|Drug groups [BR:br08330(D00240)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01454  Monobactam|DG00589  Aztreonam|D00240  Aztreonam|DG01804  Oxyimino beta-lactam|DG00589  Aztreonam|D00240  Aztreonam|Antimicrobials [BR:br08307(D00240)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Monobactam|D00240  Aztreonam (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00240)]|Chemicals|D00240  Aztreonam|D00240  Aztreonam for injection",
C06842,Beclomethasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07495)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA07 Beclometasone|D07495  Beclometasone (INN)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC15 Beclometasone|D07495  Beclometasone (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD01 Beclometasone|D07495  Beclometasone (INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA01 Beclometasone|D07495  Beclometasone (INN)|Drug groups [BR:br08330(D07495)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00097  Beclometasone|D07495  Beclometasone|Target-based classification of drugs [BR:br08310(D07495)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07495  Beclometasone (INN)",
C06843,Benazepril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07499)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA07 Benazepril|D07499  Benazepril (INN)|Drug groups [BR:br08330(D07499)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00339  Benazepril|D07499  Benazepril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00339  Benazepril|D07499  Benazepril|Metabolizing enzyme substrate|DG02924  UGT substrate|DG00339  Benazepril|D07499  Benazepril|Target-based classification of drugs [BR:br08310(D07499)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D07499  Benazepril (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07499)]|Drug metabolizing enzymes|D07499|Prodrugs [br08324.html(D07499)]|D07499|Prodrugs [br08324.html]|C06843",
C06846,Benztropine;|Benzatropine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07511)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04A ANTICHOLINERGIC AGENTS|N04AC Ethers of tropine or tropine derivatives|N04AC01 Benzatropine|D07511  Benzatropine (INN)|Drug groups [BR:br08330(D07511)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01745  Anticholinergic antiparkinson agent|DG00859  Benzatropine|D07511  Benzatropine|Target-based classification of drugs [BR:br08310(D07511)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D07511  Benzatropine (INN),
C06847,Bepridil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07520)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS|C08EA Phenylalkylamine derivatives|C08EA02 Bepridil|D07520  Bepridil (INN)|Drug groups [BR:br08330(D07520)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00333  Bepridil|D07520  Bepridil|DG01653  Antiarrhythmics|DG01807  Phenylalkylamine derivative|DG00333  Bepridil|D07520  Bepridil|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00333  Bepridil|D07520  Bepridil|DG01644  CYP2D6 substrate|DG00333  Bepridil|D07520  Bepridil|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00333  Bepridil|D07520  Bepridil|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00333  Bepridil|D07520  Bepridil|Target-based classification of drugs [BR:br08310(D07520)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-T|D07520  Bepridil (INN)|CACNA1-L|D07520  Bepridil (INN)|Potassium channels|KCNA5|D07520  Bepridil (INN)|KCND3|D07520  Bepridil (INN)|KCNH2|D07520  Bepridil (INN)|KCNQ1|D07520  Bepridil (INN)|Inward rectifier channels (Kir)|KCNJ3|D07520  Bepridil (INN)|KCNJ5|D07520  Bepridil (INN)|KCNJ8|D07520  Bepridil (INN)|KCNJ11|D07520  Bepridil (INN)|KCNJ12|D07520  Bepridil (INN)|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D07520  Bepridil (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07520)]|Drug metabolizing enzymes|D07520,
C06848,Betamethasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00244)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA04 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA05 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC01 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XC Corticosteroids, potent, other combinations|D07XC01 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB01 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD06 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA04 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA06 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB04 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA07 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA03 Betamethasone|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00244)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2454  Fluorinated adrenocorticotropic hormones|D00244  Betamethasone (JP18/USP/INN)|Drug groups [BR:br08330(D00244)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00095  Betamethasone|D00244  Betamethasone|Dermatological agent|DG03243  Atopic dermatitis agent|D00244  Betamethasone|Drug classes [BR:br08332(D00244)]|Anti-inflammatory|DG01955  Corticosteroid|D00244  Betamethasone|Dermatological agent|DG03243  Atopic dermatitis agent|D00244  Betamethasone|Target-based classification of drugs [BR:br08310(D00244)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00244  Betamethasone (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00244)]|Chemicals|D00244  Betamethasone|D00244  Betamethasone tablets",
C06849,Betaxolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07526)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB05 Betaxolol|D07526  Betaxolol (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED02 Betaxolol|D07526  Betaxolol (INN)|Drug groups [BR:br08330(D07526)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00315  Betaxolol|D07526  Betaxolol|DG03231  Antihypertensive|DG00315  Betaxolol|D07526  Betaxolol|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00315  Betaxolol|D07526  Betaxolol|Target-based classification of drugs [BR:br08310(D07526)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D07526  Betaxolol (INN)",
C06850,Bethanechol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AB Choline esters|N07AB02 Bethanechol|C06850  Bethanechol|Risk category of Japanese OTC drugs [BR:br08312]|Designated second-class OTC drugs|Inorganic and organic chemicals|Bethanechol|C06850  Bethanechol|Second-class OTC drugs|Inorganic and organic chemicals|Bethanechol chloride|C06850  Bethanechol|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG00991  Bethanechol|C06850  Bethanechol|DG01719  Parasympathomimetic agent|DG00991  Bethanechol|C06850  Bethanechol,G00991
C06852,Bisoprolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02342)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB07 Bisoprolol|D02342  Bisoprolol (JAN/USAN/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D02342)]|Cardiovascular Agents|Beta-adrenergic Blocking Agents|Beta-1 Selective|Bisoprolol|D02342  Bisoprolol (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D02342)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D02342  Bisoprolol (JAN/USAN/INN)|Drug groups [BR:br08330(D02342)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00316  Bisoprolol|D02342  Bisoprolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00316  Bisoprolol|D02342  Bisoprolol|DG03231  Antihypertensive|DG00316  Bisoprolol|D02342  Bisoprolol|Drug classes [BR:br08332(D02342)]|Cardiovascular agent|DG03231  Antihypertensive|D02342  Bisoprolol|DG01653  Antiarrhythmics|D02342  Bisoprolol|Target-based classification of drugs [BR:br08310(D02342)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D02342  Bisoprolol (JAN/USAN/INN) &lt;JP&gt;|New drug approvals in Japan [br08318.html(D02342)]|Drugs with new active ingredients|D02342",
C06853,Bitolterol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07534)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC17 Bitolterol|D07534  Bitolterol (INN)|Drug groups [BR:br08330(D07534)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01056  Bitolterol|D07534  Bitolterol|DG01951  Catecholamine adrenergic receptor agonist|DG01056  Bitolterol|D07534  Bitolterol|Target-based classification of drugs [BR:br08310(D07534)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D07534  Bitolterol (INN)",
C06854,Bleomycin A2,Component of Bleomycin A [CPD:C15774],0 Ser  1 Asn  2 Asn  3 His  4 Ala  5 Man  6 Thr  7 beta-Ala|8 Cys  9 Cys,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C06854  Bleomycin A2,
C06855,Bretylium,,,,,
C06856,Bromocriptine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03165)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02C OTHER GYNECOLOGICALS|G02CB Prolactine inhibitors|G02CB01 Bromocriptine|D03165  Bromocriptine (USAN/INN)|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BC Dopamine agonists|N04BC01 Bromocriptine|D03165  Bromocriptine (USAN/INN)|Drug groups [BR:br08330(D03165)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01468  Dopamine D2-receptor agonist|DG00452  Bromocriptine|D03165  Bromocriptine|DG01964  Ergot alkaloid|DG00452  Bromocriptine|D03165  Bromocriptine|DG01967  Antiparkinson agent|DG00452  Bromocriptine|D03165  Bromocriptine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00452  Bromocriptine|D03165  Bromocriptine|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00452  Bromocriptine|D03165  Bromocriptine|Target-based classification of drugs [BR:br08310(D03165)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D03165  Bromocriptine (USAN/INN)|Cytokines and receptors|Cytokines|CSF and other factors|PRL|D03165  Bromocriptine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D03165)]|Drug metabolizing enzymes|D03165,
C06857,Brompheniramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07543)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB01 Brompheniramine|D07543  Brompheniramine (INN)|Drug groups [BR:br08330(D07543)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01097  Brompheniramine|D07543  Brompheniramine|Target-based classification of drugs [BR:br08310(D07543)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07543  Brompheniramine (INN),
C06860,Bupropion,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07591)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX12 Bupropion|D07591  Bupropion (INN)|Drug groups [BR:br08330(D07591)]|Neuropsychiatric agent|DG03059  Noradrenalin and dopamine reuptake inhibitor (NDRI)|DG00957  Bupropion|D07591  Bupropion|Target-based classification of drugs [BR:br08310(D07591)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07591  Bupropion (INN)|SLC6A3 (DAT1)|D07591  Bupropion (INN),
C06861,Buspirone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07593)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BE Azaspirodecanedione derivatives|N05BE01 Buspirone|D07593  Buspirone (INN)|Drug groups [BR:br08330(D07593)]|Neuropsychiatric agent|DG01483  5-HT1A-receptor agonist|DG00913  Buspirone|D07593  Buspirone|Target-based classification of drugs [BR:br08310(D07593)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D07593  Buspirone (INN)|Serotonin|HTR1A|D07593  Buspirone (INN),
C06862,Busulfan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00248)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AB Alkyl sulfonates|L01AB01 Busulfan|D00248  Busulfan (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00248)]|Antineoplastics|Alkylating Agents|Busulfan|D00248  Busulfan (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00248)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4213  Sulfonate esters|D00248  Busulfan (JP18/USP/INN)|Drug groups [BR:br08330(D00248)]|Antineoplastic|DG01677  Alkylating agent|DG01721  Methanesulfonate derivative|D00248  Busulfan|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00248)]|Chemicals|D00248  Busulfan|New drug approvals in Europe [br08329.html(D00248)]|European public assessment reports (EPAR) authorised medicine|D00248,
C06863,Butorphanol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03197)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AF Morphinan derivatives|N02AF01 Butorphanol|D03197  Butorphanol (USAN/INN)|Drug groups [BR:br08330(D03197)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00821  Butorphanol|D03197  Butorphanol|Analgesic|DG01984  Opioid analgesics|DG00821  Butorphanol|D03197  Butorphanol|Target-based classification of drugs [BR:br08310(D03197)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D03197  Butorphanol (USAN/INN)|OPRK1|D03197  Butorphanol (USAN/INN),
C06865,Calcitonin;|Cibacalcin,,Cys Ser Asn Leu Ser Thr Cys Val Leu Gly Lys Leu Ser Gln Glu Leu|His Lys Leu Gln Thr Tyr Pro Arg Thr Asn Thr Gly Ser Gly Thr|Pro-NH2 (Disulfide bridge: 1-7),Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Calcitonin|C06865  Calcitonin|Bioactive peptides [BR:br08005]|Calcium-regulating peptides|Thyroid peptide hormone|C06865  Calcitonin,
C06866,Capsaicin,,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C06866  Capsaicin|Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Capsaicinoids and derivatives|C06866  Capsaicin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06866|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00250)]|M MUSCULO-SKELETAL SYSTEM|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AB Capsaicin and similar agents|M02AB01 Capsaicin|D00250  Capsaicin (JAN/USP) &lt;US&gt;|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BX Other local anesthetics|N01BX04 Capsaicin|D00250  Capsaicin (JAN/USP) &lt;US&gt;|Risk category of Japanese OTC drugs [BR:br08312(D00250)]|Third-class OTC drugs|Inorganic and organic chemicals|Capsaicin|D00250  Capsaicin (JAN/USP)|Drug groups [BR:br08330(D00250)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|D00250  Capsaicin|Target-based classification of drugs [BR:br08310(D00250)]|Ion channels|Voltage-gated ion channels|Transient receptor potential channels|TRPV1|D00250  Capsaicin (JAN/USP) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00250)]|New molecular entities and new therapeutic biological products|D00250|New drug approvals in Europe [br08329.html(D00250)]|European public assessment reports (EPAR) authorised medicine|D00250|New drug approvals in the USA, Europe and Japan [br08328.html(D00250)]|Approval dates by FDA, EMA and PMDA|D00250",
C06867,Captopril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00251)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA01 Captopril|D00251  Captopril (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00251)]|Cardiovascular Agents|Angiotensin-converting Enzyme (ACE) Inhibitors|Captopril|D00251  Captopril (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00251)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2144  Angiotensin converting enzyme inhibitors|D00251  Captopril (JP18/USP/INN)|Drug groups [BR:br08330(D00251)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|D00251  Captopril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|D00251  Captopril|Drug classes [BR:br08332(D00251)]|Cardiovascular agent|DG01501  Angiotensin-converting enzyme inhibitor|D00251  Captopril|DG03231  Antihypertensive|D00251  Captopril|Target-based classification of drugs [BR:br08310(D00251)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D00251  Captopril (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00251)]|Chemicals|D00251  Captopril|Prodrugs [br08324.html(D00251)]|D00251|Prodrugs [br08324.html]|C06867",
C06868,Carbamazepine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00252)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AF Carboxamide derivatives|N03AF01 Carbamazepine|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00252)]|Anticonvulsants|Sodium Channel Agents|Carbamazepine|D00252  Carbamazepine (JP18/USP/INN)|Bipolar Agents|Mood Stabilizers|Carbamazepine|D00252  Carbamazepine (JP18/USP/INN)|Central Nervous System Agents|Central Nervous System, Other|Carbamazepine|D00252  Carbamazepine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00252)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00252  Carbamazepine (JP18/USP/INN)|117  Psychotropics|1179  Others|D00252  Carbamazepine (JP18/USP/INN)|Drug groups [BR:br08330(D00252)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02034  Carboxamide antiepileptic|D00252  Carbamazepine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00252  Carbamazepine|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|D00252  Carbamazepine|Transporter inducer|DG01893  ABCB1 inducer|D00252  Carbamazepine|Drug classes [BR:br08332(D00252)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00252  Carbamazepine|Target-based classification of drugs [BR:br08310(D00252)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN2A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN3A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN4A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN5A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN8A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN9A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN10A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|SCN11A|D00252  Carbamazepine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00252)]|Chemicals|D00252  Carbamazepine|Drug metabolizing enzymes and transporters [br08309.html(D00252)]|Drug metabolizing enzymes|D00252|Drug transporters|D00252|Pharmacogenomic biomarkers [br08341.html(D00252)]|Polymorphisms and mutations affecting drug response|D00252",
C06869,Carbenicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07614)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA03 Carbenicillin|D07614  Carbenicillin (INN)|Drug groups [BR:br08330(D07614)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00519  Carbenicillin|D07614  Carbenicillin|DG01780  Extended spectrum penicillin|DG00519  Carbenicillin|D07614  Carbenicillin|Antimicrobials [BR:br08307(D07614)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D07614  Carbenicillin (INN)|Prodrugs [br08324.html(D07614)]|D07614|Prodrugs [br08324.html]|C06869",
C06870,Carbidopa-levodopa,,,,,
C06871,Carbinoxamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07617)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA08 Carbinoxamine|D07617  Carbinoxamine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07617)]|Second-class OTC drugs|Inorganic and organic chemicals|Carbinoxamine|D07617  Carbinoxamine (INN)|Drug groups [BR:br08330(D07617)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01095  Carbinoxamine|D07617  Carbinoxamine|Target-based classification of drugs [BR:br08310(D07617)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07617  Carbinoxamine (INN),
C06872,Carboprost;|(15S)-15-Methylprostaglandin F2alpha,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C06872  (15S)-15-Methylprostaglandin F2alpha|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02343)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AD Prostaglandins|G02AD04 Carboprost|D02343  Carboprost (USAN/INN)|Drug groups [BR:br08330(D02343)]|Hormonal agent|DG01961  Prostaglandin derivative|DG01960  Prostaglandin F derivative|DG00449  Carboprost|D02343  Carboprost|Target-based classification of drugs [BR:br08310(D02343)]|G Protein-coupled receptors|Rhodopsin family|Prostaglandin|PTGFR|D02343  Carboprost (USAN/INN),
C06873,Carmustine;|Bischloroethyl nitrosourea;|BCNU,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00254)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD01 Carmustine|D00254  Carmustine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00254)]|Antineoplastics|Alkylating Agents|Carmustine|D00254  Carmustine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00254)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4219  Others|D00254  Carmustine (JAN/USP/INN)|Drug groups [BR:br08330(D00254)]|Antineoplastic|DG01677  Alkylating agent|DG01724  Nitrosourea|D00254  Carmustine|New drug approvals in Europe [br08329.html(D00254)]|European public assessment reports (EPAR) authorised medicine|D00254|New drug approvals in Japan [br08318.html(D00254)]|Drugs with new active ingredients|D00254,
C06874,Carteolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07624)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA15 Carteolol|D07624  Carteolol (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED05 Carteolol|D07624  Carteolol (INN)|Drug groups [BR:br08330(D07624)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG00308  Carteolol|D07624  Carteolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00308  Carteolol|D07624  Carteolol|DG03231  Antihypertensive|DG00308  Carteolol|D07624  Carteolol|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00308  Carteolol|D07624  Carteolol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00308  Carteolol|D07624  Carteolol|Target-based classification of drugs [BR:br08310(D07624)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D07624  Carteolol (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07624)]|Drug metabolizing enzymes|D07624",
C06875,Carvedilol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00255)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AG Alpha and beta blocking agents|C07AG02 Carvedilol|D00255  Carvedilol (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00255)]|Cardiovascular Agents|Beta-adrenergic Blocking Agents|Beta-adrenergic Blocking Agents, Other|Carvedilol|D00255  Carvedilol (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00255)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00255  Carvedilol (JP18/USP/INN)|Drug groups [BR:br08330(D00255)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG03180  alpha1 and beta-Adrenergic receptor antagonist|DG00321  Carvedilol|D00255  Carvedilol|DG03231  Antihypertensive|DG03180  alpha1 and beta-Adrenergic receptor antagonist|DG00321  Carvedilol|D00255  Carvedilol|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00321  Carvedilol|D00255  Carvedilol|DG01642  CYP2C9 substrate|DG00321  Carvedilol|D00255  Carvedilol|DG01644  CYP2D6 substrate|DG00321  Carvedilol|D00255  Carvedilol|DG02855  CYP2E1 substrate|DG00321  Carvedilol|D00255  Carvedilol|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00321  Carvedilol|D00255  Carvedilol|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00321  Carvedilol|D00255  Carvedilol|Drug classes [BR:br08332(D00255)]|Cardiovascular agent|DG03231  Antihypertensive|D00255  Carvedilol|Target-based classification of drugs [BR:br08310(D00255)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00255  Carvedilol (JP18/USP/INN) &lt;JP/US&gt;|ADRB1|D00255  Carvedilol (JP18/USP/INN) &lt;JP/US&gt;|ADRB2|D00255  Carvedilol (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00255)]|Chemicals|D00255  Carvedilol|D00255  Carvedilol tablets|Drug metabolizing enzymes and transporters [br08309.html(D00255)]|Drug metabolizing enzymes|D00255|Drug transporters|D00255|Pharmacogenomic biomarkers [br08341.html(D00255)]|Polymorphisms and mutations affecting drug response|D00255",
C06876,Nitrosobenzene,,,,,
C06877,Cefaclor,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00256)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC04 Cefaclor|D00256  Cefaclor (JP18) &lt;JP&gt;|USP drug classification [BR:br08302(D00256)]|Antibacterials|Beta-lactam, Cephalosporins|Cefaclor|D00256  Cefaclor (JP18)|Therapeutic category of drugs in Japan [BR:br08301(D00256)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00256  Cefaclor (JP18)|Drug groups [BR:br08330(D00256)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00560  Cefaclor|D00256  Cefaclor|DG01775  Second-generation cephalosporin|DG00560  Cefaclor|D00256  Cefaclor|Drug classes [BR:br08332(D00256)]|Antibacterial|DG01488  Cephem|D00256  Cefaclor|Antimicrobials [BR:br08307(D00256)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00256  Cefaclor (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00256)]|Chemicals|D00256  Cefaclor|D00256  Cefaclor capsules|D00256  Cefaclor combination granules|D00256  Cefaclor fine granules",
C06878,Cefadroxil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00257)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB05 Cefadroxil|D00257  Cefadroxil (JP18)|Drug groups [BR:br08330(D00257)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00551  Cefadroxil|D00257  Cefadroxil|DG01774  First-generation cephalosporin|DG00551  Cefadroxil|D00257  Cefadroxil|Antimicrobials [BR:br08307(D00257)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00257  Cefadroxil (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00257)]|Chemicals|D00257  Cefadroxil|D00257  Cefadroxil capsules|D00257  Cefadroxil for syrup",
C06879,Cefamandole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02344)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC03 Cefamandole|D02344  Cefamandole (USAN/INN)|Drug groups [BR:br08330(D02344)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00559  Cefamandole|D02344  Cefamandole|DG01775  Second-generation cephalosporin|DG00559  Cefamandole|D02344  Cefamandole|Antimicrobials [BR:br08307(D02344)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D02344  Cefamandole (USAN/INN)",
C06880,Cefazolin,,,,"Compounds with biological roles [BR:br08001]|Antibiotics|beta-Lactams|Cephems|C06880  Cefazolin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02299)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB04 Cefazolin|D02299  Cefazolin (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9763  Antibiotic preparations for external use, pessaries and suppositories|C06880  Cefazolin|Drug groups [BR:br08330(D02299)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00550  Cefazolin|D02299  Cefazolin|DG01774  First-generation cephalosporin|DG00550  Cefazolin|D02299  Cefazolin|Antimicrobials [BR:br08307(D02299)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D02299  Cefazolin (USP)",
C06881,Cefixime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00258)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD08 Cefixime|D00258  Cefixime (INN)|Drug groups [BR:br08330(D00258)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00577  Cefixime|D00258  Cefixime|DG01776  Third-generation cephalosporin|DG00577  Cefixime|D00258  Cefixime|DG01804  Oxyimino beta-lactam|DG00577  Cefixime|D00258  Cefixime|Antimicrobials [BR:br08307(D00258)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00258  Cefixime (INN)",
C06882,Cefonicid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07644)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC06 Cefonicid|D07644  Cefonicid (INN)|Drug groups [BR:br08330(D07644)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00562  Cefonicid|D07644  Cefonicid|DG01775  Second-generation cephalosporin|DG00562  Cefonicid|D07644  Cefonicid|Antimicrobials [BR:br08307(D07644)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D07644  Cefonicid (INN)",
C06883,Cefoperazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07645)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD12 Cefoperazone|D07645  Cefoperazone (INN)|Drug groups [BR:br08330(D07645)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00581  Cefoperazone|D07645  Cefoperazone|DG01776  Third-generation cephalosporin|DG00581  Cefoperazone|D07645  Cefoperazone|Antimicrobials [BR:br08307(D07645)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07645  Cefoperazone (INN)",
C06884,Ceforanide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00259)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC11 Ceforanide|D00259  Ceforanide (USP/INN)|Drug groups [BR:br08330(D00259)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|D00259  Ceforanide|DG01775  Second-generation cephalosporin|D00259  Ceforanide|Antimicrobials [BR:br08307(D00259)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00259  Ceforanide (USP/INN)",
C06885,Cefotaxime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07647)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD01 Cefotaxime|D07647  Cefotaxime (INN)|Drug groups [BR:br08330(D07647)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00570  Cefotaxime|D07647  Cefotaxime|DG01776  Third-generation cephalosporin|DG00570  Cefotaxime|D07647  Cefotaxime|DG01804  Oxyimino beta-lactam|DG00570  Cefotaxime|D07647  Cefotaxime|Antimicrobials [BR:br08307(D07647)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07647  Cefotaxime (INN)",
C06886,Cefotetan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00260)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC05 Cefotetan|D00260  Cefotetan (JP18/USP/INN)|Drug groups [BR:br08330(D00260)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00561  Cefotetan|D00260  Cefotetan|DG01775  Second-generation cephalosporin|DG00561  Cefotetan|D00260  Cefotetan|Antimicrobials [BR:br08307(D00260)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00260  Cefotetan (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00260)]|Chemicals|D00260  Cefotetan",
C06887,Cefoxitin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02345)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC01 Cefoxitin|D02345  Cefoxitin (USAN/INN)|Drug groups [BR:br08330(D02345)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00557  Cefoxitin|D02345  Cefoxitin|DG01775  Second-generation cephalosporin|DG00557  Cefoxitin|D02345  Cefoxitin|Antimicrobials [BR:br08307(D02345)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D02345  Cefoxitin (USAN/INN)",
C06888,Cefprozil;|Cefprozil anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07651)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC10 Cefprozil|D07651  Cefprozil (INN)|Drug groups [BR:br08330(D07651)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00566  Cefprozil|D07651  Cefprozil|DG01775  Second-generation cephalosporin|DG00566  Cefprozil|D07651  Cefprozil|Antimicrobials [BR:br08307(D07651)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D07651  Cefprozil (INN)",
C06889,Ceftazidime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07654)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD02 Ceftazidime|D07654  Ceftazidime (INN)|Drug groups [BR:br08330(D07654)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00571  Ceftazidime|D07654  Ceftazidime|DG01776  Third-generation cephalosporin|DG00571  Ceftazidime|D07654  Ceftazidime|DG01804  Oxyimino beta-lactam|DG00571  Ceftazidime|D07654  Ceftazidime|Antimicrobials [BR:br08307(D07654)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07654  Ceftazidime (INN)",
C06890,Ceftizoxime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07658)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD07 Ceftizoxime|D07658  Ceftizoxime (INN)|Drug groups [BR:br08330(D07658)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00576  Ceftizoxime|D07658  Ceftizoxime|DG01776  Third-generation cephalosporin|DG00576  Ceftizoxime|D07658  Ceftizoxime|DG01804  Oxyimino beta-lactam|DG00576  Ceftizoxime|D07658  Ceftizoxime|Transporter substrate|DG02860  SLC22A8 substrate|D07658  Ceftizoxime|Antimicrobials [BR:br08307(D07658)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07658  Ceftizoxime (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07658)]|Drug transporters|D07658|Prodrugs [br08324.html(D07658)]|D07658|Prodrugs [br08324.html]|C06890",
C06891,"D-2,3-Diketo 4-deoxy-epi-inositol;|DKDI",,,,,
C06892,2-Deoxy-5-keto-D-gluconic acid;|DKH;|5-Dehydro-2-deoxy-D-gluconate;|2-Deoxy-D-threo-hex-5-ulosonic acid,,,,,
C06893,2-Deoxy-5-keto-D-gluconic acid 6-phosphate;|6-Phospho-5-dehydro-2-deoxy-D-gluconate;|DKHP,,,,,
C06894,Cefuroxime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00262)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC02 Cefuroxime|D00262  Cefuroxime (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA27 Cefuroxime|D00262  Cefuroxime (USAN/INN)|Drug groups [BR:br08330(D00262)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00558  Cefuroxime|D00262  Cefuroxime|DG01775  Second-generation cephalosporin|DG00558  Cefuroxime|D00262  Cefuroxime|DG01804  Oxyimino beta-lactam|DG00558  Cefuroxime|D00262  Cefuroxime|Antimicrobials [BR:br08307(D00262)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00262  Cefuroxime (USAN/INN)|Prodrugs [br08324.html(D00262)]|D00262|Prodrugs [br08324.html]|C06894",
C06895,Cephalexin;|Cefalexin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00263)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB01 Cefalexin|D00263  Cefalexin (JP18) &lt;JP&gt;|USP drug classification [BR:br08302(D00263)]|Antibacterials|Beta-lactam, Cephalosporins|Cephalexin|D00263  Cefalexin (JP18)|Therapeutic category of drugs in Japan [BR:br08301(D00263)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00263  Cefalexin (JP18)|Drug groups [BR:br08330(D00263)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00548  Cephalexin|D00263  Cefalexin|DG01774  First-generation cephalosporin|DG00548  Cephalexin|D00263  Cefalexin|Drug classes [BR:br08332(D00263)]|Antibacterial|DG01488  Cephem|D00263  Cefalexin|Antimicrobials [BR:br08307(D00263)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00263  Cefalexin (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00263)]|Chemicals|D00263  Cefalexin|D00263  Cefalexin capsules|D00263  Cefalexin combination granules|D00263  Cefalexin for syrup",
C06896,Cephapirin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07636)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB08 Cefapirin|D07636  Cefapirin (BAN)|Drug groups [BR:br08330(D07636)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00553  cephapirin|D07636  Cefapirin|DG01774  First-generation cephalosporin|DG00553  cephapirin|D07636  Cefapirin|Antimicrobials [BR:br08307(D07636)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D07636  Cefapirin (BAN)",
C06897,Cephradine;|Cefradine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00264)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB09 Cefradine|D00264  Cephradine (USP)|Drug groups [BR:br08330(D00264)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|D00264  Cephradine|DG01774  First-generation cephalosporin|D00264  Cephradine|Antimicrobials [BR:br08307(D00264)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00264  Cephradine (USP)|Antimicrobials abbreviations [BR:br08327(D00264)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00264  Cephradine (USP)",
C06899,Chloral hydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00265)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CC Aldehydes and derivatives|N05CC01 Chloral hydrate|D00265  Chloral hydrate (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00265)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1123  Chloral hydrates|D00265  Chloral hydrate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00265)]|Chemicals|D00265  Chloral hydrate",
C06900,Chlorambucil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00266)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA02 Chlorambucil|D00266  Chlorambucil (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00266)]|Antineoplastics|Alkylating Agents|Chlorambucil|D00266  Chlorambucil (JAN/USP/INN)|Drug groups [BR:br08330(D00266)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|D00266  Chlorambucil,
C06902,Chlorhexidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07668)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB03 Chlorhexidine|D07668  Chlorhexidine (INN)|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA02 Chlorhexidine|D07668  Chlorhexidine (INN)|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AC Biguanides and amidines|D08AC02 Chlorhexidine|D07668  Chlorhexidine (INN)|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA12 Chlorhexidine|D07668  Chlorhexidine (INN)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA05 Chlorhexidine|D07668  Chlorhexidine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX09 Chlorhexidine|D07668  Chlorhexidine (INN)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA09 Chlorhexidine|D07668  Chlorhexidine (INN)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA04 Chlorhexidine|D07668  Chlorhexidine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07668)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorhexidine|D07668  Chlorhexidine (INN),
C06905,Chlorpheniramine;|Chlorphenamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07398)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB04 Chlorphenamine|D07398  Chlorphenamine (INN)|Classification of Japanese OTC drugs [BR:br08313(D07398)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D07398  Chlorphenamine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07398)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D07398  Chlorphenamine (INN)|Third-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D07398  Chlorphenamine (INN)|Drug groups [BR:br08330(D07398)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01099  Chlorphenamine|D07398  Chlorphenamine|Target-based classification of drugs [BR:br08310(D07398)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07398  Chlorphenamine (INN)",
C06906,Chlorpromazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00270)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AA Phenothiazines with aliphatic side-chain|N05AA01 Chlorpromazine|D00270  Chlorpromazine (USP/INN)|Drug groups [BR:br08330(D00270)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01460  alpha2-Adrenergic receptor antagonist|DG00867  Chlorpromazine|D00270  Chlorpromazine|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00867  Chlorpromazine|D00270  Chlorpromazine|DG01491  Muscarinic cholinergic receptor antagonist|DG00867  Chlorpromazine|D00270  Chlorpromazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00867  Chlorpromazine|D00270  Chlorpromazine|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00867  Chlorpromazine|D00270  Chlorpromazine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00867  Chlorpromazine|D00270  Chlorpromazine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00867  Chlorpromazine|D00270  Chlorpromazine|Target-based classification of drugs [BR:br08310(D00270)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00270  Chlorpromazine (USP/INN)|Adrenaline|ADRA2|D00270  Chlorpromazine (USP/INN)|Dopamine|DRD2|D00270  Chlorpromazine (USP/INN)|Histamine|HRH1|D00270  Chlorpromazine (USP/INN)|Serotonin|HTR2|D00270  Chlorpromazine (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00270)]|Drug metabolizing enzymes|D00270,
C06909,Cidofovir;|Cidofovir anhydrous,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB12 Cidofovir|C06909  Cidofovir|Drug groups [BR:br08330]|Antiviral|DG01937  Anti-cytomegalovirus agent|DG00648  Cidofovir|C06909  Cidofovir,G00648
C06910,Cisapride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00274)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03F PROPULSIVES|A03FA Propulsives|A03FA02 Cisapride|D00274  Cisapride (USP/INN)|Drug groups [BR:br08330(D00274)]|Gastrointestinal agent|DG01763  Propulsive|DG00056  Cisapride|D00274  Cisapride|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00056  Cisapride|D00274  Cisapride|Target-based classification of drugs [BR:br08310(D00274)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR2A|D00274  Cisapride (USP/INN)|HTR4|D00274  Cisapride (USP/INN)|Ion channels|Ligand-gated ion channels|Serotonin|HTR3A|D00274  Cisapride (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00274)]|Drug metabolizing enzymes|D00274,
C06911,Cisplatin;|cis-Diamminedichloroplatinum(II);|[PtCl2(NH3)2];|CDDP,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00275)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XA Platinum compounds|L01XA01 Cisplatin|D00275  Cisplatin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00275)]|Antineoplastics|Alkylating Agents|Cisplatin|D00275  Cisplatin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00275)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00275  Cisplatin (JP18/USP/INN)|Drug groups [BR:br08330(D00275)]|Antineoplastic|DG01679  Platinum compound|D00275  Cisplatin|Transporter substrate|DG02854  SLC22A2 substrate|D00275  Cisplatin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00275)]|Chemicals|D00275  Cisplatin|Drug metabolizing enzymes and transporters [br08309.html(D00275)]|Drug transporters|D00275|Pharmacogenomic biomarkers [br08341.html(D00275)]|Polymorphisms and mutations affecting drug response|D00275,
C06912,Clarithromycin;|6-O-Methylerythromycin;|6-O-Methylerythromycin A,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C06912  Clarithromycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00276)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA09 Clarithromycin|D00276  Clarithromycin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00276)]|Antibacterials|Macrolides|Clarithromycin|D00276  Clarithromycin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00276)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|614  Acting mainly on gram-positive bacteria and mycoplasma|6149  Others|D00276  Clarithromycin (JP18/USP/INN)|Drug groups [BR:br08330(D00276)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00605  Clarithromycin|D00276  Clarithromycin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00605  Clarithromycin|D00276  Clarithromycin|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00605  Clarithromycin|D00276  Clarithromycin|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00605  Clarithromycin|D00276  Clarithromycin|Drug classes [BR:br08332(D00276)]|Antibacterial|DG01551  Macrolide antibiotic|D00276  Clarithromycin|Antimicrobials [BR:br08307(D00276)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D00276  Clarithromycin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00276)]|Chemicals|D00276  Clarithromycin|D00276  Clarithromycin tablets|D00276  Clarithromycin for syrup|Drug metabolizing enzymes and transporters [br08309.html(D00276)]|Drug metabolizing enzymes|D00276|Drug transporters|D00276",
C06913,Clemastine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03535)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA14 Clemastine|D03535  Clemastine (USAN)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA04 Clemastine|D03535  Clemastine (USAN)|Risk category of Japanese OTC drugs [BR:br08312(D03535)]|Second-class OTC drugs|Inorganic and organic chemicals|Clemastine|D03535  Clemastine (USAN)|Drug groups [BR:br08330(D03535)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00387  Clemastine|D03535  Clemastine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00387  Clemastine|D03535  Clemastine|Target-based classification of drugs [BR:br08310(D03535)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D03535  Clemastine (USAN)|Drug metabolizing enzymes and transporters [br08309.html(D03535)]|Drug metabolizing enzymes|D03535",
C06914,Clindamycin,,,,"Glycosides [BR:br08021]|S-glycosides|C06914  Clindamycin|Prodrugs [br08324.html]|C06914|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00277)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF01 Clindamycin|D00277  Clindamycin (USAN/INN) &lt;US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA10 Clindamycin|D00277  Clindamycin (USAN/INN) &lt;US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FF Lincosamides|J01FF01 Clindamycin|D00277  Clindamycin (USAN/INN) &lt;US&gt;|Drug groups [BR:br08330(D00277)]|Antibacterial|DG01578  Lincosamide antibiotic|DG00435  Clindamycin|D00277  Clindamycin|Drug classes [BR:br08332(D00277)]|Antibacterial|DG01578  Lincosamide antibiotic|D00277  Clindamycin|Antimicrobials [BR:br08307(D00277)]|Antibacterials|Protein biosynthesis inhibitor|Lincosamide|D00277  Clindamycin (USAN/INN) &lt;US&gt;|Prodrugs [br08324.html(D00277)]|D00277",
C06915,Clofazimine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00278)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04B DRUGS FOR TREATMENT OF LEPRA|J04BA Drugs for treatment of lepra|J04BA01 Clofazimine|D00278  Clofazimine (JAN/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00278)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|623  Leprostatics|6239  Others|D00278  Clofazimine (JAN/USP/INN)|Antimicrobials [BR:br08307(D00278)]|Antibacterials|Nucleic acid synthesis inhibitor|DNA replication inhibitor|D00278  Clofazimine (JAN/USP/INN) &lt;JP&gt;|Antimicrobials abbreviations [BR:br08327(D00278)]|Antibacterials|Nucleic acid synthesis inhibitor|DNA replication inhibitor|D00278  Clofazimine (JAN/USP/INN),
C06916,Clofibrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00279)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AB Fibrates|C10AB01 Clofibrate|D00279  Clofibrate (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00279)]|2  Agents affecting individual organs|21  Cardiovascular agents|218  Hyperlipidemia agents|2183  Clofibrates|D00279  Clofibrate (JP18/USP/INN)|Drug groups [BR:br08330(D00279)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01733  PPAR alpha agonist|DG01547  Fibrate|DG00358  Clofibrate|D00279  Clofibrate|Drug classes [BR:br08332(D00279)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D00279  Clofibrate|Target-based classification of drugs [BR:br08310(D00279)]|Nuclear receptors|Thyroid hormone like receptors|Peroxisome proliferator-activated receptor (PPAR)|NR1C1 (PPARA)|D00279  Clofibrate (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00279)]|Chemicals|D00279  Clofibrate|D00279  Clofibrate capsules",
C06917,Clomiphene,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07726)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS|G03GB Ovulation stimulants, synthetic|G03GB02 Clomifene|D07726  Clomifene (INN)|Drug groups [BR:br08330(D07726)]|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG00474  Clomifene|D07726  Clomifene|Target-based classification of drugs [BR:br08310(D07726)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D07726  Clomifene (INN)",
C06918,Clomipramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07727)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA04 Clomipramine|D07727  Clomipramine (INN)|Drug groups [BR:br08330(D07727)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00929  Clomipramine|D07727  Clomipramine|DG01728  Tricyclic antidepressant|DG00929  Clomipramine|D07727  Clomipramine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00929  Clomipramine|D07727  Clomipramine|DG01639  CYP2C19 substrate|DG00929  Clomipramine|D07727  Clomipramine|DG01644  CYP2D6 substrate|DG00929  Clomipramine|D07727  Clomipramine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00929  Clomipramine|D07727  Clomipramine|Target-based classification of drugs [BR:br08310(D07727)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07727  Clomipramine (INN)|SLC6A4 (HTT)|D07727  Clomipramine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07727)]|Drug metabolizing enzymes|D07727,
C06921,Clorazepate;|Clorazepic acid,,,,"Drug groups [BR:br08330]|Neuropsychiatric agent|DG01914  Anxiolytics, benzodiazepine derivatives|DG01218  Clorazepic acid|C06921  Clorazepate|Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C06921",G01218
C06922,Clotrimazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00282)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB18 Clotrimazole|D00282  Clotrimazole (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC01 Clotrimazole|D00282  Clotrimazole (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF02 Clotrimazole|D00282  Clotrimazole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00282)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Clotrimazole|D00282  Clotrimazole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00282)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00282  Clotrimazole (JP18/USP/INN)|26  Epidermides|265  Antiparasitic dermatosis agents|2655  Imidazoles|D00282  Clotrimazole (JP18/USP/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|629  Miscellaneous|6290  Miscellaneous|D00282  Clotrimazole (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00282)]|Drugs for women|51 Other drugs for women|D00282  Clotrimazole (JP18/USP/INN)|Agents for integumentary system|58 Ringworm drugs|D00282  Clotrimazole (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00282)]|First-class OTC drugs|Inorganic and organic chemicals|Clotrimazole|D00282  Clotrimazole (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Clotrimazole|D00282  Clotrimazole (JP18/USP/INN)|Drug groups [BR:br08330(D00282)]|Antifungal|DG01883  Imidazole antifungal|D00282  Clotrimazole|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00282  Clotrimazole|Drug classes [BR:br08332(D00282)]|Antifungal|DG01883  Imidazole antifungal|D00282  Clotrimazole|Antimicrobials [BR:br08307(D00282)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00282  Clotrimazole (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00282)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00282  Clotrimazole (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00282)]|Chemicals|D00282  Clotrimazole|Drug metabolizing enzymes and transporters [br08309.html(D00282)]|Drug metabolizing enzymes|D00282|Rx-to-OTC switch list in the USA [br08315.html(D00282)]|D00282|Rx-to-OTC switch list in Japan [br08314.html(D00282)]|D00282",
C06923,Cloxacillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07733)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF02 Cloxacillin|D07733  Cloxacillin (INN)|Drug groups [BR:br08330(D07733)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00541  Cloxacillin|D07733  Cloxacillin|DG01779  beta-Lactamase resistant penicillin|DG00541  Cloxacillin|D07733  Cloxacillin|Antimicrobials [BR:br08307(D07733)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D07733  Cloxacillin (INN)",
C06924,Clozapine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00283)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AH Diazepines, oxazepines, thiazepines and oxepines|N05AH02 Clozapine|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00283)]|Antipsychotics|Treatment-Resistant|Clozapine|D00283  Clozapine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00283)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00283  Clozapine (JAN/USP/INN)|Drug groups [BR:br08330(D00283)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01476  Dopamine D4-receptor antagonist|D00283  Clozapine|DG03200  Antipsychotic agent|DG03064  Atypical antipsychotic|D00283  Clozapine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|D00283  Clozapine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00283  Clozapine|Target-based classification of drugs [BR:br08310(D00283)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|Dopamine|DRD4|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|Serotonin|HTR2A|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|HTR2C|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|Ion channels|Ligand-gated ion channels|Serotonin|HTR3|D00283  Clozapine (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00283)]|Drugs with new active ingredients|D00283|Drug metabolizing enzymes and transporters [br08309.html(D00283)]|Drug metabolizing enzymes|D00283|Pharmacogenomic biomarkers [br08341.html(D00283)]|Polymorphisms and mutations affecting drug response|D00283",
C06925,Colestipol;|Epichlorohydrin-tetraethylenepentamine polymer,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AC Bile acid sequestrants|C10AC02 Colestipol|C06925  Colestipol|Drug groups [BR:br08330]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01945  Bile acid sequestrant|DG00359  Colestipol|C06925  Colestipol",G00359
C06928,Cromolyn;|Cromoglicic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07753)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EB Antiallergic agents, excl. corticosteroids|A07EB01 Cromoglicic acid|D07753  Cromoglicic acid (INN)|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AH Agents for dermatitis, excluding corticosteroids|D11AH03 Cromoglicic acid|D07753  Cromoglicic acid (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AC Antiallergic agents, excl. corticosteroids|R01AC01 Cromoglicic acid|D07753  Cromoglicic acid (INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BC Antiallergic agents, excl. corticosteroids|R03BC01 Cromoglicic acid|D07753  Cromoglicic acid (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX01 Cromoglicic acid|D07753  Cromoglicic acid (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07753)]|Second-class OTC drugs|Inorganic and organic chemicals|Cromoglicic acid|D07753  Cromoglicic acid (INN)|Drug groups [BR:br08330(D07753)]|Anti-allergic agent|DG01805  Mediator release inhibitor|DG00098  Cromoglicic acid|D07753  Cromoglicic acid",
C06930,Cyclizine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03621)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AE Piperazine derivatives|R06AE03 Cyclizine|D03621  Cyclizine (INN)|Drug groups [BR:br08330(D03621)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01105  Cyclizine|D03621  Cyclizine|Target-based classification of drugs [BR:br08310(D03621)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D03621  Cyclizine (INN),
C06931,Cyclobenzaprine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07758)]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS|M03BX Other centrally acting agents|M03BX08 Cyclobenzaprine|D07758  Cyclobenzaprine (INN)|Drug groups [BR:br08330(D07758)]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|DG00775  Cyclobenzaprine|D07758  Cyclobenzaprine",
C06932,Cyclopentolate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07759)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FA Anticholinergics|S01FA04 Cyclopentolate|D07759  Cyclopentolate (INN)|Drug groups [BR:br08330(D07759)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01141  Cyclopentolate|D07759  Cyclopentolate|Target-based classification of drugs [BR:br08310(D07759)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D07759  Cyclopentolate (INN),
C06933,Cyclophosphamide;|Cyclophosphamide hydrate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00287)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA01 Cyclophosphamide|D00287  Cyclophosphamide (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00287)]|Antineoplastics|Alkylating Agents|Cyclophosphamide|D00287  Cyclophosphamide (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00287)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4211  Chlorethylamines|D00287  Cyclophosphamide (USP); Cyclophosphamide hydrate (JP18)|Drug groups [BR:br08330(D00287)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG01720  Isophosphoramide mustard analog|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|DG02919  CYP2B6 substrate|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|DG02918  CYP2C8 substrate|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|DG01642  CYP2C9 substrate|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00675  Cyclophosphamide|D00287  Cyclophosphamide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00287)]|Chemicals|D00287  Cyclophosphamide hydrate|D00287  Cyclophosphamide tablets|Drug metabolizing enzymes and transporters [br08309.html(D00287)]|Drug metabolizing enzymes|D00287,
C06935,Cyproheptadine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07765)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX02 Cyproheptadine|D07765  Cyproheptadine (INN)|Drug groups [BR:br08330(D07765)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01109  Cyproheptadine|D07765  Cyproheptadine|Target-based classification of drugs [BR:br08310(D07765)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07765  Cyproheptadine (INN)|Serotonin|HTR1|D07765  Cyproheptadine (INN)|HTR2|D07765  Cyproheptadine (INN),
C06936,Dacarbazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00288)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AX Other alkylating agents|L01AX04 Dacarbazine|D00288  Dacarbazine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00288)]|Antineoplastics|Alkylating Agents|Dacarbazine|D00288  Dacarbazine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00288)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4219  Others|D00288  Dacarbazine (JAN/USP/INN)|Drug groups [BR:br08330(D00288)]|Antineoplastic|DG01677  Alkylating agent|DG00680  Dacarbazine|D00288  Dacarbazine,
C06938,Danazol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00289)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03XA Antigonadotropins and similar agents|G03XA01 Danazol|D00289  Danazol (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00289)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Androgens|Danazol|D00289  Danazol (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00289)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D00289  Danazol (JP18/USP/INN)|Drug groups [BR:br08330(D00289)]|Hormonal agent|DG01590  Androgen receptor agonist|D00289  Danazol|DG01666  Progesterone receptor agonist|D00289  Danazol|Target-based classification of drugs [BR:br08310(D00289)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A1 (ESR1)|D00289  Danazol (JP18/USP/INN) &lt;JP/US&gt;|3-Ketosteroid receptor|NR3C3 (PGR)|D00289  Danazol (JP18/USP/INN) &lt;JP/US&gt;|NR3C4 (AR)|D00289  Danazol (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00289)]|Chemicals|D00289  Danazol",
C06939,Dantrolene,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02347)]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS|M03CA Dantrolene and derivatives|M03CA01 Dantrolene|D02347  Dantrolene (USAN/INN)|Drug groups [BR:br08330(D02347)]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG00778  Dantrolene|D02347  Dantrolene|Metabolizing enzyme substrate|DG01891  CYP1A1 substrate|DG00778  Dantrolene|D02347  Dantrolene|DG01892  CYP1A2 substrate|DG00778  Dantrolene|D02347  Dantrolene|DG01633  CYP3A/CYP3A4 substrate|DG00778  Dantrolene|D02347  Dantrolene|Drug metabolizing enzymes and transporters [br08309.html(D02347)]|Drug metabolizing enzymes|D02347",
C06940,Deferoxamine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C06940  Deferoxamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03670)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AC Iron chelating agents|V03AC01 Deferoxamine|D03670  Deferoxamine (USAN)|Drug groups [BR:br08330(D03670)]|Vitamin and mineral|DG01692  Chelator|DG01691  Iron chelator|DG01159  Deferoxamine|D03670  Deferoxamine,
C06941,Delavirdine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07782)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AG Non-nucleoside reverse transcriptase inhibitors|J05AG02 Delavirdine|D07782  Delavirdine (INN)|Drug groups [BR:br08330(D07782)]|Antiviral|DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)|DG00662  Delavirdine|D07782  Delavirdine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|DG00662  Delavirdine|D07782  Delavirdine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00662  Delavirdine|D07782  Delavirdine|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00662  Delavirdine|D07782  Delavirdine|Antimicrobials [BR:br08307(D07782)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D07782  Delavirdine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07782)]|Drug metabolizing enzymes|D07782,
C06943,Desipramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07791)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA01 Desipramine|D07791  Desipramine (INN)|Drug groups [BR:br08330(D07791)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00927  Desipramine|D07791  Desipramine|DG01728  Tricyclic antidepressant|DG00927  Desipramine|D07791  Desipramine|Target-based classification of drugs [BR:br08310(D07791)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07791  Desipramine (INN)|SLC6A4 (HTT)|D07791  Desipramine (INN)|Prodrugs [br08324.html(D07791)]|D07791|Prodrugs [br08324.html]|C06943,
C06944,Desmopressin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00291)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01B POSTERIOR PITUITARY LOBE HORMONES|H01BA Vasopressin and analogues|H01BA02 Desmopressin|D00291  Desmopressin (INN)|Drug groups [BR:br08330(D00291)]|Cardiovascular agent|DG01952  Vasopressin analog|DG00497  Desmopressin|D00291  Desmopressin|Target-based classification of drugs [BR:br08310(D00291)]|G Protein-coupled receptors|Rhodopsin family|Vasopressin|AVPR2|D00291  Desmopressin (INN)|Not elsewhere classified|Organismal systems|Complement and coagulation|F8|D00291  Desmopressin (INN)",
C06946,Dexchlorpheniramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07803)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB02 Dexchlorpheniramine|D07803  Dexchlorpheniramine (INN)|Drug groups [BR:br08330(D07803)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01098  Dexchlorpheniramine|D07803  Dexchlorpheniramine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG01098  Dexchlorpheniramine|D07803  Dexchlorpheniramine|DG01633  CYP3A/CYP3A4 substrate|DG01098  Dexchlorpheniramine|D07803  Dexchlorpheniramine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG01098  Dexchlorpheniramine|D07803  Dexchlorpheniramine|Target-based classification of drugs [BR:br08310(D07803)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07803  Dexchlorpheniramine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07803)]|Drug metabolizing enzymes|D07803,
C06947,Dextromethorphan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03742)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|R05DA Opium alkaloids and derivatives|R05DA09 Dextromethorphan|D03742  Dextromethorphan (USP)|Risk category of Japanese OTC drugs [BR:br08312(D03742)]|Second-class OTC drugs|Inorganic and organic chemicals|Dextromethorphan|D03742  Dextromethorphan (USP)|Drug groups [BR:br08330(D03742)]|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|DG01078  Dextromethorphan|D03742  Dextromethorphan|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG01078  Dextromethorphan|D03742  Dextromethorphan|Target-based classification of drugs [BR:br08310(D03742)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D03742  Dextromethorphan (USP)|Transporters|Other transporters|Auxiliary transport proteins (TC:8.A)|SIGMAR1|D03742  Dextromethorphan (USP)|Drug metabolizing enzymes and transporters [br08309.html(D03742)]|Drug metabolizing enzymes|D03742",
C06948,Diazepam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00293)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BA Benzodiazepine derivatives|N05BA01 Diazepam|D00293  Diazepam (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00293)]|Anticonvulsants|Gamma-aminobutyric Acid (GABA) Augmenting Agents|Benzodiazepines|Diazepam|D00293  Diazepam (JP18/USP/INN)|Anxiolytics|Benzodiazepines|Diazepam|D00293  Diazepam (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00293)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00293  Diazepam (JP18/USP/INN)|113  Antiepileptics|1139  Others|D00293  Diazepam (JP18/USP/INN)|Drug groups [BR:br08330(D00293)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D00293  Diazepam|DG01567  GABA-A receptor agonist|D00293  Diazepam|DG01914  Anxiolytics, benzodiazepine derivatives|D00293  Diazepam|DG03199  Antiepileptic agent|D00293  Diazepam|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D00293  Diazepam|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00293  Diazepam|Drug classes [BR:br08332(D00293)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00293  Diazepam|Target-based classification of drugs [BR:br08310(D00293)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00293  Diazepam (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00293)]|Chemicals|D00293  Diazepam|D00293  Diazepam tablets|Drug metabolizing enzymes and transporters [br08309.html(D00293)]|Drug metabolizing enzymes|D00293|Pharmacogenomic biomarkers [br08341.html(D00293)]|Polymorphisms and mutations affecting drug response|D00293|Narcotics and psychotropics in Japan [br08308.html(D00293)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D00293",
C06949,Diazoxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00294)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|C02DA Thiazide derivatives|C02DA01 Diazoxide|D00294  Diazoxide (JAN/USP/INN) &lt;JP/US&gt;|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AH Drugs for treatment of hypoglycemia|V03AH01 Diazoxide|D00294  Diazoxide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00294)]|Blood Glucose Regulators|Glycemic Agents|Diazoxide|D00294  Diazoxide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00294)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00294  Diazoxide (JAN/USP/INN)|Drug groups [BR:br08330(D00294)]|Cardiovascular agent|DG01583  ATP-sensitive potassium channel opener|D00294  Diazoxide|Target-based classification of drugs [BR:br08310(D00294)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D00294  Diazoxide (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00294)]|Drugs with new active ingredients|D00294",
C06950,Dicloxacillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02348)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF01 Dicloxacillin|D02348  Dicloxacillin (USAN/INN)|Drug groups [BR:br08330(D02348)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00540  Dicloxacillin|D02348  Dicloxacillin|DG01779  beta-Lactamase resistant penicillin|DG00540  Dicloxacillin|D02348  Dicloxacillin|Antimicrobials [BR:br08307(D02348)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D02348  Dicloxacillin (USAN/INN)",
C06951,Dicyclomine;|Dicycloverin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07820)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AA Synthetic anticholinergics, esters with tertiary amino group|A03AA07 Dicycloverine|D07820  Dicycloverine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07820)]|Second-class OTC drugs|Inorganic and organic chemicals|Dicycloverine|D07820  Dicycloverine (INN)|Drug groups [BR:br08330(D07820)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00032  Dicycloverine|D07820  Dicycloverine|Target-based classification of drugs [BR:br08310(D07820)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM1|D07820  Dicycloverine (INN)|CHRM2|D07820  Dicycloverine (INN)|CHRM3|D07820  Dicycloverine (INN)",
C06952,Cimetidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00295)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BA H2-receptor antagonists|A02BA01 Cimetidine|D00295  Cimetidine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00295)]|Gastrointestinal Agents|Histamine2 (H2) Receptor Antagonists|Cimetidine|D00295  Cimetidine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00295)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2325  H2 blockers|D00295  Cimetidine (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00295)]|Agents for digestive organs|09 Histamine H2 receptor blocker containing drugs|D00295  Cimetidine (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00295)]|First-class OTC drugs|Inorganic and organic chemicals|Cimetidine|D00295  Cimetidine (JP18/USP/INN)|Drug groups [BR:br08330(D00295)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01481  Histamine receptor H2 antagonist|DG00017  Cimetidine|D00295  Cimetidine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00017  Cimetidine|D00295  Cimetidine|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00017  Cimetidine|D00295  Cimetidine|Drug classes [BR:br08332(D00295)]|Gastrointestinal agent|DG01481  Histamine receptor H2 antagonist|D00295  Cimetidine|Target-based classification of drugs [BR:br08310(D00295)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH2|D00295  Cimetidine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00295)]|Chemicals|D00295  Cimetidine|Drug metabolizing enzymes and transporters [br08309.html(D00295)]|Drug metabolizing enzymes|D00295|Rx-to-OTC switch list in the USA [br08315.html(D00295)]|D00295|Rx-to-OTC switch list in Japan [br08314.html(D00295)]|D00295,
C06953,Didanosine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00296)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF02 Didanosine|D00296  Didanosine (JAN/USP/INN)|Drug groups [BR:br08330(D00296)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D00296  Didanosine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00296  Didanosine|Antimicrobials [BR:br08307(D00296)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00296  Didanosine (JAN/USP/INN)|Antimicrobials abbreviations [BR:br08327(D00296)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00296  Didanosine (JAN/USP/INN),
C06954,Diethylpropion;|Amfepramone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07444)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AA Centrally acting antiobesity products|A08AA03 Amfepramone|D07444  Amfepramone (INN)|Drug groups [BR:br08330(D07444)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG00104  Amfepramone|D07444  Amfepramone|Target-based classification of drugs [BR:br08310(D07444)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07444  Amfepramone (INN)|SLC6A3 (DAT1)|D07444  Amfepramone (INN)|Narcotics and psychotropics in Japan [br08308.html(D07444)]|Psychotropics by Cabinet order Article 3 (78 substances)|D07444",
C06955,Digitoxin,,,,Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C06955  Digitoxin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C06955  Digitoxin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C06955  Digitoxin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C06955  Digitoxin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C06955  Digitoxin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00297)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA04 Digitoxin|D00297  Digitoxin (JAN/USP/INN)|Drug groups [BR:br08330(D00297)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D00297  Digitoxin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00297  Digitoxin|Transporter substrate|DG01665  ABCB1 substrate|D00297  Digitoxin|Target-based classification of drugs [BR:br08310(D00297)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D00297  Digitoxin (JAN/USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00297)]|Drug metabolizing enzymes|D00297|Drug transporters|D00297,
C06956,Digoxin,,,,"Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C06956  Digoxin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C06956  Digoxin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C06956  Digoxin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C06956  Digoxin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C06956  Digoxin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00298)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA05 Digoxin|D00298  Digoxin (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00298)]|Cardiovascular Agents|Antiarrhythmics|Vaughn Williams-Class V|Digoxin|D00298  Digoxin (JP18/USP)|Cardiovascular Agents, Other|Digoxin|D00298  Digoxin (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00298)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2113  Digitalis|D00298  Digoxin (JP18/USP)|Drug groups [BR:br08330(D00298)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D00298  Digoxin|DG01653  Antiarrhythmics|D00298  Digoxin|Transporter substrate|DG01665  ABCB1 substrate|D00298  Digoxin|Drug classes [BR:br08332(D00298)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00298  Digoxin|Target-based classification of drugs [BR:br08310(D00298)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D00298  Digoxin (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00298)]|Chemicals|D00298  Digoxin|D00298  Digoxin tablets|D00298  Digoxin injection|Drug metabolizing enzymes and transporters [br08309.html(D00298)]|Drug transporters|D00298",
C06957,Dihydrotachysterol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C06957  Dihydrotachysterol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00299)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CC Vitamin D and analogues|A11CC02 Dihydrotachysterol|D00299  Dihydrotachysterol (JAN/USP/INN)|Drug groups [BR:br08330(D00299)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D00299  Dihydrotachysterol|Target-based classification of drugs [BR:br08310(D00299)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00299  Dihydrotachysterol (JAN/USP/INN)",
C06958,Diltiazem,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07845)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AE Muscle relaxants|C05AE03 Diltiazem|D07845  Diltiazem (INN)|C08 CALCIUM CHANNEL BLOCKERS|C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS|C08DB Benzothiazepine derivatives|C08DB01 Diltiazem|D07845  Diltiazem (INN)|Drug groups [BR:br08330(D07845)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00331  Diltiazem|D07845  Diltiazem|DG01653  Antiarrhythmics|DG00331  Diltiazem|D07845  Diltiazem|DG03231  Antihypertensive|DG00331  Diltiazem|D07845  Diltiazem|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00331  Diltiazem|D07845  Diltiazem|Target-based classification of drugs [BR:br08310(D07845)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D07845  Diltiazem (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07845)]|Drug metabolizing enzymes|D07845,
C06960,Diphenhydramine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00300)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA32 Diphenhydramine|D00300  Diphenhydramine (JP18/INN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA02 Diphenhydramine|D00300  Diphenhydramine (JP18/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00300)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2642  Antihistamines for external use|D00300  Diphenhydramine (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00300)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00300  Diphenhydramine (JP18/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00300)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00300  Diphenhydramine (JP18/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00300  Diphenhydramine (JP18/INN)|Third-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00300  Diphenhydramine (JP18/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9532  Anti-histaminic and preparations|C06960  Diphenhydramine|Drug groups [BR:br08330(D00300)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00390  Diphenhydramine|D00300  Diphenhydramine|Drug classes [BR:br08332(D00300)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00300  Diphenhydramine|Target-based classification of drugs [BR:br08310(D00300)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00300  Diphenhydramine (JP18/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00300)]|Chemicals|D00300  Diphenhydramine",
C06961,Diphenidol,,,,Risk category of Japanese OTC drugs [BR:br08312(D03858)]|Second-class OTC drugs|Inorganic and organic chemicals|Diphenidol|D03858  Diphenidol (USAN/INN)|Target-based classification of drugs [BR:br08310(D03858)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D03858  Diphenidol (USAN/INN),
C06963,Dipivefrin;|Dipivefrine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02349)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EA Sympathomimetics in glaucoma therapy|S01EA02 Dipivefrine|D02349  Dipivefrin (USAN)|Drug groups [BR:br08330(D02349)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01129  Dipivefrine|D02349  Dipivefrin|DG01951  Catecholamine adrenergic receptor agonist|DG01129  Dipivefrine|D02349  Dipivefrin|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01129  Dipivefrine|D02349  Dipivefrin|Target-based classification of drugs [BR:br08310(D02349)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D02349  Dipivefrin (USAN)|ADRA2|D02349  Dipivefrin (USAN)|ADRB|D02349  Dipivefrin (USAN)|Prodrugs [br08324.html]|C06963,
C06965,Disopyramide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00303)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA03 Disopyramide|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D00303)]|Cardiovascular Agents|Antiarrhythmics|Vaughn Williams-Class I|Disopyramide|D00303  Disopyramide (JP18/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00303)]|2  Agents affecting individual organs|21  Cardiovascular agents|212  Antiarrhythmic agents|2129  Others|D00303  Disopyramide (JP18/USAN/INN)|Drug groups [BR:br08330(D00303)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG00194  Disopyramide|D00303  Disopyramide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00194  Disopyramide|D00303  Disopyramide|Drug classes [BR:br08332(D00303)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00303  Disopyramide|Target-based classification of drugs [BR:br08310(D00303)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN2A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN3A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN4A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN5A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN8A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN9A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN10A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|SCN11A|D00303  Disopyramide (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00303)]|Chemicals|D00303  Disopyramide|Drug metabolizing enzymes and transporters [br08309.html(D00303)]|Drug metabolizing enzymes|D00303",
C06967,Dobutamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03879)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA07 Dobutamine|D03879  Dobutamine (USAN/INN)|Drug groups [BR:br08330(D03879)]|Cardiovascular agent|DG01703  Cardiotonic|DG01699  Catecholamine cardiotonic|DG00216  Dobutamine|D03879  Dobutamine|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01451  beta1-Adrenergic receptor agonist|DG00216  Dobutamine|D03879  Dobutamine|DG01951  Catecholamine adrenergic receptor agonist|DG00216  Dobutamine|D03879  Dobutamine|Target-based classification of drugs [BR:br08310(D03879)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D03879  Dobutamine (USAN/INN),
C06969,Dorzolamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07871)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EC Carbonic anhydrase inhibitors|S01EC03 Dorzolamide|D07871  Dorzolamide (INN)|Drug groups [BR:br08330(D07871)]|Cardiovascular agent|DG01534  Carbonic anhydrase inhibitor|DG01135  Dorzolamide|D07871  Dorzolamide|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01135  Dorzolamide|D07871  Dorzolamide|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG01135  Dorzolamide|D07871  Dorzolamide|DG01639  CYP2C19 substrate|DG01135  Dorzolamide|D07871  Dorzolamide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01135  Dorzolamide|D07871  Dorzolamide|Target-based classification of drugs [BR:br08310(D07871)]|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA|D07871  Dorzolamide (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07871)]|Drug metabolizing enzymes|D07871,
C06970,Doxazosin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07874)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING|C02CA Alpha-adrenoreceptor antagonists|C02CA04 Doxazosin|D07874  Doxazosin (INN)|Drug groups [BR:br08330(D07874)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00256  Doxazosin|D07874  Doxazosin|DG01739  Peripherally-acting antiadrenergic|DG00256  Doxazosin|D07874  Doxazosin|DG03231  Antihypertensive|DG00256  Doxazosin|D07874  Doxazosin|Target-based classification of drugs [BR:br08310(D07874)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D07874  Doxazosin (INN)",
C06971,Doxepin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07875)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AX Other antipruritics|D04AX01 Doxepin|D07875  Doxepin (INN)|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA12 Doxepin|D07875  Doxepin (INN)|Drug groups [BR:br08330(D07875)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00937  Doxepin|D07875  Doxepin|DG01728  Tricyclic antidepressant|DG00937  Doxepin|D07875  Doxepin|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00937  Doxepin|D07875  Doxepin|DG01642  CYP2C9 substrate|DG00937  Doxepin|D07875  Doxepin|DG01639  CYP2C19 substrate|DG00937  Doxepin|D07875  Doxepin|DG01644  CYP2D6 substrate|DG00937  Doxepin|D07875  Doxepin|Target-based classification of drugs [BR:br08310(D07875)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07875  Doxepin (INN)|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07875  Doxepin (INN)|SLC6A4 (HTT)|D07875  Doxepin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07875)]|Drug metabolizing enzymes|D07875",
C06972,Dronabinol;|Delta9-Tetrahydrocannabinol;|Tetrahydrocannabinol;|THC,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C06972  Tetrahydrocannabinol|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C06972  Tetrahydrocannabinol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C06972|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00306)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AD Other antiemetics|A04AD10 Dronabinol|D00306  Dronabinol (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00306)]|Antiemetics|Emetogenic Therapy Adjuncts|Dronabinol|D00306  Dronabinol (USP/INN)|Drug groups [BR:br08330(D00306)]|Gastrointestinal agent|DG01762  Antiemetic|D00306  Dronabinol|Target-based classification of drugs [BR:br08310(D00306)]|G Protein-coupled receptors|Rhodopsin family|Cannabinoid|CNR|D00306  Dronabinol (USP/INN) &lt;US&gt;|Pharmacogenomic biomarkers [br08341.html(D00306)]|Polymorphisms and mutations affecting drug response|D00306|Narcotics and psychotropics in Japan [br08308.html(D00306)]|Narcotics by Cabinet Order Article 1 (157 substances)|D00306|Opium and Cannabis|D00306,
C06973,Doxycycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C06973  Doxycycline|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07876)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB22 Doxycycline|D07876  Doxycycline (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA02 Doxycycline|D07876  Doxycycline (INN)|Drug groups [BR:br08330(D07876)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00008  Doxycycline|D07876  Doxycycline|Antimicrobials [BR:br08307(D07876)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D07876  Doxycycline (INN),
C06975,Echothiophate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB03 Ecothiopate|C06975  Echothiophate|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG01131  Ecothiopate|C06975  Echothiophate|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01131  Ecothiopate|C06975  Echothiophate,G01131
C06976,Edrophonium,,,,,
C06977,Enalapril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07892)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA02 Enalapril|D07892  Enalapril (INN)|Drug groups [BR:br08330(D07892)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00335  Enalapril|D07892  Enalapril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00335  Enalapril|D07892  Enalapril|Target-based classification of drugs [BR:br08310(D07892)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D07892  Enalapril (INN)|Prodrugs [br08324.html(D07892)]|D07892|Prodrugs [br08324.html]|C06977",
C06978,Encainide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07894)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BC Antiarrhythmics, class Ic|C01BC08 Encainide|D07894  Encainide (INN)|Drug groups [BR:br08330(D07894)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01650  Class Ic antiarrhythmic agent|DG00203  Encainide|D07894  Encainide|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00203  Encainide|D07894  Encainide|Target-based classification of drugs [BR:br08310(D07894)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D07894  Encainide (INN)|SCN2A|D07894  Encainide (INN)|SCN3A|D07894  Encainide (INN)|SCN4A|D07894  Encainide (INN)|SCN5A|D07894  Encainide (INN)|SCN8A|D07894  Encainide (INN)|SCN9A|D07894  Encainide (INN)|SCN10A|D07894  Encainide (INN)|SCN11A|D07894  Encainide (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07894)]|Drug metabolizing enzymes|D07894",
C06979,Enoxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00310)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA04 Enoxacin|D00310  Enoxacin (USAN/INN)|Drug groups [BR:br08330(D00310)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00619  Enoxacin|D00310  Enoxacin|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00619  Enoxacin|D00310  Enoxacin|Antimicrobials [BR:br08307(D00310)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00310  Enoxacin (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00310)]|Drug metabolizing enzymes|D00310,
C06980,Esmolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07916)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB09 Esmolol|D07916  Esmolol (INN)|Drug groups [BR:br08330(D07916)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00318  Esmolol|D07916  Esmolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00318  Esmolol|D07916  Esmolol|Target-based classification of drugs [BR:br08310(D07916)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D07916  Esmolol (INN)",
C06981,Estazolam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00311)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD04 Estazolam|D00311  Estazolam (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00311)]|Sleep Disorder Agents|Sleep Promoting Agents|Estazolam|D00311  Estazolam (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00311)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00311  Estazolam (JP18/USP/INN)|Drug groups [BR:br08330(D00311)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D00311  Estazolam|DG03202  Hypnotic|D00311  Estazolam|DG01567  GABA-A receptor agonist|D00311  Estazolam|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00311  Estazolam|Drug classes [BR:br08332(D00311)]|Neuropsychiatric agent|DG03202  Hypnotic|D00311  Estazolam|Target-based classification of drugs [BR:br08310(D00311)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00311  Estazolam (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00311)]|Chemicals|D00311  Estazolam|Drug metabolizing enzymes and transporters [br08309.html(D00311)]|Drug metabolizing enzymes|D00311|Narcotics and psychotropics in Japan [br08308.html(D00311)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00311",
C06984,Ethambutol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07925)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AK Other drugs for treatment of tuberculosis|J04AK02 Ethambutol|D07925  Ethambutol (INN)|Drug groups [BR:br08330(D07925)]|Antibacterial|DG01966  Antitubercular|DG00643  Ethambutol|D07925  Ethambutol|Antimicrobials [BR:br08307(D07925)]|Antibacterials|Other antibacterials|Arabinosyltransferase inhibitor|D07925  Ethambutol (INN),
C06986,Spirodilactone,,,,,
C06988,"beta-1,2,3,4,5,6-Hexachlorocyclohexane;|beta-Hexachlorocyclohexane;|beta-BHC;|beta-Lindane",,,,Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C06988  beta-Hexachlorocyclohexane,
C06989,"delta-3,4,5,6-Tetrachlorocyclohexene;|3,4,5,6-Tetrachlorocyclohexene",,,,,
C06990,Chlorobenzene;|Monochlorobenzene;|Benzene chloride;|Phenyl chloride,,,,,
C06991,Etodolac,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00315)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB08 Etodolac|D00315  Etodolac (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00315)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Etodolac|D00315  Etodolac (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00315)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00315  Etodolac (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C06991  Etodolac|Drug groups [BR:br08330(D00315)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|D00315  Etodolac|DG01922  Selective COX2 inhibitor|D00315  Etodolac|Drug classes [BR:br08332(D00315)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00315  Etodolac|D00315  Etodolac|Target-based classification of drugs [BR:br08310(D00315)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D00315  Etodolac (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00315)]|Chemicals|D00315  Etodolac",
C06996,Fenfluramine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07945)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AA Centrally acting antiobesity products|A08AA02 Fenfluramine|D07945  Fenfluramine (INN)|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX26 Fenfluramine|D07945  Fenfluramine (INN)|USP drug classification [BR:br08302(D07945)]|Anticonvulsants|Anticonvulsants, Other|Fenfluramine|D07945  Fenfluramine (INN)|Drug groups [BR:br08330(D07945)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG00103  Fenfluramine|D07945  Fenfluramine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG02919  CYP2B6 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG01642  CYP2C9 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG01639  CYP2C19 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG01644  CYP2D6 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|DG02925  CYP3A5 substrate|DG00103  Fenfluramine|D07945  Fenfluramine|Target-based classification of drugs [BR:br08310(D07945)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1D|D07945  Fenfluramine (INN)|HTR2A|D07945  Fenfluramine (INN)|HTR2C|D07945  Fenfluramine (INN)|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D07945  Fenfluramine (INN)|Other transporters|Auxiliary transport proteins (TC:8.A)|SIGMAR1|D07945  Fenfluramine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07945)]|Drug metabolizing enzymes|D07945",
C06997,Fenoprofen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02350)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE04 Fenoprofen|D02350  Fenoprofen (USAN/INN)|Drug groups [BR:br08330(D02350)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|DG00754  Fenoprofen|D02350  Fenoprofen|Target-based classification of drugs [BR:br08310(D02350)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D02350  Fenoprofen (USAN/INN)|PTGS2 (COX2)|D02350  Fenoprofen (USAN/INN)",
C06999,"Fexofenadine;|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07958)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX26 Fexofenadine|D07958  Fexofenadine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07958)]|Second-class OTC drugs|Inorganic and organic chemicals|Fexofenadine|D07958  Fexofenadine (INN)|Drug groups [BR:br08330(D07958)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01117  Fexofenadine|D07958  Fexofenadine|Target-based classification of drugs [BR:br08310(D07958)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07958  Fexofenadine (INN),
C07001,Flecainide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07962)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BC Antiarrhythmics, class Ic|C01BC04 Flecainide|D07962  Flecainide (INN)|Drug groups [BR:br08330(D07962)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01650  Class Ic antiarrhythmic agent|DG00201  Flecainide|D07962  Flecainide|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00201  Flecainide|D07962  Flecainide|Target-based classification of drugs [BR:br08310(D07962)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D07962  Flecainide (INN)|SCN2A|D07962  Flecainide (INN)|SCN3A|D07962  Flecainide (INN)|SCN4A|D07962  Flecainide (INN)|SCN5A|D07962  Flecainide (INN)|SCN8A|D07962  Flecainide (INN)|SCN9A|D07962  Flecainide (INN)|SCN10A|D07962  Flecainide (INN)|SCN11A|D07962  Flecainide (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07962)]|Drug metabolizing enzymes|D07962",
C07002,Fluconazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00322)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC15 Fluconazole|D00322  Fluconazole (JP18/USP/INN) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AC Triazole and tetrazole derivatives|J02AC01 Fluconazole|D00322  Fluconazole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00322)]|Antifungals|Fluconazole|D00322  Fluconazole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00322)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|629  Miscellaneous|6290  Miscellaneous|D00322  Fluconazole (JP18/USP/INN)|Drug groups [BR:br08330(D00322)]|Antifungal|DG01523  Triazole antifungal|DG00371  Fluconazole|D00322  Fluconazole|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|DG00371  Fluconazole|D00322  Fluconazole|DG01933  CYP2C19 inhibitor|DG00371  Fluconazole|D00322  Fluconazole|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00371  Fluconazole|D00322  Fluconazole|Drug classes [BR:br08332(D00322)]|Antifungal|DG01523  Triazole antifungal|D00322  Fluconazole|Antimicrobials [BR:br08307(D00322)]|Antifungals|Ergosterol biosynthesis inhibitor|Triazole|D00322  Fluconazole (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00322)]|Chemicals|D00322  Fluconazole|D00322  Fluconazole capsules|D00322  Fluconazole injection|Drug metabolizing enzymes and transporters [br08309.html(D00322)]|Drug metabolizing enzymes|D00322|Prodrugs [br08324.html(D00322)]|D00322|Prodrugs [br08324.html]|C07002,
C07004,Fludrocortisone,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07004  Fludrocortisone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07967)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AA Mineralocorticoids|H02AA02 Fludrocortisone|D07967  Fludrocortisone (INN)|Drug groups [BR:br08330(D07967)]|Anti-inflammatory|DG01955  Corticosteroid|DG00506  Fludrocortisone|D07967  Fludrocortisone|Target-based classification of drugs [BR:br08310(D07967)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D07967  Fludrocortisone (INN)",
C07005,Flunisolide;|Flunisolide anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD04 Flunisolide|C07005  Flunisolide|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA03 Flunisolide|C07005  Flunisolide|Drug groups [BR:br08330]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG01040  Flunisolide|C07005  Flunisolide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01040  Flunisolide|C07005  Flunisolide",G01040
C07006,Fluocinolone,,,,,
C07007,Fluocinonide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00325)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA11 Fluocinonide|D00325  Fluocinonide (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC08 Fluocinonide|D00325  Fluocinonide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00325)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, High Potency|Fluocinonide|D00325  Fluocinonide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00325)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D00325  Fluocinonide (JP18/USP/INN)|Drug groups [BR:br08330(D00325)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|D00325  Fluocinonide|Dermatological agent|DG03243  Atopic dermatitis agent|D00325  Fluocinonide|Drug classes [BR:br08332(D00325)]|Anti-inflammatory|DG01955  Corticosteroid|D00325  Fluocinonide|Dermatological agent|DG03243  Atopic dermatitis agent|D00325  Fluocinonide|Target-based classification of drugs [BR:br08310(D00325)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00325  Fluocinonide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00325)]|Chemicals|D00325  Fluocinonide|Topical steroids potency [br08317.html(D00325)]|Classification in the USA|D00325|Classification in Japan|D00325",
C07010,Fluphenazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07977)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB02 Fluphenazine|D07977  Fluphenazine (INN)|Drug groups [BR:br08330(D07977)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00874  Fluphenazine|D07977  Fluphenazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00874  Fluphenazine|D07977  Fluphenazine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00874  Fluphenazine|D07977  Fluphenazine|Target-based classification of drugs [BR:br08310(D07977)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D07977  Fluphenazine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07977)]|Drug metabolizing enzymes|D07977|Prodrugs [br08324.html(D07977)]|D07977|Prodrugs [br08324.html]|C07010,
C07013,Flurbiprofen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00330)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE09 Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA19 Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AX Other throat preparations|R02AX01 Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC04 Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00330)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Nonsteroidal Anti-Inflammatory Drugs, Ophthalmic|Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00330)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00330  Flurbiprofen (JP18/USP/INN)|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D00330  Flurbiprofen (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00330)]|Drugs requiring guidance|New approved switch OTC drugs|Flurbiprofen|D00330  Flurbiprofen (JP18/USP/INN)|Drug groups [BR:br08330(D00330)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|DG00755  Flurbiprofen|D00330  Flurbiprofen|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00755  Flurbiprofen|D00330  Flurbiprofen|Drug classes [BR:br08332(D00330)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00330  Flurbiprofen|Target-based classification of drugs [BR:br08310(D00330)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00330  Flurbiprofen (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00330)]|Chemicals|D00330  Flurbiprofen|Drug metabolizing enzymes and transporters [br08309.html(D00330)]|Drug metabolizing enzymes|D00330|Pharmacogenomic biomarkers [br08341.html(D00330)]|Polymorphisms and mutations affecting drug response|D00330|Prodrugs [br08324.html(D00330)]|D00330|Prodrugs [br08324.html]|C07013",
C07014,Fluvastatin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07983)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AA HMG CoA reductase inhibitors|C10AA04 Fluvastatin|D07983  Fluvastatin (INN)|Drug groups [BR:br08330(D07983)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01660  HMG-CoA reductase inhibitor|DG00354  Fluvastatin|D07983  Fluvastatin|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00354  Fluvastatin|D07983  Fluvastatin|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00354  Fluvastatin|D07983  Fluvastatin|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|DG00354  Fluvastatin|D07983  Fluvastatin|Transporter substrate|DG02856  SLCO1B1 substrate|DG00354  Fluvastatin|D07983  Fluvastatin|Transporter inhibitor|DG02882  ABCB11 inhibitor|DG00354  Fluvastatin|D07983  Fluvastatin|Target-based classification of drugs [BR:br08310(D07983)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HMGCR|D07983  Fluvastatin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07983)]|Drug metabolizing enzymes|D07983|Drug transporters|D07983",
C07016,Fosinopril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07992)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA09 Fosinopril|D07992  Fosinopril (INN)|Drug groups [BR:br08330(D07992)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00341  Fosinopril|D07992  Fosinopril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00341  Fosinopril|D07992  Fosinopril|Target-based classification of drugs [BR:br08310(D07992)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D07992  Fosinopril (INN)|Prodrugs [br08324.html(D07992)]|D07992|Prodrugs [br08324.html]|C07016",
C07017,Furosemide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00331)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03C HIGH-CEILING DIURETICS|C03CA Sulfonamides, plain|C03CA01 Furosemide|D00331  Furosemide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00331)]|Cardiovascular Agents|Diuretics, Loop|Furosemide|D00331  Furosemide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00331)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2139  Others|D00331  Furosemide (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|922  Diuretics|9229  Other diuretics|C07017  Furosemide|Drug groups [BR:br08330(D00331)]|Cardiovascular agent|DG01690  Sulfonamide diuretic|DG01747  Furosemide type diuretic|DG00272  Furosemide|D00331  Furosemide|DG01748  Loop diuretic|DG01747  Furosemide type diuretic|DG00272  Furosemide|D00331  Furosemide|Transporter substrate|DG02920  ABCC4 substrate|DG00272  Furosemide|D00331  Furosemide|DG02859  SLC22A6 substrate|DG00272  Furosemide|D00331  Furosemide|DG02860  SLC22A8 substrate|DG00272  Furosemide|D00331  Furosemide|Target-based classification of drugs [BR:br08310(D00331)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D00331  Furosemide (JP18/USP/INN) &lt;JP/US&gt;|SLC12A2 (NKCC1)|D00331  Furosemide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00331)]|Chemicals|D00331  Furosemide|D00331  Furosemide tablets|D00331  Furosemide injection|Drug metabolizing enzymes and transporters [br08309.html(D00331)]|Drug transporters|D00331",
C07018,Gabapentin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00332)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BF Gabapentinoids|N02BF01 Gabapentin|D00332  Gabapentin (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00332)]|Anticonvulsants|Gamma-aminobutyric Acid (GABA) Augmenting Agents|GABA Agents, Other|Gabapentin|D00332  Gabapentin (JAN/USP/INN)|Central Nervous System Agents|Central Nervous System, Other|Gabapentin|D00332  Gabapentin (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00332)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00332  Gabapentin (JAN/USP/INN)|Drug groups [BR:br08330(D00332)]|Neuropsychiatric agent|DG01574  Calcium channel alpha-2 delta blocker|DG01245  Gabapentin|D00332  Gabapentin|DG03199  Antiepileptic agent|DG02037  GABA mimetic antiepileptic|DG01245  Gabapentin|D00332  Gabapentin|Drug classes [BR:br08332(D00332)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00332  Gabapentin|Target-based classification of drugs [BR:br08310(D00332)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA2D|D00332  Gabapentin (JAN/USP/INN) &lt;JP/US&gt;|Transporters|Solute carrier family|SLC6|SLC6A1 (GAT1)|D00332  Gabapentin (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00332)]|Drugs with new active ingredients|D00332|Prodrugs [br08324.html(D00332)]|D00332|Prodrugs [br08324.html]|C07018",
C07019,Ganciclovir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00333)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB06 Ganciclovir|D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AD Antivirals|S01AD09 Ganciclovir|D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00333)]|Antivirals|Anti-cytomegalovirus (CMV) Agents|Ganciclovir|D00333  Ganciclovir (JAN/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antiviral, Ophthalmic|Ganciclovir|D00333  Ganciclovir (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00333)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00333  Ganciclovir (JAN/USP/INN)|Drug groups [BR:br08330(D00333)]|Antiviral|DG02840  Anti-herpesvirus agent|DG00646  Ganciclovir|D00333  Ganciclovir|DG01937  Anti-cytomegalovirus agent|DG00646  Ganciclovir|D00333  Ganciclovir|Drug classes [BR:br08332(D00333)]|Antiviral|DG02840  Anti-herpesvirus agent|D00333  Ganciclovir|DG01937  Anti-cytomegalovirus agent|D00333  Ganciclovir|Antimicrobials [BR:br08307(D00333)]|Antivirals|Genome replication inhibitor|Herpesvirus DNA polymerase inhibitor|D00333  Ganciclovir (JAN/USP/INN) &lt;JP/US&gt;|Prodrugs [br08324.html(D00333)]|D00333|Prodrugs [br08324.html]|C07019",
C07020,Gemfibrozil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00334)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AB Fibrates|C10AB04 Gemfibrozil|D00334  Gemfibrozil (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00334)]|Cardiovascular Agents|Dyslipidemics, Fibric Acid Derivatives|Gemfibrozil|D00334  Gemfibrozil (JAN/USP/INN)|Drug groups [BR:br08330(D00334)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01733  PPAR alpha agonist|DG01547  Fibrate|D00334  Gemfibrozil|Metabolizing enzyme inhibitor|DG01641  CYP2C8 inhibitor|D00334  Gemfibrozil|Transporter inhibitor|DG02865  SLCO1B1 inhibitor|D00334  Gemfibrozil|Drug classes [BR:br08332(D00334)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D00334  Gemfibrozil|Target-based classification of drugs [BR:br08310(D00334)]|Nuclear receptors|Thyroid hormone like receptors|Peroxisome proliferator-activated receptor (PPAR)|NR1C1 (PPARA)|D00334  Gemfibrozil (JAN/USP/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00334)]|Drug metabolizing enzymes|D00334|Drug transporters|D00334",
C07022,Glyburide;|Glibenclamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00336)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BB Sulfonylureas|A10BB01 Glibenclamide|D00336  Glyburide (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00336)]|Blood Glucose Regulators|Antidiabetic Agents|Sulfonylureas|Glyburide|D00336  Glyburide (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00336)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3961  Sulfonylureas|D00336  Glyburide (USP); Glibenclamide (JP18/INN)|Drug groups [BR:br08330(D00336)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01734  Sulfonylurea|D00336  Glyburide|DG02044  Hypoglycemic agent|DG01734  Sulfonylurea|D00336  Glyburide|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00336  Glyburide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00336  Glyburide|Drug classes [BR:br08332(D00336)]|Antidiabetic agent|DG01734  Sulfonylurea|D00336  Glyburide|DG02044  Hypoglycemic agent|D00336  Glyburide|Target-based classification of drugs [BR:br08310(D00336)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D00336  Glyburide (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00336)]|Chemicals|D00336  Glibenclamide|New drug approvals in Europe [br08329.html(D00336)]|European public assessment reports (EPAR) authorised medicine|D00336|Drug metabolizing enzymes and transporters [br08309.html(D00336)]|Drug metabolizing enzymes|D00336|Pharmacogenomic biomarkers [br08341.html(D00336)]|Polymorphisms and mutations affecting drug response|D00336",
C07023,Granisetron,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04370)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AA Serotonin (5HT3) antagonists|A04AA02 Granisetron|D04370  Granisetron (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D04370)]|Antiemetics|Emetogenic Therapy Adjuncts|Granisetron|D04370  Granisetron (JAN/USAN/INN)|Drug groups [BR:br08330(D04370)]|Gastrointestinal agent|DG01489  5-HT3-receptor antagonist|DG00061  Granisetron|D04370  Granisetron|DG01762  Antiemetic|DG00061  Granisetron|D04370  Granisetron|Metabolizing enzyme substrate|DG01891  CYP1A1 substrate|DG00061  Granisetron|D04370  Granisetron|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00061  Granisetron|D04370  Granisetron|Target-based classification of drugs [BR:br08310(D04370)]|Ion channels|Ligand-gated ion channels|Serotonin|HTR3B|D04370  Granisetron (JAN/USAN/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D04370)]|European public assessment reports (EPAR) authorised medicine|D04370|Drug metabolizing enzymes and transporters [br08309.html(D04370)]|Drug metabolizing enzymes|D04370,
C07024,3'-Keto-3'-deoxy-ATP,,,,,
C07025,3'-Keto-3'-deoxy-AMP,,,,,
C07026,3'-Amino-3'-deoxy-AMP,,,,,
C07027,"N6,N6,O-Tridemethylpuromycin-5'-phosphate",,,,,
C07028,"N-Acetyl-N6,N6,O-tridemethylpuromycin-5'-phosphate",,,,,
C07029,"N-Acetyl-N6,O-didemethylpuromycin-5'-phosphate",,,,,
C07030,N-Acetyl-O-demethylpuromycin-5'-phosphate,,,,,
C07031,N-Acetyl-O-demethylpuromycin,,,,,
C07032,N-Acetylpuromycin,,,,,
C07034,Guanabenz,,,,Drug groups [BR:br08330(D04375)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG01230  Guanabenz|D04375  Guanabenz|DG03231  Antihypertensive|DG01230  Guanabenz|D04375  Guanabenz|Target-based classification of drugs [BR:br08310(D04375)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D04375  Guanabenz (USAN/INN),
C07035,Guanadrel,,,,Target-based classification of drugs [BR:br08310(D08029)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08029  Guanadrel (INN)|ADRA2|D08029  Guanadrel (INN),
C07036,Guanethidine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08030)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING|C02CC Guanidine derivatives|C02CC02 Guanethidine|D08030  Guanethidine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EX Other antiglaucoma preparations|S01EX01 Guanethidine|D08030  Guanethidine (INN)|Drug groups [BR:br08330(D08030)]|Cardiovascular agent|DG01739  Peripherally-acting antiadrenergic|DG00258  Guanethidine|D08030  Guanethidine|Neuropsychiatric agent|DG03085  Selective norepinephrine reuptake inhibitor (NRI)|DG00258  Guanethidine|D08030  Guanethidine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00258  Guanethidine|D08030  Guanethidine|Target-based classification of drugs [BR:br08310(D08030)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08030  Guanethidine (INN)",
C07037,Guanfacine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08031)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AC Imidazoline receptor agonists|C02AC02 Guanfacine|D08031  Guanfacine (INN)|Drug groups [BR:br08330(D08031)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG00250  Guanfacine|D08031  Guanfacine|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG00250  Guanfacine|D08031  Guanfacine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00250  Guanfacine|D08031  Guanfacine|DG02925  CYP3A5 substrate|DG00250  Guanfacine|D08031  Guanfacine|Target-based classification of drugs [BR:br08310(D08031)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2A|D08031  Guanfacine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08031)]|Drug metabolizing enzymes|D08031",
C07040,Hydralazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08044)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|C02DB Hydrazinophthalazine derivatives|C02DB02 Hydralazine|D08044  Hydralazine (INN)|Drug groups [BR:br08330(D08044)]|Cardiovascular agent|DG03231  Antihypertensive|DG00261  Hydralazine|D08044  Hydralazine|DG02046  Hydrazinophthalazine derivative|DG00261  Hydralazine|D08044  Hydralazine|Metabolizing enzyme substrate|DG02928  NAT substrate|DG00261  Hydralazine|D08044  Hydralazine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00261  Hydralazine|D08044  Hydralazine|Target-based classification of drugs [BR:br08310(D08044)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|AOC3|D08044  Hydralazine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08044)]|Drug metabolizing enzymes|D08044",
C07041,Hydrochlorothiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00340)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA03 Hydrochlorothiazide|D00340  Hydrochlorothiazide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00340)]|Cardiovascular Agents|Diuretics, Thiazide|Hydrochlorothiazide|D00340  Hydrochlorothiazide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00340)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2132  Thiazides|D00340  Hydrochlorothiazide (JP18/USP/INN)|214  Antihypertensives|2149  Others|D00340  Hydrochlorothiazide (JP18/USP/INN)|Drug groups [BR:br08330(D00340)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00340  Hydrochlorothiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00340  Hydrochlorothiazide|Drug classes [BR:br08332(D00340)]|Cardiovascular agent|DG03231  Antihypertensive|D00340  Hydrochlorothiazide|Target-based classification of drugs [BR:br08310(D00340)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D00340  Hydrochlorothiazide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00340)]|Chemicals|D00340  Hydrochlorothiazide",
C07042,Hydromorphone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08047)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AA Natural opium alkaloids|N02AA03 Hydromorphone|D08047  Hydromorphone (INN)|Drug groups [BR:br08330(D08047)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00811  Hydromorphone|D08047  Hydromorphone|Analgesic|DG01984  Opioid analgesics|DG00811  Hydromorphone|D08047  Hydromorphone|Metabolizing enzyme substrate|DG02924  UGT substrate|DG00811  Hydromorphone|D08047  Hydromorphone|Target-based classification of drugs [BR:br08310(D08047)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08047  Hydromorphone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08047)]|Drug metabolizing enzymes|D08047|Narcotics and psychotropics in Japan [br08308.html(D08047)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08047,
C07043,Hydroxychloroquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08050)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BA Aminoquinolines|P01BA02 Hydroxychloroquine|D08050  Hydroxychloroquine (INN)|Drug groups [BR:br08330(D08050)]|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG01015  Hydroxychloroquine|D08050  Hydroxychloroquine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01015  Hydroxychloroquine|D08050  Hydroxychloroquine|Antimicrobials [BR:br08307(D08050)]|Antiparasitics|Antmalarials|Aminoquinoline|D08050  Hydroxychloroquine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08050)]|Drug metabolizing enzymes|D08050",
C07044,Hydroxyurea;|Hydroxycarbamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00341)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX05 Hydroxycarbamide|D00341  Hydroxyurea (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00341)]|Antineoplastics|Antineoplastics, Other|Hydroxyurea|D00341  Hydroxyurea (USP)|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Hydroxyurea|D00341  Hydroxyurea (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00341)]|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4229  Others|D00341  Hydroxyurea (USP); Hydroxycarbamide (JAN/INN)|Target-based classification of drugs [BR:br08310(D00341)]|Enzymes|Oxidoreductases (EC1)|Ribonucleoside-diphosphate reductase|RRM2|D00341  Hydroxyurea (USP) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00341)]|European public assessment reports (EPAR) authorised medicine|D00341",
C07045,Hydroxyzine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08054)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BB Diphenylmethane derivatives|N05BB01 Hydroxyzine|D08054  Hydroxyzine (INN)|Drug groups [BR:br08330(D08054)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00912  Hydroxyzine|D08054  Hydroxyzine|Target-based classification of drugs [BR:br08310(D08054)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08054  Hydroxyzine (INN),
C07047,Ifosfamide;|Isophosphamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00343)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA06 Ifosfamide|D00343  Ifosfamide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00343)]|Antineoplastics|Alkylating Agents|Ifosfamide|D00343  Ifosfamide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00343)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4211  Chlorethylamines|D00343  Ifosfamide (JAN/USP/INN)|Drug groups [BR:br08330(D00343)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG01720  Isophosphoramide mustard analog|D00343  Ifosfamide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00343  Ifosfamide|Drug metabolizing enzymes and transporters [br08309.html(D00343)]|Drug metabolizing enzymes|D00343|Prodrugs [br08324.html(D00343)]|D00343|Prodrugs [br08324.html]|C07047,
C07049,Imipramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08070)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA02 Imipramine|D08070  Imipramine (INN)|Drug groups [BR:br08330(D08070)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00928  Imipramine|D08070  Imipramine|DG01728  Tricyclic antidepressant|DG00928  Imipramine|D08070  Imipramine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00928  Imipramine|D08070  Imipramine|DG01639  CYP2C19 substrate|DG00928  Imipramine|D08070  Imipramine|DG01644  CYP2D6 substrate|DG00928  Imipramine|D08070  Imipramine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00928  Imipramine|D08070  Imipramine|Target-based classification of drugs [BR:br08310(D08070)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08070  Imipramine (INN)|SLC6A4 (HTT)|D08070  Imipramine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08070)]|Drug metabolizing enzymes|D08070|Prodrugs [br08324.html(D08070)]|D08070|Prodrugs [br08324.html]|C07049,
C07051,Indinavir,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE02 Indinavir|C07051  Indinavir|Drug groups [BR:br08330]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|DG00654  Indinavir|C07051  Indinavir|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00654  Indinavir|C07051  Indinavir|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00654  Indinavir|C07051  Indinavir,G00654
C07052,Ipratropium,,,,,
C07053,Isoetharine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04625)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC07 Isoetarine|D04625  Isoetharine (USP)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC06 Isoetarine|D04625  Isoetharine (USP)|Drug groups [BR:br08330(D04625)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01234  Isoetharine|D04625  Isoetharine|DG01951  Catecholamine adrenergic receptor agonist|DG01234  Isoetharine|D04625  Isoetharine|Target-based classification of drugs [BR:br08310(D04625)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D04625  Isoetharine (USP)",
C07054,Isoniazid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00346)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AC Hydrazides|J04AC01 Isoniazid|D00346  Isoniazid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00346)]|Antimycobacterials|Antituberculars|Isoniazid|D00346  Isoniazid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00346)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|622  Tuberculosis preparations|6222  Isoniazids|D00346  Isoniazid (JP18/USP/INN)|Drug groups [BR:br08330(D00346)]|Antibacterial|DG01966  Antitubercular|DG00642  Isoniazid|D00346  Isoniazid|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00642  Isoniazid|D00346  Isoniazid|Antimicrobials [BR:br08307(D00346)]|Antibacterials|Other antibacterials|Mycolic acid biosynthesis inhibitor|D00346  Isoniazid (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00346)]|Chemicals|D00346  Isoniazid|D00346  Isoniazid tablets|D00346  Isoniazid injection,
C07055,Isopropamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB09 Isopropamide|C07055  Isopropamide|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Isopropamide|C07055  Isopropamide|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00038  Isopropamide|C07055  Isopropamide",G00038
C07056,Isoproterenol;|Isoprenaline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08090)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA02 Isoprenaline|D08090  Isoprenaline (INN)|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AB Non-selective beta-adrenoreceptor agonists|R03AB02 Isoprenaline|D08090  Isoprenaline (INN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CB Non-selective beta-adrenoreceptor agonists|R03CB01 Isoprenaline|D08090  Isoprenaline (INN)|Drug groups [BR:br08330(D08090)]|Cardiovascular agent|DG01703  Cardiotonic|DG01699  Catecholamine cardiotonic|DG00211  Isoprenaline|D08090  Isoprenaline|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG00211  Isoprenaline|D08090  Isoprenaline|DG01951  Catecholamine adrenergic receptor agonist|DG00211  Isoprenaline|D08090  Isoprenaline|Metabolizing enzyme substrate|DG01592  COMT substrate|DG00211  Isoprenaline|D08090  Isoprenaline|Target-based classification of drugs [BR:br08310(D08090)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D08090  Isoprenaline (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08090)]|Drug metabolizing enzymes|D08090",
C07058,13-cis-Retinoic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C07058  13-cis-Retinoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00348)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD04 Isotretinoin|D00348  Isotretinoin (JAN/USP) &lt;US&gt;|D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE|D10BA Retinoids for treatment of acne|D10BA01 Isotretinoin|D00348  Isotretinoin (JAN/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00348)]|Dermatological Agents|Acne and Rosacea Agents|Retinoids|Isotretinoin|D00348  Isotretinoin (JAN/USP)|Drug groups [BR:br08330(D00348)]|Vitamin and mineral|DG01604  Retinol derivative|DG00434  Isotretinoin|D00348  Isotretinoin|Target-based classification of drugs [BR:br08310(D00348)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D00348  Isotretinoin (JAN/USP) &lt;US&gt;,
C07062,Ketorolac,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08104)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB15 Ketorolac|D08104  Ketorolac (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC05 Ketorolac|D08104  Ketorolac (INN)|Drug groups [BR:br08330(D08104)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|DG00751  Ketorolac|D08104  Ketorolac|Target-based classification of drugs [BR:br08310(D08104)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D08104  Ketorolac (INN)|PTGS2 (COX2)|D08104  Ketorolac (INN)",
C07063,Labetalol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08106)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AG Alpha and beta blocking agents|C07AG01 Labetalol|D08106  Labetalol (INN)|Drug groups [BR:br08330(D08106)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG03180  alpha1 and beta-Adrenergic receptor antagonist|DG00320  Labetalol|D08106  Labetalol|DG03231  Antihypertensive|DG03180  alpha1 and beta-Adrenergic receptor antagonist|DG00320  Labetalol|D08106  Labetalol|Target-based classification of drugs [BR:br08310(D08106)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08106  Labetalol (INN)|ADRB1|D08106  Labetalol (INN)|ADRB2|D08106  Labetalol (INN),
C07064,Lactulose,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00352)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD11 Lactulose|D00352  Lactulose (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00352)]|Gastrointestinal Agents|Anti-constipation Agents|Lactulose|D00352  Lactulose (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00352)]|2  Agents affecting individual organs|23  Digestive organ agents|235  Purgatives, clysters|2359  Others|D00352  Lactulose (JP18/USP/INN)|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00352  Lactulose (JP18/USP/INN)|Drug groups [BR:br08330(D00352)]|Gastrointestinal agent|DG01770  Laxative|D00352  Lactulose|Drug classes [BR:br08332(D00352)]|Gastrointestinal agent|DG01770  Laxative|D00352  Lactulose|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00352)]|Chemicals|D00352  Lactulose",G03573
C07065,"Lamivudine;|3TC;|2',3'-Dideoxy-3'-thiacytidine",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00353)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF05 Lamivudine|D00353  Lamivudine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00353)]|Antivirals|Anti-hepatitis B (HBV) Agents|Lamivudine|D00353  Lamivudine (JAN/USP/INN)|Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)|Lamivudine|D00353  Lamivudine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00353)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00353  Lamivudine (JAN/USP/INN)|Drug groups [BR:br08330(D00353)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D00353  Lamivudine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00353  Lamivudine|Transporter substrate|DG02859  SLC22A6 substrate|D00353  Lamivudine|Drug classes [BR:br08332(D00353)]|Antiviral|DG03107  Anti-HIV agent|D00353  Lamivudine|Antimicrobials [BR:br08307(D00353)]|Antivirals|Genome replication inhibitor|HBV reverse transcriptase inhibitor|D00353  Lamivudine (JAN/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00353)]|Antivirals|Genome replication inhibitor|HBV reverse transcriptase inhibitor|D00353  Lamivudine (JAN/USP/INN)|New drug approvals in Europe [br08329.html(D00353)]|European public assessment reports (EPAR) authorised medicine|D00353|New drug approvals in Japan [br08318.html(D00353)]|Drugs with new active ingredients|D00353|Drug metabolizing enzymes and transporters [br08309.html(D00353)]|Drug transporters|D00353",
C07069,Levallorphan,,,,,
C07070,Levamisole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08114)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CE Imidazothiazole derivatives|P02CE01 Levamisole|D08114  Levamisole (INN)|Antimicrobials [BR:br08307(D08114)]|Antiparasitics|Antinematodal agents|Imidazothiazole derivatives|D08114  Levamisole (INN)",
C07072,Losartan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08146)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA01 Losartan|D08146  Losartan (INN)|Drug groups [BR:br08330(D08146)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|DG00348  Losartan|D08146  Losartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|DG00348  Losartan|D08146  Losartan|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00348  Losartan|D08146  Losartan|Target-based classification of drugs [BR:br08310(D08146)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D08146  Losartan (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08146)]|Drug metabolizing enzymes|D08146",
C07073,Lidocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00358)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BB Antiarrhythmics, class Ib|C01BB01 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD01 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AB Anesthetics for topical use|D04AB01 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB02 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AD Anesthetics, local|R02AD02 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA07 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02D OTHER OTOLOGICALS|S02DA Analgesics and anesthetics|S02DA01 Lidocaine|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00358)]|Anesthetics|Local Anesthetics|Lidocaine|D00358  Lidocaine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00358)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|121  Local anesthetics|1214  Xylidines|D00358  Lidocaine (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00358)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00358  Lidocaine (JP18/USP/INN)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00358  Lidocaine (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00358)]|Second-class OTC drugs|Inorganic and organic chemicals|Lidocaine|D00358  Lidocaine (JP18/USP/INN)|Drug groups [BR:br08330(D00358)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01651  Class Ib antiarrhythmic agent|DG00196  Lidocaine|D00358  Lidocaine|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00196  Lidocaine|D00358  Lidocaine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00196  Lidocaine|D00358  Lidocaine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00196  Lidocaine|D00358  Lidocaine|Drug classes [BR:br08332(D00358)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00358  Lidocaine|Target-based classification of drugs [BR:br08310(D00358)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN2A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN3A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN4A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN5A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN8A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN9A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN10A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|SCN11A|D00358  Lidocaine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00358)]|Chemicals|D00358  Lidocaine|D00358  Lidocaine injection|Drug metabolizing enzymes and transporters [br08309.html(D00358)]|Drug metabolizing enzymes|D00358",
C07074,Lovastatin,,,PK,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00359)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AA HMG CoA reductase inhibitors|C10AA02 Lovastatin|D00359  Lovastatin (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00359)]|Cardiovascular Agents|Dyslipidemics, HMG CoA Reductase Inhibitors|Lovastatin|D00359  Lovastatin (USP/INN)|Drug groups [BR:br08330(D00359)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01660  HMG-CoA reductase inhibitor|D00359  Lovastatin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00359  Lovastatin|Drug classes [BR:br08332(D00359)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D00359  Lovastatin|Target-based classification of drugs [BR:br08310(D00359)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HMGCR|D00359  Lovastatin (USP/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00359)]|Drug metabolizing enzymes|D00359|Prodrugs [br08324.html(D00359)]|D00359",
C07075,"Lindane;|gamma-Hexachlorocyclohexane;|1,2,3,4,5,6-Hexachlorocyclohexane;|Benzene hexachloride;|gamma-BHC",,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C07075  Lindane|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00360)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AB Chlorine containing products|P03AB02 Lindane|D00360  Lindane (USP/INN)|USP drug classification [BR:br08302(D00360)]|Dermatological Agents|Pediculicides/Scabicides|Lindane|D00360  Lindane (USP/INN)",
C07078,Lomefloxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02318)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA07 Lomefloxacin|D02318  Lomefloxacin (USAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE04 Lomefloxacin|D02318  Lomefloxacin (USAN)|Drug groups [BR:br08330(D02318)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00621  Lomefloxacin|D02318  Lomefloxacin|Antimicrobials [BR:br08307(D02318)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D02318  Lomefloxacin (USAN),
C07079,Lomustine;|1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00363)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD02 Lomustine|D00363  Lomustine (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00363)]|Antineoplastics|Alkylating Agents|Lomustine|D00363  Lomustine (USP/INN)|Drug groups [BR:br08330(D00363)]|Antineoplastic|DG01677  Alkylating agent|DG01724  Nitrosourea|D00363  Lomustine,
C07080,Loperamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08144)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07D ANTIPROPULSIVES|A07DA Antipropulsives|A07DA03 Loperamide|D08144  Loperamide (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08144)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Loperamide|D08144  Loperamide (INN)|Second-class OTC drugs|Inorganic and organic chemicals|Loperamide|D08144  Loperamide (INN)|Drug groups [BR:br08330(D08144)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00092  Loperamide|D08144  Loperamide|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00092  Loperamide|D08144  Loperamide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00092  Loperamide|D08144  Loperamide|Transporter substrate|DG01665  ABCB1 substrate|DG00092  Loperamide|D08144  Loperamide|Target-based classification of drugs [BR:br08310(D08144)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08144  Loperamide (INN)|OPRK1|D08144  Loperamide (INN)|OPRD1|D08144  Loperamide (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08144)]|Drug metabolizing enzymes|D08144|Drug transporters|D08144|Rx-to-OTC switch list in the USA [br08315.html(D08144)]|D08144",
C07083,Styrene;|Phenylethylene,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Styrenes|C07083  Styrene,
C07084,"Styrene-cis-2,3-dihydrodiol;|cis-3-Ethenylcyclohexa-3,5-diene-1,2-diol",,,,,
C07085,3-Vinylcatechol,,,,,
C07086,Phenylacetic acid;|Benzylformic acid;|Phenylacetate;|Benzeneacetic acid,,,,Prodrugs [br08324.html]|C07086|Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C07086,
C07087,"2-Hydroxy-6-oxoocta-2,4,7-trienoate",,,,,
C07088,4-Chlorophenoxyacetate;|4-CPA,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C07088  4-Chlorophenoxyacetate,
C07089,5-Chloro-2-hydroxymuconic semialdehyde,,,,,
C07090,Protoanemonin;|4-Methylenebut-2-en-4-olide;|cis-4-Methylenebut-2-en-4-olide,,,,Phytochemical compounds [BR:br08003]|Others|Others|Others|C07090  Protoanemonin|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C07090  Protoanemonin,
C07091,cis-Acetylacrylate,,,,,
C07092,"1,4-Dichlorobenzene;|p-Dichlorobenzene",,,,"Pesticides [BR:br08007]|Pesticides|Others|Fumigant|C07092  1,4-Dichlorobenzene",
C07093,"3,6-Dichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",,,,,
C07094,"3,6-Dichlorocatechol",,,,,
C07095,"2,5-Dichloro-cis,cis-muconate",,,,,
C07096,"2,6-Dichlorophenol",,,,,
C07097,"2,6-Dichlorohydroquinone",,,,,
C07098,"2,4,6-Trichlorophenol",,,,,
C07099,"2,3,6-Trichlorohydroquinone",,,,,
C07100,"2,4,5-Trichlorophenoxyacetic acid;|2,4,5-T",,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Phenoxy herbicides|C07100  2,4,5-Trichlorophenoxyacetic acid|Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Auxins|C07100  2,4,5-Trichlorophenoxyacetic acid",
C07101,"2,4,5-Trichlorophenol",,,,,
C07102,"5-Chloro-1,2,4-trihydroxybenzene",,,,,
C07103,"2-Hydroxy-1,4-benzoquinone;|Hydroxybenzoquinone",,,,,
C07104,Loxapine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02340)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AH Diazepines, oxazepines, thiazepines and oxepines|N05AH01 Loxapine|D02340  Loxapine (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D02340)]|Antipsychotics|1st Generation/Typical|Loxapine|D02340  Loxapine (USAN/INN)|Drug groups [BR:br08330(D02340)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00897  Loxapine|D02340  Loxapine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00897  Loxapine|D02340  Loxapine|DG01644  CYP2D6 substrate|DG00897  Loxapine|D02340  Loxapine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00897  Loxapine|D02340  Loxapine|Target-based classification of drugs [BR:br08310(D02340)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D02340  Loxapine (USAN/INN) &lt;US&gt;|Serotonin|HTR2A|D02340  Loxapine (USAN/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D02340)]|European public assessment reports (EPAR) authorised medicine|D02340|Drug metabolizing enzymes and transporters [br08309.html(D02340)]|Drug metabolizing enzymes|D02340",
C07105,Lys-vasopressin;|Lypressin;|8-L-Lysine vasopressin;|LVP,,Cys Tyr Phe Gln Asn Cys Pro Lys Gly-NH2 (Disulfide bridge: 1-6),Peptide,"Bioactive peptides [BR:br08005]|Pituitary hormones|Posterior pituitary hormone|C07105  Lys-vasopressin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00366)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01B POSTERIOR PITUITARY LOBE HORMONES|H01BA Vasopressin and analogues|H01BA03 Lypressin|D00366  Lypressin (USAN/INN)|Drug groups [BR:br08330(D00366)]|Cardiovascular agent|DG01952  Vasopressin analog|D00366  Lypressin|Target-based classification of drugs [BR:br08310(D00366)]|G Protein-coupled receptors|Rhodopsin family|Vasopressin|AVPR1|D00366  Lypressin (USAN/INN)|AVPR2|D00366  Lypressin (USAN/INN)",
C07106,Mafenide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02351)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BA Sulfonamides|D06BA03 Mafenide|D02351  Mafenide (USAN/INN)|Drug groups [BR:br08330(D02351)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG00404  Mafenide|D02351  Mafenide|Antimicrobials [BR:br08307(D02351)]|Antibacterials|Folic acid biosynthesis inhibitor|Other sulfonamide|D02351  Mafenide (USAN/INN),
C07107,Maprotiline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02566)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA21 Maprotiline|D02566  Maprotiline (USAN)|Drug groups [BR:br08330(D02566)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00941  Maprotiline|D02566  Maprotiline|DG01729  Tetracyclic antidepressant|DG00941  Maprotiline|D02566  Maprotiline|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00941  Maprotiline|D02566  Maprotiline|Target-based classification of drugs [BR:br08310(D02566)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D02566  Maprotiline (USAN)|Drug metabolizing enzymes and transporters [br08309.html(D02566)]|Drug metabolizing enzymes|D02566,
C07108,Tamoxifen,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08559)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BA Anti-estrogens|L02BA01 Tamoxifen|D08559  Tamoxifen (INN)|Drug groups [BR:br08330(D08559)]|Antineoplastic|DG01585  Estrogen receptor antagonist|DG01620  Tamoxifene-type antineoplastic|DG00734  Tamoxifen|D08559  Tamoxifen|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG00734  Tamoxifen|D08559  Tamoxifen|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00734  Tamoxifen|D08559  Tamoxifen|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00734  Tamoxifen|D08559  Tamoxifen|Target-based classification of drugs [BR:br08310(D08559)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D08559  Tamoxifen (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08559)]|Drug metabolizing enzymes|D08559|Prodrugs [br08324.html(D08559)]|D08559|Prodrugs [br08324.html]|C07108,
C07111,Ethylbenzene;|Phenylethane;|Ethylbenzol;|Ethylenzene,,,,,
C07112,1-Phenylethanol;|Methylphenyl carbinol;|alpha-Methylbenzyl alcohol,,,,,
C07113,Acetophenone;|1-Phenylethanone;|Phenyl methyl ketone;|Acetylbenzene;|Methyl phenyl ketone,,,,,
C07114,3-Oxo-3-phenylpropanoate;|Benzoylacetate;|3-Oxo-3-phenylpropionate;|3-Oxo-3-phenylpropionic acid,,,,,
C07115,Nitrogen mustard;|Mechlorethamine;|Chlormethine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07671)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA05 Chlormethine|D07671  Chlormethine (INN)|Drug groups [BR:br08330(D07671)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG00677  Chlormethine|D07671  Chlormethine|New drug approvals in Europe [br08329.html(D07671)]|European public assessment reports (EPAR) authorised medicine|D07671,
C07116,Meclizine;|Meclozine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08163)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AE Piperazine derivatives|R06AE05 Meclozine|D08163  Meclozine (BAN)|Risk category of Japanese OTC drugs [BR:br08312(D08163)]|Second-class OTC drugs|Inorganic and organic chemicals|Meclizine hydrochloride|D08163  Meclozine (BAN)|Drug groups [BR:br08330(D08163)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01106  Meclozine|D08163  Meclozine|Target-based classification of drugs [BR:br08310(D08163)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08163  Meclozine (BAN),
C07117,Meclofenamate;|Meclofenamic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02341)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AG Fenamates|M01AG04 Meclofenamic acid|D02341  Meclofenamic acid (USAN/INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA18 Meclofenamic acid|D02341  Meclofenamic acid (USAN/INN)|Drug groups [BR:br08330(D02341)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01911  Anti-inflammatory drug, fenamic acid derivatives|DG00758  Meclofenamic acid|D02341  Meclofenamic acid|Target-based classification of drugs [BR:br08310(D02341)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D02341  Meclofenamic acid (USAN/INN)|PTGS2 (COX2)|D02341  Meclofenamic acid (USAN/INN)",
C07118,Benzoylacetyl-CoA;|Benzoylacetyl coenzyme A,,,,,
C07119,"Medroxyprogesterone;|6alpha-Methyl-17alpha-hydroxyprogesterone;|17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07119  Medroxyprogesterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08166)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC06 Medroxyprogesterone|D08166  Medroxyprogesterone (INN)|G03D PROGESTOGENS|G03DA Pregnen (4) derivatives|G03DA02 Medroxyprogesterone|D08166  Medroxyprogesterone (INN)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AB Progestogens|L02AB02 Medroxyprogesterone|D08166  Medroxyprogesterone (INN)|Drug groups [BR:br08330(D08166)]|Hormonal agent|DG02004  Progesterone|DG00458  Medroxyprogesterone|D08166  Medroxyprogesterone|DG01666  Progesterone receptor agonist|DG00458  Medroxyprogesterone|D08166  Medroxyprogesterone|Target-based classification of drugs [BR:br08310(D08166)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D08166  Medroxyprogesterone (INN)",
C07120,"Megestrol;|17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07120  Megestrol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08167)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC05 Megestrol|D08167  Megestrol (INN)|G03D PROGESTOGENS|G03DB Pregnadien derivatives|G03DB02 Megestrol|D08167  Megestrol (INN)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AB Progestogens|L02AB01 Megestrol|D08167  Megestrol (INN)|Drug groups [BR:br08330(D08167)]|Hormonal agent|DG02004  Progesterone|DG00457  Megestrol|D08167  Megestrol|DG01666  Progesterone receptor agonist|DG00457  Megestrol|D08167  Megestrol|Target-based classification of drugs [BR:br08310(D08167)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D08167  Megestrol (INN)",
C07122,Melphalan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00369)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA03 Melphalan|D00369  Melphalan (JP18/USP/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D00369)]|Antineoplastics|Alkylating Agents|Melphalan|D00369  Melphalan (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00369)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4219  Others|D00369  Melphalan (JP18/USP/INN)|Drug groups [BR:br08330(D00369)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG00676  Melphalan|D00369  Melphalan|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00369)]|Chemicals|D00369  Melphalan,
C07123,"2-Hydroxy-6-oxo-octa-2,4-dienoate",,,,,
C07124,Tamsulosin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08560)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY|G04CA Alpha-adrenoreceptor antagonists|G04CA02 Tamsulosin|D08560  Tamsulosin (INN)|Drug groups [BR:br08330(D08560)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00490  Tamsulosin|D08560  Tamsulosin|Target-based classification of drugs [BR:br08310(D08560)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08560  Tamsulosin (INN),
C07125,Temazepam,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00370)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD07 Temazepam|D00370  Temazepam (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00370)]|Sleep Disorder Agents|Sleep Promoting Agents|Temazepam|D00370  Temazepam (USP/INN)|Drug groups [BR:br08330(D00370)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D00370  Temazepam|DG03202  Hypnotic|D00370  Temazepam|DG01567  GABA-A receptor agonist|D00370  Temazepam|Drug classes [BR:br08332(D00370)]|Neuropsychiatric agent|DG03202  Hypnotic|D00370  Temazepam|Target-based classification of drugs [BR:br08310(D00370)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00370  Temazepam (USP/INN) &lt;US&gt;|Narcotics and psychotropics in Japan [br08308.html(D00370)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00370,
C07126,Menadiol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C07126  Menadiol|Drug groups [BR:br08330(D08175)]|Blood modifier agent|DG02016  Hemostatics|DG02014  Blood coagulation accelerant|DG01603  Vitamin K|DG01602  Menadiol|D08175  Menadiol,
C07127,Terazosin;|Terazosine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08569)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY|G04CA Alpha-adrenoreceptor antagonists|G04CA03 Terazosin|D08569  Terazosin (INN)|Drug groups [BR:br08330(D08569)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00491  Terazosin|D08569  Terazosin|DG03231  Antihypertensive|DG00491  Terazosin|D08569  Terazosin|Target-based classification of drugs [BR:br08310(D08569)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08569  Terazosin (INN),
C07128,Meperidine;|Pethidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08343)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AB Phenylpiperidine derivatives|N02AB02 Pethidine|D08343  Pethidine (INN)|Drug groups [BR:br08330(D08343)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00816  Pethidine|D08343  Pethidine|Analgesic|DG01984  Opioid analgesics|DG00816  Pethidine|D08343  Pethidine|Target-based classification of drugs [BR:br08310(D08343)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08343  Pethidine (INN)|Narcotics and psychotropics in Japan [br08308.html(D08343)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08343,
C07129,Terbutaline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08570)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC03 Terbutaline|D08570  Terbutaline (INN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC03 Terbutaline|D08570  Terbutaline (INN)|Drug groups [BR:br08330(D08570)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01046  Terbutaline|D08570  Terbutaline|Target-based classification of drugs [BR:br08310(D08570)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D08570  Terbutaline (INN)|Prodrugs [br08324.html(D08570)]|D08570|Prodrugs [br08324.html]|C07129",
C07130,"Theophylline;|1,3-Dimethylxanthine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C07130  Theophylline|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00371)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03DA Xanthines|R03DA04 Theophylline|D00371  Theophylline (JP18) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00371)]|Respiratory Tract/Pulmonary Agents|Phosphodiesterase Inhibitors, Airways Disease|Theophylline|D00371  Theophylline (JP18)|Therapeutic category of drugs in Japan [BR:br08301(D00371)]|2  Agents affecting individual organs|22  Respiratory organ agents|225  Bronchodilators|2251  Xanthines|D00371  Theophylline (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00371)]|Agents for respiratory organs|26 Antitussives and expectorants|D00371  Theophylline (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D00371)]|First-class OTC drugs|Inorganic and organic chemicals|Theophylline|D00371  Theophylline (JP18)|Drug groups [BR:br08330(D00371)]|Respiratory system agent|DG01616  Xanthine derivative|DG01609  Xanthine-type bronchodilator|DG01061  Theophylline|D00371  Theophylline|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG01061  Theophylline|D00371  Theophylline|Target-based classification of drugs [BR:br08310(D00371)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA1|D00371  Theophylline (JP18) &lt;JP/US&gt;|ADORA2B|D00371  Theophylline (JP18) &lt;JP/US&gt;|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE|D00371  Theophylline (JP18) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00371)]|Chemicals|D00371  Theophylline|Drug metabolizing enzymes and transporters [br08309.html(D00371)]|Drug metabolizing enzymes|D00371",
C07131,Thiabendazole,,,,"Pesticides [BR:br08007]|Pesticides|Fungicides|Thiazole fungicides|C07131  Thiabendazole|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00372)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC06 Tiabendazole|D00372  Thiabendazole (USP)|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CA Benzimidazole derivatives|P02CA02 Tiabendazole|D00372  Thiabendazole (USP)|Drug groups [BR:br08330(D00372)]|Antifungal|DG01883  Imidazole antifungal|D00372  Thiabendazole|Antimicrobials [BR:br08307(D00372)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00372  Thiabendazole (USP)|Antiparasitics|Antinematodal agents|Benzimidazole derivatives|D00372  Thiabendazole (USP)",
C07132,Thiethylperazine;|Ethylthioperazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02354)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AD Phenothiazine derivatives|R06AD03 Thiethylperazine|D02354  Thiethylperazine (USAN/INN)|Drug groups [BR:br08330(D02354)]|Neuropsychiatric agent|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG01102  Thiethylperazine|D02354  Thiethylperazine|Target-based classification of drugs [BR:br08310(D02354)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D02354  Thiethylperazine (USAN/INN),
C07138,5-Aminosalicylate;|5-Amino-2-hydroxybenzoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00377)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EC Aminosalicylic acid and similar agents|A07EC02 Mesalazine|D00377  Mesalamine (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00377)]|Inflammatory Bowel Disease Agents|Aminosalicylates and/or Prodrugs|Mesalamine|D00377  Mesalamine (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00377)]|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D00377  Mesalamine (USP); Mesalazine (JP18/INN)|Drug groups [BR:br08330(D00377)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|D00377  Mesalamine|Drug classes [BR:br08332(D00377)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00377  Mesalamine",
C07139,Ticarcillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08593)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA13 Ticarcillin|D08593  Ticarcillin (INN)|Drug groups [BR:br08330(D08593)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00527  Ticarcillin|D08593  Ticarcillin|DG01780  Extended spectrum penicillin|DG00527  Ticarcillin|D08593  Ticarcillin|Antimicrobials [BR:br08307(D08593)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D08593  Ticarcillin (INN)",
C07140,Ticlopidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08594)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AC Platelet aggregation inhibitors excl. heparin|B01AC05 Ticlopidine|D08594  Ticlopidine (INN)|Drug groups [BR:br08330(D08594)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|DG01808  Thienopyridine|DG00156  Ticlopidine|D08594  Ticlopidine|DG01809  P2Y12 receptor antagonist|DG01808  Thienopyridine|DG00156  Ticlopidine|D08594  Ticlopidine|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00156  Ticlopidine|D08594  Ticlopidine|DG02892  CYP2B6 inhibitor|DG00156  Ticlopidine|D08594  Ticlopidine|DG01933  CYP2C19 inhibitor|DG00156  Ticlopidine|D08594  Ticlopidine|DG01645  CYP2D6 inhibitor|DG00156  Ticlopidine|D08594  Ticlopidine|Target-based classification of drugs [BR:br08310(D08594)]|G Protein-coupled receptors|Rhodopsin family|Purine / pyrimidine|P2RY12|D08594  Ticlopidine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08594)]|Drug metabolizing enzymes|D08594,
C07141,Timolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08600)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA06 Timolol|D08600  Timolol (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED01 Timolol|D08600  Timolol (INN)|Drug groups [BR:br08330(D08600)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG00306  Timolol|D08600  Timolol|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00306  Timolol|D08600  Timolol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00306  Timolol|D08600  Timolol|Target-based classification of drugs [BR:br08310(D08600)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D08600  Timolol (INN)|ADRB2|D08600  Timolol (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08600)]|Drug metabolizing enzymes|D08600",
C07142,Tocainide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06172)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BB Antiarrhythmics, class Ib|C01BB03 Tocainide|D06172  Tocainide (USAN/INN)|Drug groups [BR:br08330(D06172)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01651  Class Ib antiarrhythmic agent|DG00198  Tocainide|D06172  Tocainide|Target-based classification of drugs [BR:br08310(D06172)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D06172  Tocainide (USAN/INN)|SCN2A|D06172  Tocainide (USAN/INN)|SCN3A|D06172  Tocainide (USAN/INN)|SCN4A|D06172  Tocainide (USAN/INN)|SCN5A|D06172  Tocainide (USAN/INN)|SCN8A|D06172  Tocainide (USAN/INN)|SCN9A|D06172  Tocainide (USAN/INN)|SCN10A|D06172  Tocainide (USAN/INN)|SCN11A|D06172  Tocainide (USAN/INN)",
C07143,Mesoridazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02671)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AC Phenothiazines with piperidine structure|N05AC03 Mesoridazine|D02671  Mesoridazine (USAN/INN)|Drug groups [BR:br08330(D02671)]|Neuropsychiatric agent|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00883  Mesoridazine|D02671  Mesoridazine|Target-based classification of drugs [BR:br08310(D02671)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D02671  Mesoridazine (USAN/INN)|Serotonin|HTR2A|D02671  Mesoridazine (USAN/INN),
C07144,Metaproterenol;|Orciprenaline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08300)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AB Non-selective beta-adrenoreceptor agonists|R03AB03 Orciprenaline|D08300  Orciprenaline (INN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CB Non-selective beta-adrenoreceptor agonists|R03CB03 Orciprenaline|D08300  Orciprenaline (INN)|Drug groups [BR:br08330(D08300)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01044  Orciprenaline|D08300  Orciprenaline|Target-based classification of drugs [BR:br08310(D08300)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D08300  Orciprenaline (INN)",
C07146,Metaraminol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08192)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA09 Metaraminol|D08192  Metaraminol (INN)|Drug groups [BR:br08330(D08192)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00218  Metaraminol|D08192  Metaraminol|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG00218  Metaraminol|D08192  Metaraminol|Target-based classification of drugs [BR:br08310(D08192)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08192  Metaraminol (INN)|ADRA2|D08192  Metaraminol (INN),
C07147,"Tolazoline;|4,5-Dihydro-2-(phenylmethyl)-1H-imidazole",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08614)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AB Imidazoline derivatives|C04AB02 Tolazoline|D08614  Tolazoline (INN)|M MUSCULO-SKELETAL SYSTEM|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AX Other topical products for joint and muscular pain|M02AX02 Tolazoline|D08614  Tolazoline (INN)|Drug groups [BR:br08330(D08614)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG00281  Tolazoline|D08614  Tolazoline|Target-based classification of drugs [BR:br08310(D08614)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08614  Tolazoline (INN)|ADRA2|D08614  Tolazoline (INN),
C07148,Tolbutamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00380)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BB Sulfonylureas|A10BB03 Tolbutamide|D00380  Tolbutamide (JP18/USP/INN)|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CA Tests for diabetes|V04CA01 Tolbutamide|D00380  Tolbutamide (JP18/USP/INN)|USP drug classification [BR:br08302(D00380)]|Blood Glucose Regulators|Antidiabetic Agents|Sulfonylureas|Tolbutamide|D00380  Tolbutamide (JP18/USP/INN)|Drug groups [BR:br08330(D00380)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01734  Sulfonylurea|DG00115  Tolbutamide|D00380  Tolbutamide|DG02044  Hypoglycemic agent|DG01734  Sulfonylurea|DG00115  Tolbutamide|D00380  Tolbutamide|Target-based classification of drugs [BR:br08310(D00380)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D00380  Tolbutamide (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00380)]|Chemicals|D00380  Tolbutamide|D00380  Tolbutamide tablets",
C07149,Tolmetin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02355)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB03 Tolmetin|D02355  Tolmetin (USAN/INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA21 Tolmetin|D02355  Tolmetin (USAN/INN)|Drug groups [BR:br08330(D02355)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01906  Anti-inflammatory drug, acetic acid derivatives|DG00747  Tolmetin|D02355  Tolmetin|Target-based classification of drugs [BR:br08310(D02355)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D02355  Tolmetin (USAN/INN)|PTGS2 (COX2)|D02355  Tolmetin (USAN/INN)",
C07151,Metformin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04966)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BA Biguanides|A10BA02 Metformin|D04966  Metformin (USAN/INN)|Drug groups [BR:br08330(D04966)]|Antidiabetic agent|DG01685  Insulin sensitizer|DG01684  Biguanide antidiabetic|DG00113  Metformin|D04966  Metformin|DG02044  Hypoglycemic agent|DG01684  Biguanide antidiabetic|DG00113  Metformin|D04966  Metformin|Target-based classification of drugs [BR:br08310(D04966)]|Protein kinases|Serine/threonine kinases|CAMK group|AMPK (PRKAA)|D04966  Metformin (USAN/INN)",
C07153,Tramadol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08623)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AX Other opioids|N02AX02 Tramadol|D08623  Tramadol (INN)|Drug groups [BR:br08330(D08623)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00824  Tramadol|D08623  Tramadol|Analgesic|DG01984  Opioid analgesics|DG00824  Tramadol|D08623  Tramadol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00824  Tramadol|D08623  Tramadol|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00824  Tramadol|D08623  Tramadol|Target-based classification of drugs [BR:br08310(D08623)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08623  Tramadol (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08623)]|Drug metabolizing enzymes|D08623,
C07155,Tranylcypromine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08625)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AF Monoamine oxidase inhibitors, non-selective|N06AF04 Tranylcypromine|D08625  Tranylcypromine (INN)|Drug groups [BR:br08330(D08625)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00949  Tranylcypromine|D08625  Tranylcypromine|Target-based classification of drugs [BR:br08310(D08625)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D08625  Tranylcypromine (INN)",
C07156,Trazodone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08626)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX05 Trazodone|D08626  Trazodone (INN)|Drug groups [BR:br08330(D08626)]|Neuropsychiatric agent|DG03056  Serotonin antagonist and reuptake inhibitor (SARI)|DG00952  Trazodone|D08626  Trazodone|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00952  Trazodone|D08626  Trazodone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00952  Trazodone|D08626  Trazodone|Target-based classification of drugs [BR:br08310(D08626)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR2|D08626  Trazodone (INN)|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D08626  Trazodone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08626)]|Drug metabolizing enzymes|D08626,
C07159,"2-Oxo-Delta3-4,5,5-trimethylcyclopentenylacetate;|2-Oxo-Delta3-4,5,5-trimethylcyclopentenylacetic acid",,,,,
C07160,"[(1R)-2,2,3-Trimethyl-5-oxocyclopent-3-enyl]acetyl-CoA;|2-Oxo-Delta3-4,5,5-trimethylcyclopentenylacetyl-CoA;|2-Oxo-Delta3-4,5,5-trimethylcyclopentenylacetyl coenzyme A",,,,,
C07163,Methadone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08195)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BC Drugs used in opioid dependence|N07BC02 Methadone|D08195  Methadone (BAN)|Drug groups [BR:br08330(D08195)]|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|DG00999  Methadone|D08195  Methadone|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00999  Methadone|D08195  Methadone|Analgesic|DG01984  Opioid analgesics|DG00999  Methadone|D08195  Methadone|Metabolizing enzyme substrate|DG02919  CYP2B6 substrate|DG00999  Methadone|D08195  Methadone|DG02918  CYP2C8 substrate|DG00999  Methadone|D08195  Methadone|DG01642  CYP2C9 substrate|DG00999  Methadone|D08195  Methadone|DG01639  CYP2C19 substrate|DG00999  Methadone|D08195  Methadone|DG01644  CYP2D6 substrate|DG00999  Methadone|D08195  Methadone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00999  Methadone|D08195  Methadone|Metabolizing enzyme inducer|DG02891  CYP2B6 inducer|DG00999  Methadone|D08195  Methadone|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00999  Methadone|D08195  Methadone|Transporter substrate|DG01665  ABCB1 substrate|DG00999  Methadone|D08195  Methadone|Target-based classification of drugs [BR:br08310(D08195)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08195  Methadone (BAN)|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D08195  Methadone (BAN)|Drug metabolizing enzymes and transporters [br08309.html(D08195)]|Drug metabolizing enzymes|D08195|Drug transporters|D08195|Narcotics and psychotropics in Japan [br08308.html(D08195)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08195",
C07164,Methamphetamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08187)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BA Centrally acting sympathomimetics|N06BA03 Metamfetamine|D08187  Metamfetamine (INN)|Drug groups [BR:br08330(D08187)]|Neuropsychiatric agent|DG01971  Agents for narcolepsy|DG00968  Metamfetamine|D08187  Metamfetamine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00968  Metamfetamine|D08187  Metamfetamine|Target-based classification of drugs [BR:br08310(D08187)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08187  Metamfetamine (INN)|SLC6A3 (DAT1)|D08187  Metamfetamine (INN)|SLC6A4 (HTT)|D08187  Metamfetamine (INN)|SLC18|SLC18A1 (VMAT1)|D08187  Metamfetamine (INN)|SLC18A2 (VMAT2)|D08187  Metamfetamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08187)]|Drug metabolizing enzymes|D08187|Narcotics and psychotropics in Japan [br08308.html(D08187)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D08187",
C07165,Triclofos,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08634)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM07 Triclofos|D08634  Triclofos (INN),
C07166,Trientine;|Triethylenetetramine,,,,,
C07168,Trifluoperazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08636)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB06 Trifluoperazine|D08636  Trifluoperazine (INN)|Drug groups [BR:br08330(D08636)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00877  Trifluoperazine|D08636  Trifluoperazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00877  Trifluoperazine|D08636  Trifluoperazine|Target-based classification of drugs [BR:br08310(D08636)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08636  Trifluoperazine (INN),
C07171,Trihexyphenidyl,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08638)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04A ANTICHOLINERGIC AGENTS|N04AA Tertiary amines|N04AA01 Trihexyphenidyl|D08638  Trihexyphenidyl (INN)|Drug groups [BR:br08330(D08638)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01745  Anticholinergic antiparkinson agent|DG00851  Trihexyphenidyl|D08638  Trihexyphenidyl|DG01967  Antiparkinson agent|DG00851  Trihexyphenidyl|D08638  Trihexyphenidyl|Target-based classification of drugs [BR:br08310(D08638)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D08638  Trihexyphenidyl (INN),
C07172,Trimeprazine;|Methylpromazine;|Alimemazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07125)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AD Phenothiazine derivatives|R06AD01 Alimemazine|D07125  Alimemazine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07125)]|Second-class OTC drugs|Inorganic and organic chemicals|Alimemazine|D07125  Alimemazine (INN)|Third-class OTC drugs|Inorganic and organic chemicals|Alimemazine|D07125  Alimemazine (INN)|Drug groups [BR:br08330(D07125)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01101  Alimemazine|D07125  Alimemazine|Target-based classification of drugs [BR:br08310(D07125)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07125  Alimemazine (INN),
C07174,Trimethaphan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING|C02BA Sulfonium derivatives|C02BA01 Trimetaphan|C07174  Trimethaphan|Drug groups [BR:br08330]|Cardiovascular agent|DG01695  Ganglion-blocking antiadrenergic|DG00251  Trimetaphan|C07174  Trimethaphan",G00251
C07175,Methdilazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04979)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AD Phenothiazine derivatives|R06AD04 Methdilazine|D04979  Methdilazine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D04979)]|Second-class OTC drugs|Inorganic and organic chemicals|Methdilazine|D04979  Methdilazine (INN)|Target-based classification of drugs [BR:br08310(D04979)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D04979  Methdilazine (INN),
C07177,Methicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF03 Meticillin|C07177  Methicillin|Drug groups [BR:br08330]|Antibacterial|DG01779  beta-Lactamase resistant penicillin|DG02500  Methicillin|C07177  Methicillin",G02500
C07178,Trimethobenzamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08643)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA10 Trimethobenzamide|D08643  Trimethobenzamide (INN)|Drug groups [BR:br08330(D08643)]|Gastrointestinal agent|DG01762  Antiemetic|DG01783  Benzamide type antiemetic|DG01671  Trimethobenzamide|D08643  Trimethobenzamide,
C07180,Tripelennamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08645)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA04 Tripelennamine|D08645  Tripelennamine (INN)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AC Substituted ethylene diamines|R06AC04 Tripelennamine|D08645  Tripelennamine (INN)|Drug groups [BR:br08330(D08645)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00383  Tripelennamine|D08645  Tripelennamine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00383  Tripelennamine|D08645  Tripelennamine|Target-based classification of drugs [BR:br08310(D08645)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08645  Tripelennamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08645)]|Drug metabolizing enzymes|D08645",
C07182,"Tromethamine;|2-Amino-2-(hydroxymethyl)-1,3-propanediol;|Trometamol",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00396)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05B I.V. SOLUTIONS|B05BB Solutions affecting the electrolyte balance|B05BB03 Trometamol|D00396  Tromethamine (USP) &lt;US&gt;|B05X I.V. SOLUTION ADDITIVES|B05XX Other i.v. solution additives|B05XX02 Trometamol|D00396  Tromethamine (USP) &lt;US&gt;,
C07184,Valacyclovir;|Valacyclovir hydrochloride;|BW 256U87,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00398)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB11 Valaciclovir|D00398  Valacyclovir hydrochloride (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00398)]|Antivirals|Antiherpetic Agents|Valacyclovir|D00398  Valacyclovir hydrochloride (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00398)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00398  Valacyclovir hydrochloride (USP); Valaciclovir hydrochloride (JP18)|Drug groups [BR:br08330(D00398)]|Antiviral|DG02840  Anti-herpesvirus agent|DG00647  Valaciclovir|D00398  Valacyclovir hydrochloride|Drug classes [BR:br08332(D00398)]|Antiviral|DG02840  Anti-herpesvirus agent|D00398  Valacyclovir hydrochloride|Antimicrobials [BR:br08307(D00398)]|Antivirals|Genome replication inhibitor|Herpesvirus DNA polymerase inhibitor|D00398  Valacyclovir hydrochloride (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00398)]|Chemicals|D00398  Valaciclovir hydrochloride|D00398  Valaciclovir hydrochloride tablets|New drug approvals in Japan [br08318.html(D00398)]|Drugs with new active ingredients|D00398,
C07185,Valproic acid;|2-Propylpentanoic acid,,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C07185  2-Propylpentanoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00399)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AG Fatty acid derivatives|N03AG01 Valproic acid|D00399  Valproic acid (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00399)]|Anticonvulsants|Anticonvulsants, Other|Valproic Acid|D00399  Valproic acid (USP)|Antimigraine Agents|Antimigraine Agents, Other|Valproic Acid|D00399  Valproic acid (USP)|Bipolar Agents|Mood Stabilizers|Valproic Acid|D00399  Valproic acid (USP)|Drug groups [BR:br08330(D00399)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01573  Calcium channel T type blocker|DG00849  Valproic acid|D00399  Valproic acid|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02035  Fatty acid antiepileptic|DG00849  Valproic acid|D00399  Valproic acid|Drug classes [BR:br08332(D00399)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00399  Valproic acid|Target-based classification of drugs [BR:br08310(D00399)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-T|D00399  Valproic acid (USP) &lt;US&gt;|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|SSADH|D00399  Valproic acid (USP) &lt;US&gt;|Transferases (EC2)|Aminotransferase|ABAT|D00399  Valproic acid (USP) &lt;US&gt;|Lyases (EC4)|Carboxy-lyases|GAD|D00399  Valproic acid (USP) &lt;US&gt;|Pharmacogenomic biomarkers [br08341.html(D00399)]|Polymorphisms and mutations affecting drug response|D00399",
C07187,Venlafaxine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08670)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX16 Venlafaxine|D08670  Venlafaxine (INN)|Drug groups [BR:br08330(D08670)]|Neuropsychiatric agent|DG01658  Serotonin and norepinephrine reuptake inhibitor (SNRI)|DG00959  Venlafaxine|D08670  Venlafaxine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00959  Venlafaxine|D08670  Venlafaxine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00959  Venlafaxine|D08670  Venlafaxine|Target-based classification of drugs [BR:br08310(D08670)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08670  Venlafaxine (INN)|SLC6A4 (HTT)|D08670  Venlafaxine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08670)]|Drug metabolizing enzymes|D08670,
C07188,Verapamil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02356)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS|C08DA Phenylalkylamine derivatives|C08DA01 Verapamil|D02356  Verapamil (USAN/INN)|Drug groups [BR:br08330(D02356)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00329  Verapamil|D02356  Verapamil|DG01653  Antiarrhythmics|DG01807  Phenylalkylamine derivative|DG00329  Verapamil|D02356  Verapamil|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00329  Verapamil|D02356  Verapamil|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00329  Verapamil|D02356  Verapamil|Transporter substrate|DG01665  ABCB1 substrate|DG00329  Verapamil|D02356  Verapamil|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00329  Verapamil|D02356  Verapamil|Target-based classification of drugs [BR:br08310(D02356)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D02356  Verapamil (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02356)]|Drug metabolizing enzymes|D02356|Drug transporters|D02356,
C07189,2-Hydroxyacetophenone;|omega-Hydroxyacetophenone,,,,,
C07190,Thiamazole;|Methimazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00401)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BB Sulfur-containing imidazole derivatives|H03BB02 Thiamazole|D00401  Methimazole (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00401)]|Hormonal Agents, Suppressant (Thyroid)|Antithyroid Agents|Methimazole|D00401  Methimazole (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00401)]|2  Agents affecting individual organs|24  Hormones|243  Thyroid and parathyroid hormone preparations|2432  Antithyroid hormones|D00401  Methimazole (USP); Thiamazole (JP18/INN)|Drug groups [BR:br08330(D00401)]|Hormonal agent|DG01934  Antithyroid agent|D00401  Methimazole|Target-based classification of drugs [BR:br08310(D00401)]|Enzymes|Oxidoreductases (EC1)|Peroxidase|TPO|D00401  Methimazole (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00401)]|Chemicals|D00401  Thiamazole|D00401  Thiamazole tablets",
C07192,Methotrimeprazine;|Levomepromazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00403)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AA Phenothiazines with aliphatic side-chain|N05AA02 Levomepromazine|D00403  Methotrimeprazine (USP)|Drug groups [BR:br08330(D00403)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00868  Levomepromazine|D00403  Methotrimeprazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00868  Levomepromazine|D00403  Methotrimeprazine|Target-based classification of drugs [BR:br08310(D00403)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00403  Methotrimeprazine (USP),
C07194,Methyldopa anhydrous;|Methyldopa,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08205)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AB Methyldopa|C02AB01 Methyldopa (levorotatory)|D08205  Methyldopa (INN)|Drug groups [BR:br08330(D08205)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG00248  Methyldopa (levorotatory)|D08205  Methyldopa|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG00248  Methyldopa (levorotatory)|D08205  Methyldopa|DG01951  Catecholamine adrenergic receptor agonist|DG00248  Methyldopa (levorotatory)|D08205  Methyldopa|DG01617  Catecholamine synthesis inhibitors|DG00248  Methyldopa (levorotatory)|D08205  Methyldopa|DG03231  Antihypertensive|DG00248  Methyldopa (levorotatory)|D08205  Methyldopa|Target-based classification of drugs [BR:br08310(D08205)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D08205  Methyldopa (INN)",
C07195,Vidarabine;|9-beta-D-Arabino furanosyl adenine monohydrate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00406)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB03 Vidarabine|D00406  Vidarabine (USAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AD Antivirals|S01AD06 Vidarabine|D00406  Vidarabine (USAN)|Drug groups [BR:br08330(D00406)]|Antiviral|DG01440  Arabinofuranosyl type antiviral|DG00645  Vidarabine|D00406  Vidarabine|DG02840  Anti-herpesvirus agent|DG00645  Vidarabine|D00406  Vidarabine|Antimicrobials [BR:br08307(D00406)]|Antivirals|Genome replication inhibitor|Herpesvirus DNA polymerase inhibitor|D00406  Vidarabine (USAN),
C07196,Methylphenidate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04999)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BA Centrally acting sympathomimetics|N06BA04 Methylphenidate|D04999  Methylphenidate (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D04999)]|Central Nervous System Agents|Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines|Methylphenidate|D04999  Methylphenidate (USAN/INN)|Target-based classification of drugs [BR:br08310(D04999)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D04999  Methylphenidate (USAN/INN) &lt;US&gt;|SLC6A3 (DAT1)|D04999  Methylphenidate (USAN/INN) &lt;US&gt;|Narcotics and psychotropics in Japan [br08308.html(D04999)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D04999",
C07198,Methyltestosterone,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C07198  Methyltestosterone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00408)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA02 Methyltestosterone|D00408  Methyltestosterone (JP18/USP/INN) &lt;US&gt;|G03E ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION|G03EK Androgens and female sex hormones in combination with other drugs|G03EK01 Methyltestosterone|D00408  Methyltestosterone (JP18/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00408)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Androgens|Methyltestosterone|D00408  Methyltestosterone (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00408)]|Agents for  urogenital organs and anus|31 Other drugs for  urogenital organs and anus|D00408  Methyltestosterone (JP18/USP/INN)|Nourishing tonics and health supplements|48 Other nourishing tonics and health supplements|D00408  Methyltestosterone (JP18/USP/INN)|Agents for integumentary system|60 Hair remedies (incl. hair growth, hair tonic, anti-dandruff, and antipruritic)|D00408  Methyltestosterone (JP18/USP/INN)|61 Other agents for integumentary system|D00408  Methyltestosterone (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00408)]|First-class OTC drugs|Inorganic and organic chemicals|Methyltestosterone|D00408  Methyltestosterone (JP18/USP/INN)|Drug groups [BR:br08330(D00408)]|Hormonal agent|DG01590  Androgen receptor agonist|D00408  Methyltestosterone|DG02006  Testosterone|D00408  Methyltestosterone|Target-based classification of drugs [BR:br08310(D00408)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00408  Methyltestosterone (JP18/USP/INN) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00408)]|Chemicals|D00408  Methyltestosterone|D00408  Methyltestosterone tablets",
C07199,Methysergide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02357)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CA Ergot alkaloids|N02CA04 Methysergide|D02357  Methysergide (USAN/INN)|Drug groups [BR:br08330(D02357)]|Neuropsychiatric agent|DG01483  5-HT1A-receptor agonist|DG00835  Methysergide|D02357  Methysergide|DG01964  Ergot alkaloid|DG01982  Antimigraine, ergot alkaloid|DG00835  Methysergide|D02357  Methysergide|Analgesic|DG01484  5-HT1B-receptor agonist|DG00835  Methysergide|D02357  Methysergide|DG01485  5-HT1D-receptor agonist|DG00835  Methysergide|D02357  Methysergide|DG01518  5-HT1B/1D-receptor agonist|DG00835  Methysergide|D02357  Methysergide|Target-based classification of drugs [BR:br08310(D02357)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1A|D02357  Methysergide (USAN/INN)|HTR2|D02357  Methysergide (USAN/INN)|HTR7|D02357  Methysergide (USAN/INN)",
C07201,Vinblastine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07201  Vinblastine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C07201  Vinblastine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07201|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08675)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CA Vinca alkaloids and analogues|L01CA01 Vinblastine|D08675  Vinblastine (INN)|Drug groups [BR:br08330(D08675)]|Antineoplastic|DG01965  Vinca alkaloid antineoplastic|DG00689  Vinblastine|D08675  Vinblastine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00689  Vinblastine|D08675  Vinblastine|Target-based classification of drugs [BR:br08310(D08675)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D08675  Vinblastine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08675)]|Drug metabolizing enzymes|D08675,
C07202,Metoprolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02358)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB02 Metoprolol|D02358  Metoprolol (USAN/INN)|Drug groups [BR:br08330(D02358)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00313  Metoprolol|D02358  Metoprolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00313  Metoprolol|D02358  Metoprolol|DG03231  Antihypertensive|DG00313  Metoprolol|D02358  Metoprolol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00313  Metoprolol|D02358  Metoprolol|Target-based classification of drugs [BR:br08310(D02358)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D02358  Metoprolol (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02358)]|Drug metabolizing enzymes|D02358",
C07203,Metronidazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00409)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB17 Metronidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BX Other chemotherapeutics|D06BX01 Metronidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF01 Metronidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XD Imidazole derivatives|J01XD01 Metronidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AB Nitroimidazole derivatives|P01AB01 Metronidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00409)]|Antibacterials|Antibacterials, Other|Metronidazole|D00409  Metronidazole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00409)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00409  Metronidazole (JP18/USP/INN)|26  Epidermides|269  Miscellaneous|2699  Others|D00409  Metronidazole (JP18/USP/INN)|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|641  Antiprotozoans|6419  Others|D00409  Metronidazole (JP18/USP/INN)|Drug groups [BR:br08330(D00409)]|Antiparasitic|DG01884  Imidazole antiprotozoal|DG00006  Metronidazole|D00409  Metronidazole|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00006  Metronidazole|D00409  Metronidazole|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|DG00006  Metronidazole|D00409  Metronidazole|Antimicrobials [BR:br08307(D00409)]|Antibacterials|Bactericidal action|Imidazole|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Nitroimidazole derivatives|D00409  Metronidazole (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00409)]|Chemicals|D00409  Metronidazole|D00409  Metronidazole tablets|Drug metabolizing enzymes and transporters [br08309.html(D00409)]|Drug metabolizing enzymes|D00409",
C07204,Vincristine;|22-Oxovincaleukoblastine;|Leurocristine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07204  Vincristine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C07204  Vincristine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07204|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08679)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CA Vinca alkaloids and analogues|L01CA02 Vincristine|D08679  Vincristine (INN)|Drug groups [BR:br08330(D08679)]|Antineoplastic|DG01965  Vinca alkaloid antineoplastic|DG00690  Vincristine|D08679  Vincristine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00690  Vincristine|D08679  Vincristine|Target-based classification of drugs [BR:br08310(D08679)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D08679  Vincristine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08679)]|Drug metabolizing enzymes|D08679,
C07205,Metyrapone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00410)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CD Tests for pituitary function|V04CD01 Metyrapone|D00410  Metyrapone (JP18/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00410)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D00410  Metyrapone (JP18/USP/INN)|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|722  Various function testing reagents|7223  Diagnostic reagents for endocrine function|D00410  Metyrapone (JP18/USP/INN)|Target-based classification of drugs [BR:br08310(D00410)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP11B1|D00410  Metyrapone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00410)]|Chemicals|D00410  Metyrapone,
C07206,Zafirlukast,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00411)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03DC Leukotriene receptor antagonists|R03DC01 Zafirlukast|D00411  Zafirlukast (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00411)]|Respiratory Tract/Pulmonary Agents|Antileukotrienes|Zafirlukast|D00411  Zafirlukast (JAN/USAN/INN)|Drug groups [BR:br08330(D00411)]|Anti-allergic agent|DG01541  Cysteinyl leukotriene receptor antagonist|D00411  Zafirlukast|Target-based classification of drugs [BR:br08310(D00411)]|G Protein-coupled receptors|Rhodopsin family|Cysteinyl leukotriene|CYSLTR1|D00411  Zafirlukast (JAN/USAN/INN) &lt;US&gt;|New drug approvals in Japan [br08318.html(D00411)]|Drugs with new active ingredients|D00411,
C07207,"Zalcitabine;|2',3'-Dideoxycytidine",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00412)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF03 Zalcitabine|D00412  Zalcitabine (JAN/USP/INN)|Drug groups [BR:br08330(D00412)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D00412  Zalcitabine|DG01440  Arabinofuranosyl type antiviral|D00412  Zalcitabine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00412  Zalcitabine|Transporter substrate|DG02859  SLC22A6 substrate|D00412  Zalcitabine|Antimicrobials [BR:br08307(D00412)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00412  Zalcitabine (JAN/USP/INN)|Antimicrobials abbreviations [BR:br08327(D00412)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00412  Zalcitabine (JAN/USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00412)]|Drug transporters|D00412,
C07208,"m-Xylene;|1,3-Dimethylbenzene;|1,3-Xylene",,,,,
C07209,3-Methylbenzaldehyde;|m-Tolualdehyde,,,,,
C07210,Zidovudine;|Azidothymidine;|3'-Azido-3'-deoxythymidine;|AZT,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00413)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF01 Zidovudine|D00413  Zidovudine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00413)]|Antivirals|Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)|Zidovudine|D00413  Zidovudine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00413)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00413  Zidovudine (JP18/USP/INN)|Drug groups [BR:br08330(D00413)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D00413  Zidovudine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00413  Zidovudine|Transporter substrate|DG02859  SLC22A6 substrate|D00413  Zidovudine|DG02860  SLC22A8 substrate|D00413  Zidovudine|Drug classes [BR:br08332(D00413)]|Antiviral|DG03107  Anti-HIV agent|D00413  Zidovudine|Antimicrobials [BR:br08307(D00413)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00413  Zidovudine (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00413)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00413  Zidovudine (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00413)]|Chemicals|D00413  Zidovudine|Drug metabolizing enzymes and transporters [br08309.html(D00413)]|Drug transporters|D00413",
C07211,m-Methylbenzoate;|m-Toluic Acid;|beta-Bethylbenzoic acid;|m-Toluylic acid,,,,,
C07212,o-Xylene;|o-Dimethylbenzene;|o-Methyltoluene,,,,,
C07213,2-Methylbenzyl alcohol,,,,,
C07214,2-Methylbenzaldehyde;|o-Toluic aldehyde;|2-Formyltoluene;|o-Tolualdehyde,,,,,
C07215,o-Toluate;|o-Methylbenzoate;|o-Toluic Acid;|2-Methylbenzoic acid,,,,,
C07216,3-Methylbenzyl alcohol,,,,,
C07218,Zolmitriptan;|311C90,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00415)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CC Selective serotonin (5HT1) agonists|N02CC03 Zolmitriptan|D00415  Zolmitriptan (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00415)]|Antimigraine Agents|Serotonin (5-HT) Receptor Agonists|Zolmitriptan|D00415  Zolmitriptan (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00415)]|2  Agents affecting individual organs|21  Cardiovascular agents|216  Vasoconstrictors|2160  Vasoconstrictors|D00415  Zolmitriptan (JAN/USP/INN)|Drug groups [BR:br08330(D00415)]|Analgesic|DG01484  5-HT1B-receptor agonist|D00415  Zolmitriptan|DG01485  5-HT1D-receptor agonist|D00415  Zolmitriptan|DG01518  5-HT1B/1D-receptor agonist|D00415  Zolmitriptan|DG01943  Triptan|D00415  Zolmitriptan|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|D00415  Zolmitriptan|DG02917  MAO substrate|DG03178  MAOA substrate|D00415  Zolmitriptan|Target-based classification of drugs [BR:br08310(D00415)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1B|D00415  Zolmitriptan (JAN/USP/INN) &lt;JP/US&gt;|HTR1D|D00415  Zolmitriptan (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00415)]|Drugs with new active ingredients|D00415|Drug metabolizing enzymes and transporters [br08309.html(D00415)]|Drug metabolizing enzymes|D00415,
C07219,Zolpidem,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08690)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CF Benzodiazepine related drugs|N05CF02 Zolpidem|D08690  Zolpidem (INN)|Drug groups [BR:br08330(D08690)]|Neuropsychiatric agent|DG01836  Non-benzodiazepine sedative-hypnotics|DG00922  Zolpidem|D08690  Zolpidem|DG03202  Hypnotic|DG00922  Zolpidem|D08690  Zolpidem|DG01567  GABA-A receptor agonist|DG00922  Zolpidem|D08690  Zolpidem|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00922  Zolpidem|D08690  Zolpidem|DG01642  CYP2C9 substrate|DG00922  Zolpidem|D08690  Zolpidem|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00922  Zolpidem|D08690  Zolpidem|Target-based classification of drugs [BR:br08310(D08690)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D08690  Zolpidem (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08690)]|Drug metabolizing enzymes|D08690|Narcotics and psychotropics in Japan [br08308.html(D08690)]|Psychotropics by Cabinet order Article 3 (78 substances)|D08690,
C07220,Mexiletine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08215)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BB Antiarrhythmics, class Ib|C01BB02 Mexiletine|D08215  Mexiletine (INN)|Drug groups [BR:br08330(D08215)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01651  Class Ib antiarrhythmic agent|DG00197  Mexiletine|D08215  Mexiletine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00197  Mexiletine|D08215  Mexiletine|DG01644  CYP2D6 substrate|DG00197  Mexiletine|D08215  Mexiletine|Target-based classification of drugs [BR:br08310(D08215)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08215  Mexiletine (INN)|SCN2A|D08215  Mexiletine (INN)|SCN3A|D08215  Mexiletine (INN)|SCN4A|D08215  Mexiletine (INN)|SCN5A|D08215  Mexiletine (INN)|SCN8A|D08215  Mexiletine (INN)|SCN9A|D08215  Mexiletine (INN)|SCN10A|D08215  Mexiletine (INN)|SCN11A|D08215  Mexiletine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08215)]|Drug metabolizing enzymes|D08215",
C07221,Mezlin;|Mezlocillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05021)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA10 Mezlocillin|D05021  Mezlocillin (USAN/INN)|Drug groups [BR:br08330(D05021)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00525  Mezlocillin|D05021  Mezlocillin|DG01780  Extended spectrum penicillin|DG00525  Mezlocillin|D05021  Mezlocillin|Antimicrobials [BR:br08307(D05021)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D05021  Mezlocillin (USAN/INN)",
C07222,Mibefradil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08217)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CX Other selective calcium channel blockers with mainly vascular effects|C08CX01 Mibefradil|D08217  Mibefradil (INN)|Drug groups [BR:br08330(D08217)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01573  Calcium channel T type blocker|DG00328  Mibefradil|D08217  Mibefradil|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00328  Mibefradil|D08217  Mibefradil|DG01645  CYP2D6 inhibitor|DG00328  Mibefradil|D08217  Mibefradil|DG02852  CYP3A/CYP3A4 inhibitor|DG00328  Mibefradil|D08217  Mibefradil|Target-based classification of drugs [BR:br08310(D08217)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-T|D08217  Mibefradil (INN)|CACNA1-L|D08217  Mibefradil (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08217)]|Drug metabolizing enzymes|D08217,
C07224,Milrinone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00417)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CE Phosphodiesterase inhibitors|C01CE02 Milrinone|D00417  Milrinone (JAN/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00417)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2119  Others|D00417  Milrinone (JAN/USP/INN)|Drug groups [BR:br08330(D00417)]|Cardiovascular agent|DG01703  Cardiotonic|DG01757  Amrinone type cardiotonic|DG00229  Milrinone|D00417  Milrinone|DG01507  Phosphodiesterase III inhibitor|DG01757  Amrinone type cardiotonic|DG00229  Milrinone|D00417  Milrinone|Metabolizing enzyme substrate|DG02924  UGT substrate|DG00229  Milrinone|D00417  Milrinone|Target-based classification of drugs [BR:br08310(D00417)]|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE3|D00417  Milrinone (JAN/USP/INN) &lt;JP&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00417)]|Drug metabolizing enzymes|D00417,
C07225,Minocycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C07225  Minocycline|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05045)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB23 Minocycline|D05045  Minocycline (USAN/INN)|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF07 Minocycline|D05045  Minocycline (USAN/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA08 Minocycline|D05045  Minocycline (USAN/INN)|Drug groups [BR:br08330(D05045)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00009  Minocycline|D05045  Minocycline|Antimicrobials [BR:br08307(D05045)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D05045  Minocycline (USAN/INN),
C07228,Raloxifene;|LY 139481,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08465)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03XC Selective estrogen receptor modulators|G03XC01 Raloxifene|D08465  Raloxifene (INN)|Drug groups [BR:br08330(D08465)]|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG01621  Selective estrogen receptor modulator|DG00476  Raloxifene|D08465  Raloxifene|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG00476  Raloxifene|D08465  Raloxifene|Target-based classification of drugs [BR:br08310(D08465)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D08465  Raloxifene (INN),
C07230,Molindone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08226)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AE Indole derivatives|N05AE02 Molindone|D08226  Molindone (INN)|Drug groups [BR:br08330(D08226)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00891  Molindone|D08226  Molindone|Target-based classification of drugs [BR:br08310(D08226)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08226  Molindone (INN),
C07231,Moxalactam;|Latamoxef,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08109)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD06 Latamoxef|D08109  Latamoxef (INN)|Drug groups [BR:br08330(D08109)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01459  Oxacephem|DG00575  Latamoxef|D08109  Latamoxef|DG01776  Third-generation cephalosporin|DG00575  Latamoxef|D08109  Latamoxef|Antimicrobials [BR:br08307(D08109)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D08109  Latamoxef (INN)",
C07235,Rifabutin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00424)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB04 Rifabutin|D00424  Rifabutin (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00424)]|Antimycobacterials|Antimycobacterials, Other|Rifabutin|D00424  Rifabutin (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00424)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|616  Acting mainly on acid-fast bacteria|6169  Others|D00424  Rifabutin (JAN/USP/INN)|Drug groups [BR:br08330(D00424)]|Antibacterial|DG01966  Antitubercular|DG01598  Rifamycin antibiotic|D00424  Rifabutin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00424  Rifabutin|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|D00424  Rifabutin|Antimicrobials [BR:br08307(D00424)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D00424  Rifabutin (JAN/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00424)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D00424  Rifabutin (JAN/USP/INN)|New drug approvals in Japan [br08318.html(D00424)]|Drugs with new active ingredients|D00424|Drug metabolizing enzymes and transporters [br08309.html(D00424)]|Drug metabolizing enzymes|D00424",
C07236,Rimantadine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08483)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AC Cyclic amines|J05AC02 Rimantadine|D08483  Rimantadine (INN)|Drug groups [BR:br08330(D08483)]|Antiviral|DG03029  Anti-influenza virus agent|DG02841  Viral uncoating inhibitor|DG00650  Rimantadine|D08483  Rimantadine|Antimicrobials [BR:br08307(D08483)]|Antivirals|Entry, fusion or uncoating inhibitor|Influenza virus uncoating inhibitor|D08483  Rimantadine (INN)",
C07239,Ritodrine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02359)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02C OTHER GYNECOLOGICALS|G02CA Sympathomimetics, labour repressants|G02CA01 Ritodrine|D02359  Ritodrine (USAN/INN)|Drug groups [BR:br08330(D02359)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG00450  Ritodrine|D02359  Ritodrine|Target-based classification of drugs [BR:br08310(D02359)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D02359  Ritodrine (USAN/INN)",
C07240,Ritonavir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00427)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE03 Ritonavir|D00427  Ritonavir (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00427)]|Antivirals|Anti-HIV Agents, Protease Inhibitors (PI)|Ritonavir|D00427  Ritonavir (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00427)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00427  Ritonavir (JAN/USP/INN)|Drug groups [BR:br08330(D00427)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|D00427  Ritonavir|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D00427  Ritonavir|DG01633  CYP3A/CYP3A4 substrate|D00427  Ritonavir|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|D00427  Ritonavir|Metabolizing enzyme inducer|DG01637  CYP1A2 inducer|D00427  Ritonavir|DG02886  CYP2C9 inducer|D00427  Ritonavir|DG02885  CYP2C19 inducer|D00427  Ritonavir|Drug classes [BR:br08332(D00427)]|Antiviral|DG03107  Anti-HIV agent|D00427  Ritonavir|Antimicrobials [BR:br08307(D00427)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00427  Ritonavir (JAN/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00427)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00427  Ritonavir (JAN/USP/INN)|New drug approvals in Europe [br08329.html(D00427)]|European public assessment reports (EPAR) authorised medicine|D00427|Drug metabolizing enzymes and transporters [br08309.html(D00427)]|Drug metabolizing enzymes|D00427",
C07241,Salmeterol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05792)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC12 Salmeterol|D05792  Salmeterol (USAN/INN)|Drug groups [BR:br08330(D05792)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01051  Salmeterol|D05792  Salmeterol|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01051  Salmeterol|D05792  Salmeterol|Target-based classification of drugs [BR:br08310(D05792)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D05792  Salmeterol (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D05792)]|Drug metabolizing enzymes|D05792",
C07245,Selegiline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03731)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BD Monoamine oxidase B inhibitors|N04BD01 Selegiline|D03731  Selegiline (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D03731)]|Antidepressants|Monoamine Oxidase Inhibitors|Selegiline|D03731  Selegiline (USAN/INN)|Drug groups [BR:br08330(D03731)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01512  Monoamine oxidase B inhibitor|DG00864  Selegiline|D03731  Selegiline|DG01967  Antiparkinson agent|DG00864  Selegiline|D03731  Selegiline|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00864  Selegiline|D03731  Selegiline|DG02919  CYP2B6 substrate|DG00864  Selegiline|D03731  Selegiline|DG01644  CYP2D6 substrate|DG00864  Selegiline|D03731  Selegiline|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00864  Selegiline|D03731  Selegiline|Drug classes [BR:br08332(D03731)]|Neuropsychiatric agent|DG01967  Antiparkinson agent|D03731  Selegiline|Target-based classification of drugs [BR:br08310(D03731)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAOB|D03731  Selegiline (USAN/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D03731)]|Drug metabolizing enzymes|D03731|Narcotics and psychotropics in Japan [br08308.html(D03731)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D03731,
C07246,Sertraline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02360)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AB Selective serotonin reuptake inhibitors|N06AB06 Sertraline|D02360  Sertraline (INN)|Drug groups [BR:br08330(D02360)]|Neuropsychiatric agent|DG01659  Selective serotonin reuptake inhibitor (SSRI)|DG00945  Sertraline|D02360  Sertraline|Metabolizing enzyme substrate|DG02919  CYP2B6 substrate|DG00945  Sertraline|D02360  Sertraline|DG01642  CYP2C9 substrate|DG00945  Sertraline|D02360  Sertraline|DG01639  CYP2C19 substrate|DG00945  Sertraline|D02360  Sertraline|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00945  Sertraline|D02360  Sertraline|Target-based classification of drugs [BR:br08310(D02360)]|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D02360  Sertraline (INN)|Drug metabolizing enzymes and transporters [br08309.html(D02360)]|Drug metabolizing enzymes|D02360,
C07247,Sibutramine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08513)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AA Centrally acting antiobesity products|A08AA10 Sibutramine|D08513  Sibutramine (INN)|Drug groups [BR:br08330(D08513)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG00108  Sibutramine|D08513  Sibutramine|Target-based classification of drugs [BR:br08310(D08513)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08513  Sibutramine (INN)|SLC6A3 (DAT1)|D08513  Sibutramine (INN)|SLC6A4 (HTT)|D08513  Sibutramine (INN)",
C07250,Nafcillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08242)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF06 Nafcillin|D08242  Nafcillin (INN)|Drug groups [BR:br08330(D08242)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00544  Nafcillin|D08242  Nafcillin|DG01779  beta-Lactamase resistant penicillin|DG00544  Nafcillin|D08242  Nafcillin|Antimicrobials [BR:br08307(D08242)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D08242  Nafcillin (INN)",
C07251,Nalbuphine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08246)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AF Morphinan derivatives|N02AF02 Nalbuphine|D08246  Nalbuphine (INN)|Drug groups [BR:br08330(D08246)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00822  Nalbuphine|D08246  Nalbuphine|Analgesic|DG01984  Opioid analgesics|DG00822  Nalbuphine|D08246  Nalbuphine|Target-based classification of drugs [BR:br08310(D08246)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08246  Nalbuphine (INN)|OPRK1|D08246  Nalbuphine (INN)|OPRD1|D08246  Nalbuphine (INN),
C07252,Naloxone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08249)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AH Peripheral opioid receptor antagonists|A06AH04 Naloxone|D08249  Naloxone (INN)|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB15 Naloxone|D08249  Naloxone (INN)|Drug groups [BR:br08330(D08249)]|Analgesic|DG01586  Opioid receptor antagonist|DG01155  Naloxone|D08249  Naloxone|Target-based classification of drugs [BR:br08310(D08249)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08249  Naloxone (INN)|OPRK1|D08249  Naloxone (INN)|OPRD1|D08249  Naloxone (INN)|New drug approvals in Europe [br08329.html(D08249)]|European public assessment reports (EPAR) authorised medicine|D08249,
C07253,Naltrexone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05113)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BB Drugs used in alcohol dependence|N07BB04 Naltrexone|D05113  Naltrexone (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D05113)]|Anti-Addiction/Substance Abuse Treatment Agents|Alcohol Deterrents/Anti-craving|Naltrexone|D05113  Naltrexone (USAN/INN)|Opioid Dependence|Naltrexone|D05113  Naltrexone (USAN/INN)|Drug groups [BR:br08330(D05113)]|Analgesic|DG01586  Opioid receptor antagonist|DG00997  Naltrexone|D05113  Naltrexone|Target-based classification of drugs [BR:br08310(D05113)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D05113  Naltrexone (USAN/INN) &lt;US&gt;|OPRK1|D05113  Naltrexone (USAN/INN) &lt;US&gt;|OPRD1|D05113  Naltrexone (USAN/INN) &lt;US&gt;,
C07254,Nandrolone;|17beta-Hydroxyestr-4-en-3-one;|17beta-Hydroxy-4-estren-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C07254  Nandrolone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08250)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AB Estren derivatives|A14AB01 Nandrolone|D08250  Nandrolone (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA11 Nandrolone|D08250  Nandrolone (INN)|Drug groups [BR:br08330(D08250)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG00142  Nandrolone|D08250  Nandrolone|Target-based classification of drugs [BR:br08310(D08250)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08250  Nandrolone (INN),
C07255,Nedocromil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05129)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AC Antiallergic agents, excl. corticosteroids|R01AC07 Nedocromil|D05129  Nedocromil (USAN/INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BC Antiallergic agents, excl. corticosteroids|R03BC03 Nedocromil|D05129  Nedocromil (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX04 Nedocromil|D05129  Nedocromil (USAN/INN)|Drug groups [BR:br08330(D05129)]|Anti-allergic agent|DG01805  Mediator release inhibitor|DG01038  Nedocromil|D05129  Nedocromil",
C07256,Nefazodone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08257)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX06 Nefazodone|D08257  Nefazodone (INN)|Target-based classification of drugs [BR:br08310(D08257)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08257  Nefazodone (INN)|Serotonin|HTR2A|D08257  Nefazodone (INN)|HTR2C|D08257  Nefazodone (INN),
C07257,Nelfinavir,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08259)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE04 Nelfinavir|D08259  Nelfinavir (INN)|Drug groups [BR:br08330(D08259)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|DG00655  Nelfinavir|D08259  Nelfinavir|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00655  Nelfinavir|D08259  Nelfinavir|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00655  Nelfinavir|D08259  Nelfinavir|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00655  Nelfinavir|D08259  Nelfinavir|Antimicrobials [BR:br08307(D08259)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D08259  Nelfinavir (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08259)]|Drug metabolizing enzymes|D08259,
C07258,Neostigmine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08261)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA01 Neostigmine|D08261  Neostigmine (BAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB06 Neostigmine|D08261  Neostigmine (BAN)|Risk category of Japanese OTC drugs [BR:br08312(D08261)]|Third-class OTC drugs|Inorganic and organic chemicals|Neostigmine|D08261  Neostigmine (BAN)|Drug groups [BR:br08330(D08261)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00987  Neostigmine|D08261  Neostigmine|DG01719  Parasympathomimetic agent|DG00987  Neostigmine|D08261  Neostigmine|Target-based classification of drugs [BR:br08310(D08261)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D08261  Neostigmine (BAN),
C07259,Sildenafil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08514)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BE Drugs used in erectile dysfunction|G04BE03 Sildenafil|D08514  Sildenafil (INN)|Drug groups [BR:br08330(D08514)]|Cardiovascular agent|DG01509  Phosphodiesterase V inhibitor|DG00484  Sildenafil|D08514  Sildenafil|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00484  Sildenafil|D08514  Sildenafil|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00484  Sildenafil|D08514  Sildenafil|Target-based classification of drugs [BR:br08310(D08514)]|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE5|D08514  Sildenafil (INN)|New drug approvals in Europe [br08329.html(D08514)]|European public assessment reports (EPAR) authorised medicine|D08514|Drug metabolizing enzymes and transporters [br08309.html(D08514)]|Drug metabolizing enzymes|D08514,
C07261,Octamethyltrisiloxane,,,,,
C07263,Nevirapine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00435)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AG Non-nucleoside reverse transcriptase inhibitors|J05AG01 Nevirapine|D00435  Nevirapine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00435)]|Antivirals|Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)|Nevirapine|D00435  Nevirapine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00435)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00435  Nevirapine (JAN/USP/INN)|Drug groups [BR:br08330(D00435)]|Antiviral|DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)|D00435  Nevirapine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00435  Nevirapine|Metabolizing enzyme substrate|DG02919  CYP2B6 substrate|D00435  Nevirapine|DG01644  CYP2D6 substrate|D00435  Nevirapine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00435  Nevirapine|Drug classes [BR:br08332(D00435)]|Antiviral|DG03107  Anti-HIV agent|D00435  Nevirapine|Antimicrobials [BR:br08307(D00435)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00435  Nevirapine (JAN/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00435)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00435  Nevirapine (JAN/USP/INN)|New drug approvals in Europe [br08329.html(D00435)]|European public assessment reports (EPAR) authorised medicine|D00435|Drug metabolizing enzymes and transporters [br08309.html(D00435)]|Drug metabolizing enzymes|D00435",
C07264,Nicardipine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08270)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA04 Nicardipine|D08270  Nicardipine (INN)|Drug groups [BR:br08330(D08270)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00323  Nicardipine|D08270  Nicardipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|DG00323  Nicardipine|D08270  Nicardipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00323  Nicardipine|D08270  Nicardipine|Target-based classification of drugs [BR:br08310(D08270)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D08270  Nicardipine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08270)]|Drug metabolizing enzymes|D08270,
C07266,Nifedipine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00437)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA05 Nifedipine|D00437  Nifedipine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00437)]|Cardiovascular Agents|Calcium Channel Blocking Agents, Dihydropyridines|Nifedipine|D00437  Nifedipine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00437)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2171  Coronary dilators|D00437  Nifedipine (JP18/USP/INN)|Drug groups [BR:br08330(D00437)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|D00437  Nifedipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|D00437  Nifedipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00437  Nifedipine|Drug classes [BR:br08332(D00437)]|Cardiovascular agent|DG01928  Dihydropyridine calcium channel blocker|D00437  Nifedipine|DG03231  Antihypertensive|D00437  Nifedipine|Target-based classification of drugs [BR:br08310(D00437)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D00437  Nifedipine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00437)]|Chemicals|D00437  Nifedipine|D00437  Nifedipine extended-release capsules|D00437  Nifedipine fine granules|D00437  Nifedipine enteric fine granules|Drug metabolizing enzymes and transporters [br08309.html(D00437)]|Drug metabolizing enzymes|D00437",
C07267,Nimodipine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00438)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA06 Nimodipine|D00438  Nimodipine (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00438)]|Cardiovascular Agents|Calcium Channel Blocking Agents, Dihydropyridines|Nimodipine|D00438  Nimodipine (USP/INN)|Drug groups [BR:br08330(D00438)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|D00438  Nimodipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|D00438  Nimodipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00438  Nimodipine|Drug classes [BR:br08332(D00438)]|Cardiovascular agent|DG01928  Dihydropyridine calcium channel blocker|D00438  Nimodipine|DG03231  Antihypertensive|D00438  Nimodipine|Target-based classification of drugs [BR:br08310(D00438)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D00438  Nimodipine (USP/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00438)]|Drug metabolizing enzymes|D00438",
C07268,Nitrofurantoin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00439)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XE Nitrofuran derivatives|J01XE01 Nitrofurantoin|D00439  Nitrofurantoin (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00439)]|Antibacterials|Antibacterials, Other|Nitrofurantoin|D00439  Nitrofurantoin (JAN/USP/INN)|Drug groups [BR:br08330(D00439)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|DG01552  Hydantoin type nitrofuran|D00439  Nitrofurantoin|Antimicrobials [BR:br08307(D00439)]|Antibacterials|Bactericidal action|Hydantoin type nitrofuran|D00439  Nitrofurantoin (JAN/USP/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D00439)]|Antibacterials|Bactericidal action|Hydantoin type nitrofuran|D00439  Nitrofurantoin (JAN/USP/INN)|Pharmacogenomic biomarkers [br08341.html(D00439)]|Polymorphisms and mutations affecting drug response|D00439",
C07269,Nitroprusside;|Pentacyanidonitrosylferrate(2-),,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|C02DD Nitroferricyanide derivatives|C02DD01 Nitroprusside|C07269  Nitroprusside|Drug groups [BR:br08330]|Cardiovascular agent|DG03231  Antihypertensive|DG00263  Nitroprusside|C07269  Nitroprusside",G00263
C07270,Nizatidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00440)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BA H2-receptor antagonists|A02BA04 Nizatidine|D00440  Nizatidine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00440)]|Gastrointestinal Agents|Histamine2 (H2) Receptor Antagonists|Nizatidine|D00440  Nizatidine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00440)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2325  H2 blockers|D00440  Nizatidine (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00440)]|Agents for digestive organs|09 Histamine H2 receptor blocker containing drugs|D00440  Nizatidine (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00440)]|First-class OTC drugs|Inorganic and organic chemicals|Nizatidine|D00440  Nizatidine (JP18/USP/INN)|Drug groups [BR:br08330(D00440)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01481  Histamine receptor H2 antagonist|D00440  Nizatidine|Drug classes [BR:br08332(D00440)]|Gastrointestinal agent|DG01481  Histamine receptor H2 antagonist|D00440  Nizatidine|Target-based classification of drugs [BR:br08310(D00440)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH2|D00440  Nizatidine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00440)]|Chemicals|D00440  Nizatidine|D00440  Nizatidine capsules|Rx-to-OTC switch list in the USA [br08315.html(D00440)]|D00440|Rx-to-OTC switch list in Japan [br08314.html(D00440)]|D00440,
C07271,"Limonene-1,2-epoxide;|Limonene oxide;|(4R)-Limonene-1,2-epoxide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C07271  Limonene-1,2-epoxide|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C07271  Limonene-1,2-epoxide",
C07272,"Maleimide;|2,5-Pyrroledione",,,,,
C07273,"Succinimide;|2,5-Pyrrolidinedione;|Butanimide;|2,5-Diketopyrrolidine",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08532)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX10 Succinimide|D08532  Succinimide,
C07274,Nortriptyline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08288)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA10 Nortriptyline|D08288  Nortriptyline (INN)|Drug groups [BR:br08330(D08288)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00935  Nortriptyline|D08288  Nortriptyline|DG01728  Tricyclic antidepressant|DG00935  Nortriptyline|D08288  Nortriptyline|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00935  Nortriptyline|D08288  Nortriptyline|Target-based classification of drugs [BR:br08310(D08288)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08288  Nortriptyline (INN)|SLC6A4 (HTT)|D08288  Nortriptyline (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08288)]|Drug metabolizing enzymes|D08288,
C07275,"Glutarimide;|Piperidine-2,6-dione;|2,6-Diketopiperidine",,,,,
C07276,"Limonene-1,2-diol;|(1S,2S,4R)-Limonene-1,2-diol;|(1S,2S,4R)-Menth-8-ene-1,2-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C07276  Limonene-1,2-diol",
C07277,dTDP-D-fucose;|dTDP-alpha-D-fucopyranose,,,,,
C07278,beta-D-Galactosyl-(1->3)-N-acetyl-D-galactosamine;|beta-D-Galactopyranosyl-(1->3)-N-acetyl-D-galactosamine,,,,,G10607
C07279,2-Aminoethylarsonate;|2-Aminoethylarsonic acid,,,,,
C07280,Rhodanine;|2-Thioxo-4-thiazolidinone,,,,,
C07281,[eIF5A-precursor]-lysine;|[enzyme]-lysine,Generic compound in reaction hierarchy,,,,
C07282,[eIF5A-precursor]-deoxyhypusine;|Protein N6-(4-Aminobutyl)-L-lysine,Generic compound in reaction hierarchy,,,,
C07283,(1->3)-beta-D-Galactopyranans;|(1->3)-beta-D-Galactans,,,,,G00830
C07285,Arabino-galactose,,,,,G12550
C07287,Sulcatone;|Methylheptenone;|6-Methylhept-5-en-2-one;|6-Methyl-5-hepten-2-one,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C07287  6-Methyl-5-hepten-2-one,
C07288,Sulcatol;|6-Methylhept-5-en-2-ol;|6-Methyl-5-hepten-2-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C07288  6-Methyl-5-hepten-2-ol,
C07289,Crepenynate;|(9Z)-Octadec-9-en-12-ynoate;|(Z)-9-Octadecen-12-ynoic acid;|Crepenynic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Acetylenic fatty acids|C07289  (Z)-9-Octadecen-12-ynoic acid,
C07290,7-O-Methylluteone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C07290  7-O-Methylluteone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C07290  7-O-Methylluteone,
C07294,Methylarsonate;|Methylarsonic acid;|MAA,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Arsenical herbicides|C07294  Methylarsonate,
C07295,Methanearsonous acid;|Methylarsonous acid;|Methylarsonite,,,,,
C07296,"4,8,12-Trimethyltridecanoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C07296  4,8,12-Trimethyltridecanoyl-CoA",
C07297,3-Oxopristanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C07297  3-Oxopristanoyl-CoA,
C07301,(R)-Mandelamide,,,,,
C07302,3-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)propionyl-CoA,,,,,
C07303,4-Hydroxy-3-methoxyphenyl-beta-hydroxypropanoyl-CoA;|4-Hydroxy-3-methoxyphenyl-beta-hydroxypropionyl-CoA;|3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propionyl-CoA;|3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoyl-CoA,,,,,
C07304,Deacetylisoipecoside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C07304  Deacetylisoipecoside,
C07306,"Octreotide;|D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L- cysteinamide cyclic (2->7)-disulfide",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00442)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01C HYPOTHALAMIC HORMONES|H01CB Somatostatin and analogues|H01CB02 Octreotide|D00442  Octreotide (USAN/INN)|Drug groups [BR:br08330(D00442)]|Hormonal agent|DG01588  Somatostatin receptor agonist|DG00501  Octreotide|D00442  Octreotide|Target-based classification of drugs [BR:br08310(D00442)]|G Protein-coupled receptors|Rhodopsin family|Somatostatin|SSTR2|D00442  Octreotide (USAN/INN)",
C07307,Deacetylipecoside;|N-Deacetylipecoside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C07307  Deacetylipecoside,
C07308,Cacodylate;|Dimethylarsinate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Arsenical herbicides|C07308  Cacodylate,
C07309,Sotalol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08525)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA07 Sotalol|D08525  Sotalol (INN)|Drug groups [BR:br08330(D08525)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG00307  Sotalol|D08525  Sotalol|DG01653  Antiarrhythmics|DG01648  Class III antiarrhythmic agent|DG00307  Sotalol|D08525  Sotalol|Target-based classification of drugs [BR:br08310(D08525)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D08525  Sotalol (INN)|ADRB2|D08525  Sotalol (INN)|Ion channels|Voltage-gated ion channels|Potassium channels|KCNH2|D08525  Sotalol (INN)",
C07310,Spironolactone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00443)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS|C03DA Aldosterone antagonists|C03DA01 Spironolactone|D00443  Spironolactone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00443)]|Cardiovascular Agents|Mineralocorticoid Receptor Antagonist|Spironolactone|D00443  Spironolactone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00443)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2133  Antialdosterones|D00443  Spironolactone (JP18/USP/INN)|Drug groups [BR:br08330(D00443)]|Cardiovascular agent|DG03231  Antihypertensive|DG01676  Aldosterone antagonist|D00443  Spironolactone|DG01885  Potassium-sparing diuretic|D00443  Spironolactone|Drug classes [BR:br08332(D00443)]|Cardiovascular agent|DG01676  Aldosterone antagonist|D00443  Spironolactone|DG03231  Antihypertensive|D00443  Spironolactone|Target-based classification of drugs [BR:br08310(D00443)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D00443  Spironolactone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00443)]|Chemicals|D00443  Spironolactone|D00443  Spironolactone tablets|New drug approvals in Europe [br08329.html(D00443)]|European public assessment reports (EPAR) authorised medicine|D00443,
C07311,Stanozolol;|Androstanazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00444)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AA Androstan derivatives|A14AA02 Stanozolol|D00444  Stanozolol (JAN/USP/INN)|Drug groups [BR:br08330(D00444)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|D00444  Stanozolol|Target-based classification of drugs [BR:br08310(D00444)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00444  Stanozolol (JAN/USP/INN),
C07312,"Stavudine;|d4T;|2',3'-Didehydro-3'-deoxythimidine;|Sanilvudine",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00445)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF04 Stavudine|D00445  Stavudine (USAN/INN)|USP drug classification [BR:br08302(D00445)]|Antivirals|Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)|Stavudine|D00445  Stavudine (USAN/INN)|Drug groups [BR:br08330(D00445)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D00445  Stavudine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00445  Stavudine|Antimicrobials [BR:br08307(D00445)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00445  Stavudine (USAN/INN)|Antimicrobials abbreviations [BR:br08327(D00445)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00445  Stavudine (USAN/INN)|New drug approvals in Europe [br08329.html(D00445)]|European public assessment reports (EPAR) authorised medicine|D00445",
C07313,Streptozocin;|Zanosar,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05932)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD04 Streptozocin|D05932  Streptozocin (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D05932)]|Antineoplastics|Alkylating Agents|Streptozocin|D05932  Streptozocin (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D05932)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4219  Others|D05932  Streptozocin (JAN/USAN/INN)|Drug groups [BR:br08330(D05932)]|Antineoplastic|DG01677  Alkylating agent|DG01724  Nitrosourea|D05932  Streptozocin|New drug approvals in Japan [br08318.html(D05932)]|Drugs with new active ingredients|D05932,
C07314,Sucralfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX02 Sucralfate|C07314  Sucralfate|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Sucralfate|C07314  Sucralfate|Drug groups [BR:br08330]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|DG00025  Sucralfate|C07314  Sucralfate,G00025
C07315,Sulfamethoxazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00447)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EC Intermediate-acting sulfonamides|J01EC01 Sulfamethoxazole|D00447  Sulfamethoxazole (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00447)]|Agents for ophthalmologic use|63 Antibacterial eye drops|D00447  Sulfamethoxazole (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00447)]|Second-class OTC drugs|Inorganic and organic chemicals|Sulfamethoxazole|D00447  Sulfamethoxazole (JP18/USP/INN)|Drug groups [BR:br08330(D00447)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01785  Intermediate-acting sulfonamide|DG02848  Sulfamethoxazole|D00447  Sulfamethoxazole|Antimicrobials [BR:br08307(D00447)]|Antibacterials|Folic acid biosynthesis inhibitor|Intermediate-acting sulfonamide|D00447  Sulfamethoxazole (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00447)]|Chemicals|D00447  Sulfamethoxazole,
C07316,Sulfasalazine;|Salicylazosulfapyridine;|Salazosulfapyridine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00448)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EC Aminosalicylic acid and similar agents|A07EC01 Sulfasalazine|D00448  Sulfasalazine (USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00448)]|Inflammatory Bowel Disease Agents|Aminosalicylates and/or Prodrugs|Sulfasalazine|D00448  Sulfasalazine (USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00448)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|621  Sulfonamides|6219  Others|D00448  Sulfasalazine (USP/INN); Salazosulfapyridine (JP18)|Drug groups [BR:br08330(D00448)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|D00448  Sulfasalazine|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00448  Sulfasalazine|Transporter substrate|DG01913  ABCG2 substrate|D00448  Sulfasalazine|Drug classes [BR:br08332(D00448)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00448  Sulfasalazine|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00448  Sulfasalazine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00448)]|Chemicals|D00448  Salazosulfapyridine|Drug metabolizing enzymes and transporters [br08309.html(D00448)]|Drug transporters|D00448|Pharmacogenomic biomarkers [br08341.html(D00448)]|Polymorphisms and mutations affecting drug response|D00448",
C07317,Sulfinpyrazone;|Sulfoxyphenylpyrazolidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00449)]|M MUSCULO-SKELETAL SYSTEM|M04 ANTIGOUT PREPARATIONS|M04A ANTIGOUT PREPARATIONS|M04AB Preparations increasing uric acid excretion|M04AB02 Sulfinpyrazone|D00449  Sulfinpyrazone (JAN/USP/INN)|Drug groups [BR:br08330(D00449)]|Musculo-skeletal system agent|DG02042  Uricosurics|D00449  Sulfinpyrazone,
C07318,Sulfisoxazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00450)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EB Short-acting sulfonamides|J01EB05 Sulfafurazole|D00450  Sulfisoxazole (JP18/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AB Sulfonamides|S01AB02 Sulfafurazole|D00450  Sulfisoxazole (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00450)]|Second-class OTC drugs|Inorganic and organic chemicals|Sulfisoxazole|D00450  Sulfisoxazole (JP18/USP)|Drug groups [BR:br08330(D00450)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|DG00598  Sulfafurazole|D00450  Sulfisoxazole|Antimicrobials [BR:br08307(D00450)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D00450  Sulfisoxazole (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00450)]|Chemicals|D00450  Sulfisoxazole,
C07319,Sumatriptan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00451)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CC Selective serotonin (5HT1) agonists|N02CC01 Sumatriptan|D00451  Sumatriptan (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00451)]|Antimigraine Agents|Serotonin (5-HT) Receptor Agonists|Sumatriptan|D00451  Sumatriptan (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00451)]|2  Agents affecting individual organs|21  Cardiovascular agents|216  Vasoconstrictors|2160  Vasoconstrictors|D00451  Sumatriptan (JAN/USP/INN)|Drug groups [BR:br08330(D00451)]|Analgesic|DG01484  5-HT1B-receptor agonist|DG00836  Sumatriptan|D00451  Sumatriptan|DG01485  5-HT1D-receptor agonist|DG00836  Sumatriptan|D00451  Sumatriptan|DG01518  5-HT1B/1D-receptor agonist|DG00836  Sumatriptan|D00451  Sumatriptan|DG01943  Triptan|DG00836  Sumatriptan|D00451  Sumatriptan|Metabolizing enzyme substrate|DG02917  MAO substrate|DG03178  MAOA substrate|DG00836  Sumatriptan|D00451  Sumatriptan|Target-based classification of drugs [BR:br08310(D00451)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1B|D00451  Sumatriptan (JAN/USP/INN) &lt;JP/US&gt;|HTR1D|D00451  Sumatriptan (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00451)]|Drug metabolizing enzymes|D00451,
C07320,Suprofen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00452)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE07 Suprofen|D00452  Suprofen (JAN/USP/INN)|Drug groups [BR:br08330(D00452)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|D00452  Suprofen|Dermatological agent|DG03243  Atopic dermatitis agent|D00452  Suprofen|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00452  Suprofen|Drug metabolizing enzymes and transporters [br08309.html(D00452)]|Drug metabolizing enzymes|D00452",
C07321,Ofloxacin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00453)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA01 Ofloxacin|D00453  Ofloxacin (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE01 Ofloxacin|D00453  Ofloxacin (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA16 Ofloxacin|D00453  Ofloxacin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00453)]|Antibacterials|Quinolones|Ofloxacin|D00453  Ofloxacin (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Ofloxacin|D00453  Ofloxacin (JP18/USP/INN)|Otic Agents|Otic Anti-Infectives|Ofloxacin|D00453  Ofloxacin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00453)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00453  Ofloxacin (JP18/USP/INN)|132  Otic and nasal agents|1329  Others|D00453  Ofloxacin (JP18/USP/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D00453  Ofloxacin (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9734  Quinolone, derivatives and preparations|C07321  Ofloxacin|Drug groups [BR:br08330(D00453)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00616  Ofloxacin|D00453  Ofloxacin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00616  Ofloxacin|D00453  Ofloxacin|Drug classes [BR:br08332(D00453)]|Antibacterial|DG01549  Fluoroquinolone|D00453  Ofloxacin|Antimicrobials [BR:br08307(D00453)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00453  Ofloxacin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00453)]|Chemicals|D00453  Ofloxacin|Drug metabolizing enzymes and transporters [br08309.html(D00453)]|Drug metabolizing enzymes|D00453",
C07322,Olanzapine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00454)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AH Diazepines, oxazepines, thiazepines and oxepines|N05AH03 Olanzapine|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00454)]|Antipsychotics|2nd Generation/Atypical|Olanzapine|D00454  Olanzapine (JAN/USP/INN)|Bipolar Agents|Bipolar Agents, Other|Olanzapine|D00454  Olanzapine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00454)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00454  Olanzapine (JAN/USP/INN)|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2391  Antiemetics|D00454  Olanzapine (JAN/USP/INN)|Drug groups [BR:br08330(D00454)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00898  Olanzapine|D00454  Olanzapine|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG00898  Olanzapine|D00454  Olanzapine|DG03200  Antipsychotic agent|DG03064  Atypical antipsychotic|DG00898  Olanzapine|D00454  Olanzapine|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00898  Olanzapine|D00454  Olanzapine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00898  Olanzapine|D00454  Olanzapine|DG01644  CYP2D6 substrate|DG00898  Olanzapine|D00454  Olanzapine|Drug classes [BR:br08332(D00454)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00454  Olanzapine|Target-based classification of drugs [BR:br08310(D00454)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|Dopamine|DRD2|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|DRD3|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|DRD4|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|Histamine|HRH1|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|Serotonin|HTR2|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|HTR6|D00454  Olanzapine (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00454)]|European public assessment reports (EPAR) authorised medicine|D00454|New drug approvals in Japan [br08318.html(D00454)]|Drugs with new active ingredients|D00454|Drug metabolizing enzymes and transporters [br08309.html(D00454)]|Drug metabolizing enzymes|D00454",
C07323,Olsalazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08295)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EC Aminosalicylic acid and similar agents|A07EC03 Olsalazine|D08295  Olsalazine (INN)|Drug groups [BR:br08330(D08295)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|DG00099  Olsalazine|D08295  Olsalazine",
C07324,Omeprazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00455)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BC Proton pump inhibitors|A02BC01 Omeprazole|D00455  Omeprazole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00455)]|Gastrointestinal Agents|Proton Pump Inhibitors|Omeprazole|D00455  Omeprazole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00455)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2329  Others|D00455  Omeprazole (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|931  Stomachics, digestive and antacids|9319  Other stomachics, digestive and antacids|C07324  Omeprazole|Drug groups [BR:br08330(D00455)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01646  Proton pump inhibitor (PPI)|DG00020  Omeprazole|D00455  Omeprazole|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00020  Omeprazole|D00455  Omeprazole|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00020  Omeprazole|D00455  Omeprazole|Drug classes [BR:br08332(D00455)]|Gastrointestinal agent|DG01646  Proton pump inhibitor (PPI)|D00455  Omeprazole|Target-based classification of drugs [BR:br08310(D00455)]|Enzymes|Hydrolases (EC3)|ATPase|ATP4|D00455  Omeprazole (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00455)]|Chemicals|D00455  Omeprazole|D00455  Omeprazole enteric-coated tablets|Drug metabolizing enzymes and transporters [br08309.html(D00455)]|Drug metabolizing enzymes|D00455|Pharmacogenomic biomarkers [br08341.html(D00455)]|Polymorphisms and mutations affecting drug response|D00455|Rx-to-OTC switch list in the USA [br08315.html(D00455)]|D00455",
C07325,Ondansetron,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00456)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AA Serotonin (5HT3) antagonists|A04AA01 Ondansetron|D00456  Ondansetron (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00456)]|Antiemetics|Emetogenic Therapy Adjuncts|Ondansetron|D00456  Ondansetron (JAN/USP/INN)|Drug groups [BR:br08330(D00456)]|Gastrointestinal agent|DG01489  5-HT3-receptor antagonist|DG00060  Ondansetron|D00456  Ondansetron|DG01762  Antiemetic|DG00060  Ondansetron|D00456  Ondansetron|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00060  Ondansetron|D00456  Ondansetron|DG01644  CYP2D6 substrate|DG00060  Ondansetron|D00456  Ondansetron|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00060  Ondansetron|D00456  Ondansetron|Target-based classification of drugs [BR:br08310(D00456)]|Ion channels|Ligand-gated ion channels|Serotonin|HTR3|D00456  Ondansetron (JAN/USP/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00456)]|Drug metabolizing enzymes|D00456,
C07326,"1,5-Anhydro-D-glucitol;|1,5-Anhydro-D-sorbitol;|1,5-Anhydroglucitol",,,,,
C07327,3-Pyridinaldehyde;|Pyridine-3-aldehyde;|3-Pyridinecarboxaldehyde;|Nicotinaldehyde,,,,,
C07328,3-Methylbutanol;|Isoamyl alcohol;|Isopentyl alcohol;|3-Methylbutan-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C07328  3-Methylbutan-1-ol,
C07329,3-Methylbutanal;|Isovaleraldehyde,,,,,
C07330,"3-Methyl-2-butenal;|3-Methylbut-2-enal;|3,3-Dimethyl-acrylaldehyde;|Senecialdehyde;|Prenal",,,,,
C07331,Carbonyl sulfide,,,,,
C07332,Dibenzylsuccinate,,,,,
C07334,Oxacillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08307)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF04 Oxacillin|D08307  Oxacillin (INN)|Drug groups [BR:br08330(D08307)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00542  Oxacillin|D08307  Oxacillin|DG01779  beta-Lactamase resistant penicillin|DG00542  Oxacillin|D08307  Oxacillin|Antimicrobials [BR:br08307(D08307)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D08307  Oxacillin (INN)",
C07335,2-Amino-3-oxo-4-phosphonooxybutyrate;|L-2-Amino-3-oxo-4-phosphonooxybutyrate;|(2S)-2-Amino-3-oxo-4-phosphonooxybutanoate,,,,,
C07336,Quazepam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00457)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD10 Quazepam|D00457  Quazepam (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00457)]|Sleep Disorder Agents|Sleep Promoting Agents|Quazepam|D00457  Quazepam (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00457)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00457  Quazepam (JAN/USP/INN)|Drug groups [BR:br08330(D00457)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D00457  Quazepam|DG03202  Hypnotic|D00457  Quazepam|DG01567  GABA-A receptor agonist|D00457  Quazepam|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00457  Quazepam|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00457  Quazepam|Drug classes [BR:br08332(D00457)]|Neuropsychiatric agent|DG03202  Hypnotic|D00457  Quazepam|Target-based classification of drugs [BR:br08310(D00457)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00457  Quazepam (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00457)]|Drug metabolizing enzymes|D00457|Narcotics and psychotropics in Japan [br08308.html(D00457)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00457",
C07338,"(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid;|(9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0104 Hydroperoxy fatty acids|C07338  (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C07338  (9Z,12Z)-(11S)-11-Hydroperoxyoctadeca-9,12-dienoic acid",
C07339,Quinacrine;|Mepacrine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08179)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX05 Mepacrine|D08179  Mepacrine (INN)|Antimicrobials [BR:br08307(D08179)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Others|D08179  Mepacrine (INN)",
C07340,Quinapril hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00459)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA06 Quinapril|D00459  Quinapril hydrochloride (JP18/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00459)]|Cardiovascular Agents|Angiotensin-converting Enzyme (ACE) Inhibitors|Quinapril|D00459  Quinapril hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00459)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00338  Quinapril|D00459  Quinapril hydrochloride|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00338  Quinapril|D00459  Quinapril hydrochloride|Drug classes [BR:br08332(D00459)]|Cardiovascular agent|DG01501  Angiotensin-converting enzyme inhibitor|D00459  Quinapril hydrochloride|DG03231  Antihypertensive|D00459  Quinapril hydrochloride|Target-based classification of drugs [BR:br08310(D00459)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D00459  Quinapril hydrochloride (JP18/USP) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00459)]|Chemicals|D00459  Quinapril hydrochloride|D00459  Quinapril hydrochloride tablets",
C07341,Oxamniquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00460)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02B ANTITREMATODALS|P02BA Quinoline derivatives and related substances|P02BA02 Oxamniquine|D00460  Oxamniquine (USAN/INN)|Antimicrobials [BR:br08307(D00460)]|Antiparasitics|Antitrematodal agents|Quinoline derivatives and related substances|D00460  Oxamniquine (USAN/INN)",
C07342,Quinethazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00461)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES|C03BA Sulfonamides, plain|C03BA02 Quinethazone|D00461  Quinethazone (JAN/INN)|Drug groups [BR:br08330(D00461)]|Cardiovascular agent|DG03231  Antihypertensive|DG02992  Thiazide related diuretic|D00461  Quinethazone|DG01690  Sulfonamide diuretic|DG02992  Thiazide related diuretic|D00461  Quinethazone|Target-based classification of drugs [BR:br08310(D00461)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D00461  Quinethazone (JAN/INN)|SLC12A3 (TSC)|D00461  Quinethazone (JAN/INN)",
C07343,2-Hydroxyphytanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C07343  2-Hydroxyphytanoyl-CoA,
C07344,3-Hydroxyquinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C07344  3-Hydroxyquinine,
C07345,Betaine aldehyde hydrate,,,,,
C07346,Oxandrolone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00462)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AA Androstan derivatives|A14AA08 Oxandrolone|D00462  Oxandrolone (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00462)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Anabolic Steroids|Oxandrolone|D00462  Oxandrolone (JAN/USP/INN)|Drug groups [BR:br08330(D00462)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|D00462  Oxandrolone|Target-based classification of drugs [BR:br08310(D00462)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00462  Oxandrolone (JAN/USP/INN) &lt;US&gt;",
C07347,Thiophene-2-carbonyl-CoA,,,,,
C07348,5-Hydroxythiophene-2-carbonyl-CoA,,,,,
C07349,3'-Demethylstaurosporine;|3'-Demethoxy-3'-hydroxystaurosporine,,,,,
C07350,"Phlorisovalerophenone;|3-Methyl-1-(2,4,6-trihydroxyphenyl)butan-1-one",,,,,
C07351,"Phlorisobutyrophenone;|2-Methyl-1-(2,4,6-trihydroxyphenyl)-1-propanone",,,,,
C07354,"(7S,8S)-DiHODE;|(9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid;|(7S,8S,9Z,12Z)-7,8-Dihydroxyoctadeca-9,12-dienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C07354  (9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C07354  (9Z,12Z)-(7S,8S)-Dihydroxyoctadeca-9,12-dienoic acid",
C07355,"(9Z)-(7S,8S)-Dihydroxyoctadecenoic acid;|(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoic acid;|(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C07355  (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C07355  (9Z)-(7S,8S)-Dihydroxyoctadecenoic acid",
C07356,Oxaprozin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00463)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AE Propionic acid derivatives|M01AE12 Oxaprozin|D00463  Oxaprozin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00463)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Oxaprozin|D00463  Oxaprozin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00463)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00463  Oxaprozin (JP18/USP/INN)|Drug groups [BR:br08330(D00463)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|D00463  Oxaprozin|Drug classes [BR:br08332(D00463)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00463  Oxaprozin|Target-based classification of drugs [BR:br08310(D00463)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00463  Oxaprozin (JP18/USP/INN) &lt;JP/US&gt;|PTGS2 (COX2)|D00463  Oxaprozin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00463)]|Chemicals|D00463  Oxaprozin",
C07357,"(9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoic acid;|(9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C07357  (9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C07357  (9Z,12Z,15Z)-(7S,8S)-Dihydroxyoctadeca-9,12,15-trienoic acid",
C07359,Oxazepam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00464)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BA Benzodiazepine derivatives|N05BA04 Oxazepam|D00464  Oxazepam (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00464)]|Anxiolytics|Benzodiazepines|Oxazepam|D00464  Oxazepam (JAN/USP/INN)|Drug groups [BR:br08330(D00464)]|Neuropsychiatric agent|DG01914  Anxiolytics, benzodiazepine derivatives|D00464  Oxazepam|Target-based classification of drugs [BR:br08310(D00464)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00464  Oxazepam (JAN/USP/INN) &lt;US&gt;|Narcotics and psychotropics in Japan [br08308.html(D00464)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00464",
C07360,Oxybutynin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00465)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BD Drugs for urinary frequency and incontinence|G04BD04 Oxybutynin|D00465  Oxybutynin (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00465)]|Genitourinary Agents|Antispasmodics, Urinary|Cholinergic Muscarinic Antagonists|Oxybutynin|D00465  Oxybutynin (USAN/INN)|Drug groups [BR:br08330(D00465)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00478  Oxybutynin|D00465  Oxybutynin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00478  Oxybutynin|D00465  Oxybutynin|DG02925  CYP3A5 substrate|DG00478  Oxybutynin|D00465  Oxybutynin|Target-based classification of drugs [BR:br08310(D00465)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00465  Oxybutynin (USAN/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D00465)]|European public assessment reports (EPAR) authorised medicine|D00465|Drug metabolizing enzymes and transporters [br08309.html(D00465)]|Drug metabolizing enzymes|D00465|Rx-to-OTC switch list in the USA [br08315.html(D00465)]|D00465",
C07361,Piperacillin sodium;|Pipracil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00466)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA12 Piperacillin|D00466  Piperacillin sodium (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00466)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6131  Penicillins|D00466  Piperacillin sodium (JP18/USP)|Drug groups [BR:br08330(D00466)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00526  Piperacillin|D00466  Piperacillin sodium|DG01780  Extended spectrum penicillin|DG00526  Piperacillin|D00466  Piperacillin sodium|Drug classes [BR:br08332(D00466)]|Antibacterial|DG01480  Penicillin|D00466  Piperacillin sodium|Antimicrobials [BR:br08307(D00466)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D00466  Piperacillin sodium (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00466)]|Chemicals|D00466  Piperacillin sodium|D00466  Piperacillin sodium for injection",
C07362,Pipobroman,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00467)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AX Other alkylating agents|L01AX02 Pipobroman|D00467  Pipobroman (JAN/USAN/INN)|Drug groups [BR:br08330(D00467)]|Antineoplastic|DG01677  Alkylating agent|D00467  Pipobroman,
C07363,Oxymetazoline;|Afrin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08322)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX27 Oxymetazoline|D08322  Oxymetazoline (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA05 Oxymetazoline|D08322  Oxymetazoline (INN)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB07 Oxymetazoline|D08322  Oxymetazoline (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA04 Oxymetazoline|D08322  Oxymetazoline (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08322)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxymetazoline|D08322  Oxymetazoline (INN)|Drug groups [BR:br08330(D08322)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG01029  Oxymetazoline|D08322  Oxymetazoline|Target-based classification of drugs [BR:br08310(D08322)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1A|D08322  Oxymetazoline (INN)",
C07366,Prazepam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00470)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BA Benzodiazepine derivatives|N05BA11 Prazepam|D00470  Prazepam (JP18/USAN/INN)|Drug groups [BR:br08330(D00470)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D00470  Prazepam|DG01914  Anxiolytics, benzodiazepine derivatives|D00470  Prazepam|Target-based classification of drugs [BR:br08310(D00470)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00470  Prazepam (JP18/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00470)]|Chemicals|D00470  Prazepam|D00470  Prazepam tablets|Narcotics and psychotropics in Japan [br08308.html(D00470)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00470",
C07367,Praziquantel,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00471)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02B ANTITREMATODALS|P02BA Quinoline derivatives and related substances|P02BA01 Praziquantel|D00471  Praziquantel (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00471)]|Antiparasitics|Anthelmintics|Praziquantel|D00471  Praziquantel (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00471)]|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|642  Anthelmintics|6429  Others|D00471  Praziquantel (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9749  Other antiprotozoan agents|C07367  Praziquantel|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C07367  Praziquantel|Drug groups [BR:br08330(D00471)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00471  Praziquantel|Antimicrobials [BR:br08307(D00471)]|Antiparasitics|Antitrematodal agents|Quinoline derivatives and related substances|D00471  Praziquantel (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00471)]|Drug metabolizing enzymes|D00471",
C07368,Prazosin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08411)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING|C02CA Alpha-adrenoreceptor antagonists|C02CA01 Prazosin|D08411  Prazosin (INN)|Drug groups [BR:br08330(D08411)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00253  Prazosin|D08411  Prazosin|DG01739  Peripherally-acting antiadrenergic|DG00253  Prazosin|D08411  Prazosin|DG03231  Antihypertensive|DG00253  Prazosin|D08411  Prazosin|Transporter inhibitor|DG02881  SLC22A3 inhibitor|DG00253  Prazosin|D08411  Prazosin|Target-based classification of drugs [BR:br08310(D08411)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08411  Prazosin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08411)]|Drug transporters|D08411",
C07369,"Prednisolone;|11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07369  Prednisolone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00472)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC04 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA01 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA04 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA03 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA02 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB06 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD02 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA04 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB02 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA03 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA02 Prednisolone|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00472)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Prednisolone|D00472  Prednisolone (JP18/USP/INN)|Inflammatory Bowel Disease Agents|Glucocorticoids|Prednisolone|D00472  Prednisolone (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Prednisolone|D00472  Prednisolone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00472)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2456  Prednisolones|D00472  Prednisolone (JP18/USP/INN)|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D00472  Prednisolone (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00472)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00472  Prednisolone (JP18/USP/INN)|Agents for dental and stomatological use|74 Stomatitis remedies|D00472  Prednisolone (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00472)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Prednisolone|D00472  Prednisolone (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Prednisolone|D00472  Prednisolone (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C07369  Prednisolone|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9612  Adrenal hormone preparations|C07369  Prednisolone|Drug groups [BR:br08330(D00472)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00093  Prednisolone|D00472  Prednisolone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00472  Prednisolone|Drug classes [BR:br08332(D00472)]|Anti-inflammatory|DG01955  Corticosteroid|D00472  Prednisolone|Target-based classification of drugs [BR:br08310(D00472)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00472  Prednisolone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00472)]|Chemicals|D00472  Prednisolone|D00472  Prednisolone tablets|Drug metabolizing enzymes and transporters [br08309.html(D00472)]|Drug metabolizing enzymes|D00472|Topical steroids potency [br08317.html(D00472)]|Classification in Japan|D00472",
C07370,"Prednisone;|1,2-Dehydrocortisone;|17,21-Dihydroxypregna-1,4-diene-3,11,20-trione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07370  Prednisone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA03 Prednisone|C07370  Prednisone|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB07 Prednisone|C07370  Prednisone|Drug groups [BR:br08330]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00094  Prednisone|C07370  Prednisone",G00094
C07371,"Primidone;|5-Phenyl-5-ethyl-Hexahydropyrimidine-4,6-dione",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00474)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AA Barbiturates and derivatives|N03AA03 Primidone|D00474  Primidone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00474)]|Anticonvulsants|Gamma-aminobutyric Acid (GABA) Augmenting Agents|Barbituates|Primidone|D00474  Primidone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00474)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1135  Primidones|D00474  Primidone (JP18/USP/INN)|Drug groups [BR:br08330(D00474)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG01904  Barbiturate antiepileptic|D00474  Primidone|Drug classes [BR:br08332(D00474)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00474  Primidone|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00474)]|Chemicals|D00474  Primidone|Prodrugs [br08324.html(D00474)]|D00474|Prodrugs [br08324.html]|C07371,
C07372,Probenecid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00475)]|M MUSCULO-SKELETAL SYSTEM|M04 ANTIGOUT PREPARATIONS|M04A ANTIGOUT PREPARATIONS|M04AB Preparations increasing uric acid excretion|M04AB01 Probenecid|D00475  Probenecid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00475)]|Antigout Agents|Probenecid|D00475  Probenecid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00475)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|394  Gout preparations|3942  Probenecids|D00475  Probenecid (JP18/USP/INN)|Drug groups [BR:br08330(D00475)]|Musculo-skeletal system agent|DG02042  Uricosurics|D00475  Probenecid|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00475)]|Chemicals|D00475  Probenecid|D00475  Probenecid tablets,
C07373,Probucol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00476)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AX Other lipid modifying agents|C10AX02 Probucol|D00476  Probucol (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00476)]|2  Agents affecting individual organs|21  Cardiovascular agents|218  Hyperlipidemia agents|2189  Others|D00476  Probucol (JP18/USP/INN)|Drug groups [BR:br08330(D00476)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|D00476  Probucol|Drug classes [BR:br08332(D00476)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D00476  Probucol|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00476)]|Chemicals|D00476  Probucol|D00476  Probucol tablets|D00476  Probucol fine granules",
C07375,Procaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08422)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD05 Procaine|D08422  Procaine (INN)|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA02 Procaine|D08422  Procaine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA05 Procaine|D08422  Procaine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08422)]|Second-class OTC drugs|Inorganic and organic chemicals|Procaine|D08422  Procaine (INN)|Drug groups [BR:br08330(D08422)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00298  Procaine|D08422  Procaine|Target-based classification of drugs [BR:br08310(D08422)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08422  Procaine (INN)|SCN2A|D08422  Procaine (INN)|SCN3A|D08422  Procaine (INN)|SCN4A|D08422  Procaine (INN)|SCN5A|D08422  Procaine (INN)|SCN8A|D08422  Procaine (INN)|SCN9A|D08422  Procaine (INN)|SCN10A|D08422  Procaine (INN)|SCN11A|D08422  Procaine (INN)",
C07376,Procarbazine hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00478)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XB Methylhydrazines|L01XB01 Procarbazine|D00478  Procarbazine hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00478)]|Antineoplastics|Alkylating Agents|Procarbazine|D00478  Procarbazine hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00478)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00478  Procarbazine hydrochloride (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00478)]|Chemicals|D00478  Procarbazine hydrochloride,
C07378,Procyclidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08425)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04A ANTICHOLINERGIC AGENTS|N04AA Tertiary amines|N04AA04 Procyclidine|D08425  Procyclidine (INN)|Drug groups [BR:br08330(D08425)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01745  Anticholinergic antiparkinson agent|DG00854  Procyclidine|D08425  Procyclidine|Target-based classification of drugs [BR:br08310(D08425)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D08425  Procyclidine (INN),
C07379,Promazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08430)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AA Phenothiazines with aliphatic side-chain|N05AA03 Promazine|D08430  Promazine (INN)|Drug groups [BR:br08330(D08430)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00869  Promazine|D08430  Promazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00869  Promazine|D08430  Promazine|Target-based classification of drugs [BR:br08310(D08430)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08430  Promazine (INN),
C07381,Propafenone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08435)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BC Antiarrhythmics, class Ic|C01BC03 Propafenone|D08435  Propafenone (INN)|Drug groups [BR:br08330(D08435)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01650  Class Ic antiarrhythmic agent|DG00200  Propafenone|D08435  Propafenone|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00200  Propafenone|D08435  Propafenone|DG01644  CYP2D6 substrate|DG00200  Propafenone|D08435  Propafenone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00200  Propafenone|D08435  Propafenone|Target-based classification of drugs [BR:br08310(D08435)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08435  Propafenone (INN)|SCN2A|D08435  Propafenone (INN)|SCN3A|D08435  Propafenone (INN)|SCN4A|D08435  Propafenone (INN)|SCN5A|D08435  Propafenone (INN)|SCN8A|D08435  Propafenone (INN)|SCN9A|D08435  Propafenone (INN)|SCN10A|D08435  Propafenone (INN)|SCN11A|D08435  Propafenone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08435)]|Drug metabolizing enzymes|D08435",
C07383,Proparacaine;|Proxymetacaine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08448)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA04 Proxymetacaine|D08448  Proxymetacaine (INN)|Drug groups [BR:br08330(D08448)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01145  Proxymetacaine|D08448  Proxymetacaine|Target-based classification of drugs [BR:br08310(D08448)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08448  Proxymetacaine (INN)|SCN2A|D08448  Proxymetacaine (INN)|SCN3A|D08448  Proxymetacaine (INN)|SCN4A|D08448  Proxymetacaine (INN)|SCN5A|D08448  Proxymetacaine (INN)|SCN8A|D08448  Proxymetacaine (INN)|SCN9A|D08448  Proxymetacaine (INN)|SCN10A|D08448  Proxymetacaine (INN)|SCN11A|D08448  Proxymetacaine (INN),
C07384,Propiomazine hydrochloride;|Largon,,,,,
C07389,Pyrantel pamoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00486)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CC Tetrahydropyrimidine derivatives|P02CC01 Pyrantel|D00486  Pyrantel pamoate (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00486)]|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|642  Anthelmintics|6429  Others|D00486  Pyrantel pamoate (JP18/USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C07389  Pyrantel pamoate|Antimicrobials [BR:br08307(D00486)]|Antiparasitics|Antinematodal agents|Tetrahydropyrimidine derivatives|D00486  Pyrantel pamoate (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00486)]|Chemicals|D00486  Pyrantel pamoate|Rx-to-OTC switch list in the USA [br08315.html(D00486)]|D00486",
C07391,Pyrimethamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00488)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BD Diaminopyrimidines|P01BD01 Pyrimethamine|D00488  Pyrimethamine (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00488)]|Antiparasitics|Antiprotozoals|Pyrimethamine|D00488  Pyrimethamine (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9742  Pyrimethamine and preparations|C07391  Pyrimethamine|Drug groups [BR:br08330(D00488)]|Antiparasitic|DG01932  Antifolate, antiprotozoal|D00488  Pyrimethamine|Antimicrobials [BR:br08307(D00488)]|Antiparasitics|Antmalarials|Diaminopyrimidine|D00488  Pyrimethamine (JAN/USP/INN) &lt;US&gt;",
C07393,Oxymetholone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00490)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AA Androstan derivatives|A14AA05 Oxymetholone|D00490  Oxymetholone (JP18/USP/INN)|Drug groups [BR:br08330(D00490)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|D00490  Oxymetholone|Target-based classification of drugs [BR:br08310(D00490)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00490  Oxymetholone (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00490)]|Chemicals|D00490  Oxymetholone,
C07394,Paclitaxel,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C07394  Paclitaxel|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C07394  Paclitaxel|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C07394  Paclitaxel|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07394|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00491)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CD Taxanes|L01CD01 Paclitaxel|D00491  Paclitaxel (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00491)]|Antineoplastics|Antineoplastics, Other|Paclitaxel|D00491  Paclitaxel (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00491)]|4  Agents affecting cellular function|42  Antineoplastics|424  Plant extract preparations|4240  Plant extract preparations|D00491  Paclitaxel (JAN/USP/INN)|Drug groups [BR:br08330(D00491)]|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG01430  Paclitaxel|D00491  Paclitaxel|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01430  Paclitaxel|D00491  Paclitaxel|Target-based classification of drugs [BR:br08310(D00491)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D00491  Paclitaxel (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00491)]|European public assessment reports (EPAR) authorised medicine|D00491|Drug metabolizing enzymes and transporters [br08309.html(D00491)]|Drug metabolizing enzymes|D00491",
C07395,Pamidronate;|Pamidronic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07281)]|M MUSCULO-SKELETAL SYSTEM|M05 DRUGS FOR TREATMENT OF BONE DISEASES|M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION|M05BA Bisphosphonates|M05BA03 Pamidronic acid|D07281  Pamidronic acid (INN)|Drug groups [BR:br08330(D07281)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG01600  Bisphosphonate|DG00782  Pamidronic acid|D07281  Pamidronic acid|Target-based classification of drugs [BR:br08310(D07281)]|Enzymes|Transferases (EC2)|Alkyl/Aryl transferases|FDPS|D07281  Pamidronic acid (INN),
C07397,"Quetiapine;|2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08456)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AH Diazepines, oxazepines, thiazepines and oxepines|N05AH04 Quetiapine|D08456  Quetiapine (INN)|Drug groups [BR:br08330(D08456)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00899  Quetiapine|D08456  Quetiapine|DG03200  Antipsychotic agent|DG03064  Atypical antipsychotic|DG00899  Quetiapine|D08456  Quetiapine|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00899  Quetiapine|D08456  Quetiapine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00899  Quetiapine|D08456  Quetiapine|Target-based classification of drugs [BR:br08310(D08456)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08456  Quetiapine (INN)|Serotonin|HTR2A|D08456  Quetiapine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08456)]|Drug metabolizing enzymes|D08456",
C07398,Quinapril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03752)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA06 Quinapril|D03752  Quinapril (INN)|Drug groups [BR:br08330(D03752)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00338  Quinapril|D03752  Quinapril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00338  Quinapril|D03752  Quinapril|Target-based classification of drugs [BR:br08310(D03752)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D03752  Quinapril (INN)|Prodrugs [br08324.html(D03752)]|D03752|Prodrugs [br08324.html]|C07398",
C07400,Pralidoxime,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB04 Pralidoxime|C07400  Pralidoxime,G01153
C07401,Procainamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08421)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA02 Procainamide|D08421  Procainamide (INN)|Drug groups [BR:br08330(D08421)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG00193  Procainamide|D08421  Procainamide|Metabolizing enzyme substrate|DG02928  NAT substrate|DG00193  Procainamide|D08421  Procainamide|Transporter substrate|DG02858  SLC22A1 substrate|DG00193  Procainamide|D08421  Procainamide|DG02854  SLC22A2 substrate|DG00193  Procainamide|D08421  Procainamide|DG02964  SLC47A1 substrate|DG00193  Procainamide|D08421  Procainamide|DG03002  SLC47A2 substrate|DG00193  Procainamide|D08421  Procainamide|Target-based classification of drugs [BR:br08310(D08421)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08421  Procainamide (INN)|SCN2A|D08421  Procainamide (INN)|SCN3A|D08421  Procainamide (INN)|SCN4A|D08421  Procainamide (INN)|SCN5A|D08421  Procainamide (INN)|SCN8A|D08421  Procainamide (INN)|SCN9A|D08421  Procainamide (INN)|SCN10A|D08421  Procainamide (INN)|SCN11A|D08421  Procainamide (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08421)]|Drug metabolizing enzymes|D08421|Drug transporters|D08421|Pharmacogenomic biomarkers [br08341.html(D08421)]|Polymorphisms and mutations affecting drug response|D08421",
C07402,Procarbazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08423)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XB Methylhydrazines|L01XB01 Procarbazine|D08423  Procarbazine (INN),
C07403,Prochlorperazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00493)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB04 Prochlorperazine|D00493  Prochlorperazine (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00493)]|Antiemetics|Antiemetics, Other|Prochlorperazine|D00493  Prochlorperazine (JAN/USP/INN)|Antipsychotics|1st Generation/Typical|Prochlorperazine|D00493  Prochlorperazine (JAN/USP/INN)|Drug groups [BR:br08330(D00493)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00876  Prochlorperazine|D00493  Prochlorperazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00876  Prochlorperazine|D00493  Prochlorperazine|Target-based classification of drugs [BR:br08310(D00493)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00493  Prochlorperazine (JAN/USP/INN) &lt;US&gt;",
C07404,Promethazine;|10-(2-Dimethylaminopropyl)phenothiazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00494)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA10 Promethazine|D00494  Promethazine (JAN/INN)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AD Phenothiazine derivatives|R06AD02 Promethazine|D00494  Promethazine (JAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00494)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Promethazine|D00494  Promethazine (JAN/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Promethazine|D00494  Promethazine (JAN/INN)|Drug groups [BR:br08330(D00494)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00385  Promethazine|D00494  Promethazine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00385  Promethazine|D00494  Promethazine|Target-based classification of drugs [BR:br08310(D00494)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00494  Promethazine (JAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00494)]|Drug metabolizing enzymes|D00494",
C07405,Propiomazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02361)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM06 Propiomazine|D02361  Propiomazine (USAN/INN),
C07406,Propoxyphene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07809)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AC Diphenylpropylamine derivatives|N02AC04 Dextropropoxyphene|D07809  Dextropropoxyphene (INN)|Drug groups [BR:br08330(D07809)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00818  Dextropropoxyphene|D07809  Dextropropoxyphene|Analgesic|DG01984  Opioid analgesics|DG00818  Dextropropoxyphene|D07809  Dextropropoxyphene|Target-based classification of drugs [BR:br08310(D07809)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07809  Dextropropoxyphene (INN)|Narcotics and psychotropics in Japan [br08308.html(D07809)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D07809,
C07407,Propranolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08443)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA05 Propranolol|D08443  Propranolol (INN)|Drug groups [BR:br08330(D08443)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG00305  Propranolol|D08443  Propranolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00305  Propranolol|D08443  Propranolol|DG03231  Antihypertensive|DG00305  Propranolol|D08443  Propranolol|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00305  Propranolol|D08443  Propranolol|DG01639  CYP2C19 substrate|DG00305  Propranolol|D08443  Propranolol|DG01644  CYP2D6 substrate|DG00305  Propranolol|D08443  Propranolol|Target-based classification of drugs [BR:br08310(D08443)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D08443  Propranolol (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08443)]|Drug metabolizing enzymes|D08443",
C07408,Protriptyline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08447)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA11 Protriptyline|D08447  Protriptyline (INN)|Drug groups [BR:br08330(D08447)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00936  Protriptyline|D08447  Protriptyline|DG01728  Tricyclic antidepressant|DG00936  Protriptyline|D08447  Protriptyline|Target-based classification of drugs [BR:br08310(D08447)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08447  Protriptyline (INN)|SLC6A4 (HTT)|D08447  Protriptyline (INN),
C07409,Pyrantel,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08451)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CC Tetrahydropyrimidine derivatives|P02CC01 Pyrantel|D08451  Pyrantel (INN)|Antimicrobials [BR:br08307(D08451)]|Antiparasitics|Antinematodal agents|Tetrahydropyrimidine derivatives|D08451  Pyrantel (INN)",
C07410,Pyridostigmine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA02 Pyridostigmine|C07410  Pyridostigmine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00988  Pyridostigmine|C07410  Pyridostigmine|DG01719  Parasympathomimetic agent|DG00988  Pyridostigmine|C07410  Pyridostigmine,G00988
C07411,Paramethadione,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00495)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AC Oxazolidine derivatives|N03AC01 Paramethadione|D00495  Paramethadione (INN)|Drug groups [BR:br08330(D00495)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02032  Oxazolidine antiepileptic|D00495  Paramethadione|Target-based classification of drugs [BR:br08310(D00495)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D00495  Paramethadione (INN),
C07412,Pyrvinium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CX Other antinematodals|P02CX01 Pyrvinium|C07412  Pyrvinium|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Pyrvinium pamoate|C07412  Pyrvinium",G01027
C07413,Paramethasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07464)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB05 Paramethasone|D07464  Paramethasone (INN)|Drug groups [BR:br08330(D07464)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00508  Paramethasone|D07464  Paramethasone|Target-based classification of drugs [BR:br08310(D07464)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07464  Paramethasone (INN)",
C07414,Pargyline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08453)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02K OTHER ANTIHYPERTENSIVES|C02KC MAO inhibitors|C02KC01 Pargyline|D08453  Pargyline (INN)|Drug groups [BR:br08330(D08453)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00264  Pargyline|D08453  Pargyline|Target-based classification of drugs [BR:br08310(D08453)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D08453  Pargyline (INN),
C07415,Paroxetine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02362)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AB Selective serotonin reuptake inhibitors|N06AB05 Paroxetine|D02362  Paroxetine (USP/INN)|Drug groups [BR:br08330(D02362)]|Neuropsychiatric agent|DG01659  Selective serotonin reuptake inhibitor (SSRI)|DG00944  Paroxetine|D02362  Paroxetine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00944  Paroxetine|D02362  Paroxetine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00944  Paroxetine|D02362  Paroxetine|Target-based classification of drugs [BR:br08310(D02362)]|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D02362  Paroxetine (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02362)]|Drug metabolizing enzymes|D02362,
C07416,Penbutolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08074)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA23 Penbutolol|D08074  Penbutolol (INN)|Drug groups [BR:br08330(D08074)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG00312  Penbutolol|D08074  Penbutolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00312  Penbutolol|D08074  Penbutolol|Target-based classification of drugs [BR:br08310(D08074)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D08074  Penbutolol (INN)",
C07417,Penciclovir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05407)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BB Antivirals|D06BB06 Penciclovir|D05407  Penciclovir (USAN/INN) &lt;US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors|J05AB13 Penciclovir|D05407  Penciclovir (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D05407)]|Dermatological Agents|Topical Anti-infectives|Antivirals, dermatological|Penciclovir|D05407  Penciclovir (USAN/INN)|Drug groups [BR:br08330(D05407)]|Antiviral|DG02840  Anti-herpesvirus agent|DG00408  Penciclovir|D05407  Penciclovir|Drug classes [BR:br08332(D05407)]|Antiviral|DG02840  Anti-herpesvirus agent|D05407  Penciclovir|Antimicrobials [BR:br08307(D05407)]|Antivirals|Genome replication inhibitor|Herpesvirus DNA polymerase inhibitor|D05407  Penciclovir (USAN/INN) &lt;US&gt;|Prodrugs [br08324.html(D05407)]|D05407|Prodrugs [br08324.html]|C07417",
C07418,Penicillamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00496)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01C SPECIFIC ANTIRHEUMATIC AGENTS|M01CC Penicillamine and similar agents|M01CC01 Penicillamine|D00496  Penicillamine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00496)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral/Metal Modifiers|Penicillamine|D00496  Penicillamine (JAN/USP/INN)|Genitourinary Agents|Genitourinary Agents, Other|Penicillamine|D00496  Penicillamine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00496)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3929  Others|D00496  Penicillamine (JAN/USP/INN)|4  Agents affecting cellular function|44  Allergic agents|443  Nonspecific immunogen preparations|4430  Nonspecific immunogen preparations|D00496  Penicillamine (JAN/USP/INN)|Drug groups [BR:br08330(D00496)]|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG00763  Penicillamine|D00496  Penicillamine|Vitamin and mineral|DG01692  Chelator|DG00763  Penicillamine|D00496  Penicillamine|Drug classes [BR:br08332(D00496)]|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00496  Penicillamine",
C07420,Pentamidine,,,,,
C07421,Pentazocine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00498)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AD Benzomorphan derivatives|N02AD01 Pentazocine|D00498  Pentazocine (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00498)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00498  Pentazocine (JP18/USP/INN)|Drug groups [BR:br08330(D00498)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00819  Pentazocine|D00498  Pentazocine|Analgesic|DG01984  Opioid analgesics|DG00819  Pentazocine|D00498  Pentazocine|Target-based classification of drugs [BR:br08310(D00498)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D00498  Pentazocine (JP18/USP/INN) &lt;JP&gt;|OPRK1|D00498  Pentazocine (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00498)]|Chemicals|D00498  Pentazocine|Narcotics and psychotropics in Japan [br08308.html(D00498)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D00498",
C07422,"Pentobarbital;|5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00499)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA01 Pentobarbital|D00499  Pentobarbital (USP/INN)|Drug groups [BR:br08330(D00499)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG00915  Pentobarbital|D00499  Pentobarbital|DG01567  GABA-A receptor agonist|DG00915  Pentobarbital|D00499  Pentobarbital|Target-based classification of drugs [BR:br08310(D00499)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00499  Pentobarbital (USP/INN)|Narcotics and psychotropics in Japan [br08308.html(D00499)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D00499",
C07423,Pentobarbital sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00500)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA01 Pentobarbital|D00500  Pentobarbital sodium (JAN/USP) &lt;US&gt;|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|912  Hypnotics and sedatives|9121  Barbituric acids, thiobarbituric acids and preparations|C07423  Pentobarbital sodium|Drug groups [BR:br08330(D00500)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG00915  Pentobarbital|D00500  Pentobarbital sodium|DG01567  GABA-A receptor agonist|DG00915  Pentobarbital|D00500  Pentobarbital sodium|Target-based classification of drugs [BR:br08310(D00500)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00500  Pentobarbital sodium (JAN/USP) &lt;US&gt;",
C07424,Pentoxifylline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00501)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AD Purine derivatives|C04AD03 Pentoxifylline|D00501  Pentoxifylline (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00501)]|Cardiovascular Agents|Cardiovascular Agents, Other|Pentoxifylline|D00501  Pentoxifylline (JAN/USP/INN)|Drug groups [BR:br08330(D00501)]|Respiratory system agent|DG01616  Xanthine derivative|DG01614  Xanthine-type vasodilator|D00501  Pentoxifylline",
C07425,Pergolide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08339)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BC Dopamine agonists|N04BC02 Pergolide|D08339  Pergolide (INN)|Drug groups [BR:br08330(D08339)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG00861  Pergolide|D08339  Pergolide|DG01964  Ergot alkaloid|DG00861  Pergolide|D08339  Pergolide|DG01967  Antiparkinson agent|DG00861  Pergolide|D08339  Pergolide|Target-based classification of drugs [BR:br08310(D08339)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD1|D08339  Pergolide (INN)|DRD2|D08339  Pergolide (INN),
C07427,Perphenazine;|4-(3-(2-Chlorophenothiazin-10-YL)propyl)-1-piperazineethanol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00503)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB03 Perphenazine|D00503  Perphenazine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00503)]|Antiemetics|Antiemetics, Other|Perphenazine|D00503  Perphenazine (JP18/USP/INN)|Antipsychotics|1st Generation/Typical|Perphenazine|D00503  Perphenazine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00503)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1172  Phenothiazines|D00503  Perphenazine (JP18/USP/INN)|Drug groups [BR:br08330(D00503)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00875  Perphenazine|D00503  Perphenazine|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00875  Perphenazine|D00503  Perphenazine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00875  Perphenazine|D00503  Perphenazine|Target-based classification of drugs [BR:br08310(D00503)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00503  Perphenazine (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00503)]|Chemicals|D00503  Perphenazine|D00503  Perphenazine tablets|Drug metabolizing enzymes and transporters [br08309.html(D00503)]|Drug metabolizing enzymes|D00503|Pharmacogenomic biomarkers [br08341.html(D00503)]|Polymorphisms and mutations affecting drug response|D00503",
C07428,Phenacemide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00504)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX07 Phenacemide|D00504  Phenacemide (JAN/INN),
C07429,"Phenazopyridine;|3-(Phenylazo)-2,6-pyridinediamine",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08346)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX06 Phenazopyridine|D08346  Phenazopyridine (INN),
C07430,Phenelzine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08349)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AF Monoamine oxidase inhibitors, non-selective|N06AF03 Phenelzine|D08349  Phenelzine (BAN)|Drug groups [BR:br08330(D08349)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00948  Phenelzine|D08349  Phenelzine|Target-based classification of drugs [BR:br08310(D08349)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D08349  Phenelzine (BAN)",
C07431,Phenelzine sulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00505)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AF Monoamine oxidase inhibitors, non-selective|N06AF03 Phenelzine|D00505  Phenelzine sulfate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00505)]|Antidepressants|Monoamine Oxidase Inhibitors|Phenelzine|D00505  Phenelzine sulfate (USP)|Drug groups [BR:br08330(D00505)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00948  Phenelzine|D00505  Phenelzine sulfate|Target-based classification of drugs [BR:br08310(D00505)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D00505  Phenelzine sulfate (USP) &lt;US&gt;",
C07432,Phenmetrazine,,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C07432,
C07434,Phenobarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00506)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AA Barbiturates and derivatives|N03AA02 Phenobarbital|D00506  Phenobarbital (JP18/USP/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D00506)]|Anticonvulsants|Gamma-aminobutyric Acid (GABA) Augmenting Agents|Barbituates|Phenobarbital|D00506  Phenobarbital (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00506)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1125  Barbiturates and thiobarbiturates|D00506  Phenobarbital (JP18/USP/INN)|113  Antiepileptics|1134  Barbiturates|D00506  Phenobarbital (JP18/USP/INN)|Drug groups [BR:br08330(D00506)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|DG00845  Phenobarbital|D00506  Phenobarbital|DG03199  Antiepileptic agent|DG01904  Barbiturate antiepileptic|DG00845  Phenobarbital|D00506  Phenobarbital|Metabolizing enzyme inducer|DG01637  CYP1A2 inducer|DG00845  Phenobarbital|D00506  Phenobarbital|DG02891  CYP2B6 inducer|DG00845  Phenobarbital|D00506  Phenobarbital|DG02886  CYP2C9 inducer|DG00845  Phenobarbital|D00506  Phenobarbital|DG02853  CYP3A/CYP3A4 inducer|DG00845  Phenobarbital|D00506  Phenobarbital|Drug classes [BR:br08332(D00506)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00506  Phenobarbital|Target-based classification of drugs [BR:br08310(D00506)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00506  Phenobarbital (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00506)]|Chemicals|D00506  Phenobarbital|D00506  Phenobarbital tablets|D00506  10% Phenobarbital powder|Drug metabolizing enzymes and transporters [br08309.html(D00506)]|Drug metabolizing enzymes|D00506|Prodrugs [br08324.html(D00506)]|D00506|Narcotics and psychotropics in Japan [br08308.html(D00506)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D00506|Prodrugs [br08324.html]|C07434",
C07435,Phenoxybenzamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08358)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX02 Phenoxybenzamine|D08358  Phenoxybenzamine (INN)|Drug groups [BR:br08330(D08358)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG00285  Phenoxybenzamine|D08358  Phenoxybenzamine|Target-based classification of drugs [BR:br08310(D08358)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08358  Phenoxybenzamine (INN)|ADRA2|D08358  Phenoxybenzamine (INN),
C07436,Phenoxybenzamine hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00507)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX02 Phenoxybenzamine|D00507  Phenoxybenzamine hydrochloride (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00507)]|Cardiovascular Agents|Alpha-adrenergic Blocking Agents|Phenoxybenzamine|D00507  Phenoxybenzamine hydrochloride (USP)|Drug groups [BR:br08330(D00507)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG00285  Phenoxybenzamine|D00507  Phenoxybenzamine hydrochloride|Target-based classification of drugs [BR:br08310(D00507)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00507  Phenoxybenzamine hydrochloride (USP) &lt;US&gt;|ADRA2|D00507  Phenoxybenzamine hydrochloride (USP) &lt;US&gt;,
C07437,Phensuximide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00508)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AD Succinimide derivatives|N03AD02 Phensuximide|D00508  Phensuximide (USP/INN)|Drug groups [BR:br08330(D00508)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02033  Succinimide antiepileptic|D00508  Phensuximide,
C07438,"Phentermine;|alpha,alpha-Dimethylphenethylamine",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05458)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AA Centrally acting antiobesity products|A08AA01 Phentermine|D05458  Phentermine (USAN/INN)|Drug groups [BR:br08330(D05458)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG00102  Phentermine|D05458  Phentermine|Target-based classification of drugs [BR:br08310(D05458)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D05458  Phentermine (USAN/INN)|SLC6A3 (DAT1)|D05458  Phentermine (USAN/INN)|SLC6A4 (HTT)|D05458  Phentermine (USAN/INN)|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D05458  Phentermine (USAN/INN)|Narcotics and psychotropics in Japan [br08308.html(D05458)]|Psychotropics by Cabinet order Article 3 (78 substances)|D05458",
C07440,Phenylbutazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00510)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AA Butylpyrazolidines|M01AA01 Phenylbutazone|D00510  Phenylbutazone (JP18/USP/INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA01 Phenylbutazone|D00510  Phenylbutazone (JP18/USP/INN)|Drug groups [BR:br08330(D00510)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01947  Anti-inflammatory drug, pyrazolone|DG01949  Anti-inflammatory drug, phenylbutazones|DG00745  Phenylbutazone|D00510  Phenylbutazone|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|DG00745  Phenylbutazone|D00510  Phenylbutazone|Target-based classification of drugs [BR:br08310(D00510)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00510  Phenylbutazone (JP18/USP/INN)|PTGS2 (COX2)|D00510  Phenylbutazone (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00510)]|Chemicals|D00510  Phenylbutazone|Drug metabolizing enzymes and transporters [br08309.html(D00510)]|Drug metabolizing enzymes|D00510",
C07441,Phenylephrine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08365)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA06 Phenylephrine|D08365  Phenylephrine (INN)|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use|C05AX06 Phenylephrine|D08365  Phenylephrine (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA04 Phenylephrine|D08365  Phenylephrine (INN)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB01 Phenylephrine|D08365  Phenylephrine (INN)|R01B NASAL DECONGESTANTS FOR SYSTEMIC USE|R01BA Sympathomimetics|R01BA03 Phenylephrine|D08365  Phenylephrine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FB Sympathomimetics excl. antiglaucoma preparations|S01FB01 Phenylephrine|D08365  Phenylephrine (INN)|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA05 Phenylephrine|D08365  Phenylephrine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08365)]|Second-class OTC drugs|Inorganic and organic chemicals|Phenylephrine|D08365  Phenylephrine (INN)|Drug groups [BR:br08330(D08365)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00215  Phenylephrine|D08365  Phenylephrine|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG00215  Phenylephrine|D08365  Phenylephrine|Target-based classification of drugs [BR:br08310(D08365)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08365  Phenylephrine (INN)",
C07443,Phenytoin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00512)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AB Hydantoin derivatives|N03AB02 Phenytoin|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00512)]|Anticonvulsants|Sodium Channel Agents|Phenytoin|D00512  Phenytoin (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00512)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1132  Hydantoins|D00512  Phenytoin (JP18/USP/INN)|Drug groups [BR:br08330(D00512)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02031  Hydantoin antiepileptic|DG00846  Phenytoin|D00512  Phenytoin|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00846  Phenytoin|D00512  Phenytoin|DG01639  CYP2C19 substrate|DG00846  Phenytoin|D00512  Phenytoin|Metabolizing enzyme inducer|DG02891  CYP2B6 inducer|DG00846  Phenytoin|D00512  Phenytoin|DG02853  CYP3A/CYP3A4 inducer|DG00846  Phenytoin|D00512  Phenytoin|Transporter inducer|DG01893  ABCB1 inducer|DG00846  Phenytoin|D00512  Phenytoin|Drug classes [BR:br08332(D00512)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00512  Phenytoin|Target-based classification of drugs [BR:br08310(D00512)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN2A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN3A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN4A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN5A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN8A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN9A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN10A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|SCN11A|D00512  Phenytoin (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00512)]|Chemicals|D00512  Phenytoin|D00512  Phenytoin tablets|D00512  Phenytoin powder|Drug metabolizing enzymes and transporters [br08309.html(D00512)]|Drug metabolizing enzymes|D00512|Drug transporters|D00512|Pharmacogenomic biomarkers [br08341.html(D00512)]|Polymorphisms and mutations affecting drug response|D00512|Prodrugs [br08324.html(D00512)]|D00512|Prodrugs [br08324.html]|C07443,
C07445,Pindolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00513)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AA Beta blocking agents, non-selective|C07AA03 Pindolol|D00513  Pindolol (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00513)]|Cardiovascular Agents|Beta-adrenergic Blocking Agents|Beta-adrenergic Blocking Agents, Other|Pindolol|D00513  Pindolol (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00513)]|2  Agents affecting individual organs|21  Cardiovascular agents|212  Antiarrhythmic agents|2123  Beta blockers|D00513  Pindolol (JP18/USP/INN)|214  Antihypertensives|2149  Others|D00513  Pindolol (JP18/USP/INN)|Drug groups [BR:br08330(D00513)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|D00513  Pindolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|D00513  Pindolol|DG03231  Antihypertensive|D00513  Pindolol|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D00513  Pindolol|Transporter substrate|DG02854  SLC22A2 substrate|D00513  Pindolol|Drug classes [BR:br08332(D00513)]|Cardiovascular agent|DG03231  Antihypertensive|D00513  Pindolol|DG01653  Antiarrhythmics|D00513  Pindolol|Target-based classification of drugs [BR:br08310(D00513)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D00513  Pindolol (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00513)]|Chemicals|D00513  Pindolol|Drug metabolizing enzymes and transporters [br08309.html(D00513)]|Drug metabolizing enzymes|D00513|Drug transporters|D00513",
C07446,Isonicotinic acid,,,,,
C07447,Acetylhydrazine,,,,,
C07448,Burimamide,H2-receptor antagonist [HSA:3274] [PATH:hsa04080(3274)],,,,
C07449,Metiamide,,,,Drug groups [BR:br08330(D05004)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01481  Histamine receptor H2 antagonist|D05004  Metiamide|Target-based classification of drugs [BR:br08310(D05004)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH2|D05004  Metiamide (USAN/INN),
C07450,Dexmedetomidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00514)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM18 Dexmedetomidine|D00514  Dexmedetomidine (USAN/INN)|Drug groups [BR:br08330(D00514)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|DG01638  CYP2A6 substrate|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|DG01639  CYP2C19 substrate|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|DG01644  CYP2D6 substrate|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|DG02855  CYP2E1 substrate|DG00926  Dexmedetomidine|D00514  Dexmedetomidine|Target-based classification of drugs [BR:br08310(D00514)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D00514  Dexmedetomidine (USAN/INN)|New drug approvals in Europe [br08329.html(D00514)]|European public assessment reports (EPAR) authorised medicine|D00514|Drug metabolizing enzymes and transporters [br08309.html(D00514)]|Drug metabolizing enzymes|D00514,
C07451,Moxonidine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05087)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AC Imidazoline receptor agonists|C02AC05 Moxonidine|D05087  Moxonidine (USAN/INN)|Drug groups [BR:br08330(D05087)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|D05087  Moxonidine|Target-based classification of drugs [BR:br08310(D05087)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D05087  Moxonidine (USAN/INN)",
C07452,Tizanidine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08611)]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS|M03BX Other centrally acting agents|M03BX02 Tizanidine|D08611  Tizanidine (INN)|Drug groups [BR:br08330(D08611)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG00773  Tizanidine|D08611  Tizanidine|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|DG00773  Tizanidine|D08611  Tizanidine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00773  Tizanidine|D08611  Tizanidine|Target-based classification of drugs [BR:br08310(D08611)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D08611  Tizanidine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08611)]|Drug metabolizing enzymes|D08611",
C07453,Epinine;|Deoxyepinephrine,,,,,
C07454,N-Guanylhistamine,,,,,
C07455,Nitroglycerin;|Glyceryl trinitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00515)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DA Organic nitrates|C01DA02 Glyceryl trinitrate|D00515  Nitroglycerin (JP18/USP) &lt;JP/US&gt;|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AE Muscle relaxants|C05AE01 Glyceryl trinitrate|D00515  Nitroglycerin (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00515)]|Cardiovascular Agents|Vasodilators|Vasodilators, Direct-acting Arterial/Venous|Nitroglycerin|D00515  Nitroglycerin (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00515)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00515  Nitroglycerin (JP18/USP)|217  Vasodilators|2171  Coronary dilators|D00515  Nitroglycerin (JP18/USP)|Drug groups [BR:br08330(D00515)]|Cardiovascular agent|DG01657  Nitrovasodilator|D00515  Nitroglycerin|DG03231  Antihypertensive|D00515  Nitroglycerin|Drug classes [BR:br08332(D00515)]|Cardiovascular agent|DG03231  Antihypertensive|D00515  Nitroglycerin|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00515)]|Chemicals|D00515  Nitroglycerin tablets",
C07456,Isosorbide dinitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00516)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DA Organic nitrates|C01DA08 Isosorbide dinitrate|D00516  Isosorbide dinitrate (JP18/USP/INN) &lt;JP/US&gt;|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AE Muscle relaxants|C05AE02 Isosorbide dinitrate|D00516  Isosorbide dinitrate (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00516)]|Cardiovascular Agents|Vasodilators|Vasodilators, Direct-acting Arterial/Venous|Isosorbide Dinitrate|D00516  Isosorbide dinitrate (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00516)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2171  Coronary dilators|D00516  Isosorbide dinitrate (JP18/USP/INN)|Drug groups [BR:br08330(D00516)]|Cardiovascular agent|DG01657  Nitrovasodilator|DG01270  Isosorbide nitrate|D00516  Isosorbide dinitrate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00516)]|Chemicals|D00516  Isosorbide dinitrate|D00516  Isosorbide dinitrate tablets|Pharmacogenomic biomarkers [br08341.html(D00516)]|Polymorphisms and mutations affecting drug response|D00516",
C07457,Amyl nitrite;|Isoamyl nitrite,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00517)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB22 Amyl nitrite|D00517  Amyl nitrite (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00517)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2179  Others|D00517  Amyl nitrite (JP18/USP)|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3929  Others|D00517  Amyl nitrite (JP18/USP)|Drug groups [BR:br08330(D00517)]|Cardiovascular agent|DG01657  Nitrovasodilator|D00517  Amyl nitrite|Target-based classification of drugs [BR:br08310(D00517)]|Enzymes|Lyases (EC4)|Phosphorus-oxygen lyases|GUCY1A|D00517  Amyl nitrite (JP18/USP) &lt;JP&gt;|GUCY1B|D00517  Amyl nitrite (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00517)]|Chemicals|D00517  Amyl nitrite,
C07458,Sulfanilamide;|Sulfamine;|Prontosil album,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08543)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BA Sulfonamides|D06BA05 Sulfanilamide|D08543  Sulfanilamide (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EB Short-acting sulfonamides|J01EB06 Sulfanilamide|D08543  Sulfanilamide (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08543)]|Second-class OTC drugs|Inorganic and organic chemicals|Sulfamine|D08543  Sulfanilamide (INN)|Drug groups [BR:br08330(D08543)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|D08543  Sulfanilamide|Antimicrobials [BR:br08307(D08543)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D08543  Sulfanilamide (INN),
C07459,Dichlorphenamide;|Diclofenamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00518)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EC Carbonic anhydrase inhibitors|S01EC02 Diclofenamide|D00518  Dichlorphenamide (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00518)]|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Dichlorphenamide|D00518  Dichlorphenamide (USP)|Drug groups [BR:br08330(D00518)]|Cardiovascular agent|DG01534  Carbonic anhydrase inhibitor|D00518  Dichlorphenamide|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00518  Dichlorphenamide|Drug classes [BR:br08332(D00518)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00518  Dichlorphenamide|Target-based classification of drugs [BR:br08310(D00518)]|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA|D00518  Dichlorphenamide (USP) &lt;US&gt;",
C07460,"Chloraminophenamide;|4-Amino-6-chloro-1,3-benzenedisulfonamide",,,,,
C07461,Chlorothiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00519)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA04 Chlorothiazide|D00519  Chlorothiazide (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00519)]|Cardiovascular Agents|Diuretics, Thiazide|Chlorothiazide|D00519  Chlorothiazide (JAN/USP/INN)|Drug groups [BR:br08330(D00519)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|DG00268  Chlorothiazide|D00519  Chlorothiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|DG00268  Chlorothiazide|D00519  Chlorothiazide|Drug classes [BR:br08332(D00519)]|Cardiovascular agent|DG03231  Antihypertensive|D00519  Chlorothiazide|Target-based classification of drugs [BR:br08310(D00519)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D00519  Chlorothiazide (JAN/USP/INN) &lt;US&gt;",
C07463,Terfenadine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00521)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX12 Terfenadine|D00521  Terfenadine (JAN/USAN/INN)|Drug groups [BR:br08330(D00521)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|D00521  Terfenadine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00521  Terfenadine|Target-based classification of drugs [BR:br08310(D00521)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00521  Terfenadine (JAN/USAN/INN)|Ion channels|Voltage-gated ion channels|Potassium channels|KCNH2|D00521  Terfenadine (JAN/USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00521)]|Drug metabolizing enzymes|D00521,
C07464,Ketanserin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02363)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02K OTHER ANTIHYPERTENSIVES|C02KD Serotonin antagonists|C02KD01 Ketanserin|D02363  Ketanserin (USAN/INN)|Drug groups [BR:br08330(D02363)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01457  alpha1-Adrenergic receptor antagonist|DG00265  Ketanserin|D02363  Ketanserin|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00265  Ketanserin|D02363  Ketanserin|Target-based classification of drugs [BR:br08310(D02363)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR2A|D02363  Ketanserin (USAN/INN),
C07465,Remikiren;|Ro 42-5892,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09038)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09XA Renin-inhibitors|C09XA01 Remikiren|D09038  Remikiren (INN)|Drug groups [BR:br08330(D09038)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01923  Renin inhibitor|D09038  Remikiren|DG03231  Antihypertensive|DG01923  Renin inhibitor|D09038  Remikiren|Target-based classification of drugs [BR:br08310(D09038)]|Enzymes|Hydrolases (EC3)|Aspartic peptidases|REN|D09038  Remikiren (INN),
C07466,Enalkiren;|A 64662,,,,Drug groups [BR:br08330(D03738)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01923  Renin inhibitor|D03738  Enalkiren|DG03231  Antihypertensive|DG01923  Renin inhibitor|D03738  Enalkiren|Target-based classification of drugs [BR:br08310(D03738)]|Enzymes|Hydrolases (EC3)|Aspartic peptidases|REN|D03738  Enalkiren (USAN/INN),
C07467,Eprosartan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04040)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA02 Eprosartan|D04040  Eprosartan (USAN/INN)|Drug groups [BR:br08330(D04040)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|DG00349  Eprosartan|D04040  Eprosartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|DG00349  Eprosartan|D04040  Eprosartan|Target-based classification of drugs [BR:br08310(D04040)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D04040  Eprosartan (USAN/INN)",
C07468,Candesartan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00522)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA06 Candesartan|D00522  Candesartan (USAN/INN)|Drug groups [BR:br08330(D00522)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|DG00350  Candesartan|D00522  Candesartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|DG00350  Candesartan|D00522  Candesartan|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00350  Candesartan|D00522  Candesartan|Target-based classification of drugs [BR:br08310(D00522)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D00522  Candesartan (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00522)]|Drug metabolizing enzymes|D00522|Prodrugs [br08324.html(D00522)]|D00522|Prodrugs [br08324.html]|C07468",
C07469,Irbesartan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00523)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA04 Irbesartan|D00523  Irbesartan (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00523)]|Cardiovascular Agents|Angiotensin II Receptor Antagonists|Irbesartan|D00523  Irbesartan (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00523)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00523  Irbesartan (JP18/USP/INN)|Drug groups [BR:br08330(D00523)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|D00523  Irbesartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|D00523  Irbesartan|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00523  Irbesartan|Drug classes [BR:br08332(D00523)]|Cardiovascular agent|DG01495  Angiotensin II receptor antagonist|D00523  Irbesartan|DG03231  Antihypertensive|D00523  Irbesartan|Target-based classification of drugs [BR:br08310(D00523)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D00523  Irbesartan (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00523)]|Chemicals|D00523  Irbesartan|D00523  Irbesartan tablets|New drug approvals in Europe [br08329.html(D00523)]|European public assessment reports (EPAR) authorised medicine|D00523|New drug approvals in Japan [br08318.html(D00523)]|Drugs with new active ingredients|D00523|Drug metabolizing enzymes and transporters [br08309.html(D00523)]|Drug metabolizing enzymes|D00523",
C07471,Methacholine;|Acetyl-beta-methylcholine,,,,Drug groups [BR:br08330]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG01290  Methacholine|C07471  Methacholine,G01290
C07473,Muscarine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Alkaloids|C07473  Muscarine,
C07474,Pilocarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from histidine|Imidazole alkaloids|C07474  Pilocarpine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00525)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AX Other parasympathomimetics|N07AX01 Pilocarpine|D00525  Pilocarpine (JAN/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB01 Pilocarpine|D00525  Pilocarpine (JAN/USP)|Drug groups [BR:br08330(D00525)]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG00992  Pilocarpine|D00525  Pilocarpine|DG01719  Parasympathomimetic agent|DG00992  Pilocarpine|D00525  Pilocarpine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00992  Pilocarpine|D00525  Pilocarpine|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00992  Pilocarpine|D00525  Pilocarpine|Target-based classification of drugs [BR:br08310(D00525)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM2|D00525  Pilocarpine (JAN/USP)|CHRM3|D00525  Pilocarpine (JAN/USP)|Drug metabolizing enzymes and transporters [br08309.html(D00525)]|Drug metabolizing enzymes|D00525,
C07475,Lobeline;|(-)-Lobeline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C07475  Lobeline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07475|Drug groups [BR:br08330(D02364)]|Neuropsychiatric agent|DG01571  Nicotinic cholinergic receptor partial agonist|DG01287  Lobeline|D02364  Lobeline|Target-based classification of drugs [BR:br08310(D02364)]|Ion channels|Ligand-gated ion channels|Acetylcholine (nicotinic)|CHRN|D02364  Lobeline (INN),
C07478,"2-Hydroxy-5-methyl-cis,cis-muconate",,,,,
C07479,2-Oxo-5-methyl-cis-muconate,,,,,
C07480,"Theobromine;|3,7-Dimethylxanthine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C07480  Theobromine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES|C03BD Xanthine derivatives|C03BD01 Theobromine|C07480  Theobromine|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03DA Xanthines|R03DA07 Theobromine|C07480  Theobromine|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Theobromine|C07480  Theobromine|Drug groups [BR:br08330]|Respiratory system agent|DG01616  Xanthine derivative|DG01609  Xanthine-type bronchodilator|C07480  Theobromine",G01609
C07481,"Caffeine;|1,3,7-Trimethylxanthine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C07481  Caffeine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00528)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX26 Caffeine|D00528  Caffeine (USP) &lt;JP&gt;|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BC Xanthine derivatives|N06BC01 Caffeine|D00528  Caffeine (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00528)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2115  Caffeines|D00528  Caffeine (USP); Anhydrous caffeine (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00528)]|Agents for nervous and sensory systems|05 Alertness drug|D00528  Caffeine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00528)]|Third-class OTC drugs|Inorganic and organic chemicals|Anhydrous caffeine|D00528  Caffeine (USP)|Drug groups [BR:br08330(D00528)]|Respiratory system agent|DG01616  Xanthine derivative|DG01612  Xanthine-type central nervous system stimulant|DG00974  Caffeine|D00528  Caffeine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00974  Caffeine|D00528  Caffeine|DG02855  CYP2E1 substrate|DG00974  Caffeine|D00528  Caffeine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00974  Caffeine|D00528  Caffeine|Target-based classification of drugs [BR:br08310(D00528)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA1|D00528  Caffeine (USP) &lt;JP&gt;|ADORA2A|D00528  Caffeine (USP) &lt;JP&gt;|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE|D00528  Caffeine (USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00528)]|Chemicals|D00528  Anhydrous caffeine|Drug metabolizing enzymes and transporters [br08309.html(D00528)]|Drug metabolizing enzymes|D00528|Rx-to-OTC switch list in the USA [br08315.html(D00528)]|D00528",
C07482,Montelukast,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08229)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03DC Leukotriene receptor antagonists|R03DC03 Montelukast|D08229  Montelukast (INN)|Drug groups [BR:br08330(D08229)]|Anti-allergic agent|DG01541  Cysteinyl leukotriene receptor antagonist|DG01066  Montelukast|D08229  Montelukast|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG01066  Montelukast|D08229  Montelukast|DG01642  CYP2C9 substrate|DG01066  Montelukast|D08229  Montelukast|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01066  Montelukast|D08229  Montelukast|Target-based classification of drugs [BR:br08310(D08229)]|G Protein-coupled receptors|Rhodopsin family|Cysteinyl leukotriene|CYSLTR1|D08229  Montelukast (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08229)]|Drug metabolizing enzymes|D08229,
C07484,Zaleplon,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00530)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CF Benzodiazepine related drugs|N05CF03 Zaleplon|D00530  Zaleplon (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00530)]|Sleep Disorder Agents|Sleep Promoting Agents|Zaleplon|D00530  Zaleplon (JAN/USP/INN)|Drug groups [BR:br08330(D00530)]|Neuropsychiatric agent|DG01836  Non-benzodiazepine sedative-hypnotics|D00530  Zaleplon|DG03202  Hypnotic|D00530  Zaleplon|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00530  Zaleplon|DG02953  AOX1 substrate|D00530  Zaleplon|Drug classes [BR:br08332(D00530)]|Neuropsychiatric agent|DG03202  Hypnotic|D00530  Zaleplon|Target-based classification of drugs [BR:br08310(D00530)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABRA1|D00530  Zaleplon (JAN/USP/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00530)]|New molecular entities and new therapeutic biological products|D00530|New drug approvals in the USA, Europe and Japan [br08328.html(D00530)]|Approval dates by FDA, EMA and PMDA|D00530|Drug metabolizing enzymes and transporters [br08309.html(D00530)]|Drug metabolizing enzymes|D00530",
C07485,Oxotremorine,,,,,
C07486,"Nordazepam;|Desmethyldiazepam;|7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08283)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05B ANXIOLYTICS|N05BA Benzodiazepine derivatives|N05BA16 Nordazepam|D08283  Nordazepam (INN)|Drug groups [BR:br08330(D08283)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D08283  Nordazepam|DG01914  Anxiolytics, benzodiazepine derivatives|D08283  Nordazepam|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D08283  Nordazepam|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D08283  Nordazepam|Target-based classification of drugs [BR:br08310(D08283)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D08283  Nordazepam (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08283)]|Drug metabolizing enzymes|D08283|Narcotics and psychotropics in Japan [br08308.html(D08283)]|Psychotropics by Cabinet order Article 3 (78 substances)|D08283",
C07487,Nitrazepam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00531)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD02 Nitrazepam|D00531  Nitrazepam (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00531)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00531  Nitrazepam (JP18/USAN/INN)|113  Antiepileptics|1139  Others|D00531  Nitrazepam (JP18/USAN/INN)|Drug groups [BR:br08330(D00531)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D00531  Nitrazepam|DG03202  Hypnotic|D00531  Nitrazepam|DG01567  GABA-A receptor agonist|D00531  Nitrazepam|DG03199  Antiepileptic agent|DG02036  Benzodiazepine derivative, antiepileptic|D00531  Nitrazepam|Drug classes [BR:br08332(D00531)]|Neuropsychiatric agent|DG03202  Hypnotic|D00531  Nitrazepam|DG03199  Antiepileptic agent|D00531  Nitrazepam|Target-based classification of drugs [BR:br08310(D00531)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00531  Nitrazepam (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00531)]|Chemicals|D00531  Nitrazepam|Narcotics and psychotropics in Japan [br08308.html(D00531)]|Psychotropics by Control Act Article 2 Table 31 (10 substances)|D00531",
C07488,"DMPP;|Dimethylphenylpiperazinium iodide;|1,1-Dimethyl-4-phenylpiperazinium Iodide",,,,,
C07489,Glutethimide;|2-Ethyl-2-phenylglutarimide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00532)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CE Piperidinedione derivatives|N05CE01 Glutethimide|D00532  Glutethimide (JAN/INN)|Drug groups [BR:br08330(D00532)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D00532  Glutethimide|Target-based classification of drugs [BR:br08310(D00532)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00532  Glutethimide (JAN/INN)|Narcotics and psychotropics in Japan [br08308.html(D00532)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00532,
C07490,"Trichloroethanol;|2,2,2-Trichloroethanol",,,,,
C07491,Carbaryl;|Carbaril,,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Carbamate pesticides|C07491  Carbaryl|Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C07491  Carbaryl|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9935  Carbamate, derivatives and preparations|C07491  Carbaryl",
C07492,Oxcarbazepine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00533)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AF Carboxamide derivatives|N03AF02 Oxcarbazepine|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00533)]|Anticonvulsants|Sodium Channel Agents|Oxcarbazepine|D00533  Oxcarbazepine (JAN/USP/INN)|Drug groups [BR:br08330(D00533)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02034  Carboxamide antiepileptic|D00533  Oxcarbazepine|Metabolizing enzyme inhibitor|DG01933  CYP2C19 inhibitor|D00533  Oxcarbazepine|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|D00533  Oxcarbazepine|Drug classes [BR:br08332(D00533)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00533  Oxcarbazepine|Target-based classification of drugs [BR:br08310(D00533)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN2A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN3A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN4A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN5A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN8A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN9A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN10A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|SCN11A|D00533  Oxcarbazepine (JAN/USP/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00533)]|New molecular entities and new therapeutic biological products|D00533|New drug approvals in Japan [br08318.html(D00533)]|Drugs with new active ingredients|D00533|New drug approvals in the USA, Europe and Japan [br08328.html(D00533)]|Approval dates by FDA, EMA and PMDA|D00533|Drug metabolizing enzymes and transporters [br08309.html(D00533)]|Drug metabolizing enzymes|D00533|Pharmacogenomic biomarkers [br08341.html(D00533)]|Polymorphisms and mutations affecting drug response|D00533",
C07493,10-Hydroxycarbazepine;|10-Hydroxycarbamazepine;|GP 47779,,,,,
C07494,Soman,,,,,
C07495,"Dihydroxycarbazepine;|10,11-Dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide;|10,11-Dihydroxycarbamazepine",,,,,
C07496,"Carbamazepine-10,11-epoxide;|Carbamazepine epoxide",,,,,
C07497,Malathion,,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C07497  Malathion|Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C07497  Malathion|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00534)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AX Other ectoparasiticides, incl. scabicides|P03AX03 Malathion|D00534  Malathion (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00534)]|Dermatological Agents|Pediculicides/Scabicides|Malathion|D00534  Malathion (USP)|Drug groups [BR:br08330(D00534)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|D00534  Malathion",
C07498,Malaoxon,,,,,
C07499,Phenylethylmalonamide;|2-Phenyl-2-ethylmalondiamide;|PEMA,,,,,
C07500,Vigabatrin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00535)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AG Fatty acid derivatives|N03AG04 Vigabatrin|D00535  Vigabatrin (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00535)]|Anticonvulsants|Gamma-aminobutyric Acid (GABA) Augmenting Agents|GABA Agents, Other|Vigabatrin|D00535  Vigabatrin (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00535)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00535  Vigabatrin (JAN/USP/INN)|Drug groups [BR:br08330(D00535)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02037  GABA mimetic antiepileptic|D00535  Vigabatrin|Drug classes [BR:br08332(D00535)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00535  Vigabatrin|Target-based classification of drugs [BR:br08310(D00535)]|Enzymes|Transferases (EC2)|Aminotransferase|ABAT|D00535  Vigabatrin (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00535)]|New molecular entities and new therapeutic biological products|D00535|New drug approvals in Europe [br08329.html(D00535)]|European public assessment reports (EPAR) authorised medicine|D00535|New drug approvals in Japan [br08318.html(D00535)]|Drugs with new active ingredients|D00535|New drug approvals in the USA, Europe and Japan [br08328.html(D00535)]|Approval dates by FDA, EMA and PMDA|D00535",
C07501,Felbamate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00536)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX10 Felbamate|D00536  Felbamate (USPINN) &lt;US&gt;|USP drug classification [BR:br08302(D00536)]|Anticonvulsants|Anticonvulsants, Other|Felbamate|D00536  Felbamate (USPINN)|Target-based classification of drugs [BR:br08310(D00536)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D00536  Felbamate (USPINN) &lt;US&gt;",
C07502,Topiramate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00537)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX11 Topiramate|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00537)]|Anticonvulsants|Anticonvulsants, Other|Topiramate|D00537  Topiramate (JAN/USP/INN)|Antimigraine Agents|Antimigraine Agents, Other|Topiramate|D00537  Topiramate (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00537)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00537  Topiramate (JAN/USP/INN)|Drug groups [BR:br08330(D00537)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|D00537  Topiramate|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG01569  AMPA receptor antagonist|D00537  Topiramate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00537  Topiramate|Drug classes [BR:br08332(D00537)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00537  Topiramate|Target-based classification of drugs [BR:br08310(D00537)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|Glutamate (ionotropic), non-NMDA|GRIA|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|GRIK|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|Voltage-gated ion channels|Sodium channels|SCN1A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN2A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN3A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN4A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN5A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN8A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN9A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN10A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|SCN11A|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|Calcium channels|CACNA1-L|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA2|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|CA4|D00537  Topiramate (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00537)]|Drugs with new active ingredients|D00537|Drug metabolizing enzymes and transporters [br08309.html(D00537)]|Drug metabolizing enzymes|D00537",
C07503,Tiagabine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08588)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AG Fatty acid derivatives|N03AG06 Tiagabine|D08588  Tiagabine (INN)|Drug groups [BR:br08330(D08588)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02037  GABA mimetic antiepileptic|DG00850  Tiagabine|D08588  Tiagabine|Target-based classification of drugs [BR:br08310(D08588)]|Transporters|Solute carrier family|SLC6|SLC6A1 (GAT1)|D08588  Tiagabine (INN),
C07504,Zonisamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00538)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX15 Zonisamide|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00538)]|Anticonvulsants|Sodium Channel Agents|Zonisamide|D00538  Zonisamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00538)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00538  Zonisamide (JP18/USP/INN)|116  Antiparkinsonian agents|1169  Others|D00538  Zonisamide (JP18/USP/INN)|Drug groups [BR:br08330(D00538)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01573  Calcium channel T type blocker|D00538  Zonisamide|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00538  Zonisamide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D00538  Zonisamide|Drug classes [BR:br08332(D00538)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00538  Zonisamide|Target-based classification of drugs [BR:br08310(D00538)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN2A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN3A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN4A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN5A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN8A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN9A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN10A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|SCN11A|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|Calcium channels|CACNA1-T|D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00538)]|Chemicals|D00538  Zonisamide|D00538  Zonisamide tablets|New drug approvals in the USA [br08319.html(D00538)]|New molecular entities and new therapeutic biological products|D00538|New drug approvals in Europe [br08329.html(D00538)]|European public assessment reports (EPAR) authorised medicine|D00538|New drug approvals in the USA, Europe and Japan [br08328.html(D00538)]|Approval dates by FDA, EMA and PMDA|D00538|Drug metabolizing enzymes and transporters [br08309.html(D00538)]|Drug metabolizing enzymes|D00538",
C07505,Ethosuximide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00539)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AD Succinimide derivatives|N03AD01 Ethosuximide|D00539  Ethosuximide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00539)]|Anticonvulsants|Calcium Channel Modifying Agents|Ethosuximide|D00539  Ethosuximide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00539)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00539  Ethosuximide (JP18/USP/INN)|Drug groups [BR:br08330(D00539)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01573  Calcium channel T type blocker|D00539  Ethosuximide|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02033  Succinimide antiepileptic|D00539  Ethosuximide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00539  Ethosuximide|Drug classes [BR:br08332(D00539)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00539  Ethosuximide|Target-based classification of drugs [BR:br08310(D00539)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-T|D00539  Ethosuximide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00539)]|Chemicals|D00539  Ethosuximide|Drug metabolizing enzymes and transporters [br08309.html(D00539)]|Drug metabolizing enzymes|D00539,
C07506,Propantheline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB05 Propantheline|C07506  Propantheline|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00035  Propantheline|C07506  Propantheline|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG00035  Propantheline|C07506  Propantheline",G00035
C07508,Pirenzepine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08389)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX03 Pirenzepine|D08389  Pirenzepine (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D08389)]|Second-class OTC drugs|Inorganic and organic chemicals|Pirenzepine|D08389  Pirenzepine (USAN/INN)|Drug groups [BR:br08330(D08389)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00026  Pirenzepine|D08389  Pirenzepine|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG00026  Pirenzepine|D08389  Pirenzepine|Target-based classification of drugs [BR:br08310(D08389)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D08389  Pirenzepine (USAN/INN),
C07509,"Diacetylmonoxime;|2,3-Butanedione monoxime",,,,,
C07510,Hexamethonium,,,,,
C07511,Mecamylamine;|Versamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING|C02BB Secondary and tertiary amines|C02BB01 Mecamylamine|C07511  Mecamylamine|Drug groups [BR:br08330]|Cardiovascular agent|DG01695  Ganglion-blocking antiadrenergic|DG00252  Mecamylamine|C07511  Mecamylamine",G00252
C07512,Tetraethylammonium,,,,,
C07513,Methoxamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08201)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA10 Methoxamine|D08201  Methoxamine (BAN)|Drug groups [BR:br08330(D08201)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00219  Methoxamine|D08201  Methoxamine|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG00219  Methoxamine|D08201  Methoxamine|Target-based classification of drugs [BR:br08310(D08201)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08201  Methoxamine (BAN),
C07514,Amphetamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07445)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BA Centrally acting sympathomimetics|N06BA01 Amfetamine|D07445  Amfetamine (INN) &lt;US&gt;|USP drug classification [BR:br08302(D07445)]|Central Nervous System Agents|Attention Deficit Hyperactivity Disorder Agents, Amphetamines|Amphetamine|D07445  Amfetamine (INN)|Drug groups [BR:br08330(D07445)]|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00966  Amfetamine|D07445  Amfetamine|Target-based classification of drugs [BR:br08310(D07445)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07445  Amfetamine (INN) &lt;US&gt;|SLC6A3 (DAT1)|D07445  Amfetamine (INN) &lt;US&gt;|SLC18|SLC18A2 (VMAT2)|D07445  Amfetamine (INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D07445)]|Drug metabolizing enzymes|D07445|Prodrugs [br08324.html(D07445)]|D07445|Narcotics and psychotropics in Japan [br08308.html(D07445)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D07445|Prodrugs [br08324.html]|C07514",
C07515,Halothane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00542)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB01 Halothane|D00542  Halothane (JP18/USP/INN)|Drug groups [BR:br08330(D00542)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00542  Halothane|Metabolizing enzyme substrate|DG02855  CYP2E1 substrate|D00542  Halothane|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00542  Halothane|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00542)]|Chemicals|D00542  Halothane|Drug metabolizing enzymes and transporters [br08309.html(D00542)]|Drug metabolizing enzymes|D00542",
C07516,Enflurane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00543)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB04 Enflurane|D00543  Enflurane (JP18/USP/INN)|Drug groups [BR:br08330(D00543)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00543  Enflurane|Metabolizing enzyme substrate|DG02855  CYP2E1 substrate|D00543  Enflurane|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00543)]|Chemicals|D00543  Enflurane|Drug metabolizing enzymes and transporters [br08309.html(D00543)]|Drug metabolizing enzymes|D00543",
C07517,Methoxyflurane,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00544)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BG Other analgesics and antipyretics|N02BG09 Methoxyflurane|D00544  Methoxyflurane (USP/INN)|Drug groups [BR:br08330(D00544)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00544  Methoxyflurane|Metabolizing enzyme substrate|DG02855  CYP2E1 substrate|D00544  Methoxyflurane|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00544  Methoxyflurane|Drug metabolizing enzymes and transporters [br08309.html(D00544)]|Drug metabolizing enzymes|D00544,
C07518,Isoflurane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00545)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB06 Isoflurane|D00545  Isoflurane (JP18/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00545)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1119  Others|D00545  Isoflurane (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|911  General anesthetics|9111  Ethers and preparations|C07518  Isoflurane|Drug groups [BR:br08330(D00545)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00545  Isoflurane|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00545)]|Chemicals|D00545  Isoflurane",
C07519,Desflurane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00546)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB07 Desflurane|D00546  Desflurane (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00546)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1119  Others|D00546  Desflurane (JAN/USP/INN)|Drug groups [BR:br08330(D00546)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00546  Desflurane|New drug approvals in Japan [br08318.html(D00546)]|Drugs with new active ingredients|D00546",
C07520,Sevoflurane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00547)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB08 Sevoflurane|D00547  Sevoflurane (JP18/USAN/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00547)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1119  Others|D00547  Sevoflurane (JP18/USAN/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|911  General anesthetics|9111  Ethers and preparations|C07520  Sevoflurane|Drug groups [BR:br08330(D00547)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|DG01994  Halogenated hydrocarbons|D00547  Sevoflurane|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00547)]|Chemicals|D00547  Sevoflurane|Pharmacogenomic biomarkers [br08341.html(D00547)]|Polymorphisms and mutations affecting drug response|D00547",
C07521,Thiopental,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AF Barbiturates, plain|N01AF03 Thiopental|C07521  Thiopental|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA19 Thiopental|C07521  Thiopental|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG00790  Thiopental|C07521  Thiopental|DG01567  GABA-A receptor agonist|DG00790  Thiopental|C07521  Thiopental|DG02030  Anesthetics|DG02027  General anesthetics|DG02025  Barbiturate anesthetics|DG00790  Thiopental|C07521  Thiopental",G00790
C07522,"Etomidate;|1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00548)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX07 Etomidate|D00548  Etomidate (USP/INN) &lt;US&gt;|Drug groups [BR:br08330(D00548)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|D00548  Etomidate|Target-based classification of drugs [BR:br08310(D00548)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABRA1|D00548  Etomidate (USP/INN) &lt;US&gt;",
C07523,"Propofol;|2,6-Diisopropylphenol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00549)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX10 Propofol|D00549  Propofol (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00549)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1119  Others|D00549  Propofol (JAN/USP/INN)|Drug groups [BR:br08330(D00549)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|DG00797  Propofol|D00549  Propofol|DG02030  Anesthetics|DG02027  General anesthetics|DG00797  Propofol|D00549  Propofol|Target-based classification of drugs [BR:br08310(D00549)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00549  Propofol (JAN/USP/INN) &lt;JP/US&gt;|Prodrugs [br08324.html(D00549)]|D00549|Prodrugs [br08324.html]|C07523",
C07524,Midazolam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00550)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD08 Midazolam|D00550  Midazolam (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00550)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1124  Benzodiazepins|D00550  Midazolam (JAN/USP/INN)|113  Antiepileptics|1139  Others|D00550  Midazolam (JAN/USP/INN)|Drug groups [BR:br08330(D00550)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|DG00920  Midazolam|D00550  Midazolam|DG01567  GABA-A receptor agonist|DG00920  Midazolam|D00550  Midazolam|DG03199  Antiepileptic agent|DG00920  Midazolam|D00550  Midazolam|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00920  Midazolam|D00550  Midazolam|Drug classes [BR:br08332(D00550)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00550  Midazolam|Target-based classification of drugs [BR:br08310(D00550)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00550  Midazolam (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00550)]|Drug metabolizing enzymes|D00550|Narcotics and psychotropics in Japan [br08308.html(D00550)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00550",
C07525,Ketamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08098)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX03 Ketamine|D08098  Ketamine (INN)|Drug groups [BR:br08330(D08098)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG00796  Ketamine|D08098  Ketamine|DG01498  NMDA receptor antagonist|DG00796  Ketamine|D08098  Ketamine|Target-based classification of drugs [BR:br08310(D08098)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D08098  Ketamine (INN)|Narcotics and psychotropics in Japan [br08308.html(D08098)]|Narcotics by Cabinet Order Article 1 (157 substances)|D08098",
C07526,Tetracaine;|Amethocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00551)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD02 Tetracaine|D00551  Tetracaine (USP/INN)|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AB Anesthetics for topical use|D04AB06 Tetracaine|D00551  Tetracaine (USP/INN)|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA03 Tetracaine|D00551  Tetracaine (USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA03 Tetracaine|D00551  Tetracaine (USP/INN)|Drug groups [BR:br08330(D00551)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00296  Tetracaine|D00551  Tetracaine|Target-based classification of drugs [BR:br08310(D00551)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00551  Tetracaine (USP/INN)|SCN2A|D00551  Tetracaine (USP/INN)|SCN3A|D00551  Tetracaine (USP/INN)|SCN4A|D00551  Tetracaine (USP/INN)|SCN5A|D00551  Tetracaine (USP/INN)|SCN8A|D00551  Tetracaine (USP/INN)|SCN9A|D00551  Tetracaine (USP/INN)|SCN10A|D00551  Tetracaine (USP/INN)|SCN11A|D00551  Tetracaine (USP/INN)",
C07527,Benzocaine;|Ethyl aminobenzoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00552)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD03 Benzocaine|D00552  Benzocaine (USP/INN) &lt;JP&gt;|D DERMATOLOGICALS|D02 EMOLLIENTS AND PROTECTIVES|D02B PROTECTIVES AGAINST UV-RADIATION|D02BA Protectives against UV-radiation for topical use|D02BA01 Aminobenzoic acid|D00552  Benzocaine (USP/INN) &lt;JP&gt;|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AB Anesthetics for topical use|D04AB04 Benzocaine|D00552  Benzocaine (USP/INN) &lt;JP&gt;|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA05 Benzocaine|D00552  Benzocaine (USP/INN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AD Anesthetics, local|R02AD01 Benzocaine|D00552  Benzocaine (USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00552)]|2  Agents affecting individual organs|27  Dental preparations|271  Local anesthetics|2710  Local anesthetics|D00552  Benzocaine (USP/INN); Ethyl aminobenzoate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00552)]|Agents for digestive organs|15 Stomach pain and cramp relievers|D00552  Benzocaine (USP/INN)|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00552  Benzocaine (USP/INN)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00552  Benzocaine (USP/INN)|Agents for otolaryngologic use|72 Other agents for otolaryngologic use|D00552  Benzocaine (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00552)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Ethyl aminobenzoate|D00552  Benzocaine (USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Ethyl aminobenzoate|D00552  Benzocaine (USP/INN)|Third-class OTC drugs|Inorganic and organic chemicals|Ethyl aminobenzoate|D00552  Benzocaine (USP/INN)|Drug groups [BR:br08330(D00552)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00379  Aminobenzoic acid|D00552  Benzocaine|Target-based classification of drugs [BR:br08310(D00552)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN2A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN3A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN4A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN5A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN8A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN9A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN10A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|SCN11A|D00552  Benzocaine (USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00552)]|Chemicals|D00552  Ethyl aminobenzoate",
C07528,Mepivacaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08181)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB03 Mepivacaine|D08181  Mepivacaine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08181)]|Second-class OTC drugs|Inorganic and organic chemicals|Mepivacaine|D08181  Mepivacaine (INN)|Drug groups [BR:br08330(D08181)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00802  Mepivacaine|D08181  Mepivacaine|Target-based classification of drugs [BR:br08310(D08181)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08181  Mepivacaine (INN)|SCN2A|D08181  Mepivacaine (INN)|SCN3A|D08181  Mepivacaine (INN)|SCN4A|D08181  Mepivacaine (INN)|SCN5A|D08181  Mepivacaine (INN)|SCN8A|D08181  Mepivacaine (INN)|SCN9A|D08181  Mepivacaine (INN)|SCN10A|D08181  Mepivacaine (INN)|SCN11A|D08181  Mepivacaine (INN)",
C07529,Bupivacaine;|Marcaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07552)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB01 Bupivacaine|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D07552)]|Anesthetics|Local Anesthetics|Bupivacaine|D07552  Bupivacaine (USAN/INN)|Drug groups [BR:br08330(D07552)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00801  Bupivacaine|D07552  Bupivacaine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00801  Bupivacaine|D07552  Bupivacaine|Target-based classification of drugs [BR:br08310(D07552)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN2A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN3A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN4A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN5A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN8A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN9A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN10A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|SCN11A|D07552  Bupivacaine (USAN/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D07552)]|European public assessment reports (EPAR) authorised medicine|D07552|Drug metabolizing enzymes and transporters [br08309.html(D07552)]|Drug metabolizing enzymes|D07552",
C07530,Etidocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04095)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB07 Etidocaine|D04095  Etidocaine (USAN/INN)|Drug groups [BR:br08330(D04095)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00804  Etidocaine|D04095  Etidocaine|Target-based classification of drugs [BR:br08310(D04095)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D04095  Etidocaine (USAN/INN)|SCN2A|D04095  Etidocaine (USAN/INN)|SCN3A|D04095  Etidocaine (USAN/INN)|SCN4A|D04095  Etidocaine (USAN/INN)|SCN5A|D04095  Etidocaine (USAN/INN)|SCN8A|D04095  Etidocaine (USAN/INN)|SCN9A|D04095  Etidocaine (USAN/INN)|SCN10A|D04095  Etidocaine (USAN/INN)",
C07531,Prilocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00553)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB04 Prilocaine|D00553  Prilocaine (USP/INN)|Drug groups [BR:br08330(D00553)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01573  Calcium channel T type blocker|DG00803  Prilocaine|D00553  Prilocaine|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00803  Prilocaine|D00553  Prilocaine|Target-based classification of drugs [BR:br08310(D00553)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00553  Prilocaine (USP/INN)|SCN2A|D00553  Prilocaine (USP/INN)|SCN3A|D00553  Prilocaine (USP/INN)|SCN4A|D00553  Prilocaine (USP/INN)|SCN5A|D00553  Prilocaine (USP/INN)|SCN8A|D00553  Prilocaine (USP/INN)|SCN9A|D00553  Prilocaine (USP/INN)|SCN10A|D00553  Prilocaine (USP/INN)|SCN11A|D00553  Prilocaine (USP/INN)",
C07532,Ropivacaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08490)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB09 Ropivacaine|D08490  Ropivacaine (INN)|Drug groups [BR:br08330(D08490)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00806  Ropivacaine|D08490  Ropivacaine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00806  Ropivacaine|D08490  Ropivacaine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00806  Ropivacaine|D08490  Ropivacaine|Target-based classification of drugs [BR:br08310(D08490)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08490  Ropivacaine (INN)|SCN2A|D08490  Ropivacaine (INN)|SCN3A|D08490  Ropivacaine (INN)|SCN4A|D08490  Ropivacaine (INN)|SCN5A|D08490  Ropivacaine (INN)|SCN8A|D08490  Ropivacaine (INN)|SCN9A|D08490  Ropivacaine (INN)|SCN10A|D08490  Ropivacaine (INN)|SCN11A|D08490  Ropivacaine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08490)]|Drug metabolizing enzymes|D08490",
C07533,Prenalterol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA13 Prenalterol|C07533  Prenalterol|Drug groups [BR:br08330]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00221  Prenalterol|C07533  Prenalterol,G00221
C07534,Ethynyl estradiol;|17alpha-Ethinyl estradiol;|Ethinyl estradiol;|Ethinylestradiol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C07534  17alpha-Ethinyl estradiol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00554)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA01 Ethinylestradiol|D00554  Ethinyl estradiol (USP) &lt;JP&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AA Estrogens|L02AA03 Ethinylestradiol|D00554  Ethinyl estradiol (USP) &lt;JP&gt;|USP drug classification [BR:br08302(D00554)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Estrogens|Ethinyl Estradiol|D00554  Ethinyl estradiol (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00554)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2474  Ethinylestradiols|D00554  Ethinyl estradiol (USP); Ethinylestradiol (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00554)]|Drugs for women|51 Other drugs for women|D00554  Ethinyl estradiol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00554)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Ethinylestradiol|D00554  Ethinyl estradiol (USP)|Second-class OTC drugs|Inorganic and organic chemicals|Ethinylestradiol|D00554  Ethinyl estradiol (USP)|Drug groups [BR:br08330(D00554)]|Hormonal agent|DG01986  Estrogen|DG00461  Ethinylestradiol|D00554  Ethinyl estradiol|DG01584  Estrogen receptor agonist|DG00461  Ethinylestradiol|D00554  Ethinyl estradiol|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00461  Ethinylestradiol|D00554  Ethinyl estradiol|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00461  Ethinylestradiol|D00554  Ethinyl estradiol|Drug classes [BR:br08332(D00554)]|Endocrine and hormonal agent|DG01986  Estrogen|D00554  Ethinyl estradiol|DG01584  Estrogen receptor agonist|D00554  Ethinyl estradiol|Target-based classification of drugs [BR:br08310(D00554)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A1 (ESR1)|D00554  Ethinyl estradiol (USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00554)]|Chemicals|D00554  Ethinylestradiol|D00554  Ethinylestradiol tablets|Drug metabolizing enzymes and transporters [br08309.html(D00554)]|Drug metabolizing enzymes|D00554",
C07535,Benzo[a]pyrene;|Benzpyrene,,,,,
C07536,Amobarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00555)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA02 Amobarbital|D00555  Amobarbital (JP18/INN)|Drug groups [BR:br08330(D00555)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG00916  Amobarbital|D00555  Amobarbital|DG01567  GABA-A receptor agonist|DG00916  Amobarbital|D00555  Amobarbital|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG00916  Amobarbital|D00555  Amobarbital|Target-based classification of drugs [BR:br08310(D00555)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00555  Amobarbital (JP18/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00555)]|Chemicals|D00555  Amobarbital|Drug metabolizing enzymes and transporters [br08309.html(D00555)]|Drug metabolizing enzymes|D00555|Narcotics and psychotropics in Japan [br08308.html(D00555)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00555",
C07537,Ethylmorphine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07929)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|R05DA Opium alkaloids and derivatives|R05DA01 Ethylmorphine|D07929  Ethylmorphine (BAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA06 Ethylmorphine|D07929  Ethylmorphine (BAN)|Drug groups [BR:br08330(D07929)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01074  Ethylmorphine|D07929  Ethylmorphine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01074  Ethylmorphine|D07929  Ethylmorphine|Target-based classification of drugs [BR:br08310(D07929)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07929  Ethylmorphine (BAN)|Drug metabolizing enzymes and transporters [br08309.html(D07929)]|Drug metabolizing enzymes|D07929|Narcotics and psychotropics in Japan [br08308.html(D07929)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D07929",
C07538,Benzphetamine;|Benzfetamine,,,,Drug groups [BR:br08330(D07514)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG01755  Benzfetamine|D07514  Benzfetamine|Target-based classification of drugs [BR:br08310(D07514)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D07514  Benzfetamine (INN)|SLC6A3 (DAT1)|D07514  Benzfetamine (INN)|SLC18|SLC18A2 (VMAT2)|D07514  Benzfetamine (INN)|Narcotics and psychotropics in Japan [br08308.html(D07514)]|Psychotropics by Cabinet order Article 3 (78 substances)|D07514,
C07539,Aminopyrine;|4-Dimethylaminoantipyrine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00556)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BB Pyrazolones|N02BB03 Aminophenazone|D00556  Aminopyrine (JAN)|Drug groups [BR:br08330(D00556)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01947  Anti-inflammatory drug, pyrazolone|D00556  Aminopyrine",
C07540,6-Methylergoline,,,,,
C07541,Lysergic acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07541  Lysergic acid,
C07542,Lysergic acid diethylamide;|LSD;|Lysergide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07542  Lysergic acid diethylamide|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C07542,
C07543,Ergonovine;|Ergometrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07543  Ergonovine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C07543  Ergonovine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07905)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AB Ergot alkaloids|G02AB03 Ergometrine|D07905  Ergometrine (INN)|Drug groups [BR:br08330(D07905)]|Neuropsychiatric agent|DG01964  Ergot alkaloid|DG00446  Ergometrine|D07905  Ergometrine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00446  Ergometrine|D07905  Ergometrine|Target-based classification of drugs [BR:br08310(D07905)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D07905  Ergometrine (INN)|ADRA2|D07905  Ergometrine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07905)]|Drug metabolizing enzymes|D07905,
C07544,Ergotamine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07544  Ergotamine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C07544  Ergotamine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07544|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07906)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AB Ergot alkaloids|G02AB02 Ergot alkaloids|D07906  Ergotamine (INN)|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CA Ergot alkaloids|N02CA02 Ergotamine|D07906  Ergotamine (INN)|Drug groups [BR:br08330(D07906)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01468  Dopamine D2-receptor agonist|DG00834  Ergotamine|D07906  Ergotamine|DG01964  Ergot alkaloid|DG01982  Antimigraine, ergot alkaloid|DG00834  Ergotamine|D07906  Ergotamine|Analgesic|DG01518  5-HT1B/1D-receptor agonist|DG00834  Ergotamine|D07906  Ergotamine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00834  Ergotamine|D07906  Ergotamine|Target-based classification of drugs [BR:br08310(D07906)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D07906  Ergotamine (INN)|Serotonin|HTR1A|D07906  Ergotamine (INN)|HTR1B|D07906  Ergotamine (INN)|HTR1D|D07906  Ergotamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07906)]|Drug metabolizing enzymes|D07906",
C07545,alpha-Ergocryptine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C07545  alpha-Ergocryptine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C07545  alpha-Ergocryptine,
C07546,Succinylcholine;|Suxamethonium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS|M03AB Choline derivatives|M03AB01 Suxamethonium|C07546  Succinylcholine|Drug groups [BR:br08330]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01696  Peripherally-acting muscle relaxant|DG00768  Suxamethonium|C07546  Succinylcholine|DG01742  Quaternary ammonium compound type muscle relaxant|DG00768  Suxamethonium|C07546  Succinylcholine",G00768
C07547,Tubocurarine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C07547  Tubocurarine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C07547  Tubocurarine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS|M03AA Curare alkaloids|M03AA02 Tubocurarine|C07547  Tubocurarine|Drug groups [BR:br08330]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01696  Peripherally-acting muscle relaxant|DG03117  Nondepolarizing neuromuscular blocking agent|DG00767  Tubocurarine|C07547  Tubocurarine|DG01740  Curare alkaloid|DG00767  Tubocurarine|C07547  Tubocurarine",G00767
C07548,Atracurium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS|M03AC Other quaternary ammonium compounds|M03AC04 Atracurium|C07548  Atracurium|Drug groups [BR:br08330]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01696  Peripherally-acting muscle relaxant|DG03117  Nondepolarizing neuromuscular blocking agent|DG00771  Atracurium|C07548  Atracurium|DG01742  Quaternary ammonium compound type muscle relaxant|DG00771  Atracurium|C07548  Atracurium",G00771
C07549,Doxacurium,,,,,
C07550,Mivacurium,,,,,
C07551,Pancuronium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS|M03AC Other quaternary ammonium compounds|M03AC01 Pancuronium|C07551  Pancuronium|Drug groups [BR:br08330]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01696  Peripherally-acting muscle relaxant|DG03117  Nondepolarizing neuromuscular blocking agent|DG00769  Pancuronium|C07551  Pancuronium|DG01742  Quaternary ammonium compound type muscle relaxant|DG00769  Pancuronium|C07551  Pancuronium",G00769
C07552,Aldrin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C07552  Aldrin|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C07552  Aldrin,
C07553,Vecuronium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS|M03AC Other quaternary ammonium compounds|M03AC03 Vecuronium|C07553  Vecuronium|Drug groups [BR:br08330]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01696  Peripherally-acting muscle relaxant|DG03117  Nondepolarizing neuromuscular blocking agent|DG00770  Vecuronium|C07553  Vecuronium|DG01742  Quaternary ammonium compound type muscle relaxant|DG00770  Vecuronium|C07553  Vecuronium",G00770
C07554,Pipecuronium,,,,,
C07555,4-Nitroanisole;|p-Nitroanisole,,,,,
C07556,Rocuronium,,,,,
C07557,"2,3,7,8-Tetrachlorodibenzodioxin;|Tetrachlorodibenzodioxin;|2,3,7,8-Tetrachlorodibenzo-p-dioxin;|TCDD;|PCDD 48",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C07557  2,3,7,8-Tetrachlorodibenzodioxin (PCDD 48)",
C07558,Methitural,,,,,
C07559,Chlorphentermine,,,,,
C07560,Methaqualone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00557)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM01 Methaqualone|D00557  Methaqualone (JAN/USAN/INN)|Drug groups [BR:br08330(D00557)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D00557  Methaqualone|Narcotics and psychotropics in Japan [br08308.html(D00557)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00557,
C07561,Carbon tetrachloride;|Tetrachloromethane,,,,,
C07564,Ropinirole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08489)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BC Dopamine agonists|N04BC04 Ropinirole|D08489  Ropinirole (USAN/INN)|Drug groups [BR:br08330(D08489)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01468  Dopamine D2-receptor agonist|DG00862  Ropinirole|D08489  Ropinirole|DG01967  Antiparkinson agent|DG00862  Ropinirole|D08489  Ropinirole|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00862  Ropinirole|D08489  Ropinirole|Target-based classification of drugs [BR:br08310(D08489)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08489  Ropinirole (USAN/INN)|DRD3|D08489  Ropinirole (USAN/INN)|DRD4|D08489  Ropinirole (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D08489)]|Drug metabolizing enzymes|D08489,
C07565,Acetanilide;|N-Phenylacetamide;|N-Acetylarylamine,,,,,
C07566,Pimozide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00560)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AG Diphenylbutylpiperidine derivatives|N05AG02 Pimozide|D00560  Pimozide (JP18/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00560)]|Antipsychotics|1st Generation/Typical|Pimozide|D00560  Pimozide (JP18/USP/INN)|Drug groups [BR:br08330(D00560)]|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D00560  Pimozide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00560  Pimozide|Target-based classification of drugs [BR:br08310(D00560)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2A|D00560  Pimozide (JP18/USP/INN) &lt;US&gt;|Dopamine|DRD2|D00560  Pimozide (JP18/USP/INN) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00560)]|Chemicals|D00560  Pimozide|Drug metabolizing enzymes and transporters [br08309.html(D00560)]|Drug metabolizing enzymes|D00560|Pharmacogenomic biomarkers [br08341.html(D00560)]|Polymorphisms and mutations affecting drug response|D00560,
C07567,Sertindole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00561)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AE Indole derivatives|N05AE03 Sertindole|D00561  Sertindole (USAN/INN)|Drug groups [BR:br08330(D00561)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|D00561  Sertindole|Target-based classification of drugs [BR:br08310(D00561)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00561  Sertindole (USAN/INN)|Serotonin|HTR2A|D00561  Sertindole (USAN/INN),
C07568,Ziprasidone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08687)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AE Indole derivatives|N05AE04 Ziprasidone|D08687  Ziprasidone (INN)|Drug groups [BR:br08330(D08687)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00892  Ziprasidone|D08687  Ziprasidone|Target-based classification of drugs [BR:br08310(D08687)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08687  Ziprasidone (INN)|Serotonin|HTR2A|D08687  Ziprasidone (INN),
C07569,Propylthiouracil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00562)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BA Thiouracils|H03BA02 Propylthiouracil|D00562  Propylthiouracil (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00562)]|Hormonal Agents, Suppressant (Thyroid)|Antithyroid Agents|Propylthiouracil|D00562  Propylthiouracil (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00562)]|2  Agents affecting individual organs|24  Hormones|243  Thyroid and parathyroid hormone preparations|2432  Antithyroid hormones|D00562  Propylthiouracil (JP18/USP/INN)|Drug groups [BR:br08330(D00562)]|Hormonal agent|DG01934  Antithyroid agent|D00562  Propylthiouracil|Target-based classification of drugs [BR:br08310(D00562)]|Enzymes|Oxidoreductases (EC1)|Peroxidase|TPO|D00562  Propylthiouracil (JP18/USP/INN) &lt;JP/US&gt;|Thyroxine 5'-deiodinase|DIO1|D00562  Propylthiouracil (JP18/USP/INN) &lt;JP/US&gt;|DIO2|D00562  Propylthiouracil (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00562)]|Chemicals|D00562  Propylthiouracil|D00562  Propylthiouracil tablets",
C07570,Mirtazapine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00563)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX11 Mirtazapine|D00563  Mirtazapine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00563)]|Antidepressants|Antidepressants, Other|Mirtazapine|D00563  Mirtazapine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00563)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00563  Mirtazapine (JAN/USP/INN)|Drug groups [BR:br08330(D00563)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01460  alpha2-Adrenergic receptor antagonist|DG02838  Mirtazapine|D00563  Mirtazapine|Neuropsychiatric agent|DG01729  Tetracyclic antidepressant|DG02838  Mirtazapine|D00563  Mirtazapine|DG03077  Noradrenergic and specific serotonergic antidepressant (NaSSA)|DG02838  Mirtazapine|D00563  Mirtazapine|Gastrointestinal agent|DG01489  5-HT3-receptor antagonist|DG02838  Mirtazapine|D00563  Mirtazapine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG02838  Mirtazapine|D00563  Mirtazapine|DG01644  CYP2D6 substrate|DG02838  Mirtazapine|D00563  Mirtazapine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG02838  Mirtazapine|D00563  Mirtazapine|Target-based classification of drugs [BR:br08310(D00563)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D00563  Mirtazapine (JAN/USP/INN) &lt;JP/US&gt;|Serotonin|HTR2|D00563  Mirtazapine (JAN/USP/INN) &lt;JP/US&gt;|Ion channels|Ligand-gated ion channels|Serotonin|HTR3|D00563  Mirtazapine (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00563)]|Drugs with new active ingredients|D00563|Drug metabolizing enzymes and transporters [br08309.html(D00563)]|Drug metabolizing enzymes|D00563",
C07571,Fluvoxamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07984)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AB Selective serotonin reuptake inhibitors|N06AB08 Fluvoxamine|D07984  Fluvoxamine (INN)|Drug groups [BR:br08330(D07984)]|Neuropsychiatric agent|DG01659  Selective serotonin reuptake inhibitor (SSRI)|DG00946  Fluvoxamine|D07984  Fluvoxamine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00946  Fluvoxamine|D07984  Fluvoxamine|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00946  Fluvoxamine|D07984  Fluvoxamine|DG01643  CYP2C9 inhibitor|DG00946  Fluvoxamine|D07984  Fluvoxamine|DG01933  CYP2C19 inhibitor|DG00946  Fluvoxamine|D07984  Fluvoxamine|DG01645  CYP2D6 inhibitor|DG00946  Fluvoxamine|D07984  Fluvoxamine|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00946  Fluvoxamine|D07984  Fluvoxamine|Target-based classification of drugs [BR:br08310(D07984)]|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D07984  Fluvoxamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07984)]|Drug metabolizing enzymes|D07984,
C07572,Citalopram,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07704)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AB Selective serotonin reuptake inhibitors|N06AB04 Citalopram|D07704  Citalopram (USP/INN)|Drug groups [BR:br08330(D07704)]|Neuropsychiatric agent|DG01659  Selective serotonin reuptake inhibitor (SSRI)|DG00943  Citalopram|D07704  Citalopram|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00943  Citalopram|D07704  Citalopram|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00943  Citalopram|D07704  Citalopram|Metabolizing enzyme inhibitor|DG01933  CYP2C19 inhibitor|DG00943  Citalopram|D07704  Citalopram|Transporter substrate|DG01665  ABCB1 substrate|DG00943  Citalopram|D07704  Citalopram|Target-based classification of drugs [BR:br08310(D07704)]|Transporters|Solute carrier family|SLC6|SLC6A4 (HTT)|D07704  Citalopram (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D07704)]|Drug metabolizing enzymes|D07704|Drug transporters|D07704,
C07573,Prontosil;|Sulfamidochrysoidine;|Prontosil rubrum,,,,Drug groups [BR:br08330(D08542)]|Antibacterial|DG01787  Sulfonamide antibacterial|D08542  Sulfamidochrysoidine,
C07574,Tartrazine;|Acid Yellow 23;|Food yellow No.4,,,,,
C07575,Phencyclidine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C07575,
C07576,Psilocybin;|Psilocybine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Alkaloids|C07576  Psilocybin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07576|Prodrugs [br08324.html]|C07576|Target-based classification of drugs [BR:br08310(D12881)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR2A|D12881  Psilocybin (USAN)|Narcotics and psychotropics in Japan [br08308.html(D12881)]|Narcotics by Cabinet Order Article 1 (157 substances)|D12881,
C07577,"3,4-Methylenedioxymethamphetamine;|N-Methyl-3,4-methylenedioxyamphetamine;|MDMA",,,,Target-based classification of drugs [BR:br08310(D11172)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D11172  Midomafetamine (USAN/INN)|SLC6A3 (DAT1)|D11172  Midomafetamine (USAN/INN)|SLC6A4 (HTT)|D11172  Midomafetamine (USAN/INN)|SLC18|SLC18A2 (VMAT2)|D11172  Midomafetamine (USAN/INN)|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C07577,
C07578,Cannabidiol;|CBD,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C07578  Cannabidiol|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C07578  Cannabidiol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07578|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10915)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX24 Cannabidiol|D10915  Cannabidiol (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D10915)]|Anticonvulsants|Anticonvulsants, Other|Cannabidiol|D10915  Cannabidiol (JAN/USAN/INN)|Drug groups [BR:br08330(D10915)]|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D10915  Cannabidiol|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D10915  Cannabidiol|DG02924  UGT substrate|DG03185  UGT1A7 substrate|D10915  Cannabidiol|DG03188  UGT1A9 substrate|D10915  Cannabidiol|DG03190  UGT2B7 substrate|D10915  Cannabidiol|Transporter substrate|DG01665  ABCB1 substrate|D10915  Cannabidiol|Target-based classification of drugs [BR:br08310(D10915)]|G Protein-coupled receptors|Rhodopsin family|Cannabinoid|CNR|D10915  Cannabidiol (JAN/USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D10915)]|New molecular entities and new therapeutic biological products|D10915|New drug approvals in Europe [br08329.html(D10915)]|European public assessment reports (EPAR) authorised medicine|D10915|New drug approvals in the USA, Europe and Japan [br08328.html(D10915)]|Approval dates by FDA, EMA and PMDA|D10915|Drug metabolizing enzymes and transporters [br08309.html(D10915)]|Drug metabolizing enzymes|D10915|Drug transporters|D10915|Narcotics and psychotropics in Japan [br08308.html(D10915)]|Opium and Cannabis|D10915",
C07580,Cannabinol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C07580  Cannabinol|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C07580  Cannabinol,
C07581,Pteridine,,,,,
C07582,Pteroic acid,,,,,
C07584,"Phenindione;|2-Phenyl-1,3-indandione",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08354)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AA Vitamin K antagonists|B01AA02 Phenindione|D08354  Phenindione (INN)|Drug groups [BR:br08330(D08354)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01708  Coumarin anticoagulant|DG01761  Phenindion type coumarin derivative|D08354  Phenindione|Target-based classification of drugs [BR:br08310(D08354)]|Enzymes|Oxidoreductases (EC1)|Vitamin-K-epoxide reductase|VKORC1|D08354  Phenindione (INN),
C07585,N-Acetylisoniazid;|(N)1-Acetylisoniazid,,,,,
C07586,Fenofibrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00565)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AB Fibrates|C10AB05 Fenofibrate|D00565  Fenofibrate (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00565)]|Cardiovascular Agents|Dyslipidemics, Fibric Acid Derivatives|Fenofibrate|D00565  Fenofibrate (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00565)]|2  Agents affecting individual organs|21  Cardiovascular agents|218  Hyperlipidemia agents|2183  Clofibrates|D00565  Fenofibrate (JP18/USP/INN)|Drug groups [BR:br08330(D00565)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01733  PPAR alpha agonist|DG01547  Fibrate|DG01548  Fenofibrate|D00565  Fenofibrate|Metabolizing enzyme substrate|DG02924  UGT substrate|DG01548  Fenofibrate|D00565  Fenofibrate|Drug classes [BR:br08332(D00565)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D00565  Fenofibrate|Target-based classification of drugs [BR:br08310(D00565)]|Nuclear receptors|Thyroid hormone like receptors|Peroxisome proliferator-activated receptor (PPAR)|NR1C1 (PPARA)|D00565  Fenofibrate (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00565)]|Chemicals|D00565  Fenofibrate|D00565  Fenofibrate tablets|Drug metabolizing enzymes and transporters [br08309.html(D00565)]|Drug metabolizing enzymes|D00565",
C07587,Sodium salicylate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00566)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BA Salicylic acid and derivatives|N02BA04 Sodium salicylate|D00566  Sodium salicylate (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00566)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1143  Salicylates|D00566  Sodium salicylate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00566)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Salicylic acid|D00566  Sodium salicylate (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Salicylic acid|D00566  Sodium salicylate (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9131  Salicylic acids, derivatives and preparations|C07587  Sodium salicylate|Drug groups [BR:br08330(D00566)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|D00566  Sodium salicylate|Drug classes [BR:br08332(D00566)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00566  Sodium salicylate|Target-based classification of drugs [BR:br08310(D00566)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D00566  Sodium salicylate (JP18/USP) &lt;JP&gt;|PTGS2 (COX2)|D00566  Sodium salicylate (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00566)]|Chemicals|D00566  Sodium salicylate",
C07588,Salicyluric acid;|Salicylurate;|N-(2-Hydroxybenzoyl)-glycine,,,,,
C07589,Celecoxib,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00567)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX33 Celecoxib|D00567  Celecoxib (JP18/USP/INN) &lt;JP/US&gt;|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AH Coxibs|M01AH01 Celecoxib|D00567  Celecoxib (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00567)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Celecoxib|D00567  Celecoxib (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00567)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00567  Celecoxib (JP18/USP/INN)|Drug groups [BR:br08330(D00567)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01922  Selective COX2 inhibitor|DG01907  Anti-inflammatory drug, coxibs|D00567  Celecoxib|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00567  Celecoxib|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|D00567  Celecoxib|Drug classes [BR:br08332(D00567)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00567  Celecoxib|Target-based classification of drugs [BR:br08310(D00567)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D00567  Celecoxib (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00567)]|Chemicals|D00567  Celecoxib|New drug approvals in Japan [br08318.html(D00567)]|Drugs with new active ingredients|D00567|Drug metabolizing enzymes and transporters [br08309.html(D00567)]|Drug metabolizing enzymes|D00567|Pharmacogenomic biomarkers [br08341.html(D00567)]|Polymorphisms and mutations affecting drug response|D00567",
C07590,Rofecoxib,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00568)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AH Coxibs|M01AH02 Rofecoxib|D00568  Rofecoxib (JAN/USAN/INN)|Drug groups [BR:br08330(D00568)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01922  Selective COX2 inhibitor|DG01907  Anti-inflammatory drug, coxibs|D00568  Rofecoxib|Target-based classification of drugs [BR:br08310(D00568)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D00568  Rofecoxib (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D00568)]|New molecular entities and new therapeutic biological products|D00568|New drug approvals in the USA, Europe and Japan [br08328.html(D00568)]|Approval dates by FDA, EMA and PMDA|D00568",
C07591,Phenacetin;|Acetophenetidin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00569)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BE Anilides|N02BE03 Phenacetin|D00569  Phenacetin (JAN/INN)|Drug groups [BR:br08330(D00569)]|Anti-inflammatory|DG01981  Anilide derivative, anti-inflammatory|D00569  Phenacetin",
C07592,Colchicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C07592  Colchicine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C07592  Colchicine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00570)]|M MUSCULO-SKELETAL SYSTEM|M04 ANTIGOUT PREPARATIONS|M04A ANTIGOUT PREPARATIONS|M04AC Preparations with no effect on uric acid metabolism|M04AC01 Colchicine|D00570  Colchicine (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00570)]|Antigout Agents|Colchicine|D00570  Colchicine (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00570)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|394  Gout preparations|3941  Colchicines|D00570  Colchicine (JP18/USP)|Drug groups [BR:br08330(D00570)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00570  Colchicine|Transporter substrate|DG01665  ABCB1 substrate|D00570  Colchicine|Target-based classification of drugs [BR:br08310(D00570)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D00570  Colchicine (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00570)]|Chemicals|D00570  Colchicine|Drug metabolizing enzymes and transporters [br08309.html(D00570)]|Drug metabolizing enzymes|D00570|Drug transporters|D00570,
C07593,Rotenone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C07593  Rotenone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C07593  Rotenone|Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C07593  Rotenone|Animal drugs in Japan [BR:br08331]|95  Agents for external use|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C07593  Rotenone,
C07594,Pyrethrin I,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C07594  Pyrethrin I|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Others|C07594  Pyrethrin I|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9569  Other bath and disinfectants preparations|C07594  Pyrethrin I|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C07594  Pyrethrin I,
C07596,HLo7,,,,,
C07597,Ferroxamine;|Ferrioxamine;|Desferal-iron(III),,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C07597  Ferroxamine,
C07598,"Succimer;|meso-2,3-Dimercaptosuccinic acid",,,,USP drug classification [BR:br08302(D00572)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral/Metal Modifiers|Succimer|D00572  Succimer (USAN/INN)|Pharmacogenomic biomarkers [br08341.html(D00572)]|Polymorphisms and mutations affecting drug response|D00572,
C07599,Alloxanthine;|Oxipurinol;|Oxypurinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C07599  Alloxanthine|Drug groups [BR:br08330(D02365)]|Cardiovascular agent|DG01503  Xanthine dehydrogenase inhibitor|D02365  Oxypurinol|Musculo-skeletal system agent|DG03130  Xanthin oxidase inhibitor|D02365  Oxypurinol|Target-based classification of drugs [BR:br08310(D02365)]|Enzymes|Oxidoreductases (EC1)|Xanthine dehydrogenase/oxidase|XDH|D02365  Oxypurinol (USAN),
C07600,Allicin;|2-Propene-1-sulfinothioic acid S-2-propenyl ester,,,,,
C07601,Ginkgolide A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010454 Ginkgolides and Bilobalides|C07601  Ginkgolide A|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C07601  Ginkgolide A,
C07602,Ginkgolide B,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010454 Ginkgolides and Bilobalides|C07602  Ginkgolide B|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C07602  Ginkgolide B,
C07603,Ginkgolide C;|BN 52022,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010454 Ginkgolides and Bilobalides|C07603  Ginkgolide C|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C07603  Ginkgolide C,
C07604,Ginkgolide J;|BN 52024,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010454 Ginkgolides and Bilobalides|C07604  Ginkgolide J|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C07604  Ginkgolide J,
C07605,Bilobalide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C07605  Bilobalide,
C07606,Hypericin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C07606  Hypericin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C07606  Hypericin,
C07607,Gonadotropin-releasing hormone I;|Gonadorelin;|Gonadoliberin I;|GnRH-I,,Glp His Trp Ser Tyr Gly Leu Arg Pro Gly,Peptide,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Gonadotropin-releasing hormone|C07607  Gonadotropin-releasing hormone I|Bioactive peptides [BR:br08005]|Hypothalamic hormones|Gonadotropin-releasing hormone|C07607  Gonadotropin-releasing hormone I|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08027)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01C HYPOTHALAMIC HORMONES|H01CA Gonadotropin-releasing hormones|H01CA01 Gonadorelin|D08027  Gonadorelin (INN)|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CM Tests for fertility disturbances|V04CM01 Gonadorelin|D08027  Gonadorelin (INN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9419  Other hormone preparations|C07607  Gonadotropin-releasing hormone I|Drug groups [BR:br08330(D08027)]|Hormonal agent|DG01494  Gonadotropin-releasing hormone receptor agonist|DG00499  Gonadorelin|D08027  Gonadorelin|Target-based classification of drugs [BR:br08310(D08027)]|G Protein-coupled receptors|Rhodopsin family|Gonadotropin-releasing hormone|GNRHR|D08027  Gonadorelin (INN)",
C07608,Hyperforin,,,,,
C07609,Parthenolide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C07609  Parthenolide|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C07609  Parthenolide,
C07610,Silymarin;|Silibinin;|Silybin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C07610  Silymarin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C07610  Silymarin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08515)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA03 Silymarin|D08515  Silibinin (INN)",
C07612,Leuprolide;|Leuprorelin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08113)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AE Gonadotropin releasing hormone analogues|L02AE02 Leuprorelin|D08113  Leuprorelin (INN)|Drug groups [BR:br08330(D08113)]|Hormonal agent|DG01494  Gonadotropin-releasing hormone receptor agonist|DG00730  Leuprorelin|D08113  Leuprorelin|Target-based classification of drugs [BR:br08310(D08113)]|G Protein-coupled receptors|Rhodopsin family|Gonadotropin-releasing hormone|GNRHR|D08113  Leuprorelin (INN),
C07613,Nafarelin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08241)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01C HYPOTHALAMIC HORMONES|H01CA Gonadotropin-releasing hormones|H01CA02 Nafarelin|D08241  Nafarelin (INN)|Drug groups [BR:br08330(D08241)]|Hormonal agent|DG01494  Gonadotropin-releasing hormone receptor agonist|DG00500  Nafarelin|D08241  Nafarelin|Target-based classification of drugs [BR:br08310(D08241)]|G Protein-coupled receptors|Rhodopsin family|Gonadotropin-releasing hormone|GNRHR|D08241  Nafarelin (INN)",
C07615,Carbimazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07616)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BB Sulfur-containing imidazole derivatives|H03BB01 Carbimazole|D07616  Carbimazole (INN)|Drug groups [BR:br08330(D07616)]|Hormonal agent|DG01934  Antithyroid agent|D07616  Carbimazole|Target-based classification of drugs [BR:br08310(D07616)]|Enzymes|Oxidoreductases (EC1)|Peroxidase|TPO|D07616  Carbimazole (INN)",
C07616,Amphenone B,,,,,
C07617,Aminoglutethimide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00574)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BG Aromatase inhibitors|L02BG01 Aminoglutethimide|D00574  Aminoglutethimide (USP/INN)|Drug groups [BR:br08330(D00574)]|Antineoplastic|DG01596  Aromatase inhibitor|D00574  Aminoglutethimide|Target-based classification of drugs [BR:br08310(D00574)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP19A1 (ARO)|D00574  Aminoglutethimide (USP/INN),
C07618,Mestranol,,,,Drug groups [BR:br08330(D00575)]|Hormonal agent|DG01986  Estrogen|D00575  Mestranol|DG01584  Estrogen receptor agonist|D00575  Mestranol|Target-based classification of drugs [BR:br08310(D00575)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00575  Mestranol (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00575)]|Chemicals|D00575  Mestranol,
C07619,Quinestrol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C07619  Quinestrol|Drug groups [BR:br08330(D00576)]|Hormonal agent|DG01986  Estrogen|D00576  Quinestrol|DG01584  Estrogen receptor agonist|D00576  Quinestrol|Target-based classification of drugs [BR:br08310(D00576)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A1 (ESR1)|D00576  Quinestrol (USAN/INN),
C07620,Diethylstilbestrol;|DES,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00577)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CB Synthetic estrogens, plain|G03CB02 Diethylstilbestrol|D00577  Diethylstilbestrol (USP/INN)|G03CC Estrogens, combinations with other drugs|G03CC05 Diethylstilbestrol|D00577  Diethylstilbestrol (USP/INN)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AA Estrogens|L02AA01 Diethylstilbestrol|D00577  Diethylstilbestrol (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00577)]|First-class OTC drugs|Inorganic and organic chemicals|Diethylstilbestrol|D00577  Diethylstilbestrol (USP/INN)|Drug groups [BR:br08330(D00577)]|Hormonal agent|DG01584  Estrogen receptor agonist|DG00466  Diethylstilbestrol|D00577  Diethylstilbestrol|Target-based classification of drugs [BR:br08310(D00577)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00577  Diethylstilbestrol (USP/INN)|Prodrugs [br08324.html(D00577)]|D00577|Prodrugs [br08324.html]|C07620",
C07621,Methallenestril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CB Synthetic estrogens, plain|G03CB03 Methallenestril|C07621  Methallenestril|G03CC Estrogens, combinations with other drugs|G03CC03 Methallenestril|C07621  Methallenestril",
C07622,Voriconazole;|Vfend,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00578)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AC Triazole and tetrazole derivatives|J02AC03 Voriconazole|D00578  Voriconazole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00578)]|Antifungals|Voriconazole|D00578  Voriconazole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00578)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|617  Acting mainly on mold|6179  Others|D00578  Voriconazole (JP18/USP/INN)|Drug groups [BR:br08330(D00578)]|Antifungal|DG01523  Triazole antifungal|D00578  Voriconazole|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|D00578  Voriconazole|Drug classes [BR:br08332(D00578)]|Antifungal|DG01523  Triazole antifungal|D00578  Voriconazole|Antimicrobials [BR:br08307(D00578)]|Antifungals|Ergosterol biosynthesis inhibitor|Triazole|D00578  Voriconazole (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00578)]|Antifungals|Ergosterol biosynthesis inhibitor|Triazole|D00578  Voriconazole (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00578)]|Chemicals|D00578  Voriconazole|D00578  Voriconazole tablets|D00578  Voriconazole for injection|New drug approvals in the USA [br08319.html(D00578)]|New molecular entities and new therapeutic biological products|D00578|New drug approvals in Europe [br08329.html(D00578)]|European public assessment reports (EPAR) authorised medicine|D00578|New drug approvals in Japan [br08318.html(D00578)]|Drugs with new active ingredients|D00578|New drug approvals in the USA, Europe and Japan [br08328.html(D00578)]|Approval dates by FDA, EMA and PMDA|D00578|Drug metabolizing enzymes and transporters [br08309.html(D00578)]|Drug metabolizing enzymes|D00578|Pharmacogenomic biomarkers [br08341.html(D00578)]|Polymorphisms and mutations affecting drug response|D00578",
C07624,Abacavir,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07057)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF06 Abacavir|D07057  Abacavir (INN)|Drug groups [BR:br08330(D07057)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|DG00660  Abacavir|D07057  Abacavir|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|DG00660  Abacavir|D07057  Abacavir|Antimicrobials [BR:br08307(D07057)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D07057  Abacavir (INN),
C07625,Chloroquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02366)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BA Aminoquinolines|P01BA01 Chloroquine|D02366  Chloroquine (USP/INN)|Antimicrobials [BR:br08307(D02366)]|Antiparasitics|Antmalarials|Aminoquinoline|D02366  Chloroquine (USP/INN)",
C07626,Amodiaquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02922)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BA Aminoquinolines|P01BA06 Amodiaquine|D02922  Amodiaquine (USP/INN)|Drug groups [BR:br08330(D02922)]|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG01017  Amodiaquine|D02922  Amodiaquine|Antimicrobials [BR:br08307(D02922)]|Antiparasitics|Antmalarials|Aminoquinoline|D02922  Amodiaquine (USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02922)]|Drug metabolizing enzymes|D02922",
C07627,Primaquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08420)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BA Aminoquinolines|P01BA03 Primaquine|D08420  Primaquine (INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9741  Aminoquinoline and preparations|C07627  Primaquine|Antimicrobials [BR:br08307(D08420)]|Antiparasitics|Antmalarials|Aminoquinoline|D08420  Primaquine (INN)",
C07628,Dimethisterone;|Dimethisterone anhydrous,,,,,
C07629,Desogestrel,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C07629  Desogestrel|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02367)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC09 Desogestrel|D02367  Desogestrel (USAN/INN)|Drug groups [BR:br08330(D02367)]|Hormonal agent|DG02004  Progesterone|D02367  Desogestrel|DG01666  Progesterone receptor agonist|D02367  Desogestrel|Target-based classification of drugs [BR:br08310(D02367)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A1 (ESR1)|D02367  Desogestrel (USAN/INN)|3-Ketosteroid receptor|NR3C3 (PGR)|D02367  Desogestrel (USAN/INN)",
C07630,Sulfadoxine,,,,Drug groups [BR:br08330(D00580)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01786  Long-acting sulfonamide|D00580  Sulfadoxine|Antimicrobials [BR:br08307(D00580)]|Antibacterials|Folic acid biosynthesis inhibitor|Long-acting sulfonamide|D00580  Sulfadoxine (JAN/USP/INN),
C07631,Proguanil;|Chloroguanide;|N-(4-Chlorophenyl)-N'-(isopropyl)-imidodicarbonimidic diamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08428)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BB Biguanides|P01BB01 Proguanil|D08428  Proguanil (INN)|Drug groups [BR:br08330(D08428)]|Antiparasitic|DG01932  Antifolate, antiprotozoal|DG01018  Proguanil|D08428  Proguanil|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG01018  Proguanil|D08428  Proguanil|Antimicrobials [BR:br08307(D08428)]|Antiparasitics|Antmalarials|Biguanide|D08428  Proguanil (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08428)]|Drug metabolizing enzymes|D08428",
C07632,"Androstanediol;|Androstane-3,17-diol",,,,"Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C07632  Androstanediol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C07632  Androstane-3,17-diol",
C07633,Mefloquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04895)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BC Methanolquinolines|P01BC02 Mefloquine|D04895  Mefloquine (USAN/INN)|Drug groups [BR:br08330(D04895)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG01020  Mefloquine|D04895  Mefloquine|Antimicrobials [BR:br08307(D04895)]|Antiparasitics|Antmalarials|Methanolquinoline|D04895  Mefloquine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D04895)]|Drug metabolizing enzymes|D04895",
C07634,Halofantrine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08033)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BX Other antimalarials|P01BX01 Halofantrine|D08033  Halofantrine (INN)|Drug groups [BR:br08330(D08033)]|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG01021  Halofantrine|D08033  Halofantrine|Antimicrobials [BR:br08307(D08033)]|Antiparasitics|Antmalarials|Other antimalarials|D08033  Halofantrine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08033)]|Drug metabolizing enzymes|D08033",
C07635,Epiandrosterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C07635  Epiandrosterone,
C07636,Iodoquinol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00581)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AC Quinoline derivatives|G01AC01 Diiodohydroxyquinoline|D00581  Iodoquinol (USP)|Antimicrobials [BR:br08307(D00581)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Hydroxyquinoline derivatives|D00581  Iodoquinol (USP)",
C07637,Diloxanide furoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02480)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AC Dichloroacetamide derivatives|P01AC01 Diloxanide|D02480  Diloxanide furoate (USP)|Antimicrobials [BR:br08307(D02480)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Dichloroacetamide derivatives|D02480  Diloxanide furoate (USP)",
C07638,Sodium stibogluconate;|Antimony sodium gluconate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00582)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS|P01CB Antimony compounds|P01CB02 Sodium stibogluconate|D00582  Sodium stibogluconate (INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9754  Antimony compounds and preparations|C07638  Sodium stibogluconate|Antimicrobials [BR:br08307(D00582)]|Antiparasitics|Agents against Leishmaniasis and Trypanosomiasis|Antimony compounds|D00582  Sodium stibogluconate (INN)",
C07639,"3,3',5'-Triiodo-L-thyronine;|3,3',5'-Triiodothyronine;|Reverse triiodothyronine;|rT3",,,,,
C07640,Semustine;|Methyl-CCNU;|1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05822)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD03 Semustine|D05822  Semustine (USAN/INN)|Drug groups [BR:br08330(D05822)]|Antineoplastic|DG01677  Alkylating agent|DG01724  Nitrosourea|D05822  Semustine,
C07641,Thiotepa,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00583)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AC Ethylene imines|L01AC01 Thiotepa|D00583  Thiotepa (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00583)]|Antineoplastics|Alkylating Agents|Thiotepa|D00583  Thiotepa (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00583)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4212  Ethyleneimines|D00583  Thiotepa (JAN/USP/INN)|Drug groups [BR:br08330(D00583)]|Antineoplastic|DG01677  Alkylating agent|DG01723  Ethylene imine|DG01722  Thiotepa type ethylene imine|D00583  Thiotepa|New drug approvals in Europe [br08329.html(D00583)]|European public assessment reports (EPAR) authorised medicine|D00583|New drug approvals in Japan [br08318.html(D00583)]|Drugs with new active ingredients|D00583,
C07642,"Triethylenemelamine;|Trisaziridinyltriazine;|2,4,6-Tris(1-aziridinyl)-s-triazine",,,,,
C07643,4-Hydroxycyclophosphamide,,,,Prodrugs [br08324.html]|C07643,
C07644,4-Ketocyclophosphamide,,,,,
C07645,Aldophosphamide,,,,,
C07646,Carboxyphosphamide;|Carboxycyclophosphamide,,,,,
C07647,Phosphoramide mustard;|Phosphamide mustard,,,,,
C07648,Thioguanine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08603)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BB Purine analogues|L01BB03 Tioguanine|D08603  Tioguanine (INN)|Drug groups [BR:br08330(D08603)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG00684  Tioguanine|D08603  Tioguanine|Target-based classification of drugs [BR:br08310(D08603)]|Enzymes|Transferases (EC2)|Pentosyltransferases|HPRT1|D08603  Tioguanine (INN)",
C07649,5-FU;|Fluorouracil;|5-Fluorouracil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00584)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC02 Fluorouracil|D00584  Fluorouracil (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00584)]|Antineoplastics|Antimetabolites|Fluorouracil|D00584  Fluorouracil (JP18/USP/INN)|Dermatological Agents|Dermatological Agents, Other|Warts and Actinic Keratosis Agents|Fluorouracil|D00584  Fluorouracil (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00584)]|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4223  Fluorouracils|D00584  Fluorouracil (JP18/USP/INN)|Drug groups [BR:br08330(D00584)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|DG00687  Fluorouracil|D00584  Fluorouracil|Metabolizing enzyme substrate|DG02984  DPYD substrate|DG00687  Fluorouracil|D00584  Fluorouracil|Drug classes [BR:br08332(D00584)]|Antineoplastic|DG02018  Antimetabolite|D00584  Fluorouracil|Target-based classification of drugs [BR:br08310(D00584)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D00584  Fluorouracil (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00584)]|Chemicals|D00584  Fluorouracil|Drug metabolizing enzymes and transporters [br08309.html(D00584)]|Drug metabolizing enzymes|D00584|Pharmacogenomic biomarkers [br08341.html(D00584)]|Polymorphisms and mutations affecting drug response|D00584|Prodrugs [br08324.html(D00584)]|D00584|Prodrugs [br08324.html]|C07649",
C07650,Gemcitabine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02368)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC05 Gemcitabine|D02368  Gemcitabine (USAN/INN)|Drug groups [BR:br08330(D02368)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01439  Arabinofuranosyl type antineoplastic|DG00688  Gemcitabine|D02368  Gemcitabine|Target-based classification of drugs [BR:br08310(D02368)]|Enzymes|Oxidoreductases (EC1)|Ribonucleoside-diphosphate reductase|RRM1|D02368  Gemcitabine (USAN/INN)",
C07651,WR 1065;|2-[(3-Aminopropyl)amino]ethanethiol,,,,,
C07652,Mifepristone;|RU-486,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00585)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03XB Progesterone receptor modulators|G03XB01 Mifepristone|D00585  Mifepristone (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00585)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers), Other|Mifepristone|D00585  Mifepristone (JAN/USAN/INN)|Drug groups [BR:br08330(D00585)]|Hormonal agent|DG01667  Progesterone receptor antagonist|D00585  Mifepristone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00585  Mifepristone|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|D00585  Mifepristone|Target-based classification of drugs [BR:br08310(D00585)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00585  Mifepristone (JAN/USAN/INN) &lt;US&gt;|NR3C3 (PGR)|D00585  Mifepristone (JAN/USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00585)]|New molecular entities and new therapeutic biological products|D00585|New drug approvals in the USA, Europe and Japan [br08328.html(D00585)]|Approval dates by FDA, EMA and PMDA|D00585|Drug metabolizing enzymes and transporters [br08309.html(D00585)]|Drug metabolizing enzymes|D00585",
C07653,Flutamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00586)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BB Anti-androgens|L02BB01 Flutamide|D00586  Flutamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00586)]|Antineoplastics|Antiandrogens|Flutamide|D00586  Flutamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00586)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00586  Flutamide (JP18/USP/INN)|Drug groups [BR:br08330(D00586)]|Antineoplastic|DG01591  Androgen receptor antagonist|DG01624  Flutamide-type antiandrogen|D00586  Flutamide|Drug classes [BR:br08332(D00586)]|Antineoplastic|DG01591  Androgen receptor antagonist|D00586  Flutamide|Target-based classification of drugs [BR:br08310(D00586)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00586  Flutamide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00586)]|Chemicals|D00586  Flutamide,
C07654,Methacycline;|Metacycline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04972)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA05 Metacycline|D04972  Methacycline (USAN)|Drug groups [BR:br08330(D04972)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00514  Metacycline|D04972  Methacycline|Antimicrobials [BR:br08307(D04972)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D04972  Methacycline (USAN),
C07655,Streptobiosamine,,,,,
C07656,Gentamicin C1,Component of Gentamicin C  [CPD:C01918],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C07656,
C07657,Netilmicin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08268)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB07 Netilmicin|D08268  Netilmicin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA23 Netilmicin|D08268  Netilmicin (INN)|Drug groups [BR:br08330(D08268)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00609  Netilmicin|D08268  Netilmicin|Antimicrobials [BR:br08307(D08268)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08268  Netilmicin (INN),
C07658,Sulfadiazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00587)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EC Intermediate-acting sulfonamides|J01EC02 Sulfadiazine|D00587  Sulfadiazine (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00587)]|Antibacterials|Sulfonamides|Sulfadiazine|D00587  Sulfadiazine (JAN/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00587)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00587  Sulfadiazine (JAN/USP/INN)|56 Purulent skin remedies|D00587  Sulfadiazine (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00587)]|Second-class OTC drugs|Inorganic and organic chemicals|Sulfadiazine|D00587  Sulfadiazine (JAN/USP/INN)|Drug groups [BR:br08330(D00587)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01785  Intermediate-acting sulfonamide|DG00599  Sulfadiazine|D00587  Sulfadiazine|Antimicrobials [BR:br08307(D00587)]|Antibacterials|Folic acid biosynthesis inhibitor|Intermediate-acting sulfonamide|D00587  Sulfadiazine (JAN/USP/INN) &lt;US&gt;,
C07659,Sulfathalidine;|Phthalylsulfathiazole;|2-[[[4-[(2-Thiazolylamino)sulfonyl]phenyl]amino]carbonyl]benzoic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02440)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AB Sulfonamides|A07AB02 Phthalylsulfathiazole|D02440  Phthalylsulfathiazole (INN)|Drug groups [BR:br08330(D02440)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|D02440  Phthalylsulfathiazole|Antimicrobials [BR:br08307(D02440)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D02440  Phthalylsulfathiazole (INN)|Prodrugs [br08324.html(D02440)]|D02440|Prodrugs [br08324.html]|C07659",
C07660,Levofloxacin;|Ofloxacin S-(-)-form,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08120)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA12 Levofloxacin|D08120  Levofloxacin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE05 Levofloxacin|D08120  Levofloxacin (INN)|Drug groups [BR:br08330(D08120)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00624  Levofloxacin|D08120  Levofloxacin|DG01966  Antitubercular|DG00624  Levofloxacin|D08120  Levofloxacin|Transporter substrate|DG02857  SLCO1A2 substrate|DG00624  Levofloxacin|D08120  Levofloxacin|Antimicrobials [BR:br08307(D08120)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D08120  Levofloxacin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08120)]|Drug transporters|D08120,
C07661,Gatifloxacin;|AM 1155,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08011)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA16 Gatifloxacin|D08011  Gatifloxacin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE06 Gatifloxacin|D08011  Gatifloxacin (INN)|USP drug classification [BR:br08302(D08011)]|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Gatifloxacin|D08011  Gatifloxacin (INN)|Drug groups [BR:br08330(D08011)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00628  Gatifloxacin|D08011  Gatifloxacin|Antimicrobials [BR:br08307(D08011)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D08011  Gatifloxacin (INN)",
C07662,"Sparfloxacin;|cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00590)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA09 Sparfloxacin|D00590  Sparfloxacin (JAN/USAN/INN)|Drug groups [BR:br08330(D00590)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|D00590  Sparfloxacin|Antimicrobials [BR:br08307(D00590)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00590  Sparfloxacin (JAN/USAN/INN)|Antimicrobials abbreviations [BR:br08327(D00590)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00590  Sparfloxacin (JAN/USAN/INN),
C07663,Moxifloxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08237)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA14 Moxifloxacin|D08237  Moxifloxacin (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE07 Moxifloxacin|D08237  Moxifloxacin (INN)|Drug groups [BR:br08330(D08237)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00626  Moxifloxacin|D08237  Moxifloxacin|Antimicrobials [BR:br08307(D08237)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D08237  Moxifloxacin (INN),
C07664,Trovafloxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08654)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA13 Trovafloxacin|D08654  Trovafloxacin (INN)|Drug groups [BR:br08330(D08654)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00625  Trovafloxacin|D08654  Trovafloxacin|Antimicrobials [BR:br08307(D08654)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D08654  Trovafloxacin (INN)|Prodrugs [br08324.html(D08654)]|D08654|Prodrugs [br08324.html]|C07664,
C07665,Ethionamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00591)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AD Thiocarbamide derivatives|J04AD03 Ethionamide|D00591  Ethionamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00591)]|Antimycobacterials|Antituberculars|Ethionamide|D00591  Ethionamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00591)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|622  Tuberculosis preparations|6224  Ethionamides|D00591  Ethionamide (JP18/USP/INN)|Drug groups [BR:br08330(D00591)]|Antibacterial|DG01966  Antitubercular|DG01788  Thiocarbamide derivative|D00591  Ethionamide|Antimicrobials [BR:br08307(D00591)]|Antibacterials|Other antibacterials|Mycolic acid biosynthesis inhibitor|D00591  Ethionamide (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00591)]|Antibacterials|Other antibacterials|Mycolic acid biosynthesis inhibitor|D00591  Ethionamide (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00591)]|Chemicals|D00591  Ethionamide,
C07666,"Dapsone;|4,4'-Sulfonylbisbenzenamine;|Diaphenylsulfone",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00592)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AX Other anti-acne preparations for topical use|D10AX05 Dapsone|D00592  Dapsone (USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04B DRUGS FOR TREATMENT OF LEPRA|J04BA Drugs for treatment of lepra|J04BA02 Dapsone|D00592  Dapsone (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00592)]|Antimycobacterials|Antimycobacterials, Other|Dapsone|D00592  Dapsone (USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Dapsone|D00592  Dapsone (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00592)]|2  Agents affecting individual organs|26  Epidermides|269  Miscellaneous|2699  Others|D00592  Dapsone (USP); Diaphenylsulfone (JAN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|623  Leprostatics|6231  Sulfones|D00592  Dapsone (USP); Diaphenylsulfone (JAN)|Drug groups [BR:br08330(D00592)]|Metabolizing enzyme substrate|DG02855  CYP2E1 substrate|D00592  Dapsone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00592  Dapsone|Antimicrobials [BR:br08307(D00592)]|Antibacterials|Folic acid biosynthesis inhibitor|Diaminodiphenyl sulfone|D00592  Dapsone (USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00592)]|Drug metabolizing enzymes|D00592|Pharmacogenomic biomarkers [br08341.html(D00592)]|Polymorphisms and mutations affecting drug response|D00592|Prodrugs [br08324.html(D00592)]|D00592|Prodrugs [br08324.html]|C07666",
C07667,Gossypol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C07667  Gossypol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C07667  Gossypol,
C07668,Apraclonidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07461)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EA Sympathomimetics in glaucoma therapy|S01EA03 Apraclonidine|D07461  Apraclonidine (INN)|Drug groups [BR:br08330(D07461)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG01130  Apraclonidine|D07461  Apraclonidine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01130  Apraclonidine|D07461  Apraclonidine|Target-based classification of drugs [BR:br08310(D07461)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D07461  Apraclonidine (INN),
C07669,Glimepiride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00593)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BB Sulfonylureas|A10BB12 Glimepiride|D00593  Glimepiride (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00593)]|Blood Glucose Regulators|Antidiabetic Agents|Sulfonylureas|Glimepiride|D00593  Glimepiride (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00593)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3961  Sulfonylureas|D00593  Glimepiride (JP18/USP/INN)|Drug groups [BR:br08330(D00593)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01734  Sulfonylurea|D00593  Glimepiride|DG02044  Hypoglycemic agent|DG01734  Sulfonylurea|D00593  Glimepiride|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00593  Glimepiride|Drug classes [BR:br08332(D00593)]|Antidiabetic agent|DG01734  Sulfonylurea|D00593  Glimepiride|DG02044  Hypoglycemic agent|D00593  Glimepiride|Target-based classification of drugs [BR:br08310(D00593)]|Transporters|ABC transporters|ABCC subfamily|ABCC8 (SUR1)|D00593  Glimepiride (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00593)]|Chemicals|D00593  Glimepiride|D00593  Glimepiride tablets|Drug metabolizing enzymes and transporters [br08309.html(D00593)]|Drug metabolizing enzymes|D00593|Pharmacogenomic biomarkers [br08341.html(D00593)]|Polymorphisms and mutations affecting drug response|D00593",
C07670,Repaglinide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00594)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BX Other blood glucose lowering drugs, excl. insulins|A10BX02 Repaglinide|D00594  Repaglinide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00594)]|Blood Glucose Regulators|Antidiabetic Agents|Glucose Control Agents, Other|Repaglinide|D00594  Repaglinide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00594)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3969  Others|D00594  Repaglinide (JAN/USP/INN)|Drug groups [BR:br08330(D00594)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01735  Glinide|D00594  Repaglinide|DG02044  Hypoglycemic agent|DG01735  Glinide|D00594  Repaglinide|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|D00594  Repaglinide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00594  Repaglinide|Drug classes [BR:br08332(D00594)]|Antidiabetic agent|DG01735  Glinide|D00594  Repaglinide|DG02044  Hypoglycemic agent|D00594  Repaglinide|Target-based classification of drugs [BR:br08310(D00594)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D00594  Repaglinide (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00594)]|European public assessment reports (EPAR) authorised medicine|D00594|New drug approvals in Japan [br08318.html(D00594)]|Drugs with new active ingredients|D00594|New drug approvals in the USA, Europe and Japan [br08328.html(D00594)]|Approval dates by FDA, EMA and PMDA|D00594|Drug metabolizing enzymes and transporters [br08309.html(D00594)]|Drug metabolizing enzymes|D00594",
C07671,Histrelin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02369)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AE Gonadotropin releasing hormone analogues|L02AE05 Histrelin|D02369  Histrelin (USAN/INN)|Drug groups [BR:br08330(D02369)]|Hormonal agent|DG01494  Gonadotropin-releasing hormone receptor agonist|DG00733  Histrelin|D02369  Histrelin|Target-based classification of drugs [BR:br08310(D02369)]|G Protein-coupled receptors|Rhodopsin family|Gonadotropin-releasing hormone|GNRHR|D02369  Histrelin (USAN/INN),
C07672,Biguanide;|Guanylguanidine,,,,,
C07673,Phenformin;|DBI,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08351)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BA Biguanides|A10BA01 Phenformin|D08351  Phenformin (BAN)|Drug groups [BR:br08330(D08351)]|Antidiabetic agent|DG01685  Insulin sensitizer|DG01684  Biguanide antidiabetic|DG00112  Phenformin|D08351  Phenformin|DG02044  Hypoglycemic agent|DG01684  Biguanide antidiabetic|DG00112  Phenformin|D08351  Phenformin|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00112  Phenformin|D08351  Phenformin|Target-based classification of drugs [BR:br08310(D08351)]|Protein kinases|Serine/threonine kinases|CAMK group|AMPK (PRKAA)|D08351  Phenformin (BAN)|Drug metabolizing enzymes and transporters [br08309.html(D08351)]|Drug metabolizing enzymes|D08351",
C07674,Buformin;|1-Butylbiguanide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00595)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BA Biguanides|A10BA03 Buformin|D00595  Buformin (USAN/INN)|Drug groups [BR:br08330(D00595)]|Antidiabetic agent|DG01685  Insulin sensitizer|DG01684  Biguanide antidiabetic|DG00114  Buformin|D00595  Buformin|DG02044  Hypoglycemic agent|DG01684  Biguanide antidiabetic|DG00114  Buformin|D00595  Buformin|Target-based classification of drugs [BR:br08310(D00595)]|Protein kinases|Serine/threonine kinases|CAMK group|AMPK (PRKAA)|D00595  Buformin (USAN/INN)",
C07675,Pioglitazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08378)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BG Thiazolidinediones|A10BG03 Pioglitazone|D08378  Pioglitazone (INN)|Drug groups [BR:br08330(D08378)]|Antidiabetic agent|DG01685  Insulin sensitizer|DG01795  PPAR gamma agonist|DG01683  Thiazolidinedione|DG00117  Pioglitazone|D08378  Pioglitazone|DG02044  Hypoglycemic agent|DG01683  Thiazolidinedione|DG00117  Pioglitazone|D08378  Pioglitazone|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00117  Pioglitazone|D08378  Pioglitazone|Target-based classification of drugs [BR:br08310(D08378)]|Nuclear receptors|Thyroid hormone like receptors|Peroxisome proliferator-activated receptor (PPAR)|NR1C3 (PPARG)|D08378  Pioglitazone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08378)]|Drug metabolizing enzymes|D08378",
C07677,Acebutolol hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00597)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB04 Acebutolol|D00597  Acebutolol hydrochloride (JP18/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00597)]|Cardiovascular Agents|Antiarrhythmics|Vaughn Williams-Class II|Acebutolol|D00597  Acebutolol hydrochloride (JP18/USP)|Beta-adrenergic Blocking Agents|Beta-adrenergic Blocking Agents, Other|Acebutolol|D00597  Acebutolol hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00597)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|DG00314  Acebutolol|D00597  Acebutolol hydrochloride|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|DG00314  Acebutolol|D00597  Acebutolol hydrochloride|Drug classes [BR:br08332(D00597)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00597  Acebutolol hydrochloride|Target-based classification of drugs [BR:br08310(D00597)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D00597  Acebutolol hydrochloride (JP18/USP) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00597)]|Chemicals|D00597  Acebutolol hydrochloride",
C07693,Fenoldopam,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07946)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA19 Fenoldopam|D07946  Fenoldopam (INN)|Drug groups [BR:br08330(D07946)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01467  Dopamine D1-receptor agonist|DG00226  Fenoldopam|D07946  Fenoldopam|Target-based classification of drugs [BR:br08310(D07946)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD1|D07946  Fenoldopam (INN),
C07695,Sodium nitroprusside dihydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00614)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|C02DD Nitroferricyanide derivatives|C02DD01 Nitroprusside|D00614  Sodium nitroprusside (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00614)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00614  Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN)|Drug groups [BR:br08330(D00614)]|Cardiovascular agent|DG03231  Antihypertensive|DG00263  Nitroprusside|D00614  Sodium nitroprusside|Drug classes [BR:br08332(D00614)]|Cardiovascular agent|DG03231  Antihypertensive|D00614  Sodium nitroprusside",
C07699,Nisoldipine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00618)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA07 Nisoldipine|D00618  Nisoldipine (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00618)]|Cardiovascular Agents|Calcium Channel Blocking Agents, Dihydropyridines|Nisoldipine|D00618  Nisoldipine (JAN/USAN/INN)|Drug groups [BR:br08330(D00618)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|D00618  Nisoldipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|D00618  Nisoldipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00618  Nisoldipine|Drug classes [BR:br08332(D00618)]|Cardiovascular agent|DG01928  Dihydropyridine calcium channel blocker|D00618  Nisoldipine|DG03231  Antihypertensive|D00618  Nisoldipine|Target-based classification of drugs [BR:br08310(D00618)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D00618  Nisoldipine (JAN/USAN/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00618)]|Drug metabolizing enzymes|D00618",
C07701,Benazepril hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00620)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA07 Benazepril|D00620  Benazepril hydrochloride (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00620)]|Cardiovascular Agents|Angiotensin-converting Enzyme (ACE) Inhibitors|Benazepril|D00620  Benazepril hydrochloride (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00620)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2144  Angiotensin converting enzyme inhibitors|D00620  Benazepril hydrochloride (JAN/USP)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|921  Cardiotonics|9219  Other cardiotonics|C07701  Benazepril hydrochloride|Drug groups [BR:br08330(D00620)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00339  Benazepril|D00620  Benazepril hydrochloride|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00339  Benazepril|D00620  Benazepril hydrochloride|Metabolizing enzyme substrate|DG02924  UGT substrate|DG00339  Benazepril|D00620  Benazepril hydrochloride|Drug classes [BR:br08332(D00620)]|Cardiovascular agent|DG01501  Angiotensin-converting enzyme inhibitor|D00620  Benazepril hydrochloride|DG03231  Antihypertensive|D00620  Benazepril hydrochloride|Target-based classification of drugs [BR:br08310(D00620)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D00620  Benazepril hydrochloride (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00620)]|Drug metabolizing enzymes|D00620",
C07704,Moexipril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08225)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA13 Moexipril|D08225  Moexipril (INN)|Drug groups [BR:br08330(D08225)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00344  Moexipril|D08225  Moexipril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00344  Moexipril|D08225  Moexipril|Target-based classification of drugs [BR:br08310(D08225)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D08225  Moexipril (INN)",
C07706,Perindopril,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03753)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA04 Perindopril|D03753  Perindopril (USAN/INN)|Drug groups [BR:br08330(D03753)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00337  Perindopril|D03753  Perindopril|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00337  Perindopril|D03753  Perindopril|Target-based classification of drugs [BR:br08310(D03753)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D03753  Perindopril (USAN/INN)",
C07707,Perindopril erbumine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00624)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09A ACE INHIBITORS, PLAIN|C09AA ACE inhibitors, plain|C09AA04 Perindopril|D00624  Perindopril erbumine (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00624)]|Cardiovascular Agents|Angiotensin-converting Enzyme (ACE) Inhibitors|Perindopril|D00624  Perindopril erbumine (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00624)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2144  Angiotensin converting enzyme inhibitors|D00624  Perindopril erbumine (JAN/USP)|Drug groups [BR:br08330(D00624)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|DG00337  Perindopril|D00624  Perindopril erbumine|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|DG00337  Perindopril|D00624  Perindopril erbumine|Drug classes [BR:br08332(D00624)]|Cardiovascular agent|DG01501  Angiotensin-converting enzyme inhibitor|D00624  Perindopril erbumine|DG03231  Antihypertensive|D00624  Perindopril erbumine|Target-based classification of drugs [BR:br08310(D00624)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D00624  Perindopril erbumine (JAN/USP) &lt;JP/US&gt;|Prodrugs [br08324.html(D00624)]|D00624|Prodrugs [br08324.html]|C07707",
C07708,Miglitol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00625)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BF Alpha glucosidase inhibitors|A10BF02 Miglitol|D00625  Miglitol (JP18/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00625)]|Blood Glucose Regulators|Antidiabetic Agents|Glucose Control Agents, Other|Miglitol|D00625  Miglitol (JP18/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00625)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3969  Others|D00625  Miglitol (JP18/USAN/INN)|Drug groups [BR:br08330(D00625)]|Antidiabetic agent|DG02044  Hypoglycemic agent|DG01663  alpha-Glucosidase inhibitor|D00625  Miglitol|Drug classes [BR:br08332(D00625)]|Antidiabetic agent|DG01663  alpha-Glucosidase inhibitor|D00625  Miglitol|DG02044  Hypoglycemic agent|D00625  Miglitol|Target-based classification of drugs [BR:br08310(D00625)]|Enzymes|Hydrolases (EC3)|Glycosidases|GAA|D00625  Miglitol (JP18/USAN/INN) &lt;JP/US&gt;|GANC|D00625  Miglitol (JP18/USAN/INN) &lt;JP/US&gt;|MGAM|D00625  Miglitol (JP18/USAN/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00625)]|Chemicals|D00625  Miglitol|D00625  Miglitol tablets|New drug approvals in Japan [br08318.html(D00625)]|Drugs with new active ingredients|D00625",
C07709,Candesartan cilexetil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00626)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA06 Candesartan|D00626  Candesartan cilexetil (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00626)]|Cardiovascular Agents|Angiotensin II Receptor Antagonists|Candesartan|D00626  Candesartan cilexetil (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00626)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00626  Candesartan cilexetil (JP18/USP)|217  Vasodilators|2179  Others|D00626  Candesartan cilexetil (JP18/USP)|Drug groups [BR:br08330(D00626)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|DG00350  Candesartan|D00626  Candesartan cilexetil|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|DG00350  Candesartan|D00626  Candesartan cilexetil|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00350  Candesartan|D00626  Candesartan cilexetil|DG02970  CES substrate|D00626  Candesartan cilexetil|Drug classes [BR:br08332(D00626)]|Cardiovascular agent|DG01495  Angiotensin II receptor antagonist|D00626  Candesartan cilexetil|DG03231  Antihypertensive|D00626  Candesartan cilexetil|Target-based classification of drugs [BR:br08310(D00626)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D00626  Candesartan cilexetil (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00626)]|Chemicals|D00626  Candesartan cilexetil|D00626  Candesartan cilexetil tablets|Drug metabolizing enzymes and transporters [br08309.html(D00626)]|Drug metabolizing enzymes|D00626|Prodrugs [br08324.html(D00626)]|D00626|Prodrugs [br08324.html]|C07709",
C07710,Telmisartan,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00627)]|C CARDIOVASCULAR SYSTEM|C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM|C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN|C09CA Angiotensin II receptor blockers (ARBs), plain|C09CA07 Telmisartan|D00627  Telmisartan (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00627)]|Cardiovascular Agents|Angiotensin II Receptor Antagonists|Telmisartan|D00627  Telmisartan (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00627)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D00627  Telmisartan (JP18/USP/INN)|Drug groups [BR:br08330(D00627)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|D00627  Telmisartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|D00627  Telmisartan|Metabolizing enzyme substrate|DG02924  UGT substrate|D00627  Telmisartan|Drug classes [BR:br08332(D00627)]|Cardiovascular agent|DG01495  Angiotensin II receptor antagonist|D00627  Telmisartan|DG03231  Antihypertensive|D00627  Telmisartan|Target-based classification of drugs [BR:br08310(D00627)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D00627  Telmisartan (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00627)]|Chemicals|D00627  Telmisartan|D00627  Telmisartan tablets|New drug approvals in Europe [br08329.html(D00627)]|European public assessment reports (EPAR) authorised medicine|D00627|New drug approvals in Japan [br08318.html(D00627)]|Drugs with new active ingredients|D00627|Drug metabolizing enzymes and transporters [br08309.html(D00627)]|Drug metabolizing enzymes|D00627",
C07711,Previtamin D(3);|Previtamin D3,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C07711  Previtamin D3,
C07712,"Secalciferol;|24(R),25-Dihydroxyvitamin D3;|(24R),25-Dihydroxyvitamin D3;|(3S,5Z,7E,24R)-9,10-Secocholesta-5,7,10-triene-3,24,25-triol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C07712  Secalciferol|Drug groups [BR:br08330(D00628)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D00628  Secalciferol|Target-based classification of drugs [BR:br08310(D00628)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00628  Secalciferol (JAN/USAN/INN),
C07713,Nitrendipine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00629)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS|C08CA Dihydropyridine derivatives|C08CA08 Nitrendipine|D00629  Nitrendipine (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00629)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2171  Coronary dilators|D00629  Nitrendipine (JP18/USAN/INN)|Drug groups [BR:br08330(D00629)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|D00629  Nitrendipine|DG03231  Antihypertensive|DG01928  Dihydropyridine calcium channel blocker|D00629  Nitrendipine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00629  Nitrendipine|Drug classes [BR:br08332(D00629)]|Cardiovascular agent|DG01928  Dihydropyridine calcium channel blocker|D00629  Nitrendipine|DG03231  Antihypertensive|D00629  Nitrendipine|Target-based classification of drugs [BR:br08310(D00629)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D00629  Nitrendipine (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00629)]|Chemicals|D00629  Nitrendipine|D00629  Nitrendipine tablets|Drug metabolizing enzymes and transporters [br08309.html(D00629)]|Drug metabolizing enzymes|D00629,
C07714,Isosorbide mononitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00630)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DA Organic nitrates|C01DA14 Isosorbide mononitrate|D00630  Isosorbide mononitrate (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00630)]|Cardiovascular Agents|Vasodilators|Vasodilators, Direct-acting Arterial/Venous|Isosorbide Mononitrate|D00630  Isosorbide mononitrate (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00630)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2171  Coronary dilators|D00630  Isosorbide mononitrate (JP18/USP/INN)|Drug groups [BR:br08330(D00630)]|Cardiovascular agent|DG01657  Nitrovasodilator|DG01270  Isosorbide nitrate|D00630  Isosorbide mononitrate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00630)]|Chemicals|D00630  Isosorbide mononitrate tablets|Pharmacogenomic biomarkers [br08341.html(D00630)]|Polymorphisms and mutations affecting drug response|D00630",
C07715,"Fluorene;|Diphenylenemethane;|2,2'-Methylenebiphenyl",,,,,
C07717,"3,4-Dihydroxyfluorene",,,,,
C07718,"2-Hydroxy-4-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)-but-2-enoic acid",,,,,
C07719,2-Formyl-1-indanone,,,,,
C07720,3-Hydroxy-1-indanone,,,,,
C07721,"(+)-(3S,4R)-cis-3,4-Dihydroxy-3,4-dihydrofluorene",,,,,
C07722,"3,4-Dihydroxy-3,4-dihydro-9-fluorenone",,,,,
C07723,4-Hydroxy-9-fluorenone,,,,,
C07724,"1,2-Dihydroxyfluorene",,,,,
C07725,"2-Hydroxy-4-(2-oxo-1,3-dihydro-2H-inden-1-ylidene)but-2-enoic acid",,,,,
C07726,1-Formyl-2-indanone,,,,,
C07727,"2-Indanone;|2H-Inden-2-one, 1,3-dihydro-",,,,,
C07728,"3-Isochromanone;|1,4-Dihydro-3H-2-benzopyran-3-one",,,,,
C07729,Dibenzofuran;|Diphenylene oxide,,,,,
C07731,"2-Hydroxy-6-oxo-6-(2-hydroxyphenyl)-hexa-2,4-dienoate",,,,,
C07732,Dibenzo-p-dioxin,,,,,
C07733,"2,2',3-Trihydroxydiphenylether",,,,,
C07734,"2-Hydroxy-6-oxo-6-(2-hydroxyphenoxy)-hexa-2,4-dienoate",,,,,
C07736,"Etidronic acid;|1-Hydroxyethylidene-1,1-diphosphonic acid;|Ethane-1-hydroxy-1,1-bisphosphonate",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02373)]|M MUSCULO-SKELETAL SYSTEM|M05 DRUGS FOR TREATMENT OF BONE DISEASES|M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION|M05BA Bisphosphonates|M05BA01 Etidronic acid|D02373  Etidronic acid (USAN/INN)|Drug groups [BR:br08330(D02373)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG01600  Bisphosphonate|DG00780  Etidronic acid|D02373  Etidronic acid,
C07740,Disopyramide phosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00637)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA03 Disopyramide|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00637)]|Cardiovascular Agents|Antiarrhythmics|Vaughn Williams-Class I|Disopyramide|D00637  Disopyramide phosphate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00637)]|2  Agents affecting individual organs|21  Cardiovascular agents|212  Antiarrhythmic agents|2129  Others|D00637  Disopyramide phosphate (JAN/USP)|Drug groups [BR:br08330(D00637)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG00194  Disopyramide|D00637  Disopyramide phosphate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00194  Disopyramide|D00637  Disopyramide phosphate|Drug classes [BR:br08332(D00637)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00637  Disopyramide phosphate|Target-based classification of drugs [BR:br08310(D00637)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN2A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN3A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN4A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN5A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN8A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN9A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN10A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|SCN11A|D00637  Disopyramide phosphate (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00637)]|Drug metabolizing enzymes|D00637",
C07743,Moricizine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05077)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BG Other antiarrhythmics, class I and III|C01BG01 Moracizine|D05077  Moricizine (USAN)|Drug groups [BR:br08330(D05077)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG00208  Moracizine|D05077  Moricizine|Metabolizing enzyme inducer|DG01637  CYP1A2 inducer|DG00208  Moracizine|D05077  Moricizine|Target-based classification of drugs [BR:br08310(D05077)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN5A|D05077  Moricizine (USAN)|Drug metabolizing enzymes and transporters [br08309.html(D05077)]|Drug metabolizing enzymes|D05077",
C07750,Tolterodine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00646)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BD Drugs for urinary frequency and incontinence|G04BD07 Tolterodine|D00646  Tolterodine (USAN/INN)|Drug groups [BR:br08330(D00646)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00480  Tolterodine|D00646  Tolterodine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00480  Tolterodine|D00646  Tolterodine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00480  Tolterodine|D00646  Tolterodine|Target-based classification of drugs [BR:br08310(D00646)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM3|D00646  Tolterodine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00646)]|Drug metabolizing enzymes|D00646,
C07751,Dofetilide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00647)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BD Antiarrhythmics, class III|C01BD04 Dofetilide|D00647  Dofetilide (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00647)]|Cardiovascular Agents|Antiarrhythmics|Vaughn Williams-Class III|Dofetilide|D00647  Dofetilide (JAN/USP/INN)|Drug groups [BR:br08330(D00647)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01648  Class III antiarrhythmic agent|D00647  Dofetilide|Drug classes [BR:br08332(D00647)]|Cardiovascular agent|DG01653  Antiarrhythmics|D00647  Dofetilide|Target-based classification of drugs [BR:br08310(D00647)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCNH2|D00647  Dofetilide (JAN/USP/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00647)]|New molecular entities and new therapeutic biological products|D00647|New drug approvals in the USA, Europe and Japan [br08328.html(D00647)]|Approval dates by FDA, EMA and PMDA|D00647",
C07752,Alendronic acid;|Alendronate;|(4-Amino-1-hydroxybutylidene)bisphosphonic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07119)]|M MUSCULO-SKELETAL SYSTEM|M05 DRUGS FOR TREATMENT OF BONE DISEASES|M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION|M05BA Bisphosphonates|M05BA04 Alendronic acid|D07119  Alendronic acid (INN)|Drug groups [BR:br08330(D07119)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG01600  Bisphosphonate|DG00783  Alendronic acid|D07119  Alendronic acid|Target-based classification of drugs [BR:br08310(D07119)]|Enzymes|Transferases (EC2)|Alkyl/Aryl transferases|FDPS|D07119  Alendronic acid (INN),
C07753,Ibutilide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08060)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BD Antiarrhythmics, class III|C01BD05 Ibutilide|D08060  Ibutilide (INN)|Drug groups [BR:br08330(D08060)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01648  Class III antiarrhythmic agent|DG00205  Ibutilide|D08060  Ibutilide|Target-based classification of drugs [BR:br08310(D08060)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCNH2|D08060  Ibutilide (INN)",
C07755,Magnesium chloride;|Magnesium chloride anhydrous,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CC Magnesium|A12CC01 Magnesium chloride|C07755  Magnesium chloride|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA11 Magnesium chloride|C07755  Magnesium chloride|Drug groups [BR:br08330]|Gastrointestinal agent|DG01979  Magnesium containing preparation|DG00139  Magnesium chloride|C07755  Magnesium chloride,G00139
C07756,7-Aminocephalosporanic acid;|7-Aminocephalosporinic acid;|7-ACA;|(7R)-7-Aminocephalosporanate,,,,,
C07758,Bendroflumethiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00650)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA01 Bendroflumethiazide|D00650  Bendroflumethiazide (JAN/USP/INN)|Drug groups [BR:br08330(D00650)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00650  Bendroflumethiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00650  Bendroflumethiazide|Target-based classification of drugs [BR:br08310(D00650)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D00650  Bendroflumethiazide (JAN/USP/INN)",
C07759,Benzthiazide,,,,Drug groups [BR:br08330(D00651)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00651  Benzthiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00651  Benzthiazide|Target-based classification of drugs [BR:br08310(D00651)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D00651  Benzthiazide (JAN/INN),
C07760,Brinzolamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00652)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EC Carbonic anhydrase inhibitors|S01EC04 Brinzolamide|D00652  Brinzolamide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00652)]|Ophthalmic Agents|Intraocular Pressure Lowering Agents|Carbonic Anhydrase Inhibitors, Ophthalmic|Brinzolamide|D00652  Brinzolamide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00652)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00652  Brinzolamide (JAN/USP/INN)|Drug groups [BR:br08330(D00652)]|Cardiovascular agent|DG01534  Carbonic anhydrase inhibitor|D00652  Brinzolamide|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00652  Brinzolamide|Drug classes [BR:br08332(D00652)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00652  Brinzolamide|Target-based classification of drugs [BR:br08310(D00652)]|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA2|D00652  Brinzolamide (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00652)]|European public assessment reports (EPAR) authorised medicine|D00652|New drug approvals in Japan [br08318.html(D00652)]|Drugs with new active ingredients|D00652",
C07761,Cephalothin;|Cefalotin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07635)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB03 Cefalotin|D07635  Cefalotin (BAN)|Drug groups [BR:br08330(D07635)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00549  Cefalotin|D07635  Cefalotin|DG01774  First-generation cephalosporin|DG00549  Cefalotin|D07635  Cefalotin|Antimicrobials [BR:br08307(D07635)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D07635  Cefalotin (BAN)",
C07763,Hydroflumethiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00654)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA02 Hydroflumethiazide|D00654  Hydroflumethiazide (JAN/USP/INN)|Drug groups [BR:br08330(D00654)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00654  Hydroflumethiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00654  Hydroflumethiazide|Target-based classification of drugs [BR:br08310(D00654)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D00654  Hydroflumethiazide (JAN/USP/INN)|SLC12A3 (TSC)|D00654  Hydroflumethiazide (JAN/USP/INN)",
C07764,Methazolamide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00655)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EC Carbonic anhydrase inhibitors|S01EC05 Methazolamide|D00655  Methazolamide (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00655)]|Ophthalmic Agents|Intraocular Pressure Lowering Agents|Carbonic Anhydrase Inhibitors, Ophthalmic|Methazolamide|D00655  Methazolamide (JAN/USP/INN)|Drug groups [BR:br08330(D00655)]|Cardiovascular agent|DG01534  Carbonic anhydrase inhibitor|D00655  Methazolamide|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00655  Methazolamide|Drug classes [BR:br08332(D00655)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00655  Methazolamide|Target-based classification of drugs [BR:br08310(D00655)]|Enzymes|Lyases (EC4)|Aldehyde-lyases|CA|D00655  Methazolamide (JAN/USP/INN) &lt;US&gt;",
C07765,Methyclothiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00656)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA08 Methyclothiazide|D00656  Methyclothiazide (JAN/USP/INN)|Drug groups [BR:br08330(D00656)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00656  Methyclothiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00656  Methyclothiazide|Target-based classification of drugs [BR:br08310(D00656)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D00656  Methyclothiazide (JAN/USP/INN)|SLC12A3 (TSC)|D00656  Methyclothiazide (JAN/USP/INN)",
C07766,Polythiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00657)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA05 Polythiazide|D00657  Polythiazide (JAN/USAN/INN)|Drug groups [BR:br08330(D00657)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00657  Polythiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00657  Polythiazide|Target-based classification of drugs [BR:br08310(D00657)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D00657  Polythiazide (JAN/USAN/INN)",
C07767,Trichlormethiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00658)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA06 Trichlormethiazide|D00658  Trichlormethiazide (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00658)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2132  Thiazides|D00658  Trichlormethiazide (JP18/USP/INN)|Drug groups [BR:br08330(D00658)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D00658  Trichlormethiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D00658  Trichlormethiazide|Drug classes [BR:br08332(D00658)]|Cardiovascular agent|DG03231  Antihypertensive|D00658  Trichlormethiazide|Target-based classification of drugs [BR:br08310(D00658)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D00658  Trichlormethiazide (JP18/USP/INN) &lt;JP&gt;|SLC12A3 (TSC)|D00658  Trichlormethiazide (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00658)]|Chemicals|D00658  Trichlormethiazide|D00658  Trichlormethiazide tablets",
C07768,Azelastine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07483)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AC Antiallergic agents, excl. corticosteroids|R01AC03 Azelastine|D07483  Azelastine (INN)|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX19 Azelastine|D07483  Azelastine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX07 Azelastine|D07483  Azelastine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07483)]|Second-class OTC drugs|Inorganic and organic chemicals|Azelastine|D07483  Azelastine (INN)|Drug groups [BR:br08330(D07483)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01036  Azelastine|D07483  Azelastine|Target-based classification of drugs [BR:br08310(D07483)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07483  Azelastine (INN)",
C07770,Sulbactam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08533)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CG Beta-lactamase inhibitors|J01CG01 Sulbactam|D08533  Sulbactam (INN)|Drug groups [BR:br08330(D08533)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00545  Sulbactam|D08533  Sulbactam|DG01479  beta-Lactamase inhibitor|DG00545  Sulbactam|D08533  Sulbactam|Antimicrobials [BR:br08307(D08533)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Beta-lactamase inhibitor|D08533  Sulbactam (INN)",
C07771,Tazobactam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00660)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CG Beta-lactamase inhibitors|J01CG02 Tazobactam|D00660  Tazobactam (JP18/USP/INN)|Drug groups [BR:br08330(D00660)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00546  Tazobactam|D00660  Tazobactam|DG01479  beta-Lactamase inhibitor|DG00546  Tazobactam|D00660  Tazobactam|Antimicrobials [BR:br08307(D00660)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Beta-lactamase inhibitor|D00660  Tazobactam (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00660)]|Chemicals|D00660  Tazobactam",
C07773,Ambenonium,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA30 Ambenonium|C07773  Ambenonium|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00990  Ambenonium|C07773  Ambenonium|DG01719  Parasympathomimetic agent|DG00990  Ambenonium|C07773  Ambenonium,G00990
C07774,Azatadine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07482)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX09 Azatadine|D07482  Azatadine (INN)|Drug groups [BR:br08330(D07482)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01112  Azatadine|D07482  Azatadine|Target-based classification of drugs [BR:br08310(D07482)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07482  Azatadine (INN),
C07777,Buclizine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07547)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AE Piperazine derivatives|R06AE01 Buclizine|D07547  Buclizine (INN)|Drug groups [BR:br08330(D07547)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01104  Buclizine|D07547  Buclizine|Target-based classification of drugs [BR:br08310(D07547)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07547  Buclizine (INN),
C07778,Cetirizine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07662)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AE Piperazine derivatives|R06AE07 Cetirizine|D07662  Cetirizine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX12 Cetirizine|D07662  Cetirizine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07662)]|Second-class OTC drugs|Inorganic and organic chemicals|Cetirizine|D07662  Cetirizine (INN)|Drug groups [BR:br08330(D07662)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01107  Cetirizine|D07662  Cetirizine|Transporter substrate|DG01665  ABCB1 substrate|DG01107  Cetirizine|D07662  Cetirizine|DG02854  SLC22A2 substrate|DG01107  Cetirizine|D07662  Cetirizine|Transporter inhibitor|DG02863  SLC22A2 inhibitor|DG01107  Cetirizine|D07662  Cetirizine|Target-based classification of drugs [BR:br08310(D07662)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07662  Cetirizine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07662)]|Drug transporters|D07662,
C07780,Chlorpheniramine maleate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00665)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB04 Chlorphenamine|D00665  Chlorpheniramine maleate (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00665)]|4  Agents affecting cellular function|44  Allergic agents|441  Antihistamines|4419  Others|D00665  Chlorpheniramine maleate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00665)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00665  Chlorpheniramine maleate (JP18/USP)|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D00665  Chlorpheniramine maleate (JP18/USP)|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00665  Chlorpheniramine maleate (JP18/USP)|Allergic agents|52 Antihistamine based drugs|D00665  Chlorpheniramine maleate (JP18/USP)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00665  Chlorpheniramine maleate (JP18/USP)|Agents for ophthalmologic use|64 Allergy eye drops|D00665  Chlorpheniramine maleate (JP18/USP)|67 Eyewash|D00665  Chlorpheniramine maleate (JP18/USP)|Agents for otolaryngologic use|69 Oral medicine for nasal inflammation|D00665  Chlorpheniramine maleate (JP18/USP)|70 Nasal sprays for inflammation|D00665  Chlorpheniramine maleate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00665)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D00665  Chlorpheniramine maleate (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D00665  Chlorpheniramine maleate (JP18/USP)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|923  Antitussives and expectorante|9239  Other antitussives and expectorante|C07780  Chlorpheniramine maleate|96  Agents affecting metabolism|968  Antiallergic agents (including nonspecific antigen preparations)|9682  Chlorpheniramine, derivatives and preparations|C07780  Chlorpheniramine maleate|Drug groups [BR:br08330(D00665)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01099  Chlorphenamine|D00665  Chlorpheniramine maleate|Drug classes [BR:br08332(D00665)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00665  Chlorpheniramine maleate|Target-based classification of drugs [BR:br08310(D00665)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00665  Chlorpheniramine maleate (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00665)]|Chemicals|D00665  Chlorpheniramine maleate|D00665  Chlorpheniramine maleate tablets|D00665  Chlorpheniramine maleate powder|D00665  Chlorpheniramine maleate injection|Rx-to-OTC switch list in the USA [br08315.html(D00665)]|D00665",
C07783,Dexchlorpheniramine maleate;|d-Chlorpheniramine maleate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00668)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB02 Dexchlorpheniramine|D00668  Dexchlorpheniramine maleate (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00668)]|4  Agents affecting cellular function|44  Allergic agents|441  Antihistamines|4419  Others|D00668  Dexchlorpheniramine maleate (USP); d-Chlorpheniramine maleate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00668)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00668  Dexchlorpheniramine maleate (USP)|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D00668  Dexchlorpheniramine maleate (USP)|Allergic agents|52 Antihistamine based drugs|D00668  Dexchlorpheniramine maleate (USP)|Agents for otolaryngologic use|69 Oral medicine for nasal inflammation|D00668  Dexchlorpheniramine maleate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00668)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D00668  Dexchlorpheniramine maleate (USP)|Third-class OTC drugs|Inorganic and organic chemicals|Chlorphenamine|D00668  Dexchlorpheniramine maleate (USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|968  Antiallergic agents (including nonspecific antigen preparations)|9682  Chlorpheniramine, derivatives and preparations|C07783  Dexchlorpheniramine maleate|Drug groups [BR:br08330(D00668)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01098  Dexchlorpheniramine|D00668  Dexchlorpheniramine maleate|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG01098  Dexchlorpheniramine|D00668  Dexchlorpheniramine maleate|DG01633  CYP3A/CYP3A4 substrate|DG01098  Dexchlorpheniramine|D00668  Dexchlorpheniramine maleate|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG01098  Dexchlorpheniramine|D00668  Dexchlorpheniramine maleate|Drug classes [BR:br08332(D00668)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00668  Dexchlorpheniramine maleate|Target-based classification of drugs [BR:br08310(D00668)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00668  Dexchlorpheniramine maleate (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00668)]|Chemicals|D00668  d-Chlorpheniramine maleate|Drug metabolizing enzymes and transporters [br08309.html(D00668)]|Drug metabolizing enzymes|D00668|Rx-to-OTC switch list in the USA [br08315.html(D00668)]|D00668",
C07784,Diphenhydramine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00669)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA32 Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA02 Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00669)]|Antiemetics|Antiemetics, Other|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Antiparkinson Agents|Anticholinergics|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Respiratory Tract/Pulmonary Agents|Antihistamines|Histamine (H1) Receptor Antagonists, Sedating|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00669)]|4  Agents affecting cellular function|44  Allergic agents|441  Antihistamines|4411  Diphenhydramines|D00669  Diphenhydramine hydrochloride (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00669)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D00669  Diphenhydramine hydrochloride (JP18/USP)|04 Sedative hypnotic agents|D00669  Diphenhydramine hydrochloride (JP18/USP)|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D00669  Diphenhydramine hydrochloride (JP18/USP)|Allergic agents|52 Antihistamine based drugs|D00669  Diphenhydramine hydrochloride (JP18/USP)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00669  Diphenhydramine hydrochloride (JP18/USP)|Agents for ophthalmologic use|64 Allergy eye drops|D00669  Diphenhydramine hydrochloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00669)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D00669  Diphenhydramine hydrochloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9532  Anti-histaminic and preparations|C07784  Diphenhydramine hydrochloride|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C07784  Diphenhydramine hydrochloride|96  Agents affecting metabolism|968  Antiallergic agents (including nonspecific antigen preparations)|9681  Diphenhydramine, derivatives and preparations|C07784  Diphenhydramine hydrochloride|Drug groups [BR:br08330(D00669)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00390  Diphenhydramine|D00669  Diphenhydramine hydrochloride|Drug classes [BR:br08332(D00669)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00669  Diphenhydramine hydrochloride|Target-based classification of drugs [BR:br08310(D00669)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D00669  Diphenhydramine hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00669)]|Chemicals|D00669  Diphenhydramine hydrochloride|Rx-to-OTC switch list in the USA [br08315.html(D00669)]|D00669",
C07785,Emedastine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07890)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX06 Emedastine|D07890  Emedastine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07890)]|Second-class OTC drugs|Inorganic and organic chemicals|Emedastine|D07890  Emedastine (INN)|Drug groups [BR:br08330(D07890)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01144  Emedastine|D07890  Emedastine|Target-based classification of drugs [BR:br08310(D07890)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D07890  Emedastine (INN),
C07789,Olopatadine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08293)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AC Antiallergic agents, excl. corticosteroids|R01AC08 Olopatadine|D08293  Olopatadine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GX Other antiallergics|S01GX09 Olopatadine|D08293  Olopatadine (INN)|Drug groups [BR:br08330(D08293)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01039  Olopatadine|D08293  Olopatadine|Target-based classification of drugs [BR:br08310(D08293)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08293  Olopatadine (INN)",
C07790,Phenindamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08353)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX04 Phenindamine|D08353  Phenindamine (INN)|Drug groups [BR:br08330(D08353)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01110  Phenindamine|D08353  Phenindamine|Target-based classification of drugs [BR:br08310(D08353)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08353  Phenindamine (INN),
C07792,Naratriptan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08255)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CC Selective serotonin (5HT1) agonists|N02CC02 Naratriptan|D08255  Naratriptan (INN)|Drug groups [BR:br08330(D08255)]|Neuropsychiatric agent|DG01483  5-HT1A-receptor agonist|DG00837  Naratriptan|D08255  Naratriptan|Analgesic|DG01484  5-HT1B-receptor agonist|DG00837  Naratriptan|D08255  Naratriptan|DG01485  5-HT1D-receptor agonist|DG00837  Naratriptan|D08255  Naratriptan|DG01518  5-HT1B/1D-receptor agonist|DG00837  Naratriptan|D08255  Naratriptan|DG01943  Triptan|DG00837  Naratriptan|D08255  Naratriptan|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00837  Naratriptan|D08255  Naratriptan|DG01642  CYP2C9 substrate|DG00837  Naratriptan|D08255  Naratriptan|DG01644  CYP2D6 substrate|DG00837  Naratriptan|D08255  Naratriptan|DG02855  CYP2E1 substrate|DG00837  Naratriptan|D08255  Naratriptan|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00837  Naratriptan|D08255  Naratriptan|DG02925  CYP3A5 substrate|DG00837  Naratriptan|D08255  Naratriptan|Target-based classification of drugs [BR:br08310(D08255)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1B|D08255  Naratriptan (INN)|HTR1D|D08255  Naratriptan (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08255)]|Drug metabolizing enzymes|D08255,
C07798,Dihydroergotamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07837)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02C ANTIMIGRAINE PREPARATIONS|N02CA Ergot alkaloids|N02CA01 Dihydroergotamine|D07837  Dihydroergotamine (INN)|Drug groups [BR:br08330(D07837)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01468  Dopamine D2-receptor agonist|DG00833  Dihydroergotamine|D07837  Dihydroergotamine|DG01964  Ergot alkaloid|DG01982  Antimigraine, ergot alkaloid|DG00833  Dihydroergotamine|D07837  Dihydroergotamine|Analgesic|DG01518  5-HT1B/1D-receptor agonist|DG00833  Dihydroergotamine|D07837  Dihydroergotamine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00833  Dihydroergotamine|D07837  Dihydroergotamine|Target-based classification of drugs [BR:br08310(D07837)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR1B|D07837  Dihydroergotamine (INN)|HTR1D|D07837  Dihydroergotamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07837)]|Drug metabolizing enzymes|D07837",
C07805,Formoterol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07990)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC13 Formoterol|D07990  Formoterol (INN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC15 Formoterol|D07990  Formoterol (INN)|Drug groups [BR:br08330(D07990)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01052  Formoterol|D07990  Formoterol|Metabolizing enzyme substrate|DG02924  UGT substrate|DG01052  Formoterol|D07990  Formoterol|Target-based classification of drugs [BR:br08310(D07990)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D07990  Formoterol (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07990)]|Drug metabolizing enzymes|D07990",
C07807,Pirbuterol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08387)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC08 Pirbuterol|D08387  Pirbuterol (INN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC07 Pirbuterol|D08387  Pirbuterol (INN)|Drug groups [BR:br08330(D08387)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01048  Pirbuterol|D08387  Pirbuterol|Target-based classification of drugs [BR:br08310(D08387)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D08387  Pirbuterol (INN)",
C07809,Flavoxate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07961)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BD Drugs for urinary frequency and incontinence|G04BD02 Flavoxate|D07961  Flavoxate (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07961)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Flavoxate|D07961  Flavoxate (INN)|Second-class OTC drugs|Inorganic and organic chemicals|Flavoxate|D07961  Flavoxate (INN)|Target-based classification of drugs [BR:br08310(D07961)]|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE|D07961  Flavoxate (INN),
C07811,Hexocyclium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB10 Hexocyclium|C07811  Hexocyclium|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00039  Hexocyclium|C07811  Hexocyclium",G00039
C07813,Beclomethasone dipropionate;|Beclometasone dipropionate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00689)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA07 Beclometasone|D00689  Beclomethasone dipropionate (USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC15 Beclometasone|D00689  Beclomethasone dipropionate (USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD01 Beclometasone|D00689  Beclomethasone dipropionate (USP) &lt;JP/US&gt;|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA01 Beclometasone|D00689  Beclomethasone dipropionate (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00689)]|Respiratory Tract/Pulmonary Agents|Anti-inflammatories, Inhaled Corticosteroids|Beclomethasone|D00689  Beclomethasone dipropionate (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00689)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|132  Otic and nasal agents|1329  Others|D00689  Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18)|2  Agents affecting individual organs|22  Respiratory organ agents|229  Miscellaneous|2290  Miscellaneous|D00689  Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18)|24  Hormones|245  Adrenal hormone preparations|2459  Others|D00689  Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00689)]|Agents for otolaryngologic use|70 Nasal sprays for inflammation|D00689  Beclomethasone dipropionate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00689)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Beclometasone dipropionate|D00689  Beclomethasone dipropionate (USP)|Second-class OTC drugs|Inorganic and organic chemicals|Beclometasone dipropionate|D00689  Beclomethasone dipropionate (USP)|Drug groups [BR:br08330(D00689)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00097  Beclometasone|D00689  Beclomethasone dipropionate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00689  Beclomethasone dipropionate|Drug classes [BR:br08332(D00689)]|Anti-inflammatory|DG01955  Corticosteroid|D00689  Beclomethasone dipropionate|Target-based classification of drugs [BR:br08310(D00689)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00689  Beclomethasone dipropionate (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00689)]|Chemicals|D00689  Beclometasone dipropionate|Drug metabolizing enzymes and transporters [br08309.html(D00689)]|Drug metabolizing enzymes|D00689|Rx-to-OTC switch list in Japan [br08314.html(D00689)]|D00689",
C07814,Homatropine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01F MYDRIATICS AND CYCLOPLEGICS|S01FA Anticholinergics|S01FA05 Homatropine|C07814  Homatropine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01142  Homatropine|C07814  Homatropine,G01142
C07815,Fluticasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07981)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC17 Fluticasone|D07981  Fluticasone (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD08 Fluticasone|D07981  Fluticasone (INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA05 Fluticasone|D07981  Fluticasone (INN)|Drug groups [BR:br08330(D07981)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00420  Fluticasone|D07981  Fluticasone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00420  Fluticasone|D07981  Fluticasone|Target-based classification of drugs [BR:br08310(D07981)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07981  Fluticasone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07981)]|Drug metabolizing enzymes|D07981",
C07816,Mometasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08227)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC13 Mometasone|D08227  Mometasone (INN)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XC Corticosteroids, potent, other combinations|D07XC03 Mometasone|D08227  Mometasone (INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD09 Mometasone|D08227  Mometasone (INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA07 Mometasone|D08227  Mometasone (INN)|Drug groups [BR:br08330(D08227)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00419  Mometasone|D08227  Mometasone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00419  Mometasone|D08227  Mometasone|Target-based classification of drugs [BR:br08310(D08227)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D08227  Mometasone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08227)]|Drug metabolizing enzymes|D08227",
C07817,Mometasone furoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00690)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC13 Mometasone|D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XC Corticosteroids, potent, other combinations|D07XC03 Mometasone|D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD09 Mometasone|D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA07 Mometasone|D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00690)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, Medium Potency|Mometasone|D00690  Mometasone furoate (JAN/USP)|Respiratory Tract/Pulmonary Agents|Anti-inflammatories, Inhaled Corticosteroids|Mometasone|D00690  Mometasone furoate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00690)]|2  Agents affecting individual organs|22  Respiratory organ agents|229  Miscellaneous|2290  Miscellaneous|D00690  Mometasone furoate (JAN/USP)|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D00690  Mometasone furoate (JAN/USP)|Drug groups [BR:br08330(D00690)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00419  Mometasone|D00690  Mometasone furoate|Dermatological agent|DG03243  Atopic dermatitis agent|D00690  Mometasone furoate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00419  Mometasone|D00690  Mometasone furoate|Drug classes [BR:br08332(D00690)]|Anti-inflammatory|DG01955  Corticosteroid|D00690  Mometasone furoate|Dermatological agent|DG03243  Atopic dermatitis agent|D00690  Mometasone furoate|Target-based classification of drugs [BR:br08310(D00690)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00690  Mometasone furoate (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00690)]|Drug metabolizing enzymes|D00690|Topical steroids potency [br08317.html(D00690)]|Classification in the USA|D00690|Classification in Japan|D00690|Rx-to-OTC switch list in the USA [br08315.html(D00690)]|D00690",
C07818,Mepenzolate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB12 Mepenzolate|C07818  Mepenzolate|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00040  Mepenzolate|C07818  Mepenzolate",G00040
C07819,Dyphylline;|Diprophylline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00691)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03DA Xanthines|R03DA01 Diprophylline|D00691  Dyphylline (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00691)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2115  Caffeines|D00691  Dyphylline (USP); Diprophylline (JAN/INN)|Classification of Japanese OTC drugs [BR:br08313(D00691)]|Agents for respiratory organs|26 Antitussives and expectorants|D00691  Dyphylline (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00691)]|Second-class OTC drugs|Inorganic and organic chemicals|Diprophylline|D00691  Dyphylline (USP)|Drug groups [BR:br08330(D00691)]|Respiratory system agent|DG01616  Xanthine derivative|DG01609  Xanthine-type bronchodilator|D00691  Dyphylline|Target-based classification of drugs [BR:br08310(D00691)]|G Protein-coupled receptors|Rhodopsin family|Adenosine|ADORA1|D00691  Dyphylline (USP) &lt;JP&gt;|ADORA2B|D00691  Dyphylline (USP) &lt;JP&gt;|Enzymes|Hydrolases (EC3)|Phosphodiesterases|PDE|D00691  Dyphylline (USP) &lt;JP&gt;,
C07825,Flumazenil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00697)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB25 Flumazenil|D00697  Flumazenil (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00697)]|2  Agents affecting individual organs|22  Respiratory organ agents|221  Respiratory stimulants|2219  Others|D00697  Flumazenil (JAN/USP/INN)|Target-based classification of drugs [BR:br08310(D00697)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00697  Flumazenil (JAN/USP/INN) &lt;JP/US&gt;,
C07826,Aprobarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00698)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA05 Aprobarbital|D00698  Aprobarbital (INN)|Drug groups [BR:br08330(D00698)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|D00698  Aprobarbital|Target-based classification of drugs [BR:br08310(D00698)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00698  Aprobarbital (INN)",
C07827,Butabarbital,,,,Drug groups [BR:br08330(D03180)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG01308  Butabarbital|D03180  Butabarbital|Target-based classification of drugs [BR:br08310(D03180)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D03180  Butabarbital (USP)|Narcotics and psychotropics in Japan [br08308.html(D03180)]|Psychotropics by Cabinet order Article 3 (78 substances)|D03180,
C07829,Mephobarbital,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00700)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AA Barbiturates and derivatives|N03AA01 Methylphenobarbital|D00700  Mephobarbital (JAN/USP)|Drug groups [BR:br08330(D00700)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|D00700  Mephobarbital|DG01567  GABA-A receptor agonist|D00700  Mephobarbital|DG03199  Antiepileptic agent|DG01904  Barbiturate antiepileptic|D00700  Mephobarbital|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D00700  Mephobarbital|Target-based classification of drugs [BR:br08310(D00700)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D00700  Mephobarbital (JAN/USP)|Drug metabolizing enzymes and transporters [br08309.html(D00700)]|Drug metabolizing enzymes|D00700|Narcotics and psychotropics in Japan [br08308.html(D00700)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00700,
C07832,Ethinamate,,,,,
C07833,Ethchlorvynol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00704)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM08 Ethchlorvynol|D00704  Ethchlorvynol (JAN/USP/INN)|Narcotics and psychotropics in Japan [br08308.html(D00704)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00704,
C07834,Paraldehyde,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00705)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CC Aldehydes and derivatives|N05CC05 Paraldehyde|D00705  Paraldehyde (USP),
C07836,D-glycero-beta-D-manno-Heptose 7-phosphate,,,,,
C07837,Fomepizole;|4-Methylpyrazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00707)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB34 Fomepizole|D00707  Fomepizole (JAN/USAN/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00707)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|392  Antidotes|3929  Others|D00707  Fomepizole (JAN/USAN/INN)|Drug groups [BR:br08330(D00707)]|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|D00707  Fomepizole|DG01525  CYP2A6 inhibitor|D00707  Fomepizole|DG01643  CYP2C9 inhibitor|D00707  Fomepizole|DG01645  CYP2D6 inhibitor|D00707  Fomepizole|DG02884  CYP2E1 inhibitor|D00707  Fomepizole|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00707  Fomepizole|Target-based classification of drugs [BR:br08310(D00707)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|ADH|D00707  Fomepizole (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00707)]|Drugs with new active ingredients|D00707|Drug metabolizing enzymes and transporters [br08309.html(D00707)]|Drug metabolizing enzymes|D00707,
C07838,D-glycero-beta-D-manno-Heptose 1-phosphate,,,,,
C07839,Ethotoin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00708)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AB Hydantoin derivatives|N03AB01 Ethotoin|D00708  Ethotoin (JAN/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00708)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1132  Hydantoins|D00708  Ethotoin (JAN/USP/INN)|Drug groups [BR:br08330(D00708)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02031  Hydantoin antiepileptic|D00708  Ethotoin|Drug classes [BR:br08332(D00708)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00708  Ethotoin,
C07840,Fosphenytoin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07993)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AB Hydantoin derivatives|N03AB05 Fosphenytoin|D07993  Fosphenytoin (INN)|Drug groups [BR:br08330(D07993)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02031  Hydantoin antiepileptic|DG00847  Fosphenytoin|D07993  Fosphenytoin|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|DG00847  Fosphenytoin|D07993  Fosphenytoin|DG01639  CYP2C19 substrate|DG00847  Fosphenytoin|D07993  Fosphenytoin|Metabolizing enzyme inducer|DG02891  CYP2B6 inducer|DG00847  Fosphenytoin|D07993  Fosphenytoin|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00847  Fosphenytoin|D07993  Fosphenytoin|Transporter inducer|DG01893  ABCB1 inducer|DG00847  Fosphenytoin|D07993  Fosphenytoin|Target-based classification of drugs [BR:br08310(D07993)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D07993  Fosphenytoin (INN)|SCN2A|D07993  Fosphenytoin (INN)|SCN3A|D07993  Fosphenytoin (INN)|SCN4A|D07993  Fosphenytoin (INN)|SCN5A|D07993  Fosphenytoin (INN)|SCN8A|D07993  Fosphenytoin (INN)|SCN9A|D07993  Fosphenytoin (INN)|SCN10A|D07993  Fosphenytoin (INN)|SCN11A|D07993  Fosphenytoin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07993)]|Drug metabolizing enzymes|D07993|Drug transporters|D07993|Prodrugs [br08324.html(D07993)]|D07993|Prodrugs [br08324.html]|C07840,
C07841,Levetiracetam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00709)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX14 Levetiracetam|D00709  Levetiracetam (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00709)]|Anticonvulsants|Anticonvulsants, Other|Levetiracetam|D00709  Levetiracetam (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00709)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|113  Antiepileptics|1139  Others|D00709  Levetiracetam (JAN/USP/INN)|Drug groups [BR:br08330(D00709)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02038  Piracetam antiepileptic|D00709  Levetiracetam|Drug classes [BR:br08332(D00709)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D00709  Levetiracetam|Target-based classification of drugs [BR:br08310(D00709)]|Transporters|Major facilitator superfamily|VNT family|SV2A|D00709  Levetiracetam (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00709)]|New molecular entities and new therapeutic biological products|D00709|New drug approvals in Europe [br08329.html(D00709)]|European public assessment reports (EPAR) authorised medicine|D00709|New drug approvals in Japan [br08318.html(D00709)]|Drugs with new active ingredients|D00709|New drug approvals in the USA, Europe and Japan [br08328.html(D00709)]|Approval dates by FDA, EMA and PMDA|D00709",
C07843,Ketamine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00711)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX03 Ketamine|D00711  Ketamine hydrochloride (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00711)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|111  General anesthetics|1119  Others|D00711  Ketamine hydrochloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|911  General anesthetics|9113  Kethamine, derivatives and preparations|C07843  Ketamine hydrochloride|Drug groups [BR:br08330(D00711)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG00796  Ketamine|D00711  Ketamine hydrochloride|DG01498  NMDA receptor antagonist|DG00796  Ketamine|D00711  Ketamine hydrochloride|Target-based classification of drugs [BR:br08310(D00711)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D00711  Ketamine hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00711)]|Chemicals|D00711  Ketamine hydrochloride",
C07844,Methohexital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04985)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AF Barbiturates, plain|N01AF01 Methohexital|D04985  Methohexital (USP/INN)|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA15 Methohexital|D04985  Methohexital (USP/INN)|Drug groups [BR:br08330(D04985)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG00789  Methohexital|D04985  Methohexital|DG02030  Anesthetics|DG02027  General anesthetics|DG02025  Barbiturate anesthetics|DG00789  Methohexital|D04985  Methohexital|Target-based classification of drugs [BR:br08310(D04985)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABRA1|D04985  Methohexital (USP/INN)",
C07846,Thiamylal;|5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid,,,,Drug groups [BR:br08330(D06106)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|DG01377  Thiamylal|D06106  Thiamylal|DG01567  GABA-A receptor agonist|DG01377  Thiamylal|D06106  Thiamylal|DG02030  Anesthetics|DG02027  General anesthetics|DG02025  Barbiturate anesthetics|DG01377  Thiamylal|D06106  Thiamylal|Target-based classification of drugs [BR:br08310(D06106)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D06106  Thiamylal,
C07849,Methantheline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB07 Methantheline|C07849  Methantheline|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00036  Methantheline|C07849  Methantheline",G00036
C07851,Oxyphencyclimine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08325)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AA Synthetic anticholinergics, esters with tertiary amino group|A03AA01 Oxyphencyclimine|D08325  Oxyphencyclimine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08325)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxyphencyclimine|D08325  Oxyphencyclimine (INN)|Drug groups [BR:br08330(D08325)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00029  Oxyphencyclimine|D08325  Oxyphencyclimine|Target-based classification of drugs [BR:br08310(D08325)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM1|D08325  Oxyphencyclimine (INN)|CHRM2|D08325  Oxyphencyclimine (INN)|CHRM3|D08325  Oxyphencyclimine (INN)",
C07852,Propiverine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08441)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BD Drugs for urinary frequency and incontinence|G04BD06 Propiverine|D08441  Propiverine (INN)|Drug groups [BR:br08330(D08441)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00479  Propiverine|D08441  Propiverine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00479  Propiverine|D08441  Propiverine|Target-based classification of drugs [BR:br08310(D08441)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D08441  Propiverine (INN)|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D08441  Propiverine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08441)]|Drug metabolizing enzymes|D08441,
C07853,Clidinium,,,,,
C07861,Tridihexethyl,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB08 Tridihexethyl|C07861  Tridihexethyl|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00037  Tridihexethyl|C07861  Tridihexethyl",G00037
C07862,Tridihexethyl iodide,,,,,
C07864,Rabeprazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08463)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BC Proton pump inhibitors|A02BC04 Rabeprazole|D08463  Rabeprazole (INN)|Drug groups [BR:br08330(D08463)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01646  Proton pump inhibitor (PPI)|DG00022  Rabeprazole|D08463  Rabeprazole|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00022  Rabeprazole|D08463  Rabeprazole|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00022  Rabeprazole|D08463  Rabeprazole|Target-based classification of drugs [BR:br08310(D08463)]|Enzymes|Hydrolases (EC3)|ATPase|ATP4|D08463  Rabeprazole (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08463)]|Drug metabolizing enzymes|D08463,
C07865,Rabeprazole sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00724)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BC Proton pump inhibitors|A02BC04 Rabeprazole|D00724  Rabeprazole sodium (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00724)]|Gastrointestinal Agents|Proton Pump Inhibitors|Rabeprazole|D00724  Rabeprazole sodium (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00724)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2329  Others|D00724  Rabeprazole sodium (JP18/USP)|Drug groups [BR:br08330(D00724)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01646  Proton pump inhibitor (PPI)|DG00022  Rabeprazole|D00724  Rabeprazole sodium|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00022  Rabeprazole|D00724  Rabeprazole sodium|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00022  Rabeprazole|D00724  Rabeprazole sodium|Drug classes [BR:br08332(D00724)]|Gastrointestinal agent|DG01646  Proton pump inhibitor (PPI)|D00724  Rabeprazole sodium|Target-based classification of drugs [BR:br08310(D00724)]|Enzymes|Hydrolases (EC3)|ATPase|ATP4|D00724  Rabeprazole sodium (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00724)]|Chemicals|D00724  Rabeprazole sodium|New drug approvals in the USA [br08319.html(D00724)]|New molecular entities and new therapeutic biological products|D00724|New drug approvals in the USA, Europe and Japan [br08328.html(D00724)]|Approval dates by FDA, EMA and PMDA|D00724|Drug metabolizing enzymes and transporters [br08309.html(D00724)]|Drug metabolizing enzymes|D00724|Pharmacogenomic biomarkers [br08341.html(D00724)]|Polymorphisms and mutations affecting drug response|D00724",
C07866,Dolasetron,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07867)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AA Serotonin (5HT3) antagonists|A04AA04 Dolasetron|D07867  Dolasetron (INN)|Drug groups [BR:br08330(D07867)]|Gastrointestinal agent|DG01489  5-HT3-receptor antagonist|DG00063  Dolasetron|D07867  Dolasetron|DG01762  Antiemetic|DG00063  Dolasetron|D07867  Dolasetron|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00063  Dolasetron|D07867  Dolasetron|DG01633  CYP3A/CYP3A4 substrate|DG00063  Dolasetron|D07867  Dolasetron|Target-based classification of drugs [BR:br08310(D07867)]|Ion channels|Ligand-gated ion channels|Serotonin|HTR3|D07867  Dolasetron (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07867)]|Drug metabolizing enzymes|D07867,
C07868,Metoclopramide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00726)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03F PROPULSIVES|A03FA Propulsives|A03FA01 Metoclopramide|D00726  Metoclopramide (JP18/INN) &lt;JP&gt;|USP drug classification [BR:br08302(D00726)]|Antiemetics|Antiemetics, Other|Metoclopramide|D00726  Metoclopramide (JP18/INN)|Gastrointestinal Agents|Gastrointestinal Agents, Other|Metoclopramide|D00726  Metoclopramide (JP18/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00726)]|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D00726  Metoclopramide (JP18/INN)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|932  Antistomach, antidiarrhoics (including absorptives, antidiarrhoics, antibububble and preparations)|9329  Other antistomach, antidiarrhoics and preparations|C07868  Metoclopramide|Drug groups [BR:br08330(D00726)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00055  Metoclopramide|D00726  Metoclopramide|Gastrointestinal agent|DG01763  Propulsive|DG00055  Metoclopramide|D00726  Metoclopramide|DG01489  5-HT3-receptor antagonist|DG00055  Metoclopramide|D00726  Metoclopramide|DG01762  Antiemetic|DG01783  Benzamide type antiemetic|DG00055  Metoclopramide|D00726  Metoclopramide|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00055  Metoclopramide|D00726  Metoclopramide|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00055  Metoclopramide|D00726  Metoclopramide|Target-based classification of drugs [BR:br08310(D00726)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00726  Metoclopramide (JP18/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00726)]|Chemicals|D00726  Metoclopramide|D00726  Metoclopramide tablets|Drug metabolizing enzymes and transporters [br08309.html(D00726)]|Drug metabolizing enzymes|D00726",
C07870,Bismuth subsalicylate,,,,Risk category of Japanese OTC drugs [BR:br08312(D00728)]|Second-class OTC drugs|Inorganic and organic chemicals|Bismuth subsalicylate|D00728  Bismuth subsalicylate (JAN/USP)|Drug groups [BR:br08330(D00728)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|D00728  Bismuth subsalicylate,
C07871,Difenoxin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03809)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07D ANTIPROPULSIVES|A07DA Antipropulsives|A07DA04 Difenoxin|D03809  Difenoxin (USAN/INN)|Drug groups [BR:br08330(D03809)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG03054  Difenoxin|D03809  Difenoxin|Target-based classification of drugs [BR:br08310(D03809)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D03809  Difenoxin (USAN/INN)|Narcotics and psychotropics in Japan [br08308.html(D03809)]|Narcotics by Cabinet Order Article 1 (157 substances)|D03809",
C07872,Diphenoxylate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07861)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07D ANTIPROPULSIVES|A07DA Antipropulsives|A07DA01 Diphenoxylate|D07861  Diphenoxylate (INN)|Drug groups [BR:br08330(D07861)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00090  Diphenoxylate|D07861  Diphenoxylate|Target-based classification of drugs [BR:br08310(D07861)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07861  Diphenoxylate (INN)|Narcotics and psychotropics in Japan [br08308.html(D07861)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D07861",
C07874,"1,4-Bis(2-ethylhexyl) sulfosuccinate;|Docusate hydrogen",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0702 Wax diesters|C07874  1,4-Bis(2-ethylhexyl) sulfosuccinate",
C07875,Butamben,,,,Target-based classification of drugs [BR:br08310(D00730)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCND|D00730  Butamben (USP),
C07876,Magnesium hydroxide;|Milk of magnesia,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00731)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AA Magnesium compounds|A02AA04 Magnesium hydroxide|D00731  Magnesium hydroxide (JAN/USP) &lt;JP&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX01 Magnesium hydroxide|D00731  Magnesium hydroxide (JAN/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00731)]|2  Agents affecting individual organs|23  Digestive organ agents|234  Antacids|2344  Inorganic salts|D00731  Magnesium hydroxide (JAN/USP); Magnesia, (Milk of) (USP)|235  Purgatives, clysters|2355  Inorganic salts|D00731  Magnesium hydroxide (JAN/USP); Magnesia, (Milk of) (USP)|Classification of Japanese OTC drugs [BR:br08313(D00731)]|Agents for digestive organs|10 Antacids|D00731  Magnesium hydroxide (JAN/USP)|17 Cathartics|D00731  Magnesium hydroxide (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00731)]|Third-class OTC drugs|Inorganic and organic chemicals|Magnesium hydroxide|D00731  Magnesium hydroxide (JAN/USP)|Drug groups [BR:br08330(D00731)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|D00731  Magnesium hydroxide|DG01979  Magnesium containing preparation|D00731  Magnesium hydroxide|Rx-to-OTC switch list in the USA [br08315.html(D00731)]|D00731",
C07877,Chloroprocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07678)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA04 Chloroprocaine|D07678  Chloroprocaine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA08 Chloroprocaine|D07678  Chloroprocaine (INN)|Drug groups [BR:br08330(D07678)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00800  Chloroprocaine|D07678  Chloroprocaine|Target-based classification of drugs [BR:br08310(D07678)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D07678  Chloroprocaine (INN)|SCN2A|D07678  Chloroprocaine (INN)|SCN3A|D07678  Chloroprocaine (INN)|SCN4A|D07678  Chloroprocaine (INN)|SCN5A|D07678  Chloroprocaine (INN)|SCN8A|D07678  Chloroprocaine (INN)|SCN9A|D07678  Chloroprocaine (INN)|SCN10A|D07678  Chloroprocaine (INN)|SCN11A|D07678  Chloroprocaine (INN)",
C07879,Dibucaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00733)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD04 Cinchocaine|D00733  Dibucaine (USP)|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AB Anesthetics for topical use|D04AB02 Cinchocaine|D00733  Dibucaine (USP)|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB06 Cinchocaine|D00733  Dibucaine (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA06 Cinchocaine|D00733  Dibucaine (USP)|S02 OTOLOGICALS|S02D OTHER OTOLOGICALS|S02DA Analgesics and anesthetics|S02DA04 Cinchocaine|D00733  Dibucaine (USP)|Classification of Japanese OTC drugs [BR:br08313(D00733)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00733  Dibucaine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00733)]|Second-class OTC drugs|Inorganic and organic chemicals|Dibucaine|D00733  Dibucaine (USP)|Drug groups [BR:br08330(D00733)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00297  Dibucaine|D00733  Dibucaine|Target-based classification of drugs [BR:br08310(D00733)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00733  Dibucaine (USP)|SCN2A|D00733  Dibucaine (USP)|SCN3A|D00733  Dibucaine (USP)|SCN4A|D00733  Dibucaine (USP)|SCN5A|D00733  Dibucaine (USP)|SCN8A|D00733  Dibucaine (USP)|SCN9A|D00733  Dibucaine (USP)|SCN10A|D00733  Dibucaine (USP)|SCN11A|D00733  Dibucaine (USP)",
C07880,"Ursodiol;|Ursodeoxycholic acid;|Ursodeoxycholate;|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C07880  Ursodiol|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C07880  Ursodeoxycholic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00734)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05A BILE THERAPY|A05AA Bile acids and derivatives|A05AA02 Ursodeoxycholic acid|D00734  Ursodiol (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00734)]|Gastrointestinal Agents|Gastrointestinal Agents, Other|Ursodiol|D00734  Ursodiol (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00734)]|2  Agents affecting individual organs|23  Digestive organ agents|236  Cholagogues|2362  Bile acids|D00734  Ursodiol (USP); Ursodeoxycholic acid (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D00734)]|Agents for digestive organs|11 Stomachics|D00734  Ursodiol (USP)|13 Digestives|D00734  Ursodiol (USP)|14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators|D00734  Ursodiol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00734)]|Third-class OTC drugs|Inorganic and organic chemicals|Ursodeoxycholic acid|D00734  Ursodiol (USP)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|935  Cholagogues|9351  Bile acid, derivatives preparations|C07880  Ursodeoxycholic acid|Drug groups [BR:br08330(D00734)]|Gastrointestinal agent|DG01956  Bile acid preparation|D00734  Ursodiol|Target-based classification of drugs [BR:br08310(D00734)]|Nuclear receptors|Thyroid hormone like receptors|Liver X receptor like receptor|NR1H4 (FXR)|D00734  Ursodiol (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00734)]|Chemicals|D00734  Ursodeoxycholic acid|D00734  Ursodeoxycholic acid tablets|D00734  Ursodeoxycholic acid granules",
C07881,Dyclonine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07881)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BX Other local anesthetics|N01BX02 Dyclonine|D07881  Dyclonine (INN)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AD Anesthetics, local|R02AD04 Dyclonine|D07881  Dyclonine (INN)|Drug groups [BR:br08330(D07881)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG00809  Dyclonine|D07881  Dyclonine",
C07884,Dextroamphetamine;|Dexamfetamine;|d-Amphetamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03740)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BA Centrally acting sympathomimetics|N06BA02 Dexamfetamine|D03740  Dextroamphetamine (USAN) &lt;US&gt;|Drug groups [BR:br08330(D03740)]|Neuropsychiatric agent|DG03085  Selective norepinephrine reuptake inhibitor (NRI)|DG00967  Dexamfetamine|D03740  Dextroamphetamine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00967  Dexamfetamine|D03740  Dextroamphetamine|Target-based classification of drugs [BR:br08310(D03740)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D03740  Dextroamphetamine (USAN) &lt;US&gt;|SLC6A3 (DAT1)|D03740  Dextroamphetamine (USAN) &lt;US&gt;|SLC18|SLC18A2 (VMAT2)|D03740  Dextroamphetamine (USAN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D03740)]|Drug metabolizing enzymes|D03740|Prodrugs [br08324.html(D03740)]|D03740|Narcotics and psychotropics in Japan [br08308.html(D03740)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D03740|Prodrugs [br08324.html]|C07884",
C07886,Brimonidine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07540)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX21 Brimonidine|D07540  Brimonidine (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EA Sympathomimetics in glaucoma therapy|S01EA05 Brimonidine|D07540  Brimonidine (INN)|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA07 Brimonidine|D07540  Brimonidine (INN)|Drug groups [BR:br08330(D07540)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|DG00442  Brimonidine|D07540  Brimonidine|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG00442  Brimonidine|D07540  Brimonidine|Target-based classification of drugs [BR:br08310(D07540)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D07540  Brimonidine (INN),
C07887,"L-(-)-1-Butyl-2',6'-pipecoloxylidide;|Levobupivacaine",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08116)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BB Amides|N01BB10 Levobupivacaine|D08116  Levobupivacaine (INN)|Drug groups [BR:br08330(D08116)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00807  Levobupivacaine|D08116  Levobupivacaine|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00807  Levobupivacaine|D08116  Levobupivacaine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00807  Levobupivacaine|D08116  Levobupivacaine|Target-based classification of drugs [BR:br08310(D08116)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08116  Levobupivacaine (INN)|SCN2A|D08116  Levobupivacaine (INN)|SCN3A|D08116  Levobupivacaine (INN)|SCN4A|D08116  Levobupivacaine (INN)|SCN5A|D08116  Levobupivacaine (INN)|SCN8A|D08116  Levobupivacaine (INN)|SCN9A|D08116  Levobupivacaine (INN)|SCN10A|D08116  Levobupivacaine (INN)|SCN11A|D08116  Levobupivacaine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08116)]|Drug metabolizing enzymes|D08116",
C07888,Cyclophosphamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07760)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA01 Cyclophosphamide|D07760  Cyclophosphamide (INN)|Drug groups [BR:br08330(D07760)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG01720  Isophosphoramide mustard analog|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|DG02919  CYP2B6 substrate|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|DG02918  CYP2C8 substrate|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|DG01642  CYP2C9 substrate|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00675  Cyclophosphamide|D07760  Cyclophosphamide|Drug metabolizing enzymes and transporters [br08309.html(D07760)]|Drug metabolizing enzymes|D07760|Prodrugs [br08324.html(D07760)]|D07760|Prodrugs [br08324.html]|C07888,
C07889,Mephentermine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08180)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA11 Mephentermine|D08180  Mephentermine (INN)|Drug groups [BR:br08330(D08180)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00220  Mephentermine|D08180  Mephentermine,
C07890,Midodrine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08220)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CA Adrenergic and dopaminergic agents|C01CA17 Midodrine|D08220  Midodrine (INN)|Drug groups [BR:br08330(D08220)]|Cardiovascular agent|DG01703  Cardiotonic|DG01702  Phenethylamine cardiotonic|DG00224  Midodrine|D08220  Midodrine|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG00224  Midodrine|D08220  Midodrine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00224  Midodrine|D08220  Midodrine|Target-based classification of drugs [BR:br08310(D08220)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08220  Midodrine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08220)]|Drug metabolizing enzymes|D08220|Prodrugs [br08324.html(D08220)]|D08220,
C07892,Pramoxine;|Pramocaine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08407)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD07 Pramocaine|D08407  Pramocaine (INN)|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AB Anesthetics for topical use|D04AB07 Pramocaine|D08407  Pramocaine (INN)|Target-based classification of drugs [BR:br08310(D08407)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D08407  Pramocaine (INN)|SCN2A|D08407  Pramocaine (INN)|SCN3A|D08407  Pramocaine (INN)|SCN4A|D08407  Pramocaine (INN)|SCN5A|D08407  Pramocaine (INN)|SCN8A|D08407  Pramocaine (INN)|SCN9A|D08407  Pramocaine (INN)|SCN10A|D08407  Pramocaine (INN)|SCN11A|D08407  Pramocaine (INN)",
C07894,Procaine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00740)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD05 Procaine|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA02 Procaine|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01H LOCAL ANESTHETICS|S01HA Local anesthetics|S01HA05 Procaine|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00740)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|121  Local anesthetics|1211  Aminobenzoate alkamine esters|D00740  Procaine hydrochloride (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00740)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00740  Procaine hydrochloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00740)]|Second-class OTC drugs|Inorganic and organic chemicals|Procaine|D00740  Procaine hydrochloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|916  Local anesthetics|9161  Alkamine aminobenzoates and preparations|C07894  Procaine hydrochloride|Drug groups [BR:br08330(D00740)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|DG00298  Procaine|D00740  Procaine hydrochloride|Target-based classification of drugs [BR:br08310(D00740)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN2A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN3A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN4A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN5A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN8A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN9A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN10A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|SCN11A|D00740  Procaine hydrochloride (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00740)]|Chemicals|D00740  Procaine hydrochloride|D00740  Procaine hydrochloride injection",
C07895,Propoxycaine,,,,,
C07898,Naphazoline hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00743)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA08 Naphazoline|D00743  Naphazoline hydrochloride (JP18/USP)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB02 Naphazoline|D00743  Naphazoline hydrochloride (JP18/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA01 Naphazoline|D00743  Naphazoline hydrochloride (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00743)]|Agents for ophthalmologic use|62 General eye drops|D00743  Naphazoline hydrochloride (JP18/USP)|Agents for otolaryngologic use|70 Nasal sprays for inflammation|D00743  Naphazoline hydrochloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00743)]|Second-class OTC drugs|Inorganic and organic chemicals|Naphazoline|D00743  Naphazoline hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00743)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG01032  Naphazoline|D00743  Naphazoline hydrochloride|Target-based classification of drugs [BR:br08310(D00743)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D00743  Naphazoline hydrochloride (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00743)]|Chemicals|D00743  Naphazoline hydrochloride|Rx-to-OTC switch list in the USA [br08315.html(D00743)]|D00743",
C07899,Pemoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00744)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BA Centrally acting sympathomimetics|N06BA05 Pemoline|D00744  Pemoline (JAN/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00744)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00744  Pemoline (JAN/USAN/INN)|Drug groups [BR:br08330(D00744)]|Neuropsychiatric agent|DG01971  Agents for narcolepsy|D00744  Pemoline|Narcotics and psychotropics in Japan [br08308.html(D00744)]|Psychotropics by Cabinet order Article 3 (78 substances)|D00744",
C07904,Phendimetrazine,,,,Drug groups [BR:br08330(D08347)]|Neuropsychiatric agent|DG03085  Selective norepinephrine reuptake inhibitor (NRI)|DG01537  Phendimetrazine|D08347  Phendimetrazine|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG01537  Phendimetrazine|D08347  Phendimetrazine|Target-based classification of drugs [BR:br08310(D08347)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08347  Phendimetrazine (INN)|Narcotics and psychotropics in Japan [br08308.html(D08347)]|Psychotropics by Cabinet order Article 3 (78 substances)|D08347,
C07905,Leflunomide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00749)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors|L04AK01 Leflunomide|D00749  Leflunomide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00749)]|Immunological Agents|Immunosuppressants|Antimetabolites, Antiproliferative|Leflunomide|D00749  Leflunomide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00749)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00749  Leflunomide (JAN/USP/INN)|Drug groups [BR:br08330(D00749)]|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00749  Leflunomide|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00749  Leflunomide|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|D00749  Leflunomide|Drug classes [BR:br08332(D00749)]|Antirheumatic agent|DG01985  Disease modifying anti-rheumatic drug (DMARD)|D00749  Leflunomide|Target-based classification of drugs [BR:br08310(D00749)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|DHODH|D00749  Leflunomide (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00749)]|European public assessment reports (EPAR) authorised medicine|D00749|New drug approvals in Japan [br08318.html(D00749)]|Drugs with new active ingredients|D00749|Drug metabolizing enzymes and transporters [br08309.html(D00749)]|Drug metabolizing enzymes|D00749",
C07906,Levamisole hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00750)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CE Imidazothiazole derivatives|P02CE01 Levamisole|D00750  Levamisole hydrochloride (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C07906  Levamisole hydrochloride|Antimicrobials [BR:br08307(D00750)]|Antiparasitics|Antinematodal agents|Imidazothiazole derivatives|D00750  Levamisole hydrochloride (USP)",
C07908,Mycophenolate mofetil;|RS 61443,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00752)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AA Selective immunosuppressants|L04AA06 Mycophenolic acid|D00752  Mycophenolate mofetil (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00752)]|Immunological Agents|Immunosuppressants|Antimetabolites, Antiproliferative|Mycophenolic Acid|D00752  Mycophenolate mofetil (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00752)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|399  Miscellaneous|3999  Others|D00752  Mycophenolate mofetil (JAN/USP)|Target-based classification of drugs [BR:br08310(D00752)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|IMPDH|D00752  Mycophenolate mofetil (JAN/USP) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00752)]|European public assessment reports (EPAR) authorised medicine|D00752|Pharmacogenomic biomarkers [br08341.html(D00752)]|Polymorphisms and mutations affecting drug response|D00752|Prodrugs [br08324.html(D00752)]|D00752|Prodrugs [br08324.html]|C07908",
C07909,Sirolimus;|Rapamycin,,0 Ska  1 Mtk  2 Man  3 Mtd  4 Mtk  5 Man  6 Mte  7 Mtd  8 Mad|9 Mad  10 Mtk  11 Mak  12 Mae  13 Mtn  14 Man  15 Pip,PK,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C07909  Sirolimus (Rapamycin)|PK06 Polyenes|C07909  Sirolimus (Rapamycin)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00753)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01E PROTEIN KINASE INHIBITORS|L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors|L01EG04 Sirolimus|D00753  Sirolimus (JAN/USAN/INN) &lt;JP/US&gt;|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors|L04AH01 Sirolimus|D00753  Sirolimus (JAN/USAN/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA23 Sirolimus|D00753  Sirolimus (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00753)]|Immunological Agents|Immunosuppressants|mTOR Inhibitors|Sirolimus|D00753  Sirolimus (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00753)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00753  Sirolimus (JAN/USAN/INN)|Drug groups [BR:br08330(D00753)]|Antineoplastic|DG01597  mTOR inhibitor|D00753  Sirolimus|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00753  Sirolimus|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00753  Sirolimus|Transporter substrate|DG01665  ABCB1 substrate|D00753  Sirolimus|Drug classes [BR:br08332(D00753)]|Antineoplastic|DG01597  mTOR inhibitor|D00753  Sirolimus|Target-based classification of drugs [BR:br08310(D00753)]|Protein kinases|Serine/threonine kinases|Other|MTOR|D00753  Sirolimus (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00753)]|New molecular entities and new therapeutic biological products|D00753|New drug approvals in Europe [br08329.html(D00753)]|European public assessment reports (EPAR) authorised medicine|D00753|New drug approvals in Japan [br08318.html(D00753)]|Drugs with new active ingredients|D00753|New drug approvals in the USA, Europe and Japan [br08328.html(D00753)]|Approval dates by FDA, EMA and PMDA|D00753|Drug metabolizing enzymes and transporters [br08309.html(D00753)]|Drug metabolizing enzymes|D00753|Drug transporters|D00753",
C07910,Thalidomide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00754)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AX Other immunosuppressants|L04AX02 Thalidomide|D00754  Thalidomide (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00754)]|Antineoplastics|Immunomodulatory Agents|Thalidomide|D00754  Thalidomide (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00754)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|129  Miscellaneous|1290  Miscellaneous|D00754  Thalidomide (JAN/USP/INN)|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00754  Thalidomide (JAN/USP/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|623  Leprostatics|6239  Others|D00754  Thalidomide (JAN/USP/INN)|Target-based classification of drugs [BR:br08310(D00754)]|Cytokines and receptors|Cytokines|Tumor necrosis factors|TNF (TNFA, TNFSF2)|D00754  Thalidomide (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00754)]|European public assessment reports (EPAR) authorised medicine|D00754|New drug approvals in Japan [br08318.html(D00754)]|Drugs with new active ingredients|D00754",
C07911,"Phenylpropanolamine;|(+/-)-Phenylpropanolamine;|(R*,S*)-(+/-)-alpha-(1-Aminoethyl)benzenemethanol;|(+/-)-Norephedrine",(+)-Norephedrine [CPD:C02343]|(-)-Norephedrine [CPD:C16719],,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08368)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01B NASAL DECONGESTANTS FOR SYSTEMIC USE|R01BA Sympathomimetics|R01BA01 Phenylpropanolamine|D08368  Phenylpropanolamine (INN)|Drug groups [BR:br08330(D08368)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01041  Phenylpropanolamine|D08368  Phenylpropanolamine|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG01041  Phenylpropanolamine|D08368  Phenylpropanolamine|Target-based classification of drugs [BR:br08310(D08368)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08368  Phenylpropanolamine (INN)|ADRA2|D08368  Phenylpropanolamine (INN)|ADRB|D08368  Phenylpropanolamine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08368)]|Drug metabolizing enzymes|D08368|Narcotics and psychotropics in Japan [br08308.html(D08368)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D08368,
C07912,"Tetrahydrozoline;|Tetryzoline;|2-Tetralin-1-yl-4,5-dihydro-1H-imidazole",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08578)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA06 Tetryzoline|D08578  Tetryzoline (INN)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB03 Tetryzoline|D08578  Tetryzoline (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA02 Tetryzoline|D08578  Tetryzoline (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08578)]|Second-class OTC drugs|Inorganic and organic chemicals|Tetryzoline|D08578  Tetryzoline (INN)|Drug groups [BR:br08330(D08578)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01448  alpha1-Adrenergic receptor agonist|DG01030  Tetryzoline|D08578  Tetryzoline|Target-based classification of drugs [BR:br08310(D08578)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08578  Tetryzoline (INN)",
C07913,Xylometazoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08684)]|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AA Sympathomimetics, plain|R01AA07 Xylometazoline|D08684  Xylometazoline (INN)|R01AB Sympathomimetics, combinations excl. corticosteroids|R01AB06 Xylometazoline|D08684  Xylometazoline (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01G DECONGESTANTS AND ANTIALLERGICS|S01GA Sympathomimetics used as decongestants|S01GA03 Xylometazoline|D08684  Xylometazoline (INN)|Target-based classification of drugs [BR:br08310(D08684)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08684  Xylometazoline (INN)|ADRA2|D08684  Xylometazoline (INN)",
C07914,Levobunolol;|(-)-Bunolol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08115)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED03 Levobunolol|D08115  Levobunolol (INN)|Drug groups [BR:br08330(D08115)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01136  Levobunolol|D08115  Levobunolol|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01136  Levobunolol|D08115  Levobunolol|Target-based classification of drugs [BR:br08310(D08115)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D08115  Levobunolol (INN)|ADRB|D08115  Levobunolol (INN),
C07915,Metipranolol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02374)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED04 Metipranolol|D02374  Metipranolol (USAN/INN)|Drug groups [BR:br08330(D02374)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01137  Metipranolol|D02374  Metipranolol|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01137  Metipranolol|D02374  Metipranolol|Target-based classification of drugs [BR:br08310(D02374)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D02374  Metipranolol (USAN/INN),
C07919,Metocurine,,,,,
C07921,Metyrosine;|Metirosine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00762)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02K OTHER ANTIHYPERTENSIVES|C02KB Tyrosine hydroxylase inhibitors|C02KB01 Metirosine|D00762  Metyrosine (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00762)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00762  Metyrosine (USP); Metirosine (JAN/INN)|Drug groups [BR:br08330(D00762)]|Cardiovascular agent|DG01617  Catecholamine synthesis inhibitors|D00762  Metyrosine|Target-based classification of drugs [BR:br08310(D00762)]|Enzymes|Oxidoreductases (EC1)|Other monooxygenases|TH|D00762  Metyrosine (USP) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00762)]|Drugs with new active ingredients|D00762,
C07927,Carisoprodol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00768)]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS|M03BA Carbamic acid esters|M03BA02 Carisoprodol|D00768  Carisoprodol (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00768)]|Skeletal Muscle Relaxants|Carisoprodol|D00768  Carisoprodol (JAN/USP/INN)|Drug groups [BR:br08330(D00768)]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|DG01973  Carbamate muscle relaxant|D00768  Carisoprodol|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|D00768  Carisoprodol|Drug metabolizing enzymes and transporters [br08309.html(D00768)]|Drug metabolizing enzymes|D00768|Pharmacogenomic biomarkers [br08341.html(D00768)]|Polymorphisms and mutations affecting drug response|D00768",
C07928,Chlorphenesin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE07 Chlorphenesin|C07928  Chlorphenesin,
C07930,Chlorphenesin carbamate,,,,Therapeutic category of drugs in Japan [BR:br08301(D00770)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|122  Skeletal muscle relaxants|1225  Carbamates|D00770  Chlorphenesin carbamate (JP18/USAN)|Drug groups [BR:br08330(D00770)]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|DG01973  Carbamate muscle relaxant|D00770  Chlorphenesin carbamate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00770)]|Chemicals|D00770  Chlorphenesin carbamate|D00770  Chlorphenesin carbamate tablets,
C07931,Chlorzoxazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00771)]|M MUSCULO-SKELETAL SYSTEM|M03 MUSCLE RELAXANTS|M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS|M03BB Oxazol, thiazine, and triazine derivatives|M03BB03 Chlorzoxazone|D00771  Chlorzoxazone (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00771)]|Skeletal Muscle Relaxants|Chlorzoxazone|D00771  Chlorzoxazone (JAN/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00771)]|Agents for nervous and sensory systems|08 Other drugs for nervous and sensory organs|D00771  Chlorzoxazone (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00771)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorzoxazone|D00771  Chlorzoxazone (JAN/USP/INN)|Drug groups [BR:br08330(D00771)]|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|D00771  Chlorzoxazone",
C07933,Dantrolene sodium anhydrous,,,,,
C07934,Metaxalone,,,,USP drug classification [BR:br08302(D00773)]|Skeletal Muscle Relaxants|Metaxalone|D00773  Metaxalone (USP/INN),
C07935,Orphenadrine,,,,"Drug groups [BR:br08330(D08305)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01745  Anticholinergic antiparkinson agent|DG01252  Orphenadrine|D08305  Orphenadrine|Musculo-skeletal system agent|DG02029  Muscle relaxant|DG01974  Centrally acting muscle relaxant|DG01252  Orphenadrine|D08305  Orphenadrine|Target-based classification of drugs [BR:br08310(D08305)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08305  Orphenadrine (INN)|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D08305  Orphenadrine (INN)",
C07937,Riluzole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00775)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07X OTHER NERVOUS SYSTEM DRUGS|N07XX Other nervous system drugs|N07XX02 Riluzole|D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00775)]|Central Nervous System Agents|Amyotrophic Lateral Sclerosis (ALS) Agents|Riluzole|D00775  Riluzole (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00775)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D00775  Riluzole (JAN/USP/INN)|Drug groups [BR:br08330(D00775)]|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|D00775  Riluzole|Target-based classification of drugs [BR:br08310(D00775)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), non-NMDA|GRIA|D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;|GRIK|D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D00775)]|European public assessment reports (EPAR) authorised medicine|D00775|Drug metabolizing enzymes and transporters [br08309.html(D00775)]|Drug metabolizing enzymes|D00775",
C07939,Amantadine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00777)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BB Adamantane derivatives|N04BB01 Amantadine|D00777  Amantadine hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00777)]|Antiparkinson Agents|Antiparkinson Agents, Other|Amantadine|D00777  Amantadine hydrochloride (JP18/USP)|Antivirals|Anti-influenza Agents|Amantadine|D00777  Amantadine hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00777)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|116  Antiparkinsonian agents|1161  Amantadines|D00777  Amantadine hydrochloride (JP18/USP)|117  Psychotropics|1179  Others|D00777  Amantadine hydrochloride (JP18/USP)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00777  Amantadine hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00777)]|Antiviral|DG03029  Anti-influenza virus agent|DG02841  Viral uncoating inhibitor|DG00860  Amantadine|D00777  Amantadine hydrochloride|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|DG00860  Amantadine|D00777  Amantadine hydrochloride|DG01967  Antiparkinson agent|DG00860  Amantadine|D00777  Amantadine hydrochloride|Transporter substrate|DG02854  SLC22A2 substrate|DG00860  Amantadine|D00777  Amantadine hydrochloride|Drug classes [BR:br08332(D00777)]|Antiviral|DG03029  Anti-influenza virus agent|D00777  Amantadine hydrochloride|Neuropsychiatric agent|DG01967  Antiparkinson agent|D00777  Amantadine hydrochloride|Target-based classification of drugs [BR:br08310(D00777)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D00777  Amantadine hydrochloride (JP18/USP) &lt;JP/US&gt;|Antimicrobials [BR:br08307(D00777)]|Antivirals|Entry, fusion or uncoating inhibitor|Influenza virus uncoating inhibitor|D00777  Amantadine hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00777)]|Chemicals|D00777  Amantadine hydrochloride|Drug metabolizing enzymes and transporters [br08309.html(D00777)]|Drug transporters|D00777",
C07941,Biperiden,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00779)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04A ANTICHOLINERGIC AGENTS|N04AA Tertiary amines|N04AA02 Biperiden|D00779  Biperiden (JAN/USP/INN)|Drug groups [BR:br08330(D00779)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG01745  Anticholinergic antiparkinson agent|DG00852  Biperiden|D00779  Biperiden|DG01967  Antiparkinson agent|DG00852  Biperiden|D00779  Biperiden|Target-based classification of drugs [BR:br08310(D00779)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00779  Biperiden (JAN/USP/INN),
C07943,Entacapone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00781)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BX Other dopaminergic agents|N04BX02 Entacapone|D00781  Entacapone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00781)]|Antiparkinson Agents|Antiparkinson Agents, Other|Entacapone|D00781  Entacapone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00781)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|116  Antiparkinsonian agents|1169  Others|D00781  Entacapone (JP18/USP/INN)|Drug groups [BR:br08330(D00781)]|Neuropsychiatric agent|DG01497  Catechol O-methyltransferase inhibitor|D00781  Entacapone|DG01967  Antiparkinson agent|DG02909  COMT inhibitor|D00781  Entacapone|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|D00781  Entacapone|Drug classes [BR:br08332(D00781)]|Neuropsychiatric agent|DG01967  Antiparkinson agent|D00781  Entacapone|Target-based classification of drugs [BR:br08310(D00781)]|Enzymes|Transferases (EC2)|Methyltransferases|COMT|D00781  Entacapone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00781)]|Chemicals|D00781  Entacapone|D00781  Entacapone tablets|New drug approvals in the USA [br08319.html(D00781)]|New molecular entities and new therapeutic biological products|D00781|New drug approvals in Europe [br08329.html(D00781)]|European public assessment reports (EPAR) authorised medicine|D00781|New drug approvals in Japan [br08318.html(D00781)]|Drugs with new active ingredients|D00781|New drug approvals in the USA, Europe and Japan [br08328.html(D00781)]|Approval dates by FDA, EMA and PMDA|D00781|Drug metabolizing enzymes and transporters [br08309.html(D00781)]|Drug metabolizing enzymes|D00781",
C07949,Tolcapone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00786)]|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BX Other dopaminergic agents|N04BX01 Tolcapone|D00786  Tolcapone (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00786)]|Antiparkinson Agents|Antiparkinson Agents, Other|Tolcapone|D00786  Tolcapone (JAN/USP/INN)|Drug groups [BR:br08330(D00786)]|Neuropsychiatric agent|DG01497  Catechol O-methyltransferase inhibitor|D00786  Tolcapone|DG01967  Antiparkinson agent|DG02909  COMT inhibitor|D00786  Tolcapone|Drug classes [BR:br08332(D00786)]|Neuropsychiatric agent|DG01967  Antiparkinson agent|D00786  Tolcapone|Target-based classification of drugs [BR:br08310(D00786)]|Enzymes|Transferases (EC2)|Methyltransferases|COMT|D00786  Tolcapone (JAN/USP/INN) &lt;US&gt;|New drug approvals in Europe [br08329.html(D00786)]|European public assessment reports (EPAR) authorised medicine|D00786|Drug metabolizing enzymes and transporters [br08309.html(D00786)]|Drug metabolizing enzymes|D00786",
C07952,Chlorpromazine hydrochloride;|Chloropromazine monohydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00789)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AA Phenothiazines with aliphatic side-chain|N05AA01 Chlorpromazine|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00789)]|Antiemetics|Antiemetics, Other|Chlorpromazine|D00789  Chlorpromazine hydrochloride (JP18/USP)|Antipsychotics|1st Generation/Typical|Chlorpromazine|D00789  Chlorpromazine hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00789)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1171  Chlorpromazines|D00789  Chlorpromazine hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00789)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01460  alpha2-Adrenergic receptor antagonist|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|DG01491  Muscarinic cholinergic receptor antagonist|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00867  Chlorpromazine|D00789  Chlorpromazine hydrochloride|Drug classes [BR:br08332(D00789)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D00789  Chlorpromazine hydrochloride|Target-based classification of drugs [BR:br08310(D00789)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|Adrenaline|ADRA2|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|Dopamine|DRD2|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|Histamine|HRH1|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|Serotonin|HTR2|D00789  Chlorpromazine hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00789)]|Chemicals|D00789  Chlorpromazine hydrochloride|D00789  Chlorpromazine hydrochloride tablets|D00789  Chlorpromazine hydrochloride injection|Drug metabolizing enzymes and transporters [br08309.html(D00789)]|Drug metabolizing enzymes|D00789",
C07953,Chlorprothixene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00790)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AF Thioxanthene derivatives|N05AF03 Chlorprothixene|D00790  Chlorprothixene (JAN/USAN/INN)|Drug groups [BR:br08330(D00790)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG00894  Chlorprothixene|D00790  Chlorprothixene|Target-based classification of drugs [BR:br08310(D00790)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD1|D00790  Chlorprothixene (JAN/USAN/INN)|DRD2|D00790  Chlorprothixene (JAN/USAN/INN),
C07955,Fluphenazine enanthate;|Prolixin enanthate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00792)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB02 Fluphenazine|D00792  Fluphenazine enanthate (JP18/USP)|Drug groups [BR:br08330(D00792)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00874  Fluphenazine|D00792  Fluphenazine enanthate|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00874  Fluphenazine|D00792  Fluphenazine enanthate|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00874  Fluphenazine|D00792  Fluphenazine enanthate|Target-based classification of drugs [BR:br08310(D00792)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00792  Fluphenazine enanthate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00792)]|Chemicals|D00792  Fluphenazine enanthate|Drug metabolizing enzymes and transporters [br08309.html(D00792)]|Drug metabolizing enzymes|D00792|Prodrugs [br08324.html(D00792)]|D00792|Prodrugs [br08324.html]|C07955,
C07956,Fluphenazine depot;|Fluphenazine decanoate;|Prolixin decanoate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00793)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB02 Fluphenazine|D00793  Fluphenazine decanoate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00793)]|Antipsychotics|1st Generation/Typical|Fluphenazine|D00793  Fluphenazine decanoate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00793)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1172  Phenothiazines|D00793  Fluphenazine decanoate (JAN/USP)|Drug groups [BR:br08330(D00793)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00874  Fluphenazine|D00793  Fluphenazine decanoate|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00874  Fluphenazine|D00793  Fluphenazine decanoate|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00874  Fluphenazine|D00793  Fluphenazine decanoate|Target-based classification of drugs [BR:br08310(D00793)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00793  Fluphenazine decanoate (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00793)]|Drug metabolizing enzymes|D00793|Prodrugs [br08324.html(D00793)]|D00793|Prodrugs [br08324.html]|C07956,
C07964,Lithium carbonate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00801)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AN Lithium|N05AN01 Lithium|D00801  Lithium carbonate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00801)]|Bipolar Agents|Mood Stabilizers|Lithium|D00801  Lithium carbonate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00801)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D00801  Lithium carbonate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00801)]|Chemicals|D00801  Lithium carbonate,
C07965,Tirofiban,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08607)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AC Platelet aggregation inhibitors excl. heparin|B01AC17 Tirofiban|D08607  Tirofiban (INN)|Drug groups [BR:br08330(D08607)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|DG00159  Tirofiban|D08607  Tirofiban|DG01811  Fibrinogen receptor antagonist|DG00159  Tirofiban|D08607  Tirofiban|Target-based classification of drugs [BR:br08310(D08607)]|Cell surface molecules and ligands|Cell adhesion molecules: other families|Integrins|ITGA2B/ITGB3|D08607  Tirofiban (INN),
C07966,Cerivastatin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07661)]|C CARDIOVASCULAR SYSTEM|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AA HMG CoA reductase inhibitors|C10AA06 Cerivastatin|D07661  Cerivastatin (INN)|Drug groups [BR:br08330(D07661)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01660  HMG-CoA reductase inhibitor|DG00356  Cerivastatin|D07661  Cerivastatin|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00356  Cerivastatin|D07661  Cerivastatin|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00356  Cerivastatin|D07661  Cerivastatin|Target-based classification of drugs [BR:br08310(D07661)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HMGCR|D07661  Cerivastatin (INN)|Drug metabolizing enzymes and transporters [br08309.html(D07661)]|Drug metabolizing enzymes|D07661",
C07967,Bithionol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00802)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AB Preparations containing sulfur|D10AB01 Bithionol|D00802  Bithionol (JAN/INN)|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02B ANTITREMATODALS|P02BX Other antitrematodal agents|P02BX01 Bithionol|D00802  Bithionol (JAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00802)]|Third-class OTC drugs|Inorganic and organic chemicals|Bithionol|D00802  Bithionol (JAN/INN)|Antimicrobials [BR:br08307(D00802)]|Antiparasitics|Antitrematodal agents|Others|D00802  Bithionol (JAN/INN)",
C07968,"Diethylcarbamazine;|N,N-Diethyl-4-methyl-1-piperazinecarboxamide",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07825)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CB Piperazine and derivatives|P02CB02 Diethylcarbamazine|D07825  Diethylcarbamazine (INN)|Antimicrobials [BR:br08307(D07825)]|Antiparasitics|Antinematodal agents|Piperazine and derivatives|D07825  Diethylcarbamazine (INN)",
C07971,Metrifonate;|Trichlorfon,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C07971  Metrifonate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00805)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02B ANTITREMATODALS|P02BB Organophosphorous compounds|P02BB01 Metrifonate|D00805  Metrifonate (USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00805)]|Agents for sanitation|82 Pesticides|D00805  Metrifonate (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00805)]|Second-class OTC drugs|Not used for human|Insecticides|D00805  Metrifonate (USP/INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|C07971  Trichlorfon|Drug groups [BR:br08330(D00805)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|D00805  Metrifonate|Antimicrobials [BR:br08307(D00805)]|Antiparasitics|Antitrematodal agents|Organophosphorous compounds|D00805  Metrifonate (USP/INN)",
C07973,Piperazine;|Diethylenediamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00807)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CB Piperazine and derivatives|P02CB01 Piperazine|D00807  Piperazine (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00807)]|Second-class OTC drugs|Inorganic and organic chemicals|Piperazine|D00807  Piperazine (USP)|Antimicrobials [BR:br08307(D00807)]|Antiparasitics|Antinematodal agents|Piperazine and derivatives|D00807  Piperazine (USP)",
C07974,Suramin,,,,,
C07982,Imipramine hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00815)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA02 Imipramine|D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00815)]|Antidepressants|Tricyclics|Imipramine|D00815  Imipramine hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00815)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1174  Imipramines|D00815  Imipramine hydrochloride (JP18/USP)|Drug groups [BR:br08330(D00815)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00928  Imipramine|D00815  Imipramine hydrochloride|DG01728  Tricyclic antidepressant|DG00928  Imipramine|D00815  Imipramine hydrochloride|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00928  Imipramine|D00815  Imipramine hydrochloride|DG01639  CYP2C19 substrate|DG00928  Imipramine|D00815  Imipramine hydrochloride|DG01644  CYP2D6 substrate|DG00928  Imipramine|D00815  Imipramine hydrochloride|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00928  Imipramine|D00815  Imipramine hydrochloride|Drug classes [BR:br08332(D00815)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|D00815  Imipramine hydrochloride|Target-based classification of drugs [BR:br08310(D00815)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;|SLC6A4 (HTT)|D00815  Imipramine hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00815)]|Chemicals|D00815  Imipramine hydrochloride|D00815  Imipramine hydrochloride tablets|Drug metabolizing enzymes and transporters [br08309.html(D00815)]|Drug metabolizing enzymes|D00815|Pharmacogenomic biomarkers [br08341.html(D00815)]|Polymorphisms and mutations affecting drug response|D00815,
C07995,Magnesium salicylate;|Magnesium salicylate anhydrous,,,,,
C07996,Dehydroemetine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00828)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX09 Dehydroemetine|D00828  Dehydroemetine (INN)|Antimicrobials [BR:br08307(D00828)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Others|D00828  Dehydroemetine (INN)",
C07997,"Eflornithine;|DL-Ornithine, 2-(difluoromethyl)-",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07883)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX16 Eflornithine|D07883  Eflornithine (INN)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX79 Eflornithine|D07883  Eflornithine (INN)|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS|P01CX Other agents against leishmaniasis and trypanosomiasis|P01CX03 Eflornithine|D07883  Eflornithine (INN)|Target-based classification of drugs [BR:br08310(D07883)]|Enzymes|Lyases (EC4)|Carboxy-lyases|ODC1|D07883  Eflornithine (INN)|Antimicrobials [BR:br08307(D07883)]|Antiparasitics|Agents against Leishmaniasis and Trypanosomiasis|Others|D07883  Eflornithine (INN)",
C07999,Furazolidone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00830)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AX Other antiinfectives and antiseptics|G01AX06 Furazolidone|D00830  Furazolidone (USP/INN)|Drug groups [BR:br08330(D00830)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|D00830  Furazolidone|Antiparasitic|DG01554  5-Nitrofuran antiprotozoal|D00830  Furazolidone|Antimicrobials [BR:br08307(D00830)]|Antibacterials|Bactericidal action|5-Nitrofurans|D00830  Furazolidone (USP/INN)",
C08001,Melarsoprol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00832)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS|P01CD Arsenic compounds|P01CD01 Melarsoprol|D00832  Melarsoprol (INN)|Antimicrobials [BR:br08307(D00832)]|Antiparasitics|Agents against Leishmaniasis and Trypanosomiasis|Arsenic compounds|D00832  Melarsoprol (INN)",
C08002,Nifurtimox,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00833)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS|P01CC Nitrofuran derivatives|P01CC01 Nifurtimox|D00833  Nifurtimox (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00833)]|Antiparasitics|Antiprotozoals|Nifurtimox|D00833  Nifurtimox (USAN/INN)|Drug groups [BR:br08330(D00833)]|Antiparasitic|DG01554  5-Nitrofuran antiprotozoal|D00833  Nifurtimox|Antimicrobials [BR:br08307(D00833)]|Antiparasitics|Agents against Leishmaniasis and Trypanosomiasis|Nitrofuran derivatives|D00833  Nifurtimox (USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00833)]|New molecular entities and new therapeutic biological products|D00833|New drug approvals in the USA, Europe and Japan [br08328.html(D00833)]|Approval dates by FDA, EMA and PMDA|D00833",
C08005,Alfentanil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07122)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AH Opioid anesthetics|N01AH02 Alfentanil|D07122  Alfentanil (INN)|Drug groups [BR:br08330(D07122)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02026  Opioid anesthetics|DG00792  Alfentanil|D07122  Alfentanil|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00792  Alfentanil|D07122  Alfentanil|Analgesic|DG01984  Opioid analgesics|DG00792  Alfentanil|D07122  Alfentanil|Target-based classification of drugs [BR:br08310(D07122)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07122  Alfentanil (INN)|Narcotics and psychotropics in Japan [br08308.html(D07122)]|Narcotics by Cabinet Order Article 1 (157 substances)|D07122",
C08007,Buprenorphine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07132)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AE Oripavine derivatives|N02AE01 Buprenorphine|D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BC Drugs used in opioid dependence|N07BC01 Buprenorphine|D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D07132)]|Analgesics|Opioid Analgesics, Long-acting|Buprenorphine|D07132  Buprenorphine (JAN/INN)|Anti-Addiction/Substance Abuse Treatment Agents|Opioid Dependence|Buprenorphine|D07132  Buprenorphine (JAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D07132)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D07132  Buprenorphine (JAN/INN)|Drug groups [BR:br08330(D07132)]|Analgesic|DG01984  Opioid analgesics|DG00820  Buprenorphine|D07132  Buprenorphine|DG01586  Opioid receptor antagonist|DG00820  Buprenorphine|D07132  Buprenorphine|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00820  Buprenorphine|D07132  Buprenorphine|Target-based classification of drugs [BR:br08310(D07132)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;|OPRK1|D07132  Buprenorphine (JAN/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D07132)]|European public assessment reports (EPAR) authorised medicine|D07132|New drug approvals in Japan [br08318.html(D07132)]|Drugs with new active ingredients|D07132|New drug approvals in the USA, Europe and Japan [br08328.html(D07132)]|Approval dates by FDA, EMA and PMDA|D07132|Drug metabolizing enzymes and transporters [br08309.html(D07132)]|Drug metabolizing enzymes|D07132|Narcotics and psychotropics in Japan [br08308.html(D07132)]|Psychotropics by Cabinet order Article 3 (78 substances)|D07132",
C08010,Dezocine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00838)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AX Other opioids|N02AX03 Dezocine|D00838  Dezocine (USAN)|Drug groups [BR:br08330(D00838)]|Analgesic|DG01984  Opioid analgesics|D00838  Dezocine|DG01587  Opioid receptor agonist/antagonist|D00838  Dezocine|Target-based classification of drugs [BR:br08310(D00838)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D00838  Dezocine (USAN)|OPRK1|D00838  Dezocine (USAN),
C08012,Levomethadyl acetate;|LAAM,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04716)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BC Drugs used in opioid dependence|N07BC03 Levacetylmethadol|D04716  Levomethadyl acetate (USAN)|Drug groups [BR:br08330(D04716)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01000  Levacetylmethadol|D04716  Levomethadyl acetate|Analgesic|DG01984  Opioid analgesics|DG01000  Levacetylmethadol|D04716  Levomethadyl acetate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01000  Levacetylmethadol|D04716  Levomethadyl acetate|Target-based classification of drugs [BR:br08310(D04716)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D04716  Levomethadyl acetate (USAN)|Drug metabolizing enzymes and transporters [br08309.html(D04716)]|Drug metabolizing enzymes|D04716,
C08014,Levorphanol,,,,Drug groups [BR:br08330(D08123)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01341  Levorphanol|D08123  Levorphanol|Analgesic|DG01984  Opioid analgesics|DG01341  Levorphanol|D08123  Levorphanol|Target-based classification of drugs [BR:br08310(D08123)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08123  Levorphanol (INN),
C08018,Oxycodone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05312)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AA Natural opium alkaloids|N02AA05 Oxycodone|D05312  Oxycodone (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D05312)]|Analgesics|Opioid Analgesics, Long-acting|Oxycodone|D05312  Oxycodone (USAN/INN)|Drug groups [BR:br08330(D05312)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00813  Oxycodone|D05312  Oxycodone|Analgesic|DG01984  Opioid analgesics|DG00813  Oxycodone|D05312  Oxycodone|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00813  Oxycodone|D05312  Oxycodone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00813  Oxycodone|D05312  Oxycodone|Target-based classification of drugs [BR:br08310(D05312)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D05312  Oxycodone (USAN/INN) &lt;US&gt;|OPRK1|D05312  Oxycodone (USAN/INN) &lt;US&gt;|OPRD1|D05312  Oxycodone (USAN/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D05312)]|Drug metabolizing enzymes|D05312|Narcotics and psychotropics in Japan [br08308.html(D05312)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D05312",
C08019,Oxymorphone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08323)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AA Natural opium alkaloids|N02AA11 Oxymorphone|D08323  Oxymorphone (INN)|Drug groups [BR:br08330(D08323)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01343  Oxymorphone|D08323  Oxymorphone|Analgesic|DG01984  Opioid analgesics|DG01343  Oxymorphone|D08323  Oxymorphone|Target-based classification of drugs [BR:br08310(D08323)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08323  Oxymorphone (INN)|Narcotics and psychotropics in Japan [br08308.html(D08323)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08323,
C08021,Remifentanil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08473)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AH Opioid anesthetics|N01AH06 Remifentanil|D08473  Remifentanil (INN)|Drug groups [BR:br08330(D08473)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02026  Opioid anesthetics|DG00795  Remifentanil|D08473  Remifentanil|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00795  Remifentanil|D08473  Remifentanil|Analgesic|DG01984  Opioid analgesics|DG00795  Remifentanil|D08473  Remifentanil|Target-based classification of drugs [BR:br08310(D08473)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08473  Remifentanil (INN)|Narcotics and psychotropics in Japan [br08308.html(D08473)]|Narcotics by Cabinet Order Article 1 (157 substances)|D08473",
C08022,Sufentanil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05938)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AH Opioid anesthetics|N01AH03 Sufentanil|D05938  Sufentanil (USAN/INN)|Drug groups [BR:br08330(D05938)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02026  Opioid anesthetics|DG00793  Sufentanil|D05938  Sufentanil|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG00793  Sufentanil|D05938  Sufentanil|Analgesic|DG01984  Opioid analgesics|DG00793  Sufentanil|D05938  Sufentanil|Target-based classification of drugs [BR:br08310(D05938)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D05938  Sufentanil (USAN/INN)|New drug approvals in Europe [br08329.html(D05938)]|European public assessment reports (EPAR) authorised medicine|D05938|Narcotics and psychotropics in Japan [br08308.html(D05938)]|Narcotics by Cabinet Order Article 1 (157 substances)|D05938",
C08024,Hydrocodone;|Dihydrocodeinone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08045)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|R05DA Opium alkaloids and derivatives|R05DA03 Hydrocodone|D08045  Hydrocodone (INN)|Drug groups [BR:br08330(D08045)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG01563  mu-Opioid receptor agonist|DG01075  Hydrocodone|D08045  Hydrocodone|Metabolizing enzyme substrate|DG02919  CYP2B6 substrate|DG01075  Hydrocodone|D08045  Hydrocodone|DG01639  CYP2C19 substrate|DG01075  Hydrocodone|D08045  Hydrocodone|DG01644  CYP2D6 substrate|DG01075  Hydrocodone|D08045  Hydrocodone|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01075  Hydrocodone|D08045  Hydrocodone|Target-based classification of drugs [BR:br08310(D08045)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08045  Hydrocodone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08045)]|Drug metabolizing enzymes|D08045|Prodrugs [br08324.html(D08045)]|D08045|Narcotics and psychotropics in Japan [br08308.html(D08045)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08045|Prodrugs [br08324.html]|C08024",
C08026,Oxycodone hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00847)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AA Natural opium alkaloids|N02AA05 Oxycodone|D00847  Oxycodone hydrochloride (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00847)]|Analgesics|Opioid Analgesics, Long-acting|Oxycodone|D00847  Oxycodone hydrochloride (USP)|Opioid Analgesics, Short-acting|Oxycodone|D00847  Oxycodone hydrochloride (USP)|Drug groups [BR:br08330(D00847)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|DG00813  Oxycodone|D00847  Oxycodone hydrochloride|Analgesic|DG01984  Opioid analgesics|DG00813  Oxycodone|D00847  Oxycodone hydrochloride|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00813  Oxycodone|D00847  Oxycodone hydrochloride|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00813  Oxycodone|D00847  Oxycodone hydrochloride|Target-based classification of drugs [BR:br08310(D00847)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D00847  Oxycodone hydrochloride (USP) &lt;US&gt;|OPRK1|D00847  Oxycodone hydrochloride (USP) &lt;US&gt;|OPRD1|D00847  Oxycodone hydrochloride (USP) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00847)]|Drug metabolizing enzymes|D00847",
C08027,Nalmefene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05111)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BB Drugs used in alcohol dependence|N07BB05 Nalmefene|D05111  Nalmefene (USAN/INN)|Drug groups [BR:br08330(D05111)]|Analgesic|DG01586  Opioid receptor antagonist|DG00998  Nalmefene|D05111  Nalmefene|DG01587  Opioid receptor agonist/antagonist|DG00998  Nalmefene|D05111  Nalmefene|Target-based classification of drugs [BR:br08310(D05111)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D05111  Nalmefene (USAN/INN)|OPRK1|D05111  Nalmefene (USAN/INN)|OPRD1|D05111  Nalmefene (USAN/INN),
C08029,Methacycline hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00849)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA05 Metacycline|D00849  Methacycline hydrochloride (JAN/USP)|Drug groups [BR:br08330(D00849)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00514  Metacycline|D00849  Methacycline hydrochloride|Antimicrobials [BR:br08307(D00849)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D00849  Methacycline hydrochloride (JAN/USP),
C08031,Erythromycin estolate;|Erythromycin estorate,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C08031  Erythromycin estolate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00851)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF02 Erythromycin|D00851  Erythromycin estolate (USP)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA01 Erythromycin|D00851  Erythromycin estolate (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA17 Erythromycin|D00851  Erythromycin estolate (USP)|Drug groups [BR:br08330(D00851)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00436  Erythromycin|D00851  Erythromycin estolate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00436  Erythromycin|D00851  Erythromycin estolate|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00436  Erythromycin|D00851  Erythromycin estolate|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00436  Erythromycin|D00851  Erythromycin estolate|Antimicrobials [BR:br08307(D00851)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D00851  Erythromycin estolate (USP)|Drug metabolizing enzymes and transporters [br08309.html(D00851)]|Drug metabolizing enzymes|D00851|Drug transporters|D00851",
C08032,Quinupristin,,,,Antimicrobials [BR:br08307(D00852)]|Antibacterials|Protein biosynthesis inhibitor|Streptogramin|D00852  Quinupristin (JAN/USAN/INN),
C08033,Dalfopristin,,,,Antimicrobials [BR:br08307(D00853)]|Antibacterials|Protein biosynthesis inhibitor|Streptogramin|D00853  Dalfopristin (JAN/USAN/INN),
C08034,Quinupristin-dalfopristin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00854)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FG Streptogramins|J01FG02 Quinupristin/dalfopristin|D00854  Quinupristin and dalfopristin|Drug groups [BR:br08330(D00854)]|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00854  Quinupristin and dalfopristin|Antimicrobials [BR:br08307(D00854)]|Antibacterials|Protein biosynthesis inhibitor|Streptogramin|D00854  Quinupristin and dalfopristin|Antimicrobials abbreviations [BR:br08327(D00854)]|Antibacterials|Protein biosynthesis inhibitor|Streptogramin|D00854  Quinupristin and dalfopristin|New drug approvals in the USA [br08319.html(D00854)]|New molecular entities and new therapeutic biological products|D00854|New drug approvals in Japan [br08318.html(D00854)]|Drugs with new active ingredients|D00854|New drug approvals in the USA, Europe and Japan [br08328.html(D00854)]|Approval dates by FDA, EMA and PMDA|D00854|Drug metabolizing enzymes and transporters [br08309.html(D00854)]|Drug metabolizing enzymes|D00854",
C08037,Benzalkonium chloride;|Parasterol,Generic compound|R = C12H25 - C14H29,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00857)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ01 Benzalkonium|D00857  Benzalkonium chloride (JP18/NF/INN) &lt;JP&gt;|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA11 Benzalkonium|D00857  Benzalkonium chloride (JP18/NF/INN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA16 Benzalkonium|D00857  Benzalkonium chloride (JP18/NF/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00857)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2616  Medical soaps|D00857  Benzalkonium chloride (JP18/NF/INN)|2619  Others|D00857  Benzalkonium chloride (JP18/NF/INN)|7  Agents not mainly for therapeutic purpose|73  Public health agents|732  Germicides and disinfectants|7324  Invert soaps|D00857  Benzalkonium chloride (JP18/NF/INN)|Classification of Japanese OTC drugs [BR:br08313(D00857)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00857  Benzalkonium chloride (JP18/NF/INN)|Agents for sanitation|81 Disinfectants|D00857  Benzalkonium chloride (JP18/NF/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00857)]|Third-class OTC drugs|Inorganic and organic chemicals|Benzalkonium chloride|D00857  Benzalkonium chloride (JP18/NF/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C08037  Benzalkonium chloride|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9923  Invert soap and preparations|C08037  Benzalkonium chloride|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00857)]|Chemicals|D00857  Benzalkonium chloride|D00857  Benzalkonium chloride solution|D00857  Benzalkonium chloride concentrated solution 50,
C08038,Chlorhexidine gluconate;|Hibitane gluconate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00858)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB03 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA02 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AC Biguanides and amidines|D08AC02 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA12 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA05 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX09 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA09 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA04 Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00858)]|Dental and Oral Agents|Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00858)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2619  Others|D00858  Chlorhexidine gluconate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00858)]|Agents for respiratory organs|27 Gargles|D00858  Chlorhexidine gluconate (JP18/USP)|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00858  Chlorhexidine gluconate (JP18/USP)|56 Purulent skin remedies|D00858  Chlorhexidine gluconate (JP18/USP)|Agents for sanitation|81 Disinfectants|D00858  Chlorhexidine gluconate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00858)]|Second-class OTC drugs|Inorganic and organic chemicals|Chlorhexidine|D00858  Chlorhexidine gluconate (JP18/USP)|Animal drugs in Japan [BR:br08331(D00858)]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|D00858  Chlorhexidine gluconate|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|944  Agents for mastitis (except antibiotics, sulfonamide derivatives and preparations)|9449  Other agents for mastitist|C08038  Chlorhexidine gluconate|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C08038  Hibitane gluconate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00858)]|Chemicals|D00858  Chlorhexidine gluconate solution",
C08039,Hexachlorophene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00859)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AE Phenol and derivatives|D08AE01 Hexachlorophene|D00859  Hexachlorophene (USP/INN),
C08040,Iodine aqueous;|Iodine-potassium iodide complex;|Potassium triiodide,,,,,
C08042,Nitrofurazone;|5-Nitro-2-furaldehyde semicarbazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00862)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA03 Nitrofural|D00862  Nitrofurazone (USP)|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AF Nitrofuran derivatives|D08AF01 Nitrofural|D00862  Nitrofurazone (USP)|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA03 Nitrofural|D00862  Nitrofurazone (USP)|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS|P01CC Nitrofuran derivatives|P01CC02 Nitrofural|D00862  Nitrofurazone (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX04 Nitrofural|D00862  Nitrofurazone (USP)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA02 Nitrofural|D00862  Nitrofurazone (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|972  Agents affecting nitorofuran|9723  Nitrofrazone preparations|C08042  Nitrofurazone|Drug groups [BR:br08330(D00862)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|D00862  Nitrofurazone|Antimicrobials [BR:br08307(D00862)]|Antibacterials|Bactericidal action|5-Nitrofurans|D00862  Nitrofurazone (USP)|Antiparasitics|Agents against Leishmaniasis and Trypanosomiasis|Nitrofuran derivatives|D00862  Nitrofurazone (USP)|Antimicrobials abbreviations [BR:br08327(D00862)]|Antibacterials|Bactericidal action|5-Nitrofurans|D00862  Nitrofurazone (USP)",
C08043,Povidone-iodine;|Polyvinylpyrrolidone-iodine complex,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00863)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AG Iodine products|D08AG02 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA09 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AC Medicated shampoos|D11AC06 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AX Other antiinfectives and antiseptics|G01AX11 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA15 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX18 Povidone-iodine|D00863  Povidone-iodine (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00863)]|2  Agents affecting individual organs|22  Respiratory organ agents|226  Gargles|2260  Gargles|D00863  Povidone-iodine (JP18/USP)|26  Epidermides|261  Antimicrobial agents|2612  Iodates|D00863  Povidone-iodine (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00863)]|Agents for respiratory organs|27 Gargles|D00863  Povidone-iodine (JP18/USP)|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D00863  Povidone-iodine (JP18/USP)|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D00863  Povidone-iodine (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00863)]|Third-class OTC drugs|Inorganic and organic chemicals|Povidone-Iodine|D00863  Povidone-iodine (JP18/USP)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|943  Disinfectants for uterus and vagina (except antibiotics, sulfonamide and nitrofuran derivatives and preparations)|9433  Halogen derivatives and preparations|C08043  Povidone-iodine|95  Agents for external use|951  Antimicrobials for dermatologic use|9511  Iodine compounds and preparations|C08043  Povidone-iodine|956  Bath and disinfectants preparations|9569  Other bath and disinfectants preparations|C08043  Povidone-iodine|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9926  Halogen salts and preparations|C08043  Povidone-iodine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00863)]|Chemicals|D00863  Povidone-Iodine|Rx-to-OTC switch list in the USA [br08315.html(D00863)]|D00863",
C08046,Kanamycin sulfate;|Kanamycin monosulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00866)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA08 Kanamycin|D00866  Kanamycin sulfate (USP) &lt;JP&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB04 Kanamycin|D00866  Kanamycin sulfate (USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA24 Kanamycin|D00866  Kanamycin sulfate (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00866)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6123  Amino sugars|D00866  Kanamycin sulfate (USP); Kanamycin monosulfate (JP18)|Drug groups [BR:br08330(D00866)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00085  Kanamycin|D00866  Kanamycin sulfate|DG01966  Antitubercular|DG00085  Kanamycin|D00866  Kanamycin sulfate|Drug classes [BR:br08332(D00866)]|Antibacterial|DG01447  Aminoglycoside antibiotic|D00866  Kanamycin sulfate|Antimicrobials [BR:br08307(D00866)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D00866  Kanamycin sulfate (USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00866)]|Chemicals|D00866  Kanamycin monosulfate",
C08050,Sulfamethizole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00870)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA04 Sulfamethizole|D00870  Sulfamethizole (JP18/USP/INN)|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BA Sulfonamides|D06BA04 Sulfamethizole|D00870  Sulfamethizole (JP18/USP/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EB Short-acting sulfonamides|J01EB02 Sulfamethizole|D00870  Sulfamethizole (JP18/USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AB Sulfonamides|S01AB01 Sulfamethizole|D00870  Sulfamethizole (JP18/USP/INN)|Drug groups [BR:br08330(D00870)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|D00870  Sulfamethizole|Antimicrobials [BR:br08307(D00870)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D00870  Sulfamethizole (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00870)]|Chemicals|D00870  Sulfamethizole,
C08051,Sulfacetamide sodium anhydrous,,,,,
C08052,Cinoxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00872)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MB Other quinolones|J01MB06 Cinoxacin|D00872  Cinoxacin (JP18/USP/INN)|Drug groups [BR:br08330(D00872)]|Antibacterial|DG01550  Quinolone|D00872  Cinoxacin|Antimicrobials [BR:br08307(D00872)]|Antibacterials|Nucleic acid synthesis inhibitor|Other quinolone|D00872  Cinoxacin (JP18/USP/INN)|Antimicrobials abbreviations [BR:br08327(D00872)]|Antibacterials|Nucleic acid synthesis inhibitor|Other quinolone|D00872  Cinoxacin (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00872)]|Chemicals|D00872  Cinoxacin|D00872  Cinoxacin capsules,
C08053,Lomefloxacin hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00873)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA07 Lomefloxacin|D00873  Lomefloxacin hydrochloride (JAN/USAN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE04 Lomefloxacin|D00873  Lomefloxacin hydrochloride (JAN/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00873)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00873  Lomefloxacin hydrochloride (JAN/USAN)|132  Otic and nasal agents|1329  Others|D00873  Lomefloxacin hydrochloride (JAN/USAN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D00873  Lomefloxacin hydrochloride (JAN/USAN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9734  Quinolone, derivatives and preparations|C08053  Lomefloxacin hydrochloride|Drug groups [BR:br08330(D00873)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00621  Lomefloxacin|D00873  Lomefloxacin hydrochloride|Drug classes [BR:br08332(D00873)]|Antibacterial|DG01549  Fluoroquinolone|D00873  Lomefloxacin hydrochloride|Antimicrobials [BR:br08307(D00873)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00873  Lomefloxacin hydrochloride (JAN/USAN) &lt;JP&gt;",
C08054,Moxifloxacin hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00874)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA14 Moxifloxacin|D00874  Moxifloxacin hydrochloride (JAN/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE07 Moxifloxacin|D00874  Moxifloxacin hydrochloride (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00874)]|Antibacterials|Quinolones|Moxifloxacin|D00874  Moxifloxacin hydrochloride (JAN/USP)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Moxifloxacin|D00874  Moxifloxacin hydrochloride (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00874)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00874  Moxifloxacin hydrochloride (JAN/USP)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D00874  Moxifloxacin hydrochloride (JAN/USP)|Drug groups [BR:br08330(D00874)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00626  Moxifloxacin|D00874  Moxifloxacin hydrochloride|Drug classes [BR:br08332(D00874)]|Antibacterial|DG01549  Fluoroquinolone|D00874  Moxifloxacin hydrochloride|Antimicrobials [BR:br08307(D00874)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D00874  Moxifloxacin hydrochloride (JAN/USP) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00874)]|New molecular entities and new therapeutic biological products|D00874|New drug approvals in Japan [br08318.html(D00874)]|Drugs with new active ingredients|D00874|New drug approvals in the USA, Europe and Japan [br08328.html(D00874)]|Approval dates by FDA, EMA and PMDA|D00874",
C08055,Aminosalicylate sodium anhydrous;|Sodium p-aminosalicylate,,,,,
C08057,Cycloserine;|D-Cycloserine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00877)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB01 Cycloserine|D00877  Cycloserine (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00877)]|Antimycobacterials|Antituberculars|Cycloserine|D00877  Cycloserine (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00877)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|616  Acting mainly on acid-fast bacteria|6162  Cycloserines|D00877  Cycloserine (JP18/USP/INN)|Drug groups [BR:br08330(D00877)]|Antibacterial|DG01966  Antitubercular|D00877  Cycloserine|Antimicrobials [BR:br08307(D00877)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Other peptidoglycan biosynthesis inhibitor|D00877  Cycloserine (JP18/USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00877)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Other peptidoglycan biosynthesis inhibitor|D00877  Cycloserine (JP17/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00877)]|Chemicals|D00877  Cycloserine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08057",
C08059,Rifapentine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00879)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB05 Rifapentine|D00879  Rifapentine (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00879)]|Antimycobacterials|Antituberculars|Rifapentine|D00879  Rifapentine (USAN/INN)|Drug groups [BR:br08330(D00879)]|Antibacterial|DG01966  Antitubercular|DG01598  Rifamycin antibiotic|D00879  Rifapentine|Metabolizing enzyme inducer|DG01640  CYP2C8 inducer|D00879  Rifapentine|DG02886  CYP2C9 inducer|D00879  Rifapentine|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|D00879  Rifapentine|Antimicrobials [BR:br08307(D00879)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D00879  Rifapentine (USAN/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D00879)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D00879  Rifapentine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D00879)]|Drug metabolizing enzymes|D00879,
C08060,Carbazole;|9H-Carbazole,,,,,
C08061,"2'-Aminobiphenyl-2,3-diol",,,,,
C08062,"2-Hydroxy-6-oxo-(2'-aminophenyl)-hexa-2,4-dienoate",,,,,
C08063,"1,4-Cyclohexanedione",,,,,
C08064,Saponarin;|Isovitexin-7-O-beta-D-glucopyranoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C08064  Saponarin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C08064  Saponarin|Glycosides [BR:br08021]|C-glycosides|C08064  Saponarin,
C08065,Butoconazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07598)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF15 Butoconazole|D07598  Butoconazole (INN)|Drug groups [BR:br08330(D07598)]|Antifungal|DG01883  Imidazole antifungal|DG00444  Butoconazole|D07598  Butoconazole|Antimicrobials [BR:br08307(D07598)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D07598  Butoconazole (INN)",
C08066,Butoconazole nitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00880)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF15 Butoconazole|D00880  Butoconazole nitrate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00880)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Butoconazole|D00880  Butoconazole nitrate (USP)|Drug groups [BR:br08330(D00880)]|Antifungal|DG01883  Imidazole antifungal|DG00444  Butoconazole|D00880  Butoconazole nitrate|Drug classes [BR:br08332(D00880)]|Antifungal|DG01883  Imidazole antifungal|D00880  Butoconazole nitrate|Antimicrobials [BR:br08307(D00880)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00880  Butoconazole nitrate (USP) &lt;US&gt;|Rx-to-OTC switch list in the USA [br08315.html(D00880)]|D00880",
C08067,Butenafine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07596)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE23 Butenafine|D07596  Butenafine (INN)|Risk category of Japanese OTC drugs [BR:br08312(D07596)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Butenafine|D07596  Butenafine (INN)|Second-class OTC drugs|Inorganic and organic chemicals|Butenafine|D07596  Butenafine (INN)|Antimicrobials [BR:br08307(D07596)]|Antifungals|Ergosterol biosynthesis inhibitor|Other ergosterol biosynthesis inhibitor|D07596  Butenafine (INN),
C08068,Econazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03936)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC03 Econazole|D03936  Econazole (USAN/INN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF05 Econazole|D03936  Econazole (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D03936)]|Second-class OTC drugs|Inorganic and organic chemicals|Econazole|D03936  Econazole (USAN/INN)|Drug groups [BR:br08330(D03936)]|Antifungal|DG01883  Imidazole antifungal|DG00363  Econazole|D03936  Econazole|Antimicrobials [BR:br08307(D03936)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D03936  Econazole (USAN/INN)",
C08069,Econazole nitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00881)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC03 Econazole|D00881  Econazole nitrate (JAN/USP) &lt;US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF05 Econazole|D00881  Econazole nitrate (JAN/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00881)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Econazole|D00881  Econazole nitrate (JAN/USP)|Classification of Japanese OTC drugs [BR:br08313(D00881)]|Agents for integumentary system|58 Ringworm drugs|D00881  Econazole nitrate (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00881)]|Second-class OTC drugs|Inorganic and organic chemicals|Econazole|D00881  Econazole nitrate (JAN/USP)|Drug groups [BR:br08330(D00881)]|Antifungal|DG01883  Imidazole antifungal|DG00363  Econazole|D00881  Econazole nitrate|Drug classes [BR:br08332(D00881)]|Antifungal|DG01883  Imidazole antifungal|D00881  Econazole nitrate|Antimicrobials [BR:br08307(D00881)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00881  Econazole nitrate (JAN/USP) &lt;US&gt;|Rx-to-OTC switch list in Japan [br08314.html(D00881)]|D00881",
C08070,Miconazole nitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00882)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB09 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AC Imidazole derivatives|A07AC01 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC02 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF04 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AB Imidazole derivatives|J02AB01 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA13 Miconazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00882)]|Antifungals|Miconazole|D00882  Miconazole nitrate (JP18/USP)|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Miconazole|D00882  Miconazole nitrate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00882)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00882  Miconazole nitrate (JP18/USP)|26  Epidermides|265  Antiparasitic dermatosis agents|2655  Imidazoles|D00882  Miconazole nitrate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00882)]|Drugs for women|51 Other drugs for women|D00882  Miconazole nitrate (JP18/USP)|Agents for integumentary system|58 Ringworm drugs|D00882  Miconazole nitrate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00882)]|First-class OTC drugs|Inorganic and organic chemicals|Miconazole|D00882  Miconazole nitrate (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Miconazole|D00882  Miconazole nitrate (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C08070  Miconazole nitrate|Drug groups [BR:br08330(D00882)]|Antifungal|DG01883  Imidazole antifungal|DG00004  Miconazole|D00882  Miconazole nitrate|Metabolizing enzyme inhibitor|DG01643  CYP2C9 inhibitor|DG00004  Miconazole|D00882  Miconazole nitrate|DG02852  CYP3A/CYP3A4 inhibitor|DG00004  Miconazole|D00882  Miconazole nitrate|Drug classes [BR:br08332(D00882)]|Antifungal|DG01883  Imidazole antifungal|D00882  Miconazole nitrate|Antimicrobials [BR:br08307(D00882)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00882  Miconazole nitrate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00882)]|Chemicals|D00882  Miconazole nitrate|Drug metabolizing enzymes and transporters [br08309.html(D00882)]|Drug metabolizing enzymes|D00882|Rx-to-OTC switch list in the USA [br08315.html(D00882)]|D00882|Rx-to-OTC switch list in Japan [br08314.html(D00882)]|D00882",
C08071,Naftifine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08245)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE22 Naftifine|D08245  Naftifine (INN)|Antimicrobials [BR:br08307(D08245)]|Antifungals|Ergosterol biosynthesis inhibitor|Other ergosterol biosynthesis inhibitor|D08245  Naftifine (INN),
C08072,Naftifine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00883)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE22 Naftifine|D00883  Naftifine hydrochloride (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00883)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Naftifine|D00883  Naftifine hydrochloride (USP)|Antimicrobials [BR:br08307(D00883)]|Antifungals|Ergosterol biosynthesis inhibitor|Other ergosterol biosynthesis inhibitor|D00883  Naftifine hydrochloride (USP) &lt;US&gt;",
C08073,Natamycin;|Pimaricin,,0 Mak  1 Mad  2 Mad  3 Mad  4 Mad  5 Mak  6 Mak  7 Mtk  8 Man|9 Mak  10 Mad  11 Mad  12 Man,PK,"Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C08073  Natamycin|Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C08073  Natamycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00884)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB10 Natamycin|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA03 Natamycin|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA02 Natamycin|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA02 Natamycin|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA10 Natamycin|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00884)]|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antifungal, Ophthalmic|Natamycin|D00884  Natamycin (USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00884)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1317  Ophthalmic antibiotics|D00884  Natamycin (USP/INN); Pimaricin (JP18)|Antimicrobials [BR:br08307(D00884)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00884  Natamycin (USP/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00884)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D00884  Natamycin (USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00884)]|Chemicals|D00884  Pimaricin",
C08074,Oxiconazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08313)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC11 Oxiconazole|D08313  Oxiconazole (INN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF17 Oxiconazole|D08313  Oxiconazole (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08313)]|First-class OTC drugs|Inorganic and organic chemicals|Oxiconazole|D08313  Oxiconazole (INN)|Second-class OTC drugs|Inorganic and organic chemicals|Oxiconazole|D08313  Oxiconazole (INN)|Drug groups [BR:br08330(D08313)]|Antifungal|DG01883  Imidazole antifungal|DG00367  Oxiconazole|D08313  Oxiconazole|Antimicrobials [BR:br08307(D08313)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D08313  Oxiconazole (INN)",
C08075,Oxiconazole nitrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00885)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC11 Oxiconazole|D00885  Oxiconazole nitrate (JAN/USAN) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF17 Oxiconazole|D00885  Oxiconazole nitrate (JAN/USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00885)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Oxiconazole|D00885  Oxiconazole nitrate (JAN/USAN)|Therapeutic category of drugs in Japan [BR:br08301(D00885)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00885  Oxiconazole nitrate (JAN/USAN)|26  Epidermides|265  Antiparasitic dermatosis agents|2655  Imidazoles|D00885  Oxiconazole nitrate (JAN/USAN)|Classification of Japanese OTC drugs [BR:br08313(D00885)]|Drugs for women|51 Other drugs for women|D00885  Oxiconazole nitrate (JAN/USAN)|Agents for integumentary system|58 Ringworm drugs|D00885  Oxiconazole nitrate (JAN/USAN)|Risk category of Japanese OTC drugs [BR:br08312(D00885)]|Drugs requiring guidance|New approved switch OTC drugs|Oxiconazole nitrate|D00885  Oxiconazole nitrate (JAN/USAN)|First-class OTC drugs|Inorganic and organic chemicals|Oxiconazole|D00885  Oxiconazole nitrate (JAN/USAN)|Second-class OTC drugs|Inorganic and organic chemicals|Oxiconazole|D00885  Oxiconazole nitrate (JAN/USAN)|Drug groups [BR:br08330(D00885)]|Antifungal|DG01883  Imidazole antifungal|DG00367  Oxiconazole|D00885  Oxiconazole nitrate|Drug classes [BR:br08332(D00885)]|Antifungal|DG01883  Imidazole antifungal|D00885  Oxiconazole nitrate|Antimicrobials [BR:br08307(D00885)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00885  Oxiconazole nitrate (JAN/USAN) &lt;JP/US&gt;|Rx-to-OTC switch list in Japan [br08314.html(D00885)]|D00885",
C08076,Sulconazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08535)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC09 Sulconazole|D08535  Sulconazole (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08535)]|Second-class OTC drugs|Inorganic and organic chemicals|Sulconazole|D08535  Sulconazole (INN)|Drug groups [BR:br08330(D08535)]|Antifungal|DG01883  Imidazole antifungal|DG00366  Sulconazole|D08535  Sulconazole|Antimicrobials [BR:br08307(D08535)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D08535  Sulconazole (INN),
C08079,Terbinafine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02375)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE15 Terbinafine|D02375  Terbinafine (USAN/INN)|D01B ANTIFUNGALS FOR SYSTEMIC USE|D01BA Antifungals for systemic use|D01BA02 Terbinafine|D02375  Terbinafine (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D02375)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Terbinafine|D02375  Terbinafine (USAN/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Terbinafine|D02375  Terbinafine (USAN/INN)|Drug groups [BR:br08330(D02375)]|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|DG00375  Terbinafine|D02375  Terbinafine|DG02918  CYP2C8 substrate|DG00375  Terbinafine|D02375  Terbinafine|DG01642  CYP2C9 substrate|DG00375  Terbinafine|D02375  Terbinafine|DG01639  CYP2C19 substrate|DG00375  Terbinafine|D02375  Terbinafine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00375  Terbinafine|D02375  Terbinafine|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|DG00375  Terbinafine|D02375  Terbinafine|Antimicrobials [BR:br08307(D02375)]|Antifungals|Ergosterol biosynthesis inhibitor|Other ergosterol biosynthesis inhibitor|D02375  Terbinafine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D02375)]|Drug metabolizing enzymes|D02375,
C08080,Terconazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00888)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AG Triazole derivatives|G01AG02 Terconazole|D00888  Terconazole (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00888)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Terconazole|D00888  Terconazole (USP/INN)|Drug groups [BR:br08330(D00888)]|Antifungal|DG01523  Triazole antifungal|D00888  Terconazole|Drug classes [BR:br08332(D00888)]|Antifungal|DG01523  Triazole antifungal|D00888  Terconazole|Antimicrobials [BR:br08307(D00888)]|Antifungals|Ergosterol biosynthesis inhibitor|Triazole|D00888  Terconazole (USP/INN) &lt;US&gt;",
C08082,Tioconazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00890)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC07 Tioconazole|D00890  Tioconazole (JAN/USP/INN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AF Imidazole derivatives|G01AF08 Tioconazole|D00890  Tioconazole (JAN/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00890)]|Second-class OTC drugs|Inorganic and organic chemicals|Tioconazole|D00890  Tioconazole (JAN/USP/INN)|Drug groups [BR:br08330(D00890)]|Antifungal|DG01883  Imidazole antifungal|D00890  Tioconazole|Antimicrobials [BR:br08307(D00890)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D00890  Tioconazole (JAN/USP/INN)|Rx-to-OTC switch list in the USA [br08315.html(D00890)]|D00890|Rx-to-OTC switch list in Japan [br08314.html(D00890)]|D00890",
C08086,Amprenavir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00894)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE05 Amprenavir|D00894  Amprenavir (JAN/USAN/INN)|Drug groups [BR:br08330(D00894)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|D00894  Amprenavir|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00894  Amprenavir|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|D00894  Amprenavir|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|D00894  Amprenavir|Antimicrobials [BR:br08307(D00894)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00894  Amprenavir (JAN/USAN/INN)|Antimicrobials abbreviations [BR:br08327(D00894)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00894  Amprenavir (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D00894)]|New molecular entities and new therapeutic biological products|D00894|New drug approvals in the USA, Europe and Japan [br08328.html(D00894)]|Approval dates by FDA, EMA and PMDA|D00894|Drug metabolizing enzymes and transporters [br08309.html(D00894)]|Drug metabolizing enzymes|D00894|Prodrugs [br08324.html(D00894)]|D00894|Prodrugs [br08324.html]|C08086",
C08087,Delavirdine mesylate;|Delavirdine mesilate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00895)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AG Non-nucleoside reverse transcriptase inhibitors|J05AG02 Delavirdine|D00895  Delavirdine mesylate (USAN)|Drug groups [BR:br08330(D00895)]|Antiviral|DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)|DG00662  Delavirdine|D00895  Delavirdine mesylate|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|DG00662  Delavirdine|D00895  Delavirdine mesylate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00662  Delavirdine|D00895  Delavirdine mesylate|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00662  Delavirdine|D00895  Delavirdine mesylate|Antimicrobials [BR:br08307(D00895)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00895  Delavirdine mesylate (USAN)|New drug approvals in Japan [br08318.html(D00895)]|Drugs with new active ingredients|D00895|Drug metabolizing enzymes and transporters [br08309.html(D00895)]|Drug metabolizing enzymes|D00895,
C08088,Efavirenz,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00896)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AG Non-nucleoside reverse transcriptase inhibitors|J05AG03 Efavirenz|D00896  Efavirenz (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00896)]|Antivirals|Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)|Efavirenz|D00896  Efavirenz (JAN/USP/INN)|Drug groups [BR:br08330(D00896)]|Antiviral|DG01889  Non-nucleoside reverse transcriptase inhibitor (NNRTI)|D00896  Efavirenz|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D00896  Efavirenz|Metabolizing enzyme substrate|DG02919  CYP2B6 substrate|D00896  Efavirenz|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00896  Efavirenz|Metabolizing enzyme inducer|DG02891  CYP2B6 inducer|D00896  Efavirenz|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|D00896  Efavirenz|Drug classes [BR:br08332(D00896)]|Antiviral|DG03107  Anti-HIV agent|D00896  Efavirenz|Antimicrobials [BR:br08307(D00896)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00896  Efavirenz (JAN/USP/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D00896)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D00896  Efavirenz (JAN/USP/INN)|New drug approvals in Europe [br08329.html(D00896)]|European public assessment reports (EPAR) authorised medicine|D00896|Drug metabolizing enzymes and transporters [br08309.html(D00896)]|Drug metabolizing enzymes|D00896|Pharmacogenomic biomarkers [br08341.html(D00896)]|Polymorphisms and mutations affecting drug response|D00896",
C08089,Indinavir sulfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00897)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE02 Indinavir|D00897  Indinavir sulfate (USP)|Drug groups [BR:br08330(D00897)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|DG00654  Indinavir|D00897  Indinavir sulfate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00654  Indinavir|D00897  Indinavir sulfate|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00654  Indinavir|D00897  Indinavir sulfate|Antimicrobials [BR:br08307(D00897)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00897  Indinavir sulfate (USP)|New drug approvals in Europe [br08329.html(D00897)]|European public assessment reports (EPAR) authorised medicine|D00897|Drug metabolizing enzymes and transporters [br08309.html(D00897)]|Drug metabolizing enzymes|D00897,
C08090,Dienestrol;|Dehydrostilbestrol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00898)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CB Synthetic estrogens, plain|G03CB01 Dienestrol|D00898  Dienestrol (USP/INN)|G03CC Estrogens, combinations with other drugs|G03CC02 Dienestrol|D00898  Dienestrol (USP/INN)|Drug groups [BR:br08330(D00898)]|Hormonal agent|DG01584  Estrogen receptor agonist|D00898  Dienestrol|Target-based classification of drugs [BR:br08310(D00898)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00898  Dienestrol (USP/INN)",
C08091,Nelfinavir mesylate;|Nelfinavir mesilate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00899)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE04 Nelfinavir|D00899  Nelfinavir mesylate (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00899)]|Antivirals|Anti-HIV Agents, Protease Inhibitors (PI)|Nelfinavir|D00899  Nelfinavir mesylate (USAN/INN)|Drug groups [BR:br08330(D00899)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|DG00655  Nelfinavir|D00899  Nelfinavir mesylate|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00655  Nelfinavir|D00899  Nelfinavir mesylate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00655  Nelfinavir|D00899  Nelfinavir mesylate|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00655  Nelfinavir|D00899  Nelfinavir mesylate|Drug classes [BR:br08332(D00899)]|Antiviral|DG03107  Anti-HIV agent|D00899  Nelfinavir mesylate|Antimicrobials [BR:br08307(D00899)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D00899  Nelfinavir mesylate (USAN/INN) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00899)]|Drug metabolizing enzymes|D00899",
C08092,Oseltamivir,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08306)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AH Neuraminidase inhibitors|J05AH02 Oseltamivir|D08306  Oseltamivir (INN)|Drug groups [BR:br08330(D08306)]|Antiviral|DG03029  Anti-influenza virus agent|DG02842  Neuraminidase inhibitor|DG00665  Oseltamivir|D08306  Oseltamivir|Antimicrobials [BR:br08307(D08306)]|Antivirals|Virus release inhibitor|Neuraminidase inhibitor|D08306  Oseltamivir (INN),
C08093,Oseltamivir phosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00900)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AH Neuraminidase inhibitors|J05AH02 Oseltamivir|D00900  Oseltamivir phosphate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00900)]|Antivirals|Anti-influenza Agents|Oseltamivir|D00900  Oseltamivir phosphate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00900)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|625  Antivirals|6250  Antivirals|D00900  Oseltamivir phosphate (JAN/USP)|Drug groups [BR:br08330(D00900)]|Antiviral|DG03029  Anti-influenza virus agent|DG02842  Neuraminidase inhibitor|DG00665  Oseltamivir|D00900  Oseltamivir phosphate|Drug classes [BR:br08332(D00900)]|Antiviral|DG03029  Anti-influenza virus agent|D00900  Oseltamivir phosphate|Antimicrobials [BR:br08307(D00900)]|Antivirals|Virus release inhibitor|Neuraminidase inhibitor|D00900  Oseltamivir phosphate (JAN/USP) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00900)]|New molecular entities and new therapeutic biological products|D00900|New drug approvals in Europe [br08329.html(D00900)]|European public assessment reports (EPAR) authorised medicine|D00900|New drug approvals in Japan [br08318.html(D00900)]|Drugs with new active ingredients|D00900|New drug approvals in the USA, Europe and Japan [br08328.html(D00900)]|Approval dates by FDA, EMA and PMDA|D00900",
C08094,Rimantadine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00901)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AC Cyclic amines|J05AC02 Rimantadine|D00901  Rimantadine hydrochloride (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00901)]|Antivirals|Anti-influenza Agents|Rimantadine|D00901  Rimantadine hydrochloride (USP)|Drug groups [BR:br08330(D00901)]|Antiviral|DG03029  Anti-influenza virus agent|DG02841  Viral uncoating inhibitor|DG00650  Rimantadine|D00901  Rimantadine hydrochloride|Drug classes [BR:br08332(D00901)]|Antiviral|DG03029  Anti-influenza virus agent|D00901  Rimantadine hydrochloride|Antimicrobials [BR:br08307(D00901)]|Antivirals|Entry, fusion or uncoating inhibitor|Influenza virus uncoating inhibitor|D00901  Rimantadine hydrochloride (USP) &lt;US&gt;",
C08095,Zanamivir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00902)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AH Neuraminidase inhibitors|J05AH01 Zanamivir|D00902  Zanamivir (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00902)]|Antivirals|Anti-influenza Agents|Zanamivir|D00902  Zanamivir (USP/INN)|Drug groups [BR:br08330(D00902)]|Antiviral|DG03029  Anti-influenza virus agent|DG02842  Neuraminidase inhibitor|DG00664  Zanamivir|D00902  Zanamivir|Drug classes [BR:br08332(D00902)]|Antiviral|DG03029  Anti-influenza virus agent|D00902  Zanamivir|Antimicrobials [BR:br08307(D00902)]|Antivirals|Virus release inhibitor|Neuraminidase inhibitor|D00902  Zanamivir (USP/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D00902)]|New molecular entities and new therapeutic biological products|D00902|New drug approvals in the USA, Europe and Japan [br08328.html(D00902)]|Approval dates by FDA, EMA and PMDA|D00902",
C08098,Cefazolin sodium;|Cefazolin sodium salt,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00905)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB04 Cefazolin|D00905  Cefazolin sodium (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00905)]|Antibacterials|Beta-lactam, Cephalosporins|Cefazolin|D00905  Cefazolin sodium (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00905)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00905  Cefazolin sodium (JP18/USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9763  Antibiotic preparations for external use, pessaries and suppositories|C08098  Cefazolin sodium|Drug groups [BR:br08330(D00905)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00550  Cefazolin|D00905  Cefazolin sodium|DG01774  First-generation cephalosporin|DG00550  Cefazolin|D00905  Cefazolin sodium|Drug classes [BR:br08332(D00905)]|Antibacterial|DG01488  Cephem|D00905  Cefazolin sodium|Antimicrobials [BR:br08307(D00905)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00905  Cefazolin sodium (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00905)]|Chemicals|D00905  Cefazolin sodium|D00905  Cefazolin sodium for injection",
C08099,Cephalexin monohydrate;|Cephalexin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00906)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB01 Cefalexin|D00906  Cephalexin (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00906)]|Antibacterials|Beta-lactam, Cephalosporins|Cephalexin|D00906  Cephalexin (USP)|Drug groups [BR:br08330(D00906)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00548  Cephalexin|D00906  Cephalexin|DG01774  First-generation cephalosporin|DG00548  Cephalexin|D00906  Cephalexin|Drug classes [BR:br08332(D00906)]|Antibacterial|DG01488  Cephem|D00906  Cephalexin|Antimicrobials [BR:br08307(D00906)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00906  Cephalexin (USP) &lt;US&gt;",
C08100,Cephalothin sodium;|Cefalotin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00907)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB03 Cefalotin|D00907  Cephalothin sodium (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00907)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00907  Cephalothin sodium (USP); Cefalotin sodium (JP18)|Drug groups [BR:br08330(D00907)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00549  Cefalotin|D00907  Cephalothin sodium|DG01774  First-generation cephalosporin|DG00549  Cefalotin|D00907  Cephalothin sodium|Drug classes [BR:br08332(D00907)]|Antibacterial|DG01488  Cephem|D00907  Cephalothin sodium|Antimicrobials [BR:br08307(D00907)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00907  Cephalothin sodium (USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00907)]|Chemicals|D00907  Cefalotin sodium|D00907  Cephalothin sodium for injection",
C08101,Cephapirin sodium;|Cefapirin sodium;|Sodium cefapirin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00908)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB08 Cefapirin|D00908  Cephapirin sodium (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9763  Antibiotic preparations for external use, pessaries and suppositories|C08101  Cephapirin sodium|Drug groups [BR:br08330(D00908)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00553  cephapirin|D00908  Cephapirin sodium|DG01774  First-generation cephalosporin|DG00553  cephapirin|D00908  Cephapirin sodium|Antimicrobials [BR:br08307(D00908)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D00908  Cephapirin sodium (USP)",
C08102,Cefamandole nafate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00909)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC03 Cefamandole|D00909  Cefamandole nafate (USP)|Drug groups [BR:br08330(D00909)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00559  Cefamandole|D00909  Cefamandole nafate|DG01775  Second-generation cephalosporin|DG00559  Cefamandole|D00909  Cefamandole nafate|Antimicrobials [BR:br08307(D00909)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00909  Cefamandole nafate (USP)",
C08103,Cefmetazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00910)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC09 Cefmetazole|D00910  Cefmetazole (USP/INN)|Drug groups [BR:br08330(D00910)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00565  Cefmetazole|D00910  Cefmetazole|DG01775  Second-generation cephalosporin|DG00565  Cefmetazole|D00910  Cefmetazole|Antimicrobials [BR:br08307(D00910)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00910  Cefmetazole (USP/INN)",
C08104,Cefmetazole sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00911)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC09 Cefmetazole|D00911  Cefmetazole sodium (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00911)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00911  Cefmetazole sodium (JP18/USP)|Drug groups [BR:br08330(D00911)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00565  Cefmetazole|D00911  Cefmetazole sodium|DG01775  Second-generation cephalosporin|DG00565  Cefmetazole|D00911  Cefmetazole sodium|Drug classes [BR:br08332(D00911)]|Antibacterial|DG01488  Cephem|D00911  Cefmetazole sodium|Antimicrobials [BR:br08307(D00911)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00911  Cefmetazole sodium (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00911)]|Chemicals|D00911  Cefmetazole sodium|D00911  Cefmetazole sodium for injection",
C08105,Cefonicid sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00912)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC06 Cefonicid|D00912  Cefonicid sodium (USP)|Drug groups [BR:br08330(D00912)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00562  Cefonicid|D00912  Cefonicid sodium|DG01775  Second-generation cephalosporin|DG00562  Cefonicid|D00912  Cefonicid sodium|Antimicrobials [BR:br08307(D00912)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00912  Cefonicid sodium (USP)",
C08106,Cefoxitin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00913)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC01 Cefoxitin|D00913  Cefoxitin sodium (JAN/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00913)]|Antibacterials|Beta-lactam, Cephalosporins|Cefoxitin|D00913  Cefoxitin sodium (JAN/USP)|Drug groups [BR:br08330(D00913)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00557  Cefoxitin|D00913  Cefoxitin sodium|DG01775  Second-generation cephalosporin|DG00557  Cefoxitin|D00913  Cefoxitin sodium|Drug classes [BR:br08332(D00913)]|Antibacterial|DG01488  Cephem|D00913  Cefoxitin sodium|Antimicrobials [BR:br08307(D00913)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00913  Cefoxitin sodium (JAN/USP) &lt;US&gt;",
C08107,Cefuroxime axetil;|Cefuroxime 1-acetoxyethyl ester,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00914)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC02 Cefuroxime|D00914  Cefuroxime axetil (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA27 Cefuroxime|D00914  Cefuroxime axetil (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00914)]|Antibacterials|Beta-lactam, Cephalosporins|Cefuroxime|D00914  Cefuroxime axetil (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00914)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00914  Cefuroxime axetil (JP18/USP/INN)|Drug groups [BR:br08330(D00914)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00558  Cefuroxime|D00914  Cefuroxime axetil|DG01775  Second-generation cephalosporin|DG00558  Cefuroxime|D00914  Cefuroxime axetil|DG01804  Oxyimino beta-lactam|DG00558  Cefuroxime|D00914  Cefuroxime axetil|Drug classes [BR:br08332(D00914)]|Antibacterial|DG01488  Cephem|D00914  Cefuroxime axetil|Antimicrobials [BR:br08307(D00914)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00914  Cefuroxime axetil (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00914)]|Chemicals|D00914  Cefuroxime axetil|Prodrugs [br08324.html(D00914)]|D00914|Prodrugs [br08324.html]|C08107",
C08108,Cefuroxime sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00915)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC02 Cefuroxime|D00915  Cefuroxime sodium (JAN/USP) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA27 Cefuroxime|D00915  Cefuroxime sodium (JAN/USP) &lt;US&gt;|USP drug classification [BR:br08302(D00915)]|Antibacterials|Beta-lactam, Cephalosporins|Cefuroxime|D00915  Cefuroxime sodium (JAN/USP)|Drug groups [BR:br08330(D00915)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00558  Cefuroxime|D00915  Cefuroxime sodium|DG01775  Second-generation cephalosporin|DG00558  Cefuroxime|D00915  Cefuroxime sodium|DG01804  Oxyimino beta-lactam|DG00558  Cefuroxime|D00915  Cefuroxime sodium|Drug classes [BR:br08332(D00915)]|Antibacterial|DG01488  Cephem|D00915  Cefuroxime sodium|Antimicrobials [BR:br08307(D00915)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00915  Cefuroxime sodium (JAN/USP) &lt;US&gt;",
C08109,Loracarbef monohydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00916)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC08 Loracarbef|D00916  Loracarbef (USP)|Drug groups [BR:br08330(D00916)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01711  Carbacephem|DG00564  Loracarbef|D00916  Loracarbef|DG01775  Second-generation cephalosporin|DG00564  Loracarbef|D00916  Loracarbef|Antimicrobials [BR:br08307(D00916)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D00916  Loracarbef (USP)",
C08110,Cefdinir,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00917)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD15 Cefdinir|D00917  Cefdinir (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00917)]|Antibacterials|Beta-lactam, Cephalosporins|Cefdinir|D00917  Cefdinir (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00917)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00917  Cefdinir (JP18/USP/INN)|Drug groups [BR:br08330(D00917)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG03053  Cefdinir|D00917  Cefdinir|DG01776  Third-generation cephalosporin|DG03053  Cefdinir|D00917  Cefdinir|DG01804  Oxyimino beta-lactam|DG03053  Cefdinir|D00917  Cefdinir|Drug classes [BR:br08332(D00917)]|Antibacterial|DG01488  Cephem|D00917  Cefdinir|Antimicrobials [BR:br08307(D00917)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00917  Cefdinir (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00917)]|Chemicals|D00917  Cefdinir|D00917  Cefdinir capsules|D00917  Cefdinir fine granules",
C08111,Cefepime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02376)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DE Fourth-generation cephalosporins|J01DE01 Cefepime|D02376  Cefepime (USAN/INN)|Drug groups [BR:br08330(D02376)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00586  Cefepime|D02376  Cefepime|DG01777  Fourth-generation cephalosporin|DG00586  Cefepime|D02376  Cefepime|DG01804  Oxyimino beta-lactam|DG00586  Cefepime|D02376  Cefepime|Antimicrobials [BR:br08307(D02376)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Fourth-generation cephalosporin|D02376  Cefepime (USAN/INN)",
C08112,Cefoperazone sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00918)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD12 Cefoperazone|D00918  Cefoperazone sodium (JP18/USP)|Drug groups [BR:br08330(D00918)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00581  Cefoperazone|D00918  Cefoperazone sodium|DG01776  Third-generation cephalosporin|DG00581  Cefoperazone|D00918  Cefoperazone sodium|Antimicrobials [BR:br08307(D00918)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00918  Cefoperazone sodium (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00918)]|Chemicals|D00918  Cefoperazone sodium|D00918  Cefoperazone sodium for injection",
C08113,Cefotaxime sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00919)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD01 Cefotaxime|D00919  Cefotaxime sodium (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00919)]|Antibacterials|Beta-lactam, Cephalosporins|Cefotaxime|D00919  Cefotaxime sodium (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00919)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00919  Cefotaxime sodium (JP18/USP)|Drug groups [BR:br08330(D00919)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00570  Cefotaxime|D00919  Cefotaxime sodium|DG01776  Third-generation cephalosporin|DG00570  Cefotaxime|D00919  Cefotaxime sodium|DG01804  Oxyimino beta-lactam|DG00570  Cefotaxime|D00919  Cefotaxime sodium|Drug classes [BR:br08332(D00919)]|Antibacterial|DG01488  Cephem|D00919  Cefotaxime sodium|Antimicrobials [BR:br08307(D00919)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00919  Cefotaxime sodium (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00919)]|Chemicals|D00919  Cefotaxime sodium",
C08114,Cefpodoxime,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07650)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD13 Cefpodoxime|D07650  Cefpodoxime (INN)|Drug groups [BR:br08330(D07650)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00582  Cefpodoxime|D07650  Cefpodoxime|DG01776  Third-generation cephalosporin|DG00582  Cefpodoxime|D07650  Cefpodoxime|DG01804  Oxyimino beta-lactam|DG00582  Cefpodoxime|D07650  Cefpodoxime|Antimicrobials [BR:br08307(D07650)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07650  Cefpodoxime (INN)|Prodrugs [br08324.html(D07650)]|D07650|Prodrugs [br08324.html]|C08114",
C08115,Cefpodoxime proxetil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00920)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD13 Cefpodoxime|D00920  Cefpodoxime proxetil (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00920)]|Antibacterials|Beta-lactam, Cephalosporins|Cefpodoxime|D00920  Cefpodoxime proxetil (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00920)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00920  Cefpodoxime proxetil (JP18/USP)|Drug groups [BR:br08330(D00920)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00582  Cefpodoxime|D00920  Cefpodoxime proxetil|DG01776  Third-generation cephalosporin|DG00582  Cefpodoxime|D00920  Cefpodoxime proxetil|DG01804  Oxyimino beta-lactam|DG00582  Cefpodoxime|D00920  Cefpodoxime proxetil|Drug classes [BR:br08332(D00920)]|Antibacterial|DG01488  Cephem|D00920  Cefpodoxime proxetil|Antimicrobials [BR:br08307(D00920)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00920  Cefpodoxime proxetil (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00920)]|Chemicals|D00920  Cefpodoxime proxetil|D00920  Cefpodoxime proxetil tablets|D00920  Cefpodoxime proxetil for syrup|Prodrugs [br08324.html(D00920)]|D00920|Prodrugs [br08324.html]|C08115",
C08117,Ceftibuten,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00922)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD14 Ceftibuten|D00922  Ceftibuten (USAN/INN)|Drug groups [BR:br08330(D00922)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00583  Ceftibuten|D00922  Ceftibuten|DG01776  Third-generation cephalosporin|DG00583  Ceftibuten|D00922  Ceftibuten|Antimicrobials [BR:br08307(D00922)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00922  Ceftibuten (USAN/INN)",
C08118,Ceftizoxime sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00923)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD07 Ceftizoxime|D00923  Ceftizoxime sodium (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00923)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D00923  Ceftizoxime sodium (JP18/USP)|Drug groups [BR:br08330(D00923)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00576  Ceftizoxime|D00923  Ceftizoxime sodium|DG01776  Third-generation cephalosporin|DG00576  Ceftizoxime|D00923  Ceftizoxime sodium|DG01804  Oxyimino beta-lactam|DG00576  Ceftizoxime|D00923  Ceftizoxime sodium|Transporter substrate|DG02860  SLC22A8 substrate|D00923  Ceftizoxime sodium|Drug classes [BR:br08332(D00923)]|Antibacterial|DG01488  Cephem|D00923  Ceftizoxime sodium|Antimicrobials [BR:br08307(D00923)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D00923  Ceftizoxime sodium (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00923)]|Chemicals|D00923  Ceftizoxime sodium|Drug metabolizing enzymes and transporters [br08309.html(D00923)]|Drug transporters|D00923",
C08122,Bacampicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07487)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA06 Bacampicillin|D07487  Bacampicillin (INN)|Drug groups [BR:br08330(D07487)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00522  Bacampicillin|D07487  Bacampicillin|DG01780  Extended spectrum penicillin|DG00522  Bacampicillin|D07487  Bacampicillin|Antimicrobials [BR:br08307(D07487)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D07487  Bacampicillin (INN)|Prodrugs [br08324.html(D07487)]|D07487|Prodrugs [br08324.html]|C08122",
C08123,Bacampicillin hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00927)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA06 Bacampicillin|D00927  Bacampicillin hydrochloride (JP18/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00927)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6131  Penicillins|D00927  Bacampicillin hydrochloride (JP18/USAN)|Drug groups [BR:br08330(D00927)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00522  Bacampicillin|D00927  Bacampicillin hydrochloride|DG01780  Extended spectrum penicillin|DG00522  Bacampicillin|D00927  Bacampicillin hydrochloride|Drug classes [BR:br08332(D00927)]|Antibacterial|DG01480  Penicillin|D00927  Bacampicillin hydrochloride|Antimicrobials [BR:br08307(D00927)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D00927  Bacampicillin hydrochloride (JP18/USAN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00927)]|Chemicals|D00927  Bacampicillin hydrochloride",
C08124,Nafcillin sodium,,,,,
C08126,Penicillin V,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05411)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CE Beta-lactamase sensitive penicillins|J01CE02 Phenoxymethylpenicillin|D05411  Penicillin V (USP)|Drug groups [BR:br08330(D05411)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00535  Phenoxymethylpenicillin|D05411  Penicillin V|DG01778  beta-Lactamase sensitive penicillin|DG00535  Phenoxymethylpenicillin|D05411  Penicillin V|Antimicrobials [BR:br08307(D05411)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase sensitive penicillin|D05411  Penicillin V (USP)",
C08127,"Paricalcitol;|19-Nor-1alpha,25-dihydroxyvitamin D2",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C08127  Paricalcitol|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C08127  Paricalcitol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00930)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H05 CALCIUM HOMEOSTASIS|H05B ANTI-PARATHYROID AGENTS|H05BX Other anti-parathyroid agents|H05BX02 Paricalcitol|D00930  Paricalcitol (JAN/USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00930)]|Metabolic Bone Disease Agents|Vitamin D-related Agents|Paricalcitol|D00930  Paricalcitol (JAN/USP/INN)|Drug groups [BR:br08330(D00930)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D00930  Paricalcitol|Target-based classification of drugs [BR:br08310(D00930)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D00930  Paricalcitol (JAN/USP/INN) &lt;US&gt;",
C08129,Calcium carbonate;|Precipitated calcium carbonate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00932)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AC Calcium compounds|A02AC01 Calcium carbonate|D00932  Calcium carbonate (USP) &lt;JP&gt;|A12 MINERAL SUPPLEMENTS|A12A CALCIUM|A12AA Calcium|A12AA04 Calcium carbonate|D00932  Calcium carbonate (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00932)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D00932  Calcium carbonate (USP); Precipitated calcium carbonate (JP18); Calcium carbonate, precipitated (JAN)|23  Digestive organ agents|234  Antacids|2344  Inorganic salts|D00932  Calcium carbonate (USP); Precipitated calcium carbonate (JP18); Calcium carbonate, precipitated (JAN)|Classification of Japanese OTC drugs [BR:br08313(D00932)]|Agents for digestive organs|10 Antacids|D00932  Calcium carbonate (USP)|Nourishing tonics and health supplements|44 Calcium based drugs|D00932  Calcium carbonate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00932)]|Third-class OTC drugs|Inorganic and organic chemicals|Precipitated calcium carbonate|D00932  Calcium carbonate (USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C08129  Calcium carbonate|Drug groups [BR:br08330(D00932)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|D00932  Calcium carbonate|DG01980  Calcium|D00932  Calcium carbonate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00932)]|Chemicals|D00932  Precipitated calcium carbonate|D00932  Precipitated calcium carbonate tablets|D00932  Precipitated calcium carbonate fine granules|Rx-to-OTC switch list in the USA [br08315.html(D00932)]|D00932",
C08130,Calcium chloride anhydrous,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12A CALCIUM|A12AA Calcium|A12AA07 Calcium chloride|C08130  Calcium chloride anhydrous|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA07 Calcium chloride|C08130  Calcium chloride anhydrous|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BA Acidifiers|G04BA03 Calcium chloride|C08130  Calcium chloride anhydrous|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium chloride|C08130  Calcium chloride anhydrous|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C08130  Calcium chloride anhydrous|Drug groups [BR:br08330]|Gastrointestinal agent|DG01980  Calcium|DG00137  Calcium chloride|C08130  Calcium chloride anhydrous,G00137
C08133,Calcium gluconate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00935)]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12A CALCIUM|A12AA Calcium|A12AA03 Calcium gluconate|D00935  Calcium gluconate (USP)|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA19 Calcium gluconate|D00935  Calcium gluconate (USP)|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX03 Calcium gluconate|D00935  Calcium gluconate (USP)|Classification of Japanese OTC drugs [BR:br08313(D00935)]|Nourishing tonics and health supplements|44 Calcium based drugs|D00935  Calcium gluconate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00935)]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium gluconate|D00935  Calcium gluconate (USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C08133  Calcium gluconate|Drug groups [BR:br08330(D00935)]|Gastrointestinal agent|DG01980  Calcium|DG00135  Calcium gluconate|D00935  Calcium gluconate,
C08136,Tricalcium phosphate;|Calcium phosphate tribasic;|Synthos,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00938)]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12A CALCIUM|A12AA Calcium|A12AA01 Calcium phosphate|D00938  Tricalcium phosphate|Drug groups [BR:br08330(D00938)]|Gastrointestinal agent|DG01980  Calcium|DG00134  Calcium phosphate|D00938  Tricalcium phosphate,
C08141,Tiludronic acid;|Tiludronate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08599)]|M MUSCULO-SKELETAL SYSTEM|M05 DRUGS FOR TREATMENT OF BONE DISEASES|M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION|M05BA Bisphosphonates|M05BA05 Tiludronic acid|D08599  Tiludronic acid (INN)|Drug groups [BR:br08330(D08599)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG01600  Bisphosphonate|DG00784  Tiludronic acid|D08599  Tiludronic acid,
C08142,Sodium fluoride,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C08142  Sodium fluoride|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00943)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AA Caries prophylactic agents|A01AA01 Sodium fluoride|D00943  Sodium fluoride (JAN/USP) &lt;JP&gt;|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CD Fluoride|A12CD01 Sodium fluoride|D00943  Sodium fluoride (JAN/USP) &lt;JP&gt;|USP drug classification [BR:br08302(D00943)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Fluoride|D00943  Sodium fluoride (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00943)]|2  Agents affecting individual organs|27  Dental preparations|279  Miscellaneous|2790  Miscellaneous|D00943  Sodium fluoride (JAN/USP)|Classification of Japanese OTC drugs [BR:br08313(D00943)]|Agents for dental and stomatological use|76 Other agents for dental and stomatological use|D00943  Sodium fluoride (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00943)]|Third-class OTC drugs|Inorganic and organic chemicals|Sodium fluoride|D00943  Sodium fluoride (JAN/USP)|Rx-to-OTC switch list in the USA [br08315.html(D00943)]|D00943|Rx-to-OTC switch list in Japan [br08314.html(D00943)]|D00943,
C08145,Diethylstilbestrol diphosphate;|Fosfestrol;|Diethylstilbestrol bisphosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00946)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CB Synthetic estrogens, plain|G03CB02 Diethylstilbestrol|D00946  Diethylstilbestrol diphosphate (USP)|G03CC Estrogens, combinations with other drugs|G03CC05 Diethylstilbestrol|D00946  Diethylstilbestrol diphosphate (USP)|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AA Estrogens|L02AA01 Diethylstilbestrol|D00946  Diethylstilbestrol diphosphate (USP)|L02AA04 Fosfestrol|D00946  Diethylstilbestrol diphosphate (USP)|Drug groups [BR:br08330(D00946)]|Hormonal agent|DG01584  Estrogen receptor agonist|DG00466  Diethylstilbestrol|D00946  Diethylstilbestrol diphosphate|Target-based classification of drugs [BR:br08310(D00946)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00946  Diethylstilbestrol diphosphate (USP)|Prodrugs [br08324.html(D00946)]|D00946|Prodrugs [br08324.html]|C08145",
C08146,Linezolid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00947)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX08 Linezolid|D00947  Linezolid (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00947)]|Antibacterials|Antibacterials, Other|Linezolid|D00947  Linezolid (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00947)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6249  Others|D00947  Linezolid (JAN/USAN/INN)|Drug groups [BR:br08330(D00947)]|Antibacterial|DG01789  Oxazolidinone antibiotic|D00947  Linezolid|Antimicrobials [BR:br08307(D00947)]|Antibacterials|Protein biosynthesis inhibitor|Oxazolidinone|D00947  Linezolid (JAN/USAN/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D00947)]|Antibacterials|Protein biosynthesis inhibitor|Oxazolidinone|D00947  Linezolid (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D00947)]|New molecular entities and new therapeutic biological products|D00947|New drug approvals in Japan [br08318.html(D00947)]|Drugs with new active ingredients|D00947|New drug approvals in the USA, Europe and Japan [br08328.html(D00947)]|Approval dates by FDA, EMA and PMDA|D00947",
C08148,"Hydroxyprogesterone caproate;|Primolut depot;|17alpha-Caproyloxypregn-4-ene-3,20-dione",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00949)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DA Pregnen (4) derivatives|G03DA03 Hydroxyprogesterone|D00949  Hydroxyprogesterone caproate (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00949)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2477  Progesterones|D00949  Hydroxyprogesterone caproate (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9415  Luteinizing hormone and preparations|C08148  Hydroxyprogesterone caproate|Drug groups [BR:br08330(D00949)]|Hormonal agent|DG02004  Progesterone|DG00467  Hydroxyprogesterone|D00949  Hydroxyprogesterone caproate|DG01666  Progesterone receptor agonist|DG00467  Hydroxyprogesterone|D00949  Hydroxyprogesterone caproate|Drug classes [BR:br08332(D00949)]|Endocrine and hormonal agent|DG02004  Progesterone|D00949  Hydroxyprogesterone caproate|Target-based classification of drugs [BR:br08310(D00949)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00949  Hydroxyprogesterone caproate (JAN/USP/INN) &lt;JP/US&gt;,
C08149,Levonorgestrel;|(-)-Norgestrel,(+-)-Norgestrel [CPD:C08153],,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08149  Levonorgestrel|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00950)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC03 Levonorgestrel|D00950  Levonorgestrel (JAN/USP/INN) &lt;JP/US&gt;|G03AD Emergency contraceptives|G03AD01 Levonorgestrel|D00950  Levonorgestrel (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00950)]|Contraceptives|Oral Progestins|Levonorgestrel|D00950  Levonorgestrel (JAN/USP/INN)|Contraceptives, Other|Levonorgestrel|D00950  Levonorgestrel (JAN/USP/INN)|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Levonorgestrel|D00950  Levonorgestrel (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00950)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00950  Levonorgestrel (JAN/USP/INN)|254  Contraceptives|2549  Others|D00950  Levonorgestrel (JAN/USP/INN)|Drug groups [BR:br08330(D00950)]|Hormonal agent|DG02004  Progesterone|D00950  Levonorgestrel|DG01666  Progesterone receptor agonist|D00950  Levonorgestrel|Drug classes [BR:br08332(D00950)]|Endocrine and hormonal agent|DG02004  Progesterone|D00950  Levonorgestrel|Target-based classification of drugs [BR:br08310(D00950)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00950  Levonorgestrel (JAN/USP/INN) &lt;JP/US&gt;|Rx-to-OTC switch list in the USA [br08315.html(D00950)]|D00950",
C08150,Medroxyprogesterone acetate;|6-alpha-Methyl-17-alpha-acetoxyprogesterone;|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00951)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC06 Medroxyprogesterone|D00951  Medroxyprogesterone acetate (JP18/USP) &lt;JP/US&gt;|G03D PROGESTOGENS|G03DA Pregnen (4) derivatives|G03DA02 Medroxyprogesterone|D00951  Medroxyprogesterone acetate (JP18/USP) &lt;JP/US&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AB Progestogens|L02AB02 Medroxyprogesterone|D00951  Medroxyprogesterone acetate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00951)]|Contraceptives|Contraceptives, Other|Medroxyprogesterone|D00951  Medroxyprogesterone acetate (JP18/USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Medroxyprogesterone|D00951  Medroxyprogesterone acetate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00951)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2478  Synthetic progestins|D00951  Medroxyprogesterone acetate (JP18/USP)|Drug groups [BR:br08330(D00951)]|Hormonal agent|DG02004  Progesterone|DG00458  Medroxyprogesterone|D00951  Medroxyprogesterone acetate|DG01666  Progesterone receptor agonist|DG00458  Medroxyprogesterone|D00951  Medroxyprogesterone acetate|Drug classes [BR:br08332(D00951)]|Endocrine and hormonal agent|DG02004  Progesterone|D00951  Medroxyprogesterone acetate|Target-based classification of drugs [BR:br08310(D00951)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00951  Medroxyprogesterone acetate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00951)]|Chemicals|D00951  Medroxyprogesterone acetate",
C08151,Megestrol acetate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08151  Megestrol acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00952)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC05 Megestrol|D00952  Megestrol acetate (USP) &lt;US&gt;|G03D PROGESTOGENS|G03DB Pregnadien derivatives|G03DB02 Megestrol|D00952  Megestrol acetate (USP) &lt;US&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AB Progestogens|L02AB01 Megestrol|D00952  Megestrol acetate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00952)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Megestrol|D00952  Megestrol acetate (USP)|Drug groups [BR:br08330(D00952)]|Hormonal agent|DG02004  Progesterone|DG00457  Megestrol|D00952  Megestrol acetate|DG01666  Progesterone receptor agonist|DG00457  Megestrol|D00952  Megestrol acetate|Drug classes [BR:br08332(D00952)]|Endocrine and hormonal agent|DG02004  Progesterone|D00952  Megestrol acetate|Target-based classification of drugs [BR:br08310(D00952)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00952  Megestrol acetate (USP) &lt;US&gt;",
C08152,Norethindrone acetate;|Norethisterone acetate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00953)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC01 Norethisterone|D00953  Norethindrone acetate (USP) &lt;US&gt;|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC02 Norethisterone|D00953  Norethindrone acetate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00953)]|Contraceptives|Oral Progestins|Norethindrone|D00953  Norethindrone acetate (USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Progestins|Norethindrone|D00953  Norethindrone acetate (USP)|Drug groups [BR:br08330(D00953)]|Hormonal agent|DG02004  Progesterone|DG00456  Norethisterone|D00953  Norethindrone acetate|DG01666  Progesterone receptor agonist|DG00456  Norethisterone|D00953  Norethindrone acetate|Drug classes [BR:br08332(D00953)]|Endocrine and hormonal agent|DG02004  Progesterone|D00953  Norethindrone acetate|Target-based classification of drugs [BR:br08310(D00953)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00953  Norethindrone acetate (USP) &lt;US&gt;",
C08153,Norgestrel;|(+/-)-Norgestrel,Relative configuration|(-)-Norgestrel [CPD:C08149],,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08153  Norgestrel|Drug groups [BR:br08330(D00954)]|Hormonal agent|DG02004  Progesterone|D00954  Norgestrel|DG01666  Progesterone receptor agonist|D00954  Norgestrel|Target-based classification of drugs [BR:br08310(D00954)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D00954  Norgestrel (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00954)]|Chemicals|D00954  Norgestrel",
C08154,Nandrolone decanoate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00955)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AB Estren derivatives|A14AB01 Nandrolone|D00955  Nandrolone decanoate (JAN/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA11 Nandrolone|D00955  Nandrolone decanoate (JAN/USP)|Drug groups [BR:br08330(D00955)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG00142  Nandrolone|D00955  Nandrolone decanoate|Target-based classification of drugs [BR:br08310(D00955)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00955  Nandrolone decanoate (JAN/USP),
C08155,Nandrolone phenpropionate;|Nandrolone phenylpropionate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00956)]|A ALIMENTARY TRACT AND METABOLISM|A14 ANABOLIC AGENTS FOR SYSTEMIC USE|A14A ANABOLIC STEROIDS|A14AB Estren derivatives|A14AB01 Nandrolone|D00956  Nandrolone phenpropionate (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA11 Nandrolone|D00956  Nandrolone phenpropionate (USP)|Drug groups [BR:br08330(D00956)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG00142  Nandrolone|D00956  Nandrolone phenpropionate|Target-based classification of drugs [BR:br08310(D00956)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00956  Nandrolone phenpropionate (USP),
C08156,Testosterone cypionate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C08156  Testosterone cypionate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00957)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D00957  Testosterone cypionate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D00957)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Androgens|Testosterone|D00957  Testosterone cypionate (USP)|Drug groups [BR:br08330(D00957)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D00957  Testosterone cypionate|DG02006  Testosterone|DG00460  Testosterone|D00957  Testosterone cypionate|Target-based classification of drugs [BR:br08310(D00957)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00957  Testosterone cypionate (USP) &lt;US&gt;",
C08157,Testosterone enanthate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C08157  Testosterone enanthate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00958)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D00958  Testosterone enanthate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00958)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Androgens|Testosterone|D00958  Testosterone enanthate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00958)]|2  Agents affecting individual organs|24  Hormones|246  Androgen preparations|2461  Testosterones|D00958  Testosterone enanthate (JP18/USP)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9416  Testicular hormone and preparations|C08157  Testosterone enanthate|Drug groups [BR:br08330(D00958)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D00958  Testosterone enanthate|DG02006  Testosterone|DG00460  Testosterone|D00958  Testosterone enanthate|Target-based classification of drugs [BR:br08310(D00958)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00958  Testosterone enanthate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00958)]|Chemicals|D00958  Testosterone enanthate|D00958  Testosterone enanthate injection",
C08158,Testosterone propionate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C08158  Testosterone propionate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00959)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D00959  Testosterone propionate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00959)]|First-class OTC drugs|Inorganic and organic chemicals|Testosterone propionate|D00959  Testosterone propionate (JP18/USP)|Drug groups [BR:br08330(D00959)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D00959  Testosterone propionate|DG02006  Testosterone|DG00460  Testosterone|D00959  Testosterone propionate|Target-based classification of drugs [BR:br08310(D00959)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00959  Testosterone propionate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00959)]|Chemicals|D00959  Testosterone propionate|D00959  Testosterone propionate injection,
C08159,Anastrozole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00960)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BG Aromatase inhibitors|L02BG03 Anastrozole|D00960  Anastrozole (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00960)]|Antineoplastics|Aromatase Inhibitors|Anastrozole|D00960  Anastrozole (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00960)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00960  Anastrozole (JP18/USP/INN)|Drug groups [BR:br08330(D00960)]|Antineoplastic|DG01596  Aromatase inhibitor|D00960  Anastrozole|DG01524  Triazole antineoplastic|D00960  Anastrozole|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|D00960  Anastrozole|DG01643  CYP2C9 inhibitor|D00960  Anastrozole|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00960  Anastrozole|Drug classes [BR:br08332(D00960)]|Antineoplastic|DG01596  Aromatase inhibitor|D00960  Anastrozole|Target-based classification of drugs [BR:br08310(D00960)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP19A1 (ARO)|D00960  Anastrozole (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00960)]|Chemicals|D00960  Anastrozole|D00960  Anastrozole tablets|New drug approvals in Japan [br08318.html(D00960)]|Drugs with new active ingredients|D00960|Drug metabolizing enzymes and transporters [br08309.html(D00960)]|Drug metabolizing enzymes|D00960|Pharmacogenomic biomarkers [br08341.html(D00960)]|Somatic variations in targeted cancer therapies|D00960,
C08160,Bicalutamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00961)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BB Anti-androgens|L02BB03 Bicalutamide|D00961  Bicalutamide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00961)]|Antineoplastics|Antiandrogens|Bicalutamide|D00961  Bicalutamide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00961)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00961  Bicalutamide (JP18/USP/INN)|Drug groups [BR:br08330(D00961)]|Antineoplastic|DG01591  Androgen receptor antagonist|DG01624  Flutamide-type antiandrogen|D00961  Bicalutamide|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D00961  Bicalutamide|Drug classes [BR:br08332(D00961)]|Antineoplastic|DG01591  Androgen receptor antagonist|D00961  Bicalutamide|Target-based classification of drugs [BR:br08310(D00961)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00961  Bicalutamide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00961)]|Chemicals|D00961  Bicalutamide|D00961  Bicalutamide tablets|Drug metabolizing enzymes and transporters [br08309.html(D00961)]|Drug metabolizing enzymes|D00961,
C08161,Clomiphene citrate;|Clomifene citrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00962)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS|G03GB Ovulation stimulants, synthetic|G03GB02 Clomifene|D00962  Clomiphene citrate (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00962)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Selective Estrogen Receptor Modifying Agents|Clomiphene|D00962  Clomiphene citrate (USP)|Infertility Agents|Clomiphene|D00962  Clomiphene citrate (USP)|Therapeutic category of drugs in Japan [BR:br08301(D00962)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D00962  Clomiphene citrate (USP); Clomifene citrate (JP18)|Drug groups [BR:br08330(D00962)]|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG00474  Clomifene|D00962  Clomiphene citrate|Target-based classification of drugs [BR:br08310(D00962)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D00962  Clomiphene citrate (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00962)]|Chemicals|D00962  Clomifene citrate|D00962  Clomifene citrate tablets",
C08162,Exemestane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00963)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BG Aromatase inhibitors|L02BG06 Exemestane|D00963  Exemestane (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00963)]|Antineoplastics|Aromatase Inhibitors|Exemestane|D00963  Exemestane (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00963)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00963  Exemestane (JAN/USP/INN)|Drug groups [BR:br08330(D00963)]|Antineoplastic|DG01596  Aromatase inhibitor|D00963  Exemestane|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00963  Exemestane|Drug classes [BR:br08332(D00963)]|Antineoplastic|DG01596  Aromatase inhibitor|D00963  Exemestane|Target-based classification of drugs [BR:br08310(D00963)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP19A1 (ARO)|D00963  Exemestane (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00963)]|New molecular entities and new therapeutic biological products|D00963|New drug approvals in Japan [br08318.html(D00963)]|Drugs with new active ingredients|D00963|New drug approvals in the USA, Europe and Japan [br08328.html(D00963)]|Approval dates by FDA, EMA and PMDA|D00963|Drug metabolizing enzymes and transporters [br08309.html(D00963)]|Drug metabolizing enzymes|D00963|Pharmacogenomic biomarkers [br08341.html(D00963)]|Somatic variations in targeted cancer therapies|D00963",
C08163,Letrozole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00964)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BG Aromatase inhibitors|L02BG04 Letrozole|D00964  Letrozole (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00964)]|Antineoplastics|Aromatase Inhibitors|Letrozole|D00964  Letrozole (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00964)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|252  Genital organ agents|2529  Others|D00964  Letrozole (JAN/USP/INN)|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D00964  Letrozole (JAN/USP/INN)|Drug groups [BR:br08330(D00964)]|Antineoplastic|DG01596  Aromatase inhibitor|D00964  Letrozole|DG01524  Triazole antineoplastic|D00964  Letrozole|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|D00964  Letrozole|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00964  Letrozole|Metabolizing enzyme inhibitor|DG01525  CYP2A6 inhibitor|D00964  Letrozole|Drug classes [BR:br08332(D00964)]|Antineoplastic|DG01596  Aromatase inhibitor|D00964  Letrozole|Target-based classification of drugs [BR:br08310(D00964)]|Enzymes|Oxidoreductases (EC1)|Cytochrome P450|CYP19A1 (ARO)|D00964  Letrozole (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Japan [br08318.html(D00964)]|Drugs with new active ingredients|D00964|Drug metabolizing enzymes and transporters [br08309.html(D00964)]|Drug metabolizing enzymes|D00964|Pharmacogenomic biomarkers [br08341.html(D00964)]|Somatic variations in targeted cancer therapies|D00964,
C08164,Nilutamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00965)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BB Anti-androgens|L02BB02 Nilutamide|D00965  Nilutamide (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D00965)]|Antineoplastics|Antiandrogens|Nilutamide|D00965  Nilutamide (USAN/INN)|Drug groups [BR:br08330(D00965)]|Antineoplastic|DG01591  Androgen receptor antagonist|DG01624  Flutamide-type antiandrogen|D00965  Nilutamide|Drug classes [BR:br08332(D00965)]|Antineoplastic|DG01591  Androgen receptor antagonist|D00965  Nilutamide|Target-based classification of drugs [BR:br08310(D00965)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D00965  Nilutamide (USAN/INN) &lt;US&gt;,
C08166,Toremifene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08620)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02B HORMONE ANTAGONISTS AND RELATED AGENTS|L02BA Anti-estrogens|L02BA02 Toremifene|D08620  Toremifene (INN)|Drug groups [BR:br08330(D08620)]|Antineoplastic|DG01585  Estrogen receptor antagonist|DG01620  Tamoxifene-type antineoplastic|DG00735  Toremifene|D08620  Toremifene|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG00735  Toremifene|D08620  Toremifene|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00735  Toremifene|D08620  Toremifene|Target-based classification of drugs [BR:br08310(D08620)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D08620  Toremifene (INN)|Protein kinases|Receptor tyrosine kinases (RTK)|INSR family|IGF1R (CD221)|D08620  Toremifene (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08620)]|Drug metabolizing enzymes|D08620,
C08169,Meloxicam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00969)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AC Oxicams|M01AC06 Meloxicam|D00969  Meloxicam (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00969)]|Analgesics|Nonsteroidal Anti-inflammatory Drugs|Meloxicam|D00969  Meloxicam (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00969)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1149  Others|D00969  Meloxicam (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C08169  Meloxicam|Drug groups [BR:br08330(D00969)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01910  Anti-inflammatory drug, oxicams|D00969  Meloxicam|DG01922  Selective COX2 inhibitor|D00969  Meloxicam|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D00969  Meloxicam|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00969  Meloxicam|Drug classes [BR:br08332(D00969)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D00969  Meloxicam|D00969  Meloxicam|Target-based classification of drugs [BR:br08310(D00969)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D00969  Meloxicam (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D00969)]|New molecular entities and new therapeutic biological products|D00969|New drug approvals in Japan [br08318.html(D00969)]|Drugs with new active ingredients|D00969|New drug approvals in the USA, Europe and Japan [br08328.html(D00969)]|Approval dates by FDA, EMA and PMDA|D00969|Drug metabolizing enzymes and transporters [br08309.html(D00969)]|Drug metabolizing enzymes|D00969",
C08171,"Sodium thiosalicylate;|2-Mercapto-benzoic acid, monosodium salt",,,,"Drug groups [BR:br08330(D00971)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|DG01920  Thiosalicylic acid|D00971  Sodium thiosalicylate",
C08173,Cortisone acetate;|Cortisyl,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08173  Cortisone acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00973)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB10 Cortisone|D00973  Cortisone acetate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA03 Cortisone|D00973  Cortisone acetate (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00973)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2452  Cortisones|D00973  Cortisone acetate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00973)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00973  Cortisone acetate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00973)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Cortisone acetate|D00973  Cortisone acetate (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Cortisone acetate|D00973  Cortisone acetate (JP18/USP)|Drug groups [BR:br08330(D00973)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00509  Cortisone|D00973  Cortisone acetate|Dermatological agent|DG03243  Atopic dermatitis agent|D00973  Cortisone acetate|Drug classes [BR:br08332(D00973)]|Anti-inflammatory|DG01955  Corticosteroid|D00973  Cortisone acetate|Dermatological agent|DG03243  Atopic dermatitis agent|D00973  Cortisone acetate|Target-based classification of drugs [BR:br08310(D00973)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00973  Cortisone acetate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00973)]|Chemicals|D00973  Cortisone acetate",
C08174,Dexamethasone acetate anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07796)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC02 Dexamethasone|D07796  Dexamethasone 21-acetate|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA09 Dexamethasone|D07796  Dexamethasone 21-acetate|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB19 Dexamethasone|D07796  Dexamethasone 21-acetate|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB05 Dexamethasone|D07796  Dexamethasone 21-acetate|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA03 Dexamethasone|D07796  Dexamethasone 21-acetate|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB02 Dexamethasone|D07796  Dexamethasone 21-acetate|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD03 Dexamethasone|D07796  Dexamethasone 21-acetate|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA01 Dexamethasone|D07796  Dexamethasone 21-acetate|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB01 Dexamethasone|D07796  Dexamethasone 21-acetate|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA06 Dexamethasone|D07796  Dexamethasone 21-acetate|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA01 Dexamethasone|D07796  Dexamethasone 21-acetate|Drug groups [BR:br08330(D07796)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00011  Dexamethasone|D07796  Dexamethasone 21-acetate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00011  Dexamethasone|D07796  Dexamethasone 21-acetate|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00011  Dexamethasone|D07796  Dexamethasone 21-acetate|Target-based classification of drugs [BR:br08310(D07796)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07796  Dexamethasone 21-acetate|Drug metabolizing enzymes and transporters [br08309.html(D07796)]|Drug metabolizing enzymes|D07796",
C08175,Dexamethasone sodium phosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00975)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC02 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA09 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB19 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB05 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA03 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB02 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD03 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA01 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB01 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA06 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA01 Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00975)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP)|Inflammatory Bowel Disease Agents|Glucocorticoids|Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Dexamethasone|D00975  Dexamethasone sodium phosphate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00975)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1315  Ophthalmic cortisones|D00975  Dexamethasone sodium phosphate (JAN/USP)|132  Otic and nasal agents|1329  Others|D00975  Dexamethasone sodium phosphate (JAN/USP)|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2454  Fluorinated adrenocorticotropic hormones|D00975  Dexamethasone sodium phosphate (JAN/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9612  Adrenal hormone preparations|C08175  Dexamethasone sodium phosphate|Drug groups [BR:br08330(D00975)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00011  Dexamethasone|D00975  Dexamethasone sodium phosphate|Dermatological agent|DG03243  Atopic dermatitis agent|D00975  Dexamethasone sodium phosphate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00011  Dexamethasone|D00975  Dexamethasone sodium phosphate|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00011  Dexamethasone|D00975  Dexamethasone sodium phosphate|Drug classes [BR:br08332(D00975)]|Anti-inflammatory|DG01955  Corticosteroid|D00975  Dexamethasone sodium phosphate|Dermatological agent|DG03243  Atopic dermatitis agent|D00975  Dexamethasone sodium phosphate|Target-based classification of drugs [BR:br08310(D00975)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00975  Dexamethasone sodium phosphate (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00975)]|Drug metabolizing enzymes|D00975",
C08176,Hydrocortisone cypionate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08176  Hydrocortisone cypionate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00976)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D00976  Hydrocortisone cypionate|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D00976  Hydrocortisone cypionate|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D00976  Hydrocortisone cypionate|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D00976  Hydrocortisone cypionate|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D00976  Hydrocortisone cypionate|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D00976  Hydrocortisone cypionate|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D00976  Hydrocortisone cypionate|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D00976  Hydrocortisone cypionate|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D00976  Hydrocortisone cypionate|Drug groups [BR:br08330(D00976)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D00976  Hydrocortisone cypionate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D00976  Hydrocortisone cypionate|Target-based classification of drugs [BR:br08310(D00976)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00976  Hydrocortisone cypionate|Drug metabolizing enzymes and transporters [br08309.html(D00976)]|Drug metabolizing enzymes|D00976",
C08178,Hydrocortisone sodium succinate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00978)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00978)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP)|Inflammatory Bowel Disease Agents|Glucocorticoids|Hydrocortisone|D00978  Hydrocortisone sodium succinate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00978)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2452  Cortisones|D00978  Hydrocortisone sodium succinate (JP18/USP)|Drug groups [BR:br08330(D00978)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D00978  Hydrocortisone sodium succinate|Dermatological agent|DG03243  Atopic dermatitis agent|D00978  Hydrocortisone sodium succinate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D00978  Hydrocortisone sodium succinate|Drug classes [BR:br08332(D00978)]|Anti-inflammatory|DG01955  Corticosteroid|D00978  Hydrocortisone sodium succinate|Dermatological agent|DG03243  Atopic dermatitis agent|D00978  Hydrocortisone sodium succinate|Target-based classification of drugs [BR:br08310(D00978)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00978  Hydrocortisone sodium succinate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00978)]|Chemicals|D00978  Hydrocortisone sodium succinate|Drug metabolizing enzymes and transporters [br08309.html(D00978)]|Drug metabolizing enzymes|D00978",
C08179,"Methylprednisolone acetate;|6alpha-Methylprednisolone 21-acetate;|11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate;|M-Predrol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00979)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA01 Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP) &lt;JP/US&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA02 Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB04 Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00979)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, High Potency|Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP)|Inflammatory Bowel Disease Agents|Glucocorticoids|Methylprednisolone|D00979  Methylprednisolone acetate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00979)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2456  Prednisolones|D00979  Methylprednisolone acetate (JAN/USP)|Drug groups [BR:br08330(D00979)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00410  Methylprednisolone|D00979  Methylprednisolone acetate|Dermatological agent|DG03243  Atopic dermatitis agent|D00979  Methylprednisolone acetate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00410  Methylprednisolone|D00979  Methylprednisolone acetate|Drug classes [BR:br08332(D00979)]|Anti-inflammatory|DG01955  Corticosteroid|D00979  Methylprednisolone acetate|Dermatological agent|DG03243  Atopic dermatitis agent|D00979  Methylprednisolone acetate|Target-based classification of drugs [BR:br08310(D00979)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00979  Methylprednisolone acetate (JAN/USP) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D00979)]|Drug metabolizing enzymes|D00979",
C08180,Prednisolone acetate;|Prednisolone 21-acetate;|Pricortin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00980)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC04 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA01 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA04 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA03 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA02 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB06 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD02 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA04 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB02 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA03 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA02 Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00980)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Prednisolone|D00980  Prednisolone acetate (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00980)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1315  Ophthalmic cortisones|D00980  Prednisolone acetate (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00980)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D00980  Prednisolone acetate (JP18/USP/INN)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00980  Prednisolone acetate (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00980)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Prednisolone acetate|D00980  Prednisolone acetate (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Prednisolone acetate|D00980  Prednisolone acetate (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9537  Hormone preparations for external use|C08180  Prednisolone acetate|Drug groups [BR:br08330(D00980)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00093  Prednisolone|D00980  Prednisolone acetate|Drug classes [BR:br08332(D00980)]|Anti-inflammatory|DG01955  Corticosteroid|D00980  Prednisolone acetate|Target-based classification of drugs [BR:br08310(D00980)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00980  Prednisolone acetate (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00980)]|Chemicals|D00980  Prednisolone acetate",
C08182,Prednisolone tebutate;|Prednisolone butyl acetete,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00982)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC04 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA01 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA04 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA03 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA02 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB06 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD02 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA04 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB02 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA03 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA02 Prednisolone|D00982  Prednisolone tebutate (JAN/USP)|Drug groups [BR:br08330(D00982)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00093  Prednisolone|D00982  Prednisolone tebutate|Target-based classification of drugs [BR:br08310(D00982)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00982  Prednisolone tebutate (JAN/USP)",
C08183,Triamcinolone acetonide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00983)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC01 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA12 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB09 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB02 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB08 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD11 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA06 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA05 Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00983)]|Dental and Oral Agents|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, Medium Potency|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Glucocorticoids, High Potency|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Inflammatory Bowel Disease Agents|Glucocorticoids|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Respiratory Tract/Pulmonary Agents|Anti-inflammatories, Inhaled Corticosteroids|Triamcinolone|D00983  Triamcinolone acetonide (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00983)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D00983  Triamcinolone acetonide (JP18/USP)|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D00983  Triamcinolone acetonide (JP18/USP)|24  Hormones|245  Adrenal hormone preparations|2454  Fluorinated adrenocorticotropic hormones|D00983  Triamcinolone acetonide (JP18/USP)|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D00983  Triamcinolone acetonide (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00983)]|Agents for dental and stomatological use|74 Stomatitis remedies|D00983  Triamcinolone acetonide (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00983)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Triamcinolone acetonide|D00983  Triamcinolone acetonide (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Triamcinolone acetonide|D00983  Triamcinolone acetonide (JP18/USP)|Drug groups [BR:br08330(D00983)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00010  Triamcinolone|D00983  Triamcinolone acetonide|Dermatological agent|DG03243  Atopic dermatitis agent|D00983  Triamcinolone acetonide|Drug classes [BR:br08332(D00983)]|Anti-inflammatory|DG01955  Corticosteroid|D00983  Triamcinolone acetonide|Dermatological agent|DG03243  Atopic dermatitis agent|D00983  Triamcinolone acetonide|Target-based classification of drugs [BR:br08310(D00983)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00983  Triamcinolone acetonide (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00983)]|Chemicals|D00983  Triamcinolone acetonide|Topical steroids potency [br08317.html(D00983)]|Classification in the USA|D00983|Classification in Japan|D00983|Rx-to-OTC switch list in the USA [br08315.html(D00983)]|D00983|Rx-to-OTC switch list in Japan [br08314.html(D00983)]|D00983",
C08184,Triamcinolone diacetate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00984)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC01 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA12 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB09 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB02 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB08 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD11 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA06 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA05 Triamcinolone|D00984  Triamcinolone diacetate (JAN/USP)|Drug groups [BR:br08330(D00984)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00010  Triamcinolone|D00984  Triamcinolone diacetate|Target-based classification of drugs [BR:br08310(D00984)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00984  Triamcinolone diacetate (JAN/USP)",
C08185,Triamcinolone hexacetonide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00985)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC01 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA12 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB09 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB02 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB08 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD11 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS|R03BA Glucocorticoids|R03BA06 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA05 Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|USP drug classification [BR:br08302(D00985)]|Dental and Oral Agents|Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Triamcinolone|D00985  Triamcinolone hexacetonide (USP/INN)|Drug groups [BR:br08330(D00985)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00010  Triamcinolone|D00985  Triamcinolone hexacetonide|Target-based classification of drugs [BR:br08310(D00985)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00985  Triamcinolone hexacetonide (USP/INN)",
C08186,Fludrocortisone acetate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08186  Fludrocortisone acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00986)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AA Mineralocorticoids|H02AA02 Fludrocortisone|D00986  Fludrocortisone acetate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00986)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Fludrocortisone|D00986  Fludrocortisone acetate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D00986)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2459  Others|D00986  Fludrocortisone acetate (JP18/USP)|Drug groups [BR:br08330(D00986)]|Anti-inflammatory|DG01955  Corticosteroid|DG00506  Fludrocortisone|D00986  Fludrocortisone acetate|Drug classes [BR:br08332(D00986)]|Anti-inflammatory|DG01955  Corticosteroid|D00986  Fludrocortisone acetate|Target-based classification of drugs [BR:br08310(D00986)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D00986  Fludrocortisone acetate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00986)]|Chemicals|D00986  Fludrocortisone acetate",
C08187,Cabergoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00987)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02C OTHER GYNECOLOGICALS|G02CB Prolactine inhibitors|G02CB03 Cabergoline|D00987  Cabergoline (JP18/USP/INN) &lt;JP/US&gt;|N NERVOUS SYSTEM|N04 ANTI-PARKINSON DRUGS|N04B DOPAMINERGIC AGENTS|N04BC Dopamine agonists|N04BC06 Cabergoline|D00987  Cabergoline (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00987)]|Hormonal Agents, Suppressant (Pituitary)|Cabergoline|D00987  Cabergoline (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00987)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|116  Antiparkinsonian agents|1169  Others|D00987  Cabergoline (JP18/USP/INN)|Drug groups [BR:br08330(D00987)]|Neuropsychiatric agent|DG01472  Dopamine agonist|DG01468  Dopamine D2-receptor agonist|D00987  Cabergoline|DG01964  Ergot alkaloid|D00987  Cabergoline|DG01967  Antiparkinson agent|D00987  Cabergoline|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D00987  Cabergoline|Drug classes [BR:br08332(D00987)]|Neuropsychiatric agent|DG01967  Antiparkinson agent|D00987  Cabergoline|Target-based classification of drugs [BR:br08310(D00987)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D00987  Cabergoline (JP18/USP/INN) &lt;JP/US&gt;|Cytokines and receptors|Cytokines|CSF and other factors|PRL|D00987  Cabergoline (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00987)]|Chemicals|D00987  Cabergoline|Drug metabolizing enzymes and transporters [br08309.html(D00987)]|Drug metabolizing enzymes|D00987",
C08193,Aurothioglucose,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00991)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01C SPECIFIC ANTIRHEUMATIC AGENTS|M01CB Gold preparations|M01CB04 Aurothioglucose|D00991  Aurothioglucose (USP)|Drug groups [BR:br08330(D00991)]|Anti-inflammatory|DG01985  Disease modifying anti-rheumatic drug (DMARD)|DG01912  Gold preparations|D00991  Aurothioglucose,
C08195,Meclofenoxate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00993)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BX Other psychostimulants and nootropics|N06BX01 Meclofenoxate|D00993  Meclofenoxate (INN)",
C08197,Neostigmine bromide;|Neo proserine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00995)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA01 Neostigmine|D00995  Neostigmine bromide (JAN/USP/INN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB06 Neostigmine|D00995  Neostigmine bromide (JAN/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00995)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|123  Autonomic nervous system agents|1233  Neostigmines|D00995  Neostigmine bromide (JAN/USP/INN)|Drug groups [BR:br08330(D00995)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00987  Neostigmine|D00995  Neostigmine bromide|DG01719  Parasympathomimetic agent|DG00987  Neostigmine|D00995  Neostigmine bromide|Target-based classification of drugs [BR:br08310(D00995)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D00995  Neostigmine bromide (JAN/USP/INN) &lt;JP&gt;,
C08200,Neostigmine methylsulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00998)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA01 Neostigmine|D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB06 Neostigmine|D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00998)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|123  Autonomic nervous system agents|1233  Neostigmines|D00998  Neostigmine methylsulfate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D00998)]|Agents for ophthalmologic use|62 General eye drops|D00998  Neostigmine methylsulfate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D00998)]|Third-class OTC drugs|Inorganic and organic chemicals|Neostigmine|D00998  Neostigmine methylsulfate (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|917  Autonomic agents (Autonomics)|9172  Neostigmine, derivatives and preparations|C08200  Neostigmine methylsulfate|Drug groups [BR:br08330(D00998)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00987  Neostigmine|D00998  Neostigmine methylsulfate|DG01719  Parasympathomimetic agent|DG00987  Neostigmine|D00998  Neostigmine methylsulfate|Target-based classification of drugs [BR:br08310(D00998)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D00998  Neostigmine methylsulfate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00998)]|Chemicals|D00998  Neostigmine methylsulfate|D00998  Neostigmine methylsulfate injection",
C08201,Acetylcholine chloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00999)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01EB Parasympathomimetics|S01EB09 Acetylcholine|D00999  Acetylcholine chloride (JP18/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00999)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|123  Autonomic nervous system agents|1232  Acetylcholines|D00999  Acetylcholine chloride (JP18/USP/INN)|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|722  Various function testing reagents|7222  Diagnostic reagents for circulatory function|D00999  Acetylcholine chloride (JP18/USP/INN)|Drug groups [BR:br08330(D00999)]|Cardiovascular agent|DG01532  Nicotinic cholinergic receptor agonist|DG01133  Acetylcholine|D00999  Acetylcholine chloride|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG01133  Acetylcholine|D00999  Acetylcholine chloride|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01133  Acetylcholine|D00999  Acetylcholine chloride|Metabolizing enzyme substrate|DG02974  ACHE substrate|DG01133  Acetylcholine|D00999  Acetylcholine chloride|Drug classes [BR:br08332(D00999)]|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|D00999  Acetylcholine chloride|Target-based classification of drugs [BR:br08310(D00999)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D00999  Acetylcholine chloride (JP18/USP/INN) &lt;JP/US&gt;|Ion channels|Ligand-gated ion channels|Acetylcholine (nicotinic)|CHRN|D00999  Acetylcholine chloride (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00999)]|Chemicals|D00999  Acetylcholine chloride for injection|Drug metabolizing enzymes and transporters [br08309.html(D00999)]|Drug metabolizing enzymes|D00999,
C08202,Bethanechol chloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01000)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AB Choline esters|N07AB02 Bethanechol|D01000  Bethanechol chloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01000)]|Genitourinary Agents|Genitourinary Agents, Other|Bethanechol|D01000  Bethanechol chloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01000)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|123  Autonomic nervous system agents|1231  Quaternary ammoniums|D01000  Bethanechol chloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01000)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Bethanechol|D01000  Bethanechol chloride (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Bethanechol chloride|D01000  Bethanechol chloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|917  Autonomic agents (Autonomics)|9175  Bethanecol and preparations|C08202  Bethanechol chloride|Drug groups [BR:br08330(D01000)]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG00991  Bethanechol|D01000  Bethanechol chloride|DG01719  Parasympathomimetic agent|DG00991  Bethanechol|D01000  Bethanechol chloride|Target-based classification of drugs [BR:br08310(D01000)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D01000  Bethanechol chloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01000)]|Chemicals|D01000  Bethanechol chloride",
C08211,Doxercalciferol;|1alpha-Hydroxyergocalciferol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0301 Vitamin D2 and derivatives|C08211  Doxercalciferol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01009)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H05 CALCIUM HOMEOSTASIS|H05B ANTI-PARATHYROID AGENTS|H05BX Other anti-parathyroid agents|H05BX03 Doxercalciferol|D01009  Doxercalciferol (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D01009)]|Metabolic Bone Disease Agents|Vitamin D-related Agents|Doxercalciferol|D01009  Doxercalciferol (USAN/INN)|Drug groups [BR:br08330(D01009)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|D01009  Doxercalciferol|Target-based classification of drugs [BR:br08310(D01009)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D01009  Doxercalciferol (USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D01009)]|New molecular entities and new therapeutic biological products|D01009|New drug approvals in the USA, Europe and Japan [br08328.html(D01009)]|Approval dates by FDA, EMA and PMDA|D01009",
C08212,Levothyroxine sodium anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D11113)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03A THYROID PREPARATIONS|H03AA Thyroid hormones|H03AA01 Levothyroxine sodium|D11113  Levothyroxine sodium (INN) &lt;US&gt;|USP drug classification [BR:br08302(D11113)]|Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)|Levothyroxine|D11113  Levothyroxine sodium (INN)|Drug groups [BR:br08330(D11113)]|Hormonal agent|DG01953  Thyroid preparation|DG01608  Thyroid hormone replenisher|DG00510  Levothyroxine|D11113  Levothyroxine sodium|Target-based classification of drugs [BR:br08310(D11113)]|Nuclear receptors|Thyroid hormone like receptors|Thyroid hormone receptor (THR)|NR1A (THR)|D11113  Levothyroxine sodium (INN) &lt;US&gt;",
C08217,Iopanoic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01014)]|V VARIOUS|V08 CONTRAST MEDIA|V08A X-RAY CONTRAST MEDIA, IODINATED|V08AC Watersoluble, hepatotropic X-ray contrast media|V08AC06 Iopanoic acid|D01014  Iopanoic acid (JAN/USP/INN)",
C08219,Potassium iodide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01016)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS|R05CA Expectorants|R05CA02 Potassium iodide|D01016  Potassium iodide (JP18/USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA04 Potassium iodide|D01016  Potassium iodide (JP18/USP) &lt;JP&gt;|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB21 Potassium iodide|D01016  Potassium iodide (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01016)]|3  Agents affecting metabolism|32  Nutrients, tonics|322  Mineral preparations|3221  Iodine compounds|D01016  Potassium iodide (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01016)]|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D01016  Potassium iodide (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01016)]|Third-class OTC drugs|Inorganic and organic chemicals|Potassium iodide|D01016  Potassium iodide (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9511  Iodine compounds and preparations|C08219  Potassium iodide|96  Agents affecting metabolism|963  Mineral and preparations|9632  Halogen compounds and preparations|C08219  Potassium iodide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01016)]|Chemicals|D01016  Potassium iodide",
C08230,Hydroxocobalamin;|Vitamin B12a;|Hydroxycobalamin;|Hydroxycob(lll)alamin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01027)]|B BLOOD AND BLOOD FORMING ORGANS|B03 ANTIANEMIC PREPARATIONS|B03B VITAMIN B12 AND FOLIC ACID|B03BA Vitamin B12 (cyanocobalamin and analogues)|B03BA03 Hydroxocobalamin|D01027  Hydroxocobalamin (JAN/USP/INN) &lt;US&gt;|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB33 Hydroxocobalamin|D01027  Hydroxocobalamin (JAN/USP/INN) &lt;US&gt;|Risk category of Japanese OTC drugs [BR:br08312(D01027)]|Third-class OTC drugs|Inorganic and organic chemicals|Cyanocobalamin|D01027  Hydroxocobalamin (JAN/USP/INN)|New drug approvals in Europe [br08329.html(D01027)]|European public assessment reports (EPAR) authorised medicine|D01027|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9623  Vitamin B and preparations (except vitamin B1 preparations)|C08230  Hydroxocobalamin,
C08233,Risedronic acid;|Risedronate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08484)]|M MUSCULO-SKELETAL SYSTEM|M05 DRUGS FOR TREATMENT OF BONE DISEASES|M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION|M05BA Bisphosphonates|M05BA07 Risedronic acid|D08484  Risedronic acid (INN)|Drug groups [BR:br08330(D08484)]|Musculo-skeletal system agent|DG03232  Osteoporosis agent|DG01600  Bisphosphonate|DG00786  Risedronic acid|D08484  Risedronic acid|Target-based classification of drugs [BR:br08310(D08484)]|Enzymes|Transferases (EC2)|Alkyl/Aryl transferases|FDPS|D08484  Risedronic acid (INN),
C08234,"beta-Cymaropyranose;|D-Cymarose;|Cymarose;|2,6-Dideoxy-3-O-methyl-D-ribo-hexose",,,,,
C08235,Digitalose;|beta-D-Digitalopyranose,,,,,
C08236,alpha-D-Mannoheptulopyranose;|Mannoheptulose,,,,,
C08237,Oleandrose;|beta-L-Oleandropyranose,,,,,
C08238,alpha-Galactosyl-(1-6)-alpha-galactosyl-(1-6)-alpha-galactosyl-(1-6)-alpha-galactosyl-(1-6)-alpha-glucosyl-(1-2)-beta-fructose;|Ajugose,,,,,
C08239,Gentianose;|beta-D-Fructofuranosyl O-beta-D-glucopyranosyl-(1-6)-alpha-D-glucopyranoside,,,,,
C08240,Gentiobiose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C08240  Gentiobiose,
C08241,Sodium 2-O-L-rhamnopyranosyl-4-deoxy-alpha-L-threo-hex-4-eno-pyranosiduronate;|Lepidimoide,,,,,
C08242,Lychnose;|1F-alpha-D-Galactosylraffinose,,,,,G01504
C08243,Melezitose,,,,,
C08244,2-O-alpha-L-Rhamnopyranosyl-D-glucopyranose;|Neohesperidose,,,,,
C08245,6-O-beta-D-Xylopyranosyl-D-glucose;|Primeverose,,,,,
C08246,Robinobiose,,,,,
C08247,Rutinose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C08247  Rutinose,
C08248,Sesamose;|alpha-D-Galactosyl-(1-6)-alpha-D-galactosyl-(1-6)-beta-D-fructosyl-(2-1)-alpha-D-glucoside,,,,,
C08249,Pyrimidine 5'-deoxynucleotide,Generic compound in reaction hierarchy,,,,
C08250,Sophorose;|alpha-Sophorose;|2-O-beta-D-Glucopyranosyl-beta-D-glucopyranose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C08250  Sophorose,
C08251,Umbelliferose;|beta-D-Fructofuranosyl 2-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside,,,,,
C08252,Verbascose;|beta-D-Fructofuranosyl O-alpha-D-galactopyranosyl-(1-6)-O-alpha-D-galactopyranosyl-(1-6)-O-alpha-D-galactopyranosyl-(1-6)-alpha-D-glucopyranoside,,,,,
C08253,Fucoidan,,,,,
C08254,Clusianose,,,,,
C08255,Perseitol;|D-glycero-D-galacto-Heptitol,,,,,
C08257,(-)-Quebrachitol,,,,,
C08258,(+)-Quercitol;|d-Quercitol,,,,,
C08259,(-)-Viburnitol,,,,,
C08260,Volemitol;|D-glycero-D-manno-Heptitol,,,,,
C08261,"Azelaic acid;|Nonanedioic acid;|1,7-Heptanedicarboxylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C08261  Nonanedioic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03034)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AX Other anti-acne preparations for topical use|D10AX03 Azelaic acid|D03034  Azelaic acid (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D03034)]|Dermatological Agents|Acne and Rosacea Agents|Acne and Rosacea Agents, Other|Azelaic Acid|D03034  Azelaic acid (USAN/INN)",
C08262,3-Methylbutanoic acid;|Isovaleric acid;|Isovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C08262  3-Methylbutanoic acid,
C08263,beta-Alaninebetaine;|beta-Alanine betaine;|Propiobetaine;|Trimethylalanine,,,,,
C08264,L-Albizziine;|Albizziin;|L-2-Amino-3-ureidopropionic acid,,,,,
C08265,Alliin,,,,,
C08266,L-alpha-Amino-gamma-oxalylaminobutyric acid,,,,,
C08267,L-Azetidine 2-carboxylic acid;|Azetidyl-2-carboxylic acid;|(S)-(-)-Azetidine-2-carboxylic acid,,,,,
C08268,"L-Baikiain;|4,5-Dehydropipecolic acid",,,,,
C08269,(-)-Betonicine;|Betonicine;|trans-4-Hydroxy-L-proline betaine,,,,,
C08270,L-Canaline;|Canaline,,,,,
C08271,Coprine;|N(5)-(1-Hydroxycyclopropyl)-L-glutamine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C08271  Coprine,
C08272,Kinetin;|6-Furfuryladenine,,,,,
C08273,"2,5-Dihydrophenylalanine;|L-2,5-Dihydrophenylalanine",,,,,
C08275,L-Djenkolic acid;|Djenkolic acid,,,,,
C08276,3-(Methylthio)propanoate;|3-(Methylthio)propionic acid;|3-Methylthiopropionate;|3-(Methylsulfanyl)propanoate;|3-Methylthiopropanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0113 Thia fatty acids|C08276  3-Methylthiopropanoic acid,
C08277,Sebacic acid;|Decanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C08277  Decanedioic acid,
C08278,"Suberic acid;|Cork acid;|1,8-Octanedioic acid;|Octanedioic acid;|1,6-Hexanedicarboxylic acid",,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Dicarboxylic acids|C08278  Suberate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C08278  Octanedioic acid,
C08279,"Tiglic acid;|(E)-2,3-Dimethylacrylic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C08279  (E)-2,3-Dimethylacrylic acid",
C08280,Hypoglycin B;|Hypoglycine B;|L-gamma-Glutamyl-L-hypoglycin,,,,Phytochemical compounds [BR:br08003]|Others|Others|Others|C08280  Hypoglycin B|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C08280  Hypoglycin B,
C08281,Docosanoic acid;|Docosanoate;|Behenic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C08281  Behenic acid (22:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C08281  Docosanoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Saturated fatty acids|C08281  Behenic acid,
C08282,Chaulmoogric acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C08282  Chaulmoogric acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08282  Chaulmoogric acid,
C08283,Homostachydrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C08283  Homostachydrine,
C08284,gamma-Hydroxy-L-arginine,,,,,
C08285,"10,16-Dihydroxyhexadecanoic acid;|Hexadecanoic acid, 10,16-dihydroxy-",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C08285  10,16-Dihydroxyhexadecanoic acid",
C08286,(+)-gamma-Hydroxy-L-homoarginine,,,,,
C08287,Hypoglycin;|Hypoglycin A;|Hypoglycine A;|L-Hypoglycin,,,,Phytochemical compounds [BR:br08003]|Others|Others|Others|C08287  Hypoglycin|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C08287  Hypoglycin,
C08288,Indospicine;|L-Indospicine,,,,,
C08289,Isowillardiine,,,,,
C08290,Lathyrine;|L-Lathyrine,,,,,
C08291,3-Methylamino-L-alanine,,,,,
C08292,alpha-(Methylenecyclopropyl)glycine,,,,,
C08294,O-Oxalylhomoserine;|O-Oxalyl-L-homoserine,,,,,
C08295,S-[(E)-Prop-1-enyl]-L-cysteine S-oxide,,,,,
C08296,Quisqualic acid,,,,,
C08298,Tricholomic acid;|alpha-Amino-3-oxo-5-isoxazolidineacetic acid,,,,,
C08299,"Bufotenine;|Bufotenin;|N,N-Dimethylserotonin",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C08299  Bufotenine|Natural toxins [BR:br08009]|Venoms|Frog venoms|Others|C08299  Bufotenine,
C08300,D-Cathine;|Cathine;|(+)-Norpseudoephedrine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Phenylalanine derived alkaloids|C08300  D-Cathine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07627)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AA Centrally acting antiobesity products|A08AA07 Cathine|D07627  Cathine (INN)|Drug groups [BR:br08330(D07627)]|Gastrointestinal agent|DG01705  Anoretic|DG01704  Phenethylamine anorexic|DG00106  Cathine|D07627  Cathine|Narcotics and psychotropics in Japan [br08308.html(D07627)]|Psychotropics by Cabinet order Article 3 (78 substances)|D07627",
C08301,Cathinone;|(2S)-2-Amino-1-phenylpropan-1-one;|(-)-Cathinone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Phenylalanine derived alkaloids|C08301  D-Cathinone|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C08301,
C08302,"N,N-Dimethyltryptamine;|DMT",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C08302  N,N-Dimethyltryptamine|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C08302",
C08303,Galegine,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amines|C08303  Galegine,
C08304,"Gramine;|(1H-Indol-3-ylmethyl)dimethylamine;|(1H-Indol-3-yl)-N,N-dimethylmethanamine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C08304  Gramine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08304,
C08305,Gyromitrin;|Acetaldehyde methylformylhydrazone,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C08305  Gyromitrin,
C08306,Hexylamine;|1-Hexanamine,,,,,
C08307,Hordatine A,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amines|C08307  Hordatine A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08307,
C08308,Hordatine B,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amines|C08308  Hordatine B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08308,
C08309,"N,N-Dimethyl-5-methoxytryptamine;|O-Methylbufotenine;|Methoxybufotenin;|5-Methoxy-N,N-dimethyltryptamine;|3-[2-(N,N-Dimethylamino)ethyl]-5-methoxy-indole",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C08309  N,N-Dimethyl-5-methoxytryptamine",
C08310,N-Methylmescaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C08310  N-Methylmescaline,
C08311,Muscimol,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Alkaloids|C08311  Muscimol,
C08312,Psilocin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Alkaloids|C08312  Psilocin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08312|Prodrugs [br08324.html]|C08312|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C08312,
C08313,Skatole;|3-Methylindole,,,,,
C08314,"(9R,10R)-Dihydroxyoctadecanoic acid;|9,10-Dihydroxystearic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C08314  (9R,10R)-Dihydroxyoctadecanoic acid",
C08315,"(9Z,11E,13E)-Octadecatrienoic acid;|(9Z,11E,13E)-9,11,13-Octadecatrienoic acid;|alpha-Eleostearic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C08315  (9Z,11E,13E)-Octadeca-9,11,13-trienoic acid",
C08316,Erucic acid;|(13Z)-Docosenoic acid;|cis-13-Docosenoic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C08316  Erucic acid (22:1;13)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08316  (Z)-Docos-13-enoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08316  Erucic acid,
C08317,12-Hydroxydodecanoic acid;|omega-Hydroxydodecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C08317  12-Hydroxydodecanoic acid,
C08318,"(9Z,12Z)-(8R)-Hydroxyoctadeca-9,12-dienoic acid;|Laetisaric acid;|8-Hydroxylinoleic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C08318  (9Z,12Z)-(8R)-Hydroxyoctadeca-9,12-dienoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C08318  (9Z,12Z)-(8R)-Hydroxyoctadeca-9,12-dienoic acid",
C08319,"alpha-Licanic acid;|(9Z,11E,13E)-4-Oxooctadeca-9,11,13-trienoic acid;|4-Oxo-9,11,13-octadecatrienoic acid;|4-Oxo-cis-9,trans-11,trans-13-octadecatrienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C08319  (9Z,11E,13E)-4-Oxooctadeca-9,11,13-trienoic acid",
C08320,Tetracosanoic acid;|Lignoceric acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Saturated fatty acids|C08320  Lignoceric acid (24:0)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C08320  Tetracosanoic acid,
C08321,Malvalic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C08321  Malvalic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08321  Malvalic acid,
C08322,Myristoleic acid;|(9Z)-Tetradecenoic acid;|9-Tetradecenoic acid;|(Z)-Tetradec-9-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08322  (Z)-Tetradec-9-enoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08322  Myristoleic acid,
C08323,(15Z)-Tetracosenoic acid;|Nervonic acid;|(Z)-15-Tetracosenoic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C08323  Nervonic acid (24:1;15)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08323  (Z)-Tetracos-15-enoic acid,
C08324,Acalyphin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from other origin|C08324  Acalyphin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08324  Acalyphin,
C08325,Amygdalin;|(R)-Amygdalin;|(R)-Amygdaloside;|(R)-Laenitrile,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C08325  Amygdalin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cyanogenic glycosides|C08325  Amygdalin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08325  Amygdalin,
C08326,Anthemis glycoside A,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C08326  Anthemis glycoside A|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08326  Anthemis glycoside A,
C08327,Anthemis glycoside B,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C08327  Anthemis glycoside B|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08327  Anthemis glycoside B,
C08328,Cardiospermin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from leucine|C08328  Cardiospermin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08328  Cardiospermin,
C08329,Deidaclin;|NSC 370273,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from nonprotein amino acid|C08329  Deidaclin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08329  Deidaclin,
C08330,p-Glucosyloxymandelonitrile,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from thyrosine|C08330  p-Glucosyloxymandelonitrile|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08330  p-Glucosyloxymandelonitrile,
C08331,"Gynocardin;|2-Cyclopentene-1-carbonitrile, 1-(beta-D-glucopyranosyloxy)-4,5-dihydroxy-,(1alpha,4alpha,5beta)-",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from nonprotein amino acid|C08331  Gynocardin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08331  Gynocardin,
C08332,Heterodendrin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from leucine|C08332  Heterodendrin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08332  Heterodendrin,
C08333,Linustatin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from valine or isoleucine|C08333  Linustatin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08333  Linustatin,
C08334,Lotaustralin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from valine or isoleucine|C08334  Lotaustralin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08334  Lotaustralin,
C08335,"Lucumin;|Benzeneacetonitrile,alpha-((6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy)-,(R)-;|Mandelonitrile primeveroside",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C08335  Lucumin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08335  Lucumin,
C08336,Neolinustatin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from valine or isoleucine|C08336  Neolinustatin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08336  Neolinustatin,
C08337,Proacaciberin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from leucine|C08337  Proacaciberin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08337  Proacaciberin,
C08338,"Proacacipetalin;|3-Butenenitrile, 2-(beta-D-glucopyranosyloxy)-3-methyl-, (S)-",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from leucine|C08338  Proacacipetalin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08338  Proacacipetalin,
C08339,Proteacin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from thyrosine|C08339  Proteacin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08339  Proteacin,
C08340,"Sarmentosin;|2-Butenenitrile,4-(beta-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (E)-",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from valine or isoleucine|C08340  Sarmentosin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08340  Sarmentosin,
C08341,Sarmentosin epoxide,,,,,
C08342,"Triglochinin;|2-Hexenedioic acid,4-(cyano(beta-D-glucopyranosyloxy)methylene)-, (E,Z)-",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from thyrosine|C08342  Triglochinin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08342  Triglochinin,
C08344,Volkenin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from nonprotein amino acid|C08344  Volkenin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08344  Volkenin,
C08345,"Zierin;|Benzeneacetonitrile, alpha-(beta-D-glucopyranosyloxy)-3-hydroxy-, (S)",,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Cyanogenic glucosides derived from phenylalanine|C08345  Zierin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08345  Zierin,
C08346,beta-D-Apiose,D-Apiose (furanose) [CPD:C21040]|D-Apiose (open-chain) [CPD:C01488],,,,
C08347,2-Deoxy-alpha-D-ribopyranose,,,,,
C08348,Galacturonic acid,,,,,
C08349,beta-D-Glucosamine,,,,,
C08350,beta-D-Glucopyranuronic acid;|beta-D-Glucuronic acid,,,,,
C08351,beta-D-Hamamelopyranose;|beta-D-Hamamelose,D-Hamamelose [CPD:C01906],,,,
C08352,Quinovose;|alpha-D-Quinovopyranose,,,,,
C08353,beta-D-Ribopyranose;|Ribose,,,,,
C08354,alpha-D-Ribulose,D-Ribulose [CPD:C00309],,,,
C08355,beta-D-Sedoheptulopyranose;|beta-D-Sedoheptulose,,,,,
C08356,alpha-L-Sorbopyranose,,,,,
C08357,Estradiol-17beta 3-sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C08357  Estradiol-17beta 3-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C08357  Estradiol-17beta 3-sulfate,
C08358,2-Methoxyestrone 3-sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C08358  2-Methoxyestrone 3-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C08358  2-Methoxyestrone 3-sulfate,
C08359,2-Methoxyestradiol-17beta 3-sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C08359  2-Methoxyestradiol-17beta 3-sulfate|ST05 Steroid conjugates|ST0502 Sulfates|C08359  2-Methoxyestradiol-17beta 3-sulfate,
C08362,(9Z)-Hexadecenoic acid;|Palmitoleic acid;|cis-9-Hexadecenoic acid;|(9Z)-Hexadec-9-enoate,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C08362  Palmitoleic acid (16:1;9)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08362  (Z)-Hexadec-9-enoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08362  Palmitoleic acid,
C08363,(6Z)-Octadecenoic acid;|Petroselinic acid;|cis-6-Octadecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08363  (Z)-Octadec-6-enoic acid,
C08364,"Punicic acid;|cis-9,trans-11,cis-13-Octadecatrienoic acid;|Trichosanic acid;|(9Z,11E,13Z)-Octadeca-9,11,13-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C08364  (9Z,11E,13Z)-Octadeca-9,11,13-trienoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08364  Punicic acid",
C08365,Ricinoleic acid;|(9Z)-(12R)-Hydroxyoctadecenoic acid;|12-Hydroxy-9-octadecenoic acid;|12-Hydroxy-cis-9-octadecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C08365  (9Z)-(12R)-Hydroxyoctadecenoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C08365  (9Z)-(12R)-Hydroxyoctadecenoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08365  Ricinoleic acid,
C08366,Sterculic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C08366  Sterculic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08366  Sterculic acid,
C08367,(11E)-Octadecenoic acid;|Vaccenic acid;|trans-11-Octadecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C08367  (E)-Octadec-11-enoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Unsaturated fatty acids|C08367  Vaccenic acid,
C08368,"Vernolic acid;|(9Z)-(12S,13R)-12,13-Epoxyoctadecenoic acid;|cis-12,13-Epoxy-cis-9-octadecenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0107 Epoxy fatty acids|C08368  (9Z)-(12S,13R)-12,13-Epoxyoctadecenoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C08368  (9Z)-(12S,13R)-12,13-Epoxyoctadecenoic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08368  Vernolic acid",
C08369,Diallyl disulfide,,,,,
C08370,Diallyl sulfide;|Allyl sulfide,,,,,
C08371,Dimethyl disulfide;|Methyl disulfide,,,,,
C08372,Dimethyl trisulfide;|DMTS,,,,,
C08373,Dipropyl disulfide;|n-Propyl disulfide,,,,,
C08374,Dodecane;|n-Dodecane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08374  n-Dodecane,
C08375,"(3Z,6Z,9Z)-3,6,9-Dodecatrien-1-ol;|(Z,Z,Z)-3,6,9-Dodecatrien-1-ol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08375  (3Z,6Z,9Z)-3,6,9-Dodecatrien-1-ol",
C08376,Hentriacontane;|n-Hentriacontane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08376  n-Hentriacontane,
C08377,"14,16-Hentriacontanedione;|Hentriacontane-14,16-dione",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08377  Hentriacontane-14,16-dione",
C08378,Hentriacontan-1-ol;|1-Hentriacontanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08378  1-Hentriacontanol,
C08379,Hentriacontan-16-one;|16-Hentriacontanone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08379  Hentriacontan-16-one,
C08380,2-Heptanone;|Heptan-2-one;|Methyl n-amyl ketone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08380  Heptan-2-one,
C08381,Hexacosan-1-ol;|1-Hexacosanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08381  1-Hexacosanol,
C08382,"Lenthionine;|1,2,3,5,6-Pentathiepane",,,,,
C08383,Methyl allyl disulfide;|Allyl methyl disulfide,,,,,
C08384,Nonacosane;|n-Nonacosane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08384  n-Nonacosane,
C08385,(10S)-Nonacosan-10-ol;|Ginnol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08385  (10S)-Nonacosan-10-ol,
C08386,Nonacosan-10-one;|Ginnone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08386  Nonacosan-10-one,
C08387,Octacosan-1-ol;|1-Octacosanol;|Octacosanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08387  1-Octacosanol,
C08388,Pentadecane;|n-Pentadecane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08388  n-Pentadecane,
C08389,Propanethial S-oxide;|Thiopropanal S-oxide,,,,,
C08390,Propane-1-thiol;|Propanethiol;|Propyl mercaptan,,,,,
C08391,Propane-2-thiol;|Isopropyl mercaptan;|2-Propanethiol,,,,,
C08392,Triacontan-1-ol;|1-Triacontanol;|Myricyl alcohol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08392  1-Triacontanol,
C08393,Tritriacontane;|n-Tritriacontane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08393  n-Tritriacontane,
C08394,"Tritriacontane-16,18-dione;|N-Tritriacontane-16,18-dione",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08394  Tritriacontane-16,18-dione",
C08395,"Aethusin;|2,8,10-Tridecatriene-4,6-diyne",,,,,
C08396,"Anacyclin;|(2E,4E)-N-(2-Methylpropyl)-2,4-tetradecadiene-8,10-diynamide",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C08396  Anacyclin,
C08397,"5-(3-Buten-1-ynyl)-2,2'-bithiophene;|5-(3-Buten-1-ynyl)-2,2'-bithienyl",,,,,
C08398,Capillin,,,,,
C08399,Carlina oxide,,,,,
C08400,Glucoalyssin;|5-Methylsulfinylpentyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08400  5-Methylsulfinylpentyl glucosinolate,
C08401,Glucoberteroin;|5-Methylthiopentyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08401  5-Methylthiopentyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08401  Glucoberteroin,
C08402,Cicutoxin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08402  Cicutoxin|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C08402  Cicutoxin|Natural toxins [BR:br08009]|Phytotoxins|Others|Polyynes|C08402  Cicutoxin,
C08403,Glucobrassicanapin;|4-Pentenyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08403  4-Pentenyl glucosinolate,
C08404,Glucocapparin;|Methyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from alanine|C08404  Methyl glucosinolate,
C08405,Glucocheirolin;|3-Methylsufonylpropyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08405  3-Methylsufonylpropyl glucosinolate,
C08406,Glucocleomin;|2-Hydroxy-2-methylbutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from isoleucine|C08406  2-Hydroxy-2-methylbutyl glucosinolate,
C08407,Glucocochlearin;|1-Methylpropyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from isoleucine|C08407  1-Methylpropyl glucosinolate,
C08408,Glucoconringiin;|2-Hydroxy-2-methylpropyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from leucine|C08408  Glucoconringiin,
C08409,Glucoerucin;|4-Methylthiobutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08409  4-Methylthiobutyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08409  Glucoerucin,
C08410,Glucoerysolin;|4-Methylsulfonylbutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08410  4-Methylsulfonylbutyl glucosinolate,
C08411,Glucoiberin;|3-Methylsulfinylpropyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08411  3-Methylsulfinylpropyl glucosinolate,
C08412,Glucoiberverin;|3-Methylthiopropyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08412  3-Methylthiopropyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08412  Glucoiberverin,
C08413,Glucolepidiin;|Ethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from alanine|C08413  Ethyl glucosinolate,
C08414,Glucolimnanthin,,,,,
C08415,Gluconapin;|3-Butenylglucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08415  3-Butenyl glucosinolate,
C08416,Gluconapoleiferin;|2-Hydroxy-4-pentenyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08416  2-Hydroxy-4-pentenyl glucosinolate,
C08417,Gluconasturtiin;|2-Phenylethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from phenylalanine|C08417  2-Phenylethyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08417  Gluconasturtiin,
C08418,Glucoputranjivin;|1-Methylethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from valine|C08418  Glucoputranjivin|Glycosides [BR:br08021]|S-glycosides|C08418  Glucoputranjivin,
C08419,Glucoraphanin;|4-Methylsulfinylbutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08419  4-Methylsulfinylbutyl glucosinolate,
C08420,Glucoraphenin;|4-Methylsufinyl-3-butenyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08420  4-Methylsufinyl-3-butenyl glucosinolate,
C08422,4-Hydroxyglucobrassicin;|4-Hydroxy-3-indolylmethylglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C08422  4-Hydroxyglucobrassicin,
C08423,4-Methoxyglucobrassicin;|4-Methoxy-3-indolylmethyl glucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C08423  4-Methoxyglucobrassicin,
C08424,Neoglucobrassicin;|1-Methoxy-3-indolylmethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from tryptophan|C08424  Neoglucobrassicin|Glycosides [BR:br08021]|S-glycosides|C08424  Neoglucobrassicin,
C08425,Progoitrin;|2(R)-2-Hydroxy-3-butenyl glucosinolate;|Glucorapiferin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08425  2(R)-2-Hydroxy-3-butenyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08425  Progoitrin,
C08426,Sinalbin;|p-Hydroxybenzyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from tyrosine|C08426  p-Hydroxybenzyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08426  Sinalbin,
C08427,Sinigrin;|2-Propenyl glucosinolate;|Allylglucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C08427  2-Propenyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C08427  Sinigrin,
C08428,(N-Sulfoindol-3-yl)methylglucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from tryptophan|C08428  (N-Sulfoindol-3-yl)methylglucosinolate,
C08429,"Clitidine 5'-phosphate;|1,4-Dihydro-4-imino-1-(5-O-phosphono-beta-D-ribofuranosyl)-3-pyridinecarboxylic acid",,,,,
C08430,Convicine,,,,,
C08431,Cordycepin;|3'-Deoxyadenosine,,,,,
C08432,Isoguanosine;|Crotonoside,,,,,
C08433,Amataine;|Subssesiline,,,,,
C08434,6-Methylaminopurine;|N6-Methyladenine,,,,,
C08435,Triacanthine,,,,,
C08437,Vicine,,,,,
C08438,alpha-Amanitin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Cyclic peptides|C08438  alpha-Amanitin,
C08439,Phalloidin;|Phalloidine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Cyclic peptides|C08439  Phalloidin,
C08440,Phaseolotoxin;|N5-[Amino(sulfoamino)phosphinyl]-L-ornithyl-L-alanyl-N6-(aminoiminomethyl)-L-lysine,,,,,
C08441,Tentoxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C08441  Tentoxin,
C08442,Ustiloxin;|Ustiloxin A,,,,,
C08443,Victorin C,,,,,
C08445,Dehydrofalcarinone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08445  Dehydrofalcarinone,
C08446,"(E)-Dehydromatricaria ester;|trans-Dehydromatricaria ester;|(E)-2-Decene-4,6,8-triynoic acid methyl ester",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C08446  (E)-Dehydromatricaria ester,
C08447,"Dehydrosafynol;|(2R,11E)-11-Tridecene-3,5,7,9-tetrayne-1,2-diol",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08447  Dehydrosafynol,
C08448,Eutypine;|4-Hydroxy-3-(3-methyl-3-butene-1-ynyl)benzaldehyde,,,,,
C08449,Falcarindiol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08449  Falcarindiol,
C08450,Falcarinol;|Panaxynol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08450  Falcarinol|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C08450  Falcarinol,
C08451,"Falcarinone;|(Z)-1,9-Heptadecadiene-4,6-diyn-3-one",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C08451  Falcarinone,
C08452,"Ichthyotherol;|2H-Pyran-3-ol, tetrahydro-2-(1-nonene-3,5,7-triynyl)-, (2S-(2alpha(E),3beta))-",,,,,
C08453,"Lachnophyllum ester;|(E)-2-Decene-4,6-diynoic acid methyl ester",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C08453  Lachnophyllum ester,
C08454,"(E,E,E)-N-(2-Methylpropyl)hexadeca-2,6,8-trien-10-ynamide;|(2E,6E,8E)-N-Isobutyl-2,6,8-hexadecatriene-10-yneamide",,,,,
C08455,"Mycosinol;|(2E)-2-Hexa-2,4-diynylidene-1,6-dioxaspiro(4.4)nona-3,7-dien-9-ol",,,,,
C08456,"Phenylheptatriyne;|1-Phenylhepta-1,3,5-triyne",,,,,
C08457,"1-Phenyl-5-heptene-1,3-diyne;|Benzene, 5-heptene-1,3-diynyl-",,,,,
C08458,"Safynol;|(2R,3E,11E)-3,11-Tridecadiene-5,7,9-triyne-1,2-diol",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08458  Safynol,
C08459,Stearolic acid;|9-Stearolic acid;|9-Octadecynoic acid;|Octadec-9-ynoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Acetylenic fatty acids|C08459  Octadec-9-ynoic acid,
C08460,alpha-Terthienyl;|Terthiophene,,,,,
C08461,"Thiarubrine A;|Thiarubrin A;|3-(5-Hexene-1,3-diynyl)-6-(1-propynyl)-1,2-dithiin",,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C08461  Thiarubrine A,
C08462,"Thiarubrine B;|Thiarubrin B;|3-(3-Buten-1-ynyl)-6-(1,3-pentadiynyl)-1,2-dithiin",,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C08462  Thiarubrine B,
C08463,"Triacetylene;|1,3,5-Hexatriyne",,,,,
C08464,"1-Tridecene-3,5,7,9,11-pentayne;|Tridec-1-ene-3,5,7,9,11-pentayne",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C08464  1-Tridecene-3,5,7,9,11-pentayne",
C08465,Wyerone,,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C08465  Wyerone,
C08466,Wyerone acid,,,,,
C08467,Asimicin;|Bullatacin,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C08467  Asimicin|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08467  Asimicin,
C08468,Acremoauxin A;|2-(3-Indolyl)propanoylmannitol,,,,,
C08469,Aristolochic acid;|Aristolochic acid I,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08469  Aristolochic acid|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C08469  Aristolochic acid,
C08470,Bullatacinone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08470  Bullatacinone|PK  Polyketides|PK03 Annonaceae acetogenins|C08470  Bullatacinone,
C08471,Chalcogran,,,,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C08471  Chalcogran,
C08472,Avenanthramide A;|5-Hydroxy-2-[(2E)-3-(4-hydroxyphenyl)prop-2-enamido]benzoate,,,,,
C08473,"Cibarian;|beta-D-Glucopyranose, 1,6-bis(3-nitropropanoate)",,,,,
C08474,"Coronarian;|alpha-D-Glucopyranose, 2,6-bis(3-nitropropanoate)",,,,,
C08475,Cucumopine,,,,,
C08476,"Chelidonic acid;|4-Oxo-4H-pyran-2,6-dicarboxylic acid",,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Monocyclic gamma-pyrones|C08476  Chelidonic acid,
C08477,"Dianthalexin;|7-Hydroxy-2-phenyl-4H-3,1-benzoxazin-4-one",,,,,
C08478,"Dianthramine;|2,2'-Iminobis(4-hydroxybenzoic acid)",,,,,
C08480,6-Hydroxykynurenic acid,6-Hydroxykynurenic acid (tautomer) [CPD:C05663],,,,
C08481,"Indican;|Indican, plant",,,,,
C08482,Cucurbic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C08482  Cucurbic acid,
C08483,14-Dihydroxycornestin;|Cornexistin,,,,,
C08484,Epoxymurin-A,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C08484  Epoxymurin-A,
C08485,2-(4-Methoxyphenethyl)chromone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C08485  2-(4-Methoxyphenethyl)chromone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C08485  2-(4-Methoxyphenethyl)chromone,
C08486,"Ethyl (E,Z)-decadienoate;|(2E,4Z)-2,4-Decadienoic acid ethyl ester;|Ethyl trans-2,cis-4-decadienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C08486  Ethyl (E,Z)-decadienoate",
C08487,Ethyl tiglate;|Ethyl 2-methylbut-2-enoate;|(E)-2-Methyl-2-butenoic acid ethyl ester,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C08487  Ethyl tiglate,
C08488,Giganin,,,,,
C08489,"(Z)-3,5-Hexadienyl butyrate",,,,,
C08490,Jasmone;|cis-Jasmone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C08490  cis-Jasmone,
C08491,"(-)-Jasmonic acid;|Jasmonic acid;|{(1R,2R)-3-Oxo-2-[(Z)pent-2-enyl]cyclopent-2-enyl}acetic acid;|Jasmonate;|(-)-Jasmonate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C08491  (-)-Jasmonic acid|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08491  Jasmonate,
C08492,3-Hexenol;|Leaf alcohol;|3-Hexen-1-ol;|(3Z)-3-Hexen-1-ol;|cis-3-Hexen-1-ol;|(3Z)-Hex-3-en-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08492  (3Z)-3-Hexen-1-ol,
C08493,Indole-3-carboxaldehyde;|Indole-3-carbaldehyde,,,,,
C08494,Isotan B,,,,,
C08495,"Karakin;|Endecaphillin A;|beta-D-Glucopyranose, 1,2,6-tris(3-nitropropanoate)",,,,,
C08496,Lycomarasmine B;|Lycomarasmine,,,,,
C08497,(E)-2-Hexenal;|trans-2-Hexenal;|Leaf aldehyde;|(2E)-Hexenal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C08497  (2E)-Hexenal,
C08498,Lilac aldehyde,,,,,
C08499,"Nona-2,6-dienal;|(2E,6Z)-2,6-Nonadienal",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C08499  (2E,6Z)-2,6-Nonadienal",
C08501,gamma-Nonalactone;|delta-n-Amylbutyrolactone;|Dihydro-5-pentyl-2(3H)-furanone,,,,,
C08502,Parasorbic acid,,,,,
C08503,Pinolidoxin,,,,,
C08504,Macrozamin,,,,,
C08505,Purpureacin-1,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C08505  Purpureacin-1,
C08506,Methoxybrassinin,,,,,
C08507,Miserotoxin,,,,,
C08509,Putaminoxin,,,,,
C08510,Ruscopine,,,,,
C08511,"Tenuazonic acid;|(5S,8S)-3-Acetyl-5-sec-butylpyrrolidine-2,4-dione",keto-form [PMID:23474405],,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C08511  Tenuazonic acid,
C08512,Ranunculin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Cyanogenic glucosides|Others|C08512  Ranunculin|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C08512  Ranunculin|Glycosides [BR:br08021]|O-glycosides|Cyanogenic glycosides|C08512  Ranunculin,
C08513,Acetylcaranine;|Belamarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08513  Acetylcaranine,
C08514,3-Acetylnerbowdine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08514  3-Acetylnerbowdine,
C08515,Albomaculine,,,,,
C08516,Amaryllisine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08516  Amaryllisine,
C08517,"Ambelline;|(3alpha,11S)-1,2-Didehydro-3,7-dimethoxycrinan-11-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08517  Ambelline,
C08518,Belladine,,,,,
C08519,Brunsvigine;|(-)-Brunsvigine;|3alpha-Pancracine,,,,,
C08520,Candimine,,,,,
C08521,Caranine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08521  Caranine,
C08522,Caribine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08522  Caribine,
C08523,Carinatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08523  Carinatine,
C08524,Cavinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08524  Cavinine,
C08525,"Crinamine;|(3alpha,5alpha,11R,13beta,19alpha)-1, 2-Didehydro-3-methoxycrinan-11-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08525  Crinamine,
C08526,Galanthamine;|Galantamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08526  Galanthamine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C08526  Galanthamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04292)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06D ANTI-DEMENTIA DRUGS|N06DA Anticholinesterases|N06DA04 Galantamine|D04292  Galantamine (USAN/INN)|Drug groups [BR:br08330(D04292)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00985  Galantamine|D04292  Galantamine|DG01968  Antidementia agent|DG00985  Galantamine|D04292  Galantamine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00985  Galantamine|D04292  Galantamine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00985  Galantamine|D04292  Galantamine|Target-based classification of drugs [BR:br08310(D04292)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D04292  Galantamine (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D04292)]|Drug metabolizing enzymes|D04292,
C08527,"Haemanthamine;|Hemanthamine;|(3beta,5alpha,11R,13beta,19alpha)-1,2-Didehydro-3-methoxycrinan-11-ol;|(+)-Haemanthamine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08527  Haemanthamine,
C08528,Hippeastrine,,,,,
C08529,Kalbreclasine,,,,,
C08530,Lycorenine,,,,,
C08531,Lycoricidine,,,,,
C08532,Lycorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08532  Lycorine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C08532  Lycorine,
C08533,Narciclasine,,,,,
C08534,Narwedine;|(-)-Narwedine;|Galanthaminone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C08534  Narwedine,
C08535,Pancratistatin,,,,,
C08536,Pretazettine,,,,,
C08537,Amaranthin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08537  Amaranthin,
C08538,Betalamic acid,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Others|C08538  Betalamic acid,
C08539,"Betanidin;|(2S)-4-[2-[(2S)-2-Carboxy-2,3-dihydro-5,6-dihydroxy-1H-indol-1-yl]ethenyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",including tautomers,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08539  Betanidin,
C08540,Betanin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08540  Betanin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08540,
C08541,Bougainvillein-r-I;|Bougainvillein-v,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08541  Bougainvillein-r-I,
C08542,Celosianin II,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08542  Celosianin II,
C08543,Dopaxanthin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08543  Dopaxanthin,
C08544,Gomphrenin-I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08544  Gomphrenin-I,
C08545,Squamocin,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C08545  Squamocin,
C08546,Tiglyl tiglate;|(E)-2-Methylcrotonic acid (E)-2-methyl-2-butenyl ester,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C08546  Tiglyl tiglate,
C08547,Gomphrenin-V,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08547  Gomphrenin-V,
C08548,Humilixanthin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08548  Humilixanthin,
C08549,Indicaxanthin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08549  Indicaxanthin,
C08550,Iresinin I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08550  Iresinin I,
C08551,Isobetanin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08551  Isobetanin,
C08552,Lampranthin II,,,,,
C08553,"PM-Toxin A;|(4R,12R,20R,28R)-4,12,20,28-Tetrahydroxy-2,10,18,26-tritriacontanetetrone",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C08553  PM-Toxin A,
C08554,Miraxanthin-I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08554  Miraxanthin-I,
C08555,Miraxanthin-II,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08555  Miraxanthin-II,
C08556,Miraxanthin-III,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08556  Miraxanthin-III,
C08557,Miraxanthin-V,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08557  Miraxanthin-V|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08557,
C08558,Tuberonic acid glucoside;|12-Hydroxyjasmonic acid 12-O-beta-D-glucoside,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C08558  Tuberonic acid glucoside|FA13 Fatty acyl glycosides|FA1301 Fatty acyl glycosides of mono- and disaccharides|C08558  Tuberonic acid glucoside,
C08559,Musca-aurin-I;|Muscaaurin I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08559  Musca-aurin-I,
C08560,Musca-aurin-II;|Muscaaurin II,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08560  Musca-aurin-II,
C08561,Tuliposide A,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA13 Fatty acyl glycosides|FA1301 Fatty acyl glycosides of mono- and disaccharides|C08561  Tuliposide A,
C08562,Musca-aurin-VII;|Muscaaurin VII,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08562  Musca-aurin-VII,
C08563,Muscapurpurin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Others|C08563  Muscapurpurin,
C08564,Portulacaxanthin I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08564  Portulacaxanthin I,
C08565,Portulacaxanthin II,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08565  Portulacaxanthin II,
C08566,Portulacaxanthin III,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08566  Portulacaxanthin III,
C08567,Prebetanin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C08567  Prebetanin,
C08568,Vulgaxanthin-I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08568  Vulgaxanthin-I,
C08569,Vulgaxanthin-II,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C08569  Vulgaxanthin-II,
C08570,Tuliposide B,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA13 Fatty acyl glycosides|FA1301 Fatty acyl glycosides of mono- and disaccharides|C08570  Tuliposide B,
C08571,"gamma-Undecalactone;|2(3H)-Furanone, 5-heptyldihydro-",,,,,
C08572,Uvaricin,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C08572  Uvaricin|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C08572  Uvaricin,
C08573,Abyssinone VI,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08573  Abyssinone VI|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08573  Abyssinone VI,
C08574,Apigeninidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08574  Apigeninidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08574  Apigeninidin,
C08575,Aurantinidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08575  Aurantinidin,
C08576,Aureusidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08576  Aureusidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08576  Aureusidin,
C08577,Bracteatin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08577  Bracteatin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08577  Bracteatin,
C08578,Butein,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08578  Butein|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08578  Butein,
C08579,Antheraxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08579  Antheraxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08579  Antheraxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08579,
C08580,"Astaxanthin;|(3S,3'S)-Astaxanthin;|(3S,3'S)-3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08580  Astaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08580  Astaxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08580,
C08581,Azafrin,,,,,
C08582,"Bixin;|Methyl (9-cis)-hydrogen-6,6'-diapo-psi,psi-carotenedioate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08582  Bixin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C08582  Bixin,
C08583,Canthaxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08583  Canthaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08583  Canthaxanthin,
C08584,Capsanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08584  Capsanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08584  Capsanthin,
C08585,Capsorubin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08585  Capsorubin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08585  Capsorubin,
C08586,delta-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08586  delta-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08586  delta-Carotene,
C08587,"beta-Carotene 5,6-epoxide;|5,6-Epoxy-beta,beta-carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08587  beta-Carotene 5,6-epoxide|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08587  beta-Carotene 5,6-epoxide",
C08588,"Crocetin;|8,8'-Diapocarotene-8,8'-dioic acid",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C08588  Crocetin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C08588  Crocetin|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Crocetin|C08588  Crocetin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08588,
C08589,Crocin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C08589  Crocin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08589,
C08590,"Zeinoxanthin;|3-Hydroxy-alpha-carotene;|(3R,6'R)-beta,epsilon-Caroten-3-ol",often confused with alpha-Cryptoxanthin [CPD:C15981],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08590  Zeinoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08590  Zeinoxanthin,
C08591,beta-Cryptoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08591  beta-Cryptoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08591  beta-Cryptoxanthin,
C08592,"Echinenone;|beta,beta-Caroten-4-one",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08592  Echinenone,
C08593,Eschscholtzxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08593  Eschscholtzxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08593  Eschscholtzxanthin,
C08594,Flavoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08594  Flavoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08594  Flavoxanthin,
C08595,Capensinidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08595  Capensinidin,
C08596,Fucoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08596  Fucoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08596  Fucoxanthin,
C08597,Helenien;|Xantofyl palmitate,,,,Therapeutic category of drugs in Japan [BR:br08301(D01031)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1319  Others|D01031  Helenien (JAN); Xantofyl palmitate (INN),
C08598,Carthamone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08598  Carthamone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08598  Carthamone,
C08599,Lactucaxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08599  Lactucaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08599  Lactucaxanthin,
C08600,Silandrin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C08600  Silandrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C08600  Silandrin,
C08601,Lutein;|Xanthophyll,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08601  Lutein|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08601  Lutein|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08601,
C08602,"Lutein 5,6-epoxide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08602  Lutein 5,6-epoxide|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08602  Lutein 5,6-epoxide",
C08603,Lycoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08603  Lycoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08603  Lycoxanthin,
C08604,Cyanidin 3-O-glucoside;|Chrysanthemin;|Cyanidin 3-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08604  Cyanidin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08604  Chrysanthemin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08604  Chrysanthemin|Dietary phytochemicals [br08012.html]|Flavonoids|C08604,
C08605,Citroxanthin;|Mutatochrome,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08605  Citroxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08605  Citroxanthin,
C08606,Neoxanthin;|all-trans-Neoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08606  Neoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08606  Neoxanthin,
C08607,Neurosporaxanthin;|all-trans-Neurosporaxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08607  Neurosporaxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08607,
C08608,Norbixin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08608  Norbixin,
C08609,Physalien;|Zeaxanthin dipalmitate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08609  Physalien,
C08610,Rhodoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08610  Rhodoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08610  Rhodoxanthin,
C08611,Rubixanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08611  Rubixanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08611  Rubixanthin,
C08612,Cyanidin 3-O-(6''-glucosyl-2''-xylosylgalactoside);|Cyanidin 3-O-(6-O-beta-D-glucosyl-2-O-beta-D-xylosyl-beta-D-galactoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08612  Cyanidin 3-O-(6''-glucosyl-2''-xylosylgalactoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08612  Cyanidin 3-O-(6''-glucosyl-2''-xylosylgalactoside),
C08613,Torulene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08613  Torulene,
C08614,Violaxanthin;|all-trans-Violaxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C08614  Violaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C08614  Violaxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08614,
C08615,alpha-Amyrin,beta-Amyrin [CPD:C08616],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010617 Pachysanane triterpenoids|C08615  alpha-Amyrin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C08615  alpha-Amyrin,
C08616,beta-Amyrin;|beta-Amyrenol,alpha-Amyrin [CPD:C08615],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08616  beta-Amyrin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08616  beta-Amyrin,
C08617,Asiatic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010618 Taraxastane, ursane and bauerane triterpenoids|C08617  Asiatic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C08617  Asiatic acid",
C08618,Betulin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010614 Lupane triterpenoids|C08618  Betulin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Lupanes|C08618  Betulin,
C08619,Betulinic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010614 Lupane triterpenoids|C08619  Betulinic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Lupanes|C08619  Betulinic acid,
C08620,Cyanidin 3-O-rutinoside;|Cyanidin 3-O-rhamnosylglucoside;|Keracyanin,Cyanidin 3-rutinoside chloride [CPD:C04491],,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08620  Cyanidin 3-O-rutinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08620  Cyanidin 3-O-rutinoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08620  Cyanidin 3-O-rutinoside|Dietary phytochemicals [br08012.html]|Flavonoids|C08620,
C08621,Dammarenediol-I,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08621  Dammarenediol-I|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08621  Dammarenediol-I,
C08622,Dipterocarpol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08622  Dipterocarpol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08622  Dipterocarpol,
C08623,alpha-Elemolic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08623  alpha-Elemolic acid,
C08624,Euphol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010609 Tirucallane/euphane triterpenoids|C08624  Euphol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08624  Euphol,
C08625,Fernene,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010620 Neohopane, fernane, adianane and filicane triterpenoids|C08625  Fernene|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Hopanes|C08625  Fernene",
C08626,Friedelin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Hopanes|C08626  Friedelin,
C08627,Hopane-29-acetate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C08627  Hopane-29-acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Hopanes|C08627  Hopane-29-acetate,
C08628,Lupeol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010614 Lupane triterpenoids|C08628  Lupeol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Lupanes|C08628  Lupeol,
C08629,"Cyanidin 3,5,3'-tri-O-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08629  Cyanidin 3,5,3'-tri-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08629  Cyanidin 3,5,3'-tri-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08629  Cyanidin 3,5,3'-tri-O-glucoside",
C08630,Lupeol acetate;|3-Acetyllupeol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010614 Lupane triterpenoids|C08630  Lupeol acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Lupanes|C08630  Lupeol acetate,
C08631,Messagenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08631  Messagenin,
C08632,Papyriferic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08632  Papyriferic acid,
C08633,Pristimerin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08633  Pristimerin,
C08634,Sapelin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08634  Sapelin A,
C08635,Taccalonolide A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0116 Withanolides and derivatives|C08635  Taccalonolide A|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08635  Taccalonolide A,
C08636,Taraxasterol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010618 Taraxastane, ursane and bauerane triterpenoids|C08636  Taraxasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08636  Taraxasterol",
C08637,Taraxerol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010616 Taraxerane, multiflorane, glutinane and friedelane triterpenoids|C08637  Taraxerol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08637  Taraxerol",
C08638,Tingenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08638  Tingenone,
C08639,"Cyanidin 3,5-O-diglucoside;|Cyanin;|Cyanidin 3,5-di-O-glucoside;|Cyanidin 3,5-di-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08639  Cyanidin 3,5-O-diglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08639  Cyanin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08639  Cyanin|Dietary phytochemicals [br08012.html]|Flavonoids|C08639",
C08640,"Delphinidin 3,3',5'-tri-O-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08640  Delphinidin 3,3',5'-tri-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C08640  Delphinidin 3,3',5'-tri-O-glucoside",
C08641,Gentiodelphin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08641  Gentiodelphin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08641  Gentiodelphin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C08641  Gentiodelphin,
C08642,Heavenly blue anthocyanin;|Peonidin 3-(2-(6-(3-(glucosyl)caffeoyl)glucosyl)-6-(4-(6-(3-(glucosyl)caffeoyl)glucosyl)caffeoyl)glucoside) 5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08642  Heavenly blue anthocyanin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08642  Heavenly blue anthocyanin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08642  Heavenly blue anthocyanin,
C08643,Hirsutidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08643  Hirsutidin,
C08644,Hispidol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08644  Hispidol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08644  Hispidol,
C08646,6-Hydroxycyanidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08646  6-Hydroxycyanidin,
C08647,Cyanidin 3-O-galactoside;|Cyanidin 3-O-beta-D-galactoside;|Ideain,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08647  Cyanidin 3-O-galactoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08647  Cyanidin 3-O-galactoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C08647  Cyanidin 3-O-galactoside|Dietary phytochemicals [br08012.html]|Flavonoids|C08647,
C08648,Isobavachalcone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08648  Isobavachalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08648  Isobavachalcone,
C08649,Isobutrin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08649  Isobutrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08649  Isobutrin|Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C08649  Isobutrin,
C08650,Isoliquiritigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08650  Isoliquiritigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08650  Isoliquiritigenin,
C08651,Leptosidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08651  Leptosidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08651  Leptosidin,
C08652,Luteolinidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08652  Luteolinidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08652  Luteolinidin,
C08653,Malonylawobanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08653  Malonylawobanin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08653  Malonylawobanin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C08653  Malonylawobanin,
C08654,Acetylbrowniine;|Browniine 14-acetate,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08654  Acetylbrowniine,
C08655,"Aconifine;|Aconitane-3,8,10,13,14,15-hexol, 20-ethyl-4-(methoxymethyl)-1,6,16-trimethoxy-, 8-acetate 14-benzoate, (1-alpha,3-alpha,6-alpha,14-alpha,15-alpha,16-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08655  Aconifine,
C08656,Ajaconine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08656  Ajaconine,
C08657,Anhwiedelphinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08657  Anhwiedelphinine,
C08658,Anopterine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08658  Anopterine,
C08659,Inuline;|Anthranoyllycoctonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08659  Inuline,
C08660,Atisine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08660  Atisine,
C08661,"Avadharidine;|Aconitane-7,8-diol, 4-(((2-((4-amino-1,4-dioxobutyl)amino)benzoyl)oxy)methyl)-20-ethyl-1,6,14,16-tetramethoxy-, (1alpha,6beta,14alpha,16beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08661  Avadharidine,
C08662,"Barbinine;|Aconitan-14-one, 7,8-dihydroxy-20-ethyl-4-(((2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoyl)oxy)methyl)-1,6,16-trimethoxy-, (1-alpha,4(S),6-beta,16-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08662  Barbinine,
C08663,Beiwutine,,,,,
C08664,Bikhaconitine,,,,,
C08665,"Browniine;|Aconitane-7,8,14-triol, 20-ethyl-4-(methoxymethyl)-1,6,16-trimethoxy-, (1-alpha,6-beta,14-alpha,16-beta)-",,,,,
C08666,Cammaconine;|Columbiananine,,,,,
C08667,Cardiopetalidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08667  Cardiopetalidine,
C08668,Septentriodine;|Cashmiradelphine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08668  Septentriodine,
C08669,Cassaidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08669  Cassaidine,
C08670,Cassaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08670  Cassaine,
C08671,Condelphine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08671  Condelphine,
C08672,"Cuauchichicine;|Veatchine,15-deoxy-16,17-dihydro-15-oxo-, (16-beta,20S)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08672  Cuauchichicine,
C08673,14-Deacetylnudicauline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08673  14-Deacetylnudicauline,
C08674,Delavaine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08674  Delavaine A,
C08675,Delcorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08675  Delcorine,
C08676,Delcosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08676  Delcosine,
C08677,Delphinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08677  Delphinine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C08677  Delphinine,
C08678,Delsoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08678  Delsoline,
C08679,"Deltaline;|Aconitane-6,10-diol, 20-ethyl-4-methyl-7,8-(methylenebis(oxy))-, 1,14,16-trimethoxy-, 6-acetate, (1-alpha,6-beta,14-alpha,16-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08679  Deltaline,
C08680,Denudatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08680  Denudatine,
C08681,"Elatine;|Aconitane-4-methanol, 20-ethyl-7,8-(methylenebis(oxy))-, 1,6,14,16-tetramethoxy-2-(3-methyl-2,5-dioxo-1-pyrrolidinyl)benzoate(ester), (1-alpha,6-beta,14-alpha,16-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08681  Elatine,
C08682,Erythrophleguine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08682  Erythrophleguine,
C08683,Falaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08683  Falaconitine,
C08684,Finaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08684  Finaconitine,
C08685,Garryine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08685  Garryine,
C08686,Heteratisine,,,,,
C08687,"Hetisine;|Hetisan-2,11,13-triol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08687  Hetisine,
C08688,Hypaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08688  Hypaconitine,
C08689,Icaceine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08689  Icaceine,
C08690,Icacine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08690  Icacine,
C08691,Indaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08691  Indaconitine,
C08692,Jesaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08692  Jesaconitine,
C08693,"Karakoline;|Aconitane-1,8,14-triol, 20-ethyl-16-methoxy-4-methyl-, (1-alpha,14-alpha,16-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08693  Karakoline,
C08694,Lappaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08694  Lappaconitine,
C08695,Lindheimerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08695  Lindheimerine,
C08696,Lycaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08696  Lycaconitine,
C08697,Lycoctonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08697  Lycoctonine,
C08698,Mesaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08698  Mesaconitine|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C08698  Mesaconitine,
C08699,Methyllycaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08699  Methyllycaconitine,
C08700,Napelline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08700  Napelline,
C08701,Norerythrostachaldine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08701  Norerythrostachaldine,
C08702,Nudicauline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08702  Nudicauline,
C08703,Ovatine,,,,,
C08704,Pseudoaconitine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08704  Pseudoaconitine,
C08705,Ryanodine;|Ryania,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08705  Ryanodine|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C08705  Ryanodine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C08705  Ryanodine,
C08706,Septentrionine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08706  Septentrionine,
C08707,Songorine;|Zongorine;|Napellonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08707  Songorine,
C08708,Spiradine A;|6-Hydroxyhetisan-11-one,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08708  Spiradine A,
C08709,Spiramine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08709  Spiramine A,
C08710,Spirasine I,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08710  Spirasine I,
C08711,Spiredine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08711  Spiredine,
C08712,Staphidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08712  Staphidine,
C08713,Talatizamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08713  Talatizamine,
C08714,"Thalicsessine;|21-(2-Hydroxyethyl)-6,21-secohetisan-6,11,19-trione",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08714  Thalicsessine,
C08715,Tricornine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C08715  Tricornine,
C08716,Malvidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08716  Malvidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08716  Malvidin|Dietary phytochemicals [br08012.html]|Flavonoids|C08716,
C08717,Silychristin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C08717  Silychristin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C08717  Silychristin,
C08718,"Malvin;|Malvidin-3,5-diglucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08718  Malvin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08718  Malvin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C08718  Malvin|Dietary phytochemicals [br08012.html]|Flavonoids|C08718,
C08719,Sophoranone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C08719  Sophoranone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C08719  Sophoranone,
C08720,Maritimetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08720  Maritimetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08720  Maritimetin,
C08721,Polysialic acid acetylated at O-9,Generic compound in reaction hierarchy,,,,
C08722,"4,5-Methylenedioxy-6-hydroxyaurone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08722  4,5-Methylenedioxy-6-hydroxyaurone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C08722  4,5-Methylenedioxy-6-hydroxyaurone",
C08723,Monardaein,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08723  Monardaein|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08723  Monardaein|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C08723  Monardaein,
C08724,Okanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C08724  Okanin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C08724  Okanin,
C08725,"Pelargonin;|Pelargonidin 3,5-di-beta-D-glucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08725  Pelargonin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08725  Pelargonin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C08725  Pelargonin|Dietary phytochemicals [br08012.html]|Flavonoids|C08725,
C08726,"Peonidin;|3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium chloride",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08726  Peonidin|Dietary phytochemicals [br08012.html]|Flavonoids|C08726,
C08727,Petunidin;|Petunidin chloride,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08727  Petunidin|Dietary phytochemicals [br08012.html]|Flavonoids|C08727,
C08728,Riccionidin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08728  Riccionidin A|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08728  Riccionidin A,
C08729,Rosinidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C08729  Rosinidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C08729  Rosinidin,
C08730,Sulphuretin;|Sulfuretin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C08730  Sulphuretin,
C08731,Xenognosin A,,,,,
C08732,"Albafuran A;|4-((2E)-3,7-Dimethyl-2,6-octadienyl)-5-(6-hydroxy-2-benzofuranyl)-1,3-benzenediol",,,,Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|2-Arylbenzofurans|C08732  Albafuran A,
C08733,"Ammeline;|2-Hydroxy-4,6-diamino-1,3,5-triazine",,,,,
C08734,"Ammelide;|2,4-Dihydroxy-6-amino-1,3,5-triazine",,,,,
C08735,"2-Chloro-4-hydroxy-6-amino-1,3,5-triazine",,,,,
C08736,"6-Chloro-1,3,5-triazine-2,4(1H,3H)-dione;|2-Chloro-4,6-dihydroxy-1,3,5-triazine",,,,,
C08737,"Melamine;|2,4,6-Triamino-1,3,5-triazine",,,,,
C08738,Albanol A;|Mulberrofuran G,,,,,
C08739,alpha-Cotonefuran,,,,,
C08740,beta-Cotonefuran,,,,,
C08741,Dehydrotremetone,,,,,
C08742,"2,8-Dihydroxy-3,4,7-trimethoxydibenzofuran",,,,,
C08743,"Eriobofuran;|2,4-Dimethoxydibenzofuran-3-ol",,,,,
C08744,Dihydroeuparin;|6-Hydroxytremetone,,,,,
C08745,Lithospermic acid,,,,,
C08746,Ailanthinone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08746  Ailanthinone,
C08747,Ailanthone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08747  Ailanthone,
C08748,Azadirachtin A;|Azadirachtin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010610 Apotirucallane triterpenoids|C08748  Azadirachtin A,
C08749,Bruceantin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08749  Bruceantin,
C08750,Bruceantinol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08750  Bruceantinol,
C08751,Bruceine B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08751  Bruceine B,
C08752,Bruceine D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08752  Bruceine D,
C08753,Bruceoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08753  Bruceoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08753  Bruceoside A,
C08754,Brusatol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08754  Brusatol,
C08755,Castelanone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08755  Castelanone,
C08756,Chaparrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08756  Chaparrin,
C08757,Chaparrinone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08757  Chaparrinone,
C08758,Chaparrolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08758  Chaparrolide,
C08759,Eurycomalactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08759  Eurycomalactone,
C08760,Glaucarubin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08760  Glaucarubin,
C08761,6-Methoxy-alpha-pyrufuran,,,,,
C08762,6-O-Methyleuparin;|1-(6-Methoxy-2-prop-1-en-2-yl-1-benzofuran-5-yl)ethanone,,,,,
C08763,Glaucarubinone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08763  Glaucarubinone,
C08764,Glaucarubolone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08764  Glaucarubolone,
C08765,Glycinoeclepin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08765  Glycinoeclepin A,
C08766,Harrisonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08766  Harrisonin,
C08767,12alpha-Hydroxyamoorstatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08767  12alpha-Hydroxyamoorstatin,
C08768,Ichangin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08768  Ichangin,
C08769,Isobrucein A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08769  Isobrucein A,
C08770,Isobrucein B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08770  Isobrucein B,
C08771,Neoquassin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010611 Nortriterpenoids|C08771  Neoquassin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08771  Neoquassin,
C08772,Nigakihemiacetal A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08772  Nigakihemiacetal A,
C08773,Nomilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08773  Nomilin,
C08774,"(Z)-Dehydromatricaria ester;|cis-Dehydromatricaria ester;|(Z)-2-Decene-4,6,8-triynoic acid methyl ester",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C08774  (Z)-Dehydromatricaria ester,
C08775,Obacunone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C08775  Obacunone,
C08776,Picrasin C;|Nigakilactone J;|Quassin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08776  Nigakilactone J,
C08777,Quassimarin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08777  Quassimarin,
C08778,Quassin;|Nigakilactone D,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010611 Nortriterpenoids|C08778  Quassin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08778  Nigakilactone D,
C08779,Rutaevin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08779  Rutaevin,
C08780,Salannin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C08780  Salannin,
C08781,Samaderin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08781  Samaderin A,
C08782,Sergeolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08782  Sergeolide,
C08783,Simalikilactone D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08783  Simalikilactone D,
C08784,Soularubinone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08784  Soularubinone,
C08785,Toonacilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C08785  Toonacilin,
C08786,Trichilin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C08786  Trichilin A,
C08787,Undulatone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08787  Undulatone,
C08788,Zapoterin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08788  Zapoterin,
C08789,Bryodulcosigenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08789  Bryodulcosigenin,
C08790,Carnosifloside I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08790  Carnosifloside I,
C08791,Carnosifloside III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08791  Carnosifloside III,
C08792,Carnosifloside VI,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08792  Carnosifloside VI,
C08793,Cucurbitacin A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08793  Cucurbitacin A|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08793  Cucurbitacin A,
C08794,Cucurbitacin B,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08794  Cucurbitacin B|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08794  Cucurbitacin B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08794,
C08795,Cucurbitacin C,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08795  Cucurbitacin C|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08795  Cucurbitacin C|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08795,
C08796,Cucurbitacin D,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08796  Cucurbitacin D|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08796  Cucurbitacin D,
C08797,Cucurbitacin E,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08797  Cucurbitacin E|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08797  Cucurbitacin E|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08797,
C08798,Cucurbitacin F,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08798  Cucurbitacin F|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08798  Cucurbitacin F,
C08799,Cucurbitacin H,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08799  Cucurbitacin H|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08799  Cucurbitacin H,
C08800,Cucurbitacin I,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08800  Cucurbitacin I|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08800  Cucurbitacin I,
C08801,Cucurbitacin J,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08801  Cucurbitacin J|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08801  Cucurbitacin J,
C08802,Cucurbitacin L,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08802  Cucurbitacin L|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08802  Cucurbitacin L,
C08803,Cucurbitacin O,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08803  Cucurbitacin O|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08803  Cucurbitacin O,
C08804,Cucurbitacin P,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08804  Cucurbitacin P|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08804  Cucurbitacin P,
C08805,Cucurbitacin Q,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08805  Cucurbitacin Q|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08805  Cucurbitacin Q,
C08806,Cucurbitacin S,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08806  Cucurbitacin S|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08806  Cucurbitacin S,
C08807,11-Deoxocucurbitacin I,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08807  11-Deoxocucurbitacin I|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C08807  11-Deoxocucurbitacin I,
C08808,Gratiogenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08808  Gratiogenin|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08808  Gratiogenin,
C08809,Spinoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08809  Spinoside A,
C08810,Ajugalactone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08810  Ajugalactone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08810  Ajugalactone,
C08811,"Ajugasterone C;|2beta,3beta,11alpha,14,20,22R-Hexahydroxy-5beta-cholest-7-en-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08811  Ajugasterone C|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08811  Ajugasterone C,
C08813,"Brassicasterol;|(3beta,22E)-Ergosta-5,22-dien-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C08813  Brassicasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C08813  Brassicasterol,
C08814,Brassinolide,,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Campestane derivatives|C08814  Brassinolide|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C08814  Brassinolide|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C08814  Brassinolide|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08814,
C08816,Cyasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08816  Cyasterone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08816  Cyasterone,
C08817,Fucosterol,,,,Compounds with biological roles [BR:br08001]|Steroids|29-Carbon atoms|Stigmastane derivatives|C08817  Fucosterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08817  Fucosterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08817  Fucosterol,
C08819,Inokosterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08819  Inokosterone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08819  Inokosterone,
C08821,Isofucosterol;|Delta5-Avenasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08821  Isofucosterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08821  Isofucosterol,
C08823,"Lichesterol;|(3beta,22E)-Ergosta-5,8,22-trien-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C08823  Lichesterol,
C08825,Lophenol;|4-Methylcholest-7-en-3-ol;|4alpha-Methyl-5alpha-cholest-7-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08825  Lophenol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08825  Lophenol,
C08829,Makisterone B,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C08829  Makisterone B|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C08829  Makisterone B,
C08830,"24-Methylidenecycloartanol;|4alpha,4beta,14alpha-Trimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-3beta-ol;|24-Methylenecycloartanol;|9,19-Cyclolanostan-3-o1, 24-methylene-, (3beta)-",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C08830  24-Methylenecycloartanol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cycloartane|C08830  24-Methylenecycloartanol,
C08831,Miroestrol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Others|C08831  Miroestrol,
C08832,Podecdysone B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08832  Podecdysone B,
C08833,Pollinastanol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08833  Pollinastanol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08833  Pollinastanol,
C08834,"Polypodine B;|2beta,3beta,5beta,14,20,22R,25-Heptahydroxycholest-7-en-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08834  Polypodine B|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08834  Polypodine B,
C08835,"Ponasterone A;|25-Deoxycedysterone;|2beta,3beta,14,20,22-Pentahydroxy-5beta-cholest-7-en-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C08835  Ponasterone A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08835  Ponasterone A,
C08836,"Poriferasterol;|(3beta,22E,24R)-Stigmasta-5,22-dien-3-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|29-Carbon atoms|Poriferastane derivatives|C08836  Poriferasterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08836  Poriferasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08836  Poriferasterol,
C08837,"Poststerone;|(2beta,3beta,5beta)-2,3,14-Trihydroxypregn-7-ene-6,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C08837  Poststerone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Pregnane|C08837  Poststerone",
C08838,Pterosterone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08838  Pterosterone,
C08839,"Schottenol;|7-Stigmastenol;|(3beta,5alpha)-Stigmast-7-en-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08839  Schottenol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08839  Schottenol,
C08840,alpha-Spinasterol;|Spinasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C08840  alpha-Spinasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C08840  alpha-Spinasterol,
C08841,Withaferin A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0116 Withanolides and derivatives|C08841  Withaferin A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Others|C08841  Withaferin A,
C08842,Withanolide D,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0116 Withanolides and derivatives|C08842  Withanolide D|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Others|C08842  Withanolide D,
C08843,Adonitoxin;|Adonitoxigenin 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08843  Adonitoxin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08843  Adonitoxin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08843  Adonitoxin,
C08844,Moracin A,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|2-Arylbenzofurans|C08844  Moracin A,
C08845,Adynerin;|Adynerigenin 3-O-beta-D-diginoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08845  Adynerin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08845  Adynerin,
C08846,Mulberrofuran A,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|2-Arylbenzofurans|C08846  Mulberrofuran A,
C08847,alpha-Antiarin;|Antiarigenin 3-O-beta-D-antiaroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08847  alpha-Antiarin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C08847  alpha-Antiarin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08847  alpha-Antiarin,
C08848,Antioside;|Antiogenin 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08848  Antioside|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08848  Antioside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08848  Antioside,
C08849,Asclepin;|3'-O-Acetylcalotropin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08849  Asclepin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08849  Asclepin,
C08850,Aspecioside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08850  Aspecioside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08850  Aspecioside,
C08851,Bipindoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08851  Bipindoside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08851  Bipindoside,
C08852,Bryophyllin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08852  Bryophyllin A,
C08853,Bryotoxin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08853  Bryotoxin A,
C08854,Calactin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08854  Calactin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08854  Calactin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08854  Calactin,
C08855,Calotropin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08855  Calotropin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08855  Calotropin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08855  Calotropin,
C08856,Thevetin B,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08856  Thevetin B|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08856  Thevetin B|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08856  Thevetin B,
C08857,Cerbertin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08857  Cerbertin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08857  Cerbertin,
C08858,Convallatoxin;|Strophanthidin 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08858  Convallatoxin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08858  Convallatoxin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C08858  Convallatoxin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08858  Convallatoxin,
C08859,Cymarin;|Strophanthidin 3-O-beta-D-cymaroside,,,,Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C08859  Cymarin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08859  Cymarin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08859  Cymarin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08859  Cymarin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AC Strophanthus glycosides|C01AC03 Cymarin|C08859  Cymarin|Drug groups [BR:br08330]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01743  Strophantus glycoside|C08859  Cymarin,G01743
C08860,Decoside;|Decogenin 3-O-alpha-L-oleandroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08860  Decoside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08860  Decoside,
C08861,Diginatin;|Diginatigenin 3-O-tridigitoxoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08861  Diginatin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08861  Diginatin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08861  Diginatin,
C08862,Digitalin;|Gitoxigenin 3-O-glucosyldigitaloside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08862  Digitalin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08862  Digitalin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08862  Digitalin,
C08863,Divaricoside;|Divaside;|Sarmentogenin 3-O-alpha-L-oleandroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08863  Divaricoside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08863  Divaricoside,
C08864,Divostroside;|Sarmentogenin 3-O-alpha-L-diginoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08864  Divostroside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08864  Divostroside,
C08865,Eriocarpin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08865  Eriocarpin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08865  Eriocarpin,
C08866,Gitoxin;|Gitoxigenin 3-O-tridigitoxoside,,,,Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C08866  Gitoxin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08866  Gitoxin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08866  Gitoxin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08866  Gitoxin,
C08867,Hellebrigenin 3-acetate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C08867  Hellebrigenin 3-acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08867  Hellebrigenin 3-acetate,
C08868,Hellebrin;|Hellebrigenin 3-O-glucosylrhamnoside,,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C08868  Hellebrin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C08868  Hellebrin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08868  Hellebrin,
C08869,Helveticoside;|Strophanthidin 3-O-beta-D-digitoxoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08869  Helveticoside|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08869  Helveticoside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08869  Helveticoside,
C08870,Labriformidin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08870  Labriformidin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08870  Labriformidin,
C08871,Labriformin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08871  Labriformin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08871  Labriformin,
C08872,Lanceotoxin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08872  Lanceotoxin A,
C08873,Lanceotoxin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08873  Lanceotoxin B,
C08874,Lokundjoside;|Cuspidoside;|Bipindogenin 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08874  Lokundjoside|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08874  Lokundjoside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08874  Lokundjoside,
C08875,Musaroside;|Sarmutogenin 3-O-beta-D-digitaloside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08875  Musaroside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08875  Musaroside,
C08876,Neriifolin;|Digitoxigenin 3-(alpha-L-thevetoside),,,,Compounds with biological roles [BR:br08001]|Steroids|23-Carbon atoms|Cardanolide derivatives|C08876  Neriifolin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08876  Neriifolin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08876  Neriifolin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08876  Neriifolin,
C08877,Rhodexin A;|Sarmentogenin 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08877  Rhodexin A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08877  Rhodexin A|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C08877  Rhodexin A|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08877  Rhodexin A,
C08878,Sarmentoloside;|Sarmentologenin 3-O-(6-deoxy-alpha-L-taloside),,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08878  Sarmentoloside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08878   Sarmentoloside,
C08879,Scillaren A;|Scillarenin 3-O-glucosylrhamnoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C08879  Scillaren A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08879  Scillaren A,
C08880,Scilliroside;|Scillirosidin 3-O-beta-D-glucoside,,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C08880  Scilliroside|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C08880  Scilliroside|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Bufanolide|C08880  Scilliroside|Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C08880  Scilliroside|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|994  Rodentickides|9949  Other rodenticides|C08880  Scilliroside,
C08881,k-Strophanthoside;|Strophanthidin 3-diglucosylcymarose,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08881  k-Strophanthoside|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08881  k-Strophanthoside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08881  k-Strophanthoside,
C08882,Thevetin A;|Cannogenin 3-O-gentiobiosylthevetoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08882  Thevetin A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08882  Thevetin A|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08882  Thevetin A,
C08883,Uscharidin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0112 Cardanolides and derivatives|C08883  Uscharidin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08883  Uscharidin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08883  Uscharidin,
C08884,Vernadigin;|Strophadogenin 3-O-beta-D-diginoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C08884  Vernadigin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C08884  Vernadigin,
C08885,Agavoside A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08885  Agavoside A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08885  Agavoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08885  Agavoside A,
C08886,Asparagoside A;|(25S)-5beta-Spirostan-3beta-ol 3-O-beta-D-glucoside,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08886  Asparagoside A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08886  Asparagoside A,
C08887,Avenacoside A;|Nuatigenin 3-O-{alpha-L-rhamnopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside}-26-O-beta-D-glucopyranoside,Revised structure of avenacoside A. [PMID:22972708],,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08887  Avenacoside A,
C08888,Avenacoside B;|Nuatigenin 3-O-{alpha-L-rhamnopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside}-26-O-beta-D-glucopyranoside,Revised structure of avenacoside B [PMID:22972708],,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08888  Avenacoside B|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08888  Avenacoside B,
C08889,Capsicoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08889  Capsicoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08889  Capsicoside A,
C08890,Convallagenin A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08890  Convallagenin A|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08890  Convallagenin A,
C08891,Convallamarogenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08891  Convallamarogenin,
C08892,Convallamaroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08892  Convallamaroside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08892  Convallamaroside,
C08893,Convallasaponin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08893  Convallasaponin A,
C08894,Deltonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08894  Deltonin,
C08895,Deltoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08895  Deltoside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08895  Deltoside,
C08896,Digitogenin,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C08896  Digitogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08896  Digitogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08896  Digitogenin,
C08897,Dioscin;|3-O-[alpha-L-Rha-(1->4)-[alpha-L-Rha-(1->2)]-beta-D-Glc]diosgenin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08897  Dioscin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08897  Dioscin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08897  Dioscin,
C08898,"Diosgenin;|(3beta,25R)-Spirost-5-en-3-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C08898  Diosgenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08898  Diosgenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08898  Diosgenin,
C08899,"Gitogenin;|(2alpha,3beta,5alpha,25R)-Spirostan-2,3-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C08899  Gitogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08899  Gitogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08899  Gitogenin,
C08900,Gitonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08900  Gitonin,
C08901,Gracillin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08901  Gracillin,
C08902,"Hecogenin;|(3beta,5alpha,25R)-3-hydroxyspirostan-12-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08902  Hecogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08902  Hecogenin,
C08904,Officinalisnin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08904  Officinalisnin I|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08904  Officinalisnin I,
C08905,Osladin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cholestane|C08905  Osladin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08905  Osladin,
C08906,Parillin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08906  Parillin,
C08907,Protodioscin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08907  Protodioscin,
C08908,Protogracillin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08908  Protogracillin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08908  Protogracillin,
C08909,"Ruscogenin;|(1beta,3beta,25R)-Spirost-5-ene-1,3-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08909  Ruscogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08909  Ruscogenin,
C08910,Ruscoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08910  Ruscoside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08910  Ruscoside,
C08911,Sarsaparilloside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08911  Sarsaparilloside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08911  Sarsaparilloside,
C08912,Sarsasapogenin 3-O-4G-rhamnosylsophoroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08912  Sarsasapogenin 3-O-4G-rhamnosylsophoroside|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08912  Sarsasapogenin 3-O-4G-rhamnosylsophoroside,
C08913,Smilagenin;|(25R)-5beta-Spirostan-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C08913  Smilagenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08913  Smilagenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08913  Smilagenin,
C08914,Tigogenin;|5-alpha-Spirostan-3-beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Spirostan derivatives|C08914  Tigogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08914  Tigogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08914  Tigogenin,
C08915,Tigonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08915  Tigonin,
C08916,Tokoronin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08916  Tokoronin,
C08917,Trigonelloside C;|Asparasaponin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C08917  Trigonelloside C|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08917  Trigonelloside C,
C08918,"Yamogenin;|(3beta,25S)-Spirost-5-en-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C08918  Yamogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08918  Yamogenin,
C08919,Yamogenin 3-O-neohesperidoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C08919  Yamogenin 3-O-neohesperidoside,
C08920,Abrusoside A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C08920  Abrusoside A|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C08920  Abrusoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08920  Abrusoside A,
C08921,Aescin;|Escin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08921  Aescin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C08921  Aescin|Triterpenoid|C08921  Aescin,
C08922,Aridanin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08922  Aridanin|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08922  Aridanin,
C08923,Arvensoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08923  Arvensoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08923  Arvensoside A,
C08924,Astragaloside III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C08924  Astragaloside III|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08924  Astragaloside III,
C08925,Astrasieversianin XVI,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C08925  Astrasieversianin XVI,
C08926,Avenacin A-1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08926  Avenacin A-1|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08926  Avenacin A-1,
C08927,Avenacin B-2,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08927  Avenacin B-2,
C08928,Mulberrofuran C,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Diels-Alder adduct of chalcone|C08928  Mulberrofuran C,
C08929,"alpha-Pyrufuran;|1,3,4-Trimethoxy-2-dibenzofuranol",See beta-Pyrufuran [CPD:C08948],,,,
C08930,Azukisaponin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08930  Azukisaponin III|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08930  Azukisaponin III,
C08931,Barringtogenol C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08931  Barringtogenol C,
C08932,Bayogenin 3-O-cellobioside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08932  Bayogenin 3-O-cellobioside|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08932  Bayogenin 3-O-cellobioside|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08932  Bayogenin 3-O-cellobioside,
C08933,Camellidin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08933  Camellidin I|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08933  Camellidin I,
C08934,Camellidin II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08934  Camellidin II|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08934  Camellidin II,
C08935,Cimicifugoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08935  Cimicifugoside,
C08936,Colubrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08936  Colubrin,
C08937,Colubrinoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08937  Colubrinoside,
C08938,Cyclamin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08938  Cyclamin,
C08939,Cyclofoetoside B,,,,,
C08940,Desglucomusennin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08940  Desglucomusennin,
C08941,Dianoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08941  Dianoside A|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08941  Dianoside A,
C08942,Echinocystic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08942  Echinocystic acid,
C08943,Flaccidin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08943  Flaccidin B,
C08944,Ginsenoside Re,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08944  Ginsenoside Re|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08944  Ginsenoside Re|Dietary phytochemicals [br08012.html]|Other phytochemicals|C08944,
C08945,Ginsenoside Rf,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08945  Ginsenoside Rf|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08945  Ginsenoside Rf|Dietary phytochemicals [br08012.html]|Other phytochemicals|C08945,
C08946,Ginsenoside Rg1;|Sanchinoside C1;|(20S)-Ginsenoside Rg1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08946  Ginsenoside Rg1|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08946  Ginsenoside Rg1|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C08946|Dietary phytochemicals [br08012.html]|Other phytochemicals|C08946,
C08947,Gymnemic acid I,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08947  Gymnemic acid I|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08947  Gymnemic acid I|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08947  Gymnemic acid I,
C08948,"beta-Pyrufuran;|1,2,4-Trimethoxy-3-dibenzofuranol",See alpha-Pyrufuran [CPD:C08929],,,,
C08949,Gypenoside XXV,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08949  Gypenoside XXV|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08949  Gypenoside XXV|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08949  Gypenoside XXV,
C08950,Gypsogenin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08950  Gypsogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C08950  Gypsogenin,
C08951,Pseudorhodomyrtoxin;|psi-Rhodomyrtoxin,,,,,
C08952,Gypsogenin 3-O-rhamnosylglucuronide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08952  Gypsogenin 3-O-rhamnosylglucuronide|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08952  Gypsogenin 3-O-rhamnosylglucuronide,
C08953,Hederagenin 3-O-arabinoside;|Cauloside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08953  Hederagenin 3-O-arabinoside|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C08953  Hederagenin 3-O-arabinoside,
C08954,alpha-Hederin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08954  alpha-Hederin,
C08955,beta-Hederin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08955  beta-Hederin,
C08956,Helianthoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08956  Helianthoside A,
C08957,Ilexolide A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C08957  Ilexolide A,
C08958,Lemmatoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08958  Lemmatoxin,
C08959,Medicagenic acid 3-O-triglucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08959  Medicagenic acid 3-O-triglucoside|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08959  Medicagenic acid 3-O-triglucoside,
C08960,Musennin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08960  Musennin,
C08961,Notoginsenoside R1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C08961  Notoginsenoside R1|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08961  Notoginsenoside R1,
C08962,Olaxoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08962  Olaxoside,
C08963,Oleanoglycotoxin-A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08963  Oleanoglycotoxin-A,
C08964,Oleanoic acid 3-O-glucuronide;|Silphioside F,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08964  Oleanoic acid 3-O-glucuronide|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08964  Oleanoic acid 3-O-glucuronide,
C08965,Pfaffic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010625 Other triterpenoids|C08965  Pfaffic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08965  Pfaffic acid,
C08966,Pfaffoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08966  Pfaffoside A,
C08967,Phaseoloside D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08967  Phaseoloside D,
C08968,Phytolaccoside B;|Esculentoside B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08968  Phytolaccoside B,
C08969,Pittoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08969  Pittoside A,
C08970,Primulasaponin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08970  Primulasaponin,
C08971,Propapyriogenin A2,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08971  Propapyriogenin A2,
C08972,Quillaic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C08972  Quillaic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08972  Quillaic acid|Dietary phytochemicals [br08012.html]|Other phytochemicals|C08972,
C08973,Rotundioside B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08973  Rotundioside B,
C08974,Sainfuran,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1216 Other Flavonoids|C08974  Sainfuran|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|2-Arylbenzofurans|C08974  Sainfuran,
C08975,Saikosaponin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08975  Saikosaponin A,
C08976,Saikosaponin BK1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08976  Saikosaponin BK1,
C08977,Saponoside D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08977  Saponoside D,
C08978,Senegin II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08978  Senegin II,
C08979,Toxol,,,,,
C08980,Soyasapogenol B;|24-Hydroxysophoradiol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08980  Soyasapogenol B,
C08981,Toxyl angelate,,,,,
C08982,Soyasaponin A1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08982  Soyasaponin A1,
C08983,Soyasaponin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C08983  Soyasaponin I,
C08984,Spinasaponin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08984  Spinasaponin A,
C08985,Thalicoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08985  Thalicoside A,
C08986,Theasaponin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08986  Theasaponin,
C08987,Tubeimoside I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08987  Tubeimoside I,
C08988,Ursolic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010618 Taraxastane, ursane and bauerane triterpenoids|C08988  Ursolic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C08988  Ursolic acid",
C08989,Virgaureasaponin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08989  Virgaureasaponin I,
C08990,Yiamoloside B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C08990  Yiamoloside B,
C08991,Ziziphin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C08991  Ziziphin,
C08992,Tremetone,,,,,
C08993,Vignafuran,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1216 Other Flavonoids|C08993  Vignafuran|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|2-Arylbenzofurans|C08993  Vignafuran,
C08994,Aloesin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C08994  Aloesin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C08994  Aloesin|Glycosides [BR:br08021]|C-glycosides|C08994  Aloesin,
C08995,Aurasperone D,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Naphthopyrones|C08995  Aurasperone D,
C08996,Biflorin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C08996  Biflorin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C08996  Biflorin|Glycosides [BR:br08021]|C-glycosides|C08996  Biflorin,
C08997,"Butyrylmallotochromene;|1-Butanone, 1-(6-((3-acetyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl)-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-8-yl)-",,,,,
C08998,Cannabichromene;|CBC,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C08998  Cannabichromene,
C08999,Capillarisin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C08999  Capillarisin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C08999  Capillarisin,
C09000,Cimifugin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09000  Cimifugin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09000  Cimifugin,
C09001,"5,7-Dihydroxychromone",,,,,
C09002,"8-(3,3-Dimethylallyl)spatheliachromene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09002  8-(3,3-Dimethylallyl)spatheliachromene|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09002  8-(3,3-Dimethylallyl)spatheliachromene",
C09003,"2,2-Dimethyl-8-prenylchromene 6-carboxylic acid",,,,,
C09004,Drummondin A,,,,,
C09005,"Encecalin;|1-(7-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)ethanone",,,,,
C09006,"Eupatoriochromene;|1-(7-Hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-ethanone",,,,,
C09007,Flindersiachromone;|2-(2-Phenylethyl)chromone,,,,,
C09008,Frutinone A,,,,,
C09009,Isobutyrylmallotochromene,,,,,
C09010,Khellin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09010  Khellin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09010  Khellin,
C09011,Khellol glucoside;|Khelloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09011  Khellol glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09011  Khellol glucoside,
C09012,Lathodoratin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09012  Lathodoratin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09012  Lathodoratin,
C09013,Mallotochromene,,,,,
C09014,5-O-Methylalloptaeroxylin;|Perforatin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09014  5-O-Methylalloptaeroxylin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09014  5-O-Methylalloptaeroxylin,
C09015,Methylripariochromene A,,,,,
C09016,5-O-Methylvisamminol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09016  5-O-Methylvisamminol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09016  5-O-Methylvisamminol,
C09017,Precocene I;|Precocene 1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09017  Precocene I,
C09018,Precocene II;|Precocene 2,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09018  Precocene II,
C09019,1-Acetylaspidoalbidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09019  1-Acetylaspidoalbidine,
C09020,Adifoline,,,,,
C09021,Affinine;|17-Hydroxyvobasan-3-one,,,,,
C09022,Affinisine,,,,,
C09023,Agroclavine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09023  Agroclavine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C09023  Agroclavine,
C09024,Ajmalicine;|Raubasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09024  Ajmalicine,
C09025,Akuammicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09025  Akuammicine,
C09026,Akuammidine;|Rhazin,,,,,
C09027,Akuammine,,,,,
C09028,Alstonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09028  Alstonine,
C09029,Ptaerochromenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09029  Ptaerochromenol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09029  Ptaerochromenol,
C09030,Ptaeroglycol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09030  Ptaeroglycol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09030  Ptaeroglycol,
C09031,Pulverochromenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09031  Pulverochromenol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09031  Pulverochromenol,
C09032,Angustine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C09032  Angustine,
C09033,Antirhine,,,,,
C09034,Apodine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09034  Apodine,
C09035,Apovincamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09035  Apovincamine,
C09036,(-)-Apparicine,,,,,
C09037,Aricine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09037  Aricine,
C09038,Aspidoalbine,,,,,
C09039,Aspidodasycarpine,,,,,
C09040,Aspidofractine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09040  Aspidofractine,
C09041,Aspidospermatine,,,,,
C09042,Aspidospermine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09042  Aspidospermine,
C09043,Auricularine,,,,,
C09044,Quinquangulin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Naphthopyrones|C09044  Quinquangulin,
C09045,Baloxine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09045  Baloxine,
C09046,Bleekerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09046  Bleekerine,
C09047,Rubrofusarin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Naphthopyrones|C09047  Rubrofusarin,
C09048,"Spathelia bischromene;|2,2,6,6,10-Pentamethyl-2H,6H,12H-benzo[1,2-b:3,4-b':5,6-b'']tripyran-12-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09048  Spathelia bischromene|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09048  Spathelia bischromene,
C09049,Visnagin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C09049  Visnagin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C09049  Visnagin,
C09050,Bonafousine,,,,,
C09051,Borrecapine,,,,,
C09052,Borreline,,,,,
C09053,Alloimperatorin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09053  Alloimperatorin,
C09054,Borrerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09054  Borrerine,
C09055,6-Acetylpicropolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09055  6-Acetylpicropolin,
C09056,Ammoresinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09056  Ammoresinol,
C09057,Acutilol A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010447 Pachydictyane and cneorubin diterpenoids|C09057  Acutilol A|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09057  Acutilol A,
C09058,Ajugarin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09058  Ajugarin I,
C09059,Alectrol;|Orobanchyl acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09059  Alectrol,
C09060,Angelicin;|Isopsoralen,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09060  Angelicin,
C09061,Allogibberic acid,,,,,
C09062,Antheridic acid;|Antheridiogen-An,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C09062  Antheridic acid,
C09063,Asebotoxin II,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010418 Leucothol and grayanotoxane diterpenoids|C09063  Asebotoxin II|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Grayanoids|C09063  Asebotoxin II|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C09063  Asebotoxin II,
C09064,Atractyloside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09064  Atractyloside,
C09065,Baliospermin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09065  Baliospermin,
C09066,Cafestol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09066  Cafestol,
C09067,Callicarpone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09067  Callicarpone,
C09068,Candletoxin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09068  Candletoxin A,
C09069,Carnosol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C09069  Carnosol,
C09070,Caryoptin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09070  Caryoptin,
C09071,Cascarillin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09071  Cascarillin,
C09072,"2,7,11-Cembratrien-4,6-diol",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Cembrenes|C09072  2,7,11-Cembratrien-4,6-diol",
C09073,Chasmanthin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09073  Chasmanthin,
C09074,Clerodendrin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09074  Clerodendrin A,
C09075,Clerodin;|3-Deoxycaryoptinol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09075  Clerodin,
C09076,Coleonol;|Colforsin;|Forskolin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C09076  Coleonol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09076  Coleonol|Drug groups [BR:br08330(D03584)]|Cardiovascular agent|DG01499  Adenylate cyclase activator|DG02877  Colforsin|D03584  Colforsin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02877  Colforsin|D03584  Colforsin|Target-based classification of drugs [BR:br08310(D03584)]|Enzymes|Lyases (EC4)|Phosphorus-oxygen lyases|ADCY|D03584  Colforsin (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D03584)]|Drug metabolizing enzymes|D03584,
C09077,Columbin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09077  Columbin,
C09078,Cotylenin F,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09078  Cotylenin F,
C09079,Cyathin A3,,,,,
C09080,Daphnetoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09080  Daphnetoxin,
C09081,"7beta,12alpha-Dihydroxykaurenolide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C09081  7beta,12alpha-Dihydroxykaurenolide|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C09081  7beta,12alpha-Dihydroxykaurenolide",
C09082,Borreverine,,,,,
C09083,Brevicolline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09083  Brevicolline,
C09084,Brucine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09084  Brucine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09084  Brucine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09084,
C09085,Calebassone;|C-Calebassine,,,,,
C09086,Diterpenoid EF-D;|12-Deoxy-phorbol-13-alpha-methylbutyrate-20-acetate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C09086  Diterpenoid EF-D|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09086  Diterpenoid EF-D,
C09087,Diterpenoid SP-II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09087  Diterpenoid SP-II,
C09088,Callichiline,,,,,
C09089,Calligonine;|Elaeagnine;|Tetrahydroharman,,,,,
C09090,Enmein,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09090  Enmein,
C09091,Euphorbia factor Ti2,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09091  Euphorbia factor Ti2,
C09092,"Ferruginol;|Abieta-8,11,13-trien-12-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C09092  Ferruginol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C09092  Ferruginol,
C09093,Fusicoccin H,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010435 Fusicoccane diterpenoids|C09093  Fusicoccin H|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09093  Fusicoccin H,
C09094,"Geranylgeraniol;|2,6,10,14-Hexadecatetraen-1-ol, 3,7,11,15-tetramethyl-",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C09094  Geranylgeraniol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Linear diterpenes|C09094  Geranylgeraniol,
C09095,Gnidicin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09095  Gnidicin,
C09096,Gnididin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09096  Gnididin,
C09097,Calycanthidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09097  Calycanthidine,
C09098,"Canthin-6-one;|6H-Indolo(3,2,1-de)(1,5)naphthyridin-6-one",,,,,
C09099,Naringenin 7-O-beta-D-glucoside;|Prunin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09099  Naringenin 7-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09099  Naringenin 7-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09099  Naringenin 7-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C09099,
C09100,Caracurine V,,,,,
C09101,Gnididilatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09101  Gnididilatin,
C09102,Gniditrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09102  Gniditrin,
C09103,Grayanotoxin I;|Rhodotoxine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010418 Leucothol and grayanotoxane diterpenoids|C09103  Grayanotoxin I|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Grayanoids|C09103  Grayanotoxin I|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C09103  Grayanotoxin I,
C09104,Hallactone A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09104  Hallactone A,
C09105,Hallactone B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09105  Hallactone B,
C09106,Carapanaubine,,,,,
C09107,Catharanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09107  Catharanthine,
C09108,Huratoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09108  Huratoxin,
C09109,Hymatoxin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09109  Hymatoxin A,
C09110,Ineketone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09110  Ineketone,
C09111,"Inflexin;|3beta,11beta-Diacetoxy-1alpha-hydroxykaura-16-ene-6,15-dione",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C09111  Inflexin,
C09112,Ingenol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09112  Ingenol,
C09113,"Ingenol 3,20-dibenzoate",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09113  Ingenol 3,20-dibenzoate",
C09114,Inumakilactone A glycoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09114  Inumakilactone A glycoside,
C09115,Isodomedin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C09115  Isodomedin,
C09116,Archangelicin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09116  Archangelicin,
C09117,Isodonal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09117  Isodonal,
C09118,Isopimaric acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C09118  Isopimaric acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C09118  Isopimaric acid,
C09119,Jatrophatrione,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Mesotricyclic diterpenoids|C09119  Jatrophatrione,
C09120,Jatrophone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Mesotricyclic diterpenoids|C09120  Jatrophone,
C09121,Jodrellin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09121  Jodrellin A,
C09122,Kansuinine B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09122  Kansuinine B,
C09123,Athamantin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09123  Athamantin,
C09124,2-Ketoepimanool,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C09124  2-Ketoepimanool,
C09125,Lathyrol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010431 Lathyrane diterpenoids|C09125  Lathyrol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09125  Lathyrol,
C09126,Genistin;|Genistein 7-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C09126  Genistein 7-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C09126  Genistein 7-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C09126  Genistein 7-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C09126,
C09127,Mancinellin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09127  Mancinellin,
C09128,Marrubiin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09128  Marrubiin,
C09129,Catharine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09129  Catharine,
C09130,Ceceline,,,,,
C09131,Chanoclavine-I,,,,,
C09132,Mascaroside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09132  Mascaroside,
C09133,(-)-Chimonanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Pyrroloindole alkaloids|C09133  (-)-Chimonanthine,
C09134,Mezerein,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09134  Mezerein,
C09135,Montanin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09135  Montanin,
C09136,Montanin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09136  Montanin A,
C09137,Montanol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09137  Montanol,
C09138,Nagilactone C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09138  Nagilactone C,
C09139,Coronaridine;|(-)-Coronaridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09139  Coronaridine,
C09140,"Neocembrene;|Cembrene A;|(R)-Cembrene A;|(1E,5E,9E,12R)-1,5,9-Trimethyl-12-(propan-2-en-2-yl)cyclotetradeca-1,5,9-triene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010419 Cembrane diterpenoids|C09140  Neocembrene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Cembrenes|C09140  Neocembrene,
C09141,Byakangelicin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09141  Byakangelicin,
C09142,Cryptolepine,,,,,
C09143,"Pedilstatin;|12-O-2Z,4E-Octadienoyl-4-deoxyphorbol 13-acetate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C09143  Pedilstatin|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09143  Pedilstatin,
C09144,C-Curarine;|C-Curarine I,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09144  C-Curarine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09144  C-Curarine,
C09145,Ophiobolin A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0105 C25 isoprenoids (sesterterpenes)|PR010505 Cheilanthane and ophiobolane sesterterpenoids|C09145  Ophiobolin A,
C09146,"Eburnamine;|(-)-Eburnamine;|(14alpha)-14,15-Dihydroeburnamenin-14-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09146  Eburnamine,
C09147,Calanolide A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09147  Calanolide A,
C09148,Oryzalexin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C09148  Oryzalexin A,
C09149,Eburnamonine;|Vinburnine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09149  Eburnamonine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08676)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX17 Vinburnine|D08676  Vinburnine (INN)|Drug groups [BR:br08330(D08676)]|Cardiovascular agent|DG03055  Vinca alkaloid, vasodilator|D08676  Vinburnine",
C09150,17-Oxogrindelic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09150  17-Oxogrindelic acid,
C09151,Palmarin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09151  Palmarin,
C09152,Echitamine,,,,,
C09153,12-O-Palmitoyl-16-hydroxyphorbol 13-acetate;|Croton factor F1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09153  12-O-Palmitoyl-16-hydroxyphorbol 13-acetate,
C09154,Ellipticine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09154  Ellipticine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09154  Ellipticine,
C09155,Phorbol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C09155  Phorbol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09155  Phorbol|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C09155  Phorbol,
C09156,Epivoacorine,,,,,
C09157,Phorbol 12-tiglate 13-decanoate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010433 Tigliane and ingenane diterpenoids|C09157  Phorbol 12-tiglate 13-decanoate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09157  Phorbol 12-tiglate 13-decanoate,
C09158,Calophyllolide,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C09158  Calophyllolide|Phytochemical compounds [BR:br08003]|Others|Others|Neoflavonoids|C09158  Calophyllolide,
C09159,(+)-Pimaric acid;|Dextropimaric acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C09159  (+)-Pimaric acid,
C09160,Ergine;|Lysergamide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09160  Ergine,
C09161,Pimelea factor P2;|Daphnopsis factor R1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09161  Pimelea factor P2,
C09162,Ergocornine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09162  Ergocornine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C09162  Ergocornine,
C09163,Pisiferic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09163  Pisiferic acid,
C09164,Ergocristine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09164  Ergocristine|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C09164  Ergocristine,
C09165,"Chalepensin;|3-(alpha,alpha-Dimethylallyl)psoralen",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09165  Chalepensin,
C09166,Plaunol B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09166  Plaunol B,
C09167,Ergosine,,,,,
C09168,Plaunol D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C09168  Plaunol D,
C09169,Pleuromutilin;|Pleuromulin,,,,,
C09170,"Eseramine;|(3aS-cis)-3,3a,8,8a-Tetrahydro-N,3a,8-trimethyl-5-[[(methylamino)carbonyl]oxy]-pyrrolo[2,3-b]indole-1(2H)-carboxamide",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Pyrroloindole alkaloids|C09170  Eseramine,
C09171,Podocarpic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010412 Podocarpane diterpenoids|C09171  Podocarpic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Podocarpanes|C09171  Podocarpic acid,
C09172,Podolactone B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09172  Podolactone B,
C09173,Podolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09173  Podolide,
C09174,Ponalactone A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09174  Ponalactone A,
C09175,Portulal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09175  Portulal,
C09176,Eseridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Pyrroloindole alkaloids|C09176  Eseridine,
C09177,Premarrubiin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09177  Premarrubiin,
C09178,Resiniferonol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C09178  Resiniferonol,
C09179,Resiniferatoxin;|RTX,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09179  Resiniferatoxin,
C09180,Rhodojaponin IV,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010418 Leucothol and grayanotoxane diterpenoids|C09180  Rhodojaponin IV|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Grayanoids|C09180  Rhodojaponin IV,
C09181,Chartreusin,,,,,
C09182,Royleanone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C09182  Royleanone,
C09183,"Sclareol;|(13R)-Labd-14-ene-8alpha,13-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C09183  Sclareol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C09183  Sclareol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09183,
C09184,Shikodonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C09184  Shikodonin,
C09185,Simplexin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09185  Simplexin,
C09186,Sorgolactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C09186  Sorgolactone,
C09187,Evodiamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C09187  Evodiamine,
C09188,Spruceanol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010410 Cleistanthane and isocleistanthane diterpenoids|C09188  Spruceanol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09188  Spruceanol,
C09189,Stevioside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C09189  Stevioside|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C09189  Stevioside,
C09190,Strigol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C09190  Strigol,
C09191,Fruticosonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09191  Fruticosonine,
C09192,Synaptolepis factor K1,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09192  Synaptolepis factor K1,
C09193,Gabunamine,,,,,
C09194,Taxodione,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C09194  Taxodione,
C09195,Gabunine,,,,,
C09196,"Taxodone;|6,11-Dihydroxyabieta-7,9(11),13-trien-12-one",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C09196  Taxodone,
C09197,Geissoschizoline;|(16alpha)-Curan-17-ol,,,,,
C09198,"Terpenoid EA-I;|Excoecariatoxin;|22,23,24,25-Tetradehydro-simplexin",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09198  Terpenoid EA-I,
C09200,Geissospermine,,,,,
C09201,Tinyatoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Daphnanes|C09201  Tinyatoxin,
C09202,Tripdiolide;|Triptodiolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09202  Tripdiolide,
C09203,Gelsemicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09203  Gelsemicine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09203  Gelsemicine,
C09204,Triptolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09204  Triptolide,
C09205,Zoapatanol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C09205  Zoapatanol,
C09206,Cichoriin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09206  Cichoriin|Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C09206  Cichoriin,
C09207,Gelsemine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09207  Gelsemine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09207  Gelsemine,
C09208,Haplophytine,,,,,
C09209,Harman,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09209  Harman,
C09210,(-)-Columbianetin;|(R)-Columbianetin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09210  (R)-Columbianetin,
C09211,Hodgkinsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09211  Hodgkinsine,
C09212,11-Hydroxycanthin-6-one,,,,,
C09213,Hypaphorine;|Lenticin,,,,,
C09214,Ibogaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09214  Ibogaine,
C09215,Ibogamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09215  Ibogamine,
C09216,Daphnoretin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09216  Daphnoretin,
C09217,Isoajmaline,,,,,
C09218,Leurosidine;|Vinrosidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09218  Leurosidine,
C09219,Leurosine;|Vinleurosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09219  Leurosine,
C09220,"Mahanimbine;|(+)-3,11-Dihydro-3,5-dimethyl-3-(4-methyl-3-pentenyl)pyrano[3,2-a]carbazole",,,,,
C09221,Melosatin A,,,,,
C09222,Melosatin B,,,,,
C09223,Mesembrenone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09223  Mesembrenone,
C09224,Mesembrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09224  Mesembrine,
C09225,Mesembrinol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09225  Mesembrinol,
C09226,Mitragynine,,,,,
C09227,Mitraphylline,,,,,
C09228,"Murrayanine;|9H-Carbazole-3-carboxaldehyde, 1-methoxy-",,,,,
C09229,"Ochrolifuanine A;|16-[(1R)-2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indol-1-yl]-17-norcorynan",,,,,
C09230,Olivacine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09230  Olivacine,
C09231,Perlolyrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09231  Perlolyrine,
C09232,Physovenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Pyrroloindole alkaloids|C09232  Physovenine,
C09233,Psychotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09233  Psychotridine,
C09234,Quadrigemine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09234  Quadrigemine A,
C09235,(-)-Quebrachamine;|Quebrachamine,,,,,
C09236,Rhyncophylline;|Rhynchophylline,,,,,
C09237,Roxburghine B,,,,,
C09238,Rutaecarpine;|Rutecarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C09238  Rutecarpine,
C09239,Sarpagine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09239  Sarpagine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09239,
C09240,Sempervirine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09240  Sempervirine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09240  Sempervirine,
C09241,Serpentine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09241  Serpentine,
C09242,Tabernamine,,,,,
C09243,Tetrahydroharmine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09243  Tetrahydroharmine,
C09244,Tabersonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09244  Tabersonine,
C09245,Thienodolin,,,,,
C09246,C-Toxiferine I;|Toxiferine I,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09246  C-Toxiferine I|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C09246  C-Toxiferine I,
C09247,Trichotomine,,,,,
C09248,Tubulosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09248  Tubulosine,
C09249,Usambarensine,,,,,
C09250,Usambarine,,,,,
C09251,Vincamine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09251  Vincamine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08677)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX07 Vincamine|D08677  Vincamine (INN)|Drug groups [BR:br08330(D08677)]|Cardiovascular agent|DG03055  Vinca alkaloid, vasodilator|DG00286  Vincamine|D08677  Vincamine",
C09252,Voacamine;|Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate,,,,,
C09253,Vobasine,,,,,
C09254,Vobtusine,,,,,
C09255,Vomicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09255  Vomicine,
C09256,Yohimbine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09256  Yohimbine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08685)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BE Drugs used in erectile dysfunction|G04BE04 Yohimbine|D08685  Yohimbine (DCF)|Risk category of Japanese OTC drugs [BR:br08312(D08685)]|First-class OTC drugs|Inorganic and organic chemicals|Yohimbine|D08685  Yohimbine (DCF)|Drug groups [BR:br08330(D08685)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01465  alpha-Adrenergic receptor antagonist|DG01460  alpha2-Adrenergic receptor antagonist|DG00485  Yohimbine|D08685  Yohimbine|Target-based classification of drugs [BR:br08310(D08685)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D08685  Yohimbine (DCF),
C09257,Decuroside III,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09257  Decuroside III,
C09258,Decursin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09258  Decursin,
C09259,Decursinol,,,,,
C09260,Dihydrosamidin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09260  Dihydrosamidin,
C09261,Disenecionyl cis-khellactone,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09261  Disenecionyl cis-khellactone,
C09262,"(3'R,4'R)-3'-Epoxyangeloyloxy-4'-acetoxy-3',4'-dihydroseselin",,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09262  (3'R,4'R)-3'-Epoxyangeloyloxy-4'-acetoxy-3',4'-dihydroseselin",
C09263,Esculetin;|Aesculetin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09263  Esculetin,
C09264,Esculin;|Esculoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09264  Esculin|Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C09264  Esculin,
C09265,"Fraxetin;|7,8-Dihydroxy-6-methoxy-2H-chromen-2-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09265  Fraxetin,
C09266,Fraxin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09266  Fraxin|Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C09266  Fraxin,
C09267,Heliettin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09267  Heliettin,
C09268,Herniarin;|7-Methoxycoumarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09268  Herniarin,
C09269,Imperatorin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09269  Imperatorin,
C09270,Isosamidin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09270  Isosamidin,
C09271,Leptodactylone,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09271  Leptodactylone,
C09272,Libanorin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09272  Libanorin,
C09273,"Luvangetin;|10-Methoxy-8,8-dimethyl-2H,8H-benzo[1,2-b:5,4-b']dipyran-2-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09273  Luvangetin,
C09274,Tabernanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C09274  Tabernanthine,
C09275,Mammeisin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C09275  Mammeisin|Phytochemical compounds [BR:br08003]|Others|Others|Neoflavonoids|C09275  Mammeisin,
C09276,"Marmesin;|(+)-Marmesin;|(S)-2-(2-Hydroxypropan-2-yl)-2,3-dihydro-7H-furo[3,2-g]chromen-7-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09276  Marmesin,
C09277,Micromelin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09277  Micromelin,
C09278,Nodakenetin;|(-)-Marmesin,(+)-Marmesin [CPD:C09276],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09278  Nodakenetin,
C09279,Nodakenin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09279  Nodakenin,
C09280,Osthol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09280  Osthol,
C09281,Ostruthin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09281  Ostruthin,
C09282,Oxypeucedanin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09282  Oxypeucedanin,
C09283,Peucedanin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09283  Peucedanin,
C09284,Peucenidin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09284  Peucenidin,
C09285,Pimpinellin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09285  Pimpinellin,
C09286,Absinthin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09286  Absinthin,
C09287,Achillin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09287  Achillin,
C09288,Acroptilin;|Chlorohyssopifolin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09288  Acroptilin,
C09289,Alantolactone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09289  Alantolactone|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09289  Alantolactone,
C09290,Alatolide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C09290  Alatolide|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09290  Alatolide,
C09291,Amaralin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010342 Pseudoguaiane sesquiterpenoids|C09291  Amaralin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09291  Amaralin,
C09292,"Ambrosin;|6beta-Hydroxy-4-oxo-10alphaH-ambrosa-2,11(13)-dien-12-oic acid gamma-lactone",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09292  Ambrosin,
C09293,Angustibalin;|Helenalin 6-acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09293  Angustibalin,
C09294,Anisatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09294  Anisatin|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Sesquiterpenoids|C09294  Anisatin,
C09295,Arbusculin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09295  Arbusculin A,
C09296,Archangelolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09296  Archangelolide,
C09297,Arctiopicrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09297  Arctiopicrin,
C09298,Arctolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09298  Arctolide,
C09299,Arnicolide A;|Dihydrohelenalin acatate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09299  Arnicolide A,
C09300,Aromaticin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09300  Aromaticin,
C09301,Artabsin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09301  Artabsin,
C09302,Artecanin;|Chrysartemin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09302  Artecanin,
C09303,Arteglasin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09303  Arteglasin A,
C09304,Artemisiifolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09304  Artemisiifolin,
C09305,"Psoralen;|Ficusin;|7H-Furo[3,2-g]chromen-7-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09305  Psoralen|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09305,
C09306,Sulfur dioxide,,,,,
C09307,Pteryxin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09307  Pteryxin,
C09308,Rutamarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09308  Rutamarin,
C09309,Rutarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09309  Rutarin|Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C09309  Rutarin,
C09310,Samidin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09310  Samidin,
C09311,"Scoparone;|6,7-Dimethoxycoumarin",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09311  Scoparone,
C09312,Seselin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09312  Seselin,
C09313,"5,6,7-Trimethoxycoumarin",,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09313  5,6,7-Trimethoxycoumarin",
C09314,"Trioxsalen;|Trioxysalen;|4,8,5'-Trimethylpsoralen",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Furanocoumarins|C09314  Trioxsalen|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01034)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AD Psoralens for topical use|D05AD01 Trioxysalen|D01034  Trioxsalen (USP)|D05B ANTIPSORIATICS FOR SYSTEMIC USE|D05BA Psoralens for systemic use|D05BA01 Trioxysalen|D01034  Trioxsalen (USP),
C09315,Umbelliferone;|7-Hydroxycoumarin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09315  Umbelliferone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09315,
C09316,Visnadin;|Visnadine,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09316  Visnadin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08735)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX24 Visnadine|D08735  Visnadine (INN),
C09317,Xanthyletin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Coumarins|Coumarins|C09317  Xanthyletin,
C09318,Abyssinone I,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09318  Abyssinone I|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09318  Abyssinone I,
C09319,Abyssinone V,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09319  Abyssinone V|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09319  Abyssinone V,
C09320,"Afzelechin;|3,5,7,4'-Tetrahydroxyflavan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09320  Afzelechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09320  Afzelechin",
C09321,2'-Hydroxychalcone,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09321  2'-Hydroxychalcone,
C09322,Actinodaphnine;|Actinodaphine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09322  Actinodaphnine,
C09323,Adiantifoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09323  Adiantifoline,
C09324,(+)-Adlumine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09324  (+)-Adlumine,
C09325,Aknadicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09325  Aknadicine,
C09326,Alamarine,,,,,
C09327,Alangicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09327  Alangicine,
C09328,Alangimarckine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09328  Alangimarckine,
C09329,Alangimarine,,,,,
C09330,Alangiside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09330  Alangiside|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C09330  Alangiside,
C09331,Alpinine,,,,,
C09332,THF-L-glutamate;|Tetrahydropteroyldiglutamate;|(6S)-H4PteGlu2,,,,,
C09333,Amurensine,,,,,
C09334,Amurine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09334  Amurine,
C09335,Ancistrocladine,Hamatine (atropisomer) (CAS: 56688-90-5),,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C09335  Ancistrocladine,
C09336,Angoline,,,,,
C09337,Ankorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09337  Ankorine,
C09338,Annolobine;|Anolobine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09338  Annolobine,
C09339,(-)-Annonaine;|Anonaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09339  (-)-Annonaine,
C09340,(-)-Apoglaziovine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09340  (-)-Apoglaziovine,
C09341,(-)-Argemonine;|Argemonine,,,,,
C09342,Armepavine,,,,,
C09343,Atheroline,,,,,
C09344,Artemisin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09344  Artemisin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09344  Artemisin,
C09345,Artemorin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09345  Artemorin,
C09346,Autumnolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09346  Autumnolide,
C09347,Atherospermidine,,,,,
C09348,"6,7-Dimethoxyisoquinoline;|Backebergine",,,,,
C09349,Baileyin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09349  Baileyin,
C09350,Bakkenolide A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09350  Bakkenolide A,
C09351,Budlein A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09351  Budlein A,
C09352,(+)-Bebeerine;|Bebeerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09352  (+)-Bebeerine,
C09353,Calaxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09353  Calaxin,
C09354,Canin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09354  Canin,
C09355,Chamissonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09355  Chamissonin,
C09356,Chamissonin diacetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09356  Chamissonin diacetate,
C09357,Berbamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09357  Berbamine,
C09358,Chlorochrymorin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09358  Chlorochrymorin,
C09359,Chlorohyssopifolin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09359  Chlorohyssopifolin A,
C09360,Berberastine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09360  Berberastine,
C09361,Chromolaenide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09361  Chromolaenide,
C09362,Cnicin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09362  Cnicin,
C09363,Conchosin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09363  Conchosin A,
C09364,Bicuculline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09364  Bicuculline|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C09364  Bicuculline,
C09365,Boldine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09365  Boldine,
C09366,Bracteoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09366  Bracteoline,
C09367,Bulbocapnine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09367  Bulbocapnine,
C09368,"(-)-Caaverine;|Noraporphin-1-ol, 2-methoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09368  (-)-Caaverine,
C09369,Calafatimine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09369  Calafatimine,
C09370,Cancentrine,,,,,
C09371,Capaurine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09371  Capaurine,
C09372,Capnoidine;|(-)-Adlumidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09372  Capnoidine,
C09373,Conchosin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09373  Conchosin B,
C09374,Confertiflorin;|(+)-Confertiflorin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09374  Confertiflorin,
C09375,Carnegine;|(+/-)-Carnegine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09375  (+-)-Carnegine,
C09376,Confertifolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09376  Confertifolin,
C09377,Caseadine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09377  Caseadine,
C09378,Confertin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09378  Confertin,
C09379,Coriamyrtin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Tutinolide|C09379  Coriamyrtin|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Sesquiterpenoids|C09379  Coriamyrtin,
C09380,Cassythine;|Cassyfiline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09380  Cassythine,
C09381,Coronopilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09381  Coronopilin,
C09382,Costunolide;|(+)-Costunolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09382  Costunolide,
C09383,alpha-Cyclocostunolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09383  alpha-Cyclocostunolide,
C09384,beta-Cyclocostunolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09384  beta-Cyclocostunolide,
C09385,Cynaropicrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09385  Cynaropicrin,
C09386,Damsin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09386  Damsin,
C09387,Dehydrocostus lactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09387  Dehydrocostus lactone,
C09388,Deoxyelephantopin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C09388  Deoxyelephantopin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09388  Deoxyelephantopin,
C09389,(+)-Cassythicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09389  (+)-Cassythicine,
C09390,Cephaeline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09390  Cephaeline,
C09391,Cepharanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09391  Cepharanthine|Therapeutic category of drugs in Japan [BR:br08301(D01035)]|2  Agents affecting individual organs|29  Other agents affecting individual organs|290  Other agents affecting individual organs|2900  Other agents affecting individual organs|D01035  Cepharanthine (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01035)]|Third-class OTC drugs|Inorganic and organic chemicals|Cepharanthine|D01035  Cepharanthine (JAN),
C09392,8-Deoxylactucin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09392  8-Deoxylactucin,
C09393,Corpaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09393  Corpaine,
C09394,Desacetoxymatricarin;|Leucodin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09394  Desacetoxymatricarin,
C09395,Deacetyleupaserrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09395  Deacetyleupaserrin,
C09396,Dihydrogriesenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09396  Dihydrogriesenin,
C09397,Dihydromikanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09397  Dihydromikanolide,
C09398,Cularicine,,,,,
C09399,Drimenin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010337 Drimane sesquiterpenoids|C09399  Drimenin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09399  Drimenin,
C09400,Cularidine,,,,,
C09401,Eleganin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09401  Eleganin,
C09402,Elephantin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09402  Elephantin,
C09403,Elephantopin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C09403  Elephantopin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09403  Elephantopin,
C09404,Encelin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09404  Encelin,
C09405,Enhydrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09405  Enhydrin,
C09406,Eremanthin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09406  Eremanthin,
C09407,Eremantholide A;|Eremantholide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09407  Eremantholide A,
C09408,Eremofrullanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09408  Eremofrullanolide,
C09409,Eremophilenolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09409  Eremophilenolide,
C09410,Cularimine,,,,,
C09411,Cularine,,,,,
C09412,Erioflorin acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09412  Erioflorin acetate,
C09413,Erioflorin methacrylate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09413  Erioflorin methacrylate,
C09414,Eriolangin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09414  Eriolangin,
C09415,Daphnandrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09415  Daphnandrine,
C09416,Eupachlorin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09416  Eupachlorin,
C09417,Eupachlorin acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09417  Eupachlorin acetate,
C09418,Daphnoline,,,,,
C09419,Dauricine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09419  Dauricine,
C09420,Emetamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09420  Emetamine,
C09421,Emetine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09421  Emetine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX02 Emetine|C09421  Emetine",G01011
C09422,Erysonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09422  Erysonine,
C09423,Erysotrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09423  Erysotrine,
C09424,Erythratidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09424  Erythratidine,
C09425,Eupachloroxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09425  Eupachloroxin,
C09426,"Eschscholtzidine;|(5S)-5,6,11,12-Tetrahydro-8,9-dimethoxy-14-methyl-benzo[5,6]cycloocta[1,2-f]-1,3-benzodioxol-5,11-imine",,,,,
C09427,Eupacunin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09427  Eupacunin,
C09428,Eupacunolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09428  Eupacunolin,
C09429,Eupacunoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09429  Eupacunoxin,
C09430,Fagaridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09430  Fagaridine,
C09431,Eupaformonin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09431  Eupaformonin,
C09432,Eupaformosanin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09432  Eupaformosanin,
C09433,Eupahyssopin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09433  Eupahyssopin,
C09434,Euparotin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09434  Euparotin,
C09435,Euparotin acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09435  Euparotin acetate,
C09436,Eupaserrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09436  Eupaserrin,
C09437,Eupatocunin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09437  Eupatocunin,
C09438,Fagaronine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09438  Fagaronine,
C09439,Eupatocunoxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09439  Eupatocunoxin,
C09440,Eupatolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09440  Eupatolide,
C09441,Fetidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09441  Fetidine,
C09442,Eupatoriopicrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09442  Eupatoriopicrin,
C09443,Eupatoroxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09443  Eupatoroxin,
C09444,Fumaricine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09444  Fumaricine,
C09445,Gigantine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09445  Gigantine,
C09446,Glaucine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09446  Glaucine,
C09447,10-epi-Eupatoroxin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09447  10-epi-Eupatoroxin,
C09448,Eupatundin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09448  Eupatundin,
C09449,Euponin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09449  Euponin,
C09450,Farinosin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09450  Farinosin,
C09451,Fastigilin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09451  Fastigilin B,
C09452,Fastigilin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09452  Fastigilin C,
C09453,Florilenalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09453  Florilenalin,
C09454,Frullanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09454  Frullanolide,
C09455,Gaillardin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09455  Gaillardin,
C09456,Geigerin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09456  Geigerin,
C09457,Glaziovine,,,,,
C09458,Gyrocarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09458  Gyrocarpine,
C09459,Hasubanonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09459  Hasubanonine,
C09460,Heliamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09460  Heliamine,
C09461,Hernandezine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09461  Hernandezine,
C09462,(-)-alpha-Hydrastine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09462  (-)-alpha-Hydrastine,
C09463,Glaucolide A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09463  Glaucolide A,
C09464,Ipecoside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09464  Ipecoside,
C09465,Glaucolide B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09465  Glaucolide B,
C09466,Glechomanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09466  Glechomanolide,
C09467,Goyazensolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09467  Goyazensolide,
C09468,Gradolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09468  Gradolide,
C09469,Graminiliatrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09469  Graminiliatrin,
C09470,Granilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09470  Granilin,
C09471,Asebogenin;|Phloretin 4'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09471  Asebogenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09471  Asebogenin,
C09472,Grosshemin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09472  Grosshemin,
C09473,Helenalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09473  Helenalin,
C09474,Heliangin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09474  Heliangin,
C09475,Hiyodorilactone A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09475  Hiyodorilactone A,
C09476,7alpha-Hydroxydehydrocostus lactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09476  7alpha-Hydroxydehydrocostus lactone,
C09477,Hydroxyvernolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09477  Hydroxyvernolide,
C09478,"Auriculoside;|7,3',5'-Trihydroxy-4'-methoxyflavan 3'-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09478  Auriculoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09478  Auriculoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavans|C09478  Auriculoside",
C09479,"Betagarin;|5,2'-Dimethoxy-6,7-methylenedioxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09479  Betagarin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09479  Betagarin,
C09480,Hymenoflorin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09480  Hymenoflorin,
C09481,Hymenolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09481  Hymenolin,
C09482,Hymenoxon,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09482  Hymenoxon,
C09483,Inulicin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09483  Inulicin,
C09484,Isoalantolactone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09484  Isoalantolactone|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09484  Isoalantolactone,
C09485,Isohelenol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09485  Isohelenol,
C09486,Isomontanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09486  Isomontanolide,
C09487,Isotenulin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09487  Isotenulin,
C09488,Ivalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09488  Ivalin,
C09489,Lactucin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09489  Lactucin,
C09490,Lactupicrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09490  Lactupicrin,
C09491,Laserolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09491  Laserolide sesqui,
C09492,Laurenobiolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09492  Laurenobiolide sesqui,
C09493,Liatrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09493  Liatrin sesqui,
C09494,Ligulatin B;|Incanin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09494  Ligulatin B,
C09495,Linderane,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09495  Linderane sesqui,
C09496,Linifolin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09496  Linifolin A,
C09497,Lipiferolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09497  Lipiferolide,
C09498,Ludovicin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09498  Ludovicin A,
C09499,Matricin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C09499  Matricin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09499  Matricin,
C09500,Melampodin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09500  Melampodin A sesqui,
C09501,Melampodinin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09501  Melampodinin sesqui,
C09502,Mellitoxin;|Hyenanchin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09502  Mellitoxin,
C09503,Mexicanin E,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09503  Mexicanin E,
C09504,Mexicanin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09504  Mexicanin I,
C09505,Broussin;|7-Hydroxy-4'-methoxyflavan,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09505  Broussin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09505  Broussin",
C09506,Michelenolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09506  Michelenolide,
C09507,Micheliolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09507  Micheliolide,
C09508,Microhelenin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09508  Microhelenin A,
C09509,Microhelenin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09509  Microhelenin C,
C09510,Microlenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09510  Microlenin,
C09511,Mikanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09511  Mikanolide,
C09512,Molephantin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09512  Molephantin,
C09513,Molephantinin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09513  Molephantinin,
C09514,Multigilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09514  Multigilin,
C09515,Multiradiatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09515  Multiradiatin,
C09516,Multistatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09516  Multistatin,
C09517,Niveusin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09517  Niveusin C,
C09518,Nobilin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09518  Nobilin,
C09519,Oblongolide,,,,,
C09520,Onopordopicrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09520  Onopordopicrin,
C09521,Orizabin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09521  Orizabin,
C09522,Ovatifolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09522  Ovatifolin,
C09523,Parthenin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010342 Pseudoguaiane sesquiterpenoids|C09523  Parthenin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09523  Parthenin,
C09524,Broussonin C,,,,,
C09525,Paucin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09525  Paucin,
C09526,1-Peroxyferolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09526  1-Peroxyferolide,
C09527,Phantomolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09527  Phantomolin,
C09528,Picrotin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09528  Picrotin,
C09529,Picrotoxinin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010354 Picrotoxane sesquiterpenoids|C09529  Picrotoxinin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09529  Picrotoxinin|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Sesquiterpenoids|C09529  Picrotoxinin,
C09530,Pleniradin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09530  Pleniradin,
C09531,Plenolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09531  Plenolin,
C09532,Polhovolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09532  Polhovolide,
C09533,Provincialin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09533  Provincialin,
C09534,Pseudoivalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09534  Pseudoivalin,
C09535,Pycnolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09535  Pycnolide,
C09536,Pyrethrosin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09536  Pyrethrosin,
C09537,Quadrone,,,,,
C09538,Qing Hau Sau;|Artemisinin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09538  Artemisinin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09538  Artemisinin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02481)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BE Artemisinin and derivatives, plain|P01BE01 Artemisinin|D02481  Artemisinin (INN)|Antimicrobials [BR:br08307(D02481)]|Antiparasitics|Antmalarials|Artemisinin and derivatives|D02481  Artemisinin (INN)",
C09539,Radiatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09539  Radiatin,
C09540,Ridentin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09540  Ridentin,
C09541,"(S)-Isoboldine;|(+)-Isoboldine;|Isoboldine;|2,10-Dimethoxy-6aalpha-aporphine-1,9-diol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09541  (S)-Isoboldine,
C09542,Salonitenolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09542  Salonitenolide,
C09543,Isochondrodendrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09543  Isochondrodendrine,
C09544,Santamarin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09544  Santamarin,
C09545,beta-Santonin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09545  beta-Santonin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09545  beta-Santonin,
C09546,"Isococculidine;|Erythrinan, 1,2-didehydro-3,15-dimethoxy-, (3-beta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09546  Isococculidine,
C09547,Saupirin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09547  Saupirin,
C09548,Scorpioidin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09548  Scorpioidin,
C09549,Isocorydine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09549  Isocorydine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C09549  Isocorydine,
C09550,Isothebaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09550  Isothebaine,
C09551,Spicatin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09551  Spicatin,
C09552,Stramonin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09552  Stramonin B,
C09553,Jatrorrhizine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09553  Jatrorrhizine,
C09554,Tagitinin F,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09554  Tagitinin F,
C09555,"(-)-Laudanidine;|(R)-Laudanine;|5-[((1R)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-methoxyphenol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09555  (-)-Laudanidine,
C09556,Tamaulipin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09556  Tamaulipin A,
C09557,Tenulin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09557  Tenulin,
C09558,Laudanosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09558  Laudanosine,
C09559,Tetraneurin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09559  Tetraneurin A,
C09560,Tetraneurin E;|Ambrosanolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09560  Tetraneurin E,
C09561,Thapsigargin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C09561  Thapsigargin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09561  Thapsigargin,
C09562,Tomentosin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010339 Xanthane sesquiterpenoids|C09562  Tomentosin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09562  Tomentosin,
C09563,Trilobolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09563  Trilobolide,
C09564,Tulipinolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09564  Tulipinolide,
C09565,Laurifine,,,,,
C09566,epi-Tulipinolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09566  epi-Tulipinolide,
C09567,Liriodenine;|Oxoushinsunine,,,,,
C09568,epi-Tulipinolide diepoxide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09568  epi-Tulipinolide diepoxide,
C09569,Longifolonine,,,,,
C09570,Tutin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010354 Picrotoxane sesquiterpenoids|C09570  Tutin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Tutinolide|C09570  Tutin|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Sesquiterpenoids|C09570  Tutin,
C09571,Lophocerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09571  Lophocerine,
C09572,Ursiniolide A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09572  Ursiniolide A,
C09573,Lophophorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09573  Lophophorine,
C09574,Vermeerin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Pseudoguaianolide|C09574  Vermeerin,
C09575,(+)-Luguine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09575  (+)-Luguine,
C09576,Vernodalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09576  Vernodalin,
C09577,Vernodalol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09577  Vernodalol,
C09578,Vernoflexin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09578  Vernoflexin,
C09579,Vernoflexuoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09579  Vernoflexuoside,
C09580,Macoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09580  Macoline,
C09581,Magnoflorine;|(S)-Magnoflorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09581  Magnoflorine,
C09582,Vernolepin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09582  Vernolepin,
C09583,Vernolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09583  Vernolide,
C09584,Vernomenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09584  Vernomenin,
C09585,Vernomygdin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09585  Vernomygdin,
C09586,Viguiestenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09586  Viguiestenin,
C09587,Viscidulin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09587  Viscidulin B,
C09588,Mecambrine,,,,,
C09589,(+)-Mecambroline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09589  (+)-Mecambroline,
C09590,Thalmidine;|(+)-O-Methylthalicberine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09590  Thalmidine,
C09591,Narceine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09591  Narceine,
C09592,alpha-Narcotine;|Noscapine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09592  alpha-Narcotine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09592|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01036)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS|R05DA Opium alkaloids and derivatives|R05DA07 Noscapine|D01036  Noscapine (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D01036)]|Agents for respiratory organs|26 Antitussives and expectorants|D01036  Noscapine (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01036)]|Third-class OTC drugs|Inorganic and organic chemicals|Noscapine|D01036  Noscapine (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01036)]|Chemicals|D01036  Noscapine",
C09593,Narcotoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09593  Narcotoline,
C09594,Neopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09594  Neopine,
C09595,Nitidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09595  Nitidine,
C09596,Obaberine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09596  Obaberine,
C09597,Ochotensine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09597  Ochotensine,
C09598,Oxyacanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09598  Oxyacanthine,
C09599,Parfumine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09599  Parfumine,
C09600,Vulgarin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09600  Vulgarin,
C09601,Xanthatin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010339 Xanthane sesquiterpenoids|C09601  Xanthatin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09601  Xanthatin,
C09602,Xanthinin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09602  Xanthinin,
C09603,Xanthumin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09603  Xanthumin,
C09604,(-)-Pellotine;|Pellotine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09604  (-)-Pellotine,
C09605,Xerantholide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09605  Xerantholide,
C09606,Zaluzanin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Guaianolide|C09606  Zaluzanin C,
C09607,Zexbrevin B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09607  Zexbrevin B,
C09608,Phaeantharine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09608  Phaeantharine,
C09609,Pilocereine,,,,,
C09610,Polycarpine,,,,,
C09611,(+)-Pronuciferine,,,,,
C09612,Psychotrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09612  Psychotrine,
C09613,Pukateine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09613  Pukateine,
C09614,"Butin;|(-)-Butin;|7,3',4'-Trihydroxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09614  Butin,
C09615,Pycnamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09615  Pycnamine,
C09616,"Butrin;|Butin 7,3'-di-O-glucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09616  Butrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09616  Butrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09616  Butrin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09616,
C09617,Catechin 7-O-beta-D-xyloside,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09617  Catechin 7-O-beta-D-xyloside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09617  Catechin 7-O-beta-D-xyloside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavans|C09617  Catechin 7-O-beta-D-xyloside",
C09618,"Davidigenin;|4,2',4'-Trihydroxydihydrochalcone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09618  Davidigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09618  Davidigenin,
C09619,Rhoeadine,,,,,
C09621,(-)-alpha-Bisabolol;|Levomenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C09621  (-)-alpha-Bisabolol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09621  (-)-alpha-Bisabolol,
C09622,Botrydial,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010364 Botrydial sesquiterpenoids|C09622  Botrydial,
C09623,Buddledin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C09623  Buddledin A,
C09624,Rodiasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09624  Rodiasine,
C09625,beta-Cadinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C09625  beta-Cadinene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C09625  beta-Cadinene,
C09626,Canellal;|Muzigadial,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09626  Canellal,
C09627,Capsidiol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010325 Eremophilane sesquiterpenoids|C09627  Capsidiol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09627  Capsidiol,
C09628,Carotol;|(+)-8-Daucen-5-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010355 Daucane sesquiterpenoids|C09628  Carotol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09628  Carotol,
C09629,beta-Caryophyllene;|Caryophyllene;|(-)-beta-Caryophyllene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010312 Caryophyllane sesquiterpenoids|C09629  beta-Caryophyllene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C09629  beta-Caryophyllene,
C09630,alpha-Cedrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010369 Cedrane and isocedrane sesquiterpenoids|C09630  alpha-Cedrene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09630  alpha-Cedrene,
C09631,alpha-Cedrol;|Cedrol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010369 Cedrane and isocedrane sesquiterpenoids|C09631  alpha-Cedrol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09631  alpha-Cedrol,
C09632,Centarol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09632  Centarol,
C09633,Chamazulene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C09633  Chamazulene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09633  Chamazulene,
C09634,"Rugosinone;|1,3-Dioxolo[4,5-g]isoquinolin-5-yl(2-hydroxy-3,4-dimethoxyphenyl)methanone",,,,,
C09635,alpha-Chamigrene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09635  alpha-Chamigrene,
C09636,Diffutin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09636  Diffutin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09636  Diffutin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavans|C09636  Diffutin",
C09637,beta-Chamigrene;|(-)-beta-Chamigrene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09637  beta-Chamigrene,
C09638,Cinnamodial,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09638  Cinnamodial,
C09639,alpha-Copaene;|Copaene;|(-)-alpha-Copaene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010383 Copaane sesquiterpenoids|C09639  alpha-Copaene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09639  alpha-Copaene,
C09640,(-)-Salsoline,,,,,
C09641,"7,4'-Dihydroxyflavan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09641  7,4'-Dihydroxyflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09641  7,4'-Dihydroxyflavan",
C09642,"(-)-Salsolinol;|6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-methyl-, (S)-;|Salsolinol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09642  (-)-Salsolinol,
C09643,Sinomenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09643  Sinomenine,
C09644,"2',6'-Dihydroxy-4'-methoxydihydrochalcone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09644  2',6'-Dihydroxy-4'-methoxydihydrochalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09644  2',6'-Dihydroxy-4'-methoxydihydrochalcone",
C09645,Cuauhtemone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09645  Cuauhtemone,
C09646,"7,3'-Dihydroxy-4'-methoxy-8-methylflavan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09646  7,3'-Dihydroxy-4'-methoxy-8-methylflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09646  7,3'-Dihydroxy-4'-methoxy-8-methylflavan",
C09647,alpha-Cubebene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010344 Cubebane and ivaxillarane sesquiterpenoids|C09647  alpha-Cubebene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09647  alpha-Cubebene,
C09648,beta-Cubebene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010344 Cubebane and ivaxillarane sesquiterpenoids|C09648  beta-Cubebene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09648  beta-Cubebene,
C09649,"alpha-Curcumene;|l-alpha-Curcumene;|(-)-alpha-Curcumene;|(R)-1-(1,5-Dimethyl-4-hexenyl)-4-methylbenzene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C09649  alpha-Curcumene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09649  alpha-Curcumene,
C09650,"7,4'-Dihydroxy-8-methylflavan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09650  7,4'-Dihydroxy-8-methylflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09650  7,4'-Dihydroxy-8-methylflavan",
C09651,Cycloeudesmol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010323 Cycloeudesmane sesquiterpenoids|C09651  Cycloeudesmol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09651  Cycloeudesmol,
C09652,Daucol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09652  Daucol,
C09653,Debneyol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09653  Debneyol,
C09654,(+)-Tetrandrine;|Tetrandrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09654  (+)-Tetrandrine,
C09655,Thalicarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09655  Thalicarpine,
C09656,Thalidasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09656  Thalidasine,
C09657,"Dehydrojuvabione;|(4R)-4-[(1R)-1,5-Dimethyl-3-oxo-4-hexenyl]-1-cyclohexene-1-carboxylic acid methyl ester",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09657  Dehydrojuvabione,
C09658,Dehydromyodesmone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09658  Dehydromyodesmone,
C09659,Thalmine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09659  Thalmine,
C09660,Dehydrongaione,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010302 Furanoid farnesane sesquiterpenoids|C09660  Dehydrongaione|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09660  Dehydrongaione,
C09661,Thalsimine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09661  Thalsimine,
C09662,Diacetoxyscirpenol,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C09662  Diacetoxyscirpenol,
C09663,alpha-Eudesmol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09663  alpha-Eudesmol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09663  alpha-Eudesmol,
C09664,beta-Eudesmol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09664  beta-Eudesmol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09664  beta-Eudesmol,
C09665,"alpha-Farnesene;|(3E,6E)-alpha-Farnesene",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09665  alpha-Farnesene,
C09666,beta-Farnesene;|(E)-beta-Farnesene,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C09666  (E)-beta-Farnesene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09666  beta-Farnesene,
C09667,Tiliacorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09667  Tiliacorine,
C09668,Fumagillin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C09668  Fumagillin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX10 Fumagillin|C09668  Fumagillin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09668",
C09669,Trilobine,,,,,
C09670,Xylopine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09670  Xylopine,
C09671,Xylopinine;|Norcoralydine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C09671  Xylopinine,
C09672,"Germacrene B;|(E,E)-Germacrene B;|(E,E)-1,5-Dimethyl-8-(1-methylethylidene)-1,5-cyclodecadiene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C09672  Germacrene B|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C09672  Germacrene B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09672,
C09673,Glutinosone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09673  Glutinosone,
C09674,Graphinone;|Ovalicin,,,,,
C09675,"Guaiazulene;|1,4-Dimethyl-7-isopropylazulene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C09675  Guaiazulene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09675  Guaiazulene|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01037)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA01 Guaiazulen|D01037  1,4-Dimethyl-7-isopropylazulene (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01037)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D01037  1,4-Dimethyl-7-isopropylazulene (JAN)|Classification of Japanese OTC drugs [BR:br08313(D01037)]|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D01037  1,4-Dimethyl-7-isopropylazulene (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01037)]|Third-class OTC drugs|Inorganic and organic chemicals|1,4-Dimethyl-7-isopropylazulene|D01037  1,4-Dimethyl-7-isopropylazulene (JAN)|1,4-Dimethyl-7-isopropylazulene|D01037  1,4-Dimethyl-7-isopropylazulene (JAN)|Drug groups [BR:br08330(D01037)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01149  Guaiazulen|D01037  1,4-Dimethyl-7-isopropylazulene|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01149  Guaiazulen|D01037  1,4-Dimethyl-7-isopropylazulene|Drug classes [BR:br08332(D01037)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D01037  1,4-Dimethyl-7-isopropylazulene",
C09676,Guaiol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C09676  Guaiol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C09676  Guaiol,
C09677,Helminthosporal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09677  Helminthosporal,
C09678,Helminthosporol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010381 Sativane sesquiterpenoids|C09678  Helminthosporol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09678  Helminthosporol,
C09679,Helminthosporoside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09679  Helminthosporoside A,
C09680,Hemigossypol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C09680  Hemigossypol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09680  Hemigossypol,
C09681,Hernandulcin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09681  Hernandulcin,
C09682,Himachalol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010348 Lippifoliane and himachalane sesquiterpenoids|C09682  Himachalol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09682  Himachalol,
C09683,Hirsutic acid C,,,,,
C09684,Humulene;|alpha-Humulene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010311 Humulane sesquiterpenoids|C09684  Humulene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C09684  Humulene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09684,
C09685,10beta-Hydroxy-6beta-isobutyrylfuranoeremophilane,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09685  10beta-Hydroxy-6beta-isobutyrylfuranoeremophilane,
C09686,Hydroxyisopatchoulenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09686  Hydroxyisopatchoulenone,
C09687,Illudin M,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010359 Illudane and protoilludane sesquiterpenoids|C09687  Illudin M|Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Terpenoids|C09687  Illudin M,
C09688,Illudin S,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010359 Illudane and protoilludane sesquiterpenoids|C09688  Illudin S|Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Terpenoids|C09688  Illudin S,
C09689,Ipomeamarone;|(+)-Ngaione,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010302 Furanoid farnesane sesquiterpenoids|C09689  Ipomoeamarone|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09689  Ipomeamarone,
C09690,alpha-Irone;|(+)-cis-alpha-Irone,(+)-trans-alpha-Irone [CPD:C11350],,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09690  alpha-Irone,
C09691,Isocaryophyllene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010312 Caryophyllane sesquiterpenoids|C09691  Isocaryophyllene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C09691  Isocaryophyllene,
C09692,Isovelleral,,,,,
C09693,Juvabione,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09693  Juvabione,
C09694,Juvenile hormone III,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C09694  Juvenile hormone III|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09694  Juvenile hormone III|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09694,
C09695,Lacinilene C 7-methyl ether,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09695  Lacinilene C 7-methyl ether,
C09696,Lactaroviolin,,,,,
C09697,Laserpitin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09697  Laserpitin,
C09698,Ledol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09698  Ledol,
C09699,Longifolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010350 Longifolane sesquiterpenoids|C09699  Longifolene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C09699  Longifolene,
C09700,Lubimin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09700  Lubimin,
C09701,Marasmic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010362 Isolactarane, merulane, lactarane and marasmane sesquiterpenoids|C09701  Marasmic acid",
C09702,Mukaadial,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09702  Mukaadial,
C09704,"Nerolidol;|(3S,6E)-Nerolidol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C09704  Nerolidol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09704  Nerolidol,
C09705,Patchouli alcohol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09705  Patchouli alcohol,
C09706,Petasin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09706  Petasin,
C09707,Phaseic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09707  Phaseic acid,
C09708,Phomenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09708  Phomenone,
C09709,Phytuberin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09709  Phytuberin,
C09710,Pinguisone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09710  Pinguisone,
C09711,Piperdial,,,,,
C09712,Polygodial,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09712  Polygodial,
C09714,Rhipocephalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09714  Rhipocephalin,
C09715,Rishitin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09715  Rishitin,
C09716,Roridin A,,,,,
C09717,Rugosal A;|Rugosal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09717  Rugosal A,
C09718,beta-Santalene;|(-)-beta-Santalene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09718  beta-Santalene,
C09719,alpha-Santalol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010380 Campherenane and santalane sesquiterpenoids|C09719  alpha-Santalol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09719  alpha-Santalol,
C09720,beta-Santalol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010380 Campherenane and santalane sesquiterpenoids|C09720  beta-Santalol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09720  beta-Santalol,
C09721,Sclerosporin,,,,,
C09722,Seiricardine A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09722  Seiricardine A,
C09723,beta-Selinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C09723  beta-Selinene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09723  beta-Selinene,
C09724,"Lonchocarpol A;|Senegalensin;|6,8-Diprenylnaringenin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09724  6,8-Diprenylnaringenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09724  Lonchocarpol A",
C09725,Shiromodiol diacetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09725  Shiromodiol diacetate,
C09726,Dracorubin,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C09726  Dracorubin,
C09727,(-)-Epicatechin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09727  (-)-Epicatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09727  (-)-Epicatechin|Dietary phytochemicals [br08012.html]|Flavonoids|C09727",
C09728,(+)-Epicatechin;|ent-Epicatechin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09728  (+)-Epicatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09728  (+)-Epicatechin",
C09729,alpha-Sinensal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09729  alpha-Sinensal,
C09730,"beta-Sinensal;|2,6-Dimethyl-10-methylene-2,6,11-dodecatrienal",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09730  beta-Sinensal,
C09731,Epigallocatechin gallate;|(-)-Epigallocatechin-3-O-gallate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C09731  Epigallocatechin 3-gallate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09731  Epigallocatechin 3-gallate|Dietary phytochemicals [br08012.html]|Flavonoids|C09731,
C09732,Eriocitrin;|Eriodictyol 7-O-rutinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09732  Eriocitrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09732  Eriocitrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09732  Eriocitrin|Dietary phytochemicals [br08012.html]|Flavonoids|C09732,
C09733,Sirenin,,,,,
C09734,Farrerol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09734  Farrerol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09734  Farrerol,
C09735,"Fisetinidol;|3,7,3',4'-Tetrahydroxyflavan",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09735  Fisetinidol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C09735  Fisetinidol",
C09736,"Fisetinidol-4beta-ol;|(-)-Mollisacacidin;|Fisetinin-3,4-diol;|5-Deoxyleucocyanidin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09736  Fisetinidol-4beta-ol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3,4-diols|C09736  5-Deoxyleucocyanidin",
C09737,Solavetivone;|(-)-Solavetivone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010365 Spirovetivane sesquiterpenoids|C09737  Solavetivone|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C09737  Solavetivone,
C09738,T-2 Toxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C09738  T-2 Toxin,
C09739,Tetradymol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09739  Tetradymol,
C09740,Thujopsene;|(-)-Thujopsene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010386 Thujopsane sesquiterpenoids|C09740  (-)-Thujopsene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09740  Thujopsene|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C09740  Thujopsene,
C09741,Trichodermin,,,,,
C09742,Trichothecin,,,,,
C09743,Valerenic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010346 Valerenane sesquiterpenoids|C09743  Valerenic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09743  Valerenic acid,
C09744,alpha-Vetivone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09744  alpha-Vetivone,
C09745,beta-Vetivone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09745  beta-Vetivone,
C09746,Verrucarin A;|Muconomycin A,,,,,
C09747,Vomitoxin;|Deoxynivalenol;|DON,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010318 Trichothecane sesquiterpenoids|C09747  Vomitoxin|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C09747  Vomitoxin,
C09748,Warburganal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C09748  Warburganal,
C09749,alpha-Ylangene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09749  alpha-Ylangene,
C09750,Zingiberene;|alpha-Zingiberene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C09750  Zingiberene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C09750  Zingiberene,
C09751,"Garbanzol;|3,7,4'-Trihydroxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09751  Garbanzol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09751  Garbanzol,
C09752,Glabranin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09752  Glabranin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09752  Glabranin,
C09753,Glepidotin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09753  Glepidotin B|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09753  Glepidotin B,
C09754,Glycyphyllin;|Phloretin 2'-O-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09754  Glycyphyllin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09754  Glycyphyllin,
C09755,Hesperidin;|Hesperetin 7-O-rutinoside;|Ciratin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09755  Hesperidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09755  Hesperidin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09755  Hesperidin|Dietary phytochemicals [br08012.html]|Flavonoids|C09755|Risk category of Japanese OTC drugs [BR:br08312(D01038)]|Third-class OTC drugs|Inorganic and organic chemicals|Hesperidin|D01038  Hesperidin (JAN),
C09756,Homoeriodictyol;|Eriodictyol 3'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09756  Homoeriodictyol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09756  Homoeriodictyol,
C09757,7-Hydroxyflavan,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09757  7-Hydroxyflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09757  7-Hydroxyflavan",
C09758,"Isochamaejasmin;|3,3''-Binaringenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C09758  Isochamaejasmin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C09758  Isochamaejasmin,
C09759,"Isouvaretin;|1-(4,6-Dihydroxy-3-((2-hydroxyphenyl)methyl)-2-methoxyphenyl)-3-phenyl-1-propanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09759  Isouvaretin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09759  Isouvaretin,
C09760,Kazinol A,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09760  Kazinol A|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavans|C09760  Kazinol A",
C09761,Kolaflavanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C09761  Kolaflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C09761  Kolaflavanone,
C09762,"Liquiritigenin;|4',7-Dihydroxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09762  Liquiritigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09762  Liquiritigenin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09762,
C09763,Manniflavanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C09763  Manniflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C09763  Manniflavanone,
C09764,6-Methoxyaromadendrin 3-O-acetate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09764  6-Methoxyaromadendrin 3-O-acetate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09764  6-Methoxyaromadendrin 3-O-acetate,
C09765,Agnuside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09765  Agnuside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09765  Agnuside,
C09766,Allamandin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09766  Allamandin,
C09767,Amarogentin,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09767  Amarogentin,
C09768,Antirrhinoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09768  Antirrhinoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09768  Antirrhinoside,
C09769,Asperuloside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09769  Asperuloside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09769  Asperuloside,
C09770,6-Methoxytaxifolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09770  6-Methoxytaxifolin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09770  6-Methoxytaxifolin,
C09771,Aucubin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09771  Aucubin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09771  Aucubin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09771  Aucubin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C09771",
C09772,Boschnialactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09772  Boschnialactone,
C09773,Catalpol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09773  Catalpol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09773  Catalpol|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09773  Catalpol",
C09774,2'-O-Methylodoratol;|Methylodoratol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09774  2'-O-Methylodoratol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09774  2'-O-Methylodoratol,
C09775,Catalposide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09775  Catalposide|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09775  Catalposide,
C09776,Didrovaltratum;|Didrovaltrate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09776  Didrovaltratum|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09776  Didrovaltratum",
C09777,Dolichodial;|Iridial,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09777  Dolichodial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09777  Dolichodial",
C09778,Fulvoplumierin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09778  Fulvoplumierin,
C09779,Gardenoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09779  Gardenoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09779  Gardenoside,
C09780,Genipin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09780  Genipin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C09780,
C09781,Geniposide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09781  Geniposide|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09781  Geniposide|Dietary phytochemicals [br08012.html]|Other phytochemicals|C09781,
C09782,Gentiopicrin;|Gentiopicroside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09782  Gentiopicrin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Secoiridoids|C09782  Gentiopicrin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C09782",
C09783,Harpagoside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09783  Harpagoside|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09783  Harpagoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09783   Harpagoside",
C09784,Ipolamiide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09784  Ipolamiide|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09784  Ipolamiide,
C09785,(+)-Iridodial,Iridodial (tautomer) [CPD:C06069]|cis-trans-Iridodial lactol (tautomer) [CPD:C09804],,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09785  (+)-Iridodial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09785  (+)-Iridodial",
C09786,Iridomyrmecin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09786  Iridomyrmecin,
C09787,Isoplumericin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09787  Isoplumericin,
C09788,Monotropein,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09788  Monotropein|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09788  Monotropein|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09788  Monotropein",
C09789,Naringin;|Naringenin 7-O-neohesperidoside;|Naringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09789  Naringin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09789  Naringin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09789  Naringin|Dietary phytochemicals [br08012.html]|Flavonoids|C09789,
C09790,(+)-Neomatatabiol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09790  (+)-Neomatatabiol,
C09791,"Nepetalactone cis-trans-form;|(+)-cis,trans-Nepetalactone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09791  Nepetalactone cis-trans-form|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09791  Nepetalactone cis-trans-form",
C09792,Nepetalactone trans-cis-form,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09792  Nepetalactone trans-cis-form|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09792  Nepetalactone trans-cis-form",
C09793,Narirutin;|Naringenin 7-O-rutinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09793  Narirutin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09793  Narirutin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09793  Narirutin|Dietary phytochemicals [br08012.html]|Flavonoids|C09793,
C09794,Oleuropein,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09794  Oleuropein,
C09795,Paederoside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09795  Paederoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09795  Paederoside,
C09796,Plumericin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09796  Plumericin,
C09797,Plumieride,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09797  Plumieride|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09797  Plumieride,
C09798,Scandoside methyl ester,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09798  Scandoside methyl ester|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09798  Scandoside methyl ester,
C09799,Specionin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09799  Specionin,
C09800,Swertiamarin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Secoiridoids|C09800  Swertiamarin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C09800,
C09801,Valtratum;|Valtrate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09801  Valtratum|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09801  Valtratum",
C09802,Verbenalin;|Cornin (glycoside),,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09802  Verbenalin|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09802  Verbenalin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09802  Verbenalin|C09802  Verbenalin",
C09803,"Neoastilbin;|(2S,3S)-Taxifolin 3-rhamnoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09803  Neoastilbin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09803  Neoastilbin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09803  Neoastilbin|Dietary phytochemicals [br08012.html]|Flavonoids|C09803,
C09804,"cis-trans-Nepetalactol;|cis-trans-Iridodial lactol;|(+)-cis,trans-Nepetalactol;|(4aS,7S,7aR)-4,7-Dimethyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-ol",Iridodial (tautomer) [CPD:C06069]|(+)-Iridodial (tautomer) [CPD:C09785],,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C09804  cis-trans-Iridodial lactol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C09804  cis-trans-Nepetalactol",
C09805,Neoeriocitrin;|Eriodictyol 7-O-neohesperidoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09805  Neoeriocitrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09805  Neoeriocitrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09805  Neoeriocitrin|Dietary phytochemicals [br08012.html]|Flavonoids|C09805,
C09806,Neohesperidin;|Hesperetin 7-O-neohesperidoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09806  Neohesperidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09806  Neohesperidin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09806  Neohesperidin|Dietary phytochemicals [br08012.html]|Flavonoids|C09806,
C09807,Odoratol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09807  Odoratol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09807  Odoratol,
C09808,Phellamurin;|8-Prenyldihydrokaempferol 7-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09808  Phellamurin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09808  Phellamurin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09808  Phellamurin,
C09809,"Cyclohexa-2,5-diene-1-carbonyl-CoA;|Cyclohex-2,5-diene-1-carboxyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09809  Cyclohexa-2,5-diene-1-carbonyl-CoA",
C09810,"Cyclohexa-1,4-diene-1-carbonyl-CoA;|Cyclohex-1,4-diene-1-carboxyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09810  Cyclohexa-1,4-diene-1-carbonyl-CoA",
C09811,Cyclohex-1-ene-1-carbonyl-CoA;|Cyclohex-1-ene-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09811  Cyclohex-1-ene-1-carbonyl-CoA,
C09812,2-Hydroxycyclohexane-1-carbonyl-CoA;|2-Hydroxycyclohexane-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09812  2-Hydroxycyclohexane-1-carbonyl-CoA,
C09813,2-Oxocyclohexane-1-carbonyl-CoA;|2-Ketocyclohexane-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09813  2-Oxocyclohexane-1-carbonyl-CoA,
C09814,Benzonitrile;|Phenyl cyanide;|Cyanobenzene,,,,,
C09815,Benzamide,,,,,
C09816,Benzylsuccinate;|(R)-2-Benzylsuccinate,,,,,
C09817,Benzylsuccinyl-CoA;|(R)-2-Benzylsuccinyl-CoA,,,,,
C09818,E-Phenylitaconyl-CoA;|(E)-2-Benzylidenesuccinyl-CoA;|(E)-Benzylidenesuccinyl-CoA,,,,,
C09819,"(2S)-[(R)-Hydroxy(phenyl)methyl]succinyl-CoA;|(Hydroxymethylphenyl)succinyl-CoA;|(R,S)-2-(alpha-Hydroxybenzyl)succinyl-CoA",,,,,
C09820,(S)-2-Benzoylsuccinyl-CoA;|Benzoylsuccinyl-CoA;|2-Benzoylsuccinyl-CoA,,,,,
C09821,6-Oxocyclohex-1-ene-1-carbonyl-CoA;|6-Ketoxycyclohex-1-ene-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09821  6-Oxocyclohex-1-ene-1-carbonyl-CoA,
C09822,Cyclohexane-1-carboxylate;|Cyclohexanecarboxylic acid;|Hexahydrobenzoic acid,,,,,
C09823,Cyclohexane-1-carbonyl-CoA;|Cyclohexane-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09823  Cyclohexane-1-carbonyl-CoA,
C09824,"2,6-Dihydroxycyclohexane-1-carbonyl-CoA;|2,6-Dihydroxycyclohexane-1-carboxyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09824  2,6-Dihydroxycyclohexane-1-carbonyl-CoA",
C09825,2-Hydroxy-6-oxocyclohexane-1-carbonyl-CoA;|6-Oxo-2-hydroxycyclohexane-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C09825  2-Hydroxy-6-oxocyclohexane-1-carbonyl-CoA,
C09826,"Pinobanksin;|3,5,7-Trihydroxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09826  Pinobanksin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09826  Pinobanksin,
C09827,"Pinocembrin;|5,7-Dihydroxyflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09827  Pinocembrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09827  Pinocembrin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C09827,
C09828,Pinocembrin 7-rhamnosylglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09828  Pinocembrin 7-rhamnosylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09828  Pinocembrin 7-rhamnosylglucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09828  Pinocembrin 7-rhamnosylglucoside,
C09829,Piperaduncin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09829  Piperaduncin B|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09829  Piperaduncin B,
C09830,Poncirin;|Isosakuranetin 7-O-neohesperidoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09830  Poncirin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09830  Poncirin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C09830  Poncirin,
C09831,5'-Prenylhomoeriodictyol;|Sigmoidin B 3'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09831  5'-Prenylhomoeriodictyol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09831  5'-Prenylhomoeriodictyol,
C09832,"6-Prenylnaringenin;|5,7,4'-Trihydroxy-6-prenylflavanone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09832  6-Prenylnaringenin,
C09833,Sakuranetin;|Naringenin 7-methyl ether;|(2S)-Sakuranetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09833  Sakuranetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09833  Sakuranetin,
C09834,Sanggenon C,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Diels-Alder adduct of chalcone|C09834  Sanggenon C,
C09835,Sanggenon D,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Diels-Alder adduct of chalcone|C09835  Sanggenon D,
C09836,Ascaridole,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09836  Ascaridole|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09836  Ascaridole,
C09837,"(1S,2R,4S)-(-)-Bornyl acetate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09837  (1S,2R,4S)-(-)-Bornyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09837  (1S,2R,4S)-(-)-Bornyl acetate",
C09839,Car-3-ene;|(-)-3-Carene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09839  Car-3-ene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09839  (-)-3-Carene,
C09840,Carvacrol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09840  Carvacrol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09840  Carvacrol,
C09841,Carvone oxide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09841  Carvone oxide|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09841  Carvone oxide,
C09842,Chrysanthemic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C09842  Chrysanthemic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Others|C09842  Chrysanthemic acid,
C09843,Chrysanthenone;|(-)-Chrysanthenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09843  Chrysanthenone,
C09844,"1,8-Cineole;|1,8-Cineol;|Eucalyptol;|1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octane",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09844  1,8-Cineole|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09844  1,8-Cineole|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04115)]|R RESPIRATORY SYSTEM|R05 COUGH AND COLD PREPARATIONS|R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS|R05CA Expectorants|R05CA13 Cineole|D04115  Eucalyptol (USP)|Animal drugs in Japan [BR:br08331(D04115)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|D04115  Eucalyptol",
C09845,Cinerin I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Others|C09845  Cinerin I,
C09846,Cinerin II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Others|C09846  Cinerin II,
C09847,cis-Citral;|Neral,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09847  Neral|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09847  cis-Citral,
C09848,(R)-(+)-Citronellal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09848  (R)-(+)-Citronellal|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09848  (R)-(+)-Citronellal,
C09849,beta-Citronellol;|(R)-(+)-Citronellol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09849  beta-Citronellol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09849  beta-Citronellol,
C09850,Acrifoline,,,,,
C09851,Annofoline;|(15R)-5beta-Hydroxy-15-methyllycopodan-8-one,,,,,
C09852,Annotine,,,,,
C09853,"1,2-Dihydroxymint lactone",,,,,
C09854,Diosphenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09854  Diosphenol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09854  Diosphenol,
C09855,Annotinine,,,,,
C09856,Carolinianine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C09856  Carolinianine,
C09858,Evodone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09858  Evodone,
C09859,"Fenchone;|(1R,4S)-(-)-Fenchone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09859  Fenchone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09859  (1R,4S)-(-)-Fenchone",
C09860,Cernuine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C09860  Cernuine,
C09861,Geranyl acetate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C09861  Geranyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09861  Geranyl acetate,
C09862,Fawcettidine,,,,,
C09863,Linalyl acetate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09863  Linalyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09863  Linalyl acetate,
C09864,Fawcettimine,,,,,
C09865,Flabellidine,,,,,
C09866,Huperzine B,,,,,
C09867,Inundatine,,,,,
C09868,Menthofuran,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09868  Menthofuran|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09868  Menthofuran,
C09869,Lucidine B;|Serratanine,,,,,
C09870,(-)-Menthyl acetate;|l-Menthyl acetate;|Menthyl acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09870  (-)-Menthyl acetate,
C09871,"Nerol;|(Z)-3,7-Dimethylocta-2,6-dien-1-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09871  Nerol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09871  Nerol,
C09872,Luciduline;|(+)-Luciduline,,,,,
C09873,(E)-beta-Ocimene;|beta-Ocimene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C09873  beta-Ocimene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C09873  beta-Ocimene,
C09874,Lycocernuine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C09874  Lycocernuine,
C09875,(R)-(-)-alpha-Phellandrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09875  (R)-(-)-alpha-Phellandrene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09875  (R)-(-)-alpha-Phellandrene,
C09876,Lycodine,,,,,
C09877,(+)-beta-Phellandrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09877  (+)-beta-Phellandrene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09877  (+)-beta-Phellandrene,
C09878,Lycofawcine,,,,,
C09879,Lycoflexine,,,,,
C09880,alpha-Pinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09880  alpha-Pinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09880  alpha-Pinene,
C09881,Lyconnotine,,,,,
C09882,beta-Pinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09882  beta-Pinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09882  beta-Pinene,
C09883,Lycopodine,,,,,
C09884,Pinocarvone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09884  Pinocarvone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09884  Pinocarvone,
C09885,(+)-Piperitone;|d-Piperitone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09885  (+)-Piperitone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09885  (+)-Piperitone,
C09886,Magellanine,,,,,
C09887,Piquerol A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09887  Piquerol A,
C09888,Megastachine,,,,,
C09889,alpha-Obscurine,,,,,
C09890,beta-Obscurine,,,,,
C09891,Oxolucidine B;|Serratanine B,,,,,
C09892,Phlegmarine,,,,,
C09893,Pulegone;|(+)-Pulegone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09893  Pulegone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09893  (+)-Pulegone|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C09893  Pulegone,
C09894,Pyrethrin II,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C09894  Pyrethrin II|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Others|C09894  Pyrethrin II,
C09895,Sauroxine,,,,,
C09896,Rotundifolone;|Lippione,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09896  Rotundifolone,
C09897,Selagine,,,,,
C09898,alpha-Terpinene,See gamma-Terpinene [CPD:C09900],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09898  alpha-Terpinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09898  alpha-Terpinene,
C09899,Serratanidine,,,,,
C09900,gamma-Terpinene,See alpha-Terpinene [CPD:C09898],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09900  gamma-Terpinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09900  gamma-Terpinene,
C09901,Serratine,,,,,
C09902,(R)-(+)-alpha-Terpineol;|(+)-alpha-Terpineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09902  (R)-(+)-alpha-Terpineol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09902  (R)-(+)-alpha-Terpineol,
C09903,Spirolucidine,,,,,
C09904,beta-Thujaplicin;|Hinokitiol;|4-Isopropyltropolone,,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09904  beta-Thujaplicin|Classification of Japanese OTC drugs [BR:br08313(D04876)]|Agents for integumentary system|58 Ringworm drugs|D04876  Hinokitiol|60 Hair remedies (incl. hair growth, hair tonic, anti-dandruff, and antipruritic)|D04876  Hinokitiol|Agents for dental and stomatological use|75 Toothache and pyorrhea remedies|D04876  Hinokitiol|Risk category of Japanese OTC drugs [BR:br08312(D04876)]|Third-class OTC drugs|Inorganic and organic chemicals|Hinokitiol|D04876  Hinokitiol",
C09905,gamma-Thujaplicin;|5-Isopropyltropolone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09905  gamma-Thujaplicin,
C09906,Thujone;|(-)-3-Isothujone;|(-)-3-Thujanone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09906  Thujone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09906  Thujone,
C09907,Acanthicifoline,,,,,
C09908,Thymol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C09908  Thymol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09908  Thymol|Therapeutic category of drugs in Japan [BR:br08301(D01039)]|7  Agents not mainly for therapeutic purpose|73  Public health agents|731  Antiseptics|7319  Others|D01039  Thymol (JP18/NF)|Risk category of Japanese OTC drugs [BR:br08312(D01039)]|Third-class OTC drugs|Inorganic and organic chemicals|Thymol|D01039  Thymol (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01039)]|Chemicals|D01039  Thymol,
C09909,Thymyl acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09909  Thymyl acetate,
C09910,Actinidine;|(-)-Actinidine,,,,,
C09911,Umbellulone;|(-)-Umbellulone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C09911  Umbellulone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09911  Umbellulone,
C09912,Arenaine,,,,,
C09913,Verbenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C09913  Verbenone,
C09914,Bakankoside,,,,,
C09915,"Boschniakine;|(R)-6,7-Dihydro-7-methyl-5H-2-pyrindine-4-carbaldehyde",,,,,
C09916,Acrovestone,,,,,
C09917,Arnebinol,,,,,
C09918,"Aucuparin;|3,5-Dimethoxy-(1,1'-biphenyl)-4-ol",,,,,
C09919,Bergenin,,,,,
C09920,Brazilin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C09920  Brazilin,
C09921,3-Butylidene-7-hydroxyphthalide,,,,,
C09922,Cleomiscosin A,,,,,
C09923,Cyperine,,,,,
C09924,Daphneticin,,,,,
C09925,"5,6-Dehydrokawain",,,,"Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|alpha-Pyrones|C09925  5,6-Dehydrokawain",
C09926,Dihydromethysticin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|alpha-Pyrones|C09926  Dihydromethysticin,
C09927,Euglobal-Ia1,,,,,
C09928,Flossonol,,,,,
C09929,Garcinol,,,,,
C09930,Goniothalenol;|Altholactone,,,,,
C09931,Haematoxylin;|Natural Black 1;|C.I. 75290,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C09931  Haematoxylin,
C09932,Haemocorin,,,,,
C09933,Cantleyine,,,,,
C09934,Cassinine,,,,,
C09935,Catheduline E2,,,,,
C09936,Heritonin,,,,,
C09937,Celapanine,,,,,
C09938,(+)-8-Hydroxycalamenene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C09938  (+)-8-Hydroxycalamenene,
C09939,Strobopinin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09939  Strobopinin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C09939  Strobopinin,
C09940,Chaksine,,,,,
C09941,Hypercalin B,,,,,
C09942,Karwinaphthol B,,,,,
C09943,Dendrobine,,,,,
C09944,Karwinskione,,,,,
C09945,Deoxynupharidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C09945  Deoxynupharidine,
C09946,Enicoflavine;|3-(Aminomethylene)-alpha-ethenyltetrahydro-4-hydroxy-2-oxo-2H-pyran-4-acetaldehyde,,,,,
C09947,Kawain;|Kavain,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|alpha-Pyrones|C09947  Kawain,
C09948,Kolanone,,,,,
C09949,Fabianine,,,,,
C09950,Lapachenole,,,,,
C09951,Maclurin,,,,,
C09952,Methysticin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|alpha-Pyrones|C09952  Methysticin,
C09953,Monocerin,,,,,
C09954,"Nepodin;|Musizin;|1-(1,8-Dihydroxy-3-methylnaphthalen-2-yl)ethanone",,,,,
C09955,Ochratoxin A,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C09955  Ochratoxin A,
C09956,Ohioensin-A,,,,,
C09957,Gentianadine,,,,,
C09958,Orthosporin,,,,,
C09959,Paeoniflorin,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C09959  Paeoniflorin,
C09960,Gentianaine,,,,,
C09961,Gentianamine,,,,,
C09962,Gentioflavine,,,,,
C09963,Polygonolide,,,,,
C09964,Purpurogallin,,,,,
C09965,Rhododendrin,,,,,
C09966,Robustadial A,,,,,
C09967,Taxifolin 3-O-acetate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C09967  Taxifolin 3-O-acetate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C09967  Taxifolin 3-O-acetate,
C09968,Robustaol A,,,,,
C09969,Sarothralin,,,,,
C09970,Tephrowatsin A,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C09970  Tephrowatsin A|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 4-ols|C09970  Tephrowatsin A",
C09971,Stypandrol,,,,,
C09972,Theasinensin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C09972  Theasinensin A|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C09972  Theasinensin A,
C09973,Tremulacin,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C09973  Tremulacin,
C09974,"2,4,8-Trihydroxy-1-tetralone",,,,,
C09975,"2',4',6'-Trihydroxy-3'-formyldihydrochalcone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09975  2',4',6'-Trihydroxy-3'-formyldihydrochalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09975  2',4',6'-Trihydroxy-3'-formyldihydrochalcone",
C09976,Uncinatone,,,,,
C09977,Vismione D,,,,,
C09978,Uvaretin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C09978  Uvaretin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihydrochalcones|C09978  Uvaretin,
C09979,Xanthochymol,,,,,
C09980,Yangonin;|4-Methoxy-6-[2-(4-methoxyphenyl)ethenyl]-2H-pyran-2-one,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|alpha-Pyrones|C09980  Yangonin,
C09981,Zearalenone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C09981  Zearalenone|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C09981  Zearalenone,
C09982,Acerosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C09982  Acerosin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C09982  Acerosin,
C09983,Zinnolide,,,,,
C09984,N-(p-Hydroxyphenethyl)actinidine,,,,,
C09985,Jasminine,,,,,
C09986,Rhexifoline,,,,,
C09987,beta-Skytanthine,,,,,
C09988,Tecomine;|Tecomanine,,,,,
C09989,Tecostanine,,,,,
C09990,Thiobinupharidine,,,,,
C09991,Valerianine,,,,,
C09992,Wilfordine,,,,,
C09993,Adouetine X,,,,,
C09994,Adouetine Y,,,,,
C09995,Adouetine Z,,,,,
C09996,Americine,,,,,
C09997,Amphibine A,,,,,
C09998,Amphibine B,,,,,
C09999,Aralionine A,,,,,
C10000,Canthiumine,,,,,
C10001,Ceanothine B,,,,,
C10002,Crenatine A,,,,,
C10003,Frangulanine,,,,,
C10004,Hymenocardine,,,,,
C10005,Integerrenine,,,,,
C10006,Integerressine,,,,,
C10007,Integerrine,,,,,
C10008,Lasiodine A,,,,,
C10009,Mucronine A,,,,,
C10010,Mucronine B,,,,,
C10011,Nummularine F,,,,,
C10012,Pandamine,,,,,
C10013,Sativanine B,,,,,
C10014,Scutianine F,,,,,
C10015,Zizyphine A,,,,,
C10016,Zizyphine F,,,,,
C10017,"Agathisflavone;|6,8''-Biapigenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10017  Agathisflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10017  Agathisflavone,
C10018,"Amentoflavone;|3',8''-Biapigenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10018  Amentoflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10018  Amentoflavone,
C10019,"Apigenin 7,4'-dimethyl ether;|Apigenin dimethylether",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10019  Apigenin 7,4'-dimethyl ether|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10019  Apigenin 7,4'-dimethyl ether",
C10020,Apigenin 7-(6''-malonylglucoside);|Apigenin 7-O-(6-malonyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10020  Apigenin 7-(6''-malonylglucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10020  Apigenin 7-(6''-malonylglucoside)|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10020  Apigenin 7-(6''-malonylglucoside),
C10021,"Axillarin;|Quercetagetin 3,6-dimethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10021  Axillarin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10021  Axillarin,
C10022,Azaleatin;|Quercetin 5-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10022  Azaleatin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10022  Azaleatin,
C10023,"Baicalein;|5,6,7-Trihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10023  Baicalein|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10023  Baicalein|Dietary phytochemicals [br08012.html]|Flavonoids|C10023,
C10024,"Baicalein 5,6,7-trimethyl ether",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10024  Baicalein 5,6,7-trimethyl ether|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10024  Baicalein 5,6,7-trimethyl ether",
C10025,Baicalin;|Baicalein 7-O-glucuronide,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10025  Baicalin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10025  Baicalin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10025  Baicalin|Dietary phytochemicals [br08012.html]|Flavonoids|C10025,
C10026,Carlinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10026  Carlinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10026  Carlinoside|Glycosides [BR:br08021]|C-glycosides|C10026  Carlinoside,
C10027,Chlorflavonin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10027  Chlorflavonin,
C10028,"Chrysin;|5,7-Dihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10028  Chrysin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10028  Chrysin|Dietary phytochemicals [br08012.html]|Flavonoids|C10028,
C10029,"5,7-Dimethoxyflavone;|Chrysin 5,7-dimethyl ether",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10029  Chrysin 5,7-dimethyl ether|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10029  5,7-Dimethoxyflavone",
C10030,"Chrysosplenetin;|Chrysosplenetin B;|Quercetagetin 3,6,7,3'-tetramethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10030  Chrysosplenetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10030  Chrysosplenetin,
C10031,"Chrysosplenol C;|Quercetagetin 3,7,3'-trimethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10031  Chrysosplenol C|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10031  Chrysosplenol C,
C10032,Cirsilineol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10032  Cirsilineol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10032  Cirsilineol,
C10033,Cirsiliol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10033  Cirsiliol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10033  Cirsiliol,
C10034,"Cupressuflavone;|8,8''-Biapigenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10034  Cupressuflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10034  Cupressuflavone,
C10035,Dasytrichone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10035  Dasytrichone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10035  Dasytrichone,
C10036,"Datiscetin;|3,5,7,2'-Tetrahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10036  Datiscetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10036  Datiscetin,
C10037,"Resokaempherol;|5-Deoxykaempferol;|3,7,4'-Trihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10037  Resokaempherol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10037  Resokaempherol,
C10038,Diosmetin;|Luteolin 4'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10038  Diosmetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10038  Diosmetin,
C10039,Diosmetin 7-O-rutinoside;|Diosmin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10039  Diosmetin 7-O-rutinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10039  Diosmin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10039  Diosmin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07858)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05C CAPILLARY STABILIZING AGENTS|C05CA Bioflavonoids|C05CA03 Diosmin|D07858  Diosmin (INN),
C10040,Eupatilin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10040  Eupatilin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10040  Eupatilin,
C10041,"Fisetin;|7,3',4'-Trihydroxyflavonol",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10041  Fisetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10041  Fisetin,
C10042,Fisetin 8-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10042  Fisetin 8-C-glucoside|Glycosides [BR:br08021]|C-glycosides|C10042  Fisetin 8-C-glucoside,
C10043,Flavone;|2-Phenyl-4-benzopyron;|2-Phenyl-4-chromone,Flavone (generic) [CPD:C15608],,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10043  Flavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10043  Flavone,
C10044,"Galangin;|3,5,7-Trihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10044  Galangin,
C10045,"3,5,7-Trimethoxyflavone;|Galangin 3,5,7-trimethyl ether;|Chromen-4-one, 3,5,7-trimethoxy-2-phenyl-",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10045  Galangin 3,5,7-trimethyl ether|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10045  3,5,7-Trimethoxyflavone",
C10046,Genkwanin;|Apigenin 7-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10046  Genkwanin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10046  Genkwanin,
C10047,Geraldone;|5-Deoxychrysoeriol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10047  Geraldone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10047  Geraldone,
C10048,"Ginkgetin;|Amentoflavone 7,4'-dimethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10048  Ginkgetin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10048  Ginkgetin,
C10049,"Glepidotin A;|8-Prenylgalangin;|8-(3,3-DMA)galangin;|8-(3,3-Dimethylallyl)galangin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10049  Glepidotin A|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10049  Glepidotin A,
C10050,Gossypetin 8-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10050  Gossypetin 8-rhamnoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10050  Gossypetin 8-rhamnoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10050  Gossypetin 8-rhamnoside,
C10051,Gossypetin 8-O-glucoside;|Gossypin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10051  Gossypetin 8-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10051  Gossypin,
C10052,"Athyriol;|3-Methoxy-1,6,7-trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10052  Athyriol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10052  Athyriol",
C10053,"Bellidifolin;|3-Methoxy-1,5,8-trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10053  Bellidifolin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10053  Bellidifolin",
C10054,"Calophyllin B;|6-(3,3-Dimethylallyl)-1,5-dihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10054  Calophyllin B|C10054  Calophyllin B|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10054  Calophyllin B",
C10055,Dehydrocycloguanandin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10055  Dehydrocycloguanandin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10055  Dehydrocycloguanandin",
C10056,"Demethylbellidifolin;|1,3,5,8-Tetrahydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10056  Demethylbellidifolin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10056  Demethylbellidifolin",
C10057,Hinokiflavone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10057  Hinokiflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10057  Hinokiflavone,
C10058,Hispidulin;|Dinatin;|Scutellarein 6-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10058  Hispidulin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10058  Hispidulin,
C10059,6-Deoxyjacareubin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10059  6-Deoxyjacareubin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10059  6-Deoxyjacareubin",
C10060,"3,5-Dimethoxy-1,6-dihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10060  3,5-Dimethoxy-1,6-dihydroxyxanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10060  3,5-Dimethoxy-1,6-dihydroxyxanthone",
C10061,"Euxanthone;|1,7-Dihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10061  Euxanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10061  Euxanthone",
C10062,Gambogic acid,,,,,
C10063,"Gartanin;|1,3,5,8-Tetrahydroxy-2,4-diprenylxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10063  Gartanin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10063  Gartanin",
C10064,"Gentiacaulein;|2,8-Dihydroxy-1,6-dimethoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10064  Gentiacaulein|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10064  Gentiacaulein",
C10065,"Gentisein;|1,3,7-Trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10065  Gentisein|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10065  Gentisein",
C10066,"Gentisin;|1,7-Dihydroxy-3-methoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10066  Gentisin",
C10067,Irisxanthone,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10067  Irisxanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10067  Irisxanthone|Glycosides [BR:br08021]|C-glycosides|C10067  Irisxanthone",
C10068,6-Hydroxykaempferol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10068  6-Hydroxykaempferol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10068  6-Hydroxykaempferol,
C10069,"Isoathyriol;|6-Methoxy-1,3,7-trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10069  Isoathyriol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10069  Isoathyriol",
C10070,"Isogentisin;|1,3-Dihydroxy-7-methoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10070  Isogentisin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10070  Isogentisin",
C10071,1-Isomangostin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10071  1-Isomangostin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10071  1-Isomangostin",
C10072,"6-Hydroxyluteolin;|5,6,7,3',4'-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10072  6-Hydroxyluteolin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10072  6-Hydroxyluteolin,
C10073,Hyperin;|Quercetin 3-galactoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10073  Hyperin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10073  Hyperin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10073  Hyperin|Dietary phytochemicals [br08012.html]|Flavonoids|C10073,
C10074,Jacareubin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10074  Jacareubin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10074  Jacareubin",
C10075,"Lancerin;|4-C-Glucosyl-1,3,7-trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10075  Lancerin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10075  Lancerin|Glycosides [BR:br08021]|C-glycosides|C10075  Lancerin",
C10076,Macluraxanthone;|3-Hydroxyblancoxanthone,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10076  Macluraxanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10076  Macluraxanthone",
C10077,Mangiferin;|Chinomin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10077  Mangiferin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10077  Mangiferin|Glycosides [BR:br08021]|C-glycosides|C10077  Mangiferin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10077",
C10078,Hypolaetin;|8-Hydroxyluteolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10078  Hypolaetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10078  Hypolaetin,
C10079,"Isoetin;|5,7,2',4',5'-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10079  Isoetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10079  Isoetin,
C10080,Mangostin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10080  Mangostin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10080  Mangostin",
C10081,"Mesuaxanthone A;|1,5-Dihydroxy-3-methoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10081  Mesuaxanthone A|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10081  Mesuaxanthone A",
C10082,"Mesuaxanthone B;|1,5,6-Trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10082  Mesuaxanthone B|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10082  Mesuaxanthone B",
C10083,"2-O-Methylswertianin;|1,8-Dihydroxy-2,6-dimethoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10083  2-O-Methylswertianin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10083  2-O-Methylswertianin",
C10084,Isorhamnetin;|3-Methylquercetin;|Quercetin 3'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10084  Isorhamnetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10084  Isorhamnetin|Dietary phytochemicals [br08012.html]|Flavonoids|C10084,
C10085,Morellin,,,,,
C10086,"Norathyriol;|1,3,6,7-Tetrahydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10086  Norathyriol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10086  Norathyriol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10086",
C10087,"Norlichexanthone;|1,3,6-Trihydroxy-8-methyl-9H-xanthen-9-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10087  Norlichexanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10087  Norlichexanthone",
C10088,"Norswertianin;|1,2,6,8-Tetrahydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10088  Norswertianin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10088  Norswertianin",
C10089,Norswertianolin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10089  Norswertianolin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10089  Norswertianolin",
C10090,Psorospermin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10090  Psorospermin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10090  Psorospermin",
C10091,"Swerchirin;|5-O-Methylbellidifolin;|3,5-Dimethoxy-1,8-dihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10091  Swerchirin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10091  Swerchirin",
C10092,"Swertianin;|1,2,8-Trihydroxy-6-methoxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10092  Swertianin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10092  Swertianin",
C10093,Swertianolin;|Bellidifolin-8-O-glucoside,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10093  Swertianolin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10093  Swertianolin",
C10094,"1,3,5-Trihydroxyxanthone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10094  1,3,5-Trihydroxyxanthone|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10094  1,3,5-Trihydroxyxanthone",
C10095,Tripteroside;|Norathyriol-6-O-beta-D-glucoside,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10095  Tripteroside|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Xanthenes|C10095  Tripteroside",
C10097,Isoscutellarein;|8-Hydroxyapigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10097  Isoscutellarein|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10097  Isoscutellarein,
C10098,Kaempferide;|Kempferide;|Kaempferol 4'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10098  Kaempferide|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10098  Kaempferide,
C10099,Kuwanone G,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Diels-Alder adduct of chalcone|C10099  Kuwanone G,
C10100,Kuwanone H,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Diels-Alder adduct of chalcone|C10100  Kuwanone H,
C10101,(-)-Usnic acid;|(S)-Usnic acid;|(S)-Usnate,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C10101  (-)-Usnic acid",
C10102,"Lucenin-2;|Luteolin 6,8-di-C-glucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10102  Lucenin-2|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10102  Lucenin-2|Glycosides [BR:br08021]|C-glycosides|C10102  Lucenin-2|Dietary phytochemicals [br08012.html]|Flavonoids|C10102,
C10103,Luteolin 7-O-(6''-malonylglucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10103  Luteolin 7-O-(6''-malonylglucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10103  Luteolin 7-O-(6''-malonylglucoside)|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10103  Luteolin 7-O-(6''-malonylglucoside),
C10104,6-Methoxyluteolin 7-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10104  6-Methoxyluteolin 7-rhamnoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10104  6-Methoxyluteolin 7-rhamnoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10104  6-Methoxyluteolin 7-rhamnoside,
C10105,"Morin;|3,5,7,2',4'-Pentahydroxyflavone;|C.I.Natural Yellow 8",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10105  Morin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10105  Morin,
C10106,Morusin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10106  Morusin|Classification of Japanese OTC drugs [BR:br08313]|Agents for digestive organs|13 Digestives|C10106  Morusin|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Morusin|C10106  Morusin,
C10107,"Myricetin;|3,5,7,3',4',5'-Hexahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10107  Myricetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10107  Myricetin|Dietary phytochemicals [br08012.html]|Flavonoids|C10107,
C10108,Myricitrin;|Myricetin 3-O-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10108  Myricitrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10108  Myricitrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10108  Myricitrin|Dietary phytochemicals [br08012.html]|Flavonoids|C10108,
C10109,Neocarlinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10109  Neocarlinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10109  Neocarlinoside|Glycosides [BR:br08021]|C-glycosides|C10109  Neocarlinoside,
C10110,Neoschaftoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10110  Neoschaftoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10110  Neoschaftoside|Glycosides [BR:br08021]|C-glycosides|C10110  Neoschaftoside,
C10111,Nevadensin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10111  Nevadensin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10111  Nevadensin,
C10112,"Nobiletin;|Hexamethoxyflavone;|5,6,7,8,3',4'-Hexamethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10112  Nobiletin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10112  Nobiletin,
C10113,"Norwogonin;|5,7,8-Trihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10113  Norwogonin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10113  Norwogonin,
C10114,Orientin;|Luteolin 8-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10114  Orientin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10114  Orientin|Glycosides [BR:br08021]|C-glycosides|C10114  Orientin|Dietary phytochemicals [br08012.html]|Flavonoids|C10114,
C10115,Oxyanin A;|Oxyayanin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10115  Oxyayanin A|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10115  Oxyanin A,
C10116,Oxyanin B;|Oxyayanin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10116  Oxyayanin B|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10116  Oxyanin B,
C10117,"Pachypodol;|Quercetin 3,7,3'-trimethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10117  Pachypodol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10117  Pachypodol,
C10118,Patuletin;|Quercetagetin 6-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10118  Patuletin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10118  Patuletin,
C10119,"Pedalitin;|3',4',5,6-Tetrahydroxy-7-methoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10119  Pedalitin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10119  Pedalitin,
C10120,Pinoquercetin;|6-C-Methylquercetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10120  Pinoquercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10120  Pinoquercetin,
C10121,"Primetin;|5,8-Dihydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10121  Primetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10121  Primetin,
C10122,Quercetagetin;|6-Hydroxyquercetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10122  Quercetagetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10122  Quercetagetin,
C10123,Adenocarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10123  Adenocarpine,
C10124,Alexine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10124  Alexine,
C10125,Ammodendrine;|Spherocarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10125  Ammodendrine,
C10126,Anatabine;|(-)-Anatabine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10126  Anatabine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10126,
C10127,Anibine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10127  Anibine,
C10128,Arecaidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10128  Arecaidine,
C10129,Arecoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10129  Arecoline,
C10130,Astrocasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10130  Astrocasine,
C10131,Astrophylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10131  Astrophylline,
C10132,Australine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10132  Australine,
C10133,Brunfelsamidine,,,,,
C10134,Buchananine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10134  Buchananine,
C10135,Carpaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10135  Carpaine,
C10136,Cassine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10136  Cassine,
C10137,Codonopsine,,,,,
C10138,gamma-Coniceine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C10138  gamma-Coniceine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Piperidine alkaloids|C10138  gamma-Coniceine,
C10139,Cryptophorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10139  Cryptophorine,
C10140,Cucurbitine,,,,,
C10141,Deoxymannojirimycin;|DMJ,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10141  Deoxymannojirimycin,
C10142,Dioscorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10142  Dioscorine,
C10143,"DMDP;|2,5-Dihydroxymethyl-3,4-dihydroxypyrrolidine",,,,,
C10144,Fagomine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10144  Fagomine,
C10145,Funebrine,,,,,
C10146,Fusaric acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10146  Fusaric acid,
C10147,Gerrardine,,,,,
C10148,Girgensonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10148  Girgensonine,
C10149,Guvacine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10149  Guvacine,
C10150,Harzianopyridone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10150  Harzianopyridone,
C10151,3-Hydroxystachydrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C10151  3-Hydroxystachydrine,
C10152,(-)-Hygroline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C10152  (-)-Hygroline,
C10153,Isolobinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10153  Isolobinine,
C10154,Juliflorine,,,,,
C10155,Lentiginosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C10155  Lentiginosine,
C10156,Lobelanidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10156  Lobelanidine,
C10157,Lobelanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10157  Lobelanine,
C10158,Mearsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10158  Mearsine,
C10159,Methylconiine;|(+)-N-Methylconiine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C10159  Methylconiine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Piperidine alkaloids|C10159  Methylconiine,
C10160,Myosmine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10160  Myosmine,
C10161,Nicotyrine;|beta-Nicotyrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C10161  Nicotyrine,
C10162,Nigrifactin,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10162  Nigrifactin,
C10163,Nitramine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10163  Nitramine,
C10164,Picolinic acid;|2-Pyridinecarboxylic acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10164  Picolinic acid,
C10165,"Pinidine;|Piperidine, 2-methyl-6-(1-propenyl)-, (2R-(2alpha,6alpha(E)))-;|(-)-Pinidine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C10165  Pinidine,
C10166,Piplartine;|Piperlongumine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10166  Piplartine,
C10167,(+)-Prosopinine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C10167  (+)-Prosopinine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10167  (+)-Prosopinine,
C10168,Pseudoconhydrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10168  Pseudoconhydrine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Piperidine alkaloids|C10168  Pseudoconhydrine,
C10169,Ruspolinone,,,,,
C10170,Santiaguine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10170  Santiaguine,
C10171,(-)-Sedamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10171  (-)-Sedamine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10171,
C10172,Stachydrine;|Proline betaine;|L-Proline betaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C10172  Stachydrine,
C10173,Swainsonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C10173  Swainsonine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10173,
C10174,Piperyline;|Trichostachine,,,,,
C10175,Quercetin 3-(2G-xylosylrutinoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10175  Quercetin 3-(2G-xylosylrutinoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10175  Quercetin 3-(2G-xylosylrutinoside)|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10175  Quercetin 3-(2G-xylosylrutinoside),
C10176,Rhamnetin;|Quercetin 7-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10176  Rhamnetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10176  Rhamnetin,
C10177,Robinetin;|5-Deoxymyricetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10177  Robinetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10177  Robinetin,
C10178,Robinin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10178  Robinin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10178  Robinin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C10178  Robinin|Dietary phytochemicals [br08012.html]|Flavonoids|C10178,
C10179,"Robustaflavone;|3',6''-Biapigenin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10179  Robustaflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10179  Robustaflavone,
C10180,Santin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10180  Santin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10180  Santin,
C10181,Schaftoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10181  Schaftoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10181  Schaftoside|Glycosides [BR:br08021]|C-glycosides|C10181  Schaftoside,
C10182,Sciadopitysin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1204 Biflavonoids and polyflavonoids|C10182  Sciadopitysin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10182  Sciadopitysin,
C10183,Scullcapflavone II,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10183  Scullcapflavone II|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10183  Scullcapflavone II,
C10184,Scutellarein;|Isocarthamidin;|6-Hydroxyapigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10184  Scutellarein|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10184  Scutellarein,
C10185,Sexangularetin;|Herbacetin 8-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10185  Sexangularetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10185  Sexangularetin,
C10186,"Sinensetin;|5,6,7,3',4'-Pentamethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10186  Sinensetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10186  Sinensetin,
C10187,Swertiajaponin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10187  Swertiajaponin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10187  Swertiajaponin|Glycosides [BR:br08021]|C-glycosides|C10187  Swertiajaponin,
C10188,Tamarixetin;|Quercetin 4'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10188  Tamarixetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10188  Tamarixetin,
C10189,"Tambulin;|Herbacetin 7,8,4'-trimethyl ether",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10189  Tambulin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10189  Tambulin,
C10190,"Tangeretin;|5,6,7,8,4'-Pentamethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10190  Tangeretin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10190  Tangeretin,
C10191,Thymonin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10191  Thymonin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10191  Thymonin,
C10192,"Tricetin;|5,7,3',4',5'-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10192  Tricetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10192  Tricetin,
C10193,"Tricin;|Tricetin 3',5'-di-methyl ether;|3',5'-O-Dimethyltricetin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10193  Tricin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10193  Tricin,
C10194,Velloquercetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10194  Velloquercetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10194  Velloquercetin,
C10195,"Vicenin-2;|Apigenin-6,8-di-C-glycoside;|5,7,4'-Trihydroxyflavone-6,8-di-C-glucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10195  Vicenin-2|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10195  Vicenin-2|Glycosides [BR:br08021]|C-glycosides|C10195  Vicenin-2|Dietary phytochemicals [br08012.html]|Flavonoids|C10195,
C10196,Violanthin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10196  Violanthin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10196  Violanthin|Glycosides [BR:br08021]|C-glycosides|C10196  Violanthin,
C10197,Wogonin;|Norwogonin 8-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10197  Wogonin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10197  Wogonin,
C10198,(-)-Acanthocarpan,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10198  (-)-Acanthocarpan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10198  (-)-Acanthocarpan,
C10199,Afrormosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10199  Afrormosin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10199  Afrormosin,
C10200,"Anhydroglycinol;|3,9-Dihydroxypterocarpen",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10200  Anhydroglycinol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10200  Anhydroglycinol,
C10201,Betavulgarin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10201  Betavulgarin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10201  Betavulgarin,
C10202,Bowdichione,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10202  Bowdichione|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10202  Bowdichione,
C10203,Cajanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10203  Cajanin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10203  Cajanin,
C10204,Cajanol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10204  Cajanol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10204  Cajanol,
C10205,Coumestrol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1209 Coumestan flavonoids|C10205  Coumestrol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Coumestanes|C10205  Coumestrol,
C10206,Cristacarpin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10206  Cristacarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10206  Cristacarpin,
C10207,Cyclokievitone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10207  Cyclokievitone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10207  Cyclokievitone,
C10208,Daidzein,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10208  Daidzein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10208  Daidzein|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10208|Dietary phytochemicals [br08012.html]|Flavonoids|C10208,
C10209,Afzelechin-(4alpha->8)-afzelechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10209  Afzelechin-(4alpha->8)-afzelechin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10209  Afzelechin-(4alpha->8)-afzelechin,
C10210,Agrimoniin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10210  Agrimoniin,
C10211,Alnusiin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10211  Alnusiin,
C10212,Casuarictin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10212  Casuarictin,
C10213,Casuarinin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10213  Casuarinin,
C10214,Chebulagic acid,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10214  Chebulagic acid,
C10215,Chebulinic acid,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10215  Chebulinic acid,
C10216,Daidzin;|Daidzein 7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10216  Daidzin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10216  Daidzin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C10216  Daidzin|Dietary phytochemicals [br08012.html]|Flavonoids|C10216,
C10217,Cinchonain 1a,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C10217  Cinchonain 1a",
C10218,Coriariin A,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10218  Coriariin A,
C10219,Corilagin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10219  Corilagin,
C10220,"3,5-Di-O-galloyl-4-O-digalloylquinic acid",,,,"Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10220  3,5-Di-O-galloyl-4-O-digalloylquinic acid",
C10221,Epicatechin-(4beta->8)-ent-epicatechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10221  Epicatechin-(4beta->8)-ent-epicatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10221  Epicatechin-(4beta->8)-ent-epicatechin,
C10222,Cinnamtannin A4;|[Epicatechin-(4beta->8)]5-epicatechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10222  [Epicatechin-(4beta->8)]5-epicatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10222  Cinnamtannin A4,
C10223,Epigallocatechin-(4beta->8)-epicatechin-3-O-gallate ester,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10223  Epigallocatechin-(4beta->8)-epicatechin-3-O-gallate ester|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10223  Epigallocatechin-(4beta->8)-epicatechin-3-O-gallate ester,
C10224,Eugeniin;|Tellimagrandin II,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10224  Eugeniin,
C10225,ent-Fisetinidol-(4beta->8)-catechin-(6->4beta)-ent-fisetinidol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10225  ent-Fisetinidol-(4beta->8)-catechin-(6->4beta)-ent-fisetinidol|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10225  ent-Fisetinidol-(4beta->8)-catechin-(6->4beta)-ent-fisetinidol,
C10226,Fucofuroeckol B,,,,,
C10227,Gallocatechin-(4alpha->8)-epigallocatechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10227  Gallocatechin-(4alpha->8)-epigallocatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10227  Gallocatechin-(4alpha->8)-epigallocatechin,
C10228,Gambiriin C;|Epiafzelechin-(4beta->8)-catechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10228  Gambiriin C|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10228  Gambiriin C,
C10229,Gemin A,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10229  Gemin A,
C10230,Geraniin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10230  Geraniin,
C10231,Guibourtinidol-(4alpha->6)-catechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10231  Guibourtinidol-(4alpha->6)-catechin|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10231  Guibourtinidol-(4alpha->6)-catechin,
C10232,Isoterchebin;|Trapain,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10232  Isoterchebin,
C10233,Kandelin A-1;|Cinchonain-1a-(4beta->8)-catechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10233  Kandelin A-1|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10233  Kandelin A-1,
C10234,"Mahuannin D;|ent-Apigeniflavan-(2alpha->7,4alpha->8)-epiafzelechin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10234  Mahuannin D|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10234  Mahuannin D,
C10235,Mallotusinic acid,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10235  Mallotusinic acid,
C10236,Pedunculagin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10236  Pedunculagin,
C10237,"Proanthocyanidin A2;|Epicatechin-(2beta->7,4beta->8)-epicatechin",,,,Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10237  Proanthocyanidin A2,
C10238,Procyanidin B4;|Catechin-(4alpha->8)-epicatechin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10238  Procyanidin B4|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10238  Procyanidin B4,
C10239,Robinetinidol-(4alpha->8)-catechin-(6->4alpha)-robinetinidol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C10239  Robinetinidol-(4alpha->8)-catechin-(6->4alpha)-robinetinidol|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Proanthocyanidins|C10239  Robinetinidol-(4alpha->8)-catechin-(6->4alpha)-robinetinidol,
C10240,Rugosin D,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10240  Rugosin D,
C10241,Tellimagrandin I;|1-Desgalloyleugeniin,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10241  Tellimagrandin I,
C10242,Terminalin;|Gallagic acid,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Miscellaneous galloyl derivatives|C10242  Terminalin,
C10243,"1,2,3,4-Tetragalloyl-alpha-D-glucose",,,,"Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10243  1,2,3,4-Tetragalloyl-alpha-D-glucose",
C10244,Agrostophyllin,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Phenanthrenes|C10244  Agrostophyllin,
C10245,Astringin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10245  Astringin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10245  Astringin",
C10246,"Batatasin I;|2,5,7-Trimethoxyphenanthren-3-ol",,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Phenanthrenes|C10246  Batatasin I,
C10247,Batatasin IV;|3-[2-(2-Hydroxyphenyl)ethyl]-5-methoxyphenol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10247  Batatasin IV|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10247  Batatasin IV",
C10248,Blestriarene B,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10248  Blestriarene B",
C10249,Canaliculatol,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10249  Canaliculatol",
C10250,Chlorophorin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10250  Chlorophorin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10250  Chlorophorin",
C10251,Coelogin,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Dihydrophenanthrenes|C10251  Coelogin,
C10252,Copalliferol B,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10252  Copalliferol B",
C10253,Demethylbatatasin IV,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10253  Demethylbatatasin IV|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10253  Demethylbatatasin IV",
C10254,Dihydropinosylvin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10254  Dihydropinosylvin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10254  Dihydropinosylvin",
C10255,Dihydroresveratrol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10255  Dihydroresveratrol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10255  Dihydroresveratrol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10255",
C10256,"4,4'-Dihydroxy-3,5-dimethoxydihydrostilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10256  4,4'-Dihydroxy-3,5-dimethoxydihydrostilbene|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10256  4,4'-Dihydroxy-3,5-dimethoxydihydrostilbene",
C10257,"4,7-Dihydroxy-2-methoxy-9,10-dihydrophenanthrene",,,,,
C10258,"Flavidin;|9,10-Dihydro-5H-phenanthro[4,5-bcd]pyran-2,7-diol",,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Dihydrophenanthrenes|C10258  Flavidin,
C10259,Glepidotin C,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10259  Glepidotin C|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10259  Glepidotin C",
C10260,Gnetin A,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10260  Gnetin A",
C10261,Hircinol,,,,,
C10262,Hydrangenol,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Miscellaneous stilbenoids|C10262  Hydrangenol,
C10263,"Amabiline;|Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1H-pyrrolidizin-7-yl)methyl ester",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10263  Amabiline,
C10264,3-Hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10264  3-Hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10264  3-Hydroxy-5-methoxy-6-prenylstilbene-2-carboxylic acid",
C10265,Isobatatasin I,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Phenanthrenes|C10265  Isobatatasin I,
C10266,Isorhapontin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10266  Isorhapontin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10266  Isorhapontin",
C10267,Loroglossol,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Dihydrophenanthrenes|C10267  Loroglossol,
C10268,Lunularic acid,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10268  Lunularic acid|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10268  Lunularic acid",
C10269,"Lunularin;|3,4'-Ethylenebisphenol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10269  Lunularin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10269  Lunularin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10269",
C10270,Marchantin A,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10270  Marchantin A",
C10271,3'-O-Methylbatatasin III,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10271  3'-O-Methylbatatasin III|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10271  3'-O-Methylbatatasin III",
C10272,"Orchinol;|9,10-Dihydro-5,7-dimethoxyphenanthren-2-ol",,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Dihydrophenanthrenes|C10272  Orchinol,
C10273,Oxyresveratrol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10273  Oxyresveratrol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10273  Oxyresveratrol",
C10274,Phyllodulcin,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Miscellaneous stilbenoids|C10274  Phyllodulcin,
C10275,"Piceid;|Polydatin;|3,4,5-Trihydroxystilbene-3-beta-monoglucoside;|Resveratrol 3-O-beta-glucopyranoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10275  Piceid|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10275  Piceid|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10275",
C10276,Pinosylvin methyl ether;|5-Methoxy-3-stilbenol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10276  Pinosylvin methyl ether|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10276  Pinosylvin methyl ether",
C10277,Anacrotine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10277  Anacrotine,
C10278,O-7-Angelylheliotridine;|Rivularine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10278  O-7-Angelylheliotridine,
C10279,Angularine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10279  Angularine,
C10280,Auriculine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10280  Auriculine,
C10281,4-Prenyldihydropinosylvin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10281  4-Prenyldihydropinosylvin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Bibenzyls|C10281  4-Prenyldihydropinosylvin",
C10282,Clivoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10282  Clivoline,
C10283,4'-Prenyloxyresveratrol,,,,,
C10284,Crotanecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10284  Crotanecine,
C10285,4-Prenylresveratrol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10285  4-Prenylresveratrol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10285  4-Prenylresveratrol",
C10286,"Doronine;|4,8-Secosenecionan-8,11,16-trione, 15,20-dihydro-12-(acetyloxy)-20-chloro-15-hydroxy-4-methyl-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10286  Doronine,
C10287,Pterostilbene,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10287  Pterostilbene|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10287  Pterostilbene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10287",
C10288,Rhaponticin;|Rhapontin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C10288  Rhaponticin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenes|C10288  Rhaponticin",
C10289,epsilon-Viniferin,,,,"Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Stilbenoids|Stilbenoid dimers, stilbenoid oligomers and bis(bibenzyl)s|C10289  epsilon-Viniferin",
C10290,Acamelin,,,,,
C10291,Alizarin 2-methyl ether;|1-Hydroxy-2-methoxyanthraquinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10291  Alizarin 2-methyl ether|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10291  Alizarin 2-methyl ether,
C10292,Alkannin,,,,,
C10293,"Alkannin beta,beta-dimethylacrylate",,,,,
C10294,Aloe-emodin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10294  Aloe-emodin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10294  Aloe-emodin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10294,
C10295,Alteichin;|Alterperylenol,,,,,
C10296,Altersolanol A,,,,,
C10297,Anthragallol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10297  Anthragallol|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10297  Anthragallol,
C10298,Ardisianone,,,,,
C10299,Echimidine;|7-Angelyl-9-echimidinylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10299  Echimidine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Pyrrolizidine alkaloids|C10299  Echimidine,
C10300,Aristolindiquinone,,,,,
C10301,Europine;|9-Lasiocarpylheliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10301  Europine,
C10302,Arnebinone,,,,,
C10303,Aurantio-obtusin beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10303  Aurantio-obtusin beta-D-glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10303  Aurantio-obtusin beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10303  Aurantio-obtusin beta-D-glucoside,
C10304,Fulvine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10304  Fulvine,
C10305,Barbaloin;|Aloin;|Aloin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10305  Barbaloin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C10305  Barbaloin|Glycosides [BR:br08021]|C-glycosides|C10305  Barbaloin|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Aloin|C10305  Barbaloin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10305,
C10306,Bikaverin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Naphthopyrones|C10306  Bikaverin,
C10307,Cascaroside A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10307  Cascaroside A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C10307  Cascaroside A,
C10308,Cassiamin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10308  Cassiamin C|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10308  Cassiamin C,
C10309,Cercosporin,,,,,
C10310,Chimaphylin;|Chimaphilin,,,,,
C10311,7-Chloroemodin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10311  7-Chloroemodin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10311  7-Chloroemodin,
C10312,"Danthron;|Chrysazin;|1,8-Dihydroxyanthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10312  Danthron|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10312  Danthron|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07107)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AB Contact laxatives|A06AB03 Dantron|D07107  Dantron (INN)|Drug groups [BR:br08330(D07107)]|Gastrointestinal agent|DG01770  Laxative|D07107  Dantron,
C10313,Chryso-obtusin glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10313  Chryso-obtusin glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10313  Chryso-obtusin glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10313  Chryso-obtusin glucoside,
C10314,Chrysophanic acid 9-anthrone;|Chrysophanol anthrone;|Chrysarobin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10314  Chrysophanic acid 9-anthrone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C10314  Chrysarobin,
C10315,"Chrysophanol;|Chrysophanic acid;|1,8-Dihydroxy-3-methylanthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10315  Chrysophanol|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10315  Chrysophanol,
C10316,Chrysophanol 8-O-beta-D-glucoside;|Chrysophanol 8-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10316  Chrysophanol 8-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10316  Chrysophanol 8-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10316  Chrysophanol 8-O-beta-D-glucoside,
C10317,Coleone A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010406 Cycloaibetiane and Abeoabietaine diterpenoids|C10317  Coleone A,
C10318,Conocurvone,,,,,
C10319,Heliosupine;|7-Angelyl-9-echimidinylheliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10319  Heliosupine,
C10320,Cornudentanone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C10320  Cornudentanone,
C10321,Heliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10321  Heliotridine,
C10322,"Cyperaquinone;|3-Methyl-6-prop-1-en-2-ylfuro[3,2-f][1]benzofuran-4,8-dione",,,,,
C10323,Cypripedin,,,,,
C10324,Heliotrine;|9-Heliotrylheliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10324  Heliotrine,
C10325,Deoxylapachol,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C10325  Deoxylapachol,
C10326,Indicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10326  Indicine,
C10327,Digiferrugineol;|1-Hydroxy-2-hydroxymethylanthraquinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10327  Digiferrugineol|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10327  Digiferrugineol,
C10328,Integerrimine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10328  Integerrimine,
C10329,"1,4-Dihydroxy-2-methylanthraquinone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10329  1,4-Dihydroxy-2-methylanthraquinone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10329  1,4-Dihydroxy-2-methylanthraquinone",
C10330,Intermedine;|9-(+)-Trachelanthylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10330  Intermedine,
C10331,"2,6-Dimethoxybenzoquinone;|2,6-Dimetoxy-p-benzoquinone",,,,,
C10332,Diospyrin,,,,,
C10333,Isatidine;|Retrorsine N-oxide,,,,,
C10334,Dothistromin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10334  Dothistromin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10334  Dothistromin,
C10335,Droserone,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C10335  Droserone,
C10336,Isolycopsamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10336  Isolycopsamine,
C10337,Dunnione,,,,,
C10338,"Echinone;|6-((1S)-1-(Acetyloxy)-4-methyl-3-pentenyl)-8-hydroxy-5-methoxy-1,4-naphthalenedione",,,,,
C10339,Jacobine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10339  Jacobine,
C10340,Eleutherin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C10340  Eleutherin,
C10341,Lasiocarpine;|7-Angelyl-9-lasiocarpylheliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10341  Lasiocarpine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Pyrrolizidine alkaloids|C10341  Lasiocarpine,
C10342,Embelin,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1505 Alkyl hydroquinones and derivatives|C10342  Embelin,
C10343,Emodin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10343  Emodin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10343  Emodin,
C10344,Latifoline;|(+)-Latifoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10344  Latifoline,
C10345,"Emodin 8-glucoside;|1-beta-D-Glucopyranosyloxy-3-methyl-6-hydroxy-8-hydroxy-9,10-anthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10345  Emodin 8-glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10345  Emodin 8-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10345  Emodin 8-glucoside,
C10346,Frangulin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10346  Frangulin A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10346  Frangulin A|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10346  Frangulin A,
C10347,Lycopsamine;|9-Viridiflorylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10347  Lycopsamine,
C10348,Macrophylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10348  Macrophylline,
C10349,Frangulin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10349  Frangulin B|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10349  Frangulin B|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10349  Frangulin B,
C10350,Monocrotaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10350  Monocrotaline,
C10351,Geranylbenzoquinone,,,,,
C10352,Hibiscoquinone A,,,,,
C10353,"Nemorensine;|C(16a)-Homo-21-norsenecionan-11,16a-dione, 12,15-epoxy-1,2,15,20-tetrahydro-, (1alpha,12R,15R)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10353  Nemorensine,
C10354,2-Hydroxymethylanthraquinone;|Anthraquinone-2-methanol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10354  2-Hydroxymethylanthraquinone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10354  2-Hydroxymethylanthraquinone,
C10355,Hypoxylone,,,,,
C10356,"Otonecine;|(1R,4beta,7abeta)-2,3,5,7a-Tetrahydro-1,7a-dihydroxy-7-(hydroxymethyl)-4-methyl-1H-pyrrolizin-4-ium",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10356  Otonecine,
C10357,Parsonsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10357  Parsonsine,
C10358,Isodiospyrin,,,,,
C10359,Petasitenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10359  Petasitenine,
C10360,2-Isoprenylemodin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10360  2-Isoprenylemodin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10360  2-Isoprenylemodin,
C10361,Phalaenopsine T,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10361  Phalaenopsine T,
C10362,Kigelinone,,,,,
C10363,Platyphylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10363  Platyphylline,
C10364,Retrorsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10364  Retrorsine,
C10365,Knipholone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10365  Knipholone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10365  Knipholone,
C10366,Lapachol,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C10366  Lapachol,
C10367,beta-Lapachone,,,,,
C10368,Lawsone,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C10368  Lawsone,
C10369,Lucidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10369  Lucidin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10369  Lucidin,
C10370,"Lucidin omega-methyl ether;|2-(Methoxymethyl)-1,3-dihydroxyanthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10370  Lucidin omega-methyl ether|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10370  Lucidin omega-methyl ether,
C10371,"Mansonone C;|3,8-Dimethyl-5-isopropyl-1,2-naphthalenedione",,,,,
C10372,9-Methoxy-alpha-lapachone,,,,,
C10373,5-O-Methylembelin,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1505 Alkyl hydroquinones and derivatives|C10373  5-O-Methylembelin,
C10374,"Morindaparvin A;|1,2-Methylenedioxyanthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10374  Morindaparvin A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10374  Morindaparvin A,
C10375,Riddelline;|18-Hydroxyseneciphylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10375  Riddelline,
C10376,"Morindone;|1,2,5-Trihydroxy-6-methyl-9,10-anthracenedione",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10376  Morindone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10376  Morindone,
C10377,"Nanaomycin A;|Nanafrocin;|(1S,3R)-Nanaomycin A",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C10377  Nanaomycin A,
C10378,Rinderine;|9-(+)-Trachelanthylheliotridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10378  Rinderine,
C10379,Norobtusifolin;|2-Hydroxychrysophanol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10379  2-Hydroxychrysophanol|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10379  Norobtusifolin,
C10380,"Rosmarinine;|Senecionan-11,16-dione, 1,2-dihydro-2,12-dihydroxy-, (1alpha,2alpha)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10380  Rosmarinine,
C10381,Obtusifolin 2-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10381  Obtusifolin 2-glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10381  Obtusifolin 2-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10381  Obtusifolin 2-glucoside,
C10382,Physcion 8-gentiobioside;|Physcion diglucoside;|Physcion 8-O-beta-D-gentiobioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10382  Physcion 8-gentiobioside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10382  Physcion 8-gentiobioside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10382  Physcion 8-gentiobioside,
C10383,Sarracine;|7-Angelyl-9-sarracinylplatynecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10383  Sarracine,
C10384,Physcion 8-glucoside;|Physcion 8-O-beta-D-monoglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10384  Physcion 8-glucoside|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10384  Physcion 8-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10384  Physcion 8-glucoside,
C10385,Plastoquinone-9;|Plastoquinone A,,,,,
C10386,Senaetnine,,,,,
C10387,Plumbagin,,,,,
C10388,Senampeline A,,,,,
C10389,Prenylbenzoquinone,,,,,
C10390,Primin,,,,,
C10391,Seneciphylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10391  Seneciphylline,
C10392,Pseudohypericin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10392  Pseudohypericin,
C10393,"Senecivernine;|21-Norsenecionan-11,16-dione, 12-hydroxy-14-methyl-, (12zeta,13zeta)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10393  Senecivernine,
C10394,Pseudopurpurin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10394  Pseudopurpurin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10394  Pseudopurpurin,
C10395,Purpurin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10395  Purpurin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10395  Purpurin,
C10396,Senkirkine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10396  Senkirkine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Pyrrolizidine alkaloids|C10396  Senkirkine,
C10397,Purpurin 1-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10397  Purpurin 1-methyl ether|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10397  Purpurin 1-methyl ether,
C10398,Ramentaceone;|7-Methyljuglone,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C10398  Ramentaceone,
C10399,Rapanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1505 Alkyl hydroquinones and derivatives|C10399  Rapanone,
C10400,Supinidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10400  Supinidine,
C10401,Rhein,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10401  Rhein|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10401  Rhein|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10401,
C10402,Rubiadin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10402  Rubiadin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10402  Rubiadin,
C10403,"Supinine;|Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl ester, (7aS-(7(2R*,3S*),7aR*))-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10403  Supinine,
C10404,Sennoside A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10404  Sennoside A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C10404  Sennoside A|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C10404  Sennoside A|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10404,
C10405,Tectoquinone;|2-Methylanthraquinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10405  Tectoquinone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10405  Tectoquinone,
C10406,Tricrozarin A,,,,,
C10407,"Ventinone A;|1,4,5-Trihydroxy-7-methoxy-2,3-dimethylanthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C10407  Ventinone A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C10407  Ventinone A,
C10408,Symlandine;|7-Angelyl-9-(-)-viridiflorylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10408  Symlandine,
C10409,Symphytine;|7-Tiglyl-9-(-)-viridiflorylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10409  Symphytine,
C10410,Triangularine;|6-Angelyl-9-sarracinylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10410  Triangularine,
C10411,Tussilagine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10411  Tussilagine,
C10412,Uplandicine;|7-Acetyl-9-echimidinylretronecine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10412  Uplandicine,
C10413,Usaramine;|Mucronatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C10413  Usaramine,
C10414,Dalbergin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C10414  Dalbergin|Phytochemical compounds [BR:br08003]|Others|Others|Neoflavonoids|C10414  Dalbergin,
C10415,(+/-)-Dalbergioidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10415  (+-)-Dalbergioidin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10415  (+-)-Dalbergioidin,
C10416,Dalpanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10416  Dalpanin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10416  Dalpanin,
C10417,Deguelin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10417  Deguelin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10417  Deguelin,
C10418,5-Deoxykievitone;|(+/-)-5-Deoxykievitone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10418  (+-)-5-Deoxykievitone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10418  5-Deoxykievitone,
C10419,"Ferreirin;|2,3-Dihydro-5,7-dihydroxy-3-(2-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10419  Ferreirin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10419  Ferreirin,
C10420,Genistein 8-C-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10420  Genistein 8-C-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10420  Genistein 8-C-glucoside|Glycosides [BR:br08021]|C-glycosides|C10420  Genistein 8-C-glucoside,
C10421,Glabridin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10421  Glabridin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10421  Glabridin,
C10422,(-)-Glyceollin II,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10422  (-)-Glyceollin II|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10422  (-)-Glyceollin II,
C10424,Hildecarpin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10424  Hildecarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10424  Hildecarpin,
C10425,Hispaglabridin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10425  Hispaglabridin A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10425  Hispaglabridin A,
C10426,1'-Acetoxychavicol acetate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10426  1'-Acetoxychavicol acetate,
C10427,1'-Acetoxyeugenol acetate,,,,,
C10428,Anethole;|t-Anethole;|trans-Anethole,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10428  Anethole,
C10429,Apiole,,,,,
C10430,"beta-Asarone;|cis-Asarone;|(Z)-1-(2,4,5-Trimethoxyphenyl)-1-propene",,,,,
C10431,Caffeic acid 3-glucoside,,,,,
C10432,1-Caffeoyl-4-deoxyquinic acid,,,,,
C10433,1-Caffeoyl-beta-D-glucose,,,,,
C10434,5-O-Caffeoylshikimic acid,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C10434  5-O-Caffeoylshikimic acid,
C10435,Carpacin,,,,,
C10436,Centrolobine,,,,,
C10437,Chicoric acid,,,,,
C10438,Cinnamic acid;|Benzeneacrylic acid,Generic compound in reaction hierarchy|Usually trans-form [CPD:C00423]|Exists in cis and trans forms (the trans-form is shown here),,,,
C10439,4'-Cinnamoylmussatioside,,,,,
C10441,4-p-Coumaroylquinic acid,,,,,
C10443,Curcumin;|Kacha haldi,,,PK,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10443  Curcumin|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Diarylheptanoids|C10443  Curcumin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10443|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10443,
C10444,3'-Demethoxypiplartine,,,,,
C10445,"1,3-Dicaffeoylquinic acid;|Cynarin",,,,,
C10446,Diferulic acid,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10446  Diferulic acid,
C10447,"3,4-Dihydroxyphenylpropanoate;|Dihydrocaffeic acid;|3,4-Dihydroxyphenylpropionic acid;|3-(3,4-Dihydroxyphenyl)propanoate",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C10447,
C10448,Dihydroconiferyl alcohol;|4-Hydroxy-3-methoxy-benzenepropanol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C10448  Dihydroconiferyl alcohol,
C10449,Dillapiole;|Dillapiol,,,,,
C10450,Echinacoside,,,,,
C10451,Elemicin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10451  Elemicin,
C10452,Estragole;|1-Methoxy-4-(2-propenyl)benzene;|Methylchavicol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10452  Estragole,
C10453,Eugenol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10453  Eugenol|Classification of Japanese OTC drugs [BR:br08313(D04117)]|Agents for dental and stomatological use|75 Toothache and pyorrhea remedies|D04117  Eugenol (USP)|Risk category of Japanese OTC drugs [BR:br08312(D04117)]|Third-class OTC drugs|Inorganic and organic chemicals|Eugenol|D04117  Eugenol (USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|911  General anesthetics|9119  Other general anesthetics|C10453  Eugenol,
C10454,Methyleugenol;|O-Methyleugenol;|Eugenol methyl ether,,,,,
C10455,Fagaramide,,,,,
C10456,Forsythiaside,,,,,
C10457,Homoferreirin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10457  Homoferreirin,
C10458,Furcatin,,,,,
C10459,Gingerdione;|[6]-Gingerdione,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10459  [6]-Gingerdione,
C10460,Gingerenone A,,,,,
C10461,4-Hydroxyhomopterocarpin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10461  4-Hydroxyhomopterocarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10461  4-Hydroxyhomopterocarpin,
C10462,[6]-Gingerol;|(S)-(+)-[6]Gingerol;|6-Gingerol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10462  [6]-Gingerol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Zingiber derived compounds|C10462  [6]-Gingerol|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10462,
C10463,Grandidentatin,,,,,
C10464,12a-Hydroxyrotenone,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10464  12a-Hydroxyrotenone,
C10465,Iridin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10465  Iridin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10465  Iridin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C10465  Iridin,
C10466,Hellicoside,,,,,
C10467,Irilone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10467  Irilone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10467  Irilone,
C10468,Isochlorogenic acid b,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C10468  Isochlorogenic acid b,
C10469,Isoeugenol;|2-Methoxy-4-(prop-1-en-1-yl)phenol,,,,,
C10470,Isoferulic acid,,,,,
C10471,Irisolidone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10471  Irisolidone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10471  Irisolidone,
C10472,Isosafrole,,,,,
C10473,Jionoside B1,,,,,
C10474,Lusitanicoside,,,,,
C10475,p-Methoxycinnamaldehyde;|4-Methoxycinnamaldehyde,,,,,
C10476,p-Methoxycinnamic acid ethyl ester;|Ethyl p-methoxycinnamate,,,,,
C10477,Methyl caffeate,,,,,
C10478,Methylisoeugenol;|trans-Methylisoeugenol;|Isomethyleugenol,,,,,
C10479,Myricoside,,,,,
C10480,Myristicin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C10480  Myristicin,
C10481,Orobanchoside;|Crenatoside,,,,,
C10482,"6-Paradol;|[6]-Paradol;|3-Decanone, 1-(4-hydroxy-3-methoxyphenyl)-",,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10482  [6]-Paradol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Zingiber derived compounds|C10482  6-Paradol,
C10483,Phaseolic acid,,,,,
C10484,Phenethyl caffeate;|Caffeic acid phenethyl ester,,,,,
C10485,Plantamajoside,,,,,
C10486,"Licoisoflavone A;|2',4',5,7-Tetrahydroxy-3'-(3,3-dimethylallyl)isoflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10486  Licoisoflavone A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10486  Licoisoflavone A,
C10487,Prenyl caffeate,,,,,
C10488,Purpureaside C,,,,,
C10490,Safrole,,,,,
C10491,Lonchocarpenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1216 Other Flavonoids|C10491  Lonchocarpenin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|3-Arylcoumarins|C10491  Lonchocarpenin,
C10492,Salvianolic acid A,,,,,
C10493,Sarisan,,,,,
C10494,[6]-Shogaol;|Shogaol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10494  [6]-Shogaol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Zingiber derived compounds|C10494  [6]-Shogaol,
C10495,Lotisoflavan,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10495  Lotisoflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10495  Lotisoflavan,
C10496,Sphagnum acid,,,,,
C10497,Feruloylputrescine;|Subaphyllin,,,,,
C10498,Luteone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10498  Luteone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10498  Luteone,
C10499,Suspensaside,,,,,
C10500,"1,3,4,5-Tetracaffeoylquinic acid",,,,,
C10501,Verbascoside;|Acteoside,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C10501  Verbascoside,
C10502,(-)-Maackiain;|Inermin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10502  (-)-Maackiain|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10502  (-)-Maackiain,
C10503,Medicarpin;|(-)-Medicarpin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10503  (-)-Medicarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10503  (-)-Medicarpin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10503,
C10504,Melannin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C10504  Melannin|Phytochemical compounds [BR:br08003]|Others|Others|Neoflavonoids|C10504  Melannin,
C10505,(R)-4-Methoxydalbergione,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1210 Neoflavonoids|C10505  (R)-4-Methoxydalbergione|Phytochemical compounds [BR:br08003]|Flavonoids|Complex flavonoids|Biflavonoids and polyflavonoids|C10505  (R)-4-Methoxydalbergione,
C10506,Millettone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10506  Millettone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10506  Millettone,
C10507,Mucronulatol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10507  Mucronulatol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10507  Mucronulatol,
C10508,(-)-Nissolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10508  (-)-Nissolin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10508  (-)-Nissolin,
C10509,Ononin;|Formononetin 7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10509  Ononin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10509  Ononin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C10509  Ononin|Dietary phytochemicals [br08012.html]|Flavonoids|C10509,
C10510,Orobol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10510  Orobol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10510  Orobol,
C10511,Osajin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10511  Osajin,
C10512,Pachyrrhizone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10512  Pachyrrhizone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10512  Pachyrrhizone,
C10513,Paniculatin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10513  Paniculatin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10513  Paniculatin|Glycosides [BR:br08021]|C-glycosides|C10513  Paniculatin,
C10514,(-)-Phaseollin;|Phaseolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10514  (-)-Phaseollin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10514  (-)-Phaseollin,
C10515,(-)-Phaseollinisoflavan,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10515  (-)-Phaseollinisoflavan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10515  (-)-Phaseollinisoflavan,
C10516,Pisatin;|(+)-Pisatin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10516  Pisatin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10516  Pisatin,
C10517,2-(alpha-D-Glucosyl)-sn-glycerol 3-phosphate,,,,,
C10518,Piscerythramine,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10518  Piscerythramine|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10518  Piscerythramine,
C10519,Pomiferin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10519  Pomiferin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10519  Pomiferin,
C10520,Pratensein;|3'-Hydroxybiochanin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10520  Pratensein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10520  Pratensein,
C10521,Prunetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10521  Prunetin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10521  Prunetin,
C10522,Pseudobaptigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10522  Pseudobaptigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10522  Pseudobaptigenin,
C10523,Psoralidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1209 Coumestan flavonoids|C10523  Psoralidin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Coumestanes|C10523  Psoralidin,
C10524,Puerarin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10524  Puerarin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10524  Puerarin|Glycosides [BR:br08021]|C-glycosides|C10524  Puerarin|Dietary phytochemicals [br08012.html]|Flavonoids|C10524,
C10525,Rotenonone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10525  Rotenonone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10525  Rotenonone,
C10526,(-)-Sativan,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10526  (-)-Sativan|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10526  (-)-Sativan,
C10527,Sayanedine,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10527  Sayanedine|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10527  Sayanedine,
C10529,Sojagol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1209 Coumestan flavonoids|C10529  Sojagol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Coumestanes|C10529  Sojagol,
C10530,Sophoraisoflavanone A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10530  Sophoraisoflavanone A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C10530  Sophoraisoflavanone A,
C10531,(-)-Sparticarpin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10531  (-)-Sparticarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10531  (-)-Sparticarpin,
C10532,Sumatrol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10532  Sumatrol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10532  Sumatrol,
C10533,Tectoridin;|Shekanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10533  Tectoridin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10533  Tectoridin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C10533  Tectoridin,
C10534,Tectorigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10534  Tectorigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10534  Tectorigenin,
C10535,Tephrosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10535  Tephrosin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10535  Tephrosin,
C10536,"Texasin;|6,7-Dihydroxy-3-(4-methoxyphenyl)-4-benzopyrone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10536  Texasin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10536  Texasin,
C10537,Toxicarol;|alpha-Toxicarol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1206 Rotenoid flavonoids|C10537  Toxicarol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Rotenones|C10537  Toxicarol,
C10538,Trifolirhizin;|(-)-Maackiain 3-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10538  Trifolirhizin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10538  Trifolirhizin,
C10539,(-)-Variabilin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C10539  (-)-Variabilin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C10539  (-)-Variabilin,
C10540,(+)-Vestitol;|Vestitol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C10540  (+)-Vestitol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C10540  Vestitol,
C10541,Wedelolactone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1209 Coumestan flavonoids|C10541  Wedelolactone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Coumestanes|C10541  Wedelolactone,
C10542,Wighteone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C10542  Wighteone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C10542  Wighteone,
C10543,Acanthoside D;|(-)-Syringaresinol di-beta-D-glucoside,,,,,
C10544,1-Acetoxypinoresinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10544  1-Acetoxypinoresinol,
C10545,Arctigenin;|(-)-Arctigenin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10545  Arctigenin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10545,
C10546,Austrobailignan 1,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10546  Austrobailignan 1,
C10547,Burseran;|(+)-Burseran,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10547  Burseran,
C10548,Cleistanthin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10548  Cleistanthin A,
C10549,Cubebin,,,,,
C10550,Dehydrodieugenol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10550  Dehydrodieugenol,
C10551,Morelensin;|(-)-Morelensin;|5'-Demethoxydeoxypodophyllotoxin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10551  Morelensin,
C10552,"4'-Demethyldeoxypodophyllotoxin;|(-)-4'-Demethyldeoxypodophyllotoxin;|(5R,5aR,8aR)-5-(4-Hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10552  4'-Demethyldeoxypodophyllotoxin,
C10553,4'-Demethylpodophyllotoxin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10553  4'-Demethylpodophyllotoxin,
C10554,Denudatin B,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10554  Denudatin B,
C10555,Deoxygomisin A;|(+)-gamma-Schizandrin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10555  Deoxygomisin A,
C10556,"Deoxypodophyllotoxin;|(-)-Deoxypodophyllotoxin;|(5R,5aR,8aR)-5-(3,4,5-Trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5a)-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10556  Deoxypodophyllotoxin,
C10557,"Dihydroanhydropodorhizol;|Yatein;|(-)-Yatein;|(3R,4R)-4-(1,3-Benzodioxol-5-ylmethyl)-3-(3,4,5-trimethoxybenzyl)dihydrofuran-2(3H)-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10557  Dihydroanhydropodorhizol,
C10558,Dihydrocubebin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10558  Dihydrocubebin,
C10559,Diphyllin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10559  Diphyllin,
C10560,Eucommin A;|Medioresinol 4'-O-beta-D-glucopyranoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10560  Eucommin A|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10560,
C10561,(+)-Eudesmin;|Pinoresinol dimethyl ether,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10561  (+)-Eudesmin,
C10562,Eudesobovatol A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10562  Eudesobovatol A,
C10563,Fargesone A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10563  Fargesone A,
C10564,O-Acetylcypholophine,,,,,
C10565,Acutumidine,,,,,
C10566,Alchorneine,,,,,
C10567,Alchornine,,,,,
C10568,Anantine,,,,,
C10569,Androcymbine,,,,,
C10570,Annuloline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Others|C10570  Annuloline,
C10571,Aspergillic acid,,,,,
C10572,"Balsoxine;|2-Phenyl-5-(3,4-dimethoxyphenyl)oxazole",,,,,
C10573,Calycanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Others|C10573  Calycanthine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C10573  Calycanthine,
C10574,Futoquinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10574  Futoquinol,
C10575,"Candicine;|Ammonium, (p-hydroxyphenethyl)trimethyl-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Tyramine derivatives|C10575  Candicine,
C10576,Cannabisativine,,,,,
C10577,Casimiroedine,,,,,
C10578,Celabenzine,,,,,
C10579,Cephalomannine;|Taxol B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C10579  Cephalomannine,
C10580,Cephalotaxine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C10580  Cephalotaxine,
C10581,Cichorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10581  Cichorine,
C10582,Codonocarpine,,,,,
C10583,Crinasiadine,,,,,
C10584,Crinasiatine,,,,,
C10585,"Cryogenine;|Lythran-12-one, 4'',5''-dimethoxy-2'-hydroxy-, (10-alpha)-;|Vertine",,,,,
C10586,Cryptopleurine,,,,,
C10587,Cynometrine,,,,,
C10588,Damascenine,,,,,
C10589,Decaline;|Decalin,,,,,
C10590,Elaeocarpidine,,,,,
C10591,(+)-Elaeocarpine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C10591  (+)-Elaeocarpine,
C10592,Elaeokanine C,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Indolizidine alkaloids|C10592  Elaeokanine C,
C10593,Exserohilone,,,,,
C10594,"Ficine;|4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-(1-methyl-2-pyrrolidinyl)-2-phenyl-, (-)-",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10594  Ficine|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10594  Ficine,
C10595,Gliotoxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C10595  Gliotoxin,
C10596,Halfordinol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Others|C10596  Halfordinol,
C10597,Harringtonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C10597  Harringtonine,
C10598,Himbacine,,,,,
C10599,Homaline,,,,,
C10600,Ibotenic acid,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C10600  Ibotenic acid,
C10601,"Isoficine;|4H-1-Benzopyran-4-one, 5,7-dihydroxy-6-(1-methyl-2-pyrrolidinyl)-2-phenyl-",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10601  Isoficine|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10601  Isoficine,
C10602,Lilaline,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10602  Lilaline|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C10602  Lilaline,
C10603,Lunarine,,,,,
C10604,Lythramine,,,,,
C10605,Maculosin;|Cyclo(L-Pro-L-Tyr),,,,,
C10606,Maytansine,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C10606  Maytansine|Target-based classification of drugs [BR:br08310(D04864)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D04864  Maytansine (USAN),
C10607,Mycosporine,,,,,
C10608,Palustrine,,,,,
C10609,Phyllospadine,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C10609  Phyllospadine|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C10609  Phyllospadine,
C10610,Pilosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from histidine|Imidazole alkaloids|C10610  Pilosine,
C10611,Pithecolobine,,,,,
C10612,Pleurostyline,,,,,
C10613,Porritoxin,,,,,
C10614,Securinine,,,,,
C10615,Shihunine,,,,,
C10616,(+)-Galbacin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10616  (+)-Galbacin,
C10617,Sirodesmin H,,,,,
C10618,Sporidesmin,,,,,
C10619,Taxine A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C10619  Taxine A|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C10619  Taxine A,
C10620,(-)-Tylocrebrine,,,,,
C10621,Gomisin L1 methyl ether;|Rubschisandrin;|(-)-gamma-Schizandrin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10621  Gomisin L1 methyl ether,
C10622,Grandisin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10622  Grandisin,
C10623,Tylophorine,,,,,
C10624,Verruculotoxin,,,,,
C10625,Withasomnine,,,,,
C10626,Zinnimidine,,,,,
C10627,Hinokinin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10627  Hinokinin,
C10628,cis-Hinokiresinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Norlignans|C10628  cis-Hinokiresinol,
C10629,Acronidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10629  Acronidine,
C10630,Honokiol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10630  Honokiol,
C10631,"Acronycidine;|Furo(2,3-b)quinoline, 4,5,7,8-tetramethoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10631  Acronycidine,
C10632,Acronycine;|Acronine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10632  Acronycine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10632,
C10633,Justicidin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10633  Justicidin A,
C10634,Acrophylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10634  Acrophylline,
C10635,Aniflorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10635  Aniflorine,
C10636,Justicidin B,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10636  Justicidin B,
C10637,Anisessine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10637  Anisessine,
C10638,Kadsurenone,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10638  Kadsurenone,
C10639,Anisotine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10639  Anisotine,
C10640,Kadsurin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10640  Kadsurin A,
C10641,Aurachin D,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10641  Aurachin D|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10641,
C10642,Arborine;|Glycosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10642  Arborine,
C10643,Arborinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10643  Arborinine,
C10644,Atalanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10644  Atalanine,
C10645,Atalaphylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10645  Atalaphylline,
C10646,Lariciresinol;|(+)-Lariciresinol,(-)-Lariciresinol [CPD:C20454],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10646  (+)-Lariciresinol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10646,
C10647,Balfourodine;|(+)-Balfourodine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10647  Balfourodine,
C10648,Balfourodinium,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10648  Balfourodinium,
C10649,Bucharaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10649  Bucharaine,
C10650,Licarin A;|(+)(-)-trans-Dehydrodiisoeugenol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10650  Licarin A,
C10651,Magnolol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10651  Magnolol,
C10652,Bucharidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10652  Bucharidine,
C10653,Buntanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10653  Buntanine,
C10654,Casimiroin,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10654  Casimiroin,
C10655,Cusparine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10655  Cusparine,
C10656,Deoxypeganine;|3-Deoxyvasicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10656  Deoxypeganine,
C10657,Magnosalicin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10657  Magnosalicin,
C10658,Magnoshinin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10658  Magnoshinin,
C10659,"Deoxyvasicinone;|2,3-Trimethylene-4-quinazolone",,,,,
C10660,Dictamnine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10660  Dictamnine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C10660  Dictamnine,
C10661,Dubamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10661  Dubamine,
C10662,Dubinidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10662  Dubinidine,
C10663,Echinopsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10663  Echinopsine,
C10664,Acetosyringone,,,,,
C10665,"Echinorine;|Quinolinium, 4-methoxy-1-methyl-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10665  Echinorine,
C10666,Evoprenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10666  Evoprenine,
C10667,3-Acetyl-6-methoxybenzaldehyde,,,,,
C10668,Evoxanthidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10668  Evoxanthidine,
C10669,Agrimol C,,,,,
C10670,"Evoxine;|2,3-Butanediol, 1-((4,8-dimethoxyfuro(2,3-b)quinolin-7-yl)oxy)-3-methyl-, (+)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10670  Evoxine,
C10671,Agrimophol,,,,,
C10672,Aspidin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10672  Aspidin,
C10673,Aspidinol,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10673  Aspidinol,
C10674,Danielone,,,,,
C10675,"3',4'-Dihydroxyacetophenone",,,,,
C10676,gamma-Fagarine;|Fagarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10676  gamma-Fagarine,
C10677,Febrifugine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10677  Febrifugine,
C10678,Flindersiamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10678  Flindersiamine,
C10679,Flindersine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10679  Flindersine,
C10680,"2',6'-Dihydroxy-4'-methoxyacetophenone;|4-O-Methylphloracetophenone",,,,,
C10681,Furofoline I,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10681  Furofoline I,
C10682,"Matairesinol;|(-)-Matairesinol;|(3R,4R)-3,4-Bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10682  Matairesinol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10682,
C10683,Galipine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10683  Galipine,
C10684,"2',6'-Dimethoxy-4'-hydroxyacetophenone",,,,,
C10685,Glycobismine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10685  Glycobismine A,
C10686,Glycoperine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10686  Glycoperine,
C10687,Glycophymoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10687  Glycophymoline,
C10688,Glycosminine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10688  Glycosminine,
C10689,Graveoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10689  Graveoline,
C10690,Megaphone,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10690  Megaphone,
C10691,Haplodimerine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10691  Haplodimerine,
C10692,Haplophyllidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10692  Haplophyllidine,
C10693,Filicin;|Filixic acid BBB,,,,,
C10694,Haplopine;|Heliparvifoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10694  Haplopine,
C10695,Humulone,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10695  Humulone,
C10696,Hydroquinidine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10696  Hydroquinidine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08048)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA13 Hydroquinidine|D08048  Hydroquinidine (DCF)|Drug groups [BR:br08330(D08048)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG01791  Hydroquinidine|D08048  Hydroquinidine",
C10697,Isodictamnine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10697  Isodictamnine,
C10698,Isofebrifugine,,,,,
C10699,Japonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10699  Japonine,
C10700,4'-Hydroxyacetophenone;|(4-Hydroxyphenyl)ethan-1-one,,,,,
C10701,"Kokusaginine;|Furo(2,3-b)quinoline, 4,6,7-trimethoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10701  Kokusaginine,
C10702,4'-Hydroxy-3'-prenylacetophenone,,,,,
C10703,Leiokinine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10703  Leiokinine A,
C10704,alpha-Kosin,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10704  alpha-Kosin,
C10705,Lemobiline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10705  Lemobiline,
C10706,Lupulone,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10706  Lupulone,
C10707,Neoisostegane,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10707  Neoisostegane,
C10708,Mallotophenone,,,,,
C10709,Multifidol,,,,,
C10710,Lunacridine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10710  Lunacridine,
C10711,Lunacrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10711  Lunacrine,
C10712,Paeonol,,,,,
C10713,Lunamarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10713  Lunamarine,
C10714,"Maculine;|1,3-Dioxolo(4,5-g)furo(2,3-b)quinoline, 9-methoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10714  Maculine,
C10715,Paeonolide,,,,,
C10716,"Maculosidine;|Furo(2,3-b)quinoline, 4,6,8-trimethoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10716  Maculosidine,
C10717,Paeonoside,,,,,
C10718,Maculosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10718  Maculosine,
C10719,Nordihydroguaiaretic acid;|NDGA,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10719  Nordihydroguaiaretic acid,
C10720,Picein,,,,,
C10721,Rottlerin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C10721  Rottlerin|Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C10721  Rottlerin,
C10722,Melicopicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10722  Melicopicine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10722,
C10723,Tricyclodehydroisohumulone,,,,,
C10724,"Melicopine;|4,5-Dimethoxy-methyl-1,3-dioxolo(4,5-c)acridin-6(11H)-one",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10724  Melicopine,
C10725,Nortrachelogenin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10725  Nortrachelogenin,
C10726,Xanthoxylin,,,,,
C10727,Melochinone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10727  Melochinone,
C10728,Otobain,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10728  Otobain,
C10729,alpha-Peltatin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10729  alpha-Peltatin,
C10730,beta-Peltatin A methyl ether,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10730  beta-Peltatin A methyl ether,
C10731,"N-Methylflindersine;|5H-Pyrano(3,2-c)quinolin-5-one, 2,6-dihydro-2,2,6-trimethyl-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10731  N-Methylflindersine,
C10732,O-Methylptelefolonium,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10732  O-Methylptelefolonium,
C10733,Peganine;|Vasicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10733  Peganine,
C10734,Pteleatine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10734  Pteleatine,
C10735,Ribalinium,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10735  Ribalinium,
C10736,"Robustine;|Furo(2,3-b)quinolin-8-ol, 4-methoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10736  Robustine,
C10737,Phrymarolin I,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10737  Phrymarolin I|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C10737  Phrymarolin I,
C10738,Rutacridone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10738  Rutacridone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10738,
C10739,Rutacridone epoxide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Acridone alkaloids|C10739  Rutacridone epoxide,
C10740,Skimmianine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10740  Skimmianine,
C10741,Swietenidin B,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10741  Swietenidin B,
C10742,Tryptanthrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10742  Tryptanthrine,
C10743,"Vasicinol;|Pyrrolo(2,1-b)quinazoline-3,7-diol, 1,2,3,9-tetrahydro-, (R)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10743  Vasicinol,
C10744,Vasicinone,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinazoline alkaloids|C10744  Vasicinone,
C10745,Veprisinium;|Veprisinium salt,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C10745  Veprisinium,
C10746,Phyllanthin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10746  Phyllanthin,
C10747,Albine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10747  Albine,
C10748,Aloperine,,,,,
C10749,Ammothamnine;|Oxymatrine;|Matrine N-oxide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10749  Ammothamnine,
C10750,Anagyrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10750  Anagyrine,
C10751,Angustifoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10751  Angustifoline,
C10752,Aphylline;|(+)-Aphylline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10752  Aphylline,
C10753,Argentine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10753  Argentine,
C10754,Argyrolobine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10754  Argyrolobine,
C10755,Baptifoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10755  Baptifoline,
C10756,Cadiamine,,,,,
C10757,Calpurnine;|Hoe 933,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10757  Calpurnine,
C10758,Camoensine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10758  Camoensine,
C10759,6-Pentadecylsalicylic acid;|Anacardic acid,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1504 Anacardic acids and derivatives|C10759  6-Pentadecylsalicylic acid,
C10760,Caulophylline;|N-Methylcytisine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10760  Caulophylline,
C10761,p-Anisaldehyde,,,,,
C10762,Cinegalline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10762  Cinegalline,
C10763,Cytisine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10763  Cytisine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07770)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BA Drugs used in nicotine dependence|N07BA04 Cytisinicline|D07770  Cytisinicline (USAN)|Target-based classification of drugs [BR:br08310(D07770)]|Ion channels|Ligand-gated ion channels|Acetylcholine (nicotinic)|CHRN|D07770  Cytisinicline (USAN),
C10764,"5,6-Dehydrolupanine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10764  5,6-Dehydrolupanine",
C10765,"Antiarol;|3,4,5-Trimethoxyphenol",,,,,
C10766,Ascosalitoxin,,,,,
C10767,Dimethamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10767  Dimethamine,
C10768,(-)-Jamine;|Homoormosanine,,,,,
C10769,Lamprolobine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10769  Lamprolobine,
C10770,"Bilobol;|5-[(8Z)-Pentadec-8-en-1-yl]benzene-1,3-diol",,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C10770  Bilobol,
C10771,Leontiformine,,,,,
C10772,Lupanine;|(+)-Lupanine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10772  Lupanine,
C10773,Lupinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10773  Lupinine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10773,
C10774,Matrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10774  Matrine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C10774  Matrine,
C10775,Multiflorine,,,,,
C10776,Nuttalline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10776  Nuttalline,
C10777,(-)-Ormosanine,,,,,
C10778,Panamine,,,,,
C10779,Piptanthine,,,,,
C10780,Retamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10780  Retamine,
C10781,"Rhombifoline;|(1R)-3-(3-Butenyl)-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,4]diazocin-8-one",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10781  Rhombifoline,
C10782,Sophoramine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10782  Sophoramine,
C10783,(-)-Sparteine;|Sparteine,,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10783  (-)-Sparteine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01041)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01B ANTIARRHYTHMICS, CLASS I AND III|C01BA Antiarrhythmics, class Ia|C01BA04 Sparteine|D01041  Sparteine (INN)|Drug groups [BR:br08330(D01041)]|Cardiovascular agent|DG01653  Antiarrhythmics|DG01652  Class I antiarrhythmic agent|DG01649  Class Ia antiarrhythmic agent|DG00195  Sparteine|D01041  Sparteine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00195  Sparteine|D01041  Sparteine|Target-based classification of drugs [BR:br08310(D01041)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D01041  Sparteine (INN)|SCN2A|D01041  Sparteine (INN)|SCN3A|D01041  Sparteine (INN)|SCN4A|D01041  Sparteine (INN)|SCN5A|D01041  Sparteine (INN)|SCN8A|D01041  Sparteine (INN)|SCN9A|D01041  Sparteine (INN)|SCN10A|D01041  Sparteine (INN)|SCN11A|D01041  Sparteine (INN)|Drug metabolizing enzymes and transporters [br08309.html(D01041)]|Drug metabolizing enzymes|D01041",
C10784,Cannabidiolic acid;|Cannabidiolate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C10784  Cannabidiolic acid,
C10785,(15:1)-Cardanol;|3-[(Z)-8-Pentadecenyl]phenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C10785  (15:1)-Cardanol,
C10786,Templetine,,,,,
C10787,"2,6-Dimethoxyphenol;|Pyrogallol 1,3-dimethyl ether",,,,,
C10788,Ellagic acid,,,,Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Galloyl derivatives|C10788  Ellagic acid|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10788,
C10789,Thermospine;|(-)-Thermopsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10789  Thermospine,
C10790,Tinctorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Quinolizidine alkaloids|C10790  Tinctorine,
C10791,Tsukushinamine A,,,,,
C10792,"Gentisyl alcohol;|2,5-Dihydroxybenzyl alcohol",,,,,
C10793,Geranylhydroquinone,,,,,
C10794,Ginkgoic acid;|Ginkgolic acid,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1504 Anacardic acids and derivatives|C10794  Ginkgoic acid,
C10795,Buxamine E,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10795  Buxamine E,
C10796,alpha-Chaconine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10796  alpha-Chaconine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10796  alpha-Chaconine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10796  alpha-Chaconine|Saponins|Steroid|C10796  alpha-Chaconine,
C10797,Cyclobuxine D;|Cyclobuxine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10797  Cyclobuxine D,
C10798,Cyclopamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10798  Cyclopamine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10798  Cyclopamine,
C10799,Cycloprotobuxine C,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10799  Cycloprotobuxine C,
C10800,Grevillol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C10800  Grevillol,
C10801,Cyclovirobuxine C,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10801  Cyclovirobuxine C,
C10802,5-(Heptadec-12-enyl)resorcinol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C10802  5-(Heptadec-12-enyl)resorcinol,
C10803,Demissine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10803  Demissine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10803  Demissine|Saponins|Steroid|C10803  Demissine,
C10804,2-(Hydroxymethyl)benzoic acid;|2-Hydroxymethylbenzoic acid,,,,,
C10805,Leiocarposide,,,,,
C10806,Funtumine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10806  Funtumine,
C10807,Germine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10807  Germine,
C10808,"Imperialine;|Cevan-6-one, 3,20-dihydroxy-, (3-beta,5-alpha,17-beta)-;|Kashmirine;|Peiminine",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10808  Imperialine,
C10809,5-Pentadecylresorcinol;|Cardol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C10809  5-Pentadecylresorcinol,
C10810,Irehine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10810  Irehine,
C10811,Jervine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10811  Jervine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10811  Jervine,
C10812,Piperonal,,,,,
C10813,Kurchessine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10813  Kurchessine,
C10814,Paravallarine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10814  Paravallarine,
C10815,Protoveratrine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10815  Protoveratrine A|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10815  Protoveratrine A,
C10816,Protoveratrine B,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10816  Protoveratrine B|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10816  Protoveratrine B,
C10817,Protoverine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10817  Protoverine,
C10818,Solacapine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10818  Solacapine,
C10819,Solamargine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10819  Solamargine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10819  Solamargine,
C10820,Solanine;|alpha-Solanin,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C10820  Solanine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10820  Solanine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10820  Solanine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10820  Solanine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10820,
C10821,Solanocapsine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10821  Solanocapsine,
C10822,"Solasodine;|(3beta,22alpha,25R)-Spirosol-5-en-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C10822  Solasodine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10822  Solasodine,
C10823,Populin,,,,Glycosides [BR:br08021]|O-glycosides|Phenolic glycosides|C10823  Populin,
C10824,Solasonine,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C10824  Solasonine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10824  Solasonine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10824  Solasonine,
C10825,Terminaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10825  Terminaline,
C10826,"Tomatidine;|(3beta,5alpha,22beta,25S)-Spirosolan-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C10826  Tomatidine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10826  Tomatidine,
C10827,Tomatine,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0115 Solanidines and alkaloid derivatives|C10827  Tomatine|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10827  Tomatine|Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C10827  Tomatine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10827,
C10828,"Veracevine;|Cevane-3-beta,4-beta,12,14,16-beta,17,20-heptol, 4,9-epoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10828  Veracevine,
C10829,Veratramine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10829  Veratramine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Steroid alkaloids|C10829  Veratramine,
C10830,Peimine;|Verticine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10830  Peimine,
C10831,Zygadenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Steroid alkaloids|C10831  Zygadenine,
C10832,Sesamol,,,,,
C10833,"Syringic acid;|Syringate;|4-Hydroxy-3,5-dimethoxybenzoate;|Gallic acid 3,5-dimethyl ether",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C10833,
C10834,Theogallin,,,,,
C10835,Trichocarpin,,,,,
C10836,"3,4,3'-Tri-O-methylellagic acid",,,,"Phytochemical compounds [BR:br08003]|Others|Tannins and galloyl derivatives|Ellagitannins|C10836  3,4,3'-Tri-O-methylellagic acid",
C10837,Turgorin,,,,,
C10838,Turricolol E,,,,,
C10839,"Urushiol III;|3-(8,11-Pentadecadienyl)-1,2-benzenediol",,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C10839  Urushiol III|Phytochemical compounds [BR:br08003]|Others|Others|Others|C10839  Urushiol III|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C10839  Urushiol III,
C10840,Zinniol,,,,,
C10841,"Anatoxin a;|Ethanone, 1-(9-azabicyclo(4.2.1)non-2-en-2-yl)-, (1R)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10841  Anatoxin a|Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Anatoxins|C10841  Anatoxin a,
C10842,Anisodamine;|6-Hydroxyhyoscyamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10842  Anisodamine,
C10843,Apoatropine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10843  Apoatropine,
C10844,Apohyoscine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10844  Apohyoscine,
C10845,Belladonnine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10845  Belladonnine,
C10846,Bellendine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10846  Bellendine,
C10847,Benzoylecgonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10847  Benzoylecgonine,
C10848,Tropacocaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10848  Tropacocaine,
C10849,Brugine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10849  Brugine,
C10850,Calystegin A3;|Calystegine A3,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10850  Calystegin A3,
C10851,Calystegin B2;|Calystegine B2,,,,,
C10852,Cinnamoylcocaine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10852  Cinnamoylcocaine,
C10853,Cochlearine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10853  Cochlearine,
C10854,Convolamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10854  Convolamine,
C10855,Convoline,,,,,
C10856,Convolvine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10856  Convolvine,
C10857,Darlingine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10857  Darlingine,
C10858,Ecgonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10858  Ecgonine|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C10858,
C10859,Knightinol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10859  Knightinol,
C10860,Littorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10860  Littorine,
C10861,Meteloidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10861  Meteloidine,
C10862,Norhyoscyamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10862  Norhyoscyamine,
C10863,Phyllalbine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10863  Phyllalbine,
C10864,Physoperuvine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10864  Physoperuvine,
C10865,Pseudopelletierine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C10865  Pseudopelletierine,
C10866,Scopoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10866  Scopoline,
C10867,"Strobamine;|Cyclohepta(6)pyran-5,8-imin-4(5H)-one, 2,3,6,7,8,9-hexahydro-10-methyl-2-phenyl-,(2alpha,5beta,8beta)-(+)-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10867  Strobamine,
C10868,Tigloidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10868  Tigloidine,
C10869,Valeroidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C10869  Valeroidine,
C10870,Phyllanthostatin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10870  Phyllanthostatin A,
C10871,Picropodophyllin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10871  Picropodophyllin,
C10873,Plicatic acid,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10873  Plicatic acid,
C10874,Podophyllotoxin,,,,"Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10874  Podophyllotoxin|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C10874  Podophyllotoxin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C10874|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05529)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BB Antivirals|D06BB04 Podophyllotoxin|D05529  Podofilox (USAN) &lt;US&gt;|USP drug classification [BR:br08302(D05529)]|Dermatological Agents|Dermatological Agents, Other|Warts and Actinic Keratosis Agents|Podofilox|D05529  Podofilox (USAN)|Antimicrobials [BR:br08307(D05529)]|Antivirals|Others|Natural product|D05529  Podofilox (USAN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D05529)]|Antivirals|Others|Natural product|D05529  Podofilox (USAN)",
C10875,Podophyllotoxone,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10875  Podophyllotoxone,
C10876,Podorhizol beta-D-glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10876  Podorhizol beta-D-glucoside,
C10877,Prostalidin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10877  Prostalidin A,
C10878,Randainol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10878  Randainol,
C10879,Saucernetin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10879  Saucernetin,
C10880,Savinin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10880  Savinin,
C10881,Schisantherin A;|Gomisin C,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10881  Schisantherin A,
C10882,Sesamin;|(+)-Sesamin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10882  Sesamin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10882,
C10883,Sesamolinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10883  Sesamolinol,
C10884,Sesartemin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10884  Sesartemin,
C10885,Simplexoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10885  Simplexoside,
C10886,Steganacin;|(-)-Steganacin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10886  Steganacin,
C10887,Styraxin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10887  Styraxin,
C10888,Surinamensin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Neolignans|C10888  Surinamensin,
C10889,(+)-Syringaresinol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10889  (+)-Syringaresinol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10889,
C10890,(+)-Syringaresinol O-beta-D-glucoside;|Acanthoside B,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C10890  (+)-Syringaresinol O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Other phytochemicals|C10890,
C10891,Trachelogenin;|(-)-Trachelogenin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10891  Trachelogenin,
C10892,(+)-Veraguensin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10892  (+)-Veraguensin,
C10893,Schizandrin C;|Wuweizisu C,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10893  Schizandrin C,
C10894,Yangambin;|Lirioresinol-B dimethyl ether,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C10894  Yangambin,
C10895,Azafenidin,,,,,
C10896,Benomyl;|Benlate,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Carbamate pesticides|C10896  Benlate|Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C10896  Benomyl,
C10897,Carbendazim;|Mecarzole;|Methyl 1H-benzimidazol-2-ylcarbamate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C10897  Carbendazim,
C10898,2-Benzimidazolylguanidine,,,,,
C10899,"Allophanic acid methyl ester;|Allophanic acid, methyl ester;|1-(Methoxycarbonyl)urea",,,,,
C10900,Methyl oxalate,,,,,
C10901,2-Aminobenzimidazole;|1H-Benzimidazol-2-amine,,,,,
C10902,Methyl 5-hydroxy-2-benzimidazole carbamate,,,,,
C10903,Cinmethylin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C10903  Cinmethylin,
C10904,Cabucine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C10904  Cabucine,
C10906,D-Fructose,D-Fructose (furanose) [CPD:C00095]|D-Fructose (pyranose) [CPD:C05003]|L-Fructose [CPD:C01719],,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00114)]|V VARIOUS|V06 GENERAL NUTRIENTS|V06D OTHER NUTRIENTS|V06DC Carbohydrates|V06DC02 Fructose|D00114  Fructose (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00114)]|3  Agents affecting metabolism|32  Nutrients, tonics|323  Saccharide preparations|3232  Fructoses|D00114  Fructose (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00114)]|Chemicals|D00114  Fructose|D00114  Fructose injection",
C10907,Cloransulam-methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10907  Cloransulam-methyl,
C10908,Fluthiacet-methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C10908  Fluthiacet-methyl,
C10909,Methabenzthiazuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Urea herbicides|C10909  Methabenzthiazuron,
C10910,2-Methylthiobenzothiazole,,,,,
C10911,Bromacil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Uracil herbicides|C10911  Bromacil,
C10912,Buprofezin,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C10912  Buprofezin,
C10913,Cycloxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C10913  Cycloxydim,
C10914,Cyprodinil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C10914  Cyprodinil,
C10915,Bispyribac,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C10915  Bispyribac,
C10916,"2-Dimethylamino-5,6-dimethylpyrimidin-4-ol;|2-(Dimethylamino)-5,6-dimethyl-1H-pyrimidin-4-one",,,,,
C10917,"7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane;|PTCA",,,,,
C10918,Indeloxazine,,,,Target-based classification of drugs [BR:br08310(D08077)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D08077  Indeloxazine (INN)|SLC6A4 (HTT)|D08077  Indeloxazine (INN),
C10919,Mepanipyrim,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C10919  Mepanipyrim,
C10920,Glycidol,,,,,
C10921,Butyl acrylate,,,,,
C10922,"2,3-Dimercaptopropane-1-sulfonic acid;|DMPS",,,,,
C10923,2-Nitrofluorene;|NF,,,,,
C10924,9-Hydroxy-2-nitrofluorene;|9-OHNF,,,,,
C10925,Acetochlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10925  Acetochlor,
C10926,Hexazinone,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazinone herbicides|C10926  Hexazinone,
C10927,Cybutryne;|Irgarol 1051,,,,,
C10928,Alachlor,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C10928  Alachlor|Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10928  Alachlor,
C10929,Benalaxyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C10929  Benalaxyl,
C10930,Metamitron;|Goltix,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazinone herbicides|C10930  Metamitron,
C10931,Butachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10931  Butachlor,
C10932,Carpropamid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C10932  Carpropamid,
C10933,Amidosulfuron,,,,,
C10934,"2,6-Dichlorobenzamide;|DCB",,,,,
C10935,"N,N-Diethyl-m-toluamide;|Diethyltoluamide;|DEET",,,,"Pesticides [BR:br08007]|Pesticides|Others|Insect repellents|C10935  N,N-Diethyl-m-toluamide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02379)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BX Other insecticides and repellents|P03BX01 Diethyltoluamide|D02379  Diethyltoluamide (USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D02379)]|Agents for sanitation|82 Pesticides|D02379  Diethyltoluamide (USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D02379)]|Second-class OTC drugs|Inorganic and organic chemicals|DEET; N,N-Diethyl-meta-toluamide|D02379  Diethyltoluamide (USP/INN)|Not used for human|Insecticides|D02379  Diethyltoluamide (USP/INN)|Animal drugs in Japan [BR:br08331(D02379)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|D02379  DEET",
C10936,"N-(2,6-Dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide;|DEGA",,,,,
C10937,Bensulfuron-methyl;|Bensulfuron methyl;|Methyl bensulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10937  Bensulfuron-methyl,
C10938,"N,N-Diethylphenylacetamide;|DEPA",,,,,
C10939,"Flumetover;|N-Ethyl-N-methyl-4-(trifluoromethyl)-2-(3,4-dimethoxyphenyl)benzamide;|EMTDB",,,,,
C10940,Epicainide,,,,,
C10941,Furalaxyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C10941  Furalaxyl,
C10942,Inabenfide,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C10942  Inabenfide,
C10943,Chlorimuron-ethyl;|Chlorimuron ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10943  Chlorimuron-ethyl,
C10944,Isobutylphendienamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C10944  Isobutylphendienamide,
C10945,"Caffeic aldehyde;|3,4-Dihydroxycinnamaldehyde;|Caffeyl aldehyde",,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C10945  Caffeic aldehyde,
C10946,Metsulfuron-methyl;|Metsulfuron methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10946  Metsulfuron-methyl,
C10947,Metalaxyl,,,,,
C10948,Metazachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C10948  Metazachlor,
C10949,Nicosulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10949  Nicosulfuron,
C10950,Prosulfuron,,,,,
C10951,"N-(4-Chloro-3-methyl-5-isothiazolyl)-N-methyl-2-[p-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]phenyl]acetamide;|ITOPA",,,,,
C10952,Rimsulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10952  Rimsulfuron,
C10953,Metolachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10953  Metolachlor,
C10954,Naproanilide,,,,,
C10955,Sulfometuron methyl,,,,,
C10956,Oxycarboxin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C10956  Oxycarboxin,
C10957,Thifensulfuron-methyl;|Thifensulfuron methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10957  Thifensulfuron-methyl,
C10958,Prinomide,,,,,
C10959,Thenylchlor;|NSK-850,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C10959  Thenylchlor,
C10960,Triforine,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C10960  Triforine,
C10961,Triasulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C10961  Triasulfuron,
C10962,Tribenuron methyl;|Tribenuron-methyl,,,,,
C10963,Terbacil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Uracil herbicides|C10963  Terbacil,
C10964,Benoxacor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C10964  Benoxacor,
C10965,Bentazone,,,,,
C10966,Chlorpromazine N-oxide,,,,,
C10967,Fluperlapine,,,,,
C10968,Idazoxan,,,,,
C10969,"SC-1271;|1-(4'-Chlorophenyl)-1,4-dihydro-4-oxo-5-propoxycinnoline-3-carboxylic acid",,,,,
C10970,Benalfocin;|SK&F 86466,,,,,
C10971,"Isoimide;|N-(Bromophenyl)-3,4,5,6-tetrahydroisophthalimide",,,,,
C10972,"Imide;|N-(4-Bromophenyl)-3,4,5,6-tetrahydrophthalimide",,,,,
C10973,"Thiadiazolidinone;|5-(4-Bromophenylimino)-3,4-tetramethylene-1,3,4-thiadiazolidin-2-one",,,,,
C10974,4-Methylaminobutanal,,,,,
C10975,"Triazolidinonethione;|4-Bromophenyl-1,2-tetramethylene-1,2,4-triazolidin-3-one-5-thione",,,,,
C10976,1-Oxa-2-oxo-3-methylcycloheptane,,,,,
C10977,"Thiadiazolidinethione;|5-(4-Bromophenylimino)-3,4-tetramethylene-1,3,4-thiadiazolidine-2-thione",,,,,
C10978,"Triazolidinedithione;|4-Bromophenyl-1,2-tetramethylene-1,2,4-triazolidine-3,5-dithione",,,,,
C10979,Chlozolinate;|Dichlozolinate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C10979  Chlozolinate,
C10980,Bifenthrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10980  Bifenthrin,
C10981,Vinclozolin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Carbamate pesticides|C10981  Vinclozolin|Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C10981  Vinclozolin,
C10982,Cyfluthrin,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10982  Cyfluthrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07761)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BA Pyrethrines|P03BA01 Cyfluthrin|D07761  Cyfluthrin (BAN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C10982  Cyfluthrin",
C10983,Cyhalothrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10983  Cyhalothrin,
C10984,Cypermethrin,,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Pyrethroid pesticides|C10984  Cypermethrin|Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10984  Cypermethrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07763)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BA Pyrethrines|P03BA02 Cypermethrin|D07763  Cypermethrin (BAN)",
C10985,Deltamethrin;|Decamethrin,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10985  Deltamethrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07785)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BA Pyrethrines|P03BA03 Decamethrin|D07785  Deltamethrin (BAN)",
C10986,Procymidone,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C10986  Procymidone,
C10987,"N-(3,5-Dichlorophenyl)succinimide;|NDPS",,,,,
C10988,Fenvalerate;|Pydrin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Pyrethroid pesticides|C10988  Fenvalerate|Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10988  Fenvalerate,
C10989,Fluvalinate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C10989  Fluvalinate|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C10989  Fluvalinate,
C10990,Flumiclorac pentyl;|S-23031,,,,,
C10991,Resmethrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10991  Resmethrin|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C10991  Resmethrin,
C10992,Tefluthrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C10992  Tefluthrin,
C10993,Flumipropyn;|S-23121,,,,,
C10994,Hydramethylnon;|Amdro,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C10994  Hydramethylnon|Classification of Japanese OTC drugs [BR:br08313]|Agents for sanitation|82 Pesticides|C10994  Amdro|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Insecticides|C10994  Hydramethylnon,
C10995,Amitraz;|Mitac,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C10995  Amitraz|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C10995  Amitraz,
C10996,Daminozide,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C10996  Daminozide,
C10997,Guazatine;|Iminoctadine,,,,,
C10998,4-Aminobiphenyl,,,,,
C10999,"4,4'-Methylene-bis-(2-chloroaniline);|Methylenebis(chloroaniline);|MOCA",,,,,
C11000,"Dichloran;|Dicloran;|2,6-Dichloro-4-nitroaniline;|DCNA",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11000  Dichloran,
C11001,"2,6-Diethylaniline;|DEA",,,,,
C11002,Isofenphos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C11002  Isofenphos,
C11003,"2,4-Xylidine;|2,4-Dimethylaniline;|2,4-DMA",,,,,
C11004,"2,6-Dimethylaniline;|2,6-DMA;|2,6-Xylidine",,,,,
C11005,Isoproturon,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C11005  Isoproturon,
C11006,"2,4-Dinitrotoluene;|2,4-DNT",,,,,
C11007,Linuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C11007  Linuron,
C11008,"2,6-Dinitrotoluene;|2,6-DNT",,,,,
C11009,Chlorbromuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C11009  Chlorbromuron,
C11010,2-Fluoroaniline;|o-Fluoroaniline,3-Fluoroaniline [CPD:C11013]|4-Fluoroaniline [CPD:C11014],,,,
C11011,Metoxuron;|Dosanex,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C11011  Metoxuron,
C11012,Pencycuron,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11012  Pencycuron,
C11013,3-Fluoroaniline;|m-Fluoroaniline,2-Fluoroaniline [CPD:C11010]|4-Fluoroaniline [CPD:C11014],,,,
C11014,4-Fluoroaniline;|p-Fluoroaniline,2-Fluoroaniline [CPD:C11010]|3-Fluoroaniline [CPD:C11013],,,,
C11015,Aldicarb,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Carbamate pesticides|C11015  Aldicarb|Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C11015  Aldicarb,
C11016,"Diphenylamine;|N,N-Diphenylamine",,,,,
C11017,Kresoxim-methyl;|BAS 490 F,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C11017  Kresoxim-methyl,
C11018,Azinphos-methyl;|Azinphos methyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C11018  Azinphos-methyl,
C11019,Pendimethalin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C11019  Pendimethalin,
C11020,"2,4-DP;|Dichlorprop;|2-(2,4-Dichlorophenoxy)propionic acid",,,,"Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C11020  2,4-DP",
C11021,Diclofop methyl,,,,,
C11022,Butamifos;|Cremart,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C11022  Butamifos,
C11023,O-Ethyl-O-(5-methyl-4-nitrophenyl)(1-methylpropyl)phosphoramidothioate,Butamifos's isomer,,,,
C11024,Fenoxaprop-ethyl;|Fenoxaprop ethyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C11024  Fenoxaprop-ethyl,
C11025,Coumaphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C11025  Coumaphos,
C11026,Coumaphos anti-dimer,,,,,
C11027,Coumaphos syn-dimer,,,,,
C11028,Phosalone;|Agria 1060 A,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C11028  Phosalone,
C11029,Fluazifop butyl,,,,,
C11030,Quinalphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C11030  Quinalphos,
C11031,Haloxyfop methyl;|Haloxyfop methyl ester,,,,,
C11032,Trichlopyr;|Triclopyr,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyridine herbicides|C11032  Trichlopyr,
C11033,1-Aminomethylphosphonic acid;|Aminomethylphosphonate;|AMPA,,,,,
C11034,"MK-129;|2-[p-(p-Chlorobenzyloxy)phenyl]-4,5,6,7-tetrahydroisoindoline-1,3-dione",,,,,
C11035,Flumioxazin;|S-53482,,,,,
C11036,Bromobenzene,,,,,
C11037,Chlorothalonil;|Tetrachloroisophthalonitrile;|Daconil;|TPN,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C11037  Chlorothalonil,
C11038,2'-Deoxy-5-hydroxymethylcytidine-5'-diphosphate,,,,,
C11039,2'-Deoxy-5-hydroxymethylcytidine-5'-triphosphate,,,,,
C11040,"Dichlobenil;|2,6-Dichlorobenzonitrile",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrile herbicides|C11040  Dichlobenil,
C11041,"Chlorthiamid;|2,6-Dichlorothiobenzamide",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C11041  Chlorthiamid,
C11042,Hexachlorobenzene;|HCB,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C11042  Hexachlorobenzene|Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C11042  Hexachlorobenzene,
C11043,Methoxychlor,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C11043  Methoxychlor|Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C11043  Methoxychlor,
C11044,"2,2',4,4',5-Pentachlorodiphenyl ether;|1,2,4-Trichloro-5-(2,4-dichlorophenoxy)benzene",,,,,
C11045,Aspartame,,,,Target-based classification of drugs [BR:br08310(D02381)]|G Protein-coupled receptors|Metabotropic glutamate receptor family|Chemoreception|TAS1R2|D02381  Aspartame (NF/INN)|TAS1R3|D02381  Aspartame (NF/INN),
C11047,Azadirachtinin;|3-Acetyl-1-tigloylazadirachtinin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010610 Apotirucallane triterpenoids|C11047  3-Acetyl-1-tigloylazadirachtinin|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Limonoids|C11047  Azadirachtinin,
C11048,Brassicanal A,,,,,
C11049,24-epi-Brassinolide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C11049  24-epi-Brassinolide|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C11049  24-epi-Brassinolide,
C11050,25-Hydroxy-24-epi-brassinolide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C11050  25-Hydroxy-24-epi-brassinolide|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C11050  25-Hydroxy-24-epi-brassinolide,
C11051,26-Hydroxy-24-epi-brassinolide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C11051  26-Hydroxy-24-epi-brassinolide,
C11052,7-Ethoxycoumarin,,,,,
C11053,"9,10-Dihydrokadsurenone",,,,,
C11054,Spinosyn A;|Spinosad factor A,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C11055,Spinosyn B,,,,,
C11056,Spinosyn D;|Spinosad factor D,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C11057,"3,4,3',4'-Tetrachlorobiphenyl;|PCB 77",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Non-ortho (coplanar) PCBs|C11057  3,4,3',4'-Tetrachlorobiphenyl (PCB 77)",
C11058,"1,2,3,4-Tetrachlorodibenzodioxin;|1,2,3,4-TCDD;|1,2,3,4-Tetrachlorodibenzo-p-dioxin",,,,,
C11059,"1,3,6,8-Tetrachlorodibenzo-p-dioxin;|1,3,6,8-Tetrachlorodibenzodioxin;|1,3,6,8-TCDD",,,,,
C11060,(-)-Abscisic acid;|(-)-ABA,(-) enantiomer of Abscisic acid [CPD:C06082],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C11060  (-)-Abscisic acid,
C11061,all-trans-Retinoyl-beta-glucuronide;|Retinoyl glucuronide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C11061  all-trans-Retinoyl-beta-glucuronide,
C11062,4-Hydroxybutyryl-CoA;|4-Hydroxybutanoyl-CoA,,,,,
C11063,"Chlornitrofen;|MC-338;|2,4,6-Trichlorophenyl 4-nitrophenyl ether",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Diphenyl ether herbicides|C11063  Chlornitrofen,
C11064,Fluorodifen;|Preforan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Diphenyl ether herbicides|C11064  Fluorodifen,
C11065,Nitrofen,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C11065  Nitrofen|Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Diphenyl ether herbicides|C11065  Nitrofen,
C11066,Bifenox;|MC-4379,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Diphenyl ether herbicide|C11066  Bifenox,
C11067,MC-3761,,,,,
C11068,MC-5127,,,,,
C11069,MC-6063,,,,,
C11070,MC-7181,,,,,
C11071,Aminocarb;|Matacil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C11071  Aminocarb,
C11072,THTA;|2-Tetrahydrothiopheneacetic acid,,,,,
C11073,Benfuracarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C11073  Benfuracarb,
C11074,THTC;|2-n-Tetrahydrothiophenecarboxylic acid,,,,,
C11075,Carbetamide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Carbanilate herbicides|C11075  Carbetamide,
C11076,2-N-Dodecyltetrahydrothiophene;|DTHT,,,,,
C11077,Diethofencarb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C11077  Diethofencarb,
C11078,Fenoxycarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C11078  Fenoxycarb,
C11079,Pirimicarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C11079  Pirimicarb,
C11080,Cartap,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nereistoxin insecticides|C11080  Cartap,
C11081,EPTC;|S-Ethyl dipropylthiocarbamate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C11081  EPTC,
C11082,2-N-Undecyltetrahydrothiophene;|UTHT,,,,,
C11084,Fenothiocarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C11084  Fenothiocarb,
C11085,Fenothiocarb sulfoxide,,,,,
C11086,Molinate;|Ordram,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C11086  Molinate,
C11087,Orbencarb,,,,,
C11088,"1,2-Dibromoethane;|Ethylene dibromide",,,,,
C11089,Dichloroacetylene,,,,,
C11090,Endosulfan;|Benzoepin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C11090  Endosulfan|Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C11090  Endosulfan,
C11091,"Hexachloro-1,3-butadiene;|HCBD;|Hexachlorobutadiene",,,,,
C11092,Azocyclotin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C11092  Azocyclotin,
C11093,Cyhexatin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C11093  Cyhexatin,
C11094,Carfentrazone-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C11094  Carfentrazone-ethyl,
C11095,Clomazone;|FMC57020,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C11095  Clomazone,
C11096,Croconazole,,,,Drug groups [BR:br08330(D07752)]|Antifungal|DG01883  Imidazole antifungal|DG01297  Croconazole|D07752  Croconazole|Antimicrobials [BR:br08307(D07752)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D07752  Croconazole (INN),
C11097,F5231,,,,,
C11098,Fenpyroximate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C11098  Fenpyroximate,
C11099,Fipronil,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrazole insecticides|C11099  Fipronil|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C11099  Fipronil,
C11100,Flurochloridone;|Raiser,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C11100  Flurochloridone,
C11101,5-Hydroxymethyl-2-furaldehyde;|HMF;|5-Hydroxymethylfurfural,,,,,
C11102,Hymexazol O-glucoside;|HOG,,,,,
C11103,Hymexazol,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth stimulators|C11103  Hymexazol,
C11104,Hymexazol N-glucoside;|HNG,,,,Glycosides [BR:br08021]|N-glycosides|C11104  Hymexazol N-glucoside,
C11105,5-Methyl-3-isoxazolyl sulfate,,,,,
C11106,3-Oxobutanamide;|Acetoacetamide;|AAA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C11106  3-Oxobutanamide,
C11107,3-beta-D-Glucopyranuronosyloxy-5-methylisoxazole,,,,,
C11108,"(-)-erythro-(2R,3R)-Dihydroxybutylamide;|DBA",,,,,
C11109,HBA,,,,,
C11110,Imidacloprid,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C11110  Imidacloprid|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C11110  Imidacloprid,
C11111,Isoprothiolane,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11111  Isoprothiolane|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|966  Anticoagulants|9669  Other anticoagulants|C11111  Isoprothiolane,
C11112,"Isoprothiolane sulfoxide;|Propanedioic acid, 1,3-dithiolan-2-ylidene-, bis(1-methylethyl) ester, 5-oxide",,,,,
C11113,Methaphenilene,,,,,
C11114,Methapyrilene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AC Substituted ethylene diamines|R06AC05 Methapyrilene|C11114  Methapyrilene,
C11115,5-Methyl-2-furaldehyde;|5-Methyl-2-furfural,,,,,
C11116,"1-Methylparabanic acid;|Imidazolidinetrione, methyl-",,,,,
C11117,5-N-Methyloxaluric acid,,,,,
C11118,N-Methyl-2-pyrrolidinone;|1-Methyl-2-pyrrolidinone;|N-Methylpyrrolidone,,,,,
C11119,"3-Nitrosothiazolidine;|N-Nitroso-1,3-thiazolidine",,,,,
C11120,Rilmenidine;|Oxaminozoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08482)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING|C02AC Imidazoline receptor agonists|C02AC06 Rilmenidine|D08482  Rilmenidine (INN)|Drug groups [BR:br08330(D08482)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|D08482  Rilmenidine|Target-based classification of drugs [BR:br08310(D08482)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D08482  Rilmenidine (INN)",
C11121,Propiconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C11121  Propiconazole,
C11122,"DTP;|(2,4-Dichlorophenyl)(5-hydroxy-1,3-dimethyl-1H-pyrazol-4-yl)methanone;|4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-5-hydroxypyrazole",,,,,
C11123,"Pyrazolate;|4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-5-pyrazolyl p-toluenesulfonate",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C11123  Pyrazolate,
C11124,Spiroxamine;|KWG4168,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11124  Spiroxamine,
C11125,Sulfentrazone;|F6285,,,,,
C11126,"Tebufenpyrad;|1H-Pyrazole-5-carboxamide, 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrazole insecticides|C11126  Tebufenpyrad,
C11127,Triadimenol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C11127  Triadimenol,
C11128,"2,4,5-Tribromo-1-(4-chlorobenzoyl)imidazole",,,,,
C11129,"Isatin;|1H-Indole-2,3-dione",,,,,
C11130,"3-Hydroxyindolin-2-one;|1,3-Dihydro-3-hydroxy-2H-indol-2-one;|Dioxindole",,,,,
C11131,2-Methoxy-estradiol-17beta 3-glucuronide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11131  2-Methoxy-estradiol-17beta 3-glucuronide|ST05 Steroid conjugates|ST0501 Glucuronides|C11131  2-Methoxy-estradiol-17beta 3-glucuronide,
C11132,2-Methoxyestrone 3-glucuronide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11132  2-Methoxyestrone 3-glucuronide|ST05 Steroid conjugates|ST0501 Glucuronides|C11132  2-Methoxyestrone 3-glucuronide,
C11133,Estrone glucuronide;|Estrone 3-glucuronide;|Estrone beta-D-glucuronide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11133  Estrone 3-glucuronide|ST05 Steroid conjugates|ST0501 Glucuronides|C11133  Estrone 3-glucuronide,
C11134,Testosterone glucuronide;|Testosterone 17beta-(beta-D-glucuronide),,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C11134  Testosterone 17beta-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C11134  Testosterone glucuronide,
C11135,Androsterone glucuronide;|Androsterone 3-glucuronide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C11135  Androsterone 3-glucuronide|ST05 Steroid conjugates|ST0501 Glucuronides|C11135  Androsterone 3-glucuronide,
C11136,Etiocholan-3alpha-ol-17-one 3-glucuronide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0501 Glucuronides|C11136  Etiocholan-3alpha-ol-17-one 3-glucuronide,
C11141,(+)-Atherospermoline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11141  (+)-Atherospermoline,
C11142,Dimethyl sulfone;|Sulfonylbismethane,,,,,
C11143,Dimethyl sulfoxide;|DMSO,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01043)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX13 Dimethyl sulfoxide|D01043  Dimethyl sulfoxide (JAN/USP/INN) &lt;JP/US&gt;|M MUSCULO-SKELETAL SYSTEM|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AX Other topical products for joint and muscular pain|M02AX03 Dimethyl sulfoxide|D01043  Dimethyl sulfoxide (JAN/USP/INN) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01043)]|2  Agents affecting individual organs|25  Urogenital and anal organ agents|259  Miscellaneous|2590  Miscellaneous|D01043  Dimethyl sulfoxide (JAN/USP/INN)|New drug approvals in Japan [br08318.html(D01043)]|Drugs with new active ingredients|D01043,
C11144,Dimethyl ether;|Methoxymethane;|DME,,,,,
C11145,Methanesulfonic acid;|Methanesulfonate,,,,,
C11146,Methylmercury chloride,,,,,
C11147,Fluoromethane;|Methyl fluoride,,,,,
C11148,TCE epoxide;|Trichloroethylene epoxide;|Trichloroepoxyethane,,,,,
C11149,Dichloroacetate;|Dichloroacetic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C11149  Dichloroacetic acid,
C11150,Trichloroacetate;|Trichloroacetic acid;|TCA,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C11150  TCA,
C11151,Phenylmercury acetate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11151  Phenylmercury acetate,
C11152,Tetraphenylphosphonium,,,,,
C11153,Teniposide;|VM-26,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02698)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CB Podophyllotoxin derivatives|L01CB02 Teniposide|D02698  Teniposide (USP/INN)|USP drug classification [BR:br08302(D02698)]|Antineoplastics|Molecular Target Inhibitors|Teniposide|D02698  Teniposide (USP/INN)|Drug groups [BR:br08330(D02698)]|Antineoplastic|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|D02698  Teniposide|Target-based classification of drugs [BR:br08310(D02698)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D02698  Teniposide (USP/INN),
C11154,Trimetrexate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06238)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES|P01AX Other agents against amoebiasis and other protozoal diseases|P01AX07 Trimetrexate|D06238  Trimetrexate (USAN/INN)|Drug groups [BR:br08330(D06238)]|Antineoplastic|DG02018  Antimetabolite|DG01978  Folic acid analog|DG01930  Dihydrofolate reductase inhibitor|DG01013  Trimetrexate|D06238  Trimetrexate|Target-based classification of drugs [BR:br08310(D06238)]|Enzymes|Oxidoreductases (EC1)|Dihydrofolate reductase|DHFR|D06238  Trimetrexate (USAN/INN)|Antimicrobials [BR:br08307(D06238)]|Antiparasitics|Agents against Amebiasis and other antiprotozoals|Others|D06238  Trimetrexate (USAN/INN)",
C11155,n-Propyl gallate;|Propyl gallate,,,,,
C11156,Triadimefon,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C11156  Triadimefon,
C11158,Topotecan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08618)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CE Topoisomerase 1 (TOP1) inhibitors|L01CE01 Topotecan|D08618  Topotecan (BAN)|Drug groups [BR:br08330(D08618)]|Antineoplastic|DG01529  Topoisomerase inhibitor|DG01526  Topoisomerase I inhibitor|DG00725  Topotecan|D08618  Topotecan|Transporter substrate|DG01665  ABCB1 substrate|DG00725  Topotecan|D08618  Topotecan|DG02920  ABCC4 substrate|DG00725  Topotecan|D08618  Topotecan|DG01913  ABCG2 substrate|DG00725  Topotecan|D08618  Topotecan|Target-based classification of drugs [BR:br08310(D08618)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP1|D08618  Topotecan (BAN)|New drug approvals in Europe [br08329.html(D08618)]|European public assessment reports (EPAR) authorised medicine|D08618|Drug metabolizing enzymes and transporters [br08309.html(D08618)]|Drug transporters|D08618,
C11159,"Tiron;|1,2-Dihydroxybenzene-3,5-disulfonic acid disodium salt",,,,,
C11160,Thiram;|Tetramethylthioperoxydicarbonic diamide,,,,"Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C11160  Thiram|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06114)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AA Sulfur containing products|P03AA05 Thiram|D06114  Thiram (USAN/INN)",
C11161,Ethidium bromide;|Homidium bromide,,,,,
C11162,5'-Methoxyhydnocarpin-D,,,,,
C11163,N-(2-Methoxyphenyl)-N'-(2-naphtyl)urea;|INF271,,,,,
C11164,CCCP;|Carbonyl cyanide m-chlorophenyl hydrazone,,,,,
C11165,Thiolactomycin,,,,,
C11166,SDS;|Sodium lauryl sulfate;|Sodium dodecyl sulfate,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01045)]|Chemicals|D01045  Sodium lauryl sulfate,
C11168,Tetrabenazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08575)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07X OTHER NERVOUS SYSTEM DRUGS|N07XX Other nervous system drugs|N07XX06 Tetrabenazine|D08575  Tetrabenazine (JAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D08575)]|Central Nervous System Agents|Central Nervous System, Other|Tetrabenazine|D08575  Tetrabenazine (JAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D08575)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D08575  Tetrabenazine (JAN/INN)|Drug groups [BR:br08330(D08575)]|Metabolizing enzyme substrate|DG01892  CYP1A2 substrate|D08575  Tetrabenazine|DG01644  CYP2D6 substrate|D08575  Tetrabenazine|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D08575  Tetrabenazine|DG02972  CBR substrate|D08575  Tetrabenazine|Target-based classification of drugs [BR:br08310(D08575)]|Transporters|Solute carrier family|SLC18|SLC18A2 (VMAT2)|D08575  Tetrabenazine (JAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D08575)]|New molecular entities and new therapeutic biological products|D08575|New drug approvals in Japan [br08318.html(D08575)]|Drugs with new active ingredients|D08575|New drug approvals in the USA, Europe and Japan [br08328.html(D08575)]|Approval dates by FDA, EMA and PMDA|D08575|Drug metabolizing enzymes and transporters [br08309.html(D08575)]|Drug metabolizing enzymes|D08575|Pharmacogenomic biomarkers [br08341.html(D08575)]|Polymorphisms and mutations affecting drug response|D08575",
C11169,Sulfathiazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01047)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06B CHEMOTHERAPEUTICS FOR TOPICAL USE|D06BA Sulfonamides|D06BA02 Sulfathiazole|D01047  Sulfathiazole (USP/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EB Short-acting sulfonamides|J01EB07 Sulfathiazole|D01047  Sulfathiazole (USP/INN)|Drug groups [BR:br08330(D01047)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|D01047  Sulfathiazole|Antimicrobials [BR:br08307(D01047)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D01047  Sulfathiazole (USP/INN)|Prodrugs [br08324.html(D01047)]|D01047|Prodrugs [br08324.html]|C11169,
C11170,Sulbenicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08534)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA16 Sulbenicillin|D08534  Sulbenicillin (INN)|Drug groups [BR:br08330(D08534)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00530  Sulbenicillin|D08534  Sulbenicillin|DG01780  Extended spectrum penicillin|DG00530  Sulbenicillin|D08534  Sulbenicillin|Antimicrobials [BR:br08307(D08534)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D08534  Sulbenicillin (INN)",
C11171,Sodium deoxycholate,,,,,
C11172,Simazine,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Triazine herbicides|C11172  Simazine|Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C11172  Simazine,
C11173,SN-38,,,,Prodrugs [br08324.html]|C11173,
C11174,"1-Diphosinositol pentakisphosphate;|D-myo-Inositol, 2,3,4,5,6-pentakis(dihydrogen phosphate) 1-(trihydrogen diphosphate);|Diphospho-myo-inositol pentakisphosphate;|1D-myo-Inositol 1-diphosphate 2,3,4,5,6-pentakisphosphate",,,,,
C11175,"S-(2,4-Dinitrophenyl)glutathione",,,,,
C11177,Rhodamine 6G,,,,,
C11178,Resazurin,,,,,
C11179,Pyronine Y;|Pyronine,,,,,
C11180,Pyrimethanil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C11180  Pyrimethanil,
C11181,Proflavine,,,,,
C11182,Prochloraz,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C11182  Prochloraz,
C11184,PMEG;|9-((2-Phosphonylmethoxy)ethyl)guanine,,,,,
C11185,Nuarimol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C11185  Nuarimol,
C11186,Nonactin,,,,,
C11188,Neburon;|Kloben,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Urea herbicides|C11188  Neburon,
C11189,Hoechst 33342;|Hoe 33342,,,,,
C11190,Rhodamine 123,,,,,
C11191,cis-(Z)-Flupenthixol,,,,,
C11193,R (+)-Propanolol;|R-(+)-Propranolol;|Dexpropranolol,,,,,
C11194,Morfamquat;|Morfamquat dichloride,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C11194  Morfamquat,
C11195,Mitoxantrone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08224)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DB Anthracyclines and related substances|L01DB07 Mitoxantrone|D08224  Mitoxantrone (INN)|Drug groups [BR:br08330(D08224)]|Antineoplastic|DG01727  Anthraquinone antineoplastic|DG00701  Mitoxantrone|D08224  Mitoxantrone|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|DG00701  Mitoxantrone|D08224  Mitoxantrone|Transporter substrate|DG02861  ABCC2 substrate|DG00701  Mitoxantrone|D08224  Mitoxantrone|DG01913  ABCG2 substrate|DG00701  Mitoxantrone|D08224  Mitoxantrone|Target-based classification of drugs [BR:br08310(D08224)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D08224  Mitoxantrone (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08224)]|Drug transporters|D08224,
C11196,Methomyl,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Carbamate pesticides|C11196  Methomyl|Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C11196  Methomyl,
C11198,Melitten;|Melittin,,Gly Ile Gly Ala Val Leu Lys Val Leu Thr Thr Gly Leu Pro Ala Leu|Ile Ser Trp Ile Lys Arg Lys Arg Gln Gln-NH2,Peptide,Natural toxins [BR:br08009]|Venoms|Bee venoms|Peptides|C11198  Melitten,
C11199,Cefpirome;|HR 810,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07649)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DE Fourth-generation cephalosporins|J01DE02 Cefpirome|D07649  Cefpirome (INN)|Drug groups [BR:br08330(D07649)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00587  Cefpirome|D07649  Cefpirome|DG01777  Fourth-generation cephalosporin|DG00587  Cefpirome|D07649  Cefpirome|DG01804  Oxyimino beta-lactam|DG00587  Cefpirome|D07649  Cefpirome|Antimicrobials [BR:br08307(D07649)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Fourth-generation cephalosporin|D07649  Cefpirome (INN)",
C11200,Lenacil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Uracil herbicides|C11200  Lenacil,
C11201,Isometamidium chloride,,,,,
C11202,Cefclidin,,,,,
C11203,Cefozopran;|SCE 2787,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01052)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DE Fourth-generation cephalosporins|J01DE03 Cefozopran|D01052  Cefozopran (INN)|Drug groups [BR:br08330(D01052)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00588  Cefozopran|D01052  Cefozopran|DG01777  Fourth-generation cephalosporin|DG00588  Cefozopran|D01052  Cefozopran|DG01804  Oxyimino beta-lactam|DG00588  Cefozopran|D01052  Cefozopran|Antimicrobials [BR:br08307(D01052)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Fourth-generation cephalosporin|D01052  Cefozopran (INN)",
C11205,Hexadimethrine bromide;|Polybrene,,,,,
C11206,p-Methylaminophenol sulfate,,,,,
C11207,Fenapanil;|Phenapronil;|Sisthane,,,,,
C11208,Iprodione;|Rovrol;|Rovral,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C11208  Iprodione,
C11210,Cefoselis,,,,"Drug groups [BR:br08330(D07646)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG01206  Cefoselis|D07646  Cefoselis|DG01804  Oxyimino beta-lactam|DG01206  Cefoselis|D07646  Cefoselis|Antimicrobials [BR:br08307(D07646)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other cephalosporin|D07646  Cefoselis (INN)",
C11212,NIK250,,,,,
C11213,Valspodar;|SDZ PSC 833;|3'-Keto-bmt(1)-val(2)-cyclosporin A,,,,Target-based classification of drugs [BR:br08310(D06277)]|Enzymes|Hydrolases (EC3)|ATPase|ABCB1 (CD243)|D06277  Valspodar (USAN/INN),
C11214,"Thiocarbohydrazide;|1,3-Diamino-2-thiourea",,,,,
C11215,Arsenate ion;|Arsenate,,,,,
C11216,Zwittergent 3-14,,,,,
C11217,p-Fluorophenylalanine,,,,,
C11218,Gramicidin S,,0 D-Phe  1 Pro  2 Val  3 Orn  4 Leu  (Dimer),NRP,,
C11219,Imazalil nitrate,Imazalil [CPD:C18739],,,,
C11221,Formylmethionyl-leucyl-phenylalanine methyl ester;|FMLP OMe,,,,,
C11222,Geldanamycin,,0 Ahb  1 Mte  2 Mxk  3 Mtd  4 Mtk  5 Mxd  6 Mad  7 Mtn,PK,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Ansamycins|C11222  Geldanamycin|Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C11222  Geldanamycin,
C11223,Ferbam;|Ferric dimethyldithiocarbamate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C11223  Ferbam,
C11224,Fenuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C11224  Fenuron,
C11225,Herbimycin;|Herbimycin A,,0 Ahb  1 Mte  2 Mxk  3 Mtd  4 Mtk  5 Mxe  6 Mad  7 Mtn,PK,,
C11226,Fenarimol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C11226  Fenarimol,
C11227,Ethionine,,,,,
C11228,Estramustine,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11228  Estramustine|Prodrugs [br08324.html]|C11228|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04066)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX11 Estramustine|D04066  Estramustine (USAN/INN)|Drug groups [BR:br08330(D04066)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG00724  Estramustine|D04066  Estramustine|Target-based classification of drugs [BR:br08310(D04066)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|SRD5A2|D04066  Estramustine (USAN/INN)|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D04066  Estramustine (USAN/INN)|Prodrugs [br08324.html(D04066)]|D04066,
C11229,Epoxiconazole,,,,,
C11230,Epirubicin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07901)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DB Anthracyclines and related substances|L01DB03 Epirubicin|D07901  Epirubicin (INN)|Drug groups [BR:br08330(D07901)]|Antineoplastic|DG01682  Anthracycline antineoplastic|DG00698  Epirubicin|D07901  Epirubicin|DG01529  Topoisomerase inhibitor|DG01527  Topoisomerase II inhibitor|DG00698  Epirubicin|D07901  Epirubicin|Target-based classification of drugs [BR:br08310(D07901)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP2|D07901  Epirubicin (INN),
C11231,Docetaxel anhydrous;|Docetaxel,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07866)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CD Taxanes|L01CD02 Docetaxel|D07866  Docetaxel (JAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D07866)]|Antineoplastics|Antineoplastics, Other|Docetaxel|D07866  Docetaxel (JAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D07866)]|4  Agents affecting cellular function|42  Antineoplastics|424  Plant extract preparations|4240  Plant extract preparations|D07866  Docetaxel (JAN/INN)|Drug groups [BR:br08330(D07866)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00694  Docetaxel|D07866  Docetaxel|Target-based classification of drugs [BR:br08310(D07866)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D07866  Docetaxel (JAN/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D07866)]|European public assessment reports (EPAR) authorised medicine|D07866|Drug metabolizing enzymes and transporters [br08309.html(D07866)]|Drug metabolizing enzymes|D07866",
C11232,Diphenylcarbazide,,,,,
C11233,Dimethyl phthalate,,,,"Pesticides [BR:br08007]|Pesticides|Others|Insect repellents|C11233  Dimethyl phthalate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BX Other insecticides and repellents|P03BX02 Dimethylphthalate|C11233  Dimethyl phthalate",
C11234,Difloxacin,,,,Drug groups [BR:br08330(D07828)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG01228  Difloxacin|D07828  Difloxacin|Antimicrobials [BR:br08307(D07828)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D07828  Difloxacin (INN),
C11235,Diclobutrazol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Conazole fungicides|C11235  Diclobutrazol,
C11236,Niguldipine;|Dexniguldipine,,,,,
C11237,17beta-Estradiol 17-(beta-D-glucuronide);|Estradiol-17beta-glucuronide;|Glucuronosylestradiol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11237  17beta-Estradiol 17-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C11237  17beta-Estradiol 17-(beta-D-glucuronide),
C11238,GF 109203X;|Bisindolylmaleimide I,,,,,
C11239,MK 571;|Verlukast,,,,,
C11240,Rufloxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02474)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA10 Rufloxacin|D02474  Rufloxacin (INN)|Drug groups [BR:br08330(D02474)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00622  Rufloxacin|D02474  Rufloxacin|Antimicrobials [BR:br08307(D02474)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D02474  Rufloxacin (INN),
C11242,Bacteriochlorophyll a,,,,,
C11243,Bacteriochlorophyll b,,,,,
C11244,Bacterio-chlorophyll c;|Bacterio-chlorophyll d;|Bacterio-chlorophyll e,"Bacterio-chlorophyll c,d,e core structure",,,,
C11245,Glucuronosyletoposide;|Etoposide glucuronide,,,,,
C11246,6alpha-Glucuronosylhyodeoxycholate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0501 Glucuronides|C11246  6alpha-Glucuronosylhyodeoxycholate,
C11248,DU-6859;|Sitafloxacin,,,,,
C11249,Cyclohexane,,,,,
C11250,Demecolcine;|Colcemid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11250  Demecolcine|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CC Colchicine derivatives|L01CC01 Demecolcine|C11250  Demecolcine,
C11251,Cholesteryl palmitate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0102 Steryl esters|C11251  Cholesteryl palmitate,
C11252,Chloroneb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C11252  Chloroneb,
C11253,Cefsulodin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07653)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD03 Cefsulodin|D07653  Cefsulodin (INN)|Drug groups [BR:br08330(D07653)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00572  Cefsulodin|D07653  Cefsulodin|DG01776  Third-generation cephalosporin|DG00572  Cefsulodin|D07653  Cefsulodin|Antimicrobials [BR:br08307(D07653)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07653  Cefsulodin (INN)",
C11254,"Carminate;|Carmine;|Carminic acid;|7-Carboxy-4,6-dihydroxy-8-methyl-9,10-dioxo-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-1,3-diolate",,,,Glycosides [BR:br08021]|C-glycosides|C11254  Carmine,
C11255,Carboxin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C11255  Carboxin,
C11256,Calpeptin;|N-Cbz-leu-nleu-al,,,,,
C11257,Calcein AM,,,,,
C11258,Bitertanol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C11258  Bitertanol,
C11259,Bicozamycin;|Bicyclomycin,,,,,
C11260,"2-Amino-2-methyl-1,3-propandiol;|Aminomethyl propanediol",,,,,
C11261,"Amitrole;|3-Amino-1,2,4-triazole;|Aminotriazole;|2-Amino-1,3,4-triazole",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C11261  Amitrole|Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C11261  Amitrole,
C11262,5-Azacytidine;|Azacitidine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03021)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC07 Azacitidine|D03021  Azacitidine (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D03021)]|Antineoplastics|Antimetabolites|Azacitidine|D03021  Azacitidine (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D03021)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D03021  Azacitidine (JAN/USAN/INN)|Target-based classification of drugs [BR:br08310(D03021)]|Enzymes|Transferases (EC2)|Methyltransferases|DNMT|D03021  Azacitidine (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D03021)]|New molecular entities and new therapeutic biological products|D03021|New drug approvals in Europe [br08329.html(D03021)]|European public assessment reports (EPAR) authorised medicine|D03021|New drug approvals in Japan [br08318.html(D03021)]|Drugs with new active ingredients|D03021|New drug approvals in the USA, Europe and Japan [br08328.html(D03021)]|Approval dates by FDA, EMA and PMDA|D03021",
C11263,6-Benzylaminopurine;|N-Benzyladenine;|N6-Benzyladenine,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Cytokinins|C11263  6-Benzylaminopurine,
C11264,7-Hydroxyflavone;|7-Hydroxy-2-phenyl-4-benzopyrone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11264  7-Hydroxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C11264  7-Hydroxyflavone,
C11265,8-Azaadenosine,,,,Glycosides [BR:br08021]|N-glycosides|C11265  8-Azaadenosine,
C11266,8-Bromoadenosine,,,,,
C11268,Biapenem,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01057)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DH Carbapenems|J01DH05 Biapenem|D01057  Biapenem (JAN/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01057)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6139  Others|D01057  Biapenem (JAN/USAN/INN)|Drug groups [BR:br08330(D01057)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01458  Carbapenem|D01057  Biapenem|Drug classes [BR:br08332(D01057)]|Antibacterial|DG01458  Carbapenem|D01057  Biapenem|Antimicrobials [BR:br08307(D01057)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Carbapenem|D01057  Biapenem (JAN/USAN/INN) &lt;JP&gt;|Antimicrobials abbreviations [BR:br08327(D01057)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Carbapenem|D01057  Biapenem (JAN/USAN/INN)|New drug approvals in Japan [br08318.html(D01057)]|Drugs with new active ingredients|D01057",
C11269,Virginiamycin S1;|Virginiamycin factor S,,,,,
C11271,n-Hexane;|Hexane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C11271  n-Hexane,
C11272,Fluorobenzene,,,,,
C11273,Acriflavine,,,,Classification of Japanese OTC drugs [BR:br08313]|Agents for respiratory organs|27 Gargles|C11273  Acriflavine|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Acriflavine|C11273  Acriflavine,
C11274,"Tetrachlorosalicylanilide;|2-Hydroxy-3,4,5,6-tetrachlorobenzanilide",,,,,
C11275,Cetyltrimethylammonium bromide;|Cetrimonium bromide;|Trimethylcetylammonium bromide;|Hexadecanyltrimethylammonium bromide;|CTAB,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03454)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ02 Cetrimonium|D03454  Cetrimonium bromide (NF/INN)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA17 Cetrimonium|D03454  Cetrimonium bromide (NF/INN),
C11276,Nimustine hydrochloride;|ACNU,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01059)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD06 Nimustine|D01059  Nimustine hydrochloride (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01059)]|4  Agents affecting cellular function|42  Antineoplastics|421  Alkylating agents|4219  Others|D01059  Nimustine hydrochloride (JAN)|Drug groups [BR:br08330(D01059)]|Antineoplastic|DG01677  Alkylating agent|DG01724  Nitrosourea|DG00679  Nimustine|D01059  Nimustine hydrochloride,
C11277,Adefovir;|PMEA;|9-(2-Phosphonylmethoxyethyl)adenine,,,,Drug groups [BR:br08330(D02768)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|DG01224  Adefovir|D02768  Adefovir|Antimicrobials [BR:br08307(D02768)]|Antivirals|Genome replication inhibitor|HBV reverse transcriptase inhibitor|D02768  Adefovir (USAN/INN)|Prodrugs [br08324.html(D02768)]|D02768|Prodrugs [br08324.html]|C11277,
C11278,"Aflatoxin B1exo-8,9-epoxide-GSH;|8,9-Dihydro-8-(S-glutathionyl)-9-hydroxyaflatoxin B1",,,,"Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C11278  Aflatoxin B1exo-8,9-epoxide-GSH",
C11279,Myristyltrimethylaminium bromide;|Tetradecyltrimethylammonium bromide;|MTAB,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02164)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ04 Cetrimide|D02164  Cetrimide (JAN)|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AC Medicated shampoos|D11AC01 Cetrimide|D02164  Cetrimide (JAN)|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ04 Cetrimide|C11279  Myristyltrimethylaminium bromide|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AC Medicated shampoos|D11AC01 Cetrimide|C11279  Myristyltrimethylaminium bromide|Classification of Japanese OTC drugs [BR:br08313(D02164)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D02164  Cetrimide (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D02164)]|Second-class OTC drugs|Inorganic and organic chemicals|Cetrimide|D02164  Cetrimide (JAN),G00428
C11280,Dolastatin 10,,,,,
C11281,Anisomycin,,,,,
C11282,Azidopine,,,,,
C11283,"2,4-Dinitrophenylhydrazine",,,,,
C11284,Indolebutyric acid;|Indole-3-butyric acid;|IBA,,,,,
C11285,"Tridemorph;|2,6-Dimethyl-4-tridecylmorpholine",,,,,
C11288,"16alpha,17beta-Estriol 3-(beta-D-glucuronide)",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11288  16alpha,17beta-Estriol 3-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C11288  16alpha,17beta-Estriol 3-(beta-D-glucuronide)",
C11289,17beta-Estradiol 3-sulfate-17-(beta-D-glucuronide);|Estradiol 17beta-glucuronide 3-sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11289  17beta-Estradiol 3-sulfate-17-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C11289  17beta-Estradiol 3-sulfate-17-(beta-D-glucuronide)|ST0502 Sulfates|C11289  17beta-Estradiol 3-sulfate-17-(beta-D-glucuronide),
C11290,3-Chlorosalicylanilide,,,,,
C11292,N-Acetylleucyl-leucyl-methioninal,,,,,
C11293,Etaconazole;|CGA 64251,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Conazole fungicides|C11293  Etaconazole,
C11295,N-Acetyl-leu-leu-leu-leu-tyr-amide;|NAc-L4Y-amide,,,,,
C11296,N-Acetyl-leu-leu-leu-tyr-amide;|NAc-L3Y-amide,,,,,
C11297,N-Acetyl-leu-leu-tyr-amide;|NAc-LLY-amide,,,,,
C11298,N-Formyl-norleucyl-leucyl-phenylalanyl-methylester;|f-NLP-ME,,,,,
C11299,Virginiamycin M1;|Mikamycin A;|Pristinamycin IIA;|Streptogramin A,,,,,
C11300,Soraphen A,,0 Bnk  1 Mae  2 Mae  3 Mxk  4 Mae  5 Mtk  6 Mtk  7 Mxk  8 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11300  Soraphen A,
C11301,Sulfoglycolithocholate;|Glycolithocholate 3-sulfate;|Sulfolithocholylglycine,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0402 C26 bile acids, alcohols, and derivatives|C11301  Sulfolithocholylglycine|ST05 Steroid conjugates|ST0503 Glycine conjugates|C11301  Sulfoglycolithocholate",
C11302,S-Octyl GSH;|S-Octyl glutathione,,,,,
C11303,S-Decyl GSH;|S-Decyl glutathione,,,,,
C11304,S-(PGA1)-glutathione,,,,,
C11305,"Triphenyltetrazolium chloride;|2,3,5-Triphenyltetrazolium chloride",,,,,
C11306,Acetylleucyl-leucyl-norleucinal,,,,,
C11307,Cetylpyridinium chloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01062)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA01 Cetylpyridinium|D01062  Cetylpyridinium chloride (USP) &lt;JP&gt;|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ03 Cetylpyridinium|D01062  Cetylpyridinium chloride (USP) &lt;JP&gt;|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA07 Cetylpyridinium|D01062  Cetylpyridinium chloride (USP) &lt;JP&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA06 Cetylpyridinium|D01062  Cetylpyridinium chloride (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01062)]|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D01062  Cetylpyridinium chloride (USP); Cetylpyridinium chloride hydrate (JAN)|Classification of Japanese OTC drugs [BR:br08313(D01062)]|Agents for respiratory organs|27 Gargles|D01062  Cetylpyridinium chloride (USP)|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D01062  Cetylpyridinium chloride (USP)|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D01062  Cetylpyridinium chloride (USP)|Risk category of Japanese OTC drugs [BR:br08312(D01062)]|Third-class OTC drugs|Inorganic and organic chemicals|Cetylpyridinium|D01062  Cetylpyridinium chloride (USP)|Antimicrobials [BR:br08307(D01062)]|Antibacterials|Bactericidal action|Quaternary ammonium compound|D01062  Cetylpyridinium chloride (USP) &lt;JP&gt;,
C11308,Chymostatin,,,,,
C11309,Calcimycin;|Ionophore A23187,,,,,
C11310,1-Methyl-4-phenylpyridinium;|N-Methyl-4-phenylpyridine;|Cyperquat,,,,,
C11311,Oligomycin A,,,,,
C11312,Oligomycin B,,,,,
C11313,Oligomycin C,,,,,
C11314,Oligomycin D;|Rutamycin,,,,,
C11315,S-(4-Azidophenacyl)glutathione;|S-(p-Azidophenacyl)glutathione,,,,,
C11316,Tetraphenylarsonium,,,,,
C11317,Solutol HS 15,,,,,
C11318,DAMGO;|(D-Ala(2)-mephe(4)-gly-ol(5))enkephalin;|Tyr-D-Ala-Gly-MePhe-Gly-ol,,,,,
C11319,"3,5-Dinitrosalicylic acid",,,,,
C11320,D-Ornithine hydrochloride,,,,,
C11321,3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate;|CHAPS,,,,,
C11322,"4,5,6,7-Tetrachloro-2-trifluoromethylbenzimidazole",,,,,
C11323,"Chromotropic acid;|4,5-Dihydroxynaphthalene-2,7-disulfonic acid",,,,,
C11324,"6-(3,3-Dimethylallyl)chrysin;|6-(3,3-DMA)chrysin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11324  6-(3,3-Dimethylallyl)chrysin",
C11325,"8-(3,3-Dimethylallyl)chrysin;|8-(3,3-DMA)chrysin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11325  8-(3,3-Dimethylallyl)chrysin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C11325  8-(3,3-Dimethylallyl)chrysin",
C11326,8-Anilino-1-naphthalene sulfonic acid;|1-Anilino-8-naphthalenesulfonate;|ANS,,,,,
C11327,2-Pyridyl hydroxymethane sulfonic acid,,,,,
C11328,Leucyl-leucyl-norleucine,,,,,
C11329,N-Acetyl-ala-ala-ala-methylester;|NAc-AAA-ME,,,,,
C11330,N-Acetyl-leu-leu-tyr;|NAc-LLY,,,,,
C11331,Leu-leu-tyr;|LLY,,,,,
C11332,Leucyl-leucine,,,,,
C11333,N-Acetyl-leucyl-leucine,,,,,
C11334,Gentamicin sulfate;|Gentamycin sulfate;|Gentamicin C complex sulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01063)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX07 Gentamicin|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01G AMINOGLYCOSIDE ANTIBACTERIALS|J01GB Other aminoglycosides|J01GB03 Gentamicin|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA11 Gentamicin|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA14 Gentamicin|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA06 Gentamicin|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01063)]|Antibacterials|Aminoglycosides|Gentamicin|D01063  Gentamicin sulfate (JP18/USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Gentamicin|D01063  Gentamicin sulfate (JP18/USP)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Gentamicin|D01063  Gentamicin sulfate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01063)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1317  Ophthalmic antibiotics|D01063  Gentamicin sulfate (JP18/USP)|2  Agents affecting individual organs|26  Epidermides|263  Suppurative dermatosis agents|2634  Antibiotics for external use|D01063  Gentamicin sulfate (JP18/USP)|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6134  Amino sugars|D01063  Gentamicin sulfate (JP18/USP)|Drug groups [BR:br08330(D01063)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG00401  Gentamicin|D01063  Gentamicin sulfate|Drug classes [BR:br08332(D01063)]|Antibacterial|DG01447  Aminoglycoside antibiotic|D01063  Gentamicin sulfate|Antimicrobials [BR:br08307(D01063)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D01063  Gentamicin sulfate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01063)]|Chemicals|D01063  Gentamicin sulfate|D01063  Gentamicin sulfate injection|D01063  Gentamicin sulfate ophthalmic solution|D01063  Gentamicin sulfate ointment",
C11335,"N,N,N-Trimethylmethanaminium chloride;|Tetramethylammonium chloride",,,,,
C11336,Mersalyl acid,,,,,
C11337,Tetramisole hydrochloride;|(+/-)-Tetramisole hydrochloride,,,,,
C11338,"Bornyl acetate;|(1R,2S,4R)-(+)-Bornyl acetate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11338  Bornyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11338  (1R,2S,4R)-(+)-Bornyl acetate",
C11339,Antimycin A1,,,,,
C11340,Antimony potassium tartrate,,,,,
C11341,N-Acetylphenylalanine beta-naphthyl ester;|N-Acetyl-DL-phenylalanine beta-naphthyl ester,,,,,
C11342,Oxolinic acid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Quinone fungicides|C11342  Oxolinic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02301)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MB Other quinolones|J01MB05 Oxolinic acid|D02301  Oxolinic acid (USAN/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9732  Oxolinic acid and preparations|C11342  Oxolinic acid|Drug groups [BR:br08330(D02301)]|Antibacterial|DG01550  Quinolone|D02301  Oxolinic acid|Antimicrobials [BR:br08307(D02301)]|Antibacterials|Nucleic acid synthesis inhibitor|Other quinolone|D02301  Oxolinic acid (USAN/INN),
C11343,Salicylhydroxamic acid,,,,,
C11344,Methyl tert-butyl ether;|tert-Butyl methyl ether,,,,,
C11345,"1,2,4-Triazole-3-alanine;|Triazolealanine",,,,,
C11346,"16alpha,17beta-Estriol 17-(beta-D-glucuronide)",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide)|ST05 Steroid conjugates|ST0501 Glucuronides|C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide)|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C11346  16alpha,17beta-Estriol 17-(beta-D-glucuronide)",
C11347,S-Methyl GSH;|S-Methylglutathione,,,,,
C11348,(S)-1-Phenylethanol;|(S)-1-Phenethyl alcohol,,,,,
C11350,(+)-trans-alpha-Irone,(+)-cis-alpha-Irone [CPD:C09690],,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C11350  (+)-trans-alpha-Irone,
C11351,"N1-Amidinostreptamine 6-phosphate;|1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol 6-phosphate",,,,,
C11352,"5,6-Dichloro-1,3-cyclohexadiene",,,,,
C11353,"2-Hydroxy-3-chloropenta-2,4-dienoate",,,,,
C11354,"2-Hydroxy-cis-hex-2,4-dienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C11354  2-Hydroxy-cis-hex-2,4-dienoate",
C11355,4-Amino-4-deoxychorismate;|ADC,,,,,
C11356,"trans,trans,cis-Geranylgeranyl diphosphate;|trans,trans,cis-Geranylgeranyl pyrophosphate;|Geranylneryl diphosphate;|2-cis,6-trans,10-trans-Geranylgeranyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C11356  trans,trans,cis-Geranylgeranyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Linear diterpenes|C11356  trans,trans,cis-Geranylgeranyl diphosphate",
C11357,(-)-Anabasine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C11357  (-)-Anabasine,
C11358,D-(-)-Anaferine;|(-)-Anaferine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from lysine|Piperidine alkaloids|C11358  D-(-)-Anaferine,
C11359,(-)-Hygrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolidine alkaloids|C11359  (-)-Hygrine,
C11360,(+)-Nornicotine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C11360  (+)-Nornicotine,
C11361,N-Acetylleukotriene E4,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0302 Leukotrienes|C11361  N-Acetylleukotriene E4,
C11362,BQ 485;|Perhydroazepino-N-carbonyl-L-Leu-D-Trp-D-Trp,,,,,
C11363,Sulfobromophthalein,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08548)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CE Tests for liver functional capacity|V04CE02 Sulfobromophthalein|D08548  Sulphobromophthalein (BAN)|Drug groups [BR:br08330(D08548)]|Transporter substrate|DG02857  SLCO1A2 substrate|DG01169  Sulfobromophthalein|D08548  Sulphobromophthalein|DG02856  SLCO1B1 substrate|DG01169  Sulfobromophthalein|D08548  Sulphobromophthalein|DG02932  SLCO1B3 substrate|DG01169  Sulfobromophthalein|D08548  Sulphobromophthalein|DG02933  SLCO2B1 substrate|DG01169  Sulfobromophthalein|D08548  Sulphobromophthalein|Drug metabolizing enzymes and transporters [br08309.html(D08548)]|Drug transporters|D08548,
C11365,Irinotecan carboxylate;|CPT-11 carboxylate form,Irinotecan [CPD:C16641],,,,
C11366,SN-38 carboxylate form,,,,,
C11367,GSH-prostaglandin A1;|Glutathione-prostaglandin A1 conjugate;|PGA1-GS,,,,,
C11368,Grepafloxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA11 Grepafloxacin|C11368  Grepafloxacin|Drug groups [BR:br08330]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00623  Grepafloxacin|C11368  Grepafloxacin,G00623
C11369,Fluo-3,,,,,
C11370,N-Ethylmaleimide-S-glutathione,,,,,
C11371,Nafenopin,,,,Drug groups [BR:br08330(D05102)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01733  PPAR alpha agonist|DG01547  Fibrate|D05102  Nafenopin,
C11372,ICI D1694;|ZD1694;|Tomudex;|Raltitrexed,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01064)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BA Folic acid analogues|L01BA03 Raltitrexed|D01064  Raltitrexed (JAN/USAN/INN)|Drug groups [BR:br08330(D01064)]|Antineoplastic|DG02018  Antimetabolite|DG01978  Folic acid analog|D01064  Raltitrexed|Target-based classification of drugs [BR:br08310(D01064)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D01064  Raltitrexed (JAN/USAN/INN),
C11373,Temocaprilat;|RS 5139,,,,Prodrugs [br08324.html]|C11373,
C11374,GW1843;|1843U89,,,,,
C11375,SN38 glucuronide carboxylate form,,,,,
C11376,SN38 glucuronide;|SN-38G,,,,,
C11377,"alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein",,,,,
C11378,Ubiquinone-10;|Ubidecarenone;|Coenzyme Q10,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C11378  Coenzyme Q10|Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C11378  Ubiquinone-10|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01065)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB09 Ubidecarenone|D01065  Ubidecarenone (JP18/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01065)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2119  Others|D01065  Ubidecarenone (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D01065)]|Agents for circulatory system and blood|21 Cardiotonics (Senso containing drugs)|D01065  Ubidecarenone (JP18/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01065)]|Third-class OTC drugs|Inorganic and organic chemicals|Ubidecarenone|D01065  Ubidecarenone (JP18/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01065)]|Chemicals|D01065  Ubidecarenone|Rx-to-OTC switch list in Japan [br08314.html(D01065)]|D01065,
C11379,"Cinchonidine;|(8alpha,9R)-Cinchonan-9-ol",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C11379  Cinchonidine|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11379,
C11380,Apocynin;|Acetovanillone,,,,,
C11381,Benzoyltropein;|Benzoyltropine,,,,,
C11382,"(+)-3-Carene;|Isodiprene;|(+)-Car-3-ene;|(1S,6R)-3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11382  (+)-3-Carene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11382  (+)-3-Carene,
C11383,(+)-(S)-Carvone;|Carvol;|(+)-Carvone;|Carvone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11383  (+)-(S)-Carvone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11383  (+)-(S)-Carvone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11383,
C11384,"(S)-(-)-Citronellal;|(S)-3,7-Dimethyloct-6-enal",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C11384  (S)-(-)-Citronellal|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C11384  (S)-(-)-Citronellal,
C11385,"Globotetraosylceramide;|N-Acetyl-galactosaminyl-1,6-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide;|GalNAc-bta1->6Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer",,,,,G10525
C11386,(-)-Citronellol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C11386  (-)-Citronellol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C11386  (-)-Citronellol,
C11387,"(1S,4R)-(+)-Fenchone;|(+)-Fenchone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11387  (1S,4R)-(+)-Fenchone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11387  (1S,4R)-(+)-Fenchone",
C11388,(-)-Linalool;|(R)-(-)-Linalool;|(3R)-Linalool,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C11388  (-)-Linalool|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C11388  (-)-Linalool,
C11389,(+)-Linalool;|(S)-(+)-Linalool;|(3S)-Linalool,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C11389  (+)-Linalool|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C11389  (+)-Linalool,
C11390,(+)-Menthone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11390  (+)-Menthone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11390  (+)-Menthone,
C11391,(S)-(+)-alpha-Phellandrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11391  (S)-(+)-alpha-Phellandrene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11391  (S)-(+)-alpha-Phellandrene,
C11392,(-)-beta-Phellandrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11392  (-)-beta-Phellandrene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11392  (-)-beta-Phellandrene,
C11393,(-)-alpha-Terpineol;|(L)-alpha-Terpineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11393  (-)-alpha-Terpineol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11393  (-)-alpha-Terpineol,
C11394,(+)-Chrysanthenone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11394  (+)-Chrysanthenone,
C11395,"(4R,6R)-cis-Carveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11395  (4R,6R)-cis-Carveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11395  (4R,6R)-cis-Carveol",
C11396,"(1R,2R,4R)-Dihydrocarveol;|(-)-Dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11396  (1R,2R,4R)-Dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11396  (1R,2R,4R)-Dihydrocarveol",
C11397,"(1R,2S,4R)-Neo-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11397  (1R,2S,4R)-Neo-dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11397  (1R,2S,4R)-Neo-dihydrocarveol",
C11398,"(1R,4R)-Dihydrocarvone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11398  (1R,4R)-Dihydrocarvone",
C11399,"(1S,2S,4R)-Iso-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11399  (1S,2S,4R)-Iso-dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11399  (1S,2S,4R)-Iso-dihydrocarveol",
C11400,"(1S,2R,4R)-Neoiso-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11400  (1S,2R,4R)-Neoiso-dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11400  (1S,2R,4R)-Neoiso-dihydrocarveol",
C11401,"(1S,4R)-Iso-dihydrocarvone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11401  (1S,4R)-Iso-dihydrocarvone",
C11402,"(4R,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11402  (4R,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",
C11403,"(3S,6R)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",,,,,
C11404,(3R)-6-Hydroxy-3-isopropenyl-heptanoate,,,,,
C11405,(3R)-3-Isopropenyl-6-oxoheptanoate;|(3R)-3-Isopropenyl-6-oxoheptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C11405  (3R)-3-Isopropenyl-6-oxoheptanoic acid,
C11406,(5R)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,,,,,
C11407,(3R)-3-Isopropenyl-6-oxoheptanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11407  (3R)-3-Isopropenyl-6-oxoheptanoyl-CoA,
C11408,"(4S,6S)-cis-Carveol",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11408  (4S,6S)-cis-Carveol",
C11409,"(+)-trans-Carveol;|(4S,6R)-trans-Carveol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11409  (+)-trans-Carveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11409  (+)-trans-Carveol,
C11410,"(1R,2S,4S)-Neoiso-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11410  (1R,2S,4S)- Neoiso-dihydrocarveol",
C11411,"(1R,2R,4S)-Iso-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11411  (1R,2R,4S)-Iso-dihydrocarveol",
C11412,"(1R,4S)-Iso-dihydrocarvone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11412  (1R,4S)-Iso-dihydrocarvone",
C11413,"(1S,2S,4S)-Dihydrocarveol;|(+)-Dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11413  (1S,2S,4S)-Dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11413  (1S,2S,4S)-Dihydrocarveol",
C11414,"(4S,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone;|4-Isopropenyl-7-methyloxepan-2-one",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11414  (4S,7R)-4-Isopropenyl-7-methyl-2-oxo-oxepanone",
C11415,"(1S,4S)-Dihydrocarvone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11415  (1S,4S)-Dihydrocarvone",
C11416,"(1S,2R,4S)-Neo-dihydrocarveol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11416  (1S,2R,4S)-Neo-dihydrocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11416  (1S,2R,4S)-Neo-dihydrocarveol",
C11417,(3S)-6-Hydroxy-3-isopropenyl-heptanoate;|6-Hydroxy-3-isopropenylheptanoate,,,,,
C11418,"(3S,6S)-6-Isopropenyl-3-methyl-2-oxo-oxepanone",,,,,
C11419,(3S)-3-Isopropenyl-6-oxoheptanoate;|(3S)-3-Isopropenyl-6-oxoheptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C11419  (3S)-3-Isopropenyl-6-oxoheptanoic acid,
C11420,(5S)-6-Hydroxy-5-isopropenyl-2-methylhexanoate,,,,,
C11421,(3S)-3-Isopropenyl-6-oxoheptanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11421  (3S)-3-Isopropenyl-6-oxoheptanoyl-CoA,
C11422,Phenanthrene;|Phenanthracene,,,,,
C11425,2-Hydroxy-2H-benzo[h]chromene-2-carboxylate,,,,,
C11426,cis-4-(1'-Hydroxynaphth-2'-yl)-2-oxobut-3-enoate,,,,,
C11427,1-Hydroxy-2-naphthaldehyde,,,,,
C11428,"trans-9(S),10(S)-Dihydrodiolphenanthrene",,,,,
C11429,"Phenanthrene-9,10-oxide",,,,,
C11430,9-Hydroxyphenanthrene;|9-Phenanthrol,,,,,
C11431,"Phenanthrene-1,2-oxide",,,,,
C11432,1-Phenanthrol;|1-Hydroxyphenanthrene,,,,,
C11433,1-Methoxyphenanthrene,,,,,
C11434,2-C-Methyl-D-erythritol 4-phosphate,,,,,
C11435,4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol,,,,,
C11436,2-Phospho-4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol,,,,,
C11437,1-Deoxy-D-xylulose 5-phosphate,,,,,
C11438,C-1027 Chromophore;|C-1027,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11438,
C11439,Formyl-L-methionyl peptide,Generic compound in reaction hierarchy,,,,
C11440,Methionyl peptide,Generic compound in reaction hierarchy,,,,
C11441,Deshydroxy-C-1027 chromophore,,,,,
C11442,Aromatized C-1027 chromophore,,,,,
C11443,Aromatized deshydroxy-C-1027 chromophore,,,,,
C11445,"4-(1,2-Epoxyethyl)-8,9-epoxy-enediyne",,,,,
C11446,"4-Dihydroxyethyl-8,9-epoxy-enediyne",,,,,
C11447,"dTDP-4-dimethylamino-4,6-dideoxy-5-C-methyl-D-allose",,,,,
C11448,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carbonyl-CoA;|Benzoxazolinyl-CoA",,,,,
C11449,"(S)-3-Chloro-4,5-dihydroxy-beta-phenylalanyl-[pcp];|(3S)-3-Amino-3-(3-chloro-4,5-dihydroxyphenyl)propanoyl-[peptidyl-carrier protein]",Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C11453,"2-C-Methyl-D-erythritol 2,4-cyclodiphosphate;|3-Methyl-1,2,3,4-tetrahydroxybutane-1,3-cyclic bisphosphate",,,,,
C11455,"4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C11455  4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol",
C11456,"cis-3-(1-Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol",,,,,
C11457,3-(3-Hydroxyphenyl)propanoic acid;|Dihydro-3-coumaric acid;|3-Hydroxyphenylpropanoate;|3-(3-Hydroxyphenyl)propanoate,,,,,
C11460,dTDP-4-oxo-5-C-methyl-L-rhamnose;|dTDP-4-oxo-6-deoxy-5-C-methyl-L-mannose,,,,,
C11461,"dTDP-4-amino-4,6-dideoxy-5-C-methyl-D-allose",,,,,
C11462,"3-Hydroxy-L-tyrosyl-AMP;|3,4-Dihydroxy-L-phenylalanyl-AMP",,,,,
C11465,"3,5-Dihydroxyanthranilate;|3,5-Dihydroxyanthranilic acid",,,,,
C11466,5-Methoxy-3-hydroxyanthranilate;|5-Methoxy-3-hydroxyanthranilic acid,,,,,
C11467,N-Pyruvoyl-5-methoxy-3-hydroxyanthranilate;|N-Pyruvoyl-5-methoxy-3-hydroxyanthranilic acid,,,,,
C11468,"3,4-Dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylic acid;|Benzoxazolinate",,,,,
C11469,Calicheamicin gamma(1)I;|Calichemicin gamma1,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11469,
C11471,Dynemicin A,,,,,
C11472,"D-glycero-beta-D-manno-Heptose 1,7-bisphosphate",,,,,
C11473,Thiocyclam;|Evisect,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nereistoxin insecticides|C11473  Thiocyclam,
C11474,Nereistoxin;|NTX,,,,,
C11475,DNA containing guanine,Generic compound in reaction hierarchy,,,,
C11476,L-Arabinose,L-Arabinopyranose [CPD:C00259]|L-Arabinofuranose [CPD:C06115],,,,
C11478,tRNA containing 5-(aminomethyl)-2-thiouridine;|tRNA containing nm5s2U,Generic compound in reaction hierarchy|wobble position in the anticodon (position 34) in tRNA,,,,
C11480,"2-Methyl-6-oxohepta-2,4-dienal",,,,,
C11481,HSO3-;|Hydrogen sulfite;|Bisulfite,Sulfurous acid (conjugate acid) [CPD:C00094],,,,
C11482,Holo-Lys2;|[Enzyme]-acyl-binding site;|[Enzyme]-phosphopantetheine,Generic compound in reaction hierarchy,,,,
C11483,MEGA,,,,,
C11484,GA,,,,,
C11485,LY201116;|Ameltolide,,,,,
C11486,NAC,,,,,
C11487,EPA;|N-Ethylphenylacetamide;|N-Ethyl-2-phenylacetamide,,,,,
C11488,HMMF;|N-Hydroxymethyl-N-methylformamide,,,,,
C11489,NMF;|N-Methylformamide,,,,,
C11490,AMCC;|N-Acetyl-S-(N-methylcarbamoyl)cysteine,,,,,
C11491,NOP;|2-(2-Naphthalenyloxy)propanoic acid;|2-(2-Naphthoxy)propionic acid,,,,,
C11492,NOPM;|2-(2-Naphthoxy)propionic acid methyl ester,,,,,
C11493,Carfentrazone,,,,,
C11494,Methyl 2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-p-toluate,,,,,
C11495,Methyl 6-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-m-toluate,,,,,
C11496,(R)-2-Hydroxypropyl-CoM;|2-(R)-Hydroxypropyl-CoM,,,,,
C11497,2-Oxopropyl-CoM;|2-(2-Oxopropylthio)ethanesulfonate,,,,,
C11498,(S)-2-Hydroxypropyl-CoM;|(2S)-2-Hydroxypropyl-CoM,,,,,
C11499,(S)-3-Sulfolactate;|(2S)-3-Sulfolactate,,,,,
C11500,5'-Dehydroadenosine,,,,,
C11501,9-Riburonosyladenine,,,,,
C11502,Mycothione,,,,,G11175
C11503,3-Hydroxy-1H-quinolin-4-one,,,,,
C11504,3-Hydroxy-2-methyl-1H-quinolin-4-one,,,,,
C11505,Propylene;|Propene,,,,,
C11506,"(2R)-1,2-Epoxypropane",,,,,
C11507,"(S)-1,2-Epoxypropane",,,,,
C11508,"4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol;|Delta8,14-Sterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C11508  4alpha-Methyl-5alpha-ergosta-8,14,24(28)-trien-3beta-ol",
C11509,3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carbaldehyde,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C11509  3beta-Hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carbaldehyde,
C11510,"2,4.6-Trichloroanisole",,,,,
C11511,threo-3-Hydroxy-L-aspartate;|L-threo-3-Hydroxyaspartate,,,,,
C11512,Methyl jasmonate;|(-)-Methyl jasmonate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C11512  (-)-Methyl jasmonate,
C11513,(24R)-24-Methylcycloart-25-en-3-beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C11513  (24R)-24-Methylcycloarta-25-en-3-beta-ol,
C11514,(E)-3-(Methoxycarbonyl)pent-2-enedioate;|(2E)-3-(Methoxycarbonyl)pent-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C11514  (2E)-3-(Methoxycarbonyl)pent-2-enedioic acid,
C11515,(E)-2-(Methoxycarbonylmethyl)butenedioate;|(2E)-2-(Methoxycarbonylmethyl)but-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C11515  (2E)-2-(Methoxycarbonylmethyl)but-2-enedioic acid,
C11516,2-(alpha-D-Mannosyl)-3-phosphoglycerate,,,,,
C11519,N-Cyclohexylformamide,,,,,
C11520,Cyclohexyl isocyanide;|N-Cyclohexylisocyanide;|Cyclohexaneisonitrile,,,,,
C11521,UDP-6-sulfoquinovose,,,,,
C11522,"24-Methylenelophenol;|24-Methylidenelophenol;|4alpha-Methyl-5alpha-ergosta-7,24-dien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C11522  24-Methylenelophenol,
C11523,"24-Ethylidenelophenol;|alpha1-Sitosterol;|4-alpha-Methyl-5-alpha-stigmasta-7,Z-24-dien-3-beta-ol;|(Z)-24-Ethylidenelophenol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C11523  24-Ethylidene lophenol,
C11526,"5-PP-InsP5;|5-Diphosphoinositol pentakisphosphate;|1D-myo-Inositol 5-diphosphate pentakisphosphate;|1D-myo-Inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate",,,,,
C11527,4-Hydroxymandelate;|4-Hydroxymandelic acid,(R)-4-Hydroxymandelate [CPD:C05343]|(S)-4-Hydroxymandelate [CPD:C03198],,,,
C11529,N-Carbamoyl-L-amino acid;|N-Carbamoyl-L-2-amino acid,Generic compound in reaction hierarchy,,,,
C11531,6-O-(beta-D-Xylopyranosyl)-beta-D-glucopyranoside;|beta-Primeveroside,Generic compound in reaction hierarchy,,,,
C11535,6-O-(beta-D-Xylopyranosyl)-beta-D-glucopyranose;|beta-Primeverose,,,,,G00322
C11536,(2R)-O-Phospho-3-sulfolactate;|(2R)-Phosphosulfolactate,,,,,
C11537,(2R)-3-Sulfolactate;|(R)-3-Sulfolactate,,,,,
C11538,Cobalt-sirohydrochlorin;|Cobalt-factor II,,,,,
C11539,Cobalt-precorrin 3,,,,,
C11540,Cobalt-precorrin 4,,,,,
C11541,Cobalt-precorrin 5,,,,,
C11542,Cobalt-precorrin 6;|Cobalt-precorrin 6A,,,,,
C11543,Cobalt-dihydro-precorrin 6;|Cobalt-precorrin 6B,,,,,
C11544,2-O-(alpha-D-Mannosyl)-D-glycerate;|alpha-Mannosylglycerate;|2-O-(alpha-D-Mannopyranosyl)-D-glycerate,,,,,
C11545,Cobalt-precorrin 8;|Cobalt-precorrin-8,,,,,
C11546,2-O-(alpha-D-Glucopyranosyl)glycerol;|2-O-alpha-D-Glucosylglycerol,,,,,
C11547,3-(Acyloxy)acyl group of bacterial toxin,Generic compound in reaction hierarchy,,,,
C11548,3-Hydroxyacyl group of bacterial toxin,Generic compound in reaction hierarchy,,,,
C11549,Poly[(R)-3-hydroxyoctanoate]n;|Poly[(R)-3-hydroxyoctanoate]n-x,,,,,
C11550,Poly[(R)-3-hydroxyoctanoate]x,,,,,
C11551,Poly[(R)-3-hydroxybutanoate]n-x;|Poly[(R)-3-hydroxybutanoate]n,,,,,
C11552,Poly[(R)-3-hydroxybutanoate]x,,,,,
C11553,[Heparan sulfate]-glucosamine 3-sulfate,Generic compound in reaction hierarchy|The disaccharide repeating unit is shown here.|R = linear heparan sulfate (HS) chain|R1 = SO3H or H,,,,
C11554,"1-Phosphatidyl-1D-myo-inositol 3,4-bisphosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP08 Glycerophosphoinositol bisphosphates|GP0801 Diacylglycerophosphoinositol bisphosphates|C11554  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate)",
C11555,"1D-myo-Inositol 1,4,5,6-tetrakisphosphate;|D-myo-Inositol 1,4,5,6-tetrakisphosphate;|Inositol 1,4,5,6-tetrakisphosphate",,,,,
C11556,"1-Phosphatidyl-1D-myo-inositol 3,5-bisphosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP08 Glycerophosphoinositol bisphosphates|GP0801 Diacylglycerophosphoinositol bisphosphates|C11556  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate)",
C11557,"1-Phosphatidyl-1D-myo-inositol 5-phosphate;|1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate)",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP07 Glycerophosphoinositol monophosphates|GP0701 Diacylglycerophosphoinositol monophosphates|C11557  1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-5'-phosphate)",
C11560,"1-Carbazol-9-yl-3-(3,5-dimethylpyrazol-1-yl)-propan-2-ol",,,,,
C11561,"2-(4-Chloro-3,5-dimethylphenoxy)-N-(2-phenyl-2H-benzotriazol-5-yl)-acetamide",,,,,
C11562,"N-[2-(4-Chloro-phenyl)-acetyl]-N'-(4,7-dimethyl-quinazolin-2-yl)-guanidine",,,,,
C11563,"1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinoline",,,,,
C11564,N-(3-Benzooxazol-2-yl-4-hydroxy-phenyl)-2-p-tolyloxyacetamide,,,,,
C11565,"8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene",,,,,
C11566,"3-(4-Chloro-benzyl)-5-(2-methoxy-phenyl)-[1,2,4]oxadiazole",,,,,
C11567,"2-Phenethylsulfanyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-d]pyrimidin-4-ylamine",,,,,
C11568,"(5,12,13-Triaza-indeno[1,2-b]anthracen-13-yl)-acetic acid ethyl ester",,,,,
C11569,"2,2'-(1-Phenyl-1H-1,2,4-triazole-3,5-diyl)bis-phenol",,,,,
C11570,"2-(2-Chloro-phenyl)-5-(5-methylthiophen-2-yl)-[1,3,4]oxadiazole",,,,,
C11571,"2-p-Tolyl-5,6,7,8-tetrahydrobenzo[d]imidazo[2,1-b]thiazole",,,,,
C11572,Glycoprotein with the oligosaccharide chain attached by N-glycosyl linkage to protein L-asparagine,Generic compound in reaction hierarchy,,,,
C11573,"6,8-Di-(3,3-dimethylallyl)chrysin;|6,8-Di-DMA-chrysin;|6,8-Di-(3,3-DMA)chrysin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11573  6,8-Di-(3,3-dimethylallyl)chrysin",
C11574,6-Geranylchrysin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11574  6-Geranylchrysin,
C11575,8-Geranylchrysin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11575  8-Geranylchrysin,
C11576,"6-(3,3-Dimethylallyl)galangin;|6-(3,3-DMA)galangin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11576  6-(3,3-Dimethylallyl)galangin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C11576  6-(3,3-DMA)galangin",
C11577,"3-Methylgalangin;|5,7-Dihydroxy-3-methoxy-2-phenyl-4H-1-benzopyran-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11577  3-Methylgalangin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C11577  3-Methylgalangin,
C11578,"8-(3,3-Dimethylallyl)-3-methylgalangin;|8-(3,3-DMA)-3-methylgalangin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11578  8-(3,3-Dimethylallyl)-3-methylgalangin",
C11579,"8-(1,1-Dimethylallyl)-3-methylgalangin;|8-(1,1-DMA)-3-methylgalangin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11579  8-(1,1-Dimethylallyl)-3-methylgalangin",
C11580,"8-(1,1-Dimethylallyl)kaempferide;|8-(1,1-DMA)kaempferide",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11580  8-(1,1-Dimethylallyl)kaempferide|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C11580  8-(1,1-DMA)kaempferide",
C11581,"8-(1,1-Dimethylallyl)galangin;|8-(1,1-DMA)galangin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11581  8-(1,1-Dimethylallyl)galangin",
C11582,2-Chlorophenylhydrazine hydrochloride;|o-Chlorophenylhydrazine hydrochloride,,,,,
C11583,4-Glutathionyl cyclophosphamide,,,,,
C11584,4-Methylumbelliferone glucuronide;|4-Methylumbelliferyl glucuronide,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C11584  4-Methylumbelliferone glucuronide,
C11585,4-Methylumbelliferone sulfate;|4-Methylumbelliferyl sulfate,,,,,
C11586,alpha-Naphthyl-beta-D-glucuronide;|1-Naphthyl glucuronide,,,,,
C11587,BQ 123;|Cyclo[D-trp-D-asp-L-pro-D-val-L-leu],,,,,
C11588,"cis-3-(Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol;|cis-3-(2-Carboxy-ethyl)-3,5-cyclo-hexadiene-1,2-diol;|3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)propanoate",,,,,
C11589,BQ 518,,,,,
C11590,Beauvericin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C11590  Beauvericin,
C11591,"DIDS;|4,4'-Diisothiocyanostilbene-2,2'-disulfonic acid",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C11591  DIDS",
C11592,Diethyl pyrocarbonate,,,,,
C11593,E3040,,,,,
C11594,E3040 sulfate,,,,,
C11595,E3040 glucuronide,,,,,
C11596,FMLP;|N-Formyl-L-methionyl-L-leucyl-L-phenylalanine,N-Formyl-Met Leu Phe,,,,
C11597,Grepafloxacin glucuronide;|Grepafloxacin 3-glucuronide,,,,,
C11598,Hydroxylamine hydrochloride,,,,,
C11599,IAARh123;|[125I]Iodoaryl azido-rhodamine 123,,,,,
C11600,IACI;|N-(Hydrocinchonidin-8'-yl)-4-azido-2-hydroxybenzamide,,,,,
C11601,LDS-751,,,,,
C11602,"MC-207,110",,,,,
C11603,Monochloro-monoglutathionyl melphalan,,,,,
C11604,N-tert-Butyloxycarbonyl-deacetyl-leupeptin;|N-t-Boc-deacetyl-leupeptin,,,,,
C11605,"NAc-DNP-Cys;|N-Acetyl 2,4-dinitrophenyl cysteine;|N-Acetyl-S-(2,4-dinitrophenyl)-L-cysteine",,,,,
C11606,NAc-FnorLRF-amide;|N-Acetyl-phenylalanyl-norleucyl-arginyl-phenylalanyl-amide,,,,,
C11607,N-Acetyl-leu-leu-leu-leu-leu-tyr-amide;|NAc-L5Y-amide,,,,,
C11608,Nafenopin glucuronide,,,,,
C11609,Nigericin,,,,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C11609  Nigericin,
C11610,Pepsinostreptin;|N-Isobutyrylpepstatin;|Isobutyryl-Val-Val-Sta-Ala-Sta,"Sta = statine =(3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid",,,,
C11611,Phenyl beta-D-glucopyranoside;|Phenylglucoside,,,,,
C11612,Polymyxin B,Generic compound|Polymyxin B1 (R = CH3)|Polymyxin B2 (R = H),,,"Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C11612  Polymyxin B|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08401)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA05 Polymyxin B|D08401  Polymyxin B (INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XB Polymyxins|J01XB02 Polymyxin B|D08401  Polymyxin B (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA18 Polymyxin B|D08401  Polymyxin B (INN)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA11 Polymyxin B|D08401  Polymyxin B (INN)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA03 Polymyxin B|D08401  Polymyxin B (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08401)]|Second-class OTC drugs|Inorganic and organic chemicals|Polymyxin B|D08401  Polymyxin B (INN)|Drug groups [BR:br08330(D08401)]|Antibacterial|DG01579  Polypeptide antibiotic|DG00083  Polymyxin B|D08401  Polymyxin B|Antimicrobials [BR:br08307(D08401)]|Antibacterials|Cell membrane function inhibitor|Polypeptide|D08401  Polymyxin B (INN)",
C11613,Polymyxin B sulfate;|Polymixin B sulfate,Generic compound,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01066)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA05 Polymyxin B|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XB Polymyxins|J01XB02 Polymyxin B|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA18 Polymyxin B|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA11 Polymyxin B|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA03 Polymyxin B|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01066)]|Antibacterials|Antibacterials, Other|Polymyxin B|D01066  Polymyxin B sulfate (USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01066)]|2  Agents affecting individual organs|26  Epidermides|263  Suppurative dermatosis agents|2634  Antibiotics for external use|D01066  Polymyxin B sulfate (USP/INN); Polymixin B sulfate (JP18)|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6126  Polymyxin B|D01066  Polymyxin B sulfate (USP/INN); Polymixin B sulfate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01066)]|Second-class OTC drugs|Inorganic and organic chemicals|Polymyxin B|D01066  Polymyxin B sulfate (USP/INN)|Drug groups [BR:br08330(D01066)]|Antibacterial|DG01579  Polypeptide antibiotic|DG00083  Polymyxin B|D01066  Polymyxin B sulfate|Antimicrobials [BR:br08307(D01066)]|Antibacterials|Cell membrane function inhibitor|Polypeptide|D01066  Polymyxin B sulfate (USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01066)]|Chemicals|D01066  Polymixin B sulfate",
C11615,Pristinamycin IA;|Vernamycin B alpha;|Mikamycin B;|4-[4-(Dimethylamino)-N-methyl-L-phenylalanine]virginiamycin S1;|Streptogramin B,"4 Ala is modified by 4-dimethylparaaminophenyl. (i.e. 4-Dimethylparaaminophenylalanine, DMPAPA)|6 Gly is modified by phenyl. (i.e. Phenylglycine, Pg)",0 HPA  1 Thr  2 Abu  3 Pro  4 Ala  5 Pip  6 Gly|(Cyclization: 1-6),NRP,,
C11616,Pristinamycin IB;|Vernamycin B beta;|Efepristin;|4-[N-Methyl-4-(methylamino)-L-phenylalanine]virginiamycin S1,,,,,
C11617,Pristinamycin IC;|Vernamycin B gamma;|2-D-Alanine-4-[4-(dimethylamino)-N-methyl-L-phenylalanine]virginiamycin S1,,,,,
C11618,Puromycin dihydrochloride,,,,Antimicrobials [BR:br08307(D05655)]|Antibacterials|Protein biosynthesis inhibitor|Other protein biosynthesis inhibitor|D05655  Puromycin hydrochloride (USAN),
C11619,Spectinomycin dihydrochloride,,,,,
C11620,"Syringetin;|3',5'-O-Dimethylmyricetin;|3,5,7,4'-Tetrahydroxy-3',5'-dimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11620  Syringetin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C11620  Syringetin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11620,
C11621,Tectochrysin;|Techtochrysin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C11621  Tectochrysin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C11621  Tectochrysin,
C11622,Tetramethylrosamine,,,,,
C11623,"Triton X-100;|alpha-(4-(1,1,3,3-Tetramethylbutyl)phenyl)-omega-hydroxypoly(oxy-1,2-ethanediyl)",,,,,
C11624,Tween 20,w+x+y+z=20,,,,
C11625,Tween 80;|Polysorbate 80,w+x+y+z=20,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01067)]|Chemicals|D01067  Polysorbate 80,
C11626,Vinblastine sulfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01068)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CA Vinca alkaloids and analogues|L01CA01 Vinblastine|D01068  Vinblastine sulfate (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01068)]|4  Agents affecting cellular function|42  Antineoplastics|424  Plant extract preparations|4240  Plant extract preparations|D01068  Vinblastine sulfate (JP18/USP)|Drug groups [BR:br08330(D01068)]|Antineoplastic|DG01965  Vinca alkaloid antineoplastic|DG00689  Vinblastine|D01068  Vinblastine sulfate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00689  Vinblastine|D01068  Vinblastine sulfate|Target-based classification of drugs [BR:br08310(D01068)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D01068  Vinblastine sulfate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01068)]|Chemicals|D01068  Vinblastine sulfate|D01068  Vinblastine sulfate for injection|Drug metabolizing enzymes and transporters [br08309.html(D01068)]|Drug metabolizing enzymes|D01068,
C11627,ortho-Vanadate;|Vanadate,,,,,
C11628,p-Aminobenzamidine dihydrochloride,,,,,
C11629,"omega-Carboxy-N-acetyl-LTE4;|(7E,9E,11Z,14Z)-(5S,6R)-6-((N-Acetyl)cystein-S-yl)-5-hydroxyeicosa-7,9,11,14-tetraen-1,20-dioate;|omega-COOH-LTE4NAc",,,,,
C11630,"15,16-Dihydrobiliverdin;|15,16-Dihydrobiliverdin IXalpha;|15,16-Dihydrobiliverdin ixa",,,,,
C11631,9-Riburonosylhypoxanthine,,,,,
C11632,Polyneuridine aldehyde,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11632  Polyneuridine aldehyde,
C11633,16-Epivellosimine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11633  16-Epivellosimine,
C11634,Vellosimine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11634  Vellosimine,
C11635,10-Deoxysarpagine;|Sarpagan-17-ol,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11635  10-Deoxysarpagine,
C11636,7-Deoxyloganate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11636  7-Deoxyloganate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C11636  7-Deoxyloganate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11636  7-Deoxyloganate",
C11637,"3alpha,12alpha-Dihydroxy-5beta-chol-6-enoate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C11637  3alpha,12alpha-Dihydroxy-5beta-chol-6-enoic acid",
C11638,3-Amino-2-oxopropyl phosphate;|1-Amino-3-(phosphohydroxy)propan-2-one,,,,,
C11639,Geniposide pentaacetate;|Pentaacetyl geniposide,,,,,
C11640,Patrinoside,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11640  Patrinoside,
C11641,"3',4'-Anhydrovinblastine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11641  3',4'-Anhydrovinblastine",
C11642,19-Hydroxytabersonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11642  19-Hydroxytabersonine,
C11643,16-Hydroxytabersonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11643  16-Hydroxytabersonine,
C11644,Lamiide,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11644  Lamiide,
C11645,Lamioside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11645  Lamioside|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C11645  Lamioside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11645  Lamioside",
C11646,Deoxyloganin tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11646  Deoxyloganin tetraacetate",
C11647,Deoxyloganic acid tetraacetate,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11647  Deoxyloganic acid tetraacetate,
C11648,8-Epideoxyloganin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11648  8-Epideoxyloganin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11648  8-Epideoxyloganin",
C11649,8-Epideoxyloganic acid,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11649  8-Epideoxyloganic acid,
C11650,8-Epideoxyloganin tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11650  8-Epideoxyloganin tetraacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11650  8-Epideoxyloganin tetraacetate",
C11651,8-Epiiridodial,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11651  8-Epiiridodial",
C11652,8-Epiiridotrial glucoside;|Boschnaloside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11652  8-Epiiridotrial glucoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11652  8-Epiiridotrial glucoside",
C11653,Iridotrial glucoside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11653  Iridotrial glucoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11653  Iridotrial glucoside",
C11654,Tarennoside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11654  Tarennoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11654  Tarennoside",
C11655,Asperuloside tetraacetate,Asperuloside [CPD:C09769],,,,
C11656,8-Epiiridodial glucoside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11656  8-Epiiridodial glucoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11656  8-Epiiridodial glucoside",
C11657,Iridodial glucoside tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11657  Iridodial glucoside tetraacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11657  Iridodial glucoside tetraacetate",
C11658,8-Epiiridodial glucoside tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11658  8-Epiiridodial glucoside tetraacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11658  8-Epiiridodial glucoside tetraacetate",
C11659,10-Hydroxyloganin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11659  10-Hydroxyloganin|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11659  10-Hydroxyloganin",
C11660,10-Hydroxymorroniside,,,,,
C11661,7-Epiloganic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11661  7-Epiloganic acid|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11661  7-Epiloganic acid",
C11662,7-Epiloganin tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11662  7-Epiloganin tetraacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11662  7-Epiloganin tetraacetate",
C11663,Loganin pentaacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11663  Loganin pentaacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11663  Loganin pentaacetate",
C11664,10-Deoxygeniposide tetraacetate,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11664  10-Deoxygeniposide tetraacetate,
C11665,7-Deoxygardoside metyl ester tetraacetate,,,,,
C11666,11-Hydroxyiridodial glucoside pentaacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11666  11-Hydroxyiridodial glucoside pentaacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11666  11-Hydroxyiridodial glucoside pentaacetate",
C11667,8-epi-11-Hydroxyiridodial glucoside pentaacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11667  8-epi-11-Hydroxyiridodial glucoside pentaacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11667  8-epi-11-Hydroxyiridodial glucoside pentaacetate",
C11668,7-Dehydrologanin tetraacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11668  7-Dehydrologanin tetraacetate|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11668  7-Dehydrologanin tetraacetate",
C11669,Deutzioside pentaacetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11669  Deutzioside pentaacetate",
C11670,Iridodial glucoside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11670  Iridodial glucoside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11670  Iridodial glucoside",
C11671,Deutzioside,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11671  Deutzioside|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C11671  Deutzioside|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11671  Deutzioside",
C11672,10-Deoxygeniposidic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11672  10-Deoxygeniposidic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C11672  10-Deoxygeniposidic acid|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11672  10-Deoxygeniposidic acid",
C11673,Geniposidic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010207 Iridoid, 10-alkyliridoid and secoiridoid monoterpenoids|C11673  Geniposidic acid|C11673  Geniposidic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Iridoids|C11673  Geniposidic acid|Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C11673  Geniposidic acid",
C11674,Secogalioside,,,,,
C11675,16-Methoxytabersonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11675  16-Methoxytabersonine,
C11676,Lochnericine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11676  Lochnericine,
C11677,Horhammericine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11677  Horhammericine,
C11678,Dialdehyde,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11678  Dialdehyde,
C11679,"4,21-Dehydrocorynantheine aldehyde",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11679  4,21-Dehydrocorynantheine aldehyde",
C11680,Cathenamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11680  Cathenamine,
C11681,19-epi-Cathenamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11681  19-epi-Cathenamine,
C11682,Tetrahydroalstonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11682  Tetrahydroalstonine,
C11683,19-epi-Ajmalicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11683  19-epi-Ajmalicine,
C11684,MET-enkephalin;|Methionine enkephalin,,Tyr Gly Gly Phe Met,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Enkephalin|C11684  Met-enkephalin|Bioactive peptides [BR:br08005]|Neuropeptides|Endogenous opioid peptide|C11684  Met-enkephalin,
C11685,Clorgyline,,,,Drug groups [BR:br08330(D03248)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01558  Monoamine oxidase A inhibitor|D03248  Clorgiline|Target-based classification of drugs [BR:br08310(D03248)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAOA|D03248  Clorgiline (INN),
C11686,Uracil mustard,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06265)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AD Nitrosoureas|L01AD08 Uramustine|D06265  Uracil mustard (USAN)|Drug groups [BR:br08330(D06265)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|D06265  Uracil mustard,
C11687,Aziridine,,,,,
C11688,Asperlicin,,,,,
C11689,Curacin A,,,PKNRP,,
C11690,Epibatidine,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C11690  Epibatidine,
C11691,Stemmadenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11691  Stemmadenine,
C11692,Tetrodotoxin;|TTX,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Tetrodotoxins|C11692  Tetrodotoxin,
C11694,Quinoline-3-carboxamides,,,,,
C11695,"Anandamide;|Arachidonylethanolamide;|N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-ethanolamine;|AEA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0804 N-acyl ethanolamines (endocannabinoids)|C11695  N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-ethanolamine",
C11696,Practolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05587)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB01 Practolol|D05587  Practolol (USAN)|Drug groups [BR:br08330(D05587)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|D05587  Practolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|D05587  Practolol|Target-based classification of drugs [BR:br08310(D05587)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D05587  Practolol (USAN)",
C11697,Levcromakalim;|(-)-Cromakalim,,,,Drug groups [BR:br08330(D02385)]|Cardiovascular agent|DG01583  ATP-sensitive potassium channel opener|D02385  Levcromakalim|Target-based classification of drugs [BR:br08310(D02385)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D02385  Levcromakalim (USAN/INN)|ABCC9(SUR2)/KCNJ11(KIR6.2)|D02385  Levcromakalim (USAN/INN),
C11698,UH-301,,,,,
C11699,Glenvastatin;|HR 780,,,,,
C11700,10-Deacetylbaccatin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C11700  10-Deacetylbaccatin III|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C11700  10-Deacetylbaccatin III,
C11701,UK-47265,,,,,
C11702,Tienilic acid;|Ticrynafen,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02386)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03C HIGH-CEILING DIURETICS|C03CC Aryloxyacetic acid derivatives|C03CC02 Tienilic acid|D02386  Ticrynafen (USAN)|Drug groups [BR:br08330(D02386)]|Cardiovascular agent|DG01748  Loop diuretic|D02386  Ticrynafen|Target-based classification of drugs [BR:br08310(D02386)]|Transporters|Solute carrier family|SLC12|SLC12A1 (NKCC2)|D02386  Ticrynafen (USAN)|SLC12A2 (NKCC1)|D02386  Ticrynafen (USAN),
C11703,L-Isoprenaline;|Levisoprenaline,,,,,
C11704,DuP 697,,,,,
C11705,SC-58125,,,,,
C11706,SC-57666,,,,,
C11707,Pronethalol;|Pronetalol,,,,,
C11708,Sultopride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08549)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AL Benzamides|N05AL02 Sultopride|D08549  Sultopride (INN)|Drug groups [BR:br08330(D08549)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00900  Sultopride|D08549  Sultopride|DG03200  Antipsychotic agent|DG01941  Benzamide antipsychotic|DG00900  Sultopride|D08549  Sultopride|Target-based classification of drugs [BR:br08310(D08549)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D08549  Sultopride (INN),
C11709,DU 122290,,,,,
C11710,Devazepide;|MK-329,,,,Target-based classification of drugs [BR:br08310(D02693)]|G Protein-coupled receptors|Rhodopsin family|Cholecystokinin|CCKAR|D02693  Devazepide (USAN/INN),
C11711,Succinylproline;|Succinyl-L-proline,,,,,
C11712,Teprotide,,pyroGlu Trp Pro Arg Pro Gln Ile Pro Pro,Peptide,Drug groups [BR:br08330(D06076)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|D06076  Teprotide|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|D06076  Teprotide|Target-based classification of drugs [BR:br08310(D06076)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D06076  Teprotide (USAN/INN),
C11713,2-Naphthol;|beta-Naphthol,,,,,
C11714,1-Naphthol;|alpha-Naphthol,,,,,
C11715,Lucanthone,,,,,
C11716,Mirasan,,,,,
C11717,D1927,,,,,
C11718,L791456;|Etoricoxib,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03710)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AH Coxibs|M01AH05 Etoricoxib|D03710  Etoricoxib (USAN/INN)|Drug groups [BR:br08330(D03710)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01922  Selective COX2 inhibitor|DG01907  Anti-inflammatory drug, coxibs|D03710  Etoricoxib|Target-based classification of drugs [BR:br08310(D03710)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D03710  Etoricoxib (USAN/INN)",
C11719,L787257,,,,,
C11720,Enalaprilat;|Enalaprilate,,,,Prodrugs [br08324.html]|C11720,
C11721,Candoxatrilat,,,,,
C11723,Hexobarbitone;|Hexobarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01071)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AF Barbiturates, plain|N01AF02 Hexobarbital|D01071  Hexobarbital (JAN/INN)|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA16 Hexobarbital|D01071  Hexobarbital (JAN/INN)|Drug groups [BR:br08330(D01071)]|Neuropsychiatric agent|DG01837  Barbiturate sedative-hypnotics|D01071  Hexobarbital|DG01567  GABA-A receptor agonist|D01071  Hexobarbital|DG02030  Anesthetics|DG02027  General anesthetics|DG02025  Barbiturate anesthetics|D01071  Hexobarbital|Target-based classification of drugs [BR:br08310(D01071)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D01071  Hexobarbital (JAN/INN)",
C11724,Cycloguanil pamoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02387)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P01 ANTIPROTOZOALS|P01B ANTIMALARIALS|P01BB Biguanides|P01BB02 Cycloguanil embonate|D02387  Cycloguanil pamoate (USAN)|Drug groups [BR:br08330(D02387)]|Antiparasitic|DG01932  Antifolate, antiprotozoal|D02387  Cycloguanil pamoate|Antimicrobials [BR:br08307(D02387)]|Antiparasitics|Antmalarials|Biguanide|D02387  Cycloguanil pamoate (USAN)",
C11725,Avizafone;|LDZ,,,,,
C11726,Chloramphenicol palmitate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01072)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX02 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF03 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA05 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01B AMPHENICOLS|J01BA Amphenicols|J01BA01 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA01 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA01 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA08 Chloramphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|Drug groups [BR:br08330(D01072)]|Antibacterial|DG01576  Amphenicol type antibacterial|DG00399  Chloramphenicol|D01072  Chloramphenicol palmitate|Antimicrobials [BR:br08307(D01072)]|Antibacterials|Protein biosynthesis inhibitor|Amphenicol|D01072  Chloramphenicol palmitate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01072)]|Chemicals|D01072  Chloramphenicol palmitate|Prodrugs [br08324.html(D01072)]|D01072|Prodrugs [br08324.html]|C11726",
C11727,Chloramphenicol succinate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07675)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX02 Chloramphenicol|D07675  Chloramphenicol succinate|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF03 Chloramphenicol|D07675  Chloramphenicol succinate|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA05 Chloramphenicol|D07675  Chloramphenicol succinate|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01B AMPHENICOLS|J01BA Amphenicols|J01BA01 Chloramphenicol|D07675  Chloramphenicol succinate|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA01 Chloramphenicol|D07675  Chloramphenicol succinate|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA01 Chloramphenicol|D07675  Chloramphenicol succinate|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA08 Chloramphenicol|D07675  Chloramphenicol succinate|Drug groups [BR:br08330(D07675)]|Antibacterial|DG01576  Amphenicol type antibacterial|DG00399  Chloramphenicol|D07675  Chloramphenicol succinate|Antimicrobials [BR:br08307(D07675)]|Antibacterials|Protein biosynthesis inhibitor|Amphenicol|D07675  Chloramphenicol succinate|Prodrugs [br08324.html(D07675)]|D07675|Prodrugs [br08324.html]|C11727",
C11728,Clindamycin phosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01073)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF01 Clindamycin|D01073  Clindamycin phosphate (JP18/USP) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA10 Clindamycin|D01073  Clindamycin phosphate (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FF Lincosamides|J01FF01 Clindamycin|D01073  Clindamycin phosphate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01073)]|Antibacterials|Antibacterials, Other|Clindamycin|D01073  Clindamycin phosphate (JP18/USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Clindamycin|D01073  Clindamycin phosphate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01073)]|2  Agents affecting individual organs|26  Epidermides|263  Suppurative dermatosis agents|2634  Antibiotics for external use|D01073  Clindamycin phosphate (JP18/USP)|6  Agents against pathologic organisms and parasites|61  Antibiotics|611  Acting mainly on gram-positive bacteria|6112  Lincomycins|D01073  Clindamycin phosphate (JP18/USP)|Drug groups [BR:br08330(D01073)]|Antibacterial|DG01578  Lincosamide antibiotic|DG00435  Clindamycin|D01073  Clindamycin phosphate|Drug classes [BR:br08332(D01073)]|Antibacterial|DG01578  Lincosamide antibiotic|D01073  Clindamycin phosphate|Antimicrobials [BR:br08307(D01073)]|Antibacterials|Protein biosynthesis inhibitor|Lincosamide|D01073  Clindamycin phosphate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01073)]|Chemicals|D01073  Clindamycin phosphate|D01073  Clindamycin phosphate injection|Prodrugs [br08324.html(D01073)]|D01073|Prodrugs [br08324.html]|C11728",
C11729,Hetacillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01074)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA18 Hetacillin|D01074  Hetacillin (USAN/INN)|Drug groups [BR:br08330(D01074)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00532  Hetacillin|D01074  Hetacillin|DG01780  Extended spectrum penicillin|DG00532  Hetacillin|D01074  Hetacillin|Antimicrobials [BR:br08307(D01074)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D01074  Hetacillin (USAN/INN)|Prodrugs [br08324.html(D01074)]|D01074|Prodrugs [br08324.html]|C11729",
C11730,Temoporfin;|Foscan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06066)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XD Sensitizers used in photodynamic/radiation therapy|L01XD05 Temoporfin|D06066  Temoporfin (USAN/INN)|New drug approvals in Europe [br08329.html(D06066)]|European public assessment reports (EPAR) authorised medicine|D06066,
C11731,m-Chlorobenzamide;|3-Chlorobenzamide,,,,,
C11732,"Diethyl phenyl phosphate;|Phosphoric acid, diethyl phenyl ester",,,,,
C11733,Decamethonium,,,,,
C11734,Altanserin,,,,,
C11735,N-Ethylglycine,,,,,
C11736,5-Fluorodeoxyuridine;|Floxuridine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04197)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC09 Floxuridine|D04197  Floxuridine (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D04197)]|Antineoplastics|Antimetabolites|Floxuridine|D04197  Floxuridine (USP/INN)|Drug groups [BR:br08330(D04197)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|D04197  Floxuridine|Drug classes [BR:br08332(D04197)]|Antineoplastic|DG02018  Antimetabolite|D04197  Floxuridine|Target-based classification of drugs [BR:br08310(D04197)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D04197  Floxuridine (USP/INN) &lt;US&gt;",
C11737,CB3717,,,,,
C11738,m-Chlorophenylpiperazine;|1-(3-Chlorophenyl)piperazine;|mCPP,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C11738,
C11739,SB 200646;|N-(1-Methyl-5-indolyl)-N'-(3-pyridyl)urea,,,,,
C11740,SB 206553,,,,,
C11741,SB 221284,,,,,
C11742,SB 228357,,,,,
C11743,SB 243213,,,,,
C11744,Salvarsan;|Arsphenamine,,,,,
C11745,Succinyl sulfathiazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07060)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AB Sulfonamides|A07AB04 Succinylsulfathiazole|D07060  Succinylsulfathiazole (INN)|Drug groups [BR:br08330(D07060)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|DG00088  Succinylsulfathiazole|D07060  Succinylsulfathiazole|Antimicrobials [BR:br08307(D07060)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D07060  Succinylsulfathiazole (INN)|Prodrugs [br08324.html(D07060)]|D07060|Prodrugs [br08324.html]|C11745",
C11746,Penillic acid,,,,,
C11747,Penicillenic acid;|3-Mercapto-N-[(5-oxo-4(5H)-oxazolylidene)methyl]-valine,,,,,
C11748,Flucloxacillin;|Floxacillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04196)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF05 Flucloxacillin|D04196  Floxacillin (USAN)|Drug groups [BR:br08330(D04196)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00543  Flucloxacillin|D04196  Floxacillin|DG01779  beta-Lactamase resistant penicillin|DG00543  Flucloxacillin|D04196  Floxacillin|Antimicrobials [BR:br08307(D04196)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D04196  Floxacillin (USAN)",
C11749,(p-Aminobenzyl)penicillin;|Penicillin T,,,,,
C11750,Pivampicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08396)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA02 Pivampicillin|D08396  Pivampicillin (INN)|Drug groups [BR:br08330(D08396)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00518  Pivampicillin|D08396  Pivampicillin|DG01780  Extended spectrum penicillin|DG00518  Pivampicillin|D08396  Pivampicillin|Antimicrobials [BR:br08307(D08396)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D08396  Pivampicillin (INN)|Prodrugs [br08324.html(D08396)]|D08396|Prodrugs [br08324.html]|C11750",
C11751,Talampicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08557)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA15 Talampicillin|D08557  Talampicillin (INN)|Drug groups [BR:br08330(D08557)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00529  Talampicillin|D08557  Talampicillin|DG01780  Extended spectrum penicillin|DG00529  Talampicillin|D08557  Talampicillin|Antimicrobials [BR:br08307(D08557)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D08557  Talampicillin (INN)",
C11752,Carfecillin;|Carbenicillin phenyl,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA08 Carfecillin|C11752  Carfecillin|Drug groups [BR:br08330]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00443  Carfecillin|C11752  Carfecillin",G00443
C11754,Cephaloridine;|Cefaloridine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01075)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB02 Cefaloridine|D01075  Cephaloridine (USAN)|Drug groups [BR:br08330(D01075)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|D01075  Cephaloridine|DG01774  First-generation cephalosporin|D01075  Cephaloridine|Antimicrobials [BR:br08307(D01075)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D01075  Cephaloridine (USAN)|Antimicrobials abbreviations [BR:br08327(D01075)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D01075  Cephaloridine (USAN)",
C11755,Epithienamycin E;|MM13902,,,,,
C11756,6-Methylpenicillin,Generic compound in reaction hierarchy,,,,
C11757,Acyl-D-Ala-D-Ala,,,,,
C11758,Mupirocin;|Pseudomonic acid A,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01076)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX09 Mupirocin|D01076  Mupirocin (USP/INN) &lt;US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX06 Mupirocin|D01076  Mupirocin (USP/INN) &lt;US&gt;|USP drug classification [BR:br08302(D01076)]|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Mupirocin|D01076  Mupirocin (USP/INN)|Antimicrobials [BR:br08307(D01076)]|Antibacterials|Protein biosynthesis inhibitor|Other protein biosynthesis inhibitor|D01076  Mupirocin (USP/INN) &lt;US&gt;",
C11760,Amprotropine,,,,,
C11761,Tridihexethyl bromide,,,,,
C11762,Propantheline chloride,,,,,
C11763,Miotine,,,,,
C11764,Sarin,,,,,
C11765,"1-Methyl-1,6-dihydropyridine-2-carbaldoxime;|ProPAM",,,,,
C11766,Rivastigmine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03822)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06D ANTI-DEMENTIA DRUGS|N06DA Anticholinesterases|N06DA03 Rivastigmine|D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D03822)]|Antidementia Agents|Cholinesterase Inhibitors|Rivastigmine|D03822  Rivastigmine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D03822)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D03822  Rivastigmine (JAN/USP/INN)|Drug groups [BR:br08330(D03822)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00984  Rivastigmine|D03822  Rivastigmine|DG01594  Butyrylcholinesterase inhibitor|DG00984  Rivastigmine|D03822  Rivastigmine|DG01968  Antidementia agent|DG00984  Rivastigmine|D03822  Rivastigmine|Drug classes [BR:br08332(D03822)]|Neuropsychiatric agent|DG01968  Antidementia agent|D03822  Rivastigmine|Target-based classification of drugs [BR:br08310(D03822)]|Enzymes|Hydrolases (EC3)|Carboxylic-ester hydrolases|ACHE|D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;|BCHE|D03822  Rivastigmine (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D03822)]|European public assessment reports (EPAR) authorised medicine|D03822|New drug approvals in Japan [br08318.html(D03822)]|Drugs with new active ingredients|D03822,
C11767,Xanomeline,,,,Drug groups [BR:br08330(D06330)]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG01300  Xanomeline|D06330  Xanomeline|Target-based classification of drugs [BR:br08310(D06330)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM1|D06330  Xanomeline (USAN)|CHRM4|D06330  Xanomeline (USAN),
C11768,Levonordefrin;|alpha-Methylnoradrenaline,,,,Drug groups [BR:br08330(D02388)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01450  alpha-Adrenergic receptor agonist|DG01449  alpha2-Adrenergic receptor agonist|D02388  Levonordefrin|DG01951  Catecholamine adrenergic receptor agonist|D02388  Levonordefrin|Target-based classification of drugs [BR:br08310(D02388)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA2|D02388  Levonordefrin (USP),
C11769,R-Soterenol,,,,,
C11770,R-Salbutamol;|(-)-Salbutamol;|Levalbuterol,,,,Drug groups [BR:br08330(D08124)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01235  Levalbuterol|D08124  Levosalbutamol|Target-based classification of drugs [BR:br08310(D08124)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D08124  Levosalbutamol (INN),
C11771,Salmefamol,,,,,
C11772,DCI;|Dichloroisoproterenol,,,,,
C11773,Epanolol,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06646)]|C CARDIOVASCULAR SYSTEM|C07 BETA BLOCKING AGENTS|C07A BETA BLOCKING AGENTS|C07AB Beta blocking agents, selective|C07AB10 Epanolol|D06646  Epanolol (USAN/INN)|Drug groups [BR:br08330(D06646)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01461  beta1-Adrenergic receptor antagonist|D06646  Epanolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|D06646  Epanolol|Target-based classification of drugs [BR:br08310(D06646)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D06646  Epanolol (USAN/INN)",
C11774,Primidolol,,,,Drug groups [BR:br08330(D02389)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|D02389  Primidolol|DG01653  Antiarrhythmics|DG01806  Class II antiarrhythmic agent|D02389  Primidolol|Target-based classification of drugs [BR:br08310(D02389)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D02389  Primidolol (USAN/INN),
C11775,Xamoterol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06328)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|C01CX Other cardiac stimulants|C01CX07 Xamoterol|D06328  Xamoterol (USAN)|Drug groups [BR:br08330(D06328)]|Cardiovascular agent|DG01703  Cardiotonic|DG00231  Xamoterol|D06328  Xamoterol|Target-based classification of drugs [BR:br08310(D06328)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB1|D06328  Xamoterol (USAN),
C11776,alpha-Methyl-m-tyramine;|Gepefrine,,,,,
C11777,Iproniazid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02579)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AF Monoamine oxidase inhibitors, non-selective|N06AF05 Iproniazide|D02579  Iproniazid (INN)|Drug groups [BR:br08330(D02579)]|Neuropsychiatric agent|DG01568  MAO inhibitor|DG01519  Non-selective monoamine oxidase inhibitor|DG00950  Iproniazide|D02579  Iproniazid|Target-based classification of drugs [BR:br08310(D02579)]|Enzymes|Oxidoreductases (EC1)|Amine oxidases|MAO|D02579  Iproniazid (INN)",
C11778,3-Acetylmorphine;|O(3)-Monoacetylmorphine,,,,,
C11779,Heterocodeine,,,,,
C11780,6-Ethylmorphine,,,,,
C11781,6-Acetylmorphine;|6-O-Monoacetylmorphine,,,,,
C11782,Dihydromorphine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C11782,
C11783,Minovincinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11783  Minovincinine,
C11784,Echitovenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11784  Echitovenine,
C11785,Normorphine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C11785,
C11786,Morphine N-oxide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C11786,
C11787,Nalorphine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08247)]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AB Antidotes|V03AB02 Nalorphine|D08247  Nalorphine (INN)|Drug groups [BR:br08330(D08247)]|Analgesic|DG01586  Opioid receptor antagonist|DG01151  Nalorphine|D08247  Nalorphine|Target-based classification of drugs [BR:br08310(D08247)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08247  Nalorphine (INN)|OPRK1|D08247  Nalorphine (INN)|Narcotics and psychotropics in Japan [br08308.html(D08247)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08247,
C11788,17-Methylmorphinan;|N-Methyl morphinan,,,,,
C11789,Metazocine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C11789,
C11790,Phenazocine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AD Benzomorphan derivatives|N02AD02 Phenazocine|C11790  Phenazocine|Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C11790,
C11791,Bremazocine,,,,,
C11792,Ketobemidone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08100)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02A OPIOIDS|N02AB Phenylpiperidine derivatives|N02AB01 Ketobemidone|D08100  Ketobemidone (INN)|Drug groups [BR:br08330(D08100)]|Analgesic|DG01984  Opioid analgesics|DG00815  Ketobemidone|D08100  Ketobemidone|Target-based classification of drugs [BR:br08310(D08100)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D08100  Ketobemidone (INN)|OPRK1|D08100  Ketobemidone (INN)|OPRD1|D08100  Ketobemidone (INN)|Narcotics and psychotropics in Japan [br08308.html(D08100)]|Narcotics by Control Act Article 2 Table 1 (74 substances)|D08100,
C11793,Etorphine,,,,Drug groups [BR:br08330(D07937)]|Neuropsychiatric agent|DG01564  Opioid receptor agonist|D07937  Etorphine|Analgesic|DG01984  Opioid analgesics|D07937  Etorphine|Target-based classification of drugs [BR:br08310(D07937)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07937  Etorphine (INN)|OPRK1|D07937  Etorphine (INN)|OPRD1|D07937  Etorphine (INN)|Narcotics and psychotropics in Japan [br08308.html(D07937)]|Narcotics by Cabinet Order Article 1 (157 substances)|D07937,
C11794,Diprenorphine,,,,Drug groups [BR:br08330(D07863)]|Analgesic|DG01587  Opioid receptor agonist/antagonist|DG01273  Diprenorphine|D07863  Diprenorphine|Target-based classification of drugs [BR:br08310(D07863)]|G Protein-coupled receptors|Rhodopsin family|Opioid|OPRM1|D07863  Diprenorphine (INN)|OPRK1|D07863  Diprenorphine (INN),
C11795,Ethylketocyclazocine;|EKC,,,,,
C11796,"U50488;|trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide",,,,,
C11797,Tifluadom,,,,,
C11798,Mepyramine;|Pyrilamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08183)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA02 Mepyramine|D08183  Mepyramine (INN)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AC Substituted ethylene diamines|R06AC01 Mepyramine|D08183  Mepyramine (INN)|Drug groups [BR:br08330(D08183)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00382  Mepyramine|D08183  Mepyramine|Target-based classification of drugs [BR:br08310(D08183)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D08183  Mepyramine (INN)",
C11799,SK&F 91581,,,,,
C11800,Thiaburimamide,,,,,
C11801,4-Methylburimamide,,,,,
C11802,Oxaburimamide,,,,,
C11803,Oxmetidine,,,,,
C11804,Lamtidine,,,,,
C11805,Loxtidine;|Lavoltidine,,,,,
C11806,Pantoprazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05353)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BC Proton pump inhibitors|A02BC02 Pantoprazole|D05353  Pantoprazole (USAN/INN)|Drug groups [BR:br08330(D05353)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01646  Proton pump inhibitor (PPI)|DG00021  Pantoprazole|D05353  Pantoprazole|Metabolizing enzyme substrate|DG01639  CYP2C19 substrate|DG00021  Pantoprazole|D05353  Pantoprazole|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00021  Pantoprazole|D05353  Pantoprazole|Target-based classification of drugs [BR:br08310(D05353)]|Enzymes|Hydrolases (EC3)|ATPase|ATP4|D05353  Pantoprazole (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D05353)]|Drug metabolizing enzymes|D05353,
C11807,Vinorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11807  Vinorine,
C11808,"1,2-Dihydrovomilenine;|2-beta-(R)-1,2-Dihydrovomilenine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11808  1,2-Dihydrovomilenine",
C11809,17-O-Acetylnorajmaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11809  17-O-Acetylnorajmaline,
C11810,Norajmaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11810  Norajmaline,
C11811,1-Hydroxy-2-methyl-2-butenyl 4-diphosphate;|(E)-4-Hydroxy-3-methyl-but-2-enyl diphosphate;|(E)-4-Hydroxy-3-methylbut-2-en-1-yl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0101 C5 isoprenoids (hemiterpenes)|C11811  1-Hydroxy-2-methyl-2-butenyl 4-diphosphate,
C11812,Lochnerinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C11812  Lochnerinine,
C11813,Demethylalangiside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11813  Demethylalangiside,
C11814,Demethylisoalangiside,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11814  Demethylisoalangiside,
C11815,Isoalangiside,,,,,
C11816,Protoemetine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11816  Protoemetine,
C11817,Deoxytubulosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11817  Deoxytubulosine,
C11818,(R)-Canadine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C11818  (R)-Canadine,
C11819,Cromakalim,,,,,
C11820,alpha-Methyl-m-tyrosine,,,,,
C11821,5-Hydroxyisourate,,,,,
C11822,2-Aminomalonate semialdehyde;|2-Ammoniomalonate semialdehyde,,,,,
C11823,"2,3-Ene acid",Generic compound in reaction hierarchy,,,,
C11825,3beta-Hydroxy-5beta-pregnane-20-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C11825  3beta-Hydroxy-5beta-pregnane-20-one",
C11826,[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol;|[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol;|[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol;|[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n+1-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C11826  [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-L-Lys-D-Ala-D-Ala)]n-diphosphoundecaprenol,G10554
C11827,[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n-diphosphoundecaprenol;|[GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n+1-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C11827  [GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-g-D-Glu-A2pm-D-Ala-D-Ala)]n-diphosphoundecaprenol,G10557
C11829,13(1)-Hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester;|13(1)-Hydroxy-Mg-protoporphyrin IX 13-monomethyl ester,,,,,
C11830,13(1)-Oxo-magnesium-protoporphyrin IX 13-monomethyl ester;|13(1)-Oxo-Mg-protoporphyrin IX 13-monomethyl ester,,,,,
C11831,"Divinylprotochlorophyllide;|2,4-Divinylprotochlorophyllide;|Mg-2,4-divinyl-phaeoporphyrin a5-monomethylester;|3,8-Divinyl protochlorophyllide a",,,,,
C11832,"Divinyl chlorophyllide a;|3,8-Divinyl chlorophyllide a",,,,,
C11833,Isoclavulanic acid,,,,,
C11834,4-Benzyloxybenzyl alcohol,,,,,
C11837,N-Butyryl-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C11837  N-Butyrylhomoserine lactone,
C11838,"(S)-4,5-Dihydroxypentane-2,3-dione;|(4S)-4,5-Dihydroxy-2,3-pentanedione",,,,,
C11839,N-(3-Oxohexanoyl)homoserine lactone,,,,,
C11840,N-(3-Oxododecanoyl)homoserine lactone,,,,,
C11841,N-(3-Oxooctanoyl)homoserine lactone;|N-(3-Oxooctanoyl)-L-homoserine lactone;|OOHL,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C11841  N-(3-Oxooctanoyl)homoserine lactone,
C11842,N-(3-(S)-Hydroxybutyryl)homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C11842  N-(3-(S)-Hydroxybutyryl)homoserine lactone,
C11843,2 -(Butylamido)-4-hydroxybutanoic acid,,,,,
C11844,N-Heptanoylhomoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C11844  N-Heptanoylhomoserine lactone,
C11845,N-(3-Hydroxy-7-cis-tetradecenoyl)homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C11845  N-(3-Hydroxy-7-cis-tetradecenoyl)homoserine lactone,
C11846,Cyclo(deltaAla-L-Val),,,,,
C11847,"Cyclo(L-Phe-L-Pro);|(3S-trans)-3-Benzylhexahydropyrrolo(1,2-a)pyrazine-1,4-dione",,,,,
C11848,2-Heptyl-3-hydroxy-quinolone;|2-Heptyl-3-hydroxy-4(1H)-quinolone;|2-Heptyl-3-hydroxy-4-quinolone,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11848,
C11849,3-Hydroxy-palmitic acid methyl ester;|3-Hydroxyhexadecanoic acid methyl ester,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C11849  3-Hydroxy-palmitic acid methyl ester,
C11850,Divinylchlorophyll a,,,,,
C11851,Zn-Bacteriochlorophyll a;|Zinc bacteriochlorophyll a,,,,,
C11853,Gibberellin A14 aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11853  Gibberellin A14 aldehyde|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11853  Gibberellin A14 aldehyde,
C11854,Gibberellin A51-catabolite,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11854  Gibberellin A51-catabolite|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11854  Gibberellin A51-catabolite,
C11855,Gibberellin A29-catabolite,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11855  Gibberellin A29-catabolite|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11855  Gibberellin A29-catabolite,
C11856,Gibberellin A6,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11856  Gibberellin A6|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11856  Gibberellin A6,
C11857,Gibberellin A12,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11857  Gibberellin A12|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11857  Gibberellin A12,
C11858,Gibberellin A14,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11858  Gibberellin A14|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11858  Gibberellin A14,
C11859,Gibberellin A37 open lactone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11859  Gibberellin A37 open lactone|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11859  Gibberellin A37 open lactone,
C11860,Gibberellin A15 open lactone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11860  Gibberellin A15 open lactone|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11860  Gibberellin A15 open lactone,
C11861,Gibberellin A24,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11861  Gibberellin A24|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11861  Gibberellin A24,
C11862,Gibberellin A36,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11862  Gibberellin A36|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11862  Gibberellin A36,
C11863,Gibberellin A9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11863  Gibberellin A9|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11863  Gibberellin A9,
C11864,Gibberellin A4,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11864  Gibberellin A4|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11864  Gibberellin A4|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11864,
C11865,Gibberellin A51,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11865  Gibberellin A51|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11865  Gibberellin A51,
C11866,"2,3-Dehydro-gibberellin A9;|2,3-Didehydro-gibberellin A9",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11866  2,3-Dehydro-gibberellin A9|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11866  2,3-Dehydro-gibberellin A9",
C11867,Gibberellin A7,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11867  Gibberellin A7|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11867  Gibberellin A7,
C11868,Gibberellin A34,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11868  Gibberellin A34|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11868  Gibberellin A34,
C11869,Gibberellin A34-catabolite,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11869  Gibberellin A34-catabolite|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11869  Gibberellin A34-catabolite,
C11870,Gibberellin A8-catabolite,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11870  Gibberellin A8-catabolite|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11870  Gibberellin A8-catabolite,
C11871,Gibberellin A5,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11871  Gibberellin A5|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11871  Gibberellin A5,
C11872,Kaur-16-en-18-ol;|(-)-Kaur-16-en-18-ol;|Kaurenol;|ent-Kaur-16-en-19-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C11872  Kaur-16-en-18-ol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C11872  Kaur-16-en-18-ol,
C11873,Kaur-16-en-18-al;|(-)-Kaur-16-en-18-al;|4alpha-Kaur-16-en-18-al;|Kaurenal;|ent-Kaurenal;|ent-Kaur-16-en-19-al,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C11873  Kaur-16-en-18-al|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C11873  Kaur-16-en-18-al,
C11874,Kaur-16-en-18-oic acid;|(-)-Kaur-16-en-19-oic acid;|Kaurenic acid;|Kaurenoic acid;|ent-Kaur-16(17)-en-19-oic acid;|ent-Kaurenoic acid;|ent-Kaur-16-en-19-oic acid;|ent-Kaur-16-en-19-oate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C11874  Kaur-16-en-18-oic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C11874  Kaurenoic acid,
C11875,ent-7alpha-Hydroxykaur-16-en-19-oic acid;|(-)-Kaur-16-en-7beta-ol-19-oic acid;|ent-7alpha-Hydroxykaur-16-en-19-oate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C11875  ent-7alpha-Hydroxykaur-16-en-19-oic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C11875  ent-7alpha-Hydroxykaur-16-en-19-oic acid,
C11876,"6beta,7beta-Dihydroxykaurenoic acid;|ent-6alpha,7alpha-Dihydroxykaur-16-en-19-oic acid",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C11876  6beta,7beta-Dihydroxykaurenoic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C11876  6beta,7beta-Dihydroxykaurenoic acid",
C11877,"(+)-Sandaracopimaradiene;|ent-Sandaracopimara-8(14),15-diene;|ent-Sandaracopimaradiene;|ent-13alpha-Pimara-8(14),15-diene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C11877  (+)-Sandaracopimaradiene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C11877  (+)-Sandaracopimaradiene,
C11878,"(-)-Abietadiene;|Abietadiene;|Abieta-7,13-diene;|(4aS,4bR,10aS)-7-Isopropyl-1,1,4a-trimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11878  (-)-Abietadiene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C11878  (-)-Abietadiene,
C11879,"Levopimaradiene;|Abieta-8(14),12-diene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11879  Levopimaradiene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C11879  Levopimaradiene,
C11880,Neoabietadiene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11880  Neoabietadiene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C11880  Neoabietadiene,
C11881,Palustradiene,,,,,
C11882,"Abietinol;|Abietol;|Abieta-7,13-dien-18-ol;|((1R,4aR,4bR,10aR)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthren-1-yl)methanol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11882  Abietinol,
C11883,"Levopimarinol;|Abieta-8(14),12-dien-18-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11883  Levopimarinol,
C11884,Neoabietinol;|Neoabietol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11884  Neoabietinol,
C11885,Neoabietal;|Neoabietinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11885  Neoabietal,
C11886,"Levopimarinal;|Abieta-8(14),12-dien-18-al",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11886  Levopimarinal,
C11887,"Abietal;|Abietaldehyde;|Abietinal;|Abieta-7,13-dien-18-al;|(1R,4aR,4bR,10aR)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthrene-1-carbaldehyde",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11887  Abietal,
C11888,Levopimaric acid;|L-Pimaric acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Pimaranes|C11888  Levopimaric acid,
C11889,Neoabietic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C11889  Neoabietic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Abietanes|C11889  Neoabietic acid,
C11890,Aphidicolan-16beta-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010416 Aphidicolane diterpenoids|C11890  Aphidicolan-16beta-ol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Aphidicolane|C11890  Aphidicolan-16beta-ol,
C11891,Aphidicol-16-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010416 Aphidicolane diterpenoids|C11891  Aphidicol-16-ene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Aphidicolane|C11891  Aphidicol-16-ene,
C11892,Aphidicol-15-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010416 Aphidicolane diterpenoids|C11892  Aphidicol-15-ene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Aphidicolane|C11892  Aphidicol-15-ene,
C11893,Cembrene;|Thunbergen;|(+)-Thunbergen;|(+)-Cembrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010419 Cembrane diterpenoids|C11893  Cembrene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Cembrenes|C11893  Cembrene,
C11894,"Taxa-4(5),11(12)-diene;|Taxa-4,11-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C11894  Taxa-4(5),11(12)-diene|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C11894  Taxa-4(5),11(12)-diene",
C11895,"Taxa-4(20),11(12)-dien-5alpha-ol;|Taxa-4(20),11-dien-5alpha-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C11895  Taxa-4(20),11(12)-dien-5alpha-ol",
C11896,"Taxa-4(20),11(12)-dien-5alpha-yl acetate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C11896  Taxa-4(20),11(12)-dien-5alpha-yl acetate",
C11897,"Taxa-4(20),11(12)-dien-5alpha,13alpha-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C11897  Taxa-4(20),11(12)-dien-5alpha,13alpha-diol",
C11898,"Taxa-4(20),11(12)-dien-5alpha-acetoxy-10beta-ol;|10beta-Hydroxytaxa-4(20),11-dien-5alpha-yl acetate;|5alpha-Acetoxytaxa-4(20),11(12)-dien-10beta-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010439 Taxane and Abeotaxane diterpenoids|C11898  Taxa-4(20),11(12)-dien-5alpha-acetoxy-10beta-ol",
C11899,10-Deacetyl-2-debenzoylbaccatin III,,,,,
C11900,Baccatin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C11900  Baccatin III|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11900,
C11901,Copalyl diphosphate;|(+)-Copalyl diphosphate;|Labdadienyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C11901  Copalyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C11901  Copalyl diphosphate,
C11902,9alpha-Copalyl diphosphate;|syn-Copalyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C11902  9alpha-Copalyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C11902  9alpha-Copalyl diphosphate,
C11903,"Methanophenazine;|2-(2,3-Dihydro-all-trans-pentaprenyloxy)phenazine;|2-(2,3-Dihydropentaprenyloxy)phenazine",,,,,
C11904,Dihydromethanophenazine;|2-(Dihydropentaprenyloxy)-dihydrophenazine,,,,,
C11905,Gibberellin A53 aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C11905  Gibberellin A53 aldehyde|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C11905  Gibberellin A53 aldehyde,
C11906,Sodium arsenite;|Sodium dioxoarsenate,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Inorganic rodenticides|C11906  Sodium arsenite,
C11907,"dTDP-4-oxo-6-deoxy-D-glucose;|dTDP-4-dehydro-6-deoxy-D-glucose;|dTDP-4-dehydro-6-deoxy-alpha-D-glucose;|dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose;|dTDP-4-oxo-6-deoxy-alpha-D-glucose;|dTDP-4-dehydro-6-deoxy-alpha-D-galactose;|dTDP-4-dehydro-6-deoxy-D-galactose;|dTDP-6-deoxy-D-xylo-hexos-4-ulose;|dTDP-6-deoxy-D-xylo-4-hexulose;|4,6-Dideoxy-4-oxo-dTDP-D-glucose",,,,,
C11908,"3,6-Dideoxy-3-oxo-dTDP-D-glucose;|dTDP-3-oxo-6-deoxy-D-glucose;|dTDP-3-oxo-6-deoxy-alpha-D-glucose;|dTDP-3-dehydro-6-deoxy-alpha-D-glucopyranose;|dTDP-6-deoxy-D-ribo-hexos-3-ulose",,,,,
C11909,"dTDP-3-oxo-4,6-dideoxy-D-glucose;|dTDP-3-oxo-4,6-dideoxy-alpha-D-glucose;|dTDP-3-dehydro-4,6-dideoxy-alpha-D-glucopyranose",,,,,
C11910,"dTDP-3-amino-3,4,6-trideoxy-D-glucose;|dTDP-3-amino-3,4,6-trideoxy-alpha-D-glucose",,,,,
C11911,"dTDP-D-desosamine;|dTDP-3-dimethylamino-3,4,6-trideoxy-D-glucose;|dTDP-alpha-D-desosamine;|dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucose;|dTDP-3-dimethylamino-3,4,6-trideoxy-alpha-D-glucopyranose",,,,,
C11912,dTDP-6-deoxy-D-allose;|dTDP-6-deoxy-alpha-D-allose,,,,,
C11913,"D-Mycinose;|6-Deoxy-2,3-di-O-methyl-D-allo-hexose",,,,,
C11915,"dTDP-3-methyl-4-oxo-2,6-dideoxy-L-allose",,,,,
C11916,"dTDP-L-mycarose;|dTDP-beta-L-mycarose;|dTDP-2,6-dideoxy-3-C-methyl-beta-L-ribo-hexose",,,,,
C11917,L-Cladinose,,,,,
C11918,Maltol,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Monocyclic gamma-pyrones|C11918  Maltol,
C11919,dTDP-L-megosamine,,,,,
C11920,dTDP-L-olivose,,,,,
C11921,dTDP-L-oleandrose,,,,,
C11922,"dTDP-4-oxo-2,6-dideoxy-D-glucose;|dTDP-4-oxo-2,6-dideoxy-alpha-D-glucose;|dTDP-4-dehydro-2,6-dideoxy-alpha-D-glucose;|dTDP-4-keto-2,6-dideoxy-D-glucose",,,,,
C11923,"dTDP-D-olivose;|dTDP-2,6-dideoxy-D-glucose;|dTDP-alpha-D-olivose",,,,,
C11924,Perillic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11924  Perillic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11924  Perillic acid,
C11925,"dTDP-3-amino-3,6-dideoxy-D-glucose",,,,,
C11926,dTDP-4-oxo-6-deoxy-D-allose;|dTDP-4-dehydro-6-deoxy-alpha-D-allose;|dTDP-4-dehydro-6-deoxy-alpha-D-gulose,,,,,
C11927,"dTDP-4-oxo-2,6-dideoxy-L-mannose",,,,,
C11928,"dTDP-4-oxo-2,6-dideoxy-D-allose",,,,,
C11929,Perillyl-CoA,,,,,
C11930,"dTDP-2,6-dideoxy-D-glycero-hex-2-enos-4-ulose",,,,,
C11931,"dTDP-2,6-dideoxy-L-glycero-hex-2-enos-4-ulose",,,,,
C11932,"dTDP-2,6-dideoxy-L-erythro-hexos-3-ulose;|dTDP 1-ester with 2,6-dideoxy-L-erythro-hexopyranos-3-ulose",,,,,
C11933,dTDP-D-mycaminose;|dTDP-alpha-D-mycaminose,,,,,
C11934,2-Hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11934  2-Hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA,
C11935,4-Isopropenyl-2-oxy-cyclohexanecarboxyl-CoA;|4-Isopropenyl-2-ketocyclohexane-1-carboxyl-CoA,,,,,
C11936,3-Isopropenylpimelyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11936  3-Isopropenylpimelyl-CoA,
C11937,"(1S,4R)-1-Hydroxy-2-oxolimonene;|(1S,4R)-1-Hydroxymenth-8-en-2-one",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11937  (1S,4R)-1-Hydroxy-2-oxolimonene",
C11938,Myrtenol;|2-Pinen-10-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11938  Myrtenol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11938  Myrtenol,
C11939,Myrtenal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11939  Myrtenal|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11939  Myrtenal,
C11940,"Myrtenic acid;|6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylic acid",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11940  Myrtenic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11940  Myrtenic acid,
C11941,Pinocarveol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C11941  Pinocarveol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11941  Pinocarveol,
C11942,"trans-2-Methyl-5-isopropylhexa-2,5-dienal",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010202 Irregular acyclic monoterpenoids|C11942  trans-2-Methyl-5-isopropylhexa-2,5-dienal",
C11943,"trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010202 Irregular acyclic monoterpenoids|C11943  trans-2-Methyl-5-isopropylhexa-2,5-dienoic acid",
C11944,"cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010202 Irregular acyclic monoterpenoids|C11944  cis-2-Methyl-5-isopropylhexa-2,5-dienoic acid",
C11945,"trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11945  trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",
C11946,"cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11946  cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA",
C11947,"3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11947  3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA",
C11948,"2,6-Dimethyl-5-methylene-3-oxo-heptanoyl-CoA",,,,,
C11949,3-Isopropylbut-3-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C11949  3-Isopropylbut-3-enoyl-CoA,
C11950,3-Isopropyl-3-butenoic acid;|3-Isopropylbut-3-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C11950  3-Isopropyl-3-butenoic acid,
C11951,(+)-cis-Isopulegone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11951  (+)-cis-Isopulegone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11951  (+)-cis-Isopulegone,
C11952,(+)-Isomenthone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C11952  (+)-Isomenthone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C11952  (+)-Isomenthone,
C11953,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2b'' aglycone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11953  6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2b'' aglycone",
C11954,5-Oxoavermectin ''2b'' aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11954  5-Oxoavermectin ''2b'' aglycone,
C11955,Avermectin B2b aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11955  Avermectin B2b aglycone,
C11956,Avermectin A2b aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11956  Avermectin A2b aglycone,
C11957,Avermectin B2b monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11957  Avermectin B2b monosaccharide,
C11958,Avermectin A2b monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11958  Avermectin A2b monosaccharide,
C11959,Avermectin B2b,,0 Isk  1 Mtd  2 Man  3 Mak  4 Mak  5 Mad  6 Mtk  7 Mtd  8 Mad|9 Mtn  10 Man  11 Mtd  12 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11959  Avermectin B2b,
C11960,Avermectin A2b,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11960  Avermectin A2b,
C11961,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1b'' aglycone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11961  6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1b'' aglycone",
C11962,5-Oxoavermectin ''1b'' aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11962  5-Oxoavermectin ''1b'' aglycone,
C11963,Avermectin B1b aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11963  Avermectin B1b aglycone,
C11964,Avermectin A1b aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11964  Avermectin A1b aglycone,
C11965,Avermectin B1b monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11965  Avermectin B1b monosaccharide,
C11966,Avermectin A1b monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11966  Avermectin A1b monosaccharide,
C11967,Avermectin B1b,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11967  Avermectin B1b,
C11968,"Avermectin A1b;|Avermectin A1a, 25-de(1-methylpropyl)-25-(1-methylethyl)-",,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11968  Avermectin A1b,
C11969,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2a'' aglycone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11969  6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''2a'' aglycone",
C11970,5-Oxoavermectin ''2a'' aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11970  5-Oxoavermectin ''2a'' aglycone,
C11971,Avermectin B2a aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11971  Avermectin B2a aglycone,
C11972,Avermectin A2a aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11972  Avermectin A2a aglycone,
C11973,Avermectin B2a monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11973  Avermectin B2a monosaccharide,
C11974,Avermectin A2a monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11974  Avermectin A2a monosaccharide,
C11975,Avermectin B2a,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11975  Avermectin B2a,
C11976,"Avermectin A2a;|Avermectin A1a, 22,23-dihydro-23-hydroxy-, (23S)-",,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11976  Avermectin A2a,
C11977,"6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1a'' aglycone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11977  6,8a-Seco-6,8a-deoxy-5-oxoavermectin ''1a'' aglycone",
C11978,5-Oxoavermectin ''1a'' aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11978  5-Oxoavermectin ''1a'' aglycone,
C11979,Avermectin B1a aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11979  Avermectin B1a aglycone,
C11980,Avermectin A1a aglycone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11980  Avermectin A1a aglycone,
C11981,Avermectin B1a monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11981  Avermectin B1a monosaccharide,
C11982,Avermectin A1a monosaccharide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11982  Avermectin A1a monosaccharide,
C11983,Avermectin B1a,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11983  Avermectin B1a,
C11984,Avermectin A1a,,0 2mk  1 Mtd  2 Man  3 Mak  4 Mak  5 Mad  6 Mtk  7 Mtd  8 Mad|9 Mtn  10 Man  11 Mtd  12 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11984  Avermectin A1a|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11984,
C11985,Megalomicin A,,0 Pyk  1 Mtk  2 Mtn  3 Mte  4 Mtk  5 Mtk  6 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11985  Megalomicin A,
C11986,Megalomicin B;|4'-Acetylmegalomycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11986  Megalomicin B,
C11987,Megalomicin C1,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11987  Megalomicin C1,
C11988,Megalomicin C2,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11988  Megalomicin C2,
C11989,"8,8a-Deoxyoleandolide",,0 Mak  1 Mtk  2 Mtn  3 Mte  4 Mtk  5 Mtk  6 Mtn,PK,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11989  8,8a-Deoxyoleandolide",
C11990,Oleandolide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11990  Oleandolide,
C11991,L-Olivosyl-oleandolide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11991  L-Olivosyl-oleandolide,
C11992,L-Oleandrosyl-oleandolide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11992  L-Oleandrosyl-oleandolide,
C11993,10-Deoxymethynolide,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11993  10-Deoxymethynolide,
C11994,10-Deoxymethymycin;|YC-17,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11994  10-Deoxymethymycin,
C11995,Neomethymycin,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11995  Neomethymycin,
C11996,Methymycin,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11996  Methymycin,
C11997,Narbonolide,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn  6 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11997  Narbonolide,
C11998,Narbomycin,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn  6 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11998  Narbomycin,
C11999,Pikromycin,,0 Mtk  1 Mtd  2 Man  3 Mte  4 Mtk  5 Mtn  6 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C11999  Pikromycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C11999,
C12000,Tylactone;|Protylonolide,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12000  Tylactone,
C12001,5-O-beta-D-Mycaminosyltylactone,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12001  5-O-beta-D-Mycaminosyltylactone,
C12002,5-O-beta-D-Mycaminosyltylonolide,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12002  5-O-beta-D-Mycaminosyltylonolide,
C12003,Demethyllactenocin,,0 Mtk  1 Mtd  2 Mtd  3 Man  4 Mte  5 Etk  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12003  Demethyllactenocin,
C12006,Liposidomycin B,,,,,
C12007,Mureidomycin A;|MRD A,,,,,
C12008,Ramoplanin A2,,,,,
C12009,Telithromycin;|HMR3647;|HMR-3647;|RU66647;|RU-66647,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01078)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA15 Telithromycin|D01078  Telithromycin (JAN/USAN/INN)|Drug groups [BR:br08330(D01078)]|Antibacterial|DG01551  Macrolide antibiotic|D01078  Telithromycin|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D01078  Telithromycin|DG01633  CYP3A/CYP3A4 substrate|D01078  Telithromycin|Metabolizing enzyme inhibitor|DG01645  CYP2D6 inhibitor|D01078  Telithromycin|DG02852  CYP3A/CYP3A4 inhibitor|D01078  Telithromycin|Antimicrobials [BR:br08307(D01078)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01078  Telithromycin (JAN/USAN/INN)|Antimicrobials abbreviations [BR:br08327(D01078)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01078  Telithromycin (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D01078)]|New molecular entities and new therapeutic biological products|D01078|New drug approvals in Europe [br08329.html(D01078)]|European public assessment reports (EPAR) authorised medicine|D01078|New drug approvals in Japan [br08318.html(D01078)]|Drugs with new active ingredients|D01078|New drug approvals in the USA, Europe and Japan [br08328.html(D01078)]|Approval dates by FDA, EMA and PMDA|D01078|Drug metabolizing enzymes and transporters [br08309.html(D01078)]|Drug metabolizing enzymes|D01078",
C12011,"DMG-MINO;|9-(N,N-Dimethylglycylamido)minocycline",,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C12011  DMG-MINO,
C12012,Tigecycline;|GAR 936;|WAY-GAR-936,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01079)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA12 Tigecycline|D01079  Tigecycline (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01079)]|Antibacterials|Antibacterials, Other|Tigecycline|D01079  Tigecycline (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01079)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6129  Others|D01079  Tigecycline (JAN/USP)|Drug groups [BR:br08330(D01079)]|Antibacterial|DG01197  Tetracycline antibiotic|D01079  Tigecycline|Drug classes [BR:br08332(D01079)]|Antibacterial|DG01197  Tetracycline antibiotic|D01079  Tigecycline|Antimicrobials [BR:br08307(D01079)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D01079  Tigecycline (JAN/USP) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D01079)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D01079  Tigecycline (JAN/USP)|New drug approvals in the USA [br08319.html(D01079)]|New molecular entities and new therapeutic biological products|D01079|New drug approvals in Europe [br08329.html(D01079)]|European public assessment reports (EPAR) authorised medicine|D01079|New drug approvals in Japan [br08318.html(D01079)]|Drugs with new active ingredients|D01079|New drug approvals in the USA, Europe and Japan [br08328.html(D01079)]|Approval dates by FDA, EMA and PMDA|D01079",
C12013,Daptomycin,"FA = decanonyl|12 threo-Glu is modified by L-threo-3-methyl. (i.e. L-threo-3-Methylglutamic acid, 3mGlu)",0 FA  1 Trp  2 D-Asn  3 Asp  4 Thr  5 Gly  6 Orn  7 Asp  8 D-Ala|9 Asp  10 Gly  11 D-Ser  12 threo-Glu  13 Kyn|(Cyclization: 4-13),NRP,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01080)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX09 Daptomycin|D01080  Daptomycin (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01080)]|Antibacterials|Antibacterials, Other|Daptomycin|D01080  Daptomycin (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01080)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|611  Acting mainly on gram-positive bacteria|6119  Others|D01080  Daptomycin (JAN/USAN/INN)|Antimicrobials [BR:br08307(D01080)]|Antibacterials|Cell membrane function inhibitor|Lipopeptide|D01080  Daptomycin (JAN/USAN/INN) &lt;JP/US&gt;|Antimicrobials abbreviations [BR:br08327(D01080)]|Antibacterials|Cell membrane function inhibitor|Lipopeptide|D01080  Daptomycin (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D01080)]|New molecular entities and new therapeutic biological products|D01080|New drug approvals in Europe [br08329.html(D01080)]|European public assessment reports (EPAR) authorised medicine|D01080|New drug approvals in Japan [br08318.html(D01080)]|Drugs with new active ingredients|D01080|New drug approvals in the USA, Europe and Japan [br08328.html(D01080)]|Approval dates by FDA, EMA and PMDA|D01080",
C12014,Chloroeremomycin;|Chloroorienticin A,,0 D-Leu  1 D-Tyr  2 Asn  3 D-Hpg  4 D-Hpg  5 Tyr  6 Dpg,NRP,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12014,
C12016,A47934;|Antibiotic A 47934,"5 beta-OHTyr is beta-Hydroxytyrosine, betaHT",0 D-Hpg  1 D-Tyr  2 Dpg  3 D-Hpg  4 D-Hpg  5 beta-OHTyr  6 Dpg,NRP,,
C12017,MK826,,,,,
C12018,SM-17466,,,,,
C12019,2-(Biaryl)carbapenems,,,,,
C12020,Cethromycin;|ABT-773;|A-195773;|Abbott-195773,,,,Antimicrobials [BR:br08307(D02391)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D02391  Cethromycin (USAN/INN),
C12021,Alanylphosphate;|D-Alanyl-phosphate,,,,,
C12022,Phosphophosphinate,,,,,
C12023,Undecylprodigiosin;|2-((3-Methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene)methyl)-5-undecyl-1H-pyrrole,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12023,
C12024,Calcium-dependent antibiotic;|CDA,"6 Gly is modified by 4-hydroxyphenyl. (i.e. 4-Hydroxyphenylglycine, HPG)|9 Asn is modified by hydroxy. (i.e. Hydroxyasparagone, hAsn)|10 Glu is modified by 3-methyl. (i.e. 3-Methylglutamic acid, 3mGlu)",0 FA  1 Ser  2 Thr  3 D-Trp  4 Asp  5 Asp  6 Gly  7 Asp  8 Gly|9 D-Asn  10 Glu  11 Trp  (Cyclization: 2-11),NRP,,
C12025,"2,6-Diamino-7-hydroxy-azelaic acid",,,,,
C12026,"3,5-Dihydroxy-phenylglycine;|L-3,5-Dihydroxyphenylglycine;|(S)-3,5-Dihydroxyphenylglycine",,,,,
C12027,"2-Amino-9,10-epoxy-8-oxodecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C12027  2-Amino-9,10-epoxy-8-oxodecanoic acid",
C12029,(E)-2-Butenyl-4-methyl-threonine;|2-Butenyl-4-methylthreonine,,,,,
C12030,Mycosubtilin,Generic compound|R = fatty acid,0 Asn  1 D-Tyr  2 D-Asn  3 Gln  4 Pro  5 D-Ser  6 Asn|(Cyclization: 0-6),NRP,,
C12032,Clorobiocin;|Chlorobiocin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12032,
C12033,4-Aminophenylalanine;|p-Aminophenylalanine,,,,,
C12034,Chlorobiphenyl-chloroeremomycin;|LY333328;|Oritavancin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XA Glycopeptide antibacterials|J01XA05 Oritavancin|C12034  Chlorobiphenyl-chloroeremomycin|Drug groups [BR:br08330]|Antibacterial|DG01580  Glycopeptide antibiotic|DG00632  Oritavancin|C12034  Chlorobiphenyl-chloroeremomycin,G00632
C12035,Chlorobiphenyl-vancomycin,,,,,
C12036,Chlorobiphenyl-desleucyl-vancomycin,,,,,
C12037,Pyochelin,,0 Sal  1 Cys  2 Cys,NRP,,
C12038,Yersiniabactin,,0 Sal  1 Cys  2 Cys  3 Man  4 Cys,NRP,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12038,
C12039,Epothilone D;|Desoxyepothilone b,,0 Mao  1 Cys  2 Mtk  3 Mad  4 Mte  5 Mae  6 Mtk  7 Mtn  8 Isk|9 Man,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12039  Epothilone D|PK14 Non-ribosomal peptide/polyketide hybrids|C12039  Epothilone D,
C12040,Telomestatin,,,,,
C12041,Tyrocidine,,0 D-Phe  1 Pro  2 Phe  3 D-Phe  4 Asn  5 Gln  6 Tyr  7 Val  8 Orn|9 Leu  (Cyclization: 0-9),NRP,,
C12042,Fengycin,,0 FA  1 Glu  2 D-Orn  3 Tyr  4 D-allo-Thr  5 Glu  6 D-Ala  7 Pro|8 Gln  9 D-Tyr  10 Ile  (Cyclization: 3-10),NRP,,
C12043,Surfactin,FA = beta-hydroxy fatty acid,0 FA  1 Glu  2 Leu  3 D-Leu  4 Val  5 Asp  6 D-Leu  7 Leu,NRP,,
C12044,Rifamycin;|Rifamycin SV,,0 Ahb  1 Mtn  2 Man  3 Mtd  4 Mtk  5 Mtk  6 Mtk  7 Mtk  8 Mtd|9 Mad  10 Mtn,PK,"Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12044  Rifamycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12044|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02549)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA13 Rifamycin|D02549  Rifamycin (USAN/INN)|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX15 Rifamycin|D02549  Rifamycin (USAN/INN)|J ANTIINFECTIVES FOR SYSTEMIC USE|J04 ANTIMYCOBACTERIALS|J04A DRUGS FOR TREATMENT OF TUBERCULOSIS|J04AB Antibiotics|J04AB03 Rifamycin|D02549  Rifamycin (USAN/INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA16 Rifamycin|D02549  Rifamycin (USAN/INN)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA12 Rifamycin|D02549  Rifamycin (USAN/INN)|Drug groups [BR:br08330(D02549)]|Antibacterial|DG01966  Antitubercular|DG01598  Rifamycin antibiotic|DG00640  Rifamycin|D02549  Rifamycin|Antimicrobials [BR:br08307(D02549)]|Antibacterials|Nucleic acid synthesis inhibitor|Rifamycin|D02549  Rifamycin (USAN/INN)",
C12045,Ansamitocin P-3;|Ansamitosin P-3;|Antibiotic C15003P3;|C15003P3;|Maytansinol isobutyrate;|2'-De(acetylmethylamino)-2'-methylmaytansine,,0 Ahb  1 Mtd  2 Mad  3 Mxn  4 Mak  5 Mtd  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12045  Ansamitocin P3|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12045,
C12046,Teicoplanin A2-2;|Teichomycin A2 factor 2,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C12046  Teicoplanin A2-2,
C12047,Nanchangmycin,,0 Man  1 Mte  2 Mtd  3 Mae  4 Mtn  5 Mtk  6 Mad  7 Mte  8 Man|9 Mak  10 Mtk  11 Mtd  12 Mtn  13 Mte  14 Mtn,PK,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C12047  Nanchangmycin,
C12048,Griseorhodin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C12048  Griseorhodin A,
C12049,Neocarzinostatin chromophore,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12049,
C12050,Everninomycin;|Everninomicin,,,,,
C12051,Micrococcin;|Micrococcin P1;|BRN1070340,,,,,
C12052,Thiocillin,,,,,
C12053,Nosiheptide,,,,,
C12054,Thiostrepton,,,,,
C12055,Sulfamycin B,,,,,
C12056,Actinonin,,,,,
C12057,Cyclothialidine,,,,,
C12058,Cerulenin,,,,,
C12059,Triclosan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06226)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AE Phenol and derivatives|D08AE04 Triclosan|D06226  Triclosan (USP/INN)|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA06 Triclosan|D06226  Triclosan (USP/INN)|Rx-to-OTC switch list in the USA [br08315.html(D06226)]|D06226,
C12062,Naphthyl dipeptide,,,,,
C12063,Tunicamycin,,,,,
C12064,Resorcinol monoacetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02393)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AX Other anti-acne preparations for topical use|D10AX02 Resorcinol|D02393  Resorcinol monoacetate (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX06 Resorcinol|D02393  Resorcinol monoacetate (USP),
C12065,Tiamulin,,,,Drug groups [BR:br08330(D06127)]|Antibacterial|DG01813  Pleuromutilin|DG01437  Tiamulin|D06127  Tiamulin|Antimicrobials [BR:br08307(D06127)]|Antibacterials|Protein biosynthesis inhibitor|Pleuromutilin|D06127  Tiamulin (USP/INN),
C12066,Valnemulin,,,,Drug groups [BR:br08330(D08665)]|Antibacterial|DG01813  Pleuromutilin|DG01438  Valnemulin|D08665  Valnemulin|Antimicrobials [BR:br08307(D08665)]|Antibacterials|Protein biosynthesis inhibitor|Pleuromutilin|D08665  Valnemulin (INN),
C12067,2-Deoxy-2-dimethylamino-alpha-D-Glucose,,,,,
C12068,GE2270A,,,,,
C12069,3-Hydroxypropenoate,,,,,
C12070,Pulvomycin,,,,,
C12072,Gardneral,,,,,
C12073,11-Methoxy-vinorine,,,,,
C12075,Tetraphyllicine;|NSC72114,,,,,
C12076,Deoxyanisatin,,,,,
C12077,"Palustric acid;|NSC 148945;|8,13-Abietadien-18-oic acid",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C12077  Palustric acid,
C12078,"Dehydroabietic acid;|(-)-Dehydroabietic acid;|13-Isopropylpodocarpa-8,11,13-trien-15-oic acid;|Abieta-8,11,13-trien-18-oic acid;|Dehydroabietate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C12078  Dehydroabietic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Podocarpanes|C12078  Dehydroabietic acid,
C12079,alpha-Arbutin;|4-Hydroxyphenyl-alpha-D-glucopyranoside,Arbutin [CPD:C06186],,,,
C12080,Resistomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C12080  Resistomycin,
C12081,Soyasaponin II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C12081  Soyasaponin II,
C12082,alpha-L-Rhamnopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->2)-beta-D-glucuronopyranoside;|beta-Fabatriose,,,,,
C12083,"(5Z,7E,9E,14Z,17Z)-Icosapentaenoate;|(5Z,7E,9E,14Z,17Z)-Eicosapentaenoic acid;|(5Z,7E,9E,14Z,17Z)-Eicosapentaenoate;|5Z,7E,9E,14Z,17Z-Eicosapentaenoic acid;|(5Z,7E,9E,14Z,17Z)-Icosa-5,7,9,14,17-pentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C12083  (5Z,7E,9E,14Z,17Z)-Icosa-5,7,9,14,17-pentaenoic acid",
C12085,Bis-noryangonin,,,,,
C12087,p-Coumaroyltriacetic acid lactone,,,,,
C12088,4-Hydroxycinnamoylmethane;|4-Hydroxybenzalacetone;|p-Hydroxybenzalacetone;|4-(p-Hydroxyphenyl)-3-buten-2-one,,,,,
C12089,NAC-Diketide,,,,,
C12090,Methylstyrylpyron,,,,,
C12091,Cerberoside,,,,,
C12092,N-Methylanthraniloyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C12092  N-Methylanthraniloyl-CoA,
C12093,"1,3-Dihydroxy-N-methylacridone",,,,,
C12095,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12095  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12095  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12095  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside,
C12096,Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside;|Shisonin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12096  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12096  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12096  Cyanidin 3-O-(6-O-p-coumaroyl)glucoside-5-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12096,
C12098,Ansatrienin A,,,,,
C12099,Asukamycin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C12099  Asukamycin,
C12100,omega-Cyclohexylundecanoic acid;|Cyclohexaneundecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C12100  omega-Cyclohexylundecanoic acid,
C12101,1-Cyclohexenecarboxylic acid;|Cyclohex-1-enecarboxylic acid;|1-Cyclohexene-1-carboxylic acid,,,,,
C12102,Immunomycin;|Ascomycin;|FK520,,0 Ska  1 Mtk  2 Mtk  3 Man  4 Etd  5 Mte  6 Mte  7 Mxk  8 Mxe|9 Mtn  10 Man  11 Pip,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12102  Ascomycin (FK520),
C12103,omega-Cycloheptylundecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C12103  omega-Cycloheptylundecanoic acid,
C12104,Cycloheptanecarboxylic acid;|Cycloheptanoic acid,,,,,
C12105,Thiotropocin,,,,,
C12106,AminoDAHP,,,,,
C12107,3-Amino-5-hydroxybenzoate;|AHBA;|3-Amino-5-hydroxybenzoic acid;|3-Ahba,,,,,
C12108,5-Amino-5-deoxy-3-dehydroshikimate;|AminoDHS;|5-Deoxy-5-amino-3-dehydroshikimic acid,,,,,
C12109,AminoDHQ;|5-Deoxy-5-amino-3-dehydroquinic acid,,,,,
C12110,"Gabaculine;|3-Amino-2,3-dihydrobenzoic acid",,,,,
C12111,Manumycin A;|Manumycin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C12111  Manumycin A,
C12112,Validamycin A;|Validacin;|Validamycin;|Valimon,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C12112  Validamycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12112,
C12113,Valiolone,,,,,
C12114,4-Hydroxy-3-nitrosobenzamide,,,,,
C12115,"3-Amino-4-hydroxybenzoate;|3-Amino-4-hydroxybenzoic acid;|3,4-AHBA",,,,,
C12116,Esmeraldic acid,,,,,
C12117,Saphenic acid,,,,,
C12118,Saphenic acid methyl ester,,,,,
C12119,"Phenazine-1,6-dicarboxylic acid;|Phenazine-1,6-dicarboxylate",,,,,
C12120,6-Acetophenazine-1-carboxylic acid;|6-Acetylphenazine-1-carboxylic acid,,,,,
C12121,5-Deoxy-5-aminoshikimic acid,,,,,
C12122,Luteoliflavan,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C12122  Luteoliflavan",
C12123,"7,4'-Dihydroxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12123  7,4'-Dihydroxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12123  7,4'-Dihydroxyflavone",
C12124,Apiforol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C12124  Apiforol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 4-ols|C12124  Apiforol",
C12125,Isoformononetin;|4'-Hydroxy-7-methoxyisoflavone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C12125  Isoformononetin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C12125  Isoformononetin,
C12126,Dihydroceramide;|N-Acylsphinganine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0202 N-acylsphinganines (dihydroceramides)|C12126  N-Acylsphinganine,
C12127,(+)-Gallocatechin;|Gallocatechol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C12127  (+)-Gallocatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C12127  (+)-Gallocatechin",
C12128,(-)-Epiafzelechin;|epi-Afzelechin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C12128  (-)-Epiafzelechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C12128  (-)-Epiafzelechin",
C12129,Anemone purple anthocyanin 1,,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12129  Anemone purple anthocyanin 1,
C12130,Anemone blue anthocyanin 1,,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12130  Anemone blue anthocyanin 1,
C12131,Anemone blue anthocyanin 2,,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12131  Anemone blue anthocyanin 2,
C12132,Anemone blue anthocyanin 3,,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12132  Anemone blue anthocyanin 3,
C12133,Anemone blue anthocyanin 4,,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12133  Anemone blue anthocyanin 4,
C12134,"2'-Hydroxygenistein;|2',4',5,7-Tetrahydroxyisoflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C12134  2'-Hydroxygenistein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C12134  2'-Hydroxygenistein,
C12135,2'-Hydroxybiochanin A;|Dehydroferreirin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C12135  2'-Hydroxybiochanin A|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C12135  2'-Hydroxybiochanin A,
C12136,(-)-Epigallocatechin;|Epigallocatechol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C12136  (-)-Epigallocatechin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C12136  (-)-Epigallocatechin|Dietary phytochemicals [br08012.html]|Flavonoids|C12136",
C12137,Pelargonidin 3-O-glucoside;|Pelargonidin 3-glucoside;|Pelargonidin 3-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12137  Pelargonidin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12137  Pelargonidin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12137  Pelargonidin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12137,
C12138,Delphinidin 3-O-glucoside;|Mirtillin;|Delphinidin 3-glucoside;|Delphinidin 3-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12138  Delphinidin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12138  Delphinidin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C12138  Delphinidin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12138,
C12139,Petunidin 3-O-glucoside;|Petunidin 3-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12139  Petunidin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12139  Petunidin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C12139  Petunidin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12139,
C12140,Malvidin 3-O-glucoside;|Enin;|Malvidin-3-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12140  Malvidin 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12140  Malvidin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C12140  Malvidin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12140,
C12141,Peonidin 3-O-glucoside;|Peonidin-3-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12141  Peonidin 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12141  Peonidin 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12141,
C12142,Vetispiradiene;|(-)-Vetispiradiene;|(-)-Premnaspirodiene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010365 Spirovetivane sesquiterpenoids|C12142  Vetispiradiene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C12142  Vetispiradiene,
C12143,2-Aminoacridone;|AMAC,,,,,
C12144,Phytosphingosine;|4-D-Hydroxysphinganine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0103 4-Hydroxysphinganines (Phytosphingosines)|C12144  4-D-Hydroxysphinganine,
C12145,Phytoceramide;|Ceramide II;|N-Acyl-4-hydroxysphinganine;|(4R)-4-Hydroxysphinganine ceramide,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0203 N-acyl-4-hydroxysphinganines (phytoceramides)|C12145  N-Acyl-4-hydroxysphinganine,
C12146,C26-CoA,Generic compound in reaction hierarchy|R = C25H51 (Hexacosanoyl-CoA) or its derivatives,,,,
C12147,L-Threonine O-3-phosphate;|L-Threonine phosphate;|O-Phospho-L-threonine,,,,,
C12148,Stigmatellin A;|Stigmatellin,,0 Atd  1 Mtd  2 Mad  3 Mam  4 Mtm  5 Mte  6 Man  7 Mtn  8 Man|9 Man  10 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C12148  Stigmatellin A,
C12149,Stigmatellin X,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C12149  Stigmatellin X,
C12150,Stigmatellin Y,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C12150  Stigmatellin Y,
C12151,Mycolactone,Mycolactone A (Z isomer at C-4')|Mycolactone B (E isomer at C-4')|The structure of mycolactone B is shown here.,[1] 0 Mak  1 Mak  2 Mtd  3 Mte  4 Mtk  5 Mad  6 Mte  7 Mtk  8 Mae|9 Man|[2] 0 Mak  1 Mak  2 Mad  3 Mtd  4 Mad  5 Mtd  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12151  Mycolactone,
C12152,Niddamycin,,0 Mak  1 Mad  2 Mad  3 Man  4 Mte  5 Etk  6 Mxk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12152  Niddamycin,
C12153,Epothilone A,,0 Mao  1 Cys  2 Mtk  3 Mad  4 Mae  5 Mae  6 Mtk  7 Mtn  8 Isk|9 Man,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12153  Epothilone A|PK14 Non-ribosomal peptide/polyketide hybrids|C12153  Epothilone A,
C12154,Epothilone B;|Patupilone,,0 Mao  1 Cys  2 Mtk  3 Mad  4 Mte  5 Mae  6 Mtk  7 Mtn  8 Isk|9 Man,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12154  Epothilone B|PK14 Non-ribosomal peptide/polyketide hybrids|C12154  Epothilone B,
C12155,Nystatin A1,,,,Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C12155  Nystatin A1,
C12156,Nystatin A3,,,,Lipids [BR:br08002]|PK  Polyketides|PK06 Polyenes|C12156  Nystatin A3,
C12157,Myxalamid S,,0 Isd  1 Mtk  2 Mtd  3 Mtd  4 Mak  5 Mad  6 Mad  7 Mtn  8 Ala,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C12157  Myxalamid S,
C12158,Myxalamid A,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C12158  Myxalamid A,
C12159,Myxalamid B,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C12159  Myxalamid B,
C12160,Myxalamid C,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C12160  Myxalamid C,
C12161,Myxalamid D,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C12161  Myxalamid D,
C12162,Crinine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C12162  Crinine,
C12163,"Powelline;|1,2-Didehydro-7-methoxycrinan-3arpha-ol",,,,,
C12164,Hamayne;|Bulbispermine,,,,,
C12165,3-O-Acetylhamayne,,,,,
C12166,1-O-Acetyllycorine,,,,,
C12167,Cherylline,,,,,
C12168,Crinamidine,,,,,
C12169,1-Epideacetylbowdensine,,,,,
C12170,Zephyranthine,,,,,
C12171,"1,2-O-Diacetylzephyranthine",,,,,
C12172,11alpha-Hydroxygalanthamine,,,,,
C12173,Norgalanthamine;|N-Demethylgalanthamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C12173  Norgalanthamine,
C12174,Haemanthidine;|Hemanthidine,,,,,
C12176,Proansamycin X,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12176  Proansamycin X,
C12177,Proansamitocin,,0 Ahb  1 Mtd  2 Mad  3 Mxn  4 Mak  5 Mtd  6 Mtk  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12177  Proansamitocin,
C12178,3-Epimacronine,,,,,
C12179,Tazettine;|Sekisanin,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C12179  Tazettine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C12179  Tazettine,
C12180,(-)-8-Demethylmaritidine;|Normaritidine,,,,,
C12181,Ismine,,,,,
C12182,Trisphaeridine;|Trispheridine,,,,,
C12183,Obliquine,,,,,
C12184,Narcissidine,,,,,
C12185,Nangustine,,,,,
C12186,Pancracine,,,,,
C12187,"Pseudolycorine;|3,12-Didehydro-9-methoxygalanthan-1alpha,2beta,10-triol",,,,,
C12188,Vasconine,,,,,
C12189,Ungeremine,,,,,
C12190,9-O-Demethylhomolycorine,,,,,
C12191,ent-6beta-Hydroxybuphanisine,,,,,
C12192,ent-6alpha-Hydroxybuphanisine,,,,,
C12193,"Vittatine;|(3beta,5alpha,13beta,19alpha)-1,2-Didehydro-crinan-3-ol",,,,,
C12194,11-Hydroxyvittatine,,,,,
C12195,Zephyramine,,,,,
C12196,Bocconarborine A;|(+/-)-Bocconarborine A,,,,,
C12197,(+/-)-Bocconarborine B,,,,,
C12198,"6-(2-Hydroxyethyl)-5,6-dihydrosanguinarine",,,,,
C12199,"3-Methoxy-8,9-methylenedioxy-3,4-dihydrophenanthridine;|3-Methoxy-3,4-dihydro-[1,3]-dioxolo-[4,5-j]-phenanthridine",,,,,
C12200,"(+/-)-6-Acetonyldihydrochelerythrine;|6-Acetonyl-5,6-dihydrochelerythrine",,,,,
C12201,"(+/-)-6-Acetonyldihydrosanguinarine;|6-Acetonyl-5,6-dihydrosanguinarine;|(+/-)-8-Acetonyldihydrosanguinarine",,,,,
C12202,Platenolide I;|Platenolide A,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12202  Platenolide I,
C12203,5-Hydroxyferuloyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C12203  5-Hydroxyferuloyl-CoA|Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C12203  5-Hydroxyferuloyl-CoA,
C12204,5-Hydroxyconiferaldehyde,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C12204  5-Hydroxyconiferaldehyde,
C12205,5-Hydroxyconiferyl alcohol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Sinapate derivatives|C12205  5-Hydroxyconiferyl alcohol,
C12206,Caffeyl alcohol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C12206  Caffeyl alcohol,
C12208,p-Coumaroyl quinic acid;|trans-5-O-(4-Coumaroyl)-D-quinate,,,,,
C12210,UDP-3-ketoglucose;|UDP-3-keto-D-glucose,,,,,
C12211,UDP-kanosamine;|UDP-D-kanosamine;|UDP-alpha-D-kanosamine,,,,,
C12212,Kanosamine;|D-Kanosamine;|3-Amino-3-deoxy-D-glucose,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12212,
C12213,Kanosamine 6-phosphate;|D-Kanosamine 6-phosphate,,,,,
C12214,Aminofructose 6-phosphate;|Amino-D-fructose 6-phosphate,,,,,
C12215,Iminoerythrose 4-phosphate;|Imino-D-erythrose 4-phosphate,,,,,
C12216,Mycobactin S,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C12216  Mycobactin S,
C12217,Fe(CN)3;|Ferric cyanide;|Iron cyanide (Fe(CN)3),,,,,
C12218,Fe(CN)2;|Iron cyanide (Fe(CN)2),,,,,
C12219,Corynebactin;|Bacillibactin,,0 DHBA  1 Gly  2 Thr  (Trimer),NRP,,
C12220,Myxochelin A,,0 DHBA  1 Lys,NRP,,
C12221,Myxochelin B,,0 DHBA  1 Lys,NRP,,
C12222,Hydroxysanguinarine,,,,,
C12223,"N-Methyl-2,3,7,8-tetramethoxy-5,6-dihydrobenzophenathridine-6-ethanoic acid",,,,,
C12224,"N-Methyl-2,3,7,8-tetramethoxybenzophenanthridine-6(5H)-one",,,,,
C12225,"6-Oxochelerythrine;|Oxychelerythrine;|1,2-Dimethoxy-12-methyl-(1,3)benzodioxolo(5,6-c)phenanthridin-13(12H)-one",,,,,
C12226,"Norchelerythrine;|1,2-Dimethoxy-(1,3)benzodioxolo(5,6-c)phenanthridine",,,,,
C12227,Chelerythrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Others|C12227  Chelerythrine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C12227  Chelerythrine,
C12228,Sanguilutine,,,,,
C12229,Chelilutine,,,,,
C12230,Sanguirubine,,,,,
C12231,Anhalamine;|N-Demethylanhalidine,,,,,
C12232,Sanguinine,,,,,
C12233,"Lycoramine;|1,2-Dihydrogalanthamine",,,,,
C12234,Epinorlycoramine,,,,,
C12235,Assoanine,,,,,
C12236,Oxoassoanine;|Dihydropratosine,,,,,
C12237,2-O-Acetylpseudolycorine,,,,,
C12238,Papyramine,,,,,
C12239,9-O-Demethyl-2alpha-hydroxyhomolycorine,,,,,
C12240,Dubiusine,,,,,
C12241,O-Methyllycorenine,,,,,
C12242,Chelidonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C12242  Chelidonine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C12242  Chelidonine,
C12243,(+/-)-gamma-Lycorane,,,,,
C12244,3-Buten-1-amine,,,,,
C12245,"Methyl5-(but-3-en-1-yl)amino-1,3,4-oxadiazole-2-carboxylate",,,,,
C12246,Protorifamycin I,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12246  Protorifamycin I,
C12247,Rifamycin W,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Ansamycins|C12247  Rifamycin W|Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C12247  Rifamycin W,
C12248,"5-Hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate;|2-Oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline",,,,,
C12249,Kaempferol 3-O-glucoside;|Kaempferol 3-O-beta-D-glucoside;|Astragalin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12249  Kaempferol 3-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12249  Kaempferol 3-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12249  Kaempferol 3-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12249,
C12250,Anhydrolycorinone,,,,,
C12251,2-Iodo-6-methoxyphenol,,,,,
C12252,2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide,,,,,
C12253,Norsanguinine,,,,,
C12254,(+)-Plicamine,,,,,
C12255,7-Deoxypancratistatin,,,,,
C12256,"(+)-2,7-Dideoxypancratistatin",,,,,
C12257,Homochelidonine;|(+/-)-Homochelidonine,,,,,
C12258,Arnottin II,,,,,
C12259,(+)-Sceletium A4,,,,,
C12260,(-)-Tortuosamine;|Tortuosamine,,,,,
C12261,"2,3,4-Trioxycyclopentanone",,,,,
C12262,"4,4-Disubstituted cyclohexenone",,,,,
C12263,"1,2-Dimethoxy-4-[2-(2-propenyloxy)ethenyl]-benzene",,,,,
C12264,"6-(2-Methoxyvinyl)benzo[1,3]dioxole-5-carboxylic acid",,,,,
C12265,Lichenysin D,Generic compound|R = fatty acid,0 FA  1 Gln  2 Leu  3 D-Leu  4 Val  5 Asp  6 D-Leu  7 Ile,NRP,,
C12266,Iturin A,Generic compound|R = fatty acid,0 FA  1 Asn  2 D-Tyr  3 D-Asn  4 Gln  5 Pro  6 D-Asn  7 Ser,NRP,,
C12267,Bacillomycin D,Generic compound|R = fatty acid,0 FA  1 Asn  2 D-Tyr  3 D-Asn  4 Pro  5 Glu  6 D-Ser  7 Thr,NRP,,
C12268,Syringomycin,"0 FA is 3-hydroxy-fatty acid.|8 Asp is modified by 3-hydroxy. (i.e. 3-L-threo-Hydroxyaspartic acid, (3-OH)Asp)|9 Thr is modified by 4-chloro. (i.e. 4-Chlorothreonine, (4-Cl)Thr)",0 FA  1 Ser  2 D-Ser  3 Dab  4 D-Dab  5 Arg  6 Phe  7 Dhb  8 Asp|9 Thr  (Cyclization: 1-9),NRP,,
C12269,N-Methyl-D-aspartic acid;|N-Methyl-D-aspartate;|NMDA,,,,,
C12270,N-Acetylaspartylglutamate;|NAAG;|Isospaglumic acid;|N-Acetyl-L-aspartyl-L-glutamate,,,,,
C12271,"N-Arachidonyldopamine;|Arachidonoyl dopamine;|NADA;|N-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-dopamine",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C12271  N-Arachidonyldopamine,
C12272,N-Oleoyldopamine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C12272  N-Oleoyldopamine,
C12276,Calcium pantothenate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01082)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA31 Calcium pantothenate|D01082  Calcium pantothenate (JP18/USP/INN)|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX04 Calcium pantothenate|D01082  Calcium pantothenate (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D01082)]|Nourishing tonics and health supplements|45 Protein and amino acid based drugs|D01082  Calcium pantothenate (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01082)]|Third-class OTC drugs|Inorganic and organic chemicals|Pantothenic acid|D01082  Calcium pantothenate (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9623  Vitamin B and preparations (except vitamin B1 preparations)|C12276  Calcium pantothenate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01082)]|Chemicals|D01082  Calcium pantothenate,
C12277,Calcium hydroxide,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01083)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D01083  Calcium hydroxide (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01083)]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium hydroxide|D01083  Calcium hydroxide (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01083)]|Chemicals|D01083  Calcium hydroxide",
C12278,Copper gluconate,,,,,
C12280,Methyl acetyl ricinoleate,,,,,
C12282,Polyvinyl acetate,,,,,
C12283,Saccharin,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01085)]|Chemicals|D01085  Saccharin,
C12284,Saccharin sodium anhydrous,,,,,
C12285,Sucralose,,,,,
C12286,alpha-Ionone,See beta-Ionone [CPD:C12287],,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C12286  alpha-Ionone,
C12287,beta-Ionone;|trans-beta-Ionone,See alpha-Ionone [CPD:C12286],,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C12287  beta-Ionone,
C12288,alpha-Amylcinnamaldehyde;|alpha-Pentylcinnamaldehyde,,,,,
C12289,Isoamyl isovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C12289  Isoamyl isovalerate,
C12290,Ethyl isovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C12290  Ethyl isovalerate,
C12292,Ethyl octanoate;|Ethyl caprylate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C12292  Ethyl octanoate,
C12293,Isoamyl formate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C12293  Isoamyl formate,
C12294,Geranyl formate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C12294  Geranyl formate,
C12295,Citronellyl formate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C12295  Citronellyl formate,
C12296,Isoamyl acetate;|3-Methylbutyl acetate,,,,,
C12297,Cyclohexyl acetate,,,,,
C12298,"Citronellyl acetate;|3,7-Dimethyl-6-octen-1-yl acetate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C12298  Citronellyl acetate,
C12299,Cinnamyl acetate;|3-Phenyl-2-propenyl acetate,,,,,
C12300,alpha-Terpinyl acetate;|p-Menth-1-en-8-yl acetate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C12300  alpha-Terpinyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C12300  alpha-Terpinyl acetate,
C12301,"beta-Terpinyl acetate;|Cyclohexanol, 1-methyl-4-(1-methylethenyl)-, 1-acetate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C12301  beta-Terpinyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C12301  beta-Terpinyl acetate,
C12302,"gamma-Terpinyl acetate;|Cyclohexanol, 1-methyl-4-(1-methylethylidene)-, 1-acetate;|p-Menth-4-en-1-yl acetate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C12302  gamma-Terpinyl acetate|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C12302  gamma-Terpinyl acetate,
C12303,Phenethyl acetate;|2-Phenylethyl acetate,,,,,
C12304,Butyl acetate;|n-Butyl acetate,,,,,
C12305,Methyl salicylate;|Methyl 2-hydroxybenzoate,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01087)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2641  Methyl salicylic acids|D01087  Methyl salicylate (JP18/NF)|Classification of Japanese OTC drugs [BR:br08313(D01087)]|Agents for respiratory organs|27 Gargles|D01087  Methyl salicylate (JP18/NF)|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D01087  Methyl salicylate (JP18/NF)|Risk category of Japanese OTC drugs [BR:br08312(D01087)]|Third-class OTC drugs|Inorganic and organic chemicals|Methyl salicylate|D01087  Methyl salicylate (JP18/NF)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9531  Methyl salicylate and preparations|C12305  Methyl salicylate|Drug groups [BR:br08330(D01087)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01909  Anti-inflammatory drug, salicylic acid derivatives|D01087  Methyl salicylate|Drug classes [BR:br08332(D01087)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D01087  Methyl salicylate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01087)]|Chemicals|D01087  Methyl salicylate",
C12306,Allyl cyclohexylpropionate;|2-Propenyl 3-cyclohexylpropanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C12306  Allyl cyclohexylpropionate,
C12307,Decanal;|1-Decanal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C12307  Decanal,
C12308,Gibberellin A44;|Gibberellin 44,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C12308  Gibberellin A44|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C12308  Gibberellin A44,
C12309,Esmeraldin A,Generic compound|Mixture of long chain fatty acid esters of Esmeraldic acid [CPD:C12116]|R = various fatty acyl,,,,
C12310,Esmeraldin B,,,,,
C12311,Saphenamycin,,,,,
C12312,Indolin-2-one,,,,,
C12313,"cis-1,2-Cyclohexanediol;|cis-Cyclohexane-1,2-diol",,,,,
C12314,1-Oxa-2-oxo-3-hydroxycycloheptane,,,,,
C12316,cis-Dihydroquercetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C12316  cis-Dihydroquercetin,
C12317,D-Allothreonine;|D-allo-Threonine,,,,,
C12318,"dTDP-3-amino-2,3,6-trideoxy-4-keto-D-glucose;|dTDP-3-amino-2,3,6-trideoxy-D-threo-hexopyranos-4-ulose;|dTDP-3-amino-4-oxo-2,3,6-trideoxy-D-glucose",,,,,
C12319,"dTDP-3-amino-2,3,6-trideoxy-C-methyl-D-erythro-hexopyranos-4-ulose",,,,,
C12320,dTDP-L-4-oxovancosamine,,,,,
C12321,"dTDP-L-epivancosamine;|dTDP-beta-L-4-epi-vancosamine;|dTDP-3-amino-2,3,6-trideoxy-3-methyl-beta-L-arabino-hexopyranose",,,,,
C12322,dTDP-L-vancosamine;|dTDP-beta-L-vancosamine,,,,,
C12323,L-4-Hydroxyphenylglycine,,,,Target-based classification of drugs [BR:br08310(D05292)]|Enzymes|Transferases (EC2)|Acyltransferases|CPT1|D05292  Oxfenicine (USAN/INN),
C12324,"3,5-Dihydroxyphenylacetyl-CoA",,,,,
C12325,"3,5-Dihydroxyphenylglyoxylate;|2-(3,5-Dihydroxyphenyl)-2-oxoacetate",,,,,
C12326,"(R,S)-Scoulerine;|Scoulerine",,,,,
C12327,"Laudanosoline;|(R,S)-Laudanosoline",,,,,
C12328,"Reticuline;|(R,S)-Reticuline",,,,,
C12329,"(R,S)-Norreticuline;|Norreticuline",,,,,
C12330,"2,3,9,10-Tetrahydroxyberbine",,,,,
C12331,"2,3,9,10-Tetrahydroxyberberine",,,,,
C12332,Militarinone D,,,,,
C12333,Militarinone A,,,,,
C12334,Militarinone B,,,,,
C12335,Militarinone C,,,,,
C12336,Dioncophylline A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C12336  Dioncophylline A,
C12337,Dioncophylline C,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C12337  Dioncophylline C,
C12338,Korupensamine A,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C12338  Korupensamine A,
C12339,Dioncopeltine A;|Triphyopeltine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C12339  Dioncopeltine A,
C12340,Ancistrotectorine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Acetate derived alkaloids|C12340  Ancistrotectorine,
C12341,Dioncophyllinol B,,,,,
C12342,Ancistrobrevine A,,,,,
C12343,Isoshinanolone,,,,,
C12344,"1,8-Dihydroxy-3-methylnaphthalene",,,,,
C12345,"1,3-Dimethyl-6,8-isoquinolinediol",,,,,
C12346,"1,3-Dimethyl-8-isoquinolinol",,,,,
C12347,Deoxyribose triphosphate,,,,,
C12348,"3,5,7,9,11,13,15-Heptaoxo-hexadecanoyl-[acp]",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12348  3,5,7,9,11,13,15-Heptaoxo-hexadecanoyl-[acp]",
C12349,"3,5,7,9,11,13,15-Heptaoxo-heptadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12349  3,5,7,9,11,13,15-Heptaoxo-heptadecanoyl-[acp]",
C12350,"3,5,7,9,11,13,15-Heptaoxo-octadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12350  3,5,7,9,11,13,15-Heptaoxo-octadecanoyl-[acp]",
C12351,"3,5,7,9,11,13,15,17-Octaoxo-octadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12351  3,5,7,9,11,13,15,17-Octaoxo-octadecanoyl-[acp]",
C12352,"3,5,7,9,11,13,15,17-Octaoxo-nonadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12352  3,5,7,9,11,13,15,17-Octaoxo-nonadecanoyl-[acp]",
C12353,"3,5,7,9,11,13,15,17-Octaoxo-eicosanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12353  3,5,7,9,11,13,15,17-Octaoxo-eicosanoyl-[acp]",
C12354,"3,5,7,9,11,13,15,17,19-Nonaoxo-eicosanoyl-[acp]",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12354  3,5,7,9,11,13,15,17,19-Nonaoxo-eicosanoyl-[acp]",
C12355,"3,5,7,9,11,13,15,17,19-Nonaoxo-henicosanoyl-[acp]",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12355  3,5,7,9,11,13,15,17,19-Nonaoxo-henicosanoyl-[acp]",
C12356,"3,5,7,9,11,13,15,17,19-Nonaoxo-docosanoyl-[acp]",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12356  3,5,7,9,11,13,15,17,19-Nonaoxo-docosanoyl-[acp]",
C12357,"3,5,7,11,13,15-Heptaoxo-9-hydroxy-hexadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12357  3,5,7,11,13,15-Heptaoxo-9-hydroxy-hexadecanoyl-[acp]",
C12358,"3,5,7,11,13,15-Heptaoxo-9-hydroxy-heptadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12358  3,5,7,11,13,15-Heptaoxo-9-hydroxy-heptadecanoyl-[acp]",
C12359,"3,5,7,11,13,15-Heptaoxo-9-hydroxy-octadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12359  3,5,7,11,13,15-Heptaoxo-9-hydroxy-octadecanoyl-[acp]",
C12360,"9-Hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12360  9-Hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp]",
C12361,"9-Hydroxy-3,5,7,11,13,15,17-octaoxo-nonadecanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12361  9-Hydroxy-3,5,7,11,13,15,17-octaoxo-nonadecanoyl-[acp]",
C12362,"9-Hydroxy-3,5,7,11,13,15,17-octaoxo-eicosanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12362  9-Hydroxy-3,5,7,11,13,15,17-octaoxo-eicosanoyl-[acp]",
C12363,"9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-eicosanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12363  9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-eicosanoyl-[acp]",
C12364,"9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-henicosanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12364  9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-henicosanoyl-[acp]",
C12365,"9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-docosanoyl-[acp]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C12365  9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-docosanoyl-[acp]",
C12366,Tetracenomycin F2;|Tcm F2,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12366  Tetracenomycin F2,
C12367,Tetracenomycin F1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12367  Tetracenomycin F1,
C12368,Tetracenomycin D3,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12368  Tetracenomycin D3,
C12369,Tetracenomycin B3,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12369  Tetracenomycin B3,
C12370,Tetracenomycin E,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12370  Tetracenomycin E,
C12371,Tetracenomycin A2,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12371  Tetracenomycin A2,
C12372,Tetracenomycin M,,,,,
C12373,Tetracenomycin F1 methylester,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12373  Tetracenomycin F1 methylester,
C12374,Decarboxytetracenomycin F1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12374  Decarboxytetracenomycin F1,
C12375,Tetracenomycin D3 methylester,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12375  Tetracenomycin D3 methylester,
C12376,Tetracenomycin D1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12376  Tetracenomycin D1,
C12377,Tetracenomycin B1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12377  Tetracenomycin B1,
C12378,Tetracenomycin B2;|8-Demethyltetracenomycin A2,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12378  Tetracenomycin B2,
C12379,8-Demethyltetracenomycin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12379  8-Demethyltetracenomycin C,
C12380,Tetracenomycin X,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12380  Tetracenomycin X|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12380,
C12381,Elloramycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12381  Elloramycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12381,
C12382,4-Demethylpremithramycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12382  4-Demethylpremithramycinone,
C12383,Premithramycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12383  Premithramycinone,
C12384,Premithramycin A1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12384  Premithramycin A1,
C12385,Premithramycin A2',,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12385  Premithramycin A2',
C12386,Premithramycin A3',,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12386  Premithramycin A3',
C12387,Premithramycin A3,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12387  Premithramycin A3,
C12388,Premithramycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12388  Premithramycin B,
C12389,Mithramycin;|Plicamycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C12389  Mithramycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12389|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00468)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DC Other cytotoxic antibiotics|L01DC02 Plicamycin|D00468  Plicamycin (USAN/INN),
C12390,Dehydrorabelomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12390  Dehydrorabelomycin,
C12391,"Kinobscurinone;|4,9-Dihydroxy-2-methyl-11H-benzo[b]fluorene-5,10,11-trione",,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12391  Kinobscurinone,
C12392,Stealthin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12392  Stealthin C,
C12393,Prekinamycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12393  Prekinamycin,
C12394,Kinamycin D,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12394  Kinamycin D,
C12395,Jadomycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12395  Jadomycin B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12395,
C12396,Tetrangomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12396  Tetrangomycin,
C12397,Tetrangulol,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12397  Tetrangulol,
C12398,8-O-Methyltetrangulol,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12398  8-O-Methyltetrangulol,
C12399,19-Hydroxytetrangulol,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12399  19-Hydroxytetrangulol,
C12400,19-Hydroxy-8-O-methyltetrangulol,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12400  19-Hydroxy-8-O-methyltetrangulol,
C12401,PD116740,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12401  PD116740,
C12402,Rabelomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12402  Rabelomycin,
C12403,104-1,,,,,
C12404,Urdamycinone B,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12404  Urdamycinone B,
C12405,100-1,,,,,
C12406,Urdamycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12406  Urdamycin B,
C12407,104-2,,,,,
C12408,100-2,,,,Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C12408  100-2,
C12409,124-1,,,,,
C12410,Urdamycinone F,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12410  Urdamycinone F,
C12411,Urdamycin F,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12411  Urdamycin F|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C12411  Urdamycin F,
C12412,Aquayamycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12412  Aquayamycin,
C12413,Urdamycin A;|Kerriamycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12413  Urdamycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12413,
C12414,Urdamycin G;|Aggreticin;|OM 4842,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C12414  Urdamycin G|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C12414  Urdamycin G,
C12415,"Methyl nogalonate;|Nogalonic acid methyl ester;|NAME;|Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate",,,,,
C12416,Nogalonate;|Nogalonic acid,,,,,
C12417,Auraviketone,,,,,
C12418,Dihydro-NAME;|Dihydro-nogalonic acid methyl ester,,,,,
C12419,Auramycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12419  Auramycinone,
C12420,12-Deoxyaklanonic acid,,,,,
C12421,"Aklanonate;|Aklanonic acid;|[4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid",,,,,
C12422,"Methyl aklanonate;|Aklanonic acid methyl ester;|AAME;|Methyl [4,5-dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetate",,,,,
C12423,"Aklaviketone;|Methyl (1R,2R)-2-ethyl-2,5,7-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate",,,,,
C12424,Aklavinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12424  Aklavinone,
C12425,epsilon-Rhodomycinone;|Rhodomycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12425  epsilon-Rhodomycinone,
C12426,Rhodomycin D,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12426  Rhodomycin D,
C12427,10-Carboxy-13-deoxycarminomycin;|D 788-1,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12427  10-Carboxy-13-deoxycarminomycin,
C12428,13-Deoxycarminomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12428  13-Deoxycarminomycin,
C12429,13-Deoxydaunorubicin;|Feudomycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12429  13-Deoxydaunorubicin,
C12430,13-Dihydrodaunorubicin,"intermediate of daunorubicin synthesis (see [RN:R06688+R06689])|The configuration of 13-hydroxyl group is unknown.|The name ""13-dihydrodaunorubicin"" usually means (13S)-13-Dihydrodaunorubicin [CPD:C12433].",,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12430  13-Dihydrodaunorubicin,
C12431,13-Dihydrocarminomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12431  13-Dihydrocarminomycin,
C12432,Carminomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12432  Carminomycin,
C12433,(13S)-13-Dihydrodaunorubicin;|Daunorubicinol;|13-Dihydrodaunorubicin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C12433  (13S)-13-Dihydrodaunorubicin,
C12434,"(S)-DNPA;|4-Dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naphtho[2,3-c]pyran-3-acetic acid",,,,,
C12435,6-Deoxydihydrokalafungin;|DDHK,,,,,
C12436,Dihydrokalafungin;|DHK,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C12436  Dihydrokalafungin,
C12437,Medermycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C12437  Medermycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12437,
C12439,Phenanthroviridone aglycon,Generic compound|R = 1-methylpropyl group [CPD:C18680],,,,
C12440,Trachelanthamidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C12440  Trachelanthamidine,
C12441,"18-Carbamoyl-3,5,7,9,11,13,15,17-octaoxooctadecanoyl-[acp]",Generic compound in reaction hierarchy,,,,
C12442,"C-9 Reduced nonaketamide;|18-Carbamoyl-9-hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp]",Generic compound in reaction hierarchy,,,,
C12443,dTDP-beta-L-daunosamine,,,,,
C12444,dTDP-D-mycarose,,,,,
C12446,"dTDP-D-oliose;|dTDP-2,6-dideoxy-D-galactose",,,,,
C12447,dTDP-beta-L-rhodinose,,,,,
C12448,Ecgonine methyl ester;|Methyl ecgonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C12448  Ecgonine methyl ester,
C12449,Pseudoecgonine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C12449  Pseudoecgonine,
C12450,Pseudoecgonyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C12450  Pseudoecgonyl-CoA|Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C12450  Pseudoecgonyl-CoA,
C12451,Fridamycin E,,,,,
C12452,Acetyltropine;|3-Acetyltropine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C12452  Acetyltropine,
C12453,Acetylpseudotropine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Tropane alkaloids|C12453  Acetylpseudotropine,
C12454,Anatalline,,,,,
C12455,5-Aminopentanal,,,,,
C12456,3-Dimethylallyl-4-hydroxyphenylpyruvate;|3-(4-Hydroxy-3-prenylphenyl)pyruvate;|3-[4-Hydroxy-3-(2-methylprop-1-en-1-yl)phenyl]-2-oxopropanoate,,,,,
C12457,3-Dimethylallyl-4-hydroxymandelic acid;|3-Dimethylallyl-4-hydroxymandelate;|4-Hydroxy-3-prenylmandelate,,,,,
C12458,3-Dimethylallyl-4-hydroxybenzoate;|4-Hydroxy-3-prenylbenzoate,,,,,
C12459,3-Dimethylallyl-4-hydroxybenzaldehyde,,,,,
C12460,3-Dimethylallyl-beta-hydroxy-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12461,L-Tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12462,beta-Hydroxy-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12463,beta-Keto-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12464,3-Methyl-beta-keto-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12465,2-Hydroxy-3-methyl-beta-keto-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12466,"3-Amino-4,7-dihydroxy-8-methylcoumarin",,,,,
C12467,2-Hydroxy-beta-keto-L-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12468,"3-Amino-4,7-dihydroxycoumarin",,,,,
C12469,"3-Amino-4,7-dihydroxy-8-chlorocoumarin",,,,,
C12470,L-Prolyl-[pcp];|L-Prolyl-S-[pcp];|L-Prolyl-[peptidyl-carrier protein],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12471,Chlorobiocic acid,,,,,
C12472,Novclobiocin 105,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C12472  Novclobiocin 105,
C12473,Novclobiocin 104,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C12473  Novclobiocin 104,
C12474,Novobiocic acid,,,,,
C12475,Demethyldecarbamoylnovobiocin,,,,,
C12476,Decarbamoylnovobiocin,,,,,
C12477,"3-Methylpyrrole-2,4-dicarboxylic acid",,,,,
C12478,Coumeroic acid,,,,,
C12479,Coumermic acid,,,,,
C12480,Coumermycin D,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C12480  Coumermycin D,
C12481,dTDP-5-dimethyl-L-lyxose;|dTDP-4-O-demethyl-beta-L-noviose,,,,,
C12483,Pyrrole-2-carbonyl-[pcp];|1H-Pyrrole-2-carbonyl-[peptidyl-carrier protein],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12484,5-Methyl-pyrrole-2-carboxyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C12486,Boric acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01089)]|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA03 Boric acid|D01089  Boric acid (JP18/NF) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01089)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1314  Ophthalmic aseptic astringents|D01089  Boric acid (JP18/NF)|1319  Others|D01089  Boric acid (JP18/NF)|Classification of Japanese OTC drugs [BR:br08313(D01089)]|Agents for ophthalmologic use|67 Eyewash|D01089  Boric acid (JP18/NF)|Risk category of Japanese OTC drugs [BR:br08312(D01089)]|Third-class OTC drugs|Inorganic and organic chemicals|Boric acid|D01089  Boric acid (JP18/NF)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C12486  Boric acid|956  Bath and disinfectants preparations|9569  Other bath and disinfectants preparations|C12486  Boric acid|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01089)]|Chemicals|D01089  Boric acid",
C12490,Butenafine hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01093)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE23 Butenafine|D01093  Butenafine hydrochloride (JP18/USAN) &lt;JP&gt;|USP drug classification [BR:br08302(D01093)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Butenafine|D01093  Butenafine hydrochloride (JP18/USAN)|Therapeutic category of drugs in Japan [BR:br08301(D01093)]|2  Agents affecting individual organs|26  Epidermides|265  Antiparasitic dermatosis agents|2659  Others|D01093  Butenafine hydrochloride (JP18/USAN)|Classification of Japanese OTC drugs [BR:br08313(D01093)]|Agents for integumentary system|58 Ringworm drugs|D01093  Butenafine hydrochloride (JP18/USAN)|Risk category of Japanese OTC drugs [BR:br08312(D01093)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Butenafine|D01093  Butenafine hydrochloride (JP18/USAN)|Second-class OTC drugs|Inorganic and organic chemicals|Butenafine|D01093  Butenafine hydrochloride (JP18/USAN)|Antimicrobials [BR:br08307(D01093)]|Antifungals|Ergosterol biosynthesis inhibitor|Other ergosterol biosynthesis inhibitor|D01093  Butenafine hydrochloride (JP18/USAN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01093)]|Chemicals|D01093  Butenafine hydrochloride|D01093  Butenafine hydrochloride solution|D01093  Butenafine hydrochloride spray|D01093  Butenafine hydrochloride cream|Rx-to-OTC switch list in the USA [br08315.html(D01093)]|D01093|Rx-to-OTC switch list in Japan [br08314.html(D01093)]|D01093",
C12491,Pyrrolnitrin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01094)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA07 Pyrrolnitrin|D01094  Pyrrolnitrin (JP18/USAN/INN)|Classification of Japanese OTC drugs [BR:br08313(D01094)]|Agents for integumentary system|58 Ringworm drugs|D01094  Pyrrolnitrin (JP18/USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01094)]|Second-class OTC drugs|Inorganic and organic chemicals|Pyrrolnitrin|D01094  Pyrrolnitrin (JP18/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01094)]|Chemicals|D01094  Pyrrolnitrin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C12491,
C12505,Magnesium sulfate;|Magnesium sulfate heptahydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01108)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD04 Magnesium sulfate|D01108  Magnesium sulfate (USP) &lt;JP/US&gt;|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CC Magnesium|A12CC02 Magnesium sulfate|D01108  Magnesium sulfate (USP) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA05 Magnesium sulfate|D01108  Magnesium sulfate (USP) &lt;JP/US&gt;|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX05 Magnesium sulfate|D01108  Magnesium sulfate (USP) &lt;JP/US&gt;|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CC Tests for bile duct patency|V04CC02 Magnesium sulfate|D01108  Magnesium sulfate (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01108)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Magnesium|D01108  Magnesium sulfate (USP)|Therapeutic category of drugs in Japan [BR:br08301(D01108)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|124  Antispasmodics|1244  Magnesium salts|D01108  Magnesium sulfate (USP); Magnesium sulfate hydrate (JP18)|2  Agents affecting individual organs|23  Digestive organ agents|235  Purgatives, clysters|2355  Inorganic salts|D01108  Magnesium sulfate (USP); Magnesium sulfate hydrate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01108)]|Agents for digestive organs|17 Cathartics|D01108  Magnesium sulfate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D01108)]|Third-class OTC drugs|Inorganic and organic chemicals|Magnesium sulfate hydrate|D01108  Magnesium sulfate (USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|915  Antispasmodics|9153  Magnesium salts and preparations|C12505  Magnesium sulfate|Drug groups [BR:br08330(D01108)]|Gastrointestinal agent|DG01770  Laxative|D01108  Magnesium sulfate|DG01979  Magnesium containing preparation|D01108  Magnesium sulfate|Drug classes [BR:br08332(D01108)]|Gastrointestinal agent|DG01770  Laxative|D01108  Magnesium sulfate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01108)]|Chemicals|D01108  Magnesium sulfate hydrate|D01108  Magnesium sulfate mixture|D01108  Magnesium sulfate injection",
C12508,Nateglinide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01111)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BX Other blood glucose lowering drugs, excl. insulins|A10BX03 Nateglinide|D01111  Nateglinide (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01111)]|Blood Glucose Regulators|Antidiabetic Agents|Glucose Control Agents, Other|Nateglinide|D01111  Nateglinide (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01111)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3969  Others|D01111  Nateglinide (JP18/USP/INN)|Drug groups [BR:br08330(D01111)]|Antidiabetic agent|DG01508  Sulfonylurea receptor agonist|DG01735  Glinide|D01111  Nateglinide|DG02044  Hypoglycemic agent|DG01735  Glinide|D01111  Nateglinide|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D01111  Nateglinide|Drug classes [BR:br08332(D01111)]|Antidiabetic agent|DG01735  Glinide|D01111  Nateglinide|DG02044  Hypoglycemic agent|D01111  Nateglinide|Target-based classification of drugs [BR:br08310(D01111)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D01111  Nateglinide (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01111)]|Chemicals|D01111  Nateglinide|D01111  Nateglinide tablets|New drug approvals in the USA [br08319.html(D01111)]|New molecular entities and new therapeutic biological products|D01111|New drug approvals in Europe [br08329.html(D01111)]|European public assessment reports (EPAR) authorised medicine|D01111|New drug approvals in the USA, Europe and Japan [br08328.html(D01111)]|Approval dates by FDA, EMA and PMDA|D01111|Drug metabolizing enzymes and transporters [br08309.html(D01111)]|Drug metabolizing enzymes|D01111|Pharmacogenomic biomarkers [br08341.html(D01111)]|Polymorphisms and mutations affecting drug response|D01111",
C12512,Eplerenone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01115)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03D ALDOSTERONE ANTAGONISTS AND OTHER POTASSIUM-SPARING AGENTS|C03DA Aldosterone antagonists|C03DA04 Eplerenone|D01115  Eplerenone (JP18/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01115)]|Cardiovascular Agents|Mineralocorticoid Receptor Antagonist|Eplerenone|D01115  Eplerenone (JP18/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01115)]|2  Agents affecting individual organs|21  Cardiovascular agents|214  Antihypertensives|2149  Others|D01115  Eplerenone (JP18/USAN/INN)|Drug groups [BR:br08330(D01115)]|Cardiovascular agent|DG03231  Antihypertensive|DG01676  Aldosterone antagonist|D01115  Eplerenone|DG01885  Potassium-sparing diuretic|D01115  Eplerenone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D01115  Eplerenone|Drug classes [BR:br08332(D01115)]|Cardiovascular agent|DG01676  Aldosterone antagonist|D01115  Eplerenone|DG03231  Antihypertensive|D01115  Eplerenone|Target-based classification of drugs [BR:br08310(D01115)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D01115  Eplerenone (JP18/USAN/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01115)]|Chemicals|D01115  Eplerenone|D01115  Eplerenone tablets|New drug approvals in the USA [br08319.html(D01115)]|New molecular entities and new therapeutic biological products|D01115|New drug approvals in Japan [br08318.html(D01115)]|Drugs with new active ingredients|D01115|New drug approvals in the USA, Europe and Japan [br08328.html(D01115)]|Approval dates by FDA, EMA and PMDA|D01115|Drug metabolizing enzymes and transporters [br08309.html(D01115)]|Drug metabolizing enzymes|D01115",
C12518,"Glutaral;|1,5-Pentanedial;|Glutaraldehyde",,,,"Therapeutic category of drugs in Japan [BR:br08301(D01120)]|7  Agents not mainly for therapeutic purpose|73  Public health agents|732  Germicides and disinfectants|7321  Alcohols and aldehydes|D01120  Glutaral (JAN/USP/INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9921  Alcohol, aldehyde and preparations|C12518  Glutaral",
C12525,"5alpha-Androstan-3beta,17beta-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C12525  5alpha-Androstan-3beta,17beta-diol",
C12531,Tazarotene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01132)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AX Other antipsoriatics for topical use|D05AX05 Tazarotene|D01132  Tazarotene (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D01132)]|Dermatological Agents|Acne and Rosacea Agents|Retinoids|Tazarotene|D01132  Tazarotene (JAN/USAN/INN)|Drug groups [BR:br08330(D01132)]|Vitamin and mineral|DG01604  Retinol derivative|D01132  Tazarotene|Target-based classification of drugs [BR:br08310(D01132)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D01132  Tazarotene (JAN/USAN/INN) &lt;US&gt;|Hepatocyte nuclear factor 4 like receptors|Retinoid X receptor (RXR)|NR2B2 (RXRB)|D01132  Tazarotene (JAN/USAN/INN) &lt;US&gt;|Prodrugs [br08324.html(D01132)]|D01132,
C12535,Tranexamic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01136)]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02A ANTIFIBRINOLYTICS|B02AA Amino acids|B02AA02 Tranexamic acid|D01136  Tranexamic acid (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01136)]|Blood Products and Modifiers|Hemostasis Agents|Tranexamic Acid|D01136  Tranexamic acid (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01136)]|3  Agents affecting metabolism|33  Blood and body fluid agents|332  Hemostatics|3327  Antiplasmins|D01136  Tranexamic acid (JP18/USP/INN)|4  Agents affecting cellular function|44  Allergic agents|449  Miscellaneous|4490  Miscellaneous|D01136  Tranexamic acid (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D01136)]|Nourishing tonics and health supplements|38 Vitamin C based drugs|D01136  Tranexamic acid (JP18/USP/INN)|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D01136  Tranexamic acid (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01136)]|First-class OTC drugs|Inorganic and organic chemicals|Tranexamic acid|D01136  Tranexamic acid (JP18/USP/INN)|Third-class OTC drugs|Inorganic and organic chemicals|Tranexamic acid|D01136  Tranexamic acid (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|965  Hemostatics|9659  Other hemostatics|C12535  Tranexamic acid|966  Anticoagulants|9669  Other anticoagulants|C12535  Tranexamic acid|Drug groups [BR:br08330(D01136)]|Blood modifier agent|DG02016  Hemostatics|DG02012  Antifibrinolytic|DG01540  Plasmin inhibitor|D01136  Tranexamic acid|Target-based classification of drugs [BR:br08310(D01136)]|Enzymes|Hydrolases (EC3)|Serine peptidases|PLG|D01136  Tranexamic acid (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01136)]|Chemicals|D01136  Tranexamic acid|D01136  Tranexamic acid tablets|D01136  Tranexamic acid capsules|D01136  Tranexamic acid injection|Rx-to-OTC switch list in Japan [br08314.html(D01136)]|D01136,
C12537,Benzyl benzoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01138)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AX Other ectoparasiticides, incl. scabicides|P03AX01 Benzyl benzoate|D01138  Benzyl benzoate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01138)]|Agents for sanitation|82 Pesticides|D01138  Benzyl benzoate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01138)]|Chemicals|D01138  Benzyl benzoate",
C12538,Ammonium chloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01139)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA04 Ammonium chloride|D01139  Ammonium chloride (JAN/USP) &lt;JP&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BA Acidifiers|G04BA01 Ammonium chloride|D01139  Ammonium chloride (JAN/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01139)]|3  Agents affecting metabolism|33  Blood and body fluid agents|331  Blood substitutes|3319  Others|D01139  Ammonium chloride (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01139)]|Third-class OTC drugs|Inorganic and organic chemicals|Ammonium chloride|D01139  Ammonium chloride (JAN/USP)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|922  Diuretics|9229  Other diuretics|C12538  Ammonium chloride",
C12539,Benzethonium chloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01140)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ08 Benzethonium chloride|D01140  Benzethonium chloride (JP18/USP/INN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA09 Benzethonium|D01140  Benzethonium chloride (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01140)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2616  Medical soaps|D01140  Benzethonium chloride (JP18/USP/INN)|27  Dental preparations|279  Miscellaneous|2790  Miscellaneous|D01140  Benzethonium chloride (JP18/USP/INN)|7  Agents not mainly for therapeutic purpose|73  Public health agents|732  Germicides and disinfectants|7324  Invert soaps|D01140  Benzethonium chloride (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D01140)]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|D01140  Benzethonium chloride (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01140)]|Third-class OTC drugs|Inorganic and organic chemicals|Benzethonium chloride|D01140  Benzethonium chloride (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C12539  Benzethonium chloride|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01140)]|Chemicals|D01140  Benzethonium chloride|D01140  Benzethonium chloride solution,
C12540,Sulfamonomethoxine,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|971  Sulfonamide preparations|9712  Sulfonamide preparations for peroral and feed additive use|C12540  Sulfamonomethoxine|Drug groups [BR:br08330(D01141)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01786  Long-acting sulfonamide|DG01204  Sulfamonomethoxine|D01141  Sulfamonomethoxine|Antimicrobials [BR:br08307(D01141)]|Antibacterials|Folic acid biosynthesis inhibitor|Long-acting sulfonamide|D01141  Sulfamonomethoxine (JAN/USAN/INN),
C12552,Oxethazaine;|Oxetacaine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01152)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AD Local anesthetics|C05AD06 Oxetacaine|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01152)]|1  Agents affecting nervous system and sensory organs|12  Agents affecting peripheral nervous system|121  Local anesthetics|1219  Others|D01152  Oxethazaine (JP18/USAN); Oxetacaine (INN)|Classification of Japanese OTC drugs [BR:br08313(D01152)]|Agents for digestive organs|15 Stomach pain and cramp relievers|D01152  Oxethazaine (JP18/USAN)|Risk category of Japanese OTC drugs [BR:br08312(D01152)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxethazaine|D01152  Oxethazaine (JP18/USAN)|Drug groups [BR:br08330(D01152)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01673  Amide type local anesthetic|DG00299  Oxetacaine|D01152  Oxethazaine|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG00299  Oxetacaine|D01152  Oxethazaine|Target-based classification of drugs [BR:br08310(D01152)]|Ion channels|Voltage-gated ion channels|Sodium channels|SCN1A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN2A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN3A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN4A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN5A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN8A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN9A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN10A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|SCN11A|D01152  Oxethazaine (JP18/USAN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01152)]|Chemicals|D01152  Oxethazaine|Rx-to-OTC switch list in Japan [br08314.html(D01152)]|D01152,
C12554,Potassium acetate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01154)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA17 Potassium acetate|D01154  Potassium acetate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01154)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Potassium|D01154  Potassium acetate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01154)]|3  Agents affecting metabolism|32  Nutrients, tonics|322  Mineral preparations|3229  Others|D01154  Potassium acetate (JAN/USP)|Drug groups [BR:br08330(D01154)]|Gastrointestinal agent|DG02017  Potassium|D01154  Potassium acetate",
C12557,Cefepime hydrochloride;|Cefepime dihydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01157)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DE Fourth-generation cephalosporins|J01DE01 Cefepime|D01157  Cefepime hydrochloride (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01157)]|Antibacterials|Beta-lactam, Cephalosporins|Cefepime|D01157  Cefepime hydrochloride (USP)|Therapeutic category of drugs in Japan [BR:br08301(D01157)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6132  Cephem antibioitics|D01157  Cefepime hydrochloride (USP); Cefepime dihydrochloride hydrate (JP18)|Drug groups [BR:br08330(D01157)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00586  Cefepime|D01157  Cefepime hydrochloride|DG01777  Fourth-generation cephalosporin|DG00586  Cefepime|D01157  Cefepime hydrochloride|DG01804  Oxyimino beta-lactam|DG00586  Cefepime|D01157  Cefepime hydrochloride|Drug classes [BR:br08332(D01157)]|Antibacterial|DG01488  Cephem|D01157  Cefepime hydrochloride|Antimicrobials [BR:br08307(D01157)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Fourth-generation cephalosporin|D01157  Cefepime hydrochloride (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01157)]|Chemicals|D01157  Cefepime dihydrochloride hydrate|D01157  Cefepime dihydrochloride for injection",
C12560,Saquinavir mesylate;|Saquinavir mesilate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01160)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AE Protease inhibitors|J05AE01 Saquinavir|D01160  Saquinavir mesylate (USP)|USP drug classification [BR:br08302(D01160)]|Antivirals|Anti-HIV Agents, Protease Inhibitors (PI)|Saquinavir|D01160  Saquinavir mesylate (USP)|Drug groups [BR:br08330(D01160)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|DG00653  Saquinavir|D01160  Saquinavir mesylate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00653  Saquinavir|D01160  Saquinavir mesylate|Transporter substrate|DG01665  ABCB1 substrate|DG00653  Saquinavir|D01160  Saquinavir mesylate|Antimicrobials [BR:br08307(D01160)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D01160  Saquinavir mesylate (USP)|New drug approvals in Europe [br08329.html(D01160)]|European public assessment reports (EPAR) authorised medicine|D01160|Drug metabolizing enzymes and transporters [br08309.html(D01160)]|Drug metabolizing enzymes|D01160|Drug transporters|D01160",
C12564,Aripiprazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01164)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AX Other antipsychotics|N05AX12 Aripiprazole|D01164  Aripiprazole (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01164)]|Antidepressants|Antidepressants, Other|Aripiprazole|D01164  Aripiprazole (JAN/USP/INN)|Antipsychotics|2nd Generation/Atypical|Aripiprazole|D01164  Aripiprazole (JAN/USP/INN)|Bipolar Agents|Bipolar Agents, Other|Aripiprazole|D01164  Aripiprazole (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01164)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D01164  Aripiprazole (JAN/USP/INN)|Drug groups [BR:br08330(D01164)]|Neuropsychiatric agent|DG03200  Antipsychotic agent|DG03064  Atypical antipsychotic|DG00906  Aripiprazole|D01164  Aripiprazole|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00906  Aripiprazole|D01164  Aripiprazole|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00906  Aripiprazole|D01164  Aripiprazole|Target-based classification of drugs [BR:br08310(D01164)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D01164  Aripiprazole (JAN/USP/INN) &lt;JP/US&gt;|DRD3|D01164  Aripiprazole (JAN/USP/INN) &lt;JP/US&gt;|Serotonin|HTR1A|D01164  Aripiprazole (JAN/USP/INN) &lt;JP/US&gt;|HTR2A|D01164  Aripiprazole (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D01164)]|New molecular entities and new therapeutic biological products|D01164|New drug approvals in Europe [br08329.html(D01164)]|European public assessment reports (EPAR) authorised medicine|D01164|New drug approvals in Japan [br08318.html(D01164)]|Drugs with new active ingredients|D01164|New drug approvals in the USA, Europe and Japan [br08328.html(D01164)]|Approval dates by FDA, EMA and PMDA|D01164|Drug metabolizing enzymes and transporters [br08309.html(D01164)]|Drug metabolizing enzymes|D01164|Pharmacogenomic biomarkers [br08341.html(D01164)]|Polymorphisms and mutations affecting drug response|D01164|Prodrugs [br08324.html(D01164)]|D01164|Prodrugs [br08324.html]|C12564",
C12567,Magnesium oxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01167)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AA Magnesium compounds|A02AA02 Magnesium oxide|D01167  Magnesium oxide (JP18/USP) &lt;JP&gt;|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD02 Magnesium oxide|D01167  Magnesium oxide (JP18/USP) &lt;JP&gt;|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CC Magnesium|A12CC10 Magnesium oxide|D01167  Magnesium oxide (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01167)]|2  Agents affecting individual organs|23  Digestive organ agents|234  Antacids|2344  Inorganic salts|D01167  Magnesium oxide (JP18/USP)|235  Purgatives, clysters|2355  Inorganic salts|D01167  Magnesium oxide (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01167)]|Agents for digestive organs|14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators|D01167  Magnesium oxide (JP18/USP)|17 Cathartics|D01167  Magnesium oxide (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01167)]|Third-class OTC drugs|Inorganic and organic chemicals|Magnesium oxide|D01167  Magnesium oxide (JP18/USP)|Drug groups [BR:br08330(D01167)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|D01167  Magnesium oxide|DG01770  Laxative|D01167  Magnesium oxide|DG01979  Magnesium containing preparation|D01167  Magnesium oxide|Drug classes [BR:br08332(D01167)]|Gastrointestinal agent|DG01770  Laxative|D01167  Magnesium oxide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01167)]|Chemicals|D01167  Magnesium oxide",
C12568,Potassium hydroxide,,,,Therapeutic category of drugs in Japan [BR:br08301(D01168)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D01168  Potassium hydroxide (JP18/NF)|Risk category of Japanese OTC drugs [BR:br08312(D01168)]|Second-class OTC drugs|Inorganic and organic chemicals|Potassium hydroxide|D01168  Potassium hydroxide (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01168)]|Chemicals|D01168  Potassium hydroxide,
C12569,Sodium hydroxide,,,,Therapeutic category of drugs in Japan [BR:br08301(D01169)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D01169  Sodium hydroxide (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01169)]|Chemicals|D01169  Sodium hydroxide,
C12570,Zinc oxide,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01170)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2649  Others|D01170  Zinc oxide (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01170)]|Agents for integumentary system|56 Purulent skin remedies|D01170  Zinc oxide (JP18/USP)|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D01170  Zinc oxide (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01170)]|Third-class OTC drugs|Inorganic and organic chemicals|Zinc oxide|D01170  Zinc oxide (JP18/USP)|Zinc oxide|D01170  Zinc oxide (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9533  Zinc oxide and preparations|C12570  Zinc oxide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01170)]|Chemicals|D01170  Zinc oxide ointment|D01170  Zinc oxide",
C12574,Pheniramine maleate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01174)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA16 Pheniramine|D01174  Pheniramine maleate (JAN/USP)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AB Substituted alkylamines|R06AB05 Pheniramine|D01174  Pheniramine maleate (JAN/USP)|Classification of Japanese OTC drugs [BR:br08313(D01174)]|Agents for nervous and sensory systems|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D01174  Pheniramine maleate (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01174)]|Second-class OTC drugs|Inorganic and organic chemicals|Pheniramine|D01174  Pheniramine maleate (JAN/USP)|Drug groups [BR:br08330(D01174)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01100  Pheniramine|D01174  Pheniramine maleate|Target-based classification of drugs [BR:br08310(D01174)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D01174  Pheniramine maleate (JAN/USP)",
C12580,Trilostane,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01180)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02C ANTIADRENAL PREPARATIONS|H02CA Anticorticosteroids|H02CA01 Trilostane|D01180  Trilostane (JAN/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01180)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D01180  Trilostane (JAN/USAN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9419  Other hormone preparations|C12580  Trilostane|Target-based classification of drugs [BR:br08310(D01180)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HSD3B|D01180  Trilostane (JAN/USAN) &lt;JP&gt;",
C12590,Pheneturide;|Ethylphenacemide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01190)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX13 Pheneturide|D01190  Ethylphenacemide (JAN),
C12599,Emtricitabine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01199)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AF Nucleoside and nucleotide reverse transcriptase inhibitors|J05AF09 Emtricitabine|D01199  Emtricitabine (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D01199)]|Antivirals|Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)|Emtricitabine|D01199  Emtricitabine (JAN/USAN/INN)|Drug groups [BR:br08330(D01199)]|Antiviral|DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)|D01199  Emtricitabine|DG01440  Arabinofuranosyl type antiviral|D01199  Emtricitabine|DG03107  Anti-HIV agent|DG01656  HIV reverse transcriptase inhibitor|D01199  Emtricitabine|Transporter substrate|DG02860  SLC22A8 substrate|D01199  Emtricitabine|Drug classes [BR:br08332(D01199)]|Antiviral|DG03107  Anti-HIV agent|D01199  Emtricitabine|Antimicrobials [BR:br08307(D01199)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D01199  Emtricitabine (JAN/USAN/INN) &lt;US&gt;|Antimicrobials abbreviations [BR:br08327(D01199)]|Antivirals|Genome replication inhibitor|HIV reverse transcriptase inhibitor|D01199  Emtricitabine (JAN/USAN/INN)|New drug approvals in the USA [br08319.html(D01199)]|New molecular entities and new therapeutic biological products|D01199|New drug approvals in Europe [br08329.html(D01199)]|European public assessment reports (EPAR) authorised medicine|D01199|New drug approvals in Japan [br08318.html(D01199)]|Drugs with new active ingredients|D01199|New drug approvals in the USA, Europe and Japan [br08328.html(D01199)]|Approval dates by FDA, EMA and PMDA|D01199|Drug metabolizing enzymes and transporters [br08309.html(D01199)]|Drug transporters|D01199",
C12600,Phenolsulfonphthalein;|Phenol red,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01200)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CH Tests for renal function and ureteral injuries|V04CH03 Phenolsulfonphthalein|D01200  Phenolsulfonphthalein (JP18/NF) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01200)]|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|722  Various function testing reagents|7225  Diagnostic reagents for renal function|D01200  Phenolsulfonphthalein (JP18/NF)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01200)]|Chemicals|D01200  Phenolsulfonphthalein|D01200  Phenolsulfonphthalein injection,
C12603,Sodium bicarbonate;|Sodium hydrogencarbonate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01203)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CB Salt solutions|B05CB04 Sodium bicarbonate|D01203  Sodium bicarbonate (JP18/USP) &lt;JP/US&gt;|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA02 Sodium bicarbonate|D01203  Sodium bicarbonate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01203)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Sodium|D01203  Sodium bicarbonate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01203)]|2  Agents affecting individual organs|23  Digestive organ agents|234  Antacids|2344  Inorganic salts|D01203  Sodium bicarbonate (JP18/USP)|3  Agents affecting metabolism|34  Dialysis agents|341  Kidney dialysis agents|3410  Kidney dialysis agents|D01203  Sodium bicarbonate (JP18/USP)|39  Other agents affecting metabolism|392  Antidotes|3929  Others|D01203  Sodium bicarbonate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01203)]|Agents for digestive organs|10 Antacids|D01203  Sodium bicarbonate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01203)]|Third-class OTC drugs|Inorganic and organic chemicals|Sodium bicarbonate|D01203  Sodium bicarbonate (JP18/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9679  Other agents for liver disease and antidotes|C12603  Sodium bicarbonate|Drug groups [BR:br08330(D01203)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|D01203  Sodium bicarbonate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01203)]|Chemicals|D01203  Sodium bicarbonate|D01203  Sodium bicarbonate injection|Rx-to-OTC switch list in the USA [br08315.html(D01203)]|D01203,
C12609,Novobiocin sodium,,,,Drug groups [BR:br08330(D01209)]|Transporter inhibitor|DG02901  SLC22A6 inhibitor|D01209  Novobiocin sodium|DG02866  SLC22A8 inhibitor|D01209  Novobiocin sodium|Antimicrobials [BR:br08307(D01209)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D01209  Novobiocin sodium (JAN/USP)|Antimicrobials abbreviations [BR:br08327(D01209)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D01209  Novobiocin sodium (JAN/USP)|Drug metabolizing enzymes and transporters [br08309.html(D01209)]|Drug transporters|D01209,
C12616,Sulfamethopyrazine;|Sulfalene,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01216)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01ED Long-acting sulfonamides|J01ED02 Sulfalene|D01216  Sulfalene (USAN)|Drug groups [BR:br08330(D01216)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01786  Long-acting sulfonamide|D01216  Sulfalene|Antimicrobials [BR:br08307(D01216)]|Antibacterials|Folic acid biosynthesis inhibitor|Long-acting sulfonamide|D01216  Sulfalene (USAN),
C12621,trans-3-Hydroxycinnamate;|(2E)-3-(3-Hydroxyphenyl)prop-2-enoate,,,,,
C12622,"cis-3-(3-Carboxyethenyl)-3,5-cyclohexadiene-1,2-diol;|(2E)-3-(cis-5,6-Dihydroxycyclohexa-1,3-dien-1-yl)prop-2-enoate",,,,,
C12623,"trans-2,3-Dihydroxycinnamate;|(2E)-3-(2,3-Dihydroxyphenyl)prop-2-enoate",,,,,
C12624,"2-Hydroxy-6-ketononatrienedioate;|(2Z,4E,7E)-2-Hydroxy-6-oxonona-2,4,7-triene-1,9-dioate",,,,,
C12625,Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside);|Biochanin A 7-O-beta-D-glucoside 6''-O-malonate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C12625  Biochanin A 7-O-(6-O-malonyl-beta-D-glucoside),
C12626,Kaempferol-3-O-galactoside;|Kaempferol 3-O-beta-D-galactoside;|Trifolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12626  Kaempferol 3-O-beta-D-galactoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12626  Kaempferol-3-O-galactoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12626  Kaempferol-3-O-galactoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12626,
C12627,Apigenin 7-O-neohesperidoside;|Rhoifolin;|Rhoifoloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12627  Apigenin 7-O-neohesperidoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12627  Apigenin 7-O-neohesperidoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12627  Apigenin 7-O-neohesperidoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12627,
C12628,Vitexin 2''-O-beta-L-rhamnoside;|2''-O-Rhamnosylvitexin;|Vitexin 2''-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12628  Vitexin 2''-O-beta-L-rhamnoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12628  Vitexin 2''-O-beta-L-rhamnoside|Glycosides [BR:br08021]|C-glycosides|C12628  Vitexin 2''-O-beta-L-rhamnoside,
C12629,Isoswertisin 2''-rhamnoside;|7-O-Methylvitexin 2''-O-beta-L-rhamnoside;|2''-O-Rhamnosylisoswertisin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12629  7-O-Methylvitexin 2''-O-beta-L-rhamnoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12629  Isoswertisin 2''-rhamnoside|Glycosides [BR:br08021]|C-glycosides|C12629  Isoswertisin 2''-rhamnoside,
C12630,Scolymoside;|Luteolin-7-O-rhamnoside;|Luteolin 7-O-neohesperidoside;|Veronicastroside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12630  Luteolin 7-O-neohesperidoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12630  Scolymoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12630  Scolymoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12630,
C12631,"2-Hydroxy-2,3-dihydrogenistein;|2,4',5,7-Tetrahydroxyisoflavanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C12631  2-Hydroxy-2,3-dihydrogenistein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C12631  2-Hydroxy-2,3-dihydrogenistein",
C12632,Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide];|Luteolin 7-O-beta-D-diglucuronide,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12632  Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide],
C12633,Laricitrin;|3'-O-Methylmyricetin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12633  Laricitrin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12633  Laricitrin,
C12634,Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;|Kaempferol 3-O-beta-D-sophoroside;|Sophoraflavonoloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12634  Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12634  Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12634,
C12635,Kaempferol 3-sophorotrioside;|Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12635  Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12635  Kaempferol 3-sophorotrioside,
C12636,Kaempferol 3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside],,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12636  Kaempferol 3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside],
C12637,Quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside];|Quercetin 3-O-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12637  Quercetin 3-O-[beta-D-xylosyl-(1->2)-beta-D-glucoside]|Dietary phytochemicals [br08012.html]|Flavonoids|C12637,
C12638,Quercetin 3-O-(6-O-malonyl-beta-D-glucoside);|Quercetin 3-O-malonylglucoside;|Quercetin-3-O-(6''-malonylglucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12638  Quercetin 3-O-(6-O-malonyl-beta-D-glucoside)|Dietary phytochemicals [br08012.html]|Flavonoids|C12638,
C12639,Quercimeritrin;|Quercetin 7-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12639  Quercetin 7-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12639  Quercimeritrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12639  Quercimeritrin|Dietary phytochemicals [br08012.html]|Flavonoids|C12639,
C12640,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside;|Bisdemalonylsalvianin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12640  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12640  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12640  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside,
C12641,4'''-Demalonylsalvianin;|Monodemalonylsalvianin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12641  4'''-Demalonylsalvianin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12641  4'''-Demalonylsalvianin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12641  4'''-Demalonylsalvianin,
C12642,Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12642  Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12642  Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12642  Pelargonidin 3-O-(6-O-malonyl-beta-D-glucoside)|Dietary phytochemicals [br08012.html]|Flavonoids|C12642,
C12643,Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside);|Cyanidin 3-O-(6'-O-malonylglucoside);|Cyanidin-3-(6'-malonylglucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12643  Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12643  Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12643  Cyanidin 3-O-(6-O-malonyl-beta-D-glucoside)|Dietary phytochemicals [br08012.html]|Flavonoids|C12643,
C12644,Pelargonidin 3-O-rutinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12644  Pelargonidin 3-O-rutinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12644  Pelargonidin 3-O-rutinoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12644  Pelargonidin 3-O-rutinoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12644,
C12645,Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside;|Pelargonidin 3-rutinoside-5-glucopyranoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12645  Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12645  Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12645  Pelargonidin 3-O-rutinoside 5-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12645,
C12646,Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside;|Cyanidin 3-rutinoside 5-glucoside,Cyanidin 3-rutinoside 5-glucoside chloride [CPD:C04787],,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12646  Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12646  Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C12646  Cyanidin 3-O-rutinoside 5-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12646,
C12647,Salvianin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C12647  Salvianin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C12647  Salvianin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C12647  Salvianin,
C12649,Citric acid monohydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01222)]|A ALIMENTARY TRACT AND METABOLISM|A09 DIGESTIVES, INCL. ENZYMES|A09A DIGESTIVES, INCL. ENZYMES|A09AB Acid preparations|A09AB04 Citric acid|D01222  Citric acid monohydrate (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01222)]|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D01222  Citric acid monohydrate (USP); Citric acid hydrate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01222)]|Third-class OTC drugs|Inorganic and organic chemicals|Anhydrous citric acid|D01222  Citric acid monohydrate (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01222)]|Chemicals|D01222  Citric acid hydrate",
C12650,"Capecitabine;|(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01223)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC06 Capecitabine|D01223  Capecitabine (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01223)]|Antineoplastics|Antimetabolites|Capecitabine|D01223  Capecitabine (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01223)]|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4223  Fluorouracils|D01223  Capecitabine (JAN/USP/INN)|Drug groups [BR:br08330(D01223)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|D01223  Capecitabine|Metabolizing enzyme substrate|DG01642  CYP2C9 substrate|D01223  Capecitabine|Drug classes [BR:br08332(D01223)]|Antineoplastic|DG02018  Antimetabolite|D01223  Capecitabine|Target-based classification of drugs [BR:br08310(D01223)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D01223  Capecitabine (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in Europe [br08329.html(D01223)]|European public assessment reports (EPAR) authorised medicine|D01223|New drug approvals in Japan [br08318.html(D01223)]|Drugs with new active ingredients|D01223|Drug metabolizing enzymes and transporters [br08309.html(D01223)]|Drug metabolizing enzymes|D01223|Pharmacogenomic biomarkers [br08341.html(D01223)]|Polymorphisms and mutations affecting drug response|D01223",
C12656,Paramethasone acetate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C12656  Paramethasone acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01229)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB05 Paramethasone|D01229  Paramethasone acetate (JAN/USAN)|Drug groups [BR:br08330(D01229)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00508  Paramethasone|D01229  Paramethasone acetate|Target-based classification of drugs [BR:br08310(D01229)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01229  Paramethasone acetate (JAN/USAN)",
C12661,Pantethine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01234)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA32 Pantethine|D01234  Pantethine (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01234)]|3  Agents affecting metabolism|31  Vitamins|313  Vitamin B preparations|3133  Pantothenic acids|D01234  Pantethine (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01234)]|Agents for circulatory system and blood|23 Arteriosclerosis drugs (incl. linoleate and lecithin based drugs)|D01234  Pantethine (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01234)]|Third-class OTC drugs|Inorganic and organic chemicals|Pantethine|D01234  Pantethine (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9623  Vitamin B and preparations (except vitamin B1 preparations)|C12661  Pantethine|Drug groups [BR:br08330(D01234)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|D01234  Pantethine|Drug classes [BR:br08332(D01234)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D01234  Pantethine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01234)]|Chemicals|D01234  Pantethine,
C12662,Josamycin;|Leucomycin A3,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12662  Leucomycin A3|Prodrugs [br08324.html]|C12662|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01235)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA07 Josamycin|D01235  Josamycin (JP18/USAN/INN)|Drug groups [BR:br08330(D01235)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG00604  Josamycin|D01235  Josamycin|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00604  Josamycin|D01235  Josamycin|Antimicrobials [BR:br08307(D01235)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01235  Josamycin (JP18/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01235)]|Chemicals|D01235  Josamycin|D01235  Josamycin tablets|Drug metabolizing enzymes and transporters [br08309.html(D01235)]|Drug metabolizing enzymes|D01235|Prodrugs [br08324.html(D01235)]|D01235",
C12666,Prednisolone sodium succinate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01239)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC04 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA01 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA04 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA03 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA02 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB06 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD02 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA04 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB02 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA03 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA02 Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|USP drug classification [BR:br08302(D01239)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Prednisolone|D01239  Prednisolone sodium succinate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01239)]|2  Agents affecting individual organs|24  Hormones|245  Adrenal hormone preparations|2456  Prednisolones|D01239  Prednisolone sodium succinate (JP18/USP)|Drug groups [BR:br08330(D01239)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00093  Prednisolone|D01239  Prednisolone sodium succinate|Dermatological agent|DG03243  Atopic dermatitis agent|D01239  Prednisolone sodium succinate|Drug classes [BR:br08332(D01239)]|Anti-inflammatory|DG01955  Corticosteroid|D01239  Prednisolone sodium succinate|Dermatological agent|DG03243  Atopic dermatitis agent|D01239  Prednisolone sodium succinate|Target-based classification of drugs [BR:br08310(D01239)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01239  Prednisolone sodium succinate (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01239)]|Chemicals|D01239  Prednisolone sodium succinate for injection",
C12667,Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside;|Baimaside;|Quercetin 3-beta-D-sophoroside;|Quercetin 3-O-sophoroside;|QUOSP,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12667  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C12667,
C12668,Quercetin 3-sophorotrioside;|Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C12668  Quercetin 3-sophorotrioside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C12668  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C12668  Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,
C12669,Deslanoside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C12669  Deslanoside|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01240)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA07 Deslanoside|D01240  Deslanoside (JP18/USP/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01240)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2113  Digitalis|D01240  Deslanoside (JP18/USP/INN)|Drug groups [BR:br08330(D01240)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D01240  Deslanoside|DG01653  Antiarrhythmics|D01240  Deslanoside|Drug classes [BR:br08332(D01240)]|Cardiovascular agent|DG01653  Antiarrhythmics|D01240  Deslanoside|Target-based classification of drugs [BR:br08310(D01240)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D01240  Deslanoside (JP18/USP/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01240)]|Chemicals|D01240  Deslanoside|D01240  Deslanoside injection,
C12673,Tegafur,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01244)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC03 Tegafur|D01244  Tegafur (JP18/USAN/INN)|Drug groups [BR:br08330(D01244)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|D01244  Tegafur|Metabolizing enzyme substrate|DG01638  CYP2A6 substrate|D01244  Tegafur|Target-based classification of drugs [BR:br08310(D01244)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D01244  Tegafur (JP18/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01244)]|Chemicals|D01244  Tegafur|Drug metabolizing enzymes and transporters [br08309.html(D01244)]|Drug metabolizing enzymes|D01244|Prodrugs [br08324.html(D01244)]|D01244",
C12675,Benzylhydrochlorothiazide,,,,Therapeutic category of drugs in Japan [BR:br08301(D01246)]|2  Agents affecting individual organs|21  Cardiovascular agents|213  Diuretics|2132  Thiazides|D01246  Benzylhydrochlorothiazide (JAN)|Drug groups [BR:br08330(D01246)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D01246  Benzylhydrochlorothiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D01246  Benzylhydrochlorothiazide|Drug classes [BR:br08332(D01246)]|Cardiovascular agent|DG03231  Antihypertensive|D01246  Benzylhydrochlorothiazide|Target-based classification of drugs [BR:br08310(D01246)]|Transporters|Solute carrier family|SLC12|SLC12A3 (TSC)|D01246  Benzylhydrochlorothiazide (JAN) &lt;JP&gt;,
C12677,Acrinol;|Ethacridine lactate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Acrinol hydrate|C12677  Acrinol|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C12677  Acrinol|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C12677  Acrinol,
C12679,Berberine chloride,,,,,
C12685,Cyclothiazide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01256)]|C CARDIOVASCULAR SYSTEM|C03 DIURETICS|C03A LOW-CEILING DIURETICS, THIAZIDES|C03AA Thiazides, plain|C03AA09 Cyclothiazide|D01256  Cyclothiazide (JAN/USAN/INN)|Drug groups [BR:br08330(D01256)]|Cardiovascular agent|DG03231  Antihypertensive|DG01749  Thiazide diuretic|D01256  Cyclothiazide|DG01690  Sulfonamide diuretic|DG01749  Thiazide diuretic|D01256  Cyclothiazide",
C12691,Cefacetrile sodium;|Cephacetrile sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01262)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB10 Cefacetrile|D01262  Cephacetrile sodium (USAN)|Drug groups [BR:br08330(D01262)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00554  Cefacetrile|D01262  Cephacetrile sodium|DG01774  First-generation cephalosporin|DG00554  Cefacetrile|D01262  Cephacetrile sodium|Antimicrobials [BR:br08307(D01262)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D01262  Cephacetrile sodium (USAN)",
C12694,Epitiostanol,,,,Drug groups [BR:br08330(D01265)]|Antineoplastic|DG01585  Estrogen receptor antagonist|D01265  Epitiostanol|Target-based classification of drugs [BR:br08310(D01265)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D01265  Epitiostanol (JAN/INN)|Prodrugs [br08324.html(D01265)]|D01265|Prodrugs [br08324.html]|C12694,
C12695,Difluprednate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01266)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AC Corticosteroids, potent (group III)|D07AC19 Difluprednate|D01266  Difluprednate (JAN/USAN/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA16 Difluprednate|D01266  Difluprednate (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01266)]|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Difluprednate|D01266  Difluprednate (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01266)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D01266  Difluprednate (JAN/USAN/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C12695  Difluprednate|Drug groups [BR:br08330(D01266)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|D01266  Difluprednate|Dermatological agent|DG03243  Atopic dermatitis agent|D01266  Difluprednate|Drug classes [BR:br08332(D01266)]|Anti-inflammatory|DG01955  Corticosteroid|D01266  Difluprednate|Dermatological agent|DG03243  Atopic dermatitis agent|D01266  Difluprednate|Target-based classification of drugs [BR:br08310(D01266)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01266  Difluprednate (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D01266)]|New molecular entities and new therapeutic biological products|D01266|New drug approvals in the USA, Europe and Japan [br08328.html(D01266)]|Approval dates by FDA, EMA and PMDA|D01266|Topical steroids potency [br08317.html(D01266)]|Classification in Japan|D01266",
C12712,Carindacillin sodium;|Carbenicillin indanyl sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01283)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA05 Carindacillin|D01283  Carbenicillin indanyl sodium (USP)|Drug groups [BR:br08330(D01283)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00521  Carindacillin|D01283  Carbenicillin indanyl sodium|DG01780  Extended spectrum penicillin|DG00521  Carindacillin|D01283  Carbenicillin indanyl sodium|Antimicrobials [BR:br08307(D01283)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D01283  Carbenicillin indanyl sodium (USP)",
C12717,Dimefline hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01288)]|R RESPIRATORY SYSTEM|R07 OTHER RESPIRATORY SYSTEM PRODUCTS|R07A OTHER RESPIRATORY SYSTEM PRODUCTS|R07AB Respiratory stimulants|R07AB08 Dimefline|D01288  Dimefline hydrochloride (JAN/USAN),
C12724,Ethynodiol diacetate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C12724  Ethynodiol diacetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01294)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC06 Etynodiol|D01294  Ethynodiol diacetate (JAN/USP)|Drug groups [BR:br08330(D01294)]|Hormonal agent|DG02004  Progesterone|DG00470  Etynodiol|D01294  Ethynodiol diacetate|DG01666  Progesterone receptor agonist|DG00470  Etynodiol|D01294  Ethynodiol diacetate|Target-based classification of drugs [BR:br08310(D01294)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A1 (ESR1)|D01294  Ethynodiol diacetate (JAN/USP)|3-Ketosteroid receptor|NR3C3 (PGR)|D01294  Ethynodiol diacetate (JAN/USP)",
C12729,Chlormadinone acetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01299)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DB Pregnadien derivatives|G03DB06 Chlormadinone|D01299  Chlormadinone acetate (JP18/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01299)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2478  Synthetic progestins|D01299  Chlormadinone acetate (JP18/USAN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9415  Luteinizing hormone and preparations|C12729  Chlormadinone acetate|Drug groups [BR:br08330(D01299)]|Antineoplastic|DG01591  Androgen receptor antagonist|DG00469  Chlormadinone|D01299  Chlormadinone acetate|Hormonal agent|DG02004  Progesterone|DG00469  Chlormadinone|D01299  Chlormadinone acetate|DG01666  Progesterone receptor agonist|DG00469  Chlormadinone|D01299  Chlormadinone acetate|Drug classes [BR:br08332(D01299)]|Antineoplastic|DG01591  Androgen receptor antagonist|D01299  Chlormadinone acetate|Endocrine and hormonal agent|DG02004  Progesterone|D01299  Chlormadinone acetate|Target-based classification of drugs [BR:br08310(D01299)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D01299  Chlormadinone acetate (JP18/USAN) &lt;JP&gt;|NR3C4 (AR)|D01299  Chlormadinone acetate (JP18/USAN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01299)]|Chemicals|D01299  Chlormadinone acetate,
C12739,5'-Deoxy-5-fluorouridine;|Doxifluridine,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01309)]|4  Agents affecting cellular function|42  Antineoplastics|422  Antimetabolites|4223  Fluorouracils|D01309  Doxifluridine (JP18/INN)|Drug groups [BR:br08330(D01309)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|D01309  Doxifluridine|Drug classes [BR:br08332(D01309)]|Antineoplastic|DG02018  Antimetabolite|D01309  Doxifluridine|Target-based classification of drugs [BR:br08310(D01309)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D01309  Doxifluridine (JP18/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01309)]|Chemicals|D01309  Doxifluridine|D01309  Doxifluridine capsules|Prodrugs [br08324.html(D01309)]|D01309|Prodrugs [br08324.html]|C12739",
C12750,Bisibuthiamine;|Sulbutiamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01319)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12|A11DA Vitamin B1, plain|A11DA02 Sulbutiamine|D01319  Bisibuthiamine (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01319)]|Third-class OTC drugs|Inorganic and organic chemicals|Bisibuthiamine|D01319  Bisibuthiamine (JAN)",
C12753,Troleandomycin;|Triacetyloleandomycin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12753  Troleandomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01322)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA08 Troleandomycin|D01322  Troleandomycin (USAN/INN)|Drug groups [BR:br08330(D01322)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|D01322  Troleandomycin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D01322  Troleandomycin|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D01322  Troleandomycin|Antimicrobials [BR:br08307(D01322)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01322  Troleandomycin (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D01322)]|Drug metabolizing enzymes|D01322",
C12755,Mequitazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01324)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AD Phenothiazine derivatives|R06AD07 Mequitazine|D01324  Mequitazine (JP18/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01324)]|4  Agents affecting cellular function|44  Allergic agents|441  Antihistamines|4413  Phenothiazines|D01324  Mequitazine (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D01324)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D01324  Mequitazine (JP18/INN)|Allergic agents|52 Antihistamine based drugs|D01324  Mequitazine (JP18/INN)|Agents for otolaryngologic use|69 Oral medicine for nasal inflammation|D01324  Mequitazine (JP18/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01324)]|Second-class OTC drugs|Inorganic and organic chemicals|Mequitazine|D01324  Mequitazine (JP18/INN)|Drug groups [BR:br08330(D01324)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|D01324  Mequitazine|Dermatological agent|DG03243  Atopic dermatitis agent|D01324  Mequitazine|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D01324  Mequitazine|Drug classes [BR:br08332(D01324)]|Anti-allergic agent|DG01482  Histamine receptor H1 antagonist|D01324  Mequitazine|Dermatological agent|DG03243  Atopic dermatitis agent|D01324  Mequitazine|Target-based classification of drugs [BR:br08310(D01324)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D01324  Mequitazine (JP18/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01324)]|Chemicals|D01324  Mequitazine|D01324  Mequitazine tablets|Drug metabolizing enzymes and transporters [br08309.html(D01324)]|Drug metabolizing enzymes|D01324|Rx-to-OTC switch list in Japan [br08314.html(D01324)]|D01324,
C12766,Cyclacillin;|Ciclacillin,,,,"Drug groups [BR:br08330(D01334)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|D01334  Cyclacillin|Antimicrobials [BR:br08307(D01334)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other penicillin|D01334  Cyclacillin (USAN)|Antimicrobials abbreviations [BR:br08327(D01334)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other penicillin|D01334  Cyclacillin (USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01334)]|Chemicals|D01334  Ciclacillin",
C12767,Dibenzthion;|Sulbentine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01335)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE09 Sulbentine|D01335  Dibenzthion (JAN),
C12768,Timepidium bromide;|Timepidium bromide anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB19 Timepidium bromide|C12768  Timepidium bromide|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00041  Timepidium bromide|C12768  Timepidium bromide|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG00041  Timepidium bromide|C12768  Timepidium bromide",G00041
C12786,Dinoprost tromethamine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01352)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G02 OTHER GYNECOLOGICALS|G02A UTEROTONICS|G02AD Prostaglandins|G02AD01 Dinoprost|D01352  Dinoprost tromethamine (JAN/USP)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9419  Other hormone preparations|C12786  Dinoprost tromethamine|Drug groups [BR:br08330(D01352)]|Hormonal agent|DG01961  Prostaglandin derivative|DG01960  Prostaglandin F derivative|DG00447  Dinoprost|D01352  Dinoprost tromethamine|Target-based classification of drugs [BR:br08310(D01352)]|G Protein-coupled receptors|Rhodopsin family|Prostaglandin|PTGFR|D01352  Dinoprost tromethamine (JAN/USP),
C12796,Erythromycin ethylsuccinate,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12796  Erythromycin ethylsuccinate|Prodrugs [br08324.html]|C12796|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01361)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF02 Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA01 Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA17 Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01361)]|Antibacterials|Macrolides|Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Erythromycin|D01361  Erythromycin ethylsuccinate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D01361)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|614  Acting mainly on gram-positive bacteria and mycoplasma|6141  Erythromycins|D01361  Erythromycin ethylsuccinate (JP18/USP)|Drug groups [BR:br08330(D01361)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|DG00436  Erythromycin|D01361  Erythromycin ethylsuccinate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00436  Erythromycin|D01361  Erythromycin ethylsuccinate|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG00436  Erythromycin|D01361  Erythromycin ethylsuccinate|Transporter inhibitor|DG01622  ABCB1 inhibitor|DG00436  Erythromycin|D01361  Erythromycin ethylsuccinate|Drug classes [BR:br08332(D01361)]|Antibacterial|DG01551  Macrolide antibiotic|D01361  Erythromycin ethylsuccinate|Antimicrobials [BR:br08307(D01361)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01361  Erythromycin ethylsuccinate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01361)]|Chemicals|D01361  Erythromycin ethylsuccinate|Drug metabolizing enzymes and transporters [br08309.html(D01361)]|Drug metabolizing enzymes|D01361|Drug transporters|D01361|Prodrugs [br08324.html(D01361)]|D01361",
C12798,Tulobuterol hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01362)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC11 Tulobuterol|D01362  Tulobuterol hydrochloride (JP18) &lt;JP&gt;|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC11 Tulobuterol|D01362  Tulobuterol hydrochloride (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01362)]|2  Agents affecting individual organs|22  Respiratory organ agents|225  Bronchodilators|2259  Others|D01362  Tulobuterol hydrochloride (JP18)|Drug groups [BR:br08330(D01362)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01050  Tulobuterol|D01362  Tulobuterol hydrochloride|Target-based classification of drugs [BR:br08310(D01362)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D01362  Tulobuterol hydrochloride (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01362)]|Chemicals|D01362  Tulobuterol hydrochloride",
C12811,Allylestrenol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C12811  Allylestrenol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01374)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC01 Allylestrenol|D01374  Allylestrenol (JAN/INN)|Drug groups [BR:br08330(D01374)]|Hormonal agent|DG02004  Progesterone|D01374  Allylestrenol|DG01666  Progesterone receptor agonist|D01374  Allylestrenol|Target-based classification of drugs [BR:br08310(D01374)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D01374  Allylestrenol (JAN/INN)",
C12814,Prifinium bromide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01377)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AB Synthetic anticholinergics, quaternary ammonium compounds|A03AB18 Prifinium bromide|D01377  Prifinium bromide (JAN/INN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|917  Autonomic agents (Autonomics)|9179  Other autonomic agents|C12814  Prifinium bromide|Drug groups [BR:br08330(D01377)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|D01377  Prifinium bromide|Gastrointestinal agent|DG01975  Agents for peptic ulcer|D01377  Prifinium bromide|Target-based classification of drugs [BR:br08310(D01377)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D01377  Prifinium bromide (JAN/INN)",
C12816,Proscillaridin,,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C12816  Proscillaridin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C12816  Proscillaridin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01379)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AB Scilla glycosides|C01AB01 Proscillaridin|D01379  Proscillaridin (JAN/USAN/INN)|Drug groups [BR:br08330(D01379)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01741  Scilla glycoside|D01379  Proscillaridin|Target-based classification of drugs [BR:br08310(D01379)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D01379  Proscillaridin (JAN/USAN/INN),
C12819,Kainic acid;|alpha- Kainic acid;|Kainate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Kainic acid|C12819  Kainic acid,
C12829,Bromisovalum;|Bromovalerylurea,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01391)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CM Other hypnotics and sedatives|N05CM03 Bromisoval|D01391  Bromovalerylurea (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01391)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1121  Organic bromines|D01391  Bromovalerylurea (JP18); Bromisoval (INN)|Classification of Japanese OTC drugs [BR:br08313(D01391)]|Agents for nervous and sensory systems|04 Sedative hypnotic agents|D01391  Bromovalerylurea (JP18)|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D01391  Bromovalerylurea (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01391)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Bromovalerylurea|D01391  Bromovalerylurea (JP18)|Second-class OTC drugs|Inorganic and organic chemicals|Bromovalerylurea|D01391  Bromovalerylurea (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01391)]|Chemicals|D01391  Bromovalerylurea",
C12831,"3,4,6-Trichlorocatechol",,,,,
C12832,"3,4,6-Trichloro-cis-1,2-dihydroxycyclohexa-3,5-diene",,,,,
C12833,"2,3,5-Trichloro-cis,cis-muconate;|2,3,5-Trichloro-cis,cis-muconic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C12833  2,3,5-Trichloro-cis,cis-muconic acid",
C12834,"2,5-Dichloro-carboxymethylenebut-2-en-4-olide",,,,,
C12835,"2,5-Dichloro-4-oxohex-2-enedioate;|2,5-Dichloro-4-oxohex-2-enedioic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C12835  2,5-Dichloro-4-oxohex-2-enedioic acid",
C12836,2-Chloro-3-oxoadipate,,,,,
C12837,"3-Chloro-cis-1,2-dihydroxycyclohexa-3,5-diene;|(1R,2R)-3-Chlorocyclohexa-3,5-diene-1,2-diol",,,,,
C12838,trans-4-Carboxymethylenebut-2-en-4-olide,,,,,
C12839,Piperazine phosphate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01393)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CB Piperazine and derivatives|P02CB01 Piperazine|D01393  Piperazine phosphate (USP)|Risk category of Japanese OTC drugs [BR:br08312(D01393)]|Second-class OTC drugs|Inorganic and organic chemicals|Piperazine|D01393  Piperazine phosphate (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9751  Piperazine and preparations|C12839  Piperazine phosphate|Antimicrobials [BR:br08307(D01393)]|Antiparasitics|Antinematodal agents|Piperazine and derivatives|D01393  Piperazine phosphate (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01393)]|Chemicals|D01393  Piperazine phosphate hydrate|D01393  Piperazine phosphate tablets",
C12842,Pyricarbate;|Pyridinol carbamate,,,,,
C12849,p-Phenolsulfonic acid;|p-Hydroxybenzenesulfonic acid;|Phenolsulfonic acid;|4-Sulfophenol,,,,,
C12853,Thiamphenicol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01407)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01B AMPHENICOLS|J01BA Amphenicols|J01BA02 Thiamphenicol|D01407  Thiamphenicol (JAN/USAN/INN)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|973  Synthetic antimicrobials|9731  Thiamphenicol and preparations|C12853  Thiamphenicol|Drug groups [BR:br08330(D01407)]|Antibacterial|DG01576  Amphenicol type antibacterial|DG00516  Thiamphenicol|D01407  Thiamphenicol|Antimicrobials [BR:br08307(D01407)]|Antibacterials|Protein biosynthesis inhibitor|Amphenicol|D01407  Thiamphenicol (JAN/USAN/INN),
C12859,Estradiol valerate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C12859  Estradiol valerate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01413)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA03 Estradiol|D01413  Estradiol valerate (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01413)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Estrogens|Estradiol|D01413  Estradiol valerate (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01413)]|2  Agents affecting individual organs|24  Hormones|247  Estrogen and progesterone preparations|2473  Estradiols|D01413  Estradiol valerate (JAN/USP/INN)|Drug groups [BR:br08330(D01413)]|Hormonal agent|DG01986  Estrogen|DG00462  Estradiol|D01413  Estradiol valerate|DG01584  Estrogen receptor agonist|DG00462  Estradiol|D01413  Estradiol valerate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00462  Estradiol|D01413  Estradiol valerate|Drug classes [BR:br08332(D01413)]|Endocrine and hormonal agent|DG01986  Estrogen|D01413  Estradiol valerate|DG01584  Estrogen receptor agonist|D01413  Estradiol valerate|Target-based classification of drugs [BR:br08310(D01413)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D01413  Estradiol valerate (JAN/USP/INN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D01413)]|Drug metabolizing enzymes|D01413",
C12861,Cefotiam hexetil,,,,Prodrugs [br08324.html]|C12861,
C12862,Nedaplatin,,,,Therapeutic category of drugs in Japan [BR:br08301(D01416)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D01416  Nedaplatin (JAN/INN)|Drug groups [BR:br08330(D01416)]|Antineoplastic|DG01679  Platinum compound|D01416  Nedaplatin,
C12864,Tamibarotene;|Am 80,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01418)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D01418  Tamibarotene (JAN/USAN/INN)|Drug groups [BR:br08330(D01418)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D01418  Tamibarotene|Target-based classification of drugs [BR:br08310(D01418)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B1 (RARA)|D01418  Tamibarotene (JAN/USAN/INN) &lt;JP&gt;|New drug approvals in Japan [br08318.html(D01418)]|Drugs with new active ingredients|D01418|New drug approvals in the USA, Europe and Japan [br08328.html(D01418)]|Approval dates by FDA, EMA and PMDA|D01418|Drug metabolizing enzymes and transporters [br08309.html(D01418)]|Drug metabolizing enzymes|D01418",
C12865,Benzyl nicotinate;|Nicotinic acid benzyl ester,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01419)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AC Nicotinic acid and derivatives|C04AC01 Nicotinic acid|D01419  Benzyl nicotinate (JAN)|C10 LIPID MODIFYING AGENTS|C10A LIPID MODIFYING AGENTS, PLAIN|C10AD Nicotinic acid and derivatives|C10AD02 Nicotinic acid|D01419  Benzyl nicotinate (JAN)|Classification of Japanese OTC drugs [BR:br08313(D01419)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D01419  Benzyl nicotinate (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01419)]|Third-class OTC drugs|Inorganic and organic chemicals|Benzyl nicotinate|D01419  Benzyl nicotinate (JAN)",
C12869,Suplatast,,,,,
C12871,Lopinavir,,,,Drug groups [BR:br08330(D01425)]|Antiviral|DG03107  Anti-HIV agent|DG01647  HIV protease inhibitor|D01425  Lopinavir|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D01425  Lopinavir|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|D01425  Lopinavir|Antimicrobials [BR:br08307(D01425)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D01425  Lopinavir (JAN/USP/INN)|Antimicrobials abbreviations [BR:br08327(D01425)]|Antivirals|Polyprotein cleavage inhibitor|HIV protease inhibitor|D01425  Lopinavir (JAN/USP/INN)|Drug metabolizing enzymes and transporters [br08309.html(D01425)]|Drug metabolizing enzymes|D01425,
C12876,Tiopronin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01430)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX16 Tiopronin|D01430  Tiopronin (JAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01430)]|Genitourinary Agents|Genitourinary Agents, Other|Tiopronin|D01430  Tiopronin (JAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01430)]|3  Agents affecting metabolism|39  Other agents affecting metabolism|391  Liver disease agents|3919  Others|D01430  Tiopronin (JAN/INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|967  Agents for liver disease and antidotes|9679  Other agents for liver disease and antidotes|C12876  Tiopronin",
C12886,Dialicor;|Etafenone hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01440)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DX Other vasodilators used in cardiac diseases|C01DX07 Etafenone|D01440  Etafenone hydrochloride (JAN),
C12888,"Hydrocortisone succinate;|11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-(hydrogensuccinate);|Cortisol succinate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C12888  Hydrocortisone succinate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01442)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D01442  Hydrocortisone succinate (JP18)|Drug groups [BR:br08330(D01442)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D01442  Hydrocortisone succinate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D01442  Hydrocortisone succinate|Target-based classification of drugs [BR:br08310(D01442)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01442  Hydrocortisone succinate (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01442)]|Chemicals|D01442  Hydrocortisone succinate|Drug metabolizing enzymes and transporters [br08309.html(D01442)]|Drug metabolizing enzymes|D01442",
C12889,n-Decanohydroxamic acid;|Decanohydroxamic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C12889  n-Decanohydroxamic acid,
C12891,Acetylspiramycin;|Spiramycin II,,,,"Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C12891  Spiramycin II|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02420)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA02 Spiramycin|D02420  Acetylspiramycin (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02420)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|614  Acting mainly on gram-positive bacteria and mycoplasma|6142  Spiramycin antibiotics|D02420  Acetylspiramycin (JP18)|Drug groups [BR:br08330(D02420)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG00602  Spiramycin|D02420  Acetylspiramycin|Drug classes [BR:br08332(D02420)]|Antibacterial|DG01551  Macrolide antibiotic|D02420  Acetylspiramycin|Antimicrobials [BR:br08307(D02420)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D02420  Acetylspiramycin (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02420)]|Chemicals|D02420  Acetylspiramycin",
C12893,Magnesium carbonate;|Magnesium carbonate anhydrous,,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9569  Other bath and disinfectants preparations|C12893  Magnesium carbonate,
C12896,Carpipramine maleate,,,,Drug groups [BR:br08330(D01449)]|Neuropsychiatric agent|DG03200  Antipsychotic agent|DG01942  Iminobenzyl antipsychotic|DG01312  Carpipramine|D01449  Carpipramine maleate,
C12905,Variotin;|Pecilocin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01458)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA04 Pecilocin|D01458  Variotin (JAN)|Antimicrobials [BR:br08307(D01458)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D01458  Variotin (JAN)|Antimicrobials abbreviations [BR:br08327(D01458)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D01458  Variotin (JAN),
C12915,Nemonapride,,,,Therapeutic category of drugs in Japan [BR:br08301(D01468)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D01468  Nemonapride (JAN/INN)|Drug groups [BR:br08330(D01468)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|D01468  Nemonapride|DG03200  Antipsychotic agent|DG01941  Benzamide antipsychotic|D01468  Nemonapride|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D01468  Nemonapride|Target-based classification of drugs [BR:br08310(D01468)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D01468  Nemonapride (JAN/INN) &lt;JP&gt;|Drug metabolizing enzymes and transporters [br08309.html(D01468)]|Drug metabolizing enzymes|D01468,
C12919,"1-alpha,24(R)-Dihydroxyvitamin D3;|Tacalcitol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C12919  1-alpha,24(R)-Dihydroxyvitamin D3|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08554)]|D DERMATOLOGICALS|D05 ANTIPSORIATICS|D05A ANTIPSORIATICS FOR TOPICAL USE|D05AX Other antipsoriatics for topical use|D05AX04 Tacalcitol|D08554  Tacalcitol (INN)|Drug groups [BR:br08330(D08554)]|Gastrointestinal agent|DG01607  Vitamin D derivatives|DG01606  Activated vitamin D3|DG00395  Tacalcitol|D08554  Tacalcitol|Target-based classification of drugs [BR:br08310(D08554)]|Nuclear receptors|Thyroid hormone like receptors|Vitamin D3 like receptor|NR1I1 (VDR)|D08554  Tacalcitol (INN)",
C12933,Rolitetracycline nitrate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01486)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA09 Rolitetracycline|D01486  Rolitetracycline nitrate (JAN/USAN)|Drug groups [BR:br08330(D01486)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00515  Rolitetracycline|D01486  Rolitetracycline nitrate|Antimicrobials [BR:br08307(D01486)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D01486  Rolitetracycline nitrate (JAN/USAN),
C12935,Calcium glycerophosphate;|Calcium beta-glycerophosphate,,,,Risk category of Japanese OTC drugs [BR:br08312(D01488)]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium glycerophosphate|D01488  Calcium glycerophosphate (JAN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C12935  Calcium glycerophosphate,
C12937,Clocapramine dihydrochloride,,,,,
C12942,Paraformaldehyde,polymer of Formaldehyde [CPD:C00067],,,Classification of Japanese OTC drugs [BR:br08313(D01494)]|Agents for sanitation|81 Disinfectants|D01494  Paraformaldehyde (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01494)]|Second-class OTC drugs|Not used for human|Disinfectants|D01494  Paraformaldehyde (JP18)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C12942  Paraformaldehyde|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C12942  Paraformaldehyde|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01494)]|Chemicals|D01494  Paraformaldehyde,
C12946,Butoctamide hydrogen succinate;|Butoctamide semisuccinate,,,,,
C12948,Mazaticol hydrochloride;|KAO 264,,,,,
C12954,Dilazep dihydrochloride,,,,,
C12958,Phenylacetylglycine dimethylamide;|Ralgin,,,,,
C12959,Dimetacrine tartrate;|Dimetacrine bitartrate,,,,,
C12961,Dexamethazone metasulfobenzoate sodium;|Dexamethasone metasulfobenzoate sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01510)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC02 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA09 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB19 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB05 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA03 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB02 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD03 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA01 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB01 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA06 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA01 Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|USP drug classification [BR:br08302(D01510)]|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium (JAN)|Therapeutic category of drugs in Japan [BR:br08301(D01510)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1315  Ophthalmic cortisones|D01510  Dexamethasone metasulfobenzoate sodium (JAN)|132  Otic and nasal agents|1329  Others|D01510  Dexamethasone metasulfobenzoate sodium (JAN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9612  Adrenal hormone preparations|C12961  Dexamethasone metasulfobenzoate sodium|Drug groups [BR:br08330(D01510)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00011  Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00011  Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00011  Dexamethasone|D01510  Dexamethasone metasulfobenzoate sodium|Drug classes [BR:br08332(D01510)]|Anti-inflammatory|DG01955  Corticosteroid|D01510  Dexamethasone metasulfobenzoate sodium|Target-based classification of drugs [BR:br08310(D01510)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01510  Dexamethasone metasulfobenzoate sodium (JAN) &lt;JP&gt;|Drug metabolizing enzymes and transporters [br08309.html(D01510)]|Drug metabolizing enzymes|D01510",
C12962,Cyphenothrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C12962  Cyphenothrin|Classification of Japanese OTC drugs [BR:br08313(D01511)]|Agents for sanitation|82 Pesticides|D01511  d.d-T-Cyphenothrin (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01511)]|Second-class OTC drugs|Not used for human|Insecticides|D01511  d.d-T-Cyphenothrin (JAN),
C12967,Tocoretinate;|Tretinoin tocoferil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01516)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD01 Tretinoin|D01516  Tretinoin tocoferil (JAN) &lt;JP&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XF Retinoids for cancer treatment|L01XF01 Tretinoin|D01516  Tretinoin tocoferil (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01516)]|2  Agents affecting individual organs|26  Epidermides|269  Miscellaneous|2699  Others|D01516  Tretinoin tocoferil (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01516)]|Third-class OTC drugs|Inorganic and organic chemicals|Tretinoin tocoferil|D01516  Tretinoin tocoferil (JAN)|Drug groups [BR:br08330(D01516)]|Vitamin and mineral|DG01604  Retinol derivative|DG00433  Tretinoin|D01516  Tretinoin tocoferil|Target-based classification of drugs [BR:br08310(D01516)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D01516  Tretinoin tocoferil (JAN) &lt;JP&gt;,
C12978,Epidihydrocholesterin;|Epicholestanol;|5alpha-Cholestan-3alpha-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C12978  Epidihydrocholesterin|Target-based classification of drugs [BR:br08310(D01527)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D01527  Epidihydrocholesterin (JAN),
C12979,Cefroxadine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01528)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DB First-generation cephalosporins|J01DB11 Cefroxadine|D01528  Cefroxadine (USAN)|Drug groups [BR:br08330(D01528)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00555  Cefroxadine|D01528  Cefroxadine|DG01774  First-generation cephalosporin|DG00555  Cefroxadine|D01528  Cefroxadine|Antimicrobials [BR:br08307(D01528)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|First-generation cephalosporin|D01528  Cefroxadine (USAN)",
C12981,dl-alpha-Tocopherol nicotinate;|Tocopheryl nicotinate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01530)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA03 Tocopherol (vit E)|D01530  Tocopherol nicotinate (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01530)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D01530  Tocopherol nicotinate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01530)]|Nourishing tonics and health supplements|34 Vitamin E based drugs|D01530  Tocopherol nicotinate (JP18)|Drug groups [BR:br08330(D01530)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|D01530  Tocopherol nicotinate|Drug classes [BR:br08332(D01530)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D01530  Tocopherol nicotinate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01530)]|Chemicals|D01530  Tocopherol nicotinate,
C12986,N2-Acetyl-L-aminoadipate,,,,,
C12987,N2-Acetyl-L-aminoadipyl-delta-phosphate,,,,,
C12988,N2-Acetyl-L-aminoadipate semialdehyde,,,,,
C12989,N2-Acetyl-L-lysine;|N(alpha)-Acetyllysine,,,,,
C13008,Edaravone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01552)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07X OTHER NERVOUS SYSTEM DRUGS|N07XX Other nervous system drugs|N07XX14 Edaravone|D01552  Edaravone (USAN/JP18/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01552)]|Central Nervous System Agents|Amyotrophic Lateral Sclerosis (ALS) Agents|Edaravone|D01552  Edaravone (USAN/JP18/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01552)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|119  Miscellaneous|1190  Miscellaneous|D01552  Edaravone (USAN/JP18/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01552)]|Chemicals|D01552  Edaravone|D01552  Edaravone injection|New drug approvals in the USA [br08319.html(D01552)]|New molecular entities and new therapeutic biological products|D01552|New drug approvals in Japan [br08318.html(D01552)]|Drugs with new active ingredients|D01552|New drug approvals in the USA, Europe and Japan [br08328.html(D01552)]|Approval dates by FDA, EMA and PMDA|D01552",
C13014,1-Naphthylacetic acid;|NAA,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C13014  1-Naphthylacetic acid,
C13016,Carumonam sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01560)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DF Monobactams|J01DF02 Carumonam|D01560  Carumonam sodium (JP18/USAN)|Drug groups [BR:br08330(D01560)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01454  Monobactam|DG00590  Carumonam|D01560  Carumonam sodium|DG01804  Oxyimino beta-lactam|DG00590  Carumonam|D01560  Carumonam sodium|Antimicrobials [BR:br08307(D01560)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Monobactam|D01560  Carumonam sodium (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01560)]|Chemicals|D01560  Carumonam sodium",
C13024,Cefpimizole sodium,,,,"Drug groups [BR:br08330(D01568)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG01207  Cefpimizole|D01568  Cefpimizole sodium|Antimicrobials [BR:br08307(D01568)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other cephalosporin|D01568  Cefpimizole sodium (JAN/USAN)",
C13031,Estramustine phosphate sodium,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02398)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX11 Estramustine|D02398  Estramustine phosphate sodium (USAN)|Drug groups [BR:br08330(D02398)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG00724  Estramustine|D02398  Estramustine phosphate sodium|Target-based classification of drugs [BR:br08310(D02398)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|SRD5A2|D02398  Estramustine phosphate sodium (USAN)|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D02398  Estramustine phosphate sodium (USAN)|Prodrugs [br08324.html(D02398)]|D02398|Prodrugs [br08324.html]|C13031,
C13034,Bronopol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C13034  Bronopol|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C13034  Bronopol,
C13037,Lynestrenol,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C13037  Lynestrenol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01580)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC02 Lynestrenol|D01580  Lynestrenol (JAN/USAN)|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC03 Lynestrenol|D01580  Lynestrenol (JAN/USAN)|Drug groups [BR:br08330(D01580)]|Hormonal agent|DG02004  Progesterone|D01580  Lynestrenol|DG01666  Progesterone receptor agonist|D01580  Lynestrenol|Target-based classification of drugs [BR:br08310(D01580)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D01580  Lynestrenol (JAN/USAN)",
C13038,Flufenamic acid;|FFA,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01581)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AG Fenamates|M01AG03 Flufenamic acid|D01581  Flufenamic acid (JAN/USAN/INN)|Drug groups [BR:br08330(D01581)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01911  Anti-inflammatory drug, fenamic acid derivatives|DG00757  Flufenamic acid|D01581  Flufenamic acid|Target-based classification of drugs [BR:br08310(D01581)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D01581  Flufenamic acid (JAN/USAN/INN)|PTGS2 (COX2)|D01581  Flufenamic acid (JAN/USAN/INN)",
C13044,Tricaprilin;|Trioctanoylglycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0301 Triacylglycerols|C13044  Trioctanoyl-sn-glycerol,
C13048,p-Nitrophenyl-O-ethyl ethylphosphonate;|Ethyl 4-nitrophenyl ethylphosphonate,,,,,
C13050,Cyclic ADP-ribose;|cADPR,,,,,
C13051,Nicotinic acid adenine dinucleotide phosphate;|Nicotinate-adenine dinucleotide phosphate;|NAADP,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from nicotinic acid|Pyridine alkaloids|C13051  Nicotinic acid adenine dinucleotide phosphate,
C13055,Oxytetracycline hydrochloride;|OTC,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01596)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB25 Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AA Tetracycline and derivatives|D06AA03 Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA07 Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01A TETRACYCLINES|J01AA Tetracyclines|J01AA06 Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA04 Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01596)]|2  Agents affecting individual organs|27  Dental preparations|276  Antibiotics|2760  Antibiotics|D01596  Oxytetracycline hydrochloride (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01596)]|Agents for integumentary system|56 Purulent skin remedies|D01596  Oxytetracycline hydrochloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01596)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxytetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9762  Antibiotic preparations for peroral and feed additive use|C13055  Oxytetracycline hydrochloride|Drug groups [BR:br08330(D01596)]|Antibacterial|DG01197  Tetracycline antibiotic|DG00397  Oxytetracycline|D01596  Oxytetracycline hydrochloride|Drug classes [BR:br08332(D01596)]|Antibacterial|DG01197  Tetracycline antibiotic|D01596  Oxytetracycline hydrochloride|Antimicrobials [BR:br08307(D01596)]|Antibacterials|Protein biosynthesis inhibitor|Tetracycline|D01596  Oxytetracycline hydrochloride (JP18/USP) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01596)]|Chemicals|D01596  Oxytetracycline hydrochloride",
C13058,Calcium L-aspartate,,,,,
C13061,Acetylsulfamethoxazole,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01601)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EC Intermediate-acting sulfonamides|J01EC01 Sulfamethoxazole|D01601  Acetylsulfamethoxazole (JAN)|Drug groups [BR:br08330(D01601)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01785  Intermediate-acting sulfonamide|DG02848  Sulfamethoxazole|D01601  Acetylsulfamethoxazole|Antimicrobials [BR:br08307(D01601)]|Antibacterials|Folic acid biosynthesis inhibitor|Intermediate-acting sulfonamide|D01601  Acetylsulfamethoxazole (JAN),
C13072,Sodium picosulfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AB Contact laxatives|A06AB08 Sodium picosulfate|C13072  Sodium picosulfate|Drug groups [BR:br08330]|Gastrointestinal agent|DG01770  Laxative|DG00072  Sodium picosulfate|C13072  Sodium picosulfate,G00072
C13074,Acetylkitasamycin,Acetylleucomycin A1 and A3 (R = 3-methylbutanoyl)|Acetylleucomycin A4 and A5 (R = butanoyl)|Acetylleucomycin A6 and A7 (R = propanoyl),,,Drug groups [BR:br08330(D01614)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG01203  Kitasamycin|D01614  Acetylkitasamycin|Antimicrobials [BR:br08307(D01614)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01614  Acetylkitasamycin (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01614)]|Chemicals|D01614  Acetylkitasamycin,
C13077,Estradiol dipropionate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C13077  Estradiol dipropionate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01617)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA03 Estradiol|D01617  Estradiol dipropionate (JAN)|Drug groups [BR:br08330(D01617)]|Hormonal agent|DG01986  Estrogen|DG00462  Estradiol|D01617  Estradiol dipropionate|DG01584  Estrogen receptor agonist|DG00462  Estradiol|D01617  Estradiol dipropionate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00462  Estradiol|D01617  Estradiol dipropionate|Target-based classification of drugs [BR:br08310(D01617)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D01617  Estradiol dipropionate (JAN)|Drug metabolizing enzymes and transporters [br08309.html(D01617)]|Drug metabolizing enzymes|D01617",
C13081,Retinol acetate;|Retinyl acetate;|Vitamin A acetate;|all-trans-Retinol acetate,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C13081  Retinyl acetate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01621)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO|A11CA Vitamin A, plain|A11CA01 Retinol (vit A)|D01621  Retinol acetate (JP18)|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AD Retinoids for topical use in acne|D10AD02 Retinol|D01621  Retinol acetate (JP18)|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AX Other nasal preparations|R01AX02 Retinol|D01621  Retinol acetate (JP18)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01X OTHER OPHTHALMOLOGICALS|S01XA Other ophthalmologicals|S01XA02 Retinol|D01621  Retinol acetate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01621)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Retinol acetate|D01621  Retinol acetate (JP18)|Second-class OTC drugs|Inorganic and organic chemicals|Retinol acetate|D01621  Retinol acetate (JP18)|Third-class OTC drugs|Inorganic and organic chemicals|Retinol acetate|D01621  Retinol acetate (JP18)|Drug groups [BR:br08330(D01621)]|Vitamin and mineral|DG01604  Retinol derivative|DG00123  Retinol (vit A)|D01621  Retinol acetate|Metabolizing enzyme substrate|DG02918  CYP2C8 substrate|DG00123  Retinol (vit A)|D01621  Retinol acetate|Target-based classification of drugs [BR:br08310(D01621)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D01621  Retinol acetate (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01621)]|Chemicals|D01621  Retinol acetate|Drug metabolizing enzymes and transporters [br08309.html(D01621)]|Drug metabolizing enzymes|D01621",
C13085,Sodium glucuronate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Sodium glucuronate hydrate|C13085  Sodium glucuronate,
C13086,Propagermanium;|Proxigermanium,,,,,
C13089,Cefetamet pivoxil hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01629)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD10 Cefetamet|D01629  Cefetamet pivoxil hydrochloride (JAN)|Drug groups [BR:br08330(D01629)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00579  Cefetamet|D01629  Cefetamet pivoxil hydrochloride|DG01776  Third-generation cephalosporin|DG00579  Cefetamet|D01629  Cefetamet pivoxil hydrochloride|DG01804  Oxyimino beta-lactam|DG00579  Cefetamet|D01629  Cefetamet pivoxil hydrochloride|Antimicrobials [BR:br08307(D01629)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D01629  Cefetamet pivoxil hydrochloride (JAN)",
C13101,Hexestrol;|Exestrol,,,,Target-based classification of drugs [BR:br08310(D01641)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D01641  Hexestrol (JAN/INN),
C13102,Bismuth subnitrate;|Bismuth hydroxide nitrate oxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01642)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX12 Bismuth subnitrate|D01642  Bismuth subnitrate (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01642)]|2  Agents affecting individual organs|23  Digestive organ agents|231  Antidiarrheals, intestinal regulators|2315  Bismuth salts|D01642  Bismuth subnitrate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01642)]|Agents for digestive organs|16 Antidiarrheals|D01642  Bismuth subnitrate (JP18/USP)|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D01642  Bismuth subnitrate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01642)]|Second-class OTC drugs|Inorganic and organic chemicals|Bismuth subnitrate|D01642  Bismuth subnitrate (JP18/USP)|Third-class OTC drugs|Inorganic and organic chemicals|Bismuth subnitrate|D01642  Bismuth subnitrate (JP18/USP)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|932  Antistomach, antidiarrhoics (including absorptives, antidiarrhoics, antibububble and preparations)|9321  Astringents and preparations|C13102  Bismuth subnitrate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01642)]|Chemicals|D01642  Bismuth subnitrate",
C13103,Leucomycin V,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C13103  Leucomycin V,
C13104,Aluminoparaaminosalicylate calcium;|Alumino-p-aminosalicylic acid calcium salt,,,,,
C13106,Gadodiamide hydrate;|Gadodiamide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01645)]|V VARIOUS|V08 CONTRAST MEDIA|V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA|V08CA Paramagnetic contrast media|V08CA03 Gadodiamide|D01645  Gadodiamide hydrate (JAN) &lt;US&gt;,
C13109,Hyoscyamine methylbromide;|Atropine methobromide;|Atropine methylbromide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01648)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03B BELLADONNA AND DERIVATIVES, PLAIN|A03BA Belladonna alkaloids, tertiary amines|A03BA03 Hyoscyamine|D01648  Hyoscyamine methylbromide (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01648)]|Second-class OTC drugs|Inorganic and organic chemicals|Hyoscyamine methylbromide|D01648  Hyoscyamine methylbromide (JAN)|Drug groups [BR:br08330(D01648)]|Neuropsychiatric agent|DG01491  Muscarinic cholinergic receptor antagonist|DG00053  Hyoscyamine|D01648  Hyoscyamine methylbromide|Target-based classification of drugs [BR:br08310(D01648)]|G Protein-coupled receptors|Rhodopsin family|Acetylcholine (muscarinic)|CHRM|D01648  Hyoscyamine methylbromide (JAN)",
C13110,Propicillin potassium;|Brocillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01649)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CE Beta-lactamase sensitive penicillins|J01CE03 Propicillin|D01649  Propicillin potassium (JAN)|Drug groups [BR:br08330(D01649)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00536  Propicillin|D01649  Propicillin potassium|DG01778  beta-Lactamase sensitive penicillin|DG00536  Propicillin|D01649  Propicillin potassium|Antimicrobials [BR:br08307(D01649)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase sensitive penicillin|D01649  Propicillin potassium (JAN)",
C13112,Ancitabin hydrochloride;|Cyclocytidine,,,,"Drug groups [BR:br08330(D01651)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01439  Arabinofuranosyl type antineoplastic|D01651  Ancitabine hydrochloride",
C13127,Bropirimine,,,,Target-based classification of drugs [BR:br08310(D01666)]|Cytokines and receptors|Pattern recognition receptors|Toll-like receptors|TLR7|D01666  Bropirimine (JAN/USAN/INN),
C13129,Sultamicillin tosilate;|Sultamicillin tosylate,,,,,
C13138,beta-Butoxyethyl nicotinate;|Nicoboxil,,,,,
C13140,Calcium oxide;|Lime,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01679)]|Chemicals|D01679  Calcium oxide,
C13141,Cefcapene pivoxil,,,,Prodrugs [br08324.html]|C13141,
C13142,Cefovecin sodium,,,,"Drug groups [BR:br08330(D01681)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|D01681  Cefovecin sodium|DG01804  Oxyimino beta-lactam|D01681  Cefovecin sodium|Antimicrobials [BR:br08307(D01681)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other cephalosporin|D01681  Cefovecin sodium (JAN/USAN)",
C13143,Ceftiofur sodium,,,,"Drug groups [BR:br08330(D01682)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG01434  Ceftiofur|D01682  Ceftiofur sodium|DG01804  Oxyimino beta-lactam|DG01434  Ceftiofur|D01682  Ceftiofur sodium|Antimicrobials [BR:br08307(D01682)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other cephalosporin|D01682  Ceftiofur sodium (JAN/USAN)",
C13144,Ozagrel hydrochloride,,,,,
C13154,"Dehydrocholic acid;|3,7,12-Triketo-5beta-cholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C13154  3,7,12-Triketo-5beta-cholanoic acid|Therapeutic category of drugs in Japan [BR:br08301(D01693)]|2  Agents affecting individual organs|23  Digestive organ agents|236  Cholagogues|2362  Bile acids|D01693  Dehydrocholic acid (JP18/USP/INN); Purified dehydrocholic acid (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01693)]|Third-class OTC drugs|Inorganic and organic chemicals|Dehydrocholic acid|D01693  Dehydrocholic acid (JP18/USP/INN)|Drug groups [BR:br08330(D01693)]|Gastrointestinal agent|DG01956  Bile acid preparation|D01693  Dehydrocholic acid|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01693)]|Chemicals|D01693  Dehydrocholic acid|D01693  Purified dehydrocholic acid|D01693  Dehydrocholic acid for injection",
C13156,Lentinan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01695)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L03 IMMUNOSTIMULANTS|L03A IMMUNOSTIMULANTS|L03AX Other immunostimulants|L03AX01 Lentinan|D01695  Lentinan (JAN),
C13167,"Dihydro-alpha-ergocryptine mesylate;|9,10alpha-Dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate",,,,,
C13168,Dihydroergocristine mesylate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07833)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AE Ergot alkaloids|C04AE04 Dihydroergocristine|D07833  Dihydroergocristine mesilate (BAN)|Drug groups [BR:br08330(D07833)]|Neuropsychiatric agent|DG01964  Ergot alkaloid|DG01963  Vasodilator, ergot alkaloid|DG00284  Dihydroergocristine|D07833  Dihydroergocristine mesilate|Target-based classification of drugs [BR:br08310(D07833)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D07833  Dihydroergocristine mesilate (BAN)|ADRA2|D07833  Dihydroergocristine mesilate (BAN)",
C13173,Roxithromycin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01710)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FA Macrolides|J01FA06 Roxithromycin|D01710  Roxithromycin (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01710)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|614  Acting mainly on gram-positive bacteria and mycoplasma|6149  Others|D01710  Roxithromycin (JP18/USAN/INN)|Drug groups [BR:br08330(D01710)]|Antibacterial|DG01551  Macrolide antibiotic|DG01874  14-membered ring macrolide antibiotic|D01710  Roxithromycin|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|D01710  Roxithromycin|Drug classes [BR:br08332(D01710)]|Antibacterial|DG01551  Macrolide antibiotic|D01710  Roxithromycin|Antimicrobials [BR:br08307(D01710)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01710  Roxithromycin (JP18/USAN/INN) &lt;JP&gt;|Antimicrobials abbreviations [BR:br08327(D01710)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D01710  Roxithromycin (JP17/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01710)]|Chemicals|D01710  Roxithromycin|D01710  Roxithromycin tablets|Drug metabolizing enzymes and transporters [br08309.html(D01710)]|Drug metabolizing enzymes|D01710",
C13179,Fleroxacin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01716)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA08 Fleroxacin|D01716  Fleroxacin (JAN/USAN/INN)|Drug groups [BR:br08330(D01716)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|D01716  Fleroxacin|Antimicrobials [BR:br08307(D01716)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D01716  Fleroxacin (JAN/USAN/INN)|Antimicrobials abbreviations [BR:br08327(D01716)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D01716  Fleroxacin (JAN/USAN/INN),
C13182,Benexate hydrochloride,,,,,
C13183,beta-Cyclodextrin,,,,,
C13189,Calcium bromide,,,,,
C13192,Potassium sulfate,,,,Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01726)]|Chemicals|D01726  Potassium sulfate,
C13194,Calcium sulfate;|Gypsum,,,,,
C13197,Potassium dibasic phosphate,,,,"USP drug classification [BR:br08302(D02403)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Potassium|D02403  Potassium phosphate, dibasic (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02403)]|3  Agents affecting metabolism|33  Blood and body fluid agents|331  Blood substitutes|3319  Others|D02403  Potassium phosphate, dibasic (JAN/USP)",
C13198,Potassium bromide,,,,"Therapeutic category of drugs in Japan [BR:br08301(D01731)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|112  Hypnotics and sedatives, anxiolytics|1126  Bromides|D01731  Potassium bromide (JP18/USP)|113  Antiepileptics|1139  Others|D01731  Potassium bromide (JP18/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9632  Halogen compounds and preparations|C13198  Potassium bromide|Drug groups [BR:br08330(D01731)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D01731  Potassium bromide|Drug classes [BR:br08332(D01731)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|D01731  Potassium bromide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01731)]|Chemicals|D01731  Potassium bromide",
C13199,Sodium sulfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01732)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD13 Sodium sulfate|D01732  Anhydous sodium sulfate (JP18)|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CA Sodium|A12CA02 Sodium sulfate|D01732  Anhydous sodium sulfate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01732)]|Agents for digestive organs|17 Cathartics|D01732  Anhydous sodium sulfate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01732)]|Third-class OTC drugs|Crude drugs|Sodium sulfate hydrate|D01732  Anhydous sodium sulfate (JP18)|Drug groups [BR:br08330(D01732)]|Gastrointestinal agent|DG01770  Laxative|DG00075  Sodium sulfate|D01732  Anhydous sodium sulfate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01732)]|Crude drugs|D01732  Anhydrous sodium sulfate,
C13202,alpha-Tocopherol acetate;|Tocopherol acetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01735)]|A ALIMENTARY TRACT AND METABOLISM|A11 VITAMINS|A11H OTHER PLAIN VITAMIN PREPARATIONS|A11HA Other plain vitamin preparations|A11HA03 Tocopherol (vit E)|D01735  Tocopherol acetate (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01735)]|3  Agents affecting metabolism|31  Vitamins|315  Vitamin E preparations|3150  Vitamin E preparations|D01735  Tocopherol acetate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01735)]|Agents for  urogenital organs and anus|29 Hemorrhoid drugs for internal use|D01735  Tocopherol acetate (JP18)|Nourishing tonics and health supplements|34 Vitamin E based drugs|D01735  Tocopherol acetate (JP18)|41 Vitamin EC based drugs|D01735  Tocopherol acetate (JP18)|43 Vitamin containing supplements|D01735  Tocopherol acetate (JP18)|Agents for integumentary system|55 Chilblain and chap remedies|D01735  Tocopherol acetate (JP18)|Agents for ophthalmologic use|62 General eye drops|D01735  Tocopherol acetate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01735)]|Third-class OTC drugs|Inorganic and organic chemicals|Tocopherol acetate|D01735  Tocopherol acetate (JP18)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|958  Agents for protective skin|9582  Vitamin preparations (for external use)|C13202  Tocopherol acetate|96  Agents affecting metabolism|962  Vitamin preparations|9625  Vitamin E and preparations|C13202  Tocopherol acetate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01735)]|Chemicals|D01735  Tocopherol acetate,
C13229,Sulpyrine;|Dipyrone monohydrate;|Dipyrone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01762)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BB Pyrazolones|N02BB02 Metamizole sodium|D01762  Dipyrone (USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01762)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|114  Antipyretics and analgesics, anti-inflammatory agents|1144  Pyrazolones|D01762  Dipyrone (USAN); Sulpyrine hydrate (JP18)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9132  Pyrazolone, derivatives and preparations|C13229  Sulpyrine hydrate|Drug groups [BR:br08330(D01762)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01947  Anti-inflammatory drug, pyrazolone|DG00827  Metamizole sodium|D01762  Dipyrone|Drug classes [BR:br08332(D01762)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D01762  Dipyrone|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01762)]|Chemicals|D01762  Sulpyrine hydrate|D01762  Sulpyrine injection",
C13235,Procaterol hydrochloride;|Lontermin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02404)]|R RESPIRATORY SYSTEM|R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|R03A ADRENERGICS, INHALANTS|R03AC Selective beta-2-adrenoreceptor agonists|R03AC16 Procaterol|D02404  Procaterol hydrochloride (USAN)|R03C ADRENERGICS FOR SYSTEMIC USE|R03CC Selective beta-2-adrenoreceptor agonists|R03CC08 Procaterol|D02404  Procaterol hydrochloride (USAN)|Drug groups [BR:br08330(D02404)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01455  beta-Adrenergic receptor agonist|DG01452  beta2-Adrenergic receptor agonist|DG01055  Procaterol|D02404  Procaterol hydrochloride|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01055  Procaterol|D02404  Procaterol hydrochloride|Target-based classification of drugs [BR:br08310(D02404)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB2|D02404  Procaterol hydrochloride (USAN)|Drug metabolizing enzymes and transporters [br08309.html(D02404)]|Drug metabolizing enzymes|D02404",
C13240,Ether;|Anesthetic ether;|Diethyl ether,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01772)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AA Ethers|N01AA01 Diethyl ether|D01772  Ether (JP18/USP)|Drug groups [BR:br08330(D01772)]|Neuropsychiatric agent|DG02030  Anesthetics|DG02027  General anesthetics|DG02028  Inhalational anaesthetics|D01772  Ether|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01772)]|Chemicals|D01772  Ether",
C13244,Antipyrine;|Phenazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01776)]|N NERVOUS SYSTEM|N02 ANALGESICS|N02B OTHER ANALGESICS AND ANTIPYRETICS|N02BB Pyrazolones|N02BB01 Phenazone|D01776  Antipyrine (JP18/USP)|S SENSORY ORGANS|S02 OTOLOGICALS|S02D OTHER OTOLOGICALS|S02DA Analgesics and anesthetics|S02DA03 Phenazone|D01776  Antipyrine (JP18/USP)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C13244  Antipyrine|Drug groups [BR:br08330(D01776)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01947  Anti-inflammatory drug, pyrazolone|D01776  Antipyrine|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01776)]|Chemicals|D01776  Antipyrine",
C13249,Sodium citrate;|Trisodium citrate dihydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01781)]|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CB Salt solutions|B05CB02 Sodium citrate|D01781  Sodium citrate hydrate (JP18) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01781)]|3  Agents affecting metabolism|33  Blood and body fluid agents|333  Anticoagulants|3331  Sodium citrates for transfusion|D01781  Sodium citrate hydrate (JP18)|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|714  Flavorings, deodorants, coloring agents|7149  Others|D01781  Sodium citrate hydrate (JP18)|719  Miscellaneous|7190  Miscellaneous|D01781  Sodium citrate hydrate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D01781)]|Third-class OTC drugs|Inorganic and organic chemicals|Anhydrous citric acid|D01781  Sodium citrate hydrate (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9649  Other saccharide preparations and blood substitutes|C13249  Sodium citrate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01781)]|Chemicals|D01781  Sodium citrate hydrate|D01781  Diagnostic sodium citrate solution|D01781  Sodium citrate injection for transfusion",
C13252,Carmofur;|1-Hexylcarbamoyl-5-fluorouracil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01784)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BC Pyrimidine analogues|L01BC04 Carmofur|D01784  Carmofur (JP18/INN)|Drug groups [BR:br08330(D01784)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01935  Fluoropyrimidine antineoplastic|D01784  Carmofur|Target-based classification of drugs [BR:br08310(D01784)]|Enzymes|Transferases (EC2)|Methyltransferases|TYMS|D01784  Carmofur (JP18/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01784)]|Chemicals|D01784  Carmofur|Prodrugs [br08324.html(D01784)]|D01784",
C13254,Mebhydrolin napadisilate;|Diazoline,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01786)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AX Other antihistamines for systemic use|R06AX15 Mebhydrolin|D01786  Mebhydrolin napadisilate (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D01786)]|Second-class OTC drugs|Inorganic and organic chemicals|Mebhydrolin|D01786  Mebhydrolin napadisilate (JAN)|Drug groups [BR:br08330(D01786)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01113  Mebhydrolin|D01786  Mebhydrolin napadisilate|Target-based classification of drugs [BR:br08310(D01786)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D01786  Mebhydrolin napadisilate (JAN),
C13269,Aspoxicillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07469)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA19 Aspoxicillin|D07469  Aspoxicillin (JAN/INN)|Drug groups [BR:br08330(D07469)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00533  Aspoxicillin|D07469  Aspoxicillin|DG01780  Extended spectrum penicillin|DG00533  Aspoxicillin|D07469  Aspoxicillin|Antimicrobials [BR:br08307(D07469)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D07469  Aspoxicillin (JAN/INN)",
C13273,Plaunotol;|18-Hydroxygeranylgeraniol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C13273  Plaunotol|Drug groups [BR:br08330(D01803)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|D01803  Plaunotol,
C13280,Nicorandil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01810)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DX Other vasodilators used in cardiac diseases|C01DX16 Nicorandil|D01810  Nicorandil (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01810)]|2  Agents affecting individual organs|21  Cardiovascular agents|217  Vasodilators|2171  Coronary dilators|D01810  Nicorandil (JP18/USAN/INN)|Drug groups [BR:br08330(D01810)]|Cardiovascular agent|DG01583  ATP-sensitive potassium channel opener|D01810  Nicorandil|DG01657  Nitrovasodilator|D01810  Nicorandil|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|D01810  Nicorandil|Target-based classification of drugs [BR:br08310(D01810)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D01810  Nicorandil (JP18/USAN/INN) &lt;JP&gt;|ABCC9(SUR2)/KCNJ11(KIR6.2)|D01810  Nicorandil (JP18/USAN/INN) &lt;JP&gt;|Enzymes|Lyases (EC4)|Phosphorus-oxygen lyases|GUCY1A|D01810  Nicorandil (JP18/USAN/INN) &lt;JP&gt;|GUCY1B|D01810  Nicorandil (JP18/USAN/INN) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01810)]|Chemicals|D01810  Nicorandil,
C13297,Geranylgeranylacetone;|Teprenone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01827)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX15 Teprenone|D01827  Teprenone (JP18/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01827)]|2  Agents affecting individual organs|23  Digestive organ agents|232  Peptic ulcer agents|2329  Others|D01827  Teprenone (JP18/INN)|Classification of Japanese OTC drugs [BR:br08313(D01827)]|Agents for digestive organs|11 Stomachics|D01827  Teprenone (JP18/INN)|Risk category of Japanese OTC drugs [BR:br08312(D01827)]|Second-class OTC drugs|Inorganic and organic chemicals|Teprenone|D01827  Teprenone (JP18/INN)|Drug groups [BR:br08330(D01827)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG02008  Gastric mucosal protectant|D01827  Teprenone|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01827)]|Chemicals|D01827  Teprenone|D01827  Teprenone capsules|Rx-to-OTC switch list in Japan [br08314.html(D01827)]|D01827,
C13299,Fungichromin;|Pentamycin,,0 Mak  1 Mad  2 Mad  3 Mad  4 Mad  5 Mad  6 Mtk  7 Mak  8 Mak|9 Mak  10 Mak  11 Mak  12 Mak,PK,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01829)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA11 Pentamycin|D01829  Pentamycin (JAN)|Antimicrobials [BR:br08307(D01829)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D01829  Pentamycin (JAN)|Antimicrobials abbreviations [BR:br08327(D01829)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D01829  Pentamycin (JAN)",
C13301,Buserelin acetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01831)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L02 ENDOCRINE THERAPY|L02A HORMONES AND RELATED AGENTS|L02AE Gonadotropin releasing hormone analogues|L02AE01 Buserelin|D01831  Buserelin acetate (JAN/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01831)]|2  Agents affecting individual organs|24  Hormones|249  Miscellaneous|2499  Others|D01831  Buserelin acetate (JAN/USAN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9419  Other hormone preparations|C13301  Buserelin acetate|Drug groups [BR:br08330(D01831)]|Hormonal agent|DG01494  Gonadotropin-releasing hormone receptor agonist|DG00729  Buserelin|D01831  Buserelin acetate|Target-based classification of drugs [BR:br08310(D01831)]|G Protein-coupled receptors|Rhodopsin family|Gonadotropin-releasing hormone|GNRHR|D01831  Buserelin acetate (JAN/USAN) &lt;JP&gt;,
C13309,"2-Phytyl-1,4-naphthoquinone;|Demethylphylloquinone",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0203 Vitamin K|C13309  2-Demethylphylloquinone,
C13310,Faropenem sodium;|SUN 5555;|Fropenum sodium,,,,,
C13311,Fasoracetam;|NS 105,,,,,
C13326,Kad 1229;|Mitiglinide calcium,,,,,
C13334,"Pitavastatin;|(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate",,,,,
C13342,p-Hydroxypropiophenone;|Paroxypropione,,,,,
C13355,Aniracetam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01883)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BX Other psychostimulants and nootropics|N06BX11 Aniracetam|D01883  Aniracetam (JAN/USAN/INN)|Drug groups [BR:br08330(D01883)]|Neuropsychiatric agent|DG01969  Racetam derivative, nootropic|D01883  Aniracetam",
C13358,Hydrocortisone butyrate propionate;|Hydrocortisone buteprate;|Hydrocortisone probutate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C13358  Hydrocortisone butyrate propionate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01886)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|D07AB Corticosteroids, moderately potent (group II)|D07AB11 Hydrocortisone buteprate|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01886)]|Dermatological Agents|Dermatitis and Pruitus Agents|Glucocorticoids, Medium Potency|Hydrocortisone|D01886  Hydrocortisone probutate (USAN)|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Hydrocortisone|D01886  Hydrocortisone probutate (USAN)|Therapeutic category of drugs in Japan [BR:br08301(D01886)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D01886  Hydrocortisone probutate (USAN); Hydrocortisone butyrate propionate (JAN)|Drug groups [BR:br08330(D01886)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D01886  Hydrocortisone probutate|Dermatological agent|DG03243  Atopic dermatitis agent|D01886  Hydrocortisone probutate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D01886  Hydrocortisone probutate|Drug classes [BR:br08332(D01886)]|Anti-inflammatory|DG01955  Corticosteroid|D01886  Hydrocortisone probutate|Dermatological agent|DG03243  Atopic dermatitis agent|D01886  Hydrocortisone probutate|Target-based classification of drugs [BR:br08310(D01886)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D01886  Hydrocortisone probutate (USAN) &lt;JP/US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D01886)]|Drug metabolizing enzymes|D01886|Topical steroids potency [br08317.html(D01886)]|Classification in Japan|D01886",
C13364,"Ethyl icosapentate;|Eicosapentaenoic acid, ethyl ester",,,,,
C13373,Xenon,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01901)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AX Other general anesthetics|N01AX15 Xenon|D01901  Xenon (JAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01901)]|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|729  Miscellaneous|7290  Miscellaneous|D01901  Xenon (JAN)",
C13376,Cefpiramide sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01904)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD11 Cefpiramide|D01904  Cefpiramide sodium (JP18/USAN)|Drug groups [BR:br08330(D01904)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00580  Cefpiramide|D01904  Cefpiramide sodium|DG01776  Third-generation cephalosporin|DG00580  Cefpiramide|D01904  Cefpiramide sodium|Antimicrobials [BR:br08307(D01904)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D01904  Cefpiramide sodium (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01904)]|Chemicals|D01904  Cefpiramide sodium",
C13377,Mercuric chloride;|Mercury(II) chloride,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Inorganic fungicides|C13377  Mercuric chloride|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01905)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AK Mercurial products|D08AK03 Mercuric chloride|D01905  Mercuric chloride (JAN),
C13378,"alpha,beta-Dihydroxyethyl-TPP;|alpha,beta-Dihydroxyethyl-ThDP;|2-(1,2-Dihydroxyethyl)-TPP",,,,,
C13383,Iodoform,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01910)]|D DERMATOLOGICALS|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA13 Iodoform|D01910  Iodoform (JP18/USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01910)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2612  Iodates|D01910  Iodoform (JP18/USP)|27  Dental preparations|279  Miscellaneous|2790  Miscellaneous|D01910  Iodoform (JP18/USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C13383  Iodoform|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01910)]|Chemicals|D01910  Iodoform",
C13391,Aluminum hydroxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02416)]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AB Aluminium compounds|A02AB01 Aluminium hydroxide|D02416  Aluminum hydroxide (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02416)]|2  Agents affecting individual organs|23  Digestive organ agents|234  Antacids|2343  Aluminum-containing agents|D02416  Aluminum hydroxide (USP); Aluminum hydroxide, dried (USP); Dried aluminum hydroxide gel (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D02416)]|Second-class OTC drugs|Inorganic and organic chemicals|Aluminum hydroxide|D02416  Aluminum hydroxide (USP)|Drug groups [BR:br08330(D02416)]|Gastrointestinal agent|DG01975  Agents for peptic ulcer|DG01954  Antacid|DG01680  Aluminum compounds antacid|D02416  Aluminum hydroxide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02416)]|Chemicals|D02416  Dried aluminum hydroxide gel|D02416  Dried aluminum hydroxide gel fine granules",
C13392,Azulene,,,,Risk category of Japanese OTC drugs [BR:br08312(D09768)]|Third-class OTC drugs|Inorganic and organic chemicals|Azulene|D09768  Azulene (JAN),
C13400,Bufferin;|Aspirin softam,,,,,
C13403,Sodium caffeine benzoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02409)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CG Tests for gastric secretion|V04CG30 Caffeine and sodium benzoate|D02409  Caffeine and sodium benzoate (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02409)]|2  Agents affecting individual organs|21  Cardiovascular agents|211  Cardiotonics|2115  Caffeines|D02409  Caffeine and sodium benzoate (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D02409)]|Third-class OTC drugs|Inorganic and organic chemicals|Caffeine and sodium benzoate|D02409  Caffeine and sodium benzoate (JP18)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|921  Cardiotonics|9212  Caffeine, prine, derivatives and preparations|C13403  Sodium caffeine benzoate|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02409)]|Chemicals|D02409  Caffeine and sodium benzoate",
C13410,"Transfluthrin;|(2,3,5,6-Tetrafluorophenyl)methyl(1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C13410  Transfluthrin|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C13410  Transfluthrin,
C13414,Sodium 3-ethyl-7-isopropyl-1-azulenesulfonate,,,,,
C13415,n-Butyl-2-cyanoacrylate;|Butyl 2-cyanoacrylate polymers;|Histoacryl,,,,,
C13416,Sodium equilin sulfate,,,,,
C13422,"Hydrocortisone caproate;|[2-(11,17-Dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl]hexanoate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C13422  Hydrocortisone caproate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09796)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC03 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA02 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA01 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AA Corticosteroids, weak (group I)|D07AA02 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XA Corticosteroids, weak, other combinations|D07XA01 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB09 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA02 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB03 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA01 Hydrocortisone|D09796  Hydrocortisone caproate (JAN)|Drug groups [BR:br08330(D09796)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00012  Hydrocortisone|D09796  Hydrocortisone caproate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00012  Hydrocortisone|D09796  Hydrocortisone caproate|Target-based classification of drugs [BR:br08310(D09796)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D09796  Hydrocortisone caproate (JAN)|Drug metabolizing enzymes and transporters [br08309.html(D09796)]|Drug metabolizing enzymes|D09796",
C13424,Zanapezil fumarate,,,,,
C13425,3-Hexaprenyl-4-hydroxybenzoate;|3-Hexaprenyl-4-hydroxybenzoic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C13425  3-Hexaprenyl-4-hydroxybenzoate,
C13426,"I-123 BMIPP;|123I-15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid;|I-123-beta-methyl-p-iodophenyl-methylpentadecanoic acid",,,,"Therapeutic category of drugs in Japan [BR:br08301(D06608)]|4  Agents affecting cellular function|43  Radioactive drugs|430  Radioactive drugs|4300  Radioactive drugs|D06608  Iodofiltic acid I 123 (USAN/INN); 15-(4-Iodophenyl)-3(R,S)-methylpentadecanoic acid (123I); 15-(p-Iodophenyl)-3-methylpentadecanoic acid (123I)",
C13427,Pyrithione zinc;|Zinc pyrithione,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01938)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX12 Pyrithione zinc|D01938  Pyrithione zinc (USAN/INN),
C13429,Meglumine sodium amidotrizoate;|Urovision,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01940)]|V VARIOUS|V08 CONTRAST MEDIA|V08A X-RAY CONTRAST MEDIA, IODINATED|V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media|V08AA01 Diatrizoic acid|D01940  Meglumine sodium amidotrizoate (JP18) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01940)]|7  Agents not mainly for therapeutic purpose|72  Intracorporeal diagnostic agents|721  X-ray contrast media|7211  Iodates|D01940  Meglumine sodium amidotrizoate (JP18)|7214  Mixed preparations|D01940  Meglumine sodium amidotrizoate (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01940)]|Chemicals|D01940  Meglumine sodium amidotrizoate injection",
C13431,9'-cis-Neoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C13431  9'-cis-Neoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C13431  9'-cis-Neoxanthin,
C13433,9-cis-Violaxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C13433  9-cis-Violaxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C13433  9-cis-Violaxanthin,
C13440,Cefaloglycin;|Cephaloglycin anhydrous,,,,"Drug groups [BR:br08330(D01949)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG01205  Cefaloglycin|D01949  Cefaloglycin|Antimicrobials [BR:br08307(D01949)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other cephalosporin|D01949  Cefaloglycin (JAN)",
C13441,Dimethylaminoethyl reserpilinate dihydrochloride;|Paratensiol,,,,Drug groups [BR:br08330(D01950)]|Cardiovascular agent|DG01738  Centrally-acting antiadrenergic|DG01737  Rauwolfia alkaloid|D01950  Dimethylaminoethyl reserpilinate dihydrochloride,
C13444,Estradiol benzoate;|17-beta-Estradiol 3-benzoate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01953)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA03 Estradiol|D01953  Estradiol benzoate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D01953)]|Agents for integumentary system|60 Hair remedies (incl. hair growth, hair tonic, anti-dandruff, and antipruritic)|D01953  Estradiol benzoate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D01953)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Estradiol benzoate|D01953  Estradiol benzoate (JP18/USP)|Second-class OTC drugs|Inorganic and organic chemicals|Estradiol benzoate|D01953  Estradiol benzoate (JP18/USP)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9414  Follicle stimulating hormone and preparations|C13444  Estradiol benzoate|Drug groups [BR:br08330(D01953)]|Hormonal agent|DG01986  Estrogen|DG00462  Estradiol|D01953  Estradiol benzoate|DG01584  Estrogen receptor agonist|DG00462  Estradiol|D01953  Estradiol benzoate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00462  Estradiol|D01953  Estradiol benzoate|Target-based classification of drugs [BR:br08310(D01953)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D01953  Estradiol benzoate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01953)]|Chemicals|D01953  Estradiol benzoate|D01953  Estradiol benzoate injection (aqueous suspension)|Drug metabolizing enzymes and transporters [br08309.html(D01953)]|Drug metabolizing enzymes|D01953",
C13450,Trichomycin A,,,,,
C13451,Trichomycin B,,,,,
C13452,Tannic acid,,,,Risk category of Japanese OTC drugs [BR:br08312(D01959)]|Third-class OTC drugs|Inorganic and organic chemicals|Tannic acid|D01959  Tannic acid (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01959)]|Chemicals|D01959  Tannic acid,
C13453,"Xanthoxin;|2-cis,4-trans-Xanthoxin",,,,,
C13454,Xanthoxic acid,,,,,
C13455,Abscisic aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C13455  Abscisic aldehyde,
C13456,Abscisic alcohol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C13456  Abscisic alcohol,
C13470,Lanatoside C,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C13470  Lanatoside C|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01972)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA06 Lanatoside C|D01972  Lanatoside C (JAN/INN)|Drug groups [BR:br08330(D01972)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D01972  Lanatoside C|Target-based classification of drugs [BR:br08310(D01972)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D01972  Lanatoside C (JAN/INN),
C13478,Luliconazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01980)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AC Imidazole and triazole derivatives|D01AC18 Luliconazole|D01980  Luliconazole (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D01980)]|Dermatological Agents|Topical Anti-infectives|Antifungals, dermatological|Luliconazole|D01980  Luliconazole (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D01980)]|2  Agents affecting individual organs|26  Epidermides|265  Antiparasitic dermatosis agents|2655  Imidazoles|D01980  Luliconazole (JAN/USAN/INN)|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|629  Miscellaneous|6290  Miscellaneous|D01980  Luliconazole (JAN/USAN/INN)|Drug groups [BR:br08330(D01980)]|Antifungal|DG01883  Imidazole antifungal|D01980  Luliconazole|Metabolizing enzyme inhibitor|DG02892  CYP2B6 inhibitor|D01980  Luliconazole|DG01641  CYP2C8 inhibitor|D01980  Luliconazole|DG01933  CYP2C19 inhibitor|D01980  Luliconazole|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|D01980  Luliconazole|Drug classes [BR:br08332(D01980)]|Antifungal|DG01883  Imidazole antifungal|D01980  Luliconazole|Antimicrobials [BR:br08307(D01980)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D01980  Luliconazole (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D01980)]|New molecular entities and new therapeutic biological products|D01980|New drug approvals in Japan [br08318.html(D01980)]|Drugs with new active ingredients|D01980|New drug approvals in the USA, Europe and Japan [br08328.html(D01980)]|Approval dates by FDA, EMA and PMDA|D01980|Drug metabolizing enzymes and transporters [br08309.html(D01980)]|Drug metabolizing enzymes|D01980",
C13480,Tenofovir disoproxil,,,,Prodrugs [br08324.html]|C13480,
C13482,Phosphodimethylethanolamine,,,,,
C13487,Metofluthrin,,,,Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C13487  Metofluthrin,
C13493,Polidocanol;|Nonaethylene glycol monododecyl ether,,,,,
C13494,Mosapride citrate hydrate;|AS 4370,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D01994)]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03F PROPULSIVES|A03FA Propulsives|A03FA09 Mosapride|D01994  Mosapride citrate hydrate (JP18) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D01994)]|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D01994  Mosapride citrate hydrate (JP18)|Animal drugs in Japan [BR:br08331]|93  Agents affecting digestive organs|932  Antistomach, antidiarrhoics (including absorptives, antidiarrhoics, antibububble and preparations)|9329  Other antistomach, antidiarrhoics and preparations|C13494  Mosapride citrate hydrate|Drug groups [BR:br08330(D01994)]|Gastrointestinal agent|DG01763  Propulsive|DG01285  Mosapride|D01994  Mosapride citrate hydrate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01285  Mosapride|D01994  Mosapride citrate hydrate|Target-based classification of drugs [BR:br08310(D01994)]|G Protein-coupled receptors|Rhodopsin family|Serotonin|HTR4|D01994  Mosapride citrate hydrate (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01994)]|Chemicals|D01994  Mosapride citrate hydrate|D01994  Mosapride citrate tablets|D01994  Mosapride citrate powder|Drug metabolizing enzymes and transporters [br08309.html(D01994)]|Drug metabolizing enzymes|D01994",
C13500,Kitasamycin tartrate,,,,Drug groups [BR:br08330(D02000)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG01203  Kitasamycin|D02000  Kitasamycin tartrate|Antimicrobials [BR:br08307(D02000)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D02000  Kitasamycin tartrate (JP18)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02000)]|Chemicals|D02000  Kitasamycin tartrate,
C13503,Nitro blue tetrazolium,,,,,
C13505,Cefsulodin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02005)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD03 Cefsulodin|D02005  Cefsulodin sodium (JP18/USAN)|Drug groups [BR:br08330(D02005)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00572  Cefsulodin|D02005  Cefsulodin sodium|DG01776  Third-generation cephalosporin|DG00572  Cefsulodin|D02005  Cefsulodin sodium|Antimicrobials [BR:br08307(D02005)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D02005  Cefsulodin sodium (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02005)]|Chemicals|D02005  Cefsulodin sodium",
C13508,"Sulfoquinovosyldiacylglycerol;|SQDG;|1,2-Diacyl-3-(6-sulfo-alpha-D-quinovosyl)-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C13508  1,2-Diacyl-3-(6-sulfo-alpha-D-quinovosyl)-sn-glycerol",
C13511,Ferric gluconate;|Ferlixit;|Ferrulecit,,,,,
C13515,Rubidium hydroxide,,,,,
C13522,Mitobronitol;|Myebrol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02020)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AX Other alkylating agents|L01AX01 Mitobronitol|D02020  Mitobronitol (JAN/INN)|Drug groups [BR:br08330(D02020)]|Antineoplastic|DG01677  Alkylating agent|D02020  Mitobronitol,
C13523,Secretin;|Vitrum,"Secretin (human) (CAS: 108153-74-8) (R1 = -H, R2 = -CH2COOH)|Secretin (porcine) (CAS: 17034-35-4) (R1 = -CH2OH, R2 = -COOH)",His Ser Asp Gly Thr Phe Thr Ser Glu Leu Ser Arg Leu Arg Glu Gly|Ala Arg Leu Gln Arg Leu Leu Gln Gly Leu Val-NH2,Peptide,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Secretin|C13523  Secretin|Bioactive peptides [BR:br08005]|Non-endocrine glands secretion peptides|Gut peptide|C13523  Secretin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02021)]|V VARIOUS|V04 DIAGNOSTIC AGENTS|V04C OTHER DIAGNOSTIC AGENTS|V04CK Tests for pancreatic function|V04CK01 Secretin|D02021  Secretin (JAN/USAN/INN) &lt;US&gt;|Target-based classification of drugs [BR:br08310(D02021)]|G Protein-coupled receptors|Secretin receptor family|Secretin|SCTR|D02021  Secretin (JAN/USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D02021)]|New molecular entities and new therapeutic biological products|D02021|New drug approvals in the USA, Europe and Japan [br08328.html(D02021)]|Approval dates by FDA, EMA and PMDA|D02021",
C13524,Prochlorperazine mesylate;|Prochlorperazine mesilate;|Novamin;|Prochlorperazine methanesulfonate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02022)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB04 Prochlorperazine|D02022  Prochlorperazine mesilate (JAN) &lt;JP&gt;|USP drug classification [BR:br08302(D02022)]|Antiemetics|Antiemetics, Other|Prochlorperazine|D02022  Prochlorperazine mesilate (JAN)|Antipsychotics|1st Generation/Typical|Prochlorperazine|D02022  Prochlorperazine mesilate (JAN)|Therapeutic category of drugs in Japan [BR:br08301(D02022)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1172  Phenothiazines|D02022  Prochlorperazine mesilate (JAN)|Drug groups [BR:br08330(D02022)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00876  Prochlorperazine|D02022  Prochlorperazine mesilate|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00876  Prochlorperazine|D02022  Prochlorperazine mesilate|Target-based classification of drugs [BR:br08310(D02022)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D02022  Prochlorperazine mesilate (JAN) &lt;JP&gt;",
C13526,Sennoside B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C13526  Sennoside B|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C13526  Sennoside B|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C13526  Sennoside B|Dietary phytochemicals [br08012.html]|Other phytochemicals|C13526,
C13534,Hydrocotarnine hydrochloride,,,,,
C13540,Perphenazine maleate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02037)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AB Phenothiazines with piperazine structure|N05AB03 Perphenazine|D02037  Perphenazine maleate (JP18) &lt;JP&gt;|USP drug classification [BR:br08302(D02037)]|Antipsychotics|1st Generation/Typical|Perphenazine|D02037  Perphenazine maleate (JP18)|Therapeutic category of drugs in Japan [BR:br08301(D02037)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1172  Phenothiazines|D02037  Perphenazine maleate (JP18)|Drug groups [BR:br08330(D02037)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00875  Perphenazine|D02037  Perphenazine maleate|DG03200  Antipsychotic agent|DG01905  Phenothiazine antipsychotics|DG00875  Perphenazine|D02037  Perphenazine maleate|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|DG00875  Perphenazine|D02037  Perphenazine maleate|Target-based classification of drugs [BR:br08310(D02037)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D02037  Perphenazine maleate (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02037)]|Chemicals|D02037  Perphenazine maleate|D02037  Perphenazine maleate tablets|Drug metabolizing enzymes and transporters [br08309.html(D02037)]|Drug metabolizing enzymes|D02037,
C13542,Lactitol dihydrate,,,,,
C13546,Olprinone hydrochloride;|E 1020,,,,,
C13547,Norcholestenol iodomethyl (131 I);|Norcholestenol iodomethyl ((sup 131)I),,,,Therapeutic category of drugs in Japan [BR:br08301(D02043)]|4  Agents affecting cellular function|43  Radioactive drugs|430  Radioactive drugs|4300  Radioactive drugs|D02043  Norcholestenol iodomethyl (131I) (JAN),
C13548,Alprostadil alfadex;|G 511,,,,,
C13550,"Cerebrosterol;|24-Hydroxycholesterol;|Cholest-5-ene-3,24-diol;|(24S)-24-Hydroxycholesterol;|(24S)-Cholest-5-ene-3beta,24-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C13550  Cerebrosterol,
C13553,Colistin sodium methanesulfonate;|Colistimethate sodium,Colistin A component (R = 6-methyloctanoic acid)|Colistin B component (R = 6-methylheptanoic acid),,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02049)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA10 Colistin|D02049  Colistimethate sodium (USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XB Polymyxins|J01XB01 Colistin|D02049  Colistimethate sodium (USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02049)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|612  Acting mainly on gram-negative bacteria|6125  Colistins|D02049  Colistimethate sodium (USP); Colistin sodium methanesulfonate (JP18)|Drug groups [BR:br08330(D02049)]|Antibacterial|DG01579  Polypeptide antibiotic|DG00087  Colistin|D02049  Colistimethate sodium|Antimicrobials [BR:br08307(D02049)]|Antibacterials|Cell membrane function inhibitor|Polypeptide|D02049  Colistimethate sodium (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02049)]|Chemicals|D02049  Colistin sodium methanesulfonate|New drug approvals in Europe [br08329.html(D02049)]|European public assessment reports (EPAR) authorised medicine|D02049",
C13554,Prednisolone 21-all-cis-farnesylate,,,,,
C13556,Monobasic calcium phosphate;|Calcium biphosphate;|Monocalcium phosphate,,,,,
C13557,Potassium nitrate,,,,Risk category of Japanese OTC drugs [BR:br08312(D02051)]|Third-class OTC drugs|Inorganic and organic chemicals|Potassium nitrate|D02051  Potassium nitrate (JAN/USP),
C13558,Dibasic sodium phosphate;|Disodium phosphate,,,,,
C13563,Sodium chloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02056)]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12C OTHER MINERAL SUPPLEMENTS|A12CA Sodium|A12CA01 Sodium chloride|D02056  Sodium chloride (JP18/USP) &lt;JP/US&gt;|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CB Salt solutions|B05CB01 Sodium chloride|D02056  Sodium chloride (JP18/USP) &lt;JP/US&gt;|B05X I.V. SOLUTION ADDITIVES|B05XA Electrolyte solutions|B05XA03 Sodium chloride|D02056  Sodium chloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02056)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Sodium|D02056  Sodium chloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02056)]|3  Agents affecting metabolism|33  Blood and body fluid agents|331  Blood substitutes|3311  Physiological salines|D02056  Sodium chloride (JP18/USP)|3319  Others|D02056  Sodium chloride (JP18/USP)|7  Agents not mainly for therapeutic purpose|71  Dispensing medicines|719  Miscellaneous|7190  Miscellaneous|D02056  Sodium chloride (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D02056)]|Agents for ophthalmologic use|65 Artificial tear|D02056  Sodium chloride (JP18/USP)|Other (not belonging to any other category)|85 Other (not belonging to any other category)|D02056  Sodium chloride (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D02056)]|Third-class OTC drugs|Inorganic and organic chemicals|Sodium chloride|D02056  Sodium chloride (JP18/USP)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|964  Saccharide preparations and blood substitutes|9644  Physiological saline solutions and preparations|C13563  Sodium chloride|99  Agents for not mainly purpose of therapeutic|991  Feed additive use preparations (except antibiotic, sulfonamide derivatives and preparations)|9912  Minerals and preparations|C13563  Sodium chloride|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02056)]|Chemicals|D02056  Sodium chloride|D02056  10% Sodium chloride injection",
C13569,Chromomycin A3;|Toyomycin;|Aburamycin B,,,,,
C13587,Teicoplanin A2-1;|Teichomycin A2 factor 1,,,,,
C13588,Teicoplanin A2-3;|Teichomycin A2 factor 3,,,,,
C13591,Metipranolol hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02081)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS|S01ED Beta blocking agents|S01ED04 Metipranolol|D02081  Metipranolol hydrochloride|Drug groups [BR:br08330(D02081)]|Cardiovascular agent|DG01466  Adrenergic receptor antagonist|DG01464  beta-Adrenergic receptor antagonist (Beta blocker)|DG01137  Metipranolol|D02081  Metipranolol hydrochloride|Ophthalmic agent|DG03201  Intraocular pressure lowering agent|DG01137  Metipranolol|D02081  Metipranolol hydrochloride|Target-based classification of drugs [BR:br08310(D02081)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRB|D02081  Metipranolol hydrochloride,
C13610,Teicoplanin A2-4;|Teichomycin A2 factor 4,,,,,
C13612,Teicoplanin A2-5;|Teichomycin A2 factor 5,,,,,
C13613,Teicoplanin A3-1,,,,,
C13619,Arsenous oxide;|Arsenic trioxide,,,,"Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C13619  Arsenous oxide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02106)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX27 Arsenic trioxide|D02106  Arsenic trioxide (JP18/USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02106)]|Antineoplastics|Antineoplastics, Other|Arsenic Trioxide|D02106  Arsenic trioxide (JP18/USAN)|Therapeutic category of drugs in Japan [BR:br08301(D02106)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D02106  Arsenic trioxide (JP18/USAN)|Target-based classification of drugs [BR:br08310(D02106)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|PML-RARA|D02106  Arsenic trioxide (JP18/USAN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02106)]|Chemicals|D02106  Arsenic trioxide|New drug approvals in the USA [br08319.html(D02106)]|New molecular entities and new therapeutic biological products|D02106|New drug approvals in Europe [br08329.html(D02106)]|European public assessment reports (EPAR) authorised medicine|D02106|New drug approvals in the USA, Europe and Japan [br08328.html(D02106)]|Approval dates by FDA, EMA and PMDA|D02106",
C13620,"Tetrabromobisphenol A;|3,3',5,5'-Tetrabromobisphenol A",,,,,
C13621,"Tribromobisphenol A;|3,3',5-Tribromobisphenol A",,,,,
C13622,"Dibromobisphenol A;|3,3'-Dibromobisphenol A",,,,,
C13623,Monobromobisphenol A;|3-Monobromobisphenol A,,,,,
C13624,"Bisphenol A;|2,2-Bis(4-Hydroxyphenyl)propane",,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Bisphenols|C13624  Bisphenol A,
C13625,"4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene",,,,,
C13626,5-Hydroxybisphenol A;|5-Hydroxybisphenol;|BPAcatechol,,,,,
C13628,"4,5-Bisphenol-o-quinone;|BPAquinone",,,,,
C13629,"1,2-Bis(4-hydroxyphenyl)-2-propanol",,,,,
C13630,7-Ethoxyresorufin;|7-Ethoxyphenoxazone,,,,,
C13631,"2,2-Bis(4-hydroxyphenyl)-1-propanol",,,,,
C13632,"4,4'-Dihydroxy-alpha-methylstilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C13632  4,4'-Dihydroxy-alpha-methylstilbene",
C13633,"2,2-Bis(4-hydroxyphenyl)-propanoic acid",,,,,
C13634,"2,3-Bis(4-hydroxyphenyl)-1,2-propanediol",,,,,
C13635,"4-Hydroxyphenacyl alcohol;|2,4'-Dihydroxyacetophenone",,,,,
C13636,4-Hydroxyphenyl acetate,,,,,
C13637,4-Ethylphenol;|p-Ethylphenol,2-Ethylphenol [CPD:C14385]|3-Ethylphenol [CPD:C14386],,,,
C13638,1-(4'-Hydroxyphenyl)ethanol;|4-Hydroxy-alpha-methyl-benzenemethanol;|4-(1-Hydroxyethyl)phenol,,,,,
C13639,dl-Methylephedrine hydrochloride,,,,"Therapeutic category of drugs in Japan [BR:br08301(D02109)]|2  Agents affecting individual organs|22  Respiratory organ agents|222  Antitussives|2221  Ephedrines and Ephedra herbs|D02109  dl-Methylephedrine hydrochloride (JP18)|Classification of Japanese OTC drugs [BR:br08313(D02109)]|Agents for nervous and sensory systems|01 Cold remedy (oral use)|D02109  dl-Methylephedrine hydrochloride (JP18)|Agents for respiratory organs|26 Antitussives and expectorants|D02109  dl-Methylephedrine hydrochloride (JP18)|Agents for  urogenital organs and anus|30 Hemorrhoid drugs for external use|D02109  dl-Methylephedrine hydrochloride (JP18)|Agents for otolaryngologic use|69 Oral medicine for nasal inflammation|D02109  dl-Methylephedrine hydrochloride (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D02109)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Methylephedrine|D02109  dl-Methylephedrine hydrochloride (JP18)|Second-class OTC drugs|Inorganic and organic chemicals|Methylephedrine|D02109  dl-Methylephedrine hydrochloride (JP18)|Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|923  Antitussives and expectorante|9232  Ephedrine, ephedra and preparations|C13639  dl-Methylephedrine hydrochloride|Drug groups [BR:br08330(D02109)]|Cardiovascular agent|DG01456  Adrenergic receptor agonist|DG01229  Methylephedrine|D02109  dl-Methylephedrine hydrochloride|Unclassified|DG03282  Ephedrine-containing preparation|D02109  dl-Methylephedrine hydrochloride|Target-based classification of drugs [BR:br08310(D02109)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;|ADRA2|D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;|ADRB|D02109  dl-Methylephedrine hydrochloride (JP18) &lt;JP&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02109)]|Chemicals|D02109  dl-Methylephedrine hydrochloride|D02109  10% dl-Methylephedrine hydrochloride powder|Narcotics and psychotropics in Japan [br08308.html(D02109)]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|D02109",
C13645,Hydrobromic acid;|HBr,,,,,
C13646,m-Chlorophenylbiguanide;|mCPBG;|1-(3-Chlorophenyl)biguanide,,,,,
C13650,Debrisoquin;|Debrisoquine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING|C02CC Guanidine derivatives|C02CC04 Debrisoquine|C13650  Debrisoquin|Drug groups [BR:br08330]|Cardiovascular agent|DG01739  Peripherally-acting antiadrenergic|DG00259  Debrisoquine|C13650  Debrisoquin",G00259
C13652,Ampicillin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02119)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA01 Ampicillin|D02119  Ampicillin sodium (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA19 Ampicillin|D02119  Ampicillin sodium (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02119)]|Antibacterials|Beta-lactam, Penicillins|Ampicillin|D02119  Ampicillin sodium (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02119)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|613  Acting mainly on gram-positive and gram-negative bacteria|6131  Penicillins|D02119  Ampicillin sodium (JP18/USP)|Drug groups [BR:br08330(D02119)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00517  Ampicillin|D02119  Ampicillin sodium|DG01780  Extended spectrum penicillin|DG00517  Ampicillin|D02119  Ampicillin sodium|Drug classes [BR:br08332(D02119)]|Antibacterial|DG01480  Penicillin|D02119  Ampicillin sodium|Antimicrobials [BR:br08307(D02119)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02119  Ampicillin sodium (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02119)]|Chemicals|D02119  Ampicillin sodium|D02119  Ampicillin sodium for injection",
C13660,Piperazine citrate,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9751  Piperazine and preparations|C13660  Piperazine citrate,
C13662,Arg-vasopressin;|Argipressin;|8-L-Arginine vasopressin;|AVP;|ADH,,Cys Tyr Phe Gln Asn Cys Pro Arg Gly-NH2 (Disulfide bridge: 1-6),Peptide,"Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Arginine vasopressin|C13662  Arg-vasopressin|Bioactive peptides [BR:br08005]|Pituitary hormones|Posterior pituitary hormone|C13662  Arg-vasopressin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00101)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01B POSTERIOR PITUITARY LOBE HORMONES|H01BA Vasopressin and analogues|H01BA01 Vasopressin (Argipressin)|D00101  Vasopressin (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00101)]|2  Agents affecting individual organs|24  Hormones|241  Pituitary hormone preparations|2414  Posterior pituitary hormones|D00101  Vasopressin (JP18/USP)|Drug groups [BR:br08330(D00101)]|Cardiovascular agent|DG01952  Vasopressin analog|DG00496  Vasopressin|D00101  Vasopressin|Target-based classification of drugs [BR:br08310(D00101)]|G Protein-coupled receptors|Rhodopsin family|Vasopressin|AVPR1|D00101  Vasopressin (JP18/USP) &lt;JP/US&gt;|AVPR2|D00101  Vasopressin (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00101)]|Chemicals|D00101  Vasopressin injection",
C13664,"Bufotenidine;|N,N,N-Trimethylserotonin;|5-HTQ",,,,,
C13665,2-Methyl-5-hydroxytryptamine;|2-Me 5-HT,,,,,
C13666,Tropisetron,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02130)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AA Serotonin (5HT3) antagonists|A04AA03 Tropisetron|D02130  Tropisetron (INN)|Drug groups [BR:br08330(D02130)]|Gastrointestinal agent|DG01489  5-HT3-receptor antagonist|DG00062  Tropisetron|D02130  Tropisetron|DG01762  Antiemetic|DG00062  Tropisetron|D02130  Tropisetron|Target-based classification of drugs [BR:br08310(D02130)]|Ion channels|Ligand-gated ion channels|Serotonin|HTR3|D02130  Tropisetron (INN),
C13667,"2,3-Dioxo-6-nitro-7-sulfamoylbenzo[f]quinoxaline;|NBQX",,,,,
C13668,"CNQX;|6-Cyano-7-nitroquinoxaline-2,3-dione",,,,,
C13670,Talampanel,,,,"Target-based classification of drugs [BR:br08310(D02696)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), non-NMDA|GRIA|D02696  Talampanel (INN)",
C13671,(S)-F-Willardiine;|5-Fluorowillardiine,,,,,
C13672,AMPA;|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid,,,,,
C13673,(S)-ACPA;|(S)-2-Amino-3-(3-carboxy-5-methyl-4-isoxazolyl)porionic acid,,,,,
C13674,1-Naphthylacetylspermine,,,,,
C13675,Ampalex;|1-Piperidinyl-6-quinoxalinyl-methanone;|CX-516,,,,,
C13676,LY395153,,,,,
C13677,4-(N-Maleimido)benzyltrimethylammonium iodide;|MBTA,,,,,
C13678,4-(N-Maleimido)phenyltrimethylammonium iodide;|MPTA,,,,,
C13679,"Bis(3-azidopyridinium)-1,10-decane perchlorate;|DAPA",,,,,
C13680,Lophotoxin,,,,,
C13681,"p-N,N-(Dimethylamino)phenyldiazonium fluoroborate;|4-Dimethylaminobenzenediazonium fluoroborate",,,,,
C13682,Dihydro-beta-erythroidine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C13682  Dihydro-beta-erythroidine,
C13683,Histrionicotoxin,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C13683  Histrionicotoxin,
C13684,Clindamycin hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02132)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF01 Clindamycin|D02132  Clindamycin hydrochloride (JP18/USP) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA10 Clindamycin|D02132  Clindamycin hydrochloride (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FF Lincosamides|J01FF01 Clindamycin|D02132  Clindamycin hydrochloride (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02132)]|Antibacterials|Antibacterials, Other|Clindamycin|D02132  Clindamycin hydrochloride (JP18/USP)|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Clindamycin|D02132  Clindamycin hydrochloride (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02132)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|611  Acting mainly on gram-positive bacteria|6112  Lincomycins|D02132  Clindamycin hydrochloride (JP18/USP)|Drug groups [BR:br08330(D02132)]|Antibacterial|DG01578  Lincosamide antibiotic|DG00435  Clindamycin|D02132  Clindamycin hydrochloride|Drug classes [BR:br08332(D02132)]|Antibacterial|DG01578  Lincosamide antibiotic|D02132  Clindamycin hydrochloride|Antimicrobials [BR:br08307(D02132)]|Antibacterials|Protein biosynthesis inhibitor|Lincosamide|D02132  Clindamycin hydrochloride (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02132)]|Chemicals|D02132  Clindamycin hydrochloride|D02132  Clindamycin hydrochloride capsules",
C13687,Cunaniol,,,,,
C13688,delta-Guanidinovaleric acid,,,,,
C13689,m-Benzenesulfonium diazonium chloride,,,,,
C13690,Dopamine 3-O-sulfate;|Dopamine 3-sulfate,,,,,
C13691,Dopamine 4-O-sulfate,,,,,
C13692,Pentylenetetrazole;|Pentetrazol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07409)]|R RESPIRATORY SYSTEM|R07 OTHER RESPIRATORY SYSTEM PRODUCTS|R07A OTHER RESPIRATORY SYSTEM PRODUCTS|R07AB Respiratory stimulants|R07AB03 Pentetrazol|D07409  Pentetrazol (INN),
C13693,"4,5,6,7-Tetrahydroisoxazolo(5,4-c)pyridin-3-ol;|THIP;|Gaboxadol",,,,Drug groups [BR:br08330(D04282)]|Neuropsychiatric agent|DG01567  GABA-A receptor agonist|D04282  Gaboxadol|Target-based classification of drugs [BR:br08310(D04282)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D04282  Gaboxadol (USAN/INN),
C13694,Isoguvacine,,,,,
C13695,ZAPA;|(Z)-3-((Aminoiminomethyl)thio)-2-propenoic acid,,,,,
C13696,trans-3-Aminocyclopentane-1-carboxylic acid,,,,,
C13697,Fenamic acid;|Diphenylamine-2-carboxylic acid;|DPC,,,,,
C13698,Niflumic acid;|NFA,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08275)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AX Other antiinflammatory and antirheumatic agents, non-steroids|M01AX02 Niflumic acid|D08275  Niflumic acid (INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA17 Niflumic acid|D08275  Niflumic acid (INN)|Drug groups [BR:br08330(D08275)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D08275  Niflumic acid|Target-based classification of drugs [BR:br08310(D08275)]|Ion channels|Other ion channels|Chloride channel|CLCA|D08275  Niflumic acid (INN)|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D08275  Niflumic acid (INN)",
C13699,9-Anthroic acid;|Anthracene-9-carboxylic acid;|A9C,,,,,
C13700,Clofibric acid,,,,Drug groups [BR:br08330(D07723)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|DG01733  PPAR alpha agonist|DG01547  Fibrate|D07723  Clofibric acid,
C13701,2-(4-Chlorophenoxy)propionic acid;|2-(p-Chlorophenoxy)propionic acid;|CPP,,,,,
C13702,"4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid;|SITS",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C13702  4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid",
C13703,IAA-94;|Indanyloxyacetic acid,,,,,
C13704,"TS-TM-calix(4)arene;|5,11,17,23-Tetrasulfonato-25,26,27,28-tetramethoxy-calix(4)arene",,,,,
C13705,5-Nitro-2-(3-phenylpropylamino)benzoic acid;|NPPB,,,,,
C13706,"DNDS;|4,4'-Dinitrostilbene-2,2'-disulfonic acid",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C13706  DNDS",
C13707,RU-0211;|Lubiprostone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04790)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AX Other drugs for constipation|A06AX03 Lubiprostone|D04790  Lubiprostone (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D04790)]|Gastrointestinal Agents|Anti-constipation Agents|Lubiprostone|D04790  Lubiprostone (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D04790)]|2  Agents affecting individual organs|23  Digestive organ agents|235  Purgatives, clysters|2359  Others|D04790  Lubiprostone (JAN/USAN/INN)|Drug groups [BR:br08330(D04790)]|Gastrointestinal agent|DG01770  Laxative|D04790  Lubiprostone|Drug classes [BR:br08332(D04790)]|Gastrointestinal agent|DG01770  Laxative|D04790  Lubiprostone|Target-based classification of drugs [BR:br08310(D04790)]|Ion channels|Other ion channels|Chloride channel|CLCN2|D04790  Lubiprostone (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D04790)]|New molecular entities and new therapeutic biological products|D04790|New drug approvals in Japan [br08318.html(D04790)]|Drugs with new active ingredients|D04790|New drug approvals in the USA, Europe and Japan [br08328.html(D04790)]|Approval dates by FDA, EMA and PMDA|D04790",
C13708,IBMX;|3-Isobutyl-1-methyxanthine,,,,,
C13709,"CPX;|8-Cyclopentyl-1,3-dipropylxanthine",,,,,
C13710,4-PIOL;|5-(4-Piperidyl)isoxazol-3-ol,,,,,
C13711,"Thio-THIP;|4,5,6,7-Tetrahydroisothiazolo[5,4-c]pyridin-3-ol",,,,,
C13712,Allopregnanolone;|3alpha-Hydroxy-5alpha-pregnan-20-one;|3alpha-OH DHP,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C13712  Allopregnanolone|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D11149)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AX Other antidepressants|N06AX29 Brexanolone|D11149  Brexanolone (USAN/INN) &lt;US&gt;|Target-based classification of drugs [BR:br08310(D11149)]|Ion channels|Ligand-gated ion channels|GABA (ionotropic)|GABR|D11149  Brexanolone (USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D11149)]|New molecular entities and new therapeutic biological products|D11149|New drug approvals in the USA, Europe and Japan [br08328.html(D11149)]|Approval dates by FDA, EMA and PMDA|D11149",
C13713,"Allotetrahydrodeoxycorticosterone;|5alpha-THDOC;|3alpha,21-Dihydroxy-5alpha-pregnan-20-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C13713  Allotetrahydrodeoxycorticosterone",
C13714,alpha-EMGBL;|2-Ethyl-2-methyl-4-butyrolactone,beta-EMGBL [CPD:C13717],,,,
C13715,Miltirone,,,,,
C13716,Ro 19-4603;|RO19-4603,,,,,
C13717,beta-EMGBL;|beta-Ethyl-beta-methyl-gamma-butyrolactone,alpha-EMGBL [CPD:C13714],,,,
C13718,Dieldrin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C13718  Dieldrin|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C13718  Dieldrin,
C13719,Nocodazole,,,,,
C13720,alpha-EMTBL;|alpha-Ethyl-alpha-methyl-thiobutyrolactone,,,,,
C13721,Cyanotriphenylborate,,,,,
C13722,Adenophostin B,Adenophostin A [CPD:C13727],,,,
C13723,Dextran sulfate,,,,,
C13724,Polyvinyl sulfate,,,,,
C13725,Patent blue;|Blue VRS,,,,,
C13726,Pentosan sulfate,,,,,
C13727,Adenophostin A,Adenophostin B [CPD:C13722],,,,
C13728,4-Aminopyridine;|4-AP,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04127)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07X OTHER NERVOUS SYSTEM DRUGS|N07XX Other nervous system drugs|N07XX07 Fampridine|D04127  Dalfampridine (USAN) &lt;US&gt;|USP drug classification [BR:br08302(D04127)]|Central Nervous System Agents|Multiple Sclerosis Agents|Dalfampridine|D04127  Dalfampridine (USAN)|Target-based classification of drugs [BR:br08310(D04127)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCNA|D04127  Dalfampridine (USAN) &lt;US&gt;|KCNB|D04127  Dalfampridine (USAN) &lt;US&gt;|KCNC|D04127  Dalfampridine (USAN) &lt;US&gt;|KCND|D04127  Dalfampridine (USAN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D04127)]|New molecular entities and new therapeutic biological products|D04127|New drug approvals in Europe [br08329.html(D04127)]|European public assessment reports (EPAR) authorised medicine|D04127|New drug approvals in the USA, Europe and Japan [br08328.html(D04127)]|Approval dates by FDA, EMA and PMDA|D04127",
C13729,Pinacidil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05482)]|C CARDIOVASCULAR SYSTEM|C02 ANTIHYPERTENSIVES|C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON|C02DG Guanidine derivatives|C02DG01 Pinacidil|D05482  Pinacidil (USAN)|Drug groups [BR:br08330(D05482)]|Cardiovascular agent|DG01583  ATP-sensitive potassium channel opener|D05482  Pinacidil|Target-based classification of drugs [BR:br08310(D05482)]|Transporters|ABC transporters|ABCC subfamily|ABCC8(SUR1)/KCNJ11(KIR6.2)|D05482  Pinacidil (USAN)|ABCC9(SUR2)/KCNJ11(KIR6.2)|D05482  Pinacidil (USAN)",
C13730,LY382884,,,,,
C13731,NS-102,,,,,
C13732,Domoic acid,,,,Natural toxins [BR:br08009]|Marine biotoxins|Amnesic Shellfish Poisoning; ASP|Kainoids|C13732  Domoic acid,
C13733,(S)-ATPA,,,,,
C13734,2-Amino-5-phosphopentanoic acid,,,,,
C13735,Selfotel,,,,"Drug groups [BR:br08330(D02410)]|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|D02410  Selfotel|Target-based classification of drugs [BR:br08310(D02410)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D02410  Selfotel (USAN/INN)",
C13736,Memantine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08174)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06D ANTI-DEMENTIA DRUGS|N06DX Other anti-dementia drugs|N06DX01 Memantine|D08174  Memantine (INN)|Drug groups [BR:br08330(D08174)]|Neuropsychiatric agent|DG01498  NMDA receptor antagonist|DG00986  Memantine|D08174  Memantine|DG01968  Antidementia agent|DG00986  Memantine|D08174  Memantine|Transporter substrate|DG02854  SLC22A2 substrate|DG00986  Memantine|D08174  Memantine|Target-based classification of drugs [BR:br08310(D08174)]|Ion channels|Ligand-gated ion channels|Glutamate (ionotropic), NMDA|GRIN (NMDAR)|D08174  Memantine (INN)|New drug approvals in Europe [br08329.html(D08174)]|European public assessment reports (EPAR) authorised medicine|D08174|Drug metabolizing enzymes and transporters [br08309.html(D08174)]|Drug transporters|D08174",
C13737,Dizocilpine;|MK801,,,,,
C13738,5-Tetrazolyl-glycine;|Tet-glycine,,,,,
C13739,(R)-AMAA;|(R)-2-Amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid,,,,,
C13740,"alpha,beta-Methylene ATP",,,,,
C13741,"beta,gamma-Methylene ATP;|AMP-PCP",,,,,
C13742,Adenosine 5-O-(3-thiotriphophate);|ATP-gamma-S;|Adenosine 5'-(gamma-thio)triphosphate,,,,,
C13743,Adenosine 5-O-(3-thiodiphophate);|ADP-gamma-S,,,,,
C13744,3'-O-(4-Benzoyl)benzoyl ATP;|BzATP,,,,,
C13745,"Pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid;|PPADS",,,,,
C13746,Reactive blue 2,,,,,
C13747,"1,7-Dimethylxanthine;|Paraxanthine",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C13747  1,7-Dimethylxanthine",
C13748,9-Methyl-7-bromoeudistomin D;|MBED,,,,,
C13749,Sulmazole,,,,,
C13750,Batrachotoxin,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C13750  Batrachotoxin,
C13751,Benzamil,,,,,
C13752,Phenylamil;|Phenamil,,,,,
C13753,"6-Chloro-3,5-diaminopyrazine-3-carboxamide;|CDPC",,,,,
C13756,Dicloxacillin sodium;|Dicloxacillin sodium monohydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02137)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF01 Dicloxacillin|D02137  Dicloxacillin sodium (USP) &lt;US&gt;|USP drug classification [BR:br08302(D02137)]|Antibacterials|Beta-lactam, Penicillins|Dicloxacillin|D02137  Dicloxacillin sodium (USP)|Drug groups [BR:br08330(D02137)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00540  Dicloxacillin|D02137  Dicloxacillin sodium|DG01779  beta-Lactamase resistant penicillin|DG00540  Dicloxacillin|D02137  Dicloxacillin sodium|Drug classes [BR:br08332(D02137)]|Antibacterial|DG01480  Penicillin|D02137  Dicloxacillin sodium|Antimicrobials [BR:br08307(D02137)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D02137  Dicloxacillin sodium (USP) &lt;US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02137)]|Chemicals|D02137  Dicloxacillin sodium hydrate",
C13757,Saxitoxin,,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Others|C13757  Saxitoxin|Marine biotoxins|Paralytic shellfish poisoning; PSP|Carbamate derivatives|C13757  Saxitoxin,
C13758,Bay-K-8644;|BayK8644,,,,,
C13759,"FPL64176;|Methyl-2,5-dimethyl-4-(2-(phenylmethyl)benzoyl)-1H-pyrrole-3-carboxylate",,,,,
C13760,YC 170,,,,,
C13761,CGP 28-392;|CGP 28 392,,,,,
C13762,202-791;|PN 202-791,,,,,
C13763,Devapamil,,,,,
C13764,Gallopamil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08009)]|C CARDIOVASCULAR SYSTEM|C08 CALCIUM CHANNEL BLOCKERS|C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS|C08DA Phenylalkylamine derivatives|C08DA02 Gallopamil|D08009  Gallopamil (INN)|Drug groups [BR:br08330(D08009)]|Cardiovascular agent|DG01575  Calcium channel blocker|DG01496  Calcium channel L type blocker|DG00330  Gallopamil|D08009  Gallopamil|DG01653  Antiarrhythmics|DG01807  Phenylalkylamine derivative|DG00330  Gallopamil|D08009  Gallopamil|Target-based classification of drugs [BR:br08310(D08009)]|Ion channels|Voltage-gated ion channels|Calcium channels|CACNA1-L|D08009  Gallopamil (INN),
C13765,Tiapamil,,,,,
C13766,Emopamil,,,,,
C13767,"H37;|5,8-Diethoxypsoralen",,,,,
C13768,Colistin sulfate,Colistin A (R = CH3)|Colistin B (R = H),,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02138)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07A INTESTINAL ANTIINFECTIVES|A07AA Antibiotics|A07AA10 Colistin|D02138  Colistin sulfate (JP18/USP)|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XB Polymyxins|J01XB01 Colistin|D02138  Colistin sulfate (JP18/USP)|Classification of Japanese OTC drugs [BR:br08313(D02138)]|Agents for integumentary system|56 Purulent skin remedies|D02138  Colistin sulfate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D02138)]|Second-class OTC drugs|Inorganic and organic chemicals|Colistin|D02138  Colistin sulfate (JP18/USP)|Drug groups [BR:br08330(D02138)]|Antibacterial|DG01579  Polypeptide antibiotic|DG00087  Colistin|D02138  Colistin sulfate|Antimicrobials [BR:br08307(D02138)]|Antibacterials|Cell membrane function inhibitor|Polypeptide|D02138  Colistin sulfate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02138)]|Chemicals|D02138  Colistin sulfate",
C13769,Bufuralol,,,,,
C13771,S9947;|2'-(Benzyloxycarbonylaminomethyl)biphenyl-2-carboxylic acid 2-(2-pyridyl)ethylamide,,,,,
C13772,Clofilium,,,,,
C13773,"1,1-Diethyl-2-hydroxy-2-nitrosohydrazine;|D-NONOate",,,,,
C13776,E-4031,,,,,
C13777,Azimilide,,,,,
C13778,HMR1556,,,,,
C13779,XE991,,,,,
C13780,Linopirdine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04741)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS|N06BX Other psychostimulants and nootropics|N06BX09 Linopirdine|D04741  Linopirdine (USAN/INN)",
C13781,Teicoplanin A2;|Teichomycin A2,Generic compound|Teicoplanin A2-1 (R = CO(CH2)2(CH)2(CH2)4CH3) [CPD:C13587]|Teicoplanin A2-2 (R = CO(CH2)6CH(CH3)2) [CPD:C12046]|Teicoplanin A2-3 (R = CO(CH2)8CH3) [CPD:C13588]|Teicoplanin A2-4 (R = CO(CH2)6CH(CH3)CH2CH3) [CPD:C13610]|Teicoplanin A2-5 (R = CO(CH2)7CH(CH3)2) [CPD:C13612],,,,
C13782,Paxilline,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C13782  Paxilline,
C13783,"UCL 1684;|6,10-Diaza-3(1,3)8,(1,4)-dibenzena-1,5(1,4)-diquinolinacyclodecaphane",,,,,
C13784,TRAM-34;|1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole,,,,,
C13785,TRAM-3;|(2-Chlorophenyl)diphenylmethanol,,,,,
C13786,Cetiedil,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AX Other peripheral vasodilators|C04AX26 Cetiedil|C13786  Cetiedil,G00291
C13787,17-Methyl-6Z-octadecenoic acid;|17-Methyl-6Z-octadecenoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C13787  17-Methyl-6Z-octadecenoic acid,
C13788,UCL 1608,,,,,
C13789,Trichomycin;|Hachimycin,"Generic compound|Trichomycin A (R1 = H, R2 = OH) [CPD:C13450]|Trichomycin B (R1 = OH, R2 = H) [CPD:C13451]",,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02143)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AA Antibiotics|D01AA03 Hachimycin|D02143  Trichomycin (JP18)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA06 Hachimycin|D02143  Trichomycin (JP18)|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AA Antibiotics|J02AA02 Hachimycin|D02143  Trichomycin (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D02143)]|Second-class OTC drugs|Inorganic and organic chemicals|Trichomycin|D02143  Trichomycin (JP18)|Antimicrobials [BR:br08307(D02143)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D02143  Trichomycin (JP18)|Antimicrobials abbreviations [BR:br08327(D02143)]|Antifungals|Cell membrane function inhibitor|Polyene macrolide|D02143  Trichomycin (JP17)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02143)]|Chemicals|D02143  Trichomycin",
C13790,2S-Hydroxytetradecanoic acid;|2S-Hydroxytetradecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C13790  2S-Hydroxytetradecanoic acid,
C13791,"(6R,7S)-6,7-Epoxyoctadecanoic acid;|6R,7S-Epoxy-octadecanoic acid;|6R,7S-Epoxy-octadecanoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C13791  (6R,7S)-6,7-Epoxyoctadecanoic acid",
C13792,2-Methoxy-5Z-hexadecenoic acid;|2-Methoxy-5Z-hexadecenoate;|(5Z)-2-Methoxyhexadecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0108 Methoxy fatty acids|C13792  (5Z)-2-Methoxyhexadecenoic acid,
C13793,3-Bromo-2Z-heptenoic acid;|3-Bromo-2Z-heptenoate;|(2Z)-3-Bromoheptenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C13793  (2Z)-3-Bromoheptenoic acid,
C13794,Pitrazepin,,,,,
C13795,2S-Amino-tridecanoic acid;|2S-Amino-tridecanoate;|(S)-2-Aminotridecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C13795  2S-Amino-tridecanoic acid,
C13796,SR95531,,,,,
C13797,RU 5135,,,,,
C13798,8-(5-Hexyl-furan-2-yl)-octanoic acid;|8-(5-Hexyl-furan-2-yl)-octanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0115 Heterocyclic fatty acids|C13798  8-(5-Hexyl-furan-2-yl)-octanoic acid,
C13799,(+)-Hydrastine;|(+)-beta-Hydrastine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C13799  (+)-beta-Hydrastine,
C13800,"10-Nitrolinoleic acid;|10-Nitro-9-cis,12-cis-octadecadienoic acid;|10-Nitro-9-cis,12-cis-octadecadienoate;|(9E,12Z)-10-Nitrooctadeca-9,12-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0112 Nitro fatty acids|C13800  (9Z,12Z)-10-Nitrooctadeca-9,12-dienoic acid",
C13802,Prostaglandin D3,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C13802  Prostaglandin D3,
C13803,Alphaxalone;|Alfaxalone,,,,,
C13804,ORG 20599,,,,,
C13805,N-Butyl-beta-carboline-3-carboxylate,,,,,
C13806,Philanthotoxin 343,,,,Natural toxins [BR:br08009]|Venoms|Bee venoms|Others|C13806  Philanthotoxin 343,
C13807,"Levuglandin E2;|LGE2;|10,11-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid;|10,11-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0310 Levuglandins|C13807  Levuglandin E2,
C13808,"Levuglandin D2;|LGD2;|9,10-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid;|9,10-Seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0310 Levuglandins|C13808  Levuglandin D2,
C13809,"9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid;|8-Isoprostaglandin F2alpha;|8-Isoprostane;|8-epi-Prostaglandin F2alpha",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0311 Isoprostanes|C13809  8-Isoprostaglandin F2alpha,
C13810,Clavulone I;|Claviridenone d,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0312 Clavulones|C13810  Clavulone I,
C13811,Piperazine adipate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02145)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CB Piperazine and derivatives|P02CB01 Piperazine|D02145  Piperazine adipate (JP18/USP)|Risk category of Japanese OTC drugs [BR:br08312(D02145)]|Second-class OTC drugs|Inorganic and organic chemicals|Piperazine|D02145  Piperazine adipate (JP18/USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9751  Piperazine and preparations|C13811  Piperazine adipate|Antimicrobials [BR:br08307(D02145)]|Antiparasitics|Antinematodal agents|Piperazine and derivatives|D02145  Piperazine adipate (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02145)]|Chemicals|D02145  Piperazine adipate",
C13812,Clavulone II,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0312 Clavulones|C13812  Clavulone II,
C13813,Clavulone III,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0312 Clavulones|C13813  Clavulone III,
C13814,Clavulone IV,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0312 Clavulones|C13814  Clavulone IV,
C13815,Tetrapentylammonium,,,,,
C13816,"(9R,13R)-12-Oxo-phytodienoic acid;|(9R,13R)-12-Oxo-phyto-10Z,15Z-dienoic acid;|(10Z,15Z)-(9R,13R)-12-Oxophyto-10,15-dienoic acid;|(15Z)-12-Oxophyto-10,15-dienoate;|(9R,13R)-OPDA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0201 12-oxophytodienoic acid metabolites|C13816  (10Z,15Z)-(9R,13R)-12-Oxophyto-10,15-dienoic acid",
C13817,8-Br-cGMP;|8-Bromocyclic GMP,,,,,
C13818,F4-Neuroprostane (4-series),,,,Lipids [BR:br08002]|FA  Fatty acyls|FA04 Docosanoids|FA0401 Neuroprostanes|C13818  F4-Neuroprostane (4-series),
C13819,F4-Neuroprostane (7-series),,,,Lipids [BR:br08002]|FA  Fatty acyls|FA04 Docosanoids|FA0401 Neuroprostanes|C13819  F4-Neuroprostane (7-series),
C13820,Chromanol 293B,,,,,
C13821,Palmityl palmitate;|Hexadecyl hexadecanoate;|Hexadecanyl hexadecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C13821  Palmityl palmitate,
C13822,"2S,3R-Didecanoyl-docosane-2,3-diol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0702 Wax diesters|C13822  2S,3R-Didecanoyl-docosane-2,3-diol",
C13823,11-Undecanolactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0704 Lactones|C13823  11-Undecanolactone,
C13824,R-L3,,,,,
C13825,O-Hexanoyl-adnosine monophosphate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0708 Fatty acyl adenylates|C13825  O-Hexanoyl-adnosine monophosphate,
C13826,Retigabine;|D-23129;|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09569)]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AX Other antiepileptics|N03AX21 Retigabine|D09569  Ezogabine (USAN)|Drug groups [BR:br08330(D09569)]|Neuropsychiatric agent|DG03199  Antiepileptic agent|DG02037  GABA mimetic antiepileptic|D09569  Ezogabine|Transporter inhibitor|DG01622  ABCB1 inhibitor|D09569  Ezogabine|DG02866  SLC22A8 inhibitor|D09569  Ezogabine|Target-based classification of drugs [BR:br08310(D09569)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCNQ|D09569  Ezogabine (USAN)|New drug approvals in the USA [br08319.html(D09569)]|New molecular entities and new therapeutic biological products|D09569|New drug approvals in Europe [br08329.html(D09569)]|European public assessment reports (EPAR) authorised medicine|D09569|New drug approvals in the USA, Europe and Japan [br08328.html(D09569)]|Approval dates by FDA, EMA and PMDA|D09569|Drug metabolizing enzymes and transporters [br08309.html(D09569)]|Drug transporters|D09569",
C13827,Chloroform,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AB Halogenated hydrocarbons|N01AB02 Chloroform|C13827  Chloroform",
C13828,"8,11,14-Eicosatrienoylethanolamide;|N-(8Z,11Z,14Z-Eicosatrienoyl)-ethanolamine",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0804 N-acyl ethanolamines (endocannabinoids)|C13828  N-(8Z,11Z,14Z-Eicosatrienoyl)-ethanolamine",
C13829,"7,10,13,16-Docosatetraenoylethanolamine;|N-(7Z,10Z,13Z,16Z-Docosatetraenoyl)-ethanolamine",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0804 N-acyl ethanolamines (endocannabinoids)|C13829  N-(7Z,10Z,13Z,16Z-docosatetraenoyl)-ethanolamine",
C13830,BMS 204352;|Flindokalner,,,,Target-based classification of drugs [BR:br08310(D04192)]|Ion channels|Voltage-gated ion channels|Potassium channels|KCNQ|D04192  Flindokalner (USAN/INN)|KCNMB1|D04192  Flindokalner (USAN/INN),
C13831,Dodecanamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C13831  Dodecanamide,
C13832,"4Z,7Z,10Z-Octadecatrienenitrile",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA09 Fatty nitriles|C13832  4Z,7Z,10Z-Octadecatrienenitrile",
C13833,NS 1619,,,,,
C13834,Tridecane;|n-Tridecane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C13834  n-Tridecane,
C13835,NS 1608,,,,,
C13836,CGS 7181,,,,,
C13837,Dehydrosoyasaponin I;|DHS-I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C13837  Dehydrosoyasaponin I|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C13837  Dehydrosoyasaponin I,
C13838,"Lactobacillic acid;|11R,12S-Methylene-octadecanoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C13838  Lactobacillic acid,
C13840,1-Ethyl-2-benzimidazolinone;|1-EBIO,,,,,
C13841,Zoxazolamine,,,,,
C13842,alpha-Smegma-mycolic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0116 Mycolic acids|C13842  alpha-Semegma mycolic acid,
C13843,"17R,18S-Epoxy-5Z,8Z,11Z,14Z-icosatetraenoic acid;|(5Z,8Z,11Z,14Z)-(17R,18S)-17,18-Epoxyicosa-5,8,11,14-tetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0300 Other Eicosanoids|C13843  17R,18S-Epoxy-5Z,8Z,11Z,14Z-icosatetraenoic acid",
C13844,"DCEBIO;|5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one",,,,,
C13845,"1,3-Di-(octadec-9Z-enoyl)-1-cyano-2-methylene-propane-1,3-diol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0703 Cyano esters|C13845  1,3-Di-(octadec-9Z-enoyl)-1-cyano-2-methylene-propane-1,3-diol",
C13846,Octadecanamide;|Stearamide;|Stearic acid amide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C13846  Octadecanamide,
C13847,CP 339818,,,,,
C13848,UK 78282,,,,,
C13849,Correolide,,,,,
C13851,BRL 32872,,,,,
C13852,Sipatrigine;|BW619C89,,,,,
C13853,L 735821,,,,,
C13854,1-Dodecanoyl-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0101 Monoacylglycerols|C13854  1-Dodecanoyl-sn-glycerol,
C13856,2-Arachidonoylglycerol;|2-Arachidonoyl-sn-glycerol;|2-AG,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0101 Monoacylglycerols|C13856  2-Arachidonoyl-sn-glycerol,
C13857,1-Arachidonoylglycerol;|1-Arachidonoyl-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0101 Monoacylglycerols|C13857  1-Arachidonoyl-sn-glycerol,
C13858,1-O-Octadecyl-sn-glycerol;|1-O-Octadecylglycerol;|Batyl alcohol;|Glycerol octadecyl ether,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0102 Monoalkylglycerols|C13858  1-O-Octadecyl-sn-glycerol,
C13859,1-O-Hexadecyl-sn-glycerol;|1-O-Hexadecylglycerol;|Chimyl alcohol;|Glycerol hexadecyl ether,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0102 Monoalkylglycerols|C13859  1-O-Hexadecyl-sn-glycerol,
C13860,1-O-Octadec-9-enyl glycerol;|Selachyl alcohol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0102 Monoalkylglycerols|C13860  1-O-Octadec-9-enyl glycerol,
C13861,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C13861  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol,
C13862,1-O-Hexadecyl-2-(9Z-octadecenoyl)-sn-glycerol,,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0202 1-alkyl,2-acylglycerols|C13862  1-O-Hexadecyl-2-(9Z-octadecenoyl)-sn-glycerol",
C13863,"2,3-Di-O-phytanyl-sn-glycerol;|Archaeol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0203 Dialkylglycerols|C13863  2,3-Di-O-phytanyl-sn-glycerol",
C13864,1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0204 1Z-alkenylacylglycerols|C13864  1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycerol,
C13867,"1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-3-(8-(2E,4Z-decadienoyloxy)-5,6-octadienoyl)-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0305 Estolides|C13867  1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-3-(8-(2E,4Z-decadienoyloxy)-5,6-octadienoyl)-sn-glycerol",
C13869,1-Dodecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0301 Triacylglycerols|C13869  1-Dodecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol,
C13870,Tributyrin;|Glyceryl tributyrate;|Glycerol tributyrate,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL03 Triradylglycerols|GL0301 Triacylglycerols|C13870  Tributyrin,
C13871,"1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-3-O-beta-D-galactosyl-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C13871  1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-3-O-beta-D-galactosyl-sn-glycerol",
C13872,Caldarchaeol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0205 Di-glycerol tetraethers|C13872  Caldarchaeol,
C13874,Gentiobiosyl-caldarchaeol;|Glcbeta1-6Glcbeta-caldarchaeol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0206 Di-glycerol tetraether glycans|C13874  Gentiobiosyl-caldarchaeol,
C13875,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0101 Diacylglycerophosphocholines|C13875  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine,
C13876,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphonocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP16 Glycerophosphonocholines|GP1601 Diacylglycerophosphonocholines|C13876  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphonocholine,
C13877,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0201 Diacylglycerophosphoethanolamines|C13877  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine,
C13878,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphonoethanolamine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP17 Glycerophosphonoethanolamines|GP1701 Diacylglycerophosphonoethanolamines|C13878  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphonoethanolamine,
C13880,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP03 Glycerophosphoserines|GP0301 Diacylglycerophosphoserines|C13880  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine,
C13881,Barium cation;|Ba2+;|Barium(2+);|Barium ion,,,,,
C13883,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP04 Glycerophosphoglycerols|GP0401 Diacylglycerophosphoglycerols|C13883  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol,
C13884,Strontium cation;|Sr2+;|Strontium(2+);|Strontium ion,,,,,
C13885,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol 3'-phosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP05 Glycerophosphoglycerophosphates|GP0501 Diacylglycerophosphoglycerophosphates|C13885  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-sn-glycerol 3'-phosphate,
C13888,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP06 Glycerophosphoinositols|GP0601 Diacylglycerophosphoinositols|C13888  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol,
C13889,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate;|1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol 3-phosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1001 Diacylglycerophosphates|C13889  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate,
C13890,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-pyrophosphate;|1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol 3-pyrophosphate;|1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol 3-diphosphate,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP11 Glyceropyrophosphates|GP1101 Diacylglyceropyrophosphates|C13890  1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-pyrophosphate,
C13891,"CDP-1,2-didodecanoyl-sn-glycerol;|1,2-Didodecanoyl-sn-glycero-3-cytidine-5'-diphosphate",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP13 CDP-Glycerols|GP1301 CDP-diacylglycerols|C13891  CDP-1,2-didodecanoyl-sn-glycerol",
C13892,1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-cytidine-5'-diphosphate;|CDP-1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP13 CDP-Glycerols|GP1301 CDP-diacylglycerols|C13892  CDP-1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol,
C13894,1-O-Hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine,,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0102 1-alkyl,2-acylglycerophosphocholines|C13894  1-O-Hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine",
C13895,1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine,,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0103 1-(1Z-alkenyl),2-acylglycerophosphocholines|C13895  1-O-(1Z-Tetradecenyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine",
C13896,sn-Caldarchaeo-1-phosphoethanolamine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP18 Di-glycerol tetraether phospholipids (caldarchaeols)|C13896  sn-Caldarchaeo-1-phosphoethanolamine,
C13897,sn-Caldito-1-phosphoethanolamine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP19 Glycerol-nonitol tetraether phospholipids|C13897  sn-Caldito-1-phosphoethanolamine,
C13898,1-Palmitoyl-2-(5-hydroxy-8-oxo-6-octenedioyl)-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C13898  1-Palmitoyl-2-(5-hydroxy-8-oxo-6-octenedioyl)-sn-glycero-3-phosphocholine,
C13900,1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C13900  1-Palmitoyl-2-(5-keto-6-octenedioyl)-sn-glycero-3-phosphocholine,
C13901,1-Palmitoyl-2-(5-hydroxy-8-oxo-6-octenoyl)-sn-glycero-3-phosphocholine;|1-Palmitoyl-2-(5-hydroxy-8-oxooct-6-enoyl)-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C13901  1-Palmitoyl-2-(5-hydroxy-8-oxo-6-octenoyl)-sn-glycero-3-phosphocholine,
C13902,1-Palmitoyl-2-(5-keto-8-oxo-6-octenoyl)-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C13902  1-Palmitoyl-2-(5-keto-8-oxo-6-octenoyl)-sn-glycero-3-phosphocholine,
C13903,1-O-Hexadecyl-lyso-sn-glycero-3-phosphocholine;|1-O-Hexadecyl-2-lyso-sn-glycero-3-phosphocholine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP01 Glycerophosphocholines|GP0106 Monoalkylglycerophosphocholines|C13903  1-O-Hexadecyl-lyso-sn-glycero-3-phosphocholine,
C13906,Balofloxacin,,,,,
C13907,OM-174;|Triacyl lipid A OM-174;|Triacyl lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0103 Triacylaminosugars|C13907  Triacyl lipid A,
C13908,Diphosphoryl hexaacyl lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0106 Hexaacylaminosugars|C13908  Diphosphoryl hexaacyl lipid A,
C13909,Diphosphoryl heptaacyl lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0107 Heptaacylaminosugars|C13909  Diphosphoryl heptaacyl lipid A,
C13910,Undecylenic acid;|Undecenoic acid;|10-Undecenoic acid;|Undec-10-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C13910  Undec-10-enoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02159)]|D DERMATOLOGICALS|D01 ANTIFUNGALS FOR DERMATOLOGICAL USE|D01A ANTIFUNGALS FOR TOPICAL USE|D01AE Other antifungals for topical use|D01AE04 Undecylenic acid|D02159  Undecylenic acid (JAN/USP)|Classification of Japanese OTC drugs [BR:br08313(D02159)]|Agents for integumentary system|58 Ringworm drugs|D02159  Undecylenic acid (JAN/USP)|Risk category of Japanese OTC drugs [BR:br08312(D02159)]|Third-class OTC drugs|Inorganic and organic chemicals|Undecylenic acid|D02159  Undecylenic acid (JAN/USP),
C13914,"N,N-Dimethylsphing-4-enine",,,,"Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0107 N-methylated sphingoid bases|C13914  N,N-Dimethylsphing-4-enine",
C13915,Hexadecasphinganine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0104 Sphingoid base homologs and variants|C13915  Hexadecasphinganine,
C13916,N-(Tetradecanoyl)-sphing-4-enine,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0201 N-acylsphingosines (ceramides)|C13916  N-(Tetradecanoyl)-sphing-4-enine,
C13918,"N-(30-(9Z,12Z-Octadecadienoyloxy)-tricontanoyl)-sphing-4-enine",,,,"Lipids [BR:br08002]|SP  Sphingolipids|SP02 Ceramides|SP0204 Acylceramides|C13918  N-(30-(9Z,12Z-octadecadienoyloxy)-tricontanoyl)-sphing-4-enine",
C13920,Ml4Cer;|GlcNAc-beta1->2Man-alpha1->3Man-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G03121)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0507 Manalpha1-3Manbeta1-4Glc- (Mollu series)|G03121  GlcNAc-beta1->2Man-alpha1->3Man-beta1->4Glc-beta1->1'Cer (Ml4Cer),G03121
C13921,II2Xylbeta-Ml4Cer;|GlcNAc-beta1->2Man-alpha1->3(Xyl-beta1-2)Man-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G03045)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0507 Manalpha1-3Manbeta1-4Glc- (Mollu series)|G03045  GlcNAc-beta1->2Man-alpha1->3(Xyl-beta1-2)Man-beta1->4Glc-beta1->1'Cer,G03045
C13922,Ar4Cer;|GalNAc-beta1->4GlcNAc-beta1->3Man-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00708)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0508 GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series)|G00708  GalNAc-beta1->4GlcNAc-beta1->3Man-beta1->4Glc-beta1->1'Cer (Ar4Cer),G00708
C13923,Ar5Cer;|GalNAc-alpha1->4GalNAc-beta1->4GlcNAc-beta1->3Man-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00849)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0508 GlcNAcbeta1-3Manbeta1-4Glc- (Arthro series)|G00849  GalNAc-alpha1->4GalNAc-beta1->4GlcNAc-beta1->3Man-beta1->4Glc-beta1->1'Cer (Ar5Cer),G00849
C13924,Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer;|iGb3Cer,,,,Lipids [BR:br08002(G00403)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0506 Galalpha1-3Galbeta1-4Glc- (Isoglobo series)|G00403  Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer (iGb3Cer),G00403
C13925,iGb4Cer;|GalNAc-beta1->3Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00392)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0506 Galalpha1-3Galbeta1-4Glc- (Isoglobo series)|G00392  GalNAc-beta1->3Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer (iGb4Cer),G00392
C13926,iGb5Cer;|GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G02977)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0506 Galalpha1-3Galbeta1-4Glc- (Isoglobo series)|G02977  GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->3Gal-beta1->4Glc-beta1->1'Cer (iGb5Cer),G02977
C13927,Argiotoxin 636;|Argiopin,,,,,
C13929,Argiotoxin 659,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C13929  Argiotoxin 659,
C13931,JSTX-3;|Joro spider toxin,,,,,
C13932,Ruthenium red,,,,,
C13937,Cholinephosphorylmannosylneogalabiaosylceramide;|PGL3a,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP08 Amphoteric glycosphingolipids|C13937  Cholinephosphorylmannosylneogalabiaosylceramide,
C13938,Cholinephosphorylneogalatriaosylceramide;|PGL3b,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP08 Amphoteric glycosphingolipids|C13938  Cholinephosphorylneogalatriaosylceramide,
C13940,Sennoside;|Sennoside A&B,Sennoside A [CPD:C10404]|Sennoside B [CPD:C13526],,,,
C13945,2-Oxodecanoic acid;|2-Oxodecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C13945  2-Oxodecanoic acid,
C13946,2-Methoxy-6Z-hexadecenoic acid;|2-Methoxy-6Z-hexadecenoate;|(6Z)-2-Methoxyhexadecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0108 Methoxy fatty acids|C13946  (6Z)-2-Methoxyhexadecenoic acid,
C13947,2-Methoxyhexadecanoic acid;|2-Methoxyhexadecanoate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0108 Methoxy fatty acids|C13947  2-Methoxyhexadecanoic acid,
C13948,16-Fluorohexadecanoic acid;|16-Fluoropalmitic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C13948  16-Fluorohexadecanoic acid,
C13949,9-Chloro-10-hydroxyhexadecanoic acid;|9-Chloro-10-hydroxypalmitic acid;|9-Chloro-10-hydroxypalmitate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C13949  9-Chloro-10-hydroxyhexadecanoic acid,
C13952,UDP-N-acetyl-D-galactosaminuronic acid;|UDP-N-acetyl-alpha-D-galactosaminouronate,,,,,
C13958,"12-Nitrolinoleic acid;|12-Nitro-9-cis,12-cis-octadecadienoic acid;|(9Z,12E)-12-Nitrooctadeca-9,12-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0112 Nitro fatty acids|C13958  (9Z,12Z)-12-Nitrooctadeca-9,12-dienoic acid",
C13962,Chloramphenicol sodium succinate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02185)]|D DERMATOLOGICALS|D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE|D06A ANTIBIOTICS FOR TOPICAL USE|D06AX Other antibiotics for topical use|D06AX02 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AF Antiinfectives for treatment of acne|D10AF03 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA05 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01B AMPHENICOLS|J01BA Amphenicols|J01BA01 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA01 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA01 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA08 Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02185)]|Antibacterials|Antibacterials, Other|Chloramphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02185)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|615  Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia|6151  Chloramphenicols|D02185  Chloramphenicol sodium succinate (JP18/USP)|Drug groups [BR:br08330(D02185)]|Antibacterial|DG01576  Amphenicol type antibacterial|DG00399  Chloramphenicol|D02185  Chloramphenicol sodium succinate|Antimicrobials [BR:br08307(D02185)]|Antibacterials|Protein biosynthesis inhibitor|Amphenicol|D02185  Chloramphenicol sodium succinate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02185)]|Chemicals|D02185  Chloramphenicol sodium succinate",
C13963,Mevastatin;|Compactin;|ML-236B,,0 Mae  1 Mae  2 Mae  3 Mae  4 Mae  5 Mae  6 Mak  7 Mak  8 Man,PK,,
C13964,Fosfomycin calcium;|Calcium phosphomycin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07995)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XX Other antibacterials|J01XX01 Fosfomycin|D07995  Fosfomycin calcium|S SENSORY ORGANS|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA17 Fosfomycin|D07995  Fosfomycin calcium|Antimicrobials [BR:br08307(D07995)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Other peptidoglycan biosynthesis inhibitor|D07995  Fosfomycin calcium",
C13967,Carbenicillin sodium;|Carbenicillin disodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02190)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA03 Carbenicillin|D02190  Carbenicillin disodium (USP)|Drug groups [BR:br08330(D02190)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00519  Carbenicillin|D02190  Carbenicillin disodium|DG01780  Extended spectrum penicillin|DG00519  Carbenicillin|D02190  Carbenicillin disodium|Antimicrobials [BR:br08307(D02190)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02190  Carbenicillin disodium (USP)",
C13968,Cefamandole sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02191)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC03 Cefamandole|D02191  Cefamandole sodium (JAN)|Drug groups [BR:br08330(D02191)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00559  Cefamandole|D02191  Cefamandole sodium|DG01775  Second-generation cephalosporin|DG00559  Cefamandole|D02191  Cefamandole sodium|Antimicrobials [BR:br08307(D02191)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D02191  Cefamandole sodium (JAN)",
C13973,Methicillin sodium;|Meticillin sodium;|Sodium methicillin monohydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02196)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF03 Meticillin|D02196  Methicillin sodium (USAN)|Drug groups [BR:br08330(D02196)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|D02196  Methicillin sodium|DG01779  beta-Lactamase resistant penicillin|DG02500  Methicillin|D02196  Methicillin sodium|Antimicrobials [BR:br08307(D02196)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D02196  Methicillin sodium (USAN)",
C13974,Vincristine sulfate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02197)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CA Vinca alkaloids and analogues|L01CA02 Vincristine|D02197  Vincristine sulfate (JP18/USP) &lt;JP/US&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02197)]|4  Agents affecting cellular function|42  Antineoplastics|424  Plant extract preparations|4240  Plant extract preparations|D02197  Vincristine sulfate (JP18/USP)|Drug groups [BR:br08330(D02197)]|Antineoplastic|DG01965  Vinca alkaloid antineoplastic|DG00690  Vincristine|D02197  Vincristine sulfate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG00690  Vincristine|D02197  Vincristine sulfate|Target-based classification of drugs [BR:br08310(D02197)]|Not elsewhere classified|Cellular process|Cytoskeleton|TUBB|D02197  Vincristine sulfate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02197)]|Chemicals|D02197  Vincristine sulfate|Drug metabolizing enzymes and transporters [br08309.html(D02197)]|Drug metabolizing enzymes|D02197,
C13976,Carfecillin sodium;|Carbenicillin phenyl sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02199)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AA Antibiotics|G01AA08 Carfecillin|D02199  Carbenicillin phenyl sodium (USAN)|Drug groups [BR:br08330(D02199)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00443  Carfecillin|D02199  Carbenicillin phenyl sodium|Antimicrobials [BR:br08307(D02199)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Other penicillin|D02199  Carbenicillin phenyl sodium (USAN)|Prodrugs [br08324.html(D02199)]|D02199",
C13978,Talampicillin hydrochloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02201)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA15 Talampicillin|D02201  Talampicillin hydrochloride (JP18/USAN)|Drug groups [BR:br08330(D02201)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00529  Talampicillin|D02201  Talampicillin hydrochloride|DG01780  Extended spectrum penicillin|DG00529  Talampicillin|D02201  Talampicillin hydrochloride|Antimicrobials [BR:br08307(D02201)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02201  Talampicillin hydrochloride (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02201)]|Chemicals|D02201  Talampicillin hydrochloride",
C13980,Hetacillin potassium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02203)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA18 Hetacillin|D02203  Hetacillin potassium (JAN/USAN)|Drug groups [BR:br08330(D02203)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00532  Hetacillin|D02203  Hetacillin potassium|DG01780  Extended spectrum penicillin|DG00532  Hetacillin|D02203  Hetacillin potassium|Antimicrobials [BR:br08307(D02203)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02203  Hetacillin potassium (JAN/USAN)",
C13993,Ciprofloxacin hydrochloride;|Ciprofloxacin hydrochloride monohydrate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02216)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01M QUINOLONE ANTIBACTERIALS|J01MA Fluoroquinolones|J01MA02 Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AE Fluoroquinolones|S01AE03 Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP) &lt;JP/US&gt;|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA15 Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA07 Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02216)]|Antibacterials|Quinolones|Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP)|Ophthalmic Agents|Ophthalmic Anti-Infectives|Antibacterials, Ophthalmic|Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP)|Otic Agents|Otic Anti-Infectives|Ciprofloxacin|D02216  Ciprofloxacin hydrochloride (USP)|Therapeutic category of drugs in Japan [BR:br08301(D02216)]|6  Agents against pathologic organisms and parasites|62  Chemotherapeutics|624  Synthetic antibacterials|6241  Pyridonecarboxylic acids|D02216  Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP18)|Drug groups [BR:br08330(D02216)]|Antibacterial|DG01550  Quinolone|DG01549  Fluoroquinolone|DG00617  Ciprofloxacin|D02216  Ciprofloxacin hydrochloride|Metabolizing enzyme inhibitor|DG01634  CYP1A2 inhibitor|DG00617  Ciprofloxacin|D02216  Ciprofloxacin hydrochloride|Drug classes [BR:br08332(D02216)]|Antibacterial|DG01549  Fluoroquinolone|D02216  Ciprofloxacin hydrochloride|Antimicrobials [BR:br08307(D02216)]|Antibacterials|Nucleic acid synthesis inhibitor|Fluoroquinolone|D02216  Ciprofloxacin hydrochloride (USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02216)]|Chemicals|D02216  Ciprofloxacin hydrochloride hydrate|Drug metabolizing enzymes and transporters [br08309.html(D02216)]|Drug metabolizing enzymes|D02216",
C14001,Sulbactam sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02223)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CG Beta-lactamase inhibitors|J01CG01 Sulbactam|D02223  Sulbactam sodium (JP18/USP)|Drug groups [BR:br08330(D02223)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00545  Sulbactam|D02223  Sulbactam sodium|DG01479  beta-Lactamase inhibitor|DG00545  Sulbactam|D02223  Sulbactam sodium|Antimicrobials [BR:br08307(D02223)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Beta-lactamase inhibitor|D02223  Sulbactam sodium (JP18/USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02223)]|Chemicals|D02223  Sulbactam sodium",
C14002,Lincomycin hydrochloride;|Lincomycin hydrochloride monohydrate,,,,"Glycosides [BR:br08021]|S-glycosides|C14002  Lincomycin hydrochloride|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02346)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS|J01FF Lincosamides|J01FF02 Lincomycin|D02346  Lincomycin hydrochloride hydrate (JP18/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02346)]|Antibacterials|Antibacterials, Other|Lincomycin|D02346  Lincomycin hydrochloride hydrate (JP18/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02346)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|611  Acting mainly on gram-positive bacteria|6112  Lincomycins|D02346  Lincomycin hydrochloride hydrate (JP18/USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9762  Antibiotic preparations for peroral and feed additive use|C14002  Lincomycin hydrochloride|Drug groups [BR:br08330(D02346)]|Antibacterial|DG01578  Lincosamide antibiotic|DG00607  Lincomycin|D02346  Lincomycin hydrochloride hydrate|Drug classes [BR:br08332(D02346)]|Antibacterial|DG01578  Lincosamide antibiotic|D02346  Lincomycin hydrochloride hydrate|Antimicrobials [BR:br08307(D02346)]|Antibacterials|Protein biosynthesis inhibitor|Lincosamide|D02346  Lincomycin hydrochloride hydrate (JP18/USP) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02346)]|Chemicals|D02346  Lincomycin hydrochloride hydrate|D02346  Lincomycin hydrochloride injection",
C14007,Cefotetan disodium;|Cefotetan sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02228)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC05 Cefotetan|D02228  Cefotetan disodium (USP) &lt;US&gt;|USP drug classification [BR:br08302(D02228)]|Antibacterials|Beta-lactam, Cephalosporins|Cefotetan|D02228  Cefotetan disodium (USP)|Drug groups [BR:br08330(D02228)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00561  Cefotetan|D02228  Cefotetan disodium|DG01775  Second-generation cephalosporin|DG00561  Cefotetan|D02228  Cefotetan disodium|Drug classes [BR:br08332(D02228)]|Antibacterial|DG01488  Cephem|D02228  Cefotetan disodium|Antimicrobials [BR:br08307(D02228)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D02228  Cefotetan disodium (USP) &lt;US&gt;",
C14010,Sodium cloxacillin monohydrate;|Cloxacillin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02231)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CF Beta-lactamase resistant penicillins|J01CF02 Cloxacillin|D02231  Cloxacillin sodium (USP)|Drug groups [BR:br08330(D02231)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00541  Cloxacillin|D02231  Cloxacillin sodium|DG01779  beta-Lactamase resistant penicillin|DG00541  Cloxacillin|D02231  Cloxacillin sodium|Antimicrobials [BR:br08307(D02231)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|beta-Lactamase resistant penicillin|D02231  Cloxacillin sodium (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02231)]|Chemicals|D02231  Cloxacillin sodium hydrate",
C14015,Diphenhydramine salicylate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02419)]|D DERMATOLOGICALS|D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|D04AA Antihistamines for topical use|D04AA32 Diphenhydramine|D02419  Diphenhydramine salicylate (JAN)|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA02 Diphenhydramine|D02419  Diphenhydramine salicylate (JAN)|Classification of Japanese OTC drugs [BR:br08313(D02419)]|Agents for nervous and sensory systems|06 Antivertigo drugs (incl. motion/morning sickness remedies)|D02419  Diphenhydramine salicylate (JAN)|Allergic agents|52 Antihistamine based drugs|D02419  Diphenhydramine salicylate (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D02419)]|Second-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D02419  Diphenhydramine salicylate (JAN)|Third-class OTC drugs|Inorganic and organic chemicals|Diphenhydramine|D02419  Diphenhydramine salicylate (JAN)|Drug groups [BR:br08330(D02419)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG00390  Diphenhydramine|D02419  Diphenhydramine salicylate|Target-based classification of drugs [BR:br08310(D02419)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D02419  Diphenhydramine salicylate (JAN)",
C14021,Ticarcillin disodium;|Aerugipen,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02241)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA13 Ticarcillin|D02241  Ticarcillin disodium (USP)|Drug groups [BR:br08330(D02241)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00527  Ticarcillin|D02241  Ticarcillin disodium|DG01780  Extended spectrum penicillin|DG00527  Ticarcillin|D02241  Ticarcillin disodium|Antimicrobials [BR:br08307(D02241)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02241  Ticarcillin disodium (USP)",
C14029,Trimipramine maleate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02408)]|N NERVOUS SYSTEM|N06 PSYCHOANALEPTICS|N06A ANTIDEPRESSANTS|N06AA Non-selective monoamine reuptake inhibitors|N06AA06 Trimipramine|D02408  Trimipramine maleate (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02408)]|Antidepressants|Tricyclics|Trimipramine|D02408  Trimipramine maleate (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D02408)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1174  Imipramines|D02408  Trimipramine maleate (JAN/USP)|Drug groups [BR:br08330(D02408)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|DG00931  Trimipramine|D02408  Trimipramine maleate|DG01728  Tricyclic antidepressant|DG00931  Trimipramine|D02408  Trimipramine maleate|Drug classes [BR:br08332(D02408)]|Neuropsychiatric agent|DG01730  Non-selective monoamine reuptake inhibitor|D02408  Trimipramine maleate|Target-based classification of drugs [BR:br08310(D02408)]|Transporters|Solute carrier family|SLC6|SLC6A2 (NAT1)|D02408  Trimipramine maleate (JAN/USP) &lt;JP/US&gt;|SLC6A4 (HTT)|D02408  Trimipramine maleate (JAN/USP) &lt;JP/US&gt;|Pharmacogenomic biomarkers [br08341.html(D02408)]|Polymorphisms and mutations affecting drug response|D02408,
C14034,Piperacillin;|Piperacillin anhydrous,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08380)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA12 Piperacillin|D08380  Piperacillin (INN)|Drug groups [BR:br08330(D08380)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|DG00526  Piperacillin|D08380  Piperacillin|DG01780  Extended spectrum penicillin|DG00526  Piperacillin|D08380  Piperacillin|Antimicrobials [BR:br08307(D08380)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D08380  Piperacillin (INN)",
C14039,"1,1-Dichloroethylene;|Vinylidene chloride;|1,1-DCE",,,,,
C14040,1-Nitronaphthalene,,,,,
C14042,Sodium iodide,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9632  Halogen compounds and preparations|C14042  Sodium iodide|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D04874)]|Chemicals|D04874  Sodium iodide,
C14043,ML-236C,,,,,
C14044,"C25-Allenic-apo-aldehyde;|(3S,5R,6R)-3,5-Dihydroxy-6,7-didehydro-5,6-dihydro-12'-apo-beta-caroten-12'-al",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C14044  C25-Allenic-apo-aldehyde,
C14045,"C25-Epoxy-apo-aldehyde;|(3S,5R,6S)-5,6-Epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C14045  C25-Epoxy-apo-aldehyde,
C14049,"Glycyrrhizinate dipotassium;|Dipotassium glycyrrhizate;|Dipotassium (3beta,20beta)-20-carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-beta-D-gucopyranuronosyl-alpha-D-glucopyranosiduronate",,,,"Classification of Japanese OTC drugs [BR:br08313(D02264)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D02264  Dipotassium glycyrrhizinate (JAN)|Agents for ophthalmologic use|62 General eye drops|D02264  Dipotassium glycyrrhizinate (JAN)|67 Eyewash|D02264  Dipotassium glycyrrhizinate (JAN)|Agents for otolaryngologic use|69 Oral medicine for nasal inflammation|D02264  Dipotassium glycyrrhizinate (JAN)|Agents for dental and stomatological use|73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)|D02264  Dipotassium glycyrrhizinate (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D02264)]|Third-class OTC drugs|Inorganic and organic chemicals|Glycyrrhizin|D02264  Dipotassium glycyrrhizinate (JAN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C14049  Glycyrrhizinate dipotassium|Drug groups [BR:br08330(D02264)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|D02264  Dipotassium glycyrrhizinate|Target-based classification of drugs [BR:br08310(D02264)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HSD11B1|D02264  Dipotassium glycyrrhizinate (JAN)",
C14053,"9,10-Dihydroergocornine methanesulfonate",,,,,
C14054,Dihydro-beta-ergocryptine mesylate,,,,,
C14055,Dihydroergotoxine mesylate;|Dihydroergotoxine mesilate;|Ergoloid mesylates,Dihydroergocornine (R = CH(CH3)2) [CPD:C14053]|Dihydroergocristine (R = CH2C6H5) [CPD:C13168]|Dihydro-alpha-ergocryptine (R = CH2CH(CH3)2) [CPD:C13167]|Dihydro-beta-ergocryptine (R = CH(CH3)CH2CH3) [CPD:C14054],,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02268)]|C CARDIOVASCULAR SYSTEM|C04 PERIPHERAL VASODILATORS|C04A PERIPHERAL VASODILATORS|C04AE Ergot alkaloids|C04AE01 Ergoloid mesylates|D02268  Ergoloid mesylates (USP)|USP drug classification [BR:br08302(D02268)]|Antidementia Agents|Antidementia Agents, Other|Ergoloid Mesylates|D02268  Ergoloid mesylates (USP)|Drug groups [BR:br08330(D02268)]|Neuropsychiatric agent|DG01964  Ergot alkaloid|DG01963  Vasodilator, ergot alkaloid|DG01977  Dihydroergotoxine|D02268  Ergoloid mesylates|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG01977  Dihydroergotoxine|D02268  Ergoloid mesylates|Target-based classification of drugs [BR:br08310(D02268)]|G Protein-coupled receptors|Rhodopsin family|Adrenaline|ADRA1|D02268  Ergoloid mesylates (USP)|ADRA2|D02268  Ergoloid mesylates (USP)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02268)]|Chemicals|D02268  Dihydroergotoxine mesilate|Drug metabolizing enzymes and transporters [br08309.html(D02268)]|Drug metabolizing enzymes|D02268",
C14056,Leucomycin A1,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14056  Leucomycin A1,
C14057,Leucomycin A4,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14057  Leucomycin A4,
C14058,Leucomycin A5,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14058  Leucomycin A5,
C14059,Leucomycin A6,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14059  Leucomycin A6,
C14060,Leucomycin A7,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14060  Leucomycin A7,
C14061,Leucomycin A8,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14061  Leucomycin A8,
C14062,Leucomycin A9,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14062  Leucomycin A9,
C14063,Leucomycin A13,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14063  Leucomycin A13,
C14064,Kitasamycin;|Leucomycin,"Generic compound|Leucomycin A1 (R1 = H, R2 = COCH2CH(CH3)2) [CPD:C14056]|Leucomycin A3 (R1 = COCH3, R2 = COCH2CH(CH3)2) [CPD:C12662]|Leucomycin A4 (R1 = COCH3, R2 = CO(CH2)2CH3) [CPD:C14057]|Leucomycin A5 (R1 = H, R2 = CO(CH2)2CH3) [CPD:C14058]|Leucomycin A6 (R1 = COCH3, R2 = COCH2CH3) [CPD:C14059]|Leucomycin A7 (R1 = H, R2 = COCH2CH3) [CPD:C14060]|Leucomycin A8 (R1 = COCH3, R2 = COCH3) [CPD:C14061]|Leucomycin A9 (R1 = H, R2 = COCH3) [CPD:C14062]|Leucomycin A13 (R1 = H, R2 = CO(CH2)4CH3) [CPD:C14063]|Leucomycin V (R1 = H, R2 = H) [CPD:C13103]",,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14064  Leucomycin|Drug groups [BR:br08330(D02269)]|Antibacterial|DG01551  Macrolide antibiotic|DG01876  16-Membered ring macrolide antibiotic|DG01203  Kitasamycin|D02269  Kitasamycin|Antimicrobials [BR:br08307(D02269)]|Antibacterials|Protein biosynthesis inhibitor|Macrolide|D02269  Kitasamycin (JP18/USAN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02269)]|Chemicals|D02269  Kitasamycin,
C14077,"Phthalocyanine;|29H,31H-Phthalocyanine;|Pigment blue 16",,,,,
C14078,Congo red;|Direct red 28;|Sodium diphenyldiazo-bis-alpha-naphthylaminesulfonate,,,,,
C14079,(-)-Catechin,,,,Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3-ols|C14079  (-)-Catechin,
C14081,CBS 113A,,,,,
C14082,1-Methylnaphthalene;|alpha-Methylnaphthalene,,,,,
C14083,"cis-1,2-Dihydroxy-1,2-dihydro-8-methylnaphthalene",,,,,
C14084,"1,2-Dihydroxy-8-methylnaphthalene",,,,,
C14085,2-Hydroxy-8-methylchromene-2-carboxylate,,,,,
C14086,2-Hydroxy-3-methylbenzalpyruvate,,,,,
C14087,3-Methylsalicylaldehyde;|2-Hydroxy-3-methylbenzaldehyde,,,,,
C14088,3-Methylsalicylate,,,,,
C14089,1-Hydroxymethylnaphthalene;|1-Naphthalenemethanol,,,,,
C14090,1-Naphthaldehyde;|1-Formylnaphthalene,,,,,
C14091,1-Naphthoic acid;|1-Carboxynaphthalene;|alpha-Naphthoic acid,,,,,
C14092,"cis-1,2-Dihydroxy-1,2-dihydro-8-carboxynaphthalene",,,,,
C14093,"1,2-Dihydroxy-8-carboxynaphthalene;|7,8-Dihydroxy-1-naphthalenecarboxylic acid",,,,,
C14094,2-Carboxy-2-hydroxy-8-carboxychromene,,,,,
C14095,2-Hydroxy-3-carboxybenzalpyruvate;|3-(3-Carboxy-3-oxo-1-propenyl)-2-hydroxy-benzoic acid,,,,,
C14096,3-Formylsalicylic acid;|2-Hydroxyisophthalaldehydic acid,,,,,
C14097,"2-Hydroxyisophthalic acid;|2-Hydroxy-1,3-benzenedicarboxylic acid",,,,,
C14098,2-Methylnaphthalene;|beta-Methylnaphthalene,,,,,
C14099,2-Naphthaldehyde;|2-Naphthalenecarboxaldehyde,,,,,
C14100,4-Formylsalicylic acid;|4-Formyl-2-hydroxybenzoic acid,,,,,
C14101,2-Naphthoic acid;|2-Naphthalenecarboxylic acid;|beta-Naphthoic acid,,,,,
C14102,"cis-1,2-Dihydroxy-1,2-dihydro-7-methylnaphthalene",,,,,
C14103,4-Methylsalicylate;|m-Cresotic acid;|2-Hydroxy-4-methylbenzoic acid,,,,,
C14104,"cis-1,2-Dihydroxy-1,2-dihydro-7-hydroxymethylnaphthalene",,,,,
C14105,"1,2-Dihydroxy-7-hydroxymethylnaphthalene",,,,,
C14106,2-Hydroxy-7-hydroxymethylchromene-2-carboxylate,,,,,
C14107,2-Hydroxy-4-hydroxymethylbenzalpyruvate,,,,,
C14108,4-Hydroxymethylsalicylaldehyde;|2-Hydroxy-4-hydroxymethyl-benzaldehyde,,,,,
C14109,4-Hydroxymethylsalicylate;|2-Hydroxy-4-hydroxymethylbenzoic acid,,,,,
C14110,"4-Hydroxymethylcatechol;|3,4-Dihydroxybenzyl alcohol",,,,,
C14111,"5,6,7,8-Tetrahydro-2-naphthoic acid",,,,,
C14112,cis-2-Carboxycyclohexyl-acetic acid,,,,,
C14113,Decahydro-2-naphthoic acid;|Decahydro-2-naphthalenecarboxylic acid,,,,,
C14114,"Tetralin;|1,2,3,4-Tetrahydronaphthalene",,,,,
C14115,2-Naphtylmethylsuccinic acid;|Naphthyl-2-methyl-succinic acid,,,,,
C14116,Naphthyl-2-methyl-succinyl-CoA,,,,,
C14117,Naphthyl-2-methylene-succinyl-CoA,,,,,
C14118,Naphthyl-2-hydroxymethyl-succinyl CoA,,,,,
C14119,Naphthyl-2-oxomethyl-succinyl-CoA,,,,,
C14120,2-Naphthoyl-CoA,,,,,
C14123,BMS-268770,,,,,
C14125,UR-12947,,,,,
C14126,Ro 61-8048,,,,,
C14127,Acotiamide;|MZ-338,,,,,
C14128,CGH 2466,,,,,
C14130,2-tert-Butylphenol,3-tert-Butylphenol [CPD:C14188]|4-tert-Butylphenol [CPD:C14200],,,,
C14131,Equol;|(S)-Equol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C14131  Equol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C14131  Equol|Dietary phytochemicals [br08012.html]|Flavonoids|C14131,
C14132,4-Octylphenol;|4-n-Octylphenol;|p-Octylphenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14132  4-Octylphenol|Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Alkylphenols|C14132  4-Octylphenol,
C14133,"2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene;|1,1-Dichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethylene;|2,4'-DDE;|o,p'-DDE",,,,,
C14134,Triphenylethylene,,,,,
C14135,"4,4'-Methylenebis(N,N-dimethylaniline);|Michler's base",,,,,
C14136,"1,1,1-Trichloro-2,2-bis(4-hydroxyphenyl)ethane;|HPTE;|p,p'-Hydroxy-DDT",,,,,
C14137,6-Hydroxyflavone;|6-Hydroxy-2-phenyl-4-benzopyrone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14137  6-Hydroxyflavone,
C14138,2-sec-Butylphenol;|2-(1-Methylpropyl)phenol,,,,,
C14139,4-sec-Butylphenol;|4-(1-Methylpropyl)phenol;|1-Hydroxy-4-sec-butylbenzene,,,,,
C14142,sec-Butylbenzene;|(1-Methylpropyl)benzene;|2-Phenylbutane,,,,,
C14143,Adipyl-CoA;|5-Carboxypentanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C14143  Adipyl-CoA,
C14144,"5-Carboxy-2-pentenoyl-CoA;|2,3-Didehydroadipyl-CoA",,,,,
C14145,(3S)-3-Hydroxyadipyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C14145  (3S)-3-Hydroxyadipyl-CoA,
C14146,alpha-Zeacarotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C14146  alpha-Zeacarotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C14146  alpha-Zeacarotene,
C14147,"Cyromazine;|Cyclopropylmelamine;|2-Cyclopropylamino-4,6-diamino-s-triazine",,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C14147  Cyromazine|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C14147  Cyromazine,
C14148,"N-Cyclopropylammeline;|2-Hydroxy-4-amino-6-(cyclopropylamino)-1,3,5-triazine",,,,,
C14149,"N-Cyclopropylammelide;|2,4-Dihydroxy-6-(cyclopropylamino)-1,3,5-triazine",,,,,
C14150,Cyclopropylamine,,,,,
C14151,delta-Tocopherol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14151  delta-Tocopherol,
C14152,beta-Tocopherol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14152  beta-Tocopherol,
C14153,alpha-Tocotrienol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14153  alpha-Tocotrienol,
C14154,beta-Tocotrienol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14154  beta-Tocotrienol,
C14155,gamma-Tocotrienol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14155  gamma-Tocotrienol,
C14156,delta-Tocotrienol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0202 Vitamin E|C14156  delta-Tocotrienol,
C14157,Stylisterol A,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C14157  Stylisterol A,
C14158,Stylisterol B,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C14158  Stylisterol B,
C14159,Stylisterol C,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C14159  Stylisterol C,
C14160,Hatomasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C14160  Hatomasterol,
C14161,Gibberellin A37,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C14161  Gibberellin A37|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C14161  Gibberellin A37,
C14162,Gibberellin A15,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C14162  Gibberellin A15|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Gibberellins|C14162  Gibberellin A15,
C14163,Phenyl salicylate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX12 Phenyl salicylate|C14163  Phenyl salicylate|Risk category of Japanese OTC drugs [BR:br08312]|Designated second-class OTC drugs|Inorganic and organic chemicals|Phenyl salicylate|C14163  Phenyl salicylate|Second-class OTC drugs|Inorganic and organic chemicals|Phenyl salicylate|C14163  Phenyl salicylate|Third-class OTC drugs|Inorganic and organic chemicals|Phenyl salicylate (external use only)|C14163  Phenyl salicylate,
C14164,Acetrizoic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02457)]|V VARIOUS|V08 CONTRAST MEDIA|V08A X-RAY CONTRAST MEDIA, IODINATED|V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media|V08AA07 Acetrizoic acid|D02457  Acetrizoic acid",
C14165,Metrizoic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|V VARIOUS|V08 CONTRAST MEDIA|V08A X-RAY CONTRAST MEDIA, IODINATED|V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media|V08AA02 Metrizoic acid|C14165  Metrizoic acid",G01173
C14166,alpha-Eucaine,beta-Eucaine [CPD:C14167],,,,
C14167,beta-Eucaine,alpha-Eucaine [CPD:C14166],,,,
C14168,3-(Dimethylamino)propyl benzoate,,,,,
C14169,Stovaine;|Amylocaine,,,,,
C14170,p-Aminosalicylic acid methyl ester,,,,,
C14171,Orthoform;|Orthocaine,,,,,
C14172,Hexylcaine,,,,,
C14173,Piperocaine;|Metycaine,,,,,
C14174,Allocain-S,,,,,
C14175,"Diethyl phthalate;|Diethyl 1,2-benzenedicarboxylate",,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14175  Diethyl phthalate|Risk category of Japanese OTC drugs [BR:br08312(D03804)]|Third-class OTC drugs|Inorganic and organic chemicals|Diethyl phthalate|D03804  Diethyl phthalate (NF),
C14176,"Chlordane;|1,2,4,5,6,7,10,10-Octachloro-4,7,8,9-tetrahydro-4,7-methyleneindane",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C14176  Chlordane|Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C14176  Chlordane,
C14177,Lombricine;|L-Lombricine,,,,,
C14178,N-Phospholombricine;|N-Phospho-L-lombricine,,,,,
C14179,Sulfoacetate;|Sulfoacetic acid,,,,,
C14180,S-(Hydroxymethyl)glutathione,,,,,
C14181,2-Benzothiazolesulfonamide,,,,,
C14182,"1,3-Benzenedisulfonamide;|m-Benzenedisulfonamide",,,,,
C14183,Compactin diol lactone;|ML-236A,,,,,
C14184,Mirex,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C14184  Mirex|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C14184  Mirex,
C14185,Heptachlor;|Heptachlorane,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C14185  Heptachlor|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C14185  Heptachlor,
C14186,"Prometon;|2,4-Bis(isopropylamino)-6-methoxy-1,3,5-triazine",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C14186  Prometon,
C14187,"1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane;|o,p'-DDT;|2-(2-Chlorophenyl)-2-(4-chlorophenyl)-1,1,1-trichloroethane",,,,,
C14188,3-tert-Butylphenol,2-tert-Butylphenol [CPD:C14130]|4-tert-Butylphenol [CPD:C14200],,,,
C14189,"2,4,6-Trichloro-4'-biphenylol;|4-Hydroxy-2',4',6'-trichlorobiphenyl",,,,,
C14190,"2,3,4,5-Tetrachloro-4'-biphenylol;|4-Hydroxy-2',3',4'-5'-tetrachlorobiphenyl",,,,,
C14191,"2-Chloro-4,4'-biphenyldiol;|2-Chloro-(1,1'-biphenyl)-4,4'-diol",,,,,
C14192,"2,6-Dichloro-4'-biphenylol;|2',6'-Dichloro-(1,1'-biphenyl)-4-ol",,,,,
C14193,"2,5-Dichloro-4'-biphenylol;|2',5'-Dichloro-(1,1'-biphenyl)-4-ol",,,,,
C14194,"3,3',5,5'-Tetrachloro-4,4'-biphenyldiol",,,,,
C14195,4-Chloro-4'-biphenylol;|4-Chloro-4'-hydroxybiphenyl,,,,,
C14196,"2,3,5,6-Tetrachloro-4,4'-biphenyldiol",,,,,
C14197,"2,2',3,3',6,6'-Hexachloro-4-biphenylol;|4-Hydroxy-PCB 136",,,,,
C14198,"2,2'3,4',6,6'-Hexachloro-4-biphenylol",,,,,
C14199,"2,2',5,5'-Tetrachlorobiphenyl;|2,2',5,5'-TCB;|PCB 52",,,,,
C14200,4-tert-Butylphenol;|Butylphen,2-tert-Butylphenol [CPD:C14130]|3-tert-Butylphenol [CPD:C14188],,,,
C14201,"2,2',4,4',5,5'-Hexachlorobiphenyl;|PCB 153",,,,,
C14202,"2,2',4,4',6,6'-Hexachlorobiphenyl;|PCB 155",,,,,
C14203,"2,2',3,3',5,5'-Hexachloro-6-biphenylol",,,,,
C14204,Hydroxyflutamide,,,,,
C14205,"4-tert-Octylphenol;|4-t-Octylphenol;|4-(1,1,3,3-Tetramethylbutyl)phenol",,,,,
C14206,"M1;|2-(((3,5-Dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid",,,,,
C14207,"M2;|N-(3,5-Dichlorophenyl)-2-hydroxy-2-methyl-3-butenamide;|3',5'-Dichloro-2-hydroxy-2-methylbut-3-enanilide",,,,,
C14208,Promegestone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08431)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DB Pregnadien derivatives|G03DB07 Promegestone|D08431  Promegestone (INN)|Drug groups [BR:br08330(D08431)]|Hormonal agent|DG02004  Progesterone|D08431  Promegestone|DG01666  Progesterone receptor agonist|D08431  Promegestone|Target-based classification of drugs [BR:br08310(D08431)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D08431  Promegestone (INN),
C14209,4-Hydroxy-17beta-estradiol;|4-Hydroxyestradiol;|4-OH-Estradiol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C14209  4-Hydroxy-17beta-estradiol,
C14210,"4-Androstenediol;|Androst-4-ene-3beta,17beta-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C14210  4-Androstenediol|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14210  4-Androstenediol,
C14211,"Butylbenzyl phthalate;|Butyl phenylmethyl 1,2-benzenedicarboxylate",,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14211  Butylbenzyl phthalate,
C14212,Nafoxidine,,,,,
C14213,Aurin,,,,,
C14214,"Dibutyl phthalate;|Di-n-butyl phthalate;|Dibutyl 1,2-benzenedicarboxylate",,,,"Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14214  Dibutyl phthalate|Pesticides [BR:br08007]|Obsolete pesticides|Others|Insect repellents|C14214  Dibutyl phthalate|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BX Other insecticides and repellents|P03BX03 Dibutylphthalate|C14214  Dibutyl phthalate",
C14215,"2,4-Dihydroxybenzophenone",,,,,
C14216,"4,4'-Sulfonyldiphenol;|Bisphenol S;|1,1'-Sulfonylbis(4-hydroxybenzene)",,,,,
C14217,"1,6-Dimethylnaphthalene",,,,,
C14218,"Octane-1,8-diol;|1,8-Octanediol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14218  1,8-Octanediol",
C14219,2-Chlorophenol;|2-Chloro-1-hydroxybenzene,3-Chlorophenol [CPD:C14270]|4-Chlorophenol [CPD:C02124],,,,
C14220,"4,4'-Dihydroxybenzophenone",,,,,
C14221,6-Hydroxyflavanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14221  6-Hydroxyflavanone,
C14222,"Chrysene;|1,2-Benzophenanthrene;|Benz[a]phenanthrene",,,,,
C14223,Phenolphthalin,,,,,
C14224,4-Hydroxybiphenyl;|4-Phenylphenol,,,,,
C14225,"Bisphenol B;|4,4'-Dihydroxy-2,2-diphenylbutane;|2,2-Bis(4-hydroxyphenyl)butane",,,,,
C14226,p-tert-Amylphenol;|4-t-Amylphenol;|4-tert-Pentylphenol,,,,,
C14227,"Di-n-octyl phthalate;|Bis(n-octyl) phthalate;|Dioctyl 1,2-benzenedicarboxylate",,,,,
C14228,Parathion-methyl;|Methyl parathion;|Methylparathion,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14228  Parathion-methyl,
C14229,"Propanil;|DCPA;|N-(3,4-Dichlorophenyl)propanamide",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C14229  Propanil,
C14230,4-Hydroxybenzophenone;|(4-Hydroxyphenyl)phenylmethanone,,,,,
C14231,4-Hydroxychalcone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C14231  4-Hydroxychalcone,
C14232,4'-Hydroxychalcone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C14232  4'-Hydroxychalcone,
C14233,"4,4'-Dihydroxystilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14233  4,4'-Dihydroxystilbene",
C14234,"Dimethylstilbestrol;|(E)-4,4'-(1,2-Dimethyl-1,2-ethenediyl)bisphenol",,,,,
C14235,Triphenyl phosphate,,,,,
C14236,4-Heptyloxyphenol;|p-n-Heptyloxyphenol,,,,,
C14237,"4-[2,2-Dichloro-1-(4-methoxyphenyl)ethenyl]phenol;|Monohydroxymethoxychlor olefin",,,,,
C14238,"1,1-Dichloro-2,2-bis(4-hydroxyphenyl)ethylene;|Dihydroxymethoxychlor olefin;|4,4'-(Dichloroethenylidene)bis[phenol]",,,,,
C14239,3-Deoxyestradiol;|3-Deoxy-17beta-estradiol,,,,,
C14240,Di(2-ethylhexyl) adipate;|Dioctyl adipate;|Diethylhexyl adipate,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14240  Diethylhexyl adipate,
C14241,"4'-Hydroxyflavanone;|2,3-Dihydro-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14241  4'-Hydroxyflavanone,
C14242,Mytatrienediol;|17-alpha-Methylestriol 3-methyl ether;|16beta-Hydroxy-16-methyl-3-methylether-17beta-estradiol,,,,,
C14243,"3,3'-Dihydroxyhexestrol;|4,4'-(1,2-Diethylethylene)dipyrocatechol",,,,,
C14244,4-(Benzyloxyl)phenol;|Monobenzone;|4-(Phenylmethoxy)phenol,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05072)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AX Other dermatologicals|D11AX13 Monobenzone|D05072  Monobenzone (USP/INN),
C14245,4-Dodecylphenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14245  4-Dodecylphenol,
C14246,"2,4'-Dichlorobiphenyl;|PCB 8",,,,,
C14247,"2,2',4,4'-Tetrachlorobiphenyl;|PCB 47",,,,,
C14248,"4,4'-Dichlorobiphenyl;|PCB 15",,,,,
C14249,Norethynodrel,,,,Target-based classification of drugs [BR:br08310(D05207)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D05207  Norethynodrel (USAN),
C14250,"p,p'-Methoxychlor olefin;|1,1-Dichloro-2,2-bis(p-methoxyphenyl)ethylene;|1,1-Bis(p-methoxyphenyl)-2,2-dichloroethylene",,,,,
C14251,"1,3-Diphenyltetramethyldisiloxane;|1,1,3,3-Tetramethyl-1,3-diphenyldisiloxane",,,,,
C14252,"1,3-Dibenzyltetramethyldisiloxane",,,,,
C14253,Dibutyl adipate;|Di-n-butyl adipate,,,,,
C14254,5alpha-Androstan-17beta-ol;|Androstan-17-ol,,,,,
C14255,"Mibolerone;|17-beta-Hydroxy-7-alpha,17-dimethylestr-4-en-3-one",,,,Drug groups [BR:br08330(D05025)]|Hormonal agent|DG01590  Androgen receptor agonist|D05025  Mibolerone|Target-based classification of drugs [BR:br08310(D05025)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D05025  Mibolerone (USP/INN),
C14256,"11-Ketotestosterone;|17beta-Hydroxyandrost-4-ene-3,11-dione",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14256  11-Ketotestosterone,
C14257,"Methyltrienolone;|Metribolone;|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one",,,,,
C14258,4-Cumylphenol;|p-Cumylphenol;|2-Phenyl-2-(4-hydroxyphenyl)propane,,,,,
C14259,Stanolone benzoate;|Dihydrotestosterone benzoate;|DHT benzoate,,,,,
C14260,Diisobutyl adipate,,,,,
C14261,"Trenbolone;|17-beta-Hydroxyestra-4,9,11-trien-3-one",,,,Drug groups [BR:br08330(D08627)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG01631  Trenbolone|D08627  Trenbolone|Target-based classification of drugs [BR:br08310(D08627)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08627  Trenbolone (INN),
C14262,p-Lactophenetide;|4'-Ethoxylactanilide;|Lactylphenetidin,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Lactylphenetidine|C14262  p-Lactophenetide; Lactylphenetidin,
C14263,"N-Benzylphthalimide;|2-Benzylisoindole-1,3-dione",,,,,
C14264,"2-(4-Hydroxybenzyl)isoindole-1,3-dione",,,,,
C14265,"N-(p-Nitrobenzyl)phthalimide;|2-(4-Nitrobenzyl)isoindole-1,3-dione",,,,,
C14266,p-Chloroacetoacetanilide;|4'-Chloroacetoacetanilide,,,,,
C14267,"Anthrafravic acid;|Anthraflavin;|2,6-Dihydroxyanthraquinone",,,,,
C14268,"Fenpiclonil;|3-(2,3-Dichlorophenyl)-4-cyanopyrrole",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C14268  Fenpiclonil,
C14269,"5alpha-Androstane-3,11,17-trione",,,,,
C14270,3-Chlorophenol,2-Chlorophenol [CPD:C14219]|4-Chlorophenol [CPD:C02124],,,,
C14271,"Ethohexadiol;|2-Ethyl-1,3-hexanediol",,,,"Pesticides [BR:br08007]|Obsolete pesticides|Others|Insect repellents|C14271  Ethohexadiol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BX Other insecticides and repellents|P03BX06 Etohexadiol|C14271  Ethohexadiol",
C14272,1-Octen-3-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14272  1-Octen-3-ol,
C14273,"1,2-Octanediol;|1,2-Dihydroxyoctane",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14273  1,2-Octanediol",
C14274,4-Heptyloxybenzoic acid,,,,,
C14275,Furan,,,,,
C14276,"4-(3,5-Diphenylcyclohexyl)phenol",,,,,
C14277,"3,4-Diphenyltetrahydrofuran",,,,,
C14278,"1,1,2-Triphenylpropane",,,,,
C14279,Furfural;|2-Furaldehyde,,,,,
C14280,Furfural diethyl acetal,,,,,
C14281,5-Nitrofurfural;|5-Nitro-2-furfural;|5-Nitro-2-furaldehyde,,,,,
C14282,2-Furylmercury chloride,,,,,
C14283,"2,2'-Dihydroxy-4-methoxybenzophenone;|Dioxybenzone",,,,,
C14284,"2,2'-Dihydroxybenzophenone",,,,,
C14285,2-Hydroxy-4-methoxybenzophenone;|Oxybenzone,,,,,
C14286,"Phenolphthalein;|3,3-Bis(4-hydroxyphenyl)phthalide",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05456)]|A ALIMENTARY TRACT AND METABOLISM|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AB Contact laxatives|A06AB04 Phenolphthalein|D05456  Phenolphthalein (INN)|Drug groups [BR:br08330(D05456)]|Gastrointestinal agent|DG01770  Laxative|DG00070  Phenolphthalein|D05456  Phenolphthalein,
C14287,"4,4'-Methylenebis(2,6-di-tert-butylphenol)",,,,,
C14288,"4,4'-Methylenedianiline;|4,4'-Diaminodiphenylmethane",,,,,
C14289,Dibenzo-18-crown-6,,,,,
C14290,7-Hydroxyflavanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14290  7-Hydroxyflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C14290  7-Hydroxyflavanone,
C14291,"Carbofuran;|2,2-Dimethyl-2,3-dihydro-7-benzofuranyl N-methylcarbamate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C14291  Carbofuran,
C14292,"Dichlorophen;|2,2'-Methylenebis(4-chlorophenol)",,,,"Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C14292  Dichlorophen|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02D ANTICESTODALS|P02DX Other anticestodals|P02DX02 Dichlorophen|C14292  Dichlorophen|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C14292  Dichlorophen",
C14293,5-Nitro-2-furfuryl methyl ether;|NF 45,,,,,
C14294,"Diphenolic acid;|4,4-Bis(4-hydroxyphenyl)pentanoic acid",,,,,
C14295,Ritipenem acoxil hydrate;|Penemac;|FC/TA-891,,,,"Drug groups [BR:br08330(D09849)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01458  Carbapenem|D09849  Ritipenem acoxil hydrate|Antimicrobials [BR:br08307(D09849)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Carbapenem|D09849  Ritipenem acoxil hydrate (JAN)|Antimicrobials abbreviations [BR:br08327(D09849)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Carbapenem|D09849  Ritipenem acoxil hydrate (JAN)",
C14296,Droloxifene;|3-Hydroxytamoxifen,,,,Drug groups [BR:br08330(D03911)]|Antineoplastic|DG01585  Estrogen receptor antagonist|DG01620  Tamoxifene-type antineoplastic|DG01265  Droloxifene|D03911  Droloxifene|Hormonal agent|DG01619  Estrogen receptor antagonist/modulator|DG01265  Droloxifene|D03911  Droloxifene|Target-based classification of drugs [BR:br08310(D03911)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D03911  Droloxifene (USAN/INN),
C14297,"4,4'-Dihydroxybiphenyl;|4,4'-Biphenyldiol",,,,,
C14298,"Bis(4-hydroxyphenyl)methane;|4,4'-Dihydroxydiphenylmethane;|Bisphenol F",,,,,
C14299,Cyanazine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C14299  Cyanazine,
C14300,Di-n-pentyl phthalate;|Diamyl phthalate,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14300  Di-n-pentyl phthalate,
C14301,Dicofol;|Kelthane,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C14301  Dicofol|Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C14301  Dicofol,
C14302,"Dinoseb;|2,4-Dinitro-6-(1-methylpropyl)phenol",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Nitrophenol herbicides|C14302  Dinoseb,
C14303,"Equilenin;|3-Hydroxyestra-1,3,5(10),6,8-pentaen-17-one",,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C14303  Equilenin|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C14303  Equilenin,
C14304,"Furamizole;|5-[1-(2-Furanyl)-2-(5-nitro-2-furanyl)ethenyl]-1,3,4-oxadiazol-2-amine;|NF 161",,,,,
C14305,4-Hexyloxyphenol,,,,,
C14306,Nitrofurylacrylamide;|Z-Furan,,,,,
C14307,11beta-Chloromethylestradiol;|Org 4333,,,,,
C14308,"Methoprene;|(E,E)-1-Methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate",,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Juvenile hormone mimics|C14308  Methoprene|Classification of Japanese OTC drugs [BR:br08313(D08200)]|Agents for sanitation|82 Pesticides|D08200  Methoprene (INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C14308  Methoprene,
C14309,"5,6,7,8-Tetrahydro-2-naphthol",,,,,
C14310,"Picloram;|4-Amino-3,5,6-trichloropyridine-2-carboxylic acid",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyridine herbicides|C14310  Picloram,
C14311,4-Propylphenol,,,,,
C14312,"Propazine;|2-Chloro-4,6-bis(isopropylamino)-1,3,5-triazine",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C14312  Propazine,
C14313,"3',4',7-Trihydroxyisoflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C14313  3',4',7-Trihydroxyisoflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C14313  3',4',7-Trihydroxyisoflavone",
C14314,"4',6,7-Trihydroxyisoflavone;|6-Hydroxydaidzein",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C14314  4',6,7-Trihydroxyisoflavone",
C14315,Anthracene,,,,,
C14316,SB 218655,,,,,
C14317,"Benz[a]anthracene;|1,2-Benzanthracene",,,,,
C14318,"Benzo[ghi]perylene;|1,12-Benzoperylene",,,,,
C14319,SR 141716;|Rimonabant,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05731)]|A ALIMENTARY TRACT AND METABOLISM|A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS|A08AX Other antiobesity drugs|A08AX01 Rimonabant|D05731  Rimonabant (JAN/USAN/INN)|Drug groups [BR:br08330(D05731)]|Gastrointestinal agent|DG01705  Anoretic|DG01754  Cannabinoid receptor inverse agonist|D05731  Rimonabant|Target-based classification of drugs [BR:br08310(D05731)]|G Protein-coupled receptors|Rhodopsin family|Cannabinoid|CNR1|D05731  Rimonabant (JAN/USAN/INN)",
C14320,"Benzo[b]fluoranthene;|3,4-Benzfluoranthene",,,,,
C14321,"Benzo[k]fluoranthene;|11,12-Benzofluoranthene",,,,,
C14322,Chlorpyrifos;|Chlorpyriphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14322  Chlorpyrifos|Classification of Japanese OTC drugs [BR:br08313(D07688)]|Agents for sanitation|82 Pesticides|D07688  Chlorpyrifos (BAN),
C14323,"Butylate;|Sutan;|S-Ethyl N,N-diisobutylthiocarbamate",,,,,
C14324,Diazinon,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14324  Diazinon|Classification of Japanese OTC drugs [BR:br08313(D07856)]|Agents for sanitation|82 Pesticides|D07856  Dimpylate (INN)|Animal drugs in Japan [BR:br08331(D07856)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|D07856  Dimpylate,
C14325,"Dibenz[a,h]anthracene;|1,2:5,6-Dibenzanthracene",,,,,
C14326,Dimethoate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14326  Dimethoate,
C14327,Heptachlor epoxide,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C14327  Heptachlor epoxide,
C14328,"1,2-Dichlorobenzene;|o-Dichlorobenzene",,,,"Classification of Japanese OTC drugs [BR:br08313]|Agents for sanitation|82 Pesticides|C14328  1,2-Dichlorobenzene|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Insecticides|C14328  1,2-Dichlorobenzene|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9925  Cresols and preparations|C14328  o-Dichlorobenzene|993  Insecticides and insect-repellents|9936  Dichlorobenzene, derivatives and preparations|C14328  o-Dichlorobenzene",
C14329,"1,2-Dimethylnaphthalene",,,,,
C14330,"2,6-Dimethylnaphthalene",,,,,
C14331,4-Chloro-m-cresol;|4-Chloro-3-methylphenol;|Chlorocresol,,,,,
C14332,Metribuzin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Triazine herbicides|C14332  Metribuzin|Pesticides [BR:br08007]|Pesticides|Herbicides|Triazinone herbicides|C14332  Metribuzin,
C14333,"Propyzamide;|Pronamide;|3,5-Dichloro-N-(1,1-dimethyl-2-propynyl)benzamide",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C14333  Propyzamide,
C14334,Propoxur;|Aprocarb;|2-Isopropoxyphenyl N-methylcarbamate,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C14334  Propoxur|Classification of Japanese OTC drugs [BR:br08313(D08442)]|Agents for sanitation|82 Pesticides|D08442  Propoxur (BAN)|Risk category of Japanese OTC drugs [BR:br08312(D08442)]|Second-class OTC drugs|Not used for human|Insecticides|D08442  Propoxur (BAN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9935  Carbamate, derivatives and preparations|C14334  Propoxur",
C14335,Pyrene,,,,,
C14336,"1,2-Dibromo-3-chloropropane;|DBCP",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C14336  Dibromochloropropane,
C14337,Bioallethrin;|Allethrin;|Pynamin,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C14337  Bioallethrin|Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C14337  Bioallethrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07530)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AC Pyrethrines, incl. synthetic compounds|P03AC02 Bioallethrin|D07530  Bioallethrin (BAN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C14337  Allethrin|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C14337  Allethrin|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C14337  Allethrin",
C14338,Quintozene;|Pentachloronitrobenzene;|PCNB,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C14338  Quintozene,
C14339,"3,3'-Dimethylbisphenol A;|2,2-Bis(4-hydroxy-3-methylphenyl)propane",,,,,
C14340,4-Phenethylphenol;|4-(2-Phenylethyl)phenol,,,,,
C14341,"4,4'-Dihydroxybibenzyl;|4,4'-(1,2-Ethanediyl)bisphenol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14341  4,4'-Dihydroxybibenzyl",
C14342,3-Hydroxybiphenyl;|3-Phenylphenol,,,,,
C14343,"Trifluralin;|2,6-Dinitro-N,N-dipropyl-4-trifluoromethylaniline",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Others|C14343  Trifluralin|Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C14343  Trifluralin,
C14344,"4',6-Dihydroxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14344  4',6-Dihydroxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C14344  4',6-Dihydroxyflavone",
C14345,"Bisphenol A dimethacrylate;|2,2-Di(4-methacryloxyphenyl)propane",,,,,
C14346,"Bisphenol A bis(chloroformate);|2,2-Bis[p-(chloroformyloxy)phenyl]propane",,,,,
C14347,"Bisphenol A bis(2-hydroxyethyl)ether;|Bisphenol A ethoxylate;|2,2-Bis[4-(2-hydroxyethoxy)phenyl]propane",,,,,
C14348,"Bisphenol A diglycidyl ether;|2,2-Bis(4-glycidyloxyphenyl)propane",,,,,
C14349,"1,1-Bis(4-hydroxyphenyl)ethane;|Bisphenol E",,,,,
C14350,"2,2-Bis(4-hydroxyphenyl)hexafluoropropane;|Bisphenol AF",,,,,
C14351,4-Butoxyphenol,,,,,
C14352,6-Bromo-2-naphthol,,,,,
C14353,2-Chlorobiphenyl;|2-Monochlorobiphenyl;|PCB 1,,,,,
C14354,"2,5-Dichlorobiphenyl;|PCB 9",,,,,
C14355,"2,6-Dichlorobiphenyl;|PCB 10",,,,,
C14356,"3,5-Dichlorobiphenyl;|PCB 14",,,,,
C14357,"2,3,4-Trichlorobiphenyl;|PCB 21",,,,,
C14358,"2,3',5-Trichlorobiphenyl;|PCB 26",,,,,
C14359,"2,3,6-Trichlorobiphenyl;|PCB 24",,,,,
C14360,"2,2',4,5-Tetrachlorobiphenyl;|PCB 48",,,,,
C14361,"2,3,4,4'-Tetrachlorobiphenyl;|PCB 60",,,,,
C14362,"2,3,4,5-Tetrachlorobiphenyl;|PCB 61",,,,,
C14363,"2,3,5,6-Tetrachlorobiphenyl;|PCB 65",,,,,
C14364,"2,4,4',6-Tetrachlorobiphenyl;|PCB 75",,,,,
C14365,"2,3,3',4,5-Pentachlorobiphenyl;|PCB 106",,,,,
C14366,"2,3,4,5,6-Pentachlorobiphenyl;|PCB 116",,,,,
C14367,"2,2',3,3',5,5'-Hexachlorobiphenyl;|PCB 133",,,,,
C14368,Decachlorobiphenyl;|PCB 209,,,,,
C14369,"2,2',3,3',6,6'-Hexachlorobiphenyl;|PCB 136",,,,,
C14370,"2-Hydroxy-3,5-dichlorobiphenyl;|3,5-Dichloro-2-hydroxybiphenyl;|2,4-Dichloro-6-phenylphenol",,,,,
C14371,"4-Hydroxy-3,5-dichlorobiphenyl;|3,5-Dichloro-4-hydroxybiphenyl",,,,,
C14372,"2-Hydroxy-2',3',4',5,5'-pentachlorobiphenyl;|2',3',4',5,5'-Pentachloro-2-hydroxybiphenyl",,,,,
C14373,"4-Hydroxy-2,2',3',4',5'-pentachlorobiphenyl;|2,2',3',4',5'-Pentachloro-4-biphenylol",,,,,
C14374,"4-Hydroxy-2,2',3',4',6'-pentachlorobiphenyl;|2,2',3',4',6'-Pentachloro-4-biphenylol",,,,,
C14375,"4-Hydroxy-2,2',3',5',6'-pentachlorobiphenyl;|2,2',3',5',6'-Pentachloro-4-biphenylol",,,,,
C14376,"4-Hydroxy-2,2',4',6'-tetrachlorobiphenyl;|2,2',4',6'-Tetrachloro-4-biphenylol",,,,,
C14377,"4-Hydroxy-2',3,3',4',5'-pentachlorobiphenyl;|2',3,3',4',5'-Pentachloro-4-biphenylol;|4-Hydroxy-PCB 106",,,,,
C14378,"4-Hydroxy-2',3,3',4',6'-pentachlorobiphenyl;|2',3,3',4',6'-Pentachloro-4-biphenylol",,,,,
C14379,"4-Hydroxy-2',3,3',5',6'-pentachlorobiphenyl;|2',3,3',5',6'-Pentachloro-4-biphenylol",,,,,
C14380,"4-Hydroxy-2',3,4',6'-tetrachlorobiphenyl;|2',3,4',6'-Tetrachloro-4-biphenylol",,,,,
C14381,"4-Hydroxy-2,3,3',4',5-pentachlorobiphenyl;|2,3,3',4',5-Pentachloro-4-biphenylol",,,,,
C14382,"4-Hydroxy-2,2',3,4',5,5',6-heptachlorobiphenyl;|2,2',3,4',5,5',6-Heptachloro-4-biphenylol;|4-Hydroxy-PCB 187",,,,,
C14383,16-Ketoestradiol;|16-Oxo-17beta-estradiol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C14383  16-Ketoestradiol,
C14384,"Benzo[b]fluorene;|2,3-Benzofluorene",,,,,
C14385,2-Ethylphenol;|o-Ethylphenol,3-Ethylphenol [CPD:C14386]|4-Ethylphenol [CPD:C13637],,,,
C14386,3-Ethylphenol,2-Ethylphenol [CPD:C14385]|4-Ethylphenol [CPD:C13637],,,,
C14387,Phenothrin;|Sumithrin,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C14387  Phenothrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08357)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AC Pyrethrines, incl. synthetic compounds|P03AC03 Phenothrin|D08357  Phenothrin (INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D08357)]|6  Agents against pathologic organisms and parasites|64  Parasitics (systemic)|642  Anthelmintics|6429  Others|D08357  Phenothrin (INN)|Classification of Japanese OTC drugs [BR:br08313(D08357)]|Agents for sanitation|82 Pesticides|D08357  Phenothrin (INN)|Risk category of Japanese OTC drugs [BR:br08312(D08357)]|Second-class OTC drugs|Inorganic and organic chemicals|Phenothrin|D08357  Phenothrin (INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C14387  Phenothrin",
C14388,Permethrin,,,,"Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Pyrethroid pesticides|C14388  Permethrin|Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C14388  Permethrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05443)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AC Pyrethrines, incl. synthetic compounds|P03AC04 Permethrin|D05443  Permethrin (USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D05443)]|Dermatological Agents|Pediculicides/Scabicides|Permethrin|D05443  Permethrin (USAN/INN)|Classification of Japanese OTC drugs [BR:br08313(D05443)]|Agents for sanitation|82 Pesticides|D05443  Permethrin (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D05443)]|Second-class OTC drugs|Not used for human|Insecticides|D05443  Permethrin (USAN/INN)|Rx-to-OTC switch list in the USA [br08315.html(D05443)]|D05443|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C14388  Permethrin",
C14389,"1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane;|Monohydroxymethoxychlor",,,,,
C14390,Heptanal;|n-Heptaldehyde,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C14390  Heptanal,
C14391,"Diethylstilbestrol dimethyl ether;|(E)-1,1'-(1,2-Diethyl-1,2-ethenediyl)bis(4-methoxybenzene)",,,,,
C14392,"Equilin;|3-Hydroxyestra-1,3,5(10),7-tetraen-17-one",,,,Compounds with biological roles [BR:br08001]|Steroids|18-Carbon atoms|Estrane derivatives|C14392  Equilin|Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C14392  Equilin|Drug groups [BR:br08330(D04041)]|Hormonal agent|DG01986  Estrogen|D04041  Equilin|DG01584  Estrogen receptor agonist|D04041  Equilin|Target-based classification of drugs [BR:br08310(D04041)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D04041  Equilin (USP),
C14393,Benzylparaben;|Benzyl parahydroxybenzoate;|Benzyl 4-hydroxybenzoate,,,,,
C14394,4-Nitrotoluene;|1-Methyl-4-nitrobenzene,,,,,
C14395,alpha-Methylstyrene;|1-Methyl-1-phenylethylene;|2-Phenylpropene,,,,,
C14396,Cumene;|Isopropylbenzene,,,,,
C14397,"Dinitrochlorobenzene;|1-Chloro-2,4-dinitrobenzene",,,,,
C14398,Ethylenethiourea;|2-Mercaptoimidazoline,,,,,
C14399,"1,3-Dichloro-2-propanol",,,,,
C14400,"1,2,3-Trichloropropane",,,,,
C14401,"2,4-Diaminotoluene",,,,,
C14402,"1,2-Diaminobenzene;|o-Phenylenediamine;|2-Phenylene diamine",m-Phenylenediamine [CPD:C02454]|p-Phenylenediamine [CPD:C19499],,,,
C14403,ortho-Toluidine;|o-Toluidine;|2-Aminotoluene,,,,,
C14404,"2,4-DB;|4-(2,4-Dichlorophenoxy)butyric acid",,,,"Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C14404  2,4-DB",
C14405,N-Phenyl-1-naphthylamine,,,,,
C14406,3-Nitrofluoranthene,,,,,
C14407,2-Chloronitrobenzene;|1-Chloro-2-nitrobenzene,,,,,
C14408,"1,2,3-Trichlorobenzene",,,,,
C14409,2-Hydroxydibenzofuran;|Dibenzofuran-2-ol,,,,,
C14410,Phenbenzamine hydrochloride,,,,,
C14411,Dicyclopentadiene,,,,,
C14412,4-Toluenesulfonamide,,,,,
C14413,Triphenyltin chloride,,,,,
C14414,2-Nitrofuran;|AI3-23606,,,,,
C14415,Thiourea,,,,,
C14416,"Trp-P-2;|3-Amino-1-methyl-5H-pyrido[4,3-b]indole",,,,,
C14417,2-Anthramine;|2-Aminoanthracene,,,,,
C14418,3-Nitrophenol;|m-Hydroxynitrobenzene,,,,,
C14419,"2,4-Dichloroaniline;|2,4-DCA",,,,,
C14420,Fenthion;|MPP;|4-Methylmercapto-3-methylphenyl dimethyl thiophosphate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14420  Fenthion|Classification of Japanese OTC drugs [BR:br08313(D07950)]|Agents for sanitation|82 Pesticides|D07950  Fenthion (BAN),
C14421,1-Nitropyrene,,,,,
C14422,N-Nitrosodiethylamine;|NDEA;|Diethylnitrosamine,,,,,
C14423,"1,8-Dinitropyrene",,,,,
C14424,"1,6-Dinitropyrene",,,,,
C14425,Fenobucarb;|2-sec-Butylphenyl N-methylcarbamate;|BPMC,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C14425  Fenobucarb|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9935  Carbamate, derivatives and preparations|C14425  2-sec-Butylphenyl N-methylcarbamate",
C14426,"Acephate;|O,S-Dimethylacetylphosphoroamidothioate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Phosphoramido insecticides|C14426  Acephate,
C14427,"Diflubenzuron;|N-(4-Chlorophenylcarbamoyl)-2,6-difluorobenzamide",,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C14427  Diflubenzuron|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C14427  Diflubenzuron,
C14428,Thiobencarb;|Benthiocarb;|S-4-Chlorobenzyl diethylthiocarbamate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C14428  Thiobencarb,
C14429,Phenthoate;|Fenthoate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14429  Phenthoate,
C14430,"Dichlorvos;|2,2-Dichloroethenyl dimethyl phosphate;|DDVP",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14430  Dichlorvos|Classification of Japanese OTC drugs [BR:br08313(D03791)]|Agents for sanitation|82 Pesticides|D03791  Dichlorvos (USAN/INN)|Risk category of Japanese OTC drugs [BR:br08312(D03791)]|First-class OTC drugs|Inorganic and organic chemicals|Dichlorvos|D03791  Dichlorvos (USAN/INN)|Second-class OTC drugs|Not used for human|Insecticides|D03791  Dichlorvos (USAN/INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|C14430  Dichlorvos|Drug groups [BR:br08330(D03791)]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|D03791  Dichlorvos,
C14431,Methidathion,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14431  Methidathion,
C14432,"Thiophanate-methyl;|1,2-Di-(3-methoxycarbonyl-2-thioureido)benzene",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C14432  Thiophanate-methyl,
C14433,"Bendiocarb;|2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C14433  Bendiocarb,
C14434,EPN;|O-Ethyl O-p-nitrophenyl phenylphosphonothioate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14434  EPN,
C14435,"Benzo[e]pyrene;|1,2-Benzpyrene",,,,,
C14436,"Edifenphos;|EDDP;|O-Ethyl-S,S-diphenyl dithiophosphate",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organophosphorus fungicides|C14436  Edifenphos,
C14437,2-Mercaptobenzothiazole;|Captax,,,,,
C14438,Captan,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C14438  Captan,
C14439,Tributyl phosphate;|TBP,,,,,
C14440,"1,4-Dioxane;|p-Dioxane",,,,,
C14441,"16-Ketoestrone;|3-Hydroxy-1,3,5(10)-estratriene-16,17-dione",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0201 C18 steroids (estrogens) and derivatives|C14441  16-Ketoestrone,
C14442,"Fenitrothion;|O,O-Dimethyl O-(3-methyl-4-nitrophenyl) phosphorothioate;|MEP",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14442  Fenitrothion|Classification of Japanese OTC drugs [BR:br08313]|Agents for sanitation|82 Pesticides|C14442  Fenitrothion|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Insecticides|C14442  Fenitrothion|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|C14442  Fenitrothion,
C14443,"3,3'-Dimethylbenzidine;|3,3'-Dimethyl-4,4'-diaminobiphenyl;|o-Tolidine",,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Vitro diagnostics listed below|------  Glucose kit (OTC)|C14443  o-Tlidine,
C14444,2-Aminoanthraquinone,,,,,
C14445,Tris(2-chloroethyl)phosphate,,,,,
C14446,Tris(butoxyethyl)phosphate;|Tris(2-butoxyethyl) phosphate,,,,,
C14447,2-Methylpyridine;|2-Picoline,,,,,
C14448,"Glyoxal;|Oxalaldehyde;|1,2-Ethanedione",,,,,
C14449,"Epichlorohydrin;|1-Chloro-2,3-epoxypropane",,,,,
C14450,4-Chloroaniline;|1-Amino-4-chlorobenzene,,,,,
C14451,4-Chlorotoluene,,,,,
C14452,"Morpholine;|Tetrahydro-1,4-oxazine",,,,,
C14453,4-Bromophenol,,,,,
C14454,"2,4,6-Tribromophenol",,,,,
C14455,N-Ethylaniline;|N-Ethylbenzenamine,,,,,
C14456,4-Chloronitrobenzene;|1-Chloro-4-nitrobenzene,,,,,
C14457,"Simetryn;|2,4-Di(ethylamino)-6-methylthio-1,3,5-triazine",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C14457  Simetryn,
C14458,"Dihydrogenistein;|4',5,7-Trihydroxyisoflavan-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C14458  Dihydrogenistein,
C14459,2-Hydroxybenzo[a]pyrene,,,,,
C14460,2-Hydroxyfluorene;|Fluoren-2-ol,,,,,
C14461,3-Hydroxybenzo[a]pyrene,,,,,
C14462,"3,4-Dichlorophenol",,,,,
C14463,(R)-3-Hydroxy-3-methyl-2-oxopentanoate;|(R)-3-Hydroxy-3-methyl-2-oxopentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C14463  (R)-3-Hydroxy-3-methyl-2-oxopentanoic acid,
C14464,4-Butylphenol;|4-n-Butylphenol;|p-Hydroxybutylbenzene,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14464  4-Butylphenol,
C14465,4-Hexylphenol;|4-n-Hexylphenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14465  4-Hexylphenol,
C14466,4-Pentylphenol;|4-n-Pentylphenol;|p-Amylphenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14466  4-Pentylphenol,
C14467,"cis-1,2-Diphenylcyclobutane",,,,,
C14468,Diisopropyl phthalate,,,,,
C14469,Di-n-propylphthalate;|Dipropyl phthalate,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14469  Di-n-propylphthalate,
C14470,3-Methylcholanthrene,,,,,
C14471,"4-Hydroxy-2,2',4',5,5'-pentachlorobiphenyl;|2,2',4',5,5'-Pentachloro-4-biphenylol",,,,,
C14472,"4',5,6,7-Tetramethoxyflavone;|Tetra-O-methylscutellarein",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14472  4',5,6,7-Tetramethoxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C14472  4',5,6,7-Tetramethoxyflavone",
C14473,1(2H)-Phthalazinone;|Phthalazin-1-one;|Phthalazone,,,,,
C14474,Benzarone;|2-Ethyl-3-(4-hydroxybenzoyl)benzofuran,,,,,
C14475,"Bolasterone;|7alpha,17alpha-Dimethyltestosterone;|17beta-Hydroxy-7alpha,17-dimethylandrost-4-en-3-one;|U19763",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14475  Bolasterone|Drug groups [BR:br08330(D03144)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|D03144  Bolasterone|Target-based classification of drugs [BR:br08310(D03144)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D03144  Bolasterone (USAN/INN),
C14476,"Xanthomicrol;|4',5-Dihydroxy-6,7,8-trimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14476  Xanthomicrol,
C14477,"3,3-Difluoro-5alpha-androstan-17beta-yl acetate;|3,3-Difluoroandrostane-17-ol acetate",,,,,
C14478,"21-Deoxycortisone;|17alpha-Hydroxypregn-4-ene-3,11,20-trione",,,,,
C14479,"Flumethasone;|6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04208)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB03 Flumetasone|D04208  Flumethasone (USAN)|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB01 Flumetasone|D04208  Flumethasone (USAN)|Drug groups [BR:br08330(D04208)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00412  Flumetasone|D04208  Flumethasone|Target-based classification of drugs [BR:br08310(D04208)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D04208  Flumethasone (USAN)",
C14480,"5-Diazouracil;|2,6-Dioxo-5-diazopyrimidine",,,,,
C14481,1-Hydroxy-2-acetamidofluorene;|1-Hydroxy-N-2-fluorenylacetamide;|N-(1-Hydroxyfluoren-2-yl)-acetamide,,,,,
C14482,3beta-Hydroxypregn-5-ene;|5-Pregnen-3beta-ol,,,,,
C14483,17alpha-Methylestradiol,,,,,
C14484,9-Fluoroprednisolone;|Isoflupredone,,,,,
C14485,17beta-Dihydroequilin,,,,,
C14486,Norethindrone enanthate;|Norethisterone enanthate;|17alpha-Ethynyl-17beta-heptanoyloxy-4-estren-3-one,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08285)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE|G03AC Progestogens|G03AC01 Norethisterone|D08285  Norethisterone enantate|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC02 Norethisterone|D08285  Norethisterone enantate|Drug groups [BR:br08330(D08285)]|Hormonal agent|DG02004  Progesterone|DG00456  Norethisterone|D08285  Norethisterone enantate|DG01666  Progesterone receptor agonist|DG00456  Norethisterone|D08285  Norethisterone enantate|Target-based classification of drugs [BR:br08310(D08285)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C3 (PGR)|D08285  Norethisterone enantate,
C14487,Ethisterone;|17alpha-Ethinyl testosterone;|Progestolets;|17alpha-Ethynyl-17beta-hydroxyandrost-4-en-3-one,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC04 Ethisterone|C14487  Ethisterone,
C14488,"21-Fluoroprogesterone;|21-Fluoropregn-4-ene-3,20-dione",,,,,
C14489,"19-Norprogesterone;|19-Norpregn-4-ene-3,20-dione",,,,,
C14490,Stenbolone;|17beta-Hydroxy-2-methyl-5alpha-androst-1-en-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14490  Stenbolone,
C14491,Normethandrolone;|Methylestrenolone;|17alpha-Methyl-19-nortestosterone;|Normethandrone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03D PROGESTOGENS|G03DC Estren derivatives|G03DC31 Methylestrenolone|C14491  Normethandrolone,
C14492,Ulifloxacin;|NM 394,,,,Prodrugs [br08324.html]|C14492,
C14493,"Methandriol;|Protandren;|17alpha-Methylandrost-5-ene-3beta,17beta-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14493  Methandriol|Drug groups [BR:br08330(D08196)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG01276  Methandriol|D08196  Methandriol|Target-based classification of drugs [BR:br08310(D08196)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08196  Methandriol (INN),
C14494,4-Chloroacetanilide,,,,,
C14495,Eburicoic acid,,,,,
C14496,"Estrololactone;|3-Hydroxy-D-homo-17a-oxaestra-1,3,5(10)-trien-17-one",,,,,
C14497,"6beta-Hydroxytestosterone;|6beta,17beta-Dihydroxyandrost-4-en-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14497  6beta-Hydroxytestosterone,
C14498,17alpha-Dihydroequilenin,,,,,
C14499,"1,2-Epoxyhexadecane",,,,,
C14500,"19-Norandrostenedione;|Delta4-Estrene-3,17-dione",,,,,
C14501,"N,N'-Diphenyl-p-phenylenediamine;|DPPD",,,,,
C14502,"Boldenone;|17beta-Boldenone;|17beta-Hydroxyandrost-1,4-diene-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14502  Boldenone|Drug groups [BR:br08330(D07536)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG01275  Boldenone|D07536  Boldenone|Target-based classification of drugs [BR:br08310(D07536)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D07536  Boldenone (INN),
C14503,"16-Dehydropregnenolone acetate;|3beta-Acetyloxy-pregna-5,16-dien-20-one",,,,,
C14504,"Di-n-hexyl phthalate;|Dihexyl 1,2-benzenedicarboxylate;|Dihexyl phthalate",,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14504  Di-n-hexyl phthalate,
C14505,"Di-n-decyl phthalate;|Didecyl phthalate;|Didecyl 1,2-benzenedicarboxylate",,,,,
C14506,Chlorpropham;|Chloropropham;|N-3-Chlorophenylisopropylcarbamate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Carbanilate herbicides|C14506  Chlorpropham,
C14507,Diphenyl carbonate,,,,,
C14508,"Mesitylene;|1,3,5-Trimethylbenzene",,,,,
C14509,1-Tridecanol;|Tridecyl alcohol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14509  1-Tridecanol,
C14510,Fensulfothion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C14510  Fensulfothion,
C14511,"Bisphenol A glycidylmethacrylate;|Bis-GMA;|2,2-Bis[4-(2-hydroxy-3-methacryloxypropoxy)phenyl]propane;|Bisphenol A diglycidyl methacrylate",,,,,
C14512,Benzofuran,,,,,
C14513,"Tetrachlorvinphos;|2-Chloro-1-(2,4,5-trichlorophenyl)vinyl dimethyl phosphate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14513  Tetrachlorvinphos|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|C14513  Tetrachlorvinphos,
C14514,"Chinomethionat;|Quinomethionate;|6-Methyl-2,3-quinoxalinedithiol cyclic S,S-dithiocarbonate",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C14514  Chinomethionat,
C14515,Camphorquinone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C14515  Camphorquinone,
C14516,Kojic acid;|5-Hydroxy-2-(hydroxymethyl)-4-pyrone,,,,,
C14517,Pretilachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C14517  Pretilachlor,
C14518,"1,2,3-Trimethylbenzene;|Hemimellitene",,,,,
C14519,1-Hydroxypyrene,,,,,
C14520,Chlorpyrifos-methyl;|Chloropyriphos-methyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14520  Chlorpyrifos-methyl,
C14521,"2,4-Dibromophenol",,,,,
C14522,3-Ethyltoluene;|1-Methyl-3-ethylbenzene,,,,,
C14523,Diisopropyl adipate,,,,,
C14524,Flucythrinate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C14524  Flucythrinate,
C14525,"Mefenacet;|2-(1,3-Benzothiazol-2-yloxy)-N-methylacetanilide",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C14525  Mefenacet,
C14526,Esprocarb,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C14526  Esprocarb,
C14527,Methyl methacrylate;|MMA;|Methyl 2-methylpropenoate,,,,,
C14528,"Tetrachlorobisphenol A;|3,3',5,5'-Tetrachlorobisphenol A;|Tetrachlorodian;|2,2-Bis(4-hydroxy-3,5-dichlorophenyl)propane",,,,,
C14529,Dicyclohexyl phthalate,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Phthalates|C14529  Dicyclohexyl phthalate,
C14530,2-Hydroxyethyl methacrylate;|HEMA,,,,,
C14531,Azomycin;|2-Nitroimidazole,,,,,
C14532,"Fenoprop;|2-(2,4,5-Trichlorophenoxy)propionic acid;|2,4,5-TP;|Silvex",,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Auxins|C14532  Fenoprop,
C14533,"1,2,4-Trimethylbenzene;|Pseudocumene",,,,,
C14534,"1,2,4,5-Tetramethylbenzene;|Durene",,,,,
C14535,4-t-Butylbenzoic acid;|p-tert-Butylbenzoic acid,,,,,
C14536,"Glycitein;|7,4'-Dihydroxy-6-methoxyisoflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C14536  Glycitein|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C14536  Glycitein|Dietary phytochemicals [br08012.html]|Flavonoids|C14536,
C14537,"Trimethylolpropane triacrylate;|2-Ethyl-2-(hydroxymethyl)-1,3-propanediol triacrylate;|TMPTA",,,,,
C14538,"Trimethylolpropane trimethacrylate;|2-Ethyl-2(hydroxymethyl)-1,3-propanediol trimethacrylate;|TMPT",,,,,
C14539,Krm 1657,,,,,
C14540,Rifamycin S,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14540  Rifamycin S,
C14541,(R)-4'-Deoxyindenestrol,,,,,
C14542,(S)-4'-Deoxyindenestrol,,,,,
C14543,(R)-5-Deoxyindenestrol,,,,,
C14544,(S)-5-Deoxyindenestrol,,,,,
C14545,(S)-Indenestrol A,,,,,
C14546,(R)-Indenestrol A,,,,,
C14547,(S)-Indenestrol B,,,,,
C14548,(R)-Indenestrol B,,,,,
C14549,Triphenylsilanol;|Triphenylhydroxysilane,,,,,
C14550,4-Nonylphenol;|4-n-Nonylphenol;|p-Nonylphenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14550  4-Nonylphenol,
C14551,Diethylstilbestrol monomethyl ether;|Mestilbol,,,,,
C14552,"11-Ketoetiocholanolone;|3alpha-Hydroxy-5beta-androstane-11,17-dione",,,,,
C14553,"3alpha,11beta-Dihydroxy-5beta-androstane-17-one;|11beta-Hydroxyetiocholanolone",,,,,
C14554,"Deoxycorticosterone acetate;|21-Acetoxypregn-4-ene-3,20-dione;|Percotol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03698)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AA Mineralocorticoids|H02AA03 Desoxycortone|D03698  Desoxycorticosterone acetate (USP)|Target-based classification of drugs [BR:br08310(D03698)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C2 (MR)|D03698  Desoxycorticosterone acetate (USP)",
C14555,"11alpha,17beta-Dihydroxy-17-methylandrost-4-en-3-one;|11alpha-Hydroxy-17alpha-methyltestosterone",,,,,
C14556,9-Hydroxybenzo[a]pyrene,,,,,
C14557,8-Hydroxybenzo[a]pyrene,,,,,
C14558,7-Hydroxybenzo[a]pyrene,,,,,
C14559,5-Hydroxybenzo[a]pyrene,,,,,
C14560,4-Hydroxybenzo[a]pyrene,,,,,
C14561,"2,4,6-Triphenyl-1-hexene",,,,,
C14562,"2,4-Diphenyl-1-butene",,,,,
C14563,12-Hydroxybenzo[a]pyrene,,,,,
C14564,11-Hydroxybenzo[a]pyrene,,,,,
C14565,10-Hydroxybenzo[a]pyrene,,,,,
C14566,Diethyl adipate;|Diethyl hexanedioate,,,,,
C14567,Acetyleugenol,,,,,
C14568,"Bromobutide;|Sumiherb;|2-Bromo-3,3-dimethyl-N-(1-methyl-1-phenylethyl)butanamide;|(RS)-2-Bromo-N-(alpha,alpha-dimethylbenzyl)-3,3-dimethylbutyramide",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C14568  Bromobutide,
C14569,"4,4'-Biphenyldithiol;|4,4'-Dimercaptobiphenyl;|4,4'-Thiobiphenyl",,,,,
C14570,Dimethyl adipate;|Dimethyl hexanedioate,,,,,
C14571,Dimepiperate;|S-1-Methyl-1-phenylethyl piperidine 1-carbothioate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C14571  Dimepiperate,
C14572,2-Ethyltoluene;|o-Methylethylbenzene;|1-Ethyl-2-methylbenzene,,,,,
C14573,"3,3',4,4',5-Pentachlorobiphenyl;|PCB 126",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Non-ortho (coplanar) PCBs|C14573  3,3',4,4',5-Pentachlorobiphenyl (PCB 126)",
C14574,"Chlorobenzilate;|Ethyl-4,4'-dichlorobenzilate;|Ethyl 2-hydroxy-2,2-bis(4-chlorophenyl)acetate",,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C14574  Chlorobenzilate,
C14575,Di-n-heptyl phthalate,,,,,
C14576,6-Hydroxybenzo[a]pyrene,,,,,
C14577,Diisooctyl phthalate,,,,,
C14578,Diisodecyl phthalate,,,,,
C14579,"Xylylcarb;|3,4-Dimethylphenyl methylcarbamate;|Meobal;|MPMC",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C14579  Xylylcarb,
C14580,Isoxathion;|Karphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C14580  Isoxathion,
C14581,"1,3-Diphenylpropane",,,,,
C14582,"2,4-Dimethylphenol;|2,4-Xylenol;|1-Hydroxy-2,4-dimethylbenzene",,,,,
C14583,"1,4-Diethylbenzene;|p-Diethylbenzene",,,,,
C14584,Chlorobenside;|4-Chlorobenzyl 4-chlorophenyl sulfide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C14584  Chlorobenside,
C14585,4-Chlorochalcone;|3-(4-Chlorophenyl)-1-phenyl-2-propen-1-one,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C14585  4-Chlorochalcone,
C14586,"6alpha-Methylprogesterone;|6alpha-Methylpregn-4-ene-3,20-dione",,,,,
C14587,"11alpha-Hydroxyandrosta-1,4-diene-3,17-dione",,,,,
C14588,17beta-Hydroxy-7alpha-methylandrost-4-en-3-one;|7alpha-Methyltestosterone,,,,,
C14589,"1,2-Bis(4-nitrophenyl)ethane;|4,4'-Dinitrodibenzyl",,,,,
C14590,"Estra-1,3,5(10),6-tetraen-3,17beta-diol;|6-Dehydroestradiol",,,,,
C14591,Pyridarone;|4-(2-Benzofuranyl)pyridine,,,,,
C14592,N-Methyl-N'-nitro-N-nitrosoguanidine;|1-Methyl-3-nitro-1-nitrosoguanidine;|Methylnitronitrosoguanidine;|MNNG,,,,,
C14593,"Epimestrol;|3-Methoxy-17-epiestriol;|3-Methoxyestra-1,3,5(10)-triene-16alpha,17alpha-diol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04021)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS|G03GB Ovulation stimulants, synthetic|G03GB03 Epimestrol|D04021  Epimestrol (USAN/INN)",
C14594,"3alpha,17alpha,21-Trihydroxy-5beta-pregnan-20-one;|Tetrahydro-11-deoxycortisol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C14594  3alpha,17alpha,21-Trihydroxy-5beta-pregnan-20-one",
C14595,Methylnitrosourea;|N-Methyl-N-nitrosourea;|NMH,,,,,
C14596,Ethamoxytriphetol;|4-Methoxy-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol,,,,,
C14597,"2,3-Bis(p-methoxyphenyl)acrylonitrile;|2,3-Di(4-methoxyphenyl)acrylonitrile",,,,,
C14598,"3alpha,17alpha-Dihydroxy-5beta-pregnane-11,20-dione;|17alpha-Hydroxy-11-ketopregnanolone",,,,,
C14599,"2,3,3-Triphenylacrylonitrile;|Triphenylcyanoethylene",,,,,
C14600,"16alpha-Hydroxytestosterone;|16alpha,17beta-Dihydroxy-4-androsten-3-one",,,,,
C14601,Methyl methoxyacetate,,,,,
C14602,3-Hydroxyaminophenol;|3-Hydroxylaminophenol,,,,,
C14603,17beta-Hydroxyestr-4-en-3-one cyclopentanepropionate;|19-Nortestosterone cyclopentylpropionate,,,,,
C14604,Aminohydroquinone,,,,,
C14605,Metholone;|Dromostanolone;|17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one,,,,,
C14606,"3alpha,11beta-Dihydroxy-5alpha-androstane-17-one;|11beta-Hydroxyandrosterone",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14606  3alpha,11beta-Dihydroxy-5alpha-androstane-17-one",
C14607,Testosterone decanoate;|17beta-Hydroxyandrost-4-en-3-one decanoate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08573)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D08573  Testosterone decanoate|Drug groups [BR:br08330(D08573)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D08573  Testosterone decanoate|DG02006  Testosterone|DG00460  Testosterone|D08573  Testosterone decanoate|Target-based classification of drugs [BR:br08310(D08573)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08573  Testosterone decanoate,
C14608,"3alpha,6alpha-Dihydroxy-5beta-pregnan-20-one;|6alpha-Hydroxypregnanolone",,,,,
C14609,"3alpha,17alpha-Dihydroxy-5beta-pregnan-20-one;|17alpha-Hydroxypregnanolone",,,,,
C14610,"(S)-5-Oxo-2,5-dihydrofuran-2-acetate;|(+)-Muconolactone",,,,,
C14611,1-Chloro-2-(chlorophenylmethyl)benzene,,,,,
C14612,"Rubrophen;|4-[Bis(4-hydroxy-3-methoxyphenyl)methylene]-2-methoxy-2,5-cyclohexadien-1-one",,,,,
C14613,Allenolic acid;|6-Hydroxy-2-naphthalenepropanoic acid,,,,,
C14614,6-(Pentylthio)purine;|6-Amylmercaptopurine,,,,,
C14615,"17beta-Hydroxy-17-methylandrost-4-ene-3,11-dione",,,,,
C14616,"(3alpha,5beta,11beta,17beta)-9-Fluoro-17-methylandrostane-3,11,17-triol;|9alpha-Fluoro-17alpha-methyl-5beta-androstane-3alpha,11beta,17-triol",,,,,
C14617,Chrysoidine free base;|Grasan Chrysoidine,,,,,
C14618,"6alpha-Fluoroprednisolone;|Fluprednisolone;|6alpha-Fluoro-11beta,17alpha,21-trihydroxypregna-1,4-diene-3,20-dione",,,,Target-based classification of drugs [BR:br08310(D04227)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D04227  Fluprednisolone (USAN/INN),
C14619,o-Chloroacetanilide;|2'-Chloroacetanilide;|N-(2-Chlorophenyl)acetamide,,,,,
C14620,"2-Acetamido-6H-dibenzo[b,d]pyran-6-one",,,,,
C14621,"9-Fluoro-17-methyl-11-oxotestosterone;|9alpha-Fluoro-17beta-hydroxy-17alpha-methylandrost-4-ene-3,11-dione",,,,,
C14622,(E)-1-Methoxy-4-[2-(4-nitrophenyl)ethenyl]benzene;|(E)-Methoxy-4'-nitrostilbene,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14622  (E)-1-Methoxy-4-[2-(4-nitrophenyl)ethenyl]benzene",
C14623,6-(Ethylthio)purine;|6-Ethylmercaptopurine,,,,,
C14624,"Androstane-3,17-diol dipropionate;|5alpha-Androstane-3alpha,17beta-diol dipropionate",,,,,
C14625,9alpha-Fluoro-6alpha-methylprednisolone 21-acetate,,,,,
C14626,2'-Carboxy-4-[bis(2-chloroethyl)amino]-2-methylazobenzene;|Azo-mustard;|CB 1414,,,,,
C14627,"14alpha,17beta-Dihydroxyandrost-4-en-3-one;|14-Hydroxytestosterone",,,,,
C14628,"4,5alpha-Dihydro-2-(hydroxymethylene)testosterone;|17beta-Hydroxy-2-hydroxymethylene-5alpha-androstan-3-one",,,,,
C14629,"Fluorometholone 17-acetate;|9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate;|6alpha-Methyl-9alpha-fluoro-17-acetoxy-21-deoxyprednisolone",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04221)]|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA06 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB06 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB04 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA01 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA07 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB05 Fluorometholone|D04221  Fluorometholone acetate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D04221)]|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Fluorometholone|D04221  Fluorometholone acetate (USP)|Drug groups [BR:br08330(D04221)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00294  Fluorometholone|D04221  Fluorometholone acetate|Drug classes [BR:br08332(D04221)]|Anti-inflammatory|DG01955  Corticosteroid|D04221  Fluorometholone acetate|Target-based classification of drugs [BR:br08310(D04221)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D04221  Fluorometholone acetate (USP) &lt;US&gt;",
C14630,"9alpha-Fluoro-11beta-hydroxy-6alpha-methylpregn-4-ene-3,20-dione",,,,,
C14631,"5-Androstene-3beta,16alpha-diol;|3beta,16alpha-Dihydroxy-5-androstene;|Cetadiol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14631  5-Androstene-3beta,16alpha-diol",
C14632,"6alpha-Methylpregn-4-ene-3,11,20-trione;|6alpha-Methyl-11-oxoprogesterone;|SKI22936",,,,,
C14633,7-Hydroxy-2-acetamidofluorene;|N-(7-Hydroxy-9H-fluoren-2-yl)acetamide,,,,,
C14634,Methandriol dipropionate,,,,Drug groups [BR:br08330(D08197)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG01276  Methandriol|D08197  Methandriol dipropionate|Target-based classification of drugs [BR:br08310(D08197)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08197  Methandriol dipropionate,
C14635,"16alpha,17alpha-Epoxy-20-oxopregn-5-en-3beta-yl acetate;|16alpha,17alpha-Epoxypregnenolone acetate",,,,,
C14636,"9alpha-Fluoro-11beta,17alpha,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate;|Isoflupredone acetate;|U-6013",,,,,
C14637,"16beta-Hydroxy-3,11-dioxopregna-4,17(20)-dien-21-oic acid, gamma-lactone",,,,,
C14638,"9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregn-4-ene-3,20-dione;|9alpha-Fluoro-16alpha-hydroxyhydrocortisone",,,,,
C14639,"2-Indanone oxime;|1,3-Dihydro-2H-inden-2-one oxime",,,,,
C14640,Estradiol 17beta-cyclopentylpropionate;|Estradiol cypionate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04063)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CA Natural and semisynthetic estrogens, plain|G03CA03 Estradiol|D04063  Estradiol cypionate (USP) &lt;US&gt;|USP drug classification [BR:br08302(D04063)]|Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|Estrogens|Estradiol|D04063  Estradiol cypionate (USP)|Drug groups [BR:br08330(D04063)]|Hormonal agent|DG01986  Estrogen|DG00462  Estradiol|D04063  Estradiol cypionate|DG01584  Estrogen receptor agonist|DG00462  Estradiol|D04063  Estradiol cypionate|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00462  Estradiol|D04063  Estradiol cypionate|Drug classes [BR:br08332(D04063)]|Endocrine and hormonal agent|DG01986  Estrogen|D04063  Estradiol cypionate|DG01584  Estrogen receptor agonist|D04063  Estradiol cypionate|Target-based classification of drugs [BR:br08310(D04063)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D04063  Estradiol cypionate (USP) &lt;US&gt;|Drug metabolizing enzymes and transporters [br08309.html(D04063)]|Drug metabolizing enzymes|D04063",
C14641,Cholesteryl oleate;|Cholest-5-en-3-beta-yl oleate;|Cholesteryl cis-9-octadecenoate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0102 Steryl esters|C14641  Cholesteryl oleate,
C14642,"Melengestrol acetate;|17-Hydroxy-6-methyl-16-methylenepregna-4,6-diene-3,20-dione acetate;|17alpha-Acetoxy-6-methyl-16-methylenepregna-4,6-diene-3,20-dione",,,,,
C14643,"Medrysone;|11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02289)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA08 Medrysone|D02289  Medrysone (USAN)|Drug groups [BR:br08330(D02289)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|D02289  Medrysone|Target-based classification of drugs [BR:br08310(D02289)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D02289  Medrysone (USAN)",
C14644,4-Bromophenylthiourea;|N-p-Bromophenylthiourea,,,,,
C14645,"Estradiol-17-phenylpropionate;|Estra-1,3,5(10)-triene-3,17beta-diol 17-benzenepropionate",,,,,
C14646,"Pregna-4,11-diene-3,20-dione;|11-Dehydroprogesterone",,,,,
C14647,"Braxoron;|9alpha-Bromo-11-oxoprogesterone;|9alpha-Bromopregn-4-ene-3,11,20-trione",,,,,
C14648,"6alpha-Chloro-17-acetoxyprogesterone;|6alpha-Chloro-17-hydroxypregn-4-ene-3,20-dione acetate",,,,,
C14649,"15alpha-Hydroxytestosterone;|15alpha,17beta-Dihydroxyandrost-4-en-3-one",,,,,
C14650,"3-Hydroxyestra-1,3,5(10),6-tetraen-17-one;|6-Dehydroestrone",,,,,
C14651,"16alpha,17alpha-Epoxy-3,20-dioxopregn-4-en-21-yl acetate;|16,17-Epoxydeoxycorticosterone acetate",,,,,
C14652,"19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol;|17alpha-Ethynylestr-5(10)-ene-3alpha,17beta-diol",,,,,
C14653,Descinolone acetonide;|21-Deoxytriamcinoline acetonide,,,,Target-based classification of drugs [BR:br08310(D03691)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D03691  Descinolone acetonide (USAN),
C14654,"12alpha-Hydroxyprogesterone;|12alpha-Hydroxy-4-pregnene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C14654  12alpha-Hydroxyprogesterone",
C14655,"17,17-Dimethyl-18-norandrosta-4,13-dien-3-one",,,,,
C14656,3-Hydroxy-2-acetamidofluorene;|N-(3-Hydroxy-2-fluorenyl)acetamide,,,,,
C14657,"2,3-Diphenyl-1-indanone;|2,3-Diphenyl-1H-inden-1-one;|2,3-Diphenylindone",,,,,
C14658,Pregnenolone acetate;|3beta-Hydroxypregn-5-en-20-one acetate,,,,,
C14660,Carbestrol;|3-Ethyl-4-(p-methoxyphenyl)-2-methyl-3-cyclohexene-1-carboxylic acid,,,,,
C14661,"3-Methoxy-19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ol;|17alpha-Ethyl-17beta-estradiol 3-methyl ether",,,,,
C14662,(E)-4-Nitrostilbene;|trans-p-Nitrostilbene,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14662  (E)-4-Nitrostilbene",
C14663,Testosterone isocaproate;|17beta-Hydroxyandrost-4-ene-3-one 4-methylvalerate,,,,,
C14664,"11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoropregn-4-ene-3,20-dione 16,17-acetonide",,,,,
C14665,"Oranabol;|Oxymesterone;|4,17beta-Dihydroxy-17alpha-methylandrost-4-en-3-one;|4-Hydroxy-17alpha-methyltestosterone",,,,,
C14666,1-(4-Methoxyphenyl)-2-phenylethane;|1-Methoxy-4-(2-phenylethyl)benzene;|4-Methoxydibenzyl,,,,,
C14667,Testosterone phenylpropionate;|17beta-Hydroxyandrost-4-en-3-one 3-phenylpropionate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08574)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03B ANDROGENS|G03BA 3-oxoandrosten (4) derivatives|G03BA03 Testosterone|D08574  Testosterone phenylpropionate|Drug groups [BR:br08330(D08574)]|Hormonal agent|DG01590  Androgen receptor agonist|DG00460  Testosterone|D08574  Testosterone phenylpropionate|DG02006  Testosterone|DG00460  Testosterone|D08574  Testosterone phenylpropionate|Target-based classification of drugs [BR:br08310(D08574)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D08574  Testosterone phenylpropionate,
C14668,"Cortancyl;|Prednisone 21-acetate;|21-Acetoxy-17alpha-hydroxypregna-1,4-diene-3,11,20-trione",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08416)]|A ALIMENTARY TRACT AND METABOLISM|A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS|A07E INTESTINAL ANTIINFLAMMATORY AGENTS|A07EA Corticosteroids acting locally|A07EA03 Prednisone|D08416  Prednisone acetate|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB07 Prednisone|D08416  Prednisone acetate|Drug groups [BR:br08330(D08416)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00094  Prednisone|D08416  Prednisone acetate|Target-based classification of drugs [BR:br08310(D08416)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D08416  Prednisone acetate",
C14669,"12alpha-Bromo-11beta-hydroxypregn-4-ene-3,20-dione;|11beta-Hydroxy-12alpha-bromoprogesterone",,,,,
C14670,"17-Ethynyl-10-hydroxy-19-nortestosterone;|17alpha-Ethinyl-10beta,17beta-dihydroxy-4-estren-3-one;|10beta-Hydroxynorethindrone",,,,,
C14671,"11-Ketoandrosterone;|3alpha-Hydroxy-5alpha-androstane-11,17-dione",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C14671  11-Ketoandrosterone,
C14672,p-Chlorobenzhydrol;|(4-Chlorophenyl)phenylmethanol,,,,,
C14673,"Cholesta-5,7-dien-3beta-ol benzoate;|7-Dehydrocholesterol benzoate",,,,,
C14674,"16alpha,17alpha-Dihydroxyprogesterone acetophenide",,,,,
C14675,"11beta,21-Dihydroxypregn-4-ene-3,20-dione 21-acetate;|Corticosterone 21-acetate",,,,,
C14676,"4-Chloroprogesterone;|4-Chloropregn-4-ene-3,20-dione",,,,,
C14677,"1-Dehydroprogesterone;|Delta1-Progesterone;|Pregna-1,4-diene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C14677  1-Dehydroprogesterone",
C14678,5-Hydroxy-2-acetamidofluorene;|N-(5-Hydroxy-2-fluorenyl)acetamide,,,,,
C14679,p-Methoxystilbene;|1-(p-Methoxyphenyl)-2-phenylethene,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14679  p-Methoxystilbene",
C14680,"5beta-Pregnane-3alpha,17alpha,20alpha-triol",,,,,
C14681,"16-alpha,17-Epoxypregn-4-ene-3,20-dione;|16alpha,17alpha-Epoxyprogesterone",,,,,
C14682,"3-Methoxyestra-2,5(10)-dien-17beta-ol",,,,,
C14683,"11beta,17beta-Dihydroxy-17-methylandrost-4-en-3-one;|11beta-Hydroxy-17alpha-methyltestosterone",,,,,
C14684,"17beta-Hydroxy-17-methylandrosta-4,9(11)-dien-3-one;|4,9(11)-Androstadien-17alpha-methyl-17beta-ol-3-one",,,,,
C14685,"1,2-Dihydrostilbene;|1,2-Diphenylethane;|Dibenzyl",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14685  1,2-Dihydrostilbene",
C14686,Dicyclohexylamine;|N-Cyclohexylcyclohexanamine,,,,,
C14687,2-Ethoxyethanol,,,,,
C14688,"Bis(2-chloroethyl)ether;|2,2'-Dichlorethyl ether;|1,5-Dichloro-3-oxapentane",,,,,
C14689,"Diethylene glycol;|2,2'-Oxydiethanol;|1,5-Dihydroxy-3-oxapentane",,,,,
C14690,"Tetraethylenepentamine;|1,11-Diamino-3,6,9-triazaundecane",,,,,
C14691,"Triethylamine;|N,N-Diethylethanamine",,,,,
C14692,Chlorodibromomethane;|Dibromochloromethane,,,,,
C14693,"Butylhydroxytoluene;|BHT;|2,6-Di-t-butyl-4-methylphenol;|2,6-Di-tert-butyl-p-cresol;|Butylated hydroxytoluene;|2,6-Bis(1,1-dimethylethyl)-4-methylphenol",,,,,
C14694,N-Phenyl-2-naphthylamine;|Neozone;|2-Phenylaminonaphthalene,,,,,
C14695,Nitrilotriacetic acid;|Triglycollamic acid;|Nitrilotriacetate,,,,,
C14696,1-Nonanol;|n-Nonyl alcohol;|1-Hydroxynonane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14696  1-Nonanol,
C14697,4-Isopentylphenol;|p-Isoamylphenol,,,,,
C14698,4-Heptylphenol;|4-n-Heptylphenol;|p-Heptylphenol;|p-Hydroxyheptylbenzene,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C14698  4-Heptylphenol,
C14699,1-Hydroxychlordene;|Chlordene hydroxide,,,,,
C14700,"2-Chloro-1,1,2-trifluoroethyl ethyl ether;|Ethoxyflurane",,,,,
C14701,"Paraquat;|1,1'-Dimethyl-4,4'-bipyridinium",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Bipyridinium herbicides|C14701  Paraquat,
C14702,"1,2-Dinitrobenzene;|o-Dinitrobenzene",,,,,
C14703,"1,8-Dimethylnaphthalene",,,,,
C14704,N-Nitrosodimethylamine;|Dimethylnitrosamine,,,,,
C14705,"1,1,1,2-Tetrachloroethane",,,,,
C14706,Diethyl sulfate;|DES,,,,,
C14707,Bromoform;|Tribromomethane,,,,,
C14708,Bromodichloromethane,,,,,
C14709,"1,1-Dimethylethyl benzoate;|tert-Butyl benzoate",,,,,
C14710,Isobutanol;|Isobutyl alcohol;|2-Methyl-1-propanol;|1-Hydroxymethylpropane;|2-Methylpropan-1-ol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C14710  2-Methylpropan-1-ol,
C14711,Nickel chloride;|Nickel(II) chloride,,,,,
C14712,"2,5-Dichloroaniline;|1-Amino-2,5-dichlorobenzene;|2,5-DCA",,,,,
C14713,"2,4-Dinitroaniline;|1-Amino-2,4-dinitrobenzene",,,,,
C14714,"2-(m-Chlorophenyl)-2-(p-chlorophenyl)-1,1-dichloroethane;|m,p'-DDD",,,,,
C14715,"4-Chloro-3,5-dimethylphenol;|Chloroxylenol",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03473)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AE Phenol and derivatives|D08AE05 Chloroxylenol|D03473  Chloroxylenol (USP/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C14715  Chloroxylenol|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C14715  Chloroxylenol|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9925  Cresols and preparations|C14715  Chloroxylenol,
C14716,2-Ethylhexyl-4-hydroxybenzoate,,,,,
C14717,"15-Deoxy-Delta12,14-PGJ2;|15-Deoxy-Delta12,14-prostaglandin J2;|15-Deoxy-PGJ2",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C14717  15-Deoxy-delta-12,14-Prostaglandin J2",
C14718,Heptyl p-hydroxybenzoate;|Heptylparaben,,,,,
C14719,"Methallenestrilphenol;|N-3-(6-Hydroxy-2-naphthyl)-2,2-dimethylpentanoic acid;|alpha,alpha-Dimethyl-beta-ethylallenolic acid;|beta-Ethyl-6-hydroxy-alpha,alpha-dimethyl-2-naphthalenepropanoic acid",,,,,
C14720,4-Ethyl-7-hydroxy-3-(p-methoxyphenyl)coumarin,,,,,
C14721,34a-Deoxy-rifamycin W,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14721  34a-Deoxy-rifamycin W,
C14722,Rifamycin W-hemiacetal,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14722  Rifamycin W-hemiacetal,
C14723,Rifamycin Z,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14723  Rifamycin Z,
C14724,Demethyl-desacetyl-rifamycin S,,,,,
C14725,27-O-Demethyl-25-O-desacetylrifamycin SV;|Demethyl-desacetyl-rifamycin SV,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14725  27-O-Demethyl-25-O-desacetylrifamycin SV,
C14726,"2,2',3,3',4',5,5'-Heptachloro-4-biphenylol",,,,,
C14727,27-O-Demethylrifamycin SV,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C14727  27-O-Demethylrifamycin SV,
C14728,"2,2',3,3',4',5-Hexachloro-4-biphenylol",,,,,
C14729,"2',3,3',4',5-Pentachloro-4-biphenylol",,,,,
C14730,"2,2',3,4',5,5'-Hexachloro-4-biphenylol",,,,,
C14731,"16alpha-Bromo-17beta-estradiol;|16alpha-Bromo-1,3,5(10)-estratriene-3,17beta-diol",,,,,
C14732,"5-OxoETE;|(6E,8Z,11Z,14Z)-5-Oxoicosa-6,8,11,14-tetraenoic acid;|5-Oxoeicosatetraenoic acid;|5-Oxoicosatetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14732  5-OxoETE,
C14733,"2',3',4',5'-Tetrachloro-3-biphenylol;|2',3',4',5'-Tetrachloro-3-hydroxybiphenyl",,,,,
C14734,"2',5'-Dichloro-3-biphenylol;|2',5'-Dichloro-3-hydroxybiphenyl",,,,,
C14736,"2',5'-Dichloro-2-biphenylol;|2',5'-Dichloro-2-hydroxybiphenyl",,,,,
C14737,"4,3',5'-Trichloro-4'-biphenol;|3,4',5-Trichloro-4-biphenylol",,,,,
C14738,Indanestrol,,,,,
C14739,"alpha,alpha'-Diethyl-3,4,3',4'-stilbenetetraol;|3,4,3',4'-Tetrahydroxy-alpha,alpha'-diethylstilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14739  alpha,alpha'-Diethyl-3,4,3',4'-stilbenetetraol",
C14740,"alpha,alpha'-Diethyl-3,4,4'-stilbenetriol;|3,4,4'-Trihydroxy-alpha,alpha'-diethylstilbene;|(E)-4-[1-Ethyl-2-(4-hydroxyphenyl)-1-butenyl]-1,2-benzenediol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14740  alpha,alpha'-Diethyl-3,4,4'-stilbenetriol",
C14741,4-Isopropyl-3-methylphenol;|4-Isopropyl-m-cresol;|o-Cymen-5y-ol,,,,Classification of Japanese OTC drugs [BR:br08313]|Agents for integumentary system|54 Disinfectants (incl. special bandages)|C14741  4-Isopropyl-3-methylphenol|56 Purulent skin remedies|C14741  4-Isopropyl-3-methylphenol|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C14741  4-Isopropyl-3-methylphenol,
C14742,N-Nitrosodiphenylamine,,,,,
C14743,"Isophorone;|1,1,3-Trimethyl-3-cyclohexene-5-one",,,,,
C14744,"Dacthal;|Chlorthal-dimethyl;|Dimethyl 2,3,5,6-tetrachloroterephthalate",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C14744  Dacthal,
C14745,Zindoxifene,,,,,
C14746,"Chlordimeform;|Chlorphenamidine;|N'-(4-Chloro-2-methylphenyl)-N,N-dimethylformamidine",,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C14746  Chlordimeform,
C14747,"2,2'-Bisphenol F;|Bis(2-hydroxyphenyl)methane",,,,,
C14748,"20-HETE;|(5Z,8Z,11Z,14Z)-20-Hydroxyicosa-5,8,11,14-tetraenoic acid;|20-Hydroxyeicosatetraenoic acid;|20-Hydroxyicosatetraenoic acid;|20-Hydroxy arachidonic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14748  20-HETE,
C14749,19(S)-HETE;|(19S)-Hydroxyeicosatetraenoic acid;|(19S)-Hydroxyicosatetraenoic acid;|(19S)-Hydroxy arachidonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14749  19(S)-HETE,
C14750,alpha-Zearalenol;|trans-Zearalenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14750  alpha-Zearalenol|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C14750  alpha-Zearalenol,
C14751,beta-Zearalenol;|beta-trans-Zearalenol,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14751  beta-Zearalenol|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C14751  beta-Zearalenol,
C14752,alpha-Zearalanol;|Zeranol,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14752  alpha-Zearalanol|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C14752  alpha-Zearalanol,
C14753,beta-Zearalanol;|Taleranol,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14753  beta-Zearalanol,
C14754,Zearalanone;|(S)-Zearalanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C14754  Zearalanone,
C14755,2-Chloro-4-biphenylol;|2-Chloro-4-hydroxybiphenyl,,,,,
C14756,"2,2',3,6,6'-Pentachloro-4-biphenylol",,,,,
C14757,"Moxestrol;|11beta-Methoxy-17alpha-ethinylestradiol;|17alpha-Ethinyl-11beta-methoxy-1,3,5(10)-estratrien-3,17-diol",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|G GENITO URINARY SYSTEM AND SEX HORMONES|G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM|G03C ESTROGENS|G03CB Synthetic estrogens, plain|G03CB04 Moxestrol|C14757  Moxestrol",
C14758,"ICI 164384;|N-n-Butyl-N-methyl-11-[3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl]undecanamide",,,,,
C14759,"4,4'-Diaminodiphenyl ether;|4-Aminophenyl ether;|4,4'-Oxybisbenzenamine;|4,4'-Oxydianiline",,,,,
C14760,Amaranth;|Food red No.2,,,,,
C14761,"trans,trans-1,4-Diphenyl-1,3-butadiene",,,,,
C14762,"13(S)-HODE;|(13S)-Hydroxyoctadecadienoic acid;|(9Z,11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14762  (9Z, 11E)-(13S)-13-Hydroxyoctadeca-9,11-dienoic acid",
C14763,trans-4-Hydroxystilbene;|(E)-4-Stilbenol,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C14763  trans-4-Hydroxystilbene",
C14764,2-Thiophenesulfonamide,,,,,
C14765,"13-OxoODE;|13-KODE;|(9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14765  (9Z,11E)-13-Oxooctadeca-9,11-dienoic acid",
C14766,"9-OxoODE;|9-KODE;|(10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14766  (10E,12Z)-9-Oxooctadeca-10,12-dienoic acid",
C14767,"9(S)-HODE;|(9S)-Hydroxyoctadecadienoic acid;|(10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14767  (10E,12Z)-(9S)-9-Hydroxyoctadeca-10,12-dienoic acid",
C14768,"5,6-EET;|(8Z,11Z,14Z)-5,6-Epoxyeicosa-8,11,14-trienoic acid;|(8Z,11Z,14Z)-5,6-Epoxyicosa-8,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14768  5,6-EET",
C14769,"8,9-EET;|(5Z,11Z,14Z)-8,9-Epoxyeicosa-5,11,14-trienoic acid;|(5Z,11Z,14Z)-8,9-Epoxyicosa-5,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14769  8,9-EET",
C14770,"11,12-EET;|(5Z,8Z,14Z)-11,12-Epoxyeicosa-5,8,14-trienoic acid;|(5Z,8Z,14Z)-11,12-Epoxyicosa-5,8,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14770  11,12-EET",
C14771,"14,15-EET;|(5Z,8Z,11Z)-14,15-Epoxyeicosa-5.8.11-trienoic acid;|(5Z,8Z,11Z)-14,15-Epoxyicosa-5.8.11-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14771  14,15-EET",
C14772,"5,6-DHET;|(8Z,11Z,14Z)-5,6-Dihydroxyeicosa-8,11,14-trienoic acid;|(8Z,11Z,14Z)-5,6-Dihydroxyicosa-8,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14772  5,6-DHET",
C14773,"8,9-DHET;|(5Z,11Z,14Z)-8,9-Dihydroxyeicosa-5,11,14-trienoic acid;|(5Z,11Z,14Z)-8,9-Dihydroxyicosa-5,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14773  8,9-DHET",
C14774,"11,12-DHET;|(5Z,8Z,14Z)-11,12-Dihydroxyeicosa-5,8,14-trienoic acid;|(5Z,8Z,14Z)-11,12-Dihydroxyicosa-5,8,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14774  11,12-DHET",
C14775,"14,15-DHET;|(5Z,8Z,11Z)-14,15-Dihydroxyeicosa-5,8,11-trienoic acid;|(5Z,8Z,11Z)-14,15-Dihydroxyicosa-5,8,11-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14775  14,15-DHET",
C14776,"8(S)-HETE;|(5Z,9E,11Z,14Z)-(8S)-8-Hydroxyeicosa-5,9,11,14-tetraenoic acid;|(5Z,9E,11Z,14Z)-(8S)-8-Hydroxyicosa-5,9,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14776  8(S)-HETE,
C14777,"12(S)-HETE;|(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid;|(5Z,8Z,10E,14Z)-(12S)-12-Hydroxyicosa-5,8,10,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14777  12(S)-HETE,
C14778,"16(R)-HETE;|(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyeicosa-5,8,11,14-tetraenoic acid;|(5Z,8Z,11Z,14Z)-(16R)-16-Hydroxyicosa-5,8,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14778  16(R)-HETE,
C14779,"9(S)-HETE;|(5Z,7E,11Z,14Z)-(9S)-9-Hydroxyeicosa-5,7,11,14-tetraenoic acid;|(5Z,7E,11Z,14Z)-(9S)-9-Hydroxyicosa-5,7,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14779  9(S)-HETE,
C14780,"11(R)-HETE;|(5Z,8Z,12E,14Z)-(11R)-Hydroxyeicosa-5,8,12,14-tetraenoic acid;|(5Z,8Z,12E,14Z)-(11R)-Hydroxyicosa-5,8,12,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14780  11(R)-HETE,
C14781,"15H-11,12-EETA;|15-Hydroxy-11,12-epoxyeicosatrienoic acid;|(5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyeicosa-5,8,13-trienoic acid;|(5Z,8Z,13E)-(15S)-11,12-Epoxy-15-hydroxyicosa-5,8,13-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14781  15-Hydroxy-11,12-EETA",
C14782,"11,12,15-THETA;|11,12,15-Trihydroxyicosatrienoic acid;|(5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyeicosa-5,8,12-trienoic acid;|(5Z,8Z,13E)-(15S)-11,12,15-Trihydroxyicosa-5,8,12-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14782  11,12,15-THETA",
C14783,"1,2-Naphthoquinone;|1,2-Naphthalenedione",,,,,
C14784,"1,2-Dihydroxy-3,4-epoxy-1,2,3,4-tetrahydronaphthalene",,,,,
C14785,"1,4-Dihydroxynaphthalene;|1,4-Naphthohydroquinone;|Naphthalene-1,4-diol",,,,,
C14786,"(1R,2S)-Naphthalene 1,2-oxide;|(1R,2S)-Naphthalene epoxide",,,,,
C14787,"(1S,2R)-Naphthalene 1,2-oxide;|(1S,2R)-Naphthalene epoxide",,,,,
C14788,1-Nitrosonaphthalene,,,,,
C14789,N-Hydroxy-1-aminonaphthalene;|1-Naphthylhydroxylamine,,,,,
C14790,1-Naphthylamine,,,,,
C14791,"(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene",,,,,
C14792,"(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene",,,,,
C14793,"(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene",,,,,
C14794,"2,3-Dinor-8-iso prostaglandin F2alpha;|2,3-Dinor-8-iso PGF2alpha",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C14794  2,3-Dinor-8-iso prostaglandin F2alpha|FA0311 Isoprostanes|C14794  2,3-Dinor-8-iso prostaglandin F2alpha",
C14795,"2,3-Dinor-8-iso prostaglandin F1alpha;|2,3-Dinor-8-iso PGF1alpha",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0301 Prostaglandins|C14795  2,3-Dinor-8-iso prostaglandin F1alpha",
C14796,"(1R)-Hydroxy-(2R)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",,,,,
C14797,"(1R)-N-Acetyl-L-cysteinyl-(2R)-hydroxy-1,2-dihydronaphthalene",,,,,
C14798,"(1S)-Hydroxy-(2S)-N-acetyl-L-cysteinyl-1,2-dihydronaphthalene",,,,,
C14799,"(1R,2R)-3-[(1,2-Dihydro-2-hydroxy-1-naphthalenyl)thio]-2-oxopropanoic acid",,,,,
C14800,"1-Nitronaphthalene-5,6-oxide",,,,,
C14801,"1-Nitro-5,6-dihydroxy-dihydronaphthalene;|1,2-Dihydro-5-nitro-1,2-naphthalenediol",,,,,
C14802,"1-Nitronaphthalene-7,8-oxide",,,,,
C14803,"1-Nitro-7-hydroxy-8-glutathionyl-7,8-dihydronaphthalene",,,,,
C14804,"1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronaphthalene",,,,,
C14805,"1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene",,,,,
C14806,"1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene",,,,,
C14807,"12-OxoETE;|12-KETE;|(5Z,8Z,10E,14Z)-12-Oxoeicosa-5,8,10,14-tetraenoic acid;|(5Z,8Z,10E,14Z)-12-Oxoicosa-5,8,10,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14807  12-OxoETE,
C14808,"Hepoxilin A3;|(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyeicosa-5,9,14-trienoic acid;|(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0309 Hepoxilins|C14808  Hepoxilin A3,
C14809,"Trioxilin A3;|(5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyeicosa-5,9,14-trienoic acid;|(5Z,9E,14Z)-(11R,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0309 Hepoxilins|C14809  Trioxilin A3,
C14810,"Hepoxilin B3;|(5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoic acid;|(5Z,8Z,14Z)-(11S,12S)-11,12-Epoxy-10-hydroxyicosa-5,8,14-trienoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0309 Hepoxilins|C14810  Hepoxilin B3,
C14811,"Trioxilin B3;|(5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyeicosa-5,8,14-trienoic acid;|(5Z,8Z,14Z)-(11R,12R)-10,11,12-Trihydroxyicosa-5,8,14-trienoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0309 Hepoxilins|C14811  Trioxilin B3,
C14812,"12(R)-HPETE;|(5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyeicosa-5,8,10,14-tetraenoic acid;|(5Z,8Z,10E,14Z)-(12R)-12-Hydroperoxyicosa-5,8,10,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14812  12(R)-HPETE,
C14813,"11H-14,15-EETA;|11-Hydroxy-14,15-EETA;|11-Hydroxy-14,15-epoxyeicosatrienoic acid;|(5Z,8Z,12E)-14,15-Epoxy-11-hydroxyeicosa-5,8,12-trienoic acid;|(5Z,8Z,12E)-14,15-Epoxy-11-hydroxyicosa-5,8,12-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0308 Epoxyeicosatrienoic acids|C14813  11-Hydroxy-14,15-EETA",
C14814,"11,14,15-THETA;|11,14,15-Trihydroxyicosatrienoic acid;|(5Z,8Z,12E)-11,14,15-Trihydroxyeicosa-5,8,12-trienoic acid;|(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0305 Hydroxy/hydroperoxyeicosatrienoic acids|C14814  11,14,15-THETA",
C14815,"5,6-Epoxytetraene;|(7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyeicosa-7,9,11,13-tetraenoic acid;|(7E,9E,11Z,13E)-(5S,6S,15S)-5,6-Epoxy-15-hydroxyicosa-7,9,11,13-tetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14815  5,6-Epoxytetraene",
C14816,Sch 59884,,,,,
C14817,BMS 379224,,,,,
C14818,Fe2+;|Fe(II);|Ferrous ion;|Iron(2+),,,,,
C14819,Fe3+;|Fe(III);|Ferric ion;|Iron(3+),,,,,
C14820,"11(R)-HPETE;|(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyeicosa-5,8,12,14-tetraenoic acid;|(5Z,8Z,12E,14Z)-(11R)-Hydroperoxyicosa-5,8,12,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14820  11(R)-HPETE,
C14821,"9(S)-HPETE;|(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyeicosa-5,7,11,14-tetraenoic acid;|(5Z,7E,11Z,14Z)-(9S)-9-Hydroperoxyicosa-5,7,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14821  9(S)-HPETE,
C14822,"12(R)-HETE;|(5Z,8Z,10E,14Z)-(12R)-12-Hydroxyeicosa-5,8,10,14-tetraenoic acid;|(5Z,8Z,10E,14Z)-(12R)-12-Hydroxyicosa-5,8,10,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14822  12(R)-HETE,
C14823,"8(S)-HPETE;|(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyeicosa-5,9,11,14-tetraenoic acid;|(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14823  8(S)-HPETE,
C14824,"8(R)-HETE;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroxyeicosa-5,9,11,14-tetraenoate;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroxyicosa-5,9,11,14-tetraenoate;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroxyeicosa-5,9,11,14-tetraenoic acid;|(5Z,9E,11Z,14Z)-(8R)-8-Hydroxyicosa-5,9,11,14-tetraenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0306 Hydroxy/hydroperoxyeicosatetraenoic acids|C14824  8(R)-HETE,
C14825,"9(10)-EpOME;|(9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14825  (9R,10S)-(12Z)-9,10-Epoxyoctadecenoic acid",
C14826,"12(13)-EpOME;|(12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14826  (12R,13S)-(9Z)-12,13-Epoxyoctadecenoic acid",
C14827,"9(S)-HPODE;|9(S)-HPOD;|(10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid;|(9S,10E,12Z)-9-Hydroperoxy-10,12-octadecadienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14827  (10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid",
C14828,"9,10-DHOME;|9,10-DHOA;|(12Z)-9,10-Dihydroxyoctadec-12-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C14828  (12Z)-9,10-Dihydroxyoctadec-12-enoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14828  (12Z)-9,10-Dihydroxyoctadec-12-enoic acid",
C14829,"12,13-DHOME;|12,13-DHOA;|(9Z)-12,13-Dihydroxyoctadec-9-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C14829  (9Z)-12,13-Dihydroxyoctadec-9-enoic acid|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14829  (9Z)-12,13-Dihydroxyoctadec-9-enoic acid",
C14830,GDP-4-keto-6-L-deoxygalactose,,,,,
C14831,"8(R)-HPODE;|(9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid;|(8R,9Z,12Z)-8-Hydroperoxyoctadeca-9,12-dienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14831  (9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid",
C14832,"12,13-Epoxy-9-hydroxy-10-octadecenoate;|12(R),13(S)-Epoxy-9(S)-hydroxy-10(E)-octadecenoic acid;|(10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14832  (10E)-(9S,12R,13S)-12,13-Epoxy-9-hydroxyoctadec-10-enoic acid",
C14833,"9,12,13-TriHOME;|9(S),12(S),13(S)-Trihydroxy-10(E)-octadecenoic acid;|(10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14833  (10E)-(9S,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoic acid",
C14834,"9,10-Epoxy-13-hydroxy-11-octadecenoate;|(11E)-9,10-Epoxyoctadecenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14834  (11E)-9,10-Epoxyoctadecenoic acid",
C14835,"9,10,13-TriHOME;|9,10,13-Trihydroxyoctadec-11-enoic acid;|(11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14835  (11E)-9,10,13-Trihydroxyoctadec-11-enoic acid",
C14836,"9,10-12,13-Diepoxyoctadecanoate;|9,10-12,13-Diepoxyoctadecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14836  9,10-12,13-Diepoxyoctadecanoic acid",
C14837,"9,10-Dihydroxy-12,13-epoxyoctadecanoate;|9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C14837  9,10-Dihydroxy-12,13-epoxyoctadecanoic acid",
C14838,"Y 23684;|2-(4-Chlorophenyl)-5,6-dihydro-[1]benzothepino[5,4-c]pyridazin-3(2H)-one-7-oxide",,,,,
C14839,"Bromobenzene-3,4-oxide;|Bromobenzene-3,4-epoxide",,,,,
C14840,"Bromobenzene-2,3-oxide;|Bromobenzene-2,3-epoxide",,,,,
C14841,2-Bromophenol;|o-Bromophenol,,,,,
C14842,"Bromobenzene-2,3-dihydrodiol;|3-Bromo-3,5-cyclohexadiene-1,2-diol",,,,,
C14843,4-Bromocatechol,,,,,
C14844,"Bromobenzene-3,4-dihydrodiol;|4-Bromo-3,5-cyclohexadiene-1,2-diol",,,,,
C14845,"4-Bromophenol-2,3-epoxide",,,,,
C14846,"4-Bromo-3,5-cyclohexadiene-1,2-dione;|4-Bromo-1,2-benzoquinone",,,,,
C14847,"3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene",,,,,
C14848,"2,3-Dihydro-2-S-glutathionyl-3-hydroxy bromobenzene",,,,,
C14849,"Benzo[a]pyrene-9,10-oxide;|Benzo[a]pyrene-9,10-epoxide",,,,,
C14850,"Benzo[a]pyrene-7,8-oxide;|Benzo[a]pyrene-7,8-epoxide",,,,,
C14851,"Benzo[a]pyrene-4,5-oxide;|Benzo[a]pyrene-4,5-epoxide",,,,,
C14852,"Benzo[a]pyrene-7,8-dihydrodiol",,,,,
C14853,"Benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide;|7,8-Dihydro-7,8-dihydroxybenzo[a]pyrene 9,10-oxide",,,,,
C14854,"9-Hydroxybenzo[a]pyrene-4,5-oxide;|9-Hydroxybenzo[a]pyrene-4,5-epoxide",,,,,
C14855,"4,5-Dihydro-4-hydroxy-5-S-glutathionyl-benzo[a]pyrene",,,,,
C14856,"7,8-Dihydro-7-hydroxy-8-S-glutathionyl-benzo[a]pyrene",,,,,
C14857,"1,1-Dichloroethylene epoxide;|2,2-Dichlorooxirane",,,,,
C14858,"2,2-Dichloroacetaldehyde",,,,,
C14859,Chloroacetyl chloride,,,,,
C14860,"2,2-Dichloro-1,1-ethanediol",,,,,
C14861,"S-(2,2-Dichloro-1-hydroxy)ethyl glutathione",,,,,
C14862,2-S-Glutathionyl acetate;|S-(Carboxymethyl)glutathione,,,,,
C14863,2-(S-Glutathionyl)acetyl glutathione,,,,,
C14864,S-(2-Chloroacetyl)glutathione,,,,,
C14865,2-(S-Glutathionyl)acetyl chloride,,,,,
C14866,Chloral;|Trichloroacetaldehyde,,,,,
C14867,Dichloroacetyl chloride,,,,,
C14868,"S-(1,2-Dichlorovinyl)glutathione;|DCVG",,,,,
C14869,"Trichloroethanol glucuronide;|Urochloralic acid;|2,2,2-Trichloroethyl beta-D-glucopyranosiduronic acid",,,,,
C14870,2-Bromoacetaldehyde,,,,,
C14871,S-(Formylmethyl)glutathione,,,,,
C14872,Thiodiacetic acid,,,,,
C14873,Thiodiacetic acid sulfoxide,,,,,
C14874,Glutathione episulfonium ion,,,,,
C14875,S-(2-Hydroxyethyl)glutathione,,,,,
C14876,S-(2-Hydroxyethyl)-N-acetyl-L-cysteine,,,,,
C14877,S-[2-(N7-Guanyl)ethyl]-N-acetyl-L-cysteine,,,,,
C14878,"6alpha,17-Dimethyl-5alpha-androstane-3beta,17beta-diol",,,,,
C14879,"17-Methyl-3-(2,4-cyclopentadien-1-ylidene)-5alpha-androstane-17beta-ol",,,,,
C14880,"16alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with 2-furyl methyl ketone",,,,,
C14881,"17-Hydroxy-3-oxo-19-nor-5alpha,17alpha-pregnane-21-carboxylic acid, gamma-lactone",,,,,
C14882,"2alpha-Methyl-5alpha-androstane-3alpha,17beta-diol",,,,,
C14883,"(3beta,5alpha,11beta,17beta)-9-Fluoro-17-methylandrostane-3,11,17-triol;|9-Fluoro-17alpha-methyl-5alpha-androstane-3beta,11beta,17-triol",,,,,
C14884,"cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester",,,,,
C14885,"9-Fluoro-11beta-hydroxy-16beta-methylandrosta-1,4-diene-3,17-dione",,,,,
C14886,"16beta-Fluoroandrost-4-ene-3,17-dione",,,,,
C14887,"11alpha,17beta-Dihydroxy-17alpha-methylandrosta-1,4-dien-3-one",,,,,
C14888,"(+)-Methallenestrilphenol;|(+)-3-(6-Hydroxy-2-naphthyl)-2,2-dimethylpentanoic acid;|(+)-beta-Ethyl-6-hydroxy-alpha,alpha-dimethyl-2-naphthalenepropanoic acid",,,,,
C14889,"5alpha-Androstane-2beta-fluoro-17beta-ol-3-one acetate;|(2beta,5alpha,17beta)-17-(Acetyloxy)-2-fluoro-androstan-3-one",,,,,
C14890,17beta-Hydroxy-6beta-methylandrost-4-en-3-one;|6beta-Methyltestosterone,,,,,
C14891,"7alpha,17beta-Dihydroxy-17alpha-methylandrost-4-en-3-one;|7alpha-Hydroxy-17alpha-methyltestosterone",,,,,
C14892,"17-Allylestra-1,3,5(10)-triene-3,17beta-diol",,,,,
C14893,2-(4-Chlorophenyl)-3-phenyl-3-(2-pyridinyl)acrylonitrile,,,,,
C14894,"3',6'-Dihydroxy-2',4,4'-trimethoxy-chalcone;|1-(3,6-Dihydroxy-2,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-2-propen-1-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C14894  3',6'-Dihydroxy-2',4,4'-trimethoxy-chalcone",
C14895,"1-(2-Hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-one",,,,,
C14896,"1-Methyl-6-(1,2,3,4-tetrahydro-6-methoxy-2-naphthyl)-2(1H)-pyridone",,,,,
C14897,"p-(3,4-Dihydro-6-methoxy-2-naphthyl)phenol",,,,,
C14898,"4,4a,5,6,7,8-Hexahydro-6-(p-hydroxyphenyl)-2(3H)-naphthalenone",,,,,
C14899,3-Dehydro-L-gulonate 6-phosphate,,,,,
C14900,"6-(1,2,3,4-Tetrahydro-6-methoxy-2-naphthyl)-2(1H)-pyridone",,,,,
C14901,"1-Methyl-6-(1,2,3,4-tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridone",,,,,
C14902,"6-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)-2(1H)-pyridone",,,,,
C14903,"2,3-Bis(p-hydroxyphenyl)acrylonitrile",,,,,
C14904,alpha-(p-Methoxyphenyl)-3-pyridineacrylonitrile,,,,,
C14905,2-Chloro-beta-(4-chlorophenyl)phenethyl alcohol,,,,,
C14906,"(5alpha,17beta)-3-Methyl-androst-2-en-17-ol",,,,,
C14907,"7alpha,17beta-Dihydroxyandrosta-1,4-dien-3-one",,,,,
C14908,"3-Ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one",,,,,
C14909,"9alpha-Hydroxyandrosta-1,4-diene-3,17-dione",,,,,
C14910,"4,4-Difluoro-17beta-hydroxy-17alpha-methyl-androst-5-en-3-one",,,,,
C14911,17beta-Hydroxy-2-oxa-5alpha-androstan-3-one,,,,,
C14912,"1,2,4,5-Tetrahydrotestolactone;|D-Homo-17a-oxa-5alpha-androstane-3,17-dione",,,,,
C14913,17beta-Hydroxy-4-oxa-5alpha-androstan-3-one acetate,,,,,
C14914,"3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine",,,,,
C14915,"3-(2,4-Cyclopentadien-1-ylidene)-5alpha-androstan-17beta-ol",,,,,
C14916,Nirvanol,,,,,
C14917,"9-Thiocyanato-androst-4-ene-3,11,17-trione",,,,,
C14918,"9-Bromo-16alpha-methyl-pregn-4-ene-3,11,20-trione",,,,,
C14919,17beta-Hydroxy-2alpha-(methoxymethyl)-17-methyl-5alpha-androstan-3-one,,,,,
C14920,"N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)acetamide",,,,,
C14921,3-Oxo-N-phenyl-N-(phenylmethyl)butanamide,,,,,
C14922,"15beta-Hydroxy-7alpha-mercapto-pregn-4-ene-3,20-dione 7-acetate",,,,,
C14923,"12alpha-(Chloromethyl)-12-hydroxy-pregn-4-ene-3,20-dione",,,,,
C14924,"3beta,21-Dihydroxy-pregna-5,7,9(11)-trien-20-one diacetate",,,,,
C14925,"17beta-Hydroxy-2-methylandrost-1,4-dien-3-one",,,,,
C14926,"3-Hydroxy-2-(4-morpholinylmethyl)estra-1,3,5(10)-trien-17-one;|2-Morpholinomethylestrone",,,,,
C14927,"N-(6-Oxo-6H-dibenzo[b,d]pyran-2-yl)methanesulfonamide",,,,,
C14928,17-[[3-(1-Pyrrolidinyl)propyl]imino]androst-5-en-3beta-ol acetate,,,,,
C14929,17beta-Hydroxy-16alpha-methoxy-androst-4-en-3-one,,,,,
C14930,"3-Methoxy-androsta-3,5-diene-7,17-dione",,,,,
C14931,"16-Butyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol",,,,,
C14932,11beta-Hydroxy-5alpha-androstan-17-one,,,,,
C14933,17-Propyl-5alpha-androst-2-en-17beta-ol,,,,,
C14934,"16-Propyl-3-methoxy-estra-1,3,5(10)-triene-16beta,17beta-diol",,,,,
C14935,m-(beta-Acetyl-alpha-ethyl-p-hydroxyphenethyl)benzoic acid,,,,,
C14936,2-(p-Methoxyphenyl)-3-(m-chlorophenyl)acrylonitrile,,,,,
C14937,"6beta-(Dimethylamino)-3beta,5-dihydroxy-5alpha-pregnan-20-one",,,,,
C14938,N-[(4-Chlorophenyl)methyl]-N-ethyl-2-pyridinamine,,,,,
C14939,"11beta-17-Dihydroxy-6alpha-methylpregn-4-ene-3,20-dione;|6alpha-Methyl-11beta,17alpha-dihydroxyprogesterone",,,,,
C14940,"2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14940  2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14942,"2-(2,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14942  2-(2,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C14942  2-(2,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14943,"2-(2,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14943  2-(2,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14944,"2-(3,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14944  2-(3,5-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14945,"3-Methoxy-16-methyl-estra-2,5(10)-diene-16beta,17beta-diol",,,,,
C14946,1-Dehydro-15alpha-hydroxytestololactone,,,,,
C14947,"17-Propylestra-1,3,5(10)-triene-3,17beta-diol diacetate",,,,,
C14948,"2-(4-Ethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14948  2-(4-Ethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14949,"3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one",,,,,
C14950,"3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one",,,,,
C14951,"3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one",,,,,
C14952,"3-Amino-6H-dibenzo[b,d]pyran-6-one",,,,,
C14953,"2-(3,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14953  2-(3,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C14953  2-(3,4,5-Trimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14954,"17-Methylandrosta-4,6-diene-3beta,17beta-diol 3-acetate",,,,,
C14955,"17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate",,,,,
C14956,3alpha-Hydroxy-2alpha-methyl-5alpha-androstan-17-one;|2alpha-Methylandrosterone,,,,,
C14957,3beta-(Acetyloxy)-5beta-methyl-6beta-chloroestr-9-en-17-one,,,,,
C14958,17a-Aza-D-homoandrost-5-en-3beta-ol,,,,,
C14959,"Estra-1,3,5(10),16-tetraen-3-ol benzoate",,,,,
C14960,"1alpha,5alpha-Dimercaptoandrostane-3alpha,17beta-diol",,,,,
C14961,3beta-Hydroxy-16beta-(hydroxymethyl)-5alpha-androstan-17-one,,,,,
C14962,"17-Hydroxy-5alpha,17alpha-pregn-1-en-3-one",,,,,
C14963,"2-[4-(Acetyloxy)phenyl]-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14963  2-[4-(Acetyloxy)phenyl]-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one",
C14964,"11alpha-Hydroxy-12alpha-methyl-pregn-4-ene-3,20-dione",,,,,
C14965,"N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)methanesulfonamide",,,,,
C14966,17beta-[Bis(2-hydroxyethyl)amino]androst-5-en-3beta-ol,,,,,
C14967,1-[2-Bromo-1-(4-chlorophenyl)ethenyl]-2-chlorobenzene,,,,,
C14968,"3-(2,4-Cyclopentadien-1-ylidene)pregn-4-en-20-one",,,,,
C14969,"4',6-Dihydroxy-5,7-dimethoxyflavanone;|2,3-Dihydro-6-hydroxy-2-(4-hydroxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14969  4',6-Dihydroxy-5,7-dimethoxyflavanone",
C14970,"2alpha-(Hydroxymethyl)-5alpha-androstane-3beta,17beta-diol",,,,,
C14971,"N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)-2,2,2-trifluoroacetamide",,,,,
C14972,"3-Deoxyestrone;|Adopron;|Estra-1,3,5(10)-trien-17-one",,,,,
C14973,17beta-Hydroxy-7alpha-mercaptoandrost-4-en-3-one 7-propionate;|S-(17beta-Hydroxy-3-oxoandrost-4-en-7alpha-yl)propanethioate,,,,,
C14974,"3-Methoxy-16-methylestra-1,3,5(10)-triene-16beta,17beta-diol 17-acetate",,,,,
C14975,D-Homo-17a-oxa-5alpha-androstan-3beta-ol,,,,,
C14976,"3alpha,21-Dihydroxy-D-homo-5beta-pregn-17a(20)-en-11-one",,,,,
C14977,"2alpha-(Hydroxymethyl)-17-methyl-5alpha-androstane-3beta,17beta-diol",,,,,
C14978,17beta-Hydroxy-2alpha-(methoxymethyl)-5alpha-androstan-3-one,,,,,
C14979,3beta-Cyclopentyl-5alpha-androstan-17beta-ol,,,,,
C14980,"16beta-Methyl-D-homo-17a-oxa-5alpha-androstane-3,17-dione",,,,,
C14981,3beta-Fluoro-5beta-pregnan-20-one,,,,,
C14982,"6beta,17-Dimethyl-5alpha-androstane-3beta,17beta-diol",,,,,
C14983,"6beta-Hydroxy-D-homo-17a-oxaandrost-4-ene-3,17-dione",,,,,
C14984,"17-Hydroxy-3-oxo-19-nor-5beta,17alpha-pregnane-21-carboxylic acid, gamma-lactone",,,,,
C14985,"6-Hydroxy-4',5,7-trimethoxyflavone;|6-Hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14985  6-Hydroxy-4',5,7-trimethoxyflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C14985  6-Hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",
C14986,"2-(4-Hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one;|4'-Hydroxy-5,6,7-trimethoxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C14986  2-(4-Hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",
C14987,"2,3-Dihydroxycyclopentaneundecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0114 Carbocyclic fatty acids|C14987  2,3-Dihydroxycyclopentaneundecanoic acid",
C14988,"4-Nitroestra-1,3,5(10)-triene-3,17beta-diol;|4-Nitroestradiol",,,,,
C14990,"Cyclic-3,20-bis(1,2-ethanediyl acetal)-11alpha-(acetyloxy)-5alpha,6alpha-epoxypregnane-3,20-dione",,,,,
C14991,"3beta,21-Dihydroxy-4,4,14-trimethyl-5alpha-pregn-8-en-20-one",,,,,
C14992,"3-(Acetyloxy)-9-mercaptoandrosta-3,5-diene-11,17-dione",,,,,
C14994,"3-Methoxy-16-octylestra-1,3,5(10)-triene-16beta,17beta-diol",,,,,
C14995,"3-Methoxy-16-ethylestra-1,3,5(10)-triene-16beta,17beta-diol",,,,,
C14996,"12-(2,3-Dihydroxycyclopentyl)-2-dodecanone",,,,,
C14997,"6-Hydroxy-4',5,7-trimethoxyflavanone;|2,3-Dihydro-6-hydroxy-2-(4-methoxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C14997  6-Hydroxy-4',5,7-trimethoxyflavanone",
C14998,17beta-(1H-Imidazol-4-yl)androst-5-en-3beta-ol,,,,,
C14999,"10-Hydroxyestra-1,4-dien-3-one acetate",,,,,
C15000,17beta-(Benzoyloxy)-B-norandrost-4-en-3-one,,,,,
C15001,3beta-(Acetyloxy)-5alpha-androst-16-ene-16-carboxaldehyde,,,,,
C15002,"11alpha,15alpha-Dihydroxypregn-4-ene-3,20-dione",,,,,
C15003,17-Hydroxy-19-nor-17alpha-pregn-5(10)-en-3-one,,,,,
C15004,16beta-Chloro-17beta-hydroxyandrost-4-en-3-one;|16beta-Chlorotestosterone,,,,,
C15005,"4-Aminoestra-1,3,5(10)-triene-3,17beta-diol",,,,,
C15006,"2-Aminoestra-1,3,5(10)-triene-3,17beta-diol;|2-Aminoestradiol",,,,,
C15007,"2-Nitroestra-1,3,5(10)-triene-3,17beta-diol;|2-Nitroestradiol",,,,,
C15008,"1,2,3,4,4a,9,10,10a-Octahydro-6-hydroxy-7-isopropyl-1,4a-dimethyl-1-phenanthrenemethanol",,,,,
C15009,"17beta-Hydroxyandrost-4-ene-3,11-dione propionate",,,,,
C15010,"16beta-Chloroandrost-4-ene-3,17-dione",,,,,
C15011,"11beta,17beta-Dihydroxy-6alpha,17-dimethylandrost-4-en-3-one",,,,,
C15012,"17beta-Hydroxy-2,17-dimethyl-5alpha-androst-1-en-3-one",,,,,
C15013,"3beta-(1-Pyrrolidinyl)-5alpha-pregnane-11,20-dione",,,,,
C15014,"3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime",,,,,
C15015,"2beta,21-Dihydroxypregn-4-ene-3,20-dione",,,,,
C15016,"19-Norpregna-4,17(20)-dien-3-one",,,,,
C15017,17beta-Hydroxy-5alpha-androst-2-ene-2-carboxaldehyde,,,,,
C15018,"3-Hydroxy-2-nitroestra-1,3,5(10)-trien-17-one;|2-Nitroestrone",,,,,
C15019,"4'-Hydroxy-5,6,7-trimethoxyflavanone;|2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C15019  4'-Hydroxy-5,6,7-trimethoxyflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C15019  2,3-Dihydro-2-(4-hydroxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",
C15020,"17beta-Methylestra-1,3,5(10)-trien-3-ol",,,,,
C15021,"4,4'-(Diphenylethenylidene)bis[N,N-dimethylbenzenamine]",,,,,
C15022,"11alpha,17beta-Dihydroxy-2alpha,17-dimethylandrost-4-en-3-one",,,,,
C15023,19-Chloro-3beta-hydroxyandrost-5-en-17-one acetate,,,,,
C15024,19-Chloro-17beta-hydroxyandrost-4-en-3-one,,,,,
C15025,(S)-Carnitine;|D-Carnitine,,,,,
C15026,"L-365260;|N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea",,,,,
C15027,"2,2-Dimethyl-3,4-bis(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate",,,,,
C15028,"alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol",,,,,
C15029,"3,6-Dimethoxy-19-norpregna-1,3,5,7,9-pentaen-20-one",,,,,
C15030,"3,6-Dimethoxyestra-1,3,5(10),6,8-pentaene-17beta-carboxylic acid methyl ester",,,,,
C15031,"Nortangeretin;|2-(4-Hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one;|5,6,7,8,4'-Pentahydroxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C15031  Nortangeretin,
C15032,1-(4-Methoxyphenyl)-3-(4-morpholinyl)-1-propanone;|4'-Methoxy-3-morpholino-propiophenone,,,,,
C15033,"Hydroxystenozole;|17alpha-Methyl-2'H-androsta-2,4-dieno[3,2-c]pyrazol-17beta-ol",,,,,
C15034,"16alpha-Hydroxycorticosterone;|11beta,16alpha,21-Trihydroxypregn-4-ene-3,20-dione",,,,,
C15035,17beta-Hydroxy-2alpha-(hydroxymethyl)-5alpha-androstan-3-one,,,,,
C15036,"2alpha-Methyl-5alpha-androstane-3,17-dione",,,,,
C15037,"Oplophorus luciferin;|8-Benzyl-2-(4-hydroxybenzyl)-6-(4-hydroxyphenyl)imidazo-[1,2a]pyrazin-3(7H)-one;|Coelenterazine",,,,,
C15038,Oxidized Oplophorus luciferin;|Coelenteramide,,,,,
C15039,3-(m-Aminophenyl)-2-(p-methoxyphenyl)acrylonitrile,,,,,
C15040,"GYKI 52466;|4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine",,,,,
C15041,"17-Methylandrost-5-ene-3beta,11beta,17beta-triol",,,,,
C15042,4-(2-Pyrazinylethenyl)phenol,,,,,
C15043,2-[2-(4-Pyridinyl)-1-butenyl]phenol,,,,,
C15044,"2,3-Dimethoxy-[2-(4-Pyridinyl)-1-butenyl]phenol;|4-[1-[(2,3-Dimethoxyphenyl)methylene]propyl]pyridine",,,,,
C15045,4-Chloro-[2-(4-Pyridinyl)-1-butenyl]phenol;|4-[1-[(4-Chlorophenyl)methylene]propyl]pyridine,,,,,
C15046,"Pregna-5,16,20-triene-3beta,20-diol diacetate",,,,,
C15047,"11,17-Dimethyl-5alpha-androstane-11beta,17beta-diol",,,,,
C15048,7-(Acetyloxy)-3-(3-pyridinyl)-2H-1-benzopyran-2-one,,,,,
C15049,(2-Butylbenzofuran-3-yl)(4-hydroxyphenyl)ketone;|2-Butyl-3-(4-hydroxybenzoyl)benzofuran,,,,,
C15050,"2,2-Dimethyl-3-[4-(acetyloxy)phenyl]-4-ethyl-2H-1-benzopyran-7-ol acetate;|4-Ethyl-3-(p-hydroxyphenyl)-2,2-dimethyl-2H-1-benzopyran-7-ol diacetate",,,,,
C15051,7-Hydroxy-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-2-one;|7-Hydroxy-3-(4-methoxyphenyl)-4-propylcoumarin,,,,,
C15052,7-Hydroxy-3-(4-methoxyphenyl)-4-methylcoumarin;|7-Hydroxy-3-(4-methoxyphenyl)-4-methyl-2H-1-benzopyran-2-one,,,,,
C15053,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-propyl-2H-1-benzopyran-7-ol acetate",,,,,
C15054,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol",,,,,
C15055,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-2H-1-benzopyran-7-ol acetate",,,,,
C15056,"2,2,4-Trimethyl-3-(4-fluorophenyl)-2H-1-benzopyran-7-ol acetate",,,,,
C15057,"3-Ethoxyandrosta-3,5-dien-17beta-ol propanoate",,,,,
C15058,"2alpha-Methyl-5alpha-androstane-3beta,17beta-diol",,,,,
C15059,"2,2,4-Trimethyl-3-(4-methoxyphenyl)-2H-1-benzopyran-7-ol acetate",,,,,
C15060,"7-Methoxy-2,2,4-trimethyl-3-(4-methoxyphenyl)-2H-1-benzopyran",,,,,
C15061,"2,2-Dibutyl-3-(4-methoxyphenyl)-4-methyl-2H-1-benzopyran-7-ol acetate",,,,,
C15062,"17beta-Hydroxy-3-methoxyestra-1,3,5(10)-triene-17-carbonitrile",,,,,
C15063,"3-Methoxy-D-homoestra-1,3,5(10),8,14-pentaen-17abeta-ol",,,,,
C15064,17beta-(Hydroxymethyl)androst-4-en-3-one acetate,,,,,
C15065,"9-Fluoro-11beta-hydroxy-A-norpregn-3(5)-ene-2,20-dione",,,,,
C15066,"alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C15066  alpha,alpha'-Diethyl-4,4'-bis(2-propynyloxy)stilbene",
C15067,4-Chloro-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol,,,,,
C15068,17beta-Hydroxy-4-oxa-5alpha-androst-1-en-3-one acetate,,,,,
C15069,"4,4'-(Butane-1,1-diyl)diphenol;|1,1-Bis(4-hydroxyphenyl)butane",,,,,
C15070,"17beta-Hydroxy-1,17-dimethylestr-5(10)-en-3-one",,,,,
C15071,"6beta-Fluoro-5alpha-hydroxypregnane-3,20-dione",,,,,
C15072,"6beta,19-Epoxy-17beta-hydroxyandrost-4-en-3-one",,,,,
C15073,"17alpha-Chloroethynylestradiol;|21-Chloro-19-nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol",,,,,
C15074,16alpha-Fluoro-17alpha-hydroxyandrost-4-en-3-one,,,,,
C15075,3-Fluoro-1-(4-hydroxyphenyl)-1-propanone,,,,,
C15076,"5,6,7,4'-Tetramethoxyisoflavone;|3-(4-Methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C15076  5,6,7,4'-Tetramethoxyisoflavone",
C15077,1-Phenyl-3-(phenylsulfonyl)-2-propen-1-one;|3-(Phenylsulfonyl)acrylophenone,,,,,
C15078,"3-Methoxyestra-1,3,5(10)-triene-16,17-dione 16-oxime;|3-Methoxyestra-1,3,5(10)-trien-16-oximino-17-one",,,,,
C15079,"9-Fluoro-11beta-hydroxypregna-4,16-diene-3,20-dione",,,,,
C15080,"4-Benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalcone",,,,,
C15081,"trans-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid ethyl ester",,,,,
C15082,4-(1-Ethyl-2-phenylbutyl)phenol,,,,,
C15083,1-Chloro-2-[1-(4-chlorophenyl)ethenyl]benzene,,,,,
C15084,"2,3-Diphenyl-3-(2-pyridinyl)acrylonitrile",,,,,
C15085,"17-Methyl-18-norandrosta-4,13(17)-dien-3-one",,,,,
C15086,"3-Allyloxyestra-1,3,5(10),7-tetraene-16,17-dione dioxime",,,,,
C15087,"3-Hydroxyestra-1,3,5(10),7-tetraene-16,17-dione 16-oxime",,,,,
C15088,4-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|4-Fluorotestosterone propionate,,,,,
C15089,"1,6-Dihydro-1-(3-methoxyphenethyl)-6-oxonicotinic acid",,,,,
C15090,"17-Hydroxy-3-oxo-17alpha-pregna-1,4-diene-21-carboxylic acid, gamma-lactone",,,,,
C15091,"9-Fluoro-17beta-hydroxy-6alpha,17-dimethylandrost-4-ene-3,11-dione",,,,,
C15092,"9-Fluoro-11beta,17beta-dihydroxy-16alpha-methylandrosta-1,4-dien-3-one",,,,,
C15093,3beta-Fluoroandrost-5-en-17beta-ol,,,,,
C15094,"GYKI 52895;|4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine",,,,,
C15095,"Coumestrol diacetate;|3,9-Diacetoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one",,,,,
C15096,"GV 150013X;|N-Phenyl-N'-[(3R)-2,3,4,5-tetrahydro-2,4-dioxo-1-phenyl-5-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-1H-1,5-benzodiazepin-3-yl]urea",,,,,
C15097,"Androst-5-ene-3beta,17beta,19-triol",,,,,
C15098,"21-Fluoro-11beta-hydroxypregn-4-ene-3,20-dione;|21-Fluoro-11beta-hydroxyprogesterone",,,,,
C15099,"17beta-Hydroxy-2alpha,17-dimethyl-5alpha-androstan-3-one;|2alpha,17alpha-Dimethyldihydrotestosterone",,,,,
C15100,"4',6-Dihydroxy-5,7-dimethoxyflavone;|6-Hydroxy-2-(4-hydroxyphenyl)-5,7-dimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C15100  4',6-Dihydroxy-5,7-dimethoxyflavone",
C15101,17-Methyl-5-alpha-androst-2-en-17-beta-ol,,,,,
C15102,"1,2,3,4-Tetrahydro-4-oxo-1-naphthoic acid",,,,,
C15103,"11alpha,17beta-Dihydroxy-1,4-androstadien-3-one",,,,,
C15104,LY-202769;|2-[2-(5-Chloro-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4(3H)-quinazolinone,,,,,
C15105,"9-Fluoro-16alpha-hydroxyandrost-4-ene-3,11,17-trione",,,,,
C15106,3-Oxopregn-4-ene-20beta-carboxaldehyde dioxime,,,,,
C15107,"3-Methoxyestra-1,3,5(10),16-tetraene",,,,,
C15108,"17beta-Hydroxy-6alpha,17-dimethylandrost-4-en-3-one;|6alpha,17alpha-Dimethyltestosterone",,,,,
C15109,"Gardenin B;|5-Hydroxy-2-(4-methoxyphenyl)-6,7,8-trimethoxy-4H-1-benzopyran-4-one;|5-Hydroxy-4',6,7,8-tetramethoxyflavone;|Demethyltangeretin",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C15109  Gardenin B|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C15109  Gardenin B,
C15110,1-[6-Hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-3-yl]ethanone;|6-Hydroxy-2-(4-hydroxyphenyl)-3-benzofuranyl methyl ketone,,,,,
C15111,1-[2-(4-Hydroxyphenyl)-1-benzofuran-3-yl]ethanone;|2-(4-Hydroxyphenyl)-3-benzofuranyl methyl ketone,,,,,
C15112,"4,4-Difluoro-17beta-hydroxyandrost-5-en-3-one propionate",,,,,
C15113,"9-Fluoro-11beta,17beta-dihydroxy-2,17-dimethylandrost-4-en-3-one",,,,,
C15114,"3-Methoxy-5,10-seco-5,19-cycloandrosta-1(10),2,4-trien-17-one;|3-Methoxy-5,19-cyclo-5,10-secoandrosta-1(10),2,4-trien-17-one",,,,,
C15115,"11beta-Hydroxy-6alpha,11-dimethylpregn-4-ene-3,20-dione;|11beta-Hydroxy-6alpha,11-dimethylprogesterone",,,,,
C15116,"2alpha-Methylpregn-4-ene-3,20-dione;|2alpha-Methylprogesterone",,,,,
C15117,"3-Methyl-19-nor-17alpha-pregna-1,3,5(10)-trien-17-ol",,,,,
C15118,"4',5,6,7-Tetramethoxyflavanone;|2,3-Dihydro-2-(4-methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C15118  4',5,6,7-Tetramethoxyflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C15118  2,3-Dihydro-2-(4-methoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one",
C15119,B-Norcholest-4-en-3-one,,,,,
C15120,alpha-(p-Methoxyphenyl)-4-pyridineacrylic acid,,,,,
C15121,alpha-(p-Methoxyphenyl)-2-pyridineacrylonitrile,,,,,
C15122,alpha-(p-Methoxyphenyl)-6-methyl-2-pyridineacrylic acid,,,,,
C15123,"1,1-Dichloro-2,2-diphenylethane",,,,,
C15124,"3-Methoxy-D-homoestra-1,3,5(10),8-tetraen-17a-one",,,,,
C15125,N-(Cyclohexylmethyl)-N-methylbenzenamine;|N-Methyl-N-phenylcyclohexanemethylamine,,,,,
C15126,"2,17beta-Dihydroxy-17-methylandrosta-1,4-dien-3-one",,,,,
C15127,"6alpha-Fluoropregn-4-ene-3,20-dione;|6alpha-Fluoroprogesterone",,,,,
C15128,"1'H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol",,,,,
C15129,"Estra-1,3,5(10)-triene-2,17beta-diol;|2-Hydroxy-3-deoxyestradiol",,,,,
C15130,"6beta,19-Epoxypregn-4-ene-3,20-dione",,,,,
C15131,"2,5-Dimethoxystilbene;|1,4-Dimethoxy-2-(2-phenylethenyl)benzene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C15131  2,5-Dimethoxystilbene",
C15132,"11alpha,12alpha-Epoxy-5beta-pregnane-3,20-dione",,,,,
C15133,"4-Methyl-4-aza-5-pregnene-3,20-dione",,,,,
C15134,"3-(1,2,3,4-Tetrahydro-6-hydroxy-2-naphthyl)cyclopentanone",,,,,
C15135,3beta-Hydroxy-17-oxoandrost-5-en-19-al acetate,,,,,
C15136,3beta-Hydroxy-D-homo-17a-oxa-5alpha-androstan-17-one;|Isoandrololactone,,,,,
C15137,17beta-Hydroxy-2alpha-(hydroxymethyl)-17-methyl-5alpha-androstan-3-one,,,,,
C15138,"17beta-Methoxyandrost-5-ene-3beta,16beta-diol",,,,,
C15139,D-Homo-17a-oxa-5alpha-androstan-3beta-ol acetate,,,,,
C15140,"3,3-Difluoro-17-methyl-5alpha-androstan-17beta-ol",,,,,
C15141,N-(Phenylmethyl)-N-methyl-2-pyridinamine,,,,,
C15142,"3-Methoxy-D-homoestra-1,3,5(10),8-tetraen-17abeta-ol",,,,,
C15143,"(2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)ketone",,,,,
C15144,"16beta,17beta-Dihydroxy-16-methylestr-4-en-3-one",,,,,
C15145,"4,4-Bis[4-(acetyloxy)phenyl]3-hexanone;|4,4-Bis(4-hydroxyphenyl)-3-hexanone diacetate",,,,,
C15146,"Pregna-4,16-diene-3,11,20-trione",,,,,
C15147,"9-Fluoro-11beta-hydroxy-16alpha-methylandrosta-1,4-diene-3,17-dione",,,,,
C15148,"9-Fluoro-16alpha-methylpregn-4-ene-3,11,20-trione",,,,,
C15149,17beta-Acetamidoandrost-4-en-3-one,,,,,
C15150,"14-Hydroxyandrosta-1,4-diene-3,17-dione",,,,,
C15151,17beta-Hydroxy-4-oxa-5alpha-estr-1-en-3-one acetate,,,,,
C15152,"4,4-Difluoropregn-5-ene-3,20-dione",,,,,
C15153,"(-)-Methallenestrilphenol;|(-)-3-(6-Hydroxy-2-naphthyl)-2,2-dimethylpentanoic acid;|(-)-beta-Ethyl-6-hydroxy-alpha,alpha-dimethyl-2-naphthalenepropanoic acid",,,,,
C15154,"4beta,5beta-Epoxypregnane-3,20-dione",,,,,
C15155,"9-Bromo-11beta-hydroxy-16alpha-methylpregn-4-ene-3,20-dione",,,,,
C15156,3-Acetyl-5alpha-androst-2-en-17beta-ol,,,,,
C15157,"3-Acetyl-5alpha-androstane-3beta,17beta-diol 3-acetate",,,,,
C15158,3alpha-Ethynyl-3-hydroxy-5alpha-androstan-17-one,,,,,
C15159,"3beta,13-Dihydroxy-16-(hydroxymethylene)-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone",,,,,
C15160,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-6-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol",,,,,
C15161,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-7-hydroxy-2H-1-benzopyran-8-methanol diacetate",,,,,
C15162,"2,2-Dimethyl-3-(4-methoxyphenyl)-4-ethyl-8-(1-pyrrolidinylmethyl)-2H-1-benzopyran-7-ol",,,,,
C15163,"17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol",,,,,
C15164,"12alpha-Fluoro-11beta,17beta-dihydroxyandrost-4-en-3-one",,,,,
C15165,"12alpha-Fluoro-11beta,17beta-dihydroxyandrosta-1,4-dien-3-one",,,,,
C15166,"5alpha-Androstane-2alpha-fluoro-17beta-ol-3-one acetate;|(2alpha,5alpha,17beta)-17-(Acetyloxy)-2-fluoro-androstan-3-one",,,,,
C15167,"3-Methoxy-19-norpregna-1,3,5(10)-trien-20-one",,,,,
C15168,"4,4'-(2-Ethyl-1-butenylidene)diphenol;|1,1-Bis(4-hydroxyphenyl)-2-ethyl-1-butene",,,,,
C15169,"16alpha-Fluoroandrost-4-ene-3,17-dione",,,,,
C15170,"17-Methyl-18,19-dinor-17alpha-pregna-4,13-dien-3-one",,,,,
C15171,17beta-Hydroxyestr-4-en-3-one benzoate;|Nandrolone benzoate,,,,,
C15172,"6alpha-Fluoro-11beta,17-dihydroxypregn-4-ene-3,20-dione;|6alpha-Fluoro-11beta,17-dihydroxyprogesterone",,,,,
C15173,3beta-Hydroxy-16-phosphonopregn-5-en-20-one monoethyl ester;|(3beta-Hydroxy-20-oxopregn-5-en-16-yl)phosphonic acid monoethyl ester,,,,,
C15174,"Estra-1,3,5-(10)-trien-17-one-3-oxyacetic acid;|3-O-(Carboxymethyl)estrone",,,,,
C15175,"17beta-Hydroxy-4,17-dimethyl-4-azaandrost-5-en-3-one",,,,,
C15176,"17-Methyl-5alpha-androst-2-ene-1alpha,17beta-diol",,,,,
C15177,"17-Methylandrosta-2,4-dieno[2,3-d]isoxazol-17beta-ol",,,,,
C15178,5-Nitro-2-furancarboxaldehyde (2-hydroxyethyl)hydrazone,,,,,
C15179,"1,1-Diphenyl-2-(4-methoxyphenyl)propene",,,,,
C15180,17beta-Hydroxy-4-mercaptoandrost-4-en-3-one 4-acetate 17-propionate,,,,,
C15181,Wortmannin,,,,,
C15182,Temsirolimus;|CCI 779;|42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06068)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01E PROTEIN KINASE INHIBITORS|L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors|L01EG01 Temsirolimus|D06068  Temsirolimus (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D06068)]|Antineoplastics|Molecular Target Inhibitors|Temsirolimus|D06068  Temsirolimus (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D06068)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D06068  Temsirolimus (JAN/USAN/INN)|Drug groups [BR:br08330(D06068)]|Antineoplastic|DG01597  mTOR inhibitor|D06068  Temsirolimus|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D06068  Temsirolimus|Drug classes [BR:br08332(D06068)]|Antineoplastic|DG01597  mTOR inhibitor|D06068  Temsirolimus|Target-based classification of drugs [BR:br08310(D06068)]|Protein kinases|Serine/threonine kinases|Other|MTOR|D06068  Temsirolimus (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D06068)]|New molecular entities and new therapeutic biological products|D06068|New drug approvals in Europe [br08329.html(D06068)]|European public assessment reports (EPAR) authorised medicine|D06068|New drug approvals in Japan [br08318.html(D06068)]|Drugs with new active ingredients|D06068|New drug approvals in the USA, Europe and Japan [br08328.html(D06068)]|Approval dates by FDA, EMA and PMDA|D06068|Drug metabolizing enzymes and transporters [br08309.html(D06068)]|Drug metabolizing enzymes|D06068",
C15183,AP 23573;|42-(Dimethylphosphinate)rapamycin;|Deforolimus,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08900)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01E PROTEIN KINASE INHIBITORS|L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors|L01EG03 Ridaforolimus|D08900  Ridaforolimus (JAN/USAN/INN)|Drug groups [BR:br08330(D08900)]|Antineoplastic|DG01597  mTOR inhibitor|D08900  Ridaforolimus|Target-based classification of drugs [BR:br08310(D08900)]|Protein kinases|Serine/threonine kinases|Other|MTOR|D08900  Ridaforolimus (JAN/USAN/INN),
C15184,17beta-Hydroxy-6alpha-methylandrost-4-en-3-one;|6alpha-Methyltestosterone,,,,,
C15185,"21-Acetyloxy-17-hydroxypregna-1,4-diene-3,20-dione;|11-Deoxyprednisone acetate",,,,,
C15186,"5alpha,17alpha-Pregn-2-en-20-yn-17-ol acetate;|17alpha-Ethynyl-5alpha-androst-2-en 17beta-acetate",,,,,
C15187,"11beta,12beta-Epoxypregn-4-ene-3,20-dione;|11beta,12beta-Epoxyprogesterone",,,,,
C15188,"19-Nor-5alpha-pregnane-3,20-dione",,,,,
C15189,3-(4-Chlorophenyl)-2H-1-benzopyran-2-one;|3-(p-Chlorophenyl)coumarin,,,,,
C15190,"12alpha-Methylpregna-4,9(11)-diene-3,20-dione",,,,,
C15191,(2-Isopropyl-1-benzofuran-3-yl)(4-hydroxyphenyl)methanone;|2-Isopropyl-3-(4-hydroxybenzoyl)benzofuran,,,,,
C15192,"9beta,11beta-Epoxy-17beta-hydroxy-17-methylandrost-4-en-3-one",,,,,
C15193,2-[3-Ethyl-5-(4-methoxyphenyl)-1H-pyrazol-4-yl]phenol,,,,,
C15194,"Androsta-4,9(11)-diene-3,17-dione;|9(11)-Dehydroandrostenedione",,,,,
C15195,LY 294002;|2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,,,,,
C15196,"3,4-Dihydro-8,9-dihydroxy-1(2H)-anthracenone",,,,,
C15197,17beta-Pyrazol-3-ylandrost-5-en-3beta-ol,,,,,
C15198,"3-Ethyl-5alpha-androstane-3alpha,17beta-diol",,,,,
C15199,"3-Ethynyl-5alpha-androstane-3beta,17beta-diol",,,,,
C15200,"9beta,11beta-Epoxyandrost-4-ene-3,17-dione",,,,,
C15201,"5beta-Estrane-3alpha,17beta-diol;|19-Nor-5beta-androstane-3alpha,17beta-diol",,,,,
C15202,2'-Chloro-4-biphenylol,,,,,
C15203,6-Hydroxy-2'-methoxyflavone;|6-Hydroxy-2-(2-methoxyphenyl)-4H-1-benzopyran-4-one,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C15203  6-Hydroxy-2'-methoxyflavone,
C15204,3'-Hydroxyflavanone,Generic compound in reaction hierarchy,,,,
C15205,Diisobutyl phthalate;|DIBP,,,,,
C15206,"3,3-Bis(4-hydroxyphenyl)pentane;|4,4'-(1-Ethylpropane-1,1,-diyl)diphenol",,,,,
C15207,17beta-Estradiol-3-(beta-D-glucuronide) 17-sulfate;|Estradiol 3-glucuronide 17beta-sulfate,,,,,
C15208,"Bisphenol A bis(2-hydroxypropyl) ether;|Bisphenol A propoxylate;|2,2-Bis[4-(2-hydroxy-2-methylethoxy)phenyl]propane",,,,,
C15209,Bisphenol A ethoxylate diacrylate,,,,,
C15210,"1,1-Bis(4-hydroxyphenyl)propane",,,,,
C15211,"4,4-Bis(4-hydroxyphenyl)heptane",,,,,
C15212,"2,2',5-Trichloro-4-hydroxybiphenyl",,,,,
C15213,"2,2',3',4,4',5,5'-Heptachloro-3-biphenylol",,,,,
C15214,"alpha-Hexachlorocyclohexane;|alpha-HCH;|1alpha,2alpha,3beta,4alpha,5beta,6beta-Hexachlorocyclohexane;|alpha-Lindane",,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C15214  alpha-Hexachlorocyclohexane,
C15215,"3-Hydroxyestra-1,3,5(10)-trien-16-one",,,,,
C15216,"3-Methoxyestriol;|Estriol 3-methyl ether;|3-Methoxyestra-1,3,5(10)-triene-16alpha,17beta-diol",,,,,
C15217,4-[1-Ethyl-2-(4-methylphenyl)butyl]phenol;|3-(p-Phenyl)-4-(p-tolyl)hexane,,,,,
C15218,"2,2',4,4'-Tetrahydroxybenzil;|Bis(2,4-dihydroxyphenyl)ethanedione",,,,,
C15219,"2,6-Dimethylhexestrol;|4-[1-Ethyl-2-(4-hydroxyphenyl)butyl]-3,5-dimethylphenol",,,,,
C15220,2-Chloro-4-methylphenol;|2-Chloro-p-cresol,,,,,
C15221,Diisononyl phthalate,,,,,
C15222,"3,6,4'-Trihydroxyflavone;|3,6-Dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C15222  3,6,4'-Trihydroxyflavone",
C15224,Tributyltin chloride;|Tri-n-butylchlorotin;|Tributylchlorostannane,,,,,
C15226,Thallium chloride;|Thallous chloride,,,,,
C15227,Potassium dichromate,,,,,
C15228,"beta-Estradiol 17-acetate;|Estra-1,3,5(10)-triene-3,17beta-diol 17-acetate;|17beta-Acetylestradiol",,,,,
C15229,Ziram,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Dithiocarbamate pesticides|C15229  Ziram|Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C15229  Ziram,
C15230,"Iprobenfos;|IBP;|Kitazin P;|S-Benzyl O,O-diisopropyl phosphorothioate",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organophosphorus fungicides|C15230  Iprobenfos,
C15231,Maneb,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Dithiocarbamate pesticides|C15231  Maneb|Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C15231  Maneb,
C15232,Zineb,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Dithiocarbamate pesticides|C15232  Zineb|Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C15232  Zineb,
C15233,Cadmium chloride,,,,,
C15234,Lead nitrate,,,,,
C15235,Antimony trichloride;|Antimony(III) chloride;|Trichlorostibine,,,,,
C15236,"8-Hydroxy-2,3,4-trichlorodibenzofuran",,,,,
C15237,8-Hydroxy-2-chlorodibenzofuran;|8-Chloro-2-dibenzofuranol,,,,,
C15238,"8-Hydroxy-3,4,6-trichlorodibenzofuran;|4,6,7-Trichloro-2-dibenzofuranol",,,,,
C15239,"8-Hydroxy-3,4-dichlorodibenzofuran;|6,7-Dichloro-2-dibenzofuranol",,,,,
C15240,"6-Hydroxy-3,4-dichlorodibenzofuran;|6,7-Dichloro-4-dibenzofuranol",,,,,
C15241,8-Hydroxy-3-chlorodibenzofuran;|7-Chloro-2-dibenzofuranol,,,,,
C15242,"8-Chloro-2,7-dibenzofurandiol;|3,8-Dihydroxy-2-chlorodibenzofuran",,,,,
C15243,"3-Hydroxy-2,8-dichlorodibenzofuran;|2,8-Dichloro-3-dibenzofuranol",,,,,
C15244,"7-Hydroxy-1,2,3,6,8-pentachlorodibenzofuran;|2,4,7,8,9-Pentachloro-3-dibenzofuranol",,,,,
C15245,"7-Hydroxy-3,4-dichlorodibenzofuran;|6,7-Dichloro-3-dibenzofuranol",,,,,
C15246,"9-Hydroxy-3,4-dichlorodibenzofuran;|6,7-Dichloro-1-dibenzofuranol",,,,,
C15247,"9-Hydroxy-2,6-dichlorodibenzofuran;|4,8-Dichloro-1-dibenzofuranol",,,,,
C15248,"4-Hydroxy-2',3,5,5'-tetrachlorobiphenyl;|2',3,5,5'-Tetrachloro-4-biphenylol",,,,,
C15249,"2-(3,5-Dichlorophenylcarbamoyl)-1,2-dimethylcyclopropane-1-carboxylic acid",,,,,
C15250,"3-(3,4-Dichlorophenyl)-1-hydroxy-1-methylurea;|Hydroxylinuron",,,,,
C15251,3-Aza-A-homocholest-4a-en-4-one,,,,,
C15252,"17beta-Hydroxy-4alpha-methyl-5alpha-androstan-3-one;|4,5alpha-Dihydro-4alpha-methyltestosterone",,,,,
C15253,16beta-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|16beta-Fluorotestosterone propionate,,,,,
C15254,"3-(Allyloxy)estra-1,3,5(10)-triene-16alpha,17beta-diol;|3-(2-Propenyloxy)estra-1,3,5(10)-triene-16alpha,17beta-diol;|3-Allyloxyestriol",,,,,
C15255,"1-Methylestra-1,3,5(10),6-tetraene-3,17beta-diol",,,,,
C15256,"6alpha-Fluoro-17-hydroxycorticosterone 21-acetate;|6alpha-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate",,,,,
C15257,17beta-Hydroxyestr-5(10)-en-3-one;|Prenortestosterone,,,,,
C15258,17beta-Hydroxy-2alpha-methylestr-4-en-3-one;|2alpha-Methyl-19-nortestosterone,,,,,
C15259,"17beta-Hydroxy-2alpha,17-dimethylestr-4-en-3-one;|2alpha,17-Dimethyl-19-nortestosterone",,,,,
C15260,"5beta-Pregn-11-ene-3,20-dione",,,,,
C15261,"Estra-1,3,5(10)-triene-3,16beta-diol;|16beta-Estradiol",,,,,
C15262,"3-Methoxyestra-1,3,5(10)-trien-16beta-ol;|16beta-Estradiol-3-methyl ether",,,,,
C15263,"A-Norpregn-3(5)-ene-2,20-dione;|A-Norprogesterone",,,,,
C15264,17beta-Hydroxy-5alpha-androstane acetate;|17beta-Acetoxy-5alpha-androstane,,,,,
C15265,"16beta-Methylpregn-4-ene-3,20-dione;|16beta-Methylprogesterone",,,,,
C15266,17abeta-Hydroxy-D-homoandrost-4-en-3-one propionate;|D-Homotestosterone propionate,,,,,
C15267,"(17Z)-3,11-Dioxopregna-4,17(20)-dien-21-oic acid methyl ester",,,,,
C15268,"trans-2-(4-Nitrophenyl)-3-phenyloxirane;|trans- alpha,alpha'-Epoxy-4-nitrobibenzyl;|trans-4-Nitrostilbene oxide",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C15268  trans-2-(4-Nitrophenyl)-3-phenyloxirane",
C15269,"9-Fluoro-11beta,17,21-trihydroxy-2alpha-methylpregn-4-ene-3,20-dione 21-acetate;|9-Fluoro-2alpha-methylcortisol 21-acetate",,,,,
C15270,"Cycloguanil hydrochloride;|1-(4-Chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine monohydrochloride",,,,,
C15271,"9-Fluoro-2alpha-methylpregn-4-ene-3,11,20-trione;|9-Fluoro-2alpha-methyl-11-oxoprogesterone",,,,,
C15272,"3alpha,12alpha-Dihydroxy-5beta-pregnan-20-one diacetate",,,,,
C15273,17beta-Hydroxy-5alpha-androst-1-en-3-one propionate,,,,,
C15274,"Allobetulin;|Allobetulinol;|19beta,28-Epoxy-18alpha-oleanan-3beta-ol",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C15274  Allobetulinol,
C15275,"21-Acetoxy-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione;|17-Hydroxy-6alpha-methylcorticosterone 21-acetate",,,,,
C15276,2alpha-Fluoro-17beta-hydroxyandrost-4-en-3-one;|2alpha-Fluorotestosterone,,,,,
C15277,"3-Hydroxy-19-norpregna-1,3,5(10)-trien-20-one",,,,,
C15278,"4,4'-(2-Methylpropylidene)bisphenol;|4,4'-Isobutylidenediphenol",,,,,
C15279,2-Amino-6-(benzylthio)purine;|6-Benzylthioguanine;|Benzythioguanine,,,,,
C15280,"16alpha,17-Isopropylidenedioxy-6alpha-methylprogesterone;|16alpha,17-Dihydroxy-6alpha-methylpregn-4-ene-3,20-dione cyclic acetal with acetone",,,,,
C15281,17beta-Nitro-5alpha-androstane,,,,,
C15282,17beta-Hydroxyestr-5(10)-en-3-one acetate;|19-Norandrost-5(10)-en-17beta-acetoxy-3-one,,,,,
C15283,17beta-Hydroxy-5alpha-androstan-3-one cyclohexanecarboxylate,,,,,
C15284,"6beta,17beta-Dihydroxyandrost-4-en-3-one diacetate;|6beta-Hydroxytestosterone diacetate",,,,,
C15285,"17alpha-Methyl-5alpha-androstane-3beta,11beta,17beta-triol;|U6952",,,,,
C15286,"4beta,5-Epoxy-17beta-hydroxy-5beta-androstan-3-one;|4beta,5beta-Epoxytestosterone",,,,,
C15287,"11beta,17beta-Dihydroxy-17alpha-methylandrosta-1,4-dien-3-one",,,,,
C15288,"5alpha-Androstane-11beta,17beta-diol",,,,,
C15289,"16alpha,17beta-Dihydroxyandrost-4-en-3-one dipropionate",,,,,
C15290,"2alpha,17beta-Dihydroxyandrost-4-en-3-one dipropionate;|2alpha-Hydroxytestosterone dipropionate",,,,,
C15291,"6alpha-Hydroxycortisol;|6alpha,11beta,17,21-Tetrahydroxypregn-4-ene-3,20-dione",,,,,
C15292,A-Nor-5alpha-cholestan-2-one,,,,,
C15293,"17beta-Hydroxyandrosta-4,9(11)-dien-3-one;|9(11)-Dehydrotestosterone",,,,,
C15294,"N-Methylindolo[3,2-b]-5alpha-cholest-2-ene;|1'-Methyl-1'H-5alpha-cholest-2-eno[3,2-b]indole",,,,,
C15295,"17beta-Hydroxy-3-methoxyestra-1,3,5(10)-trien-16-one;|16-Oxoestradiol 3-methyl ether",,,,,
C15296,"4,4'-Dinitrostilbene",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C15296  4,4'-Dinitrostilbene",
C15297,"2,4-Dinitro-1-(3-nitrophenoxy)benzene;|2,4-Dinitro-3'-nitrodiphenyl ether",,,,,
C15298,5alpha-Androstan-2-en-17beta-ol;|17beta-Hydroxy-5alpha-androst-2-ene,,,,,
C15299,"7alpha-Methyl-4-pregnene-3,20-dione;|7alpha-Methylprogesterone",,,,,
C15300,"Spiro[benzofuran-2(3H),1'-[2]cyclohexene]-7-chloro-4,6-dimethoxy-6'-methyl-2'-(methylthio)-3,4'-dione",,,,,
C15301,"2alpha-Methylpregn-4-ene-3,11,20-trione;|2alpha-Methyl-11-oxoprogesterone",,,,,
C15302,"11beta,17,21-Trihydroxy-2alpha-methylpregn-4-ene-3,20-dione 21-acetate;|17-Hydroxy-2alpha-methylcorticosterone 21-acetate;|2alpha-Methylcortisol acetate",,,,,
C15303,"(Z)-11beta,21-Dihydroxypregna-1,4,17(20)-trien-3-one",,,,,
C15304,"3beta,19-Dihydroxyandrost-5-en-17-one 3-acetate;|3beta-Acetoxy-19-hydroxyandrost-5-en-17-one",,,,,
C15305,"9-Chloro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetate;|9-Chloro-17-hydroxycorticosterone 21-acetate;|9alpha-Chlorocortisol acetate",,,,,
C15306,"11alpha,17beta-Dihydroxyandrost-4-en-3-one;|11alpha-Hydroxytestosterone",,,,,
C15307,"17beta-Hydroxy-7alpha-methylandrost-1,4-diene-3-one;|1-Dehydro-7alpha-methyltestosterone",,,,,
C15308,"3-Hydroxy-1-methylestra-1,3,5(10),6-tetraen-17-one;|1-Methyl-6-dehydroestrone",,,,,
C15309,"17,21-Epoxy-9-fluoro-11beta-hydroxypregn-4-ene-3,20-dione;|17,21-Epoxy-9-fluoro-11beta-hydroxyprogesterone",,,,,
C15310,"6alpha-Fluoro-17-hydroxypregn-4-ene-3,20-dione acetate",,,,,
C15311,"N,N-Bis(2-chloroethyl)-DL-alanine hydrochloride",,,,,
C15312,"9alpha-Fluoro-11beta-hydroxy-4-pregnene-3,20-dione;|11beta-Hydroxy-9alpha-fluoroprogesterone",,,,,
C15313,"3,17beta-Diacetoxyestra-1,3,5(10)-trien-6-one;|3,17beta-Dihydroxyestra-1,3,5(10)-trien-6-one diacetate;|6-Oxo-17beta-estradiol diacetate",,,,,
C15314,"11beta,17beta-Dihydroxyandrost-4-en-3-one 17-propionate;|11beta-Hydroxytestosterone 17-propionate",,,,,
C15315,"1-Methylestra-1,3,5(10)-triene-3,17beta-diol;|1-Methylestradiol",,,,,
C15316,5alpha-Androstane-2alpha-methyl-17beta-ol,,,,,
C15317,"9-Fluoro-11beta-hydroxy-16alpha-methylpregn-4-ene-3,20-dione",,,,,
C15318,17abeta-Hydroxy-D-homoandrost-4-en-3-one;|D-Homotestosterone,,,,,
C15319,"9alpha-Fluoro-11beta,17alpha,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione;|9alpha-Fluoro-6alpha-methylprednisolone",,,,,
C15320,"21-Fluoro-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione;|21-Fluoro-11beta,17-dihydroxy-6alpha-methylprogesterone",,,,,
C15321,6alpha-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|6alpha-Fluorotestosterone propionate,,,,,
C15322,"2alpha,3alpha-(Difluoromethylene)-5alpha-androstan-17beta-ol acetate",,,,,
C15323,"3-Hydroxy-1-methylestra-1,3,5(10)-trien-17-one;|1-Methylestrone",,,,,
C15324,"Androst-4-ene-3beta,17beta-diol diacetate;|3beta,17beta-Diacetoxyandrost-4-ene",,,,,
C15325,"6-Azaequilenin;|3-Hydroxy-6-azaestra-1,3,5(10),6,8-pentaen-17-one",,,,,
C15326,17beta-Hydroxy-2alpha-methyl-5alpha-estran-3-one,,,,,
C15327,"6alpha-Fluoropregn-4-ene-3,11,20-trione;|6alpha-Fluoro-11-oxoprogesterone",,,,,
C15328,"N,N-Diethyl-2-[4-[6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl]phenoxy]ethanamine hydrochloride",,,,,
C15329,"21-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione",,,,,
C15330,3beta-Fluoro-5alpha-androstan-17beta-ol,,,,,
C15331,"17beta-Hydroxy-6beta-methyl-5alpha-androstan-3-one propionate;|4,5alpha-Dihydro-6beta-methyltestosterone propionate",,,,,
C15332,"3beta-Hydroxy-5alpha-androstane-7,17-dione",,,,,
C15333,"3alpha-Hydroxy-5beta-pregn-16-ene-11,20-dione 3-acetate",,,,,
C15334,"17beta-Hydroxy-4,4-dimethylandrost-5-en-3-one",,,,,
C15335,3beta-Hydroxy-5-androsten-16-one;|5-Androsten-3beta-ol-16-one,,,,,
C15336,"3beta,4-Dimethyl-4-aza-5alpha-cholestane",,,,,
C15337,Allocholesterol;|Coprostenol;|3beta-Hydroxycholest-4-ene;|4-Cholesten-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Cholestane derivatives|C15337  Allocholesterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15337  Allocholesterol,
C15338,"11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-5alpha-androstan-3-one",,,,,
C15339,"17alpha,2alpha-Dimethyl-17beta-hydroxy-4-androsten-3-one;|2alpha,17-Dimethyltestosterone",,,,,
C15340,"20,21,21-Trifluoro-3-methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol;|17-(Trifluorovinyl)-3-(methyl ether)-17beta-estradiol",,,,,
C15341,Fluorofelbamate,,,,,
C15342,"17beta-Hydroxy-2alpha,17-dimethyl-4,9(11)-androstadien-3-one;|9(11)-Dehydro-2alpha,17-dimethyltestosterone",,,,,
C15343,"HR1917;|4',4''-Di-2-imidazolin-2-yl-2-nitroterephthalanilide dihydrochloride",,,,,
C15344,"N-Butyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine;|NSC4928",,,,,
C15345,"3beta-[(Tetrahydro-2H-pyran-2-yl)oxy]androst-5-en-17beta-ol;|Androst-5-ene-3beta,17beta-diol 3-tetrahydropyranyl ether",,,,,
C15346,"5alpha-Androstane-3beta,17beta-diol diacetate;|3beta,17beta-Diacetoxy-5alpha-androstane",,,,,
C15347,6-(Isopropylthio)purine,,,,,
C15348,6-(Allylthio)purine,,,,,
C15349,"11beta,17beta-Dihydroxy-17-methyl-5alpha-androstan-3-one;|4,5alpha-Dihydro-11beta-hydroxy-17-methyltestosterone",,,,,
C15350,"Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate",,,,,
C15351,"7alpha-Hydroxytestololactone;|7alpha-Hydroxy-D-homo-17a-oxaandrost-4-ene-3,17-dione",,,,,
C15352,6-(Dibromomethylene)-17beta-hydroxyandrost-4-en-3-one;|6-(Dibromomethylene)testosterone,,,,,
C15353,"17alpha-Methyl-17beta-hydroxyandrosta-4,6-dien-3-one;|17alpha-Methyl-6,7-dehydrotestosterone",,,,,
C15354,"17beta-Hydroxy-17-methyl-5alpha-androstane-3,11-dione",,,,,
C15355,"11alpha-Hydroxy-5beta-pregnane-3,20-dione",,,,,
C15356,17beta-Amino-5alpha-androstan-11beta-ol,,,,,
C15357,"Cholesta-3,5-dien-7-one",,,,,
C15358,4-Chloro-17alpha-methyl-17beta-hydroxy-4-androsten-3-one;|4-Chloro-17alpha-methyltestosterone,,,,,
C15359,6-(Dibromomethylene)-17beta-hydroxy-androst-4-en-3-one propionate,,,,,
C15360,"Evadol hydrochloride;|2-Amino-1,2-bis(p-methoxyphenyl)ethanol hydrochloride;|beta-Amino-4-methoxy-alpha-(4-methoxyphenyl)benzeneethanol hydrochloride",,,,,
C15361,"Descinolone;|9-Fluoro-11beta,16alpha,17-trihydroxypregna-1,4-diene-3,20-dione",,,,,
C15362,"4-Nitroestrone;|3-Hydroxy-4-nitroestra-1,3,5(10)-trien-17-one",,,,,
C15363,"6beta,11alpha-Dihydroxyprogesterone;|6beta,11alpha-Dihydroxypregn-4-ene-3,20-dione",,,,,
C15364,"15alpha-Hydroxyprogesterone;|15alpha-Hydroxypregn-4-ene-3,20-dione",,,,,
C15365,"4-Pregnene-16alpha,21-diol-3,20-dione;|16alpha,21-Dihydroxypregn-4-ene-3,20-dione",,,,,
C15366,"Estrone 16-oxime;|3-Hydroxyestra-1,3,5(10)-triene-16,17-dione 16-oxime",,,,,
C15367,3beta-Methoxyandrost-5-en-16beta-ol,,,,,
C15368,"5beta-Pregnane-3alpha,17alpha,20alpha-triol-11-one;|Pregnanetriolone;|(3alpha,5beta,20S)-3,17,20-Trihydroxypregnan-11-one",,,,,
C15369,"9alpha-Fluoro-11beta-hydroxy-2alpha-methyl-4-pregnene-3,20-dione;|9alpha-Fluoro-11beta-hydroxy-2alpha-methylprogesterone",,,,,
C15370,"Androsta-5,16-dieno[17,16-b]quinolin-3beta-ol;|16,17-(3',2'-Quinolino)androst-5-en-3beta-ol",,,,,
C15371,"9-Bromo-17beta-hydroxy-17-methylandrost-4-ene-3,11-dione",,,,,
C15372,"11alpha,17beta-Dihydroxyandrost-4-en-3-one diacetate;|11alpha-Hydroxytestosterone diacetate",,,,,
C15373,5alpha-Androstan-17beta-ol propionate,,,,,
C15374,17beta-Hydroxy-7alpha-methylandrost-4-en-3-one propionate;|7alpha-Methyltestosterone propionate,,,,,
C15375,"Apocholic acid;|3alpha,12alpha-Dihydroxy-5beta-chol-8(14)-en-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15375  Apocholic acid",
C15376,"17alpha-Methyl-5alpha-androstane-3alpha,17beta-diol",,,,,
C15377,1-Testosterone;|17beta-Hydroxy-5alpha-androst-1-en-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C15377  1-Testosterone,
C15378,B-Norcholesterol;|3beta-Hydroxy-B-norcholest-5-ene,,,,,
C15379,"3beta-Hydroxylanostane-7,11-dione acetate",,,,,
C15380,"9-Fluoro-11beta,16alpha-dihydroxypregn-4-ene-3,20-dione",,,,,
C15381,"6alpha,9-Difluoro-11beta-hydroxypregn-4-ene-3,20-dione;|6alpha,9-Difluoro-11beta-hydroxyprogesterone",,,,,
C15382,"Estra-1,3,5(10)-triene-3,6alpha,17beta-triol triacetate",,,,,
C15383,"(5-Phenyl-1,2,4-triazol-3-yl)urea;|3-Phenyl-5-ureido-1,2,4-triazole",,,,,
C15384,"12alpha-Hydroxy-5beta-pregnane-3,20-dione",,,,,
C15385,"D-Homo-A-nor-17a-oxaandrost-3(5)-ene-2,17-dione;|A-Nortestololactone",,,,,
C15386,"D-Homo-17a-oxaandrosta-4,6-diene-3,17-dione",,,,,
C15387,1-Dehydro-9-fluoro-11-oxotestololactone,,,,,
C15388,"3-Methoxy-19-nor-17alpha-pregna-1,3,5(10),20-tetraen-17-ol;|17-Vinylestradiol 3-methyl ether",,,,,
C15389,"4,4'-Stilbenedicarboxamidine dihydrochloride;|Stilbamidine dihydrochloride",,,,,
C15390,"1alpha,5alpha-Epidithio-17a-oxa-D-homoandrostan-3,17-dione",,,,,
C15391,"3alpha,12alpha-Dihydroxy-5beta-pregnan-20-one",,,,,
C15392,"1-Chloro-4-(2,2-dichloro-1-phenylethyl)benzene;|1,1-Dichloro-2-(p-chlorophenyl)-2-phenylethane",,,,,
C15393,2-Chlorobenzhydrol,,,,,
C15394,"2,2,2-Trifluoro-N-(6-oxo-6H-dibenzo[b,d]pyran-2-yl)acetamide;|6-(2,2,2-Trifluoroacetamide)-3,4-benzocoumarin",,,,,
C15395,17beta-Hydroxy-4-methylestr-4-en-3-one;|4-Methyl-19-nortestosterone,,,,,
C15396,3beta-Chloro-5-androsten-17beta-ol,,,,,
C15397,6-(2-Chloroallylthio)purine,,,,,
C15398,"10,13-Dimethyl-11-docosyne-10,13-diol",,,,,
C15399,"17-Methyl-5alpha-androstane-11beta,17beta-diol",,,,,
C15400,"9-Chloro-11beta,17beta-dihydroxy-17-methylandrost-4-en-3-one;|9-Chloro-11beta-hydroxy-17-methyltestosterone",,,,,
C15401,"11beta,17beta-Dihydroxy-4,17-dimethylandrost-4-en-3-one;|11beta-Hydroxy-4,17-dimethyltestosterone",,,,,
C15402,"17beta-Hydroxy-7alpha,17-dimethylandrosta-1,4-dien-3-one;|1-Dehydro-7alpha,17-dimethyltestosterone",,,,,
C15403,"3alpha,11beta,17alpha-Trihydroxy-5beta-pregnan-20-one;|Tetrahydro-21-deoxycortisol",,,,,
C15404,"3beta,17-Dihydroxy-5alpha-pregnane-11,20-dione 3-acetate",,,,,
C15405,17beta-Carbomethoxyandrost-5-en-3beta-ol;|3beta-Hydroxyandrost-5-ene-17beta-carboxylic acid methyl ester,,,,,
C15406,"5alpha-Androst-1-ene-3,11,17-trione",,,,,
C15407,"9-Chloro-17beta-hydroxy-17-methylandrost-4-ene-3,11-dione",,,,,
C15408,2alpha-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|2alpha-Fluorotestosterone propionate,,,,,
C15409,17beta-Hydroxy-A-norandrost-3(5)-en-2-one propionate,,,,,
C15410,1-(o-Chlorophenyl)-1-(p-chlorophenyl)ethane;|1-Chloro-2-[1-(4-chlorophenyl)ethyl]benzene,,,,,
C15411,"beta-Chloro-alpha-phenylbenzeneethanamine hydrochloride;|2-Chloro-1,2-diphenylethylamine hydrochloride",,,,,
C15412,17beta-Hydroxy-4-methylandrost-4-en-3-one;|4-Methyltestosterone,,,,,
C15413,"17beta-Hydroxy-4,4,17-trimethylandrost-5-en-3-one",,,,,
C15414,6alpha-Fluoro-17beta-hydroxyandrost-4-en-3-one acetate;|6alpha-Fluorotestosterone acetate,,,,,
C15415,1-Phenyl-5-mercaptotetrazole;|1-Phenyltetrazole-5-thiol,,,,,
C15416,"17beta-Hydroxy-5alpha-androstan-3,6-dione;|6-Ketodihydrotestosterone",,,,,
C15417,3beta-Hydroxy-5alpha-pregnan-20-one acetate;|3beta-Acetoxy-5alpha-pregnan-20-one,,,,,
C15418,5-(alpha-Phenylethyl)semioxamazide;|5-(alpha-Methylbenzyl)semioxamazide,,,,,
C15419,trans-2-Phenylcyclopropanecarboxylic acid,,,,,
C15420,5alpha-Pregn-2-en-20-one,,,,,
C15421,2-Methyl-5alpha-androst-2-en-17beta-ol acetate,,,,,
C15422,2alpha-Methyl-17beta-[(tetrahydro-2H-pyran-2-yl)oxy]-5alpha-androstan-3-one,,,,,
C15423,"Androst-4-ene-3alpha,17beta-diol diacetate;|3alpha,17beta-Diacetoxyandrost-4-ene",,,,,
C15424,"Estra-1,3,5(10)-triene-3,17beta-diol 3-phosphate;|Estra-1,3,5(10)-triene-3,17beta-diol 3-(dihydrogen phosphate);|17beta-Estradiol 3-phosphate",,,,,
C15425,"21-Hydroxypregn-4-ene-3,20-dione hydrogen succinate;|21-(3-Carboxy-1-oxopropoxy)pregn-4-ene-3,20-dione;|11-Deoxycorticosterone hydrogen succinate",,,,,
C15426,"2,5-Bis[(iodomercuri)methyl]-p-dioxane",,,,,
C15427,"2-Amino-1,2-bis(p-chlorophenyl)ethanol",,,,,
C15428,Asiaticoside;|Madecassol,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C15428  Asiaticoside,
C15429,"17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-(hydrogensuccinate);|21-(3-Carboxy-1-oxopropoxy)-17-hydroxypregn-4-ene-3,11,20-trione;|Cortisone 21-succinate",,,,,
C15430,"3-Hydroxyestra-1,3,5(10)-trien-17-one O-(carboxymethyl)oxime;|Estrone 17-O-carboxymethyloxime",,,,,
C15431,"17-Ethynyl-5alpha-androstan-17beta-ol;|5alpha,17alpha-Pregn-20-yn-17beta-ol",,,,,
C15432,"Flurogestone acetate;|9alpha-Fluoro-11-hydroxy,17alpha-acetoxyprogesterone;|9-Fluoro-11beta,17-dihydroxypregn-4-ene-3,20-dione 17-acetate",,,,,
C15433,"1-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)-1H-pyrrole-2,5-dione",,,,,
C15434,"11beta,17beta-Dihydroxy-12alpha-methylandrost-4-en-3-one;|11beta-Hydroxy-12alpha-methyltestosterone",,,,,
C15435,Fenbutatin oxide;|Bis[tris(2-methyl-2-phenylpropyl)tin]oxide,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C15435  Fenbutatin oxide,
C15436,"Didecyldimethylammonium chloride;|N-Decyl-N,N-dimethyl-1-decanaminium chloride",,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07822)]|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AJ Quaternary ammonium compounds|D08AJ06 Didecyldimethylammonium chloride|D07822  Didecyldimethylammonium chloride|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9923  Invert soap and preparations|C15436  Didecyldimethylammonium chloride,
C15437,"1,3,5-Triphenylcyclohexane",,,,,
C15438,Bis(2-butoxyethyl)phthalate;|beta-Butoxyethyl phthalate,,,,,
C15439,2-Methacryloyloxyethyl phenyl phosphate;|Phenyl-P,,,,,
C15440,"Estra-1,3,5(10)-triene-3,6beta,17beta-triol triacetate",,,,,
C15441,"Cholesteryl linoleate;|(Z,Z)-(3beta)-Cholest-5-en-3-ol 9,12-octadecadienoate",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0102 Steryl esters|C15441  Cholesteryl linoleate,
C15442,"5-Androstene-3beta,16beta-diol",,,,,
C15443,"3-(Allyloxy)estra-1,3,5(10)-triene-16beta,17beta-diol;|3-(2-Propenyloxy)estra-1,3,5(10)-triene-16beta,17beta-diol",,,,,
C15444,"11beta,17beta-Dihydroxy-9alpha-fluoro-17alpha-methyl-5beta-androstan-3-one",,,,,
C15445,"1'H-5alpha-Cholest-2-eno[3,2-b]indole",,,,,
C15446,6beta-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|6beta-Fluorotestosterone propionate,,,,,
C15447,16alpha-Fluoro-17beta-hydroxyandrost-4-en-3-one propionate;|16alpha-Fluorotestosterone propionate,,,,,
C15448,Urethane dimethacrylate;|UDMA,"Generic compound|R1 = CH3, R2 = H or R1 = H, R2 = CH3",,,,
C15449,"trans-1,2-Diphenylcyclobutane",,,,,
C15450,"S 1033;|(5Z,9alpha,11alpha,13E)-9,11-Dihydroxyprosta-5,13-dien-1-oic acid monosodium salt",,,,,
C15451,Hinokitiol glucoside;|beta-Thujaplicin 2-O-beta-D-glucoside,,,,,
C15452,"4,4'-Diaminostilbene dihydrochloride",,,,,
C15453,"Doisynoestrol;|cis-1-Ethyl-1,2,3,4-tetrahydro-7-methoxy-2-methyl-2-phenanthrenecarboxylic acid",,,,,
C15454,"Hexestrol monomethyl ether;|(R*,S*)-4-[1-Ethyl-2-(4-methoxyphenyl)butyl]phenol",,,,,
C15455,Sodium molybdate;|Sodium molybdate(VI),,,,,
C15456,"11beta,13-Dihydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid, delta-lactone",,,,,
C15457,trans-2-(4-Methoxyphenyl)-3-(4-nitrophenyl)oxirane;|trans-4-Methoxy-4'-nitrostilbene oxide,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C15457  trans-2-(4-Methoxyphenyl)-3-(4-nitrophenyl)oxirane",
C15458,"(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol",,,,,
C15459,"13-Hydroxy-2-(hydroxymethylene)-3-oxo-13,17-seco-5alpha-androstan-17-oic acid, delta-lactone",,,,,
C15460,17beta-Hydroxy-17-methyl-5alpha-androst-9(11)-en-3-one,,,,,
C15461,"17beta-Acetyl-1,2,3,4,6alpha,7alpha,10,12,13,14alpha,16,17-dodecahydro-3beta-hydroxy-10beta,13beta-dimethyl-5beta,8beta-etheno-15H-cyclopenta[a]phenanthrene-6,7-dicarboxylic anhydride acetate",,,,,
C15462,"cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid",,,,,
C15463,"(R*,S*)-4-[1-Ethyl-2-(4-fluorophenyl)butyl]phenol",,,,,
C15464,(+)-12-(2-Cyclopenten-1-yl)-2-dodecanone,,,,,
C15465,6-Oxabicyclo[3.1.0]hexane-2-undecanoic acid methyl ester,,,,,
C15466,"N-(6-Oxo-6H-dibenzo[b,d]pyran-3-yl)maleamic acid",,,,,
C15467,"6beta,17-Dihydroxy-3,5-cyclo-5alpha,17alpha-pregn-20-ene-21-carboxylic acid, gamma-lactone",,,,,
C15468,"3,5-Cyclo-5alpha,17alpha-pregn-20-yne-6beta,17-diol",,,,,
C15471,Bismuth,,,,,
C15472,Germanium,,,,,
C15473,Lithium,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08133)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AN Lithium|N05AN01 Lithium|D08133  Lithium,
C15474,Tropolone,,,,,
C15475,U 0521,,,,,
C15476,Norselegiline,,,,,
C15477,CGP 28014,,,,,
C15478,"D-Fucosamine;|2-Amino-2,6-dideoxy-D-galactose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C15478  D-Fucosamine,
C15479,"D-Quinovosamine;|2-Amino-2,6-dideoxy-D-glucose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C15479  D-Quinovosamine,
C15480,"N-Acetyl-D-fucosamine;|2-Acetamido-2,6-dideoxy-D-galactose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C15480  N-Acetyl-D-fucosamine,
C15481,"N-Acetyl-D-quinovosamine;|2-Acetamido-2,6-dideoxy-D-glucose",,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Amino sugars|C15481  N-Acetyl-D-quinovosamine,
C15482,Bacitracin A,,0 Ile  1 Cys  2 Leu  3 D-Glu  4 Ile  5 Lys  6 D-Orn  7 Ile|8 D-Phe  9 His  10 D-Asp  11 Asn  (Cyclization: 5-11),NRP,Compounds with biological roles [BR:br08001]|Antibiotics|Polyketides and nonribosomal peptides|Non-ribosomal peptides|C15482  Bacitracin A,
C15484,Isopregnanolone;|Epiallopregnanolone;|3beta-Hydroxy-5alpha-pregnan-20-one,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C15484  Isopregnanolone",
C15485,2'-Deoxymugineic acid,,,,,
C15486,3''-Deamino-3''-oxonicotianamine,,,,,
C15488,Fluoroacetaldehyde,,,,,
C15489,S-2-(Indol-3-yl)acetyl-CoA;|(Indol-3-yl)acetyl-CoA,,,,,
C15492,"all-trans-13,14-Dihydroretinol;|13,14-Dihydroretinol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C15492  all-trans-13,14-Dihydroretinol",
C15493,9-cis-Retinoic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C15493  9-cis-Retinoic acid|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02815)]|D DERMATOLOGICALS|D11 OTHER DERMATOLOGICAL PREPARATIONS|D11A OTHER DERMATOLOGICAL PREPARATIONS|D11AH Agents for dermatitis, excluding corticosteroids|D11AH04 Alitretinoin|D02815  Alitretinoin (USAN) &lt;US&gt;|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XF Retinoids for cancer treatment|L01XF02 Alitretinoin|D02815  Alitretinoin (USAN) &lt;US&gt;|USP drug classification [BR:br08302(D02815)]|Antineoplastics|Retinoids|Alitretinoin|D02815  Alitretinoin (USAN)|Drug groups [BR:br08330(D02815)]|Vitamin and mineral|DG01604  Retinol derivative|D02815  Alitretinoin|Target-based classification of drugs [BR:br08310(D02815)]|Nuclear receptors|Thyroid hormone like receptors|Retinoic acid receptor (RAR)|NR1B (RAR)|D02815  Alitretinoin (USAN) &lt;US&gt;|Hepatocyte nuclear factor 4 like receptors|Retinoid X receptor (RXR)|NR2B (RXR)|D02815  Alitretinoin (USAN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D02815)]|New molecular entities and new therapeutic biological products|D02815|New drug approvals in Europe [br08329.html(D02815)]|European public assessment reports (EPAR) authorised medicine|D02815|New drug approvals in the USA, Europe and Japan [br08328.html(D02815)]|Approval dates by FDA, EMA and PMDA|D02815",
C15494,"Decylubiquinone;|6-Decylubiquinone;|2,3-Dimethoxy-5-methyl-6-decyl-1,4-benzoquinone",,,,,
C15495,"Decylubiquinol;|6-Decylubiquinol;|2-Decyl-5,6-dimethoxy-3-methyl-1,4-benzenediol",,,,,
C15496,Oxidized thiol-containing reductant;|Thiol-containing reductant disulfide form;|R'-S-S-R';|Disulfide,Generic compound in reaction hierarchy,,,,
C15497,"1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide;|Reduced nicotinamide riboside",,,,,
C15498,ROOH;|Hydroperoxide,Generic compound in reaction hierarchy,,,,
C15499,"Pentane-2,4-dione;|Acetylacetone;|2,4-Dioxopentane",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C15499  Pentane-2,4-dione",
C15500,Mugineic acid,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15500,
C15501,3-Epihydroxymugineic acid,,,,,
C15502,3-Epihydroxy-2'-deoxymugineic acid,,,,,
C15503,"N,N-Dihydroxy-L-tyrosine",,,,,
C15504,Demethylsulochrin,,,,,
C15505,"2,3,5,6-Tetrachlorophenol",,,,,
C15508,"1,2-Epoxypropane;|1,2-Propylene oxide;|Propylene oxide",,,,,
C15509,"Glyceocarpin;|2-Dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan;|(6aS,11aS)-3,6a,9-Trihydroxy-2-prenylpterocarpan",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C15509  Glyceocarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C15509  Glyceocarpin,
C15510,"4-Glyceollidin;|4-Dimethylallylglycinol;|4-Dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan;|(6aS,11aS)-3,6a,9-Trihydroxy-4-prenylpterocarpan",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C15510  4-Glyceollidin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C15510  4-Glyceollidin,
C15511,Glyceollin III,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C15511  Glyceollin III|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C15511  Glyceollin III,
C15512,Phenylacetone;|1-Phenyl-2-propanone,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C15512,
C15513,Benzyl acetate,,,,,
C15514,8'-Hydroxyabscisate;|8'-Hydroxyabscisic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C15514  8'-Hydroxyabscisate,
C15515,"Murideoxycholate;|Murideoxycholic acid;|6beta-Hydroxylithocholate;|3alpha,6beta-Dihydroxy-5beta-cholanic acid",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C15515  Murideoxycholate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15515  Murideoxycholate",
C15516,"Taurohyocholate;|N-(3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oyl)taurine",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0504 Taurine conjugates|C15516  Taurohyocholate,
C15517,"Hyodeoxycholate;|Hyodesoxycholic acid;|6alpha-Hydroxylithocholate;|Iodeoxycholic acid;|3alpha,6alpha-Dihydroxy-5beta-cholanic acid",,,,"Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Cholane derivatives|C15517  Hyodeoxycholate|Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15517  Hyodeoxycholate",
C15518,"(24S)-Cholest-5-ene-3beta,7alpha,24-triol;|5-Cholesten-3beta,7alpha,24(S)-triol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C15518  (24S)-Cholest-5-ene-3beta,7alpha,24-triol",
C15519,"25-Hydroxycholesterol;|Cholest-5-ene-3beta,25-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15519  25-Hydroxycholesterol,
C15520,"Cholest-5-ene-3beta,7alpha,25-triol;|7alpha,25-Dihydroxycholesterol;|5-Cholesten-3beta,7alpha,25-triol;|3beta,7alpha,25-Trihydroxycholest-5-ene",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C15520  Cholest-5-ene-3beta,7alpha,25-triol",
C15521,Alkanesulfonate;|Aliphatic sulfonate,Generic compound in reaction hierarchy,,,,
C15522,"4a-Hydroxytetrahydrobiopterin;|4a-Hydroxy-5,6,4,8-tetrahydrobiopterin;|(6R)-6-(L-erythro-1,2-Dihydroxypropyl)-5,6,7,8-tetrahydro-4a-hydroxypterin;|6-[(1R,2S)-1,2-Dihydroxypropyl]-5,6,7,8-tetrahydro-4a-hydroxypterin",,,,,
C15523,"2,6-Dihydroxynicotinate",,,,,
C15524,Phenylglyoxylyl-CoA,,,,,
C15525,"Eriodictyol chalcone;|2',3,4,4',6'-Pentahydroxychalcone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C15525  Eriodictyol chalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C15525  Eriodictyol chalcone,
C15527,Precorrin 1,,,,,
C15528,[Cytochrome c]-arginine,,,,,
C15529,[Cytochrome c]-N(omega)-methylarginine,,,,,
C15530,Corydaline;|(+)-Corydaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C15530  Corydaline,
C15531,2'-O-Methylisoliquiritigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C15531  2'-O-Methylisoliquiritigenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C15531  2'-O-Methylisoliquiritigenin,
C15532,N-Acetyl-L-citrulline,,,,,
C15533,4-Fluoro-L-threonine,,,,,
C15534,2-Arylethylamine,Generic compound in reaction hierarchy,,,,
C15535,N-Acetyl-2-arylethylamine,Generic compound in reaction hierarchy,,,,
C15536,Dihydromonacolin L,,,,,
C15537,Taxuyunnanin C,,,,,
C15538,10-Desacetyltaxuyunnanin C,,,,,
C15539,Anthocyanidin 3-O-beta-D-glucoside;|Anthocyanidin-3-O-D-glucoside,Generic compound in reaction hierarchy,,,,
C15540,Anthocyanidin 3-O-(6-O-malonyl-beta-D-glucoside),Generic compound in reaction hierarchy,,,,
C15541,NDP-glucose;|NDP-D-glucose;|NDP-alpha-D-glucose,Generic compound in reaction hierarchy|UDP-glucose [CPD:C00029]|ADP-glucose [CPD:C00498],,,,
C15542,D-Mannosyl-1-phosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C15542  D-Mannosyl-1-phosphoundecaprenol,
C15543,6-(alpha-D-Mannosyl)-beta-D-mannosyl-R,,,,,
C15544,4-(N-Acetyl-beta-D-glucosaminyl)-beta-D-mannosyl-R,,,,,
C15545,cis-Zeatin;|(Z)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15545,
C15546,O-beta-D-Glucopyranosyl-cis-zeatin;|cis-Zeatin-O-glucoside,,,,,
C15547,"1,4-Dihydroxy-2-naphthoyl-CoA",,,,,
C15548,2-alpha-D-Glucosyl-D-glucose;|Kojibiose;|alpha-D-Glucopyranosyl-(1->2)-D-glucopyranose,,,,,
C15549,Anthocyanin;|Anthocyanidin 3-glycoside,Generic compound in reaction hierarchy,,,,
C15550,Anthocyanin 3'-O-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C15550  Anthocyanin 3'-O-beta-D-glucoside,
C15551,CV 2961;|S 8308,,,,,
C15552,PD 123177,,,,,
C15553,PD 123319,,,,,
C15554,EXP 3174,,,,,
C15555,Flavonol 3-O-D-glycoside;|Flavonol 3-O-beta-D-glycoside,Generic compound in reaction hierarchy|Glucoside or galactoside,,,,
C15556,"L-3,4-Dihydroxybutan-2-one 4-phosphate;|1-Deoxy-L-glycero-tetrulose 4-phosphate;|2-Hydroxy-3-oxobutyl phosphate",,,,,
C15557,Glycolithocholate;|Glycolithocholic acid,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0503 Glycine conjugates|C15557  Glycolithocholate,
C15558,Dermatan 6'-sulfate,,,,,
C15559,Glycochenodeoxycholate 7-sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0503 Glycine conjugates|C15559  Glycochenodeoxycholate 7-sulfate,
C15560,Deoxycholoyl-CoA,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15560  Deoxycholoyl-CoA",
C15561,N-Benzylformamide,,,,,
C15562,Benzylamine;|Benzenemethanamine,,,,,
C15563,2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,,,,Glycosides [BR:br08021]|N-glycosides|C15563  2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one,
C15565,(S)-2-Hydroxyacid;|(S)-2-Hydroxy acid;|(S)-2-Hydroxyalkanoic acid;|(S)-2-Hydroxycarboxylic acid;|(2S)-2-Hydroxycarboxylate,Generic compound in reaction hierarchy,,,,
C15566,D-Dopachrome,,,,,
C15567,"2,7,4'-Trihydroxyisoflavanone;|2,4',7-Trihydroxyisoflavanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C15567  2,7,4'-Trihydroxyisoflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C15567  2,7,4'-Trihydroxyisoflavanone",
C15568,"7alpha,12alpha-Dihydroxy-3-oxochol-4-enoate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15568  7alpha,12alpha-Dihydroxy-3-oxochol-4-enoate",
C15569,"12alpha-Hydroxy-3-oxochola-4,6-dienoate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C15569  12alpha-Hydroxy-3-oxochola-4,6-dienoate",
C15570,"Dihydroflavonol;|Flavanonol;|2,3-Dihydroflavonol",Generic compound in reaction hierarchy,,,,
C15571,Catechol,Generic compound in reaction hierarchy|Catechol (non-generic) [CPD:C00090],,,,
C15572,Guaiacol,Generic compound in reaction hierarchy|Guaiacol (non-generic) [CPD:C01502],,,,
C15573,beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15574,N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15575,N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15576,beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15577,N-Acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15578,beta-D-Glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan,Generic compound in reaction hierarchy|R = glycan side-chain of proteoglycan,,,,
C15579,Flavanone 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C15579  Flavanone 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside],
C15580,Flavonol 7-O-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C15580  Flavonol 7-O-beta-D-glucoside,
C15581,Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C15581  Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside,
C15582,Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C15582  Flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside,
C15583,Phenyl acetate,Generic compound in reaction hierarchy|Phenyl acetate (non-generic) [CPD:C00548],,,,
C15584,Phenol,Generic compound in reaction hierarchy|Phenol (non-generic) [CPD:C00146],,,,
C15586,N-D-Ribosylpurine;|Purine nucleoside;|Purine ribonucleoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|N-glycosides|C15586  N-D-Ribosylpurine,
C15587,Purine;|Purine base,Generic compound in reaction hierarchy,,,,
C15588,Glycol,Generic compound in reaction hierarchy,,,,
C15589,Chalcone,Generic compound in reaction hierarchy,,,,
C15591,"(6R)-2-Acetyl-6-(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)-3-hydroxy-6-methyl-2,4-cyclohexadien-1-one;|Reduced-(S)-usnate",,,,,
C15593,2-Dehydropyranose,Generic compound in reaction hierarchy,,,,
C15595,3-Dehydropyranoside,Generic compound in reaction hierarchy,,,,
C15596,n-Alkanal,Generic compound in reaction hierarchy,,,,
C15597,Alk-2-enal,Generic compound in reaction hierarchy,,,,
C15598,Flavanol;|Flavan-3-ol,"Generic compound|(2S,3R)-Flavan-3-ol [CPD:C21379]|(2S,3S)-Flavan-3-ol [CPD:C21380]|(2R,3R)-Flavan-3-ol [CPD:C22577]",,,,
C15599,"6-(2-Amino-2-carboxyethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylate;|6-(2-Amino-2-carboxyethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylic acid",,,,,
C15602,Quinone,"Generic compound in reaction hierarchy|Including p-Benzoquinone [CPD:C00472], o-Benzoquinone [CPD:C02351] and related compounds",,,,
C15603,Hydroquinone;|p-Hydroquinone;|Quinol;|Reduced quinone,Generic compound in reaction hierarchy|Hydroquinone (non-generic) [CPD:C00530],,,,
C15604,Prenal,"Generic compound in reaction hierarchy|Geranial (n=2) [CPD:C01499]|(2E,6E)-Farnesal (n=3) [CPD:C03461]",,,,
C15605,N-Formyl-D-kynurenine,,,,,
C15606,"1,2-Dihydroxy-5-(methylthio)pent-1-en-3-one;|1,2-Dihydroxy-5-(methylsulfanyl)pent-1-en-3-one",,,,,
C15607,3-Oxo-3-ureidopropanoate;|Malonuric acid,,,,,
C15608,Flavone,Generic compound in reaction hierarchy|Flavone (non-generic) [CPD:C10043],,,Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavones|C15608  Flavone (generic compound),
C15609,"3',5'-Dihydroxyflavanone",Generic compound in reaction hierarchy,,,,
C15610,"Cholest-5-ene-3beta,26-diol;|Cholest-5-ene-3beta,27-diol;|26-Hydroxycholesterol;|27-Hydroxycholesterol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15610  27-Hydroxycholesterol,
C15612,Senecionine N-oxide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C15612  Senecionine N-oxide|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15612,
C15613,"(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C15613  (25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",
C15614,"(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA;|(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C15614  (24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA",
C15615,7-Hydroxyisoflavone,Generic compound in reaction hierarchy,,,,
C15616,7-Methoxyisoflavone,Generic compound in reaction hierarchy,,,,
C15617,Pirinixic acid,,,,,
C15618,Sobetirome;|GC-1,,,,Drug groups [BR:br08330(D09381)]|Hormonal agent|DG01953  Thyroid preparation|D09381  Sobetirome|Target-based classification of drugs [BR:br08310(D09381)]|Nuclear receptors|Thyroid hormone like receptors|Thyroid hormone receptor (THR)|NR1A2 (THRB)|D09381  Sobetirome (USAN),
C15619,Am 580,,,,,
C15620,GW 6471,,,,,
C15622,GW 7647,,,,,
C15623,GW 409544;|GW 9544,,,,,
C15624,GW 2433,,,,,
C15625,GW 0742,,,,,
C15626,GW 1929,,,,,
C15627,GW 9662;|2-Chloro-5-nitrobenzanilide,,,,,
C15628,SR 12813;|GW 485801,,,,,
C15629,CGP 52608,,,,,
C15630,T 0901317;|T0901317,,,,,
C15631,GW 3965,,,,,
C15632,"24(S),25-Epoxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15632  24(S),25-Epoxycholesterol",
C15633,"5,6-24(S),25-Diepoxycholesterol;|(24S,25)-Epoxycholesterol alpha-epoxide;|5alpha,6alpha-24S,25-Diepoxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15633  5,6-24(S),25-Diepoxycholesterol",
C15634,Arotinoid acid;|TTNPB;|Ro 13-7410,,,,,
C15635,GW 4064;|GW-4064,,,,,
C15636,6-Ethylchenodeoxycholic acid;|6-ECDCA;|6-Ethyl-CDCA;|6alpha-Ethyl-chenodeoxycholic acid,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09360)]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05A BILE THERAPY|A05AA Bile acids and derivatives|A05AA04 Obeticholic acid|D09360  Obeticholic acid (JAN/USAN/INN) &lt;US&gt;|USP drug classification [BR:br08302(D09360)]|Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment|Obeticholic Acid|D09360  Obeticholic acid (JAN/USAN/INN)|Drug groups [BR:br08330(D09360)]|Gastrointestinal agent|DG01956  Bile acid preparation|D09360  Obeticholic acid|Target-based classification of drugs [BR:br08310(D09360)]|Nuclear receptors|Thyroid hormone like receptors|Liver X receptor like receptor|NR1H4 (FXR)|D09360  Obeticholic acid (JAN/USAN/INN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D09360)]|New molecular entities and new therapeutic biological products|D09360|New drug approvals in Europe [br08329.html(D09360)]|European public assessment reports (EPAR) authorised medicine|D09360|New drug approvals in the USA, Europe and Japan [br08328.html(D09360)]|Approval dates by FDA, EMA and PMDA|D09360",
C15637,Pregnenolone carbonitrile;|3beta-Hydroxy-20-oxo-5-pregnene-16alpha-carbonitrile;|Pregnenolone-16alpha-carbonitrile;|PCN,,,,,
C15638,3-Androstanol;|5alpha-Androstan-3alpha-ol;|Androstanol,,,,Compounds with biological roles [BR:br08001]|Steroids|19-Carbon atoms|Androstane derivatives|C15638  3-Androstanol,
C15639,"CITCO;|6-(4-Chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",,,,,
C15640,LG 100268,,,,,
C15641,XCT 790,,,,,
C15642,GSK 4716,,,,,
C15643,Dexamethasone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00292)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AC Corticosteroids for local oral treatment|A01AC02 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|C CARDIOVASCULAR SYSTEM|C05 VASOPROTECTIVES|C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C05AA Corticosteroids|C05AA09 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB19 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|D07X CORTICOSTEROIDS, OTHER COMBINATIONS|D07XB Corticosteroids, moderately potent, other combinations|D07XB05 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AA Corticosteroids, combinations for treatment of acne|D10AA03 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H02 CORTICOSTEROIDS FOR SYSTEMIC USE|H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN|H02AB Glucocorticoids|H02AB02 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|R RESPIRATORY SYSTEM|R01 NASAL PREPARATIONS|R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|R01AD Corticosteroids|R01AD03 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BA Corticosteroids, plain|S01BA01 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION|S01CB Corticosteroids/antiinfectives/mydriatics in combination|S01CB01 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|S02 OTOLOGICALS|S02B CORTICOSTEROIDS|S02BA Corticosteroids|S02BA06 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03B CORTICOSTEROIDS|S03BA Corticosteroids|S03BA01 Dexamethasone|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D00292)]|Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)|Dexamethasone|D00292  Dexamethasone (JP18/USP/INN)|Inflammatory Bowel Disease Agents|Glucocorticoids|Dexamethasone|D00292  Dexamethasone (JP18/USP/INN)|Ophthalmic Agents|Ophthalmic Anti-inflammatories|Glucocorticoids, Ophthalmic|Dexamethasone|D00292  Dexamethasone (JP18/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D00292)]|1  Agents affecting nervous system and sensory organs|13  Agents affecting sensory organs|131  Ophthalmic agents|1315  Ophthalmic cortisones|D00292  Dexamethasone (JP18/USP/INN)|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2399  Others|D00292  Dexamethasone (JP18/USP/INN)|24  Hormones|245  Adrenal hormone preparations|2454  Fluorinated adrenocorticotropic hormones|D00292  Dexamethasone (JP18/USP/INN)|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2646  Adrenocorticotropic hormones|D00292  Dexamethasone (JP18/USP/INN)|Classification of Japanese OTC drugs [BR:br08313(D00292)]|Agents for integumentary system|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00292  Dexamethasone (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D00292)]|Designated second-class OTC drugs|Inorganic and organic chemicals|Dexamethasone|D00292  Dexamethasone (JP18/USP/INN)|Second-class OTC drugs|Inorganic and organic chemicals|Dexamethasone|D00292  Dexamethasone (JP18/USP/INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C15643  Dexamethasone|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9612  Adrenal hormone preparations|C15643  Dexamethasone|Drug groups [BR:br08330(D00292)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00011  Dexamethasone|D00292  Dexamethasone|Dermatological agent|DG03243  Atopic dermatitis agent|D00292  Dexamethasone|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00011  Dexamethasone|D00292  Dexamethasone|Metabolizing enzyme inducer|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00011  Dexamethasone|D00292  Dexamethasone|Drug classes [BR:br08332(D00292)]|Anti-inflammatory|DG01955  Corticosteroid|D00292  Dexamethasone|Dermatological agent|DG03243  Atopic dermatitis agent|D00292  Dexamethasone|Target-based classification of drugs [BR:br08310(D00292)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D00292  Dexamethasone (JP18/USP/INN) &lt;JP/US&gt;|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00292)]|Chemicals|D00292  Dexamethasone|New drug approvals in Europe [br08329.html(D00292)]|European public assessment reports (EPAR) authorised medicine|D00292|Drug metabolizing enzymes and transporters [br08309.html(D00292)]|Drug metabolizing enzymes|D00292|Topical steroids potency [br08317.html(D00292)]|Classification in Japan|D00292",
C15644,GW 0791,,,,,
C15645,1-(1-Alkenyl)-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL01 Monoradylglycerols|GL0103 Mono-(1Z-alkenyl)-glycerols|C15645  1-(1-Alkenyl)-sn-glycerol,
C15646,1-(1-Alkenyl)-sn-glycero-3-phosphate,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1007 1Z-alkenylglycerophosphates|C15646  1-(1-Alkenyl)-sn-glycero-3-phosphate,
C15647,2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate,Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP10 Glycerophosphates|GP1003 1-(1Z-alkenyl),2-acylglycerophosphates|C15647  2-Acyl-1-(1-alkenyl)-sn-glycero-3-phosphate",
C15648,Octachlorocamphene,,,,,
C15649,Fexaramine,,,,,
C15650,"2,3-Diketo-5-methylthiopentyl-1-phosphate;|5-(Methylthio)-2,3-dioxopentyl phosphate;|5-(Methylsulfanyl)-2,3-dioxopentyl phosphate",,,,,
C15651,2-Hydroxy-3-keto-5-methylthiopentenyl-1-phosphate;|2-Hydroxy-5-(methylthio)-3-oxopent-1-enyl phosphate;|2-Hydroxy-5-(methylsulfanyl)-3-oxopent-1-enyl phosphate,,,,,
C15652,Neomycin C,Component of Neomycin [CPD:C00384],,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15652,
C15653,Peptide-L-methionine (R)-S-oxide,,,,,
C15654,Kni 102,,,,,
C15655,Kynostatin 272;|KNI-272,,,,,
C15656,alpha-N-Acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-xylosylproteoglycan;|[Protein]-3-O-(alpha-D-GlcNAc-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl)-L-serine,Generic compound in reaction hierarchy,,,,G00162
C15657,BILA 2185BS,,,,,
C15658,6-(alpha-D-Glucosaminyl)-1D-myo-inositol,,,,,G12396
C15659,TMC 126;|UIC 94003,,,,,
C15660,A 77003,,,,,
C15661,A 80987,,,,,
C15662,Dmp 323,,,,,
C15663,CMN 131;|Pyridyl-2-thioacetamide monohydrochloride,,,,,
C15664,B 823-08,,,,,
C15665,Ro 18-5364,,,,,
C15666,(7R)-7-(4-Carboxybutanamido)cephalosporanate;|7-Glutarylaminocephalosporanate,,,,,
C15667,5-Carboxyamino-1-(5-phospho-D-ribosyl)imidazole,,,,,
C15668,"1-Pyrroline;|3,4-Dihydro-2H-pyrrole",,,,,
C15669,Teicoplanin A3;|Teichomycin A3,Teicoplanin A3-1 (R3 = alpha-D-Mannose) [CPD:C13613]|Teicoplanin A3-2 (R3 = H),,,,
C15670,Heme A,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C15670  Heme A,
C15672,Heme O,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C15672  Heme O,
C15673,2-Dehydro-L-idonate;|2-Dehydro-L-idonic acid;|L-Sorbosonate;|L-Sorbosonic acid;|2-Keto-L-gulonate;|2-Keto-L-gulonic acid;|L-xylo-Hex-2-ulosonic acid;|L-Ketoidonate;|L-Ketoidonic acid,,,,,
C15674,Myxothiazol A,,0 3md  1 Mad  2 Man  3 Cys  4 Cys  5 Mam  6 Mtm  7 Mao  8 Gly,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C15674  Myxothiazol A,
C15675,Myxothiazol Z,,0 3md  1 Mad  2 Man  3 Cys  4 Cys  5 Mam  6 Mtm  7 Mao  8 Gly,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C15675  Myxothiazol Z,
C15676,HC-toxin,,0 D-Pro  1 Ala  2 D-Ala  3 Aeo  (Cyclization: 0-3),NRP,,
C15677,Leinamycin,,0 Ala  1 Cys  2 Mad  3 Man  4 Mad  5 Mte  6 Man  7 Man,PKNRP,,
C15678,Chalcomycin,,0 Mak  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtn  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15678  Chalcomycin,
C15679,Lankamycin,,0 2mk  1 Mtk  2 Mtn  3 Mte  4 Mtk  5 Mtk  6 Mtn,PK,,
C15680,Mycinamicin II;|Mirosamicin,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15680  Mycinamicin II|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|976  Antibiotic preparations|9761  Antibiotic preparations injection use|C15680  Mirosamicin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15680,
C15681,Mycinamicin III,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15681  Mycinamicin III,
C15682,Mycinamicin VI,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15682  Mycinamicin VI,
C15683,Mycinamicin VII,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15683  Mycinamicin VII,
C15684,Mycinamicin VIII,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15684  Mycinamicin VIII,
C15685,Protomycinolide IV,,0 Mtk  1 Mtd  2 Mad  3 Man  4 Mte  5 Mtk  6 Mtd  7 Man,PK,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15685  Protomycinolide IV,
C15686,Arthrofactin,FA = 3-hydroxydecanoyl,0 FA  1 D-Leu  2 D-Asp  3 D-Thr  4 D-Leu  5 D-Leu  6 D-Ser  7 Leu|8 D-Ser  9 Ile  10 Ile  11 Asp  (Cyclization: 1-11),NRP,,
C15687,Borrelidin,,"0 trans-Cyclopentane-1,2-dicarboxylate  1 Mad  2 Mad  3 Mtk|4 Mte  5 Mte  6 Mte  7 Mtk  8 Man",PK,,
C15688,Vicenistatin,,"0 (2S,3S)  -3-Methylaspartate  1 Mad  2 Mad  3 Mte  4 Mtd  5 Mak|6 Mtd  7 Mad  8 Man",PKNRP,,
C15689,"Aureothin;|2-Methoxy-3,5-dimethyl-6-[(2R,4Z)-4-[(2E)-2-methyl-3-(4-nitrophenyl)prop-2-en-1-ylidene]oxolan-2-yl]-4H-pyran-4-one",,0 Pba  1 Mtd  2 Mte  3 Man  4 Mtn  5 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C15689  Aureothin,
C15690,Salinomycin,,0 Mad  1 Ete  2 Mad  3 Mte  4 Man  5 Mad  6 Man  7 Mte  8 Mtk|9 Etn  10 Mtk  11 Mtk  12 Mte  13 Mad  14 Etn,PK,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C15690  Salinomycin|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9749  Other antiprotozoan agents|C15690  Salinomycin,
C15691,Anabaenopeptilide 90A,"0 Gln is modified by formyl. (i.e. Formylglutamine)|5 Tyr is modified by N,O-dimethyl. (i.e. N,O-Dimethyltyrosine, diMeTyr)",0 Gln  1 Thr  2 Hty  3 Ahp  4 Thr  5 Tyr  6 Ile|(Cyclization: 1-6),NRP,,
C15692,Anabaenopeptilide 90B,"0 Gln is modified by formyl. (i.e. Formylglutamine)|5 Tyr is modified by N-methyl-3'-chloro. (i.e. N-Methyl-3'-chlorothyrosine, Me(Cl)Tyr)",0 Gln  1 Thr  2 Hty  3 Ahp  4 Thr  5 Tyr  6 Ile|(Cyclization: 1-6),NRP,,
C15693,Barbamide,,0 Leu  1 Man  2 Phe  3 Cys,PKNRP,,
C15694,Epothilone C,,0 Mao  1 Cys  2 Mtk  3 Mad  4 Mae  5 Mae  6 Mtk  7 Mtn  8 Isk|9 Man,PKNRP,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C15694  Epothilone C|PK14 Non-ribosomal peptide/polyketide hybrids|C15694  Epothilone C,
C15695,Complestatin;|Chloropeptin II,"2 and 4 D-Hpg are modified by 3,5-dichloro. (i.e. D-3,5-Dichloro-4-hydroxyphenylglycine)",0 4-Hydroxybenzoylformate  1 Trp  2 D-Hpg  3 D-Hpg  4 D-Hpg|5 Tyr  6 D-Hpg,NRP,,
C15696,Melithiazol A,,0 Iso  1 Cys  2 Cys  3 Mam  4 Mtm  5 Man  6 Gly,PKNRP,,
C15697,Nostopeptolide A1,"2 Pro is modified by 4-methyl. (i.e. 4-Methylproline, MePro)|3 Leu is modified by acetate. (i.e. Leucylacetate, LeuAc)",0 Butyrate-Ile  1 Ser  2 Pro  3 Leu  4 Man  5 Leu  6 Gly  7 Asn|8 Tyr  9 Pro  (Cyclization: 1-9),PKNRP,,
C15698,Nostopeptolide A2,"2 Pro is modified by 4-methyl. (i.e. 4-Methylproline, MePro)|3 Leu is modified by acetate. (i.e. Leucylacetate, LeuAc)",0 Butyrate-Val  1 Ser  2 Pro  3 Leu  4 Man  5 Leu  6 Gly  7 Asn|8 Tyr  9 Pro  (Cyclization: 1-9),PKNRP,,
C15699,gamma-L-Glutamylputrescine,,,,,
C15700,gamma-Glutamyl-gamma-aminobutyraldehyde,,,,,
C15701,Syringolin A,"1 Lys is modified by 3,4-dehydro. (i.e. 3,4-Dehydrolysine)",0 Val  1 Lys  2 Val  3 Man,PKNRP,,
C15702,Tubulysin A,0 Pip is modified by N-methyl. (i.e. N-Methyl-L-pipecolic acid),0 Pip  1 Ile  2 Val  3 Mao  4 Cys  5 Tyr  6 Mtn,PKNRP,,
C15703,Tubulysin B,0 Pip is modified by N-methyl. (i.e. N-Methyl-L-pipecolic acid),0 Pip  1 Ile  2 Val  3 Mao  4 Cys  5 Tyr  6 Mtn,PKNRP,,
C15704,Tubulysin D,0 Pip is modified by N-methyl. (i.e. N-Methyl-L-pipecolic acid),0 Pip  1 Ile  2 Val  3 Mao  4 Cys  5 Phe  6 Mtn,PKNRP,,
C15705,Tubulysin E,0 Pip is modified by N-methyl. (i.e. N-Methyl-L-pipecolic acid),0 Pip  1 Ile  2 Val  3 Mao  4 Cys  5 Phe  6 Mtn,PKNRP,,
C15706,Spinosyn H,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C15707,Spinosyn J,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C15708,Spinosyn K,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C15709,Spinosyn P,,0 Mtk  1 Mae  2 Mak  3 Mtk  4 Mad  5 Mak  6 Mak  7 Mad  8 Mad|9 Mad  10 Man,PK,,
C15710,Phoslactomycin B,,0 Chd  1 Mad  2 Mak  3 Mak  4 Etd  5 Mak  6 Etk  7 Man,PK,,
C15711,Balhimycin,"0 Leu is modified by N-methyl. (i.e. N-Methyl-(R)-leucine, MeLeu)|1 and 5 Tyr are modified by (R)-chloro-beta-hydroxy. (i.e. (R)-Chloro-beta-hydroxytyrosine)",0 D-Leu  1 D-Tyr  2 Asn  3 D-Hpg  4 D-Hpg  5 Tyr  6 Dpg,NRP,,
C15712,Melithiazole E;|Cystothiazole A,,0 Iso  1 Cys  2 Cys  3 Mam  4 Mtm  5 Man  6 Gly,PKNRP,,
C15713,Nodularin,"6 MeDhb, N-methyldehydrobutyrine is modified from L-Thr by methylation (NdaA [UP:Q847C7]) and dehydration (NdaH [UP:Q847C1]).|7 D-MeAsp is D-erythro-beta-methylaspartic acid.",0 Phenylacetate  1 Mtd  2 Mtd  3 Maa  4 Mtn  5 D-Glu  6 MeDhb|7 D-MeAsp  8 Arg  (Cyclization: 5-8),PKNRP,Natural toxins [BR:br08009]|Cyanotoxins|Peptides|Others|C15713  Nodularin,
C15714,Myxochromide S1,"1 Thr is modified by N-methyl. (i.e. N-Methylthreonine, MeThr)",0 FA  1 Thr  2 Leu  3 Ala  5 Ala  6 Gln  (Cyclization: 1-6),NRP,,
C15715,Myxochromide S2,"1 Thr is modified by N-methyl. (i.e. N-Methylthreonine, MeThr)",0 FA  1 Thr  2 Leu  3 Ala  5 Ala  6 Gln  (Cyclization: 1-6),NRP,,
C15716,Myxochromide S3,"1 Thr is modified by N-methyl. (i.e. N-Methylthreonine, MeThr)",0 FA  1 Thr  2 Leu  3 Ala  5 Ala  6 Gln  (Cyclization: 1-6),NRP,,
C15717,ECO 02301,,0 4ak  1 Mak  2 Mad  3 Mak  4 Mak  5 Mak  6 Mak  7 Mad  8 Mak|9 Mak  10 Mak  11 Man  12 Mtk  13 Mad  14 Mad  15 Mad  16 Mad|17 Mad  18 Mak  19 Mtk  20 Mtd  21 Mae  22 Mad  23 Mad  24 Mad|25 Mad  26 Man,PK,,
C15718,Pyoverdine I,0 Tyr and 1 Dab are modified to form a fluorescent dihydroxyquinoline chromophore.|5 fOHOrn and 7 fOHOrn are N5-Formyl-N5-hydroxyornithine.,0 Suc-Tyr  1 Dab  2 D-Ser  3 Arg  4 D-Ser  5 fOHOrn  6 Lys|7 fOHOrn  8 Thr  9 Thr  (Cyclization: 6-9),NRP,,
C15719,Coelichelin,0 Orn is modified by 5-hydroxy-5-formyl. (i.e. 5-Hydroxy-5-formylornithine)|2 Orn is modified by 5-hydroxy. (i.e. 5-Hydroxyornithine),0 Orn  1 Thr  2 Orn,NRP,,
C15720,Lyngbyatoxin;|Lyngbyatoxin A,"0 Val is modified by N-methyl. (i.e. N-Methylvalin, MeVal)",0 Val  1 Trp,NRP,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Others|C15720  Lyngbyatoxin,
C15721,Triostin A,"3 Cys is modified by N-methyl. (i.e. N-Methylcysteine, MeCys)|4 Val is modified by N-methyl. (i.e. N-Methylvaline, MeVal)",0 QA  1 D-Ser  2 Ala  3 Cys  4 Val  (Dimer),NRP,,
C15722,Quinomycin A;|Echinomycin,"3 Cys is modified by N-methyl. (i.e. N-Methylcysteine, MeCys)|4 Val is modified by N-methyl. (i.e. N-Methylvaline, MeVal)",0 QA  1 D-Ser  2 Ala  3 Cys  4 Val  (Dimer),NRP,,
C15723,Nostocyclopeptide A1,"5 Pro is modified by 4-methyl. (i.e. 4-Methylproline, MePro)",0 Tyr  1 Gly  2 Gln  3 Ile  4 Ser  5 Pro  6 Leu|(Cyclization: 0-6),NRP,,
C15724,Nostocyclopeptide A2,"5 Pro is modified by 4-methyl. (i.e. 4-Mehtylproline, MePro)",0 Tyr  1 Gly  2 Gln  3 Ile  4 Ser  5 Pro  6 Phe|(Cyclization: 0-6),NRP,,
C15725,Nostocyclopeptide A3,"5 Pro is modified by 4-methyl. (i.e. 4-Mehtylproline, MePro)|6 Phe is modified by p-methyl. (i.e. p-methylphenylalanine, MePhe)",0 Tyr  1 Gly  2 Gln  3 Ile  4 Ser  5 Pro  6 Phe|(Cyclization: 0-6),NRP,,
C15726,Zwittermicin A,,0 Ser  1 Mak  2 Nmk  3 Hmn  4 Dpr,PKNRP,,
C15727,Thiocoraline,"3 Cys is modified by N-methyl. (i.e. N-Methyl-L-cysteine)|4 Cys is modified by N,S-dimethyl. (i.e. N,S-Dimethyl-L-cysteine)",0 3HQA  1 D-Cys  2 Gly  3 Cys  4 Cys  (Dimer),NRP,,
C15728,Chivosazole A,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15729,Chivosazole B,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15730,Chivosazole C,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15731,Chivosazole D,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15732,Chivosazole E,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15733,Chivosazole F,,0 Mak  1 Mak  2 Mtk  3 Mtd  4 Mad  5 Mad  6 Mak  7 Mak  8 Mtn|9 Ser  10 Mad  11 Mak  12 Mtd  13 Mtd  14 Mad  15 Mad  16 Man,PKNRP,,
C15734,Patellamide A,,Ile Thr Val Cys Ile Ser Val Cys,Peptide,,
C15735,Patellamide C,,Val Thr Ala Cys Ile Thr Phe Cys,Peptide,,
C15736,Patellamide B,,,,,
C15737,Patellamide D,,,,,
C15738,Ascidiacyclamide,,,,,
C15739,Westiellamide,,0 Thr  1 Val  2 Thr  3 Val  4 Thr  5 Val  (Cyclization: 0-5),NRP,,
C15740,Enniatin B,,0 Ala  1 Val  2 Val  3 Val  4 Val  5 Val,NRP,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C15740  Enniatin B,
C15741,Methylsulfomycin I,,,,,
C15742,Cyanopeptolin A,"FA = hexanoyl|6 Phe is modified by N-methyl. (i.e. N-Methyphenylalanine, MePhe)",0 FA  1 Asp  2 Thr  3 Arg  4 Ahp  5 Leu  6 Phe  7 Val|(Cyclization: 2-7),NRP,,
C15743,Cyanopeptolin S,"Ga = Glyceric acid|5 Phe is modified by N-methyl. (i.e. N-Methylphenylalanine, MePhe)",0 Ga-3-O-sulfate  1 Thr  2 Arg  3 Ahp  4 Ile  5 Phe  6 Ile|(Cyclization: 1-6),NRP,,
C15744,Aeruginopeptin 95A,"7 Phe is modified by N-methyl. (i.e. N-Methylphenylalanine, MePhe)",0 Hpl  1 Thr  2 Gln  3 Thr  4 Tyr  5 Ahp  6 Thr  7 Phe  8 Ile|(Cyclization: 3-8),NRP,,
C15745,Aeruginopeptin 95B,"4 Tyr is modified by 1',2',3',4'-tetrahydro. (i.e. 1',2',3',4'-tetrahydrotyrosine, ThTyr)|7 Phe is modified by N-methyl. (i.e. N-Methylphenylalanine, MePhe)",0 Hpl  1 Thr  2 Gln  3 Thr  4 Tyr  5 Ahp  6 Thr  7 Phe  8 Ile|(Cyclization: 3-8),NRP,,
C15746,Aeruginopeptin 228A,"6 Phe is modified by N-methyl. (i.e. N-Methylphenylalanine, MePhe)",0 Hpl  1 Gln  2 Thr  3 Tyr  4 Ahp  5 Thr  6 Phe  7 Ile|(Cyclization: 2-7),NRP,,
C15747,Aeruginopeptin 228B,,0 Hpl  1 Gln  2 Thr  3 Tyr  4 Ahp  5 Thr  6 Phe  7 Ile,NRP,,
C15748,Aeruginopeptin 917S-A;|Microcystilide A,"6 Tyr is modified by N-methyl. (i.e. N-Methyltyrosine, MeTyr)",0 Hpl  1 Gln  2 Thr  3 Tyr  4 Ahp  5 Leu  6 Tyr  7 Ile|(Cyclization: 2-7),NRP,,
C15749,Aeruginopeptin 917S-B,"3 Tyr is modified by tetrahydro. (i.e. tetrahydrotyrosine, ThTyr)|6 Tyr is modified by N-methyl. (i.e. N-Methyltyrosine, MeTyr)",0 Hpl  1 Gln  2 Thr  3 Tyr  4 Ahp  5 Leu  6 Tyr  7 Ile|(Cyclization: 2-7),NRP,,
C15750,Aeruginopeptin 917S-C,"6 Tyr is modified by N-methyl. (i.e. N-Methyltyrosine, MeTyr)",0 Hpl  1 Gln  2 Thr  3 Leu  4 Ahp  5 Leu  6 Tyr  7 Ile|(Cyclization: 2-7),NRP,,
C15751,Spicamycin,,,PKNRP,,
C15752,Lienomycin,,0 Mae  1 Mak  2 Mad  3 Mak  4 Mad  5 Mak  6 Mak  7 Mak  8 Mak|9 Mad  10 Mak  11 Mak  12 Mak  13 Man  14 Mtk  15 Mad  16 Ete|17 Mad  18 Mak  19 Mtk  20 Mtd  21 Mad  22 Mad  23 Mad  24 Mad|25 Mae  26 Man,PK,,
C15753,Dihydroalbocycline,,0 Mak  1 Mte  2 Mad  3 Mtk  4 Mad  5 Mte  6 Man,PK,,
C15754,Septacidin,,,PKNRP,,
C15755,Dihydropicromycin,,0 Mtk  1 Mte  2 Man  3 Mte  4 Mtk  5 Mtn  6 Mtn,PK,,
C15756,Antibiotic TA,,0 Mak  1 Mak  2 Mae  3 Mad  4 Mad  5 Mae  6 Mae  7 Man  8 Mae|9 Mae  10 Mte  11 Mtn,PK,,
C15757,Enniatin B4;|Enniatin D,,0 Abu  1 Val  2 Val  3 Val  4 Val  5 Val,NRP,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C15757  Enniatin D,
C15758,Lankacidin C,,,PK,,
C15759,Hedamycin,,,PK,,
C15760,Pederin,,0 Mak  1 Mte  2 Mak  3 Man  4 Gly  5 Mak  6 Mtk  7 Mak,PKNRP,,
C15761,Concanamycin A,,0 Mad  1 Mak  2 Mtk  3 Mak  4 Mtk  5 Mtk  6 Mxd  7 Mad  8 Mte|9 Mtk  10 Etk  11 Mtd  12 Mtd  13 Mxn,PK,,
C15762,Onnamide A;|Onnamide,,0 Mak  1 Mte  2 Mak  3 Man  4 Gly  5 Mak  6 Mtk  7 Mak  8 Mae|9 Mad  10 Mad  11 Mad  12 Man,PKNRP,,
C15763,SW 163C,"3 Cys is modified by N-methyl. (i.e. N-Methylcysteine, MeCys)",0 3HQA  1 D-Ser  2 Ala  3 Cys  4 N-Methyl-cyclopropane  (Dimer),NRP,,
C15764,UK 63598,"3 Cys is modified by N,S-dimethyl. (i.e. N,S-Dimethylcysteine)",0 3HQA  1 D-Ser  2 Ala  3 Cys  4 N-Methyl-cyclopropane  (Dimer),NRP,,
C15765,Coronafacic acid,,0 Etn  1 Man,PK,,
C15766,Halstoctacosanolide A,,,PK,,
C15767,4-(L-gamma-Glutamylamino)butanoate;|4-(gamma-L-Glutamylamino)butanoate;|gamma-Glutamyl-gamma-aminobutyrate;|4-(Glutamylamino)butanoate;|gamma-Glutamyl-GABA,,,,,
C15769,"HBOA;|2-Hydroxy-1,4-benzoxazin-3-one;|2-Hydroxy-2H-1,4-benzoxazin-3(4H)-one",,,,,
C15770,"DIBOA;|2,4-Dihydroxy-1,4-benzoxazin-3-one;|2,4-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15770,
C15771,"TRIBOA;|2,4,7-Trihydroxy-2H-1,4-benzoxazin-3(4H)-one",,,,,
C15772,"DIBOA-glucoside;|2,4-Dihydroxy-1,4-benzoxazin-3-one glucoside;|(2R)-4-Hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15772,
C15773,Bleomycin,Generic compound|Bleomycin A [CPD:C15774]|Bleomycin B [CPD:C15775],,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C15773  Bleomycin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07535)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DC Other cytotoxic antibiotics|L01DC01 Bleomycin|D07535  Bleomycin (INN),
C15774,Bleomycin A,Component of Bleomycin [CPD:C15773]|Bleomycin A1 (R = S(O)CH3)|Bleomycin A2 (R = S(CH3)2) [CPD:C06854]|Bleomycin A5 (R = NH(CH2)4NH2)|Bleomycin A6 (R = NH(CH2)4NH(CH2)3NH2),,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C15774  Bleomycin A,
C15775,Bleomycin B,Component of Bleomycin [CPD:C15773]|Bleomycin B1' (Bleomycinamide) (R = H)|Bleomycin B2 (R = (CH2)4NHC(NH)NH2) [CPD:C01895]|Bleomycin B4 (R = (CH2)4N(C(NH)NH2)(CH2)4NHC(NH)NH2)|Bleomycin B6 (R = (CH2)4NHC(NH)NH(CH2)4NHC(NH)NH(CH2)4NHC(NH)NH2),,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C15775  Bleomycin B,
C15776,4alpha-Methylfecosterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15776  4alpha-Methylfecosterol,
C15777,"Episterol;|(3beta,5alpha)-Ergosta-7,24(28)-dien-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15777  Episterol,
C15780,"5-Dehydroepisterol;|5,7,24(28)-Ergostatrienol;|Ergosta-5,7,24(28)-trien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15780  5-Dehydroepisterol,
C15781,24-Methylenecholesterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15781  24-Methylenecholesterol,
C15782,Delta7-Avenasterol;|7-Dehydroavenasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C15782  Delta7-Avenasterol,
C15783,5-Dehydroavenasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C15783  5-Dehydroavenasterol,
C15784,Campest-4-en-3beta-ol;|(24R)-Ergost-4-en-3beta-ol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15784  Campest-4-en-3beta-ol,
C15785,Campest-4-en-3-one;|(24R)-Ergost-4-en-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15785  Campest-4-en-3-one,
C15786,5alpha-Campestan-3-one;|(24R)-5alpha-Ergostan-3-one,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15786  5alpha-Campestan-3-one,
C15787,Campestanol;|5alpha-Campestanol;|(24R)-5alpha-Ergostan-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Campestane derivatives|C15787  Campestanol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15787  Campestanol,
C15788,6alpha-Hydroxycampestanol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15788  6alpha-Hydroxycampestanol,
C15789,6-Oxocampestanol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15789  6-Oxocampestanol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C15789  6-Oxocampestanol,
C15790,Cathasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15790  Cathasterone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C15790  Cathasterone,
C15791,"Teasterone;|(3beta,5alpha,22R,23R,24S)-3,22,23-Trihydroxyergostan-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15791  Teasterone,
C15792,3-Dehydroteasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15792  3-Dehydroteasterone,
C15793,"Typhasterol;|2-Deoxycastasterone;|(3alpha,5alpha,22R,23R,24S)-3,22,23-Trihydroxyergostan-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15793  Typhasterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C15793  Typhasterol,
C15794,"Castasterone;|(2alpha,3alpha,5alpha,22R,23R,24S)-2,3,22,23-Tetrahydroxyergostan-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15794  Castasterone|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C15794  Castasterone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15794,
C15795,22alpha-Hydroxy-campesterol;|(22S)-22-Hydroxy-campesterol;|(22S)-22-hydroxycampesterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15795  22alpha-Hydroxy-campesterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Ergostane|C15795  22alpha-Hydroxy-campesterol,
C15796,"(22S)-22-Hydroxycampest-4-en-3-one;|22alpha-Hydroxy-campest-4-en-3-one;|(22S,24R)-22-Hydroxy-ergost-4 en-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15796  22alpha-Hydroxy-campest-4-en-3-one,
C15797,"22alpha-Hydroxy-5alpha-campestan-3-one;|(22S,24R)-22-Hydroxy-5alpha-ergostan-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15797  22alpha-Hydroxy-5alpha-campestan-3-one,
C15798,6-Deoxocathasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15798  6-Deoxocathasterone,
C15799,6-Deoxoteasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15799  6-Deoxoteasterone,
C15800,3-Dehydro-6-deoxoteasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15800  3-Dehydro-6-deoxoteasterone,
C15801,6-Deoxotyphasterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15801  6-Deoxotyphasterol,
C15802,6-Deoxocastasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15802  6-Deoxocastasterone,
C15803,6alpha-Hydroxycastasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C15803  6alpha-Hydroxycastasterone,
C15808,"4alpha-Methylzymosterol-4-carboxylate;|4alpha-Carboxy-4beta-methyl-5alpha-cholesta-8,24-dien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15808  4alpha-Methylzymosterol-4-carboxylate,
C15809,Iminoglycine;|Iminoacetic acid;|2-Iminoacetate,,,,,
C15810,Sulfur-carrier protein;|[Sulfur-carrier protein];|[Sulfur-carrier protein]-Gly-Gly,Generic compound in reaction hierarchy,,,,
C15811,[Enzyme]-cysteine,Generic compound in reaction hierarchy,,,,
C15812,[Enzyme]-S-sulfanylcysteine,Generic compound in reaction hierarchy,,,,
C15813,Adenylyl-[sulfur-carrier protein];|[Sulfur-carrier protein]-Gly-Gly-AMP,Generic compound in reaction hierarchy,,,,
C15814,Thiocarboxy-[sulfur-carrier protein];|[Sulfur-carrier protein]-Gly-NH-CH2-C(O)SH,Generic compound in reaction hierarchy,,,,
C15816,3-Keto-4-methylzymosterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15816  3-Keto-4-methylzymosterol,
C15817,Heme C,,,,,
C15818,Soraphen O,,0 Bnk  1 Mae  2 Mae  3 Mxk  4 Mae  5 Mtn,PK,,
C15819,FK463;|Micafungin sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02465)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J02 ANTIMYCOTICS FOR SYSTEMIC USE|J02A ANTIMYCOTICS FOR SYSTEMIC USE|J02AX Other antimycotics for systemic use|J02AX05 Micafungin|D02465  Micafungin sodium (JAN/USAN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02465)]|Antifungals|Micafungin|D02465  Micafungin sodium (JAN/USAN)|Therapeutic category of drugs in Japan [BR:br08301(D02465)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|617  Acting mainly on mold|6179  Others|D02465  Micafungin sodium (JAN/USAN)|Antimicrobials [BR:br08307(D02465)]|Antifungals|Cell membrane function inhibitor|Echinocandin|D02465  Micafungin sodium (JAN/USAN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D02465)]|New molecular entities and new therapeutic biological products|D02465|New drug approvals in Europe [br08329.html(D02465)]|European public assessment reports (EPAR) authorised medicine|D02465|New drug approvals in Japan [br08318.html(D02465)]|Drugs with new active ingredients|D02465|New drug approvals in the USA, Europe and Japan [br08328.html(D02465)]|Approval dates by FDA, EMA and PMDA|D02465",
C15820,Teicoplanin,"5 Tyr is modified by beta-hydroxy. (i.e. beta-Hydroxytyrosine, betaHT)|Teicoplanin A1 (R1 = H, R2 = H, R3 = H)|Teicoplanin A2 [CPD:C13781]|Teicoplanin A3 [CPD:C15669]",0 D-Hpg  1 D-Tyr  2 Dpg  3 D-Hpg  4 D-Hpg  5 Tyr  6 Dpg,NRP,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02142)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01X OTHER ANTIBACTERIALS|J01XA Glycopeptide antibacterials|J01XA02 Teicoplanin|D02142  Teicoplanin (JP18/USAN/INN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D02142)]|6  Agents against pathologic organisms and parasites|61  Antibiotics|611  Acting mainly on gram-positive bacteria|6119  Others|D02142  Teicoplanin (JP18/USAN/INN)|Drug groups [BR:br08330(D02142)]|Antibacterial|DG01580  Glycopeptide antibiotic|D02142  Teicoplanin|Drug classes [BR:br08332(D02142)]|Antibacterial|DG01580  Glycopeptide antibiotic|D02142  Teicoplanin|Antimicrobials [BR:br08307(D02142)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Glycopeptide|D02142  Teicoplanin (JP18/USAN/INN) &lt;JP&gt;|Antimicrobials abbreviations [BR:br08327(D02142)]|Antibacterials|Cell wall biosynthesis inhibitor, other|Glycopeptide|D02142  Teicoplanin (JP17/USAN/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02142)]|Chemicals|D02142  Teicoplanin",
C15821,Rimocidine,,0 Etk  1 Mad  2 Mad  3 Mad  4 Mad  5 Mak  6 Mak  7 Mtk  8 Man|9 Man  10 Mak  11 Mae  12 Man  13 Mak  14 Etn,PK,,
C15822,CE-108,,0 Mak  1 Mad  2 Mad  3 Mad  4 Mad  5 Mak  6 Mak  7 Mtk  8 Man|9 Man  10 Mak  11 Mae  12 Man  13 Mak  14 Etn,PK,,
C15823,Progeldanamycin,,0 Ahb  1 Mte  2 Mxk  3 Mtd  4 Mtk  5 Mxe  6 Mad  7 Mtn,PK,,
C15824,Cephabacin F3;|Cephabacin,,0 Ala  1 Ala  2 Ala  3 Arg  4 Man,PKNRP,,
C15834,Narasin B;|A28086B,,0 Mad  1 Ete  2 Mad  3 Mte  4 Man  5 Mad  6 Man  7 Mte  8 Mtk|9 Etn  10 Mtk  11 Mtk  12 Mte  13 Mtd  14 Etn,PK,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C15834  Narasin B,
C15842,Lipomycin;|alpha-Lipomycin,,0 Isk  1 Mtd  2 Mtd  3 Mad  4 Mad  5 Mad  6 Man  7 Man  8 Glu,PKNRP,,
C15844,Elaiophylin,,,PK,,
C15846,Isomigrastatin,,0 Xpa  1 Man  2 Mtd  3 Mtk  4 Mtk  5 Mad  6 Mae  7 Mad  8 Man,PK,,
C15847,X-206,,0 Mtk  1 Mte  2 Mak  3 Mte  4 Mtk  5 Mte  6 Mak  7 Mak  8 Mte|9 Mtk  10 Mak  11 Mte  12 Mtk  13 Mtk  14 Mtk  15 Mae  16 Mtk|17 Mtn,PK,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C15847  X-206,
C15848,Angiotensin III,,Arg Val Tyr Ile His Pro Phe,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Angiotensin|C15848  Angiotensin III|Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C15848  Angiotensin III,
C15849,"Angiotensin IV;|Angiotensin II, 1-des-asn-2-arg",,Val Tyr Ile His Pro Phe,Peptide,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Peptide hormones|Angiotensin|C15849  Angiotensin IV|Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C15849  Angiotensin IV,
C15850,Angiotensin (1-7),,Asp Arg Val Tyr Ile His Pro,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C15850  Angiotensin (1-7),
C15851,Angiotensin (1-9),,Asp Arg Val Tyr Ile His Pro Phe His,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C15851  Angiotensin (1-9),
C15852,Angiotensin (1-5),,Asp Arg Val Tyr Ile,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C15852  Angiotensin (1-5),
C15853,Dehydrospermidine,,,,,
C15854,N-(4-Aminobutylidene)-[eIF5A-precursor]-lysine;|N-(4-Aminobutylidene)-[enzyme]-lysine,,,,,
C15857,"9,9'-dicis-zeta-Carotene;|9,9'-Di-cis-zeta-carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15857  9,9'-Di-cis-zeta-carotene",
C15858,"7,9,7',9'-tetracis-Lycopene;|7,9,7',9'-Tetra-cis-lycopene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15858  7,9,7',9'-Tetra-cis-lycopene",
C15859,1'-Hydroxy-gamma-carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15859  1'-Hydroxy-gamma-carotene,
C15860,1'-Hydroxytorulene;|Myxocoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15860  1'-Hydroxytorulene,
C15861,1'-Hydroxy-gamma-carotene glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15861  1'-Hydroxy-gamma-carotene glucoside,
C15864,1'-Hydroxy-gamma-carotene glucoside ester,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15864  1'-Hydroxy-gamma-carotene glucoside ester,
C15867,"3,4-Dehydrolycopene;|all-trans-3,4-Didehydrolycopene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15867  3,4-Dehydrolycopene",
C15874,"3,4-Dehydrorhodopin;|3,4-Didehydrorhodopin;|1-Hydroxy-3,4-didehydro-1,2-dihydrolycopene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15874  3,4-Dehydrorhodopin",
C15877,Anhydrorhodovibrin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15877  Anhydrorhodovibrin,
C15878,Rhodovibrin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15878  Rhodovibrin,
C15879,Hydroxyspirilloxanthin;|Monodemethyl spirilloxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15879  Hydroxyspirilloxanthin,
C15881,Spirilloxanthin;|Rhodoviolascin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15881  Spirilloxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15881,
C15882,"2-Methyl-6-phytylquinol;|2-Methyl-6-phytyl-1,4-hydroquinone;|2-Methyl-6-phytylbenzene-1,4-diol;|2-Methyl-6-phytyl-1,4-benzoquinol",,,,,
C15883,"2,3-Dimethyl-5-phytylquinol;|2,3-Dimethyl-5-phytyl-1,4-hydroquinone;|2,3-Dimethyl-6-phytylbenzene-1,4-diol",,,,,
C15884,2-Ketospirilloxanthin;|2-Oxospirilloxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15884  2-Ketospirilloxanthin,
C15885,"2,2'-Diketospirilloxanthin;|2,2'-Dioxospirilloxanthin",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15885  2,2'-Diketospirilloxanthin",
C15886,"3,4-Dihydroanhydrorhodovibrin",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15886  3,4-Dihydroanhydrorhodovibrin",
C15887,"3',4'-Dihydrorhodovibrin",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15887  3',4'-Dihydrorhodovibrin",
C15888,"3,4,3',4'-Tetrahydrospirilloxanthin",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15888  3,4,3',4'-Tetrahydrospirilloxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15888",
C15892,Chloroxanthin;|Hydroxyneurosporene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15892  Chloroxanthin,
C15895,"3,4-Dihydrospheroidene;|Methoxyneurosporene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15895  3,4-Dihydrospheroidene",
C15898,Demethylspheroidene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15898  Demethylspheroidene,
C15900,Spheroidene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15900  Spheroidene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15900,
C15902,Hydroxyspheroidene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15902  Hydroxyspheroidene,
C15903,Spheroidenone;|Spheroiden-2-one,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15903  Spheroidenone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15903,
C15905,Hydroxyspheroidenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15905  Hydroxyspheroidenone,
C15907,"1',2'-Dihydro-gamma-carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15907  1',2'-Dihydro-gamma-carotene",
C15908,Chlorobactene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15908  Chlorobactene,
C15910,"1',2'-Dihydrochlorobactene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15910  1',2'-Dihydrochlorobactene",
C15911,Hydroxychlorobactene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15911  Hydroxychlorobactene,
C15914,Hydroxychlorobactene glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15914  Hydroxychlorobactene glucoside,
C15915,"4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15915  4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol",
C15917,Hydroxychlorobactene glucoside ester,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15917  Hydroxychlorobactene glucoside ester,
C15919,Myxol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15919  Myxol,
C15923,L-Gulose,D-Gulose [CPD:C06465],,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Aldoses|C15923  L-Gulose,
C15924,L-Gulose 1-phosphate,,,,,
C15925,GDP-L-gulose,,,,,
C15926,beta-L-Galactose 1-phosphate;|L-Galactose 1-phosphate,,,,,
C15927,Leucokinin I,,Asp Pro Ala Phe Asn Ser Trp Gly-NH2,Peptide,,
C15928,4-Ketomyxol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15928  4-Ketomyxol,
C15930,L-Galactonate;|L-Galactonic acid,,,,,
C15932,4-Hydroxymyxol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15932  4-Hydroxymyxol,
C15933,Deoxymyxol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15933  Deoxymyxol,
C15935,"(2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15935  (2'S)-Deoxymyxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",
C15937,"(3R,2'S)-Myxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15937  (3R,2'S)-Myxol 2'-(2,4-di-O-methyl-alpha-L-fucoside)|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C15937",
C15939,N-Acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R,Generic compound in reaction hierarchy,,,,
C15940,(2'S)-Deoxymyxol 2'-alpha-L-fucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15940  (2'S)-Deoxymyxol 2'-alpha-L-fucoside,
C15941,"(3R,2'S)-Myxol 2'-alpha-L-fucoside",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15941  (3R,2'S)-Myxol 2'-alpha-L-fucoside",
C15942,"(3S,2'S)-4-Ketomyxol 2'-alpha-L-fucoside",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15942  (3S,2'S)-4-Ketomyxol 2'-alpha-L-fucoside",
C15943,Isorenieratene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15943  Isorenieratene,
C15952,Thermocryptoxanthin-11,,,,,
C15954,Thermocryptoxanthin-13,,,,,
C15955,Thermocryptoxanthin-15,,,,,
C15956,Thermozeaxanthin-13,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15956  Thermozeaxanthin-13,
C15957,Thermozeaxanthin-15,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15957  Thermozeaxanthin-15,
C15958,Thermozeaxanthin-17,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15958  Thermozeaxanthin-17,
C15959,Thermobiszeaxanthin-13-13,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15959  Thermobiszeaxanthin-13-13,
C15963,Thermobiszeaxanthin-13-15,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15963  Thermobiszeaxanthin-13-15,
C15964,Thermobiszeaxanthin-15-15,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15964  Thermobiszeaxanthin-15-15,
C15965,3'-Hydroxyechinenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15965  3'-Hydroxyechinenone,
C15966,3-Hydroxyechinenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15966  3-Hydroxyechinenone,
C15967,Phoenicoxanthin;|Adonirubin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15967  Phoenicoxanthin,
C15968,"Adonixanthin;|4-Ketozeaxanthin;|3,3'-Dihydroxy-beta,beta-carotene-4-one",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15968  Adonixanthin,
C15969,Zeaxanthin diglucoside;|Zeaxanthin-beta-D-diglucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15969  Zeaxanthin diglucoside,
C15970,Abscisic acid glucose ester;|Abscisic acid-beta-D-glucopyranosyl ester;|beta-D-Glucopyranosyl abscisate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C15970  Abscisic acid glucose ester,
C15971,Dihydrophaseic acid;|(-)-Dihydrophaseic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010305 Cyclofarnesane sesquiterpenoids|C15971  Dihydrophaseic acid,
C15972,Enzyme N6-(lipoyl)lysine;|Lipoamide-E;|[E2 protein]-N6-lipoyl-L-lysine;|[Lipoyl-carrier protein E2]-N6-lipoyl-L-lysine,"Generic compound in reaction hierarchy|The oxidized lipoyllysine residue in EC 2.3.1.12, dihydrolipoyllysine-residue acetyltransferase ( EC 2.3.1.61, dihydrolipoyllysine-residue succinyltransferase or EC 2.3.1.168, dihydrolipoyllysine-residue (2-methylpropanoyl)transferase ).",,,,
C15973,Enzyme N6-(dihydrolipoyl)lysine;|Dihydrolipoamide-E;|[E2 protein]-N6-[(R)-dihydrolipoyl]-L-lysine;|[Lipoyl-carrier protein E2]-N6-[(R)-dihydrolipoyl]-L-lysine,"Generic compound in reaction hierarchy|The reduced lipoyllysine residue in EC 2.3.1.12, dihydrolipoyllysine-residue acetyltransferase ( EC 2.3.1.61, dihydrolipoyllysine-residue succinyltransferase or EC 2.3.1.168, dihydrolipoyllysine-residue (2-methylpropanoyl)transferase ).",,,,
C15974,3-Methyl-1-hydroxybutyl-ThPP;|3-Methyl-1-hydroxybutyl-TPP,,,,,
C15975,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine;|S-(3-Methylbutanoyl)-dihydrolipoamide-E,Generic compound in reaction hierarchy|The 3-methylbutanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].,,,,
C15976,2-Methyl-1-hydroxypropyl-ThPP;|2-Methyl-1-hydroxypropyl-TPP,,,,,
C15977,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine;|S-(2-Methylpropanoyl)-dihydrolipoamide-E;|S-(2-Methylpropionyl)-dihydrolipoamide-E;|Enzyme N6-(S-[2-methylpropanoyl]dihydrolipoyl)lysine,Generic compound in reaction hierarchy|The 2-methylpropanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].,,,,
C15978,2-Methyl-1-hydroxybutyl-ThPP;|2-Methyl-1-hydroxybutyl-TPP,,,,,
C15979,[Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine;|S-(2-Methylbutanoyl)-dihydrolipoamide-E,Generic compound in reaction hierarchy|The 2-methylbutanoyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue (2-methylpropanoyl)transferase [EC:2.3.1.168].,,,,
C15980,(S)-2-Methylbutanoyl-CoA,,,,,
C15981,"alpha-Cryptoxanthin;|(3'R,6'R)-beta,epsilon-Caroten-3'-ol",often confused with Zeinoxanthin [CPD:C08590],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15981  alpha-Cryptoxanthin|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C15981  alpha-Cryptoxanthin,
C15982,Thermocryptoxanthin,Generic compound in reaction hierarchy|Thermocryptoxanthin-11 (n=4) [CPD:C15952]|Thermocryptoxanthin-13 (n=6) [CPD:C15954]|Thermocryptoxanthin-15 (n=8) [CPD:C15955],,,,
C15983,Thermozeaxanthin;|Zeaxanthin glucoside ester,Generic compound in reaction hierarchy|Thermozeaxanthin-13 (n=6) [CPD:C15956]|Thermozeaxanthin-15 (n=8) [CPD:C15957]|Thermozeaxanthin-17 (n=10) [CPD:C15958],,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15983  Thermozeaxanthin,
C15984,Thermobiszeaxanthin;|Zeaxanthin diglucoside diester,"Generic compound in reaction hierarchy|Thermobiszeaxanthin-13-13 (n1=6,n2=6) [CPD:C15959]|Thermobiszeaxanthin-13-15 (n1=6,n2=8) [CPD:C15963]|Thermobiszeaxanthin-15-15 (n1=8,n2=8) [CPD:C15964]",,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C15984  Thermobiszeaxanthin,
C15985,17-O-Acetylajmaline,,,,,
C15986,"2,6-Dihydroxypseudooxynicotine;|1-(2,6-Dihydroxypyridin-3-yl)-4-(methylamino)butan-1-one",,,,,
C15987,4-Methylaminobutyrate;|gamma-N-Methylaminobutyrate,,,,,
C15988,"(9S,10S)-9,10-Dihydroxyoctadecanoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C15988  (9S,10S)-9,10-Dihydroxyoctadecanoic acid",
C15989,"(9S,10S)-10-Hydroxy-9-(phosphonooxy)octadecanoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C15989  (9S,10S)-10-Hydroxy-9-(phosphonooxy)octadecanoic acid",
C15990,"1L-myo-Inositol 1,2,3,4,6-pentakisphosphate;|myo-Inositol 1,2,3,4,6-pentakisphosphate",,,,,
C15991,myo-Inositol pentakisphosphate,Generic compound in reaction hierarchy,,,,
C15992,"Cholesterol-5alpha,6alpha-epoxide;|5,6alpha-Epoxy-5alpha-cholestan-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C15992  Cholesterol-5alpha,6alpha-epoxide",
C15996,7-Cyano-7-carbaguanine;|7-Cyano-7-deazaguanine,,,,,
C15997,"Potassium 2,6-dihydroxytriazinecarboxylate;|Potassium oxonate;|Oteracil potassium",,,,,
C15998,L-Methionine (R)-S-oxide,,,,,
C15999,L-Methionine (S)-S-oxide,,,,,
C16001,Reactive black 5,,,,,
C16008,T-kinin;|Ile-Ser-bradykinin,,ISLMKRPPGF SPFR,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Bradykinin|C16008  T-kinin,
C16011,Protein-omega-N-(ADP-D-ribosyl)-L-arginine;|Protein-Nomega-(ADP-D-ribosyl)-L-arginine;|Nomega-(ADP-D-ribosyl)-protein-L-arginine,Generic compound in reaction hierarchy,,,,
C16014,cis-Stilbene oxide,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C16014  cis-Stilbene oxide",
C16015,"(+)-(1R,2R)-1,2-Diphenylethane-1,2-diol",,,,,
C16028,"Amorpha-4,11-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C16028  Amorpha-4,11-diene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C16028  Amorpha-4,11-diene",
C16038,"2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine;|PhIP",,,,,
C16069,3-Sulfolactate,,,,,
C16070,"6-(alpha-D-Glucosaminyl)-1D-myo-inositol 1,2-cyclic phosphate",,,,,
C16071,"Riboflavin cyclic-4',5'-phosphate",,,,,
C16072,Aliphatic nitrile,Generic compound in reaction hierarchy,,,,
C16074,Phenylacetonitrile;|Benzyl cyanide,,,,,
C16075,(Z)-Phenylacetaldehyde oxime;|Z-Phenylacetaldoxime,,,,,
C16097,Neurokinin A;|Substance K;|Neuromedin L,,His Lys Thr Asp Ser Phe Val Gly Leu Met-NH2,Peptide,Bioactive peptides [BR:br08005]|Neuropeptides|Tachykinin|C16097  Neurokinin A,
C16098,Neurokinin B;|Neuromedin K;|Tachykinin-3,,Asp Met His Asp Phe Phe Val Gly Leu Met-NH2,Peptide,Bioactive peptides [BR:br08005]|Neuropeptides|Tachykinin|C16098  Neurokinin B,
C16108,Adrenorphin,,Tyr Gly Gly Phe Met Arg Arg Val-NH2,Peptide,Bioactive peptides [BR:br08005]|Neuropeptides|Endogenous opioid peptide|C16108  Adrenorphin,
C16116,L-Aminoacyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C16138,L-Pyrrolysine;|Pyrrolysine,,,,Compounds with biological roles [BR:br08001]|Peptides|Amino acids|Other amino acids|C16138  Pyrrolysine (Pyl),
C16140,L-Lysyl-tRNA(Pyl),Generic compound in reaction hierarchy|Pyl = Pyrrolysine [CPD:C16138],,,,
C16141,(+)-Germacrene A;|(+)-(R)-Germacrene A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C16141  (+)-Germacrene A|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C16141  (+)-Germacrene A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16141,
C16142,(-)-Germacrene D,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C16142  (-)-Germacrene D|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C16142  (-)-Germacrene D|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16142,
C16143,"(1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol;|Germacradienol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C16143  (1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C16143  Germacradienol",
C16144,"4,4'-Diapophytoene;|Dehydrosqualene;|15-cis-4,4'-Diapophytoene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C16144  4,4'-Diapophytoene",
C16145,"4,4'-Diaponeurosporene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C16145  4,4'-Diaponeurosporene",
C16146,"4,4'-Diaponeurosporenic acid",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C16146  4,4'-Diaponeurosporenic acid",
C16147,"Glucosyl-4,4'-diaponeurosporenoate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C16147  Glucosyl-4,4'-diaponeurosporenoate",
C16148,Staphyloxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C16148  Staphyloxanthin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16148,
C16149,(3Z)-4-(2-Carboxyphenyl)-2-oxobut-3-enoate;|cis-2'-Carboxybenzalpyruvate,,,,,
C16150,"(R,S)-Nicotine;|(+/-)-3-(1-Methyl-2-pyrrolidinyl)pyridine",,,,,
C16151,"2,6-Dihydroxy-N-methylmyosmine",,,,,
C16152,"Blue pigment;|Nicotine blue;|(E)-2,2',5,5'-Tetrahydroxy-6H,6'H-[3,3'-bipyridinylidene]-6,6'-dione",,,,,
C16153,UDP-L-Ara4N;|UDP-4-amino-4-deoxy-L-arabinose;|UDP-4-amino-4-deoxy-beta-L-arabinopyranose,,,,,
C16154,UDP-L-Ara4FN;|Uridine 5'-diphospho-beta-(4-deoxy-4-formamido-L-arabinose);|UDP-4-deoxy-4-formamido-beta-L-arabinopyranose,,,,,
C16155,UDP-L-Ara4O;|UDP-4''-ketopentose;|Uridine 5'-diphospho-beta-(L-threo-pentapyranosyl-4''-ulose);|UDP-beta-L-threo-pentapyranos-4-ulose;|UDP-4-keto-D-xylose,,,,,
C16156,"Undecaprenyl phosphate alpha-L-Ara4FN;|4-Deoxy-4-formamido-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl phosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C16156  Undecaprenyl phosphate alpha-L-Ara4FN,
C16157,"Undecaprenyl phosphate alpha-L-Ara4N;|4-Amino-4-deoxy-alpha-L-arabinopyranosyl ditrans,octacis-undecaprenyl phosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C16157  Undecaprenyl phosphate alpha-L-Ara4N,
C16159,2-Formylglutarate,,,,,
C16160,"Linoleoyl-[acyl-carrier protein];|Linoleoyl-ACP;|(9Z,12Z)-Octadecadienoyl-[acyl-carrier protein];|(9Z,12Z)-Octadecadienoyl-ACP",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C16160  (9Z,12Z)-Octadecadienoyl-[acp]",
C16161,"alpha-Linolenoyl-ACP;|alpha-Linolenoyl-[acyl-carrier protein];|(9Z,12Z,15Z)-Octadecatrienoyl-ACP;|(9Z,12Z,15Z)-Octadecatrienoyl-[acyl-carrier protein]",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C16161  (9Z,12Z,15Z)-Octadecatrienoyl-[acp]",
C16162,"(9Z,12Z,15Z)-Octadecatrienoyl-CoA;|alpha-Linolenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16162  (9Z,12Z,15Z)-Octadecatrienoyl-CoA",
C16163,"(6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA;|Stearidonoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16163  (6Z,9Z,12Z,15Z)-Octadecatetraenoyl-CoA",
C16164,"(8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA;|(8Z,11Z,14Z,17Z)-Icosa-8,11,14,17-tetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16164  (8Z,11Z,14Z,17Z)-Icosatetraenoyl-CoA",
C16165,"(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA;|(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16165  (5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA",
C16166,"(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16166  (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA",
C16167,"(9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16167  (9Z,12Z,15Z,18Z,21Z)-Tetracosapentaenoyl-CoA",
C16168,"(6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16168  (6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA",
C16169,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16169  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA",
C16170,"(7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16170  (7Z,10Z,13Z,16Z)-Docosatetraenoyl-CoA",
C16171,"(9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16171  (9Z,12Z,15Z,18Z)-Tetracosatetraenoyl-CoA",
C16172,"(6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16172  (6Z,9Z,12Z,15Z,18Z)-Tetracosapentaenoyl-CoA",
C16173,"(4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16173  (4Z,7Z,10Z,13Z,16Z)-Docosapentaenoyl-CoA",
C16177,beta-D-Galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R,Generic compound in reaction hierarchy,,,,
C16179,"(11Z,14Z,17Z)-Icosatrienoyl-CoA;|(11Z,14Z,17Z)-Icosa-11,14,17-trienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16179  (11Z,14Z,17Z)-Icosatrienoyl-CoA",
C16180,"(11Z,14Z)-Icosadienoyl-CoA;|(11Z,14Z)-Icosa-11,14-dienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16180  (11Z,14Z)-Icosadienoyl-CoA",
C16181,"beta-2,3,4,5,6-Pentachlorocyclohexanol",,,,,
C16182,"beta-2,3,5,6-Tetrachloro-1,4-cyclohexanediol",,,,,
C16183,alpha-D-Arabinopyranose 1-phosphate,,,,,
C16184,"(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid ethyl ester;|EPA ethyl ester;|Ethyl (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate;|Ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate;|Ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C16184  Ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate|USP drug classification [BR:br08302(D01892)]|Cardiovascular Agents|Dyslipidemics, Other|Icosapent Ethyl|D01892  Icosapent ethyl (USAN)|Therapeutic category of drugs in Japan [BR:br08301(D01892)]|2  Agents affecting individual organs|21  Cardiovascular agents|218  Hyperlipidemia agents|2189  Others|D01892  Icosapent ethyl (USAN); Ethyl icosapentate (JP18)|3  Agents affecting metabolism|33  Blood and body fluid agents|339  Miscellaneous|3399  Others|D01892  Icosapent ethyl (USAN); Ethyl icosapentate (JP18)|Classification of Japanese OTC drugs [BR:br08313(D01892)]|Agents for circulatory system and blood|25 Other drugs for circulatory system and blood|D01892  Icosapent ethyl (USAN)|Other (not belonging to any other category)|85 Other (not belonging to any other category)|D01892  Icosapent ethyl (USAN)|Risk category of Japanese OTC drugs [BR:br08312(D01892)]|First-class OTC drugs|Inorganic and organic chemicals|Ethyl icosapentate|D01892  Icosapent ethyl (USAN)|Drug groups [BR:br08330(D01892)]|Hypolipidemic agent|DG01946  Hypolipidemic agent|D01892  Icosapent ethyl|Blood modifier agent|DG01950  Antithrombotic agent|DG01712  Antiplatelet agent|D01892  Icosapent ethyl|Drug classes [BR:br08332(D01892)]|Cardiovascular agent|DG01946  Hypolipidemic agent|D01892  Icosapent ethyl|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D01892)]|Chemicals|D01892  Ethyl icosapentate|D01892  Ethyl icosapentate capsules|New drug approvals in Europe [br08329.html(D01892)]|European public assessment reports (EPAR) authorised medicine|D01892|Rx-to-OTC switch list in Japan [br08314.html(D01892)]|D01892",
C16185,"(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid ethyl ester;|DHA ethyl ester",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA04 Docosanoids|FA0400 Other Docosanoids|C16185  (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid ethyl ester",
C16186,L-Ascorbate 6-phosphate,,,,,
C16187,"7,2'-Dihydroxy-4'-methoxy-isoflavanol;|DMI;|(3R,4R)-4'-Methoxyisoflavan-2',4,7-triol",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C16187  7,2'-Dihydroxy-4'-methoxy-isoflavanol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C16187  7,2'-Dihydroxy-4'-methoxy-isoflavanol",
C16188,"7-Hydroxy-2',4',5'-trimethoxyisoflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16188  7-Hydroxy-2',4',5'-trimethoxyisoflavone",
C16189,9-Demethylmunduserone,,,,,
C16190,"2,7-Dihydroxy-4'-methoxyisoflavanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16190  2,7-Dihydroxy-4'-methoxyisoflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C16190  2,7-Dihydroxy-4'-methoxyisoflavanone",
C16191,Malonyldaidzin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16191  Malonyldaidzin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16191  Malonyldaidzin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C16191  Malonyldaidzin|Dietary phytochemicals [br08012.html]|Flavonoids|C16191,
C16192,Malonylgenistin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16192  Malonylgenistin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16192  Malonylgenistin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C16192  Malonylgenistin|Dietary phytochemicals [br08012.html]|Flavonoids|C16192,
C16193,"1,6-Naphthalenedisulfonic acid",,,,,
C16194,"2,6-Naphthalenedisulfonic acid",,,,,
C16195,Glycitin;|Glycitein 7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16195  Glycitin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16195  Glycitin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C16195  Glycitin|Dietary phytochemicals [br08012.html]|Flavonoids|C16195,
C16196,"1,2-Dihydroxynaphthalene-6-sulfonate",,,,,
C16197,Malonylglycitin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16197  Malonylglycitin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16197  Malonylglycitin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C16197  Malonylglycitin|Dietary phytochemicals [br08012.html]|Flavonoids|C16197,
C16198,(Z)-4-(2-Hydroxy-5-sulfonatophenyl)-2-oxo-3-butenoate,,,,,
C16199,5-Sulfosalicylate;|Sulfosalicylic acid,,,,,
C16200,Phenylboronic acid;|Benzeneboronic acid,,,,,
C16201,1-Naphthalenesulfonic acid;|Naphthalene-1-sulfonate,,,,,
C16202,2-Naphthalenesulfonic acid;|Naphthalene-2-sulfonate,,,,,
C16203,"Anthracene-cis-1,2-dihydrodiol;|cis-1,2-Dihydroanthracene-1,2-diol",,,,,
C16204,"1,2-Anthracenediol",,,,,
C16205,"Anthracene-9,10-dihydrodiol",,,,,
C16206,"9,10-Dihydroxyanthracene;|9,10-Anthracenediol",,,,,
C16207,"Anthraquinone;|9,10-Anthraquinone",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16207  Anthraquinone|Pesticides [BR:br08007]|Pesticides|Others|Bird repellent|C16207  Anthraquinone,
C16208,1-Methoxy-2-hydroxyanthracene,,,,,
C16209,3-(2-Carboxyvinyl)naphthalene-2-carboxylic acid,,,,,
C16210,4-(3-Hydroxy-2-naphthyl)-2-oxobut-3-enoic acid,,,,,
C16211,"6,7-Benzocoumarin",,,,,
C16212,3-Hydroxy-2-naphthoate,,,,,
C16213,"2,3-Dihydroxynaphthalene",,,,,
C16214,"3-[6-(Carboxymethylene)cyclohexa-2,4-dien-1-ylidene]-2-oxopropanate",,,,,
C16215,"1,2-Dihydrophthalic acid;|Cyclohexa-3,5-diene-1,2-dicarboxylate",,,,,
C16216,3-Oxostearoyl-CoA;|3-Oxooctadecanoyl-CoA;|beta-Ketostearoyl-CoA;|3-Ketostearoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16216  3-Oxooctadecanoyl-CoA,
C16217,3-Hydroxyoctadecanoyl-CoA;|3-Hydroxystearoyl-CoA;|beta-Hydroxystearoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16217  3-Hydroxyoctadecanoyl-CoA,
C16218,(2E)-Octadecenoyl-CoA;|trans-Octadec-2-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16218  (2E)-Octadecenoyl-CoA,
C16219,3-Oxostearoyl-[acp];|3-Oxooctadecanoyl-[acp];|beta-Ketostearoyl-[acp];|3-Ketostearoyl-[acp],,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C16219  3-Oxooctadecanoyl-[acp],
C16220,(3R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein];|(R)-3-Hydroxyoctadecanoyl-[acp];|(R)-3-Hydroxyoctadecanoyl-[acyl-carrier protein];|(R)-3-Hydroxystearoyl-[acp];|(R)-3-Hydroxystearoyl-[acyl-carrier protein],,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C16220  (3R)-3-Hydroxyoctadecanoyl-[acp],
C16221,(2E)-Octadecenoyl-[acp];|trans-Octadec-2-enoyl-[acp],,,,,
C16222,Formononetin 7-O-(6-O-malonyl-beta-D-glucoside);|Formononetin 7-O-glucoside-6''-O-malonate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16222  Formononetin 7-O-glucoside-6''-O-malonate|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16222  Formononetin 7-O-glucoside-6''-O-malonate|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Isoflavones|C16222  Formononetin 7-O-glucoside-6''-O-malonate|Dietary phytochemicals [br08012.html]|Flavonoids|C16222,
C16223,(-)-Medicocarpin;|Medicarpin 3-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C16223  (-)-Medicocarpin|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C16223  (-)-Medicocarpin,
C16224,Medicarpin 3-O-glucoside-6'-malonate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C16224  Medicarpin 3-O-glucoside-6'-malonate|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C16224  Medicarpin 3-O-glucoside-6'-malonate,
C16225,(-)-Vestitol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C16225  (-)-Vestitol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanes|C16225  (-)-Vestitol,
C16226,"2',7-Dihydroxy-4',5'-methylenedioxyisoflavone;|DMI",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16226  2',7-Dihydroxy-4',5'-methylenedioxyisoflavone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavones|C16226  2',7-Dihydroxy-4',5'-methylenedioxyisoflavone",
C16227,(+)-Sophorol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16227  (+)-Sophorol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C16227  (+)-Sophorol,
C16228,(-)-Sophorol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16228  (-)-Sophorol|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C16228  (-)-Sophorol,
C16229,(+)-Maackiain,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C16229  (+)-Maackiain|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C16229  (+)-Maackiain,
C16230,(+)-6a-Hydroxymaackiain,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C16230  (+)-6a-Hydroxymaackiain|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C16230  (+)-6a-Hydroxymaackiain,
C16231,(-)-Maackiain-3-O-glucosyl-6''-O-malonate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C16231  (-)-Maackiain-3-O-glucosyl-6''-O-malonate|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Pterocarpans|C16231  (-)-Maackiain-3-O-glucosyl-6''-O-malonate,
C16232,"6,7,4'-Trihydroxyflavanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16232  6,7,4'-Trihydroxyflavanone",
C16233,"2,6,7,4'-Tetrahydroxyisoflavanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C16233  2,6,7,4'-Tetrahydroxyisoflavanone|Phytochemical compounds [BR:br08003]|Flavonoids|Isoflavonoids|Isoflavanones|C16233  2,6,7,4'-Tetrahydroxyisoflavanone",
C16234,o-Nitrobenzoate;|2-Nitrobenzoic acid,,,,,
C16235,o-Hydroxylaminobenzoate;|2-Hydroxylaminobenzoic acid,,,,,
C16236,[Protein]-N6-(octanoyl)-L-lysine;|Protein N6-(octanoyl)lysine,Generic compound in reaction hierarchy|R = E2 subunit of oxo-acid dehydrogenase complexes [CPD:C22160] or H protein [CPD:C22159],,,,
C16237,Protein N6-(lipoyl)lysine;|[Lipoyl-carrier protein]-N6-(lipoyl)lysine,Generic compound in reaction hierarchy|R = E2 subunit of oxo-acid dehydrogenase complexes [CPD:C15972] or H protein [CPD:C02051],,,,
C16238,Lipoyl-AMP,,,,,
C16239,Lipoyl-[acp];|Lipoyl-[acyl carrier protein];|Lipoyl-ACP,Generic compound in reaction hierarchy,,,,
C16240,[Lipoyl-carrier protein]-L-lysine;|Apoprotein,Generic compound in reaction hierarchy|R = E2 subunit of oxo-acid dehydrogenase complexes [CPD:C22158] or H protein [CPD:C22157],,,,
C16241,"(R)-Lipoate;|(R)-Lipoic acid;|(R)-(+)-Lipoate;|R-(+)-Lipoic acid;|1,2-Dithiolane-3R-pentanoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0113 Thia fatty acids|C16241  (R)-Lipoic acid,
C16242,Cobalt-precorrin 5A,,,,,
C16243,Cobalt-precorrin 5B,,,,,
C16244,Cobalt-precorrin 7,,,,,
C16245,D-Glucuronic acid,,,,,
C16246,"3,5-Dibromo-4-hydroxybenzamide",,,,,
C16247,"2,6-Dibromophenol",,,,,
C16248,"2,6-Dibromohydroquinone",,,,,
C16249,2-Bromomaleylacetate,,,,,
C16250,MTIC,,,,,
C16251,3-epi-6-Deoxocathasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C16251  3-epi-6-Deoxocathasterone,
C16252,"(22R,23R)-22,23-Dihydroxycampesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C16252  (22R,23R)-22,23-Dihydroxycampesterol",
C16253,"(22R,23R)-22,23-Dihydroxy-campest-4-en-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C16253  (22R,23R)-22,23-Dihydroxy-campest-4-en-3-one",
C16254,[Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine;|S-Succinyldihydrolipoamide-E;|Enzyme N6-(S-succinyldihydrolipoyl)lysine,Generic compound in reaction hierarchy|The succinyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue succinyltransferase [EC:2.3.1.61].,,,,
C16255,[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine;|S-Acetyldihydrolipoamide-E;|Enzyme N6-(S-acetyldihydrolipoyl)lysine,Generic compound in reaction hierarchy|The acetyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue acetyltransferase [EC:2.3.1.12].,,,,
C16256,(E)-Cinnamoyl-CoA,,,,,
C16257,(R)-Phenyllactyl-CoA;|(R)-3-(Phenyl)lactoyl-CoA,,,,,
C16258,"Petromyzonol;|5alpha-Cholan-3alpha,7alpha,12alpha,24-tetrol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C16258  Petromyzonol",
C16259,"Petromyzonol 24-sulfate;|5alpha-Cholan-3alpha,7alpha,12alpha-triol 24-sulfate",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0502 Sulfates|C16259  Petromyzonol 24-sulfate,
C16260,"Scymnol;|5beta-Scymnol;|5beta-Cholestane-3alpha,7alpha,12alpha,24,26,27-hexol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C16260  Scymnol",
C16261,5beta-Scymnol sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0502 Sulfates|C16261  5beta-Scymnol sulfate,
C16262,"1-Hydro-1,1a-dihydroxy-9-fluorenone",,,,,
C16263,"2,3-Dihydroxy-2'-carboxybiphenyl",,,,,
C16264,"2-Hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate",,,,,
C16265,N-Acetylgalactosamine 4-sulfate,,,,,
C16266,3-Chloro-2-hydroxymuconic semialdehyde,,,,,
C16267,Cyclopropanecarboxylate,,,,,
C16268,Cyclopropanecarboxyl-CoA,,,,,
C16269,"(+)-epi-Isozizaene;|(3S,3aR,6S)-3,7,7,8-Tetramethyl-2,3,4,5,6,7-hexahydro-1H-3a,6-methanoazulene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010370 Zizaane and prezizaane sesquiterpenoids|C16269  (+)-epi-Isozizaene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C16269  (+)-epi-Isozizaene,
C16270,Rhodopinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16270  Rhodopinal,
C16271,Rhodopinal glucoside,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16271  Rhodopinal glucoside,
C16272,3-Hydroxy-5-oxohexanoate,,,,,
C16273,3-Hydroxy-5-oxohexanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16273  3-Hydroxy-5-oxohexanoyl-CoA,
C16274,"(2S,2'S)-Oscillol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16274  (2S,2'S)-Oscillol",
C16275,"(2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16275  (2S,2'S)-Oscillol 2,2'-di(alpha-L-fucoside)",
C16276,epsilon-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16276  epsilon-Carotene|Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Carotenoids|C16276  epsilon-Carotene,
C16277,R.g.-Keto I,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16277  R.g.-Keto I,
C16278,R.g.-Keto III,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16278  R.g.-Keto III,
C16279,Thiothece-474,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16279  Thiothece-474,
C16280,Okenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16280  Okenone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16280,
C16281,Thiobenzamide,,,,,
C16282,Caloxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16282  Caloxanthin,
C16283,Thiobenzamide S-oxide,,,,,
C16284,Nostoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16284  Nostoxanthin,
C16285,"Thiobenzamide S,S-dioxide",,,,,
C16286,"Geosmin;|(-)-Geosmin;|trans-1,10-Dimethyl-trans-9-decalol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C16286  Geosmin|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C16286  Geosmin,
C16287,D-Thevetose,,,,,
C16288,"Pelargonidin 3-O-3'',6''-O-dimalonylglucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16288  Pelargonidin 3-O-3'',6''-O-dimalonylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16288  Pelargonidin 3-O-3'',6''-O-dimalonylglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16288  Pelargonidin 3-O-3'',6''-O-dimalonylglucoside",
C16289,"Cyanidin 3-O-3'',6''-O-dimalonylglucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16289  Cyanidin 3-O-3'',6''-O-dimalonylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16289  Cyanidin 3-O-3'',6''-O-dimalonylglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16289  Cyanidin 3-O-3'',6''-O-dimalonylglucoside",
C16290,"Delphinidin 3-O-3'',6''-O-dimalonylglucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16290  Delphinidin 3-O-3'',6''-O-dimalonylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16290  Delphinidin 3-O-3'',6''-O-dimalonylglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16290  Delphinidin 3-O-3'',6''-O-dimalonylglucoside",
C16291,"7,8-Dihydro-beta-carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16291  7,8-Dihydro-beta-carotene",
C16292,Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16292  Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16292  Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16292  Cyanidin-3-(p-coumaroyl)-rutinoside-5-glucoside,
C16293,Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16293  Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16293  Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16293  Peonidin-3-(p-coumaroyl)-rutinoside-5-glucoside,
C16294,Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16294  Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16294  Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16294  Delphinidin-3-(p-coumaroyl)-rutinoside-5-glucoside,
C16295,Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16295  Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16295  Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16295  Petunidin-3-(p-coumaroyl)-rutinoside-5-glucoside,
C16296,Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16296  Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16296  Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16296  Malvidin-3-(p-coumaroyl)-rutinoside-5-glucoside,
C16297,Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16297  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16297  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16297  Pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside),
C16298,Cyanidin 5-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16298  Cyanidin 5-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16298  Cyanidin 5-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16298  Cyanidin 5-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16298,
C16299,Malonylshisonin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16299  Malonylshisonin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16299  Malonylshisonin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16299  Malonylshisonin|Dietary phytochemicals [br08012.html]|Flavonoids|C16299,
C16300,"Stearidonic acid;|6,9,12,15-Octadecatetraenoic acid;|(6Z,9Z,12Z,15Z)-Octadecatetraenoic acid;|6Z,9Z,12Z,15Z-Octadecatetraenoic acid;|(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16300  (6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoic acid",
C16301,Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16301  Delphinidin 3-O-(6-O-malonyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16301  Delphinidin 3-O-(6''-O-malonyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16301  Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16301,
C16302,Ternatin A1,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16302  Ternatin A1|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16302  Ternatin A1|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16302  Ternatin A1,
C16303,"Ternatin C5;|Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside-3',5'-di-O-beta-D-glucoside",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16303  Ternatin C5|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16303  Ternatin C5|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16303  Ternatin C5|Dietary phytochemicals [br08012.html]|Flavonoids|C16303,
C16304,Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside;|Delphinidin 3-O-(6''-O-malonyl)-beta-D-glucoside-3'-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16304  Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16304  Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16304  Delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16304,
C16305,Pelargonidin 3-O-sophoroside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16305  Pelargonidin 3-O-sophoroside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16305  Pelargonidin 3-O-sophoroside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16305  Pelargonidin 3-O-sophoroside|Dietary phytochemicals [br08012.html]|Flavonoids|C16305,
C16306,Cyanidin 3-O-sophoroside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16306  Cyanidin 3-O-sophoroside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16306  Cyanidin 3-O-sophoroside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16306  Cyanidin 3-O-sophoroside|Dietary phytochemicals [br08012.html]|Flavonoids|C16306,
C16307,Delphinidin 3-O-sophoroside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16307  Delphinidin 3-O-sophoroside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16307  Delphinidin 3-O-sophoroside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16307  Delphinidin 3-O-sophoroside|Dietary phytochemicals [br08012.html]|Flavonoids|C16307,
C16308,Traumatic acid;|(2E)-Dodecenedioic acid;|Dodec-2-enedioic acid;|(2E)-Dodec-2-enedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C16308  (2E)-Dodec-2-enedioic acid,
C16309,Traumatin;|(10E)-12-Oxododecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C16309  (10E)-12-Oxododecenoic acid,
C16310,3-Hexenal;|(3Z)-Hexenal,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C16310  (3Z)-Hexenal,
C16311,12-Oxo-9(Z)-dodecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C16311  12-Oxo-9(Z)-dodecenoic acid,
C16312,"Delphinidin 3,5-diglucoside;|Delphin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16312  Delphinidin 3,5-diglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16312  Delphin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16312  Delphin|Dietary phytochemicals [br08012.html]|Flavonoids|C16312",
C16313,Delphinidin 3-glucoside 5-caffoyl-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16313  Delphinidin 3-glucoside 5-caffoyl-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16313  Delphinidin 3-glucoside 5-caffoyl-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16313  Delphinidin 3-glucoside 5-caffoyl-glucoside,
C16314,"Delphinidin 3,5,3'-triglucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16314  Delphinidin 3,5,3'-triglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16314  Delphinidin 3,5,3'-triglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16314  Delphinidin 3,5,3'-triglucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16314",
C16315,Delphinidin 3-O-rutinoside;|Tulipanin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16315  Delphinidin 3-O-rutinoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16315  Tulipanin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16315  Tulipanin|Dietary phytochemicals [br08012.html]|Flavonoids|C16315,
C16316,"13(S)-HOT;|(9Z,11E,15Z)-(13S)-Hydroxyoctadeca-9,11,15-trienoate;|(9Z,11E,15Z)-(13S)-13-Hydroxyoctadeca-9,11,15-trienoic acid;|(9Z,11E,13S,15Z)-13-Hydroxyoctadeca-9,11,15-trienoic acid;|13(S)-HOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16316  (9Z,11E,14Z)-(13S)-13-Hydroxyoctadeca-9,11,14-trienoic acid",
C16317,(+)-7-Isojasmonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C16317  (+)-7-Isojasmonic acid,
C16318,(+)-7-Isomethyljasmonate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C16318  (+)-7-Isomethyljasmonate,
C16319,"Etherolenic acid;|(9Z,11E,1'E,3'Z)-12-(1',3'-Hexadienyloxy)-9,11-dodecadienoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA10 Fatty ethers|C16319  Etherolenic acid,
C16320,"Colnelenic acid;|(8E)-9-[(1E,3Z,6Z)-Nona-1,3,6-trien-1-yloxy]non-8-enoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA10 Fatty ethers|C16320  Colnelenic acid,
C16321,"9(S)-HPOT;|(10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid;|9(S)-HpOTrE;|(9S,10E,12Z,15Z)-9-Hydroperoxy-10,12,15-octadecatrienoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16321  (10E,12Z,15Z)-(9S)-9-Hydroperoxyoctadeca-10,12,15-trienoic acid",
C16322,9-Oxononanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C16322  9-Oxononanoic acid,
C16323,"3,6-Nonadienal",,,,,
C16324,"9,10-EOT;|9,10-Epoxyoctadecatrienoic acid;|(9S)-(10E,12Z,15Z)-9,10-Epoxyoctadecatri-10,12,15-enoic acid;|9,10-EOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16324  (9S)-(10E,12Z,15Z)-9,10-Epoxyoctadecatri-10,12,15-enoic acid",
C16325,"10-OPDA;|10-Oxo-11,15-phytodienoic acid;|(11Z,15Z)-10-Oxo-11,15-phytodienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16325  (11Z,15Z)-10-Oxo-11,15-phytodienoic acid",
C16326,"9(S)-HOT;|(9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid;|9(S)-HOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16326  (9S)-(10E,12Z,15Z)-9-Hydroxyoctadecatri-10,12,15-enoic acid",
C16327,OPC8-CoA,,,,,
C16328,trans-2-Enoyl-OPC8-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16328  trans-2-Enoyl-OPC8-CoA,
C16329,3-Hydroxy-OPC8-CoA,,,,,
C16330,3-Oxo-OPC8-CoA,,,,,
C16331,OPC6-CoA,,,,,
C16332,trans-2-Enoyl-OPC6-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16332  trans-2-Enoyl-OPC6-CoA,
C16333,3-Hydroxy-OPC6-CoA,,,,,
C16334,3-Oxo-OPC6-CoA,,,,,
C16335,OPC4-CoA,,,,,
C16336,trans-2-Enoyl-OPC4-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16336  trans-2-Enoyl-OPC4-CoA,
C16337,3-Hydroxy-OPC4-CoA,,,,,
C16338,3-Oxo-OPC4-CoA,,,,,
C16339,(+)-7-Isojasmonic acid CoA,,,,,
C16340,beta-Isorenieratene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16340  beta-Isorenieratene,
C16341,"2(R)-HPOT;|(2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid;|2(R)-HpOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16341  (2R)-(9Z,12Z,15Z)-2-Hydroperoxyoctadecatri-9,12,15-enoic acid",
C16342,"2(R)-HOT;|(2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid;|2(R)-HOTrE",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16342  (2R)-(9Z,12Z,15Z)-2-Hydroxyoctadecatri-9,12,15-enoic acid",
C16343,"Heptadecatrienal;|(8Z,11Z,14Z)-8,11,14-Heptadecatrienal",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C16343  (8Z,11Z,14Z)-8,11,14-Heptadecatrienal",
C16344,"Norlinolenic acid;|(8Z,11Z,14Z)-Heptadecatrienoic acid;|(8Z,11Z,14Z)-8,11,14-Heptadecatrienoic acid;|8Z,11Z,14Z-Heptadecatrienoic acid;|(8Z,11Z,14Z)-Heptadeca-8,11,14-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16344  (8Z,11Z,14Z)-Heptadeca-8,11,14-trienoic acid",
C16345,Volicitin;|N-(17-Hydroxylinolenoyl)-L-glutamine,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C16345  Volicitin,
C16346,"17-Hydroxylinolenic acid;|(9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C16346  (9Z,12Z,15Z)-17-Hydroxyoctadecatri-9,12,15-enoic acid",
C16347,Deinoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16347  Deinoxanthin,
C16348,cis-3-Chloroallyl aldehyde;|cis-3-Chloro-2-propenal,,,,,
C16349,Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16349  Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16349  Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16349  Pelargonidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),
C16350,Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16350  Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16350  Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16350  Cyanidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),
C16351,Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16351  Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16351  Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16351  Delphinidin 3-O-beta-D-glucoside 5-O-(6-coumaroyl-beta-D-glucoside),
C16352,7-Methylxanthosine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16352  7-Methylxanthosine,
C16353,7-Methylxanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16353  7-Methylxanthine,
C16354,"Albireodelphin;|Delphinidin 3,3'-diglucoside 5-(6-caffeoyl)glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16354  Delphinidin 3,3'-diglucoside 5-(6-caffeoyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16354  Albireodelphin|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16354  Albireodelphin",
C16355,7-Methyluric acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16355  7-Methyluric acid,
C16356,"1,7-Dimethyluric acid",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16356  1,7-Dimethyluric acid",
C16357,3-Methylxanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16357  3-Methylxanthine,
C16358,1-Methylxanthine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16358  1-Methylxanthine,
C16359,1-Methyluric acid,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16359  1-Methyluric acid,
C16360,"3,7-Dimethyluric acid",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16360  3,7-Dimethyluric acid",
C16361,"1,3,7-Trimethyluric acid;|1,3,7-Trimethylurate",,,,"Phytochemical compounds [BR:br08003]|Alkaloids|Others|Purine alkaloids|C16361  1,3,7-Trimethyluric acid",
C16362,"3,6,8-Trimethylallantoin",,,,,
C16363,N-Methylurea;|Methylurea,,,,,
C16364,"N,N'-Dimethylurea;|1,3-Dimethylurea",,,,,
C16365,5-Acetylamino-6-formylamino-3-methyluracil;|AFMU,,,,,
C16366,5-Acetylamino-6-amino-3-methyluracil;|AAMU,,,,,
C16367,Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16367  Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside)|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16367  Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside)|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16367  Delphinidin 3-O-(6-caffeoyl-beta-D-glucoside),
C16368,Pelargonidin 3-(6-p-coumaroyl)glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16368  Pelargonidin 3-(6-p-coumaroyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16368  Pelargonidin 3-(6-p-coumaroyl)glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16368  Pelargonidin 3-(6-p-coumaroyl)glucoside,
C16369,Cyanidin 3-(6-p-caffeoyl)glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16369  Cyanidin 3-(6-p-caffeoyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16369  Cyanidin 3-(6-p-caffeoyl)glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16369  Cyanidin 3-(6-p-caffeoyl)glucoside,
C16370,Delphinidin 3-(6-p-coumaroyl)glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16370  Delphinidin 3-(6-p-coumaroyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16370  Delphinidin 3-(6-p-coumaroyl)glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C16370  Delphinidin 3-(6-p-coumaroyl)glucoside,
C16371,Pelargonidin 3-glucoside 5-caffeoylglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16371  Pelargonidin 3-glucoside 5-caffeoylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16371  Pelargonidin 3-glucoside 5-caffeoylglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated pelargonidin|C16371  Pelargonidin 3-glucoside 5-caffeoylglucoside,
C16372,Cyanidin 3-glucoside 5-caffeoylglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16372  Cyanidin 3-glucoside 5-caffeoylglucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16372  Cyanidin 3-glucoside 5-caffeoylglucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16372  Cyanidin 3-glucoside 5-caffeoylglucoside,
C16373,Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C16373  Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Anthocyanidins and anthocyanins|C16373  Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C16373  Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside|C16373  Cyanidin-3-O-(6''-O-malonyl-2''-O-glucuronyl)glucoside,
C16374,"(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA;|(2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosa-2,6,9,12,15,18,21-heptaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16374  (2E,6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA",
C16375,"(3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA;|(6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosa-6,9,12,15,18,21-hexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16375  (3R,6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexaenoyl-CoA",
C16376,"(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexaenoyl-CoA;|(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosa-6,9,12,15,18,21-hexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16376  (6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexaenoyl-CoA",
C16386,(R)-Nicotine;|D-Nicotine;|2'-beta-H-Nicotine,,,,,
C16387,"(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA;|(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosa-2,6,9,12,15,18-hexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16387  (2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexaenoyl-CoA",
C16388,"(3R,6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapentaenoyl-CoA;|(6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosa-6,9,12,15,18-pentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16388  (3R,6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapentaenoyl-CoA",
C16389,"(6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosapentaenoyl-CoA;|(6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosa-6,9,12,15,18-pentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16389  (6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosapentaenoyl-CoA",
C16390,(S)-2-(Hydroxymethyl)glutarate,,,,,
C16391,"Trinitrotoluene;|2,4,6-Trinitrotoluene",,,,,
C16392,"4-Hydroxylamino-2,6-dinitrotoluene",,,,,
C16393,"2-Hydroxylamino-4,6-dinitrotoluene",,,,,
C16394,"4-Amino-2,6-dinitrotoluene",,,,,
C16395,"2-Amino-4,6-dinitrotoluene",,,,,
C16396,"2,4-Diamino-6-nitrotoluene",,,,,
C16397,"2,6-Diamino-4-nitrotoluene",,,,,
C16398,2-Amino-4-nitrotoluene;|5-Nitro-o-toluidine,,,,,
C16399,"2,4-Diamino-6-hydroxylaminotoluene",,,,,
C16400,"2,4,6-Triaminotoluene",,,,,
C16401,"2,4,6-Trihydroxytoluene;|2-Methylphloroglucinol",,,,,
C16402,"2,4-Dihydroxylamino-6-nitrotoluene",,,,,
C16403,4-Amino-2-hydroxylamino-6-nitrotoluene,,,,,
C16404,Pinocembrin chalcone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16404  Pinocembrin chalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16404  Pinocembrin chalcone,
C16405,Homoeriodictyol chalcone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16405  Homoeriodictyol chalcone|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16405  Homoeriodictyol chalcone,
C16406,Phlorizin chalcone;|Chalcone 2'-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16406  Phlorizin chalcone|Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C16406  Phlorizin chalcone,
C16407,"2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside;|THC 4'-glucoside;|Chalconaringenin 4'-glucoside;|2',4,4',6'-Tetrahydroxychalcone 4'-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C16407  2',4,4',6'-Tetrahydroxychalcone 4'-O-glucoside",
C16408,"2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside;|PHC 4'-O-glucoside;|2',3,4,4',6'-Pentahydroxychalcone 4'-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C16408  2',3,4,4',6'-Peptahydroxychalcone 4'-O-glucoside",
C16409,Aureusidin 6-O-glucoside;|Aureusidin 6-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C16409  Aureusidin 6-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C16409  Aureusidin 6-O-glucoside,
C16410,Bracteatin 6-O-glucoside;|Bracteatin 6-O-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1213 Aurone flavonoids|C16410  Bracteatin 6-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Aurones|C16410  Bracteatin 6-O-glucoside,
C16411,"4,4',6,6'-Tetranitro-2,2'-azoxytoluene",,,,,
C16412,"2,4',6,6'-Tetranitro-2',4-azoxytoluene",,,,,
C16413,"2,2',6,6'-Tetranitro-4,4'-azoxytoluene",,,,,
C16414,2-Amino-5-hydroxyl-4-hydroxylamino-6-nitrotoluene;|4-Amino-6-hydroxylamino-3-methyl-2-nitrophenol,,,,,
C16415,5-Deoxyleucopelargonidin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C16415  5-Deoxyleucopelargonidin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavan 3,4-diols|C16415  5-Deoxyleucopelargonidin",
C16416,Desmethylxanthohumol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16416  Desmethylxanthohumol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16416  Desmethylxanthohumol,
C16417,"Xanthohumol;|(2E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16417  Xanthohumol|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Chalcones|C16417  Xanthohumol,
C16418,Pinobanksin 3-O-acetate,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16418  Pinobanksin 3-O-acetate|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Dihyroflavonols|C16418  Pinobanksin 3-O-acetate,
C16419,Pinostrobin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16419  Pinostrobin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C16419  Pinostrobin,
C16420,4-Acetamido-2-amino-6-nitrotoluene,,,,,
C16421,AI-2;|Autoinducer 2,,,,,
C16422,Hesperetin 7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16422  Hesperetin 7-O-glucoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C16422  Hesperetin 7-O-glucoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C16422  Hesperetin 7-O-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16422,
C16423,Naringin chalcone,,,,Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C16423  Naringin chalcone,
C16424,Isopentenyladenosine-5'-triphosphate;|Isopentenyl-ATP;|N6-(Dimethylallyl)adenosine 5'-triphosphate;|N6-Prenyladenosine 5'-triphosphate,,,,,
C16426,Isopentenyladenosine-5'-diphosphate;|Isopentenyl-ADP;|N6-(Dimethylallyl)adenosine 5'-diphosphate;|N6-Prenyladenosine 5'-diphosphate,,,,,
C16427,Isopentenyl adenosine,,,,,
C16428,trans-Zeatin riboside triphosphate,,,,,
C16429,trans-Zeatin riboside diphosphate,,,,,
C16430,trans-Zeatin riboside monophosphate,,,,,
C16431,trans-Zeatin riboside,,,,,
C16432,5-Hydroxyectoine,,,,,
C16433,Aspartate;|Aspartic acid,,,,,
C16434,Isoleucine,,,,,
C16435,Proline,L-Proline [CPD:C00148]|D-Proline [CPD:C00763],,,,
C16436,Valine,,,,,
C16438,Asparagine,D-Asparagine [CPD:C01905]|L-Asparagine [CPD:C00152],,,,
C16439,Leucine,,,,,
C16440,Lysine,,,,,
C16441,cis-Zeatin riboside monophosphate,,,,,
C16443,trans-Zeatin-7-beta-D-glucoside,,,,Glycosides [BR:br08021]|N-glycosides|C16443  trans-Zeatin-7-beta-D-glucoside,
C16444,Benzidine,,,,,
C16445,Dihydrozeatin riboside monophosphate,,,,,
C16446,"Chlornaphazine;|N,N-Bis(2-chloroethyl)-2-naphthylamine",,,,,
C16447,Dihydrozeatin riboside,,,,,
C16448,Dihydrozeatin-O-glucoside,,,,,
C16449,cis-Zeatin riboside,,,,,
C16450,"1,3-Butadiene",,,,,
C16452,N'-Nitrosonornicotine;|NNN,,,,,
C16453,4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone;|NNK,,,,,
C16454,Radon-222,,,,,
C16455,Radium-224,,,,,
C16456,Radium-226,,,,,
C16457,Radium-228,,,,,
C16460,Beryllium,,,,,
C16461,"Geranic acid;|3,7-Dimethylocta-2,6-dienoate;|Geranate;|3,7-Dimethylocta-2,6-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16461  3,7-Dimethylocta-2,6-dienoate",
C16462,"Citronellate;|Citronellic acid;|3,7-Dimethyl-6-octenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16462  3,7-Dimethyl-6-octenoic acid",
C16463,"3',5'-Cyclic diGMP;|cdiGMP;|3',5'-Cyclic diguanylic acid;|Bis-(3',5')-cyclic diGMP;|Cyclic di-3',5'-guanylate",,,,,
C16464,Citronellyl-CoA,,,,,
C16465,trans-Geranyl-CoA,,,,,
C16466,7-Methyl-3-oxo-6-octenoyl-CoA;|7-Methyl-3-oxooct-6-enoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16466  7-Methyl-3-oxo-6-octenoyl-CoA,
C16467,cis-Prenyl-tRNA;|tRNA containing N6-(cis-hydroxy)isopentenyladenosine,,,,,
C16468,"(2E)-5-Methylhexa-2,4-dienoyl-CoA",,,,,
C16469,3-Hydroxy-5-methylhex-4-enoyl-CoA,,,,,
C16470,5-Methylhex-4-enoyl-CoA,,,,,
C16471,5-Methyl-3-oxo-4-hexenoyl-CoA,,,,,
C16472,3-Fluorocatechol,,,,,
C16473,4-Fluorocatechol,,,,,
C16474,"3-Fluoro-cis,cis-muconate",,,,,
C16475,"2-Fluoro-cis,cis-muconate",,,,,
C16476,4-Fluoromuconolactone,,,,,
C16477,5-Fluoromuconolactone,,,,,
C16478,"3-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",,,,,
C16479,"5-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",,,,,
C16480,"4-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",,,,,
C16481,"6-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",,,,,
C16482,"2-Fluorocyclohexadiene-cis,cis-1,2-diol-1-carboxylate",,,,,
C16483,"4-Fluorocyclohexadiene-cis,cis-1,2-diol",,,,,
C16484,"1-Fluorocyclohexadiene-cis,cis-1,2-diol",,,,,
C16485,4-Fluorophenol,,,,,
C16486,Astaxanthin diester,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C16486  Astaxanthin diester,
C16487,Hydrofluoric acid;|Hydrogen fluoride;|Fluoride,,,,,
C16488,Fructoselysine;|N6-(D-Fructosyl)-L-lysine,,,,,
C16489,Fructoselysine 6-phosphate,,,,,
C16490,Kaempferol 3-O-beta-D-glucosylgalactoside;|Panasenoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C16490  Kaempferol 3-O-beta-D-glucosylgalactoside|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavonols|C16490  Kaempferol 3-O-beta-D-glucosylgalactoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C16490  Kaempferol 3-O-beta-D-glucosylgalactoside|Dietary phytochemicals [br08012.html]|Flavonoids|C16490,
C16491,Isovitexin 2''-O-arabinoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C16491  Isovitexin 2''-O-arabinoside|Glycosides [BR:br08021]|C-glycosides|C16491  Isovitexin 2''-O-arabinoside,
C16492,8-C-Glucosylnaringenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16492  8-C-Glucosylnaringenin|Phytochemical compounds [BR:br08003]|Flavonoids|Flavonoids|Flavanones|C16492  8-C-Glucosylnaringenin|Glycosides [BR:br08021]|C-glycosides|C16492  8-C-Glucosylnaringenin,
C16493,"2,22,25-Trideoxyecdysone;|3beta,14alpha-Dihydroxy-5beta-cholest-7-en-6-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C16493  2,22,25-Trideoxyecdysone",
C16494,"2,22-Dideoxyecdysone",,,,,
C16495,"2-Deoxyecdysone;|(3beta,5beta,22R)-3,14,22,25-Tetrahydroxycholest-7-en-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C16495  2-Deoxyecdysone,
C16496,3-Epiecdysone,,,,,
C16497,3-Dehydro-2-deoxyecdysone,,,,,
C16498,"2,22-Dideoxy-3-dehydroecdysone",,,,,
C16499,26-Hydroxyecdysone,,,,,
C16500,"20,26-Dihydroxyecdysone;|(2beta,3beta,5beta,22R)-2,3,14,20,22,25,26-Heptahydroxycholest-7-en-6-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C16500  20,26-Dihydroxyecdysone",
C16501,Farnesal,"Generic compound in reaction hierarchy|2-trans,6-trans-Farnesal [CPD:C03461]",,,,
C16502,"Farnesoic acid;|trans,trans-Farnesoic acid;|(2E,6E)-Farnesoate",,,,,
C16503,"Methyl farnesoate;|Methyl (2E,6E)-farnesoate",,,,,
C16504,"Juvenile hormone III acid;|Juvenile-hormone-III carboxylate;|(2E,6E,10R)-10,11-Epoxy-3,7,11-trimethyldodeca-2,6-dienoate",,,,,
C16505,(10S)-Juvenile hormone III diol,,,,,
C16506,(10S)-Juvenile hormone III acid diol,,,,,
C16507,(10S)-Juvenile hormone III diol phosphate,,,,,
C16508,12-trans-Hydroxy juvenile hormone III,,,,,
C16509,"14alpha-Hydroxy-5beta-cholest-7-ene-3,6-dione",,,,,
C16511,L-Homocysteic acid;|(2S)-2-Amino-4-sulfobutanoic acid,,,,,
C16512,Palmitoylethanolamide;|Palmidrol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0804 N-acyl ethanolamines (endocannabinoids)|C16512  Palmitoylethanolamide,
C16513,"(7Z,10Z,13Z,16Z,19Z)-Docosapentaenoic acid;|(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid;|Docosapentaenoic acid;|7Z,10Z,13Z,16Z,19Z-Docosapentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16513  (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid|FA04 Docosanoids|FA0400 Other Docosanoids|C16513  (7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid",
C16516,Indolylmethylthiohydroximate;|(E)-2-(1H-Indol-3-yl)-1-thioacetohydroximate,,,,,
C16517,Indolylmethyl-desulfoglucosinolate;|Desulfoglucobrassicin,,,,Glycosides [BR:br08021]|S-glycosides|C16517  Indolylmethyl-desulfoglucosinolate,
C16518,S-(Indolylmethylthiohydroximoyl)-L-cysteine,,,,,
C16519,2-Succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate;|5-Enolpyruvoyl-6-hydroxy-2-succinylcyclohex-3-ene-1-carboxylate;|SEPHCHC,,,,,
C16520,Hexadecenoyl-[acyl-carrier protein];|(9Z)-Hexadec-9-enoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C16520  (9Z)-Hexadec-9-enoyl-[acp],
C16521,"Isoprene;|2-Methyl-1,3-butadiene",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Hemiterpenoids (C5)|C16521  Isoprene,
C16522,"Icosatrienoic acid;|Eicosatrienoic acid;|ETA;|11,14,17-Icosatrienoic acid;|(11Z,14Z,17Z)-Icosa-11,14,17-trienoic acid;|11,14,17-Eicosatrienoic acid;|(11Z,14Z,17Z)-Eicosa-11,14,17-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16522  (11Z,14Z,17Z)-Icosa-11,14,17-trienoic acid",
C16523,3'-N-Debenzoyl-2'-deoxytaxol;|beta-Phenylalanoyl baccatin III;|13-O-beta-Phenylalanoylbaccatin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C16523  3'-N-Debenzoyl-2'-deoxytaxol,
C16524,3'-N-Debenzoyltaxol;|13-O-3-Phenylisoserinoyl baccatin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C16524  3'-N-Debenzoyltaxol,
C16525,"Icosadienoic acid;|Eicosadienoic acid;|11,14-Icosadienoic acid;|(11Z,14Z)-Icosa-11,14-dienoic acid;|11,14-Eicosadienoic acid;|(11Z,14Z)-Eicosa-11,14-dienoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C16525  Icosadienoic acid (20:2;11,14)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16525  (11Z,14Z)-Icosa-11,14-dienoic acid",
C16526,Icosenoic acid;|Eicosenoic acid;|11-Icosenoic acid;|11-Eicosenoic acid;|(11Z)-Icosenoic acid;|(11Z)-Eicosenoic acid;|(Z)-Icosa-11-enoic acid,,,,Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C16526  Icosenoic acid (20:1;11)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C16526  (Z)-Icos-11-enoic acid,
C16527,"Adrenic acid;|7,10,13,16-Docosatetraenoic acid;|(7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid;|7Z,10Z,13Z,16Z-Docosatetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16527  (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid|FA04 Docosanoids|FA0400 Other Docosanoids|C16527  (7Z,10Z,13Z,16Z)-Docosa-7,10,13,16-tetraenoic acid",
C16528,Docosanoyl-CoA;|Behenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16528  Docosanoyl-CoA,
C16529,Tetracosanoyl-CoA;|Lignoceroyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16529  Tetracosanoyl-CoA,
C16530,Icosenoyl-CoA;|Eicosenoyl-CoA;|(11Z)-Icosenoyl-CoA;|(11Z)-Eicosenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16530  (11Z)-Icosenoyl-CoA,
C16531,Docosenoyl-CoA;|(13Z)-Docosenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16531  (13Z)-Docosenoyl-CoA,
C16532,Tetracosenoyl-CoA;|Nervonoyl-CoA;|(15Z)-Tetracosenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16532  (15Z)-Tetracosenoyl-CoA,
C16533,"(13Z,16Z)-Docosadienoic acid;|(13Z,16Z)-Docosa-13,16-dienoic acid;|13Z,16Z-Docosadienoic acid",,,,"Compounds with biological roles [BR:br08001]|Lipids|Fatty acids|Unsaturated fatty acids|C16533  Docosadienoic acid (22:2;13,16)|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16533  (13Z,16Z)-Docosa-13,16-dienoic acid|FA04 Docosanoids|FA0400 Other Docosanoids|C16533  (13Z,16Z)-Docosa-13,16-dienoic acid",
C16534,"13,16,19-Docosatrienoic acid;|(13E,16E,19E)-Docosa-13,16,19-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C16534  (13E,16E,19E)-Docosa-13,16,19-trienoic acid|FA04 Docosanoids|FA0400 Other Docosanoids|C16534  (13E,16E,19E)-Docosa-13,16,19-trienoic acid",
C16535,Nonadecanoic acid;|Nonadecylic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C16535  Nonadecanoic acid,
C16536,9E-Heptadecenoic acid;|(E)-Heptadec-9-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C16536  (E)-Heptadec-9-enoic acid,
C16537,Pentadecanoic acid;|Pentadecylic acid;|n-Pentadecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C16537  Pentadecanoic acid,
C16538,"1,5-Anhydro-D-mannitol",,,,,
C16540,7(1)-Hydroxychlorophyllide a,,,,,
C16541,Chlorophyllide b,,,,,
C16542,APC,,,,,
C16543,NPC,,,,,
C16544,alpha-Hydroxytamoxifen,,,,,
C16545,Tamoxifen N-oxide,,,,,
C16546,N-Desmethyltamoxifen,,,,,
C16547,Endoxifen;|4-Hydroxy-N-desmethyltamoxifen,,,,Prodrugs [br08324.html]|C16547,
C16548,"N,N-Didesmethyltamoxifen",,,,,
C16549,alpha-Hydroxy-N-desmethyltamoxifen,,,,,
C16550,Dechloroethylcyclophosphamide;|3-Dechloroethylifosfamide,,,,,
C16551,Alcophosphamide,,,,,
C16552,Nornitrogen mustard,,,,,
C16553,4-Hydroxyifosfamide,,,,Prodrugs [br08324.html]|C16553,
C16554,4-Ketoifosfamide,,,,,
C16555,2-Dechloroethylifosfamide,,,,,
C16556,Aldoifosfamide,,,,,
C16557,Carboxyifosfamide,,,,,
C16558,Alcoifosfamide,,,,,
C16559,Isophosphoramide mustard;|Ifosfamide mustard;|Isophosphamide mustard,,,,Drug groups [BR:br08330(D09364)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|DG01720  Isophosphoramide mustard analog|DG01514  Palifosfamide|D09364  Palifosfamide,
C16560,3-Hydroxylidocaine,,,,,
C16561,Monoethylglycinexylidide,,,,,
C16562,Glutathionylspermine,,,,,
C16563,"Bis(glutathionyl)spermine;|N1,N12-Bis(glutathionyl)spermine",,,,,
C16564,Bis(glutathionyl)spermine disulfide,,,,,
C16565,Aminopropylcadaverine,,,,,
C16566,Glutathionylaminopropylcadaverine,,,,,
C16567,"Homotrypanothione;|N1,N9-Bis(glutathionyl)aminopropylcadaverine",,,,,
C16568,Homotrypanothione disulfide,,,,,
C16569,Glycinexylidide;|GX,,,,,
C16570,"4-Hydroxy-2,6-dimethylaniline;|3,5-Dimethyl-4-aminophenol",,,,,
C16571,2-Amino-3-methylbenzoate,,,,,
C16572,3-Hydroxymonoethylglycinexylidide,,,,,
C16573,3'-Hydroxyropivacaine,,,,,
C16574,4'-Hydroxyropivacaine,,,,,
C16575,"(S)-2',6'-Pipecoloxylidide",,,,,
C16576,Norcodeine;|N-Desmethylcodeine,,,,,
C16577,Codeine-6-glucuronide,,,,,
C16578,Morphine-6-glucuronide,,,,Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C16578  Morphine-6-glucuronide,
C16579,"trans-Homoaconitate;|(E)-1,2,4-But-1-enetricarboxylic acid",,,,,
C16581,"D-threo-Aldono-1,5-lactone;|(2S,3R)-Aldono-1,5-lactone",Generic compound in reaction hierarchy,,,,
C16582,2-Hydroxyfelbamate,,,,,
C16583,"(R)-(Homo)2-citrate;|(R)-2-Hydroxy-1,2,5-pentanetricarboxylate;|(R)-2-Hydroxy-1,2,5-pentanetricarboxylic acid",,,,,
C16584,p-Hydroxyfelbamate,,,,,
C16586,"2-Phenyl-1,3-propanediol monocarbamate",,,,,
C16587,3-Carbamoyl-2-phenylpropionaldehyde,,,,,
C16588,2-Oxopimelate;|alpha-Ketopimelate;|2-Oxoheptanedionic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C16588  2-Oxopimelate,
C16589,2-Oxosuberate;|2-Oxooctanedionic acid;|alpha-Ketosuberate,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|2-Oxocarboxylic acids|C16589  2-Oxosuberate,
C16590,7-Oxoheptanoic acid;|7-Ketoheptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C16590  7-Oxoheptanoic acid,
C16591,3-Carbamoyl-2-phenylpropionic acid,,,,,
C16592,Atropaldehyde;|2-Phenylpropenal,,,,,
C16593,7-Mercaptoheptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0113 Thia fatty acids|C16593  7-Mercaptoheptanoic acid,
C16594,7-Mercaptoheptanoylthreonine,,,,,
C16595,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",,,,,
C16596,"5-Phenyl-1,3-oxazinane-2,4-dione",,,,,
C16597,"(-)-threo-Iso(homo)2-citrate;|(-)-threo-1-Hydroxy-1,2,5-pentanetricarboxylic acid;|1-Hydroxypentane-1,2,5-tricarboxylate;|threo-(Homo)2-isocitrate",,,,,
C16598,"(R)-(Homo)3-citrate;|(R)-2-Hydroxy-1,2,6-hexanetricarboxylate;|(R)-2-Hydroxy-1,2,6-hexanetricarboxylic acid",,,,,
C16600,"(-)-threo-Iso(homo)3-citrate;|(-)-threo-1-Hydroxy-1,2,6-hexanetricarboxylic acid;|1-Hydroxyhexane-1,2,6-tricarboxylate;|threo-(Homo)3-isocitrate",,,,,
C16601,2-Hydroxycarbamazepine,,,,,
C16602,3-Hydroxycarbamazepine,,,,,
C16603,"2,3-Dihydroxycarbamazepine",,,,,
C16604,2-Hydroxyiminostilbene,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1309 Diphenyl ethers, biphenyls, dibenzyls and stilbenes|C16604  2-Hydroxyiminostilbene",
C16605,"2H-Dibenz[b,f]azepin-2-one",,,,,
C16606,Carbamazepine-o-quinone,,,,,
C16607,Citalopram N-oxide,,,,,
C16608,Demethylcitalopram,,,,,
C16609,Didemethylcitalopram,,,,,
C16610,Citalopram propionic acid,,,,,
C16611,Citalopram alcohol,,,,,
C16612,Citalopram aldehyde,,,,,
C16613,6-Thiourate;|6-Thiouric acid,,,,,
C16614,6-Methylmercaptopurine;|Thiopurine S-methylether,,,,,
C16615,6-Methylthiopurine 5'-monophosphate ribonucleotide;|6-Methylthioinosine-5'-monophosphate,,,,,
C16616,6-Mercaptopurine ribonucleoside 5'-diphosphate;|6-Thioinosine-5'-diphosphate,,,,Glycosides [BR:br08021]|N-glycosides|C16616  6-Mercaptopurine ribonucleoside 5'-diphosphate,
C16617,6-Mercaptopurine ribonucleoside triphosphate;|6-Thioinosine-5'-triphosphate,,,,Glycosides [BR:br08021]|N-glycosides|C16617  6-Mercaptopurine ribonucleoside triphosphate,
C16618,6-Thioxanthine 5'-monophosphate,,,,,
C16619,6-Thioguanosine monophosphate,,,,,
C16620,6-Methylthioguanosine monophosphate,,,,,
C16621,1-Methyl-4-nitroimidazole,,,,,
C16622,"N,N'-Diacetylhydrazine;|Diacetylhydrazine",,,,,
C16623,Isonicotinylglycine;|Isonicotinuric acid,,,,,
C16624,Isoniazid pyruvate,,,,,
C16625,Isoniazid alpha-ketoglutaric acid,,,,,
C16626,Albendazole sulfone,,,,,
C16627,Albendazole-2-aminosulfone,,,,,
C16628,Albendazole-beta-hydroxysulphone,,,,,
C16629,Albendazole-gamma-hydroxysulphone,,,,,
C16630,"5,6-Dihydro-5-fluorouracil;|5-Fluorodihydrouracil",,,,,
C16631,alpha-Fluoro-beta-ureidopropionic acid;|2-Fluoro-3-ureidopropionic acid,,,,,
C16632,alpha-Fluoro-beta-alanine;|3-Amino-2-fluoropropionic acid,,,,,
C16633,5-Fluorouridine,,,,,
C16634,5-Fluorouridine monophosphate,,,,,
C16635,5'-Deoxy-5-fluorocytidine,,,,Glycosides [BR:br08021]|N-glycosides|C16635  5'-Deoxy-5-fluorocytidine,
C16637,5-Deoxyribose-1-phosphate;|5-Deoxy-alpha-D-ribose-1-phosphate,,,,,
C16638,O-Phosphoseryl-tRNA(Sec),Generic compound in reaction hierarchy,,,,
C16639,beta-D-Ribofuranose,,,,,
C16640,CAI-1;|Cholerae autoinducer-1,,,,,
C16641,Irinotecan,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Quinoline alkaloids|C16641  Irinotecan|Prodrugs [br08324.html]|C16641|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08086)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CE Topoisomerase 1 (TOP1) inhibitors|L01CE02 Irinotecan|D08086  Irinotecan (INN)|Drug groups [BR:br08330(D08086)]|Antineoplastic|DG01529  Topoisomerase inhibitor|DG01526  Topoisomerase I inhibitor|DG00726  Irinotecan|D08086  Irinotecan|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00726  Irinotecan|D08086  Irinotecan|DG02970  CES substrate|DG00726  Irinotecan|D08086  Irinotecan|DG02924  UGT substrate|DG03183  UGT1A1 substrate|DG00726  Irinotecan|D08086  Irinotecan|Target-based classification of drugs [BR:br08310(D08086)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP1|D08086  Irinotecan (INN)|Drug metabolizing enzymes and transporters [br08309.html(D08086)]|Drug metabolizing enzymes|D08086|Prodrugs [br08324.html(D08086)]|D08086,
C16643,Morphine-3-glucuronide,,,,Glycosides [BR:br08021]|O-glycosides|Glycoalkaloid|C16643  Morphine-3-glucuronide,
C16644,"1-(3,4-Dimethoxyphenyl)ethane-1,2-diol",,,,,
C16645,"(13Z,16Z)-Docosadienoyl-CoA;|(13Z,16Z)-Docosadi-13,16-enoyl-CoA;|13Z,16Z-Docosadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C16645  (13Z,16Z)-Docosadienoyl-CoA",
C16647,"N,N-Diethylglycine",,,,,
C16648,2-n-Propyl-4-pentenoic acid;|4-En-valproic acid;|4-Ene-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16648  2-n-Propyl-4-pentenoic acid,
C16649,4-Hydroxyvalproic acid;|2-n-Propyl-4-hydroxypentanoic acid;|4-OH-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C16649  4-Hydroxyvalproic acid,
C16650,5-Hydroxyvalproic acid;|2-n-Propyl-5-hydroxypentanoic acid;|5-OH-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C16650  5-Hydroxyvalproic acid,
C16651,3-Hydroxyvalproic acid;|2-n-Propyl-3-hydroxypentanoic acid;|3-OH-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C16651  3-Hydroxyvalproic acid,
C16652,3-Oxovalproic acid;|2-n-Propyl-3-oxopentanoic acid;|3-Keto-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16652  2-n-Propyl-3-oxopentanoic acid,
C16653,2-n-Propyl-2-pentenoic acid;|2-En-valproic acid;|2-Ene-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16653  2-n-Propyl-2-pentenoic acid,
C16654,2-n-Propyl-3-pentenoic acid;|3-En-valproic acid;|3-Ene-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16654  2-n-Propyl-3-pentenoic acid,
C16655,2-n-Propyl-4-oxopentanoic acid;|4-Oxovalproic acid;|4-Keto-VPA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16655  2-n-Propyl-4-oxopentanoic acid,
C16656,"2-Propyl-2,4-pentadienoic acid;|2,4-Diene-VPA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16656  2-Propyl-2,4-pentadienoic acid",
C16657,2-Propylsuccinic acid;|2-PSA,,,,,
C16658,2-Propylglutaric acid;|2-PGA,,,,,
C16659,"2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine;|EDDP",,,,,
C16660,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline;|EMDP",,,,,
C16661,L-alpha-Acetyl-N-normethadol;|nor-LAAM,,,,,
C16662,"L-alpha-Acetyl-N,N-dinormethadol;|dinor-LAAM",,,,,
C16665,12-Methyltetradecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16665  12-Methyltetradecanoic acid,
C16666,Vanillylamine,,,,,
C16667,"1,2-Dimyristyl-sn-glycerol;|1,2-Ditetradecanoyl-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL02 Diradylglycerols|GL0201 Diacylglycerols|C16667  1,2-Dimyristyl-sn-glycerol",
C16669,Oligonucleotide 5'-diphosphate,,,,,
C16671,"3,6-Dihydronicotinic acid",,,,,
C16672,Benzylpenicilloic acid,,,,,
C16673,"Isoglutamine;|4,5-Diamino-5-oxopentanoic acid;|DL-Isoglutamine",,,,,
C16674,Formylisoglutamine;|DL-Formylisoglutamine,,,,,
C16675,7-Aminomethyl-7-carbaguanine;|7-Aminomethyl-7-deazaguanine,,,,,
C16676,N6-Alkylaminopurine-9-beta-D-glucoside,Generic compound in reaction hierarchy,,,,
C16677,all-trans-4-Hydroxyretinoic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16677  all-trans-4-Hydroxyretinoic acid,
C16678,all-trans-4-Oxoretinoic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16678  all-trans-4-Oxoretinoic acid,
C16679,all-trans-18-Hydroxyretinoic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16679  all-trans-18-Hydroxyretinoic acid,
C16680,"all-trans-5,6-Epoxyretinoic acid;|all-trans-5,6-Epoxy-5,6-dihydroretinoic acid",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16680  all-trans-5,6-Epoxyretinoic acid",
C16681,9-cis-Retinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16681  9-cis-Retinal,
C16682,9-cis-Retinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16682  9-cis-Retinol,
C16683,4-Oxoretinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C16683  4-Oxoretinol,
C16684,N-Acetoxyarylamine,Generic compound in reaction hierarchy,,,,
C16685,N-Hydroxyarylamine,Generic compound in reaction hierarchy,,,,
C16687,Phosphomannan mannosephosphate,,,,,
C16688,Sucrose 6-phosphate;|6-Phosphosucrose;|6-O-Phosphonosucrose;|beta-D-Fructofuranosyl-6-O-phosphono-alpha-D-glucopyranoside,,,,,
C16689,poly-cis-Polyprenyl diphosphate longer by one C5 unit,,,,,
C16690,5-L-Glutamyl-D-glutamyl-peptide;|gamma-L-Glutamyl-D-glutamyl-peptide,,,,,
C16691,"DNA 2,6-diamino-5-formamido-3,4-dihydro-4-oxopyrimidine",Generic compound in reaction hierarchy,,,,
C16692,Mannopine,,,,,
C16693,Plastoquinol,Generic compound in reaction hierarchy|Plastoquinol-1 (n=1) [CPD:C02185]|Plastoquinol-9 (n=9) [CPD:C16695],,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C16693  Plastoquinol,
C16694,Plastoquinone-1,,,,,
C16695,Plastoquinol-9;|Plastoquinol A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C16695  Plastoquinol-9,
C16696,Dolichotheline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from histidine|Imidazole alkaloids|C16696  Dolichotheline,
C16697,1-Indolizidinone;|1-Ketooctahydroindolizine,,,,,
C16698,N-Acetylmuramic acid 6-phosphate;|N-Acetylmuramate 6-phosphate;|MurNAc 6-phosphate,,,,,
C16699,2-O-(6-Phospho-alpha-mannosyl)-D-glycerate;|2-O-(6-Phospho-alpha-D-mannosyl)-D-glycerate,,,,,
C16700,"3,4-Dihydroxybenzaldehyde;|Protocatechualdehyde",,,,,
C16701,Norbelladine,,,,,
C16702,4'-O-Methylnorbelladine,,,,,
C16703,N-Demethylnarwedine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16703  N-Demethylnarwedine,
C16704,Anhalonidine,,,,,
C16705,Anhalonine;|O-Methylanhalonidine,,,,,
C16706,4-Hydroxydihydrocinnamaldehyde;|3-(p-Hydroxyphenyl)propanal,,,,,
C16707,(S)-Autumnaline;|Autumnaline,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16707  (S)-Autumnaline,
C16708,Isoandrocymbine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16708  Isoandrocymbine,
C16709,O-Methylandrocymbine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16709  O-Methylandrocymbine,
C16710,N-Formyldemecolcine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16710  N-Formyldemecolcine,
C16711,Vitamin K epoxide,Generic compound in reaction hierarchy,,,,
C16712,Deacetylcolchicine;|Trimethylcolchicinic acid methyl ether,,,,,
C16713,Floramultine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16713  Floramultine,
C16714,Kreysigine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C16714  Kreysigine,
C16715,"2-Oxo-1,2-dihydroquinoline-4-carboxylate",,,,,
C16716,"4-Hydroxy-2-quinolone;|4-Hydroxy-2(1H)-quinolone;|2,4-Dihydroxyquinoline",,,,,
C16717,Limonoate D-ring-lactone,,,,,
C16718,Limonoate A-ring-lactone,,,,,
C16719,(-)-Norephedrine;|l-Phenylpropanolamine,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C16719,
C16720,Peptide 2-[3-carboxy-3-(dimethylammonio)propyl]-L-histidine;|2-[3-Carboxy-3-(dimethylammonio)propyl]-L-histidine;|EF-2 2-[3-carboxy-3-(dimethylammonio)propyl]-L-histidine;|Elongation factor 2 2-[3-carboxy-3-(dimethylammonio)propyl]-L-histidine;|2-[(3S)-3-Carboxy-3-(dimethylamino)propyl]-L-histidine-[translation elongation factor 2],Generic compound in reaction hierarchy|Precursor of Diphthamide [CPD:C02872]|Modified histidine residue of elongation factor 2(EF-2),,,,
C16721,Platydesmine,,,,,
C16722,Acceptor,Generic compound in reaction hierarchy|Acceptor of gamma-L-glutamyltransferase EC 2.3.2.9|R = aryl or cyclohexyl group,,,,
C16723,Pumiloside,,,,,
C16724,Strictosamide,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C16724  Strictosamide,
C16725,Deoxypumiloside,,,,,
C16726,Cinchoninone;|Cinchonan-9-one,,,,,
C16727,Cinchonamine,,,,,
C16728,Quinidinone,,,,,
C16729,"[Thyroglobulin]-L-thyroxine;|[Thyroglobulin]-3,5,3'5'-tetraiodo-L-thyronine",Generic compound in reaction hierarchy|Prohormone of L-Thyroxine [CPD:C01829],,,,
C16730,"Thyroglobulin triiodothyronine;|[Thyroglobulin]-3,5,3'-triiodo-L-thyronine",Generic compound in reaction hierarchy|Prohormone of Triiodothyronine [CPD:C02465],,,,
C16731,"[Thyroglobulin]-3,5-diiodo-L-tyrosine",,,,,
C16732,[Thyroglobulin]-3-iodo-L-tyrosine,,,,,
C16733,[Thyroglobulin]-L-tyrosine,Generic compound in reaction hierarchy,,,,
C16734,Thyroglobulin dehydroalanine;|[Thyroglobulin]-aminoacrylate,,,,,
C16735,Corynantheal,,,,,
C16737,5-Deoxy-D-glucuronate;|5-Deoxy-D-glucuronic acid;|5-Deoxy-D-xylo-hexuronic acid,,,,,
C16738,Sulfuric monoester;|Ester sulfate,Generic compound in reaction hierarchy|R = alkyl group [CPD:C02000]|R = aromatic group [CPD:C00850],,,,
C16739,L-Arginyl-protein;|N-Terminal L-arginyl-[protein],Generic compound in reaction hierarchy,,,,
C16740,Procollagen L-lysine,,,,,
C16741,L-Hydroxylysine;|5-Hydroxy-L-lysine;|L-erythro-5-Hydroxylysine;|(5R)-5-Hydroxy-L-lysine,,,,,
C16742,allo-Hydroxy-L-lysine;|Allohydroxy-L-lysine,,,,,
C16743,Phosphoallohydroxy-L-lysine,,,,,
C16744,Spongothymidine,,,,Glycosides [BR:br08021]|N-glycosides|C16744  Spongothymidine,
C16745,Spongouridine,,,,Glycosides [BR:br08021]|N-glycosides|C16745  Spongouridine,
C16746,Discodermolide,,,,,
C16747,Spergualin,,,,,
C16748,Patulin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16748  Patulin,
C16749,Acetylgitaloxin;|alpha-Acetylgitaloxin,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C16749  Acetylgitaloxin,
C16750,Acetylintermedine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C16750  Acetylintermedine,
C16751,Acetyllycopsamine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from ornithine|Pyrrolizidine alkaloids|C16751  Acetyllycopsamine,
C16752,Acevaltrate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C16752  Acevaltrate,
C16753,Aflatoxin B2,,,PK,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C16753  Aflatoxin B2|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Aflatoxins|C16753  Aflatoxin B2,
C16754,Aflatoxin G2,,,PK,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C16754  Aflatoxin G2|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Aflatoxins|C16754  Aflatoxin G2,
C16755,Aflatoxin G1,,,PK,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C16755  Aflatoxin G1|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Aflatoxins|C16755  Aflatoxin G1,
C16756,Aflatoxin M1,,,PK,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C16756  Aflatoxin M1|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Aflatoxins|C16756  Aflatoxin M1,
C16757,(Z)-Ajoene,,,,,
C16758,(E)-Ajoene,,,,,
C16759,S-Allyl-L-cysteine,,,,,
C16760,Aloe emodin anthrone,Aloe-emodin [CPD:C10294],,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16760  Aloe emodin anthrone|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16760  Aloe emodin anthrone|Dietary phytochemicals [br08012.html]|Other phytochemicals|C16760,
C16761,Neosurugatoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C16761  Neosurugatoxin,
C16762,Ciguatoxin I;|CTX,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16762  Ciguatoxin I,
C16763,Luteoskyrin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16763  Luteoskyrin,
C16764,Rugulosin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16764  Rugulosin,
C16765,Citrinin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16765  Citrinin,
C16766,Citreoviridin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16766  Citreoviridin,
C16767,Rubratoxin B,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16767  Rubratoxin B,
C16768,Sporidesmin J,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16768  Sporidesmin J,
C16769,Aplysiatoxin,,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Aplysiatoxins|C16769  Aplysiatoxin,
C16770,19-Bromoaplysiatoxin,,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Aplysiatoxins|C16770  19-Bromoaplysiatoxin,
C16771,Oscillatoxin A,,,,,
C16772,alpha-Terpineol;|dl-alpha-Terpineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C16772  DL-alpha-Terpineol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C16772  alpha-Terpineol,
C16773,Bisabolol oxide A,,,,,
C16774,Bisabolol oxide B,,,,,
C16775,(S)-beta-Bisabolene;|beta-Bisabolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C16775  beta-Bisabolene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C16775  (S)-beta-Bisabolene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16775,
C16776,beta-Sesquiphellandrene;|(-)-beta-Sesquiphellandrene,,,,,
C16777,Sabinene;|Sabinen,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C16777  Sabinene|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C16777  Sabinene,
C16778,Cantharidin,,,,"USP drug classification [BR:br08302(D11745)]|Dermatological Agents|Dermatological Agents, Other|Dermatological Agents, Miscellaneous|Cantharidin|D11745  Cantharidin (JAN/USAN)|New drug approvals in the USA [br08319.html(D11745)]|New molecular entities and new therapeutic biological products|D11745|New drug approvals in the USA, Europe and Japan [br08328.html(D11745)]|Approval dates by FDA, EMA and PMDA|D11745",
C16779,Dendrolasin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C16779  Dendrolasin,
C16780,Jasmolin I,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C16780  Jasmolin I,
C16781,Jasmolin II,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C16781  Jasmolin II,
C16782,(-)-Solenopsin A,,,,,
C16783,Meliantriol,,,,,
C16784,HMT-toxin,,,,,
C16785,PM-toxin B,,,,,
C16786,AM-toxin I,,,,,
C16787,AK-toxin I,,,,,
C16788,Pyriculol,,,,,
C16789,Toxoflavine,,,,,
C16790,Coronatine,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C16790  Coronatine,
C16791,Halichondrin B,,,,,
C16792,Panaxytriol,,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C16792  Panaxytriol,
C16793,Corynomycolic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C16793  Corynomycolic acid,
C16794,Tuberculostearic acid;|10-Methyloctadecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C16794  10-Methyloctadecanoic acid,
C16795,Hydnocarpic acid,,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C16795  Hydnocarpic acid,
C16796,Islandicin;|Funiculosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16796  Islandicin,
C16797,Sennoside C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16797  Sennoside C|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16797  Sennoside C|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C16797  Sennoside C,
C16798,Sennoside D,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16798  Sennoside D|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16798  Sennoside D|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C16798  Sennoside D|Dietary phytochemicals [br08012.html]|Other phytochemicals|C16798,
C16799,Cascaroside B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16799  Cascaroside B|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16799  Cascaroside B,
C16800,Cascaroside D,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16800  Cascaroside D|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16800  Cascaroside D,
C16801,Cascaroside C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16801  Cascaroside C|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C16801  Cascaroside C,
C16802,Glucofrangulin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16802  Glucofrangulin A|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C16802  Glucofrangulin A|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C16802  Glucofrangulin A,
C16803,Glucofrangulin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C16803  Glucofrangulin B|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C16803  Glucofrangulin B|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C16803  Glucofrangulin B,
C16804,Penicillic acid,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16804  Penicillic acid,
C16805,Coumachlor,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Coumarin rodenticides|C16805  Coumachlor,
C16806,Coumatetralyl,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C16806  Coumatetralyl,
C16807,Difenacoum,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C16807  Difenacoum,
C16808,Isosilybin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16808  Isosilybin,
C16809,Isovaltrate,,,,,
C16810,Bioresmethrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C16810  Bioresmethrin|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C16810  Bioresmethrin,
C16811,Baldrinal,,,,,
C16812,Homobaldrinal,,,,,
C16813,Valeranone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010331 Valerane sesquiterpenoids|C16813  Valeranone,
C16814,gamma-Bisabolene;|(Z)-gamma-Bisabolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C16814  gamma-Bisabolene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C16814  gamma-Bisabolene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16814,
C16815,alpha-Cadinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010333 Cadinane sesquiterpenoids|C16815  alpha-Cadinene,
C16816,Ginkgolide M,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010454 Ginkgolides and Bilobalides|C16816  Ginkgolide M|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Ginkgolides|C16816  Ginkgolide M,
C16817,Goitrin,,,,,
C16818,Ophiobolin F;|Ophiobolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0105 C25 isoprenoids (sesterterpenes)|PR010505 Cheilanthane and ophiobolane sesterterpenoids|C16818  Ophiobolin F,
C16819,"Neotigogenin;|(3beta,5alpha,25S)-Spirostan-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0108 Spirostanols and derivatives|C16819  Neotigogenin|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C16819  Neotigogenin,
C16820,k-Strophanthin-beta,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C16820  k-Strophanthin-beta,
C16821,Guvacoline,,,,,
C16822,9-Aminocamptothecin,,,,,
C16823,Distigmine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07A PARASYMPATHOMIMETICS|N07AA Anticholinesterases|N07AA03 Distigmine|C16823  Distigmine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG01595  Cholinesterase inhibitor|DG01593  Acetylcholinesterase inhibitor|DG00989  Distigmine|C16823  Distigmine|DG01719  Parasympathomimetic agent|DG00989  Distigmine|C16823  Distigmine,G00989
C16825,Neomenthyl acetate,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C16825  Neomenthyl acetate,
C16826,"2-cis,6-trans-Farnesyl diphosphate;|(2Z,6E)-Farnesyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C16826  2-cis,6-trans-Farnesyl diphosphate",
C16827,p-Coumaroyl-D-glucose;|1-O-(4-Coumaroyl)-beta-D-glucose;|1-O-(4-Hydroxycinnamoyl)-beta-D-glucose,,,,,
C16828,Caffeoquinone;|Caffeic acid quinone,,,,,
C16829,gamma-Humulene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010311 Humulane sesquiterpenoids|C16829  gamma-Humulene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C16829  gamma-Humulene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C16829,
C16831,L-2-Methyltryptophan;|2-Methyl-L-tryptophan,,,,,
C16832,[Protein]-N6-[(R)-dihydrolipoyl]-L-lysine;|[Lipoyl-carrier protein]-N6-[(R)-dihydrolipoyl]-L-lysine;|Protein N6-(dihydrolipoyl)lysine,Generic compound in reaction hierarchy|R = E2 subunit of oxo-acid dehydrogenase complexes [CPD:C15973] or H protein [CPD:C02972],,,,
C16833,beta-Phenylalanoyl-CoA;|(R)-beta-Phenylalanoyl-CoA;|(R)-3-Amino-3-phenylpropanoyl-CoA;|Amino phenylpropanoyl-CoA,,,,,
C16834,1-Pentanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C16834  1-Pentanol,
C16835,Succinic aldehyde;|Succindialdehyde,,,,,
C16836,"1,4'-Bipiperidine-1'-carboxylic acid;|[1,4'-Bipiperidine]-1'-carboxylic acid",,,,,
C16837,4-Amino-1-piperidinecarboxylic acid,,,,,
C16838,Alternariol,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C16838  Alternariol,
C16839,Brevetoxin A,,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C16839  Brevetoxin A,
C16840,Eudistomin G,,,,,
C16841,Squalamine,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0505 Other Steroid conjugates|C16841  Squalamine,
C16842,SQ 26180,,,,,
C16843,Deoxynojirimycin;|Moranolin,,,,Drug groups [BR:br08330(D09605)]|Antidiabetic agent|DG02044  Hypoglycemic agent|DG01663  alpha-Glucosidase inhibitor|DG01280  Duvoglustat|D09605  Duvoglustat|Target-based classification of drugs [BR:br08310(D09605)]|Enzymes|Hydrolases (EC3)|Glycosidases|GAA|D09605  Duvoglustat (USAN/INN),
C16844,Hydroxyl radical;|Hydrogen oxide,,,,,
C16845,Peroxynitrite,,,,,
C16846,Cinchonidinone;|(8alpha)-Cinchonan-9-one,,,,,
C16847,Didemnin B,,,,,
C16848,"6-Deoxy-5-ketofructose 1-phosphate;|1-Deoxy-D-threo-hexo-2,5-diulose 6-phosphate",,,,,
C16849,"Hydroxypyruvaldehyde phosphate;|2,3-Dioxopropyl phosphate",,,,,
C16850,"2-Amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C16850  2-Amino-3,7-dideoxy-D-threo-hept-6-ulosonic acid",
C16851,Palytoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Palytoxins|C16851  Palytoxin,
C16852,Gambiertoxin 4b;|Ciguatoxin 4B;|CTX-4B,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16852  Gambiertoxin 4b,
C16854,Maitotoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16854  Maitotoxin,
C16855,Gonyautoxin 1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|Carbamate derivatives|C16855  Gonyautoxin 1,
C16856,Gonyautoxin 2,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|Carbamate derivatives|C16856  Gonyautoxin 2,
C16857,Brevetoxin B,,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C16857  Brevetoxin B,
C16858,Pachydictyol A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010447 Pachydictyane and cneorubin diterpenoids|C16858  Pachydictyol A,
C16859,Renillafoulin A,,,,,
C16860,"2,5,6-Tribromo-1-methylgramine",,,,,
C16861,13-Deoxytedanolide,,,,,
C16862,Plitidepsin;|Dehydrodidemnin B;|Aplidine;|Didemnin A,,,,,
C16865,Scytophycin C,,,,,
C16868,"Tauroursodeoxycholic acid;|N-(3alpha,7beta-Dihydroxy-5beta-cholan-24-oyl)-taurine",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0504 Taurine conjugates|C16868  Tauroursodeoxycholic acid,
C16870,Dinophysistoxin 1;|DTX 1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Okadaic acid and derivatives|C16870  Dinophysistoxin 1,
C16871,Pectenotoxin 1;|PTX 1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Others|C16871  Pectenotoxin 1,
C16872,Yessotoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Cyclic polyethers|C16872  Yessotoxin,
C16873,"Bombykol;|(Z,E)-10,12-Hexadecadien-1-ol;|(10E,12Z)-Hexadeca-10,12-dien-1-ol",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C16873  (10E,12Z)-Hexadeca-10,12-dien-1-ol",
C16874,Makisterone A,,,,,
C16875,Trabectedin;|Ecteinascidin 743,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06199)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS|L01CX Other plant alkaloids and natural products|L01CX01 Trabectedin|D06199  Trabectedin (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D06199)]|Antineoplastics|Alkylating Agents|Trabectedin|D06199  Trabectedin (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D06199)]|4  Agents affecting cellular function|42  Antineoplastics|429  Miscellaneous|4291  Other Antitumors|D06199  Trabectedin (JAN/USAN/INN)|Drug groups [BR:br08330(D06199)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D06199  Trabectedin|New drug approvals in the USA [br08319.html(D06199)]|New molecular entities and new therapeutic biological products|D06199|New drug approvals in Europe [br08329.html(D06199)]|European public assessment reports (EPAR) authorised medicine|D06199|New drug approvals in Japan [br08318.html(D06199)]|Drugs with new active ingredients|D06199|New drug approvals in the USA, Europe and Japan [br08328.html(D06199)]|Approval dates by FDA, EMA and PMDA|D06199|Drug metabolizing enzymes and transporters [br08309.html(D06199)]|Drug metabolizing enzymes|D06199",
C16876,Kahalalide F,,,,,
C16877,Cryptophycin 1;|Cryptophycin,,,,,
C16878,Aplyronine A,,,,,
C16880,S 1319,,,,,
C16881,Isohomohalichondrin B;|IHB,,,,,
C16883,Jasplakinolide;|Jaspamide,,,,,
C16884,D-Threitol,,,,,
C16885,Gambieric acid A,Revised structure of gambieric acid A [PMID:19422179],,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16885  Gambieric acid A,
C16886,Gambieric acid B,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16886  Gambieric acid B,
C16887,Gambieric acid C,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16887  Gambieric acid C,
C16888,Gambieric acid D,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C16888  Gambieric acid D,
C16889,Pahutoxin,,,,,
C16890,"5alpha-Cyprinol;|(3alpha,5alpha,7alpha,12alpha)-Cholestane-3,7,12,26,27-pentol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C16890  5alpha-Cyprinol",
C16891,Callystatin A,,,,,
C16892,KRN 7000,,,,,
C16893,Stellettamide A,,,,,
C16894,Plakinamine A,,,,,
C16895,Plakinamine B,,,,,
C16896,Nakitriol,,,,,
C16899,Goniodomin A,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Macrolides|C16899  Goniodomin A,
C16901,Latrunculin A,,,,,
C16902,Mycalolide B,,,,,
C16903,Perazine,,,,,
C16904,Tolytoxin,,,,,
C16905,Dolastatin 11,,,,,
C16906,Anabaseine,,,,,
C16907,Azaspiracid,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C16907  Azaspiracid,
C16908,Caryophyllene epoxide;|Caryophyllene oxide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010312 Caryophyllane sesquiterpenoids|C16908  Caryophyllene epoxide,
C16909,"1,4-Cineole;|1,4-Epoxy-p-menthane",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C16909  1,4-Cineole|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C16909  1,4-Cineole",
C16910,Acutumine,,,,,
C16911,Afzelin;|Kaempferin;|Kaempferol 3-O-alpha-L-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C16911  Afzelin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C16911  Afzelin|Dietary phytochemicals [br08012.html]|Flavonoids|C16911,
C16912,Alphitolic acid;|2alpha-Hydroxybetulinic acid,,,,,
C16913,Anemonin;|Pulsatilla camphor,,,,Phytochemical compounds [BR:br08003]|Others|Others|Others|C16913  Anemonin,
C16914,Isobyakangelicol;|Anhydrobyakangelicin,,,,,
C16915,Arctiin;|Arctigenin-4-glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C16915  Arctiin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C16915,
C16916,Arundoin,,,,,
C16918,Atractylodin,,,,,
C16919,Atractylone;|Atractylol;|Atractyloxide,,,,,
C16920,Bornyl isovalerate;|Bornyval;|Hysterol,Relative configuration (including both enantiomers),,,,
C16921,Bufadienolide,,,,,
C16922,"Bufalin;|(3beta,5beta)-3,14-Dihydroxybufa-20,22-dienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16922  Bufalin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C16922  Bufalin|Natural toxins [BR:br08009]|Venoms|Frog venoms|Bufotoxins|C16922  Bufalin,
C16923,"Bufotalin;|3beta,14,16beta-Trihydroxy-5beta-bufa-20,22-dienolide 16-acetate",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16923  Bufotalin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C16923  Bufotalin|Natural toxins [BR:br08009]|Venoms|Frog venoms|Bufotoxins|C16923  Bufotalin,
C16924,Butylidenephthalide,,,,,
C16925,Byakangelicol,,,,,
C16926,Capillarin,,,,,
C16927,Capillene,,,,,
C16928,"Capillone;|1-Phenyl-2,4-hexadiene-1-one",,,,,
C16929,Catalpalactone,,,,,
C16930,Chavicol,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Others|C16930  Chavicol,
C16931,Cinobufagin,,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16931  Cinobufagin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C16931  Cinobufagin,
C16932,Cinobufotalin,,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16932  Cinobufotalin|Natural toxins [BR:br08009]|Venoms|Frog venoms|Bufotoxins|C16932  Cinobufotalin,
C16933,"3,6-Dihydropyridine",,,,,
C16937,Cnidilide,,,,,
C16938,Coptisine,,,,,
C16939,Crataegolic acid;|Masilinic acid,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010618 Taraxastane, ursane and bauerane triterpenoids|C16939  Crataegolic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C16939  Crataegolic acid",
C16940,Carthamidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16940  Carthamidin,
C16941,Carthamin,,,,,
C16942,Curcumenol,,,,,
C16943,Curzerenone,Relative configuration (including both enantiomers),,,,
C16945,Cyperol,,,,,
C16946,Cyperolone,,,,,
C16947,Decanoyl acetaldehyde,,,,,
C16949,Dehydrocurdione,,,,,
C16950,Dehydroeburicoic acid;|Dehydrotrametenolic acid,,,,,
C16951,Deoxyschizandrin,,,,,
C16952,Dihydrocapsaicin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C16952  Dihydrocapsaicin|Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Capsaicinoids and derivatives|C16952  Dihydrocapsaicin,
C16953,"Dihydrocorynantheine;|18,19-Dihydrocorynantheine",,,,,
C16954,Disinomenine;|Bisinomenine,,,,,
C16955,Eucarvone,,,,,
C16956,Evocarpine,,,,,
C16957,Fargesin,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C16957  Fargesin,
C16958,Fernenol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010620 Neohopane, fernane, adianane and filicane triterpenoids|C16958  Fernenol",
C16959,Furanodiene,,,,,
C16960,Furanodienone,,,,,
C16962,"Gamabufogenin;|Gamabufotalin;|(3beta,5beta,11alpha)-3,11,14-Trihydroxybufa-20,22-dienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16962  Gamabufogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C16962  Gamabufogenin,
C16963,Gardoside,,,,,
C16964,Gastrodin;|4-(Hydroxymethyl)phenyl-beta-D-glucopyranoside,,,,,
C16965,Genipin 1-beta-gentiobioside,,,,,
C16966,Germacrone,,,,,
C16967,Glutinone;|Alnusenone,,,,,
C16968,Glycyrol;|Neoglycyrol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1209 Coumestan flavonoids|C16968  Glycyrol,
C16969,"Hellebrigenin;|Bufotalidin;|(3beta,5beta)-3,5,14-Trihydroxy-19-oxobufa-20,22-dienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C16969  Hellebrigenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C16969  Hellebrigenin,
C16970,Hinesol,,,,,
C16971,Hirsuteine,,,,,
C16972,Hirsutine,,,,,
C16973,Isoarborinol,,,,,
C16974,Isocyperol,,,,,
C16975,Isoelemicin,,,,,
C16976,Isoimperatorin,,,,,
C16977,Isokobusone,,,,,
C16978,Isoliquiritin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C16978  Isoliquiritin|Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C16978  Isoliquiritin,
C16979,Isomangiferin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C16979  Isomangiferin|Glycosides [BR:br08021]|C-glycosides|C16979  Isomangiferin",
C16980,Isorhynchophylline,,,,,
C16981,"Kaempferitrin;|Kaempferol 3,7-dirhamnoside;|Kaempferol-3,7-O-alpha-L-dirhamnoside;|Kaempferol-dirhamnoside;|Lespenefril",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C16981  Kaempferitrin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C16981  Kaempferitrin|Dietary phytochemicals [br08012.html]|Flavonoids|C16981,
C16982,Kakuol;|Kakoul,,,,,
C16983,Kobusone,,,,,
C16984,Laurolitsine,,,,,
C16985,Leonurine;|Norboldine,,,,,
C16986,Licoricidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1208 Isoflavans|C16986  Licoricidin,
C16987,Ligustilide,,,,,
C16988,Linderenol;|Linderene,,,,,
C16989,Liquiritin;|Liquiritigenin-4'-beta-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C16989  Liquiritin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C16989  Liquiritin,
C16990,Lupenone,,,,,
C16991,Magnocurarine,,,,,
C16992,Callinecdysone A,,,,,
C16993,Ectocarpen,,,,,
C16994,Anthopleurine,,,,,
C16995,Methyl palmitate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C16995  Methyl palmitate,
C16996,Methyl nigakinone,,,,,
C16997,Michelalbine,,,,,
C16998,Pavoninin 1,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C16998  Pavoninin 1,
C16999,Futalosine,,,,,
C17000,Morroniside,,,,,
C17002,Neocnidilide,,,,,
C17003,Neogitogenin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C17003  Neogitogenin,
C17004,Kalihinol A,,,,,
C17005,Callytriol C,,,,,
C17007,Axisothiocyanate 3,,,,,
C17008,Mycalamide A,,,,,
C17009,Mycalamide B,,,,,
C17010,Dehypoxanthine futalosine,,,,,
C17011,Leonuridine,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17011  Leonuridine,
C17012,Nigakilactone A;|Quassin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17012  Nigakilactone A,
C17013,Nigakilactone B;|Simalikalactone A;|Quassin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17013  Nigakilactone B,
C17016,Nemertelline,,,,,
C17017,Cyclic dehypoxanthine futalosine,,,,,
C17018,"1,4-Dihydroxy-6-naphthoate;|5,8-Dihydroxy-2-naphthoate",,,,,
C17019,Navenone A,,,,,
C17020,Navenone B,,,,,
C17021,Navenone C,,,,,
C17022,O-Phosphoseryl-tRNA(Cys),Generic compound in reaction hierarchy,,,,
C17023,Sulfur donor;|S-donor,Generic compound in reaction hierarchy,,,,
C17024,Mosesin 4,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17024  Mosesin 4,
C17027,L-Pyrrolysyl-tRNA(Pyl),,,,,
C17029,Nigakilactone C;|Quassin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17029  Nigakilactone C,
C17030,Nigakilactone E,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17030  Nigakilactone E,
C17031,Nigakilactone F,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17031  Nigakilactone F,
C17032,Nigakilactone H,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17032  Nigakilactone H,
C17033,Nigakilactone K,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17033  Nigakilactone K,
C17034,Nigakilactone L,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17034  Nigakilactone L,
C17035,Nigakilactone M,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17035  Nigakilactone M,
C17036,Nigakilactone N,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17036  Nigakilactone N,
C17038,Ophiopogonin B,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17038  Ophiopogonin B,
C17039,Obtusifolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17039  Obtusifolin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17039  Obtusifolin,
C17040,Obtusin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17040  Obtusin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17040  Obtusin,
C17041,Ophiopogonin A,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17041  Ophiopogonin A,
C17042,Ophiopogonin D,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17042  Ophiopogonin D,
C17044,Pachymic acid,,,,,
C17045,Physcion;|Emodin monomethyl ether;|Rheochrysidin;|Parienin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17045  Physcion|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17045  Physcion,
C17046,Phellodendrine,,,,,
C17047,Phellopterin,,,,,
C17048,Forsythin;|Phillyrin;|Phillygenin-O-glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C17048  Forsythin|Dietary phytochemicals [br08012.html]|Other phytochemicals|C17048,
C17049,Picrasin A;|Nigakilactone G,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17049  Nigakilactone G,
C17050,Picrasin B;|Nigakilactone I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17050  Nigakilactone I,
C17051,Picrasin D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17051  Picrasin D,
C17052,Picrasin E,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17052  Picrasin E,
C17053,Picrasin F,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17053  Picrasin F,
C17054,Picrasin G,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17054  Picrasin G,
C17055,Picrocrocin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C17055  Picrocrocin,
C17056,Plantaginin;|Scutellarein 7beta-D-glucopyranoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17056  Plantaginin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C17056  Plantaginin,
C17057,Puerarin xyloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C17057  Puerarin xyloside|Glycosides [BR:br08021]|C-glycosides|C17057  Puerarin xyloside,
C17058,"Resibufogenin;|Bufogein;|(3beta,5beta,15beta)-14,15-Epoxy-3-hydroxybufa-20,22-dienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C17058  Resibufogenin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C17058  Resibufogenin,
C17059,"Rhamnocitrin;|7-Methylkaempferol;|3,4',5-Trihydroxy-7-methoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17059  Rhamnocitrin,
C17060,Isotetrandrine,,,,,
C17061,Rubidium cation;|Rb+;|Rubidium(1+);|Rubidium ion,,,,,
C17062,Safranal,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C17062  Safranal,
C17063,Salicifoline,,,,,
C17064,Schizandrin,,,,,
C17065,Sesquicarene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010307 Cyclobisabolane sesquiterpenoids|C17065  Sesquicarene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17065  Sesquicarene,
C17066,Shanzhiside,,,,,
C17067,Siaresinol;|Siaresinolic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C17067  Siaresinol,
C17068,Valerosidatum;|Valerosidate,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17068  Valerosidatum,
C17069,Sophoranol;|5-Hydroxymatrine,,,,,
C17070,Sumaresinol;|Sumaresinolic acid,,,,,
C17071,Sweroside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C17071,
C17072,"Telocinobufagin;|(3beta,5beta)-3,5,14-Trihydroxybufa-20,22-dienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C17072  Telocinobufagin|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0113 Bufanolides and derivatives|C17072  Telocinobufagin,
C17073,Terpineol-4;|Terpinen-4-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17073  Terpineol-4,
C17074,Timosaponin A-I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Spirostan|C17074  Timosaponin A-I,
C17075,Timosaponin A-III,,,,,
C17076,Tridecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C17076  Tridecanoic acid,
C17077,Tuduranine,,,,,
C17079,3-Bromo-tyrosine;|3-Bromotyrosine,,,,,
C17080,"3,5-Dibromo-tyrosine;|3,5-Dibromotyrosine",,,,,
C17083,Worenine,,,,,
C17084,"6,6'-Dibromoindigotin;|6,6'-Dibromoindigo;|Tyrian purple",,,,,
C17085,Zederone,,,,,
C17086,Tyrindoxyl sulfate,,,,,
C17087,"dTDP-(3R)-amino-3,6-dideoxy-D-glucose;|dTDP-3-amino-3,6-dideoxy-D-allose",,,,,
C17088,alpha-Bergamotene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17088  alpha-Bergamotene,
C17089,6-Chloroindole;|6-Chloro-1H-indole,,,,,
C17090,alpha-Cyperone,,,,,
C17091,alpha-Sanshool,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amides|C17091  alpha-Sanshool,
C17092,Clionamide,,,,,
C17093,"dTDP-3-amino-4,6-dideoxy-3,4-dehydroglucose",,,,,
C17094,beta-Elemene,,,,,
C17097,Caulerpin,,,,,
C17098,"Lanosol;|2,3-Dibromo-4,5-dihydroxybenzyl alcohol",,,,,
C17099,Aeroplysinin 1,,,,,
C17100,Thelepin,,,,,
C17101,"3,5-Dinitroguaiacol",,,,,
C17102,Cartilagineal,,,,,
C17103,Costatol,,,,,
C17104,Costatone,,,,,
C17105,Plocamene D,,,,,
C17106,Mertensene,,,,,
C17107,Violacene,,,,,
C17108,Plocamene E,,,,,
C17109,Plocamene C,,,,,
C17110,Plocamene B,,,,,
C17111,Caespitol,,,,,
C17112,Isocaespitol,,,,,
C17113,Furocaespitane,,,,,
C17114,Spirolaurenone,,,,,
C17116,Nidificene;|Intricatene,,,,,
C17117,Nidifidienol,,,,,
C17118,Elatol;|(+)-Elatol,,,,,
C17120,beta-Gurjunene,,,,,
C17121,"Obtusol;|Spiro(5.5)undecan-3-ol, 2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylene-, (2S,3R,6S,8S,9S)-",,,,,
C17123,epi-Friedelanol;|beta-Friedelinol,,,,,
C17124,gamma-Eudesmol;|Machilol;|Selinenol;|Uncineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C17124  gamma-Eudesmol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C17124  gamma-Eudesmol,
C17125,(-)-Isomenthone;|l-Isomenthone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17125  (-)-Isomenthone,
C17126,Neobyakangelicol,,,,,
C17127,Prepacifenol epoxide,,,,,
C17132,Aplysin,,,,,
C17133,Filiformin;|(-)-Filiformin,,,,,
C17135,Filiforminol,,,,,
C17136,Laurinterol,,,,,
C17139,"dTDP-3,4-dioxo-2,6-dideoxy-L-glucose",,,,,
C17140,Tribuloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17140  Tribuloside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C17140  Tribuloside,
C17141,[Heparan sulfate]-glucosamine,,,,,
C17142,[Heparan sulfate]-N-sulfoglucosamine,,,,,
C17144,3-Octanol,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C17144  3-Octanol,
C17145,3-Octanone;|Octan-3-one,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C17145  Octan-3-one,
C17146,4-Guanidino-1-butanol,,,,,
C17147,Neochlorogenic acid;|trans-Neochlorogenic acid;|Neochlorogenate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Caffeate derivatives|C17147  Neochlorogenic acid,
C17148,Oleanolic acid;|3beta-Hydroxyolean-12-en-28-oic acid;|Astrantiagenin C;|Caryophyllin;|Oleanolate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C17148  Oleanolic acid|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C17148  Oleanolic acid,
C17156,Manoalide,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0105 C25 isoprenoids (sesterterpenes)|PR010502 Cyclohexane sesterterpenoids|C17156  Manoalide,
C17158,Plakortic acid,,,,,
C17159,Halistanol sulfate,,,,,
C17160,Fistularin 1,,,,,
C17161,Fistularin 2,,,,,
C17162,Aerophobin 1,,,,,
C17163,Aerophobin 2,,,,,
C17166,Sceptrin,,,,,
C17167,Eudistomin C,,,,,
C17168,Eudistomin H,,,,,
C17169,Eudistomin N,,,,,
C17177,Aplysinal,,,,,
C17179,beta-Snyderol,,,,,
C17181,Kylinone,,,,,
C17184,Rhodolaureol,,,,,
C17193,Heterocladol,,,,,
C17202,S-Palmitoylprotein;|Protein S-palmitoyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C17203,N-Hydroxyl-tryptamine,,,,,
C17204,Indole-3-acetaldoxime N-oxide;|IAOx N-oxide;|1-(1H-Indol-3-yl)-2-aci-nitroethane,,,,,
C17205,(R)-2-O-Sulfolactate,,,,,
C17206,Uracil 5-carbaldehyde;|5-Formyluracil,,,,,
C17207,"1,4-beta-D-Mannooligosaccharide;|[(1->4)-beta-D-Mannosyl]n",,,,,
C17208,Neosaxitoxin;|NeoSTX,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|Carbamate derivatives|C17208  Neosaxitoxin,
C17209,2-Deoxy-scyllo-inosose;|2-Deoxyinosose;|2-Deoxy-L-scyllo-inosose,,,,,
C17210,2-(2'-Methylthio)ethylmalic acid;|2-(2'-Methylthio)ethylmalate,,,,,
C17211,2-Oxo-5-methylthiopentanoic acid;|5-(Methylthio)-2-oxo-pentanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17211  2-Oxo-5-methylthiopentanoic acid,
C17212,3-(2'-Methylthio)ethylmalic acid;|3-(2'-Methylthio)ethylmalate,,,,,
C17213,Homomethionine;|L-Homomethionine,,,,,
C17214,2-(3'-Methylthio)propylmalic acid;|2-(3'-Methylthio)propylmalate,,,,,
C17215,3-(3'-Methylthio)propylmalic acid;|3-(3'-Methylthio)propylmalate,,,,,
C17216,2-Oxo-6-methylthiohexanoic acid;|6-(Methylthio)-2-oxo-hexanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17216  2-Oxo-6-methylthiohexanoic acid,
C17217,Dihomomethionine;|L-Dihomomethionine,,,,,
C17218,2-(4'-Methylthio)butylmalic acid;|2-(4'-Methylthio)butylmalate,,,,,
C17219,3-(4'-Methylthio)butylmalic acid;|3-(4'-Methylthio)butylmalate,,,,,
C17220,2-Oxo-7-methylthioheptanoic acid;|7-(Methylthio)-2-oxo-heptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17220  2-Oxo-7-methylthioheptanoic acid,
C17221,Trihomomethionine;|L-Trihomomethionine;|2-Amino-7-(methylsulfanyl)heptanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C17221  2-Amino-7-(methylsulfanyl)heptanoic acid,
C17222,2-(5'-Methylthio)pentylmalic acid;|2-(5'-Methylthio)pentylmalate,,,,,
C17223,3-(5'-Methylthio)pentylmalic acid;|3-(5'-Methylthio)pentylmalate,,,,,
C17224,2-Oxo-8-methylthiooctanoic acid;|8-Methylthio-2-octanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17224  2-Oxo-8-methylthiooctanoic acid,
C17225,Tetrahomomethionine;|L-Tetrahomomethionine,,,,,
C17226,2-(6'-Methylthio)hexylmalic acid;|2-(6'-Methylthio)hexylmalate,,,,,
C17227,3-(6'-Methylthio)hexylmalic acid;|3-(6'-Methylthio)hexylmalate,,,,,
C17228,2-Oxo-9-methylthiononanoic acid;|9-Methylthio-2-nonanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17228  2-Oxo-9-methylthiononanoic acid,
C17229,Pentahomomethionine;|L-Pentahomomethionine,,,,,
C17230,2-(7'-Methylthio)heptylmalic acid;|2-(7'-Methylthio)heptylmalate,,,,,
C17231,3-(7'-Methylthio)heptylmalic acid;|3-(7'-Methylthio)heptylmalate,,,,,
C17232,2-Oxo-10-methylthiodecanoic acid;|10-Methylthio-2-decanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C17232  2-Oxo-10-methylthiodecanoic acid,
C17233,Hexahomomethionine;|L-Hexahomomethionine,,,,,
C17234,2-Aminobut-2-enoate;|(2Z)-2-Aminobut-2-enoic acid;|2-Ammoniobut-2-enoate,2-Ammoniobut-2-enoate (zwitterion form),,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C17234  2-Aminobut-2-enoic acid,
C17235,L-Homophenylalanine,,,,,
C17236,3-Phenylpropionaldoxim,,,,,
C17237,S-(Phenylacetothiohydroximoyl)-L-cysteine,,,,,
C17238,S-(Hydroxyphenylacetothiohydroximoyl)-L-cysteine,,,,,
C17239,p-Hydroxyphenylacetothiohydroximate,,,,,
C17240,p-Hydroxybenzyldesulphoglucosinolate;|Desulfo-p-hydroxybenzylglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C17240  p-Hydroxybenzyldesulphoglucosinolate,
C17241,4-Methylthiobutanaldoxime;|(E)-4-(Methylthio)-butanaldoxime,,,,,
C17242,S-(4-Methylthiobutylthiohydroximoyl)-L-cysteine,,,,,
C17243,4-Methylthiobutylthiohydroximate,,,,,
C17244,3-Methylthiopropyl-desulfoglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C17244  3-Methylthiopropyl-desulfoglucosinolate,
C17245,5-Methylthiopentanaldoxime;|(E)-5-(Methylthio)pentanaldoxime,,,,,
C17246,6-Methylthiohexanaldoxime;|(E)-6-(Methylthio)hexanaldoxime,,,,,
C17248,4-Methylthiobutyl-desulfoglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C17248  4-Methylthiobutyl-desulfoglucosinolate,
C17249,7-Methylthioheptanaldoxime;|(E)-7-(Methylthio)heptanaldoxime;|7-(Methylsulfanyl)heptanal oxime,,,,,
C17250,Glucolesquerellin;|6-Methylthiohexyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C17250  6-Methylthiohexyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C17250  Glucolesquerellin,
C17251,8-Methylthiooctanaldoxime;|(E)-8-(Methylthio)octanaldoxime,,,,,
C17252,7-Methylthioheptyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C17252  7-Methylthioheptyl glucosinolate,
C17253,9-Methylthiononanaldoxime;|(E)-9-(Methylthio)nonanaldoxime,,,,,
C17254,8-Methylthiooctyl glucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C17254  8-Methylthiooctyl glucosinolate,
C17255,3-Methylbutyraldehyde oxime,,,,,
C17256,2-Methylpropyl glucosinolate;|Isobutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from leucine|C17256  2-Methylpropyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C17256  2-Methylpropyl glucosinolate,
C17257,2-Methylbutyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from isoleucine|C17257  2-Methylbutyl glucosinolate,
C17258,Calcium sulfate hemihydrate,,,,,
C17259,desulfo-Glucosinolate;|Desulfoglucosinolate,,,,,
C17260,Glucosinolate,,,,,
C17261,Thiohydroximic acid;|Thiohydroximate,,,,,
C17262,S-Alkyl-thiohydroximate;|S-(2-Amino-2-carboxyethyl)-thiohydroximate;|S-Thiohydroximoyl-L-cysteine,,,,,
C17263,2-Alkylmalic acid,Generic compound in reaction hierarchy,,,,
C17264,3-Alkylmalic acid,Generic compound in reaction hierarchy,,,,
C17265,Aliphatic oxo acid;|2-Oxo acid with one additional methylene group,Generic compound in reaction hierarchy|R = aliphatic group,,,,
C17266,Homoamino acid,Generic compound in reaction hierarchy|Chain-elongationed amino acid,,,,
C17267,S-Sulfanylglutathione;|Glutathione hydrodisulfide,,,,,
C17268,"Pyruvophenone;|1-Phenyl-1,2-propanedione",,,,,
C17269,GDP-D-arabinopyranose;|GDP-alpha-D-arabinopyranose,,,,,
C17271,Glucohirsutin;|8-Methylsulfinyloctyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C17271  8-Methylsulfinyloctyl glucosinolate,
C17272,Glucoarabin;|9-Methylsulfinylnonyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from methionine|C17272  9-Methylsulfinylnonyl glucosinolate,
C17273,Glucoaubrietin;|4-Methoxybenzyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from tyrosine|C17273  4-Methoxybenzyl glucosinolate,
C17274,Glucobarbarin;|2(R)-Hydroxy-2-phenylethyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from phenylalanine|C17274  2(R)-Hydroxy-2-phenylethyl glucosinolate|Glycosides [BR:br08021]|S-glycosides|C17274  Glucobarbarin,
C17275,Glucosisymbrin;|1-Methyl-2-hydroxyetyl glucosinolate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Glucosinolates|Glucosinolates derived from valine|C17275  Glucosisymbrin,
C17276,Retinol-(cellular-retinol-binding-protein),,,,,
C17277,(+)-Valencene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17277  (+)-Valencene,
C17278,Ximenic acid;|(17Z)-Hexacosenoic acid;|17Z-Hexacosenoic acid;|(17Z)-Hexacos-17-enoic acid;|(Z)-Hexacos-17-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C17278  (Z)-Hexacos-17-enoic acid,
C17279,Ximenoyl-CoA;|(17Z)-Hexacosenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C17279  (17Z)-Hexacosenoyl-CoA,
C17280,GDP-4-keto-6-deoxy-D-lyxo-heptose,,,,,
C17281,GDP-6-deoxy-D-manno-heptose,,,,,
C17302,AL-294;|Ethyl 2-chloro-3-(4-(2-methyl-2-phenylpropoxy)phenyl)propanoate,,,,,
C17303,"AL-321;|5-(4-(2-Methyl-2-phenylpropoxy)benzyl)thiazolidine-2,4-dione",,,,,
C17309,"Cilazaprilat;|(1S,9S)-9-((S)-1-Carboxy-3-phenylpropylamino)-10-oxo-4,6,7,8,9,10-hexahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid",,,,Prodrugs [br08324.html]|C17309,
C17322,tRNA containing 2-thiouridine;|tRNA containing s2U,,,,,
C17323,tRNA containing 5-carboxymethylaminomethyl-2-thiouridine;|tRNA containing cmnm5s2U,Generic compound in reaction hierarchy|wobble position in the anticodon (position 34) in tRNA,,,,
C17324,tRNA adenine;|Adenosine in tRNA,,,,,
C17325,tRNA cytosine,,,,,
C17326,"CDP-4-dehydro-3,6-dideoxy-D-glucose epimer",,,,,
C17327,CDP-ascarylose,,,,,
C17328,UDP-4-keto-rhamnose,,,,,
C17331,"7alpha,24-Dihydroxy-4-cholesten-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17331  7alpha,24-Dihydroxy-4-cholesten-3-one",
C17332,"7alpha,25-Dihydroxy-4-cholesten-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17332  7alpha,25-Dihydroxy-4-cholesten-3-one",
C17333,3beta-Hydroxy-5-cholestenoate;|3beta-Hydroxycholest-5-en-27-oic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17333  3beta-Hydroxy-5-cholestenoate",
C17335,"3beta,7alpha-Dihydroxy-5-cholestenoate;|3beta,7alpha-Dihydroxy-5-cholesten-26-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17335  3beta,7alpha-Dihydroxy-5-cholestenoate",
C17336,"7alpha,26-Dihydroxy-4-cholesten-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17336  7alpha,26-Dihydroxy-4-cholesten-3-one",
C17337,7alpha-Hydroxy-3-oxo-4-cholestenoate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17337  7alpha-Hydroxy-3-oxo-4-cholestenoate",
C17339,"4-Cholesten-7alpha,12alpha-diol-3-one;|7alpha,12alpha-Dihydroxy-4-cholesten-3-one",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17339  4-Cholesten-7alpha,12alpha-diol-3-one",
C17343,"(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17343  (25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA",
C17345,"(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17345  (25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",
C17346,"(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C17346  (25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA",
C17349,Guanidine;|Carbamidine,,,,,
C17350,Nocardicin B,,,,,
C17351,Nocardicin C,,,,,
C17352,Isonocardicin C,,,,,
C17353,Nocardicin D,,,,,
C17354,Nocardicin F,,,,,
C17355,Nocardicin G,,,,,
C17356,2-Formyloxymethylclavam,,,,,
C17357,2-Hydroxymethylclavam,,,,,
C17358,Clavam-2-carboxylate,,,,,
C17359,8-Hydroxyalanylclavam,,,,,
C17360,Alanylclavam,,,,,
C17361,2-Hydroxyethylclavam;|Hydroxyethylclavam,,,,,
C17362,Clavamycin B,,,,,
C17363,Clavamycin C,,,,,
C17364,Clavamycin D,,,,,
C17365,Clavamycin E,,,,,
C17366,"(2S,5S)-trans-Carboxymethylproline;|(2S,5S)-5-Carboxymethylproline",,,,,
C17367,"(3S,5S)-Carbapenam-3-carboxylic acid;|(3S,5S)-Carbapenam-3-carboxylate",,,,,
C17368,8-Dehydroxythienamycin;|8-Deshydroxythienamycin;|Deshydroxythienamycin;|NS-5,,,,,
C17369,Northienamycin,,,,,
C17370,PS-5;|Antibiotic PS 5,,,,,
C17371,PS-6;|Antibiotic PS 6,,,,,
C17372,Epithienamycin A,,,,,
C17373,OA-6129 B1,,,,,
C17374,OA-6129 B2,,,,,
C17375,OA-6129 D,,,,,
C17376,OA-6129 E,,,,,
C17377,N-Acetylthienamycin,,,,,
C17378,O-Acylpseudotropine,Generic compound in reaction hierarchy,,,,
C17379,Lead oxide,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Lead oxide|C17379  Lead oxide,
C17380,Diacetylaminoazotoluene;|Pellidole;|Periphermine,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Periphermine|C17380  Diacetylaminoazotoluene,
C17382,Ferrous lactate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Ferrous lactate|C17382  Ferrous lactate,
C17383,Cobaltous sulfate,,,,"Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Cobalt sulfate|C17383  Cobaltous sulfate|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|991  Feed additive use preparations (except antibiotic, sulfonamide derivatives and preparations)|9912  Minerals and preparations|C17383  Cobaltous sulfate",
C17384,Citronellal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C17384  Citronellal,
C17385,2-Methoxy-5-nitrophenol;|5-Nitroguaiacol,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Mononitroguaiacol|C17385  5-Nitroguaiacol,
C17386,2-Methoxy-4-nitrophenol;|4-Nitroguaiacol,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Mononitroguaiacol|C17386  4-Nitroguaiacol,
C17387,Cycleanine,,,,,
C17388,L-Galacturonic acid calcium salt,,,,,
C17389,Zinc lactate,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Zinc lactate|C17389  Zinc lactate,
C17391,Sakuranin;|NSC 407308,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17391  Sakuranin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C17391  Sakuranin,
C17392,Calcium sulfide,,,,Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Calcium sulfide|C17392  Calcium sulfide,
C17393,Methyl hesperidin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17393  Methyl hesperidin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C17393  Methyl hesperidin|Risk category of Japanese OTC drugs [BR:br08312]|Third-class OTC drugs|Inorganic and organic chemicals|Methyl hesperidin|C17393  Methyl hesperidin,
C17394,Karounidiol,,,,,
C17395,Clavamycin F,,,,,
C17396,Epithienamycin B,,,,,
C17397,Epithienamycin C,,,,,
C17398,Epithienamycin D,,,,,
C17399,Epithienamycin F,,,,,
C17400,Asparenomycin A,,,,,
C17401,Cobalt-factor III,,,,,
C17402,Penicillin F;|2-Pentenylpenicillin,,,,,
C17403,Penicillin K;|Penicillin A,,,,,
C17404,Penicillin X,,,,,
C17405,Penicillin O,,,,,
C17407,Tenofovir,,,,Prodrugs [br08324.html]|C17407,
C17409,Chinese gallotannin,,,,,
C17410,Platycodin D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17410  Platycodin D,
C17411,"o-Methylpsychotrine;|1',2'-Dehydroemetin",,,,,
C17412,Shikonin,,,,Phytochemical compounds [BR:br08003]|Others|Naphthoquinones|alpha-Naphthoquinones|C17412  Shikonin,
C17413,Acetylshikonin,,,,,
C17414,Isobutylshikonin;|Isobutyrylshikonin,,,,,
C17415,"beta,beta-Dimethylacrylshikonin;|Dmask",,,,,
C17416,"Astrapterocarpan;|(6aR,11aR)-3-Hydroxy-9,10-dimethoxypterocarpan",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1207 Pterocarpans|C17416  Astrapterocarpan,
C17417,Onjisaponin F;|Polygalasaponin XXXI,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17417  Onjisaponin F,
C17418,Genisteine;|Genisteine-alkaloid;|alpha-Isosparteine,,,,,
C17419,Soyasapogenol A,,,,,
C17420,Soyasapogenol E,,,,,
C17421,Soyasapogenol F;|Soyasapogenol B1,,,,,
C17422,Soyasapogenol C;|Sapogenol C,,,,,
C17423,Soyasapogenol D,,,,,
C17424,Lindenenone,,,,,
C17425,Linderalactone,,,,,
C17426,Dicentrine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C17426  Dicentrine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C17426  Dicentrine,
C17427,Kanokonol,,,,,
C17428,Kanokoside A,,,,,
C17429,Kanokoside B;|Suspensolide F,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17429  Kanokoside B,
C17430,Kanokoside C,,,,,
C17431,Kanokoside D,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17431  Kanokoside D,
C17432,all-trans-Decaprenyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17432  all-trans-Decaprenyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Others|Polyterpenoids|C17432  all-trans-Decaprenyl diphosphate,
C17433,Tricosane;|n-Tricosane,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA11 Hydrocarbons|C17433  n-Tricosane,
C17434,"di-trans,poly-cis-Hexaprenyl diphosphate;|ditrans,tricis-Hexaprenyl diphosphate",,,,,
C17435,"di-trans,poly-cis-Pentaprenyl diphosphate;|ditrans,dicis-Pentaprenyl diphosphate;|2-cis,6-cis,10-trans,14-trans-Pentaprenyl diphosphate;|2-cis,6-cis,10-trans,14-trans-Geranylfarnesyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0105 C25 isoprenoids (sesterterpenes)|PR010501 Acyclic sesterterpenoids|C17435  di-trans,poly-cis-Pentaprenyl diphosphate",
C17436,"di-trans,poly-cis-Heptaprenyl diphosphate;|ditrans,tetracis-Heptaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17436  di-trans,poly-cis-Heptaprenyl diphosphate",
C17437,"di-trans,poly-cis-Octaprenyl diphosphate;|ditrans,pentacis-Octaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C17437  di-trans,poly-cis-Octaprenyl diphosphate",
C17438,"di-trans,poly-cis-Nonaprenyl diphosphate;|ditrans,hexacis-Nonaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17438  di-trans,poly-cis-Nonaprenyl diphosphate",
C17439,Dihydrogeranylgeranyl diphosphate,,,,,
C17440,Tetrahydrogeranylgeranyl diphosphate,,,,,
C17441,Polygalacin D,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17441  Polygalacin D,
C17442,Isomatrine,,,,,
C17443,Platycodin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17443  Platycodin A,
C17444,Kurarinol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17444  Kurarinol,
C17445,Kuraridinol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C17445  Kuraridinol,
C17446,Kurarinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17446  Kurarinone,
C17447,"(3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol;|(+)-Falcarinol",,,,,
C17449,Astilbin;|Taxifolin 3-O-rhamnoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17449  Astilbin|Dietary phytochemicals [br08012.html]|Flavonoids|C17449,
C17450,Rehmaionoside A,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17450  Rehmaionoside A,
C17451,Rehmaionoside B,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17451  Rehmaionoside B,
C17452,Rehmaionoside C,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17452  Rehmaionoside C,
C17453,Paeoniflorigenone,,,,,
C17454,Paeonilactone A,,,,,
C17455,Paeonilactone B,,,,,
C17456,Paeonilactone C,,,,,
C17457,Albiflorin,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17457  Albiflorin,
C17458,"Gallotannin;|1,3,6-Tri-o-galloyl-beta-D-glucose",,,,,
C17459,Alisol A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17459  Alisol A,
C17460,Alisol B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17460  Alisol B,
C17461,Alisol C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17461  Alisol C,
C17462,Alismol,,,,,
C17463,Nupharidine,,,,,
C17464,Nupharamine,,,,,
C17465,Parishin B,,,,,
C17466,Parishin C,,,,,
C17467,p-Hydroxybenzyl alcohol;|4-Hydroxybenzyl alcohol;|p-Methylolphenol,,,,,
C17468,Methylprotodioscin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C17468  Methylprotodioscin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17468  Methylprotodioscin,
C17469,Pseudoprotodioscin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Furostan|C17469  Pseudoprotodioscin|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17469  Pseudoprotodioscin,
C17470,Asparasaponin II,,,,,
C17471,Ophiopogonone A,,,,,
C17472,Ophiopogonone B,,,,,
C17473,Methylophiopogonone A,,,,,
C17474,Methylophiopogonone B,,,,,
C17475,Ophiopogonanone A,,,,,
C17476,Osthenol-7-O-beta-D-gentiobioside,,,,Glycosides [BR:br08021]|O-glycosides|Coumarin glycosides|C17476  Osthenol-7-O-beta-D-gentiobioside,
C17477,D-Galacturonic acid calcium salt,,,,,
C17478,Calcium oxalate,,,,,
C17479,"Fraxidin;|8-Hydroxy-6,7-dimethoxy-2H-1-benzopyran-2-one",,,,,
C17480,"Isofraxidin;|7-Hydroxy-6,8-dimethoxy-2H-1-benzopyran-2-one",,,,,
C17482,(-)-Deltoin,,,,,
C17483,Hamaudol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C17483  Hamaudol|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C17483  Hamaudol,
C17484,sec-o-Glucosylhamaudol,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C17484  sec-o-Glucosylhamaudol,
C17485,Ignavine,,,,,
C17486,Coryneine,,,,,
C17487,Platycodin C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17487  Platycodin C,
C17488,Furanogermenone,,,,,
C17489,"(4S,5S)-(+)-Germacrone 4,5-epoxide",,,,,
C17490,Zedoarol,,,,,
C17491,13-Hydroxygermacrone,,,,,
C17492,Curcumenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010340 Carabrane sesquiterpenoids|C17492  Curcumenone,
C17493,Curdione,,,,,
C17494,Turmerone,,,,,
C17495,[8]-Gingerol;|(8)-Gingerol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17495  [8]-Gingerol|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Zingiber derived compounds|C17495  [8]-Gingerol,
C17496,[10]-Gingerol;|(10)-Gingerol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17496  [10]-Gingerol,
C17497,Zingerone;|Zingiberone;|Vanillylacetone;|[0]-Paradol,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17497  Zingerone|Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Zingiber derived compounds|C17497  Zingerone,
C17498,Galanolactone;|(+)-Galanolactone,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C17498  Galanolactone,
C17499,Notopterol,,,,,
C17500,"6-Iminocyclohexa-2,4-dienone;|1,2-Benzoquinone monoimine",,,,,
C17501,Cyperotundone;|Cyperenone,,,,,
C17502,Sugetriol,,,,,
C17503,Cnidilin;|Isophellopterin,,,,,
C17504,Sugeonol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010345 Patchoulane sesquiterpenoids|C17504  Sugeonol,
C17505,Cyperene;|(-)-Cyperene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010345 Patchoulane sesquiterpenoids|C17505  Cyperene,
C17506,Sugeonyl acetate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010345 Patchoulane sesquiterpenoids|C17506  Sugeonyl acetate,
C17507,Palmatoside G,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C17507  Palmatoside G,
C17508,Isocolumbin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C17508  Isocolumbin,
C17509,Thymine dimer;|Cyclobutadithymine (in DNA);|cis-syn Thymine dimer;|T-T dimer,,,,,
C17510,Two thymine residues (in DNA);|Two adjacent thymine residues (in DNA),,,,,
C17512,N-Methylanthranilamide;|N-Methyl-2-aminobenzamide,,,,,
C17513,trans-Crocetin (beta-D-glucosyl) (beta-D-gentibiosyl) ester;|beta-D-Gentiobiosyl beta-D-glucosyl crocetin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C17513  beta-D-Gentiobiosyl beta-D-glucosyl crocetin,
C17514,4-o-Galloylbergenin,,,,,
C17515,Capsi-amide;|N-(13-Methyltetradecyl)acetamide;|CAP-A,,,,,
C17516,Capsianside A,,,,,
C17517,beta-Terpineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17517  beta-Terpineol,
C17518,gamma-Terpineol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17518  gamma-Terpineol,
C17519,Amaroswerin,,,,,
C17520,11-o-Galloylbergenin,,,,,
C17521,Mallotinic acid,,,,,
C17522,Mallogenin-3-o-alpha-L-rhamnopyranoside;|Malloside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C17522  Mallogenin-3-o-alpha-L-rhamnopyranoside,
C17523,Panogenin-3-o-alpha-L-rhamnopyranoside;|Panoside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C17523  Panogenin-3-o-alpha-L-rhamnopyranoside,
C17524,Coroglaucigenin-3-o-alpha-L-rhamnopyranoside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C17524  Coroglaucigenin-3-o-alpha-L-rhamnopyranoside,
C17525,Corotoxigenin-3-O-alpha-L-rhamnopyranoside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C17525  Corotoxigenin-3-O-alpha-L-rhamnopyranoside,
C17526,Boivinide A;|Corotoxigenin-3-O-beta-D-glucopyranosyl-(1->4)-beta-D-digitalopyranoside,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C17526  Boivinide A,
C17527,Rengyol,,,,,
C17528,beta-Hydroxyacteoside,,,,,
C17529,(-)-Pinoresinol glucoside,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignan glycosides|C17529  (-)-Pinoresinol glucoside|Dietary phytochemicals [br08012.html]|Other phytochemicals|C17529,
C17530,Methyl acetate;|Devoton;|Tereton,,,,,
C17531,Plantagoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17531  Plantagoside|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C17531  Plantagoside,
C17532,Metoxadiazone,,,,Classification of Japanese OTC drugs [BR:br08313]|Agents for sanitation|82 Pesticides|C17532  Metoxadiazone|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Insecticides|C17532  Metoxadiazone,
C17533,Gambirtannine,,,,,
C17534,Cylindrin,,,,,
C17535,Aplotaxene,,,,,
C17536,Sibiricoside A,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17536  Sibiricoside A,
C17537,Sibiricoside B,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17537  Sibiricoside B,
C17538,Cimigenol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C17538  Cimigenol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17538  Cimigenol,
C17539,Chikusetsusaponin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17539  Chikusetsusaponin III|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17539  Chikusetsusaponin III,
C17540,Chikusetsusaponin IV;|Araloside A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C17540  Chikusetsusaponin IV|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17540  Chikusetsusaponin IV,
C17541,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)-D-alanyl-D-alanine;|Und-PP-MurNAc-(GlcNAc)-L-Ala-D-isoglutaminyl-L-Lys-(Gly)-D-Ala-D-Ala,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17541  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)-D-alanyl-D-alanine,
C17542,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)3-D-alanyl-D-alanine;|Und-PP-MurNAc-(GlcNAc)-L-Ala-D-isoglutaminyl-L-Lys-(Gly)3-D-Ala-D-Ala,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17542  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-isoglutaminyl-L-lysyl-(glycyl)3-D-alanyl-D-alanine,
C17543,Chikusetsusaponin V;|Ginsenoside Ro,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C17543  Chikusetsusaponin V|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17543  Chikusetsusaponin V,
C17544,Chikusetsusaponin Ia,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17544  Chikusetsusaponin Ia|Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17544  Chikusetsusaponin Ia,
C17545,Chikusetsusaponin Ib,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C17545  Chikusetsusaponin Ib|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17545  Chikusetsusaponin Ib,
C17546,Akeboside Stf,,,,,
C17547,Akeboside Std;|Akebia saponin C;|Cauloside C,,,,,
C17548,Akeboside Ste,,,,,
C17549,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl-L-alanyl)-D-alanyl-D-alanine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17549  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl-L-alanyl)-D-alanyl-D-alanine,
C17550,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17550  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-(L-alanyl)-D-alanyl-D-alanine,
C17551,"2-Polyprenyl-6-hydroxyphenol;|3-Polyprenylcatechol;|3-(all-trans-Polyprenyl)benzene-1,2-diol",Generic compound in reaction hierarchy|n=5-9|3-Hexaprenylcatechol [CPD:C05801],,,,
C17552,2-Polyprenyl-6-methoxyphenol;|2-Methoxy-6-(all-trans-polyprenyl)phenol,Generic compound in reaction hierarchy|n=5-9|2-Hexaprenyl-6-methoxyphenol [CPD:C05802],,,,
C17553,Condurango glycoside A,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17553  Condurango glycoside A,
C17554,"3,4-Dihydroxy-5-polyprenylbenzoate;|3-Polyprenyl-4,5-dihydroxybenzoate;|3,4-Dihydroxy-5-all-trans-polyprenylbenzoate",Generic compound in reaction hierarchy|n=5-9,,,,
C17555,Icariin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17555  Icariin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C17555  Icariin,
C17556,"di-trans,poly-cis-Undecaprenyl phosphate;|Undecaprenyl phosphate;|ditrans,octacis-Undecaprenyl phosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C17556  di-trans,poly-cis-Undecaprenyl phosphate",
C17557,Lonicerin,,,,,
C17558,"di-trans,poly-cis-Undecaprenol;|Undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0301 Bactoprenols|C17558  di-trans,poly-cis-Undecaprenol",
C17559,3-Methoxy-4-hydroxy-5-polyprenylbenzoate;|3-Polyprenyl-4-hydroxy-5-methoxybenzoate;|3-Methoxy-4-hydroxy-5-all-trans-polyprenylbenzoate,Generic compound in reaction hierarchy|n=5-9,,,,
C17560,"2-Polyprenyl-6-methoxy-1,4-benzoquinone",Generic compound in reaction hierarchy|n=5-9,,,,
C17561,"2-Polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone",Generic compound in reaction hierarchy|n=5-9,,,,
C17562,"2-Polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone",Generic compound in reaction hierarchy|n=5-9,,,,
C17563,Multinoside A,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17563  Multinoside A|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C17563  Multinoside A,
C17564,Zizybeoside I,,,,,
C17565,Zizybeoside II,,,,,
C17566,Coixenolide,,,,,
C17567,Lotusine;|(-)-Lotusine;|D-(-)-Lotusine,,,,,
C17568,Ubiquinone-6;|Coenzyme Q6,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C17568  Ubiquinone-6,
C17569,Ubiquinone-8;|Coenzyme Q8,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C17569  Ubiquinone-8,
C17570,"2-Methyl-6-solanyl-1,4-benzoquinol;|2-Methyl-6-nonaprenyl-benzene-1,4-diol;|2-Methyl-6-all-trans-nonaprenylbenzene-1,4-diol;|2-Methyl-6-solanesylbenzene-1,4-diol;|MSBQ",,,,,
C17571,5'-Hydroxystreptomycin,,,,,
C17572,Bluensidine 6-phosphate,,,,,
C17573,Bluensomycin,,,,,
C17574,2-epi-Streptamine,,,,,
C17575,Actinamine;|Spectinamine,,,,,
C17576,3-Keto-scyllo-inosamine,,,,,
C17577,myo-Inosose-5,,,,,
C17578,neo-Inosamine-2;|2L-2-Amino-2-deoxy-neo-inositol,,,,,
C17579,Hygromycin A,,,,,
C17580,2-Deoxy-scyllo-inosamine,,,,,
C17581,"3-Amino-2,3-dideoxy-scyllo-inosose;|2-Deoxy-3-keto-scyllo-inosamine",,,,,
C17582,2'-N-Acetylparomamine,,,,,
C17583,6'-Dehydro-6'-oxoparomamine;|6'-Dehydroparomamine;|6'-Oxoparomamine,,,,,
C17584,Xylostasin,,,,,
C17585,Butirosin A,,,,Compounds with biological roles [BR:br08001]|Antibiotics|Aminoglycosides|2-Deoxystreptamines|C17585  Butirosin A,
C17586,Butirosin B,,,,,
C17587,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyneomycin C,,,,,
C17588,6'''-Deamino-6'''-hydroxyneomycin C;|6'''-Hydroxyneomycin C;|Neomycin Y2,,,,,
C17589,6'''-Deamino-6'''-oxoneomycin C;|6'''-Oxoneomycin C;|6'''-Deamino-6'''-dehydro-6'''-oxoneomycin C,,,,,
C17590,Catechin;|(+/-)-Catechin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1202 Flavans, Flavanols and Leucoanthocyanidins|C17590  Catechin",
C17591,(S)-Corytuberine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C17591  (S)-Corytuberine,
C17592,Laudanine,(R)-Laudanine [CPD:C09555]|(S)-Laudanine [CPD:C20712],,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C17592  Laudanine,
C17593,Uncarine A,,,,,
C17594,Uncarine B;|Formosamine,,,,,
C17595,Uncarine C,,,,,
C17596,Uncarine D;|Speciophylline,,,,,
C17597,Uncarine E,,,,,
C17598,Uncarine F,,,,,
C17599,Methylarbutin,,,,,
C17600,Multiflorin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17600  Multiflorin B|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavones and flavonols|C17600  Multiflorin B,
C17601,2(5H)-Furanone;|gamma-Crotonolactone;|Butenolide,,,,,
C17602,2(3H)-Furanone;|alpha-Crotonolactone,,,,,
C17603,Kikkanol A,,,,,
C17604,Kikkanol B,,,,,
C17605,Kikkanol C,,,,,
C17606,Kikkanol D,,,,,
C17607,Kikkanol E,,,,,
C17608,Kikkanol F,,,,,
C17609,Chrysantherol,,,,,
C17610,Chrysanthetriol,,,,,
C17611,Chrysanthemol,,,,,
C17612,Indicumenone,,,,,
C17613,Handelin,,,,,
C17614,1-Octen-3-ol-3-o-beta-D-xylopyranosyl(1->6)-beta-D-glucopyranoside,,,,,
C17615,Kukoamine A,,,,,
C17616,Kukoamine B,,,,,
C17617,Kukoamine C,,,,,
C17618,Kukoamine D,,,,,
C17619,10-(beta-Dimethylaminopropionyl)phenothiazine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AC Synthetic antispasmodics, amides with tertiary amines|A03AC02 Dimethylaminopropionylphenothiazine|C17619  10-(beta-Dimethylaminopropionyl)phenothiazine",
C17620,"Epomediol;|2,6-Dihydroxycineol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17620  Epomediol|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A05 BILE AND LIVER THERAPY|A05B LIVER THERAPY, LIPOTROPICS|A05BA Liver therapy|A05BA05 Epomediol|C17620  Epomediol",
C17621,(6E)-8-Hydroxygeraniol;|10-Hydroxygeraniol;|8-Hydroxygeraniol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C17621  (6E)-8-Hydroxygeraniol|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C17621  10-Hydroxygeraniol,
C17622,(6E)-8-Oxogeranial;|10-Oxogeranial;|8-Oxogeranial,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C17622  (6E)-8-Oxogeranial|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Linear monoterpenes|C17622  10-Oxogeranial,
C17623,(-)-Pulegone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C17623  (-)-Pulegone|Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C17623  (-)-Pulegone,
C17624,Cinnamtannin A1;|Proanthocyanidin C1;|Procyanidin C1,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C17624  Cinnamtannin A1,
C17625,Cinnamtannin A2,,,,,
C17626,Cinnamtannin A3,,,,,
C17628,Prenol,Generic compound in reaction hierarchy,,,,
C17629,Cinnamtannin B2,,,,,
C17631,Cinnamtannin B1,,,,,
C17632,Cinnamtannin D1,,,,,
C17633,Cinnamtannin D2,,,,,
C17634,Schizonepetoside A,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17634  Schizonepetoside A,
C17635,Schizonepetoside B,,,,,
C17636,Schizonepetoside C,,,,,
C17637,Schizonepetoside D,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17637  Schizonepetoside D,
C17638,Schizonepetoside E,,,,Glycosides [BR:br08021]|O-glycosides|Iridoid glycosides|C17638  Schizonepetoside E,
C17639,Procyanidin B2;|Procyanidol B2,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C17639  Procyanidin B2,
C17640,Procyanidin B5;|Procyanidol B5,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1203 Proanthocyanidins|C17640  Procyanidin B5,
C17641,Cinncassiol C3,,,,,
C17642,Cinncassiol C2,,,,,
C17643,Cinncassiol C1,,,,,
C17644,"Ursocholate;|Ursocholic acid;|3alpha,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic acid;|3alpha,7beta,12alpha-Trihydroxy-5beta-cholanic acid;|7beta-Hydroxyisocholic acid;|7-Epicholic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17644  Ursocholate",
C17645,Cinncassiol A,,,,,
C17646,12-Epideoxycholic acid;|12-Epideoxycholate,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17646  12-Epideoxycholic acid",
C17647,"alpha-Muricholate;|alpha-Muricholic acid;|5beta-Cholanic acid-3alpha,6beta,7alpha-triol;|3alpha,6beta,7alpha-Trihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17647  alpha-Muricholate",
C17648,Cinncassiol B,,,,,
C17649,"Hyocholate;|Hyocholic acid;|Iocholic acid;|gamma-Muricholate;|alpha-Hyocholic acid;|3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid;|6alpha-Hydroxychenodeoxycholic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17649  Hyocholate",
C17650,"Vulpecholate;|Vulpecholic acid;|1alpha,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17650  Vulpecholate",
C17651,"alpha-Phocaecholic acid;|3alpha,7alpha,12alpha,23R-Tetrahydroxycholanic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17651  alpha-Phocaecholic acid",
C17652,Cinncassiol D1,,,,,
C17653,Cinncassiol D2,,,,,
C17654,"beta-Phocaecholate;|beta-Phocaecholic acid;|(23R)-Hydroxychenodeoxycholate;|(3alpha,5beta,7alpha,23R)-3,7,23-Trihydroxycholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17654  beta-Phocaecholate",
C17655,Cinncassiol D3,,,,,
C17656,Cinncassiol D4,,,,,
C17657,Bitocholate;|Bitocholic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17657  Bitocholate",
C17658,Isolithocholate;|Isolithocholic acid;|beta-Lithocholic acid;|beta-Lithocholanic acid;|3-Epilithocholic acid;|3beta-Hydroxy-5beta-cholan-24-oic acid;|3beta-Hydroxy-5beta-cholan-24-oic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17658  Isolithocholate",
C17659,Cinncassiol E,,,,,
C17660,"Isochenodeoxycholate;|Isochenodeoxycholic acid;|3beta,7alpha-Dihydroxy-5beta-cholanic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17660  Isochenodeoxycholate",
C17661,"Isodeoxycholate;|Isodeoxycholic acid;|7alpha,12alpha-Dihydroxy-5beta-cholanic acid;|7alpha,12alpha-Dihydroxycholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17661  Isodeoxycholate",
C17662,"Isoursodeoxycholate;|Isoursodeoxycholic acid;|3beta,7beta-Dihydroxy-5beta-cholanoic acid;|3beta,7beta-Dihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17662  Isoursodeoxycholate",
C17663,3-Phenylpropyl acetate;|Hydrocinnamyl acetate,,,,,
C17664,"Allochenodeoxycholate;|Allochenodeoxycholic acid;|3alpha,7alpha-Dihydroxy-5alpha-cholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17664  Allochenodeoxycholate",
C17665,2-Phenylpropyl acetate,,,,,
C17666,1-Phenylpropyl acetate,,,,,
C17667,Avicholate;|Avicholic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17667  Avicholate",
C17668,"Haemulcholate;|Hemulcholic acid;|3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17668  Haemulcholate",
C17669,Chryso-obtusin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17669  Chryso-obtusin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17669  Chryso-obtusin,
C17670,Aurantio-obtusin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17670  Aurantio-obtusin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17670  Aurantio-obtusin,
C17671,Norrubrofusarin,,,,,
C17672,Torachrysone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C17672  Torachrysone,
C17673,Toralactone,,,,,
C17674,Cassiaside B2,,,,,
C17675,Neocarthamin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C17675  Neocarthamin|Glycosides [BR:br08021]|O-glycosides|Flavonoid glycosides|Flavanones|C17675  Neocarthamin,
C17676,Cryptomeridiol;|Proximadiol,,,,,
C17677,Eudesobovatol B,,,,,
C17678,Magnoloside A,,,,,
C17679,Magnoloside B,,,,,
C17680,Magnoloside C,,,,,
C17682,Neoarctin A,,,,,
C17683,Neoarctin B,,,,,
C17684,Lappaol A,,,,,
C17685,Lappaol B,,,,,
C17686,Lappaol C,,,,,
C17687,"Allodeoxycholate;|5alpha-Deoxycholic acid;|3alpha,12alpha-Dihydroxy-5alpha-cholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17687  Allodeoxycholate",
C17688,Aluminum acetoacetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AB Aluminium compounds|A02AB05 Aluminium acetoacetate|C17688  Aluminum acetoacetate,
C17689,"Ursodeoxycholoyl-CoA;|3alpha,7beta-Dihydroxy-5beta-cholanoyl-CoA",,,,,
C17690,4-(4-Hydroxyphenyl)-2-butanol;|4-HPB;|Rhododendrol;|Betuligenol,,,,,
C17691,"2-epi-5-epi-Valiolone;|(2S,3S,4S,5R)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one",,,,,
C17692,2-epi-5-epi-Valiolone 7-phosphate,,,,,
C17693,5-epi-Valiolone 7-phosphate,,,,,
C17694,5-epi-Valiolone,,,,,
C17695,2-Keto-5-epi-valiolone,,,,,
C17696,Valienone,,,,,
C17697,Valienone 7-phosphate,,,,,
C17698,Salbostatin,,,,,
C17699,Cetoniacytone A,,,,,
C17700,Validoxylamine A,,,,,
C17701,Gentamicin A2,,,,,
C17702,Gentamicin X2,,,,,
C17703,Antibiotic G-418;|G418;|Geneticin,,,,,
C17704,Antibiotic JI-20A;|JI-20A,,,,,
C17705,Antibiotic JI-20B;|JI-20B,,,,,
C17706,Gentamicin C2b;|Sagamicin,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08219)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AA Antibiotics|S01AA22 Micronomicin|D08219  Micronomicin (DCF)|Drug groups [BR:br08330(D08219)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG01123  Micronomicin|D08219  Micronomicin|Antimicrobials [BR:br08307(D08219)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D08219  Micronomicin (DCF)|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C17706,
C17707,Lividomycin A,,,,,
C17708,Fortimicin A;|Astromicin,,,,Drug groups [BR:br08330(D07470)]|Antibacterial|DG01447  Aminoglycoside antibiotic|DG01200  Astromicin|D07470  Astromicin|Antimicrobials [BR:br08307(D07470)]|Antibacterials|Protein biosynthesis inhibitor|Aminoglycoside|D07470  Astromicin (INN),
C17709,Fortimicin B,,,,,
C17710,Sannamycin A;|Istamycin A,,,,,
C17711,Sannamycin B;|Istamycin A0,,,,,
C17712,Paromomycin II;|Neomycin F,,,,,
C17714,Heptanoic acid,,,,Compounds with biological roles [BR:br08001]|Organic acids|Carboxylic acids|Monocarboxylic acids|C17714  Enanthate; Heptanoate|Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C17714  Heptanoic acid,
C17715,Undecanoic acid;|Hendecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C17715  Undecanoic acid,
C17716,Dehydrofalcarinol,,,,,
C17717,"5-Phenyl-1,3-pentadiyne",,,,,
C17718,Sulfamethoxazole sodium,,,,Classification of Japanese OTC drugs [BR:br08313]|Agents for ophthalmologic use|63 Antibacterial eye drops|C17718  Sulfamethizole sodium|Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Sulfamethoxazole|C17718  Sulfamethoxazole sodium,
C17719,Tenitramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01D VASODILATORS USED IN CARDIAC DISEASES|C01DA Organic nitrates|C01DA38 Tenitramine|C17719  Tenitramine,
C17720,Difenpiramide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AB Acetic acid derivatives and related substances|M01AB12 Difenpiramide|C17720  Difenpiramide",
C17721,Vinyl ether,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AA Ethers|N01AA02 Vinyl ether|C17721  Vinyl ether",
C17722,Narcobarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01A ANESTHETICS, GENERAL|N01AG Barbiturates in combination with other drugs|N01AG01 Narcobarbital|C17722  Narcobarbital",
C17723,Metabutethamine,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BA Esters of aminobenzoic acid|N01BA01 Metabutethamine|C17723  Metabutethamine|Drug groups [BR:br08330]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|DG01674  Esterified local anesthetic|C17723  Metabutethamine",G01674
C17724,Ethadione,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N03 ANTIEPILEPTICS|N03A ANTIEPILEPTICS|N03AC Oxazolidine derivatives|N03AC03 Ethadione|C17724  Ethadione,
C17725,Heptabarbital,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CA Barbiturates, plain|N05CA11 Heptabarbital|C17725  Heptabarbital",
C17726,"beta-Muricholate;|beta-Muricholic acid;|3alpha,6beta,7beta-Trihydroxy-5beta-cholan-24-oic acid;|5beta-Cholanic acid-3alpha,6beta,7beta-triol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17726  beta-Muricholate",
C17727,omega-Muricholate;|omega-Muricholic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17727  omega-Muricholate",
C17728,Idanpramine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AX Other drugs for functional gastrointestinal disorders|A03AX06 Idanpramine|C17728  Idanpramine,
C17729,"Nicofetamide;|N-(1,2-Diphenylethyl)nicotinamide",,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03A DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS|A03AC Synthetic antispasmodics, amides with tertiary amines|A03AC04 Nicofetamide|C17729  Nicofetamide",
C17730,"Piperidione;|3,3-Diethyl-2,4-dioxopiperidine",,,,,
C17731,Sodium folinate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|V VARIOUS|V03 ALL OTHER THERAPEUTIC PRODUCTS|V03A ALL OTHER THERAPEUTIC PRODUCTS|V03AF Detoxifying agents for antineoplastic treatment|V03AF06 Sodium folinate|C17731  Sodium folinate,
C17732,Magnesium peroxide,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02A ANTACIDS|A02AA Magnesium compounds|A02AA03 Magnesium peroxide|C17732  Magnesium peroxide|A06 DRUGS FOR CONSTIPATION|A06A DRUGS FOR CONSTIPATION|A06AD Osmotically acting laxatives|A06AD03 Magnesium peroxide|C17732  Magnesium peroxide,
C17733,"7-Oxateasterone;|(22R,23R,24S)-3beta,22,23-Trihydroxy-7-oxa-5alpha-ergostane-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C17733  7-Oxateasterone,
C17734,Acetoxolone;|Acetylglycyrrhetinic acid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|A ALIMENTARY TRACT AND METABOLISM|A02 DRUGS FOR ACID RELATED DISORDERS|A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)|A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)|A02BX09 Acetoxolone|C17734  Acetoxolone,
C17735,"7-Oxatyphasterol;|(22R,23R,24S)-3alpha,22,23-Trihydroxy-7-oxa-5alpha-ergostane-6-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C17735  7-Oxatyphasterol,
C17737,"Allocholic acid;|Allocholate;|3alpha,7alpha,12alpha-Trihydroxy-5alpha-cholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C17737  Allocholic acid",
C17740,p-Coumaroyl-diketide-CoA;|(4-Coumaroyl)acetyl-CoA,,,,,
C17741,Feruloyl-diketide-CoA;|Feruloylacetyl-CoA,,,,,
C17742,Demethoxycurcumin,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17742  Demethoxycurcumin,
C17743,Bisdemethoxycurcumin,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17743  Bisdemethoxycurcumin,
C17744,"1-(4-Hydroxyphenyl)-1-decene-3,5-dione",,,,"Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C17744  1-(4-Hydroxyphenyl)-1-decene-3,5-dione",
C17745,"1-(3,4-Dihydroxyphenyl)-1-decene-3,5-dione",,,,"Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17745  1-(3,4-Dihydroxyphenyl)-1-decene-3,5-dione",
C17746,1-Dehydro-[6]-gingerdione,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17746  1-Dehydro-[6]-gingerdione,
C17747,5-Hydroxy-1-(4-hydroxyphenyl)-3-decanone,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1501 Alkyl phenols and derivatives|C17747  5-Hydroxy-1-(4-hydroxyphenyl)-3-decanone,
C17748,"1-(3,4-Dihydroxyphenyl)-5-hydroxy-3-decanone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17748  1-(3,4-Dihydroxyphenyl)-5-hydroxy-3-decanone",
C17749,Curcumin monoglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17749  Curcumin monoglucoside|Dietary phytochemicals [br08012.html]|Other phytochemicals|C17749,
C17750,Curcumin diglucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17750  Curcumin diglucoside|Dietary phytochemicals [br08012.html]|Other phytochemicals|C17750,
C17751,cyclo-Dopa 5-O-glucoside,,,,,
C17752,cyclo-Dopa-glucuronylglucoside,,,,,
C17753,Dopaxanthin quinone,,,,,
C17754,3-Methoxytyramine-betaxanthin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betaxanthins|C17754  3-Methoxytyramine-betaxanthin,
C17755,Dopamine quinone,,,,,
C17756,"2-Descarboxy-cyclo-dopa;|Indoline-5,6-diol;|5,6-Indolinediol",,,,,
C17757,2-Descarboxy-betanidin,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Betalains|Betacyanins|C17757  2-Descarboxy-betanidin,
C17758,"4,5-seco-Dopa",,,,,
C17759,1-O-Feruloyl-beta-D-glucose;|1-Feruloyl-D-glucose,,,,,
C17760,Senegin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17760  Senegin III,
C17761,Senegin IV,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C17761  Senegin IV,
C17762,Homoplantaginin;|Hispidulin 7-O-glucoside;|Hispiduloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17762  Homoplantaginin,
C17763,6-Hydroxyluteolin 7-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17763  6-Hydroxyluteolin 7-glucoside,
C17764,Glabric acid,,,,,
C17765,Licoricone,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C17765  Licoricone,
C17766,Condurangogenin C,,,,,
C17767,Condurangogenin A;|Kondurangogenin A,,,,,
C17768,Condurango glycoside A0,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C17768  Condurango glycoside A0,
C17769,Condurango glycoside C,,,,,
C17770,Sarcostin,,,,,
C17771,Lithospermoside;|Griffonin,,,,,
C17772,Gambiriin A1,,,,,
C17773,Gambiriin A2,,,,,
C17774,Gambiriin A3,,,,,
C17775,Gambiriin B1,,,,,
C17776,Gambiriin B2,,,,,
C17777,Gambiriin B3,,,,,
C17778,Isobarbaloin;|Aloin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17778  Isobarbaloin|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthrone type|C17778  Isobarbaloin|Glycosides [BR:br08021]|C-glycosides|C17778  Isobarbaloin,
C17779,Aloinoside A,,,,,
C17780,Aloinoside B,,,,,
C17781,2''-o-p-Coumaroylaloesin,,,,,
C17782,"3,5-Dimethoxyallylbenzene",,,,,
C17783,Capillanol,,,,,
C17784,"Pectolinarigenin;|5,7-Dihydroxy-4',6-dimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17784  Pectolinarigenin,
C17785,"Cirsimaritin;|Scrophulein;|4',5-Dihydroxy-6,7-dimethoxyflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17785  Cirsimaritin,
C17786,6-Demethoxycapillarisin,,,,,
C17787,Arcapillin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17787  Arcapillin,
C17788,Eupatolitin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17788  Eupatolitin,
C17789,Capillartemisin A,,,,,
C17790,Dehydrocorydaline,,,,,
C17791,Cycloaraloside C,,,,,
C17792,Cycloaraloside F,,,,,
C17793,Isoastragaloside I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17793  Isoastragaloside I,
C17794,Isoastragaloside II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17794  Isoastragaloside II,
C17795,Capillartemisin B,,,,,
C17796,Norcapillene,,,,,
C17797,Astragaloside I,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17797  Astragaloside I|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17797  Astragaloside I,
C17798,Astragaloside II,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17798  Astragaloside II|Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17798  Astragaloside II,
C17799,Astragaloside IV,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17799  Astragaloside IV,
C17800,Astragaloside V,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17800  Astragaloside V,
C17801,Astragaloside VI,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17801  Astragaloside VI,
C17802,Astragaloside VII,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Protostanes|C17802  Astragaloside VII,
C17803,Dimethyl suberate;|Octanedioic acid dimethyl,,,,,
C17804,Clematichinenoside A,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Triterpenoid|C17804  Clematichinenoside A,
C17805,Clematichinenoside B,,,,,
C17806,Clematichinenoside C,,,,,
C17807,Huzhongoside B,,,,,
C17808,Clemaphenol A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C17808  Clemaphenol A,
C17809,Polygonimitin B,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C17809  Polygonimitin B",
C17810,Citreorosein;|omega-Hydroxyemodin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17810  Citreorosein,
C17811,"Questinol;|1,6-Dihydroxy-3-(hydroxymethyl)-8-methoxy-9,10-anthracenedione",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C17811  Questinol|Phytochemical compounds [BR:br08003]|Polyketides|Anthraquinones|Anthraquinone type|C17811  Questinol,
C17812,Lappaol D,,,,,
C17814,Gomisin B;|Schisantherin B,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C17814  Gomisin B,
C17815,Civetol,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Crude drugs|Civet|C17815  Civetol|Third-class OTC drugs|Crude drugs|Civet|C17815  Civetol,
C17816,Gomisin D,,,,,
C17817,Gomisin E,,,,,
C17818,Gomisin F,,,,,
C17819,Gomisin G,,,,,
C17820,Gomisin H,,,,,
C17821,"2,4,5-Trimethoxy-1-allylbenzene;|gamma-Asarone",,,,,
C17822,"3,4,5-Trimethoxytoluene",,,,,
C17823,"2,4,5-Trimethoxytoluene",,,,,
C17824,(+/-)-Asarinol A,,,,,
C17825,(+/-)-Asarinol B,,,,,
C17826,Hexahydrocurcumin,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17826  Hexahydrocurcumin,
C17827,Hydroxy-gamma-sanshool,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C17827  Hydroxy-gamma-sanshool|Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amides|C17827  Hydroxy-gamma-sanshool,
C17828,Protojujuboside A,,,,,
C17829,Protojujuboside B,,,,,
C17830,Protojujuboside B1,,,,,
C17831,Jujuboside A,,,,,
C17832,Jujuboside B,,,,,
C17833,Jujuboside C,,,,,
C17834,Spinosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17834  Spinosin|Glycosides [BR:br08021]|C-glycosides|C17834  Spinosin,
C17835,Swertisin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17835  Swertisin|Glycosides [BR:br08021]|C-glycosides|C17835  Swertisin,
C17836,6''-Feruloylspinosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17836  6''-Feruloylspinosin,
C17837,Isospinosin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C17837  Isospinosin,
C17838,Visamminol,,,,,
C17839,Terrestriamide,,,,,
C17840,Dehydrozingerone,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1502 Alkyl catechols and derivatives|C17840  Dehydrozingerone,
C17841,Dahurinol,,,,,
C17842,Acerinol,,,,,
C17843,Norvisnagin,,,,,
C17844,(+)-Demethoxyaschantin,,,,,
C17845,(+)-Aschantin,,,,,
C17846,alpha-Asaron,,,,,
C17847,Magnosalin,,,,,
C17848,Biondinin A,,,,,
C17849,Biondinin B,,,,,
C17850,Biondinin C,,,,,
C17851,Biondinin D,Relative configuration,,,,
C17852,Biondinin E,,,,,
C17853,Senkyunolide,,,,,
C17854,Butylphthalide,,,,,
C17855,Coniferyl ferulate,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Monolignols|Coniferyl alcohol derivatives|C17855  Coniferyl ferulate,
C17856,Atractylodinol,,,,,
C17857,Acetylatractylodinol,,,,,
C17858,Atractyloside A,,,,,
C17859,Atractyloside B,,,,,
C17860,Atractyloside C,,,,,
C17861,Atractyloside D,,,,,
C17862,Atractyloside E,,,,,
C17863,Atractyloside F,,,,,
C17864,Atractyloside G,,,,,
C17865,Atractyloside H,,,,,
C17866,Atractyloside I,,,,,
C17867,Cyclomorusin,,,,,
C17868,Morusinol;|Oxyhydromorusin,,,,,
C17869,Sanggenon A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C17869  Sanggenon A,
C17870,Sanggenon B,,,,,
C17871,Sanggenon E,,,,,
C17872,Corynantheine,,,,,
C17873,2-Hydroxytetracosanoic acid,,,,,
C17874,Uncaric acid A,,,,,
C17875,Sedanonic acid lactone,,,,,
C17877,Dioxation,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C17877  Dioxation,
C17878,Eucommiol,,,,,
C17879,Nigakinone,,,,,
C17880,Cryptocyanin;|Cryptocyanine iodide,,,,Classification of Japanese OTC drugs [BR:br08313]|Other (not belonging to any other category)|85 Other (not belonging to any other category)|C17880  Cryptocyanin,
C17881,Zhebeinine,,,,,
C17882,Peiminoside,,,,,
C17883,4-Vinylguaiacol;|2-Methoxy-4-vinylphenol,,,,,
C17884,3beta-Hydroxyatractylon,,,,,
C17885,Atractylenolide I,,,,,
C17886,Atractylenolide II,,,,,
C17887,Atractylenolide III,,,,,
C17888,Eriojaposide A,,,,,
C17889,Eriojaposide B,,,,,
C17890,Euscaphic acid,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Ursanes|C17890  Euscaphic acid,
C17891,"Cryptogenin;|Kryptogenin;|(3beta,25R)-3,26-Dihydroxycholest-5-ene-16,22-dione",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C17891  Cryptogenin,
C17892,Arecatannin B1,,,,,
C17893,Arecatannin A2,,,,,
C17894,Arecatannin A1,,,,,
C17895,Arecatannin A3,,,,,
C17896,Arecatannin B2,,,,,
C17897,Arecatannin C1,,,,,
C17898,Sinactine,,,,,
C17899,Isosinomenine,,,,,
C17900,Menisdaurilide,,,,,
C17901,Simiarenol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010620 Neohopane, fernane, adianane and filicane triterpenoids|C17901  Simiarenol",
C17902,Ephedroxane,,,,,
C17903,(+)-N-Methylpseudoephedrine,,,,,
C17904,alpha-Allokainic acid,,,,,
C17905,Cannabisin A,,,,,
C17906,Cannabisin B,Relative configuration (including both enantiomers),,,,
C17907,Cannabisin C,Relative configuration,,,,
C17908,Cannabisin D,Relative configuration,,,,
C17909,Cannabisin E,Relative configuration,,,,
C17910,Cannabisin F,,,,,
C17911,Cannabisin G,,,,,
C17912,Isozaluzanin C,,,,,
C17913,Isodehydrocostus lactone,,,,,
C17914,Nootkatone,,,,,
C17915,Nootkatol,,,,,
C17916,Coixinden A,,,,,
C17917,Coixinden B,,,,,
C17918,Scabraside,,,,,
C17919,Rindoside,,,,,
C17920,Dihydroabietic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C17920  Dihydroabietic acid,
C17921,Scopoloside I,,,,,
C17922,Scopoloside II,,,,,
C17925,Nordephrine;|alpha-Methylnorepinephrine;|alpha-Methylnoradrenaline,,,,,
C17926,2-Pyridinemethanamine,,,,,
C17927,Thiazolylethylamine;|2-(2-Aminoethyl)thiazole,,,,,
C17928,2-Methylhistamine,,,,,
C17929,4-Methylhistamine,,,,,
C17930,Dimaprit,,,,,
C17931,Imetit,,,,,
C17932,Immepip,,,,,
C17933,Thioperamide,,,,,
C17934,Clobenpropit,,,,,
C17935,Cysteinyldopa;|5-S-Cysteinyl-DOPA,,,,,
C17937,Eumelanin,Eumelanin is a polymer that consists of repeating units of DHI and DHICA.|R = H or COOH,,,,
C17938,"5,6-Indolequinone-2-carboxylic acid",,,,,
C17939,10-Hydroxycamptothecin,,,,,
C17940,Rhizocticin B,,,,,
C17941,2-Oxo-4-phosphonobutanoate;|2-Oxo-4-phosphonobutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA00 Other Fatty Acyls|C17941  2-Oxo-4-phosphonobutanoic acid,
C17942,FR 900098;|(3-(Acetylhydroxyamino)propyl)phosphonic acid,,,,,
C17943,Formylphosphonate;|Phosphonoformaldehyde;|Formylphosphonic acid,,,,,
C17944,Rhizocticin A,,,,,
C17945,Phosphonoformyl-CMP;|CMP-5'-phosphonoformate,,,,,
C17946,Carboxyphosphonopyruvate,,,,,
C17947,2-Phosphinomethylmalate;|2-Phosphinomethylmalic acid;|2-(Hydrohydroxyphosphorylmethyl)malate,,,,,
C17948,Deamino-alpha-keto-demethylphosphinothricin;|4-(Hydroxyphosphinyl)-2-oxobutyric acid;|2-Oxo-4-phosphinobutanoate;|4-Hydrohydroxyphosphoryl-2-oxobutanoate,,,,,
C17949,N-Acetyldemethylphosphinothricin;|N-Adpt,,,,,
C17950,N-Acetyldemethylphosphinothricin tripeptide,,,,,
C17951,N-Acetylbialaphos;|N-Acetylphosphinothricin tripeptide,,,,,
C17952,N-Acetylphosphinothricin;|L-N-Acetylphosphinothricin;|N-Acetyl-L-glufosinate;|N-Acetylphinothricin,,,,,
C17953,(5S)-Albaflavenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010370 Zizaane and prezizaane sesquiterpenoids|C17953  (5S)-Albaflavenol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17953  (5S)-Albaflavenol,
C17954,Albaflavenone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010370 Zizaane and prezizaane sesquiterpenoids|C17954  Albaflavenone|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17954  Albaflavenone,
C17955,(5R)-Albaflavenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010370 Zizaane and prezizaane sesquiterpenoids|C17955  (5R)-Albaflavenol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C17955  (5R)-Albaflavenol,
C17956,Grandifloric acid,,,,,
C17957,Irigenin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C17957  Irigenin,
C17958,Irisflorentin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C17958  Irisflorentin,
C17959,alpha-L-Rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C17959  alpha-L-Rhamnosyl-(1->3)-alpha-D-galactosyl-diphosphoundecaprenol,
C17960,Rhizocticin C,,,,,
C17961,Rhizocticin D,,,,,
C17962,Demethylphosphinothricin;|(2S)-2-Amino-4-(hydroxyphosphinyl)butanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C17962  (2S)-2-Amino-4-(hydroxyphosphinyl)butanoic acid,
C17963,Colchicoside,,,,,
C17964,Pilocarpidine,,,,,
C17965,trans-Lachnophyllol,,,,,
C17966,Shionone;|Shionon,,,,,
C17967,Bluensidine,,,,,
C17968,Kasugamycin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Antibiotic fungicides|C17968  Kasugamycin,
C17969,Minosaminomycin,,,,,
C17970,Spenolimycin,,,,,
C17971,Fortimicin FU-10,,,,,
C17972,Fortimicin AO,,,,,
C17973,Fortimicin KL1,,,,,
C17974,Fortimicin KK1,,,,,
C17975,Fortimicin AP,,,,,
C17976,Fortimicin KH,,,,,
C17977,Fortimicin KR,,,,,
C17978,1-epi-Fortimicin B,,,,,
C17979,Formimidoyl-fortimicin A;|Dactimicin;|SF-2052,,,,,
C17980,1-Epidactimicin,,,,,
C17981,Istamycin FU-10,,,,,
C17982,Istamycin AO,,,,,
C17983,Istamycin KL1,,,,,
C17984,Istamycin AP,,,,,
C17985,Istamycin Y0,,,,,
C17986,Istamycin X0;|Sannamycin G,,,,,
C17987,Istamycin A1,,,,,
C17988,Istamycin A2,,,,,
C17989,Istamycin A3,,,,,
C17990,Istamycin B0,,,,,
C17991,Istamycin B,,,,,
C17992,Istamycin B1,,,,,
C17993,Istamycin B3,,,,,
C17994,Istamycin C0,,,,,
C17995,Istamycin C,,,,,
C17996,Istamycin C1,,,,,
C17997,Oxyapramycin,,,,,
C17998,Saccharocin;|KA-5685;|4''-Deamino-4''-hydroxyapramycin,,,,,
C17999,6-O-Glc-paromamine,,,,,
C18000,Nebramycin factor 4;|6''-O-Carbamoylkanamycin B,,,,,
C18001,Nebramycin 5';|Nebramycin factor 5';|6''-O-Carbamoyltobramycin,,,,,
C18002,5-Ribosylparomamine;|Ribosylparomamine,,,,,
C18003,Lividomycin B;|3'-Deoxyparomomycin I,,,,,
C18004,5''-Phosphoribostamycin,,,,,
C18005,gamma-L-Glutamyl-butirosin B,,,,,
C18006,gamma-L-Glutamyl-[acp];|gamma-L-Glutamyl-[acyl carrier protein];|gamma-L-Glutamyl-ACP,Generic compound in reaction hierarchy,,,,
C18007,4-Aminobutyryl-[acp];|4-Aminobutyryl-[acyl carrier protein];|GABA-ACP,Generic compound in reaction hierarchy,,,,
C18008,4-(gamma-L-Glutamylamino)butanoyl-[acp];|gamma-L-Glutamyl-4-aminobutyryl-[acp];|gamma-L-Glutamyl-4-aminobutyryl-[acyl carrier protein];|gamma-L-Glutamyl-4-aminobutyryl-ACP,,,,,
C18009,4-(gamma-L-Glutamylamino)-(2S)-2-hydroxybutanoyl-[acp];|gamma-L-Glutamyl-4-amino-2-hydroxybutyryl-[acp];|gamma-L-Glutamyl-4-amino-2-hydroxybutyryl-[acyl carrier protein];|gamma-L-Glutamyl-4-amino-2-hydroxybutyryl-ACP,,,,,
C18010,Deltorphin A;|Dermenkephalin,,Tyr D-Met Phe His Leu Met Asp-NH2,Peptide,,
C18011,"7-Hydroxy-6-methylhepta-3,5-dienal",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C18011  7-Hydroxy-6-methylhepta-3,5-dienal",
C18012,"Flaviolin;|2,5,7-Trihydroxy-1,4-naphthalenedione;|4,5,7-Trihydroxynaphthalene-1,2-dione",,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C18012  Flaviolin,
C18013,"3,3'-Biflaviolin;|3,3',6,6',8,8'-Hexahydroxy-2,2'-binaphthalene-1,1',4,4'-tetraone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C18013  3,3'-Biflaviolin",
C18014,"3,8'-Biflaviolin;|2,3',4,6',7,8'-Hexahydroxy-1,2'-binaphthalene-1',4',5,8-tetraone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C18014  3,8'-Biflaviolin",
C18015,Momilactone A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18015  Momilactone A,
C18016,"3beta-Hydroxy-9beta-pimara-7,15-diene-19,6beta-olide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18016  3beta-Hydroxy-9beta-pimara-7,15-diene-19,6beta-olide",
C18017,"1,6-Dihydrocarveol;|8-p-Menthen-2-ol;|6-Methyl-3-isopropenylcyclohexanol;|Menth-8-en-2-ol","Generic compound in reaction hierarchy|Eight stereoisomers|(1R,2R,4R) [CPD:C11396]|(1R,2R,4S) [CPD:C11411]|(1R,2S,4R) [CPD:C11397]|(1R,2S,4S) [CPD:C11410]|(1S,2R,4R) [CPD:C11400]|(1S,2R,4S) [CPD:C11416]|(1S,2S,4R) [CPD:C11399]|(1S,2S,4S) [CPD:C11413]",,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18017  1,6-Dihydrocarveol",
C18018,Dihydrocarvone;|p-Menth-8-en-2-one;|2-Methyl-5-(1-methylethenyl)cyclohexanone;|Menth-8-en-2-one,"Generic compound in reaction hierarchy|Four stereoisomers|(1R,4R) [CPD:C11398]|(1R,4S) [CPD:C11412]|(1S,4R) [CPD:C11401]|(1S,4S) [CPD:C11415]",,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18018  Dihydrocarvone,
C18019,1-Hydroxy-p-menth-8-en-2-one;|2-Hydroxy-2-methyl-5-(1-methylethenyl)cyclohexanone;|1-Hydroxymenth-8-en-2-one,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18019  1-Hydroxy-p-menth-8-en-2-one,
C18020,"p-Menth-8-ene-1,2-diol;|1-Methyl-4-(1-methylethenyl)-1,2-cyclohexanediol;|Menth-8-ene-1,2-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18020  p-Menth-8-ene-1,2-diol",
C18021,Pheophorbide a,,,,,
C18022,Red chlorophyll catabolite,,,,,
C18023,"Sophoraflavanone B;|Flavaprenin;|8-Prenylnaringenin;|(-)-(2S)-8-Dimethylallylnaringenin;|(-)-(2S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C18023  Sophoraflavanone B|Dietary phytochemicals [br08012.html]|Flavonoids|C18023,
C18024,"Leachianone G;|(-)-(2S)-2'-Hydroxy-8-dimethylallylnaringenin;|(-)-(2S)-5,7-Dihydroxy-8-(2-hydroxy-3-methylbut-2-enyl)-2-(4-hydroxyphenyl)chroman-4-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C18024  Leachianone G,
C18025,(+)-Menthofuran;|(R)-Menthofuran,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18025  (+)-Menthofuran,
C18026,(2S)-Ethylmalonyl-CoA;|(S)-Ethylmalonyl-CoA;|Ethylmalonyl-CoA;|Ethylmalonyl coenzyme A,,,,,
C18027,"(4R,7S)-7-Isopropyl-4-methyloxepan-2-one;|(4R,7S)-4-Methyl-7-(1-methylethyl)-2-oxepanone;|Mentholactone",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18027  (4R,7S)-7-Isopropyl-4-methyloxepan-2-one",
C18028,"L-Fucono-1,5-lactone",,,,,
C18029,"dTDP-3-oxo-2,6-dideoxy-D-glucose;|dTDP-(2,6-dideoxy-alpha-D-erythro-hexopyranos-3-ulos-1-yl) ester",,,,,
C18030,"dTDP-2,6-dideoxy-D-kanosamine;|dTDP-(3-amino-2,3,6-trideoxy-alpha-D-arabino-hexopyranosyl) ester",,,,,
C18031,dTDP-D-angolosamine,,,,,
C18032,"dTDP-4-oxo-2,3,6-trideoxy-D-glucose;|dTDP-[(2R,6R)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl] ester;|dTDP-4-dehydro-2,3,6-trideoxy-alpha-D-hexopyranose",,,,,
C18033,"dTDP-4-amino-2,3,4,6-tetradeoxy-D-glucose;|dTDP-[(2R,5S,6R)-5-aminotetrahydro-6-methyl-2H-pyran-2-yl] ester;|dTDP-4-amino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose",,,,,
C18034,"dTDP-D-forosamine;|dTDP-alpha-D-forosamine;|dTDP-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl] ester;|dTDP-4-(dimethylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose",,,,,
C18035,"dTDP-3-methyl-4-oxo-2,6-dideoxy-D-glucose;|dTDP-(2,6-dideoxy-3-C-methyl-alpha-D-threo-hexopyranos-4-ulos-1-yl) ester",,,,,
C18036,Strigolactone ABC-rings,,,,,
C18037,5-Deoxystrigol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C18037  5-Deoxystrigol,
C18038,"7alpha-Hydroxypregnenolone;|3beta,7alpha-Dihydroxy-5-pregnen-20-one",,,,,
C18039,"Aldosterone hemiacetal;|11beta,18-Epoxy-18,21-dihydroxypregn-4-ene-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C18039  Aldosterone hemiacetal",
C18040,"5alpha-Dihydrodeoxycorticosterone;|5alpha-Pregnan-21-ol-3,20-dione;|Allopregnane-21-ol-3,20-dione",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C18040  5alpha-Dihydrodeoxycorticosterone",
C18041,5alpha-Pregnan-20alpha-ol-3-one;|Allopregnan-20alpha-ol-3-one,,,,,
C18042,"5alpha-Pregnane-3alpha,20alpha-diol;|Allopregnane-3alpha,20alpha-diol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0203 C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives|C18042  5alpha-Pregnane-3alpha,20alpha-diol",
C18043,Cholesterol sulfate;|Cholest-5-en-3beta-ol sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0502 Sulfates|C18043  Cholesterol sulfate,
C18044,3beta-Hydroxypregn-5-en-20-one sulfate;|Pregnenolone sulfate,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST05 Steroid conjugates|ST0502 Sulfates|C18044  3beta-Hydroxypregn-5-en-20-one sulfate,
C18045,"7alpha-Hydroxydehydroepiandrosterone;|7alpha-OH-DHEA;|3beta,7alpha-Dihydroxy-5-androstene-17-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST02 Steroids|ST0202 C19 steroids (androgens) and derivatives|C18045  7alpha-Hydroxydehydroepiandrosterone,
C18046,Biotinyl-[protein];|Biotin protein of malonate decarboxylase,Generic compound in reaction hierarchy,,,,
C18047,Carboxybiotinyl-[protein],Generic compound in reaction hierarchy,,,,
C18048,N-Succinyl-L-citrulline,,,,,
C18049,N-Acyl-L-homoserine lactone,Generic compound in reaction hierarchy,,,,
C18050,beta-D-Fructofuranosyl-alpha-D-mannopyranoside 6F-phosphate;|Mannosylfructose 6-phosphate,,,,,
C18051,Chrysanthemyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010206 Cyclopropane and cyclobutane monoterpenoids|C18051  Chrysanthemyl diphosphate,
C18052,Lavandulyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C18052  Lavandulyl diphosphate,
C18053,Sophoraflavanone G,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1214 Flavanones|C18053  Sophoraflavanone G,
C18054,"2-Amino-2-deoxyisochorismate;|(2S)-2-Amino-4-deoxychorismate;|(2S,3S)-3-(1-Carboxyvinyloxy)-2,3-dihydroanthranilate",,,,,
C18055,N-Acetyl-alpha-D-hexosamine 1-phosphate,Generic compound in reaction hierarchy,,,,
C18056,N-Desmethylzolmitriptan;|183C91,,,,,
C18059,"CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP13 CDP-Glycerols|GP1304 CDP-Dialkylglycerols|C18059  CDP-2,3-bis-(O-geranylgeranyl)-sn-glycerol",
C18060,N-Acetyl-alpha-D-galactosamine 1-phosphate,,,,,
C18061,N-Acyl-L-homoserine,Generic compound in reaction hierarchy,,,,
C18062,"TRIBOA-glucoside;|2,4,7-Trihydroxy-1,4-benzoxazin-3-one-glucoside;|2,4,7-Trihydroxy-2H-1,4-benzoxazin-3(4H)-one-glucoside;|(2R)-4,7-Dihydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-2-yl beta-D-glucopyranoside",,,,,
C18063,C-13(2)-Carboxypyropheophorbide a;|C-13(2)-Carboxylpyropheophorbide a,,,,,
C18064,Pyropheophorbide a,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C18064  Pyropheophorbide a,
C18066,7-Isopropyl-4-methyloxepan-2-one,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C18066  7-Isopropyl-4-methyloxepan-2-one,
C18067,"6-Hydroxy-3,7-dimethyloctanoate;|6-Hydroxy-3,7-dimethyloctanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C18067  6-Hydroxy-3,7-dimethyloctanoic acid",
C18068,beta-D-Fructofuranosyl-alpha-D-mannopyranoside;|Mannosylfructose,,,,,
C18069,"N1,N5,N10-Tricoumaroyl spermidine",,,,,
C18070,"N1,N5,N10-Tricaffeoyl spermidine",,,,,
C18071,"N1,N5,N10-Triferuloyl spermidine",,,,,
C18072,"N1,N5,N10-Tri(hydroxyferuloyl) spermidine",,,,,
C18073,"N1,N5-Di(hydroxyferuloyl)-N10-sinapoyl spermidine",,,,,
C18075,"11beta,17beta-Dihydroxy-4-androsten-3-one;|11beta-Hydroxytestosterone",,,,,
C18076,5'-Phosphoguanylyl(3'->5')guanosine,,,,,
C18077,Methylenedioxycinnamic acid;|MDCA,,,,,
C18078,Ayapin,,,,,
C18079,Isoscopoletin,,,,,
C18080,Osthenol,,,,,
C18081,Sphondin,,,,,
C18082,Isobergapten,,,,,
C18083,Demethylsuberosin;|7-Demethylsuberosin,,,,,
C18084,Isobergaptol,,,,,
C18085,6-Hydroxyangelicin;|Heratomol,,,,,
C18086,2'-Hydroxy caffeic acid,Generic compound|R = CO2H or CO-SCoA,,,,
C18087,2'-Hydroxyferulic acid,Generic compound|R = CO2H or CO-SCoA,,,,
C18088,2'-Hydroxy-MDCA,Generic compound|R = CO2H or CO-SCoA,,,,
C18089,"2',4'-Dihydroxycinnamic acid",Generic compound|R = CO2H or CO-SCoA,,,,
C18090,Tricaine;|3-Aminobenzoic acid;|m-Aminobenzoate,,,,,
C18091,Ethylnitronate,,,,,
C18092,"dTDP-L-ristosamine;|dTDP-3-amino-2,3,6-trideoxy-L-allose;|dTDP-3-amino-2,3,6-trideoxy-L-ribo-hexose",,,,,
C18093,Iopodic acid,,,,,
C18094,UDP-L-arabinofuranose;|UDP-beta-L-arabinofuranose,,,,,
C18095,Deltorphin B;|Deltorphin II,,,,,
C18096,D-Allulose 6-phosphate,,,,,
C18097,Deltorphin C;|Deltorphin I,,,,,
C18098,Primary fluorescent chlorophyll catabolite,,,,,
C18099,"1,2,3,7,8-Pentachlorodibenzodioxin;|1,2,3,7,8-Pentachlorodibenzo-p-dioxin;|1,2,3,7,8-PeCDD;|PCDD 54",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18099  1,2,3,7,8-Pentachlorodibenzodioxin (PCDD 54)",
C18100,"1,2,3,4,7,8-Hexachlorodibenzodioxin;|1,2,3,4,7,8-Hexachlorodibenzo-p-dioxin;|1,2,3,4,7,8-HxCDD;|PCDD 66",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18100  1,2,3,4,7,8-Hexachlorodibenzodioxin (PCDD 66)",
C18101,"1,2,3,6,7,8-Hexachlorodibenzodioxin;|1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin;|1,2,3,6,7,8-HxCDD;|PCDD 67",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18101  1,2,3,6,7,8-Hexachlorodibenzodioxin (PCDD 67)",
C18102,"1,2,3,7,8,9-Hexachlorodibenzodioxin;|1,2,3,7,8,9-Hexachlorodibenzo-p-dioxin;|1,2,3,7,8,9-HxCDD;|PCDD 70",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18102  1,2,3,7,8,9-Hexachlorodibenzodioxin (PCDD 70)",
C18103,"1,2,3,4,6,7,8-Heptachlorodibenzodioxin;|1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin;|1,2,3,4,6,7,8-HpCDD;|PCDD 73",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18103  1,2,3,4,6,7,8-Heptachlorodibenzodioxin (PCDD 73)",
C18104,"2,3,7,8-Tetrachlorodibenzofuran;|2,3,7,8-TCDF;|PCDF 83",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18104  2,3,7,8-Tetrachlorodibenzofuran (PCDF 83)",
C18105,"1,2,3,7,8-Pentachlorodibenzofuran;|1,2,3,7,8-PeCDF;|PCDF 94",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18105  1,2,3,7,8-Pentachlorodibenzofuran (PCDF 94)",
C18106,"2,3,4,7,8-Pentachlorodibenzofuran;|2,3,4,7,8-PeCDF;|PCDF 114",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18106  2,3,4,7,8-Pentachlorodibenzofuran (PCDF 114)",
C18107,"1,2,3,4,7,8-Hexachlorodibenzofuran;|1,2,3,4,7,8-HxCDF;|PCDF 118",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18107  1,2,3,4,7,8-Hexachlorodibenzofuran (PCDF 118)",
C18108,"1,2,3,7,8,9-Hexachlorodibenzofuran;|1,2,3,7,8,9-HxCDF;|PCDF 124",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18108  1,2,3,7,8,9-Hexachlorodibenzofuran (PCDF 124)",
C18109,"1,2,3,6,7,8-Hexachlorodibenzofuran;|1,2,3,6,7,8-HxCDF;|PCDF 121",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18109  1,2,3,6,7,8-Hexachlorodibenzofuran (PCDF 121)",
C18110,"2,3,4,6,7,8-Hexachlorodibenzofuran;|2,3,4,6,7,8-HxCDF;|PCDF 130",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18110  2,3,4,6,7,8-Hexachlorodibenzofuran (PCDF 130)",
C18111,"1,2,3,4,6,7,8-Heptachlorodibenzofuran;|1,2,3,4,6,7,8-HpCDF;|PCDF 131",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18111  1,2,3,4,6,7,8-Heptachlorodibenzofuran (PCDF 131)",
C18112,"1,2,3,4,7,8,9-Heptachlorodibenzofuran;|1,2,3,4,7,8,9-HpCDF;|PCDF 134",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18112  1,2,3,4,7,8,9-Heptachlorodibenzofuran (PCDF 134)",
C18113,"1,2,3,4,6,7,8,9-Octachlorodibenzofuran;|Octachlorodibenzofuran;|OCDF;|PCDF 135",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDFs|C18113  1,2,3,4,6,7,8,9-Octachlorodibenzofuran (PCDF 135)",
C18114,"3,4,4',5-Tetrachlorobiphenyl;|PCB 81",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Non-ortho (coplanar) PCBs|C18114  3,4,4',5-Tetrachlorobiphenyl (PDB 81)",
C18115,"3,4,5,3',4',5'-Hexachlorobiphenyl;|PCB 169",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Non-ortho (coplanar) PCBs|C18115  3,4,5,3',4',5'-Hexachlorobiphenyl (PCB 169)",
C18116,"2,3,4,3',4'-Pentachlorobiphenyl;|PCB 105",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18116  2,3,4,3',4'-Pentachlorobiphenyl (PCB 105)",
C18117,"2,3,4,4',5-Pentachlorobiphenyl;|PCB 114",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18117  2,3,4,4',5-Pentachlorobiphenyl (PCB 114)",
C18118,"2,3',4,4',5-Pentachlorobiphenyl;|PCB 118",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18118  2,3',4,4',5-Pentachlorobiphenyl (PCB 118)",
C18119,"2,3',4,4',5'-Pentachlorobiphenyl;|PCB 123",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18119  2,3',4,4',5'-Pentachlorobiphenyl (PCB 123)",
C18120,"2,3,3',4,4',5-Hexachlorobiphenyl;|PCB 156",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18120  2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156)",
C18121,"2,3,3',4,4',5'-Hexachlorobiphenyl;|PCB 157",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18121  2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157)",
C18122,"2,3',4,4',5,5'-Hexachlorobiphenyl;|PCB 167",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18122  2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167)",
C18123,"2,3,3',4,4',5,5'-Heptachlorobiphenyl;|PCB 189",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|Mono-ortho PCBs|C18123  2,3,3',4,4',5,5'-Heptachlorobiphenyl (PCB 189)",
C18124,Endrin,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C18124  Endrin|Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18124  Endrin,
C18125,1-Acyl-sn-glycero-3-phosphoserine;|1-Acyl-2-lyso-phosphatidylserine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP03 Glycerophosphoserines|GP0305 Monoacylglycerophosphoserines|C18125  1-Acyl-sn-glycero-3-phosphoserine,
C18126,1-Acyl-sn-glycero-3-phosphoglycerol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP04 Glycerophosphoglycerols|GP0405 Monoacylglycerophosphoglycerols|C18126  1-Acyl-sn-glycero-3-phosphoglycerol,
C18127,beta-Funaltrexamine;|beta-FNA,,,,,
C18128,Naltrindole;|NTI,,,,,
C18129,Monolysocardiolipin;|MLCL,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP12 Glycerophosphoglycerophosphoglycerols|GP1202 Diacylglycerophosphoglycerophosphomonoradylglycerols|C18129  Monolysocardiolipin,
C18130,Norbinaltorphimine;|norBNI,,,,,
C18131,Geranyl-hydroxybenzoate,,,,,
C18132,3''-Hydroxy-geranylhydroquinone;|3''-Hydroxygeranylhydroquinone,,,,,
C18133,Deoxyshikonin,,,,,
C18134,Dihydroechinofuran,,,,,
C18135,Dihydroshikonofuran,,,,,
C18136,2''-Adenylylgentamicin A,,,,,
C18137,"2,2',4,4',5,5'-Hexabromodiphenyl ether;|BDE 153",,,,,
C18138,"2,2',4,4',5,6'-Hexabromodiphenyl ether;|PBDE 154;|BDE 154",,,,"Endocrine disrupting compounds [BR:br08006]|Flame retardants|PBDEs|C18138  2,2',4,4',5,6'-Hexabromodiphenyl ether (PBDE 154)",
C18139,"2,2',3,3',4',5,6'-Heptabromodiphenyl ether;|1,2,3,5-Tetrabromo-4-(2,3,5-tribromophenoxy)-benzene;|BDE 175",,,,,
C18140,"2,2',3,4,4',5',6-Heptabromodiphenyl ether;|1,2,3,5-Tetrabromo-4-(2,4,5-tribromophenoxy)-benzene;|BDE 183",,,,,
C18141,"Pentachlorobenzene;|1,2,3,4,5-Pentachlorobenzene;|PCB",,,,,
C18142,Perfluorooctanesulfonic acid;|Perfluorooctylsulfonic acid;|PFOS,,,,,
C18143,Perfluorooctylsulfonyl fluoride,,,,,
C18145,trans-Nonachlor,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C18145  trans-Nonachlor,
C18146,Oxychlordane,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Organochlorine pesticides|C18146  Oxychlordane,
C18147,Esfenvalerate,,,,Endocrine disrupting compounds [BR:br08006]|Pesticides and herbicides|Pyrethroid pesticides|C18147  Esfenvalerate|Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18147  Esfenvalerate,
C18148,Octachlorostyrene,,,,Endocrine disrupting compounds [BR:br08006]|Plasticizers and plastics|Styrenes|C18148  Octachlorostyrene,
C18149,Tributyltin oxide;|TBTO,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18149  Tributyltin oxide,
C18150,n-Butylbenzene,,,,,
C18151,7(1)-Hydroxychlorophyll a;|7-Hydroxymethylchlorophyll a,,,,,
C18152,3-Vinylbacteriochlorophyllide a;|3-Deacetyl-3-vinylbacteriochlorophyllide a,,,,,
C18153,3-Hydroxyethylbacteriochlorophyllide a;|3-Deacetyl-3-(1-hydroxyethyl)bacteriochlorophyllide a,,,,,
C18154,3-Hydroxyethylchlorophyllide a;|3-Devinyl-3-(1-hydroxyethyl)chlorophyllide a,,,,,
C18155,Bacteriochlorophyllide a,,,,,
C18156,Bacteriochlorophyllide b,,,,,
C18157,8-Ethyl-12-methyl-3-vinylbacteriochlorophyllide d,,,,,
C18158,17-Oxosparteine,,,,,
C18160,Bacteriochlorophyllide d,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C18161,Bacteriochlorophyllide c,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C18162,Bacteriochlorophyll d,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C18163,Bacteriochlorophyll c,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C18164,Deoxymiroestrol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Others|C18164  Deoxymiroestrol,
C18165,Enterolactone,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C18165,
C18166,Enterodiol,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C18166,
C18167,Secoisolariciresinol;|(-)-Secoisolariciresinol,(+)-Secoisolariciresinol [CPD:C20456],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C18167  (-)-Secoisolariciresinol|Dietary phytochemicals [br08012.html]|Other phytochemicals|C18167,
C18168,Diacylglycerylhomoserine;|DGHS,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GL  Glycerolipids|GL00 Other Glycerolipids|C18168  Diacylglycerylhomoserine,
C18169,"Diacylglyceryl-N,N,N-trimethylhomoserine;|DGTS",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL00 Other Glycerolipids|C18169  Diacylglyceryl-N,N,N-trimethylhomoserine",
C18170,3-Acetamidopropanal,,,,,
C18171,"Resolvin E1;|5S,12R,18R-Trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0314 Resolvin Es|C18171  Resolvin E1,
C18172,Carboxyspermidine;|2-Amino-4-[(4-aminobutyl)amino]-butanoic acid,,,,,
C18173,"Resolvin E2;|5S,18R-Dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0314 Resolvin Es|C18173  Resolvin E2,
C18174,Carboxynorspermidine,,,,,
C18175,"5,6-Epoxy-18R-HEPE;|5,6-Epoxy,18R-hydroxy-7E,9E,11Z,14Z,16E-eicosapentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids|C18175  5,6-Epoxy-18R-HEPE",
C18176,"5S-Hydroperoxy-18R-HEPE;|5S-Hydroperoxy-18R-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids|C18176  5S-Hydroperoxy-18R-HEPE,
C18177,"18R-HEPE;|18R-Hydroxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA03 Eicosanoids|FA0307 Hydroxy/hydroperoxyeicosapentaenoic acids|C18177  18R-HEPE,
C18178,"Resolvin D1;|7S,8R,17S-Trihydroxydocosa-4Z,9E,11E,13Z,15E,19Z-hexaenoic acid",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA04 Docosanoids|FA0403 Resolvin Ds|C18178  Resolvin D1,
C18179,Resolvin D2,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA04 Docosanoids|FA0403 Resolvin Ds|C18179  Resolvin D2,
C18180,"1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin;|Octachlorodibenzo-p-dioxin;|OCDD;|PCDD 75",,,,"Endocrine disrupting compounds [BR:br08006]|Dioxins and dioxin-like compounds|PCDDs|C18180  1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin (PCDD 75)",
C18191,13-Sophorosyloxydocosanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA13 Fatty acyl glycosides|FA1302 Sophorolipids|C18191  13-Sophorosyloxydocosanoic acid,
C18192,"Vitamin D4;|22-Dihydroergocalciferol;|(5Z,7E)-(3S)-9,10-Seco-5,7,10(19)-ergostatrien-3-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0303 Vitamin D4 and derivatives|C18192  Vitamin D4,
C18193,"Vitamin D5;|(5Z,7E)-9,10-Secostigmasta-5,7,10(19)-trien-3beta-ol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0304 Vitamin D5 and derivatives|C18193  Vitamin D5,
C18195,(3R)-11-cis-3-Hydroxyretinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C18195  (3R)-11-cis-3-Hydroxyretinal,
C18196,(3R)-all-trans-3-Hydroxyretinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C18196  (3R)-all-trans-3-Hydroxyretinal,
C18202,8-Methyl-6-nonenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C18202  8-Methyl-6-nonenoic acid,
C18203,"2,2',4,4',5-Pentabromodiphenyl ether;|PBDE 99;|BDE 99",,,,"Endocrine disrupting compounds [BR:br08006]|Flame retardants|PBDEs|C18203  2,2',4,4',5-Pentabromodiphenyl ether (PBDE 99)",
C18204,"2,2',4,5'-Tetrabromodiphenyl ether;|PBDE 49;|BDE 49",,,,"Endocrine disrupting compounds [BR:br08006]|Flame retardants|PBDEs|C18204  2,2',4,5'-Tetrabromodiphenyl ether (PBDE 49)",
C18205,"2,2',4,4'-Tetrabromodiphenyl ether;|PBDE 47;|BDE 47",,,,"Endocrine disrupting compounds [BR:br08006]|Flame retardants|PBDEs|C18205  2,2',4,4'-Tetrabromodiphenyl ether (PBDE 47)",
C18206,cis-11-Methyl-2-dodecenoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C18206  cis-11-Methyl-2-dodecenoic acid,
C18211,"Isopimara-7,15-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18211  Isopimara-7,15-diene",
C18212,Jamaicamide A,,,,,
C18213,Jamaicamide B,,,,,
C18214,Jamaicamide C,,,,,
C18215,Bis(4-hydroxyphenyl)methanol,,,,,
C18216,4-Hydroxyphenyl-4-hydroxybenzoate,,,,,
C18217,16-Feruloyloxypalmitate;|16-Feruloyloxypalmitic acid,,,,,
C18218,16-Hydroxypalmitate;|16-Hydroxypalmitic acid;|16-Hydroxyhexadecanoic acid;|Juniperic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C18218  16-Hydroxyhexadecanoic acid,
C18219,Palustradienol,,,,,
C18220,Palustradienal,,,,,
C18221,Isopimaradienol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18221  Isopimaradienol,
C18222,Isopimaradienal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18222  Isopimaradienal,
C18223,Stemar-13-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C18223  Stemar-13-ene,
C18224,Stemod-13(17)-ene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C18224  Stemod-13(17)-ene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18224,
C18225,"9beta-Pimara-7,15-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18225  9beta-Pimara-7,15-diene",
C18226,"ent-Cassa-12,15-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010412 Podocarpane diterpenoids|C18226  ent-Cassa-12,15-diene",
C18228,"ent-Pimara-8(14),15-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C18228  ent-Pimara-8(14),15-diene",
C18229,"Fusicocca-2,10(14)-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010435 Fusicoccane diterpenoids|C18229  Fusicocca-2,10(14)-diene",
C18230,Calcitroic acid,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C18230  Calcitroic acid,
C18231,"Calcitetrol;|1alpha,24R,25-Trihydroxyvitamin D3;|(1S,3R,5Z,7E,24R,25)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24,25-tetrol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST03 Secosteroids|ST0302 Vitamin D3 and derivatives|C18231  Calcitetrol,
C18232,N-Formylmaleamic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C18232  N-Formylmaleamic acid,
C18235,S-(Hydroxymethyl)mycothiol,,,,,
C18236,"1,2,3,4-Tetrachlorobenzene",,,,,
C18237,Molybdoenzyme molybdenum cofactor;|Molybdenum cofactor,,,,Compounds with biological roles [BR:br08001]|Vitamins and cofactors|Cofactors|Coenzymes|C18237  Molybdenum cofactor,
C18238,cis-Chlorobenzene dihydrodiol,,,,,
C18239,Precursor Z;|Cyclic pyranopterin monophosphate;|Cyclic pyranopterin phosphate;|cPMP,,,,,
C18240,"Tetrachlorocatechol;|Tetrachloro-1,2-benzenediol",,,,,
C18241,"Tetrachloro-cis,cis-muconate;|Tetrachloro-cis,cis-muconic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C18241  Tetrachloro-cis,cis-muconic acid",
C18242,"2,3,5-Trichlorodienelactone",,,,,
C18243,"2,3,5-Trichloromaleylacetate",,,,,
C18244,"2,4-Dichloro-3-oxoadipate",,,,,
C18245,8-epi-Cedrol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010369 Cedrane and isocedrane sesquiterpenoids|C18245  8-epi-Cedrol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C18245  8-epi-Cedrol,
C18246,"1,1,1-Trichloroethane;|Methylchloroform",,,,,
C18247,"1,1-Dichloroethane",,,,,
C18248,Chloroethane;|Ethyl chloride,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04088)]|N NERVOUS SYSTEM|N01 ANESTHETICS|N01B ANESTHETICS, LOCAL|N01BX Other local anesthetics|N01BX01 Ethyl chloride|D04088  Ethyl chloride (USP)|Drug groups [BR:br08330(D04088)]|Neuropsychiatric agent|DG02030  Anesthetics|DG01675  Local anesthetic|D04088  Ethyl chloride",
C18249,"cis-4,5-Dihydroxy-4,5-dihydropyrene;|cis-4,5-Dihydro-4,5-pyrenediol",,,,,
C18250,"4,5-Dihydroxypyrene",,,,,
C18251,"Pyrene-4,5-dione;|4,5-Pyrenequinone",,,,,
C18252,"Phenanthrene-4,5-dicarboxylate",,,,,
C18253,Phenanthrene-4-carboxylate;|4-Phenanthroic acid,,,,,
C18254,"Pyrene-4,5-oxide;|Pyrene-4,5-epoxide",,,,,
C18255,"trans-4,5-Dihydroxy-4,5-dihydropyrene;|trans-4,5-Pyrenedihydrodiol",,,,,
C18256,"cis-3,4-Phenanthrenedihydrodiol-4-carboxylate",,,,,
C18257,"Pyrene-1,6-dione;|1,6-Pyrenequinone",,,,,
C18258,"Pyrene-1,8-dione;|1,8-Pyrenequinone",,,,,
C18259,1-Methoxypyrene,,,,,
C18260,"1,6-Dimethoxypyrene",,,,,
C18261,1-Hydroxy-6-methoxypyrene;|6-Methoxy-1-pyrenol,,,,,
C18262,"1-Methoxypyrene-6,7-oxide",,,,,
C18263,"1,6-Dihydroxypyrene;|1,6-Pyrenediol",,,,,
C18264,"1,8-Dihydroxypyrene;|1,8-Pyrenediol",,,,,
C18265,"1-Hydroxypyrene-6,7-oxide",,,,,
C18266,"1-Hydroxypyrene-7,8-oxide",,,,,
C18267,"Pyrene-1,2-oxide",,,,,
C18268,2-Hydroxypyrene;|2-Pyrenol,,,,,
C18269,1-Pyrenylsulfate,,,,,
C18270,"Benzo[a]pyrene-cis-4,5-dihydrodiol",,,,,
C18271,cis-4-(7-Hydroxtpyren-8-yl)-2-oxobut-3-enoate,,,,,
C18272,cis-4-(8-Hydroxypyren-7-yl)-2-oxobut-3-enoate,,,,,
C18273,"7,8-Dihydropyrene-8-carboxylate;|1,2-Dihydropyrene-1-carboxylate",,,,,
C18274,"7,8-Dihydropyrene-7-carboxylate;|1,2-Dihydropyrene-2-carboxylate",,,,,
C18275,"Benzo[a]pyrene-cis-7,8-dihydrodiol",,,,,
C18276,"Benzo[a]pyrene-cis-9,10-dihydrodiol",,,,,
C18277,"4,5-Chrysenedicarboxylate",,,,,
C18278,"9,10-Dihydroxybenzo[a]pyrene;|Benzo[a]pyrene-9,10-diol",,,,,
C18279,"4,5-Dihydroxybenzo[a]pyrene;|Benzo[a]pyrene-4,5-diol",,,,,
C18280,"11,12-Dihydroxybenzo[a]pyrene;|Benzo[a]pyrene-11,12-diol",,,,,
C18281,"10-Oxabenzo[def]chrysen-9-one;|9H-Pyreno[1,2-b]pyran-9-one",,,,,
C18282,5-Chrysenecarboxylate,,,,,
C18283,4-Chrysenecarboxylate,,,,,
C18284,"Benzo[a]pyrene-cis-11,12-dihydrodiol",,,,,
C18285,"Benzo[a]pyrene-trans-11,12-dihydrodiol",,,,,
C18286,"Benzo[a]pyrene-11,12-epoxide",,,,,
C18293,Nonaketamide monocyclic intermediate,Generic compound in reaction hierarchy,,,,
C18294,Nonaketamide tricyclic intermediate,Generic compound in reaction hierarchy,,,,
C18295,Pretetramid;|Pretetramide,,,,,
C18296,"5a,11a-Dehydrooxytetracycline",,,,"Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C18296  5a,11a-Dehydrooxytetracycline",
C18297,Anhydrochlortetracycline;|Anhydro-7-chlorotetracycline,,,,,
C18298,"5a,11a-Dehydrochlortetracycline;|Dehydrochlortetracycline;|5a,11a-Dehydro-7-chlorotetracycline",,,,,
C18299,4-Aminoanhydrochlortetracycline;|4-Aminoanhydro-7-chlorotetracycline,,,,,
C18300,"2,4-Dichlorotoluene",,,,,
C18301,"4,6-Dichloro-3-methyl-cis-1,2-dihydroxycyclohexa-3,5-diene",,,,,
C18302,"4,6-Dichloro-3-methylcatechol",,,,,
C18303,"3,5-Dichloro-2-methylmuconate",,,,,
C18304,2-Chloro-5-methyl-cis-dienelactone,,,,,
C18305,2-Chloro-5-methylmaleylacetate,,,,,
C18306,5-Methylmaleylacetate,,,,,
C18307,2-Methyl-3-oxoadipate,,,,,
C18308,"3,5-Dichloro-2-methylmuconolactone",,,,,
C18309,3-Chloro-2-methyldienelactone,,,,,
C18310,3-Chloro-2-methylmaleylacetate,,,,,
C18311,4-Methyl-3-oxoadipate-enol-lactone,,,,,
C18312,4-Methyl-3-oxoadipate,,,,,
C18314,"Phthalate 3,4-cis-dihydrodiol",,,,,
C18315,4-Methyl-5-nitrocatechol,,,,,
C18316,"2-Hydroxy-5-methylquinone;|2-Hydroxy-5-methyl-1,4-benzoquinone",,,,,
C18317,"2,4,5-Trihydroxytoluene",,,,,
C18318,"cis,cis-2,4-Dihydroxy-5-methyl-6-oxo-2,4-hexadienoate",,,,,
C18319,2-Methylbutyrate;|2-Methylbutyric acid;|2-Methylbutanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0102 Branched fatty acids|C18319  2-Methylbutanoic acid,
C18320,4-Amino-2-nitrotoluene,,,,,
C18321,"trans,octacis-Decaprenyl diphosphate;|(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-Decaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C18321  trans,octacis-Decaprenyl diphosphate",
C18323,3-Methylfumaryl-CoA;|(E)-3-Carboxybut-2-enoyl-CoA;|Mesaconyl-C4-CoA,,,,,
C18324,(2S)-Methylsuccinyl-CoA;|Methylsuccinyl-CoA;|Methylsuccinyl-coenzyme A,,,,,
C18325,Feruloylagmatine,,,,,
C18326,p-Coumaroylputrescine,,,,,
C18327,"7,9,12-Octaketide intermediate 1",Generic compound in reaction hierarchy,,,,
C18328,"7,9,12-Octaketide intermediate 2",Generic compound in reaction hierarchy,,,,
C18329,"7,9,12-Octaketide intermediate 3",Generic compound in reaction hierarchy,,,,
C18330,"7,9,12-Decaketide intermediate 1",Generic compound in reaction hierarchy,,,,
C18331,"7,9,12-Decaketide intermediate 2",Generic compound in reaction hierarchy,,,,
C18332,"7,9,12-Decaketide intermediate 3",Generic compound in reaction hierarchy,,,,
C18333,"7,9,12-Decaketide intermediate 4",Generic compound in reaction hierarchy,,,,
C18334,"7,9,12-Decaketide intermediate 5",Generic compound in reaction hierarchy,,,,
C18335,"7,9,12-Decaketide intermediate 6",Generic compound in reaction hierarchy,,,,
C18336,"7,12-Decaketide intermediate 1",Generic compound in reaction hierarchy,,,,
C18337,"9,14-Decaketide intermediate 1",Generic compound in reaction hierarchy,,,,
C18338,"5-Carboxyvanillic acid;|5-Carboxyvanillate;|4-Hydroxy-5-methoxy-1,3-benzenedicarboxylate;|4-Hydroxy-5-methoxyisophthalate",,,,,
C18339,L-Ascorbic acid-2-glucoside;|AA-2G,,,,,
C18340,Magnesium L-ascorbic acid-2-phosphate;|VC-PMG;|AP,,,,,
C18341,Sodium L-ascorbic acid 2-phosphate;|VCP-NA,,,,,
C18342,3-O-Ethyl-L-ascorbic acid;|L-Ascorbic acid ethyl ester,,,,,
C18343,4-Butylresorcinol;|4-n-Butylresorcinol;|Rucinol (TN),,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C18343  4-Butylresorcinol,
C18344,Adenosine 5'-phosphate disodium,,,,,
C18345,"4-Carboxy-2-hydroxy-6-methoxy-6-oxohexa-2,4-dienoate",,,,,
C18346,4-Methoxy potassium salicylate;|4MSK,,,,,
C18347,"5,5'-Dehydrodivanillate",,,,,
C18348,"2,2',3-Trihydroxy-3'-methoxy-5,5'-dicarboxybiphenyl",,,,,
C18349,4-[2-(5-Carboxy-2-hydroxy-3-methoxyphenyl)-2-oxoethylidene]-2-hydroxy-2-pentenedioate,,,,,
C18350,Asulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18350  Asulam,
C18351,"4-Aminocatechol;|4-Amino-1,2-benzenediol;|3,4-Dihydroxyaniline",,,,,
C18352,Oxocamphor;|10-Oxocamphor;|beta-Oxocamphor,,,,"Animal drugs in Japan [BR:br08331]|92  Agents affecting circulatory organs, respiratory organs and urinary organs|921  Cardiotonics|9213  Camphor, derivatives and preparations|C18352  10-Oxocamphor",
C18353,Octaketide bicyclic intermediate,Generic compound in reaction hierarchy|R = S-ACP or OH,,,,
C18354,(S)-Chiral alcohol,,,,,
C18355,(R)-Chiral alcohol,Generic compound in reaction hierarchy,,,,
C18356,(S)-Hemiketal,,,,,
C18357,(R)-Hemiketal,Generic compound in reaction hierarchy,,,,
C18358,DHKred-OH;|Hydroxylated dihydrokalafungin dihydroquinone,,,,,
C18359,Dihydrogranaticin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1303 Benzoisochromanquinones|C18359  Dihydrogranaticin,
C18360,Dihydrokalafungin dihydroquinone form;|DHKred,,,,,
C18361,Mafoprazine mesylate,,,,Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|912  Hypnotics and sedatives|9129  Other hypnotics and sedatives|C18361  Mafoprazine mesylate,
C18362,Tepoxalin,,,,"Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C18362  Tepoxalin|Target-based classification of drugs [BR:br08310(D06075)]|Enzymes|Oxidoreductases (EC1)|Dioxygenases|ALOX5|D06075  Tepoxalin (USAN/INN)",
C18363,Firocoxib,,,,"Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C18363  Firocoxib|Drug groups [BR:br08330(D03712)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01922  Selective COX2 inhibitor|DG01907  Anti-inflammatory drug, coxibs|D03712  Firocoxib|Target-based classification of drugs [BR:br08310(D03712)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D03712  Firocoxib (USAN/INN)",
C18364,Carprofen,,,,"Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C18364  Carprofen|Drug groups [BR:br08330(D03410)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01908  Anti-inflammatory drug, propionic acid derivatives|D03410  Carprofen|Target-based classification of drugs [BR:br08310(D03410)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D03410  Carprofen (USP/INN)|PTGS2 (COX2)|D03410  Carprofen (USP/INN)",
C18365,Carbetocin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07229)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES|H01B POSTERIOR PITUITARY LOBE HORMONES|H01BB Oxytocin and analogues|H01BB03 Carbetocin|D07229  Carbetocin (USAN/INN/BAN)|Animal drugs in Japan [BR:br08331]|94  Agents for breeding|941  Hormone preparations (except posterior-pituitary hormone and preparations)|9417  Synthetic oestrogenic substionces and preparations|C18365  Carbetocin|942  Oxytocics|9422  Posterior pituitary hormone and preparations|C18365  Carbetocin|Target-based classification of drugs [BR:br08310(D07229)]|G Protein-coupled receptors|Rhodopsin family|Oxytocin|OXTR|D07229  Carbetocin (USAN/INN/BAN)",
C18366,Sodium iodate,,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9511  Iodine compounds and preparations|C18366  Sodium iodate,
C18367,Malachite green,,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C18367  Malachite green|954  Anti-dermoinfectives|9549  Other anti-dermoinfectives|C18367  Malachite green,
C18368,Chlorine dioxide;|Chlorine peroxide,,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9519  Other antimicrobials for dermatologic use|C18368  Chlorine peroxide,
C18369,dl-Camphor;|Camphor,,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Monoterpenoids (C10)|Cyclic monoterpenes|C18369  dl-Camphor|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00098)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01E OTHER CARDIAC PREPARATIONS|C01EB Other cardiac preparations|C01EB02 Camphora|D00098  Camphor (USP) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D00098)]|2  Agents affecting individual organs|26  Epidermides|264  Analgesics, anti-itchings, astringents, anti-inflammatory agents|2645  Peppermint rubber and camphor peppermint|D00098  Camphor (USP); dl-Camphor (JP18)|Classification of Japanese OTC drugs [BR:br08313(D00098)]|Agents for nervous and sensory systems|02 Cold remedy (external use)|D00098  Camphor (USP)|Agents for integumentary system|56 Purulent skin remedies|D00098  Camphor (USP)|57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)|D00098  Camphor (USP)|Risk category of Japanese OTC drugs [BR:br08312(D00098)]|Third-class OTC drugs|Inorganic and organic chemicals|dl-Camphor|D00098  Camphor (USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|953  Analgesics, anti-itchings, astringents and antiinflammatory agents|9539  Other analgesics, anti-itchings, astringents and inflammatory agents|C18369  dl-Camphor|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00098)]|Chemicals|D00098  dl-Camphor",
C18370,Alkyldiaminoethylglycine hydrochloride;|Alkylpolyaminoethylglycine hydrochloride,Generic compound|R = C8H17 - C16H33,,,Therapeutic category of drugs in Japan [BR:br08301(D04734)]|2  Agents affecting individual organs|26  Epidermides|261  Antimicrobial agents|2619  Others|D04734  Alkyldiaminoethylglycine hydrochloride (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D04734)]|Third-class OTC drugs|Inorganic and organic chemicals|Alkyldiaminoethylglycine hydrochloride|D04734  Alkyldiaminoethylglycine hydrochloride (JAN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C18370  Alkyldiaminoethylglycine hydrochloride|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9923  Invert soap and preparations|C18370  Alkyldiaminoethylglycine hydrochloride,
C18371,"Stearyltrimethylammonium chloride;|1-Octadecanaminium, N,N,N-trimethyl-, chloride",,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C18371  Stearyltrimethylammonium chloride,
C18372,Chlorhexidine acetate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07669)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB03 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|B BLOOD AND BLOOD FORMING ORGANS|B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS|B05C IRRIGATING SOLUTIONS|B05CA Antiinfectives|B05CA02 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AC Biguanides and amidines|D08AC02 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|D09 MEDICATED DRESSINGS|D09A MEDICATED DRESSINGS|D09AA Medicated dressings with antiinfectives|D09AA12 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA05 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01A ANTIINFECTIVES|S01AX Other antiinfectives|S01AX09 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|S02 OTOLOGICALS|S02A ANTIINFECTIVES|S02AA Antiinfectives|S02AA09 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS|S03A ANTIINFECTIVES|S03AA Antiinfectives|S03AA04 Chlorhexidine|D07669  Chlorhexidine acetate (USP)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C18372  Chlorhexidine acetate|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9929  Other agents for disinfections|C18372  Chlorhexidine acetate,
C18373,Tetramethrin;|Neo-pynamin;|Phthalthrin,,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18373  Tetramethrin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07368)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03B INSECTICIDES AND REPELLENTS|P03BA Pyrethrines|P03BA04 Tetramethrin|D07368  Tetramethrin (INN)|Animal drugs in Japan [BR:br08331]|95  Agents for external use|956  Bath and disinfectants preparations|9562  Disinfectants preparations|C18373  Neo-pynamin|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C18373  Phthalthrin",
C18374,Clostebol acetate,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9615  Anabolic steroid hormone and preparations|C18374  Clostebol acetate|Drug groups [BR:br08330(D07732)]|Hormonal agent|DG01590  Androgen receptor agonist|DG01605  Anabolic steroid|DG01632  Clostebol|D07732  Clostebol acetate,
C18375,Osaterone acetate,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|961  Hormone preparations (except agents for breeding and external use)|9619  Other hormone preparations|C18375  Osaterone acetate|Target-based classification of drugs [BR:br08310(D11105)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C4 (AR)|D11105  Osaterone acetate (JAN),
C18376,Fursultiamine hydrochloride,,,,Therapeutic category of drugs in Japan [BR:br08301(D03321)]|3  Agents affecting metabolism|31  Vitamins|312  Vitamin B1 preparations|3122  Vitamin B1 derivatives|D03321  Fursultiamine hydrochloride (JP18)|Classification of Japanese OTC drugs [BR:br08313(D03321)]|Nourishing tonics and health supplements|35 Vitamin B1 based drugs|D03321  Fursultiamine hydrochloride (JP18)|42 Vitamin B1B6B12 based drugs|D03321  Fursultiamine hydrochloride (JP18)|43 Vitamin containing supplements|D03321  Fursultiamine hydrochloride (JP18)|Risk category of Japanese OTC drugs [BR:br08312(D03321)]|Third-class OTC drugs|Inorganic and organic chemicals|Fursultiamine|D03321  Fursultiamine hydrochloride (JP18)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9622  Vitamin B1 and preparations|C18376  Fursultiamine hydrochloride|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D03321)]|Chemicals|D03321  Fursultiamine hydrochloride,
C18377,Thiamine disulfide,,,,Therapeutic category of drugs in Japan [BR:br08301(D03299)]|3  Agents affecting metabolism|31  Vitamins|312  Vitamin B1 preparations|3122  Vitamin B1 derivatives|D03299  Thiamine disulfide (JAN)|Classification of Japanese OTC drugs [BR:br08313(D03299)]|Nourishing tonics and health supplements|35 Vitamin B1 based drugs|D03299  Thiamine disulfide (JAN)|42 Vitamin B1B6B12 based drugs|D03299  Thiamine disulfide (JAN)|43 Vitamin containing supplements|D03299  Thiamine disulfide (JAN)|Risk category of Japanese OTC drugs [BR:br08312(D03299)]|Third-class OTC drugs|Inorganic and organic chemicals|Thiamine disulfide|D03299  Thiamine disulfide (JAN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9622  Vitamin B1 and preparations|C18377  Thiamine disulfide,
C18378,Menadione sodium bisulfite,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08177)]|B BLOOD AND BLOOD FORMING ORGANS|B02 ANTIHEMORRHAGICS|B02B VITAMIN K AND OTHER HEMOSTATICS|B02BA Vitamin K|B02BA02 Menadione|D08177  Menadione sodium bisulfite (INN)|Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|962  Vitamin preparations|9626  Vitamin K and preparations|C18378  Menadione sodium bisulfite|Drug groups [BR:br08330(D08177)]|Blood modifier agent|DG02016  Hemostatics|DG02014  Blood coagulation accelerant|DG01603  Vitamin K|DG00166  Menadione|D08177  Menadione sodium bisulfite,
C18379,Calcium propionate,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C18379  Calcium propionate|969  Other agents affecting metabolism|9696  Organic acid and preparations|C18379  Calcium propionate,
C18380,Calcium levulinate anhydrous,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9631  Calcium compounds and preparations (except calcium iodid and calcium bromide)|C18380  Calcium levulinate,
C18381,Calcium iodide,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9632  Halogen compounds and preparations|C18381  Calcium iodide,
C18382,Ethylendiamine dihydroiodide;|EDDI,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|963  Mineral and preparations|9632  Halogen compounds and preparations|C18382  Ethylendiamine dihydroiodide,
C18384,Magnesium dipropionate,,,,Animal drugs in Japan [BR:br08331]|96  Agents affecting metabolism|969  Other agents affecting metabolism|9696  Organic acid and preparations|C18384  Magnesium dipropionate,
C18386,Sulfadimethoxine sodium,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08538)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01ED Long-acting sulfonamides|J01ED01 Sulfadimethoxine|D08538  Sulfadimethoxine sodium (USP)|Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|971  Sulfonamide preparations|9713  Sulfonamide preparations for external use, pessaries and suppositories|C18386  Sulfadimethoxine sodium|Drug groups [BR:br08330(D08538)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01786  Long-acting sulfonamide|DG00600  Sulfadimethoxine|D08538  Sulfadimethoxine sodium|Antimicrobials [BR:br08307(D08538)]|Antibacterials|Folic acid biosynthesis inhibitor|Long-acting sulfonamide|D08538  Sulfadimethoxine sodium (USP)",
C18387,Sulfamoyldapsone,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9749  Other antiprotozoan agents|C18387  Sulfamoyldapsone,
C18388,Diminazene,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9749  Other antiprotozoan agents|C18388  Diminazene|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C18388  Emodepside,
C18389,Nicarbazin,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|974  Antiprotozoan agents|9749  Other antiprotozoan agents|C18389  Nicarbazin,
C18390,Emodepside,,,,,
C18391,Dithiazanine iodide,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C18391  Dithiazanine iodide,
C18392,Bromofenofos,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C18392  Bromofenofos,
C18393,"Disophenol;|2,6-Diiod-4-nitrophenol",,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C18393  Disophenol,
C18394,Anilofos,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18394  Anilofos,
C18395,Cadusafos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18395  Cadusafos,
C18396,Methyridine,,,,Animal drugs in Japan [BR:br08331]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9759  Other anthelmintics for digestive organs|C18396  Methyridine,
C18397,Cyanophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18397  Cyanophos,
C18398,Dichlofenthion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18398  Dichlofenthion,
C18399,Ethephon,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18399  Ethephon,
C18400,Disulfoton;|Ethylthiometon,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18400  Disulfoton,
C18401,Fosetyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organophosphorus fungicides|C18401  Fosetyl,
C18402,Fosthiazate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nematicides|C18402  Fosthiazate,
C18403,Pirimiphos-methyl;|Pirimiphosmethyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18403  Pirimiphos-methyl,
C18404,Profenofos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18404  Profenofos,
C18405,Prothiofos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18405  Prothiofos|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|C18405  Prothiofos,
C18406,Pyraclofos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18406  Pyraclofos,
C18407,Tolclofos-methyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organophosphorus fungicides|C18407  Tolclofos-methyl,
C18408,Acrinathrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18408  Acrinathrin,
C18409,Cycloprothrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18409  Cycloprothrin,
C18410,Etofenprox,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18410  Etofenprox|Classification of Japanese OTC drugs [BR:br08313(D09202)]|Agents for sanitation|82 Pesticides|D09202  Etofenprox (INN)|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C18410  Etofenprox,
C18411,Fenpropathrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18411  Fenpropathrin,
C18412,Silafluofen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18412  Silafluofen,
C18413,Tralomethrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18413  Tralomethrin,
C18414,Alanycarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18414  Alanycarb,
C18415,Benthiavalicarb isopropyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C18415  Benthiavalicarb isopropyl,
C18416,Carbosulfan,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18416  Carbosulfan,
C18417,Desmedipham,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Carbanilate herbicides|C18417  Desmedipham,
C18418,Isoprocarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18418  Isoprocarb,
C18419,Oxamyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18419  Oxamyl,
C18420,Phenmedipham,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Carbanilate herbicides|C18420  Phenmedipham,
C18421,Propamocarb hydrochloride,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C18421  Propamocarb hydrochloride,
C18422,Pyributicarb,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18422  Pyributicarb,
C18423,Thiodicarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18423  Thiodicarb,
C18424,Metam-sodium;|Carbam,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18424  Metam-sodium,
C18425,Cumyluron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Urea herbicides|C18425  Cumyluron,
C18426,Chlorfluazuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18426  Chlorfluazuron,
C18427,Daimuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18427  Daimuron,
C18428,Diuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18428  Diuron,
C18429,Flucetosulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18429  Flucetosulfuron,
C18430,Flufenoxuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18430  Flufenoxuron,
C18431,Iodosulfuron-methyl-sodium;|Iodosulfuron-methyl sodium salt,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18431  Iodosulfuron-methyl-sodium,
C18432,Isouron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Urea herbicides|C18432  Isouron,
C18433,Karbutilate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C18433  Karbutilate,
C18434,Lufenuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18434  Lufenuron|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18434  Lufenuron,
C18435,Siduron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18435  Siduron,
C18436,Tebuthiuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Urea herbicides|C18436  Tebuthiuron,
C18437,Teflubenzuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18437  Teflubenzuron,
C18438,Azimsulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18438  Azimsulfuron,
C18439,Cyclosulfamuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18439  Cyclosulfamuron,
C18440,Ethoxysulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18440  Ethoxysulfuron,
C18441,Flazasulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18441  Flazasulfuron,
C18442,Halosulfuron-methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18442  Halosulfuron-methyl,
C18443,Imazosulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18443  Imazosulfuron,
C18444,Pyrazosulfuron-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18444  Pyrazosulfuron-ethyl,
C18445,Chloropicrin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C18445  Chloropicrin,
C18446,Dienochlor,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18446  Dienochlor,
C18447,Methyl bromide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18447  Methyl bromide,
C18448,Methyl iodide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18448  Methyl iodide,
C18449,Amobam,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18449  Amobam,
C18450,Propineb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18450  Propineb,
C18451,Tetradifon,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18451  Tetradifon,
C18452,Benfuresate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18452  Benfuresate,
C18453,Bispyribac-sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18453  Bispyribac-sodium,
C18454,Chlorantraniliprole,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrazole insecticides|C18454  Chlorantraniliprole,
C18455,Chlorfenapyr,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18455  Chlorfenapyr,
C18456,Cyproconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18456  Cyproconazole,
C18457,Dazomet,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18457  Dazomet,
C18458,Diclomezine,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18458  Diclomezine,
C18459,Difenoconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18459  Difenoconazole,
C18460,Echlomezole;|Etridiazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18460  Echlomezole,
C18461,Fenbuconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18461  Fenbuconazole,
C18462,Fludioxonil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18462  Fludioxonil,
C18463,Flonicamid,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18463  Flonicamid,
C18464,Fluopicolide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18464  Fluopicolide,
C18465,Flurprimidol,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18465  Flurprimidol,
C18466,Hexaconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18466  Hexaconazole,
C18467,Hexythiazox,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18467  Hexythiazox,
C18468,Imibenconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18468  Imibenconazole,
C18469,Imicyafos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nematicides|C18469  Imicyafos,
C18470,Indanofan,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18470  Indanofan,
C18471,Ipconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18471  Ipconazole,
C18472,"L-Capreomycidine;|(2S,3R)-Capreomycidine;|(S)-2-Amino-2-[(R)-2-iminohexahydropyrimidin-4-yl]acetic acid",,,,,
C18473,"beta-Hydroxyarginine;|(3S)-Hydroxy-(2S)-arginine;|(2S,3S)-3-Hydroxyarginine;|(3S)-3-Hydroxy-L-arginine",,,,,
C18474,Maleic hydrazide,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18474  Maleic hydrazide,
C18475,Mepiquat chloride,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18475  Mepiquat chloride,
C18476,Metconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18476  Metconazole,
C18477,Myclobutanil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18477  Myclobutanil,
C18478,Oxyquinoline sulfate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02414)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB07 Oxyquinoline|D02414  Oxyquinoline sulfate (NF)|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AH Quinoline derivatives|D08AH03 Oxyquinoline|D02414  Oxyquinoline sulfate (NF)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AC Quinoline derivatives|G01AC30 Oxyquinoline|D02414  Oxyquinoline sulfate (NF)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA14 Oxyquinoline|D02414  Oxyquinoline sulfate (NF)|Classification of Japanese OTC drugs [BR:br08313(D02414)]|Agents for sanitation|81 Disinfectants|D02414  Oxyquinoline sulfate (NF)|Risk category of Japanese OTC drugs [BR:br08312(D02414)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxyquinoline|D02414  Oxyquinoline sulfate (NF)",
C18479,Paclobutrazol,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18479  Paclobutrazol,
C18480,Pefurazoate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18480  Pefurazoate,
C18481,Penoxsulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18481  Penoxsulam,
C18482,Penthiopyrad,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18482  Penthiopyrad,
C18483,Probenazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18483  Probenazole,
C18484,Pyridalyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18484  Pyridalyl,
C18485,Pyriftalid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18485  Pyriftalid,
C18486,Pyriminobac-methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18486  Pyriminobac-methyl,
C18487,Pyroquilon,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18487  Pyroquilon,
C18488,Spiromesifen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18488  Spiromesifen,
C18489,Tebuconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18489  Tebuconazole,
C18490,Tetraconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18490  Tetraconazole,
C18491,Tolfenpyrad,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrazole insecticides|C18491  Tolfenpyrad,
C18492,Tricyclazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18492  Tricyclazole,
C18493,Triflumizole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18493  Triflumizole,
C18494,Uniconazole P,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18494  Uniconazole P,
C18495,Etoxazole,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18495  Etoxazole|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18495  Etoxazole,
C18496,Oxadiazon,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18496  Oxadiazon,
C18497,Cafenstrole,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18497  Cafenstrole,
C18498,Cymoxanil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Aliphatic nitrogen fungicides|C18498  Cymoxanil,
C18499,Dimethenamid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18499  Dimethenamid,
C18500,Etobenzanid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18500  Etobenzanid,
C18501,Fentrazamide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18501  Fentrazamide,
C18502,Flutolanil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18502  Flutolanil,
C18503,Furametpyr,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18503  Furametpyr,
C18504,Isoxaben,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18504  Isoxaben,
C18505,Thifluzamide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Thiazole fungicides|C18505  Thifluzamide,
C18506,Furamethrin,,,,Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C18506  Furamethrin,
C18507,Acetamiprid,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18507  Acetamiprid,
C18508,Clothianidin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18508  Clothianidin,
C18509,Dinotefuran,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18509  Dinotefuran|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18509  Dinotefuran,
C18510,Prallethrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18510  Prallethrin|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C18510  Prallethrin,
C18511,Nitenpyram,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18511  Nitenpyram|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18511  Nitenpyram,
C18512,Thiacloprid,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18512  Thiacloprid,
C18513,Thiamethoxam,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Neonicotinoid insecticides|C18513  Thiamethoxam,
C18514,Chlorophacinone,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C18514  Chlorophacinone,
C18515,Chromafenozide,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Moulting hormone agonists|C18515  Chromafenozide,
C18516,Cyflufenamid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18516  Cyflufenamid,
C18517,Cyflumetofen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18517  Cyflumetofen,
C18518,Diclocymet,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18518  Diclocymet,
C18519,Fenoxanil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18519  Fenoxanil,
C18520,Flubendiamide,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18520  Flubendiamide,
C18521,Flusulfamide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18521  Flusulfamide,
C18522,Mandipropamid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18522  Mandipropamid,
C18523,Metaflumizone,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18523  Metaflumizone|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18523  Metaflumizone,
C18524,Empenthrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18524  Empenthrin|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9931  Pyrethrum and preparations (including synthetic)|C18524  Empenthrin,
C18525,Methoxyfenozide,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Moulting hormone agonists|C18525  Methoxyfenozide,
C18526,Tebufenozide,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Moulting hormone agonists|C18526  Tebufenozide,
C18527,Fluazifop,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C18527  Fluazifop,
C18528,MCPA;|(2-Methyl-4-chlorophenoxy)acetic acid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18528  MCPA,
C18529,2-Methyl-4-chlorophenoxybutyric acid;|MCPB,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18529  2-Methyl-4-chlorophenoxybutyric acid,
C18530,Quizalofop-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18530  Quizalofop-ethyl,
C18531,Clomeprop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18531  Clomeprop,
C18532,Ethychlozate,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18532  Ethychlozate,
C18533,alpha-Naphthylacetamide;|1-Naphthaleneacetamide,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C18533  alpha-Naphthylacetamide,
C18534,1-Naphthaleneacetic acid sodium salt,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C18534  1-Naphthaleneacetic acid sodium salt,
C18535,Acequinocyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18535  Acequinocyl,
C18536,Benzobicyclon,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18536  Benzobicyclon,
C18537,Dimethametryn,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18537  Dimethametryn,
C18538,Prohydrojasmon,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18538  Prohydrojasmon,
C18539,Sethoxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18539  Sethoxydim,
C18540,Tepraloxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18540  Tepraloxydim,
C18541,Trinexapac-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18541  Trinexapac-ethyl,
C18542,Prometryn,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18542  Prometryn,
C18543,Flupoxam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18543  Flupoxam,
C18544,Simeconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18544  Simeconazole,
C18545,Cyenopyrafen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18545  Cyenopyrafen,
C18546,Ioxynil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrile herbicides|C18546  Ioxynil,
C18547,Boscalid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18547  Boscalid,
C18548,Mepronil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18548  Mepronil,
C18549,Diflufenican,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyridine herbicides|C18549  Diflufenican,
C18550,Tiadinil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18550  Tiadinil,
C18551,Fluoroimide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C18551  Fluoroimide,
C18552,Ethiprole,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrazole insecticides|C18552  Ethiprole,
C18553,Spirodiclofen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18553  Spirodiclofen,
C18554,Pyraflufen-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C18554  Pyraflufen-ethyl,
C18555,Benzofenap,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C18555  Benzofenap,
C18556,Pyrazoxyfen,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C18556  Pyrazoxyfen,
C18557,Milbemectin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18557  Milbemectin,
C18558,Azoxystrobin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C18558  Azoxystrobin,
C18559,Metominostrobin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C18559  Metominostrobin,
C18560,Orysastrobin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C18560  Orysastrobin,
C18561,Pyraclostrobin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C18561  Pyraclostrobin,
C18562,Trifloxystrobin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Strobilurin fungicides|C18562  Trifloxystrobin,
C18563,Bensultap,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nereistoxin insecticides|C18563  Bensultap,
C18564,Glyphosate-isopropylammonium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18564  Glyphosate-isopropylammonium,
C18565,Glyphosate-monoammonium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18565  Glyphosate-monoammonium,
C18566,Calcium peroxide,,,,,
C18567,Thallium sulfate,,,,"Pesticides [BR:br08007]|Pesticides|Rodenticides|Inorganic rodenticides|C18567  Thallium sulfate|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|994  Rodentickides|9944  Thallium, barium, compounds and preparations|C18567  Thallium sulfate",
C18568,Iminoctadine acetate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Aliphatic nitrogen fungicides|C18568  Iminoctadine acetate,
C18569,Indoxacarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18569  Indoxacarb,
C18570,Chloridazon,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18570  Chloridazon,
C18571,Oxaziclomefone,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18571  Oxaziclomefone,
C18572,Oxpoconazole fumarate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18572  Oxpoconazole fumarate,
C18573,Cyazofamid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18573  Cyazofamid,
C18574,Dithianon,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Quinone fungicides|C18574  Dithianon,
C18575,Quinoxaline,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18575  Quinoxaline,
C18576,Clofentezine,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Mite growth regulators|C18576  Clofentezine,
C18577,Diquat,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Bipyridinium herbicides|C18577  Diquat,
C18578,Fluazinam,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyridine fungicides|C18578  Fluazinam,
C18579,Ferimzone;|(Z)-Ferimzone,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C18579  Ferimzone,
C18580,Pyriprole,,,,Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18580  Pyriprole,
C18581,Amisulbrom,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18581  Amisulbrom,
C18582,Butralin,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18582  Butralin,
C18583,Dimethomorph,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Morpholine fungicides|C18583  Dimethomorph,
C18584,Quinoclamin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18584  Quinoclamin,
C18585,Chlormequat,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18585  Chlormequat,
C18586,"Calcium formate;|Formic acid, calcium salt",,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18586  Calcium formate,
C18587,Methyl isothiocyanate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Nematicides|C18587  Methyl isothiocyanate,
C18588,Sodium fluoroacetate;|Sodium monofluoroacetate,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Organofluorine rodenticides|C18588  Sodium fluoroacetate,
C18589,Bifenazate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18589  Bifenazate,
C18590,Pymetrozine,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Antifeedants|C18590  Pymetrozine,
C18591,Famoxadone,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C18591  Famoxadone,
C18592,Pentoxazone,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18592  Pentoxazone,
C18593,Fenhexamid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18593  Fenhexamid,
C18594,Bentazone-sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18594  Bentazone-sodium,
C18595,Fluacrypyrim,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18595  Fluacrypyrim,
C18596,Bromadiolone,,,,"Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C18596  Bromadiolone|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|994  Rodentickides|9943  Cumarin, derivatives and preparations|C18596  Bromadiolone",
C18597,Dicamba,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18597  Dicamba,
C18598,Imazamox,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Imidazolinone herbicides|C18598  Imazamox,
C18599,Coumafuryl;|Fumarin,,,,"Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Coumarin rodenticides|C18599  Coumafuryl|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|994  Rodentickides|9943  Cumarin, derivatives and preparations|C18599  Fumarin",
C18600,"Dalapon;|2,2-DPA;|2,2-Dichloropropanoic acid",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18600  Dalapon,
C18601,Sodium oleate,,,,,
C18602,Propargite;|BPPS,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18602  Propargite,
C18603,Pyrimidifen,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18603  Pyrimidifen,
C18604,Forchlorfenuron,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth stimulators|C18604  Forchlorfenuron,
C18605,Pyriproxyfen,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Juvenile hormone mimics|C18605  Pyriproxyfen|Classification of Japanese OTC drugs [BR:br08313(D08455)]|Agents for sanitation|82 Pesticides|D08455  Pyriproxyfen|Risk category of Japanese OTC drugs [BR:br08312(D08455)]|Second-class OTC drugs|Not used for human|Insecticides|D08455  Pyriproxyfen|Animal drugs in Japan [BR:br08331(D08455)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|D08455  Pyriproxyfen,
C18606,Potassium bicarbonate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02077)]|A ALIMENTARY TRACT AND METABOLISM|A12 MINERAL SUPPLEMENTS|A12B POTASSIUM|A12BA Potassium|A12BA04 Potassium hydrogencarbonate|D02077  Potassium bicarbonate (USP)|USP drug classification [BR:br08302(D02077)]|Electrolytes/Minerals/Metals/Vitamins|Electrolyte/Mineral Replacement|Potassium|D02077  Potassium bicarbonate (USP)|Drug groups [BR:br08330(D02077)]|Gastrointestinal agent|DG02017  Potassium|D02077  Potassium bicarbonate,
C18607,Cyhalofop-butyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18607  Cyhalofop-butyl,
C18608,Mecoprop-P;|(R)-2-(4-Chloro-o-tolyloxy)propionic acid;|(R)-2-(4-Chloro-2-methylphenoxy)propanoate;|(R)-Mecoprop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18608  Mecoprop-P,
C18609,Clethodim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18609  Clethodim,
C18610,Monoammonium glycyrrhizinate,,,,"Risk category of Japanese OTC drugs [BR:br08312(D04987)]|Third-class OTC drugs|Inorganic and organic chemicals|Glycyrrhizin|D04987  Monoammonium glycyrrhizinate (JAN)|Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C18610  Monoammonium glycyrrhizinate|Target-based classification of drugs [BR:br08310(D04987)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|HSD11B1|D04987  Monoammonium glycyrrhizinate (JAN)",
C18611,Phthalide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C18611  Phthalide,
C18612,Nonoxynol-9 iodine,,,,Animal drugs in Japan [BR:br08331]|95  Agents for external use|951  Antimicrobials for dermatologic use|9511  Iodine compounds and preparations|C18612  Nonoxynol iodine|99  Agents for not mainly purpose of therapeutic|992  Amphoteric soap and preparations|9926  Halogen salts and preparations|C18612  Nonoxynol-9 iodine,
C18613,Pyraclonil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrile herbicides|C18613  Pyraclonil,
C18614,Pyridaben,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18614  Pyridaben,
C18615,Triflumuron;|Trifluron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18615  Triflumuron|Animal drugs in Japan [BR:br08331]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|C18615  Triflumuron,
C18616,Methoxymalonyl-[acp];|Methoxymalonyl-ACP;|(2R)-Methoxymalonyl-[acp],,,,,
C18617,Hydroxymalonyl-[acp];|Hydroxymalonyl-ACP;|(2R)-Hydroxymalonyl-[acp],,,,,
C18618,Aminomalonyl-[acp];|Aminomalonyl-ACP;|(2S)-Aminomalonyl-[acp],,,,,
C18619,4-Dimethylamino-L-phenylalanine,,,,,
C18620,3-Hydroxypicolinic acid,,,,,
C18621,3-Hydroxyquinaldic acid,,,,,
C18622,L-Homotyrosine,,,,,
C18623,L-Phenylglycine;|Phenylglycine,,,,,
C18624,Quinoxaline-2-carboxylic acid,,,,,
C18625,4-Nitrobenzoate;|4-Nitrobenzoic acid;|p-Nitrobenzoic acid,,,,,
C18626,Metalaxyl-M,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18626  Metalaxyl-M,
C18627,"1,3-Dichloropropene;|D-D 92",,,,"Pesticides [BR:br08007]|Pesticides|Insecticides|Nematicides|C18627  1,3-Dichloropropene",
C18628,Thiadiazin;|Milneb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18628  Thiadiazin,
C18629,Deoxynogalonate;|12-Deoxynogalonic acid,,,,,
C18630,"Nogalaviketone;|Methyl 5,7-dihydroxy-2-methyl-4,6,11-trioxo-3,4,6,11-tetrahydrotetracene-1-carboxylate",,,,,
C18631,Nogalavinone;|Nogalamycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18631  Nogalavinone,
C18632,1-OH-Nogalamycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18632  1-OH-Nogalamycinone,
C18633,Nogalamycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18633  Nogalamycin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18633,
C18634,Aclacinomycin T;|Rhodosaminyl-aklavinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18634  Aclacinomycin T,
C18635,Aclacinomycin S;|L-2-Deoxyfucosyl-L-rhodosaminyl-aklavinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18635  Aclacinomycin S,
C18636,dTDP-2-deoxy-beta-L-fucose;|dTDP-L-2-deoxyfucose,,,,,
C18637,Aclacinomycin N,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18637  Aclacinomycin N,
C18638,Aclacinomycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18638  Aclacinomycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18638|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02756)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES|L01DB Anthracyclines and related substances|L01DB04 Aclarubicin|D02756  Aclarubicin (USAN/INN)|Drug groups [BR:br08330(D02756)]|Antineoplastic|DG01682  Anthracycline antineoplastic|DG00699  Aclarubicin|D02756  Aclarubicin|DG01529  Topoisomerase inhibitor|DG00699  Aclarubicin|D02756  Aclarubicin|Target-based classification of drugs [BR:br08310(D02756)]|Enzymes|Isomerases (EC5)|DNA topoisomerase|TOP1|D02756  Aclarubicin (USAN/INN)|TOP2|D02756  Aclarubicin (USAN/INN),G09914
C18639,Aclacinomycin Y,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18639  Aclacinomycin Y,
C18640,epsilon-Rhodomycin T,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18640  epsilon-Rhodomycin T,
C18641,15-Demethoxy-epsilon-rhodomycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18641  15-Demethoxy-epsilon-rhodomycin,
C18642,beta-Rhodomycin;|Rhodomycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C18642  Rhodomycin B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18642,
C18643,dTDP-beta-L-rhodosamine;|dTDP-L-rhodosamine,,,,,
C18644,Azinphos-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18644  Azinphos-ethyl,
C18645,Butocarboxim,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18645  Butocarboxim,
C18646,Butoxycarboxim,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18646  Butoxycarboxim,
C18647,Calcium arsenate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Arsenical insecticides|C18647  Calcium arsenate,
C18648,Lead arsenate;|Lead hydrogen arsenate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Arsenical insecticides|C18648  Lead arsenate,
C18649,Ethiofencarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18649  Ethiofencarb,
C18650,Furathiocarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18650  Furathiocarb,
C18651,Methiocarb,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18651  Methiocarb,
C18652,Thiofanox,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18652  Thiofanox,
C18653,"DNOC;|4,6-Dinitro-o-cresol;|2,4-Dinitro-6-methylphenol",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrophenol herbicides|C18653  DNOC,
C18654,Chlorfenvinphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18654  Chlorfenvinphos,
C18655,Demeton-S-methyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18655  Demeton-S-methyl,
C18656,Dicrotophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18656  Dicrotophos,
C18657,Triazophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18657  Triazophos,
C18658,Famphur;|Famophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18658  Famphur,
C18659,Fenamiphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Phosphoramido insecticides|C18659  Fenamiphos,
C18660,Heptenophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18660  Heptenophos,
C18661,Mecarbam,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18661  Mecarbam,
C18662,Omethoate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18662  Omethoate,
C18663,Monocrotophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18663  Monocrotophos,
C18664,Oxydemeton-methyl,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18664  Oxydemeton-methyl,
C18665,Thiometon,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18665  Thiometon,
C18666,Vamidothion,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18666  Vamidothion,
C18667,Methamidophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Phosphoramido insecticides|C18667  Methamidophos,
C18668,Formetanate;|Dicarzol,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18668  Formetanate,
C18669,Propetamphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Phosphoramido insecticides|C18669  Propetamphos,
C18670,Mercuric oxide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Inorganic fungicides|C18670  Mercuric oxide,
C18671,Dinoterb,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrophenol herbicides|C18671  Dinoterb,
C18672,Methylmercury;|Methylmercury ion;|CH3Hg+,Methylmercury chloride (chloride salt) [CPD:C11146],,,,
C18673,Sodium cyanide,,,,,
C18675,Fluoroacetamide,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Organofluorine rodenticides|C18675  Fluoroacetamide,
C18676,"alpha-Chlorohydrin;|3-Monochloro-1,2-propanediol",,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C18676  alpha-Chlorohydrin,
C18677,Chlorethoxyfos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18677  Chlorethoxyfos,
C18678,UWM6,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18678  UWM6,
C18679,"2,3-Dehydro-UWM6;|Prejadomycin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18679  2,3-Dehydro-UWM6",
C18680,Jadomycin A;|Jadomycin B aglycon,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18680  Jadomycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18680,
C18681,C1'-C9-Glycosylated UWM6,,,,,
C18682,11-Deoxylandomycinone,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18682  11-Deoxylandomycinone,
C18683,Landomycin H,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18683  Landomycin H|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C18683  Landomycin H,
C18684,Landomycin D,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18684  Landomycin D|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C18684  Landomycin D,
C18685,Landomycin E,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18685  Landomycin E|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18685,
C18686,Chlormephos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18686  Chlormephos,
C18687,Ethoprophos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18687  Ethoprophos,
C18688,Mevinphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18688  Mevinphos,
C18689,Phosphamidon,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18689  Phosphamidon,
C18690,Phorate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18690  Phorate,
C18691,Sulfotep,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18691  Sulfotep,
C18692,Tebupirimfos;|Tebupirimphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18692  Tebupirimfos,
C18693,Terbufos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18693  Terbufos,
C18694,Brodifacoum,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C18694  Brodifacoum,
C18695,Difethialone,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C18695  Difethialone|Drug groups [BR:br08330(D09807)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01708  Coumarin anticoagulant|DG01759  Dicumarol type coumarin derivative|D09807  Difethiarol,
C18696,Flocoumafen,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Coumarin rodenticides|C18696  Flocoumafen|Target-based classification of drugs [BR:br08310(D07134)]|Enzymes|Oxidoreductases (EC1)|Vitamin-K-epoxide reductase|VKORC1|D07134  Flocoumafen (JAN),
C18697,Bromethalin,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C18697  Bromethalin,
C18698,Diphenadione,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C18698  Diphenadione|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07136)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AA Vitamin K antagonists|B01AA10 Diphenadione|D07136  Diphenadione (INN)|Drug groups [BR:br08330(D07136)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01708  Coumarin anticoagulant|DG01761  Phenindion type coumarin derivative|D07136  Diphenadione|Target-based classification of drugs [BR:br08310(D07136)]|Enzymes|Oxidoreductases (EC1)|Vitamin-K-epoxide reductase|VKORC1|D07136  Diphenadione (INN),
C18699,(-)-Jasmonoyl-L-isoleucine;|(-)-JA-L-Ile,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C18699  (-)-Jasmonoyl-L-isoleucine,
C18700,Ametryn,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18700  Ametryn,
C18701,Azaconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18701  Azaconazole|Drug groups [BR:br08330(D03023)]|Antifungal|DG01523  Triazole antifungal|D03023  Azaconazole|Antimicrobials [BR:br08307(D03023)]|Antifungals|Ergosterol biosynthesis inhibitor|Triazole|D03023  Azaconazole (USAN/INN),
C18702,Azamethiphos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18702  Azamethiphos|Animal drugs in Japan [BR:br08331(D07479)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9932  Organic phosphorus and preparations|D07479  Azamethiphos,
C18703,Bensulide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18703  Bensulide,
C18704,Bromuconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18704  Bromuconazole,
C18705,Butroxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18705  Butroxydim,
C18706,Butylamine,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18706  Butylamine,
C18707,Chloralose,,,,Pesticides [BR:br08007]|Pesticides|Rodenticides|Others|C18707  Chloralose,
C18708,Chlorphonium chloride;|Phosfon D,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18708  Chlorphonium chloride,
C18709,Decaketide tricyclic intermediate,,,,,
C18710,3A-Deolivosylpremithramycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C18710  3A-Deolivosylpremithramycin B,
C18711,Mithramycin DK,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C18711  Mithramycin DK,
C18712,Copper hydroxide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Copper fungicides|C18712  Copper hydroxide,
C18713,Copper sulfate;|Copper(II) sulfate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Copper fungicides|C18713  Copper sulfate,
C18714,Cuprous oxide;|Copper (I) oxide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Copper fungicides|C18714  Cuprous oxide,
C18715,alpha-Cypermethrin;|Alphamethrin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18715  alpha-Cypermethrin,
C18716,Diclofop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18716  Diclofop,
C18717,Difenzoquat,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyrazole herbicides|C18717  Difenzoquat,
C18718,Dimethachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18718  Dimethachlor,
C18719,"Dimethipin;|2,3-Dihydro-5,6-dimethyl-1,4-dithiine 1,1,4,4-tetraoxide",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18719  Dimethipin,
C18720,Diniconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18720  Diniconazole,
C18721,Dinobuton,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18721  Dinobuton,
C18722,Diphenamid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18722  Diphenamid,
C18723,Dodine;|Dodecylguanidine acetate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Aliphatic nitrogen fungicides|C18723  Dodine,
C18724,Endothal-disodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18724  Endothal-disodium,
C18725,Ethion,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18725  Ethion,
C18726,Fenpropidin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18726  Fenpropidin,
C18727,Fenazaquin,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18727  Fenazaquin,
C18728,Fentin acetate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organotin fungicides|C18728  Fentin acetate,
C18729,Fentin hydroxide;|Fentin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organotin fungicides|C18729  Fentin hydroxide,
C18730,Fluchloralin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C18730  Fluchloralin,
C18731,Flufenacet,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18731  Flufenacet,
C18732,Fluoroglycofen,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Diphenyl ether herbicide|C18732  Fluoroglycofen,
C18733,Flusilazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18733  Flusilazole,
C18734,Flutriafol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18734  Flutriafol,
C18735,Fluxofenim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18735  Fluxofenim,
C18736,Fomesafen,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18736  Fomesafen,
C18737,Fuberidazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18737  Fuberidazole,
C18738,"BHC;|1,2,3,4,5,6-Hexachlorocyclohexane",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organochlorine insecticides|C18738  BHC,
C18739,Enilconazole;|Imazalil,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18739  Enilconazole|Drug groups [BR:br08330(D03997)]|Antifungal|DG01883  Imidazole antifungal|D03997  Enilconazole|Antimicrobials [BR:br08307(D03997)]|Antifungals|Ergosterol biosynthesis inhibitor|Imidazole|D03997  Enilconazole (USAN/INN),
C18740,Ioxynil octanoate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Nitrile herbicides|C18740  Ioxynil octanoate,
C18741,MCPA-thioethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18741  MCPA-thioethyl,
C18742,Mecoprop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18742  Mecoprop,
C18743,Mefluidide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18743  Mefluidide,
C18744,Metaldehyde,,,,Pesticides [BR:br08007]|Pesticides|Others|Molluscacide|C18744  Metaldehyde,
C18745,Methacrifos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18745  Methacrifos,
C18746,Methasulfocarb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18746  Methasulfocarb,
C18747,Metolcarb;|Tsumacide;|MTMC,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18747  Metolcarb,
C18748,Nabam,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dithiocarbamate fungicides|C18748  Nabam,
C18749,Naled,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18749  Naled,
C18750,2-Napthyloxyacetic acid,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Auxins|C18750  2-Napthyloxyacetic acid,
C18751,Nitrapyrin,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18751  Nitrapyrin,
C18752,Octhilinone,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Thiazole fungicides|C18752  Octhilinone,
C18753,Oxadixyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18753  Oxadixyl,
C18754,Captafol,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C18754  Captafol,
C18755,Pebulate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18755  Pebulate,
C18756,Phosmet,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18756  Phosmet,
C18757,Phoxim,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18757  Phoxim,
C18758,Piperophos,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18758  Piperophos,
C18759,Propachlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18759  Propachlor,
C18760,Prosulfocarb,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18760  Prosulfocarb,
C18761,Pyrazophos,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organophosphorus fungicides|C18761  Pyrazophos,
C18762,Pyridafenthion;|Pyridaphenthion,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18762  Pyridafenthion,
C18763,Quizalofop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18763  Quizalofop,
C18764,Quizalofop-P-tefuryl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18764  Quizalofop-P-tefuryl,
C18765,Sodium chlorate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Inorganic herbicides|C18765  Sodium chlorate,
C18766,Sulfluramid,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18766  Sulfluramid,
C18767,"2,3,6-TBA;|2,3,6-Trichlorobenzoic acid",,,,"Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18767  2,3,6-TBA",
C18768,Terbumeton,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18768  Terbumeton,
C18769,Tralkoxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18769  Tralkoxydim,
C18770,Triazamate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18770  Triazamate,
C18771,"XMC;|3,5-Xylyl methylcarbamate;|Cosban",,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Carbamate insecticides|C18771  XMC,
C18772,Alloxydim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Cyclohexene oxime herbicides|C18772  Alloxydim,
C18773,Ammonium sulfamate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Inorganic herbicides|C18773  Ammonium sulfamate,
C18774,Ancymidol,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18774  Ancymidol,
C18775,Benazolin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18775  Benazolin,
C18776,Bupirimate,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyrimidine fungicides|C18776  Bupirimate,
C18777,Chlorimuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18777  Chlorimuron,
C18778,8-D-Olivosyl-landomycin;|Landomycin I,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18778  Landomycin I|Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C18778  8-D-Olivosyl-landomycin,
C18779,"Clopyralid;|3,6-Dichloro-2-pyridinecarboxylic acid",,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18779  Clopyralid,
C18780,Cycloate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18780  Cycloate,
C18781,Diafenthiuron,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Acaricides|C18781  Diafenthiuron,
C18782,Dichlormid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18782  Dichlormid,
C18783,Dimefuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18783  Dimefuron,
C18784,Dimethirimol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Pyrimidine fungicides|C18784  Dimethirimol,
C18785,Dinitramine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C18785  Dinitramine,
C18786,Dodemorph,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Morpholine fungicides|C18786  Dodemorph,
C18787,Fenpropimorph,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Morpholine fungicides|C18787  Fenpropimorph,
C18788,Flamprop-M,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18788  Flamprop-M,
C18789,Fosamine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Organophosphorus herbicides|C18789  Fosamine,
C18790,tau-Fluvalinate,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Pyrethroid insecticides|C18790  tau-Fluvalinate,
C18791,Halofenozide,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Moulting hormone agonists|C18791  Halofenozide,
C18792,Methyldymron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18792  Methyldymron,
C18793,Metobromuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C18793  Metobromuron,
C18794,Monolinuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18794  Monolinuron,
C18795,MGK 264;|N-Octylbicycloheptene dicarboximide,,,,Pesticides [BR:br08007]|Pesticides|Others|Insect repellents|C18795  MGK 264,
C18796,(2R)-2-Hydroxy-2-methylbutanenitrile;|2-Hydroxy-2-methylbutanenitrile,,,,,
C18797,(S)-Hydroxynitrile;|(S)-Cyanohydrin,Generic compound in reaction hierarchy,,,,
C18798,"5,10-Methylene-H4SPT;|5,10-Methylene-tetrahydrosarcinapterin;|Methylene-tetrahydrosarcinapterin",,,,,
C18799,5-Methyl-H4SPT;|5-Methyl-tetrahydrosarcinapterin;|5-Methyltetrahydrosarcinapterin;|N5-Methyl-tetrahydrosarcinapterin,,,,,
C18800,Ofurace,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18800  Ofurace,
C18801,Penconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18801  Penconazole,
C18802,"Tetrahydrosarcinapterin;|H4SPT;|5,6,7,8-Tetrahydrosarcinapterin",,,,,
C18803,Pyridate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18803  Pyridate,
C18804,Pyrifenox,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Pyridine fungicides|C18804  Pyrifenox,
C18805,Pyrithiobac-sodium;|Pyrithiobac sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18805  Pyrithiobac-sodium,
C18806,Quinclorac,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18806  Quinclorac,
C18807,Spirotetramat,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18807  Spirotetramat,
C18808,TCA-sodium;|Trichloroacetic acid sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18808  TCA-sodium,
C18809,Temefos;|Temephos,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Organophosphorus insecticides|C18809  Temefos,
C18810,Terbuthylazine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18810  Terbuthylazine,
C18811,Terbutryn,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18811  Terbutryn,
C18812,Thidiazuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18812  Thidiazuron,
C18813,Tri-allate;|Triallate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18813  Tri-allate,
C18814,Trietazine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Triazine herbicides|C18814  Trietazine,
C18815,Triticonazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18815  Triticonazole,
C18816,Cryolite;|Aluminum sodium fluoride,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18816  Cryolite,
C18817,Chlorotoluron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18817  Chlorotoluron,
C18818,Cinosulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18818  Cinosulfuron,
C18819,Cloxyfonac-sodium,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Others|C18819  Cloxyfonac-sodium,
C18820,Dichlofluanid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18820  Dichlofluanid,
C18821,Diclosulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18821  Diclosulam,
C18822,Landomycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18822  Landomycin A|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C18822,
C18823,Landomycin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18823  Landomycin B,
C18824,Landomycin J,,,,Lipids [BR:br08002]|PK  Polyketides|PK08 Angucyclines|C18824  Landomycin J,
C18825,Dikegulac;|Diprogulic acid,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18825  Dikegulac,
C18826,Dithiopyr,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyridine herbicides|C18826  Dithiopyr,
C18827,Ethalfluralin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C18827  Ethalfluralin,
C18828,Ethirimol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Pyrimidine fungicides|C18828  Ethirimol,
C18829,Ethofumesate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18829  Ethofumesate,
C18830,Ethyl 3-(N-butylacetamido)propionate;|Ethyl butylacetylaminopropionate,,,,Pesticides [BR:br08007]|Pesticides|Others|Insect repellents|C18830  Ethyl 3-(N-butylacetamido)propionate,
C18831,Fenchlorazole-ethyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18831  Fenchlorazole-ethyl,
C18832,Fenclorim,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18832  Fenclorim,
C18833,Fenfuram,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18833  Fenfuram,
C18834,Propylmalonyl-CoA,,,,,
C18835,(R)-DNPA,,,,,
C18836,Griseophenone C,,,,,
C18837,Griseophenone B,,,,,
C18838,Dehydrogriseofulvin,,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1306 Dibenzofurans, griseofulvins, dibenzopyrans and xanthones|C18838  Dehydrogriseofulvin",
C18839,Prechromomycin B,,,,,
C18840,R1128A,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C18840  R1128A,
C18841,R1128B,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C18841  R1128B,
C18842,R1128C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C18842  R1128C,
C18843,R1128D,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1304 Anthracenes and phenanthrenes|C18843  R1128D,
C18844,Spiramycin III,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C18844  Spiramycin III,
C18845,Mycinamicin I,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C18845  Mycinamicin I,
C18846,Mycinamicin IV,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C18846  Mycinamicin IV,
C18847,Mycinamicin V,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C18847  Mycinamicin V,
C18848,Chalcolactone,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C18848  Chalcolactone,
C18849,Flumetralin,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18849  Flumetralin,
C18850,Florasulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18850  Florasulam,
C18851,Flucarbazone-sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18851  Flucarbazone-sodium,
C18852,Flumetsulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18852  Flumetsulam,
C18853,Fluometuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenylurea herbicides|C18853  Fluometuron,
C18854,Flupropanate,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18854  Flupropanate,
C18855,Flupyrsulfuron-methyl sodium,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18855  Flupyrsulfuron-methyl sodium,
C18856,Flurecol,,,,Pesticides [BR:br08007]|Pesticides|Plant growth regulators|Growth inhibitors / retardants|C18856  Flurecol,
C18857,Fluridone,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18857  Fluridone,
C18858,Fluroxypyr,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Pyridine herbicides|C18858  Fluroxypyr,
C18859,Fluthiacet,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18859  Fluthiacet,
C18860,Folpet,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Dicarboximide fungicides|C18860  Folpet,
C18861,Hexaflumuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18861  Hexaflumuron,
C18862,Hydroprene,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18862  Hydroprene,
C18863,2-(Octylthio)ethanol;|2-Hydroxyethyl octyl sulphide,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18863  2-(Octylthio)ethanol,
C18864,Imazapyr,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Imidazolinone herbicides|C18864  Imazapyr,
C18865,Imazethapyr,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Imidazolinone herbicides|C18865  Imazethapyr,
C18866,Iprovalicarb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C18866  Iprovalicarb,
C18867,Metosulam,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18867  Metosulam,
C18868,Napropamide,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18868  Napropamide,
C18869,Naptalam;|N-1-Naphthylphthalamic acid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Amide herbicides|C18869  Naptalam,
C18870,Selenodiglutathione;|GSSeSG,,,,,
C18871,Glutathioselenol;|GSSeH,,,,,
C18872,Trimethylselenonium,,,,,
C18873,Nitrothal-isopropyl,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18873  Nitrothal-isopropyl,
C18874,Norflurazon,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18874  Norflurazon,
C18875,Novaluron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18875  Novaluron,
C18876,Noviflumuron,,,,Pesticides [BR:br08007]|Pesticides|Insect growth regulators|Chitin synthesis inhibitors|C18876  Noviflumuron,
C18877,Oryzalin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C18877  Oryzalin,
C18878,Oxabetrinil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Others|C18878  Oxabetrinil,
C18879,Oxine-copper;|Copper 8-hydroxyquinoline,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Copper fungicides|C18879  Oxine-copper,
C18880,Piperonyl butoxide,,,,Pesticides [BR:br08007]|Pesticides|Others|Synergist|C18880  Piperonyl butoxide|Animal drugs in Japan [BR:br08331(D08383)]|99  Agents for not mainly purpose of therapeutic|993  Insecticides and insect-repellents|9939  Other insecticides and insect repellents|D08383  Piperonyl butoxide,
C18881,Oxyfluorfen,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Diphenyl ether herbicide|C18881  Oxyfluorfen,
C18882,Pentanochlor,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Anilide herbicides|C18882  Pentanochlor,
C18883,Primisulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18883  Primisulfuron,
C18884,Prodiamine,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C18884  Prodiamine,
C18885,Propamocarb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C18885  Propamocarb,
C18886,Propaquizafop,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Phenoxy herbicides|C18886  Propaquizafop,
C18887,Propham,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Carbanilate herbicides|C18887  Propham,
C18888,Prothioconazole,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Conazole fungicides|C18888  Prothioconazole,
C18889,Pyrazosulfuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18889  Pyrazosulfuron,
C18890,Pyriminobac,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18890  Pyriminobac,
C18891,Quinmerac,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Benzoic acid herbicides|C18891  Quinmerac,
C18892,Quinoxyfen,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Others|C18892  Quinoxyfen,
C18893,1-Methylseleno-N-acetyl-D-galactosamine,,,,,
C18894,Spinetoram,,,,Pesticides [BR:br08007]|Pesticides|Insecticides|Others|C18894  Spinetoram,
C18895,Sulfometuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18895  Sulfometuron,
C18896,Tebutam;|Butam,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C18896  Tebutam,
C18897,"Tecnazene;|2,3,5,6-Tetrachloro-1-nitrobenzene",,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Organochlorine fungicides|C18897  Tecnazene,
C18898,Tiocarbazil;|Thiocarbazil,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Thiocarbamate herbicides|C18898  Tiocarbazil,
C18899,Tolylfluanid,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18899  Tolylfluanid,
C18900,Tribenuron,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18900  Tribenuron,
C18901,Triflusulfuron-methyl,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Sulfonylurea herbicides|C18901  Triflusulfuron-methyl,
C18902,Methylselenic acid;|Methylseleninate,,,,,
C18903,Zoxamide,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Amide fungicides|C18903  Zoxamide,
C18904,Methylselenopyruvate;|beta-Methylselenopyruvate,,,,,
C18905,Methylselenocysteine Se-oxide;|Methylselenocysteine selenooxide,,,,,
C18906,Aldoxycarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18906  Aldoxycarb,
C18907,Benodanil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18907  Benodanil,
C18908,Chloraniformethan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18908  Chloraniformethan,
C18909,Cyprofuram,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18909  Cyprofuram,
C18910,"2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one;|2,5-Diamino-6-(1-D-ribitylamino)pyrimidin-4(3H)-one 5'-phosphate",,,,"Glycosides [BR:br08021]|N-glycosides|C18910  2,5-Diamino-6-(5-phospho-D-ribitylamino)pyrimidin-4(3H)-one",
C18911,(R)-4-Phosphopantoate,,,,,
C18912,Furmecyclox,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18912  Furmecyclox,
C18913,Mebenil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18913  Mebenil,
C18914,Pyracarbolid,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18914  Pyracarbolid,
C18915,Salicylanilide,,,,,
C18916,Trichlamide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Amide fungicides|C18916  Trichlamide,
C18917,Cypendazole,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Carbamate fungicides|C18917  Cypendazole,
C18918,Thiophanate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Carbamate fungicides|C18918  Thiophanate,
C18919,Furconazole-cis,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Conazole fungicides|C18919  Furconazole-cis,
C18920,Fluoromidine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18920  Fluoromidine,
C18921,Myclozolin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Dicarboximide fungicides|C18921  Myclozolin,
C18922,Dinocton 6,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18922  Dinocton 6,
C18923,Carbamorph,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18923  Carbamorph,
C18924,Benquinox,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18924  Benquinox,
C18925,Ditalimfos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Organophosphorus fungicides|C18925  Ditalimfos,
C18926,Phosdiphen,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Organophosphorus fungicides|C18926  Phosdiphen,
C18927,Triamiphos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Organophosphorus fungicides|C18927  Triamiphos,
C18928,Dichlozoline,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Dicarboximide fungicides|C18928  Dichlozoline,
C18929,Drazoxolon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18929  Drazoxolon,
C18930,Buthiobate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Pyridine fungicides|C18930  Buthiobate,
C18931,Pyridinitril,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Pyridine fungicides|C18931  Pyridinitril,
C18932,Triarimol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Pyrimidine fungicides|C18932  Triarimol,
C18933,"Chloranil;|p-Chloranil;|2,3,5,6-Tetrachloro-1,4-benzoquinone",,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18933  Chloranil,
C18934,Metsulfovax,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18934  Metsulfovax,
C18935,Anilazine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18935  Anilazine,
C18936,"Chlorquinox;|5,6,7,8-Tetrachloroquinoxaline",,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18936  Chlorquinox,
C18937,Fenaminosulf;|para-Dimethylaminoazobenzenediazo sodium sulfonate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18937  Fenaminosulf,
C18938,Fenitropan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18938  Fenitropan,
C18939,Fluotrimazole,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18939  Fluotrimazole,
C18940,Glyodin;|Glyodin acetate,,,,,
C18941,Halacrinate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18941  Halacrinate,
C18942,Mecarbinzid,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18942  Mecarbinzid,
C18943,Prothiocarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18943  Prothiocarb,
C18944,Quinacetol sulfate;|Quinacetol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18944  Quinacetol sulfate,
C18945,Thicyofen,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18945  Thicyofen,
C18946,Thioquinox,,,,Pesticides [BR:br08007]|Obsolete pesticides|Fungicides|Others|C18946  Thioquinox,
C18947,Allyxycarb,,,,,
C18948,Bufencarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18948  Bufencarb,
C18949,Butacarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18949  Butacarb,
C18950,Carbanolate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18950  Carbanolate,
C18951,Cloethocarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18951  Cloethocarb,
C18952,Mexacarbate;|Zectran,,,,,
C18953,Dioxacarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18953  Dioxacarb,
C18954,Nitrilacarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18954  Nitrilacarb,
C18955,Promacyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18955  Promacyl,
C18956,Promecarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Carbamate insecticide|C18956  Promecarb,
C18957,"2,3,5-Trimethacarb",,,,,
C18958,Bromocyclen;|Bromociclen,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18958  Bromocyclen,
C18959,Chlorbicyclen,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18959  Chlorbicyclen,
C18960,Isobenzan;|Telodrin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18960  Isobenzan,
C18961,Isodrin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18961  Isodrin,
C18962,Kelevan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organochlorine insecticides|C18962  Kelevan,
C18963,Amidithion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18963  Amidithion,
C18964,Athidathion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18964  Athidathion,
C18965,Bromofos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18965  Bromofos,
C18966,Bromophos-ethyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18966  Bromophos-ethyl,
C18967,Butonate,,,,,
C18968,Carbophenothion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18968  Carbophenothion,
C18969,Chlorphoxim,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18969  Chlorphoxim,
C18970,Chlorthiophos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18970  Chlorthiophos,
C18971,Crotoxyphos;|Crotoxyfos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18971  Crotoxyphos,
C18972,Crufomate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18972  Crufomate,
C18973,Cyanofenphos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18973  Cyanofenphos,
C18974,Cyanthoate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18974  Cyanthoate,
C18975,Demephion-O,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18975  Demephion-O,
C18976,Demephion-S,,,,,
C18977,Demeton-O,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18977  Demeton-O,
C18978,Demeton-S,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18978  Demeton-S,
C18979,Demeton-S-methylsulphon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18979  Demeton-S-methylsulphon,
C18980,Dimefox,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18980  Dimefox,
C18981,Salithion;|Dioxabenzofos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18981  Salithion,
C18982,Endothion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18982  Endothion,
C18983,Ethoate-methyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18983  Ethoate-methyl,
C18984,Oxydeprofos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18984  Oxydeprofos,
C18985,Etrimfos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18985  Etrimfos,
C18986,Fenchlorphos;|Fenclofos;|Ronnel,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18986  Fenchlorphos,
C18987,Fonofos;|Dyphonate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18987  Fonofos,
C18988,Formothion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18988  Formothion,
C18989,Fosmethilan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18989  Fosmethilan,
C18992,Vinylidene chloride-vinyl chloride copolymer;|Saran,,,,,
C18993,"2,5-Xylidine;|2,5-Dimethyl-benzenamine",,,,,
C18999,Fosthietan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C18999  Fosthietan,
C19000,IPSP,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19000  IPSP,
C19001,Isazofos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19001  Isazofos,
C19002,Iodofenphos;|Jodfenphos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19002  Iodofenphos,
C19003,Leptophos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19003  Leptophos,
C19004,Lythidathion,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19004  Lythidathion,
C19005,Mecarphon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19005  Mecarphon,
C19006,Menazon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19006  Menazon,
C19007,Mephosfolan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19007  Mephosfolan,
C19008,Mipafox,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19008  Mipafox,
C19009,Oxydisulfoton,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19009  Oxydisulfoton,
C19010,Phenkapton,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19010  Phenkapton,
C19011,Phosfolan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19011  Phosfolan,
C19012,Pirimiphos-ethyl;|Pirimiphosethyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19012  Pirimiphos-ethyl,
C19013,Propaphos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19013  Propaphos,
C19014,Prothoate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19014  Prothoate,
C19015,Schradan;|Octamethyl pyrophosphortetramide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19015  Schradan,
C19016,Sulprofos,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19016  Sulprofos,
C19017,TEPP;|Tetraethyl pyrophosphate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19017  TEPP,
C19018,Trichloronat,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19018  Trichloronat,
C19019,Aramite,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19019  Aramite,
C19020,Azothoate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19020  Azothoate,
C19021,Benzoximate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19021  Benzoximate,
C19022,Binapacryl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19022  Binapacryl,
C19023,Chlorfenethol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19023  Chlorfenethol,
C19024,Chlorfenson,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19024  Chlorfenson,
C19025,Chlorfensulphide;|Azosulfide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19025  Chlorfensulphide,
C19026,Chloromethiuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19026  Chloromethiuron,
C19027,Chloropropylate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19027  Chloropropylate,
C19028,Dialifor,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19028  Dialifor,
C19029,Fenazaflor;|Tarzol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19029  Fenazaflor,
C19030,Fenson,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19030  Fenson,
C19031,Fluenetil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19031  Fluenetil,
C19032,Tetrasul,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19032  Tetrasul,
C19033,Carbon disulfide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Fumigants|C19033  Carbon disulfide,
C19034,"1,2-Dichloropropane",,,,"Pesticides [BR:br08007]|Obsolete pesticides|Others|Fumigants|C19034  1,2-Dichloropropane",
C19035,Diamidafos;|Nellite,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Nematicides|C19035  Diamidafos,
C19036,Thionazin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Nematicides|C19036  Thionazin,
C19037,Chloromebuform,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19037  Chloromebuform,
C19038,Dinex,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Acaricides|C19038  Dinex,
C19039,Malonoben,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C19039  Malonoben,
C19040,Sodium hexafluorosilicate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Others|C19040  Sodium hexafluorosilicate,
C19041,Flubenzimine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insect growth regulators|Mite growth regulators|C19041  Flubenzimine,
C19042,Kinoprene,,,,Pesticides [BR:br08007]|Obsolete pesticides|Insect growth regulators|Juvenile hormone mimics|C19042  Kinoprene,
C19043,Allidochlor,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19043  Allidochlor,
C19044,Benzoylprop-ethyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19044  Benzoylprop-ethyl,
C19045,Butenachlor,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19045  Butenachlor,
C19046,Chloranocryl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19046  Chloranocryl,
C19047,Isocarbamid,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19047  Isocarbamid,
C19048,Quinonamid,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Amide herbicides|C19048  Quinonamid,
C19049,Cypromid,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19049  Cypromid,
C19050,Delachlor,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19050  Delachlor,
C19051,Diethatyl-ethyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19051  Diethatyl-ethyl,
C19052,Flamprop,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19052  Flamprop,
C19053,Monalide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19053  Monalide,
C19054,Perfluidone,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Anilide herbicides|C19054  Perfluidone,
C19055,Hexaflurate;|Potassium hexafluoroarsenate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19055  Hexaflurate,
C19056,Chloramben,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Benzoic acid herbicides|C19056  Chloramben,
C19057,Tricamba,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Benzoic acid herbicides|C19057  Tricamba,
C19058,Benzthiazuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19058  Benzthiazuron,
C19059,Barban,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Carbanilate herbicides|C19059  Barban,
C19060,Chlorbufam,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Carbanilate herbicides|C19060  Chlorbufam,
C19061,Phenisopham,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Carbanilate herbicides|C19061  Phenisopham,
C19062,SWEP,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Carbanilate herbicides|C19062  SWEP,
C19063,Isopropalin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Dinitroaniline herbicides|C19063  Isopropalin,
C19064,Nitralin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Dinitroaniline herbicides|C19064  Nitralin,
C19065,Profluralin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Dinitroaniline herbicides|C19065  Profluralin,
C19066,Chlomethoxyfen,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Diphenyl ether herbicides|C19066  Chlomethoxyfen,
C19067,Potassium cyanate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19067  Potassium cyanate,
C19068,Medinoterb acetate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Nitrophenol herbicides|C19068  Medinoterb acetate,
C19069,Bromofenoxim,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C19069  Bromofenoxim,
C19070,Clofop,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C19070  Clofop,
C19071,Disul,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C19071  Disul,
C19072,Erbon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C19072  Erbon,
C19073,Isoxapyrifop,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenoxy herbicides|C19073  Isoxapyrifop,
C19074,Buturon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19074  Buturon,
C19075,Chloroxuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19075  Chloroxuron,
C19076,Difenoxuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19076  Difenoxuron,
C19077,Fenuron-TCA;|Fenuron TCA,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19077  Fenuron-TCA,
C19078,tRNA with a 3' cytidine,,,,,
C19079,(4R)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone;|(4R)-7-Hydroxy-4-isopropenyl-7-methyloxepan-2-one,,,,,
C19080,tRNA with a 3' CC end;|tRNA with a 3' CC,,,,,
C19081,"(4S)-Limonene-1,2-epoxide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C19081  (4S)-Limonene-1,2-epoxide",
C19082,"(1R,2R,4S)-Limonene-1,2-diol;|(1R,2R,4S)-Menth-8-ene-1,2-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C19082  (1R,2R,4S)-Limonene-1,2-diol",
C19083,"(1R,4S)-1-Hydroxy-2-oxolimonene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C19083  (1R,4S)-1-Hydroxy-2-oxolimonene",
C19084,(4S)-7-Hydroxy-4-isopropenyl-7-methyl-2-oxo-oxepanone;|(4S)-7-Hydroxy-4-isopropenyl-7-methyloxepan-2-one,,,,,
C19085,tRNA with a 3' CCA end,,,,,
C19086,Methiuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19086  Methiuron,
C19087,Monuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19087  Monuron,
C19088,Monuron-TCA;|Monuron TCA,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19088  Monuron-TCA,
C19089,Parafluron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19089  Parafluron,
C19090,Phenobenzuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19090  Phenobenzuron,
C19091,Haloxydine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19091  Haloxydine,
C19092,Ethidimuron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19092  Ethidimuron,
C19093,Thiazafluron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19093  Thiazafluron,
C19094,Diallat;|Di-allate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Thiocarbamate herbicides|C19094  Diallat,
C19095,Ethiolate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Thiocarbamate herbicides|C19095  Ethiolate,
C19096,Sulfallate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Thiocarbamate herbicides|C19096  Sulfallate,
C19097,Vernolate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Thiocarbamate herbicides|C19097  Vernolate,
C19098,Atraton,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19098  Atraton,
C19099,Aziprotryne,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19099  Aziprotryne,
C19100,Desmetryn,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19100  Desmetryn,
C19101,Dipropetryn,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19101  Dipropetryn,
C19102,Eglinazine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19102  Eglinazine,
C19103,Ipazine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19103  Ipazine,
C19104,Methoprotryne,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19104  Methoprotryne,
C19105,Proglinazine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19105  Proglinazine,
C19106,Secbumeton,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Triazine herbicides|C19106  Secbumeton,
C19107,Isomethiozin,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19107  Isomethiozin,
C19108,Isocil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19108  Isocil,
C19109,Cycluron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19109  Cycluron,
C19110,Isonoruron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19110  Isonoruron,
C19111,Noruron,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Urea herbicides|C19111  Noruron,
C19112,Buthidazole,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19112  Buthidazole,
C19113,Calcium carbimide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19113  Calcium carbimide|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03288)]|N NERVOUS SYSTEM|N07 OTHER NERVOUS SYSTEM DRUGS|N07B DRUGS USED IN ADDICTIVE DISORDERS|N07BB Drugs used in alcohol dependence|N07BB02 Calcium carbimide|D03288  Calcium carbimide (INN),
C19114,Chlorfenac,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19114  Chlorfenac,
C19115,Chlorfenprop-methyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19115  Chlorfenprop-methyl,
C19116,Credazine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19116  Credazine,
C19117,Cyometrinil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19117  Cyometrinil,
C19118,Dimexano,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19118  Dimexano,
C19119,Dinoseb acetate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Nitrophenol herbicides|C19119  Dinoseb acetate,
C19120,Dixanthogen;|EXD,,,,"Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19120  Dixanthogen|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07366)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS|P03A ECTOPARASITICIDES, INCL. SCABICIDES|P03AA Sulfur containing products|P03AA01 Dixanthogen|D07366  Dixanthogen (INN)",
C19121,Fenthiaprop,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Phenylurea herbicides|C19121  Fenthiaprop,
C19122,Hexachloroacetone,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19122  Hexachloroacetone,
C19123,Methazole,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19123  Methazole,
C19124,"Methoxyphenone;|4-Methoxy-3,3'-dimethylbenzophenone",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19124  Methoxyphenone,
C19125,"Naphthalic anhydride;|1,8-Naphthalic anhydride",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19125  Naphthalic anhydride,
C19126,Oxapyrazon,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19126  Oxapyrazon,
C19127,Proxan,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19127  Proxan,
C19128,"Pydanon;|Hexahydro-4-hydroxy-3,6-dioxopyridazine-4-acetic acid",,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19128  Pydanon,
C19129,Terbucarb,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19129  Terbucarb,
C19130,Tridiphane,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19130  Tridiphane,
C19131,Etacelasil;|Alsol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Others|C19131  Etacelasil,
C19132,Glyphosine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Growth inhibitors / retardants|C19132  Glyphosine,
C19133,Piproctanyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Growth inhibitors / retardants|C19133  Piproctanyl,
C19134,Heptopargil,,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Others|C19134  Heptopargil,
C19135,Triapenthenol,,,,Pesticides [BR:br08007]|Obsolete pesticides|Plant growth regulators|Others|C19135  Triapenthenol,
C19136,ANTU;|alpha-Naphthylthiourea,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19136  ANTU,
C19137,Bisthiosemi,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19137  Bisthiosemi,
C19138,Crimidine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19138  Crimidine,
C19139,Norbormide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19139  Norbormide,
C19140,Phosacetim,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19140  Phosacetim,
C19141,Pindone,,,,Pesticides [BR:br08007]|Obsolete pesticides|Rodenticides|Others|C19141  Pindone,
C19142,Butopyronoxyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Insect repellents|C19142  Butopyronoxyl,
C19143,Dibutyl succinate,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Insect repellents|C19143  Dibutyl succinate,
C19144,Trifenmorph;|4-Tritylmorpholine,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Molluscacide|C19144  Trifenmorph,
C19145,"Propyl isome;|1,2,3,4-Tetrahydro-3-methyl-6,7-methylenebisoxynaphthalene-1,2-dicarboxylic acid dipropyl",,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Synergists|C19145  Propyl isome,
C19146,Sesamex,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Synergists|C19146  Sesamex,
C19147,Piperonyl sulfoxide,,,,Pesticides [BR:br08007]|Obsolete pesticides|Others|Synergists|C19147  Piperonyl sulfoxide,
C19148,"S-Seven;|O-Ethyl O-2,4-dichlorophenyl thionobenzenephosphonate;|EPBP",,,,Pesticides [BR:br08007]|Obsolete pesticides|Insecticides|Organophosphorus insecticides|C19148  S-Seven,
C19149,TCA-ethadyl,,,,Pesticides [BR:br08007]|Obsolete pesticides|Herbicides|Others|C19149  TCA-ethadyl,
C19150,Diethyldithiocarbamic acid,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Inorganic and organic chemicals|Diethyldithiocarbamate|C19150  Diethyldithiocarbamic acid,
C19151,Coenzyme F420-3;|Coenzyme alpha-F420-3,,,,,
C19152,Coenzyme F420-1,,,,,
C19153,Coenzyme F420-0;|Factor 420-0;|Oxidized coenzyme F420-0,,,,,
C19154,"7,8-Didemethyl-8-hydroxy-5-deazariboflavin",,,,,
C19155,(2S)-Lactyl-2-diphospho-5'-guanosine,,,,,
C19156,(2S)-2-Phospholactate,,,,,
C19157,Thorium-232,,,,,
C19158,Bis(chloromethyl) ether;|BCME,,,,,
C19159,Plutonium,,,,,
C19160,Chloromethyl methyl ether,,,,,
C19162,"Phosphorus-32;|Phosphorus, isotope of mass 32",,,,,
C19164,Sulfur mustard;|Mustard gas;|Iprit,,,,,
C19165,Benzal chloride,,,,,
C19166,Benzotrichloride,,,,,
C19167,Benzyl chloride,,,,,
C19168,Benzoyl chloride,,,,,
C19169,4-Chloro-ortho-toluidine;|4-Chloro-o-toluidine;|2-Amino-5-chlorotoluene,,,,,
C19170,Chlorozotocin,,,,,
C19171,Cobalt,Cobalt and cobalt compounds|Usually existing as +2 cations|Co2+ [CPD:C00175],,,,
C19173,Cyclopenta[cd]pyrene,,,,,
C19174,"Dibenzo[a,l]pyrene;|Dibenzo[def,p]chrysene;|1,2,9,10-Dibenzopyrene",,,,,
C19175,Dimethylcarbamoyl chloride,,,,,
C19176,"1,2-Dimethylhydrazine",,,,,
C19177,Dimethyl sulfate,,,,,
C19178,N-Nitroso-N-ethylurea,,,,,
C19180,"2-Amino-3-methylimidazo[4,5-f]quinoline;|IQ",,,,,
C19181,Methyl methanesulfonate;|MMS,,,,,
C19182,"Tris(2,3-dibromopropyl) phosphate",,,,,
C19184,Vinyl bromide,,,,,
C19185,Vinyl fluoride,,,,,
C19186,"2-Amino-9H-pyrido[2,3-b]indole;|2-Amino-alpha-carboline;|A-alpha-C",,,,,
C19187,para-Aminoazobenzene;|4-Aminoazobenzene;|Aniline yellow,,,,,
C19188,ortho-Aminoazotoluene;|C.I. Solvent Yellow 3,,,,,
C19189,"2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole;|Triafur",,,,,
C19190,"Trehalose-6,6'-dibehenate;|Trehalose 6,6'-dibehenate;|TDB","Synthetic analog of Trehalose-6,6'-dimycolate [CPD:C21790]",,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C19190  Trehalose-6,6'-dibehenate",
C19191,ortho-Anisidine;|o-Anisidine,,,,,
C19193,Auramine,,,,,
C19194,Azaserine,,,,,
C19195,Benz[j]aceanthrylene,,,,,
C19196,Benzo[j]fluoranthene,,,,,
C19197,"Benzo[c]phenanthrene;|3,4-Benzphenanthrene",,,,,
C19198,Benzyl violet 4B;|Benzyl violet,,,,,
C19199,"2,2-Bis(bromomethyl)propane-1,3-diol;|Pentaerythritol dibromide",,,,,
C19201,beta-Butyrolactone,,,,,
C19203,"Poligeenan;|Carrageenan, degraded",,,,,
C19204,"Chlorendic acid;|1,4,5,6,7,7-Hexachloro-5-norbornene-2,3-dicarboxylic acid",,,,,
C19205,3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone,,,,,
C19206,1-Chloro-2-methylpropene;|1-Chloro-2-methyl-1-propene,,,,,
C19207,"4-Chloro-ortho-phenylenediamine;|4-Chloro-1,2-benzenediamine",,,,,
C19208,"Chloroprene;|2-Chloro-1,3-butadiene",,,,,
C19209,CI Acid red 114,,,,,
C19210,CI Basic red 9,,,,,
C19211,"1-Amino-2,4-dibromoanthraquinone",,,,,
C19212,Bromochloroacetic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C19212  Bromochloroacetic acid,
C19213,C.I. Direct blue 15,,,,,
C19214,Citrus Red No.2;|Citrus Red 2,,,,,
C19215,Cobalt sulfate;|Cobalt(II) sulfate,,,,,
C19216,para-Cresidine;|p-Cresidine,,,,,
C19217,"N,N'-Diacetylbenzidine;|4,4'-Diacetylbenzidine",,,,,
C19218,"2,4-Diaminoanisole",,,,,
C19219,"Dibenz[a,h]acridine",,,,,
C19220,"Dibenz[a,j]acridine",,,,,
C19221,"7H-Dibenzo[c,g]carbazole",,,,,
C19222,"Dibenzo[a,h]pyrene;|3,4:8,9-Dibenzopyrene",,,,,
C19223,"Dibenzo[a,i]pyrene",,,,,
C19224,"2,3-Dibromo-1-propanol;|2,3-Dibromopropanol",,,,,
C19225,"3,3'-Dichlorobenzidine",,,,,
C19226,"3,3'-Dichloro-4,4'-diaminodiphenyl ether",,,,,
C19227,"1,2-Diethylhydrazine",,,,,
C19228,Diglycidyl resorcinol ether,,,,,
C19229,"Dihydrosafrole;|1,2-(Methylenedioxy)-4-propylbenzene",,,,,
C19230,Diisopropyl sulfate,,,,,
C19231,"3,3'-Dimethoxybenzidine;|ortho-Dianisidine",,,,,
C19232,"trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2- furyl)-vinyl]-1,3,4-oxadiazole;|N,N-dimethyl-N'-(5-(2-(5-nitro-2-furyl)vinyl)-1,3,4-oxadiazol-2-yl)-Formamidine",,,,,
C19233,"1,1-Dimethylhydrazine",,,,,
C19234,"3,7-Dinitrofluoranthene",,,,,
C19235,"3,9-Dinitrofluoranthene",,,,,
C19236,"Disperse Blue 1;|1,4,5,8-Tetraamino-9,10-anthracenedione",,,,,
C19237,"1,2-Epoxybutane;|1-Butene oxide",,,,,
C19238,Ethyl acrylate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C19238  Ethyl acrylate,
C19239,Ethyl methanesulfonate,,,,,
C19240,Nifurthiazole;|2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole,,,,Drug groups [BR:br08330(D05167)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|D05167  Nifurthiazole|Antimicrobials [BR:br08307(D05167)]|Antibacterials|Bactericidal action|5-Nitrofurans|D05167  Nifurthiazole (USAN/INN),
C19241,Fumonisin B1,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C19241  Fumonisin B1|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Fumonisins|C19241  Fumonisin B1,
C19242,Fumonisin B2,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C19242  Fumonisin B2|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Fumonisins|C19242  Fumonisin B2,
C19243,Fusarin C,,,,,
C19244,"Glu-P-1;|2-Amino-6-methyldipyrid[1,2-a:3',2'-d]imidazole",,,,,
C19245,"Glu-P-2;|2-Aminodipyrido[1,2-a:3',2'-d]imidazole",,,,,
C19246,Glycidaldehyde;|2-Oxiranecarboxaldehyde,,,,,
C19247,"HC Blue No.1;|2,2'-[[4-(Methylamino)-3-nitrophenyl]imino]bisethanol",,,,,
C19248,Hexachloroethane,,,,,
C19249,"2,4-Hexadienal;|(E,E)-2,4-Hexadienal",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA06 Fatty aldehydes|C19249  (E,E)-2,4-Hexadienal",
C19250,Hexamethylphosphoramide;|HMPA,,,,,
C19251,"Indeno[1,2,3-cd]pyrene",,,,,
C19252,Magenta;|Fuchsin;|Rosaniline hydrochloride,,,,,
C19253,"2-Amino-3-methyl-9H-pyrido[2,3-b]indole;|MeA-alpha-C",,,,,
C19254,"MeIQ;|2-Amino-3,4-dimethylimidazo[4,5-f]quinoline",,,,,
C19255,"MeIQx;|8-Methyl-IQX;|2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline",,,,,
C19256,Merphalan;|Sarcolysin,,,,,
C19257,2-Methylaziridine;|Propyleneimine,,,,,
C19258,Methylazoxymethanol acetate,,,,,
C19259,5-Methylchrysene,,,,,
C19260,"4,4'-Methylene bis(2-methylaniline)",,,,,
C19261,2-Methylimidazole,,,,,
C19262,4-Methylimidazole,,,,,
C19263,Methyl isobutyl ketone;|4-Methylpentan-2-one,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C19263  4-Methylpentan-2-one,
C19264,2-Methyl-1-nitroanthraquinone,,,,,
C19265,Methylthiouracil,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07231)]|H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS|H03 THYROID THERAPY|H03B ANTITHYROID PREPARATIONS|H03BA Thiouracils|H03BA01 Methylthiouracil|D07231  Methylthiouracil (INN)|Drug groups [BR:br08330(D07231)]|Hormonal agent|DG01934  Antithyroid agent|D07231  Methylthiouracil|Target-based classification of drugs [BR:br08310(D07231)]|Enzymes|Oxidoreductases (EC1)|Peroxidase|TPO|D07231  Methylthiouracil (INN)",
C19266,"4,4'-Bis(dimethylamino)benzophenone;|Michler's ketone",,,,,
C19267,Levofuraltadone;|5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2- oxazolidinone,,,,Drug groups [BR:br08330(D04714)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|D04714  Levofuraltadone|Antiparasitic|DG01554  5-Nitrofuran antiprotozoal|D04714  Levofuraltadone|Antimicrobials [BR:br08307(D04714)]|Antibacterials|Bactericidal action|5-Nitrofurans|D04714  Levofuraltadone (USAN/INN),
C19268,Niridazole,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05170)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02B ANTITREMATODALS|P02BX Other antitrematodal agents|P02BX02 Niridazole|D05170  Niridazole (USAN/INN)|Antimicrobials [BR:br08307(D05170)]|Antiparasitics|Antitrematodal agents|Others|D05170  Niridazole (USAN/INN)",
C19269,5-Nitroacenaphthene,,,,,
C19270,2-Nitroanisole;|o-Nitroanisole,,,,,
C19271,6-Nitrochrysene,,,,,
C19272,Nifuradene;|1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone,,,,Drug groups [BR:br08330(D02514)]|Antibacterial|DG01553  5-Nitrofuran antibacterial|D02514  Nifuradene|Antimicrobials [BR:br08307(D02514)]|Antibacterials|Bactericidal action|5-Nitrofurans|D02514  Nifuradene (USAN/INN),
C19273,N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide;|Furothiazole,,,,,
C19274,Nitrogen mustard N-oxide,,,,,
C19275,Nitromethane,,,,,
C19276,4-Nitropyrene,,,,,
C19277,"N-Nitrosodi-n-butylamine;|N,N-Dibutylnitrosoamine",,,,,
C19278,N-Nitrosodiethanolamine,,,,,
C19279,N-Nitrosodi-n-propylamine,,,,,
C19280,3-(N-Nitrosomethylamino)propionitrile;|3-(Methylnitrosamino)propionitrile,,,,,
C19281,N-Nitrosomethylethylamine,,,,,
C19282,N-Nitrosomethylvinylamine,,,,,
C19283,N-Nitrosomorpholine,,,,,
C19284,N-Nitrosopiperidine,,,,,
C19285,N-Nitrosopyrrolidine,,,,,
C19286,N-Nitrososarcosine,,,,,
C19287,Oil Orange SS,,,,,
C19289,Panfuran S;|Dihydroxymethylfuratrizine,,,,,
C19290,Phenazopyridine hydrochloride,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05450)]|G GENITO URINARY SYSTEM AND SEX HORMONES|G04 UROLOGICALS|G04B UROLOGICALS|G04BX Other urologicals|G04BX06 Phenazopyridine|D05450  Phenazopyridine hydrochloride (USP),
C19291,Phenyl glycidyl ether,,,,,
C19293,Ponceau 3R,,,,,
C19294,Ponceau MX;|Acid Red 26,,,,,
C19295,Potassium bromate,,,,,
C19296,"1,3-Propane sultone",,,,,
C19297,Propiolactone;|beta-Propiolactone,,,,,
C19298,Sodium ortho-phenylphenate,,,,,
C19299,Tetrafluoroethylene,,,,,
C19300,Tetranitromethane,,,,,
C19301,N-Nitroso-N-methylurethane,,,,,
C19302,Thioacetamide,,,,,
C19303,"4,4'-Thiodianiline;|4,4'-Thiobisbenzenamine",,,,,
C19304,Thiouracil;|4-Hydroxy-2-pyrimidinethiol,,,,,
C19305,"Trichlormethine;|2,2',2''-Trichlorotriethylamine hydrochloride",,,,,
C19306,"Trp-P-1;|3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole",,,,,
C19307,Trypan blue,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D12658)]|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01K SURGICAL AIDS|S01KX Other surgical aids|S01KX02 Trypan blue|D12658  Trypan blue &lt;US&gt;|New drug approvals in the USA [br08319.html]|New molecular entities and new therapeutic biological products|C19307,
C19309,Vinyl acetate,,,,,
C19310,4-Vinylcyclohexene;|4-Vinyl-1-cyclohexene,,,,,
C19311,4-Vinylcyclohexene diepoxide,,,,,
C19312,Acenaphthene,,,,,
C19314,"Acepyrene;|3,4-Dihydrocyclopenta[cd]pyrene",,,,,
C19315,"Acridine orange;|3,6-Bis(dimethylamino)acridine",,,,,
C19316,Allyl chloride,,,,,
C19317,Allyl isothiocyanate;|Mustard oil,,,,,
C19318,Allyl isovalerate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0701 Wax monoesters|C19318  Allyl isovalerate,
C19319,5-Aminoacenaphthene;|5-Acenaphthenamine,,,,,
C19320,1-Amino-2-methylanthraquinone,,,,,
C19321,2-Amino-4-nitrophenol,,,,,
C19322,2-Amino-5-nitrophenol,,,,,
C19323,4-Amino-2-nitrophenol,,,,,
C19324,2-Amino-5-nitrothiazole;|Aminonitrothiazole,,,,,
C19325,11-Aminoundecanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0110 Amino fatty acids|C19325  11-Aminoundecanoic acid,
C19326,para-Anisidine;|1-Amino-4-methoxybenzene,,,,,
C19327,"Anthanthrene;|Dibenzo[cd,jk]pyrene",,,,,
C19329,Apholate,,,,,
C19330,para-Aramid fibrils;|Kevlar 49,,,,,
C19331,Arsenobetaine,,,,,
C19332,2-(1-Aziridinyl)ethanol;|1-Aziridineethanol,,,,,
C19333,Aziridyl benzoquinone;|Benzoquinone aziridine,,,,,
C19334,Azobenzene,,,,,
C19335,11H-Benz[bc]aceanthrylene,,,,,
C19336,Benz[l]aceanthrylene,,,,,
C19337,Benz[a]acridine,,,,,
C19338,Benz[c]acridine;|12-Azabenz[a]anthracene,,,,,
C19339,"Benzo[b]chrysene;|1,2:6,7-Dibenzophenanthrene",,,,,
C19340,Benzo[g]chrysene,,,,,
C19341,Benzo[a]fluoranthene,,,,,
C19342,"Benzo[ghi]fluoranthene;|2,13-Benzofluoranthene",,,,,
C19343,Benzo[a]fluorene;|11H-Benzo[a]fluorene,,,,,
C19344,Benzo[c]fluorene;|7H-Benzo[c]fluorene,,,,,
C19345,para-Benzoquinone dioxime,,,,,
C19346,Benzoyl peroxide,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D03093)]|D DERMATOLOGICALS|D10 ANTI-ACNE PREPARATIONS|D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE|D10AE Peroxides|D10AE01 Benzoyl peroxide|D03093  Benzoyl peroxide (JAN/USP) &lt;JP/US&gt;|USP drug classification [BR:br08302(D03093)]|Dermatological Agents|Topical Anti-infectives|Antibacterials, dermatological|Benzoyl Peroxide|D03093  Benzoyl peroxide (JAN/USP)|Therapeutic category of drugs in Japan [BR:br08301(D03093)]|2  Agents affecting individual organs|26  Epidermides|269  Miscellaneous|2699  Others|D03093  Benzoyl peroxide (JAN/USP)|New drug approvals in Japan [br08318.html(D03093)]|Drugs with new active ingredients|D03093",
C19347,Bis(1-aziridinyl)morpholinophosphine sulfide,,,,,
C19348,"1,2-Bis(chloromethoxy)ethane",,,,,
C19349,"1,4-Bis(chloromethoxymethyl)benzene",,,,,
C19350,Bis(2-chloro-1-methylethyl)ether;|DCIP,,,,,
C19351,"Bis(2,3-epoxycyclopentyl)ether",,,,,
C19352,"Brilliant blue;|Brilliant blue FCF, disodium salt;|Food blue No.1",,,,,
C19353,Bromochloroacetonitrile,,,,,
C19354,Bromoethane;|Ethyl bromide,,,,,
C19355,2-Butoxyethanol,,,,,
C19356,"1-tert-Butoxy-2-propanol;|1-(1,1-Dimethylethoxy)-2-propanol;|Propylene glycol mono-t-buthyl ether",,,,,
C19357,3-Carbethoxypsoralen,,,,,
C19358,Carmoisine;|Azorubin;|C.I. Acid Red 14,,,,,
C19359,Chloramine,,,,,
C19360,Chloroacetonitrile,,,,,
C19361,Chlorodifluoromethane,,,,,
C19362,Chlorofluoromethane,,,,,
C19363,3-Chloro-2-methylpropene,,,,,
C19364,1-Chloro-3-nitrobenzene,,,,,
C19365,"4-Chloro-meta-phenylenediamine;|4-Chloro-1,3-benzenediamine",,,,,
C19366,5-Chloro-ortho-toluidine;|5-Chloro-o-toluidine,,,,,
C19367,"2-Chloro-1,1,1-trifluoroethane",,,,,
C19369,Chrysoidine,,,,,
C19370,"CI Acid Orange 3;|C.I. Acid Orange 3;|2-Anilino-5-(2,4-dinitroanilino)-benzenesulfonic acid",,,,,
C19371,CI Acid Orange 20;|C.I. Acid Orange 20,,,,,
C19372,CI Orange G;|C.I. Orange G,,,,,
C19373,CI Pigment Red 3;|C.I. Pigment Red 3,,,,,
C19374,Cinnamyl anthranilate,,,,,
C19375,Coronene,,,,,
C19376,meta-Cresidine;|m-Cresidine;|4-Methoxy-2-methyl-benzenamine,,,,,
C19377,Crotonaldehyde;|2-Butenal,,,,,
C19378,Cyclamate;|Sodium cyclamate,,,,,
C19379,Cyclochlorotine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C19379  Cyclochlorotine,
C19380,4H-Cyclopenta[def]chrysene,,,,,
C19381,"5,6-Cyclopenteno-1,2-benzanthracene;|2,3-Dihydro-1H-benzo[a]cyclopent[h]anthracene",,,,,
C19382,D and C Red No. 9;|C.I. Pigment Red 53,,,,,
C19383,Decabromodiphenyl oxide,,,,,
C19384,"1,2-Diamino-4-nitrobenzene",,,,,
C19385,"1,4-Diamino-2-nitrobenzene",,,,,
C19386,"2,5-Diaminotoluene;|2-Methyl-1,4-benzenediamine",,,,,
C19387,Diazomethane,,,,,
C19388,"Dibenz[a,c]anthracene;|Benzo[b]triphenylene;|Benzotriphenylene",,,,,
C19389,"Dibenz[a,j]anthracene;|Dibenzo-1,2,7,8-anthracene",,,,,
C19390,"Dibenzo[a,e]fluoranthene;|2,3,5,6-Dibenzofluoranthene",,,,,
C19391,"13H-Dibenzo[a,g]fluorene",,,,,
C19392,"Dibenzo[h,rst]pentaphene",,,,,
C19393,"Dibenzo[a,e]pyrene;|Naphtho[1,2,3,4-def]chrysene",,,,,
C19394,"Dibenzo[e,l]pyrene",,,,,
C19395,Dichloroacetonitrile,,,,,
C19396,Dibromoacetonitrile,,,,,
C19397,"1,3-Dichlorobenzene;|meta-Dichlorobenzene",,,,,
C19398,"trans-1,4-Dichlorobutene;|trans-1,4-Dichloro-2-butene",,,,,
C19399,"2,6-Dichloro-para-phenylenediamine;|2,6-Dichloro-1,4-benzenediamine",,,,,
C19400,"N,N'-Diethylthiourea;|1,3-Diethyl-2-thiourea",,,,,
C19401,"Dihydroaceanthrylene;|1,2-Dihydroaceanthrylene",,,,,
C19402,Dimethoxane,,,,,
C19403,"3,3'-Dimethoxybenzidine-4,4'-diisocyanate",,,,,
C19404,"4,4'-Dimethylangelicin",,,,,
C19405,"4,5'-Dimethylangelicin",,,,,
C19406,Dimethyl hydrogen phosphite,,,,,
C19407,"1,4-Dimethylphenanthrene",,,,,
C19408,"1,3-Dinitropyrene",,,,,
C19409,Dinitrosopentamethylenetetramine,,,,,
C19410,"3,5-Dinitrotoluene",,,,,
C19411,"2,4'-Diphenyldiamine;|2,4'-Diaminobiphenyl",,,,,
C19412,Disperse Yellow 3;|N-[4-[2-(2-hydroxy-5-methylphenyl)diazenyl]phenyl]-acetamide,,,,,
C19413,Doxefazepam,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07327)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05C HYPNOTICS AND SEDATIVES|N05CD Benzodiazepine derivatives|N05CD12 Doxefazepam|D07327  Doxefazepam (INN)|Drug groups [BR:br08330(D07327)]|Neuropsychiatric agent|DG01835  Benzodiazepine sedative-hypnotics|D07327  Doxefazepam,
C19414,Doxylamine succinate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02327)]|R RESPIRATORY SYSTEM|R06 ANTIHISTAMINES FOR SYSTEMIC USE|R06A ANTIHISTAMINES FOR SYSTEMIC USE|R06AA Aminoalkyl ethers|R06AA09 Doxylamine|D02327  Doxylamine succinate (USP)|Drug groups [BR:br08330(D02327)]|Anti-allergic agent|DG01557  Histamine receptor antagonist|DG01482  Histamine receptor H1 antagonist|DG01096  Doxylamine|D02327  Doxylamine succinate|Target-based classification of drugs [BR:br08310(D02327)]|G Protein-coupled receptors|Rhodopsin family|Histamine|HRH1|D02327  Doxylamine succinate (USP)|Rx-to-OTC switch list in the USA [br08315.html(D02327)]|D02327,
C19415,Dulcin;|p-Ethoxyphenylurea,,,,,
C19416,Eosin;|D & C Red no. 21,,,,,
C19417,"3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate",,,,,
C19418,"9,10-Epoxystearate;|9,10-Epoxystearic acid;|9,10-Epoxyoctadecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C19418  9,10-Epoxyoctadecanoic acid",
C19419,Ethylene sulfide;|Thiirane,,,,,
C19420,2-Ethylhexyl acrylate,,,,,
C19421,Ethyl selenac,,,,,
C19422,Evans blue,,,,,
C19423,Fast green FCF,,,,,
C19425,Fluoranthene,,,,,
C19426,Glycidyl oleate,,,,,
C19427,Glycidyl stearate,,,,,
C19428,Guinea green B;|C.I. Acid green 3,,,,,
C19429,"HC Blue No. 2;|2,2'-[[4-[(2-Hydroxyethyl)amino]-3-nitrophenyl]imino]bis-ethanol",,,,,
C19430,HC Red No. 3;|2-[(4-Amino-2-nitrophenyl)amino]-ethanol,,,,,
C19431,HC Yellow No. 4;|2-[[2-(2-Hydroxyethoxy)-4-nitrophenyl]amino]-ethanol,,,,,
C19432,Hycanthone mesylate,,,,,
C19433,4-Hydroxyazobenzene;|4-(Phenylazo)phenol,,,,,
C19434,8-Hydroxyquinoline;|Oxyquinoline,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05321)]|A ALIMENTARY TRACT AND METABOLISM|A01 STOMATOLOGICAL PREPARATIONS|A01A STOMATOLOGICAL PREPARATIONS|A01AB Antiinfectives and antiseptics for local oral treatment|A01AB07 Oxyquinoline|D05321  Oxyquinoline (USAN)|D DERMATOLOGICALS|D08 ANTISEPTICS AND DISINFECTANTS|D08A ANTISEPTICS AND DISINFECTANTS|D08AH Quinoline derivatives|D08AH03 Oxyquinoline|D05321  Oxyquinoline (USAN)|G GENITO URINARY SYSTEM AND SEX HORMONES|G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS|G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS|G01AC Quinoline derivatives|G01AC30 Oxyquinoline|D05321  Oxyquinoline (USAN)|R RESPIRATORY SYSTEM|R02 THROAT PREPARATIONS|R02A THROAT PREPARATIONS|R02AA Antiseptics|R02AA14 Oxyquinoline|D05321  Oxyquinoline (USAN)|Risk category of Japanese OTC drugs [BR:br08312(D05321)]|Second-class OTC drugs|Inorganic and organic chemicals|Oxyquinoline|D05321  Oxyquinoline (USAN)",
C19435,Hydroxysenkirkine,,,,,
C19438,Lauroyl peroxide;|Dilauroyl peroxide,,,,,
C19439,Light green SF;|C.I. Acid green 5,,,,,
C19440,Malonaldehyde;|Malondialdehyde,,,,,
C19441,Mannomustine dihydrochloride;|Degranol,,,,,
C19442,Medphalan;|D-Melphalan,Melphalan [CPD:C07122],,,,
C19443,Methyl acrylate,,,,,
C19444,5-Methylangelicin,,,,,
C19445,Methyl carbamate,,,,,
C19446,Methyl chloride,,,,,
C19447,1-Methylchrysene,,,,,
C19448,2-Methylchrysene,,,,,
C19449,3-Methylchrysene,,,,,
C19450,4-Methylchrysene,,,,,
C19451,6-Methylchrysene,,,,,
C19452,"N-Methyl-N,4-dinitrosoaniline;|N,4-Dinitrosomethylaniline",,,,,
C19453,"4,4'-Methylenediphenyl diisocyanate;|Methylenebisphenyl diisocyanate",,,,,
C19454,2-Methylfluoranthene,,,,,
C19455,3-Methylfluoranthene,,,,,
C19456,N-Methylolacrylamide;|N-(Hydroxymethyl)acrylamide,,,,,
C19457,1-Methylphenanthrene,,,,,
C19458,"7-Methylpyrido[3,4-c]psoralen",,,,,
C19459,Methyl red;|o-Methyl red;|2-(4-Dimethylaminophenyl)diazenylbenzoate,,,,,
C19460,Methyl selenac;|Tetrakis(dimethyldithiocarbamato)-selenium,,,,,
C19461,Musk ambrette,,,,,
C19462,Musk xylene,,,,,
C19463,"1,5-Naphthalenediamine",,,,,
C19464,"1,5-Naphthalene diisocyanate",,,,,
C19465,"Naphtho[1,2-b]fluoranthene;|Indeno[1,2,3-hi]chrysene",,,,,
C19466,"Naphtho[2,1-a]fluoranthene;|Dibenz[a,j]aceanthrylene",,,,,
C19467,"Naphtho[2,3-e]pyrene;|Dibenzo[de,qr]naphthacene",,,,,
C19468,Nithiazide,,,,,
C19469,5-Nitro-ortho-anisidine;|2-Methoxy-5-nitroaniline,,,,,
C19470,9-Nitroanthracene,,,,,
C19471,7-Nitrobenz[a]anthracene,,,,,
C19472,6-Nitrobenzo[a]pyrene,,,,,
C19473,"4-Nitrobiphenyl;|4-Nitro-1,1'-biphenyl",,,,,
C19474,2-Nitronaphthalene,,,,,
C19475,3-Nitroperylene,,,,,
C19476,2-Nitropyrene,,,,,
C19477,N'-Nitrosoanabasine;|3-(1-Nitroso-2-piperidinyl)-pyridine,,,,,
C19478,N'-Nitrosoanatabine;|NAT,,,,,
C19479,para-Nitrosodiphenylamine;|4-Nitroso-N-phenyl-benzenamine,,,,,
C19480,N-Nitrosofolic acid,,,,,
C19481,N-Nitrosoguvacine,,,,,
C19482,N-Nitrosoguvacoline,,,,,
C19483,N-Nitrosohydroxyproline;|4-Hydroxy-1-nitroso-L-proline,,,,,
C19484,3-(N-Nitrosomethylamino)propionaldehyde;|3-(Methylnitrosoamino)-propanal,,,,,
C19485,N-Nitrosoproline;|1-Nitroso-L-proline,,,,,
C19486,3-Nitrotoluene,,,,,
C19487,Nitrovin;|Difurazone,,,,Animal drugs in Japan [BR:br08331(D02534)]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|972  Agents affecting nitorofuran|9722  Difrazone preparations|D02534  Difurazone,
C19488,"7,12-Dimethylbenz[a]anthracene;|DMBA",,,,,
C19489,"1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene",,,,,
C19490,"trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene;|trans-DMBA-3,4-dihydrodiol",,,,,
C19491,(E)-2-Methylbutanal oxime,,,,,
C19492,Nylon 6;|Policapram,polymer of epsilon-Caprolactam [CPD:C06593],,,,
C19493,Estradiol mustard;|Oestradiol mustard,,,,,
C19494,Oxyphenbutazone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08324)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AA Butylpyrazolidines|M01AA03 Oxyphenbutazone|D08324  Oxyphenbutazone (INN)|M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN|M02AA Antiinflammatory preparations, non-steroids for topical use|M02AA04 Oxyphenbutazone|D08324  Oxyphenbutazone (INN)|S SENSORY ORGANS|S01 OPHTHALMOLOGICALS|S01B ANTIINFLAMMATORY AGENTS|S01BC Antiinflammatory agents, non-steroids|S01BC02 Oxyphenbutazone|D08324  Oxyphenbutazone (INN)|Drug groups [BR:br08330(D08324)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01947  Anti-inflammatory drug, pyrazolone|DG01949  Anti-inflammatory drug, phenylbutazones|DG00746  Oxyphenbutazone|D08324  Oxyphenbutazone|Target-based classification of drugs [BR:br08310(D08324)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS1 (COX1)|D08324  Oxyphenbutazone (INN)|PTGS2 (COX2)|D08324  Oxyphenbutazone (INN)",
C19495,"Penicillic acid;|3-Methoxy-5-methyl-4-oxo-2,5-hexadienoic acid",,,,,
C19496,"Pentachloroethane;|1,1,1,2,2-Pentachloro-ethane",,,,,
C19497,Perylene,,,,,
C19498,Phenicarbazide,,,,,
C19499,"para-Phenylenediamine;|1,4-Benzenediamine",o-Phenylenediamine [CPD:C14402]|m-Phenylenediamine [CPD:C02454],,,,
C19500,Picene;|Benzo[a]chrysene,,,,,
C19501,Polyacrylic acid,polymer of Acrylic acid [CPD:C00511],,,,
C19502,Polychloroprene,polymer of Chloroprene [CPD:C19208],,,,
C19503,Polyethylene,polymer of Ethylene [CPD:C06547],,,,
C19504,Polymethyl methacrylate,polymer of Methyl methacrylate [CPD:C14527],,,,
C19505,Polipropene 25;|Polypropylene,,,,,
C19506,Polystyrene,polymer of Styrene [CPD:C07083],,,,
C19507,Polytetrafluoroethylene;|Polytef,polymer of Tetrafluoroethylene [CPD:C19299],,,,
C19508,Polyvinyl chloride,polymer of Vinyl chloride [CPD:C06793],,,,
C19509,Polyvinyl pyrrolidone;|Povidone,,,,Classification of Japanese OTC drugs [BR:br08313(D02295)]|Agents for ophthalmologic use|65 Artificial tear|D02295  Povidone (JP18/USP/INN)|Risk category of Japanese OTC drugs [BR:br08312(D02295)]|Third-class OTC drugs|Inorganic and organic chemicals|Polyvinylpyrrolidone|D02295  Povidone (JP18/USP/INN)|Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D02295)]|Chemicals|D02295  Povidone,
C19510,Ponceau SX;|C.I. 14700,,,,,
C19511,"Potassium bis(2-hydroxyethyl)dithiocarbamate;|Bis(2-hydroxyethyl)dithiocarbamic acid, potassium salt",,,,,
C19512,Prednimustine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05602)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AA Nitrogen mustard analogues|L01AA08 Prednimustine|D05602  Prednimustine (USAN/INN)|Drug groups [BR:br08330(D05602)]|Antineoplastic|DG01677  Alkylating agent|DG01678  Nitrogen mustard analog|D05602  Prednimustine,
C19513,Pronetalol hydrochloride,,,,,
C19514,n-Propyl carbamate,,,,,
C19515,Ptaquiloside;|Braxin C,,,,Phytochemical compounds [BR:br08003]|Others|Others|Others|C19515  Braxin C|Natural toxins [BR:br08009]|Phytotoxins|Others|Others|C19515  Ptaquiloside,
C19516,"Pyrido[3,4-c]psoralen",,,,,
C19517,Rhodamine B,,,,,
C19518,Ripazepam,,,,,
C19520,Scarlet Red;|1-[2-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]diazenyl]-2-naphthalenol,,,,,
C19521,Semicarbazide hydrochloride,,,,,
C19523,Sodium chlorite;|Textone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]|D DERMATOLOGICALS|D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS|D03A CICATRIZANTS|D03AX Other cicatrizants|D03AX11 Sodium chlorite|C19523  Sodium chlorite,
C19524,"Succinic anhydride;|Dihydro-2,5-furandione",,,,,
C19525,Sudan I;|C.I. Solvent Yellow 14,,,,,
C19526,Sudan II;|C.I. Solvent Orange 7,,,,,
C19527,Sudan III;|C.I. Solvent Red 23,,,,,
C19528,"Sudan Brown RR;|C.I. 11285;|4-[2-(1-Naphthalenyl)diazenyl]-1,3-benzenediamine",,,,,
C19529,Sudan Red 7B;|Oil Violet;|C.I. Solvent Red 19;|N-Ethyl-1-[2-[4-(2-phenyldiazenyl)phenyl]diazenyl]-2-naphthalenamine,,,,,
C19530,Sulfamethazine,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02436)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01E SULFONAMIDES AND TRIMETHOPRIM|J01EB Short-acting sulfonamides|J01EB03 Sulfadimidine|D02436  Sulfamethazine (USP)|Drug groups [BR:br08330(D02436)]|Antibacterial|DG01787  Sulfonamide antibacterial|DG01784  Short-acting sulfonamide|DG00597  Sulfadimidine|D02436  Sulfamethazine|Antimicrobials [BR:br08307(D02436)]|Antibacterials|Folic acid biosynthesis inhibitor|Short-acting sulfonamide|D02436  Sulfamethazine (USP),
C19531,Sunset Yellow FCF;|C.I. Food Yellow 3;|Food yellow No.5,,,,,
C19533,"2,2',5,5'-Tetrachlorobenzidine",,,,,
C19534,"1,1,2,2-Tetrachloroethane;|Tetrachloroethane",,,,,
C19535,"Trichloroacetonitrile;|2,2,2-Trichloro-acetonitrile",,,,,
C19536,"1,1,2-Trichloroethane",,,,,
C19537,Triethylene glycol diglycidyl ether;|Etoglucid,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07256)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AG Epoxides|L01AG01 Etoglucid|D07256  Etoglucid (INN)|Drug groups [BR:br08330(D07256)]|Antineoplastic|DG01677  Alkylating agent|DG01725  Epoxide|D07256  Etoglucid,
C19538,"4,4',6-Trimethylangelicin",,,,,
C19539,"2,4,5-Trimethylaniline",,,,,
C19540,"2,4,6-Trimethylaniline",,,,,
C19541,Triphenylene,,,,,
C19542,Triaziquone;|Tris(aziridinyl)-para-benzoquinone,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07254)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AC Ethylene imines|L01AC02 Triaziquone|D07254  Triaziquone (INN)|Drug groups [BR:br08330(D07254)]|Antineoplastic|DG01677  Alkylating agent|DG01723  Ethylene imine|D07254  Triaziquone,
C19543,Tris(1-aziridinyl)phosphine oxide;|TEPA;|APO,,,,,
C19544,"1,2,3-Tris(chloromethoxy)propane",,,,,
C19545,"Vat Yellow 4;|C.I. Vat Yellow 4;|Dibenzo[b,def]chrysene-7,14-dione",,,,,
C19546,Vinyl chloride-vinyl acetate copolymer;|Pevikon,,,,,
C19547,"Vinylidene fluoride;|1,1-Difluoroethene",,,,,
C19548,N-Vinyl-2-pyrrolidone;|1-Ethenyl-2-pyrrolidinone,,,,,
C19552,Yellow AB;|1-(2-Phenyldiazenyl)-2-naphthalenamine,,,,,
C19553,Yellow OB;|1-[2-(2-Methylphenyl)diazenyl]-2-naphthalenamine,,,,,
C19556,Tris(2-methyl-1-aziridinyl)phosphine oxide;|Metepa,,,,,
C19557,Treosulfan,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07253)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01A ALKYLATING AGENTS|L01AB Alkyl sulfonates|L01AB02 Treosulfan|D07253  Treosulfan (USAN/INN)|Drug groups [BR:br08330(D07253)]|Antineoplastic|DG01677  Alkylating agent|DG01721  Methanesulfonate derivative|D07253  Treosulfan|New drug approvals in Europe [br08329.html(D07253)]|European public assessment reports (EPAR) authorised medicine|D07253,
C19558,AF-2;|Furylfuramide;|2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide,,,,,
C19559,"(1aalpha,2beta,3alpha,11calpha)-1a,2,3,11c-Tetrahydro-6,11-dimethylbenzo[6,7]phenanthro[3,4-b]oxirene-2,3-diol",,,,,
C19561,7-Hydroxymethyl-12-methylbenz[a]anthracene;|12-Methylbenz[a]anthracene-7-methanol,,,,,
C19562,7-Hydroxymethyl-12-methylbenz[a]anthracene sulfate,,,,,
C19563,4-[(Hydroxymethyl)nitrosoamino]-1-(3-pyridinyl)-1-butanone,,,,,
C19564,4-(Nitrosoamino)-1-(3-pyridinyl)-1-butanone,,,,,
C19565,4-Hydroxy-1-(3-pyridinyl)-1-butanone,,,,,
C19566,4-Hydroxy-4-(methylnitrosoamino)-1-(3-pyridinyl)-1-butanone,,,,,
C19567,4-Oxo-1-(3-pyridyl)-1-butanone;|gamma-Oxo-3-pyridinebutanal;|4-Oxo-4-(pyridin-3-yl)butanal;|3-Succinoylsemialdehyde-pyridine,,,,,
C19568,N-Nitrosomethanamine,,,,,
C19569,3-Succinoylpyridine;|4-Oxo-4-(pyridin-3-yl)butanoate,,,,,
C19570,Ethyl tellurac,,,,,
C19573,Styrene-acrylonitrile copolymer,copolymer of Acrylonitrile [CPD:C01998] and Styrene [CPD:C07083],,,,
C19574,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol;|NNAL,,,,,
C19575,Styrene-butadiene copolymer,"copolymer of 1,3-Butadiene [CPD:C16450] and Styrene [CPD:C07083]",,,,
C19577,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",,,,,
C19578,5-(3-Pyridyl)-2-hydroxytetrahydrofuran,,,,,
C19579,gamma-Hydroxy-3-pyridinebutanoate,,,,,
C19580,alpha-[3-[(Hydroxymethyl)nitrosoamino]propyl]-3-pyridinemethanol,,,,,
C19581,alpha-[3-(Nitrosoamino)propyl]-3-pyridinemethanol,,,,,
C19582,"1-(3-Pyridinyl)-1,4-butanediol",,,,,
C19583,Fusarenone X;|Fusarenon-X,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C19583  Fusarenone X,
C19584,Aflatoxicol;|AFL,,,,,
C19585,Aflatoxin Q1,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19585  Aflatoxin Q1,
C19586,"Aflatoxin B1-exo-8,9-epoxide;|2,3-Epoxyaflatoxin B1",,,,"Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19586  Aflatoxin B1-exo-8,9-epoxide",
C19587,Aflatoxin P1;|AFP1,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19587  Aflatoxin P1,
C19588,"Aflatoxin B1 diol;|Aflatoxin B1-2,3-dihydrodiol",,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19588  Aflatoxin B1 diol,
C19589,Aflatoxin B1 dialdehyde,,,,Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19589  Aflatoxin B1 dialdehyde,
C19590,"6-[2,3-Dihydroxy-1-(hydroxymethyl)propyl]-1,2-dihydro-7-hydroxy-9-methoxy-cyclopenta[c][1]benzopyran-3,4-dione",,,,,
C19591,"1,2,3,4-Tetrahydro-alpha,7-dihydroxy-beta-(hydroxymethyl)-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-propanal",,,,,
C19592,"alpha-(1,2-Dihydroxyethyl)-1,2,3,4-tetrahydro-7-hydroxy-9-methoxy-3,4-dioxocyclopenta[c][1]benzopyran-6-acetaldehyde",,,,,
C19594,"Aflatoxin-M1-8,9-epoxide",,,,"Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19594  Aflatoxin-M1-8,9-epoxide",
C19595,"Aflatoxin B1-endo-8,9-epoxide",,,,"Lipids [BR:br08002]|PK  Polyketides|PK10 Aflatoxins and related substances|C19595  Aflatoxin B1-endo-8,9-epoxide",
C19597,2-Nitrotoluene,,,,,
C19599,Sodium diethyldithiocarbamate;|Ditiocarb sodium,,,,,
C19600,Calcium salicylate,,,,,
C19601,"Theobromine, calcium salt;|3,7-Dihydro-3,7-dimethyl-1H-purine-2,6-dione, calcium salt",,,,,
C19602,4-(Methylnitrosamino)-1-(1-oxido-3-pyridinyl)-1-butanone;|4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone;|NNK-N-oxide,,,,,
C19603,4-(Methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanol;|NNAL-N-oxide,,,,,
C19604,"7,12-Dimethylbenz[a]anthracene 5,6-oxide;|DMBA-5,6-epoxide",,,,,
C19605,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide;|NNAL-O-glucuronide,,,,,
C19606,NNAL-N-glucuronide,,,,,
C19607,"trans-5,6-Dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthracene;|trans-DMBA-5,6-dihydrodiol",,,,,
C19609,Nickel(2+);|Ni2+;|Ni(II),,,,,
C19610,Manganese(2+);|Mn2+;|Mn(II),,,,,
C19611,Manganese(3+);|Mn3+;|Mn(III),,,,,
C19612,Coriose;|D-altro-3-Heptulose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Monosaccharides|Ketoses|C19612  Coriose,
C19613,"Juvenile hormone I;|Methyl (2E,6E,10R,11S)-10,11-epoxy-7-ethyl-3,11-dimethyl-2,6-tridecadienoate",,,,,
C19614,16-Oxopalmitate,,,,,
C19615,Hexadecanedioate;|Hexadecanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C19615  Hexadecanedioic acid,
C19616,18-Hydroxyoleate;|18-Hydroxyoleic acid;|(9Z)-18-Hydroxyoctadec-9-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C19616  (9Z)-18-Hydroxyoctadec-9-enoic acid,
C19617,18-Oxooleate,,,,,
C19618,"Octadec-9-ene-1,18-dioic-acid",,,,,
C19619,(+)-Germacrene D,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C19619  (+)-Germacrene D|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19619  (+)-Germacrene D,
C19620,"9,10-Epoxy-18-hydroxystearate",,,,,
C19621,"9,10,18-Trihydroxystearate;|9,10,18-Trihydroxystearic acid;|9,10,18-Trihydroxyoctadecanoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0200 Other Octadecanoids|C19621  9,10,18-Trihydroxyoctadecanoic acid",
C19622,"9,10-Dihydroxystearate",,,,,
C19623,22-Hydroxydocosanoate;|22-Hydroxydocosanoic acid;|Phellonic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C19623  22-Hydroxydocosanoic acid,
C19624,22-Oxodocosanoate,,,,,
C19625,Docosanedioate;|Docosanedioic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0117 Dicarboxylic acids|C19625  Docosanedioic acid,
C19631,6-Hydroxy-3-succinoylpyridine;|4-(6-Hydroxypyridin-3-yl)-4-oxobutanoate,,,,,
C19632,Kojibiose;|2-O-alpha-D-Glucopyranosyl-D-glucose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C19632  Kojibiose,
C19633,Maltulose;|4-O-alpha-D-Glucopyranosyl-D-fructose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C19633  Maltulose,
C19634,Melibiulose;|6-O-alpha-D-Galactopyranosyl-D-fructose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C19634  Melibiulose,
C19635,Scillabiose;|6-Deoxy-4-O-beta-D-glucopyranosyl-L-mannose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C19635  Scillabiose,
C19636,Turanose;|3-O-alpha-D-Glucopyranosyl-D-fructose;|D-Turanose,,,,Compounds with biological roles [BR:br08001]|Carbohydrates|Oligosaccharides|Disaccharides|C19636  Turanose,
C19637,"Coenzyme M disulfide;|(S-CoM)2;|Coenzyme M;|2,2'-Dithiodiethanesulfonic acid",HS-CoM [CPD:C03576],,,,
C19638,5alpha-Gonane,,,,,
C19639,Gonane;|18-Norestrane,,,,,
C19640,5beta-Gonane,,,,,
C19641,Estrane;|19-Norandrostane,,,,,
C19642,5beta-Cholanic acid;|Ursocholanic acid,,,,,
C19643,"Scillarenin;|3beta,14-Dihydroxy-14beta-bufa-4,20,22-trienolide",,,,Compounds with biological roles [BR:br08001]|Steroids|24-Carbon atoms|Bufanolide derivatives|C19643  Scillarenin,
C19644,Stigmastanol;|beta-Sitostanol,,,,Compounds with biological roles [BR:br08001]|Steroids|29-Carbon atoms|Stigmastane derivatives|C19644  Stigmastanol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C19644  Stigmastanol,
C19647,Epoxyqueuosine in tRNA,Generic compound in reaction hierarchy,,,,
C19648,"Pseudotigogenin;|(25R)-5alpha-Furost-20(22)-ene-3beta,26-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Furostan derivatives|C19648  Pseudotigogenin,
C19649,"Pseudosarsasapogenin;|(25S)-5beta-Furost-20(22)-ene-3beta,26-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Furostan derivatives|C19649  Pseudosarsasapogenin,
C19650,"Pseudosmilagenin;|(25R)-5beta-Furost-20(22)-ene-3beta,26-diol",,,,Compounds with biological roles [BR:br08001]|Steroids|27-Carbon atoms|Furostan derivatives|C19650  Pseudosmilagenin,
C19651,Ergostanol;|(24S)-5alpha-Ergostan-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Ergostane derivatives|C19651  Ergostanol,
C19652,alpha-Ergostenol;|5alpha-Ergosta-8(14)-ene-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Ergostane derivatives|C19652  alpha-Ergostenol,
C19653,"Lumisterol;|9beta,10alpha-Ergosta-5,7,22-trien-3beta-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|28-Carbon atoms|Ergostane derivatives|C19653  Lumisterol,
C19654,"gamma-Sitosterol;|22,23-Dihydroporiferasterol",,,,Compounds with biological roles [BR:br08001]|Steroids|29-Carbon atoms|Poriferastane derivatives|C19654  gamma-Sitosterol|Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Stigmastane|C19654  gamma-Sitosterol,
C19655,Gorgosterol;|Gorgost-5-en-3beta-ol,,,,Compounds with biological roles [BR:br08001]|Steroids|30-Carbon atoms|Gorgostane derivatives|C19655  Gorgosterol|Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0106 Gorgosterols and derivatives|C19655  Gorgosterol,
C19656,"Sarcoaldesterol A;|(3beta,5alpha,6beta,11alpha)-Gorgostane-3,5,6,11-tetrol",,,,Compounds with biological roles [BR:br08001]|Steroids|30-Carbon atoms|Gorgostane derivatives|C19656  Sarcoaldesterol A,
C19657,"Acanthasterol;|(3beta,5alpha)-Gorgost-7-en-3-ol",,,,Compounds with biological roles [BR:br08001]|Steroids|30-Carbon atoms|Gorgostane derivatives|C19657  Acanthasterol,
C19658,Cardanolide,,,,,
C19659,5alpha-Cholane;|Allocholane,,,,,
C19660,Bufanolide,Generic compound,,,,
C19661,Cholestane,,,,,
C19662,Spirostan,,,,,
C19663,Furostan,,,,,
C19664,Ergostane,,,,,
C19665,5alpha-Campestane;|(24R)-24-Methyl-5alpha-cholestane,,,,,
C19666,Stigmastane,,,,,
C19667,5alpha-Poriferastane,,,,,
C19668,Gorgostane,,,,,
C19669,Thermospermine,,,,,
C19670,Oleamide;|Oleyl amide;|(Z)-9-Octadecenamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0801 Primary amides|C19670  (Z)-9-Octadecenamide,
C19673,Malonyl-[acp] methyl ester;|Malonyl-[acyl-carrier protein] methyl ester,,,,,
C19674,D-Arabinitol 1-phosphate;|D-Arabitol 1-phosphate,,,,,
C19675,"(R)-2,3-Dihydroxypropane-1-sulfonate",,,,,
C19676,"Germacra-1(10),4,11(13)-trien-12-ol",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19676  Germacra-1(10),4,11(13)-trien-12-ol",
C19677,"Germacra-1(10),4,11(13)-trien-12-al",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19677  Germacra-1(10),4,11(13)-trien-12-al",
C19678,"Germacrene A acid;|Germacra-1(10),4,11(13)-trien-12-oate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C19678  Germacrene A acid|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19678  Germacrene A acid,
C19679,L-Sorbosone;|1-Dehydro-L-sorbose,,,,,
C19680,"N,N-Dimethyl-4-nitrosoaniline;|Accelerine",,,,,
C19681,"4-(Hydroxylamino)-N,N-dimethylaniline;|4-(Dimethylamino)-N-hydroxyaniline",,,,,
C19682,"3,4-Didehydroadipyl-CoA;|cis-3,4-Dehydroadipyl-CoA",,,,,
C19683,"3,4-Didehydroadipyl-CoA semialdehyde;|cis-3,4-Dehydroadipyl-CoA semialdehyde;|(3Z)-6-Oxohex-3-enoyl-CoA",,,,,
C19684,"2,3-Epoxy-2,3-dihydrobenzoyl-CoA",,,,,
C19685,Sulfoacetyl-CoA,,,,,
C19686,3-(1-Carboxyvinyloxy)anthranilate;|2-Amino-3-[(1-carboxyethenyl)oxy]benzoate;|3-Enolpyruvoylanthranilate,,,,,
C19687,7-Chloro-L-tryptophan,,,,,
C19688,2-Imino-3-(7-chloroindol-3-yl)propanoate;|7-Chlorodehydrotryptophan,,,,,
C19689,Glutathione amide;|L-gamma-Glutamyl-L-cysteinylglycinamide,,,,,
C19690,Glutathione amide disulfide,,,,,
C19691,"Farnesylcysteine;|S-(2E,6E)-Farnesyl-L-cysteine;|S-trans-trans-Farnesylcysteine",,,,,
C19692,Polysulfide;|(Sulfide)n;|Polysulfane,,,,,
C19693,Reactive Blue 5,,,,,
C19694,D-Alanyl-(R)-lactate;|D-Alanyl-D-lactate;|(2R)-2-(D-Alanyloxy)propanoic acid;|(R)-2-[(R)-2-Aminopropanoyloxy]propanoic acid,,,,,
C19695,[beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n,,,,,
C19696,[beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-6-N-(beta-D-Asp)-L-Lys-D-Ala-D-Ala)]n,,,,,
C19697,Hypochlorous acid;|Hypochlorite;|HClO,,,,,
C19698,"3,4-Bis(7-chloroindol-3-yl)pyrrole-2,5-dicarboxylate;|Dichlorochromopyrrolate",,,,,
C19699,Dichloroarcyriaflavin A;|Rebeccamycin aglycon,,,,,
C19700,4'-O-Demethylrebeccamycin,,,,Glycosides [BR:br08021]|N-glycosides|C19700  4'-O-Demethylrebeccamycin,
C19701,Rebeccamycin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C19701,
C19702,1-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol,,,,,
C19703,1-O-[2-(L-Cysteinamido)-2-deoxy-alpha-D-glucopyranosyl]-1D-myo-inositol;|Desacetylmycothiol,,,,,
C19704,Dinoflagellate luciferin,,,,,
C19705,Oxidized dinoflagellate luciferin,,,,,
C19706,cis-3-Hydroxy-L-proline;|cis-3-Hydroxyproline,,,,,
C19707,(+)-Columbianetin;|(S)-Columbianetin,,,,,
C19708,5-Epiaristolochene;|(+)-5-Epiaristolochene;|5-epi-Aristolochene;|(+)-5-epi-Aristolochene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010327 Aristolane sesquiterpenoids|C19708  5-Epiaristolochene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19708  5-Epiaristolochene,
C19709,[L-Asp(4-L-Arg)]n;|Cyanophycin,Generic compound in reaction hierarchy,,,,
C19710,[L-Asp(4-L-Arg)]n-L-Asp,,,,,
C19711,Solavetivol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19711  Solavetivol,
C19712,N-Hydroxy-L-phenylalanine;|2-(Hydroxyamino)-3-phenylpropanoate,,,,,
C19713,[L-Asp(4-L-Arg)]n+1,,,,,
C19714,(E)-Phenylacetaldoxime;|(E)-Phenylacetaldehyde oxime,,,,,
C19715,"N,N-Dihydroxy-L-phenylalanine",,,,,
C19716,N-Hydroxy-L-tryptophan,,,,,
C19717,"N,N-Dihydroxy-L-tryptophan",,,,,
C19719,D-Alanyl-D-serine,,,,,
C19720,N6-(UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl)-D-lysine,,,,,
C19721,5-Hydroxypyrrole-2-carboxylate,,,,,
C19722,[tRNA(Ile2)]-cytidine34,,,,,
C19723,[tRNA(Ile2)]-lysidine34,,,,,
C19724,Cobyrinate c-monamide;|Cobyrinic acid c-monoamide,,,,,
C19725,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronate;|UDP-alpha-D-GlcNAc3NAcA;|UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-glucuronic acid",,,,,
C19726,"15beta-Hydroxyprogesterone;|15beta-Hydroxypregn-4-ene-3,20-dione",,,,,
C19727,"5-Hydroxypseudobaptigenin;|5,7-Dihydroxy-3',4'-methylenedioxyisoflavone",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1205 Isoflavonoids|C19727  5-Hydroxypseudobaptigenin,
C19728,all-trans-8'-Apo-beta-carotenal;|8'-Apo-beta-carotenal,,,,,
C19729,"(2E,4E,6E)-2,6-Dimethylocta-2,4,6-trienedial",,,,,
C19730,"Crocetin dialdehyde;|8,8'-Diapocarotene-8,8'-dial",,,,,
C19731,"(3S)-3-Hydroxycyclocitral;|3beta-Hydroxy-beta-cyclocitral;|(4R)-4-Hydroxy-2,6,6-trimethylcyclohex-1-en-1-carboxaldehyde",,,,,
C19732,"24-Hydroxy-beta-amyrin;|Olean-12-ene-3beta,24-diol",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Oleananes|C19732  24-Hydroxy-beta-amyrin,
C19733,"Sophoradiol;|Olean-12-ene-3beta,22beta-diol",,,,,
C19734,(-)-alpha-Gurjunene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C19734  (-)-alpha-Gurjunene,
C19735,(-)-endo-alpha-Bergamotene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19735  (-)-endo-alpha-Bergamotene,
C19736,(+)-alpha-Santalene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19736  (+)-alpha-Santalene,
C19737,(+)-endo-beta-Bergamotene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19737  (+)-endo-beta-Bergamotene,
C19738,(-)-gamma-Cadinene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C19738  (-)-gamma-Cadinene,
C19739,3'-O-Methyltricetin;|Selagin;|Tricetin 3'-methyl ether,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C19739  3'-O-Methyltricetin,
C19740,(+)-alpha-Barbatene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C19740  (+)-alpha-Barbatene,
C19741,(+)-Cubenene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C19741  (+)-Cubenene,
C19742,(+)-delta-Selinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C19742  (+)-delta-Selinene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19742  (+)-delta-Selinene,
C19743,(-)-Drimenol;|Drimenol;|Drim-7-en-11-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010337 Drimane sesquiterpenoids|C19743  (-)-Drimenol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C19743  Drimenol,
C19744,(+)-Epicubenol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C19744  (+)-Epicubenol,
C19745,"UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronate;|UDP-alpha-D-ManNAc3NAcA;|UDP-2,3-diacetamido-2,3-dideoxy-alpha-D-mannuronic acid",,,,,
C19746,"(3R,6E)-Nerolidol",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C19746  (3R,6E)-Nerolidol",
C19747,Germacrene C,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C19747  Germacrene C|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Germacrenes|C19747  Germacrene C|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C19747,
C19748,(E)-gamma-Bisabolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C19748  (E)-gamma-Bisabolene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19748  (E)-gamma-Bisabolene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C19748,
C19749,(E)-alpha-Bisabolene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C19749  (E)-alpha-Bisabolene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19749  (E)-alpha-Bisabolene|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C19749,
C19750,"3,5-Dihydroxybiphenyl;|3,5-Biphenyldiol;|5-Phenylresorcinol",,,,,
C19752,"(S)-beta-Macrocarpene;|(1'S)-4',5,5-Trimethyl-1,1'-bi(cyclohexane)-1,3'-diene",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19752  (S)-beta-Macrocarpene,
C19753,"cis-Muurola-3,5-diene",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C19753  cis-Muurola-3,5-diene",
C19754,"cis-Muurola-4(14),5-diene",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Cadinanes|C19754  cis-Muurola-4(14),5-diene",
C19755,Patchoulol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C19755  Patchoulol,
C19756,Presilphiperfolan-8beta-ol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C19756  Presilphiperfolan-8beta-ol,
C19757,(3Z)-Hex-3-en-1-yl acetate;|(Z)-3-Hexen-1-ol acetate;|cis-3-Hexenyl acetate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0710 Short fatty esters|C19757  (3Z)-Hex-3-en-1-yl acetate,
C19758,beta-D-Galactosyl-(1->4)-L-rhamnose,,,,,
C19759,"7,9,9'-tricis-Neurosporene;|7,9,9'-tri-cis-Neurosporene",,,,,
C19760,"2-cis,6-cis-Farnesyl diphosphate;|(2Z,6Z)-Farnesyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010301 Acyclic farnesane sesquiterpenoids|C19760  2-cis,6-cis-Farnesyl diphosphate|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Farnesenes|C19760  (2Z,6Z)-Farnesyl diphosphate",
C19761,1-O-(2-Acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol 3-phosphate,,,,,
C19762,Cyanidin 3-O-(2-O-beta-D-glucuronosyl)-beta-D-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C19762  Cyanidin 3-O-(2-O-beta-D-glucuronosyl)-beta-D-glucoside,
C19763,Soyasapogenol B 3-O-D-glucuronide;|Soyasapogenol B 3-O-beta-D-glucuronide,,,,,
C19764,"9,15,9'-tricis-zeta-Carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C19764  9,15,9'-tricis-zeta-Carotene",
C19765,"15,9'-dicis-Phytofluene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C19765  15,9'-dicis-Phytofluene",
C19766,5'-Deoxy-5'-fluoroadenosine,,,,,
C19767,7-(3-Methylbut-2-enyl)-L-tryptophan;|7-Prenyl-L-tryptophan,,,,,
C19768,5-Deoxy-5-chloroadenosine,,,,,
C19769,"1,6-Anhydro-N-acetyl-beta-muramate",,,,,
C19770,N-Acetyl-beta-muramate 6-phosphate,,,,,
C19771,2'-(5-Triphosphoribosyl)-3'-dephospho-CoA;|2'-(5-Triphospho-alpha-D-ribosyl)-3'-dephospho-CoA,,,,,
C19772,"alpha-D-Glucopyranosyl-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19772  alpha-D-Glucopyranosyl-diphospho-ditrans,octacis-undecaprenol",
C19773,3-O-alpha-D-Mannopyranosyl-alpha-D-mannopyranose,,,,,
C19774,3-O-(6-O-alpha-D-Xylosylphospho-alpha-D-mannopyranosyl)-alpha-D-mannopyranose,,,,,
C19775,Fluoroacetyl-CoA;|Fluoroacetyl-coenzyme A,,,,,
C19776,"1,2-Diacyl-sn-glycerol 3-diphosphate;|1,2-Diacyl-sn-glycerol 3-pyrophosphate",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP11 Glyceropyrophosphates|GP1101 Diacylglyceropyrophosphates|C19776  1,2-Diacyl-sn-glycerol 3-pyrophosphate",
C19777,L-Homoserine lactone,,,,,
C19778,(R)-Piperazine-2-carboxamide,,,,,
C19779,beta-Alaninamide;|beta-Alanine amide;|3-Aminopropionamide,,,,,
C19780,(R)-Piperazine-2-carboxylate;|(R)-Piperazine-2-carboxylic acid;|(R)-2-Piperazinecarboxylate,,,,,
C19781,L-Prolinamide;|(S)-Pyrrolidine-2-carboxamide,,,,,
C19782,(S)-Piperazine-2-carboxamide,,,,,
C19783,(S)-Piperazine-2-carboxylate;|(S)-Piperazine-2-carboxylic acid;|(S)-2-Piperazinecarboxylate,,,,,
C19784,1-O-(2-Acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol;|1-O-[2-(Acetylamino)-2-deoxy-alpha-D-glucopyranosyl]-D-myo-inositol;|1-(2-Acetamido-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol,,,,,
C19785,Streptothricin F;|Racemomycin A,,,,,
C19786,Streptothricin F acid,,,,,
C19787,5'-S-Methyl-5'-thioinosine;|5'-Deoxy-5'-methylthioinosine;|S-Methyl-5'-thioinosine,,,,,
C19788,5-Nitroanthranilate;|2-Amino-5-nitrobenzoate,,,,,
C19789,5-Nitrosalicylate;|2-Hydroxy-5-nitrobenzoate,,,,,
C19790,Reduced flavin,Generic compound in reaction hierarchy,,,,
C19791,2-O-(alpha-D-Glucopyranosyl)-3-phospho-D-glycerate;|(2R)-2-(alpha-D-Glucopyranosyloxy)-3-(phosphonooxy)propanoate,,,,,
C19792,2-O-(alpha-D-Glucopyranosyl)-D-glycerate;|(R)-2-(alpha-D-Glucopyranosyloxy)-3-hydroxypropanoate,,,,,
C19793,2-O-[2-O-(alpha-D-Mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D-glycerate,,,,,
C19794,CDP-1L-myo-inositol,,,,,
C19795,"1-Hydroxy-1,2-dihydrolycopene;|Rhodopin;|1-Hydroxylycopene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C19795  Rhodopin,
C19796,Quercetin 3-O-rhamnoside 7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C19796  Quercetin 3-O-rhamnoside 7-O-glucoside,
C19797,"4,4'-Diapolycopene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C19797  4,4'-Diapolycopene",
C19798,"4,4'-Diapolycopenedial;|4,4'-Diapolycopene-4,4'-dial",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C19798  4,4'-Diapolycopenedial|C19798  4,4'-Diapolycopenedial",
C19799,"Bis(1L-myo-inositol)-3,1'-phosphate 1-phosphate",,,,,
C19800,(3-Phenoxyphenyl)methanol;|3-Phenoxybenzenemethanol,,,,,
C19801,Isomultiflorenol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010616 Taraxerane, multiflorane, glutinane and friedelane triterpenoids|C19801  Isomultiflorenol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19801  Isomultiflorenol",
C19802,[Protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine;|[Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine,Generic compound in reaction hierarchy,,,,
C19803,[Protein]-L-threonine,Generic compound in reaction hierarchy,,,,
C19804,[Protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine;|[Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine,Generic compound in reaction hierarchy,,,,
C19805,Aminopentol;|AP1,,,,,
C19806,"Propane-1,2,3-tricarboxylate;|Tricarballylate",,,,,
C19807,"3',4',5'-O-Trimethyltricetin;|5,7-Dihydroxy-3',4',5'-trimethoxyflavone",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C19807  3',4',5'-O-Trimethyltricetin",
C19808,Glucovanillin,,,,,
C19809,(S)-Piperidine-2-carboxamide,,,,,
C19810,"ent-Pimara-9(11),15-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C19810  ent-Pimara-9(11),15-diene",
C19811,9-cis-Epoxycarotenoid,,,,,
C19812,12'-apo-Carotenal,,,,,
C19813,threo-3-Hydroxy-D-aspartate,,,,,
C19814,Terpentetriene,,,,,
C19815,Terpentedienyl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010404 Colensane and clerodane diterpenoids|C19815  Terpentedienyl diphosphate,
C19816,Elisabethatriene,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010441 Amphilectane, cycloamphilectane, adociane and neoamphilectane diterpenoids|C19816  Elisabethatriene",
C19817,Phyllocladan-16alpha-ol,,,,,
C19818,beta-Phellandrene,,,,,
C19819,Cucurbitadienol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C19819  Cucurbitadienol,
C19820,"Protostadienol;|(17Z)-Protosta-17(20),24-dien-3beta-ol",,,,,
C19821,2-Hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one;|Microthecin,,,,,
C19822,"1,5-Anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose;|Ascopyrone M",,,,,
C19823,"UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hexos-4-ulose;|UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose;|UDP-4-keto-6-deoxy-L-N-acetylaltrosamine","UDP-2-acetamido-2,6-dideoxy-beta-L-arabino-hex-4-ulose is named incorrectly.",,,,
C19824,D-5-Monosubstituted hydantoin,,,,,
C19825,L-5-Monosubstituted hydantoin,,,,,
C19826,"1,5-Anhydro-4-deoxy-D-glycero-hex-1-en-3-ulose;|Ascopyrone P;|5-Hydroxy-2-(hydroxymethyl)-2H-pyran-4(3H)-one",,,,,
C19827,"Colneleate;|(8E)-9-[(1E,3Z)-Nona-1,3-dien-1-yloxy]non-8-enoate",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA10 Fatty ethers|C19827  Colneleic acid,
C19828,"Arabidiol;|(13R,14R,17E)-Malabarica-17,21-diene-3beta,14-diol",,,,,
C19829,"Dammarenediol-II;|(20S)-Dammar-24-ene-3beta,20-diol;|Dammar-24-ene-3beta,20-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C19829  Dammarenediol-II|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19829  Dammarenediol II,
C19830,"(5S,6S)-6-Amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate;|trans-2,3-Dihydro-3-hydroxyanthranilate;|trans-2,3-Dihydro-3-hydroxyanthranilic acid;|DHHA",,,,,
C19831,"(1R,6S)-6-Amino-5-oxocyclohex-2-ene-1-carboxylate",,,,,
C19832,Thalianol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010624 Polypodane, malabaricane and podiodane triterpenoids|C19832  Thalianol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Others|C19832  Thalianol",
C19833,Germanicol;|(3beta)-Olean-18-en-3-ol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19833  Germanicol,
C19834,"Dammara-20,24-diene;|Dammara-18(28),21-diene",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19834  Dammara-20,24-diene",
C19835,Camelliol C,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Liner triterpenes|C19835  Camelliol C,
C19836,"Tuberculosinyl diphosphate;|Halima-5(6),13-dien-15-yl diphosphate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C19836  Tuberculosinyl diphosphate,
C19837,Indole-3-carboxylate;|Indole-3-carboxylic acid,,,,,
C19838,D-erythro-3-Hydroxyaspartate,,,,,
C19839,"4,4'-Diaponeurosporen-4-al",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C19839  4,4'-Diaponeurosporen-4-al",
C19840,"4,4'-Diapophytofluene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C19840  4,4'-Diapophytofluene",
C19841,"4,4'-Diapo-zeta-carotene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C19841  4,4'-Diapo-zeta-carotene",
C19842,Peptidoglycan-D-glucosamine;|Deacetylated peptidoglycan,"Generic compound in reaction hierarchy|R = tetrapeptide, pentapeptide or cross-linked peptide",,,,
C19843,L-Asp(4-L-Arg),,,,,
C19844,"(1S,3R)-3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate",,,,,
C19845,Pimeloyl-[acyl-carrier protein];|Pimeloyl-[acp];|Pimelyl-[acyl-carrier protein];|Pimelyl-[acp];|7-Hydroxy-7-oxoheptanoyl-[acyl-carrier protein],,,,,
C19846,Pimeloyl-[acyl-carrier protein] methyl ester;|Pimeloyl-[acp] methyl ester;|Pimelyl-[acyl-carrier protein] methyl ester;|Pimelyl-[acp] methyl ester,,,,,
C19847,Demethylmenaquinol,,,,,
C19848,Adenylated molybdopterin;|Adenylyl-molybdopterin,,,,,
C19850,4-O-Phosphohygromycin B,,,,,
C19851,"ADP-ribose 1'',2''-phosphate;|ADP-ribose 1"",2""-cyclic phosphate",,,,,
C19852,"tritrans,heptacis-Undecaprenyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19852  tritrans,heptacis-Undecaprenyl diphosphate",
C19853,"trans,polycis-Polyprenyl diphosphate",n=9-11,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR00 Other Prenol lipids|C19853  trans,polycis-Polyprenyl diphosphate",
C19854,"D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19854  D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",
C19855,"D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19855  D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",
C19856,"D-Glc-beta-(1->4)-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19856  D-Glc-beta-(1->4)-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",
C19857,"D-Man-beta-(1->4)-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19857  D-Man-beta-(1->4)-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",
C19858,"2-Methoxy-6-all-trans-polyprenyl-1,4-benzoquinol",,,,,
C19859,"6-Methoxy-3-methyl-2-all-trans-polyprenyl-1,4-benzoquinol",Generic compound in reaction hierarchy|n=5-9,,,,
C19863,"Lupan-3beta,20-diol;|3beta,20-Dihydroxylupane;|Monogynol A",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010614 Lupane triterpenoids|C19863  Lupan-3beta,20-diol|Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Lupanes|C19863  Lupan-3beta,20-diol",
C19864,trans-Permethrin,Relative configuration (including both enantiomers),,,,
C19865,Soyasaponin III,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19865  Soyasaponin III,
C19866,N-Acetyl-beta-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide,,,,,G02027
C19867,beta-D-Glucosyl crocetin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C19867  beta-D-Glucosyl crocetin,
C19868,Bis(beta-D-glucosyl) crocetin;|Crocetin diglucosyl ester,,,,,
C19869,beta-D-Gentiobiosyl crocetin,,,,,
C19870,"4,6-CH3(COO-)C-D-Man-beta-(1->4)-D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C19870  4,6-CH3(COO-)C-D-Man-beta-(1->4)-D-GlcA-beta-(1->2)-D-Man-alpha-(1->3)-D-Glc-beta-(1->4)-D-Glc-alpha-1-diphospho-ditrans,octacis-undecaprenol",
C19871,Guanylyl molybdenum cofactor;|Molybdopterin guanine dinucleotide cofactor,,,,,
C19872,N-Formyl-4-amino-5-aminomethyl-2-methylpyrimidine;|2-Methyl-4-amino-5-(formylaminomethyl)pyrimidine;|FAMP,,,,,
C19873,26-Hydroxycastasterone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C19873  26-Hydroxycastasterone,
C19874,26-Hydroxybrassinolide,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0114 Brassinolides and derivatives|C19874  26-Hydroxybrassinolide,
C19875,alpha-Kdo-(2->8)-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C19875  alpha-Kdo-(2->8)-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA,G13060
C19876,alpha-Kdo-(2->8)-[alpha-Kdo-(2->4)]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C19876  alpha-Kdo-(2->8)-[alpha-Kdo-(2->4)]-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IVA,G13061
C19877,4-O-Phospho-alpha-Kdo-(2->6)-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C19877  4-O-Phospho-alpha-Kdo-(2->6)-lipid IVA,
C19878,D-glycero-alpha-D-manno-Heptose 7-phosphate,,,,,
C19879,"D-glycero-alpha-D-manno-Heptose 1,7-bisphosphate",,,,,
C19880,D-glycero-alpha-D-manno-Heptose 1-phosphate,,,,,
C19881,GDP-D-glycero-alpha-D-manno-heptose,,,,,
C19882,D-glycero-D-manno-Heptose 7-phosphate,Generic compound in reaction hierarchy,,,,
C19883,alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C19883  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid IVA,
C19884,Lipid IIA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0104 Tetraacylaminosugars|C19884  Lipid IIA,
C19885,alpha-Aminoadipate carrier protein LysW;|[LysW];|[Lysine-biosynthesis-protein LysW]-C-terminal-L-glutamate,,,,,
C19886,LysW-gamma-L-alpha-aminoadipate;|[LysW]-L-2-aminoadipate;|[Lysine-biosynthesis-protein LysW]-C-terminal-gamma-(L-2-aminoadip-2-yl)-L-glutamate,,,,,
C19887,LysW-gamma-L-alpha-aminoadipyl 6-phosphate,,,,,
C19888,LysW-gamma-L-alpha-aminoadipate 6-semialdehyde,,,,,
C19889,LysW-gamma-L-lysine,,,,,
C19890,alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C19890  alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-[4-P-L-Ara4N]-lipid A,
C19891,"1D-chiro-Inositol;|1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol;|(+)-Inositol",,,,,
C19892,"4'-Apo-beta,psi-caroten-4'-al;|beta-Apo-4'-carotenal",,,,,
C19893,10-epi-gamma-Eudesmol;|10alpha-Eudesm-4-en-11-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C19893  10-epi-gamma-Eudesmol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C19893  10-epi-gamma-Eudesmol,
C19894,"1,1'-Dihydroxylycopene;|1,1'-Dihydroxy-1,1',2,2'-tetrahydrolycopene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C19894  1,1'-Dihydroxylycopene",
C19895,4'-Methoxyflavanone,Generic compound in reaction hierarchy,,,,
C19896,4'-Hydroxyflavanone,Generic compound in reaction hierarchy|4'-Hydroxyflavanone (non-generic) [CPD:C14241],,,,
C19897,Debromohymenialdisine;|(Z)-Debromohymenialdisine;|DBH,,,,,
C19898,Manzamine A;|Keramamine A,,,,,
C19899,Dolastatin 15;|NSC 617668,,,,,
C19900,12-epi-Scalaradial,,,,,
C19901,Luffariellolide,,,,,
C19902,Contignasterol,,,,,
C19903,Lasonolide A,,,,,
C19904,Latrunculin B,,,,,
C19905,"DMXB-A;|GTS-21;|2,4-Dimethoxybenzylidene anabaseine",,,,,
C19907,Pyrrole,,,,,
C19908,(+)-beta-Chamigrene,,,,,
C19909,N-Acetyl-alpha-neuraminate;|alpha-Neu5Ac,,,,,
C19910,N-Acetyl-beta-neuraminate;|beta-Neu5Ac,,,,,
C19911,Iminodiacetate,,,,,
C19912,N-Arachidonoyl-phosphatidylethanolamine,,,,,
C19913,Phospho-anandamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0802 N-acyl amines|C19913  Phospho-anandamide,
C19914,Myriocin;|Thermozymocidin;|ISP-1,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0106 Oxo fatty acids|C19914  Myriocin|SP  Sphingolipids|SP01 Sphingoid bases|SP0108 Sphingoid base analogs|C19914  Myriocin,
C19915,Pyrazinoic acid;|2-Pyrazinecarboxylic acid,Pyrazinamide [CPD:C01956] metabolite,,,Prodrugs [br08324.html]|C19915,
C19916,"Halomon;|6-Bromo-3-(bromomethyl)-7-methyl-2,3,7-trichloro-1-octene",,,,,
C19917,Pateamine;|Pateamine A,,,,,
C19918,Parkeol;|Lanost-9(11)-en-3beta-ol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Dammarenes|C19918  Parkeol,
C19919,Safranin;|C.I. Basic Red 2,,,,,
C19920,Diatoxanthin;|all-trans-Diatoxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C19920  Diatoxanthin,
C19921,Diadinoxanthin;|Diadinoxanthin A,,,,,
C19928,Molybdopterin guanine dinucleotide,,,,,
C19929,"N(alpha)-Acetyl-L-2,4-diaminobutyrate;|N-alpha-Acetyl-L-2,4-diaminobutyrate;|N2-Acetyl-L-2,4-diaminobutanoate;|(2S)-2-Acetamido-4-aminobutanoate",,,,,
C19930,tert-Butylbicyclophosphorothionate;|tert-Butylbicyclophosphorothioic acid;|TBPS,,,,,
C19931,Raucaffrinoline,,,,,
C19932,Perakine;|Raucaffrine,,,,,
C19933,Prosolanapyrone II,,,,,
C19934,"Prosolanapyrone III;|4-Methoxy-2-oxo-6-(1E,7E,9E)-undeca-1,7,9-trien-1-yl-2H-pyran-3-carboxaldehyde",,,,,
C19935,Azide;|Nitrogen ion (N3-);|Azide ion;|Hydrazoate,,,,,
C19936,"(9R,10E,12Z,15Z)-9-Hydroperoxyoctadeca-10,12,15-trienoate",,,,,
C19937,"(8E,10R,12Z)-10-Hydroperoxy-8,12-octadecadienoate",,,,,
C19938,Pentalen-13-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C19938  Pentalen-13-ol,
C19939,Pentalen-13-al,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C19939  Pentalen-13-al|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C19939  Pentalen-13-al,
C19942,11alpha-Hydroxy-beta-amyrin;|11alpha-Dihydroxyolean-12-ene,,,,,
C19943,11-Oxo-beta-amyrin;|3beta-Hydroxyolean-12-en-11-one,,,,,
C19944,"3-Hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione;|Secophenol",,,,,
C19945,"3-Oxo-5,6-dehydrosuberyl-CoA;|3-Oxo-5,6-didehydrosuberoyl-CoA",,,,,
C19946,"3-Oxo-5,6-dehydrosuberyl-CoA semialdehyde",,,,,
C19947,"dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose",,,,,
C19948,"dTDP-3-dimethylamino-3,6-dideoxy-alpha-D-galactopyranose;|dTDP-D-ravidosamine",,,,,
C19949,Acromelic acid A,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C19949  Acromelic acid A,
C19950,Samandarine,,,,Natural toxins [BR:br08009]|Venoms|Others|Salamandra venoms|C19950  Samandarine,
C19951,Samandarone,,,,Natural toxins [BR:br08009]|Venoms|Others|Salamandra venoms|C19951  Samandarone,
C19952,HT-2 Toxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C19952  HT-2 Toxin,
C19953,"Cytochalasin A;|(7S,13E,16R,21E)-7-Hydroxy-16-methyl-10-phenyl-24-oxa[14]cytochalasa-6(12),13,21-triene-1,20,23-trione",,,,Lipids [BR:br08002]|PK  Polyketides|PK11 Cytochalasins|C19953  Cytochalasin A|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C19953  Cytochalasin A,
C19954,Cytochalasin B,,,,Lipids [BR:br08002]|PK  Polyketides|PK11 Cytochalasins|C19954  Cytochalasin B|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C19954  Cytochalasin B,
C19955,Phomopsin A,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C19955  Phomopsin A,
C19956,Neoilludin A,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Terpenoids|C19956  Neoilludin A,
C19957,Fasciculol E,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Terpenoids|C19957  Fasciculol E,
C19958,Fasciculol F,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Terpenoids|C19958  Fasciculol F,
C19959,Orellanine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Alkaloids|C19959  Orellanine,
C19960,dTDP-3-dehydro-6-deoxy-alpha-D-galactopyranose;|dTDP-6-deoxy-D-xylo-hexos-3-ulose;|dTDP-6-deoxy-D-xylo-hex-3-ulose,dTDP-6-deoxy-D-xylo-hex-3-ulose is named incorrectly.,,,,
C19961,"UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-altrosamine;|UDP-4-amino-4,6-dideoxy-beta-L-AltNAc;|UDP-2-acetamido-4-amino-2,4,6-trideoxy-beta-L-altrose",,,,,
C19962,13-cis-Retinol;|Neovitamin A,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C19962  13-cis-Retinol,
C19963,Tuberculosinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C19963  Tuberculosinol,
C19964,(13S)-Isotuberculosinol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C19964  (13S)-Isotuberculosinol,
C19965,beta-D-4-Deoxy-Delta4-GlcA-(1->4)-beta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glc;|beta-D-4-Deoxy-Delta4-GlcAp-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp,,,,,
C19966,beta-D-Glc-(1->4)-alpha-L-Rha-(1->3)-D-Glc;|beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-D-Glcp,,,,,
C19967,"8-Oxo-dGTP;|8-Oxodeoxyguanosine triphosphate;|8-Oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate",,,,,
C19968,"8-Oxo-dGMP;|2'-Deoxy-7,8-dihydro-8-oxo-5'-guanylate;|8-Hydroxydeoxyguanosine 5'-monophosphate",,,,,
C19969,2-Hydroxy-dATP;|2-Hydroxy-2'-deoxyadenosine 5'-triphosphate,,,,,
C19970,2-Hydroxy-dAMP,,,,,
C19971,"UDP-2,4-bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose;|UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altrose",,,,,
C19972,"2,4-Bis(acetamido)-2,4,6-trideoxy-beta-L-altropyranose",,,,,
C19973,(+)-beta-Caryophyllene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010312 Caryophyllane sesquiterpenoids|C19973  (+)-beta-Caryophyllene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Humulenes|C19973  (+)-beta-Caryophyllene,
C19974,(+)-Caryolan-1-ol,,,,,
C19975,2-Oxepin-2(3H)-ylideneacetyl-CoA,,,,,
C19976,Valinopine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C19976  Valinopine,
C19977,Clitidine;|Chrytidine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C19977  Clitidine,
C19978,Sclerocitrin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C19978  Sclerocitrin,
C19979,Ustalic acid,,,,Natural toxins [BR:br08009]|Fungal toxins|Mushroom toxins|Others|C19979  Ustalic acid,
C19980,Domesticine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C19980  Domesticine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C19980  Domesticine,
C19981,Gloriosine;|N-Deacetyl-N-formylcolchicine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C19981  Gloriosine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Isoquinoline alkaloids|C19981  Gloriosine,
C19982,"Gelsedine;|(Spiro(3H-indole-3,7'(6'H)-(3,) (6)methano(1H)oxepino(4,3-b)pyrrol)-2(1H)-one,) 2'-ethyl-2',3',3'a, 4',8',8'a-hexahydro-1-methoxy-",,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tryptophan and anthranilic acid|Indole alkaloids|C19982  Gelsedine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Indole alkaloids|C19982  Gelsedine,
C19983,Conhydrine;|(+)-alpha-Conhydrine,,,,Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Piperidine alkaloids|C19983  Conhydrine,
C19984,Cerberin;|2'-Acetylneriifolin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C19984  Cerberin|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C19984  Cerberin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C19984  Cerberin,
C19985,Nantenine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived from tyrosine|Isoquinoline alkaloids|C19985  Nantenine|Natural toxins [BR:br08009]|Phytotoxins|Alkaloids|Others|C19985  Nantenine,
C19986,Convalloside,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C19986  Convalloside|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C19986  Convalloside|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C19986  Convalloside,
C19987,Oleandrin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C19987  Oleandrin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C19987  Oleandrin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C19987  Oleandrin,
C19988,Strophanthidin;|Corchoside A aglycon,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Steroids|Cardanolide|C19988  Strophanthidin|Natural toxins [BR:br08009]|Phytotoxins|Glycosides|Cardiac glycosides|C19988  Strophanthidin|Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C19988  Strophanthidin,
C19989,Taxine B,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Taxanes|C19989  Taxine B|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C19989  Taxine B,
C19990,Aconine;|Jesaconine,,,,Phytochemical compounds [BR:br08003]|Alkaloids|Alkaloids derived by amination reactions|Terpenoid alkaloids|C19990  Aconine|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C19990  Aconine,
C19991,Euphornin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Others|C19991  Euphornin|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C19991  Euphornin,
C19992,"Rhodojaponin I;|Grayanotoxane-5,6,10,14,16-pentol, 2,3-epoxy-, 6,14-diacetate, (2beta,3beta,6beta,14R)-",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010418 Leucothol and grayanotoxane diterpenoids|C19992  Rhodojaponin I|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Grayanoids|C19992  Rhodojaponin I|Natural toxins [BR:br08009]|Phytotoxins|Terpenoids|Diterpenoids|C19992  Rhodojaponin I,
C19993,"Virol A;|(8E,10E,12S)-8,10-Heptadecadiene-4,6-diyne-1,12-diol",,,,Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C19993  Virol A|Natural toxins [BR:br08009]|Phytotoxins|Others|Polyynes|C19993  Virol A,
C19994,"Virol B;|(8S,9Z)-9-Heptadecene-4,6-diyne-1,8-diol",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C19994  Virol B|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C19994  Virol B|Natural toxins [BR:br08009]|Phytotoxins|Others|Polyynes|C19994  Virol B,
C19995,Microcystin RR,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C19995  Microcystin RR|Natural toxins [BR:br08009]|Cyanotoxins|Peptides|Microcystins|C19995  Microcystin RR,
C19996,Microcystin RA,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C19996  Microcystin RA|Natural toxins [BR:br08009]|Cyanotoxins|Peptides|Microcystins|C19996  Microcystin RA,
C19997,Microcystin YR,,,,Lipids [BR:br08002]|PK  Polyketides|PK14 Non-ribosomal peptide/polyketide hybrids|C19997  Microcystin YR|Natural toxins [BR:br08009]|Cyanotoxins|Peptides|Microcystins|C19997  Microcystin YR,
C19998,"Anatoxin a(s);|Anatoxin-A(S);|Guanitoxin;|Phosphoric acid, mono[(5S)-2-amino-5-[(dimethylamino)methyl]-4,5-dihydro-1H-imidazol-1-yl] monomethyl ester",,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Anatoxins|C19998  Anatoxin a(s),
C19999,"Cylindrospermopsin;|(2aS,3R,4S,5aS,7R)-7-[(R)-(2,6-Dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)(hydroxy)methyl]-3-methyl-2a,3,4,5,5a,6,7,8-octahydro-2H-1,8,8b-triazaacenaphthylen-4-yl hydrogen sulfate",,,,Natural toxins [BR:br08009]|Cyanotoxins|Alkaloids|Others|C19999  Cylindrospermopsin,
C20000,"Onchidal;|[E,(+)]-2-[(E)-2-Acetoxyethenyl]-4-(2,2-dimethyl-6-methylenecyclohexyl)-2-butenal",,,,Natural toxins [BR:br08009]|Venoms|Mollusk venoms|Others|C20000  Onchidal,
C20001,CTX 3C;|Ciguatoxin CTX 3C;|Ciguatoxin 3C,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C20001  CTX 3C,
C20002,Ciguatoxin 4A;|CTX 4A;|Scaritoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C20002  Ciguatoxin 4A,
C20003,Caribbean ciguatoxin 1;|C-CTX 1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C20003  Caribbean ciguatoxin 1,
C20004,Gambierol,,,,Natural toxins [BR:br08009]|Marine biotoxins|Ciguatera fish poisoning; CFP|Cyclic polyethers|C20004  Gambierol,
C20005,Dinophysistoxin 4;|DTX-4,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Okadaic acid and derivatives|C20005  Dinophysistoxin 4,
C20006,Acanthifolicin;|Acanthifolic acid,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Okadaic acid and derivatives|C20006  Acanthifolicin,
C20007,Caribenolide I,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Macrolides|C20007  Caribenolide I,
C20008,Hoffmanniolide,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Macrolides|C20008  Hoffmanniolide,
C20009,Iriomoteolide 1a;|Iriomoteolide-1a,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Macrolides|C20009  Iriomoteolide 1a,
C20010,Anatibant;|LF 16-0687,,,,,
C20011,"Homoyessotoxin;|Yessotoxin, 3-de(2-(sulfooxy)ethyl)-3-(3-(sulfooxy)propyl)-",,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Cyclic polyethers|C20011  Homoyessotoxin,
C20012,Pectenotoxin 2;|43-Deoxypectenotoxin 1;|PTX 2,,,,Natural toxins [BR:br08009]|Marine biotoxins|Diarrhetic shellfish poisoning; DSP|Others|C20012  Pectenotoxin 2,
C20013,Brevetoxin B1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C20013  Brevetoxin B1,
C20014,Brevetoxin B2,,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C20014  Brevetoxin B2,
C20015,"Brevetoxin C;|Brevetoxin B, 43-chloro-41-deformyl-41,43-dihydro-41-oxo-",,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C20015  Brevetoxin C,
C20016,Hemibrevetoxin B,,,,Natural toxins [BR:br08009]|Marine biotoxins|Neurotoxic Shellfish Poison; NSP|Cyclic polyethers|C20016  Hemibrevetoxin B,
C20017,Satratoxin H,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Trichothecenes|C20017  Satratoxin H,
C20018,Gonyautoxin 5;|Gonyautoxin V;|GTX5;|Toxin B1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|N-Sulfo-carbamoyl derivatives|C20018  Gonyautoxin 5,
C20019,Gonyautoxin 6;|Gonyautoxin VI;|GTX6;|Toxin B2,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|N-Sulfo-carbamoyl derivatives|C20019  Gonyautoxin 6,
C20020,Gonyautoxin 8;|GTX8;|Gonyautoxin VIII;|Protogonyautoxin II;|Toxin C2,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|N-Sulfo-carbamoyl derivatives|C20020  Gonyautoxin 8,
C20021,Decarbamoylsaxitoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|Decarbamoyl derivatives|C20021  Decarbamoylsaxitoxin,
C20022,Decarbamoylgonyautoxin 1,,,,Natural toxins [BR:br08009]|Marine biotoxins|Paralytic shellfish poisoning; PSP|Decarbamoyl derivatives|C20022  Decarbamoylgonyautoxin 1,
C20023,Prorocentrolide,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C20023  Prorocentrolide,
C20024,Prorocentrolide B,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C20024  Prorocentrolide B,
C20025,Gymnodimine;|Gymnodimine A;|GYM A,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Others|C20025  Gymnodimine,
C20026,11-Deoxytetrodotoxin,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Tetrodotoxins|C20026  11-Deoxytetrodotoxin,
C20027,Isodomoic acid A,,,,Natural toxins [BR:br08009]|Marine biotoxins|Amnesic Shellfish Poisoning; ASP|Kainoids|C20027  Isodomoic acid A,
C20028,Ostreocin D,,,,Natural toxins [BR:br08009]|Marine biotoxins|Others|Palytoxins|C20028  Ostreocin D,
C20029,Eledoisin,,Glp Pro Ser Lys Asp Ala Phe Ile Gly Leu Met-NH2,Peptide,Natural toxins [BR:br08009]|Venoms|Mollusk venoms|Peptides|C20029  Eledoisin,
C20030,Dermorphin,,Tyr D-Ala Phe Gly Tyr Pro Ser-NH2,Peptide,Natural toxins [BR:br08009]|Venoms|Frog venoms|Others|C20030  Dermorphin,
C20031,Pumiliotoxin 251D;|PTX 251D,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C20031  Pumiliotoxin 251D,
C20032,Batrachotoxinin A,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C20032  Batrachotoxinin A,
C20033,Pumiliotoxin A,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C20033  Pumiliotoxin A,
C20034,Allopumiliotoxin 267A,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Alkaloids|C20034  Allopumiliotoxin 267A,
C20035,Arenobufagin,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Bufotoxins|C20035  Arenobufagin,
C20036,Marinobufagenin;|Marinobufagin,,,,Natural toxins [BR:br08009]|Venoms|Frog venoms|Bufotoxins|C20036  Marinobufagenin,
C20044,Enanthotoxin;|Oenanthotoxin,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA05 Fatty alcohols|C20044  Enanthotoxin|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Polyynes|C20044  Enanthotoxin|Natural toxins [BR:br08009]|Phytotoxins|Others|Polyynes|C20044  Enanthotoxin,
C20045,Verruculogen;|TR 1;|TR 1 toxin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C20045  Verruculogen,
C20046,Mollicellin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1308 Depsides and depsidones|C20046  Mollicellin C|Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C20046  Mollicellin C,
C20048,Apamine;|Apamin,,Cys Asn Cys Lys Ala Pro Glu Thr Ala Leu Cys Ala Arg Arg Cys Gln|Gln His-NH2 (Disulfide bridge: 1-11; 3-15),Peptide,Natural toxins [BR:br08009]|Venoms|Bee venoms|Peptides|C20048  Apamine,
C20050,Polisteskinin JT,,RTRPPGFSPF R,Peptide,Natural toxins [BR:br08009]|Venoms|Bee venoms|Wasp kinins|C20050  Polisteskinin JT,
C20052,Philanthotoxin,,,,Natural toxins [BR:br08009]|Venoms|Bee venoms|Others|C20052  Philanthotoxin,
C20059,Samandenone,,,,Natural toxins [BR:br08009]|Venoms|Others|Salamandra venoms|C20059  Samandenone,
C20060,Cephalostatin 1,,,,Natural toxins [BR:br08009]|Venoms|Others|Others|C20060  Cephalostatin 1,
C20061,Ritterazine A,,,,Natural toxins [BR:br08009]|Venoms|Others|Others|C20061  Ritterazine A,
C20062,"2-(1,2-Epoxy-1,2-dihydrophenyl)acetyl-CoA",,,,,
C20070,Penitrem A,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20070  Penitrem A,
C20073,Xestoquinone;|(+)-Xestoquinone;|XQN,,,,,
C20082,"Pseudaminic acid;|5,7-Bis(acetylamino)-3,5,7,9-tetradeoxy-L-glycero-alpha-L-manno-2-nonulopyranosonic acid;|Pse5Ac7Ac",,,,,
C20083,CMP-pseudaminic acid;|CMP-Pse5Ac7Ac,,,,,
C20084,Contulakin G;|Contulakin-G,,Glp Ser Glu Glu Gly Gly Ser Asn Ala Thr Lys Lys Pro Tyr Ile Leu,Peptide,Natural toxins [BR:br08009]|Venoms|Mollusk venoms|Peptides|C20084  Contulakin G,
C20093,Argiopinin I,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C20093  Argiopinin I,
C20094,Argiopinin II,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C20094  Argiopinin II,
C20095,Argiopinin III,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C20095  Argiopinin III,
C20096,Pseudoargiopinin I,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C20096  Pseudoargiopinin I,
C20097,Pseudoargiopinin III,,,,Natural toxins [BR:br08009]|Venoms|Spider venoms|Argiopinins|C20097  Pseudoargiopinin III,
C20119,Protein-cysteine;|Protein C-terminal CAAX,Generic compound in reaction hierarchy|Proteins having C-terminal sequence Cys-aliphatic-aliphatic-X,,,,
C20120,S-Farnesyl protein;|S-Farnesyl protein C-terminal CAAX,Generic compound in reaction hierarchy|Proteins having C-terminal sequence S-farnesyl-Cys-aliphatic-aliphatic-X,,,,
C20121,"trans,trans-Farnesyl phosphate;|Farnesyl phosphate;|(2E,6E)-Farnesyl phosphate",,,,,
C20122,"Dibenz[c,h]acridine;|14-Azadibenz[a,j]anthracene;|3,4:5,6-Dibenzacridine",,,,,
C20123,"Dibromoacetic acid;|2,2-Dibromoacetic acid;|DBAA",,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0109 Halogenated fatty acids|C20123  Dibromoacetic acid,
C20124,"Benzo[b]naphtho[2,1-d]thiophene;|1,2-Benzo-9-thiafluorene",,,,,
C20125,Dibenzothiophene,,,,,
C20126,"Methylone;|2-(Methylamino)-1-(1,3-benzodioxol-5-yl)-1-propanone",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C20126,
C20127,alpha-Methyltryptamine;|Indopan,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C20127,
C20128,"Bombykal;|(Z,E)-10,12-Hexadecadienal",,,,,
C20129,(S)-Warfarin,,,,,
C20130,(S)-Mephenytoin,,,,,
C20131,Aclatonium,,,,Drug groups [BR:br08330]|Neuropsychiatric agent|DG01490  Muscarinic cholinergic receptor agonist|DG01291  Aclatonium|C20131  Aclatonium,G01291
C20132,Platensimycin;|(-)-Platensimycin,,,,,
C20133,Sugiresinol;|Sequirin A,,,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Norlignans|C20133  Sugiresinol,
C20134,19-Chloroproansamitocin,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20134  19-Chloroproansamitocin,
C20135,20-O-Methyl-19-chloroproansamitocin,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20135  20-O-Methyl-19-chloroproansamitocin,
C20136,"N-Demethyl-desepoxymaytansinol;|N-Desmethyl-4,5-desepoxymaytansinol",,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20136  N-Demethyl-desepoxymaytansinol,
C20137,N-Demethyl-desepoxyansamitocin P-3;|N-Demethyl-desepoxy-AP-3,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20137  N-Demethyl-desepoxyansamitocin P-3,
C20138,N-Demethylansamitocin P-3;|N-Demethyl-AP-3;|PND-3,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20138  N-Demethylansamitocin P-3,
C20139,Ansamitocinoside P-3;|AGP-3,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20139  Ansamitocinoside P-3,
C20140,4''-O-Carbamoyl ansamitocinoside P-3;|ACGP-3,,,,Lipids [BR:br08002]|PK  Polyketides|PK05 Ansamycins and related polyketides|C20140  4''-O-Carbamoyl ansamitocinoside P-3,
C20141,Acridine,,,,,
C20142,Acridone;|9(10H)-Acridone,,,,,
C20143,(25S)-26-Hydroxycholest-4-en-3-one,,,,,
C20144,"Androsta-1,4-diene-3,17-dione",,,,,
C20145,ent-Isokaurene;|Kaur-15-ene;|Kryptomeren,,,,,
C20146,ent-2alpha-Hydroxyisokaurene;|ent-Isokauren-2beta-ol,,,,,
C20147,"9beta-Pimara-7,15-dien-19-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C20147  9beta-Pimara-7,15-dien-19-ol",
C20148,"9beta-Pimara-7,15-dien-19-al",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C20148  9beta-Pimara-7,15-dien-19-al",
C20149,"9beta-Pimara-7,15-dien-19-oate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010408 Pimarane diterpenoids|C20149  9beta-Pimara-7,15-dien-19-oate",
C20150,"ent-11beta-Hydroxycassa-12,15-diene",,,,,
C20151,"10beta,14beta-Dihydroxytaxa-4(20),11-dien-5alpha-yl acetate;|5alpha-Acetoxy-10beta,14beta-dihydroxytaxadiene",,,,,
C20152,"Taxusin;|Taxa-4(20),11-diene-5alpha,9alpha,10beta,13alpha-tetrayl tetraacetate",,,,,
C20153,7beta-Hydroxytaxusin,,,,,
C20154,"3-Methoxy-4',5-dihydroxy-trans-stilbene",,,,,
C20155,8-Oxoguanine,,,,,
C20156,"dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose",,,,,
C20157,beta-Carboline;|Norharman,,,,,
C20158,"(13E)-Labda-7,13-dien-15-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C20158  (13E)-Labda-7,13-dien-15-ol",
C20159,"7-epi-alpha-Selinene;|(-)-7-epi-alpha-Selinene;|(2S,4aR,8aR)-4a,8-Dimethyl-2-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,8a-octahydronaphthalene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20159  7-epi-alpha-Selinene,
C20160,CTOP;|Phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide,,D-Phe Cys Tyr D-Trp Orn Thr Pen Thr-NH2 (Disulfide bridge: 2-7),Peptide,,
C20161,alpha-Guaiene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C20161  alpha-Guaiene,
C20162,Viridiflorene,,,,,
C20163,"5-epi-alpha-Selinene;|5beta-Eudesma-3,11-diene;|(2R,4aR,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(prop-1-en-2-yl)naphthalene;|8a-epi-alpha-Selinene;|(2R,4aR,8aS)-1,2,3,4,4a,5,6,8a-Octahydro-4a,8-dimethyl-2-(1-methylethenyl)naphthalene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20163  5-epi-alpha-Selinene,
C20164,"DPDPE;|2,5-Pen-enkephalin;|Enkephalin, penicillamine(2,5)-",,,,,
C20165,"DSLET;|2-Ser-thr-leu-enkephalin;|Enkephalin, Ser(2), Leu(5), Thr(6)-;|[D-Ser2,Leu5]Enkephalin-Thr6",,Tyr D-Ser Gly Phe Leu Thr,Peptide,,
C20166,Naltriben;|NTB,,,,,
C20167,7-Benzylidenenaltrexone;|BNTX,,,,,
C20168,(-)TAN-67,(+)TAN-67 [CPD:C20169],,,,
C20169,(+)TAN-67,(-)TAN-67 [CPD:C20168],,,,
C20170,Benzoyl isothiocyanate,,,,,
C20171,Icilin;|AG 3-5,,,,,
C20172,Cubebol,,,,,
C20173,(+)-gamma-Cadinene,,,,,
C20174,delta-Guaiene;|alpha-Bulnesene,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Eudesmanes|C20174  delta-Guaiene,
C20175,Bicyclogermacrene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010310 Lepidozanes and bicyclogermacrane sesquiterpenoids|C20175  Bicyclogermacrene,
C20176,"8-Oxo-dGDP;|8-Oxo-7,8-dihydro-2'-deoxyguanosine 5'-diphosphate",,,,,
C20177,7-epi-Sesquithujene;|(+)-7-epi-Sesquithujene,,,,,
C20178,Sesquithujene;|(+)-Sesquithujene,,,,,
C20179,gamma-Curcumene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C20179  gamma-Curcumene|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C20179  gamma-Curcumene,
C20180,(-)-alpha-Cuprenene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010314 Cuparane sesquiterpenoids|C20180  (-)-alpha-Cuprenene,
C20181,Avermitilol,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Others|C20181  Avermitilol,
C20182,"(-)-delta-Cadinene;|(1R,8aS)-4,7-Dimethyl-1-(propan-2-yl)-1,2,3,5,6,8a-hexahydronaphthalene",,,,,
C20183,N7-Methylguanosine 5'-diphosphate;|N7-Methyl-GDP,,,,,
C20184,"(+)-T-Muurolol;|(+)-tau-Muurolol;|(1R,4R,4aS,8aR)-1,6-Dimethyl-4-(propan-2-yl)-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol",,,,,
C20185,"(12E)-9alpha-Labda-8(17),12,14-triene;|syn-Labda-8(17),12E,14-triene;|(4aS,5R,8aS)-1,1,4a-Trimethyl-6-methylidene-5-[(2E)-3-methylpenta-2,4-dien-1-yl]decahydronaphthalene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C20185  (12E)-9alpha-Labda-8(17),12,14-triene",
C20186,"5S,8R-DiHODE;|(5S,8R)-DiHODE;|(5S,8R,9Z,12Z)-5,8-Dihydroxyoctadeca-9,12-dienoate",,,,,
C20187,Achilleol B,,,,,
C20188,Glutinol,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010616 Taraxerane, multiflorane, glutinane and friedelane triterpenoids|C20188  Glutinol",
C20189,Baccharis oxide,,,,,
C20190,"P1,P6-Bis(5'-adenosyl)hexaphosphate",,,,,
C20191,"alpha-seco-Amyrin;|8,14-Secoursa-7,13-diene-3beta-ol",,,,,
C20192,Marneral,,,,,
C20193,"beta-seco-Amyrin;|8,14-Secooleana-7,13-diene-3beta-ol",,,,,
C20194,delta-Amyrin,,,,,
C20195,"Tirucalla-7,24-dien-3beta-ol",,,,,
C20196,Salvinorin A,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C20196  Salvinorin A,
C20197,Prostratin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Tiglianes|C20197  Prostratin,
C20198,Adenosine 5'-pentaphosphate,,,,,
C20199,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoate;|9,17-Dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic acid;|DOHNAA;|HIP",,,,,
C20200,Baruol,,,,,
C20201,"(-)-Solanapyrone A;|Solanapyrone A;|4-Methoxy-6-((1R,2S,4aR,8aR)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-2-oxo-2H-pyran-3-carboxaldehyde",,,,,
C20202,"BRACO-19;|9-[4-(N,N-Dimethylamino)phenylamino]-3,6-bis (3-pyrrolodino-propionamido) acridine",,,,,
C20203,Capsiate,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Capsaicinoids and derivatives|C20203  Capsiate,
C20204,Entadamide A,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Amides|C20204  Entadamide A,
C20205,Tanabalin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Clerodanes|C20205  Tanabalin,
C20206,Albaspidin BB,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C20206  Albaspidin BB,
C20207,Grandinol,,,,Phytochemical compounds [BR:br08003]|Polyketides|Others|Phloroglucinols|C20207  Grandinol,
C20208,syn-Stemoden-19-oate,,,,,
C20209,Meconic acid;|Poppy acid,,,,Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Monocyclic gamma-pyrones|C20209  Meconic acid,
C20210,Eugenin;|2-Methyl-5-hydroxy-7-methoxychromone,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1311 Benzopyranoids|C20210  Eugenin|Phytochemical compounds [BR:br08003]|Polyketides|Pyrones|Chromones|C20210  Eugenin,
C20211,Yakuchinone A;|Yakuchinone-A,,,,Phytochemical compounds [BR:br08003]|Shikimate / acetate-malonate pathway derived compounds|Others|Diarylheptanoids|C20211  Yakuchinone A,
C20212,Steviol;|13-Hydroxykaur-16-en-18-oic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010413 Kaurane and phyllocladane diterpenoids|C20212  Steviol|Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Kaurenes|C20212  Steviol,
C20213,Annonacin,,,,Lipids [BR:br08002]|PK  Polyketides|PK03 Annonaceae acetogenins|C20213  Annonacin|Phytochemical compounds [BR:br08003]|Fatty acids related compounds|Fatty acids|Others|C20213  Annonacin,
C20214,Andrographolide,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Diterpenoids (C20)|Labdanes|C20214  Andrographolide,
C20215,Homocapsaicin;|Homocapsaicin I,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Capsaicinoids and derivatives|C20215  Homocapsaicin,
C20216,Nordihydrocapsaicin;|N-((4-H ydroxy-3-methoxyphenyl)methyl)-7-methyl-octanamide,,,,Phytochemical compounds [BR:br08003]|Amino acid related compounds|Others|Capsaicinoids and derivatives|C20216  Nordihydrocapsaicin,
C20217,Cannabidivarin;|CBDV,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20217  Cannabidivarin|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C20217  Cannabidivarin,
C20218,Cannabielsoin;|Cannabielsoin A;|CBE,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20218  Cannabielsoin|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C20218  Cannabielsoin,
C20219,Cannabigerol;|CBG,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1503 Alkyl resorcinols and derivatives|C20219  Cannabigerol|Phytochemical compounds [BR:br08003]|Polyketides|Others|Cannabinoids|C20219  Cannabigerol,
C20220,AM251;|AM 251;|AM-251,,,,,
C20221,(6E)-8-Oxolinalool;|trans-8-Oxolinalool,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C20221  (6E)-8-Oxolinalool,
C20222,(6E)-8-Hydroxygeranial,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C20222  (6E)-8-Hydroxygeranial,
C20223,(6E)-8-Oxogeraniol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C20223  (6E)-8-Oxogeraniol,
C20224,Coniferyl ester,Generic compound in reaction hierarchy,,,,
C20225,Coniferyl acetate,,,,,
C20226,"Benzil;|1,2-Diphenylethane-1,2-dione",,,,,
C20227,(S)-Benzoin,,,,,
C20228,(R)-Benzoin,,,,,
C20229,10-Hydroxy-alpha-humulene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010311 Humulane sesquiterpenoids|C20229  10-Hydroxy-alpha-humulene,
C20230,(+)-Sabinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C20230  (+)-Sabinene,
C20231,(Z)-3-Ureidoacrylate peracid;|Ureidoperacrylic acid,,,,,
C20232,(Z)-2-Methylureidoacrylate peracid,,,,,
C20233,17-Hydroxylupanine,,,,,
C20234,(3R)-5-Guanidino-3-methyl-2-oxopentanoate;|(3R)-5-Carbamimidamido-3-methyl-2-oxopentanoate,,,,,
C20235,(E)-2-Methylgeranyl diphosphate,,,,,
C20236,4-O-beta-D-Mannopyranosyl-D-glucopyranose,,,,,
C20237,alpha-Maltose 1-phosphate,,,,,
C20238,(2R)-Ethylmalonyl-CoA,,,,,
C20239,"6-Carboxy-5,6,7,8-tetrahydropterin;|6-Carboxytetrahydropterin",,,,,
C20240,"(2Z,4Z)-2-Hydroxyhexa-2,4-dienoate;|(2Z,4Z)-2-Hydroxyhexa-2,4-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0105 Hydroxy fatty acids|C20240  (2Z,4Z)-2-Hydroxyhexa-2,4-dienoic acid",
C20241,Tricyclene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010213 Tricyclic monoterpenoids|C20241  Tricyclene,
C20242,"(-)-Sabinene;|(1S,5S)-1-Isopropyl-4-methylenebicyclo[3.1.0]hexane",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C20242  (-)-Sabinene,
C20243,"2-Methylisoborneol;|1,2,7,7-Tetramethyl-exo-bicycloheptan-2-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C20243  2-Methylisoborneol,
C20244,"(+)-beta-Pinene;|(1R,5R)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]hept-2-ene",,,,,
C20245,UDP-N-acetyl-alpha-D-glucosamine 3'-phosphate,,,,,
C20246,"2-[(2R,5Z)-2-Carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate;|cThz*-P",,,,,
C20247,"2-(2-Carboxy-4-methylthiazol-5-yl)ethyl phosphate;|4-Methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazole-2-carboxylate;|cThz-P",,,,,
C20248,7-Carboxy-7-carbaguanine;|7-Carboxy-7-deazaguanine,,,,,
C20249,(Z)-3-Peroxyaminoacrylate,,,,,
C20250,(Z)-2-Methylperoxyaminoacrylate,,,,,
C20251,"1-Keto-D-chiro-inositol;|2D-2,3,5/4,6-Pentahydroxycyclohexanone",,,,,
C20252,"5-Androstene-3,17-dione",,,,,
C20253,Aminoacrylate;|(Z)-3-Aminoacrylate,,,,,
C20254,Ureidoacrylate;|(Z)-3-Ureidoacrylate,,,,,
C20255,Methylaminoacrylate;|(Z)-2-Methylaminoacrylate;|(Z)-2-Methyl-3-aminoacrylate,,,,,
C20256,Methylureidoacrylate;|(Z)-2-Methylureidoacrylate;|(Z)-2-Methyl-3-ureidoacrylate;|(2Z)-3-(Carbamoylamino)-2-methylprop-2-enoate,,,,,
C20258,"(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydrodipicolinate;|(2S,4S)-4-Hydroxy-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate;|HTPA",,,,,
C20259,Mertansine;|DM 1,,,,,
C20260,(+)-Thujan-3-one;|(+)-Isothujone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C20260  (+)-Thujan-3-one,
C20261,(+)-Thujan-3-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C20261  (+)-Thujan-3-ol,
C20262,Zerumbone,,,,,
C20263,"L-threo-7,8-Dihydrobiopterin",,,,,
C20264,L-threo-Tetrahydrobiopterin,,,,,
C20265,"2,3-Epoxymenaquinone;|Vitamin K2 2,3-epoxide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C20265  2,3-Epoxymenaquinone|PR0203 Vitamin K|C20265  2,3-Epoxymenaquinone",
C20266,AMD 070,,,,"Drug groups [BR:br08330(D11510)]|Metabolizing enzyme substrate|DG01644  CYP2D6 substrate|D11510  Mavorixafor|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|D11510  Mavorixafor|Target-based classification of drugs [BR:br08310(D11510)]|Cytokines and receptors|Cytokine receptors|Chemokine receptors|CXCR4 (CD184)|D11510  Mavorixafor (USAN) &lt;US&gt;|New drug approvals in the USA [br08319.html(D11510)]|New molecular entities and new therapeutic biological products|D11510|New drug approvals in the USA, Europe and Japan [br08328.html(D11510)]|Approval dates by FDA, EMA and PMDA|D11510|Drug metabolizing enzymes and transporters [br08309.html(D11510)]|Drug metabolizing enzymes|D11510",
C20267,4-Amino-5-aminomethyl-2-methylpyrimidine;|Amino-HMP,,,,,
C20268,Combretastatin A-4;|Combretastatin A4,,,,,
C20269,Eugenol quinone methide,,,,,
C20270,Copal-8-ol diphosphate;|(13E)-8alpha-Hydroxylabd-13-en-15-yl diphosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C20270  Copal-8-ol diphosphate,
C20271,"[(1R)-2,2,3-Trimethyl-5-oxocyclopent-3-enyl]acetate",,,,,
C20272,alpha-Muurolene;|(+)-alpha-Muurolene,,,,,
C20273,gamma-Muurolene;|(+)-gamma-Muurolene,,,,,
C20274,beta-Copaene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010383 Copaane sesquiterpenoids|C20274  beta-Copaene,
C20275,(+)-Sativene,,,,,
C20276,Tetraprenyl-beta-curcumene,,,,,
C20277,"(2R,3R)-3-Methylornithine;|(3R)-3-Methyl-D-ornithine",,,,,
C20278,"(2R,3R)-3-Methylornithinyl-N6-lysine;|N6-[(3R)-3-Methyl-D-ornithinyl]-L-lysine",,,,,
C20279,"(2R,3R)-3-Methylglutamyl-5-semialdehyde-N6-lysine",,,,,
C20280,"1-Phenylazo-2,6-dihydroxynaphthalene;|6-OH-Sudan I",,,,,
C20281,1-(4-Hydroxyphenylazo)-2-naphthol;|4'-OH-Sudan I,,,,,
C20282,"1-(4-Hydroxyphenylazo)-naphthalene-2,6-diol;|4',6-diOH-Sudan I",,,,,
C20283,"1-(3,4-Dihydroxyphenylazo)-2-naphthol;|3',4'-diOH-Sudan I",,,,,
C20284,Benzenediazonium;|Benzenediazonium ion,,,,,
C20285,4-Acetylaminobiphenyl,,,,,
C20286,"2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine;|2-Hydroxyamino-PhIP",,,,,
C20287,"2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine;|N-Acetoxy-PhIP",,,,,
C20288,N-Sulfonyloxy-PhIP,,,,,
C20289,N-Hydroxy-IQ,,,,,
C20290,N-Acetoxy-IQ,,,,,
C20291,N-Hydroxy-MeIQx,,,,,
C20292,Tetramethylammonium;|Tetramethylammonium ion,,,,,
C20293,N-Acetoxy-MeIQx,,,,,
C20297,Narcotine hemiacetal,,,,,
C20299,Papaveroxine,,,,,
C20300,Dimethylarsinous acid,,,,,
C20301,alpha-Hydroxy-NDMA;|N-Nitrosohydroxymethylmethylamine,,,,,
C20302,Methyldiazonium ion;|Methanediazonium,,,,,
C20303,Chloroethylene oxide,,,,,
C20304,S-(2-Chloroethyl)glutathione,,,,,
C20305,"1,2-Dichloroethanol",,,,,
C20306,Methyldiazohydroxide,,,,,
C20307,Artemisinic alcohol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20307  Artemisinic alcohol,
C20308,Artemisinic aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20308  Artemisinic aldehyde,
C20309,Artemisinate;|Artemisinic acid,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20309  Artemisinate,
C20310,N-Hydroxy-L-isoleucine,,,,,
C20311,"N,N-Dihydroxy-L-isoleucine",,,,,
C20312,(Z)-2-Methylbutanal oxime,,,,,
C20313,N-Hydroxy-L-valine,,,,,
C20314,"N,N-Dihydroxy-L-valine",,,,,
C20315,(Z)-2-Methylpropanal oxime,,,,,
C20316,4-Nitrosobiphenyl,,,,,
C20317,"S-(1,2-Dichlorovinyl)-L-cysteine;|DCVC",,,,,
C20318,"S-(1,2-Dichlorovinyl)thiol;|DCVT",,,,,
C20319,Hydronitroxide radical,,,,,
C20320,"Bornane-2,6-dione;|6-Oxocamphor",,,,,
C20321,"[(2R)-3,3,4-Trimethyl-6-oxo-3,6-dihydro-1H-pyran-2-yl]acetyl-CoA",,,,,
C20322,(+)-6-exo-Hydroxycamphor,,,,,
C20323,(+)-6-endo-Hydroxycamphor,,,,,
C20324,"[(1S)-4-Hydroxy-2,2,3-trimethylcyclopent-3-enyl]acetate",,,,,
C20325,(11R)-Dihydroartemisinic aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C20325  (11R)-Dihydroartemisinic aldehyde,
C20326,"2-exo-Hydroxy-1,8-cineole",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010209 Menthane monoterpenoids|C20326  2-exo-Hydroxy-1,8-cineole",
C20327,2-Oxo-4-phenylbutyric acid;|2-Oxo-4-phenylbutanoic acid;|2-Oxo-4-phenylbutanoate,,,,,
C20328,N-Acetyl-alpha-D-glucosamine,,,,,
C20329,"Abieta-7,13-dien-18,18-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C20329  Abieta-7,13-dien-18,18-diol",
C20330,5-Hydroxy-L-arginine;|L-Hydroxyarginine;|delta-Hydroxyarginine,,,,,
C20331,"beta-Carotene-15,15'-epoxide",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C20331  beta-Carotene-15,15'-epoxide",
C20332,"15,15'-Dihydroxy-beta-carotene",,,,,
C20333,N2-Citryl-N6-acetyl-N6-hydroxy-L-lysine;|N2-Citryl-N6-acetyl-N6-hydroxylysine,,,,,
C20334,"1,2,6-Hexanetriol",,,,,
C20335,"1,3-Butanediol;|1,3-Butylene glycol",,,,,
C20336,Alphazurine FG,,,,,
C20337,Alizarin cyanin green;|C.I. Acid green 25,,,,,
C20338,2-Octyl dodecanol;|Octyldodecanol,,,,,
C20339,"N,N-Dimethylacetamide",,,,,
C20340,"L-Ascorbic acid, 6-octadecanoate;|L-Ascorbic acid monostearate",,,,,
C20341,Disodium malate;|Disodium DL-malate,,,,,
C20342,Isobutylparaben;|Isobutyl parahydroxybenzoate,,,,,
C20343,Isopropylparaben;|Isopropyl 4-hydroxybenzoate,,,,,
C20344,New coccine;|C.I. Acid red 18;|Food red No.102,,,,,
C20345,Isopentenyl phosphate;|3-Methylbut-3-en-1-yl phosphate,,,,,
C20346,C.I. Acid red 33;|Azofuchsin,,,,,
C20347,Rose bengal;|Tetrachlorotetraiodofluorescein disodium salt,,,,,
C20348,Lissamine rhodamine B,,,,,
C20349,Quinoline yellow WS;|C.I. Acid yellow 3,,,,,
C20350,2'-Deamino-2'-hydroxyneamine,,,,,
C20351,2'-Deamino-2'-hydroxy-6'-dehydroparomamine,,,,,
C20352,"trans,octacis-Decaprenylphospho-beta-D-ribofuranose 5-phosphate",,,,,
C20353,2'-Deamino-2'-hydroxyparomamine,,,,,
C20354,3-O-alpha-D-Glucopyranosyl-L-rhamnopyranose;|3-O-alpha-D-Glucosyl-L-rhamnose,,,,,
C20355,Glyceryl tri(2-ethylhexanoate),,,,,
C20356,Isooctadecanoic acid;|Isostearic acid,,,,,
C20357,"UDP-N,N'-diacetylbacillosamine;|UDP-2,4-diacetamido-2,4,6-trideoxy-alpha-D-glucopyranose",,,,,
C20358,Caloxetate trisodium,Coordination compound,,,,
C20359,"UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucuronate",,,,,
C20360,Sodium methallylsulfonate;|Sodium methallyl sulfonate,,,,,
C20361,Pseudooxynicotine;|4-(Methylamino)-1-(pyridin-3-yl)butan-1-one,,,,,
C20362,Ethyl maltol,,,,,
C20363,"Ethylene carbonate;|1,3-Dioxolan-2-one",,,,,
C20364,Erythorbic acid;|Isoascorbic acid,,,,,
C20365,Decyl oleate,,,,,
C20366,2-Oxo-3-(5-oxofuran-2-ylidene)propanoate,,,,,
C20367,"4-Nitro-6-oxohepta-2,4-dienedioate",,,,,
C20368,"trans,octacis-Decaprenylphospho-beta-D-ribofuranose",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C20368  trans,octacis-Decaprenylphospho-beta-D-ribofuranose",
C20369,"trans,octacis-Decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C20369  trans,octacis-Decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose",
C20370,"trans,octacis-Decaprenylphospho-beta-D-arabinofuranose",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C20370  trans,octacis-Decaprenylphospho-beta-D-arabinofuranose",
C20371,Ecgonone methyl ester,,,,,
C20372,3-Ketoglutaryl-[acp] methyl ester;|3-Ketoglutaryl-[acyl-carrier protein] methyl ester,,,,,
C20373,3-Hydroxyglutaryl-[acp] methyl ester;|3-Hydroxyglutaryl-[acyl-carrier protein] methyl ester,,,,,
C20374,Enoylglutaryl-[acp] methyl ester;|Enoylglutaryl-[acyl-carrier protein] methyl ester,,,,,
C20375,Glutaryl-[acp] methyl ester;|Glutaryl-[acyl-carrier protein] methyl ester,,,,,
C20376,3-Ketopimeloyl-[acp] methyl ester;|3-Ketopimeloyl-[acyl-carrier protein] methyl ester,,,,,
C20377,3-Hydroxypimeloyl-[acp] methyl ester;|3-Hydroxypimeloyl-[acyl-carrier protein] methyl ester,,,,,
C20378,Enoylpimeloyl-[acp] methyl ester;|Enoylpimeloyl-[acyl-carrier protein] methyl ester,,,,,
C20379,Chanoclavine-I aldehyde,,,,,
C20380,Mycophenolate,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05096)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L04 IMMUNOSUPPRESSANTS|L04A IMMUNOSUPPRESSANTS|L04AA Selective immunosuppressants|L04AA06 Mycophenolic acid|D05096  Mycophenolic acid (USAN/INN)|Target-based classification of drugs [BR:br08310(D05096)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|IMPDH|D05096  Mycophenolic acid (USAN/INN)|Pharmacogenomic biomarkers [br08341.html(D05096)]|Polymorphisms and mutations affecting drug response|D05096|Prodrugs [br08324.html(D05096)]|D05096|Prodrugs [br08324.html]|C20380,
C20381,"3,3'-Bipyridine-2,2',5,5',6,6'-hexol",,,,,
C20382,"Imidazol-2-one;|1,3-Dihydroimidazol-2-one;|4-Imidazolin-2-one",,,,,
C20383,Mycophenolic acid O-acyl-glucuronide,,,,,
C20384,Bisnorbiotin,,,,,
C20385,Tetranorbiotin,,,,,
C20386,Biotin sulfoxide,,,,,
C20387,Biotin sulfone,,,,,
C20388,"12(S)-HHT;|(12S,5Z,8E,10E)-12-Hydroxy-5,8,10-heptadecatrienoic acid",,,,,
C20389,Lauryltrimethylaminium bromide;|Dodecyltrimethylammonium bromide;|LTAB,,,,,
C20390,"N-Acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20390  N-Acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol",G13118
C20394,2-Hydroxybenzoyl-CoA;|Salicoyl-CoA,,,,,
C20395,UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate;|UDP-3-keto-GlcNAcA,,,,,
C20396,Methylphosphonate,,,,,
C20397,Pentalenolactone F,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20397  Pentalenolactone F,
C20398,Pentalenolactone E,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20398  Pentalenolactone E,
C20399,Pentalenolactone D,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20399  Pentalenolactone D,
C20400,1-Deoxy-11-oxopentalenate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20400  1-Deoxy-11-oxopentalenate,
C20402,Neopentalenolactone D,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20402  Neopentalenolactone D,
C20403,1-Deoxy-11beta-hydroxypentalenate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20403  1-Deoxy-11beta-hydroxypentalenate,
C20404,1-Deoxypentalenate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20404  1-Deoxypentalenate,
C20405,Pentalenate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20405  Pentalenate,
C20406,Cannabigerolate;|CBGA,,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1504 Anacardic acids and derivatives|C20406  Cannabigerolate,
C20407,Pentalenolactone;|Arenaemycin E,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010374 Pentalenane sesquiterpenoids|C20407  Pentalenolactone|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20407,
C20408,"Festuclavine;|6,8-beta-Dimethylergoline",,,,,
C20409,"6,8-Dimethyl-6,7-didehydroergoline",,,,,
C20410,4-Dimethylallyl-L-abrine;|4-(3-Methylbut-2-enyl)-L-abrine;|4-Prenyl-L-abrine,,,,,
C20411,"3-Methyl-1,2-didehydro-2,3-dihydrosqualene",,,,,
C20412,"3,22-Dimethyl-1,2,23,24-tetradehydro-2,3,22,23-tetrahydrosqualene",,,,,
C20413,"3,5,7-Trioxododecanoyl-CoA",,,,,
C20414,4-Hydroxycoumarin,,,,,
C20415,"dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose;|dTDP-Fuc4NAc",,,,,
C20416,"alpha-L-Rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20416  alpha-L-Rhamnopyranosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-trans,octacis-decaprenol",G13119
C20417,"2,4-Dihydroxy-6-pentylbenzoate;|Olivetolic acid",,,,Lipids [BR:br08002]|PK  Polyketides|PK15 Phenolic lipids|PK1504 Anacardic acids and derivatives|C20417  Olivetolic acid,
C20418,"N,N'-Diacetyllegionaminate;|Leg5Ac7Ac",,,,,
C20419,"CMP-N,N'-diacetyllegionaminate;|CMP-Leg5Ac7Ac",,,,,
C20420,"tritrans,heptacis-Undecaprenyl phosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0302 Bactoprenol monophosphates|C20420  tritrans,heptacis-Undecaprenyl phosphate",
C20421,"N,N'-Diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20421  N,N'-Diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenol",
C20422,alpha-D-Ribose 1-methylphosphonate 5-triphosphate,,,,,
C20423,alpha-D-Ribose 1-methylphosphonate 5-phosphate,,,,,
C20424,"2,4-Diacetamido-2,4,6-trideoxy-D-mannopyranose;|2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",,,,,
C20425,"beta-Cyclocitral;|2,6,6-Trimethyl-1-cyclohexene-1-carbaldehyde",,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C20425  beta-Cyclocitral,
C20426,Mycorradicin,,,,Phytochemical compounds [BR:br08003]|Terpenoids|Carotenoids and apocarotenoids|Apocarotenoids|C20426  Mycorradicin,
C20427,"N-Acetyl-D-galactosaminyl-alpha-(1->3)-N,N'-diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20427  N-Acetyl-D-galactosaminyl-alpha-(1->3)-N,N'-diacetyl-alpha-D-bacillosaminyldiphospho-tritrans,heptacis-undecaprenol",
C20428,(3S)-11-cis-3-Hydroxyretinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C20428  (3S)-11-cis-3-Hydroxyretinal,
C20429,(3S)-all-trans-3-Hydroxyretinal,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C20429  (3S)-all-trans-3-Hydroxyretinal,
C20430,(+)-Larreatricin,,,,,
C20431,(+)-3'-Hydroxylarreatricin,,,,,
C20432,C30 Botryococcene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010603 Botryococcene triterpenoids|C20432  C30 Botryococcene,
C20433,"3-Methyl-1,2-didehydro-2,3-dihydrobotryococcene;|Showacene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010603 Botryococcene triterpenoids|C20433  3-Methyl-1,2-didehydro-2,3-dihydrobotryococcene",
C20434,"20-Methyl-21,22-didehydro-20,21-dihydrobotryococcene;|Isoshowacene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010603 Botryococcene triterpenoids|C20434  20-Methyl-21,22-didehydro-20,21-dihydrobotryococcene",
C20435,"3,20-Dimethyl-1,2,21,22-tetradehydro-2,3,20,21-tetrahydrobotryococcene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010603 Botryococcene triterpenoids|C20435  3,20-Dimethyl-1,2,21,22-tetradehydro-2,3,20,21-tetrahydrobotryococcene",
C20436,Fumigaclavine A,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20436,
C20437,"Fumigaclavine B;|6,8-alpha-Dimethylergolin-9-beta-ol",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20437,
C20438,Fumigaclavine C,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20438,
C20439,NBMPR;|4-Nitrobenzylthioinosine,,,,,
C20440,"alpha-D-Ribose 1,2-cyclic phosphate 5-phosphate;|5-Phospho-alpha-D-ribose 1,2-cyclic phosphate",,,,,
C20441,Furfuryl alcohol;|2-Furancarbinol;|2-Furanmethanol,,,,,
C20442,"Dermatan 2,4-sulfate",,,,,
C20443,"5-Hydroxymethylfurfuryl alcohol;|2,5-Bis(hydroxymethyl)furan",,,,,
C20444,Dihydrodemethylsterigmatocystin;|DHDMST,,,,,
C20445,Dihydrosterigmatocystin;|DHST,,,,,
C20446,tRNA 7-aminomethyl-7-carbaguanine;|tRNA preQ1;|7-Aminomethyl-7-carbaguanine in tRNA,Generic compound in reaction hierarchy,,,,
C20447,2-Oxoglutaryl-CoA;|2-Oxoglutaroyl-CoA,,,,,
C20448,5-Hydroxymethyl-2-furoate;|5-Hydroxymethyl-2-furoic acid,,,,,
C20449,5-Formyl-2-furoate;|5-Formyl-2-furancarboxylate;|5-Formylfuran-2-carboxylate,,,,,
C20450,"2,5-Furandicarboxylate;|Furan-2,5-dicarboxylate",,,,,
C20451,tRNA hypoxanthine,,,,,
C20452,"Norsolorinic acid;|Norsolorinate;|2-Hexanoyl-1,3,6,8-tetrahydroxy-9,10-anthraquinone",,,,,
C20453,"Norsolorinic acid anthrone;|Noranthrone;|2-Hexanoyl-1,3,6,8-tetrahydroxyanthracen-9(10H)-one",,,,,
C20454,(-)-Lariciresinol,(+)-Lariciresinol [CPD:C10646],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C20454  (-)-Lariciresinol,
C20455,(-)-Pinoresinol,(+)-Pinoresinol [CPD:C05366],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C20455  (-)-Pinoresinol,
C20456,(+)-Secoisolariciresinol,(-)-Secoisolariciresinol [CPD:C18167],,,Phytochemical compounds [BR:br08003]|Phenylpropanoids|Lignans|Lignans|C20456  (+)-Secoisolariciresinol,
C20457,"6,8-Dimethyl-6,7,8,9-tetradehydroergoline",,,,,
C20458,tRNA(Ala) hypoxanthine;|Hypoxanthine in tRNA(Ala),,,,,
C20459,tRNA(Ala) adenine;|Adenine in tRNA(Ala),,,,,
C20460,Cyanidin 3-O-[6-O-(6-O-4-hydroxycinnamoyl-beta-D-glucosyl)-2-O-beta-D-xylosyl-beta-D-galactoside],,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20460  Cyanidin 3-O-[6-O-(6-O-4-hydroxycinnamoyl-beta-D-glucosyl)-2-O-beta-D-xylosyl-beta-D-galactoside],
C20461,Anthocyanidin 3-O-[6-O-(4-hydroxycinnamoyl)-beta-D-glucoside],Generic compound in reaction hierarchy,,,,
C20462,"5,7-Dihydroxy-2-methyl-4H-chromen-4-one",,,,,
C20463,Purine deoxyribonucleoside;|Purine 2'-deoxyribonucleoside,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|N-glycosides|C20463  Purine deoxyribonucleoside,
C20464,Isochavicol;|t-Anol;|trans-Anol;|(E)-4-Propenylphenol;|(E)-4-Hydroxypropenylbenzene,,,,,
C20465,Coumaryl acetate,,,,,
C20466,"2,3-Bis-(O-geranylgeranyl)-sn-glycero-1-phospho-L-serine",,,,,
C20467,Anthocyanidin 3-O-beta-D-sambubioside,Generic compound in reaction hierarchy,,,,
C20468,Cyanidin 3-O-(beta-D-xylosyl-(1->2)-beta-D-galactoside),,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20468  Cyanidin 3-O-(beta-D-xylosyl-(1->2)-beta-D-galactoside),
C20469,"Cyanidin 3,7-di-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20469  Cyanidin 3,7-di-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C20469",
C20470,1-O-Vanilloyl-beta-D-glucose,,,,,
C20471,Anthocyanidin 3-O-sophoroside,Generic compound in reaction hierarchy,,,,
C20472,Anthocyanidin 3-O-[2-O-(4-coumaroyl)-alpha-L-rhamnosyl-(1->6)-beta-D-glucoside],Generic compound in reaction hierarchy,,,,
C20473,Anthocyanidin 3-O-[2-O-(4-coumaroyl)-alpha-L-rhamnosyl-(1->6)-beta-D-glucoside] 5-O-beta-D-glucoside,Generic compound in reaction hierarchy,,,,
C20474,Anthocyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,Generic compound in reaction hierarchy,,,,
C20475,"Sporulenol;|(1R,2R,4aS,4bR,6aS,10aS,10bR,12aS)-2,4b,7,7,10a,12a-Hexamethyl-1-[(3R)-3-(4-methylcyclohexa-1,4-dien-1-yl)butyl]octadecahydrochrysen-2-ol",,,,,
C20476,"Delta6-Protoilludene;|(4aS,7aS,7bR)-3,6,6,7b-Tetramethyl-2,4,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[1,2-e]indene",,,,,
C20477,"(-)-alpha-Isocomene;|(1R,3aS,5aS,8aR)-1,3a,4,5a-Tetramethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010376 Isocomane sesquiterpenoids|C20477  (-)-alpha-Isocomene,
C20478,(E)-2-epi-beta-Caryophyllene;|2-epi-(E)-beta-Caryophyllene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010312 Caryophyllane sesquiterpenoids|C20478  (E)-2-epi-beta-Caryophyllene,
C20479,(+)-epi-alpha-Bisabolol;|(2S)-6-Methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C20479  (+)-epi-alpha-Bisabolol|Phytochemical compounds [BR:br08003]|Terpenoids|Sesquiterpenoids (C15)|Bisabolanes|C20479  (+)-epi-alpha-Bisabolol,
C20480,"Valerena-4,7(11)-diene;|(4S,7R,7aR)-3,7-Dimethyl-4-(2-methylprop-1-en-1-yl)-2,4,5,6,7,7a-hexahydro-1H-indene",,,,,
C20481,"cis-Abienol;|(12Z)-Labda-12,14-dien-8alpha-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C20481  cis-Abienol,
C20482,"(6R)-6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide;|(R)-NADH-hydrate;|(R)-NADHX",,,,,
C20483,"(6R)-6beta-Hydroxy-1,4,5,6-tetrahydronicotinamide-adenine dinucleotide phosphate;|(R)-NADPH-hydrate;|(R)-NADPHX",,,,,
C20484,9-cis-beta-Carotene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C20484  9-cis-beta-Carotene,
C20485,(4S)-4-Hydroxy-2-oxoglutarate;|(S)-2-Hydroxy-4-oxopentanedioate;|L-4-Hydroxy-2-oxoglutarate,,,,,
C20486,"7-Epizingiberene;|(5R)-2-Methyl-5-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010306 Bisabolane sesquiterpenoids|C20486  7-Epizingiberene,
C20487,L-beta-Phenylalanine;|(R)-3-Amino-3-phenylpropanoate,,,,,
C20488,D-beta-Phenylalanine;|(S)-3-Amino-3-phenylpropanoate;|(S)-beta-Phenylalanine,,,,,
C20489,Pelargonidin 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20489  Pelargonidin 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20489,
C20490,Cyanidin 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20490  Cyanidin 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20490,
C20491,Delphinidin 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20491  Delphinidin 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20491,
C20492,Pelargonidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20492  Pelargonidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20492,
C20493,Cyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20493  Cyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated cyanidin|C20493  Cyanidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20493,
C20494,Delphinidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20494  Delphinidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C20494  Delphinidin 5-O-beta-D-glucoside 3-O-beta-D-sambubioside|Dietary phytochemicals [br08012.html]|Flavonoids|C20494,
C20495,"Pelargonidin 3,7-di-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20495  Pelargonidin 3,7-di-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C20495",
C20496,"Delphinidin 3,7-di-O-beta-D-glucoside",,,,"Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1201 Anthocyanidins|C20496  Delphinidin 3,7-di-O-beta-D-glucoside|Glycosides [BR:br08021]|O-glycosides|Anthocyanin glycosides|Glycosylated delphinidin|C20496  Delphinidin 3,7-di-O-beta-D-glucoside|Dietary phytochemicals [br08012.html]|Flavonoids|C20496",
C20497,"N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol;|Und-PP-GlcNAc-ManNAcA;|Lipid II",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20497  N-Acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",
C20498,"4-Acetamido-4,6-dideoxy-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol;|Und-PP-GlcNAc-ManNAcA-Fuc4NAc;|Lipid III",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20498  4-Acetamido-4,6-dideoxy-alpha-D-galactosyl-(1->4)-N-acetyl-beta-D-mannosaminuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",
C20499,"(1'S)-Averantin;|1,3,6,8-Tetrahydroxy-[(1S)-2-hydroxyhexyl]-9,10-anthraquinone",,,,,
C20500,"(1'S,5'S)-5'-Hydroxyaverantin;|(1'S,5'S)-Hydroxyaverantin",,,,,
C20501,"(1'S,5'R)-5'-Hydroxyaverantin;|(1'S,5'R)-Hydroxyaverantin",,,,,
C20502,"5'-Oxoaverantin;|1,3,6,8-Tetrahydroxy-2-[(1S)-1-hydroxy-5-oxohexyl]anthracene-9,10-dione",,,,,
C20503,1'-Hydroxyversicolorone;|Hydroxyversicolorone,,,,,
C20504,Versicolorone,,,,,
C20505,Versiconal hemiacetal acetate,,,,,
C20506,Versiconol acetate,,,,,
C20507,Versiconal,,,,,
C20508,Versiconol,,,,,
C20509,2'-Dehydrokanamycin A;|2'-Oxokanamycin,,,,,
C20510,30-Hydroxy-11-oxo-beta-amyrin,,,,,
C20511,Glycyrrhetaldehyde,,,,,
C20512,Tryprostatin B,,,,,
C20513,6-Hydroxytryprostatin B;|Desmethyltryprostatin A,,,,,
C20514,"Cyclo(L-leucyl-L-leucyl);|(3S,6S)-3,6-Diisobutylpiperazine-2,5-dione",,,,,
C20515,"Pulcherriminic acid;|2,5-Dihydroxy-3,6-bis(2-methylpropyl)pyrazine bis-N-oxide",,,,,
C20516,Cyclo(L-tyrosyl-L-tyrosyl),,,,,
C20517,Mycocyclosin,,,,,
C20518,"2,3-Bis-(O-phytanyl)-sn-glycerol 1-phosphate",,,,,
C20519,"Cyclo(L-leucyl-L-phenylalanyl);|(3S,6S)-3-Benzyl-6-(2-methylpropyl)piperazine-2,5-dione",,,,,
C20520,"Albonoursin;|(3Z,6Z)-3-Benzylidene-6-(2-methylpropylidene)piperazine-2,5-dione",,,,,
C20521,"Cyclo[(Z)-alpha,beta-didehydrophenylalanyl-L-leucyl];|(3Z,6S)-3-Benzylidene-6-(2-methylpropyl)piperazine-2,5-dione",,,,,
C20522,Dihydrourocanate;|Deaminohistidine;|3-(1H-Imidazol-4-yl)propanoate,,,,,
C20525,3-Geranylgeranylindole;|3-(Geranylgeranyl)indole,,,,,
C20526,"10,11-Epoxy-3-geranylgeranylindole",,,,,
C20527,Emindole SB,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20527  Emindole SB,
C20528,Terpendole B,,,,,
C20529,"14,15-Epoxyemindole SB",,,,,
C20530,Paspaline,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20530  Paspaline|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20530,
C20531,13-Desoxypaxilline;|13-Deoxypaxilline,,,,,
C20532,"20,21-Diprenylterpendole I",,,,,
C20533,Lolitrem K,,,,,
C20534,"12-Demethyl-11,12-dehydropaspaline",,,,,
C20535,"beta-PC-M6;|beta-10-Hydroxy-12-demethyl-11,12-dehydropaspaline",,,,,
C20536,Terpendole E,,,,,
C20542,13-Desoxyterpendole I,,,,,
C20543,Terpendole I,,,,,
C20545,Terpendole J,,,,,
C20546,Terpendole C,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20546  Terpendole C,
C20548,Lolitriol,,,,,
C20549,Lolitrem J,,,,,
C20550,Lolitrem E,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20550,
C20551,Lolitrem B,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20551  Lolitrem B|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20551,
C20552,Terpendole K,,,,,
C20553,Paspalicine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20553  Paspalicine,
C20554,Paspalinine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20554  Paspalinine,
C20555,Aflatrem,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20555  Aflatrem|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20555,
C20558,"alpha-PC-M6;|alpha-10-Hydroxy-12-demethyl-11,12-dehydropaspaline",,,,,
C20559,4-(beta-D-Ribofuranosyl)aniline 5'-phosphate,,,,,
C20560,N1-(3-Aminopropyl)agmatine;|N1-Aminopropylagmatine;|N1-(Aminopropyl)agmatine,,,,,
C20561,"21,22-Diprenylpaxilline",,,,,
C20562,"N-[(7,8-Dihydropterin-6-yl)methyl]-4-(beta-D-ribofuranosyl)aniline 5'-phosphate",,,,,
C20563,Brevianamide F;|Cyclo(L-Trp-L-Pro),,,,,
C20564,Fumitremorgin A,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20564,
C20565,"Cyclic di-3',5'-adenylate;|Cyclic di-AMP;|Cyclic bis(3'->5')diadenylate",,,,,
C20566,"7,8-Dihydroneopterin 2'-phosphate",,,,,
C20567,"7,8-Dihydroneopterin 2',3'-cyclic phosphate",,,,,
C20568,beta-L-Arabinofuranosyl-(1->2)-beta-L-arabinofuranose,,,,,
C20569,beta-L-Arabinofuranose,,,,,
C20570,"alpha-1,5-L-Arabinobiose",,,,,
C20571,"alpha-1,5-L-Arabinotriose",,,,,
C20572,"alpha-1,5-L-Arabinotetraose",,,,,
C20573,Aldotetraouronic acid,,,,,
C20574,"(1'S,5'S)-Averufin",,,,,
C20575,Versicolorin B,,,,,
C20576,"Kunzeaol;|6beta-Hydroxygermacra-1(10),4-diene;|(1R,2E,6E,10R)-3,7-Dimethyl-10-isopropylcyclodeca-2,6-dienol",,,,,
C20577,6-Tuliposide A;|6-O-(4-Hydroxy-2-methylenebutanoyl)-D-glucose,,,,,
C20578,Tulipalin A;|2-Methylenebutanolactone,,,,,
C20579,"Cyclopeptine;|(3S)-3-Benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione",,,,,
C20580,[tRNA(Ile2)]-2-agmatinylcytidine34,,,,,
C20581,cis-(Homo)2-aconitate,,,,,
C20582,cis-(Homo)3-aconitate,,,,,
C20583,Versicolorin A,,,,,
C20584,Lolicine A,,,,,
C20585,Lolicine B,,,,,
C20586,Terpendole G,,,,,
C20587,Paspaline B,,,,,
C20588,Tetrabromophenol blue,,,,Risk category of Japanese OTC drugs [BR:br08312]|Second-class OTC drugs|Not used for human|Vitro diagnostics listed below|------  Urine protein kit (OTC)|C20588  Tetrabromophenol blue,
C20589,D-Glucosaminate-6-phosphate;|2-Amino-2-deoxy-D-gluconate 6-phosphate,,,,,
C20590,beta-Ergocryptine,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Ergot alkaloids|C20590  beta-Ergocryptine,
C20591,Fusaproliferin;|(-)-Fusaproliferin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C20591  Fusaproliferin,
C20592,Moniliformin,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Others|C20592  Moniliformin,
C20593,beta-Paxitriol;|10beta-Hydroxypaxilline,,,,,
C20594,"20,21-Diprenylterpendole J",hypothetical intermediate of lolitrem E synthesis (see [RN:R10369+R10367]),,,,
C20595,"20,21-Diprenylterpendole C",hypothetical intermediate of lolitrem B synthesis (see [RN:R10369+R10367]),,,,
C20596,Penitrem D,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20596  Penitrem D,
C20597,Penitrem E,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20597  Penitrem E,
C20598,Penitrem F,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20598  Penitrem F,
C20599,Pennigritrem,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20599  Pennigritrem,
C20600,Janthitrem B,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20600  Janthitrem B,
C20601,Janthitrem C,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20601  Janthitrem C,
C20602,L-Enduracididine,,,,,
C20603,(3S)-3-Hydroxy-L-enduracididine,,,,,
C20604,"Fumitremorgin C;|(5aS,12S,14aS)-9-Methoxy-12-(2-methylprop-1-en-1-yl)-1,2,3,5a,6,11,12,14a-octahydro-5H,14H-pyrrolo[1'',2'':4',5']pyrazino[1',2':1,6]pyrido[3,4-b]indole-5,14-dione",,,,,
C20605,"12alpha,13alpha-Dihydroxyfumitremorgin C;|12,13-Dihydroxyfumitremorgin C",,,,,
C20607,"Tryprostatin A;|(3S,8aS)-3-{[6-Methoxy-2-(3-methylbut-2-en-1-yl)-1H-indol-3-yl]methyl}hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",,,,,
C20608,(S)-2-Chloropropanoate;|(S)-2-Chloropropanoic acid,,,,,
C20609,2-Chloroacrylate;|2-Chloroacrylic acid,,,,,
C20612,"GDP-4-dehydro-3,6-dideoxy-alpha-D-mannose",,,,,
C20613,GDP-beta-L-colitose,,,,,
C20614,Kanamycin X,,,,,
C20615,(R)-8-Oxocitronellyl enol,,,,,
C20616,"Aldono-1,5-lactone",Generic compound in reaction hierarchy,,,,
C20617,"beta-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20617  beta-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20618,"beta-D-Gal-(1->4)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20618  beta-D-Gal-(1->4)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20619,"beta-D-Glc-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20619  beta-D-Glc-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20620,"N-Acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol;|N-Acetyl-alpha-D-galactosaminyl-1-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20620  N-Acetyl-alpha-D-galactosaminyl-diphospho-ditrans,octacis-undecaprenol",
C20621,"alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20621  alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",
C20622,"beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20622  beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",
C20623,Caldariellaquinol,,,,,
C20624,Caldariellaquinone,,,,,
C20625,"alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20625  alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",
C20626,"alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20626  alpha-D-Gal-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)-alpha-D-GalNAc-diphospho-ditrans,octacis-undecaprenol",
C20627,"CDP-2,3-bis-(O-phytanyl)-sn-glycerol",,,,,
C20628,"2,3-Bis-(O-phytanyl)-sn-glycero-1-phospho-L-serine",,,,,
C20629,8-Demethylnovobiocic acid,,,,,
C20630,Fumitremorgin B,,,,,
C20631,"(2S,3S)-3-Hydroxyasparagine",,,,,
C20632,Methyl gibberellin A9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C20632  Methyl gibberellin A9,
C20633,Methyl gibberellin A4,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010417 Gibberellins|C20633  Methyl gibberellin A4,
C20634,O-Methyl anthranilate,,,,,
C20635,Methyl (indol-3-yl)acetate,,,,,
C20636,Deoxybrevianamide E,,,,,
C20637,"5-[[(4,7-Dihydroxy-2-oxo-2H-1-benzopyran-3-yl)amino]carbonyl]-4-methyl-1H-pyrrole-3-carboxylate",,,,,
C20638,"GDP-4-amino-4,6-dideoxy-alpha-D-mannose;|GDP-alpha-D-perosamine",,,,,
C20639,O-Ureido-L-serine;|(2S)-2-Amino-3-[(carbamoylamino)oxy]propanoate;|(2S)-2-Amino-3-(carbamoylamino)oxypropanoic acid,,,,,
C20640,Cyclic GMP-AMP;|Cyclic Gp(2'-5')Ap(3'-5');|cGAMP(2'-5'),,,,,
C20641,L-Threonylcarbamoyladenylate;|L-Threonylcarbamoyl-AMP;|TC-AMP,,,,,
C20642,1-Archaetidyl-1D-myo-inositol 3-phosphate;|1-Saturated archaetidyl-1D-myo-inositol 3-phosphate;|Archaetidylinositol phosphate,,,,,
C20643,2-Heptyl-4(1H)-quinolone;|2-Heptyl-4-quinolone;|2-Heptyl-4-hydroxyquinoline,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20643,
C20644,"2-Amino-4,5-dihydroxy-6-oxo-7-(phosphooxy)heptanoate;|2-Amino-4,5-dihydroxy-6-oxo-7-(phosphonooxy)heptanoate;|2-Amino-4,5-dihydroxy-6-oxo-7-(phosphonooxy)heptanoic acid;|2-Amino-4,5-dihydroxy-6-one-heptanoic acid-7-phosphate",,,,,
C20645,Methyl benzoate,,,,,
C20646,(3S)-2-Oxo-3-phenylbutanoate;|(3S)-beta-Methylphenylpyruvate,,,,,
C20647,N1-Methyladenine in rRNA,Generic compound in reaction hierarchy,,,,
C20648,Adenine in rRNA,Generic compound in reaction hierarchy,,,,
C20649,7-[(3S)-(3-Amino-3-carboxypropyl)]wyosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe) precursor,,,,
C20650,7-(Dihydroxymethyl)bacteriochlorophyllide c,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C20651,O-Ureido-D-serine;|(2R)-2-Amino-3-[(carbamoylamino)oxy]propanoate;|(2R)-2-Amino-3-(carbamoylamino)oxypropanoic acid,,,,,
C20652,7-[(3S)-3-Amino-3-carboxypropyl]-4-demethylwyosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe) precursor,,,,
C20653,2-Benzylmalic acid;|2-Benzylmalate,,,,,
C20654,3-Benzylmalic acid;|3-Benzylmalate,,,,,
C20656,(L-Prolyl)adenylate,,,,,
C20657,"meso-2,3-Butanediol",,,,,
C20658,O-Acetyl-ADP-ribose;|2''-O-Acetyl-ADP-ribose;|AADPR,,,,,
C20659,7-[(3S)-3-Amino-3-(methoxycarbonyl)propyl]wyosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe) precursor,,,,
C20660,Wybutosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe),,,,
C20661,7-(2-Hydroxy-3-amino-3-carboxypropyl)wyosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe) precursor,,,,
C20662,Hydroxywybutosine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe),,,,
C20663,L-Histidine-[translation elongation factor 2],Generic compound in reaction hierarchy,,,,
C20664,"(-)-Bornyl diphosphate;|(2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl diphosphate",,,,,
C20665,Aryl-carrier protein;|[Aryl-carrier protein];|Holo-[aryl-carrier protein],Generic compound in reaction hierarchy,,,,
C20666,5-Oxo-delta-bilirubin;|delta-Staphylobilin,,,,,
C20667,15-Oxo-beta-bilirubin;|beta-Staphylobilin,,,,,
C20668,3-Dehydro-D-glucose 6-phosphate,,,,,
C20669,2-Amino-5-chlorophenol,,,,,
C20670,2-Amino-5-chloromuconate 6-semialdehyde,,,,,
C20672,"GDP-4-acetamido-4,6-dideoxy-alpha-D-mannose;|GDP-N-acetyl-alpha-D-perosamine",,,,,
C20673,N-Isovaleryl-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C20673  N-Isovaleryl-L-homoserine lactone,
C20674,N7-Methylguanosine,,,,,
C20675,Short-chain acyl-CoA,Generic compound in reaction hierarchy,,,,
C20676,"Short-chain trans-2,3-dehydroacyl-CoA",Generic compound in reaction hierarchy,,,,
C20677,N-(4-Coumaroyl)-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C20677  N-(4-Coumaroyl)-L-homoserine lactone,
C20678,26-Deglucoprotodioscin,,,,,
C20679,Tungstate;|Tungstic acid,,,,,
C20680,2-Dehydro-3-deoxy-L-galactonate;|2-Keto-3-deoxy-L-galactonate;|L-threo-3-Deoxy-hexulosonate,,,,,
C20681,"(E,E)-Geranyllinalool;|(6E,10E)-Geranyllinalool;|(6E,10E)-3,7,11,15-Tetramethylhexadeca-1,6,10,14-tetraen-3-ol",,,,,
C20682,dTDP-alpha-D-fucofuranose,,,,,
C20683,Long-chain acyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R= acyl-carrier protein,,,,
C20684,O-Carbamoyladenylate,,,,,
C20685,"(R)-(2,4-Dichlorophenoxy)propanoate;|(R)-Dichlorprop",,,,,
C20686,(S)-2-(4-Chloro-2-methylphenoxy)propanoate;|(S)-Mecoprop,,,,,
C20687,"(S)-(2,4-Dichlorophenoxy)propanoate;|(S)-Dichlorprop",,,,,
C20688,N1-Methylguanine in tRNA(Phe),Generic compound in reaction hierarchy|3'-adjacent to the anticodon (position 37) in cytoplasmic tRNA(Phe) precursor,,,,
C20689,15-Demethylaclacinomycin T,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1305 Anthracyclinones|C20689  15-Demethylaclacinomycin T,
C20690,"1D-myo-Inositol 1,5-bis(diphosphate) 2,3,4,6-tetrakisphosphate",,,,,
C20691,4-Demethylwyosine in tRNA(Phe);|imG-14 in tRNA(Phe),,,,,
C20692,9-cis-10'-Apo-beta-carotenal,,,,,
C20693,Carlactone,,,,,
C20694,"(2E,4E,6E)-7-Hydroxy-4-methylhepta-2,4,6-trienal",,,,,
C20695,all-trans-10'-Apo-beta-carotenal,,,,,
C20696,13-Apo-beta-carotenone,,,,,
C20697,"(2E,4E,6E)-4-Methylocta-2,4,6-trienedial",,,,,
C20698,2-Aminoethyl diphenylborinate;|2-APB,,,,,
C20699,6''-O-Carbamoylkanamycin A,,,,,
C20700,"(E,E)-4,8,12-Trimethyltrideca-1,3,7,11-tetraene;|(3E,7E)-4,8,12-Trimethyltrideca-1,3,7,11-tetraene;|TMTT",,,,,
C20701,But-3-en-2-one;|But-1-en-3-one;|Methyl vinyl ketone;|Butenone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA12 Oxygenated hydrocarbons|C20701  But-3-en-2-one,
C20702,"(8E,10S)-10-Hydroperoxyoctadeca-8-enoate;|(8E,10S)-10-Hydroperoxy-8-octadecenoate",,,,,
C20703,"(8E,10S,12Z)-10-Hydroperoxyoctadeca-8,12-dienoate",,,,,
C20704,"(8E,10S,12Z,15Z)-10-Hydroperoxyoctadeca-8,12,15-trienoate",,,,,
C20705,"4-O-(beta-L-Arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl-(1->2)-beta-L-arabinofuranosyl)-(2S,4S)-4-hydroxyproline;|(Ara-f)3-Hyp",,,,,
C20706,"4-O-(beta-L-Arabinofuranosyl)-(2S,4S)-4-hydroxyproline",,,,,
C20707,26-Desgluco-avenacoside B,,,,,
C20708,Robenacoxib,,,,"Animal drugs in Japan [BR:br08331]|91  Agents affecting nervous system|913  Antipyretics, analgesics and antiinflammatory|9139  Other antipyretics, analgesics and antiinflammatory|C20708  Robenacoxib",
C20709,"Diosgenin 3-O-beta-D-glucopyranoside;|(3beta,25R)-Spirost-5-en-3-ol 3-O-beta-D-glucopyranoside",,,,,
C20710,"(4R,5R)-4,5-Dihydroxycyclohexa-1(6),2-diene-1-carboxylate;|(3R,4R)-3,4-Dihydroxycyclohexa-1,5-diene-1-carboxylate;|DCDC",,,,,
C20711,Miltiradiene,,,,,
C20712,"(S)-Laudanine;|(+)-Laudanidine;|5-[((1S)-6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl]-2-methoxyphenol",,,,,
C20713,Ginsenoside Rb1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20713  Ginsenoside Rb1|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20713|Dietary phytochemicals [br08012.html]|Other phytochemicals|C20713,
C20714,3-Oxodecanoate,,,,,
C20715,"Protopanaxadiol;|Dammar-24-ene-3beta,12beta,20-triol;|(20S)-Protopanaxadiol",,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C20715,
C20716,"Protopanaxatriol;|Dammar-24-ene-3beta,6alpha,12beta,20-tetrol",,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C20716,
C20717,"4-Hydroxy-2,5-dimethylfuran-3(2H)-one;|Dimethylhydroxy furanone",,,,,
C20718,4-Hydroxy-5-methyl-2-methylenefuran-3(2H)-one,,,,,
C20719,Vancomycin aglycone,,,,,
C20720,Desvancosaminyl-vancomycin;|Vancomycin pseudoaglycone;|Devancosaminyl-vancomycin,,,,,
C20721,Chloroorienticin B,,,,,
C20722,3-O-(alpha-D-Mannosyl)-L-threonyl-[protein];|[Protein]-3-O-(alpha-D-mannosyl)-L-threonine;|O-D-Mannosylprotein,Generic compound in reaction hierarchy|3-O-(alpha-D-Mannosyl)-L-serinyl-[protein] [CPD:C02863],,,,
C20723,3-O-[N-Acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl-[protein],Generic compound in reaction hierarchy,,,,
C20724,(+)-Thujopsene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010386 Thujopsane sesquiterpenoids|C20724  (+)-Thujopsene,
C20725,Ginsenoside Rd,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20725  Ginsenoside Rd|Dietary phytochemicals [br08012.html]|Other phytochemicals|C20725,
C20726,Phenyl 5-phospho-alpha-D-ribofuranoside,,,,,
C20727,Kaempferol 3-O-beta-D-xyloside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C20727  Kaempferol 3-O-beta-D-xyloside|Dietary phytochemicals [br08012.html]|Flavonoids|C20727,
C20729,[Sulfur-carrier protein]-Gly-NH-CH2-C(O)-S-L-cysteine;|[Sulfur-carrier protein]-S-L-cysteine,Generic compound in reaction hierarchy,,,,
C20730,[Protein]-FMN-L-Threonine;|[Protein]-flavin mononucleotide-L-threonine;|[Protein]-riboflavin-5'-phosphate-L-threonine,,,,,
C20731,Penitrem B,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20731  Penitrem B,
C20732,Mycothiol S-conjugate,Generic compound in reaction hierarchy,,,,
C20734,3-O-[N-Acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl-[protein],Generic compound in reaction hierarchy,,,,
C20735,N-Acyl-aromatic-L-amino acid,Generic compound in reaction hierarchy,,,,
C20736,Gypenoside XVII;|Ginsenoside XVII,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20736  Gypenoside XVII,
C20737,"6-Geranylgeranyl-2-methylbenzene-1,4-diol",,,,,
C20738,"6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol",,,,,
C20739,Neopikromycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C20739  Neopikromycin,
C20740,Novapikromycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C20740  Novapikromycin,
C20741,Novamethymycin,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C20741  Novamethymycin,
C20742,2'-Phospho-cyclic ADP-ribose;|cADPRP,,,,,
C20743,Protein N6-acetyl-L-lysine;|Acetylprotein;|[Protein]-N6-acetyl-L-lysine,Generic compound in reaction hierarchy,,,,
C20744,alpha-NADH,,,,,
C20745,alpha-NADPH,,,,,
C20746,(3R)-Citramalyl-CoA;|D-Citramalyl-CoA;|(R)-Citramalyl-CoA,,,,,
C20747,(R)-Malyl-CoA;|(3R)-3-Carboxy-3-hydroxypropanoyl-CoA,,,,,
C20748,(E)-4-(Trimethylammonio)but-2-enoyl-CoA;|Crotonobetainyl-CoA,,,,,
C20749,4-Trimethylammoniobutanoyl-CoA;|gamma-Butyrobetainyl-CoA,,,,,
C20750,L-Carnitinyl-CoA,,,,,
C20751,N6-L-Threonylcarbamoyladenine in tRNA;|t6A in tRNA,Generic compound in reaction hierarchy,,,,
C20752,2-Methylthio-N6-L-threonylcarbamoyladenine in tRNA;|2-(Methylsulfanyl)-N6-L-threonylcarbamoyladenine in tRNA;|ms2t6A in tRNA,Generic compound in reaction hierarchy,,,,
C20753,2-Methylthio-N6-dimethylallyladenine in tRNA;|2-Methylthio-N6-isopentenyladenine in tRNA;|2-(Methylsulfanyl)-N6-dimethylallyladenine in tRNA;|N6-(3-Methylbut-2-en-1-yl)-2-(methylsulfanyl)adenine in tRNA;|2-(Methylsulfanyl)-N6-prenyladenine in tRNA;|ms2i6A in tRNA,Generic compound in reaction hierarchy,,,,
C20754,2-Thio-N6-L-threonylcarbamoyladenine in tRNA;|2-Sulfanyl-N6-L-threonylcarbamoyladenine in tRNA,Generic compound in reaction hierarchy,,,,
C20755,2-Thio-N6-dimethylallyladenine in tRNA;|2-Sulfanyl-N6-dimethylallyladenine in tRNA;|N6-(3-Methylbut-2-en-1-yl)-2-thioadenine in tRNA,Generic compound in reaction hierarchy,,,,
C20756,[Ribosomal protein uS12]-L-aspartate,Generic compound in reaction hierarchy,,,,
C20757,[Ribosomal protein uS12]-3-thioaspartate,Generic compound in reaction hierarchy,,,,
C20758,[Ribosomal protein uS12]-3-methylthioaspartate;|3-(Methylsulfanyl)-L-aspartate-[ribosomal protein uS12],Generic compound in reaction hierarchy,,,,
C20759,Desulfo-A47934,,,,,
C20760,20-Oxo-5-O-beta-mycaminosyltylactone;|23-Deoxy-5-O-beta-mycaminosyltylonolide,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C20760  20-Oxo-5-O-beta-mycaminosyltylactone,
C20761,"alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20761  alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20762,"3-O-Phospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20762  3-O-Phospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20763,"3-O-Methylphospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20763  3-O-Methylphospho-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C20764,Phytyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010401 Acyclic diterpenoids|C20764  Phytyl phosphate,
C20765,"dTDP-beta-L-evernosamine;|dTDP-3-amino-2,3,6-trideoxy-3-C-methyl-4-O-methyl-beta-L-arabino-hexopyranose",,,,,
C20766,dTDP-N-hydroxy-beta-L-evernosamine,,,,,
C20767,"dTDP-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitroso-beta-L-arabino-hexopyranose",,,,,
C20768,"UDP-2-acetamido-2,6-dideoxy-beta-L-talose;|UDP-N-acetyl-beta-L-pneumosamine",,,,,
C20769,"UDP-2-acetamido-2,6-dideoxy-beta-L-lyxo-4-hexulose;|UDP-4-keto-N-acetyl-beta-L-rhamnosamine;|UDP-4-keto-L-RhaNAc",,,,,
C20770,N-Methylpavine,,,,,
C20771,(+/-)-Pavine,,,,,
C20772,3-[(1-Carboxyvinyl)oxy]benzoate;|3-[(1-Carboxyethenyl)oxy]benzoic acid,,,,,
C20773,6-Amino-6-deoxyfutalosine,,,,,
C20774,UDP-N-acetyl-beta-L-fucosamine,,,,,
C20775,beta-Citryl-L-glutamate;|beta-Citrylglutamate,,,,,
C20776,N-Acetylaspartylglutamylglutamate;|N-Acetyl-L-aspartyl-L-glutamyl-L-glutamate;|NAAG2,,,,,
C20777,Gypenoside LXXV;|Ginsenoside LXXV,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20777  Gypenoside LXXV,
C20778,Ginsenoside Rg3;|(20S)-Ginsenoside Rg3,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20778  Ginsenoside Rg3|Dietary phytochemicals [br08012.html]|Other phytochemicals|C20778,
C20779,Ginsenoside F2,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20779  Ginsenoside F2|Dietary phytochemicals [br08012.html]|Other phytochemicals|C20779,
C20780,Ginsenoside F1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C20780  Ginsenoside F1|Dietary phytochemicals [br08012.html]|Other phytochemicals|C20780,
C20781,"2,4-Diketo-3-deoxy-L-fuconate;|2,4-Didehydro-3-deoxy-L-fuconate;|(5S)-5-Hydroxy-2,4-dioxohexanoate;|2,4-Diketo-3-deoxy-L-rhamnonate;|2,4-Didehydro-3-deoxy-L-rhamnonate",,,,,
C20782,(S)-2-Phenyloxirane;|(S)-Styrene oxide,,,,,
C20783,Propane,,,,,
C20784,ADP-5-ethyl-4-methylthiazole-2-carboxylate;|Adenosine diphospho-5-beta-ethyl-4-methylthiazole-2-carboxylic acid,,,,,
C20785,Eleutheroside A;|Sitogluside;|beta-Sitosterol D-glucoside,,,,Glycosides [BR:br08021]|O-glycosides|Saponins|Steroid|C20785  Eleutheroside A,
C20786,Eleutheroside E,,,,,
C20787,"23,24-Dihydrocucurbitacin B",,,,"Phytochemical compounds [BR:br08003]|Terpenoids|Triterpenoids (C30)|Cucurbitanes|C20787  23,24-Dihydrocucurbitacin B",
C20788,"Homocystine;|4,4'-Dithiobis(2-aminobutyric acid)","Generic compound in reaction hierarchy|The name ""Homocystine"" usually means L-Homocystine [CPD:C01817].",,,,
C20789,"7-Deoxyloganetate;|(1S,4aS,7S,7aR)-1-Hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate",,,,,
C20790,7-Deoxyloganetin,,,,,
C20791,Methyl thioether;|Methyl sulfide,Generic compound in reaction hierarchy|Dimethyl sulfide (R = CH3) [CPD:C00580],,,,
C20792,Oleoylethanolamide;|OEA,,,,,
C20793,3-Hydroxyoctanoate;|3-Hydroxyoctanoic acid,,,,,
C20794,n-7 Unsaturated acyl-[acyl-carrier protein];|omega-7 Fatty acyl-[acyl-carrier protein],Generic compound in reaction hierarchy|Hexadecenoyl-[acyl-carrier protein] (n=3) [CPD:C16520],,,,
C20795,Penitrem C,,,,Natural toxins [BR:br08009]|Fungal toxins|Mycotoxins|Indole diterpene alkaloids|C20795  Penitrem C,
C20796,N6-Dimethyladenine in rRNA;|rRNA containing N6-dimethyladenine,Generic compound in reaction hierarchy,,,,
C20799,Grixazone B,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20799,
C20800,3-Methyl-L-tyrosine,,,,,
C20801,3-Hydroxy-5-methyl-L-tyrosine,,,,,
C20802,(4S)-4-Hydroxy-L-isoleucine;|Hydroxyisoleucine,,,,,
C20803,5-Methyl-1-naphthoate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20803  5-Methyl-1-naphthoate,
C20804,alpha-Longipinene;|(+)-alpha-Longipinene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010349 Longipinane sesquiterpenoids|C20804  alpha-Longipinene,
C20805,3-Hydroxy-5-methyl-1-naphthoate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20805  3-Hydroxy-5-methyl-1-naphthoate,
C20806,omega-Hydroxyphylloquinone,,,,,
C20807,3-Hydroxy-L-phenylalanine;|3-Tyrosine,,,,,
C20808,2-Methyl-1-pyrroline,,,,,
C20809,(R)-2-Methylpyrrolidine,,,,,
C20810,(S)-3-Chloro-beta-tyrosyl-[pcp];|(3S)-3-Amino-3-(3-chloro-4-hydroxyphenyl)propanoyl-[peptidyl-carrier protein],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C20811,"(-)-exo-alpha-Bergamotene;|trans-alpha-Bergamotene;|(1S,5S,6R)-2,6-Dimethyl-6-(4-methylpent-3-en-1-yl)bicyclo[3.1.1]hept-2-ene",,,,,
C20813,OA-6129 A,,,,,
C20814,OA-6129 C,,,,,
C20815,MM 4550,,,,,
C20816,Deacetylepithienamycin F;|Deacetyl MM 17880;|NA 26975,,,,,
C20817,C20817;|Carbapenem biosynthesis intermediate 1,,,,,
C20818,C20818;|Carbapenem biosynthesis intermediate 2,,,,,
C20819,C20819;|Carbapenem biosynthesis intermediate 5,,,,,
C20820,"2,3-Dihydrothienamycin",,,,,
C20821,C20821;|Carbapenem biosynthesis intermediate 6,,,,,
C20822,C20822;|Carbapenem biosynthesis intermediate 3,,,,,
C20823,C20823;|Carbapenem biosynthesis intermediate 4,,,,,
C20824,"3-Nitrobenzanthrone;|3-Nitro-7H-benzo[d,e]anthracen-7-one",,,,,
C20825,Seminolipid;|3-Sulfogalactosyl-1-alkyl-2-acylglycerol;|3-Sulfogalactosyl-2-acyl-1-alkyl-sn-glycerol;|1-O-Alkyl-2-O-acyl-3-beta-(3'-sulfogalactosyl)-sn-glycerol,,,,Compounds with biological roles [BR:br08001]|Lipids|Glycolipids|Glyceroglycolipids|C20825  Seminolipid|Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0502 Glycosylalkylacylglycerols|C20825  1-O-Alkyl-2-O-acyl-3-beta-(3'-sulfogalactosyl)-sn-glycerol,
C20826,Isovalerylcarnitine;|O-Isovaleryl-L-carnitine,,,,,
C20827,3-Hydroxyisovalerate;|3-Hydroxy-3-methylbutyrate,,,,,
C20828,3-Methylcrotonylglycine,,,,,
C20829,Sulfoquinovose;|6-Deoxy-6-sulfo-D-glucopyranose;|6-Deoxy-6-sulfo-D-glucose,,,,,
C20830,6-Deoxy-6-sulfo-D-fructose,,,,,
C20831,6-Deoxy-6-sulfo-D-fructose 1-phosphate,,,,,
C20834,"Cyclooctat-9-en-7-ol;|(1S,3aS,4R,7S,9aS,10aS)-1,4,9a-Trimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulen-4-ol",,,,,
C20835,alpha-L-Fucopyranose;|alpha-L-Fucose,,,,,
C20836,beta-L-Fucopyranose;|beta-L-Fucose,,,,,
C20838,"3-[(3aS,4S,7aS)-7a-Methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl-CoA;|HIP-CoA",,,,,
C20839,(25R)-3-Oxocholest-4-en-26-oate;|3-Oxo-4-cholesten-26-oate;|3-Oxo-4-cholesten-26-oic acid,,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C20839  (25R)-3-Oxocholest-4-en-26-oate",
C20840,(25S)-3-Oxocholest-4-en-26-oyl-CoA,,,,,
C20841,2-Hydroxy-7-methoxy-5-methyl-1-naphthoate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20841  2-Hydroxy-7-methoxy-5-methyl-1-naphthoate,
C20842,2-Hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA,,,,,
C20843,N5-Phenyl-L-glutamine;|gamma-Glutamylanilide,,,,,
C20844,"(2Z,4S,5R)-2-Amino-4,5,6-trihydroxyhex-2-enoate",,,,,
C20845,"(4S,5R)-4,5,6-Trihydroxy-2-iminohexanoate",,,,,
C20846,3-Oxo-3-ureidoisobutyrate,,,,,
C20847,(R)-Mevalonate 3-phosphate;|(R)-3-Phosphomevalonate,,,,,
C20848,"(R)-Mevalonate 3,5-bisphosphate;|(R)-3,5-Diphosphomevalonate;|(R)-3,5-Bisphosphomevalonate",,,,,
C20849,UDP-2-acetamido-3-dehydro-2-deoxy-alpha-D-glucopyranose,,,,,
C20850,N5-Hydroxy-L-ornithine;|delta-N-Hydroxyornithine,,,,,
C20851,"Dihydromonacolin L acid;|(3R,5R)-7-[(1S,2S,4aR,6R,8aS)-2,6-Dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen1yl]-3,5-dihydroxyheptanoate",,,,,
C20852,"3alpha-Hydroxy-3,5-dihydromonacolin L acid;|(3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-Hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate",,,,,
C20853,"Monacolin L acid;|(3R,5R)-7-[(1S,2S,6R,8aR)-2,6-Dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate",,,,,
C20854,"Monacolin J acid;|(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-Hydroxy-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",,,,,
C20855,"22-Hydroxydocosahexaenoate;|(4Z,7Z,10Z,13Z,16Z,19Z)-22-Hydroxydocosahexaenoic acid",,,,,
C20856,2-Hydroxy-5-methyl-1-naphthoate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20856  2-Hydroxy-5-methyl-1-naphthoate,
C20857,"2,7-Dihydroxy-5-methyl-1-naphthoate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20857  2,7-Dihydroxy-5-methyl-1-naphthoate",
C20858,Protein N5-methyl-L-glutamine,,,,,
C20859,Galactosyl-1-alkyl-2-acylglycerol;|Galactosyl-2-acyl-1-alkyl-sn-glycerol;|1-O-Alkyl-2-O-acyl-3-beta-galactosyl-sn-glycerol,,,,Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0502 Glycosylalkylacylglycerols|C20859  1-O-Alkyl-2-O-acyl-3-beta-galactosyl-sn-glycerol,
C20860,"Triglucosyldiacylglycerol;|1,2-Diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C20860  1,2-Diacyl-3-O-[beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl]-sn-glycerol",
C20861,"Mannobiose;|beta-1,4-Mannobiose",,,,,
C20862,5'-(N7-Methyl 5'-triphosphoguanosine)-(2'-O-methyl-purine-ribonucleotide)-(2'-O-methyl-ribonucleotide)-[mRNA],Generic compound in reaction hierarchy|R1 = adenine base or guanine base,,,,
C20863,5'-Phospho-[mRNA];|(5')pPur-mRNA,Generic compound in reaction hierarchy|R1 = adenine or guanine base,,,,
C20864,5'-Triphospho-[mRNA];|(5')pppPur-mRNA,Generic compound in reaction hierarchy|R1 = adenine or guanine base,,,,
C20865,"3beta,12alpha-Dihydroxy-5beta-cholanoate;|3beta,12alpha-Dihydroxy-5beta-cholanoic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C20865  3beta,12alpha-Dihydroxy-5beta-cholanoate",
C20866,"Alloavicholate;|Alloavicholic acid;|3alpha,7alpha,16alpha-Trihydroxy-5alpha-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C20866  Alloavicholate",
C20867,"Avideoxycholate;|Avideoxycholic acid;|3alpha,16alpha-Dihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C20867  Avideoxycholate",
C20868,"Cygnocholate;|Cygnocholic acid;|3alpha,7alpha,15alpha-Trihydroxy-5beta-cholan-24-oic acid",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0401 C24 bile acids, alcohols, and derivatives|C20868  Cygnocholate",
C20869,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac);|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-lactate,,,,,
C20870,3-(Methylthio)propanoyl-CoA;|3-(Methylsulfanyl)propanoyl-CoA,,,,,
C20871,3'-Hydroxyflavone,Generic compound in reaction hierarchy,,,,
C20872,3'-Methoxyflavone,Generic compound in reaction hierarchy,,,,
C20873,UDPMurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ser);|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine;|UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-serine,,,,,
C20874,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine;|GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ser)-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20874  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-serine,
C20875,Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate;|GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac)-diphosphoundecaprenol;|GlcNAc-(1->4)-MurNAc(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Lac)-diphosphoundecaprenol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20875  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-L-lysyl-D-alanyl-D-lactate,
C20876,Very-long-chain acyl-CoA,Generic compound in reaction hierarchy,,,,
C20877,Very-long-chain 3-oxoacyl-CoA,Generic compound in reaction hierarchy,,,,
C20878,Very-long-chain (3R)-3-hydroxyacyl-CoA,Generic compound in reaction hierarchy,,,,
C20879,"Very-long-chain trans-2,3-dehydroacyl-CoA",Generic compound in reaction hierarchy,,,,
C20880,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-lactate;|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-lactate",,,,,
C20881,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate;|Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20881  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-D-alanyl-D-Lactate",
C20882,"Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate;|Und-PP-MurNAc-(GlcNAc)-L-Ala-D-Glu-LL-dap-(Gly)-D-Ala-D-Lac;|Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C20882  Undecaprenyl-diphospho-N-acetylmuramoyl-(N-acetylglucosamine)-L-alanyl-D-glutamyl-LL-2,6-diaminopimeloyl-(glycyl)-D-alanyl-D-lactate",
C20883,"3,4-Dihydroxybenzoyl-[aryl-carrier protein];|3,4-Dihydroxybenzoyl-[acp]",,,,,
C20884,"(3,4-Dihydroxybenzoyl)adenylate",,,,,
C20885,N-Citryl-spermidine,,,,,
C20886,"UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminopimelate;|UDP-N-acetylmuramoyl-L-alanyl-gamma-D-glutamyl-LL-2,6-diaminoheptanedioate",,,,,
C20887,"beta-D-Mannosyl-1,4-N-acetyl-D-glucosamine;|4-O-beta-D-Mannopyranosyl-N-acetyl-D-glucosamine",,,,,G00971
C20888,Cellobionate;|Cellobionic acid;|4-O-beta-D-Glucopyranosyl-D-gluconate,,,,,
C20889,"D-Galactaro-1,5-lactone",,,,,
C20890,"D-Glucaro-1,5-lactone",,,,,
C20891,Isoxazolin-5-one;|5-Hydroxyisoxazole,including tautomers,,,,
C20892,3-(5-Oxoisoxazolin-2-yl)-L-alanine;|beta-(Isoxazolin-5-on-2-yl)-L-alanine,,,,,
C20893,3-(5-Oxoisoxazolin-4-yl)-L-alanine;|beta-(Isoxazolin-5-on-4-yl)-L-alanine,,,,,
C20894,beta-Citraurin;|3-Hydroxy-beta-apo-8'-carotenal;|3beta-Hydroxy-8'-apo-beta-carotenal,,,,,
C20895,"(2S,3S)-3-Methylphenylalanine",,,,,
C20896,"D-Galactaro-1,4-lactone",,,,,
C20897,"Glycerophosphoglycoglycerolipid;|(sn-Gro-1-P)->6Glc-alpha1->2Glc-alpha1->3acyl2Gro;|(sn-Gro-1-P)->6Glcalpha1->2Glcalpha1->3acyl2Gro;|1,2-Diacyl-3-[6''-(sn-glycero-1-phospho-)-alpha-D-kojibiosyl]-sn-glycerol",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C20897  1,2-Diacyl-3-[6''-(sn-glycero-1-phospho-)-alpha-D-kojibiosyl]-sn-glycerol",
C20898,Lipoteichoic acid;|(sn-Gro-1-P)n->6Glc-beta1->6Glc-beta1->3acyl2Gro,Generic compound in reaction hierarchy|The hydroxy groups of Gro-1-P subunits may be D-alanylated or glycosylated.,,,,
C20899,"Furan-2,5-dicarbaldehyde;|2,5-Furandicarboxaldehyde",,,,,
C20900,5-(Dihydroxymethyl)furan-2-carbaldehyde,,,,,
C20901,5-(Dihydroxymethyl)furan-2-carboxylate,,,,,
C20902,"3,6-Anhydro-alpha-L-galactopyranose",,,,,
C20903,"3,6-Anhydro-L-galactonate",,,,,
C20904,2-Iminopropanoate,,,,,
C20905,2-Iminobutanoate,,,,,
C20906,"Galactosylglucosyldiacylglycerol;|Gal-alpha1->2Glc-alpha1->3acyl2Gro;|1,2-Diacyl-3-O-[alpha-D-galactopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]-sn-glycerol",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C20906  1,2-Diacyl-3-O-[alpha-D-galactopyranosyl-(1->2)-O-alpha-D-glucopyranosyl]-sn-glycerol",G13188
C20907,"Chondroitin 4,6-sulfate;|Chondroitin sulfate E",,,,,
C20908,Dermatan 4-sulfate;|Chondroitin sulfate B,,,,,G13022
C20909,"Dermatan 4,6-sulfate",,,,,
C20910,L-4-Hydroxyphenylglycyl-L-arginine;|L-pHPg-L-Arg,,,,,
C20911,C20911;|Tabtoxin biosynthesis intermediate 1,,,,,
C20912,C20912;|Tabtoxin biosynthesis intermediate 2,,,,,
C20913,C20913;|Tabtoxin biosynthesis intermediate 3,,,,,
C20914,C20914;|Tabtoxin biosynthesis intermediate 4,,,,,
C20915,C20915;|Tabtoxin biosynthesis intermediate 5,,,,,
C20916,C20916;|Tabtoxin biosynthesis intermediate 6,,,,,
C20917,Tabtoxin;|beta-Tabtoxin,,,,,
C20918,Tabtoxinine-beta-lactam,,,,,
C20919,Isotabtoxin;|delta-Tabtoxin,,,,,
C20920,Tabtoxinine-delta-lactam,,,,,
C20921,N1-Acetyl-tabtoxinine-beta-lactam,,,,,
C20922,"Cembrene C;|(1E,5E,9E)-1,5,9-Trimethyl-12-(propan-2-ylidene)cyclotetradeca-1,5,9-triene",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010419 Cembrane diterpenoids|C20922  Cembrene C,
C20923,"(R)-Nephthenol;|2-[(1R,3E,7E,11E)-4,8,12-Trimethyltetradeca-3,7,11-trien-1-yl]propan-2-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010419 Cembrane diterpenoids|C20923  (R)-Nephthenol,
C20924,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethylcyclopentadeca-4,8,12-trien-1-ol",,,,,
C20925,"L-Alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate;|L-Alanyl-gamma-D-glutamyl-meso-2,6-diaminopimelate",,,,,
C20926,gamma-Glutamyltyramine;|gamma-L-Glutamyltyramine,,,,,
C20927,Sulfazecin;|SQ 26445,,,,,
C20928,MM 42842,,,,,
C20929,3alpha-Hydroxy-3-aminoacylmonobactamic acid,Generic compound,,,,
C20931,4-Amino-4-deoxy-L-arabinose;|L-Ara4N,,,,,
C20933,(9Z)-Hexadec-9-enoyl-KDO2-lipid IV(A);|Palmitoleoyl-KDO2-lipid IV(A);|(9Z)-Hexadec-9-enoyl-KDO2-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C20933  Palmitoleoyl-KDO2-lipid IV(A),
C20934,3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonate;|3-Deoxy-D-glycero-D-galacto-non-2-ulosonic acid;|2-Keto-3-deoxy-D-glycero-D-galacto-nononic acid;|KDN;|Deaminated neuraminic acid;|Ketodeoxynonulonic acid;|3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid,,,,,
C20935,"2-5A;|2',5'-Oligoadenylate 5'-triphosphate",Generic compound in reaction hierarchy|pppA2'p5'A2'p5'A (n=3) [CPD:C20936],,,,
C20936,"pppA2'p5'A2'p5'A;|Trimeric 2-5A;|2',5'-Triadenylate 5'-triphosphate",,,,,
C20937,Nitroxyl,,,,,
C20938,"2,2'-Disulfonyl azobenzene",,,,,
C20939,"3-[(4-Amino-6-chloro-1,3,5-triazin-2-yl)amino]benzenesulfonate",,,,,
C20940,L-Dihydroanticapsin,,,,,
C20941,L-Anticapsin;|Anticapsin,,,,,
C20942,Bacilysin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20942,
C20943,"(R)-Ipsdienol;|(4R)-2-Methyl-6-methyleneocta-2,7-dien-4-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C20943  (R)-Ipsdienol,
C20944,"Ipsdienone;|2-Methyl-6-methyleneocta-2,7-dien-4-one",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010201 Acyclic monoterpenoids|C20944  Ipsdienone,
C20945,Erythrodiol,,,,,
C20946,Oleanolic aldehyde,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010615 Oleanane triterpenoids|C20946  Oleanolic aldehyde,
C20947,(Z)-Icos-5-enoyl-CoA,,,,,
C20948,LysW-L-glutamate;|LysW-glutamate;|LysW-gamma-(L-glutamyl)-L-glutamate,R = LysW,,,,
C20949,LysW-L-glutamyl 5-phosphate;|[Amino-group carrier protein]-C-terminal-gamma-(5-phospho-L-glutamyl)-L-glutamate,,,,,
C20950,LysW-L-glutamate 5-semialdehyde;|[Amino-group carrier protein]-C-terminal-gamma-(L-glutamate 5-semialdehyde-2-yl)-L-glutamate,,,,,
C20951,LysW-L-ornithine,,,,,
C20952,"N1-(3,4-Dihydroxybenzoyl)-N8-citryl spermidine;|3,4-Dihydroxybenzoyl-citryl-spermidine",,,,,
C20953,"3-[(4R)-4-Hydroxycyclohexa-1,5-dien-1-yl]-2-oxopropanoate",,,,,
C20954,(5-Formylfuran-3-yl)methyl phosphate;|2-Furaldehyde phosphate;|4-HFC-P;|4-(Hydroxymethyl)-2-furancarboxaldehyde phosphate,,,,,
C20955,3-(Methylthio)acryloyl-CoA;|Methylthioacryloyl-CoA;|3-(Methylsulfanyl)acryloyl-CoA,,,,,
C20956,alpha-D-Sedoheptulopyranose 7-phosphate,,,,,
C20957,L-Alanyl-D-glutamate,,,,,
C20958,L-Alanyl-L-glutamate,,,,,
C20959,"(4S)-4-Hydroxy-5-phosphooxypentane-2,3-dione;|(4S)-4-Hydroxy-5-phosphonooxypentane-2,3-dione;|Phospho-DPD;|P-DPD;|(2S)-2-Hydroxy-3,4-dioxopentyl phosphate;|Phospho-AI-2",,,,,
C20960,"3-Hydroxy-5-phosphooxypentane-2,4-dione;|3-Hydroxy-5-phosphonooxypentane-2,4-dione;|3-Hydroxy-2,4-pentadione-5-phosphate;|P-HPD;|3-Hydroxy-2,4-dioxopentyl phosphate",,,,,
C20961,"N3-Fumaroyl-L-2,3-diaminopropanoate;|N3-Fumaroyl-(S)-2,3-diaminopropanoate;|(2E)-4-{[(2S)-2-Amino-2-carboxyethyl]amino}-4-oxobut-2-enoate",,,,,
C20962,Dapdiamide A;|3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-valine,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20962,
C20963,Dapdiamide B;|3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-isoleucine,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20963,
C20964,Dapdiamide C;|3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanyl-L-leucine,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C20964,
C20965,"N(beta)-Epoxysuccinamoyl-DAP-Val;|N(beta)-Epoxysuccinamoyl-diaminopropionyl-valine;|3-({[(2R,3R)-3-Carbamoyloxiran-2-yl]carbonyl}amino)-L-alanyl-L-valine",,,,,
C20966,3-{[(2E)-4-Amino-4-oxobut-2-enoyl]amino}-L-alanine,,,,,
C20967,"N(beta)-Epoxysuccinamoyl-DAP;|N(beta)-Epoxysuccinamoyl-diaminopropionate;|3-({[(2R,3R)-3-Carbamoyloxiran-2-yl]carbonyl}amino)-L-alanine",,,,,
C20968,3-Hydroxy-3-(methylthio)propanoyl-CoA;|3-Hydroxy-3-(methylsulfanyl)propanoyl-CoA,,,,,
C20969,Carboxyphosphate,,,,,
C20970,Angiotensin A,,Ala Arg Val Tyr Ile His Pro Phe,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C20970  Angiotensin A,
C20971,Alamandine,,Ala Arg Val Tyr Ile His Pro,Peptide,Bioactive peptides [BR:br08005]|Cardiovascular peptides|Angiotensin|C20971  Alamandine,
C20972,Angiotensin (5-8);|Angiotensin-(5-8),,Ile His Pro Phe,Peptide,,
C20973,Angiotensin (5-7);|Angiotensin-(5-7),,Ile His Pro,Peptide,,
C20974,8-Demethyl-8-alpha-L-rhamnosyltetracenomycin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20974  8-Demethyl-8-alpha-L-rhamnosyltetracenomycin C,
C20975,8-Demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20975  8-Demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C,
C20976,"8-Demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20976  8-Demethyl-8-(2,3-di-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",
C20977,"8-Demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C20977  8-Demethyl-8-(2,3,4-tri-O-methyl-alpha-L-rhamnosyl)tetracenomycin C",
C20978,Glucoselysine,,,,,
C20979,Glucoselysine-6-phosphate,,,,,
C20980,3-Methoxy-5-methyl-1-naphthoate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20980  3-Methoxy-5-methyl-1-naphthoate,
C20981,"5,10-Dihydrophenazine-1-carboxylate",,,,,
C20982,"9-(Dimethylallyl)-5,10-dihydrophenazine-1-carboxylate;|9-Prenyl-5,10-dihydrophenazine-1-carboxylate;|Dihydroendophenazine A",,,,,
C20983,4-O-Dimethylallyl-L-tyrosine;|4-O-Prenyl-L-tyrosine,,,,,
C20984,3-Linalylflaviolin,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C20984  3-Linalylflaviolin,
C20985,"2-Sulfotrehalose;|2-O-Sulfo-alpha,alpha-trehalose",,,,,
C20986,"D-Ribose 2,5-bisphosphate",,,,,
C20987,3-Sulfinopropanoyl-CoA,,,,,
C20988,[N-(6-Aminohexanoyl)]n;|6-Aminohexanoate oligomer;|Nylon-6 oligomer,,,,,
C20990,6-Aminohexanoate cyclic oligomer;|Nylon-6 cyclic oligomer,,,,,
C20991,"1,2-Diacyl-3-O-[beta-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol;|Galbeta1->6Galbeta1->3acyl2Gro",,,,"Lipids [BR:br08002]|GL  Glycerolipids|GL05 Glycosyldiradylglycerols|GL0501 Glycosyldiacylglycerols|C20991  1,2-Diacyl-3-O-[beta-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol",
C20992,"Juvenile hormone I acid;|(2E,6E,10R,11S)-10,11-Epoxy-7-ethyl-3,11-dimethyl-2,6-tridecadienoate",,,,,
C20993,S-(L-Histidin-5-yl)-L-cysteine S-oxide,,,,,
C20994,S-(Hercyn-2-yl)-L-cysteine S-oxide,,,,,
C20995,gamma-L-Glutamyl-S-(hercyn-2-yl)-L-cysteine S-oxide,,,,,
C20996,(14E)-Hexadec-14-enoyl-CoA,,,,,
C20997,(14Z)-Hexadec-14-enoyl-CoA,,,,,
C20998,(11Z)-Hexadec-11-enoyl-CoA,,,,,
C20999,"(10E,12Z)-Hexadeca-10,12-dienoyl-CoA",,,,,
C21000,"(9Z,12Z)-Hexadeca-9,12-dienoyl-CoA",,,,,
C21001,"2-O,3-Dimethylflaviolin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21001  2-O,3-Dimethylflaviolin",
C21002,"6-Linalyl-2-O,3-dimethylflaviolin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21002  6-Linalyl-2-O,3-dimethylflaviolin",
C21003,"7-O-Geranyl-2-O,3-dimethylflaviolin",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21003  7-O-Geranyl-2-O,3-dimethylflaviolin",
C21004,"Norspermine;|N,N'-Bis(3-aminopropyl)-1,3-propanediamine",,,,,
C21005,18-Hydroxyoleoyl-CoA,,,,,
C21006,18-Hydroxylinoleoyl-CoA,,,,,
C21007,"5,6,7,8-Tetrahydromonapterin",,,,,
C21008,"7,8-Dihydromonapterin",,,,,
C21009,N4-Aminopropylspermidine,,,,,
C21010,N4-Bis(aminopropyl)spermidine,,,,,
C21011,[Protein]-N(epsilon)-(carboxymethyl)lysine;|CML-R,,,,,
C21012,[Protein]-N(epsilon)-(carboxyethyl)lysine;|CEL-R,,,,,
C21013,[Protein]-pyrraline;|Pyrraline-R,,,,,
C21014,[Protein]-pentosidine;|Pentosidine-R,,,,,
C21015,gamma-L-Glutamyl-L-2-aminobutyrate,,,,,
C21016,Ophthalmate;|gamma-L-Glutamyl-L-2-aminobutyrylglycine,,,,,
C21017,2-(alpha-Hydroxypropyl)thiamine diphosphate;|2-Hydroxypropyl-ThPP,,,,,
C21018,Enzyme N6-(S-propyldihydrolipoyl)lysine;|S-Propyldihydrolipoamide-E,,,,,
C21019,1-Acyl-2-[(12R)-12-hydroxyoleoyl]-sn-glycero-3-phosphocholine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2001 Oxidized glycerophosphocholines|C21019  1-Acyl-2-[(12R)-12-hydroxyoleoyl]-sn-glycero-3-phosphocholine,
C21020,(2'R)-2'-Hydroxyphytoceramide,Generic compound in reaction hierarchy,,,,
C21021,(2'R)-2'-Hydroxydihydroceramide,Generic compound in reaction hierarchy,,,,
C21022,"(4E,8E)-Sphinga-4,8-dienine ceramide;|N-Acyl-(4E,8E)-sphinga-4,8-dienine",Generic compound in reaction hierarchy,,,,
C21023,"(4E,8E,10E)-Sphinga-4,8,10-trienine ceramide",Generic compound in reaction hierarchy,,,,
C21024,"(4R,8E)-4-Hydroxysphing-8-enine ceramide",Generic compound in reaction hierarchy,,,,
C21025,"(4R,8Z)-4-Hydroxysphing-8-enine ceramide",Generic compound in reaction hierarchy,,,,
C21026,Iminoarginine;|5-Carbamimidamido-2-iminopentanoate,,,,,
C21027,N-Acetylmuramic acid alpha-1-phosphate;|N-Acetylmuramate alpha-1-phosphate;|MurNAc alpha-1-phosphate;|N-Acetyl-alpha-D-muramate 1-phosphate,,,,,
C21028,"(R)-5,6-Dihydrothymine;|(5R)-Dihydrothymine",,,,,
C21029,(R)-3-Ureidoisobutyrate;|(R)-N-Carbamyl-beta-aminoisobutyrate,,,,,
C21030,(R)-Methylmalonate semialdehyde,"Methylmalonate semialdehyde [CPD:C00349] (non-enzymatic racemization, see [RN:R11028])",,,,
C21031,5-Hydroxymethylcytosine in DNA;|DNA 5-hydroxymethylcytosine,Generic compound in reaction hierarchy,,,,
C21032,L-Altrose;|L-Altropyranose,,,,,
C21033,6-Deoxy-L-altrose;|6-Deoxy-L-altropyranose,,,,,
C21034,L-Altruronic acid;|L-Altropyranuronic acid,,,,,
C21035,L-Altrosamine;|2-Amino-2-deoxy-L-altropyranose,,,,,
C21036,N-Acetyl-L-altrosamine;|2-Acetamido-2-deoxy-L-altropyranose,,,,,
C21037,D-Alluronic acid;|D-Allopyranuronic acid,,,,,
C21038,D-Allosamine;|2-Amino-2-deoxy-D-allopyranose,,,,,
C21039,N-Acetyl-D-allosamine;|2-Acetamido-2-deoxy-D-allopyranose,,,,,
C21040,D-Apiofuranose;|Apiose;|3-C-(Hydroxymethyl)-D-erythofuranose;|D-Apiose,D-Apiose (open-chain) [CPD:C01488]|beta-D-Apiose [CPD:C08346],,,,
C21041,"Bacillosamine;|2,4-Diamino-2,4,6-trideoxy-D-glucopyranose",,,,,
C21042,D-glycero-D-manno-Heptose;|D-glycero-D-manno-Heptopyranose,,,,,
C21043,L-glycero-D-manno-Heptose;|L-glycero-D-manno-Heptopyranose,,,,,
C21044,3-Deoxy-lyxo-heptulosaric acid;|3-Deoxy-D-lyxo-hept-2-ulopyranosaric acid,,,,,
C21045,"D-Digitoxose;|2,6-Dideoxy-D-ribo-hexopyranose",,,,,
C21046,"N-Acetyl-L-fucosamine;|2-Acetamido-2,6-dideoxy-L-galactopyranose",,,,,
C21047,D-Guluronic acid;|D-Gulopyranuronic acid,,,,,
C21048,D-Gulosamine;|2-Amino-2-deoxy-D-gulopyranose,,,,,
C21049,N-Acetyl-D-gulosamine;|2-Acetamido-2-deoxy-D-gulopyranose,,,,,
C21050,L-Idose;|L-Idopyranose,,,,,
C21051,L-Idosamine;|2-Amino-2-deoxy-L-idopyranose,,,,,
C21052,N-Acetyl-L-idosamine;|2-Acetamido-2-deoxy-L-idopyranose,,,,,
C21053,N-Glycolylmuramic acid;|2-Glycolylamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose,,,,,
C21054,"Olivose;|D-Olivose;|2,6-Dideoxy-D-arabino-hexopyranose",,,,,
C21055,"Paratose;|3,6-Dideoxy-D-ribo-hexopyranose",,,,,
C21056,"N-Acetyl-L-rhamnosamine;|2-Acetamido-2,6-dideoxy-L-mannopyranose",,,,,
C21057,D-Ribose;|D-Ribopyranose,beta-D-Ribopyranose [CPD:C08353],,,,
C21058,6-Deoxy-D-talose;|6-Deoxy-D-talopyranose,,,,,
C21059,D-Taluronic acid;|D-Talopyranuronic acid,,,,,
C21060,D-Talosamine;|2-Amino-2-deoxy-D-talopyranose,,,,,
C21061,N-Acetyl-D-talosamine;|2-Acetamido-2-deoxy-D-talopyranose,,,,,
C21062,"Tyvelose;|3,6-Dideoxy-D-arabino-hexopyranose",,,,,
C21063,Ketodeoxyoctonic acid;|Ketodeoxyoctulonic acid;|3-Deoxy-D-manno-oct-2-ulopyranosonic acid,Ketodeoxyoctulonic acid is named incorrectly.|Ketodeoxyoctonate (open-chain) [CPD:C01187],,,,
C21064,"6-Deoxy-6-sulfo-D-glucono-1,5-lactone",,,,,
C21065,"7,8-Dihydroxanthopterin",,,,,
C21066,D-Galactofuranose,D-Galactopyranose [CPD:C00124],,,,
C21067,D-Arabinofuranose,D-Arabinopyranose [CPD:C00216],,,,
C21068,[5-(Aminomethyl)furan-3-yl]methyl phosphate;|5-(Aminomethyl)-3-furanmethanol phosphate,,,,,
C21069,[5-(Aminomethyl)furan-3-yl]methyl diphosphate;|5-(Aminomethyl)-3-furanmethanol diphosphate,,,,,
C21070,(4-{4-[2-(gamma-L-Glutamylamino)ethyl]phenoxymethyl}furan-2-yl)methanamine;|4-[N-(gamma-L-Glutamyl)-p-(beta-aminoethyl)phenoxymethyl]-2-(aminomethyl)furan;|APMF-Glu,,,,,
C21071,"dTDP-3-O-methyl-4-oxo-2,6-dideoxy-L-mannose;|dTDP-4-keto-3-O-methyl-2,6-dideoxy-L-mannose",,,,,
C21072,Palmitoleoyl-CoA;|(9Z)-Hexadec-9-enoyl-CoA;|(9Z)-Hexadecenoyl-CoA;|9Z-Hexadecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21072  (9Z)-Hexadecenoyl-CoA,
C21073,"dTDP-3-N,N-dimethylamino-2,3,6-trideoxy-4-keto-D-glucose;|dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-D-glucose",,,,,
C21074,"dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-L-allose;|dTDP-3-N,N-dimethylamino-4-keto-2,3,6-trideoxy-L-allose",,,,,
C21075,"5-(N-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridin-2-ol;|6-Hydroxy-N-methylmyosmine",,,,,
C21076,"Delta4-Dafachronic acid;|(25S),26-3-Keto-4-cholestenoic acid;|(25S)-Delta4-Dafachronic acid;|(25S)-3-Oxocholest-4-en-26-oate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST04 Bile acids and derivatives|ST0403 C27 bile acids, alcohols, and derivatives|C21076  Delta4-Dafachronic acid",
C21077,"Delta7-Dafachronic acid;|3-Keto-7,(5alpha)-cholestenoic acid;|(25S)-Delta7-Dafachronic acid",,,,,
C21078,"2,6-Dimethyldeca-2,4,6,8-tetraenedial",,,,,
C21079,5'-Dehydrouridine;|Uridine-5'-aldehyde,,,,,
C21080,7-Hydroxydodecanoate,,,,,
C21081,"Gentisyl-CoA;|2,5-Dihydroxybenzoyl-CoA",,,,,
C21082,"(5Z,11Z,14Z)-Icosa-5,11,14-trienoyl-CoA",,,,,
C21083,"(5Z,11Z,14Z,17Z)-Icosa-5,11,14,17-tetraenoyl-CoA",,,,,
C21084,Demethylphylloquinol,,,,,
C21085,"3-[(1E,4R)-4-Hydroxycyclohex-2-en-1-ylidene]-2-oxopropanoate",,,,,
C21086,"(3E)-3-[(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-ylidene]-2-oxopropanoate;|Epoxy-3E-H2HPP",,,,,
C21087,"3-[(1R,2S,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-2-oxopropanoate;|Epoxy-4S-H4HPP",,,,,
C21088,"L-Altarate;|L-Talarate;|(2R,3R,4S,5R)-2,3,4,5-Tetrahydroxyhexanedioate",,,,,
C21089,(R)-2-Hydroxyisocaproyl-CoA;|(R)-2-Hydroxy-4-methylpentanoyl-CoA,,,,,
C21090,Isocaprenoyl-CoA;|(E)-2-Isocaprenoyl-CoA;|4-Methylpent-2-enoyl-CoA,,,,,
C21091,"(2S,3R)-2,3-Dihydroxy-5-oxohexanedioate;|3-Deoxy-D-threo-hex-2-ulosarate",,,,,
C21092,D-allo-Isoleucine,,,,,
C21093,Terpentecin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010404 Colensane and clerodane diterpenoids|C21093  Terpentecin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21093,
C21094,"7,8-Dihydromonapterin 3'-triphosphate",,,,,
C21095,"D-Glucaro-1,4-lactone",,,,,
C21096,L-allo-Isoleucine,,,,,
C21097,Peptidyl-carrier protein;|PCP;|[Peptidyl-carrier protein];|[pcp],Generic compound in reaction hierarchy,,,,
C21098,L-allo-Isoleucyl-[peptidyl-carrier protein],,,,,
C21099,L-Arginyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C21100,"Caldopentamine;|N-(3-Aminopropyl)-N'-{3-[(3-aminopropyl)amino]propyl}-1,3-propanediamine",,,,,
C21101,Protein N(omega)-phospho-L-arginine;|[Protein]-N(omega)-phospho-L-arginine,,,,,
C21102,5'-Deoxyinosine,,,,,
C21103,"2,6-Dichloro-p-benzoquinone;|2,6-Dichloro-1,4-benzoquinone",,,,,
C21104,"2,5-Dichloro-p-benzoquinone;|2,5-Dichloro-1,4-benzoquinone",,,,,
C21105,5-Chloro-2-hydroxy-p-benzoquinone,,,,,
C21106,24-epi-Campesterol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C21106  24-epi-Campesterol,
C21107,4-(beta-D-Ribofuranosyl)phenol 5'-phosphate,,,,,
C21108,Dihydromonacolin L-[acyl-carrier protein],,,,,
C21109,Aminopyrrolnitrin,,,,,
C21110,Monodechloroaminopyrrolnitrin,,,,,
C21111,Pyrithiamine;|1-(4-Amino-2-methylpyrimid-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium,,,,,
C21112,Oxypyrithiamine;|1-(4-Hydroxy-2-methylpyrimid-5-ylmethyl)-3-(2-hydroxyethyl)-2-methylpyridinium,,,,,
C21113,NMNH;|Reduced nicotinamide nucleotide,,,,,
C21114,(4Z)-Hexadec-4-enoyl-[acyl-carrier protein],,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C21114  (4Z)-Hexadec-4-enoyl-[acp],
C21115,(6Z)-Hexadec-6-enoyl-[acyl-carrier protein];|Delta6-Hexadecenoyl-[acyl-carrier protein];|Sapienoyl-[acyl-carrier-protein],,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0706 Fatty acyl ACPs|C21115  (6Z)-Hexadec-6-enoyl-[acp],
C21116,Hydroxysqualene;|12-Hydroxysqualene,,,,,
C21117,Adenosylhopane,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21117  Adenosylhopane,
C21118,Ribosylhopane,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21118  Ribosylhopane,
C21119,"Bacteriohopanetetrol;|Tetrahydroxybacteriohopane;|Bacteriohopane-32,33,34,35-tetrol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21119  Bacteriohopanetetrol,
C21120,Bacteriohopanetetrol-acetylglucosamine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21120  Bacteriohopanetetrol-acetylglucosamine,
C21121,Bacteriohopanetetrol-glucosamine;|Tetrahydroxybacteriohopane-glucosamine,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21121  Bacteriohopanetetrol-glucosamine,
C21122,Bacteriohopanetetrol cyclitol ether;|Tetrahydroxybacteriohopane cyclitol ether,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21122  Bacteriohopanetetrol cyclitol ether,
C21123,Aminobacteriohopanetriol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR04 Hopanoids|C21123  Aminobacteriohopanetriol,
C21124,IPA imine;|2-Imino-3-(indol-3-yl)propanoate,,,,,
C21125,Chromopyrrolate;|Chromopyrrolic acid,,,,,
C21126,K-252c,,,,,
C21127,Holyrine A,,,,,
C21128,O-Demethyl-N-demethyl-staurosporine;|3'-O-Demethyl-4'-N-demethyl-staurosporine,,,,,
C21129,(S)-2-Methylbutanoyl-[acp];|(S)-2-Methylbutanoyl-[acyl-carrier protein],,,,,
C21130,Lovastatin acid;|Mevinolinic acid,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21130|Prodrugs [br08324.html]|C21130,
C21131,Protodeoxyviolaceinic acid;|Protodeoxyviolaceinate,,,,,
C21132,Deoxyviolaceinic acid;|Deoxyviolaceinate,,,,,
C21133,Deoxyviolacein,,,,,
C21134,Protoviolaceinic acid;|Protoviolaceinate,,,,,
C21135,Violaceinic acid;|Violaceinate,,,,,
C21136,Violacein,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21136,
C21137,"dTDP-3-amino-4-oxo-2,3,6-trideoxy-L-allose;|dTDP-3-amino-4-keto-2,3,6-trideoxy-L-allose",,,,,
C21138,trans-2-Octenal;|(E)-Oct-2-enal,,,,,
C21139,(S)-3-Acetyloctanal,,,,,
C21140,Aurachin B,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21140,
C21141,"4-Hydroxy-2-methyl-3-oxo-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline 1-oxide",,,,,
C21142,"3,4-Dihydroxy-2-methy-4-[(2E,6E)-farnesyl]-3,4-dihydroquinoline 1-oxide",,,,,
C21143,2'-N-Hydroxyrifampicin;|2'-N-Hydroxy-4-oxorifampicin,,,,,
C21144,"1,3,7-Trimethyl-5-hydroxyisourate",,,,,
C21145,Protoasukamycin,,,,,
C21146,4-Hydroxyprotoasukamycin,,,,,
C21147,Asperlicin C,,,,,
C21148,Asperlicin E,,,,,
C21149,Dibenzothiophene-5-oxide,,,,,
C21150,"Dibenzothiophene-5,5-dioxide;|Dibenzothiophene sulfone",,,,,
C21151,Peptide diphthine methyl ester;|EF-2 diphthine methyl ester;|Diphthine methyl ester-[translation elongation factor 2],Generic compound in reaction hierarchy|Precursor of Diphthamide [CPD:C02872]|Modified histidine residue of elongation factor 2(EF-2),,,,
C21152,"N,N'-Diacetylchitobiose 6'-phosphate",,,,,
C21153,Adenosylcobalamin 5'-phosphate,,,,,
C21154,"N-Methylmyosmine;|3-(4,5-Dihydro-1-methyl-1H-pyrrol-2-yl)pyridine;|3-(1-Methyl-4,5-dihydro-1H-pyrrol-2-yl)pyridine",,,,,
C21155,Isatinate,,,,,
C21156,Acarbose 7IV-phosphate;|Acarbose 7-phosphate,,,,,
C21157,KDO2-lipid A 1-diphosphate;|alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid A 1-diphosphate,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21157  KDO2-lipid A 1-diphosphate,
C21158,"Nucleoside 3',5'-bisphosphate",Generic compound in reaction hierarchy,,,,
C21159,"2,4-Dinitroanisole",,,,,
C21160,L-Alanyl-gamma-D-glutamyl-L-lysine;|L-Ala-gamma-D-Glu-L-Lys,,,,,
C21161,Mitomycin A,,,,,
C21162,Mitomycin B,,,,,
C21163,7-Demethylmitomycin A;|6-Demethylmitomycin A,,,,,
C21164,7-Demethylmitomycin B;|6-Demethylmitomycin B,,,,,
C21165,"9-Methyl-(4E,8E)-sphinga-4,8-dienine ceramide;|(E,E)-9-Methylsphinga-4,8-dienine ceramide",Generic compound in reaction hierarchy,,,,
C21166,4-Hydroxy-3-methylbenzaldehyde,,,,,
C21167,4-Hydroxy-3-methylbenzoate;|4-Hydroxy-m-toluate,,,,,
C21168,"4-Hydroxyisophthalate;|4-Hydroxy-1,3-benzenedicarboxylate",,,,,
C21169,"N1,N8-Bis(4-coumaroyl)spermidine;|N1,N10-Dicoumaroyl spermidine",,,,,
C21170,"N1,N8-Bis(sinapoyl)spermidine;|N1,N10-Disinapoyl spermidine",,,,,
C21171,[Wnt]-O-(9Z)-hexadec-9-enoyl-L-serine,,,,,
C21172,[Wnt]-L-serine,,,,,
C21173,PEtN-KDO2-lipid A;|7-O-Ethanolaminephospho-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21173  PEtN-KDO2-lipid A,
C21174,PEtN-KDO2-lipid IV(A);|7-O-Ethanolaminephospho-alpha-Kdo-(2->4)-alpha-Kdo-(2->6)-lipid IV(A),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21174  PEtN-KDO2-lipid IV(A),
C21175,"Dihydrocaffeoyl-CoA;|3-(3,4-Dihydroxyphenyl)propanoyl-CoA;|Hydrocaffeyl-CoA",,,,,
C21176,3''-Oxoribostamycin,,,,,
C21177,Prokaryotic ubiquitin-like protein;|[Prokaryotic ubiquitin-like protein]-L-glutamate;|Pup,,,,,
C21178,Pupylated protein;|N6-([Prokaryotic ubiquitin-like protein]-gamma-L-glutamyl)-[protein]-L-lysine,Generic compound in reaction hierarchy,,,,
C21179,[Prokaryotic ubiquitin-like protein]-L-glutamine,,,,,
C21180,"2-Dehydro-3,6-dideoxy-6-sulfo-D-gluconate;|2-Keto-3,6-dideoxy-6-sulfogluconate",,,,,
C21181,(2S)-3-Sulfolactaldehyde,,,,,
C21182,6-Deoxy-6-sulfo-D-gluconate;|6-Deoxy-6-sulfogluconate,,,,,
C21183,"Bursehernin;|(-)-Bursehernin;|(3R,4R)-4-(2H-1,3-Benzodioxol-5-ylmethyl)-3-[(3,4-dimethoxyphenyl)methyl]oxolan-2-one",,,,,
C21184,"(-)-5'-Demethylyatein;|(3R,4R)-4-(2H-1,3-Benzodioxol-5-ylmethyl)-3-[(3-hydroxy-4,5-dimethoxyphenyl)methyl]oxolan-2-one",,,,,
C21185,"4'-Demethylepipodophyllotoxin;|(-)-4'-Demethylepipodophyllotoxin;|(5R,5aR,8aR,9S)-9-Hydroxy-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one",,,,,
C21186,"6-Tuliposide B;|6-O-[(3S)-3,4-Dihydroxy-2-methylenebutanoyl]-D-glucose",,,,,
C21187,Tulipalin B;|(4S)-4-Hydroxy-3-methylideneoxolan-2-one,,,,,
C21188,"Protein N(omega),N(omega)-dimethyl-L-arginine;|Protein asymmetric dimethylarginine",Generic compound in reaction hierarchy,,,,
C21189,"Protein N(omega),N(omega)'-dimethyl-L-arginine;|Protein symmetric dimethylarginine",Generic compound in reaction hierarchy,,,,
C21190,Protein N5-methyl-L-arginine,Generic compound in reaction hierarchy,,,,
C21191,"Pluviatolide;|(-)-Pluviatolide;|(3R,4R)-4-(2H-1,3-Benzodioxol-5-ylmethyl)-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one",,,,,
C21192,Epoxypheophorbide a,,,,,
C21193,Hexa-acyl lipid A in lipopolysaccharide,Generic compound in reaction hierarchy|R = R core and O-antigen,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21193  Hexa-acyl lipid A in lipopolysaccharide,
C21194,Hepta-acyl lipid A in lipopolysaccharide,Generic compound in reaction hierarchy|R = R core and O-antigen,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21194  Hepta-acyl lipid A in lipopolysaccharide,
C21195,N-(3-Hydroxybutanoyl)-L-homoserine lactone;|3-Hydroxy-C4-HSL;|N-[(RS)-3-Hydroxybutyryl]-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21195  N-(3-Hydroxybutanoyl)-L-homoserine lactone,
C21197,N-Hexanoyl-L-homoserine lactone;|C6-HSL;|N-[(3S)-Tetrahydro-2-oxo-3-furanyl]-hexanamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21197  N-Hexanoyl-L-homoserine lactone,
C21198,N-(3-Oxohexanoyl)-L-homoserine lactone;|3-Oxo-C6-HSL;|N-(beta-Ketocaproyl)-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21198  N-(3-Oxohexanoyl)-L-homoserine lactone,
C21199,N-Octanoyl-L-homoserine lactone;|C8-HSL;|N-[(3S)-Tetrahydro-2-oxo-3-furanyl]octanamide,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21199  N-Octanoyl-L-homoserine lactone,
C21200,N-3-Hydroxyoctanoyl-L-homoserine lactone;|3-OH-C8-HSL;|3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide;|N-(3-Hydroxyoctanoyl)-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21200  N-3-Hydroxyoctanoyl-L-homoserine lactone,
C21201,N-3-Oxo-dodecanoyl-L-homoserine lactone;|3-Oxo-C12-HSL;|3-Oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-dodecanamide;|N-(3-Oxododecanoyl)-L-homoserine lactone,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA08 Fatty amides|FA0803 Fatty acyl homoserine lactones|C21201  N-(3-Oxododecanoyl)-L-homoserine lactone,
C21202,cis-2-Dodecenoic acid;|BDSF,,,,,
C21203,Geranyl phosphate,,,,,
C21204,5-epi-Valiolol 7-phosphate,,,,,
C21205,1-epi-Valienol 7-phosphate,,,,,
C21206,"1,7-Diphospho-1-epi-valienol",,,,,
C21207,NDP-1-epi-valienol 7-phosphate,,,,,
C21208,dTDP-acarviose-7-phosphate,,,,,
C21209,1-epi-Valienol 1-phosphate,,,,,
C21210,NDP-1-epi-valienol,,,,,
C21211,Salbostatin 6'-phosphate,,,,,
C21212,Archaeal dolichyl phosphate;|Dolichyl phosphate,n = 7-8|Dolichyl phosphate (eucaryotic) [CPD:C00110],,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C21212  Archaeal dolichyl phosphate,
C21213,"Archaeal dolichyl 3-O-(2,3-diacetamido-2,3-dideoxy-beta-D-glucuronsyl)-N-acetyl-alpha-D-glucosaminyl phosphate;|Dol-P-GlcNAc-Glc-2,3-diNAcA",n = 7-8,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C21213  Archaeal dolichyl 3-O-(2,3-diacetamido-2,3-dideoxy-beta-D-glucuronsyl)-N-acetyl-alpha-D-glucosaminyl phosphate",
C21214,Dimethylallyl phosphate;|Prenyl phosphate,,,,,
C21215,Prenylated FMNH2;|Reduced prFMN,,,,,
C21216,Validamine 7-phosphate,,,,,
C21217,Geranylgeranyl bacteriochlorophyllide a,,,,,
C21218,Validone 7-phosphate,,,,,
C21219,Validoxylamine A 7'-phosphate,,,,,
C21240,Gentamicin C 2''-phosphate,Generic compound in reaction hierarchy,,,,
C21247,2-Amino-5-epi-valiolone,,,,,
C21248,2-Aminovalienone,,,,,
C21249,Cetoniacytone B,,,,,
C21250,2-Methyl-trans-aconitate,,,,,
C21251,6'-Oxokanamycin X,,,,,
C21252,6'-Oxokanamycin C,,,,,
C21253,Kanamycin D,,,,,
C21254,3''-Deamino-3''-hydroxykanamycin B;|Nebramycin factor 3,,,,,
C21255,Lividamine,,,,,
C21256,6'-Oxolividamine,,,,,
C21257,4'-Oxolividamine;|3'-Deoxy-4'-oxoparomamine,,,,,
C21258,4'-Oxonebramine,,,,,
C21259,Nebramine;|3'-Deoxyneamine,,,,,
C21260,5''-Phosphoribosylparomamine,,,,,
C21261,2'''-N-Acetyl-6'''-deamino-6'''-hydroxyparomomycin II,,,,,
C21262,6'''-Deamino-6'''-hydroxyparomomycin II,,,,,
C21263,6'''-Deamino-6'''-oxoparomomycin II,,,,,
C21264,5'''-epi-Lividomycin B,,,,,
C21265,3''-Oxogentamicin A2,,,,,
C21266,3''-Amino-3''-deoxygentamicin A2;|3''-Demethyl-gentamicin A,,,,,
C21267,6'-Oxogentamicin X2,,,,,
C21268,6'-Oxo-G418,,,,,
C21269,Antibiotic JI-20Ba;|JI-20Ba,,,,,
C21270,Gentamicin C2a,,,,,
C21272,3-(4-Aminophenyl)pyruvate;|p-Aminophenylpyruvic acid;|p-Aminophenylpyruvate,,,,,
C21273,Benfluralin,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Dinitroaniline herbicides|C21273  Benfluralin,
C21275,Mycolactone C,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C21275  Mycolactone C,
C21276,Mycolactone D,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C21276  Mycolactone D,
C21277,Mycolactone E,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C21277  Mycolactone E,
C21278,Mycolactone F,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C21278  Mycolactone F,
C21279,BGC 945;|ONX 0801,,,,,
C21280,AG 2034,,,,,
C21281,"Demethyl-4-deoxygadusol;|2,3,5-Trihydroxy-5-(hydroxymethyl)cyclohex-2-en-1-one",,,,,
C21282,"2-epi-Valiolone;|(2S,3S,4S,5S)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohexan-1-one",,,,,
C21283,3-Indoleacrylate;|(2E)-3-(1H-Indol-3-yl)prop-2-enoate;|3-(Indol-3-yl)acrylate,,,,,
C21284,Fe-coproporphyrin III;|Coproheme III,,,,,
C21285,D-Erythrulose 1-phosphate,,,,,
C21286,L-Erythrulose 4-phosphate,,,,,
C21287,2-Hydroxyisobutanoyl-CoA;|2-Hydroxy-2-methylpropanoyl-CoA,,,,,
C21288,"(2S,3R)-2-Hydroxy-3-(indol-3-yl)butanoate;|Indolmycenate",,,,,
C21289,(R)-3-(Indol-3-yl)-2-oxobutyrate;|(R)-3-(Indol-3-yl)-2-oxobutanoate;|(R)-beta-Methylindolepyruvate,,,,,
C21290,"2-Methylpropane-1,2-diol;|Isobutene glycol",,,,,
C21291,2-Hydroxy-2-methylpropanal;|2-Hydroxyisobutyraldehyde,,,,,
C21292,Maduropeptin chromophore;|(-)-Maduropeptin chromophore,,,,,
C21293,Validamycin B,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21293,
C21294,D-Erythritol 1-phosphate,,,,,
C21295,5-Methylphenazine-1-carboxylate,,,,,
C21296,1alpha-Hydroxytestosterone,,,,,
C21297,2-Hydroxy-2-methylpropanoate;|2-Hydroxyisobutyrate,,,,,
C21298,"2,6-Dihydroxybenzoate;|gamma-Resorcylate",,,,,
C21299,RCH2NHR',Generic compound in reaction hierarchy|R2 = H [CPD:C00375],,,,
C21300,R'NH2,Generic compound in reaction hierarchy|R = H [CPD:C00014]|R = CH3 [CPD: C00218],,,,
C21301,Kedarcidin chromophore,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21301,
C21303,(25R)-26-Hydroxycholest-4-en-3-one,,,,,
C21304,(25S)-26-Oxocholest-4-en-3-one,,,,,
C21305,(25R)-26-Oxocholest-4-en-3-one,,,,,
C21306,"3,4-Dihydro-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",,,,,
C21307,"3,4-Dihydro-7-hydroxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate",,,,,
C21308,(S)-beta-Tyrosine,,,,,
C21309,(S)-beta-Tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C21310,"(8S)-3',8-Cyclo-7,8-dihydroguanosine 5'-triphosphate",,,,,
C21311,3-(4-Hydroxyphenyl)-3-oxopropanoyl-[pcp];|4'-Hydroxyphenyl-3-ketopropionyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C21312,6-Methylsalicylyl-CoA,,,,,
C21313,"3,6-Dimethylsalicylyl-CoA",,,,,
C21314,NDP-D-mannose,,,,,
C21315,NDP-4-oxo-6-deoxy-D-mannose,,,,,
C21316,"NDP-2,6-dideoxy-D-glycero-hex-2-enos-4-ulose",,,,,
C21317,"NDP-2-amino-4-oxo-2,6-dideoxy-D-galactose",,,,,
C21318,"NDP-2-amino-2,6-dideoxy-D-galactose",,,,,
C21319,"NDP-2-methylamino-2,6-dideoxy-D-galactose",,,,,
C21320,"3,6,8-Trihydroxy-2-naphthoate;|3,6,8-Trihydroxy-2-naphthoic acid",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21320  3,6,8-Trihydroxy-2-naphthoate",
C21321,"3,6,7,8-Tetrahydroxy-2-naphthoate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21321  3,6,7,8-Tetrahydroxy-2-naphthoate",
C21322,"3-Hydroxy-6,7,8-trimethoxy-2-naphthoate",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21322  3-Hydroxy-6,7,8-trimethoxy-2-naphthoate",
C21323,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoate;|3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoic acid",,,,"Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1302 Naphthalenes and naphthoquinones|C21323  3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoate",
C21324,"3-Hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA",,,,,
C21325,Azatyrosine;|2-Aza-L-tyrosine,,,,,
C21326,(R)-2-Aza-beta-tyrosine,,,,,
C21327,(R)-2-Aza-beta-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C21328,(R)-2-Aza-3-chloro-beta-tyrosyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C21329,Benzoyl cyanide;|Benzoyl nitrile,,,,,
C21330,Aurachin C,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21330,
C21331,"Aurachin C epoxide;|2-Hydroxy-1a-methyl-7a-[(2E,6E)-farnesyl]-1a,2-dihydrooxireno[2,3-b]quinolin-7(7aH)-one",,,,,
C21332,"8-Dehydro-3-deoxy-D-manno-octulosonate;|3,8-Dideoxy-8-oxo-D-manno-octulosonate",,,,,
C21333,"8-Amino-3,8-dideoxy-D-manno-octulosonate;|Kdo8N",,,,,
C21334,"CMP-8-amino-3,8-dideoxy-beta-D-manno-octulosonate;|CMP-Kdo8N",,,,,
C21335,"1,2-beta-Oligomannan;|1,2-beta-D-Mannooligosaccharide;|[(1->2)-beta-D-Mannosyl]n","Generic compound in reaction hierarchy|beta-1,2-Mannobiose (n=2) [CPD:C21336]|beta-1,2-Mannotriose (n=3) [CPD:C21454]",,,,
C21336,"beta-1,2-Mannobiose;|beta-D-Mannopyranosyl-(1->2)-D-mannopyranose",,,,,
C21337,Calicheamicinone,,,,,
C21338,Calicheamicin T0,,,,,
C21339,4-Deoxy-4-thio-alpha-D-digitoxosyl-calicheamicin T0,,,,,
C21340,Calicheamicin PsAg,,,,,
C21341,Calicheamicin alpha1(I),,,,,
C21342,Calicheamicin alpha3(I),,,,,
C21343,Orsellinate-[acp],,,,,
C21344,2-Methoxyorsellinate-[acp],,,,,
C21345,5-Iodo-2-methoxyorsellinate-[acp],,,,,
C21346,3-Hydroxy-5-iodo-2-methoxyorsellinate-[acp],,,,,
C21347,"5-Iodo-2,3-dimethoxyorsellinate-[acp];|4-Hydroxy-5-iodo-2,3-dimethoxy-6-methylbenzoate-[acp]",,,,,
C21348,"dTDP-4-hydroxyamino-4,6-dideoxy-alpha-D-glucose",,,,,
C21349,dTDP-4-deoxy-4-thio-alpha-D-digitoxose,,,,,
C21350,dTDP-3-O-methyl-beta-L-rhamnose,,,,,
C21351,dTDP-4-oxo-alpha-D-xylose;|dTDP-4-keto-alpha-D-xylose;|dTDP-4-dehydro-alpha-D-xylose,,,,,
C21352,dTDP-4-oxo-2-deoxy-alpha-D-pentos-2-ene;|dTDP-2-deoxy-4-keto-alpha-D-pentos-2-ene,,,,,
C21353,dTDP-4-oxo-2-deoxy-beta-L-xylose;|dTDP-4-keto-2-deoxy-beta-L-xylose;|dTDP-4-dehydro-2-deoxy-beta-L-xylose,,,,,
C21354,"dTDP-4-amino-2,4-dideoxy-beta-L-xylose",,,,,
C21355,"dTDP-4-methylamino-2,4-dideoxy-beta-L-xylose",,,,,
C21356,"dTDP-4-ethylamino-3-O-methyl-2,4-dideoxy-L-threo-pentopyranose",,,,,
C21357,"3-Hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-[acp];|3-Hydroxy-4,6,8,10,12,14-hexadecahexaenoyl-[acp]",,,,,
C21358,"1,3,5,7,9,11,13-Pentadecaheptaene",,,,,
C21361,3-(2-Chloro-3-hydroxy-4-methoxyphenyl)-3-hydroxypropanoyl-[pcp],,,,,
C21362,dTDP-3-methyl-4-oxo-alpha-D-ribopyranose,,,,,
C21363,dTDP-madurosamine;|dTDP-4-amino-3-methyl-4-deoxy-alpha-D-ribopyranose,,,,,
C21364,[Fructose-bisphosphate aldolase]-L-lysine,Generic compound in reaction hierarchy,,,,
C21365,"[Fructose-bisphosphate aldolase]-N6,N6,N6-trimethyl-L-lysine",Generic compound in reaction hierarchy,,,,
C21366,3-O-[N-Acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-(6-phospho)mannosyl]-L-threonyl-[protein];|O3-[N-Acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-(6-phospho)mannosyl]-L-threonyl-[protein],,,,,
C21367,Valienol 1-phosphate,,,,,
C21368,GDP-valienol,,,,,
C21369,N-(2-Methylpropanyl)hydroxylamine;|N-Hydroxy-2-methylpropanamine;|N-(2-Methylpropyl)hydroxylamine;|Isobutylhydroxylamine,,,,,
C21370,(S)-Nandinine,,,,,
C21371,Validone,,,,,
C21372,3-Phosphinomethylmalate;|3-(Hydrohydroxyphosphorylmethyl)malate,,,,,
C21373,"(3R)-3,4-Epoxy-3-methylbut-1-ene",,,,,
C21374,2-(Glutathion-S-yl)-2-methylbut-3-en-1-ol,,,,,
C21375,3-Hydroxy-4-methylanthranilyl-[aryl-carrier protein];|3-Hydroxy-4-methylanthranilyl-[acp],,,,,
C21376,"3,5-Dihydroxy-4-methylanthranilyl-[aryl-carrier protein];|3,5-Dihydroxy-4-methylanthranilyl-[acp]",,,,,
C21377,[F-actin]-L-methionine,,,,,
C21378,[F-actin]-L-methionine-(R)-S-oxide,,,,,
C21379,"(2S,3R)-Flavan-3-ol",Generic compound in reaction hierarchy,,,,
C21380,"(2S,3S)-Flavan-3-ol",Generic compound in reaction hierarchy,,,,
C21381,Anthocyanidin with a 3-hydroxy group,Generic compound in reaction hierarchy,,,,
C21382,"R-THMF;|(2R,4S)-2-Methyl-2,3,3,4-tetrahydroxytetrahydrofuran",,,,,
C21383,3-Deoxy-D-glycero-D-galacto-non-2-ulopyranosonate 9-phosphate;|2-Keto-3-deoxy-D-glycero-D-galacto-nononate 9-phosphate;|3-Deoxy-D-glycero-D-galacto-non-2-ulosonate 9-phosphate;|KDN 9-phosphate,,,,,
C21384,CMP-3-deoxy-D-glycero-D-galacto-non-2-ulopyranosonate;|CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate;|CMP-3-deoxy-D-glycero-beta-D-galacto-non-2-ulosonate;|CMP-KDN,,,,,
C21385,trans-12-Hydroxyjasmonic acid;|trans-12-Hydroxyjasmonate,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C21385  trans-12-Hydroxyjasmonic acid,
C21386,L-Leucyl-L-arginyl-protein;|N-Terminal L-leucyl-L-arginyl-[protein],Generic compound in reaction hierarchy,,,,
C21387,L-Leucyl-L-lysyl-protein;|N-Terminal L-leucyl-L-lysyl-[protein],Generic compound in reaction hierarchy,,,,
C21388,L-Lysyl-protein;|N-Terminal L-lysyl-[protein],Generic compound in reaction hierarchy,,,,
C21389,tert-Butyl alcohol;|tert-Butanol,,,,,
C21390,Butane;|Butan,,,,,
C21391,11a-Hydroxytetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C21391  11a-Hydroxytetracycline,
C21392,Multi-methyl-branched acyl-[acp],,,,,
C21393,"C32-Mycocerosyl-[acp];|(2R,4R,6R,8R)-2,4,6,8-Tetramethyloctacosanoyl-[acp]",,,,,
C21394,"C27-Mycolipanoyl-[acp];|(2S,4S,6S)-2,4,6-Trimethyltetracosanoyl-[acp]",,,,,
C21395,"dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-D-glucose;|dTDP-4-(methylamino)-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranose",,,,,
C21396,Ethylenediaminetriacetic acid;|Ethylenediaminetriacetate;|ED3A,,,,,
C21397,"Ethylenediamine-N,N'-diacetic acid;|Ethylenediaminediacetate;|EDDA",,,,,
C21398,Methanesulfinic acid;|Methanesulfinate,,,,,
C21399,Isocaproate;|4-Methylpentanoate,,,,,
C21400,Isocaproyl-CoA;|4-Methylpentanoyl-CoA,,,,,
C21401,tert-Amyl alcohol;|2-Methyl-2-butanol;|TAA,,,,,
C21402,Isoprenyl alcohol;|2-Methyl-3-buten-2-ol,,,,,
C21403,2-Acetamidoethylphosphonate,,,,,
C21404,N-Ethylacetamide,,,,,
C21405,"(4aS,10bR)-Noroxomaritidine",,,,,
C21406,"(4aR,10bS)-Noroxomaritidine",,,,,
C21407,7-(Hydroxymethyl)bacteriochlorophyllide c,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C21408,"(1R,6R)-1,4,5,5a,6,9-Hexahydrophenazine-1,6-dicarboxylate",,,,,
C21409,"(1R,10aS)-1,4,10,10a-Tetrahydrophenazine-1,6-dicarboxylate",,,,,
C21410,"(5aS)-5,5a-Dihydrophenazine-1,6-dicarboxylate",,,,,
C21411,"(1R,10aS)-1,4,10,10a-Tetrahydrophenazine-1-carboxylate",,,,,
C21412,"(10aS)-10,10a-Dihydrophenazine-1-carboxylate",,,,,
C21413,"(1R)-1,4,5,10-Tetrahydrophenazine-1-carboxylate",,,,,
C21414,"Naphthalene-1,2,4,8-tetrol",,,,,
C21415,Valienol 7-phosphate,,,,,
C21416,"2-Amino-1,5-anhydro-2-deoxyglucitol",,,,,
C21417,"(2R,3R)-Dihydroflavonol",Generic compound in reaction hierarchy,,,,
C21418,"(2R,3S,4S)-Leucoanthocyanidin;|(2R,3S,4S)-Flavan-3,4-diol",Generic compound in reaction hierarchy,,,,
C21419,"1-(3,4-Dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol",,,,,
C21420,"(3,4-Dimethoxyphenyl)methanol;|Veratryl alcohol;|3,4-Dimethoxybenzyl alcohol",,,,,
C21421,"(3,4-Dimethoxyphenyl)methanol radical",,,,,
C21422,"1-(4-Hydroxy-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol",,,,,
C21423,"1,2-Dihydro-beta-NAD",,,,,
C21424,"1,6-Dihydro-beta-NAD",,,,,
C21425,"Abieta-8,11,13-triene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010405 Abietane diterpenoids|C21425  Abieta-8,11,13-triene",
C21426,3-Vinyl bacteriochlorophyllide d,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C21427,"8,12-Diethyl-3-vinylbacteriochlorophyllide d",,,,,
C21428,12-Ethyl-8-propyl-3-vinylbacteriochlorophyllide d,,,,,
C21429,12-Ethyl-8-isobutyl-3-vinylbacteriochlorophyllide d,,,,,
C21430,Malonamoyl-[acyl-carrier protein];|Malonamoyl-[acp],Generic compound in reaction hierarchy|R = acyl-carrier protein,,,,
C21431,8-Ethyl-12-methylbacteriochlorophyllide d,,,,,
C21432,"8,12-Diethylbacteriochlorophyllide d",,,,,
C21433,12-Ethyl-8-propylbacteriochlorophyllide d,,,,,
C21434,12-Ethyl-8-isobutylbacteriochlorophyllide d,,,,,
C21435,Geranylgeranyl bacteriochlorophyllide b,,,,,
C21436,4-Methylamino-4-de(dimethylamino)anhydrotetracycline,,,,,
C21437,[Sulfur-carrier protein]-Gly-Gly-L-Cys;|[Sulfur-carrier protein]-L-cysteine,Generic compound in reaction hierarchy,,,,
C21438,11a-Hydroxyoxytetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C21438  11a-Hydroxyoxytetracycline,
C21439,11a-Hydroxy-7-chlortetracycline,,,,Lipids [BR:br08002]|PK  Polyketides|PK07 Linear tetracyclines|C21439  11a-Hydroxy-7-chlortetracycline,
C21440,[Protein]-S-sulfanyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C21441,Bacteriochlorophyllide g,,,,,
C21442,Phenazine-1-carboxylate,,,,,
C21443,N-Demethylindolmycin,,,,,
C21444,Indolmycin,,,,,
C21445,17-(4-Hydroxyphenyl)heptadecanoyl adenylate,,,,,
C21446,17-(4-Hydroxyphenyl)heptadecanoate,,,,,
C21447,19-(4-Hydroxyphenyl)nonadecanoyl adenylate,,,,,
C21448,19-(4-Hydroxyphenyl)nonadecanoate,,,,,
C21449,Lithocholoyl-CoA,,,,,
C21450,4-(2-Hydroxyethoxycarbonyl)benzoate;|4-[(2-Hydroxyethoxy)carbonyl]benzoate;|Mono(2-hydroxyethyl) terephthalate;|Mono(ethylene terephthalate),,,,,
C21451,Poly(ethylene terephthalate);|Polyethylene terephthalate;|(Ethylene terephthalate)n,,,,,
C21452,(2-Aminobenzoyl)acetyl-CoA;|2-Aminobenzoylacetyl-CoA,,,,,
C21453,(2-Aminobenzoyl)acetate;|2-Aminobenzoylacetate,,,,,
C21454,"beta-1,2-Mannotriose;|beta-D-Mannopyranosyl-(1->2)-beta-D-mannopyranosyl-(1->2)-D-mannopyranose",,,,,
C21455,L-Leucyl-L-glutamyl-protein;|N-Terminal L-leucyl-L-glutamyl-[protein],,,,,
C21456,L-Glutamyl-protein;|N-Terminal L-glutamyl-[protein],,,,,
C21457,L-Leucyl-L-aspartyl-protein;|N-Terminal L-leucyl-L-aspartyl-[protein],,,,,
C21458,L-Aspartyl-protein;|N-Terminal L-aspartyl-[protein],,,,,
C21459,6-Hydroxyferuloyl-CoA,,,,,
C21460,(3-Hydroxy-4-methylanthranilyl)adenylate;|3-Hydroxy-4-methylanthraniloyl-AMP;|2-Amino-3-hydroxy-4-methylbenzoyl-AMP,,,,,
C21461,KDO2-lipid A 1-(2-aminoethyl diphosphate),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21461  KDO2-lipid A 1-(2-aminoethyl diphosphate),
C21462,KDO2-lipid A 4'-(2-aminoethyl diphosphate),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21462  KDO2-lipid A 4'-(2-aminoethyl diphosphate),
C21463,"KDO2-lipid A 1,4'-bis(2-aminoethyl diphosphate)",,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21463  KDO2-lipid A 1,4'-bis(2-aminoethyl diphosphate)",
C21464,"4-O-[(2R)-1-Glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C21464  4-O-[(2R)-1-Glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",G13165
C21465,L-Asparaginyl-protein;|N-Terminal L-asparaginyl-[protein],,,,,
C21466,Protein Nomega-(1-hydroxy-2-oxopropyl)-L-arginine;|[Protein]-Nomega-(1-hydroxy-2-oxopropyl)-L-arginine,,,,,
C21467,Protein N6-(1-hydroxy-2-oxopropyl)-L-lysine;|[Protein]-N6-(1-hydroxy-2-oxopropyl)-L-lysine,,,,,
C21468,Protein S-(1-hydroxy-2-oxopropyl)-L-cysteine;|[Protein]-S-(1-hydroxy-2-oxopropyl)-L-cysteine,,,,,
C21469,"7alpha,12alpha-Dihydroxy-3-oxochol-4-en-24-oyl-CoA",,,,,
C21470,"12alpha-Hydroxy-3-oxochola-4,6-dien-24-oyl-CoA",,,,,
C21471,7alpha-Hydroxy-3-oxochol-4-en-24-oyl-CoA;|3-Oxo-Delta4-chenodeoxycholyl-CoA,,,,,
C21472,"3-Oxochola-4,6-dien-24-oyl-CoA;|3-Oxo-Delta4,6-lithocholyl-CoA",,,,,
C21473,"(1R,5aS,6R)-4a-Hydroxy-1,4,4a,5,5a,6,9,10a-octahydrophenazine-1,6-dicarboxylate",,,,,
C21474,"5,10-Dihydrophenazine-1,6-dicarboxylate",,,,,
C21475,"5,10-Dihydrophenazine",,,,,
C21476,Phenazine;|Dibenzopyrazine;|Acridizine,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21476,
C21477,1-Hydroxyphenazine,,,,,
C21478,Erastin,,,,,
C21479,"RSL3;|(1S,3R)-RSL3",,,,,
C21480,"1-Octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0201 Diacylglycerophosphoethanolamines|C21480  1-Octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine",
C21481,"1-Octadecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0201 Diacylglycerophosphoethanolamines|C21481  1-Octadecanoyl-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoethanolamine",
C21482,"1-Octadecanoyl-2-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine;|18:0/15-HETE-PE",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2002 Oxidized glycerophosphoethanolamines|C21482  1-Octadecanoyl-2-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine",
C21483,"1-Octadecanoyl-2-(15S-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine;|18:0/15-HpETE-PE",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP20 Oxidized glycerophospholipids|GP2002 Oxidized glycerophosphoethanolamines|C21483  1-Octadecanoyl-2-(15S-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine",
C21484,1-Octadecanoyl-sn-glycero-3-phosphoethanolamine,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP02 Glycerophosphoethanolamines|GP0205 Monoacylglycerophosphoethanolamines|C21484  1-Octadecanoyl-sn-glycero-3-phosphoethanolamine,
C21485,Cytidylyl molybdenum cofactor;|Molybdopterin cytosine dinucleotide cofactor,,,,,
C21486,Thio-molybdenum cofactor,,,,,
C21487,L-Cysteinyl-protein;|L-Cysteinyl-[PCP];|L-Cysteinyl-[peptidyl-carrier protein],Generic compound in reaction hierarchy,,,,
C21488,S-Anthraniloyl-L-cysteinyl-protein,Generic compound in reaction hierarchy,,,,
C21489,S-Octanoyl-L-cysteinyl-protein,Generic compound in reaction hierarchy,,,,
C21490,"1-(2-Aminophenyl)decane-1,3-dione",,,,,
C21491,(S)-Tembetarine,,,,,
C21492,4'-O-Methylxanthohumol,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C21492  4'-O-Methylxanthohumol,
C21493,"alpha-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C21493  alpha-D-Gal-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C21494,alpha-L-Fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-R,Generic compound in reaction hierarchy,,,,
C21495,8-Geranylumbelliferone,,,,,
C21496,8-Geranylesculetin,,,,,
C21497,4-Hydroxybenzoyl-adenylate;|4-Hydroxybenzoyl-AMP,,,,,
C21498,2-Acylphloroglucinol,Generic compound in reaction hierarchy,,,,
C21499,2-Acyl-4-prenylphloroglucinol,Generic compound in reaction hierarchy,,,,
C21500,"2-Acyl-4,6-bisprenylphloroglucinol;|2-Acyl-4,6-bis(prenyl)phloroglucinol",Generic compound in reaction hierarchy,,,,
C21501,"2-Acyl-4,6,6-trisprenylcyclohexa-2,4-dien-1-one;|2-Acyl-4,6,6-tris(prenyl)cyclohexa-2,4-dien-1-one;|beta-Bitter acid",Generic compound in reaction hierarchy,,,,
C21502,"4-O-Di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13172
C21503,"4-O-[1-D-Ribitylphospho-(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13168
C21504,"4-O-[(1-D-Ribitylphospho)n-(1-D-ribitylphospho)-(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13169
C21505,4-Hydroxybenzoyl-[acp];|4-Hydroxybenzoyl-[acyl-carrier protein],,,,,
C21506,17-(4-Hydroxyphenyl)heptadecanoyl-[acp];|17-(4-Hydroxyphenyl)heptadecanoyl-[acyl-carrier protein],,,,,
C21507,19-(4-Hydroxyphenyl)nonadecanoyl-[acp];|19-(4-Hydroxyphenyl)nonadecanoyl-[acyl-carrier protein],,,,,
C21508,"4-O-(D-Ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13173
C21509,Jasmonoyl-L-amino acid,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0202 Jasmonic acids|C21509  Jasmonoyl-L-amino acid,
C21510,Nickel-sirohydrochlorin;|Ni-sirohydrochlorin,,,,,
C21511,"Nickel-sirohydrochlorin a,c-diamide;|Ni-sirohydrochlorin a,c-diamide",,,,,
C21512,"15,17(3)-Seco-F430-17(3)-acid",,,,,
C21513,Turicine;|(+)-Turicine;|cis-4-Hydroxy-D-proline betaine,,,,,
C21514,D-Proline betaine,,,,,
C21515,Trandolaprilat,,,,Prodrugs [br08324.html]|C21515,
C21516,Paliperidone;|9-Hydroxyrisperidone,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D05339)]|N NERVOUS SYSTEM|N05 PSYCHOLEPTICS|N05A ANTIPSYCHOTICS|N05AX Other antipsychotics|N05AX13 Paliperidone|D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D05339)]|Antipsychotics|2nd Generation/Atypical|Paliperidone|D05339  Paliperidone (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D05339)]|1  Agents affecting nervous system and sensory organs|11  Agents affecting central nervous system|117  Psychotropics|1179  Others|D05339  Paliperidone (JAN/USP/INN)|Drug groups [BR:br08330(D05339)]|Neuropsychiatric agent|DG01478  Dopamine antagonist|DG01474  Dopamine D2-receptor antagonist|DG00907  Paliperidone|D05339  Paliperidone|DG03005  Serotonin-dopamine antagonist (SDA)|DG00907  Paliperidone|D05339  Paliperidone|DG03200  Antipsychotic agent|DG03064  Atypical antipsychotic|DG00907  Paliperidone|D05339  Paliperidone|Target-based classification of drugs [BR:br08310(D05339)]|G Protein-coupled receptors|Rhodopsin family|Dopamine|DRD2|D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;|Serotonin|HTR2A|D05339  Paliperidone (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D05339)]|New molecular entities and new therapeutic biological products|D05339|New drug approvals in Europe [br08329.html(D05339)]|European public assessment reports (EPAR) authorised medicine|D05339|New drug approvals in Japan [br08318.html(D05339)]|Drugs with new active ingredients|D05339|New drug approvals in the USA, Europe and Japan [br08328.html(D05339)]|Approval dates by FDA, EMA and PMDA|D05339|Prodrugs [br08324.html(D05339)]|D05339|Prodrugs [br08324.html]|C21516",
C21517,Perindoprilat,,,,Prodrugs [br08324.html]|C21517,
C21518,Tazarotenic acid;|AGN 190299,,,,Prodrugs [br08324.html]|C21518,
C21519,Imidaprilat,,,,Prodrugs [br08324.html]|C21519,
C21520,18-502;|4-(2-Hydroxy-3-tert-butylaminopropoxy)-2-methylindole;|4-(3-t-Butylamino-2-hydroxypropoxy)-2-methylindole,Active metabolite of bopindolol,,,Prodrugs [br08324.html]|C21520,
C21521,"Deglymidodrine;|Desglymidodrine;|DMAE;|2-Amino-1-(2,5-dimethoxyphenyl)ethanol",,,,Prodrugs [br08324.html]|C21521,
C21522,Tebipenem,,,,Prodrugs [br08324.html]|C21522,
C21523,L-Tagatose,,,,,
C21524,D-Altritol,,,,,
C21525,2-Methylbutanenitrile,,,,,
C21526,Menaquinone-9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C21526  Menaquinone-9,
C21527,"beta-Dihydromenaquinone-9;|MK-9(II-H2);|2-Methyl-3-[(2E,10E,14E,18E,22E,26E,30E,33E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,10,14,18,22,26,30,33-octaen-1-yl]naphthalene-1,4-dione",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C21527  beta-Dihydromenaquinone-9,
C21528,"(9Z,12Z)-Hexadeca-9,12,15-trienoyl-CoA",,,,,
C21529,"Linoleoyl-[glycerolipid];|(9Z,12Z)-Octadeca-9,12-dienoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C21530,"Pinolenoyl-[glycerolipid];|(5Z,9Z,12Z)-Octadeca-5,9,12-trienoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C21531,"alpha-Linolenoyl-[glycerolipid];|(9Z,12Z,15Z)-Octadeca-9,12,15-trienoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C21532,"Coniferonoyl-[glycerolipid];|(5Z,9Z,12Z,15Z)-Octadeca-5,9,12,15-tetraenoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C21533,Deacetylalacepril;|Desacetyl-alacepril;|Desacetylalacepril,,,,,
C21534,L-Polyhomomethionine,Generic compound in reaction hierarchy,,,,
C21535,omega-(Methylthio)-(E)-alkanal oxime;|(E)-omega-(Methylthio)alkanal oxime;|(E)-omega-(Methylsulfanyl)alkanal oxime,Generic compound in reaction hierarchy,,,,
C21536,L-N-Hydroxypolyhomomethionine,Generic compound in reaction hierarchy,,,,
C21537,"L-N,N-Dihydroxypolyhomomethionine",Generic compound in reaction hierarchy,,,,
C21538,1-aci-Nitro-omega-(methylthio)alkane;|1-(Methylsulfanyl)-4-aci-nitroalkane,Generic compound in reaction hierarchy,,,,
C21539,(E)-1-(Glutathione-S-yl)-omega-(methylthio)alkylhydroximate;|S-[(1E)-1-(Hydroxyimino)-omega-(methylsulfanyl)alkyl]-L-glutathione,Generic compound in reaction hierarchy,,,,
C21540,Quinaprilat,,,,Drug groups [BR:br08330(D03773)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|D03773  Quinaprilat|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|D03773  Quinaprilat|Target-based classification of drugs [BR:br08310(D03773)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D03773  Quinaprilat (USAN/INN)|Prodrugs [br08324.html(D03773)]|D03773|Prodrugs [br08324.html]|C21540,
C21541,Benazeprilat,,,,Drug groups [BR:br08330(D03077)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|D03077  Benazeprilat|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|D03077  Benazeprilat|Target-based classification of drugs [BR:br08310(D03077)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D03077  Benazeprilat (USAN/INN)|Prodrugs [br08324.html(D03077)]|D03077|Prodrugs [br08324.html]|C21541,
C21542,Fosinoprilat,,,,Drug groups [BR:br08330(D03772)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01501  Angiotensin-converting enzyme inhibitor|D03772  Fosinoprilat|DG03231  Antihypertensive|DG01501  Angiotensin-converting enzyme inhibitor|D03772  Fosinoprilat|Target-based classification of drugs [BR:br08310(D03772)]|Enzymes|Hydrolases (EC3)|Peptidyl-dipeptidases|ACE (CD143)|D03772  Fosinoprilat (USAN/INN)|Prodrugs [br08324.html(D03772)]|D03772|Prodrugs [br08324.html]|C21542,
C21543,Olmesartan,,,,Drug groups [BR:br08330(D05246)]|Cardiovascular agent|DG01925  Renin-angiotensin system inhibitor|DG01495  Angiotensin II receptor antagonist|DG01544  Olmesartan|D05246  Olmesartan|DG03231  Antihypertensive|DG01495  Angiotensin II receptor antagonist|DG01544  Olmesartan|D05246  Olmesartan|Transporter substrate|DG01665  ABCB1 substrate|DG01544  Olmesartan|D05246  Olmesartan|DG02861  ABCC2 substrate|DG01544  Olmesartan|D05246  Olmesartan|DG01913  ABCG2 substrate|DG01544  Olmesartan|D05246  Olmesartan|Target-based classification of drugs [BR:br08310(D05246)]|G Protein-coupled receptors|Rhodopsin family|Angiotensin|AGTR1|D05246  Olmesartan (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D05246)]|Drug transporters|D05246|Prodrugs [br08324.html(D05246)]|D05246|Prodrugs [br08324.html]|C21543,
C21544,Cefotiam,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07648)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DC Second-generation cephalosporins|J01DC07 Cefotiam|D07648  Cefotiam (INN)|Drug groups [BR:br08330(D07648)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00563  Cefotiam|D07648  Cefotiam|DG01775  Second-generation cephalosporin|DG00563  Cefotiam|D07648  Cefotiam|Antimicrobials [BR:br08307(D07648)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Second-generation cephalosporin|D07648  Cefotiam (INN)|Prodrugs [br08324.html(D07648)]|D07648|Prodrugs [br08324.html]|C21544",
C21545,Mecillinam;|Amdinocillin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02888)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS|J01CA Penicillins with extended spectrum|J01CA11 Mecillinam|D02888  Amdinocillin (USAN)|Drug groups [BR:br08330(D02888)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01713  Penicillin skeleton group|DG01480  Penicillin|D02888  Amdinocillin|DG01780  Extended spectrum penicillin|D02888  Amdinocillin|Antimicrobials [BR:br08307(D02888)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02888  Amdinocillin (USAN)|Antimicrobials abbreviations [BR:br08327(D02888)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Extended spectrum penicillin|D02888  Amdinocillin (USAN)|Prodrugs [br08324.html(D02888)]|D02888|Prodrugs [br08324.html]|C21545",
C21546,Cefditoren,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07639)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD16 Cefditoren|D07639  Cefditoren (INN)|Drug groups [BR:br08330(D07639)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00584  Cefditoren|D07639  Cefditoren|DG01776  Third-generation cephalosporin|DG00584  Cefditoren|D07639  Cefditoren|DG01804  Oxyimino beta-lactam|DG00584  Cefditoren|D07639  Cefditoren|Antimicrobials [BR:br08307(D07639)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07639  Cefditoren (INN)|Prodrugs [br08324.html(D07639)]|D07639|Prodrugs [br08324.html]|C21546",
C21547,Cefcapene;|CFPN,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07638)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD17 Cefcapene|D07638  Cefcapene (INN)|Drug groups [BR:br08330(D07638)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG00585  Cefcapene|D07638  Cefcapene|DG01776  Third-generation cephalosporin|DG00585  Cefcapene|D07638  Cefcapene|Antimicrobials [BR:br08307(D07638)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07638  Cefcapene (INN)|Prodrugs [br08324.html(D07638)]|D07638|Prodrugs [br08324.html]|C21547",
C21548,Cefteram;|CFTM;|T-2525,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07655)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J01 ANTIBACTERIALS FOR SYSTEMIC USE|J01D OTHER BETA-LACTAM ANTIBACTERIALS|J01DD Third-generation cephalosporins|J01DD18 Cefteram|D07655  Cefteram (INN)|Drug groups [BR:br08330(D07655)]|Antibacterial|DG01710  beta-Lactam antibiotic|DG01714  Cephalosporin skeleton group|DG01488  Cephem|DG01208  Cefteram|D07655  Cefteram|DG01804  Oxyimino beta-lactam|DG01208  Cefteram|D07655  Cefteram|Antimicrobials [BR:br08307(D07655)]|Antibacterials|Cell wall biosynthesis inhibitor, beta-lactam|Third-generation cephalosporin|D07655  Cefteram (INN)|Prodrugs [br08324.html(D07655)]|D07655|Prodrugs [br08324.html]|C21548",
C21549,Miproxifene;|DP-TAT-59,,,,Prodrugs [br08324.html]|C21549,
C21550,Fludarabine;|2F-Ara-A,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07966)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01B ANTIMETABOLITES|L01BB Purine analogues|L01BB05 Fludarabine|D07966  Fludarabine (INN)|Drug groups [BR:br08330(D07966)]|Antineoplastic|DG02018  Antimetabolite|DG01958  Nucleic acid derivative, antineoplastic|DG01439  Arabinofuranosyl type antineoplastic|DG00685  Fludarabine|D07966  Fludarabine|Target-based classification of drugs [BR:br08310(D07966)]|Enzymes|Oxidoreductases (EC1)|Ribonucleoside-diphosphate reductase|RRM1|D07966  Fludarabine (INN)|Prodrugs [br08324.html(D07966)]|D07966|Prodrugs [br08324.html]|C21550",
C21551,Melagatran,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07143)]|B BLOOD AND BLOOD FORMING ORGANS|B01 ANTITHROMBOTIC AGENTS|B01A ANTITHROMBOTIC AGENTS|B01AE Direct thrombin inhibitors|B01AE04 Melagatran|D07143  Melagatran (INN)|Drug groups [BR:br08330(D07143)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01511  Thrombin inhibitor|D07143  Melagatran|Target-based classification of drugs [BR:br08310(D07143)]|Enzymes|Hydrolases (EC3)|Serine peptidases|F2|D07143  Melagatran (INN)|Prodrugs [br08324.html(D07143)]|D07143|Prodrugs [br08324.html]|C21551,
C21552,Valdecoxib,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02709)]|M MUSCULO-SKELETAL SYSTEM|M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS|M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS|M01AH Coxibs|M01AH03 Valdecoxib|D02709  Valdecoxib (USAN/INN)|Drug groups [BR:br08330(D02709)]|Anti-inflammatory|DG01504  Nonsteroidal anti-inflammatory drug (NSAID)|DG01922  Selective COX2 inhibitor|DG01907  Anti-inflammatory drug, coxibs|D02709  Valdecoxib|Target-based classification of drugs [BR:br08310(D02709)]|Enzymes|Oxidoreductases (EC1)|Prostaglandin synthase|PTGS2 (COX2)|D02709  Valdecoxib (USAN/INN)|New drug approvals in the USA [br08319.html(D02709)]|New molecular entities and new therapeutic biological products|D02709|New drug approvals in the USA, Europe and Japan [br08328.html(D02709)]|Approval dates by FDA, EMA and PMDA|D02709|Prodrugs [br08324.html(D02709)]|D02709|Prodrugs [br08324.html]|C21552",
C21553,Fluocortin,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07972)]|D DERMATOLOGICALS|D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS|D07A CORTICOSTEROIDS, PLAIN|D07AB Corticosteroids, moderately potent (group II)|D07AB04 Fluocortin|D07972  Fluocortin (INN)|Drug groups [BR:br08330(D07972)]|Anti-inflammatory|DG01955  Corticosteroid|DG02068  Glucocorticoid|DG00413  Fluocortin|D07972  Fluocortin|Target-based classification of drugs [BR:br08310(D07972)]|Nuclear receptors|Estrogen like receptors|3-Ketosteroid receptor|NR3C1 (GR)|D07972  Fluocortin (INN)",
C21554,Torcitabine;|L-dC;|2'-Deoxy-beta-L-cytidine;|beta-L-2'-Deoxycytidine,,,,Drug groups [BR:br08330(D06196)]|Antiviral|DG01440  Arabinofuranosyl type antiviral|D06196  Torcitabine|Antimicrobials [BR:br08307(D06196)]|Antivirals|Genome replication inhibitor|HBV reverse transcriptase inhibitor|D06196  Torcitabine (USAN/INN)|Prodrugs [br08324.html(D06196)]|D06196|Prodrugs [br08324.html]|C21554,
C21555,Aprepitant,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D02968)]|A ALIMENTARY TRACT AND METABOLISM|A04 ANTIEMETICS AND ANTINAUSEANTS|A04A ANTIEMETICS AND ANTINAUSEANTS|A04AD Other antiemetics|A04AD12 Aprepitant|D02968  Aprepitant (JAN/USP/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D02968)]|Antiemetics|Emetogenic Therapy Adjuncts|Aprepitant|D02968  Aprepitant (JAN/USP/INN)|Therapeutic category of drugs in Japan [BR:br08301(D02968)]|2  Agents affecting individual organs|23  Digestive organ agents|239  Miscellaneous|2391  Antiemetics|D02968  Aprepitant (JAN/USP/INN)|Drug groups [BR:br08330(D02968)]|Gastrointestinal agent|DG01762  Antiemetic|DG00066  Aprepitant|D02968  Aprepitant|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG02913  CYP3A4 substrate|DG00066  Aprepitant|D02968  Aprepitant|Metabolizing enzyme inhibitor|DG02852  CYP3A/CYP3A4 inhibitor|DG01522  CYP3A4 inhibitor|DG00066  Aprepitant|D02968  Aprepitant|Metabolizing enzyme inducer|DG02886  CYP2C9 inducer|DG00066  Aprepitant|D02968  Aprepitant|DG02853  CYP3A/CYP3A4 inducer|DG01635  CYP3A4 inducer|DG00066  Aprepitant|D02968  Aprepitant|Target-based classification of drugs [BR:br08310(D02968)]|G Protein-coupled receptors|Rhodopsin family|Tachykinin|TACR1 (NK1R)|D02968  Aprepitant (JAN/USP/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D02968)]|New molecular entities and new therapeutic biological products|D02968|New drug approvals in Europe [br08329.html(D02968)]|European public assessment reports (EPAR) authorised medicine|D02968|New drug approvals in Japan [br08318.html(D02968)]|Drugs with new active ingredients|D02968|New drug approvals in the USA, Europe and Japan [br08328.html(D02968)]|Approval dates by FDA, EMA and PMDA|D02968|Drug metabolizing enzymes and transporters [br08309.html(D02968)]|Drug metabolizing enzymes|D02968|Prodrugs [br08324.html(D02968)]|D02968|Prodrugs [br08324.html]|C21555",
C21556,Dabigatran,,,,Drug groups [BR:br08330(D09707)]|Blood modifier agent|DG01950  Antithrombotic agent|DG01511  Thrombin inhibitor|DG00164  Dabigatran|D09707  Dabigatran|DG03320  Direct oral anticoagulant (DOAC)|DG00164  Dabigatran|D09707  Dabigatran|Transporter substrate|DG01665  ABCB1 substrate|DG00164  Dabigatran|D09707  Dabigatran|Target-based classification of drugs [BR:br08310(D09707)]|Enzymes|Hydrolases (EC3)|Serine peptidases|F2|D09707  Dabigatran (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D09707)]|Drug transporters|D09707|Prodrugs [br08324.html(D09707)]|D09707|Prodrugs [br08324.html]|C21556,
C21557,Laninamivir,,,,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D09410)]|J ANTIINFECTIVES FOR SYSTEMIC USE|J05 ANTIVIRALS FOR SYSTEMIC USE|J05A DIRECT ACTING ANTIVIRALS|J05AH Neuraminidase inhibitors|J05AH04 Laninamivir|D09410  Laninamivir (INN)|Drug groups [BR:br08330(D09410)]|Antiviral|DG03029  Anti-influenza virus agent|DG02842  Neuraminidase inhibitor|DG01201  Laninamivir|D09410  Laninamivir|Antimicrobials [BR:br08307(D09410)]|Antivirals|Virus release inhibitor|Neuraminidase inhibitor|D09410  Laninamivir (INN)|Prodrugs [br08324.html(D09410)]|D09410|Prodrugs [br08324.html]|C21557,
C21558,Temsavir;|BMS-626529,,,,"Drug groups [BR:br08330(D10734)]|Metabolizing enzyme substrate|DG01633  CYP3A/CYP3A4 substrate|DG01860  Temsavir|D10734  Temsavir|Transporter substrate|DG01665  ABCB1 substrate|DG01860  Temsavir|D10734  Temsavir|DG01913  ABCG2 substrate|DG01860  Temsavir|D10734  Temsavir|Transporter inhibitor|DG02862  ABCG2 inhibitor|DG01860  Temsavir|D10734  Temsavir|DG02865  SLCO1B1 inhibitor|DG01860  Temsavir|D10734  Temsavir|DG02907  SLCO1B3 inhibitor|DG01860  Temsavir|D10734  Temsavir|Antimicrobials [BR:br08307(D10734)]|Antivirals|Entry, fusion or uncoating inhibitor|HIV gp41/gp120|D10734  Temsavir (USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D10734)]|Drug metabolizing enzymes|D10734|Drug transporters|D10734|Prodrugs [br08324.html(D10734)]|D10734|Prodrugs [br08324.html]|C21558",
C21559,N-[(2S)-2-Amino-2-carboxyethyl]-L-glutamate,,,,,
C21560,"ent-Sandaracopimaradien-3beta-ol;|(3R,4aR,4bR,7S,10aS)-7-Ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthren-2-ol",,,,,
C21561,"Oryzalexin E;|ent-Sandaracopimaradiene-3beta,9alpha-diol;|(3R,4aR,4bS,7S,10aR)-7-Ethenyl-1,1,4a,7-tetramethyl-1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydrophenanthren-2,4b-diol",,,,,
C21562,"Oryzalexin D;|ent-Sandaracopimaradiene-3beta,7alpha-diol",,,,,
C21563,2-(Glutathione-S-yl)-hydroquinone,,,,,
C21564,"[(1->4)-N-Acetyl-beta-D-glucosaminyl]n-(1->4)-N-acetyl-2-deoxy-2-amino-D-glucono-1,5-lactone",,,,,
C21565,"Prodigiosin;|4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)-2,2'-bipyrrole",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21565,
C21566,6-O-Methyldeacetylisoipecoside;|6-O-Methyl-N-deacetylisoipecoside,,,,,
C21567,Pyrrolyl-2-carboxyl-S-[acyl-carrier protein];|Pyrrolyl-2-carboxyl-S-[acp],Generic compound in reaction hierarchy|R = acyl-carrier protein,,,,
C21568,"4-Hydroxy-2,2'-bipyrrole-5-methanol",,,,,
C21569,"4-Hydroxy-2,2'-bipyrrole-5-carbaldehyde",,,,,
C21570,"4-Methoxy-2,2'-bipyrrole-5-carbaldehyde;|4-Methoxy-2,2'-bipyrrole-5-carboxaldehyde",,,,,
C21571,2-Methyl-3-n-amyl-dihydropyrrole,,,,,
C21572,2-Methyl-3-n-amyl-pyrrole;|2-Methyl-3-pentylpyrrole;|2-Methyl-3-amylpyrrole,,,,,
C21573,"4-Keto-2-undecylpyrroline;|4-Keto-2-undecyl-4,5-dihydropyrrole",,,,,
C21574,2-Undecylpyrrole,,,,,
C21575,Delaprilat,,,,Prodrugs [br08324.html]|C21575,
C21576,Zofenoprilat,,,,Prodrugs [br08324.html]|C21576,
C21577,"LY404039;|(1R,4S,5S,6S)-4-Amino-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid 2,2-dioxide",,,,Prodrugs [br08324.html]|C21577,
C21578,Bromo-isophosphoramide mustard;|Bromo-IPM;|Br-IPM,,,,Prodrugs [br08324.html]|C21578,
C21579,12ADT;|8-O-(12-Aminododecanoyl)-8-O-debutanoyl thapsigargin,,,,,
C21580,12ADT-Asp,,,,Prodrugs [br08324.html]|C21580,
C21581,Simvastatin acid;|Tenivastatin,,,,Prodrugs [br08324.html]|C21581,
C21582,Bacteriochlorophyllide e,Generic compound in reaction hierarchy|R1 = ethyl or propyl or isobutyl or neopentyl|R2 = methyl or ethyl,,,,
C21583,6-O-Methyl-N-deacetylisoipecoside aglycon,,,,,
C21584,7'-O-Demethylcephaeline,,,,,
C21585,4-Phospho-D-threonate,,,,,
C21586,(S)-1-Hydroxy-cis-N-methylcanadine,,,,,
C21587,"(13S,14R)-1,13-Dihydroxy-cis-N-methylcanadine",,,,,
C21588,"(13S,14R)-13-O-Acetyl-1-hydroxy-cis-N-methylcanadine",,,,,
C21589,"(13S,14R)-13-O-Acetyl-1,8-dihydroxy-cis-N-methylcanadine",,,,,
C21590,4'-O-Desmethyl-3-O-acetylpapaveroxine;|3-O-Acetyl-4'-O-demethylpapaveroxine,,,,,
C21591,3-O-Acetylpapaveroxine,,,,,
C21592,Ceftizoxime alapivoxil,,,,Prodrugs [br08324.html]|C21592,
C21593,"D-Erythronate;|(2R,3R)-2,3,4-Trihydroxybutanoate",,,,,
C21594,Clindamycin palmitate,,,,Glycosides [BR:br08021]|S-glycosides|C21594  Clindamycin palmitate|Prodrugs [br08324.html]|C21594,
C21595,Erythromycin 2'-acetate;|2'-Acetylerythromycin;|2'-O-Acetylerythromycin A,,,,Lipids [BR:br08002]|PK  Polyketides|PK04 Macrolides and lactone polyketides|C21595  Erythromycin 2'-acetate|Prodrugs [br08324.html]|C21595,
C21596,Cytarabine ocfosphate;|Fosteabine,,,,,
C21598,Laninamivir octanoate,,,,Prodrugs [br08324.html]|C21598,
C21599,4'-O-Desmethylpapaveroxine,,,,,
C21600,Narcotoline hemiacetal,,,,,
C21601,3-(Aminomethyl)indole;|(1H-Indol-3-yl)methanamine,,,,,
C21602,(1H-Indol-3-yl)-N-methylmethanamine,,,,,
C21603,Anaerobilin,,,,,
C21604,(3S)-6-Acetamido-3-aminohexanoate,,,,,
C21605,Arbaclofen;|(R)-Baclofen,,,,Drug groups [BR:br08330(D09791)]|Neuropsychiatric agent|DG01565  GABA-B receptor agonist|DG01354  Arbaclofen|D09791  Arbaclofen|Target-based classification of drugs [BR:br08310(D09791)]|G Protein-coupled receptors|Metabotropic glutamate receptor family|GABA (metabotropic)|GABBR|D09791  Arbaclofen (USAN)|Prodrugs [br08324.html(D09791)]|D09791|Prodrugs [br08324.html]|C21605,
C21606,2-O-(alpha-D-Mannosyl)-1-phosphatidyl-1D-myo-inositol;|2-O-alpha-D-Mannosyl-1-phosphatidyl-1D-myo-inositol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C21606  2-O-alpha-D-Mannosyl-1-phosphatidyl-1D-myo-inositol,G11291
C21607,"2,6-Di-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol",,,,"Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C21607  2,6-Di-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol",G13102
C21608,2-O-(6-O-Acyl-alpha-D-mannosyl)-6-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C21608  2-O-(6-O-Acyl-alpha-D-mannosyl)-6-O-alpha-D-mannosyl-1-phosphatidyl-1D-myo-inositol,G13108
C21609,2-O-(6-O-Acyl-alpha-D-mannosyl)-1-phosphatidyl-1D-myo-inositol,,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP15 Glycerophosphoinositolglycans|GP1501 Diacylglycerophosphoinositolglycans|C21609  2-O-(6-O-Acyl-alpha-D-mannosyl)-1-phosphatidyl-1D-myo-inositol,G13107
C21610,3-Dehydro-4-phospho-D-erythronate,,,,,
C21611,3-Dehydro-4-phospho-L-erythronate,,,,,
C21612,3-Dehydro-L-erythronate,,,,,
C21613,(R)-2-(Phosphonomethyl)malate,,,,,
C21614,Glycolaldehyde phosphate,,,,,
C21615,Glycolaldehyde triphosphate,,,,,
C21616,Psicoselysine;|N6-(D-Psicosyl)-L-lysine,,,,,
C21617,2-Dehydro-D-erythronate,,,,,
C21618,2-Dehydro-L-erythronate,,,,,
C21619,(2-Hydroxy-1H-indol-3-yl)acetate,,,,,
C21620,S-[(E)-N-Hydroxy(indol-3-yl)acetimidoyl]-L-glutathione,,,,,
C21621,Methanofuran,Generic compound in reaction hierarchy,,,,
C21622,S-[(Z)-N-Hydroxy(phenyl)acetimidoyl]-L-glutathione,,,,,
C21623,1-aci-Nitro-2-phenylethane,,,,,
C21624,Mycobilin a,,,,,
C21625,Mycobilin b,,,,,
C21626,"[(1->4)-beta-D-Glucosyl]n-(1->4)-D-glucono-1,5-lactone",,,,,
C21628,4-Dehydro-beta-D-glucosyl-[(1->4)-beta-D-glucosyl]n-1,,,,,
C21629,Formylmethanofuran,Generic compound in reaction hierarchy,,,,
C21630,(S)-Norlaudanine,,,,,
C21631,(S)-Tetrahydropapaverine,,,,,
C21632,2-Hydroxyparaconate,,,,,
C21633,Noroxopluviine,,,,,
C21634,Norcraugsodine,,,,,
C21635,"(4aR,10bS)-Normaritidine;|Macowine",,,,,
C21637,Elwesine,,,,,
C21639,Maritinamine,,,,,
C21640,6-(1'-Hydroxy-2'-oxopropyl)-tetrahydropterin;|1'-Hydroxy-2'-oxopropyltetrahydropterin,,,,,
C21641,Hydroperoxyl radical;|Perhydroxyl radical,,,,,
C21642,4-Hydroxynonenal;|4-Hydroxy-2-nonenal;|4-HNE,,,,,
C21643,"3-Dehydro-scyllo-inosose;|2,4-Didehydroinositol",,,,,
C21644,5-Dehydro-L-gluconate;|5-Keto-L-gluconate,,,,,
C21645,"(2R,3S)-2-Alkyl-3-hydroxyalkanoate",Generic compound in reaction hierarchy,,,,
C21646,8-Amino-8-demethylriboflavin,,,,,
C21647,Roseoflavin;|8-Demethyl-8-(dimethylamino)riboflavin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21647,
C21648,8-Demethyl-8-(methylamino)riboflavin,,,,,
C21649,"D-Threonate;|(2S,3R)-2,3,4-Trihydroxybutanoate",,,,,
C21650,7-Methylthioheptyl-desulfoglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C21650  7-Methylthioheptyl-desulfoglucosinolate,
C21651,(R)-2-Alkyl-3-oxoalkanoate;|(2R)-2-Alkyl-3-oxoalkanoate,Generic compound in reaction hierarchy,,,,
C21652,RNA 2'-terminal-phosphate;|(Ribonucleotide)n-2'-phosphate,,,,,
C21653,(+)-Kolavelool,,,,,
C21654,(+)-Kolavenyl diphosphate,,,,,
C21655,"Cyclobis-1,6-alpha-nigerosyl;|Cycloalternan",,,,,
C21656,ent-8alpha-Hydroxylabd-13-en-15-yl diphosphate,,,,,
C21657,cis-3-Alkyl-4-alkyloxetan-2-one,Generic compound in reaction hierarchy,,,,
C21658,Peregrinol diphosphate;|(13E)-9-Hydroxy-8alpha-labda-13-en-15-yl diphosphate,,,,,
C21659,"alpha-Isomaltosyl-1,3-isomaltose",,,,,
C21660,"(+)-Isoafricanol;|(1aS,4aR,5R,7aS,7bR)-3,3,5,7b-Tetramethyldecahydro-4aH-cyclopropa[e]azulen-4a-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010347 Africanane sesquiterpenoids|C21660  (+)-Isoafricanol,
C21661,(-)-Spiroviolene,,,,,
C21662,(E)-1-(L-Cysteinylglycine-S-yl)-N-hydroxy-omega-(methylsulfanyl)alkane-1-imine,,,,,
C21663,(E)-1-(L-Cysteinylglycine-S-yl)-N-hydroxy-2-(1H-indol-3-yl)ethane-1-imine,,,,,
C21664,(Glutathione-S-yl)(1H-indol-3-yl)acetonitrile,,,,,
C21665,(L-Cysteinylglycine-S-yl)(1H-indol-3-yl)acetonitrile,,,,,
C21666,"(3R,4R)-3-[(1S)-1-Hydroxyalkyl]-4-(hydroxymethyl)oxolan-2-one",Generic compound in reaction hierarchy,,,,
C21667,(Z)-1-(L-Cysteinylglycine-S-yl)-N-hydroxy-2-phenylethane-1-imine,,,,,
C21668,"(3R,4R)-3-Alkanoyl-4-(hydroxymethyl)oxolan-2-one",Generic compound in reaction hierarchy,,,,
C21669,12-Hydroxyjasmonate;|12-Hydroxyjasmonic acid,,,,,
C21670,"Tsukubadiene;|(1S,3aS,5Z,7aS,10aR,11Z)-1,5,8,8,10a-Pentamethyl-2,3,3a,4,7,7a,8,9,10,10a-decahydro-1H-dicyclopenta[a,d][9]annulene",,,,,
C21671,12-Sulfooxyjasmonate;|12-Hydroxyjasmonate sulfate,,,,,
C21672,Ornithine lipid,Generic compound in reaction hierarchy,,,,
C21673,N-Methylornithine lipid,Generic compound in reaction hierarchy,,,,
C21674,"N,N-Dimethylornithine lipid",Generic compound in reaction hierarchy,,,,
C21675,"N,N,N-Trimethylornithine lipid",Generic compound in reaction hierarchy,,,,
C21676,"(2S,3R,6S,9S)-(-)-Protoillud-7-ene;|(2aS,4aS,7aS,7bR)-3,6,6,7b-Tetramethyl-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]indene",,,,,
C21677,"(3S)-(+)-Asterisca-2(9),6-diene;|(4S,7Z)-2,2,4,7-Tetramethyl-2,3,4,5,6,9-hexahydro-1H-cyclopenta[8]annulene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010358 Asteriscane sesquiterpenoids|C21677  (3S)-(+)-Asterisca-2(9),6-diene",
C21678,"(3R)-3-Hydroxy-16-methoxy-1,2-didehydro-2,3-dihydrotabersonine",,,,,
C21679,"(-)-alpha-Amorphene;|(1S,4aR,8aS)-4,7-Dimethyl-1-(propan-2-yl)-1,2,4a,5,6,8a-hexahydronaphthalene",,,,,
C21680,Lyso-ornithine lipid,Generic compound in reaction hierarchy,,,,
C21681,"(+)-Corvol ether B;|(1S,3R,5aR,6S,8aR)-3,6-Dimethyl-1-(propan-2-yl)hexahydro-1H,3H-3,8a-methanocyclopenta[c]oxepine",,,,,
C21682,"(3R)-3-Hydroxy-2,3-dihydrotabersonine",,,,,
C21683,"(3R)-3-Hydroxy-1,2-didehydro-2,3-dihydrotabersonine",,,,,
C21684,"(+)-Eremophilene;|(3S,4aS,5R)-4a,5-Dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene",,,,,
C21685,"(1R,4R,5S)-(-)-Guaia-6,10(14)-diene;|(1R)-1-Methyl-4-methylidene-7-(propan-2-yl)-1,2,3,3a,4,5,6,8a-octahydroazulene;|(1R)-7-Isopropyl-1-methyl-4-methylene-1,2,3,3a,4,5,6,8a-octahydroazulene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C21685  (1R,4R,5S)-(-)-Guaia-6,10(14)-diene",
C21686,"(+)-(1E,4E,6S,7R)-Germacra-1(10),4-dien-6-ol;|(1S,2E,6E,10R)-3,7-Dimethyl-10-(propan-2-yl)cyclodeca-2,6-dien-1-ol",,,,,
C21687,"(3E,7E)-Dolabella-3,7-dien-18-ol;|2-[(1R,3aR,5E,9E,12aR)-3a,6,10-Trimethyl-1,2,3,3a,4,7,8,11,12,12a-decahydrocyclopenta[11]annulen-1-yl]propan-2-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010424 Dolabellane and modified dolabellane diterpenoids|C21687  (3E,7E)-Dolabella-3,7-dien-18-ol",
C21688,"(3E,7E)-Dolathalia-3,7,11-triene;|(7E,11E)-3,3,7,11,13a-Pentamethy1-2,3,5,6,9,10,13,13a-octahydro-1H-benzo[11]annulene",,,,,
C21689,"7-epi-alpha-Eudesmol;|(-)-7-epi-alpha-Eudesmol;|2-[(2S,4aR,8aR)-4a,8-Dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-2-yl]propan-2-ol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C21689  7-epi-alpha-Eudesmol,
C21690,"4-epi-Cubebol;|(+)-4-epi-Cubebol;|(3S,3aS,3bR,4S,7S,7aS)-4-(2-Hydroxypropan-2-yl)-7-methyloctahydro-1H-cyclopenta[1,3]cyclopropa[1,2]benzen-3-ol",,,,,
C21691,omega-(Methylthio)alkyl-glucosinolate;|omega-(Methylsulfanyl)alkyl-glucosinolate,Generic compound in reaction hierarchy,,,,
C21692,omega-(Methylsulfinyl)alkyl-glucosinolate,Generic compound in reaction hierarchy,,,,
C21693,"(+)-Corvol ether A;|(1R,4S,4aR,7R,8aR)-4,7-Dimethyl-1-(propan-2-yl)decahydro-1,7-epoxynaphthalene",,,,,
C21694,10-epi-Juneol;|10alpha-Eudesm-4(14)-en-6alpha-ol,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C21694  10-epi-Juneol,
C21695,tau-Cadinol;|10beta-Cadin-4-en-10-ol,,,,,
C21696,12-Hydroxyjasmonoyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C21697,12-Hydroxy-12-oxojasmonoyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C21698,"(2E,6E)-Hedycaryol;|(1E,4E,7R)-Germacra-1(10),4-dien-11-ol",,,,,
C21699,12-Oxojasmonoyl-L-amino acid,Generic compound in reaction hierarchy,,,,
C21700,10-epi-Cubebol,,,,,
C21701,Sesterfisherol,,,,,
C21702,beta-Thujene,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C21702  beta-Thujene,
C21703,"Stellata-2,6,19-triene",,,,,
C21704,Stellatate;|Stellatic acid,,,,,
C21705,"Guaia-4,6-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010341 Guaiane sesquiterpenoids|C21705  Guaia-4,6-diene",
C21706,"Pseudolaratriene;|(1RS,3aSR,8aRS)-3a,6-Dimethyl-1-(6-methylhepta-2,5-dien-2-yl)-1,2,3,3a,4,7,8,8a-octahydrohydroazulene",,,,,
C21707,"Selina-4(15),7(11)-diene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C21707  Selina-4(15),7(11)-diene",
C21708,"(+)-(2S,3R,9R)-Pristinol;|(1R,6R,9aS)-1,4,8,8-Tetramethyl-2,3,5,6,7,8,9,9a-octahydro-1H-cyclopenta[8]annulen-6-ol",,,,,
C21709,Nezukol;|Pimar-15-en-8-ol,,,,,
C21710,5-Hydroxy-alpha-gurjunene,,,,,
C21711,ent-Atiserene,,,,,
C21712,"2-Chloro-N-(2,6-diethylphenyl)acetamide",,,,,
C21713,Butyl formate,,,,,
C21714,"ent-13-epi-Manoyl oxide;|(13R)-ent-8,13-Epoxylabd-14-ene",,,,,
C21715,"(2Z,6E)-Hedycaryol;|(1E,4Z,7R)-Germacra-1(10),4-dien-11-ol",,,,,
C21716,"beta-Geranylfarnesene;|(6E,10E,14E)-7,11,15,19-Tetramethyl-3-methyleneicosa-1,6,10,14,18-pentaene",,,,,
C21717,beta-Hexaprene,,,,,
C21718,beta-Heptaprene,,,,,
C21719,2-(L-Cystein-S-yl)-2-(1H-indol-3-yl)acetonitrile,,,,,
C21720,"(13R)-9,13-Epoxylabd-14-ene",,,,,
C21721,Camalexin;|3-(Thiazol-2-yl)indole,,,,,
C21722,"(R)-Dihydrocamalexate;|(4R)-2-(1H-Indol-3-yl)-4,5-dihydrothiazole-4-carboxylate",,,,,
C21723,Biliverdin-IX-delta,,,,,
C21724,Biliverdin-IX-beta,,,,,
C21725,"Manoyl oxide;|(13R)-Manoyl oxide;|(13R)-8,13-Epoxylabd-14-ene",,,,,
C21726,"Cycloaraneosene;|(1R,3aR,9aS,10aR)-1,9a-Dimethyl-4-methylene-7-(propan-2-yl)-1,2,3,3a,4,5,6,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene",,,,,
C21727,"(13E)-Labda-7,13-dien-15-yl diphosphate;|(13E)-Labda-7,13-dienyl diphosphate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C21727  (13E)-Labda-7,13-dien-15-yl diphosphate",
C21728,"Labda-7,13(16),14-triene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C21728  Labda-7,13(16),14-triene",
C21729,"(12E)-Labda-8(17),12,14-triene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010403 Labdane and halimane diterpenoids|C21729  (12E)-Labda-8(17),12,14-triene",
C21730,epsilon-(gamma-L-Glutamyl)-L-lysine,,,,,
C21731,"2-(Hydroxysulfanyl)hercynine;|Nalpha,Nalpha,Nalpha-Trimethyl-2-(hydroxysulfanyl)-L-histidine;|2-Sulfenohercynine",,,,,
C21732,"(3S,22S)-2,3:22,23-Diepoxy-2,3,22,23-tetrahydrosqualene;|2,3,22,23-Dioxidosqualene",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C21732  (3S,22S)-2,3:22,23-Diepoxy-2,3,22,23-tetrahydrosqualene",
C21733,"Pre-alpha-onocerin;|(21S)-21,22-Epoxypolypoda-8(26)-13,17-trien-3beta-ol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010624 Polypodane, malabaricane and podiodane triterpenoids|C21733  Pre-alpha-onocerin",
C21734,"alpha-Onocerin;|8,14-Secogammacera-8(26),14(27)-diene-3beta,21alpha-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010623 Serratane and onocerane triterpenoids|C21734  alpha-Onocerin,
C21735,"(-)-Kolavenyl diphosphate;|(2E)-5-[(1R,2S,4aS,8aS)-1,2,4a,5-Tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl diposphate",,,,,
C21736,4-Sulfanylbutanoate,,,,,
C21737,"4,4'-Disulfanediyldibutanoate",,,,,
C21738,"(4R)-4,2'-Dihydroxyisoflavan",Generic compound in reaction hierarchy,,,,
C21739,(3R)-2'-Hydroxyisoflavanone,Generic compound in reaction hierarchy,,,,
C21740,[Sulfatase]-L-cysteine,Generic compound in reaction hierarchy|R = sulfatase,,,,
C21741,[Sulfatase]-3-oxo-L-alanine;|[Sulfatase]-(S)-formylglycine;|[Sulfatase]-(S)-Calpha-formylglycine;|[Sulfatase]-FGly,Generic compound in reaction hierarchy|R = sulfatase,,,,
C21742,beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R,,,,,
C21743,beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-R,,,,,
C21744,Mn(IV)O2;|Manganese dioxide,,,,,
C21746,8-Methylthiooctyl-desulfoglucosinolate,,,,Glycosides [BR:br08021]|S-glycosides|C21746  8-Methylthiooctyl-desulfoglucosinolate,
C21747,N-Acetyl-beta-D-glucosaminyl-(1->4)-D-glucosamine,,,,,
C21748,5-Fluorouridine diphosphate,,,,,
C21749,5-Fluorouridine triphosphate,,,,,
C21750,5-Fluorodeoxyuridine diphosphate,,,,,
C21751,5-Fluorodeoxyuridine triphosphate,,,,,
C21752,2-Hydroxyethyl-CoM,,,,,
C21753,2-Chloro-2-hydroxyethyl-CoM,,,,,
C21754,Isonicotinoyl radical,,,,,
C21755,Isonicotinoyl-NAD+;|INH-NAD+,,,,,
C21756,Isonicotinoyl-NADP+;|INH-NADP+,,,,,
C21757,4-Isonicotinoylnicotinamide;|4-INN,,,,,
C21759,Isonicotinoyl-NAD adduct;|INH-NAD adduct,,,,,
C21760,Isonicotinoyl-NADP adduct;|INH-NADP adduct,,,,,
C21761,(3R)-3-Hydroxy-4-oxobutanoate,,,,,
C21762,4-Hydroxytryptamine,,,,,
C21763,Long-chain alkane,Generic compound in reaction hierarchy,,,,
C21764,5-Hydroxybenzimidazole,,,,,
C21765,Rhizathalene A,,,,,
C21766,"4,4'-Diapolycopen-4-al",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C21766  4,4'-Diapolycopen-4-al",
C21767,"Pyridinium-3,5-bisthiocarboxylate mononucleotide;|P2TMN;|Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide",,,,,
C21768,"4,4'-Diapolycopen-4-oate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C21768  4,4'-Diapolycopen-4-oate",
C21769,"Ni(II)-pyridinium-3,5-bisthiocarboxylate mononucleotide",,,,,
C21770,"4,4'-Diapolycopene-4,4'-dioate",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010601 Acyclic triterpenoids|C21770  4,4'-Diapolycopene-4,4'-dioate|C21770  4,4'-Diapolycopene-4,4'-dioate",
C21771,"L-Firefly luciferin;|(R)-4,5-Dihydro-2-(6-hydroxy-1,3-benzothiazol-2-yl)thiazole-4-carboxylate",,,,,
C21772,L-Firefly luciferyl-CoA,,,,,
C21773,"[(3S,4R)-4-Alkanoyl-5-oxooxolan-3-yl]methyl phosphate",Generic compound in reaction hierarchy,,,,
C21774,"(4-Alkanoyl-5-oxo-2,5-dihydrofuran-3-yl)methyl phosphate",Generic compound in reaction hierarchy,,,,
C21775,1-(4-Methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-yl)methyl]methanamine,,,,,
C21776,"2-({[(4-Methoxyphenyl)methyl](methyl)amino}methyl)-2-methylpropane-1,3-diol",,,,,
C21777,4-Hydroxy-L-tryptophan,,,,,
C21778,Norbaeocystin;|4-Hydroxytryptamine 4-phosphate,,,,,
C21779,Baeocystin;|4-Hydroxy-N-methyltryptamine 4-phosphate,,,,,
C21780,"alpha-D-Mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C21780  alpha-D-Mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",
C21781,"alpha-D-Mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C21781  alpha-D-Mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-alpha-D-mannosyl-(1->3)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",
C21782,Mogrol,,,,,
C21783,Mogroside IE,,,,,
C21784,Nerylneryl diphosphate;|all-cis-Tetraprenyl diphosphate,,,,,
C21785,N5-Phospho-L-glutamine,,,,,
C21786,Oleuropein aglycone,,,,,
C21787,S-Sulfinatoglutathione,,,,,
C21788,Tulathromycin A,,,,,
C21789,Tulathromycin B,,,,,
C21790,"Mycobacterial trehalose dimycolate;|Mycobacterial TDM;|Trehalose dimycolate;|Trehalose-6,6'-dimycolate;|TDM;|Cord factor",Generic compound in reaction hierarchy|The structure of alpha-mycolate TDM from M. tuberculosis is shown here.,,,Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C21790  Trehalose dimycolate,
C21793,4-Phenylbutyrate;|4-Phenylbutanoate;|4-Phenylbutyric acid,,,,,
C21794,2-Hydroxyornithine lipid,Generic compound in reaction hierarchy,,,,
C21795,"(3E)-4,8-Dimethylnona-1,3,7-triene",,,,,
C21796,11-Hydroxyferruginol,,,,,
C21797,"all-trans-3,4-Didehydroretinol;|Vitamin A2",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0109 Retinoids|C21797  all-trans-3,4-Didehydroretinol",
C21798,Adenine in U6 snRNA;|Adenine(43) in U6 snRNA,Generic compound in reaction hierarchy,,,,
C21799,N6-Methyladenine in U6 snRNA;|N6-Methyladenine(43) in U6 snRNA,Generic compound in reaction hierarchy,,,,
C21800,(+)-O-Methylkolavelool,,,,,
C21801,(+)-Demethylpiperitol;|Sesamin monocatechol,,,,,
C21802,(+)-Didemethylpinoresinol;|Sesamin dicatechol,,,,,
C21803,8-Demethyl-8-formylriboflavin 5'-phosphate,,,,,
C21804,8-Carboxy-8-demethylriboflavin 5'-phosphate;|8-Demethyl-8-carboxyriboflavin 5'-phosphate,,,,,
C21805,8-Amino-8-demethylriboflavin 5'-phosphate;|8-Demethyl-8-aminoriboflavin 5'-phosphate,,,,,
C21808,21-Phosphorifampicin,,,,,
C21811,Wall teichoic acid;|[(4-D-Ala)-(2-GlcNAc)-Rib-ol-P]n-[Gro-P]m-beta-ManNAc-(1->4)-alpha-GlcNAc-P-peptidoglycan,Representative chemical structure of wall teichoic acid from Staphylococcus aureus (m=1-3 and n=20-40).,,,,
C21812,Wall teichoic acid;|[(2-GlcNAc)-Rib-ol-P]n-[Gro-P]m-beta-ManNAc-(1->4)-alpha-GlcNAc-P-peptidoglycan,Representative chemical structure of wall teichoic acid from Staphylococcus aureus (m=1-3 and n=20-40).,,,,
C21814,[SoxY protein]-S-disulfanyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C21815,[SoxY protein]-S-sulfosulfanyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C21816,alpha-D-Galacturonosyl-[(1->2)-alpha-L-rhamnosyl-(1->4)-alpha-D-galacturonosyl]n;|Rhamnogalacturonan I,Generic compound in reaction hierarchy,,,,
C21817,[(1->2)-alpha-L-Rhamnosyl-(1->4)-alpha-D-galacturonosyl]n;|Rhamnogalacturonan I,Generic compound in reaction hierarchy,,,,
C21818,"Carnosic acid;|Salvin;|11,12-Dihydroxyabieta-8,11,13-trien-20-oic acid",,,,,
C21819,"Salviol;|Abieta-8,11,13-triene-2alpha,12-diol",,,,,
C21820,"Maniladiol;|16beta-Hydroxy-beta-amyrin;|Olean-12-ene-3beta,16beta-diol",,,,,
C21821,"Daturadiol;|6beta-Hydroxy-beta-amyrin;|Olean-12-ene-3beta,6beta-diol",,,,,
C21822,"Sugiol;|12-Hydroxyabieta-8,11,13-trien-7-one",,,,,
C21823,11-Hydroxysugiol,,,,,
C21824,"11,20-Dihydroxysugiol",,,,,
C21825,"9beta-Pimara-7,15-diene-3beta-ol",,,,,
C21826,"ent-3beta-Hydroxycassa-12,15-dien-2-one",,,,,
C21827,"ent-Cassa-12,15-dien-2beta-ol",,,,,
C21828,"ent-Cassa-12,15-dien-2-one",,,,,
C21829,"ent-Cassa-12,15-diene-2beta,3beta-diol",,,,,
C21830,"11,20-Dihydroxyferruginol",,,,,
C21831,"ent-2alpha,3alpha-Dihydroxyisokaurene;|ent-Isokaurene-2beta,3beta-diol",,,,,
C21832,"(4S)- 2,3-Dehydroflavan-3,4-diol",Generic compound in reaction hierarchy,,,,
C21833,Kaempferol-3-O-rutinoside;|Nictoflorin,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C21833  Kaempferol-3-O-rutinoside|Dietary phytochemicals [br08012.html]|Flavonoids|C21833,
C21834,"(4Z,8Z)-4,8-Dimethyl-12-oxotrideca-4,8-dienal",,,,,
C21835,"12,18-Didecarboxysiroheme",,,,,
C21836,"meso-Zeaxanthin;|(3R,3'S)-beta,beta-Carotene-3,3'-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0107 C40 isoprenoids (tetraterpenes)|C21836  meso-Zeaxanthin,
C21837,3-Geranyl-3-[(Z)-2-isocyanoethenyl]-1H-indole,,,,,
C21838,Hapalindole H,,,,,
C21839,12-epi-Hapalindole U,,,,,
C21840,"12-epi-Fischerindole U;|(6aS,9S,10R,10aS)-9-Ethenyl-10-isocyano-6,6,9-trimethyl-5,6,6a,7,8,9,10,10a-octahydroindeno[2,1-b]indole",,,,,
C21841,"11-Oxocucurbitadienol;|3beta-Hydroxycucurbita-7,24-dien-11-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C21841  11-Oxocucurbitadienol,
C21842,11-Hydroxycucurbitadienol,,,,,
C21843,"Drimendiol;|Drim-7-ene-11,12-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010337 Drimane sesquiterpenoids|C21843  Drimendiol,
C21844,Adenine in mRNA,Generic compound in reaction hierarchy,,,,
C21845,N6-Methyladenine in mRNA,Generic compound in reaction hierarchy,,,,
C21846,Sordaricin,,,,,
C21847,4'-O-Demethylsordarin,,,,,
C21848,GDP-6-deoxy-alpha-D-altrose,,,,,
C21849,"4-O-(2-N-Acetyl-beta-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13176
C21850,3-Bromo-4-hydroxybenzoate,,,,,
C21851,"Pyridinium-3,5-biscarboxylic acid mononucleotide;|P2CMN;|Pyridin-1-ium-3,5-dicarboxylate mononucleotide;|Pyridinium-3,5-biscarboxylate mononucleotide",,,,,
C21852,"3,5-Dibromobenzene-1,2-diol",,,,,
C21853,"3-Bromo-4,5-dihydroxybenzoate",,,,,
C21854,Kaempferol 3-O-rhamnoside-7-O-glucoside,,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1211 Flavones and Flavonols|C21854  Kaempferol 3-O-rhamnoside-7-O-glucoside,
C21855,5-Chloro-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein],,,,,
C21856,"4,5-Dichloro-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]",,,,,
C21858,N-(4-Oxoglutaryl)-L-cysteinylglycine;|Deaminated glutathione,,,,,
C21859,"cis-3-[2,2-Dichloro-1-(4-chlorophenyl)vinyl]-6-chlorocyclohexa-3,5-diene-1,2-diol;|cis-2,3-Dihydrodiol-DDE",,,,,
C21860,"3-Demethylubiquinol;|3-Methoxy-6-methyl-5-(all trans-polyprenyl)benzene-1,2,4-triol;|3-Demethylubiquinol-n",Generic compound in reaction hierarchy|n=5-9,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C21860  3-Demethylubiquinol,
C21861,[Protein]-dehydroalanine,Generic compound in reaction hierarchy,,,,
C21862,5-Bromo-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein],,,,,
C21863,"4,5-Dibromo-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]",,,,,
C21864,"3,4,5-Tribromo-1H-pyrrole-2-carbonyl-[peptidyl-carrier protein]",,,,,
C21865,5-Chloro-L-tryptophan,,,,,
C21866,6-Chloro-L-tryptophan,,,,,
C21867,6-Chloro-D-tryptophan,,,,,
C21868,"6,7-Dichloro-L-tryptophan",,,,,
C21869,"4-O-[(2-beta-D-Glucosyl-1-D-ribitylphospho)n-(1-D-ribitylphospho)-(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13170
C21870,"4-O-(2-N-Acetyl-alpha-D-glucosaminyl-D-ribitylphospho)n-di[(2R)-1-glycerophospho]-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13174
C21871,(E)-omega-(Methylthio)alkyl-thiohydroximate;|(E)-omega-(Methylsulfanyl)alkyl-thiohydroximate,Generic compound in reaction hierarchy,,,,
C21872,Aliphatic desulfoglucosinolate;|omega-(Methylthio)alkylhydroximate S-glucoside,Generic compound in reaction hierarchy,,,,
C21873,2-Methylquinolin-4-ol;|2-Methyl-4-hydroxyquinoline,,,,,
C21874,Aurachin B epoxide,,,,,
C21875,Aurachin A,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21875,
C21876,Fenbendazole;|Methyl [5-(phenylsulfanyl)-1H-benzimidazol-2-yl]carbamate,,,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D04140)]|P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS|P02 ANTHELMINTICS|P02C ANTINEMATODAL AGENTS|P02CA Benzimidazole derivatives|P02CA06 Fenbendazole|D04140  Fenbendazole (USP/INN)|Animal drugs in Japan [BR:br08331(D04140)]|97  Agents against pathogenic micro-organisms and parasites (except biological products and disinfectants)|975  Anthelmintics for digestive organs|9752  Thiabendazole derivatives and preparations|D04140  Fenbendazole|Antimicrobials [BR:br08307(D04140)]|Antiparasitics|Antinematodal agents|Benzimidazole derivatives|D04140  Fenbendazole (USP/INN)",
C21877,5-Carboxy-1-(5-O-phospho-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl adenylate,,,,,
C21878,Pyridinium-3-carboxy-5-thiocarboxylic acid mononucleotide;|PCTMN;|Pyridin-1-ium-3-carboxylate-5-thiocarboxylate mononucleotide,,,,,
C21879,1-(5-O-Phospho-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium-3-carbonyl adenylate,,,,,
C21880,[Protein]-S-[5-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridin-1-ium-3-carbonyl]-L-cysteine,Generic compound in reaction hierarchy,,,,
C21881,[Protein]-S-[1-(5-O-phosphono-beta-D-ribofuranosyl)-5-(sulfanylcarbonyl)pyridin-1-ium-3-carbonyl]-L-cysteine,Generic compound in reaction hierarchy,,,,
C21882,Fenbendazole S-oxide;|Oxfendazole,,,,,
C21883,Hydroxyalbendazole;|Methyl [5-(3-hydroxypropylsulfanyl)-1H-benzimidazol-2-yl]carbamate,,,,,
C21884,4'-Hydroxyfenbendazole;|Methyl [5-(4-hydroxyphenylsulfanyl)-1H-benzimidazol-2-yl]carbamate,,,,,
C21885,omega-Hydroxy-beta-dihydromenaquinone-9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C21885  omega-Hydroxy-beta-dihydromenaquinone-9,
C21886,omega-Hydroxy-long-chain fatty acid,Generic compound in reaction hierarchy,,,,
C21887,"Rhizobitoxine;|(2S,3E)-2-Amino-4-[(2R)-2-amino-3-hydroxypropoxy]but-3-enoate",,,,,
C21888,Dihydrorhizobitoxine;|(2S)-2-Amino-4-[(2R)-2-amino-3-hydroxypropoxy]butanoate,,,,,
C21889,(2S)-3-(4-Hydroxyphenyl)-2-isocyanopropanoate;|L-Tyrosine isonitrile,,,,,
C21890,4-[(E)-2-Isocyanoethenyl]phenol,,,,,
C21891,(2E)-3-(4-Hydroxyphenyl)-2-isocyanoprop-2-enoate,,,,,
C21892,(2S)-3-(1H-Indol-3-yl)-2-isocyanopropanoate;|L-Tryptophan isonitrile,,,,,
C21893,3-[(Z)-2-Isocyanoethenyl]-1H-indole,,,,,
C21894,3-[(E)-2-Isocyanoethenyl]-1H-indole,,,,,
C21895,2-Acetylphloroglucinol;|Monoacetylphloroglucinol,,,,,
C21896,"2,4-Diacetylphloroglucinol",,,,,
C21897,Dihydrochanoclavine-I aldehyde,,,,,
C21898,[SoxY protein]-S-sulfanyl-L-cysteine,Generic compound in reaction hierarchy,,,,
C21899,[SoxY protein]-S-(2-sulfodisulfanyl)-L-cysteine,Generic compound in reaction hierarchy,,,,
C21900,[SAMP]-Gly-Gly,Generic compound in reaction hierarchy,,,,
C21901,[SAMP]-Gly-Gly-AMP,Generic compound in reaction hierarchy,,,,
C21902,Archaeal dolichyl beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate;|Dolichyl beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C21902  Archaeal dolichyl beta-D-glucuronosyl-(1->4)-alpha-D-glucosyl phosphate,
C21903,Delta9-Tetrahydrocannabinolate,,,,Lipids [BR:br08002]|PK  Polyketides|PK13 Aromatic polyketides|PK1312 Other aromatic polyketides|C21903  Delta9-Tetrahydrocannabinolate,
C21904,Mycobacterial trehalose monomycolate;|Mycobacterial TMM;|Trehalose monomycolate;|TMM,Generic compound in reaction hierarchy|The structure of alpha-mycolate TMM from M. tuberculosis is shown here.,,,Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C21904  Trehalose monomycolate,
C21905,3-Oxocholan-24-oyl-CoA,,,,,
C21906,3-Oxochol-4-en-24-oyl-CoA,,,,,
C21907,12alpha-Hydroxy-3-oxocholan-24-oyl-CoA,,,,,
C21908,12alpha-Hydroxy-3-oxochol-4-en-24-oyl-CoA,,,,,
C21909,7alpha-Hydroxy-3-oxochol-24-oyl-CoA;|3-Oxochenodeoxycholoyl-CoA,,,,,
C21910,"7alpha,12alpha-Dihydroxy-3-oxochol-24-oyl-CoA;|3-Oxocholoyl-CoA",,,,,
C21911,7beta-Hydroxy-3-oxochol-24-oyl-CoA,,,,,
C21912,7beta-Hydroxy-3-oxochol-4-en-24-oyl-CoA,,,,,
C21913,Dihydro-4-coumaroyl-CoA,,,,,
C21914,Dihydroferuloyl-CoA,,,,,
C21915,Carotenoid beta-end group,Generic compound in reaction hierarchy,,,,
C21916,Carotenoid phi-end group,Generic compound in reaction hierarchy,,,,
C21917,Carotenoid chi-end group,Generic compound in reaction hierarchy,,,,
C21918,14alpha-Methylsteroid,Generic compound in reaction hierarchy,,,,
C21919,Delta14-Steroid,Generic compound in reaction hierarchy,,,,
C21920,14alpha-Hydroxymethylsteroid,Generic compound in reaction hierarchy,,,,
C21921,14alpha-Formylsteroid,Generic compound in reaction hierarchy,,,,
C21922,"6alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate",,,,,
C21923,"9-Hydroxy-12-oxo-10(E),15(Z)-octadecadienoic acid",,,,,
C21924,9-Hydroxy-12-oxo-15(Z)-octadecenoic acid,,,,,
C21925,Medium-chain fatty acid,Generic compound in reaction hierarchy,,,,
C21926,Medium-chain acyl-CoA,Generic compound in reaction hierarchy,,,,
C21927,Medium-chain acyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R= acyl-carrier protein,,,,
C21928,"(2Z,4E)-4-Amino-6-oxohepta-2,4-dienedioate",,,,,
C21929,"(-)-Bornane-2,5-dione;|(1S)-Bornane-2,5-dione;|3,6-Diketocamphane;|(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptane-2,5-dione",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C21929  (-)-Bornane-2,5-dione",
C21930,"(-)-5-Oxo-1,2-campholide;|(1S,5S)-1,8,8-Trimethyl-2-oxabicyclo[3.2.1]octane-3,6-dione",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0102 C10 isoprenoids (monoterpenes)|PR010212 Bicyclic monoterpenoids|C21930  (-)-5-Oxo-1,2-campholide",
C21931,Cerotic acid;|Hexacosanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C21931  Hexacosanoic acid,
C21932,Cerotoyl-CoA;|Hexacosanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21932  Hexacosanoyl-CoA,
C21933,Montanic acid;|Octacosanoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0101 Straight chain fatty acids|C21933  Octacosanoic acid,
C21934,Montanoyl-CoA;|Octacosanoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21934  Octacosanoyl-CoA,
C21935,"(6Z,9Z)-Octadecadienoyl-CoA;|6Z,9Z-Octadecadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21935  (6Z,9Z)-Octadecadienoyl-CoA",
C21936,"(8Z,11Z)-Icosadienoic acid;|(8Z,11Z)-Eicosadienoic acid;|8Z,11Z-Eicosadienoic acid;|(8Z,11Z)-Icosa-8,11-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21936  (8Z,11Z)-Icosa-8,11-dienoic acid",
C21937,"(8Z,11Z)-Icosadienoyl-CoA;|(8Z,11Z)-Eicosadienoyl-CoA;|8Z,11Z-Eicosadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21937  (8Z,11Z)-Icosadienoyl-CoA",
C21938,"Mead acid;|5,8,11-Eicosatrienoic acid;|(5Z,8Z,11Z)-Eicosatrienoate;|5Z,8Z,11Z-Eicosatrienoic acid;|(5Z,8Z,11Z)-Icosatrienoic acid;|(5Z,8Z,11Z)-Icosa-5,8,11-trienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21938  (5Z,8Z,11Z)-Icosa-5,8,11-trienoic acid",
C21939,"(5Z,8Z,11Z)-Icosatrienoyl-CoA;|(5Z,8Z,11Z)-Eicosatrienoyl-CoA;|5Z,8Z,11Z-Eicosatrienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21939  (5Z,8Z,11Z)-Icosatrienoyl-CoA",
C21940,"(7Z,10Z,13Z)-Docosatrienoic acid;|7Z,10Z,13Z-Docosatrienoic acid",,,,,
C21941,"(7Z,10Z,13Z)-Docosatrienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21941  (7Z,10Z,13Z)-Docosatrienoyl-CoA",
C21942,Sapienic acid;|(6Z)-Hexadecenoic acid;|6Z-Hexadecenoic acid;|(Z)-Hexadec-6-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C21942  (Z)-Hexadec-6-enoic acid,
C21943,Sapienoyl-CoA;|(6Z)-Hexadecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21943  (6Z)-Hexadecenoyl-CoA,
C21944,cis-Vaccenic acid;|cis-11-Octadecenoic acid;|11Z-Octadecenoic acid;|(Z)-Octadec-11-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C21944  (Z)-Octadec-11-enoic acid,
C21945,cis-Vaccenoyl-CoA;|(11Z)-Octadecenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21945  (11Z)-Octadecenoyl-CoA,
C21946,Paullinic acid;|13Z-Eicosenoic acid;|(Z)-Eicos-13-enoic acid;|(Z)-Icos-13-enoic acid,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Monounsaturated fatty acids|C21946  (Z)-Icos-13-enoic acid,
C21947,Paullinoyl-CoA;|(13Z)-Icosenoyl-CoA;|(13Z)-Eicosenoyl-CoA,,,,Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21947  (13Z)-Icosenoyl-CoA,
C21948,"Shibic acid;|11Z,14Z,17Z,20Z,23Z-Hexacosapentaenoic acid;|(11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoic acid;|(11Z,14Z,17Z,20Z,23Z)-Hexacosa-11,14,17,20,23-pentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21948  (11Z,14Z,17Z,20Z,23Z)-Hexacosa-11,14,17,20,23-pentaenoic acid",
C21949,"(11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21949  (11Z,14Z,17Z,20Z,23Z)-Hexacosapentaenoyl-CoA",
C21950,"(13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoic acid;|13Z,16Z,19Z,22Z,25Z-Octacosapentaenoic acid;|(13Z,16Z,19Z,22Z,25Z)-Octacosa-13,16,19,22,25-pentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21950  (13Z,16Z,19Z,22Z,25Z)-Octacosa-13,16,19,22,25-pentaenoic acid",
C21951,"(13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21951  (13Z,16Z,19Z,22Z,25Z)-Octacosapentaenoyl-CoA",
C21952,"(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoic acid;|8Z,11Z,14Z,17Z,20Z,23Z-Hexacosahexaenoic acid;|(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosa-8,11,14,17,20,23-hexaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21952  (8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosa-8,11,14,17,20,23-hexaenoic acid",
C21953,"(8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21953  (8Z,11Z,14Z,17Z,20Z,23Z)-Hexacosahexaenoyl-CoA",
C21954,(+)-Piperitol,,,,,
C21955,"L-Galactono-1,5-lactone",,,,,
C21956,"1,6-Didemethyltoxoflavin",,,,,
C21957,Reumycin;|1-Demethyltoxoflavin,,,,,
C21958,"(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoic acid;|10Z,13Z,16Z,19Z,22Z,25Z-Octacosahexaenoic acid;|(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosa-10,13,16,19,22,25-hexaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21958  (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosa-10,13,16,19,22,25-hexaenoic acid",
C21959,"(10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21959  (10Z,13Z,16Z,19Z,22Z,25Z)-Octacosahexaenoyl-CoA",
C21960,"(11Z,14Z,17Z,20Z)-Hexacosatetraenoic acid;|11Z,14Z,17Z,20Z-Hexacosatetraenoic acid;|(11Z,14Z,17Z,20Z)-Hexacosa-11,14,17,20-tetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21960  (11Z,14Z,17Z,20Z)-Hexacosa-11,14,17,20-tetraenoic acid",
C21961,"(11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21961  (11Z,14Z,17Z,20Z)-Hexacosatetraenoyl-CoA",
C21962,"(13Z,16Z,19Z,22Z)-Octacosatetraenoic acid;|13Z,16Z,19Z,22Z-Octacosatetraenoic acid;|(13Z,16Z,19Z,22Z)-Octacosa-13,16,19,22-tetraenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21962  (13Z,16Z,19Z,22Z)-Octacosa-13,16,19,22-tetraenoic acid",
C21963,"(13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21963  (13Z,16Z,19Z,22Z)-Octacosatetraenoyl-CoA",
C21964,"(8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoic acid;|8Z,11Z,14Z,17Z,20Z-Hexacosapentaenoic acid;|(8Z,11Z,14Z,17Z,20Z)-Hexacosa-8,11,14,17,20-pentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21964  (8Z,11Z,14Z,17Z,20Z)-Hexacosa-8,11,14,17,20-pentaenoic acid",
C21965,"(8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21965  (8Z,11Z,14Z,17Z,20Z)-Hexacosapentaenoyl-CoA",
C21966,"(10Z,13Z,16Z,19Z,22Z)-Octacosapentaenoic acid;|10Z,13Z,16Z,19Z,22Z-Octacosapentaenoic acid;|(10Z,13Z,16Z,19Z,22Z)-Octacosa-10,13,16,19,22-pentaenoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21966  (10Z,13Z,16Z,19Z,22Z)-Octacosa-10,13,16,19,22-pentaenoic acid",
C21967,"(10Z,13Z,16Z,19Z,22Z)-Octacosapentaenoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21967  (10Z,13Z,16Z,19Z,22Z)-Octacosapentaenoyl-CoA",
C21968,2-O-[alpha-D-Glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate,,,,,
C21969,2-O-[6-O-Octanoyl-alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate,,,,,
C21970,2-Acylphloroglucinol 1-O-beta-D-glucoside,,,,,
C21971,"5-Amino-5-(4-hydroxybenzyl)-6-(D-ribitylimino)-5,6-dihydrouracil",,,,,
C21972,[SoxY protein]-L-cysteine,Generic compound in reaction hierarchy,,,,
C21973,Hapalindole U,,,,,
C21974,Hapalindole G,,,,,
C21975,"12-epi-Fischerindole G;|(6aR,8R,9S,10R,10aS)-8-Chloro-9-ethenyl-10-isocyano-6,6,9-trimethyl-5,6,6a,7,8,9,10,10a-octahydroindeno[2,1-b]indole",,,,,
C21976,L-Threonyl-[L-threonyl-carrier protein],Generic compound in reaction hierarchy|R=L-threonyl-carrier protein,,,,
C21977,4-Chloro-L-threonyl-[L-threonyl-carrier protein],Generic compound in reaction hierarchy|R=L-threonyl-carrier protein,,,,
C21978,"Cyclooctat-9-ene-5,7-diol;|(1S,3R,3aS,4R,7S,9aS,10aS)-1,4,9a-Trimethyl-7-(propan-2-yl)-1,2,3,3a,4,5,7,8,9,9a,10,10a-dodecahydrodicyclopenta[a,d][8]annulene-3,4-diol",,,,,
C21979,"Cyclooctatin;|Cycloctat-9-ene-5,7,18-triol",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C21979,
C21980,"(6Z,9Z)-Hexadecadienoic acid;|6Z,9Z-Hexadecadienoic acid;|(6Z,9Z)-Hexadeca-6,9-dienoic acid",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA01 Fatty Acids and Conjugates|FA0103 Unsaturated fatty acids|Polyunsaturated fatty acids|C21980  (6Z,9Z)-Hexadeca-6,9-dienoic acid",
C21981,"(6Z,9Z)-Hexadecadienoyl-CoA",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA07 Fatty esters|FA0705 Fatty acyl CoAs|C21981  (6Z,9Z)-Hexadecadienoyl-CoA",
C21982,Lipid IVB;|2-Deoxy-2-{[(3R)-3-hydroxytetradecanoyl]amino}-3-O-[(3R)-3-hydroxytetradecanoyl]-4-O-phospho-beta-D-glucopyranosyl-(1->6)-2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-(hexadecanoyloxy)tetradecanoyl]amino}-1-O-phospho-alpha-D-glucopyranose,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0105 Pentaacylaminosugars|C21982  Lipid IVB,
C21983,Deacyl-lipid IVB;|Deacyl-IVB,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0104 Tetraacylaminosugars|C21983  Deacyl-lipid IVB,
C21984,Deacyl-lipid IVA;|Deacyl-IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0103 Triacylaminosugars|C21984  Deacyl-lipid IVA,
C21988,H. pylori KDO2-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21988  H. pylori KDO2-lipid A,
C21991,Palmitoleoyl-myristoyl-KDO2-lipid A;|(KDO)2-(palmitoleoyl-myristoyl)-lipid A;|Cold adapted KDO2-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21991  Palmitoleoyl-myristoyl-KDO2-lipid A,
C21992,3'-O-Deacylated KDO2-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21992  3'-O-Deacylated KDO2-lipid A,
C21993,C16-KDO2-lipid A;|Palmitoylated KDO2-lipid A;|Palmitoyl-KDO2-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21993  C16-KDO2-lipid A,
C21994,1-Dephospho-KDO2-lipid A;|1-Dephosphorylated KDO2-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21994  1-Dephospho-KDO2-lipid A,
C21995,1-PEtN-KDO2-lipid A;|H. pylori KDO2-lipid A 1-(2-aminoethyl phosphate),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21995  1-PEtN-KDO2-lipid A,
C21996,1-PEtN-KDO-lipid A;|H. pylori KDO-lipid A 1-(2-aminoethyl phosphate),,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21996  1-PEtN-KDO-lipid A,
C21997,4'-Dephosphorylated 1-PEtN-KDO-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21997  4'-Dephosphorylated 1-PEtN-KDO-lipid A,
C21998,H. pylori KDO-lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21998  H. pylori KDO-lipid A,
C21999,Stearoyl-KDO2-lipid IVA;|Octadecanoyl-KDO2-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C21999  Stearoyl-KDO2-lipid IVA,
C22000,(R)-3-(Tetradecanoyloxy)tetradecanoic acid;|(R)-3-(Myristoyloxy)myristic acid,,,,,
C22001,(R)-3-Hydroxymyristic acid;|(R)-3-Hydroxytetradecanoic acid,,,,,
C22002,Lipid IIB,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0105 Pentaacylaminosugars|C22002  Lipid IIB,
C22003,(S)-2-Hydroxymyristate-modified lipid A,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C22003  (S)-2-Hydroxymyristate-modified lipid A,
C22004,"N8,N'8-Citryl-bis(spermidine)",,,,,
C22005,2-Hydroxyflavanone,Generic compound in reaction hierarchy,,,,
C22006,(R)-(Indol-3-yl)lactate;|(R)-3-(Indol-3-yl)lactate,,,,,
C22007,"Sideretin;|5,7,8-Trihydroxy-6-methoxy-2H-chromen-2-one",reduced form,,,,
C22008,"Dolabradiene;|(4aS,4bR,7S,8aR,10aS)-7-Ethenyl-4b,7,10a-trimethyl-1-methylidenetetradecahydrophenanthrene",,,,,
C22009,"15,16-Epoxydolabrene",,,,,
C22010,"3beta-Hydroxy-15,16-epoxydolabrene",,,,,
C22011,"Zealexin A1;|(4S)-4-(5,5-Dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carboxylate",,,,,
C22012,"[(4S)-4-(5,5-Dimethylcyclohex-1-en-1-yl)-cyclohex-1-en-1-yl]methanol",,,,,
C22013,"(4S)-4-(5,5-Dimethylcyclohex-1-en-1-yl)cyclohex-1-ene-1-carbaldehyde",,,,,
C22014,7-Deoxyloganetic alcohol,,,,,
C22015,Indole-3-carbonyl nitrile;|2-(1H-Indole-3-yl)-2-oxoacetonitrile,,,,,
C22016,4-Hydroxyindole-3-carbonyl nitrile;|2-(4-Hydroxy-1H-indole-3-yl)-2-oxoacetonitrile,,,,,
C22017,1-Hexacosanoyl-2-acyl-[phosphoglycerolipid],Generic compound in reaction hierarchy,,,,
C22018,1-[(17Z)-Hexacos-17-enoyl]-2-acyl-[phosphoglycerolipid],Generic compound in reaction hierarchy,,,,
C22019,1-Tetracosanoyl-2-acyl-[phosphoglycerolipid],Generic compound in reaction hierarchy,,,,
C22020,1-[(15Z)-Tetracos-15-enoyl]-2-acyl-[phosphoglycerolipid],Generic compound in reaction hierarchy,,,,
C22021,L-Tyrosinal;|(2S)-2-Amino-3-(4-hydroxyphenyl)propanal,,,,,
C22022,trans-Delta2-Meromycolyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R= acyl-carrier protein,,,,
C22023,Meromycolyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R= acyl-carrier protein,,,,
C22024,Staphylopine;|(2S)-4-{[(1R)-1-Carboxy-2-(1H-imidazol-4-yl)ethyl]amino}-2-[(1-carboxyethyl)amino]butanoate,,,,,
C22025,(2S)-2-Amino-4-{[(1R)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]amino}butanoate;|N-[(3S)-3-Amino-3-carboxypropyl]-D-histidine,,,,,
C22026,(R)-3-(Tetradecanoyloxy)hexadecanoic acid,,,,,
C22027,8-Methylmenaquinone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C22027  8-Methylmenaquinone,
C22028,2-Demethyl-8-methylmenaquinone,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C22028  2-Demethyl-8-methylmenaquinone,
C22029,alpha-D-Galactosamine 1-phosphate,,,,,
C22030,5-Amino-1-(beta-D-ribosyl)imidazole,,,,,
C22031,Cytidine 5'-diphosphoramidate,,,,,
C22032,Cytidine 3'-phospho-5'-diphosphoramidate;|3'-Phospho-cytidine-5'-diphosphoramidate,,,,,
C22033,N5-(Cytidine 5'-diphosphoramidyl)-L-glutamine,,,,,
C22034,"D-Xylono-1,4-lactone 5-phosphate;|5-Phospho-D-xylono-1,4-lactone",,,,,
C22035,5-Phospho-D-xylonate,,,,,
C22036,"L-Arabino-1,4-lactone 5-phosphate",,,,,
C22037,5-Phospho-L-arabinate;|5-Phospho-L-arabinonate,,,,,
C22038,"(R)-3-(3,4-Dihydroxyphenyl)lactate",,,,,
C22039,"2-Carboxy-1,4-naphthoquinone;|1,4-Dioxo-2-naphthoic acid",,,,,
C22040,S-Methyl-L-cysteine,,,,,
C22041,Acifluorfen;|5-[2-Chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid,,,,Pesticides [BR:br08007]|Pesticides|Herbicides|Diphenyl ether herbicide|C22041  Acifluorfen,
C22042,Pyribencarb,,,,Pesticides [BR:br08007]|Pesticides|Fungicides|Carbamate fungicides|C22042  Pyribencarb|Pyridine fungicides|C22042  Pyribencarb|Strobilurin fungicides|C22042  Pyribencarb,
C22043,"7-epi-ent-Eudesmane-5,11-diol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C22043  7-epi-ent-Eudesmane-5,11-diol",
C22044,alpha-Selinene,IUBMB,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010319 Eudesmane sesquiterpenoids|C22044  alpha-Selinene,
C22045,(-)-5-Epieremophilene,,,,,
C22046,Nocamycin E,,,,,
C22047,Nocamycin I,,,,,
C22048,"4-O-Methylxanthohumol;|(2E)-1-[2,4-Dihydroxy-6-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-(4-methoxyphenyl)prop-2-en-1-one",,,,Lipids [BR:br08002]|PK  Polyketides|PK12 Flavonoids|PK1212 Chalcones and dihydrochalcones|C22048  4-O-Methylxanthohumol,
C22049,"8beta-Hydroxygermacrene A acid;|8beta-Hydroxygermacra-1(10),4,11(13)-trien-12-oate",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0103 C15 isoprenoids (sesquiterpenes)|PR010309 Germacrane sesquiterpenoids|C22049  8beta-Hydroxygermacrene A acid,
C22050,"6alpha,8beta-Dihydroxygermacra-1(10),4,11(13)-trien-12-oate",,,,,
C22051,"8alpha-Hydroxygermacra-1(10),4,11(13)-trien-12-oate",,,,,
C22052,beta-Pinacene,,,,,
C22053,UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-L-glutamate;|UDP-MurNAc-L-Ala-L-Glu,,,,,
C22054,"8-epi-Inunolide;|Germacra-1(10),4,11(13)-trien-12,8alpha-lactone",,,,,
C22055,Lycopaoctaene,,,,,
C22056,Nonaflavuxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22056  Nonaflavuxanthin,
C22057,Flavuxanthin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22057  Flavuxanthin,
C22058,Dihydroisopentenyldehydrorhodopin,,,,,
C22059,Isopentenyldehydrorhodopin,,,,,
C22060,Dihydrobisanhydrobacterioruberin,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22060  Dihydrobisanhydrobacterioruberin,
C22061,2-(Long-chain-fatty acyl)-trehalose,Generic compound in reaction hierarchy|R = long-chain fatty acyl,,,,
C22062,Mycolipenoyl-CoA,,,,,
C22063,2-(Long-chain-fatty acyl)-3-mycolipenoyl-trehalose,Generic compound in reaction hierarchy|R = long-chain fatty acyl,,,,
C22064,Medium-chain 3-oxoacyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22065,2-Oxo-3-(phosphooxy)propyl 3-oxoalkanoate,Generic compound in reaction hierarchy,,,,
C22066,2'-Hydroxy-beta-oxodihydrochalcone,Generic compound in reaction hierarchy,,,,
C22067,3'-(beta-D-Glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone,Generic compound in reaction hierarchy,,,Glycosides [BR:br08021]|O-glycosides|Chalcone glycosides|C22067  3'-(beta-D-Glucopyranosyl)-2'-hydroxy-beta-oxodihydrochalcone,
C22068,H. pylori KDO2-lipid IVA,,,,Lipids [BR:br08002]|SL  Saccharolipids|SL02 Acylaminosugar glycans|C22068  H. pylori KDO2-lipid IVA,
C22069,"N1-(3,4-Dihydroxybenzoyl)-N8,N'8-citryl-bis(spermidine)",,,,,
C22070,"2,4-Dihydroxycinnamoyl-CoA;|(2E)-3-(2,4-Dihydroxyphenyl)prop-2-enoyl-CoA",,,,,
C22071,Pterocarpan,Generic compound in reaction hierarchy,,,,
C22072,2-[(L-Alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate,,,,,
C22073,2-[(2-Aminoethylcarbamoyl)methyl]-2-hydroxybutanedioate,,,,,
C22074,2-[(L-Alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2-hydroxypropanoate,,,,,
C22075,Staphyloferrin B,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22075,
C22076,[Protein]-(3S)-3-hydroxy-L-lysine,Generic compound in reaction hierarchy,,,,
C22077,6-Sulfo-alpha-D-quinovose;|alpha-Sulfoquinovose;|6-Deoxy-6-sulfo-alpha-D-glucopyranose,,,,,
C22078,6-Sulfo-beta-D-quinovose;|beta-Sulfoquinovose;|6-Deoxy-6-sulfo-beta-D-glucopyranose,,,,,
C22079,"Luteothin;|Deoxyaureothin;|2-[(3E,5E)-3,5-Dimethyl-6-(4-nitrophenyl)hexa-3,5-dien-1-yl]-6-methoxy-3,5-dimethyl-4H-pyran-4-one",,,,,
C22080,(7R)-7-Hydroxyluteothin,,,,,
C22081,4-Amino-L-phenylalanyl-[peptidyl-carrier-protein],Generic compound in reaction hierarchy,,,,
C22083,"beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-O-P-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C22083  beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-O-P-Glu-L-Lys-D-Ala-D-Ala)-diphospho-ditrans,octacis-undecaprenol",
C22084,1-Carboxybiuret;|N-[(Carbamoylamino)carbonyl]carbamate,,,,,
C22085,"Urea-1,3-dicarboxylate",,,,,
C22086,Demethylluteothin,,,,,
C22087,"(2E,5S,6E,8E,10E)-5-Hydroxydodeca-2,6,8,10-tetraenal",,,,,
C22088,"Bis(myo-inositol) 1,3'-phosphate",,,,,
C22089,"2-O-(beta-D-Mannosyl-(1->2)-beta-D-mannosyl)-bis(myo-inositol) 1,3'-phosphate;|2-(O-beta-D-Mannosyl-1,2-O-beta-D-mannosyl)-di-myo-inositol-1,3'-phosphate;|MMDIP",,,,,
C22090,"2-O-(beta-D-Mannosyl)-bis(myo-inositol) 1,3'-phosphate;|2-(O-beta-D-Mannosyl)-di-myo-inositol-1,3'-phosphate;|MDIP",,,,,
C22091,"(2E,5S,6E,8E,10E)-1-Aminododeca-2,6,8,10-tetraen-5-ol",,,,,
C22092,5'-O-Phosphonoadenylyl-(3'->5')-adenosine;|pApA,,,,,
C22093,6-Deoxy-D-gulose;|6-Deoxy-D-gulopyranose,,,,,
C22094,"3'-(Hydroxy)phthioceranyl-2'-palmitoyl(stearoyl)-2-O-sulfo-alpha,alpha-trehalose",Generic compound in reaction hierarchy|l=14 or 16|m=4-9|n=14 or 16,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C22094  3'-(Hydroxy)phthioceranyl-2'-palmitoyl(stearoyl)-2-O-sulfo-alpha,alpha-trehalose",
C22095,"3,6,6'-Tris-(hydroxy)phthioceranyl-2-palmitoyl(stearoyl)-2'-sulfo-alpha,alpha-trehalose",Generic compound in reaction hierarchy|l=14 or 16|m=4-9|n=14 or 16,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C22095  3,6,6'-Tris-(hydroxy)phthioceranyl-2-palmitoyl(stearoyl)-2'-sulfo-alpha,alpha-trehalose",
C22096,"2'-Palmitoyl/stearoyl-2-O-sulfo-alpha,alpha-trehalose",Generic compound in reaction hierarchy|n=14 or 16,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C22096  2'-Palmitoyl/stearoyl-2-O-sulfo-alpha,alpha-trehalose",
C22097,(1->6)-alpha-D-Glucan containing a (1->3)-alpha-D-glucose branch,,,,,
C22098,Monopotassium glycyrrhizin;|Monopotassium glycyrrhizinate,,,,,
C22099,Sennoside A calcium salt,,,,Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C22099  Sennoside A calcium salt,
C22100,Sennoside B calcium salt,,,,Glycosides [BR:br08021]|O-glycosides|Anthraquinone glycosides|C22100  Sennoside B calcium salt,
C22101,N5-Citryl-D-ornithine;|delta-Citryl-D-ornithine;|N5-[(S)-Citryl]-D-ornithine,,,,,
C22102,Staphyloferrin A,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22102,
C22103,"3beta-Hydroxy-4,4-dimethylsteroid",Generic compound in reaction hierarchy,,,,
C22104,3beta-Hydroxy-4beta-hydroxymethyl-4alpha-methylsteroid,Generic compound in reaction hierarchy,,,,
C22105,3beta-Hydroxy-4beta-formyl-4alpha-methylsteroid,Generic compound in reaction hierarchy,,,,
C22106,3beta-Hydroxy-4alpha-methylsteroid-4beta-carboxylate,Generic compound in reaction hierarchy,,,,
C22107,4alpha-Methyl-3-oxosteroid,Generic compound in reaction hierarchy,,,,
C22108,Hydropyrene,,,,,
C22109,Hydropyrenol,,,,,
C22110,Isoelisabethatriene,,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0104 C20 isoprenoids (diterpenes)|PR010441 Amphilectane, cycloamphilectane, adociane and neoamphilectane diterpenoids|C22110  Isoelisabethatriene",
C22111,3beta-Hydroxysteroid-4alpha-carboxylate,Generic compound in reaction hierarchy,,,,
C22112,"4alpha-Carboxy-5alpha-cholesta-8,24-dien-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22112  4alpha-Carboxy-5alpha-cholesta-8,24-dien-3beta-ol",
C22113,16alpha-Hydroxy-beta-amyrin,,,,,
C22114,"4alpha-(Hydroxymethyl)-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-3beta-ol;|24-Methylenecycloartane-3,28-diol",,,,,
C22115,"4alpha-Formyl-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-3beta-ol",,,,,
C22116,"3beta-Hydroxy-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-4alpha-carboxylate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C22116  3beta-Hydroxy-4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(24(1))-en-4alpha-carboxylate",
C22117,"4alpha-(Hydroxymethyl)ergosta-7,24(24(1))-dien-3beta-ol",,,,,
C22118,"4alpha-Formylergosta-7,24(24(1))-dien-3beta-ol",,,,,
C22119,"3beta-Hydroxyergosta-7,24(24(1))-dien-4alpha-carboxylate",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C22119  3beta-Hydroxyergosta-7,24(24(1))-dien-4alpha-carboxylate",
C22120,"4alpha-Carboxy-stigmasta-7,24(24(1))-dien-3beta-ol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C22120  4alpha-Carboxy-stigmasta-7,24(24(1))-dien-3beta-ol",
C22121,Cycloeucalenone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0110 Cycloartanols and derivatives|C22121  Cycloeucalenone,
C22122,"Episterone;|5alpha-Ergosta-7,24(28)-dien-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0103 Ergosterols and C24-methyl derivatives|C22122  Episterone,
C22123,Avenastenone,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0104 Stigmasterols and C24-ethyl derivatives|C22123  Avenastenone,
C22124,Palmitoyl-[(hydroxy)phthioceranic acid synthase],Generic compound in reaction hierarchy,,,,
C22125,C40-Phthioceranyl-[(hydroxy)phthioceranic acid synthase],Generic compound in reaction hierarchy,,,,
C22126,C37-Phthioceranyl-[(hydroxy)phthioceranic acid synthase],Generic compound in reaction hierarchy,,,,
C22127,Ginsenoside C-K,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C22127  Ginsenoside C-K|Dietary phytochemicals [br08012.html]|Other phytochemicals|C22127,
C22128,(20S)-Ginsenoside Rh2,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C22128  (20S)-Ginsenoside Rh2|Dietary phytochemicals [br08012.html]|Other phytochemicals|C22128,
C22129,Ginsenoside Rh1,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0106 C30 isoprenoids (triterpenes)|PR010608 Dammarane triterpenoids|C22129  Ginsenoside Rh1|Dietary phytochemicals [br08012.html]|Other phytochemicals|C22129,
C22130,Oleanolate 3-O-beta-D-glucoside,,,,,
C22131,3''-O-Acetyl-ADP-D-ribose,,,,,
C22132,(Stearoyl)adenylate,,,,,
C22134,Stearoyl-[(hydroxy)phthioceranic acid synthase];|Stearoyl-[pcp],Generic compound in reaction hierarchy,,,,
C22135,(Palmitoyl)adenylate,,,,,
C22136,"Zymosterone;|5alpha-Cholesta-8,24-dien-3-one",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22136  Zymosterone,
C22137,4-Chloro-L-lysine,,,,,
C22138,L-Propargylglycine,,,,,
C22139,gamma-L-Glutamyl-L-propargylglycine,,,,,
C22140,L-gamma-Glutamyl-(3R)-L-beta-ethynylserine,,,,,
C22141,L-beta-Ethynylserine,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22141,
C22142,Cyclo(L-Trp-L-Phe),,,,,
C22143,N-Methyl-cyclo(L-Trp-L-Phe),,,,,
C22144,(-)-Ditryptophenaline,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22144,
C22145,Fumiquinazoline F,,,,,
C22146,"Fumiquinazoline F-indoline-2',3'-diol",,,,,
C22147,Fumiquinazoline A,,,,,
C22148,Fumiquinazoline C,,,,,
C22149,Fumiquinazoline D,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22149,
C22152,Bergamottin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22152,
C22153,Epoxybergamottin,,,,,
C22156,"6',7'-Dihydroxybergamottin;|6,7-Dihydroxybergamottin",,,,,
C22157,Glycine cleavage system H;|[Glycine cleavage system H]-L-lysine;|[GcvH]-L-lysine;|[GCSH]-L-lysine,Generic compound in reaction hierarchy,,,,
C22158,Lipoyl-carrier protein E2;|[Lipoyl-carrier protein E2]-L-lysine;|[E2 protein]-L-lysine,Generic compound in reaction hierarchy,,,,
C22159,[Glycine cleavage system H]-N6-octanoyl-L-lysine;|[GcvH]-N6-octanoyl-L-lysine;|[GCSH]-N6-octanoyl-L-lysine,Generic compound in reaction hierarchy,,,,
C22160,[Lipoyl-carrier protein E2]-N6-octanoyl-L-lysine;|[E2 protein]-N6-octanoyl-L-lysine,Generic compound in reaction hierarchy,,,,
C22161,Dihydrolipoyl-AMP,,,,,
C22162,Histidyltryptophyldiketopiperazine,,,,,
C22163,Roquefortine D,,,,,
C22164,Dehydrohistidyltryptophyldiketopiperazine,,,,,
C22165,Roquefortine C,,,,,
C22166,Glandicoline A,,,,,
C22167,Glandicoline B,,,,,
C22168,Meleagrin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22168,
C22169,N1-Hydroxy-roquefortine C,,,,,
C22170,Roquefortine L,,,,,
C22171,Roquefortine F,,,,,
C22172,Neoxaline,,,,,
C22173,Harderoheme III,,,,,
C22174,Valerianol,,,,,
C22175,Cyclolaudenol;|(24S)-24-Methylcycloart-25-en-3beta-ol,,,,,
C22176,"2-O-Sulfo-2'-palmitoyl-alpha,alpha-trehalose",,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C22176  2-O-Sulfo-2'-palmitoyl-alpha,alpha-trehalose",
C22177,"2-O-Sulfo-2'-stearoyl-alpha,alpha-trehalose",,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL03 Acyltrehaloses|C22177  2-O-Sulfo-2'-stearoyl-alpha,alpha-trehalose",
C22178,4-Nitrobenzoyl-CoA,,,,,
C22179,Demethyldeoxyspectinabilin,,,,,
C22180,Monoglucosyl-enterobactin,,,,,
C22181,Diglucosyl-enterobactin;|Salmochelin S4,,,,,
C22182,Triglucosyl-enterobactin,,,,,
C22183,Very-long-chain inositol phospho-(2'R)-2'-hydroxyphytoceramide,Generic compound in reaction hierarchy,,,,
C22184,Very-long-chain mannosylinositol phospho-(2'R)-2'-hydroxyphytoceramide;|Very-long-chain mannosylinositol phospho-alpha-hydroxyphytoceramide,Generic compound in reaction hierarchy,,,,
C22185,"N-(2,3-Dihydroxybenzoyl)-L-serine trimer;|O-3-{O-3-[N-(2,3-Dihydroxybenzoyl)-L-seryl]-N-(2,3-dihydroxybenzoyl)-L-seryl}-N-(2,3-dihydroxybenzoyl)-L-serine",,,,,
C22186,"Triglucosyl-(2,3-dihydroxybenzoylserine)3;|O-3-{O-3-[N-(2,3-Dihydroxybenzoyl)-C-5-deoxy-beta-D-glucosyl-L-seryl]-N-(2,3-dihydroxybenzoyl)-C-5-deoxy-beta-D-glucosyl-L-seryl}-N-(2,3-dihydroxybenzoyl)-C-5-deoxy-beta-D-glucosyl-L-serine",,,,,
C22187,"Diglucosyl-(2,3-dihydroxybenzoylserine)3;|Salmochelin S2",,,,,
C22188,"Monoglucosyl-(2,3-dihydroxybenzoylserine)3;|O-3-{O-3-[N-(2,3-Dihydroxybenzoyl)-C-5-deoxy-beta-D-glucosyl-L-seryl]-N-(2,3-dihydroxybenzoyl)-L-seryl}-N-(2,3-dihydroxybenzoyl)-L-serine",,,,,
C22189,Acetyldigoxin,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C22189  Acetyldigoxin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D07555)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA02 Acetyldigoxin|D07555  Acetyldigoxin|Drug groups [BR:br08330(D07555)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D07555  Acetyldigoxin|Target-based classification of drugs [BR:br08310(D07555)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D07555  Acetyldigoxin,
C22190,beta-Acetyldigoxin;|Acetyldigoxin beta isomer,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C22190  beta-Acetyldigoxin|Drug groups [BR:br08330(D07556)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D07556  beta-Acetyldigoxin|Target-based classification of drugs [BR:br08310(D07556)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D07556  beta-Acetyldigoxin,
C22191,Acetyldigitoxin,,,,Glycosides [BR:br08021]|O-glycosides|Cardiac glycosides|C22191  Acetyldigitoxin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06881)]|C CARDIOVASCULAR SYSTEM|C01 CARDIAC THERAPY|C01A CARDIAC GLYCOSIDES|C01AA Digitalis glycosides|C01AA01 Acetyldigitoxin|D06881  Acetyldigitoxin (INN)|Drug groups [BR:br08330(D06881)]|Cardiovascular agent|DG01703  Cardiotonic|DG01698  Cardiac glycoside|DG01697  Digitalis cardiac glycoside|D06881  Acetyldigitoxin|Target-based classification of drugs [BR:br08310(D06881)]|Enzymes|Hydrolases (EC3)|ATPase|ATP1A|D06881  Acetyldigitoxin (INN),
C22192,Anthelmycin;|Antelmycin,,,,Glycosides [BR:br08021]|N-glycosides|C22192  Anthelmycin,
C22193,Dapagliflozin,,,,"Glycosides [BR:br08021]|C-glycosides|C22193  Dapagliflozin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D08897)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors|A10BK01 Dapagliflozin|D08897  Dapagliflozin (JAN/USAN/INN)|Drug groups [BR:br08330(D08897)]|Antidiabetic agent|DG02044  Hypoglycemic agent|DG01794  SGLT2 inhibitor|DG00122  Dapagliflozin|D08897  Dapagliflozin|Metabolizing enzyme substrate|DG02924  UGT substrate|DG03188  UGT1A9 substrate|DG00122  Dapagliflozin|D08897  Dapagliflozin|Target-based classification of drugs [BR:br08310(D08897)]|Transporters|Solute carrier family|SLC5|SLC5A2 (SGLT2)|D08897  Dapagliflozin (JAN/USAN/INN)|Drug metabolizing enzymes and transporters [br08309.html(D08897)]|Drug metabolizing enzymes|D08897",
C22194,Empagliflozin,,,,"Glycosides [BR:br08021]|C-glycosides|C22194  Empagliflozin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D10459)]|A ALIMENTARY TRACT AND METABOLISM|A10 DRUGS USED IN DIABETES|A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS|A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors|A10BK03 Empagliflozin|D10459  Empagliflozin (JAN/USAN/INN) &lt;JP/US&gt;|USP drug classification [BR:br08302(D10459)]|Blood Glucose Regulators|Antidiabetic Agents|Sodium-Glucose Co-Transporter 2 (SGLT2) Inhbitor|Empagliflozin|D10459  Empagliflozin (JAN/USAN/INN)|Cardiovascular Agents|Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i)|Empagliflozin|D10459  Empagliflozin (JAN/USAN/INN)|Therapeutic category of drugs in Japan [BR:br08301(D10459)]|2  Agents affecting individual organs|21  Cardiovascular agents|219  Miscellaneous|2190  Miscellaneous|D10459  Empagliflozin (JAN/USAN/INN)|3  Agents affecting metabolism|39  Other agents affecting metabolism|396  Antidiabetic agents|3969  Others|D10459  Empagliflozin (JAN/USAN/INN)|399  Miscellaneous|3999  Others|D10459  Empagliflozin (JAN/USAN/INN)|Drug groups [BR:br08330(D10459)]|Antidiabetic agent|DG02044  Hypoglycemic agent|DG01794  SGLT2 inhibitor|D10459  Empagliflozin|Metabolizing enzyme substrate|DG02924  UGT substrate|DG03184  UGT1A3 substrate|D10459  Empagliflozin|DG03186  UGT1A8 substrate|D10459  Empagliflozin|DG03188  UGT1A9 substrate|D10459  Empagliflozin|DG03190  UGT2B7 substrate|D10459  Empagliflozin|Transporter substrate|DG01665  ABCB1 substrate|D10459  Empagliflozin|DG01913  ABCG2 substrate|D10459  Empagliflozin|Drug classes [BR:br08332(D10459)]|Antidiabetic agent|DG01794  SGLT2 inhibitor|D10459  Empagliflozin|DG02044  Hypoglycemic agent|D10459  Empagliflozin|Target-based classification of drugs [BR:br08310(D10459)]|Transporters|Solute carrier family|SLC5|SLC5A2 (SGLT2)|D10459  Empagliflozin (JAN/USAN/INN) &lt;JP/US&gt;|New drug approvals in the USA [br08319.html(D10459)]|New molecular entities and new therapeutic biological products|D10459|New drug approvals in Europe [br08329.html(D10459)]|European public assessment reports (EPAR) authorised medicine|D10459|New drug approvals in Japan [br08318.html(D10459)]|Drugs with new active ingredients|D10459|New drug approvals in the USA, Europe and Japan [br08328.html(D10459)]|Approval dates by FDA, EMA and PMDA|D10459|Drug metabolizing enzymes and transporters [br08309.html(D10459)]|Drug metabolizing enzymes|D10459|Drug transporters|D10459",
C22195,Pyrazofurin;|Pirazofurin,,,,Glycosides [BR:br08021]|C-glycosides|C22195  Pyrazofurin,
C22196,Tiazofurin;|Tiazofurine,,,,Glycosides [BR:br08021]|C-glycosides|C22196  Tiazofurin|Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D06130)]|L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS|L01 ANTINEOPLASTIC AGENTS|L01X OTHER ANTINEOPLASTIC AGENTS|L01XX Other antineoplastic agents|L01XX18 Tiazofurine|D06130  Tiazofurin (USAN)|Target-based classification of drugs [BR:br08310(D06130)]|Enzymes|Oxidoreductases (EC1)|Dehydrogenases|IMPDH|D06130  Tiazofurin (USAN),
C22197,Semduramicin,,,,Lipids [BR:br08002]|PK  Polyketides|PK09 Polyether antibiotics|C22197  Semduramicin|Glycosides [BR:br08021]|C-glycosides|C22197  Semduramicin,
C22198,Oxidised coenzyme F420-(gamma-Glu)n,,,,,
C22199,Reduced coenzyme F420-(gamma-Glu)n,,,,,
C22200,"(+)-cis,cis-Nepetalactol;|(4aR,7S,7aS)-4,7-Dimethyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-ol",,,,,
C22201,"(+)-cis,cis-Nepetalactone",,,,,
C22202,"2-Oxoindole-3-acetate;|2-Oxoindole-3-acetic acid;|2-Indolinone-3-acetate;|2-(2-Oxo-1,3-dihydroindol-3-yl)acetate",,,,,
C22203,Isophthalate;|Isophthalic acid,,,,,
C22204,Isophthalyl-CoA,,,,,
C22205,(R)-3-(4-Hydroxyphenyl)lactoyl-CoA,,,,,
C22206,(R)-3-(Indol-3-yl)lactoyl-CoA;|(R)-3-Indolelactyl-CoA,,,,,
C22207,3-(Indol-3-yl)acryloyl-CoA,,,,,
C22208,Sodorifen,,,,,
C22209,Pre-sodorifen diphosphate,,,,,
C22210,4-Amino-4-deoxyprephenate,,,,,
C22211,Marinolic acid,Generic compound in reaction hierarchy,,,,
C22212,Marinoloyl-CoA,Generic compound in reaction hierarchy,,,,
C22213,Pseudomonic acid,Generic compound in reaction hierarchy,,,,
C22214,Pseudomonoyl-CoA,Generic compound in reaction hierarchy,,,,
C22215,Long-chain 3-hydroxysterol ester,Generic compound in reaction hierarchy,,,,
C22216,Cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate};|HEP-CMP,,,,,
C22217,Cytidine 5'-({hydroxy[(S)-2-hydroxypropyl]phosphonoyl}phosphate);|(2S)-HPP-CMP,,,,,
C22218,"D-Apionolactone;|(3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)oxolan-2-one",,,,,
C22219,D-Apionate,,,,,
C22220,"3-Oxoisoapionate;|2,4-Dihydroxy-2-(hydroxymethyl)-3-oxobutanoate",,,,,
C22221,7-Deoxycylindrospermopsin,,,,,
C22222,7-epi-Cylindrospermopsin,,,,,
C22223,N-Methyl-L-proline,,,,,
C22224,(Indol-3-yl)acetyl-L-aspartate,,,,,
C22225,(S)-8-Oxocitronellyl enol,,,,,
C22226,Icosanoyl-[(phenol)carboxyphthiodiolenone synthase],,,,,
C22227,[Sulfatase]-L-serine,Generic compound in reaction hierarchy|R = sulfatase,,,,
C22228,(2R)-2-Hydroxy fatty acid,Generic compound in reaction hierarchy,,,,
C22229,"[alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",,,,"Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0303 Bactoprenol diphosphates|C22229  [alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)]n-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-Man-(1->3)-alpha-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol",
C22230,(1->6)-alpha-D-Glucan containing a (1->2)-alpha-D-glucose branch,,,,,
C22231,Amicoumacin A,,,,,
C22232,Amicoumacin A 2-phosphate,,,,,
C22233,(Salicyl)adenylate;|2-Hydroxybenzoyl-AMP;|(2-Hydroxybenzoyl)adenylate,,,,,
C22234,8-Oxo-GTP;|8-Oxoguanosine triphosphate,,,,,
C22235,8-Oxo-GDP;|8-Oxoguanosine 5'-diphosphate,,,,,
C22236,3-(1H-Indol-3-yl)propanoate,,,,,
C22237,Glycerophosphoserine,,,,,
C22238,FMN-N5-oxide,,,,,
C22239,"4a-Hydroxy-5,6,7,8-tetrahydropteridine",Generic compound in reaction hierarchy,,,,
C22240,"N-Acetyl-6-deoxy-L-altrosamine;|2-Acetamido-2,6-dideoxy-L-altropyranose",,,,,
C22241,"N-Acetyl-6-deoxy-D-talosamine;|2-Acetamido-2,6-dideoxy-D-talopyranose",,,,,
C22242,Acofriose;|D-Acofriose;|3-O-Methyl-D-rhamnose,,,,,
C22243,L-Acofriose;|3-O-Methyl-L-rhamnose,,,,,
C22244,"Ascarylose;|3,6-Dideoxy-L-arabino-hexopyranose",,,,,
C22245,UDP-2-acetamido-2-deoxy-alpha-D-galacturonamide;|UDP-GalNAcAN,,,,,
C22246,"UDP-2,3-dideoxy-2-acetamido-3-acetamidino-alpha-D-mannuronic acid;|UDP-D-Man(2NAc3NAm)A",,,,,
C22247,"UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-glucopyranose;|UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-glucose",,,,,
C22248,"UDP-2-acetamido-4-(D-alanylamino)-2,4,6-trideoxy-alpha-D-mannopyranose",,,,,
C22249,"2-Acetamido-4-(D-alanylamino)-2,4,6-trideoxy-D-mannopyranose",,,,,
C22250,5-N-Acetyl-7-N-(D-alanyl)-legionaminic acid;|Leg5Ac7Ala,,,,,
C22251,CMP-5-N-acetyl-7-N-(D-alanyl)-legionaminic acid;|CMP-Leg5Ac7Ala,,,,,
C22252,"UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-idose",,,,,
C22253,"UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-gulose",,,,,
C22254,"2,4-Diacetamido-2,4,6-trideoxy-beta-L-gulose",,,,,
C22255,"5,7-Diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonic acid;|Di-N-acetyl-8-epilegionaminic acid;|N,N'-Diacetyl-8-epilegionaminate;|8eLeg5Ac7Ac",,,,,
C22256,"CMP-5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonic acid;|CMP-di-N-acetyl-8-epilegionaminic acid;|CMP-N,N'-diacetyl-8-epilegionaminate;|CMP-8eLeg5Ac7Ac",,,,,
C22257,"dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose;|dTDP-D-Qui3NAc",,,,,
C22258,"(2E,4Z)-2,4-Dienoyl-CoA",Generic compound in reaction hierarchy,,,,
C22259,"UDP-2-acetamido-2,6-dideoxy-beta-L-mannose;|UDP-N-acetyl-L-rhamnosamine;|UDP-L-RhaNAc",,,,,
C22260,"UDP-2-acetamido-2,6-dideoxy-beta-L-glucose;|UDP-L-QuiNAc",,,,,
C22261,"UDP-2-acetamido-2,6-dideoxy-alpha-D-galactose;|UDP-N-acetyl-alpha-D-fucosamine;|UDP-D-FucNAc",,,,,
C22262,"UDP-2-acetamido-2,6-dideoxy-alpha-D-glucose;|UDP-N-acetyl-alpha-D-quinovosamine;|UDP-N-acetyl-6-deoxy-alpha-D-glucosamine;|UDP-D-QuiNAc",,,,,
C22263,(S)-2-Methylamino-1-phenylpropan-1-one;|(S)-Methcathinone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22263,
C22264,(L-Arginyl)adenylate;|L-Arginyl-AMP;|L-Arginyl-adenylate,,,,,
C22265,L-Arginyl-[pcp];|L-Arginyl-[peptidyl-carrier protein],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C22266,5-Methylaminomethyl-2-(S-geranyl)thiouridine in tRNA,Generic compound in reaction hierarchy|hypermodified  uridine located in the wobble position of the anticodon (position 34) of tRNA,,,,
C22267,5-Methylaminomethyl-2-(Se-phospho)selenouridine in tRNA,Generic compound in reaction hierarchy|hypermodified  uridine located in the wobble position of the anticodon (position 34) of tRNA,,,,
C22268,5-Methylaminomethyl-2-selenouridine in tRNA,Generic compound in reaction hierarchy|hypermodified  uridine located in the wobble position of the anticodon (position 34) of tRNA,,,,
C22269,"(2E)-3,7-Dimethylocta-2,6-diene-1-thiol;|Thiogeraniol",,,,,
C22270,"UDP-2,6-dideoxy-2-acetamidino-beta-L-galactose;|UDP-L-FucNAm",,,,,
C22271,[(1R)-1-Hydroxy-2-(trimethylamino)ethyl]phosphonate,,,,,
C22272,(+)-Perillyl alcohol;|(R)-Perillyl alcohol;|[(4R)-4-(Prop-1-en-2-yl)cyclohex-1-en-1-yl]methanol,,,,,
C22273,Petrobactin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22273,
C22274,8-Oxo-GMP;|8-Oxoguanosine 5'-phosphate,,,,,
C22275,GS-441524,,,,Prodrugs [br08324.html]|C22275,
C22276,"UDP-4-amino-4,6-dideoxy-N-acetyl-beta-L-idosamine;|UDP-2-acetamido-4-amino-2,4,6-trideoxy-beta-L-idose",,,,,
C22277,"Dehydro coenzyme F420-0;|Dehydro factor 420-0;|7,8-Didemethyl-8-hydroxy-5-deazariboflavin 5'-(1-carboxyvinyl)phosphate;|2-{[5-Deoxy-5-(8-hydroxy-2,4-dioxopyrimidino[4,5-b]quinolin-10(2H)-yl)-L-ribityloxy]hydroxyphosphoryloxy}prop-2-enoate",,,,,
C22278,3-Oxoisoapionate 4-phosphate,,,,,
C22279,(2-Methylthio)acetaldehyde;|(2-Methylsulfanyl)acetaldehyde,,,,,
C22280,5-Deoxy-D-ribulose 1-phosphate,,,,,
C22281,[2-(Trimethylamino)ethyl]phosphonate,,,,,
C22282,"3,5,6-Trichloropyridin-2-ol",,,,,
C22283,"3,6-Dichloropyridine-2,5-dione",,,,,
C22284,"6-Chloro-3-hydroxypyridine-2,5-dione;|6-Chloro-2,5-carbonyl-3-pyridine dione",,,,,
C22285,"3,6-Dichloropyridine-2,5-diol",,,,,
C22286,"6-Chloropyridine-2,3,5-triol",,,,,
C22287,"3,6-Dihydroxypyridine-2,5-dione",,,,,
C22288,5-Deoxy-D-ribose,,,,,
C22289,(6E)-8-Methylnon-6-enoyl-CoA;|8-Methylnon-6-enoyl-CoA,,,,,
C22290,"2-Chloro-6-hydroxy-1,4-benzoquinone;|6-Chloro-2-hydroxy-1,4-benzoquinone",,,,,
C22291,"3,3'-Di-O-methyl-4alpha-mannobiose;|3-O-Methyl-alpha-D-mannopyranosyl-(1->4)-3-O-methyl-alpha-D-mannopyranose",,,,,
C22292,"1,3,3'-Tri-O-methyl-4alpha-mannobiose",,,,,
C22293,N4-Acetylcytidine,,,,,
C22294,N-Acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R,Generic compound in reaction hierarchy,,,,
C22295,N-Acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-R,Generic compound in reaction hierarchy,,,,
C22296,[Protein]-(3R)-3-hydroxy-L-arginine,Generic compound in reaction hierarchy,,,,
C22297,Enolpyruvoyl-2-diphospho-5'-guanosine,,,,,
C22298,3-(D-Glyceryl)-diphospho-5'-guanosine;|3-[(R)-Glyceryl]-diphospho-5'-guanosine,,,,,
C22299,3PG-factor 420-0,,,,,
C22300,3(1)-Hydroxy-L-isoleucine,,,,,
C22301,"(4S)-31,4-Dihydroxy-L-isoleucine",,,,,
C22302,(+)-6-Hydroxypinoresinol,,,,,
C22309,"Apulose;|1,3,4-Trihydroxy-3-(hydroxymethyl)butan-2-one",,,,,
C22310,Fructose 3-phosphate,,,,,
C22311,3-Deoxyglucosone,,,,,
C22312,3-Sulfanylpropanoate;|3-Mercaptopropionate;|3-Mercaptopropanoic acid,,,,,
C22313,3-Sulfinopropanoate;|3-Sulfinopropionic acid,,,,,
C22314,(3R)-3-Hydroxy-L-glutamate,,,,,
C22315,(2R)-2-Hydroxy-4-(methylsulfanyl)butanoate,,,,,
C22316,(2R)-4-(Dimethylsulfaniumyl)-2-hydroxybutanoate,,,,,
C22317,2-Heptyl-1-methoxyquinolin-4(1H)-one;|HMOQ,,,,,
C22318,Apulose 4-phosphate,,,,,
C22319,1-Tuberculosinyladenosine,,,,,
C22320,beta-D-Glucosaminyl-(1->4)-N-acetyl-D-glucosamine,,,,,
C22321,"N,N-Dimethyl-N'-phenylurea compound",Generic compound in reaction hierarchy,,,,
C22322,N-Methyl-N'-phenylurea compound,,,,,
C22323,"alpha-N-Dichloroacetyl-p-aminophenylserinol;|N-[(1R,2R)-1-(4-Aminophenyl)-1,3-dihydroxypropan-2-yl]-2,2-dichloroacetamide",,,,,
C22324,N6-[(2E)-4-Hydroxy-3-methylbut-2-en-1-yl]-2-(methylsulfanyl)adenine in tRNA;|ms2io6A in tRNA,Generic compound in reaction hierarchy,,,,
C22325,25-Hydroxycholest-4-en-3-one,,,,,
C22326,"Steroid 1,3-dione",Generic compound in reaction hierarchy,,,,
C22327,1-Hydroxy-3-oxo-steroid,Generic compound in reaction hierarchy,,,,
C22328,Heme I,,,,,
C22329,Hydroxyheme I,,,,,
C22330,"3-Amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one;|AHDP",,,,,
C22331,"5-[(4-Hydroxyphenyl)methyl]-4,4-dimethylpyrrolidine-2,3-dione;|Pre-mycofactocinone;|PMFT",,,,,
C22332,"5-[(4-Hydroxyphenyl)methyl]-3-imino-4,4-dimethylpyrrolidin-2-one",,,,,
C22333,"N,N-Dihydroxy-L-aspartate;|(2S)-2-(Dihydroxyamino)butanedioic acid",,,,,
C22334,(2S)-2-Nitrosobutanedioate,,,,,
C22337,D-Ribulose 1-phosphate,,,,,
C22338,Dihydro-heme d1,,,,,
C22339,Heme d1,,,,,
C22340,Heptaprenylglyceryl phosphate,,,,,
C22341,Heptaprenylglycerol,,,,,
C22342,Diacetylheptaprenylglycerol,,,,,
C22343,Dec-9-enoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,,
C22344,C-Terminal [mycofactocin precursor peptide]-glycyl-L-valyl-L-tyrosine,R = MftA,,,,
C22345,C-Terminal [mycofactocin precursor peptide]-glycyl-L-valyl-4-[2-aminoethenyl]phenol,R = MftA,,,,
C22346,"1'-Hydroxy-1',2'-dihydro-beta,psi-caroten-4'-one",,,,,
C22347,"Bisanhydrobacterioruberin;|2,2'-Bis(3-methylbut-2-enyl)-3,4,3',4'-tetradehydro-1,2,1',2'-tetrahydro-psi,psi-carotene-1,1'-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22347  Bisanhydrobacterioruberin,
C22348,"Monoanhydrobacterioruberin;|2-(3-Hydroxy-3-methylbutyl)-2'-(3-methylbut-2-enyl)-3,4,3',4'-tetradehydro-1,2,1',2'-tetrahydro-psi,psi-carotene-1,1'-diol",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22348  Monoanhydrobacterioruberin,
C22349,"Bacterioruberin;|psi,psi-Carotene, 3,3',4,4'-tetradehydro-1,1',2,2'-tetrahydro-1,1'-dihydroxy-2,2'-bis(3-hydroxy-3-methylbutyl)-, (2S,2'S)-",,,,Lipids [BR:br08002]|PR  Prenol lipids|PR01 Isoprenoids|PR0108 Polyterpenes|C22349  Bacterioruberin|Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22349,
C22350,"Levoglucosan;|1,6-Anhydro-beta-D-glucopyranose",,,,,
C22351,3-Dehydrolevoglucosan,,,,,
C22352,Ultra-long-chain fatty acid,Generic compound in reaction hierarchy,,,,
C22353,Ultra-long-chain omega-hydroxy fatty acid,Generic compound in reaction hierarchy,,,,
C22354,Dec-9-ynoyl-[acyl-carrier protein],Generic compound in reaction hierarchy,,,,
C22355,"Benzo[a]pyrene-7,8-diol;|Benzo[a]pyrene-7,8-catechol;|B[a]P-7,8-catechol",,,,,
C22356,"Benzo[a]pyrene-7,8-dione;|B[a]P-7,8-dione",,,,,
C22357,"17beta-Estradiol-2,3-quinone;|Estradiol-2,3-quinone",,,,,
C22358,"17beta-Estradiol-3,4-quinone;|Estradiol-3,4-quinone",,,,,
C22359,S-Methyl-1-thio-D-xylulose 5-phosphate,,,,,
C22360,S-Methyl-1-thio-D-ribulose 5-phosphate,,,,,
C22361,Glycyl-AMP;|(Glycyl)adenylate,,,,,
C22362,Glycyl-[peptidyl-carrier protein];|Glycyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C22363,(L-Alanyl)adenylate;|L-Alanyl-adenylate;|L-Alanyl-AMP,,,,,
C22364,L-Alanyl-[peptidyl-carrier protein];|L-Alanyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C22365,"C-Terminal [mycofactocin precursor peptide]-glycyl-3-amino-5-[(4-hydroxyphenyl)methyl]-4,4-dimethylpyrrolidin-2-one",R = MftA,,,,
C22366,(L-Glutamyl)adenylate;|L-Glutamyl-AMP,,,,,
C22367,L-Glutamyl-[peptidyl-carrier protein];|L-Glutamyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C22368,5-Methyl-3-oxohexanoyl-[acyl-carrier-protein];|3-Keto-5-methylhexanoyl-[acyl-carrier-protein],Generic compound in reaction hierarchy,,,,
C22369,4-Methyl-3-oxopentanoyl-[acyl-carrier-protein];|3-Keto-4-methylvaleryl-[acyl-carrier-protein],Generic compound in reaction hierarchy,,,,
C22370,(4S)-4-Methyl-3-oxohexanoyl-[acyl-carrier-protein];|(4S)-3-Keto-3-methylhexanoyl-[acyl-carrier-protein],Generic compound in reaction hierarchy,,,,
C22371,5-Hydroxyanthranilate,,,,,
C22372,"Avenanthramide C;|2-[(2E)-3-(3,4-Dihydroxyphenyl)prop-2-enamido]-5-hydroxybenzoate",,,,,
C22373,4-O-Methyl-D-glucopyranuronate ester,Generic compound in reaction hierarchy,,,,
C22374,4-O-Methyl-D-glucuronic acid,,,,,
C22375,4'-Hydroxyisoflavone,Generic compound in reaction hierarchy,,,,
C22376,Calcium oxybate,,,,,
C22377,Potassium oxybate,,,,,
C22378,Magnesium oxybate,,,,,
C22379,FMN-N5-peroxide,,,,,
C22380,N-Hydroxy-L-aspartate;|Hydroxyaspartic acid,,,,,
C22382,Aceneuramate;|Aceneuramic acid,N-Acetylneuraminate (pyranose) [CPD:C00270],,,"Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D11016)]|M MUSCULO-SKELETAL SYSTEM|M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM|M09AX Other drugs for disorders of the musculo-skeletal system|M09AX05 Aceneuramic acid|D11016  Aceneuramic acid (JAN/USAN) &lt;JP&gt;|Therapeutic category of drugs in Japan [BR:br08301(D11016)]|1  Agents affecting nervous system and sensory organs|19  Other agents affecting nervous system and sensory organs|190  Other agents affecting nervous system and sensory organs|1900  Other agents affecting nervous system and sensory organs|D11016  Aceneuramic acid (JAN/USAN)|Drug groups [BR:br08330(D11016)]|Unclassified|DG03304  NPL substrate|DG02580  Aceneuramic acid|D11016  Aceneuramic acid|New drug approvals in Japan [br08318.html(D11016)]|Drugs with new active ingredients|D11016|New drug approvals in the USA, Europe and Japan [br08328.html(D11016)]|Approval dates by FDA, EMA and PMDA|D11016|Drug metabolizing enzymes and transporters [br08309.html(D11016)]|Drug metabolizing enzymes|D11016",
C22383,"(2S)-2,3-Dihydroxypropane-1-sulfonate;|(2S)-3-Sulfopropanediol;|(S)-DHPS;|(S)-2,3-Dihydroxypropane-1-sulfonate;|2(S)-Dihydroxypropanesulfonate",,,,,
C22384,3-Oxopropane-1-sulfonate;|3-Sulfopropionaldehyde,,,,,
C22385,(L-Cysteinyl)adenylate;|L-Cysteinyl-AMP,,,,,
C22386,(L-Threonyl)adenylate,,,,,
C22387,(2R)-2-Hydroperoxyfatty acid,Generic compound in reaction hierarchy,,,,
C22388,(2S)-2-Nitrobutanedioate;|Nitrosuccinate;|2-Nitrobutanedioate,,,,,
C22389,3-Amino-5-hydroxybenzoyl-[acyl-carrier protein];|3-Amino-5-hydroxybenzoyl-[acp],Generic compound in reaction hierarchy,,,,
C22390,L-Seryl-[peptidyl-carrier protein];|L-Seryl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C22391,(L-Tryptophyl)adenylate,,,,,
C22392,L-Tryptophyl-[peptidyl-carrier protein];|L-Tryptophyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl-carrier protein),,,,
C22393,1-Arsono-3-phospho-D-glycerate;|[(2R)-2-Hydroxy-3-phosphopropanoyl]oxyarsonate,,,,,
C22394,Salicyl-[peptidyl-carrier protein];|Salicyl-[pcp],Generic compound in reaction hierarchy|R = PCP (peptidyl carrier protein),,,,
C22395,N6-Succino-2-amino-2'-deoxyadenylate;|dSMP;|2-Amino-2'-deoxy-N6-[(2S)-succino]adenylate,,,,,
C22396,Protein-(5S)-C-methyl-L-arginine,Generic compound in reaction hierarchy,,,,
C22397,"GDP-N-formyl-alpha-D-perosamine;|GDP-4-formylamino-4,6-dideoxy-alpha-D-mannose",,,,,
C22398,Poly[(R)-3-hydroxyalkanoate]n;|Poly[(R)-3-hydroxyalkanoate]n+1,Generic compound in reaction hierarchy|R = alkyl group,,,,
C22399,omega-Sulfo-beta-dihydromenaquinone-9,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR02 Quinones and hydroquinones|PR0201 Ubiquinones|C22399  omega-Sulfo-beta-dihydromenaquinone-9,
C22400,2-Acyl-sn-glycero-3-phospho-1D-myo-inositol,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|GP  Glycerophospholipids|GP06 Glycerophosphoinositols|GP0605 Monoacylglycerophosphoinositols|C22400  2-Acyl-sn-glycero-3-phospho-1D-myo-inositol,
C22401,2-Hydroxy-3-methyl-fatty-acyl-CoA,Generic compound in reaction hierarchy,,,,
C22402,2-Methyl-branched fatty aldehyde,Generic compound in reaction hierarchy,,,,
C22403,2-Butyloctyl sulfate,,,,,
C22404,2-Butyloctan-1-ol,,,,,
C22405,(2R)-2-Hydroxy-long-chain fatty acyl-CoA,Generic compound in reaction hierarchy,,,,
C22406,Long-chain fatty aldehyde,Generic compound in reaction hierarchy,,,,
C22407,C-Terminal [mycofactocin precursor peptide]-glycine,Generic compound in reaction hierarchy|R = MftA,,,,
C22408,"2,3-Dihydroxybenzoyl-[aryl-carrier protein];|2,3-Dihydroxybenzoyl-[acp]",Generic compound in reaction hierarchy,,,,
C22409,UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0101 Monoacylaminosugars|C22409  UDP-3-O-[(3R)-3-hydroxyacyl]-alpha-D-glucosamine,
C22410,"UDP-2-N,3-O-bis[(3R)-3-hydroxyacyl]-alpha-D-glucosamine",Generic compound in reaction hierarchy,,,"Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0102 Diacylaminosugars|C22410  UDP-2-N,3-O-bis[(3R)-3-hydroxyacyl]-alpha-D-glucosamine",
C22411,"4-O-{Poly[(2R)-glycerophospho]-(2R)-glycerophospho}-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol",,,,,G13166
C22412,"4-O-{Poly[(2R)-2-alpha-D-glucosyl-1-glycerophospho]-(2R)-glycerophospho}-N-acetyl-beta-D-mannosaminyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol;|[(2-Glc)-Gro-P]n-Gro-P-ManNAc-GlcNAc-PP-undecaprenol",,,,,G13167
C22413,(E)-Alk-1-en-1-SO-peroxol;|(E)-S-Alk-1-en-1-ylthiohydroperoxide,Generic compound in reaction hierarchy,,,,
C22415,(Z)-Alkanethial oxide;|(Z)-Alkylidene-lambda4-sulfanone;|(Z)-(Alkylidenesulfaniumyl)oxidanide,Generic compound in reaction hierarchy,,,,
C22416,Cremeomycin;|6-Carboxy-2-diazonio-3-methoxyphenolate,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22416,
C22417,Trimethylarsane;|Trimethylarsine,,,,,
C22418,UDP-3-O-[(3R)-3-hydroxyacyl]-N-acetyl-alpha-D-glucosamine,Generic compound in reaction hierarchy,,,Lipids [BR:br08002]|SL  Saccharolipids|SL01 Acylaminosugars|SL0102 Diacylaminosugars|C22418  UDP-3-O-[(3R)-3-hydroxyacyl]-N-acetyl-alpha-D-glucosamine,
C22419,N(delta)-Hydroxy-N(omega)-methyl-L-arginine,,,,,
C22420,"N(delta),N'(omega)-Dihydroxy-N(omega)-methyl-L-arginine",,,,,
C22421,4-(1-Methyl-2-pyrrolidinyl)-3-oxobutanoate;|4-(1-Methyl-2-pyrrolidinyl)-3-oxobutanoic acid,,,,,
C22422,N(delta)-Hydroxy-N(omega)-methyl-N(omega)-nitroso-L-citrulline,,,,,
C22423,Cu+;|Copper(1+);|Cuprous ion,,,,,
C22424,Cu2+;|Copper(2+);|Cupric cation,,,,,
C22425,3-Amino-2-hydroxy-4-methoxybenzoate;|3-Amino-2-hydroxy-4-methoxybenzoic acid,,,,,
C22426,L-Norcarnitine;|(3R)-4-(Dimethylamino)-3-hydroxybutanoate,,,,,
C22427,"UDP-2-acetamido-3-amino-2,3-dideoxy-alpha-D-glucopyranose;|UDP-GlcNAc3N",,,,,
C22428,"UDP-2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxyacyl]amino}-alpha-D-glucopyranose;|UDP-3-N-[(3R)-3-hydroxyacyl]-GlcNAc3N",Generic compound in reaction hierarchy,,,,
C22429,6-Diazo-5-oxo-L-norleucine,,,,,
C22430,Phenyllactylglucose,,,,,
C22431,Arsenic triglutathione,,,,,
C22432,Paspalic acid,,,,,
C22433,19-Hydroxycucurbitadienol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22433  19-Hydroxycucurbitadienol,
C22434,"19,25-Dihydroxycucurbitadienol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22434  19,25-Dihydroxycucurbitadienol",
C22435,Deacetylcucurbitacin C,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22435  Deacetylcucurbitacin C,
C22436,11-Carbonyl-20beta-hydroxycucurbitadienol,,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22436  11-Carbonyl-20beta-hydroxycucurbitadienol,
C22437,"11-Carbonyl-2beta,20beta-dihydroxycucurbitadienol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22437  11-Carbonyl-2beta,20beta-dihydroxycucurbitadienol",
C22438,"3,5-Dehydroshikimate",,,,,
C22439,"2-Aminoadenine;|2,6-Diaminopurine",,,,,
C22440,"2-Amino-2'-deoxyadenosine;|2,6-Diaminopurinedeoxyriboside",,,,,
C22441,dZMP;|2-Amino-2'-deoxyadenosine 5'-monophosphate,,,,,
C22442,dZDP;|2-Amino-2'-deoxyadenosine 5'-diphosphate,,,,,
C22443,dZTP;|2-Amino-2'-deoxyadenosine 5'-triphosphate,,,,,
C22444,"5,8-Dihydroxypsoralen",,,,,
C22445,8-Hydroxybergapten,,,,,
C22446,"22-Hydroxycholesterol;|Cholest-5-ene-3beta,22-diol",,,,Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22446  22-Hydroxycholesterol,
C22447,"22,26-Dihydroxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22447  22,26-Dihydroxycholesterol",
C22448,"16alpha,22,26-Trihydroxycholesterol",,,,"Lipids [BR:br08002]|ST  Sterol lipids|ST01 Sterols|ST0101 Cholesterol and derivatives|C22448  16alpha,22,26-Trihydroxycholesterol",
C22449,Paerucumarin,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22449,
C22450,5-Methoxybenzimidazole;|5-Methoxy-1H-benzimidazole,,,,,
C22451,5-Methoxy-6-methylbenzimidazole;|5-Methoxy-6-methyl-1H-benzimidazole,,,,,
C22452,"6,7,8-Trihydroxycoumarin",,,,,
C22453,trans-Anhydromevalonate 5-phosphate;|trans-Anhydromevalonate phosphate;|tAHMP;|(2E)-3-Methyl-5-phosphooxypent-2-enoate,,,,,
C22454,"11alpha-Hydroxy-9,15-dioxoprostanoate;|13,14-Dihydro-15-ketoprostaglandin E1",,,,,
C22455,"3-Amino-2,4-dihydroxybenzoate;|3-Amino-2,4-dihydroxybenzoic acid",,,,,
C22456,"(3S)-1,2-Diazinane-3-carboxylate;|(3S)-Pyridazin-3-carboxylate;|L-Piperazate",,,,,
C22457,N-Acetyl-6-diazo-5-oxo-L-norleucine,,,,,
C22458,8-Amino-7-(carboxyamino)nonanoate,,,,,
C22459,D-Tagatopyranose 1-phosphate;|D-Tagatose 1-phosphate,,,,,
C22460,[Gamma-glutamyl-L-cysteine]-S-conjugate,Generic compound in reaction hierarchy,,,,
C22461,N-Methyl carbamate ester,Generic compound in reaction hierarchy,,,,
C22462,S-(Methylsulfanyl)glutathione;|S-Methylthio glutathione,,,,,
C22463,(8S)-8-Amino-7-oxononanoate,,,,,
C22464,"(7R,8S)-8-Amino-7-(carboxyamino)nonanoate",,,,,
C22465,"[Protein]-N6-[(2S,3R)-2-amino-8-carboxyoctan-3-yl]-L-lysine",Generic compound in reaction hierarchy,,,,
C22466,Hyoscyamine aldehyde,,,,,
C22467,Gangliotriaosylceramide-II3 sulfate;|SM2a,,,,Lipids [BR:br08002]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0602 Sulfoglycosphingolipids (sulfatides)|C22467  GalNAc-beta1->4-S-3Gal-beta1->4Glc-beta1->1'Cer (SM2a),
C22468,Galactosylgloboside;|SSEA-3;|Gb5Cer;|Gal-beta1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00097)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0502 Galalpha1-4Galbeta1-4Glc- (Globo series)|G00097  Gal-beta1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer|Cancer-associated carbohydrates [br08441.html(G00097)]|Glycosphingolipid|G00097,G00097
C22469,Globo-H;|Fuc-alpha1->2Gal-beta1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00099)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0502 Galalpha1-4Galbeta1-4Glc- (Globo series)|G00099  Fuc-alpha1->2Gal-beta1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer|Blood groups and carbohydrate antigens [br08110.html(G00099)]|ABO blood group|G00099|Cancer-associated carbohydrates [br08441.html(G00099)]|Glycosphingolipid|G00099,G00099
C22470,Fuc-Lc4Cer;|III4-a-Fuc-Lc4Cer;|Lea glycolipid;|Fuc-alpha1->4(Gal-beta1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|Fuc-alpha1->4(Gal-beta1->3)GlcNAc-beta1->3LacCer,,,,Lipids [BR:br08002(G00046)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00046  Fuc-alpha1->4(Gal-beta1->3)GlcNAc-beta1->3LacCer|Blood groups and carbohydrate antigens [br08110.html(G00046)]|Lewis blood group|G00046,G00046
C22471,Type II A antigen;|GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00054)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00054  GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Type 2A)|Blood groups and carbohydrate antigens [br08110.html(G00054)]|ABO blood group|G00054,G00054
C22472,Type II B antigen;|Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00052)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00052  Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Type 2B)|Blood groups and carbohydrate antigens [br08110.html(G00052)]|ABO blood group|G00052,G00052
C22473,IV2Fuc-nLc4Cer;|IV2-a-Fuc-nLc4Cer;|Type IIH glycolipid;|Fuc-alpha1->2Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00055)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00055  Fuc-alpha1->2Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Type 2H)|Blood groups and carbohydrate antigens [br08110.html(G00055)]|ABO blood group|G00055,G00055
C22474,Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00057)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00057  Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G00057
C22475,Type IIIH glycolipid;|Fuc-alpha1->2Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00058)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00058  Fuc-alpha1->2Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Type 3H)|Blood groups and carbohydrate antigens [br08110.html(G00058)]|ABO blood group|G00058,G00058
C22476,"III3,IV2Fuc-nLc4Cer;|IV2-a-Fuc,III3-a-Fuc-nLc4Cer;|Ley glycolipid;|Fuc-alpha1->2Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer",,,,Lipids [BR:br08002(G00056)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00056  Fuc-alpha1->2Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer|Blood groups and carbohydrate antigens [br08110.html(G00056)]|Lewis blood group|G00056,G00056
C22477,Type IIIA glycolipid;|GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00059)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00059  GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (Type 3A)|Blood groups and carbohydrate antigens [br08110.html(G00059)]|ABO blood group|G00059,G00059
C22478,III3Fuc-nLc4Cer;|Lacto-N-fucopentaosyl III ceramide;|LNF III cer;|SSEA-1;|Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00060)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0505 Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)|G00060  Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer (SSEA-1)|Blood groups and carbohydrate antigens [br08110.html(G00060)]|Lewis blood group|G00060,G00060
C22479,Fuc-alpha1->4(Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3LacCer;|Fuc-alpha1->4(Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|BLeb glycolipid,,,,Lipids [BR:br08002(G00040)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00040  Fuc-alpha1->4(Gal-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3LacCer|Blood groups and carbohydrate antigens [br08110.html(G00040)]|Lewis blood group|G00040,G00040
C22480,Fuc-alpha1->4(GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3LacCer;|Fuc-alpha1->4(GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer;|ALeb glycolipid,,,,Lipids [BR:br08002(G00043)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00043  Fuc-alpha1->4(GalNAc-alpha1->3(Fuc-alpha1->2)Gal-beta1->3)GlcNAc-beta1->3LacCer|Blood groups and carbohydrate antigens [br08110.html(G00043)]|Lewis blood group|G00043,G00043
C22481,Gal-alpha1->3Gal-beta1->3GlcNAc-beta1->3LacCer;|Gal-alpha1->3Gal-beta1->3GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00038)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00038  Gal-alpha1->3Gal-beta1->3GlcNAc-beta1->3LacCer,G00038
C22482,"IV2Fuc,III4Fuc-Lc4Cer;|Leb glycolipid;|Fuc-alpha1->4(Fuc-alpha1->2Gal-beta1->3)GlcNAc-beta1->3LacCer;|Fuc-alpha1->4(Fuc-alpha1->2Gal-beta1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer",,,,Lipids [BR:br08002(G00045)]|SP  Sphingolipids|SP05 Neutral glycosphingolipids|SP0504 Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)|G00045  Fuc-alpha1->4(Fuc-alpha1->2Gal-beta1->3)GlcNAc-beta1->3LacCer|Blood groups and carbohydrate antigens [br08110.html(G00045)]|Lewis blood group|G00045,G00045
C22483,3'-isoLM1;|IV3-a-Neu5Ac-Lc4Cer;|sLc4Cer;|Neu5Ac-alpha2->3Gal-beta1->3GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00047)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00047  Neu5Ac-alpha2->3Gal-beta1->3GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G00047
C22484,Sialyl-6-paragloboside;|6'-LM1;|IV6-a-Neu5Ac-nLc4Cer;|Neu5Ac-alpha2->6Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,,,,Lipids [BR:br08002(G00061)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00061  Neu5Ac-alpha2->6Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G00061
C22485,"IV3NeuAc,III3Fuc-nLc4Cer;|Neu5Ac-alpha2->3Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer",,,,Lipids [BR:br08002(G00063)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00063  Neu5Ac-alpha2->3Gal-beta1->4(Fuc-alpha1->3)GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer|Blood groups and carbohydrate antigens [br08110.html(G00063)]|Lewis blood group|G00063,G00063
C22486,"3',8'-LD1;|Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer",,,,Lipids [BR:br08002(G00064)]|SP  Sphingolipids|SP06 Acidic glycosphingolipids|SP0601 Gangliosides|G00064  Neu5Ac-alpha2->8Neu5Ac-alpha2->3Gal-beta1->4GlcNAc-beta1->3Gal-beta1->4Glc-beta1->1'Cer,G00064
C22487,Benzylmalonyl-CoA,,,,,
C22488,"N-Acetyl-D-glucosamino-1,5-lactone",,,,,
C22489,"N-Acetyl-D-galactosamino-1,5-lactone",,,,,
C22490,N-Terminal-L-methionyl-[tubulin],Generic compound in reaction hierarchy,,,,
C22491,N-Terminal-Nalpha-acetyl-L-methionyl-[tubulin],Generic compound in reaction hierarchy,,,,
C22492,beta-D-Glucosyl-(1->4)-D-galactose,,,,,
C22493,3'-NADP+;|3'-Nicotinamide adenine dinucleotide phosphate;|Nicotinamide adenine dinucleotide 3'-phosphate,,,,,
C22494,Phenylsuccinate;|Phenylsuccinic acid,,,,,
C22495,2-Phenylsuccinyl-CoA,,,,,
C22496,3-Phenylsuccinyl-CoA,,,,,
C22497,alpha-Isomaltosyl-(1->4)-maltotriose,,,,,
C22498,alpha-Isomaltosyl-(1->3)-alpha-isomaltosyl-(1->4)-maltotriose,,,,,
C22499,"8-Hydroxyadenine;|7,8-Dihydro-8-oxoadenine",,,,,
C22500,"2,8-Dihydroxyadenine",,,,,
C22501,alpha-D-Xylulofuranose,,,,,
C22502,alpha-D-Fructofuranose;|alpha-D-Fructose,,,,,
C22503,"8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoate;|8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoic acid;|(9R,13R)-10,11-Dihydro-12-oxo-15-phytoenoate",,,,"Lipids [BR:br08002]|FA  Fatty acyls|FA02 Octadecanoids|FA0201 12-oxophytodienoic acid metabolites|C22503  8-[(1R,2R)-3-Oxo-2-{(Z)-pent-2-enyl}cyclopentyl]octanoic acid",
C22504,cis-Alkene,Generic compound in reaction hierarchy,,,,
C22505,"Chondroitin 2,6-sulfate;|Chondroitin sulfate D",,,,,
C22506,Archaeal dolichyl alpha-D-glucosyl phosphate;|Dolichyl alpha-D-glucosyl phosphate,,,,Lipids [BR:br08002]|PR  Prenol lipids|PR03 Polyprenols|PR0308 Dolichol monophosphates|C22506  Archaeal dolichyl alpha-D-glucosyl phosphate,
C22507,6-Sulfo-D-rhamnose,,,,,
C22508,6-Dehydro-D-glucose;|6-Oxo-Glc;|6-Oxo-D-quinovose,,,,,
C22509,"3',5'-Cyclic UMP;|Uridine 3',5'-cyclic monophosphate;|cUMP",,,,,
C22510,4-Deoxy-4-sulfo-D-erythrose,,,,,
C22511,4-Deoxy-4-sulfo-D-erythrulose,,,,,
C22512,Solabiose,,,,,
C22513,sn-3-O-(Farnesylgeranyl)glycerol 1-phosphate,,,,,
C22514,"2,3-Bis-O-(geranylfarnesyl)-sn-glycerol 1-phosphate",,,,,
C22515,3-Dehydro-D-glucoside,Generic compound in reaction hierarchy,,,,
C22516,(3R)-3-[(Carboxylmethyl)amino]fatty acid,Generic compound in reaction hierarchy,,,,
C22517,(3R)-3-{[Carboxy(hydroxy)methyl]amino}fatty acid,Generic compound in reaction hierarchy,,,,
C22518,(3R)-3-Isocyanyl-fatty acid,Generic compound in reaction hierarchy,,,,
C22519,[Protein]-(3S)-3-hydroxy-L-histidine,Generic compound in reaction hierarchy,,,,
C22520,2alpha-Hydroxytaxusin,,,,,
C22521,"2alpha,7beta-Dihydroxytaxusin",,,,,
C22522,Secondary-alkyl amine,Generic compound in reaction hierarchy,,,,
C22523,N-(1-Deoxy-D-fructos-1-yl)amine,Generic compound in reaction hierarchy,,,,
C22524,"2-[(3S,4R,5R)-3,4,5,6-Tetrahydroxy-2-oxohexylidene]amine",Generic compound in reaction hierarchy,,,,
C22525,D-Glucosone,,,,,
C22526,(1-Deoxy-D-fructos-1-yl)amine,,,,,
C22527,O-4''-alpha-D-Mannosylqueuosine in tRNA(Asp),Generic compound in reaction hierarchy,,,,
C22529,(R)-S-Adenosyl-L-methionine,,,,,
C22530,"3'-Dehydrocarminate;|7-[(2S,3S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-oxooxan-2-yl]-3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxoanthracene-2-carboxylic acid;|3'-Keto-carminic acid",,,,,
C22548,Estetrol,,,,Compounds with biological roles [BR:br08001]|Hormones and transmitters|Steroid hormones|Estrogens|C22548  Estetrol (E4)|Target-based classification of drugs [BR:br08310(D11513)]|Nuclear receptors|Estrogen like receptors|Estrogen receptor|NR3A (ESR)|D11513  Estetrol (USAN),
C22549,[Heparan sulfate]-glucosamine,Generic compound in reaction hierarchy|The disaccharide repeating unit is shown here.|R = linear heparan sulfate (HS) chain|R1 = SO3H or H,,,,
C22550,Poly[(1->4)-beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl],The disaccharide repeating unit is shown here.|R = linear polysaccharide,,,,
C22551,Heparosan D-glucuronate;|Heparosan D-glucuronic acid;|Poly[(1->4)-beta-D-glucuronosyl-(1->4)-alpha-D-glucosaminyl],The disaccharide repeating unit is shown here.|R = linear polysaccharide,,,,
C22552,Alphitonin,,,,,
C22553,Maesopsin,,,,,
C22554,Heparan sulfate containing L-iduronate 2-sulfate,Generic compound in reaction hierarchy|The disaccharide unit is shown here.|R = linear heparan sulfate (HS) chain|R1 = SO3H or H,,,,
C22555,3-O-Sulfated heparan sulfate containing L-iduronate 2-sulfate;|3-O-Sulfated heparan sulfate,Generic compound in reaction hierarchy|The disaccharide unit is shown here.|R = linear heparan sulfate (HS) chain|R1 = SO3H or H,,,,
C22556,(R)-Dihydrodaidzein,,,,,
C22557,(S)-Dihydrodaidzein,,,,,
C22558,"(3S,4R)-Tetrahydrodaidzein",,,,,
C22559,O-Desmethylangolensin,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22559,
C22560,6'-Hydroxy-O-desmethylangolensin,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22560,
C22561,3''-Oxopuerarin,,,,,
C22562,"1,5-Anhydro-D-erythro-hex-1-en-3-ulose;|(2R,3R)-3,5-Dihydroxy-2-(hydroxymethyl)-2,3-dihydropyran-4-one",,,,,
C22563,"gamma-Linolenoyl-[glycerolipid];|(6Z,9Z,12Z)-Octadeca-6,9,12-trienoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C22564,"Stearidonoyl-[glycerolipid];|(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoyl-[glycerolipid]",Generic compound in reaction hierarchy,,,,
C22565,"2-Hydroxy-1-(2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)propan-1-one",,,,,
C22566,"2-Hydroxy-1-(2,4,6-trihydroxyphenyl)-3-(3,4-dihydroxyphenyl)propan-1-one",,,,,
C22567,"3-Hydroxyphloretin;|3-(3,4-Dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one",,,,,
C22568,"5,7,8-Trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one",,,,,
C22569,"(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate",,,,,
C22570,5-(4-Hydroxyphenyl)-3-oxovalero-delta-lactone,,,,,
C22571,5-Hydroxy-5-(4-hydroxyphenyl)-3-oxopentanoate,,,,,
C22572,4-Hydroxy-4-(4-hydroxyphenyl)-butan-2-one,,,,,
C22573,Adenine in double-stranded RNA,Generic compound in reaction hierarchy,,,,
C22574,Hypoxanthine in double-stranded RNA,Generic compound in reaction hierarchy,,,,
C22575,"UDP-2-acetamido-4-amino-2,4,6-trideoxy-D-galactose",,,,,
C22576,UDP-2-acetamido-2-deoxy-L-altruronic acid;|UDP-L-AltNAcA,,,,,
C22577,"(2R,3R)-Flavan-3-ol",Generic compound in reaction hierarchy,,,,
C22578,Flavylium cation;|Flavylium;|2-Phenylbenzopyrylium;|Flavylium ion;|2-Phenylchromenylium,Core structure of Anthocyanidins and anthocyanins.,,,,
C22579,Lignan,Generic compound|The parent structure lignane is shown here.,,,,
C22580,"6,7,4'-Trihydroxyisoflavanone;|Dihydro-6,7,4'-trihydroxyisoflavone;|6-Hydroxydihydrodaidzein",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22580,
C22581,5'-Methoxy-O-desmethylangolensin,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22581,
C22582,Pinoresinol diglucoside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22582,
C22583,Matairesinoside;|Matairesinol 4'-O-glucoside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22583,
C22584,Secoisolariciresinol diglucoside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22584,
C22585,Medioresinol;|(+)-Medioresinol,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22585,
C22586,Phillygenin;|(+)-Phillygenin,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22586,
C22587,Asarinin;|(-)-Asarinin,,,,,
C22588,"3,4,5-Trihydroxyphenylacetate;|2-(3,4,5-Trihydroxyphenyl)acetic Acid",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22588,
C22589,Isorhamnetin 3-O-glucoside;|Isorhamnetin-3-O-beta-D-glucoside,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22589,
C22590,Sennidin A,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22590,
C22591,Sennidin B,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22591,
C22592,Sennidin C,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22592,
C22593,Sennidin D,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22593,
C22594,Epicatechin gallate;|(-)-Epicatechin-3-O-gallate,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22594,
C22595,Urolithin A,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22595,
C22596,Urolithin B,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22596,
C22597,Sesaminol,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22597,
C22598,Sesaminol triglucoside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22598,
C22599,Xanthone,,,,,
C22600,trans-Stilbene,,,,,
C22601,Punicalagin,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22601,
C22602,"3,5-Dihydroxyphenylpropanoate;|3-(3,5-Dihydroxyphenyl)propionic acid",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22602,
C22603,"Oroxylin A;|6-Methoxybaicalein;|5,7-Dihydroxy-6-methoxyflavone",,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22603,
C22604,Oleanane,,,,,
C22605,Lariciresinol 4-O-beta-D-glucoside,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22605,
C22606,Isoxanthohumol;|5-Methylsophoraflavanone B;|7-Hydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-enyl)chroman-4-one,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22606,
C22607,Isourolithin A,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22607,
C22608,Avicularin;|Quercetin 3-O-alpha-L-arabinofuranoside,,,,Dietary phytochemicals [br08012.html]|Flavonoids|C22608,
C22609,Dammarane,,,,,
C22610,(-)-3-exo-Hydroxycamphor,,,,,
C22611,N-Acetyl-D-glutamate;|N-Acetyl-D-glutamic acid,,,,,
C22612,"(-)-Cyatha-3,12-diene;|(3aS,5aS,10aS)-3a,5a,8-Trimethyl-1-(propan-2-yl)-2,3,4,5,6,9,10,10a-octahydrocyclohepta[e]indene",,,,,
C22613,"Neoverrucosan-5beta-ol;|(1aS,3R,3aS,5aR,8S,8aR,8bR,8cS)-1a,3a,5a-Trimethyl-8-(propan-2-yl)tetradecahydrocyclopenta[a]cyclopropa[h]naphthalen-3-ol",,,,,
C22614,"Verrucosan-2beta-ol;|(1S,3aR,5aS,6aR,7aR,8S,8aR,9bR)-1-(Propan=2-yl)tetradecahydrocyclopenta[a]cyclopropa[g]naphthalene-8-ol",,,,,
C22615,"(R)-Axinyssene;|(+)-Axinyssene;|(4R)-4-[(5E)-6,10-Dimethylundeca-1,5,9-trien-2-yl]-1-methylcyclohexene",,,,,
C22616,"Lydicene;|(4aR,6aS)-2,2,4alpha,6alpha,9-Pentamethyl-1,3,4,5,6,7,10,11-octahydro-1H-cyclohepta[a]naphthalene",,,,,
C22617,"(+)-exo-beta-Bergamotene;|beta-trans-Bergamotene;|(1S,5S,6R)-6-Methyl-2-methylidene-6-(4-methylpent-3-enyl)bicyclo[3.1.1]heptane",,,,,
C22618,"Fumagillol;|(3R,4S,5S,6R)-5-Methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-ol",,,,,
C22619,5-Dehydrofumagillol;|5-Keto-fumagillol,,,,,
C22620,5-Formylcytosine in DNA,,,,,
C22621,5-Carboxycytosine in DNA,,,,,
C22622,Dehydrocyclopeptine;|(Z)-Dehydrocyclopeptine,,,,,
C22623,"(-)-Cyclopenine;|(3S,3'R)-4-Methyl-3'-phenyl-1H-spiro[1,4-benzodiazepine-3,2'-oxirane]-2,5-dione",,,,,
C22624,Vinylglycine,,,,,
C22625,(2E)-2-Aminobut-2-enoate,,,,,
C22626,N-Hydroxyguanidine,,,,,
C22627,(5R)-Hydroxy-(+)-exo-beta-bergamotene,,,,,
C22628,(3S)-3-[2-Methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-4-methylidenecyclohexan-1-one;|5-Keto-cordycol,,,,,
C22629,5-Dehydro-6-demethoxyfumagillol;|5-Keto-demethoxyfumagillol,,,,,
C22630,N-(Sulfonatooxy)alkanimidothioate,Generic compound in reaction hierarchy,,,,
C22631,5-Dehydro-6-demethoxy-6-hydroxyfumagillol,,,,,
C22632,beta-D-Glucosyl-(1->2)-D-glucoside,Generic compound in reaction hierarchy,,,,
C22633,3-O-beta-D-Glucosyl-beta-D-glucuronoside;|3-O-beta-D-Glucosyl-beta-D-glucuronide,Generic compound in reaction hierarchy,,,,
C22634,"2,3-Bis-(O-phytanyl)-sn-glycero-phospholipid;|Archaeol phospholipid",Generic compound in reaction hierarchy,,,,
C22635,3-Dehydro-D-glucopyranose;|3-Dehydro-D-glucose,,,,,
C22636,Glycerol dibiphytanyl glycerol tetraether phospholipid;|GDGT,Generic compound in reaction hierarchy,,,,
C22637,Epithionitrile,Generic compound in reaction hierarchy|2-(Thiiran-2-yl)acetonitrile (n=1) [CPD:C22643],,,,
C22638,N-(Sulfonatooxy)alkenimidothioic acid,Generic compound in reaction hierarchy|N-(Sulfonatooxy)prop-2-enimidothioate (N=1) [CPD:C22641],,,,
C22639,Macrocyclic archaeol phospholipid,Generic compound in reaction hierarchy,,,,
C22640,Phenyl-N-(sulfonatooxy)methanimidothioate,,,,,
C22641,N-(Sulfonatooxy)prop-2-enimidothioate,,,,,
C22642,Prop-2-enylthiocyanate;|Allylthiocyanate,,,,,
C22643,2-(Thiiran-2-yl)acetonitrile,,,,,
C22644,Viridicatin,,,,,
C22645,Methyl isocyanate,,,,,
C22646,N-(4-Aminobutylpyrrolinium) ion,,,,,
C22647,N-(4-Oxobutylpyrrolinium) ion,,,,,
C22648,1-Formylpyrrolizidine,,,,,
C22649,"2-Hydroxy-2,27-secorifampicin",,,,,
C22650,Prefumagillin,,,,,
C22651,Dodecapentaenoyl-[acyl-carrier protein];|Dodecapentaenoyl-[acp],Generic compound in reaction hierarchy,,,,
C22652,Quillaic acid 3-O-beta-D-glucuronide;|Quillaic acid 3-O-beta-D-GlcA,,,,,
C22653,"Quillaic acid 3-O-beta-D-galactosyl-1,2-beta-D-glucuronide;|Quillaic acid 3-O-beta-D-Gal-(1->2)-beta-D-GlcA",,,,,
C22654,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA",,,,,
C22655,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA",,,,,
C22656,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Fuc",,,,,
C22657,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-fucoside;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Fuc",,,,,
C22658,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22659,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22660,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22661,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22662,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-xylosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Xyl-(1->3)-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22663,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-xylosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Xyl-(1->3)-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22664,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Api-(1->3)-O-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22665,"Quillaic acid 3-O-alpha-L-rhamnosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide-28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-alpha-L-rhamnosyl-1,2-beta-D-fucoside;|Quillaic acid 3-O-alpha-L-Rha-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Api-(1->3)-O-beta-D-Xyl-(1->4)-alpha-L-Rha-(1->2)-beta-D-Fuc",,,,,
C22666,"Quillaic acid 3-O-beta-D-xylosyl-1,3-(beta-D-galactosyl-1,2)-beta-D-glucuronide 28-O-beta-D-apiosyl-1,3-beta-D-xylosyl-1,4-(beta-D-glucosyl-1,3)-alpha-L-rhamnosyl-1,2-(alpha-L-rhamnosyl-1,3)-4-O-acetyl-beta-D-fucoside;|Quillaic acid 3-O-beta-D-Xyl-(1->3)-[beta-D-Gal-(1->2)]-beta-D-GlcA-28-O-beta-D-Api-(1->3)-O-beta-D-Xyl-(1->4)-[beta-D-Glc-(1->3)]-alpha-L-Rha-(1->2)-[alpha-L-Rha-(1->3)]-4-O-acetyl-beta-D-Fuc;|QS-7",,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22666|Dietary phytochemicals [br08012.html]|Other phytochemicals|C22666,
C22667,4-Carboxy-1-hydroxybutyryl-ThPP,,,,,
C22668,Colibactin,,,,,
C22672,Aucubigenin,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22672,
C22673,Aucubinine A,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22673,
C22674,Aucubinine B,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22674,
C22675,Genipinine,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22675,
C22676,Loganetin,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22676,
C22677,Sweroside aglycone,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22677,
C22678,Naucledal,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22678,
C22679,Erythrocentaurin,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22679,
C22680,Gentinopicral,,,,Dietary phytochemicals [br08012.html]|Other phytochemicals|C22680,
C22681,Andrimid,,,,,
C22683,Protonitazene,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22683,
C22684,"(S)-Tetrahydroprotoberberine;|(S)-7,8,13,14-Tetrahydroprotoberberine",Generic compound in reaction hierarchy|(S)-Tetrahydroprotoberberine (non-generic) [CPD:C05204],,,,
C22685,Ethyl 4-phenylpiperidine-4-carboxylate;|4-Phenylpiperidine-4-carboxylic acid ethyl ester;|Pethidine intermediate B;|Norpethidine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C22685,
C22686,"4-Dimethylamino-2,2-diphenylvaleronitrile;|4-Cyano-2-dimethylamino-4,4-diphenylbutane;|Methadone intermediate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C22686,
C22687,1-Methyl-4-phenylpiperidine-4-carbonitrile;|4-Cyano-1-methyl-4-phenylpiperidine;|Pethidine intermediate A,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C22687,
C22688,"2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid;|3-Methyl-4-(4-morpholinyl)-2,2-diphenylbutanoic acid;|Moramide intermediate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Control Act Article 2 Table 1 (74 substances)|C22688,
C22689,"Kermesate;|Kermesic acid;|3,5,6,8-Tetrahydroxy-1-methyl-9,10-dioxo-9,10-dihydroanthracene-2-carboxylate",,,,,
C22690,2''-O-Lipoyl-ADP-D-ribose,,,,,
C22691,Ergosteryl-3beta-O-L-aspartate,,,,,
C22692,[Protein]-O-phospho-L-serine,Generic compound in reaction hierarchy,,,,
C22693,[Protein]-O-phospho-L-threonine,Generic compound in reaction hierarchy,,,,
C22694,Ipecoside aglycone,,,,,
C22695,N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;|N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide;|APINACA N-(5-fluoropentyl);|5F-APINACA,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22695,
C22696,(1R)-(2-Amino-1-hydroxyethyl)phosphonate,,,,,
C22697,(E)-2-Aminoethenylphosphonate,,,,,
C22698,"ADB-CHMINACA;|N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-cyclohexylmethyl-1H-indazole-3-carboxamide",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22698,
C22699,"ADB-FUBINACA;|N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22699,
C22700,2-Aminopropiophenone;|(+/-)-Cathinone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22700,
C22701,N-Pyrrolidino etonitazene;|Etonitazepyne,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22701,
C22702,AB-CHMINACA;|N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-cyclohexylmethyl-1H-indazole-3-carboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22702,
C22703,AB-FUBINACA;|N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22703,
C22704,AB-PINACA;|N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22704,
C22705,Ethcathinone;|2-Ethylamino-1-phenylpropan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22705,
C22706,N-Ethylhexedrone;|2-Ethylamino-1-phenylhexan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22706,
C22707,4-Methylethcathinone;|2-Ethylamino-1-(4-methylphenyl)propan-1-one;|4-MEC,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22707,
C22708,"Eutylone;|2-Ethylamino-1-(3,4-methylenedioxyphenyl)butane-1-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22708,
C22709,"Ethylone;|2-Ethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22709,
C22710,"N-Ethylpentylone;|2-Ethylamino-1-(3,4-methylenedioxyphenyl)pentan-1-one;|Ephylone",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22710,
C22711,Methoxetamine;|2-Ethylamino-2-(3-methoxyphenyl)cyclohexanone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22711,
C22712,"4-Deoxy-L-threo-hex-4-enopyranuronate;|4,5-Unsaturated D-galacturonate;|4,5-Unsaturated D-glucuronate",,,,,
C22713,"4-Deoxy-L-erythro-hex-4-enopyranuronate;|4,5-Unsaturated D-mannuronate;|4,5-Unsaturated L-guluronate",,,,,
C22714,"2,5-Dimethoxy-4-ethylamphetamine;|4-Ethyl-2,5-dimethoxy-alpha-methylphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22714,
C22715,"2,5-Dimethoxy-4-ethylthiophenethylamine;|2C-T-2;|2-(4-Ethylsulfanyl-2,5-dimethoxyphenyl)ethanamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22715,
C22716,Eticyclidine;|N-Ethyl-1-phenylcyclohexylamine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22716,
C22717,"3,4-Methylenedioxy-N-ethylamphetamine;|N-Ethyl MDA;|N-Ethyl-alpha-methyl-3,4-methylenedioxyphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22717,
C22718,1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;|Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate;|5F-PB-22,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22718,
C22719,"2,5-Dimethoxy-4-chloroamphetamine;|1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22719,
C22720,"N-(2-Methoxybenzyl)-2-(4-chloro-2,5-dimethoxyphenyl)ethanamine;|2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine;|25C-NBOMe",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22720,
C22721,Clephedrone;|1-(4-Chlorophenyl)-2-methylaminopropan-1-one;|4-Chloromethcathinone;|4-CMC,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22721,
C22722,Cumyl-4CN-BINACA;|1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide;|4-Cyano Cumyl-BUTINACA;|SGT-78,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22722,
C22723,"N,N-Diallyl-5-methoxytryptamine;|5-MeO-DALT",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22723,
C22724,"5-Methoxy-N,N-diisopropyltryptamine;|3-[2-(Diisopropylamino)ethyl]-5-methoxyindole;|5-MeO-DIPT",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22724,
C22725,Isotonitazene;|1-(Diethylamino)ethyl-2-(4-isopropoxybenzyl)-5-nitrobenzimidazole,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22725,
C22726,"N,N-Diethyltryptamine;|3-(2-Diethylaminoethyl)indole;|DET",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22726,
C22727,Metonitazene;|1-(Diethylamino)ethyl-2-(4-methoxybenzyl)-5-nitrobenzimidazole,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22727,
C22728,"1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine;|MT-45",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22728,
C22729,"3,4-Dichloro-N-[(1-dimethylaminocyclohexyl)methyl]benzamide;|AH-7921",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22729,
C22730,"3,4-Dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide;|U-47700",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22730,
C22731,"4-Methylaminorex;|2-Amino-4-methyl-5-phenyl-2-oxazoline;|4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22731,
C22732,"Dihydroetorphine;|7,8-Dihydro-7alpha-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22732,
C22733,"1-(1,2-Diphenylethyl)piperidine;|Diphenidine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22733,
C22734,"Dimethylheptylpyran;|DMHP;|3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22734,
C22735,"2,5-Dimethoxy-4-isopropylthiophenethylamine;|2C-T-4",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22735,
C22736,"2,5-Dimethoxy-4-methylamphetamine;|2,5-Dimethoxy-4,alpha-dimethylphenethylamin;|DOM",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22736,
C22737,"2,5-Dimethoxy-4-propylthiophenethylamine;|2C-T-7",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22737,
C22738,"2,5-Dimethoxyamphetamine;|2,5-DMA;|2,5-Dimethoxy-alpha-methylphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22738,
C22739,Thiofentanyl;|N-{1-[2-(2-Thienyl)ethyl]-4-piperidyl}propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22739,
C22740,"delta10-Tetrahydrocannabinol;|delta2-Tetrahydrocannabinol;|6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22740,
C22741,"delta8-Tetrahydrocannabinol;|(6aR-trans)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22741,
C22742,"(1S,3R,4R)-delta5-Tetrahydrocannabinol;|(6aR,9S,10aR)-delta7-Tetrahydrocannabinol;|(6aR,9S,10aR)-6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22742,
C22743,"delta3-Tetrahydrocannabinol;|7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;|delta6a(10a)-THC",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22743,
C22744,"1R-trans-delta4-Tetrahydrocannabinol;|(9R,10aR)-8,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol;|(9R,10aR)-delta6a,7-Tetrahydrocannabinol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22744,
C22745,1-(3-Trifluoromethylphenyl)piperazine;|TFMPP,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22745,
C22746,"2,4,5-Trimethoxyamphetamine;|2,4,5-Trimethoxy-alpha-methylphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22746,
C22747,"3,4,5-Trimethoxyamphetamine;|3,4,5-Trimethoxy-alpha-methylphenethylamine;|TMA",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22747,
C22748,1-Pentyl-3-(1-naphthoyl)indole;|JWH-018;|1-Naphthalenyl(1-pentyl-1H-indol-3-yl)methanone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22748,
C22749,beta-Hydroxyfentanyl;|N-[1-(beta-Hydroxyphenethyl)-4-piperidyl]propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22749,
C22750,Ohmefentanyl;|beta-Hydroxy-3-methylfentanyl;|N-[1-(beta-Hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22750,
C22751,"Cannabicyclohexanol;|2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22751,
C22752,Ethylphenidate;|Ethyl 2-phenyl-2-(piperidin-2-yl)acetate,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22752,
C22753,alpha-Pyrrolidinohexiophenone;|alpha-PHP;|1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22753,
C22754,alpha-Pyrrolidinovalerophenone;|alpha-PVP;|1-Phenyl-2-(pyrrolidin-1-yl)pentan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22754,
C22755,Acrylfentanyl;|Acryloylfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22755,
C22756,Acetylfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22756,
C22757,Cyclopropylfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22757,
C22758,Tetrahydrofuranylfentanyl;|THF-F;|THF-fentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22758,
C22759,Crotonylfentanyl;|(E)-N-(1-Phenethylpiperidin-4-yl)-N-phenylbut-2-enamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22759,
C22760,Butyrlfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylbutanamide;|N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22760,
C22761,Furanylfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22761,
C22762,Valerylfentanyl;|N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22762,
C22763,1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine;|1-Phenethyl-4-phenyl-4-piperidinol acetate;|PEPAP,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22763,
C22764,1-Butyl-3-(1-naphthoyl)indole;|JWH-073;|1-Naphthalenyl(1-butyl-1H-indol-3-yl)methanone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22764,
C22765,4-Fluorobutyrfentanyl;|p-FBF;|N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide;|N-(4-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22765,
C22766,ortho-Fluorofentanyl;|2-Fluorofentanyl;|N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide;|N-(2-Fluorophenyl)-N-(1-phenylethylpiperidin-4-yl)propanamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22766,
C22767,4-Fluoroamphetamine;|1-(4-Fluorophenyl)propane-2-amine;|4-FA;|p-Fluoroamphetamine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22767,
C22768,4-Fluoroisobutyryl fentanyl;|N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide;|N-(4-Fluorophenyl)-2-methyl-N-(1-phenylethylpiperidin-4-yl)propanamide;|4-FIBF,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22768,
C22769,p-Fluorofentanyl;|Parafluorofentanyl;|4-Fluoro-N-(1-phenethyl-4-piperidyl)propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22769,
C22770,"[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone;|XLR-11;|[1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropan-1-yl)methanone",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22770,
C22771,[1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone;|AM2201,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22771,
C22772,[1-(5-Fluoropentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone;|MAM-2201,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22772,
C22773,"25B-NBOMe;|2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22773,
C22774,"25I-NBOMe;|2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22774,
C22775,"4-Bromo-2,5-dimethoxyphenethylamine;|2C-B",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22775,
C22776,"4-Iodo-2,5-dimethoxyphenethylamine;|2C-I;|2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22776,
C22777,"Brorphine;|1-{1-[1-(4-Bromophenyl)ethyl]piperidin-4-yl}-1,3-dihydro-2H-benzo[d]imidazol-2-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22777,
C22778,"11-Hydroxytetrahydrocannabinol;|11-Hydroxy-delta9-tetrahydrocannabinol;|(6aR,10aR)-6a,7,8,10a-Tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-methanol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22778,
C22779,"Synhexyl;|Parahexyl;|3-Hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22779,
C22780,1-Benzylpiperazine;|BZP,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22780,
C22781,"(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone;|UR-144;|(1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropan-1-yl)methanone",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22781,
C22782,"Cumyl-PEGACLONE;|5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22782,
C22783,Methcathinone;|2-Methylamino-1-phenylpropan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22783,
C22784,Pentedrone;|2-Methylamino-1-phenylpentan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22784,
C22785,Mephedrone;|2-Methylamino-1-(4-methylphenyl)propan-1-one;|4-Methylmethcathinone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22785,
C22786,"N-Methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine;|MBDB;|N-Methyl-alpha-ethyl-3,4-methylenedioxyphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22786,
C22787,"MDMB-CHMICA;|Methyl (2S)-2-(1-cyclohexylmethyl-1H-indole-3-carboxamido)-3,3-dimethylbutanoate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22787,
C22788,"MDMB-4EN-PINACA;|Methyl (2S)-3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22788,
C22789,alpha-Methylthiofentanyl;|N-{1-[1-Methyl-2-(2-thienyl)ethyl]-4-piperidyl}propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22789,
C22790,3-Methylthiofentanyl;|N-{3-Methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl}propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22790,
C22791,Acetyl-alpha-methylfentanyl;|N-[1-(alpha-Methylphenethyl)-4-piperidyl]acetanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22791,
C22792,alpha-Methylfentanyl;|N-[1-(alpha-Methylphenethyl)-4-piperidyl]propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22792,
C22793,Mefentanyl;|3-Methylfentanyl;|N-(3-Methyl-1-phenethyl-4-piperidyl)propionanilide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22793,
C22794,Methoxyacetylfentanyl;|2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22794,
C22795,Methiopropamine;|N-Methyl-1-(thiophen-2-yl)propan-2-amine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22795,
C22796,1-Pentyl-3-(4-methyl-1-napthoyl)indole;|JWH-122;|(4-Methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22796,
C22797,Desmethylprodine;|MPPP;|1-Methyl-4-phenyl-4-piperidinol propionate,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22797,
C22798,Meperidinic acid;|1-Methyl-4-phenylpiperidine-4-carboxylic acid;|Pethidine intermediate C,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22798,
C22799,"4F-MDMB-BINACA;|Methyl (2S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22799,
C22800,AMB-FUBINACA;|Methyl (2S)-2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoate;|FUB-AMB;|MMB-FUBINACA,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22800,
C22801,"5F-MDMB-PINACA;|Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22801,
C22802,Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate;|5-Fluoro-AMP;|5F-AMB,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22802,
C22803,"5F-MDMB-PICA;|Methyl (2S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22803,
C22804,4-Methylthioamphetamine;|4-MTA;|alpha-Methyl-4-methylthiophenethylamine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22804,
C22805,"4,4'-Dimethylaminorex;|4,4'-DMAR;|4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22805,
C22806,"3,4-Methylenedioxy-N-hydroxy-N-methylamphetamine;|N-Methyl-N-[1-(3,4-methylenedioxyphenyl)propan-2-yl]hydroxylamine;|N-Hydroxy MDMA",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22806,
C22807,"N-Hydroxy-3,4-methylenedioxyamphetamine;|N-[alpha-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine;|N-Hydroxy MDA",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22807,
C22808,"Methylenedioxypyrovalerone;|MDPV;|1-(3,4-Methylenedioxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22808,
C22809,1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine;|3-Methoxyphencyclidine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22809,
C22810,p-Methoxymethamphetamine;|1-(4-Methoxyphenyl)-N-methylpropan-2-amine,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22810,
C22811,4-Methoxyamphetamine;|4-Methoxy-alpha-methylphenethylamine;|PMA,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22811,
C22812,"5-Methoxy-3,4-methylenedioxyamphetamine;|3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine;|MMDA",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22812,
C22813,"2-Chlorodiazepam;|Diclazepam;|7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C22813,
C22814,"Clonazolam;|6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;|6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-s-triazolo[4,3-a][1,4]benzodiazepine",,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C22814,
C22815,"Flualprazolam;|8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C22815,
C22816,"Phenazepam;|7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one",,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C22816,
C22817,"Flubromazolam;|8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine;|8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine",,,,Narcotics and psychotropics in Japan [br08308.html]|Psychotropics by Cabinet order Article 3 (78 substances)|C22817,
C22818,"ADB-BUTINACA;|N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butylindazole-3-carboxamide;|N-(1-Amino-3,3-dimethy-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide",,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22818,
C22819,Methyl alpha-acetylphenylacetate;|MAPA;|Methyl 3-oxo-2-phenylbutanoate,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22819,
C22820,2-Phenyl-3-oxobutanamide;|alpha-Phenylacetoacetamide;|3-Oxo-2-phenylbutanamide,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22820,
C22821,"Deprenyl;|N,alpha-Dimethyl-N-2-propynylphenethylamine",,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22821,
C22822,Racephedrine;|1-Phenyl-2-methylaminopropanol,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22822,
C22823,1-Chloro-N-methyl-1-phenyl-2-propanamine;|1-Phenyl-1-chloro-2-methylamino propane,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22823,
C22824,1-Chloro-2-dimethylamino-1-phenylpropane;|1-Phenyl-1-chloro-2-dimethylaminopropane,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22824,
C22825,Dimethylamphetamine;|1-Phenyl-2-dimethylaminopropane,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22825,
C22826,2-Phenylacetoacetonitrile;|2-Acetyl-2-phenylacetonitrile,,,,Narcotics and psychotropics in Japan [br08308.html]|Stimulants by Control Act Article 2 Appended Table and Cabinet Order|C22826,
C22827,Etodesnitazene;|Etazene,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22827,
C22828,3-Methylmethcathinone;|2-Methylamino-1-(3-methylphenyl)propan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22828,
C22829,alpha-Pyrrolidinoisohexaphenone;|alpha-Pihp;|4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one,,,,Narcotics and psychotropics in Japan [br08308.html]|Narcotics by Cabinet Order Article 1 (157 substances)|C22829,
C22831,"5alpha-Pregnan-17alpha-ol-3,20-dione",,,,,
C22832,"5alpha-Pregnane-3alpha,17alpha-diol-20-one;|3alpha,17alpha-Dihydroxy-5alpha-pregnan-20-one;|17alpha-Hydroxyallopregnanolone",,,,,
C22834,Protein-trisulfide,Generic compound in reaction hierarchy,,,,
C22835,4-Carboxy-3-alkylbut-2-enoyl-[acyl-carrier protein];|4-Carboxy-3-alkylbut-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22836,3-Alkylbut-2-enoyl-[acyl-carrier protein];|3-Alkylbut-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22837,"(+)-delta-Cadinol;|(1S,4R,4aS,8aR)-1,6-Dimethyl-4-(propan-2-yl)-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-ol;|(+)-Torreyol",,,,,
C22838,"Colleterpenol;|(2S)-2-[(1R,3E,7E,11E)-4,8,12-Trimethylcyclotetradeca-3,7,11-trien-1-yl]undeca-5,9-dien-2-ol",,,,,
C22839,"delta-Araneosene;|(3aR,5E,9E)-3a,6,10-Trimethyl-1-(propan-2-yl)-2,3,3a,4,7,8,11,12-octahydrocyclopenta[11]annulene",,,,,
C22840,"(5R,12R,14S)-Dolasta-1(15),8-diene;|(3aR,4aS,8aR)-3a,8a-Dimethyl-5-methylene-1-(propan-2-yl)-2,3,3a,4,4a,5,6,7,8,8a,9,10-dodecahydrobenzo[f]azulene",,,,,
C22841,"Somaliensene A;|(1S,5R,6R)-6-Methyl-6-[(3E,7E,11E)-trimethyltrideca-3,7,11-trien-1-yl]bicyclo[3.1.1]hept-2-ene",,,,,
C22842,"(-)-Somaliensene B;|(4S)-1-Methyl-4-[(5E,9E,13E)-6,10,14-trimethylpentadeca-1,5,9,13-tetraen-2-yl]cyclohex-1-en",,,,,
C22843,"Demethylgadusol;|(4R,5R)-2,3,4,5-Tetrahydroxy-5-(hydroxymethyl)cyclohex-2-en-1-one",,,,,
C22844,"Variediene;|(3aR,3bS,6E,10Z,11aR)-3,3,6,10,11a-Pentamethyl-2,3,3a,3b,4,5,8,9,11,11a-decahydro-1H-cyclonona[a]pentalene",,,,,
C22845,"(2E)-alpha-Cericerene;|(1E,4R,7E,11E)-1,7,11-Trimethyl-4-[(2E)-6-methylhepta-2,5-dien-2-yl]cyclotetrdeca-1,7,11-triene",,,,,
C22846,"Gadusol;|(4R,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-one",,,,,
C22847,3-Carboxymethyl-3-hydroxy-acyl-[acp];|3-Carboxymethyl-3-hydroxy-acyl-[acyl-carrier protein],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22848,"N-(1H-1,3-Benzodiazol-2-yl)carbamate",,,,,
C22849,"3-Aminoavenalumate;|(2E,4E)-5-(3-Amino-4-hydroxyphenyl)penta-2,4-dienoate",,,,,
C22850,"3-Diazoavenalumate;|1-{3-[(1E,3E)-4-Carboxylatobuta-1,3-dien-1-yl]-6-oxocyclohexa-2,4-dien-1-ylidene}diazenium",,,,,
C22851,"1D-myo-Inositol 1,2,5,6-tetrakisphosphate",,,,,
C22852,"1D-myo-Inositol 1,2,6-trisphosphate",,,,,
C22853,"1D-myo-Inositol 1,2-bisphosphate",,,,,
C22854,1D-myo-Inositol 2-phosphate,,,,,
C22855,Glucose monomycolate;|GMM,Generic compound in reaction hierarchy|R = alpha-branch chain|R1 = meromycolic chain,,,,
C22857,Very-long-chain alpha-carboxyacyl-CoA,Generic compound in reaction hierarchy,,,,
C22858,Long-chain 3-oxoacyl-[acyl-carrier protein];|Long-chain 3-oxoacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22859,Long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein];|Long-chain (3R)-3-hydroxyacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22860,Long-chain trans-2-enoyl-[acyl-carrier protein];|Long-chain trans-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22861,Very-long-chain acyl-[acyl-carrier protein];|Very-long-chain acyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22862,Very-long-chain 3-oxoacyl-[acyl-carrier protein];|Very-long-chain 3-oxoacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22863,Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein];|Very-long-chain (3R)-3-hydroxyacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22864,Very-long-chain trans-2-enoyl-[acyl-carrier protein];|Very-long-chain trans-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein,,,,
C22865,Ultra-long-chain mono-unsaturated acyl-[acyl-carrier protein];|Ultra-long-chain mono-unsaturated acyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = mono-unsaturated ultra-long-chain,,,,
C22866,Ultra-long-chain mono-unsaturated 3-oxo-fatty acyl-[acyl-carrier protein];|Ultra-long-chain mono-unsaturated 3-oxo-fatty acyl-[acp];|Ultra-long-chain mono-unsaturated 3-oxoacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = mono-unsaturated ultra-long-chain,,,,
C22867,Ultra-long-chain mono-unsaturated (3R)-3-hydroxyacyl-[acyl-carrier protein];|Ultra-long-chain mono-unsaturated (3R)-3-hydroxyacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = mono-unsaturated ultra-long-chain,,,,
C22868,Ultra-long-chain mono-unsaturated trans-2-enoyl-[acyl-carrier protein];|Ultra-long-chain mono-unsaturated trans-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = mono-unsaturated ultra-long-chain,,,,
C22869,Ultra-long-chain di-unsaturated acyl-[acyl-carrier protein];|Ultra-long-chain di-unsaturated acyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = di-unsaturated ultra-long-chain,,,,
C22870,Ultra-long-chain di-unsaturated 3-oxo-fatty acyl-[acyl-carrier protein];|Ultra-long-chain di-unsaturated 3-oxo-fatty acyl-[acp];|Ultra-long-chain di-unsaturated 3-oxoacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = di-unsaturated ultra-long-chain,,,,
C22871,Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acyl-carrier protein];|Ultra-long-chain di-unsaturated (3R)-3-hydroxyacyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = di-unsaturated ultra-long-chain,,,,
C22872,Ultra-long-chain di-unsaturated trans-2-enoyl-[acyl-carrier protein];|Ultra-long-chain di-unsaturated trans-2-enoyl-[acp],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = di-unsaturated ultra-long-chain,,,,
C22873,Meromycolic acid,Generic compound in reaction hierarchy|R1 = meromycolic chain,,,,
C22874,Meromycoloyl-[acp Pks13],Generic compound in reaction hierarchy|S-R = acyl-carrier protein|R1 = meromycolic chain,,,,
C22875,Trehalose mycolic-beta-ketoester,Generic compound in reaction hierarchy|R = alpha-branch chain|R1 = meromycolic chain,,,,
C22876,Trehalose monomycolate;|TMM,Generic compound in reaction hierarchy|R = alpha-branch chain|R1 = meromycolic chain|Mycobacterial TMM [CPD:C21904],,,,
C22877,Trehalose dimycolate;|TDM,Generic compound in reaction hierarchy|R = alpha-branch chain|R1 = meromycolic chain|Mycobacterial TDM [CPD:C21790],,,,
C22878,Mycolic acid;|Mycolate,Generic compound in reaction hierarchy|R1 = meromycolic chain|R = alpha-branch chain,,,,
C22880,[Methionine synthase]-cob(I)alamin,Generic compound in reaction hierarchy,,,,
C22881,Iron(III) oxide-hydroxide;|[FeO(OH)],,,,,
C22882,N-Deacetylipecoside aglycone,,,,,
C22883,6-O-Methyl-N-deacetylipecoside,,,,,
C22884,6-O-Methyl-N-deacetylipecoside aglycone,,,,,
C22885,cis-4-Hydroxycyclohexane-1-carboxylate;|cis-4-Hydroxycyclohexanecarboxylate,,,,,
C22886,N1-[(S)-3-amino-3-carboxypropyl]agmatine;|Carboxyaminopropylagmatine,,,,,
C22887,4-Oxocyclohex-2-ene-1-carboxylate,,,,,
C22888,N-Hydroxyputrescine;|N-(4-Aminobutyl)hydroxylamine,,,,,
C22889,"5,20-Epoxytax-11-en-4alpha-ol;|Oxo-taxadiene-4alpha-ol",,,,,
C22890,3-Hydroxy-3-(4-hydroxyphenyl)propanoate,,,,,
C22891,"5,20-Epoxytax-11-ene-4alpha,9alpha-diol;|Oxo-taxadiene-4alpha,9alpha-diol",,,,,
C22892,3-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)propanoate,,,,,
C22893,Rhazimal,,,,,
C22894,"Talaropentaene;|(3aS,5E,9E)-3a,6,10-Trimethyl-1-[(2xi,4E,8E)-undeca-5,9-dien-2-yl]-3,3a,4,7,8,11,12-octahydrocyclopenta[11]annulene",,,,,
C22895,"Macrophomene;|(1S,22R)-Tricyclo[20.1.0(1,22)]docosa-2,6,10,14,18-pentaene",,,,,
C22896,"Phomopsene;|(1S,6aS,6bR,9aR,10aS)-1,4,7,7,9a-Pentamethyl-1,2,3,5,6,6a,6b,7,8,9,9a,10-dodecahydrodicyclopenta[a,d]indene",,,,,
C22897,"Bonnadiene;|(1R,7R,7aR,11aR)-1,4,9-Trimethyl-7-(propan-2-yl)-2,3,5,6,7,7a,10,11-octahydro-1H-benzo[d]azulene",,,,,
C22898,"Allokutznerene;|(3S,3aS,7aR,10aR,10bS)-3,6,7a,10,10-Pentamethyl-1,2,3,4,5,7,7a,8,9,10,10a,10b-dodecahydrodicyclopenta[d,g]indene",,,,,
C22899,alpha-L-Rhamnosyl-(1->4)-D-glucuronate;|alpha-L-Rhamnosyl-(1->4)-D-glucuronic acid,,,,,
C22900,Fatty acid phytyl ester,Generic compound in reaction hierarchy,,,,
C22901,"Cattleyene;|(3R,3aS,5aS,5bR,8aR)-3,3a,6,6,8a-Pentamethyl-2,3,3a,4,5,5a,5b,6,7,8,8a,9-dodecahydro-1H-pentaleno[2,1-e]indene",,,,,
C22902,"N1-Acetyl-N1-hydroxyputrescine;|N1-Acetyl-N1-hydroxybutane-1,4-diamine",,,,,
C22903,"Ambiguine A;|(6aS,8R,9R,10R,10aS)-8-Chloro-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl)-9-vinyl-2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole",,,,,
C22904,(3R)-3-Methyl-L-arginine,,,,,
C22905,"Ambiguine H;|(6aS,9R,10R,10aS)-9-Ethenyl-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl)-2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole",,,,,
C22906,"Betaine-CoA;|Glycinebetainyl-CoA;|Betainyl-CoA;|N,N,N-Trimethylglycyl-CoA",,,,,
C22907,"(R)-Salsolinol;|(+)-Salsolinol;|(1R)-1,2,3,4-Tetrahydro-1-methylisoquinoline-6,7-diol",,,,,
C22908,(+)-2-epi-Prezizaene,,,,,
C22909,(-)-alpha-Cedrene,,,,,
C22910,"(Z)-beta-Ocimene;|(3Z)-3,7-Dimethyl-1,3,6-octatriene",,,,,
C22911,ent-Beyerene;|ent-Beyer-15-ene;|Beyer-15-ene,,,,,
C22912,Pre-putrebactin;|4-{[4-({4-[(4-Aminobutyl)(hydroxy)amino]-4-oxobutanoyl}amino)butyl](hydroxy)amino}-4-oxobutanoate,,,,,
C22913,"Putrebactin;|1,11-dihydroxy-1,6,11,16-tetraazacycloicosane-2,5,12,15-tetrone",,,,,
C22914,N1-Hydroxy-N1-succinylputrescine,,,,,
C22915,N1-Hydroxy-N1-succinylcadaverine,,,,,
C22916,Bisucaberin B;|Pre-bisucaberin;|3-[(5-{3-[(5-Aminopentyl)(hydroxy)carbamoyl]propanamido}pentyl)(hydroxy)carbamoyl]propanoate,,,,,
C22917,"Bisucaberin;|1,12-Dihydroxy-1,6,12,17-tetrazacyclodocosane-2,5,13,16-tetrone",,,,,
C22918,"(9Z,11E)-12-[(1E)-Hex-1-en-1-yloxy]dodeca-9,11-dienoic acid;|Etheroleic acid",,,,,
C22919,Isobutyraldehyde;|2-Methylpropanal;|2-Methyl-1-propanal,,,,,
C22920,"4-Oxocyclohex-2,5-dienecarboxylate;|4-Oxocyclohexa-2,5-diene-1-carboxylic acid",,,,,
C22921,Lactobionate;|Lactobionic acid;|4-O-beta-D-Galactopyranosyl-D-gluconic acid,,,,,G00916
C22922,17-Dehydropreakuammicine,,,,,
C22923,Norfluorocurarine,,,,,
C22924,18-Hydroxynorfluorocurarine,,,,,
C22925,Wieland-Gumlich aldehyde;|Caracurine VII;|1-Deacetyldiaboline,,,,,
C22926,Diaboline,,,,Secondary metabolites in pathway maps [br08011.html]|Biosynthetic pathways and modules of secondary metabolites|C22926,
C22927,Prestrychnine,,,,,
C22928,Isostrychnine,,,,,
C22929,10-Hydroxystrychnine,,,,,
C22930,beta-Colubrine;|10-Methoxystrychnine,,,,,
C22931,11-Demethylbrucine,,,,,
C22932,"Hydroxycitrate;|Hydroxycitric acid;|1,2-Dihydroxy-1,2,3-propanetricarboxylic acid",,,,,
C22933,Stemmadenine acetate,,,,,
C22934,Precondylocarpine acetate,,,,,
C22935,Dihydroprecondylocarpine acetate,,,,,
C22936,"3,17-Didehydrostemmadenine",,,,,
C22937,17-Dehydrostemmadenine,,,,,
C22938,UDP-N-acetyl-alpha-D-xylosamine,,,,,
C22939,"Chondrochloren A;|(2R,3R,4R,5E,8S,9S,10R)-N-[(Z)-2-(3-Chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide",,,,,
C22940,"Chondrochloren B;|(2R,3R,4R,5E,8S,9S,10R)-N-[(Z)-2-(3-Chloro-4-hydroxyphenyl)ethenyl]-2-ethoxy-3,9-dihydroxy-4-methoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide",,,,,
C22941,1'-Carboxy-chondrochloren A,,,,,
C22942,1'-Carboxy-chondrochloren B,,,,,
C22943,"3-Amino-1,5-dihydropyridine-2,6-dione",,,,,
C22944,"Indigoidine;|3-(5-Amino-2-hydroxy-6-oxo-1H-pyridin-3-yl)-5-iminopyridine-2,6-dione",,,,,
C22945,4-Methylajmaline;|Nbeta-Methylajmaline,,,,,
C22946,"(2R,3R,5S)-2-(S-Pantetheinyl)-carbapenam-3-carboxylate",,,,,
C22947,"(2R,3R,5S,6R)-6-(Methyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate",,,,,
C22948,"(2R,3R,5S,6R)-6-(Ethyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate",,,,,
C22949,5'-Deoxyadenosin-5'-yl radical,,,,,
C22950,Rhazimol,,,,,
C22951,Akuammiline,,,,,
C22952,"4'-Phosphooxetanocin A;|[(2S,3R,4R)-4-(6-Aminopurin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl phosphate",,,,,
C22953,"Oxetanocin A;|[(2S,3R,4R)-4-(6-Aminopurin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methanol",,,,,
C22954,[Protein] with lanthionine crosslink,Generic compound in reaction hierarchy,,,,
C22955,[Protein] with 3-methyllanthionine crosslink,Generic compound in reaction hierarchy,,,,
C22956,[Protein]-(Z)-2-aminobutenoate,Generic compound in reaction hierarchy,,,,
C22957,beta-D-Galactofuranoside,Generic compound in reaction hierarchy,,,,
C22958,beta-D-Galf-(1->5)-beta-D-galactofuranoside,Generic compound in reaction hierarchy,,,,
C22959,4'-Phospho-dehydrooxetanocin,,,,,
C22960,Dehydrosecodine,,,,,
C22961,17-Dehydropreakuammicine hydrate,,,,,
C22962,"(20S)-19,20-Dihydrovomilenine",,,,,
C22963,C22963;|GPI-anchor biosynthesis intermediate 1,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl|R2 = unsaturated fatty acyl,,,,G13046
C22964,C22964;|GPI-anchor biosynthesis intermediate 2,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl,,,,G13046
C22965,C22965;|GPI-anchor biosynthesis intermediate 3,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl,,,,G13046
C22966,C22966;|GPI-anchor biosynthesis intermediate 4,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl|R2 = unsaturated fatty acyl,,,,G13353
C22967,C22967;|GPI-anchor biosynthesis intermediate 5,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl,,,,G13353
C22968,C22968;|GPI-anchor biosynthesis intermediate 6,Generic compound in reaction hierarchy|R = protein|R1 = fatty acyl,,,,G13353
C22969,Unsaturated fatty acid,Generic compound in reaction hierarchy|R = unsaturated chain,,,,
C22970,C22970;|GPI-anchor biosynthesis intermediate 7,Generic compound in reaction hierarchy|R = unsaturated fatty acyl|R1 = fatty acyl|R2 = protein,,,,G13150
C22971,C22971;|GPI-anchor biosynthesis intermediate 8,Generic compound in reaction hierarchy|R = unsaturated fatty acyl|R1 = fatty acyl|R2 = protein,,,,G13151
C22972,C22972;|GPI-anchor biosynthesis intermediate 9,Generic compound in reaction hierarchy|R = unsaturated fatty acyl|R1 = fatty acyl|R2 = protein,,,,G00142
C22973,UDP-yelosamine;|UDP-N-acetyl-D-fucosamine-4N-(2)-oxoglutarate;|UDP-D-FucNAc-4N-(2)-oxoglutarate,,,,,
C22974,"ditrans,polycis-Polyprenal",Generic compound in reaction hierarchy,,,,
C22975,Dolichal,Generic compound in reaction hierarchy,,,,
C22976,(Z)-(2-Aminovinyl)sulfanolate,,,,,
C22977,(Z)-2-Aminoethene-1-sulfonate,,,,,
C22978,2-Oxoethane-1-sulfonamide;|2-Sulfamoylacetaldehyde,,,,,
C22979,CMP-N-acetyl-9-O-acetyl-beta-neuraminate,,,,,
C22980,4-Nitro-L-tryptophan,,,,,
C22981,3-Nitro-L-tyrosine,,,,,
C22982,2'-N-Hydroxynocardicin C,,,,,
C22983,"2'-N,N-Dihydroxynocardicin C",,,,,
C22986,3'-Hydroxyisoflavone,Generic compound in reaction hierarchy,,,,
C22987,3'-Methoxyisoflavone,Generic compound in reaction hierarchy,,,,
C22988,4'-O-Methyl-trans-resveratrol,,,,,
C22989,N-Amidino-L-valine,,,,,
C22990,Nalpha-Amidino-L-arginine,,,,,
C22991,"3,5-Dicaffeoylquinate;|3,5-Dicaffeoylquinic acid",,,,,
C22992,11-Methyldodecanoyl-[acp],Generic compound in reaction hierarchy,,,,
C22993,N-(11-Methyldodecanoyl)-L-phenylalanine,,,,,
C22994,(3R)-3-Methyl-L-phenylalanyl-[peptidyl carrier-protein],Generic compound in reaction hierarchy,,,,
C22995,"(Sulfonamide-N)(L-isoleucyl)altemicidin;|SB-203207;|4-(Aminocarbonyl)-7-[[(2-amino-3-methylpentanoyl)aminosulphonyl]acetamido]-2,4a,5,6,7,7a-hexahydro-6-hydroxy-2-methyl-1H-2- pyrindine-7-carboxylate",,,,,
C22996,"SB-203208;|4-(Aminocarbonyl)-7-[[(2-amino-3-methyl pentanoyl)-aminosulphonyl]acetamido]-2,4a,5,6,7,7a-hexahydro-6-(2- amino-3-phenylbutanoyl oxy)-2-methyl-1H-2-pyrindine-7-carboxylate",,,,,
C22997,"Altemicidin;|(4aR,6S,7R,7aS)-4-Carbamoyl-6-hydroxy-2-methyl-7-[(2-sulamoylacetyl)amino]-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyridine-7-carboxylate",,,,,
C22998,"(4aR,7S)-2-(Adenosyl(5')diphospho(5)ribosyl)-7-amino-4-carbamoyl-4a,5,6,7-tetrahydro-2H-cyclopenta[c]pyridine-7-carboxylate",,,,,
C22999,2-Fluorodeschloroketamine;|Fluoroketamine;|2-(2-Fluorophenyl)-2-(methylamino)cyclohexanone,,,,,
C23000,"4-Hydroxy-4alpha,5beta-5,20-epoxytax-11-en-9-one;|Oxo-taxadiene-4alpha-ol-9-one",,,,,
C23001,3-Aminopropyl(dimethyl)sulfanium;|Dimethylsulfoniopropanoate-amine;|DMSP-amine,,,,,
C23002,3-Dimethylsulfoniopropionaldehyde;|3-Dimethylsulfoniopropanal;|DMSP-aldehyde,,,,,
